<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0703233338
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2023
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Trijan
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        TOFACITINIB
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        56
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        3716.05
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            The Arab Pharmaceutical Manufacturing PSC (Sahab) Co Ltd 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 441]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)	
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        L04AA29
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Trijan is a medicine that contains the active substance tofacitinib.</p><p>&nbsp;</p><p>Trijan is used for the treatment of the following inflammatory diseases:</p><p>&middot;&nbsp;&nbsp;&nbsp; Rheumatoid arthritis</p><p>&middot;&nbsp;&nbsp;&nbsp; Psoriatic arthritis</p><p>&middot;&nbsp;&nbsp;&nbsp; Ulcerative colitis</p><p>&nbsp;</p><p><strong>Rheumatoid arthritis </strong></p><p>Trijan is used to treat adult patients with moderate to severe active rheumatoid arthritis, a long-term disease that mainly causes pain and swelling of your joints.</p><p>&nbsp;</p><p>Trijan is used together with methotrexate when previous rheumatoid arthritis treatment was not sufficient or was not well tolerated. Trijan can also be taken on its own in those cases where methotrexate treatment is not tolerated or treatment with methotrexate is not advised.</p><p>&nbsp;</p><p>Tofacitinib<strong> </strong>has been shown to reduce pain and swelling of the joints and improve the ability to perform daily activities, when given on its own or together with methotrexate.</p><p><strong>&nbsp;</strong></p><p><strong>Psoriatic arthritis </strong></p><p>Trijan is used to treat a condition called psoriatic arthritis. This condition is an inflammatory disease of the joints, often accompanied by psoriasis. If you have active psoriatic arthritis you will be first given another medicine to treat your psoriatic arthritis. If you do not respond well enough or the medicine is not tolerated, you may be given Trijan to reduce the sign and symptoms of active psoriatic arthritis and improve the ability to perform daily activities.</p><p>&nbsp;</p><p>Trijan is used together with methotrexate to treat adult patients with active psoriatic arthritis.</p><p>&nbsp;</p><p><strong>Ulcerative colitis </strong></p><p>Ulcerative colitis is an inflammatory disease of the large bowel. Trijan is used to reduce the signs and symptoms of ulcerative colitis when you did not respond well enough or were intolerant to previous ulcerative colitis treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Trijan:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; If you are allergic to tofacitinib or any of the other ingredients of this medicine (listed in section 6)</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have a severe infection such as bloodstream infection or active tuberculosis</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have been informed that you have severe liver problems, including cirrhosis (scarring of the liver)</p><p>&middot;&nbsp;&nbsp;&nbsp; If you are pregnant or breast-feeding</p><p>&nbsp;</p><p>Don&rsquo;t take Trijan 10 mg twice daily if you have any of the following conditions:</p><p>&middot;&nbsp;&nbsp;&nbsp; Are taking combined hormonal contraceptives or hormone replacement therapy</p><p>&middot;&nbsp;&nbsp;&nbsp; Have heart failure (when the heart does not work as well as it should)</p><p>&middot;&nbsp;&nbsp;&nbsp; Have had blood clots in the veins</p><p>&middot;&nbsp;&nbsp;&nbsp; Have cancer</p><p>&middot;&nbsp;&nbsp;&nbsp; Will have or have recently had major surgery</p><p>&nbsp;</p><p>If you are not sure regarding any of the information provided above, please contact your doctor.</p><p>&nbsp;</p><p><strong>Warnings and Precautions </strong></p><p>Talk to your doctor or pharmacist before taking Trijan:</p><p>&middot;&nbsp;&nbsp;&nbsp; If you think you have an infection or have symptoms of an infection such as fever, sweating, chills, muscle aches, cough, shortness of breath, new phlegm or change in phlegm, weight loss, warm or red or painful skin or sores on your body, difficulty or pain when swallowing, diarrhoea or stomach pain, burning when you urinate or urinating more often than normal, feeling very tired</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have any condition that increases your chance of infection (e.g., diabetes, HIV/AIDS, or a weak immune system)</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have any kind of infection, are being treated for any infection, or if you have infections that keep coming back. Tell your doctor immediately if you feel unwell. Trijan can reduce your body&rsquo;s ability to respond to infections and may make an existing infection worse or increase the chance of getting a new infection</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have or have a history of tuberculosis or have been in close contact with someone with tuberculosis. Your doctor will test you for tuberculosis before starting Trijan and may retest during treatment</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have any chronic lung disease</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have liver problems</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have or had hepatitis B or hepatitis C (viruses that affect the liver). The virus may become active while you are taking Trijan. Your doctor may do blood tests for hepatitis before you start treatment with Trijan and while you are taking Trijan</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have ever had any type of cancer. Trijan may increase your risk of certain cancers. Lymphoma and other cancers (such as lung, breast, melanoma, prostate and pancreatic) have been reported in patients treated with tofacitinib. If you develop cancer while taking Trijan your doctor will review whether to stop Trijan treatment</p><p>&middot;&nbsp;&nbsp;&nbsp; If you are at high risk of developing skin cancer, your doctor may recommend that you have regular skin examinations while taking Trijan.</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have had diverticulitis (a type of inflammation of the large intestine) or ulcers in stomach or intestines (see section 4)</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have kidney problems</p><p>&middot;&nbsp;&nbsp;&nbsp; If you are planning to get vaccinated, tell your doctor. Certain types of vaccines should not be given when taking Trijan. Before you start Trijan, you should be up to date with all recommended vaccinations. Your doctor will decide whether you need to have herpes zoster vaccination</p><p>&middot;&nbsp;&nbsp;&nbsp; If you have heart problems, high blood pressure, or high cholesterol</p><p>&nbsp;</p><p>There have been reports of patients treated with tofacitinib who have developed blood clots. Talk to your doctor if you smoke. He / she will also evaluate whether your body weight, age, or problems being mobile will affect your risk to develop blood clots.</p><p>&nbsp;</p><p><em>Additional monitoring tests </em></p><p>Your doctor should perform blood tests before you start taking Trijan, and after 4 to 8 weeks of treatment and then every 3 months, to determine if you have a low white blood cell (neutrophil or lymphocyte) count, or a low red blood cell count (anaemia).</p><p>&nbsp;</p><p>You should not receive Trijan if your white blood cell (neutrophil or lymphocyte) count or red blood cell count is too low. If needed, your doctor may interrupt your Trijan treatment to reduce the risk of infection (white blood cell counts) or anaemia (red blood cell counts).</p><p>&nbsp;</p><p>Your doctor may also perform other tests, for example to check your blood cholesterol levels or monitor the health of your liver. Your doctor should test your cholesterol levels 8 weeks after you start receiving Trijan. Your doctor should perform liver tests periodically.</p><p>&nbsp;</p><p><strong>Elderly </strong></p><p>There is a higher rate of infections in patients aged 65 years and older. Tell your doctor as soon as you notice any signs or symptoms of infections.</p><p>&nbsp;</p><p><strong>Asian patients </strong></p><p>There is a higher rate of shingles in Japanese and Korean patients. Tell your doctor if you notice any painful blisters on your skin.</p><p>&nbsp;</p><p>You may also be at higher risk of certain lung problems. Tell your doctor if you notice any breathing difficulties.</p><p>&nbsp;</p><p><strong>Children and adolescents</strong></p><p>Tofacitinib<strong> </strong>is not recommended for use in children or adolescents under 18 years of age. The safety and benefits of tofacitinib<strong> </strong>in children or adolescents have not yet been established.</p><p><strong>&nbsp;</strong></p><p><strong>Other medicines and Trijan</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>&nbsp;</p><p>Trijan may be used in combination with methotrexate or sometimes alone when used to treat rheumatoid arthritis. In general, fewer side effects were seen when tofacitinib<strong> </strong>was used alone in rheumatoid arthritis.</p><p>&nbsp;</p><p>Some medicines should not be taken with Trijan. If taken with Trijan, they could alter the level of Trijan in your body, and the dose of Trijan may require adjustment. You should tell your doctor if you are using medicines (taken by mouth) that contain any of the following active substances:</p><p>&middot;&nbsp;&nbsp;&nbsp; Antibiotics such as clarithromycin and rifampicin, used to treat bacterial infections</p><p>&middot;&nbsp;&nbsp;&nbsp; Fluconazole, ketoconazole, clotrimazole, itraconazole, and voriconazole, used to treat fungal infections</p><p>&nbsp;</p><p>Trijan is not recommended for use with medicines that depress the immune system, including so-called targeted biologic (antibody) therapies, such as those that inhibit tumour necrosis factor, interleukin-17, interleukin-12/interleukin-23, anti-integrins, and strong chemical immunosuppressants including azathioprine, mercaptopurine, ciclosporine, and tacrolimus. Taking Trijan with these medicines may increase your risk of side effects including infection.</p><p>&nbsp;</p><p>Serious infections may happen more often in people who also take corticosteroids (e.g., prednisone).</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility </strong></p><p>If you are a woman of childbearing age, you should use effective birth control during treatment with Trijan and for at least 4 weeks after the last dose.</p><p><strong>&nbsp;</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Trijan must not be used during pregnancy. Tell your doctor right away if you become pregnant while taking Trijan.</p><p>&nbsp;</p><p>If you are taking Trijan and breast-feeding, you must stop breast-feeding until you talk to your doctor about stopping treatment with Trijan.</p><p>&nbsp;</p><p><strong>Driving and using machines </strong></p><p>Tofacitinib<strong> </strong>has no or limited effect on your ability to drive or use machines.</p><p>&nbsp;</p><p><strong>Trijan </strong><strong>contains lactose</strong></p><p>Trijan contains lactose. Each 5 mg and 10 mg film-coated tablet contain 59 mg or 118 mg lactose; respectively.</p><p>&nbsp;</p><p>If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine is provided to you and supervised by a specialised doctor who knows how to treat your condition.</p><p>&nbsp;</p><p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p><strong>Rheumatoid arthritis </strong></p><p>&middot;&nbsp;&nbsp;&nbsp; The recommended dose is 5 mg twice a day.</p><p>&nbsp;</p><p><strong>Psoriatic arthritis </strong></p><p>&middot;&nbsp;&nbsp;&nbsp; The recommended dose is 5 mg twice a day.</p><p>&nbsp;</p><p><strong>Ulcerative colitis</strong></p><p>&middot;&nbsp; &nbsp;The recommended dose is 10 mg twice a day for 8 weeks, followed by 5 mg twice a day.</p><p>&middot;&nbsp; &nbsp;Your doctor may decide to extend the initial 10 mg twice a day treatment by an additional 8 weeks (16 weeks in total), followed by 5 mg twice a day.</p><p>&middot;&nbsp; &nbsp;Your doctor may decide to stop Trijan if Trijan does not work for you within 16 weeks.</p><p>&middot;&nbsp; &nbsp;For patients, who have previously taken biologic medicines to treat ulcerative colitis (such as those that block the activity of tumour necrosis factor in the body) and these medicines did not work, the doctor may decide to continue giving 10 mg twice a day. Your doctor will tell you if this applies to you.</p><p>&middot;&nbsp; &nbsp;If maintaining Trijan 5 mg twice a day did not work for you, your doctor may decide to increase the dose to 10 mg twice a day.</p><p>&middot;&nbsp; If your treatment is interrupted, your doctor may decide to restart your treatment.</p><p>&nbsp;</p><p>Try to take your tablet at the same time every day (one tablet in the morning and one tablet in the evening).</p><p>&nbsp;</p><p>Your doctor may reduce the dose if you have liver or kidney problems or if you are prescribed certain other medicines. Your doctor may also stop treatment temporarily or permanently if blood tests show low white blood cell or red blood cell counts.</p><p>&nbsp;</p><p>Trijan is for oral use. You can take Trijan with or without food.</p><p>&nbsp;</p><p><strong>If you take more </strong><strong>Trijan </strong><strong>than you should</strong></p><p>If you take more tablets than you should, immediately tell your doctor or pharmacist.</p><p>&nbsp;</p><p><strong>If you forget to take </strong><strong>Trijan</strong></p><p>Do not take a double dose to make up for a forgotten tablet. Take your next tablet at the usual time and continue as before.</p><p>&nbsp;</p><p><strong>If you stop taking </strong><strong>Trijan</strong></p><p>You should not stop taking Trijan without discussing this with your doctor.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>Some may be serious and need medical attention.</p><p>&nbsp;</p><p><strong><em>Possible serious side effects </em></strong></p><p>In rare cases, infection may be life-threatening.</p><p>&nbsp;</p><p>If you notice any of the following serious side effects you need to tell a doctor straight away.</p><p>&nbsp;</p><p><strong>Signs of serious infections (common) include</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; Fever and chills</p><p>&middot;&nbsp;&nbsp;&nbsp; Cough</p><p>&middot;&nbsp;&nbsp;&nbsp; Skin blisters</p><p>&middot;&nbsp;&nbsp;&nbsp; Stomach ache</p><p>&middot;&nbsp;&nbsp;&nbsp; Persistent headaches</p><p>&nbsp;</p><p><strong>Signs of allergic reactions (rare) include</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; Chest tightness</p><p>&middot;&nbsp;&nbsp;&nbsp; Wheezing</p><p>&middot;&nbsp;&nbsp;&nbsp; Severe dizziness or light-headedness</p><p>&middot;&nbsp;&nbsp;&nbsp; Swelling of the lips, tongue or throat</p><p>&middot;&nbsp;&nbsp;&nbsp; Hives (itching or skin rash)</p><p>&nbsp;</p><p><strong>Signs of stomach problems (uncommon: ulcers or holes in your stomach or intestines) include</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; Fever</p><p>&middot;&nbsp;&nbsp;&nbsp; Stomach or abdominal pain</p><p>&middot;&nbsp;&nbsp;&nbsp; Blood in the stool</p><p>&middot;&nbsp;&nbsp;&nbsp; Unexplained changes in bowel habits</p><p>&nbsp;</p><p>Holes in stomach or intestines happen most often in people who also take nonsteroidal anti-inflammatory drugs or corticosteroids (e.g., prednisone).</p><p>&nbsp;</p><p><strong><em>Other side effects which have been observed with </em></strong><strong><em>t</em></strong><strong><em>ofacitinib are listed below.</em></strong></p><p>&nbsp;</p><p><strong>Common </strong>(may affect up to 1 in 10 people): lung infection (pneumonia and bronchitis), shingles (herpes zoster), infections of nose, throat or the windpipe (nasopharyngitis), influenza, sinusitis, urinary bladder infection (cystitis), sore throat (pharyngitis), increased muscle enzymes in the blood (sign of muscle problems), stomach (belly) pain (which may be from inflammation of the stomach lining), vomiting, diarrhoea, feeling sick (nausea), indigestion, joint sprain, low red blood cell count (anaemia), fever, fatigue (tiredness), swelling of the feet and hands, headache, high blood pressure (hypertension), cough, rash.</p><p>&nbsp;</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people): tuberculosis, kidney infection, skin infection, herpes simplex or cold sores (oral herpes), low white blood cell counts, increased liver enzymes in the blood (sign of liver problems), blood creatinine increased (a possible sign of kidney problems), increased cholesterol, weight gain, dehydration, muscle strain, pain in the muscles and joints, tendonitis, joint swelling, abnormal sensations, poor sleep, sinus congestion, shortness of breath or difficulty breathing, skin redness, itching, fatty liver, painful inflammation of small pockets in the lining of your intestine (diverticulitis), viral infections, viral infections affecting the gut, some types of skin cancers (non-melanoma-types).</p><p>&nbsp;</p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people): blood infection (sepsis), disseminated tuberculosis involving bones and other organs, other unusual infections, joint infections.</p><p>&nbsp;</p><p><strong>Very rare </strong>(may affect up to 1 in 10,000 people): tuberculosis involving the brain and spinal cord, meningitis.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not store above 30&deg;C.</p><p>Store in the original package in order to protect from moisture.</p><p>Do not use this medicine after the expiry date which is stated on the carton after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.</p><p>Do not use this medicine if you notice the tablets show visible signs of deterioration (for example, are broken or discoloured).</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is tofacitinib citrate.</p><p>&nbsp;</p><p>Each film-coated tablet of Trijan 5 mg Film-coated Tablets contains 8.08 mg tofacitinib citrate equivalent to 5 mg tofacitinib.</p><p>&nbsp;</p><p>Each film-coated tablet of Trijan 10 mg Film-coated Tablets contains 16.16 mg tofacitinib citrate equivalent to 10 mg tofacitinib.</p><p>&nbsp;</p><p>The other ingredients are: <em>Tablet core:</em> Microcrystalline cellulose, lactose, croscarmellose sodium and magnesium stearate. <em>Tablet coat:</em> Opadry white.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Trijan 5 mg Film-coated Tablets are white to off-white round film-coated tablets embossed with “SP04” on one side in aluminum/aluminum blisters.

Pack size:
60 film-coated tablets.

Trijan 10 mg Film-coated Tablets are white to off-white oval biconcave shaped film-coated tablets embossed with “W215” on one side in aluminum/aluminum blisters.

Pack size:
56 film-coated tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder</strong></p><p>Jazeera Pharmaceutical Industries<br />Al-Kharj Road<br />P.O. BOX 106229<br />Riyadh 11666, Saudi Arabia<br />Tel: + (966-11) 8107023, + (966-11) 2142472<br />Fax: + (966-11) 2078170<br />e-mail: jpimedical@hikma.com</p><p>&nbsp;</p><p><strong>Manufacturer</strong></p><p>The Arab Pharmaceutical Manufacturing PSC<br />Sahab<br />Industrial City<br />P.O. Box 41<br />Amman 11512, Jordan<br />Tel: + (962-6) 4023916<br />Fax: + (962-6) 4023917</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can also help provide more information on the safety of this medicine.</p><ul><li>&nbsp; &nbsp; Saudi Arabia</li></ul><p>The National Pharmacovigilance Centre (NPC)</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><ul><li>&nbsp; &nbsp; Other GCC States</li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 11/2019; version number SA1.0.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ترايجان هو دواء يحتوي على المادة الفعّالة توفاسيتينيب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يستخدم ترايجان لعلاج الأمراض الالتهابية التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; التهاب المفاصل الروماتويدي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; التهاب المفاصل الصدفي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; التهاب القولون التقرحي</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التهاب المفاصل الروماتويدي </strong></p><p dir="RTL">يستخدم ترايجان لعلاج المرضى البالغين الذين يعانون من التهاب المفاصل الروماتويدي المتوسط إلى الشديد، وهو مرض طويل الأمد يسبب بصورة رئيسية ألماً وتورماً في المفاصل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتم تناول ترايجان وميثوتركسيت معاً في حال كان علاج التهاب المفاصل الروماتويدي السابق غير كافٍ أو لم يتم تحمله جيدًا. يمكن تناول ترايجان وحده أيضًا في تلك الحالات، حيث لا يمكن تحمل علاج ميثوتركسيت أو لا ينصح بالعلاج مع ميثوتركسيت.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أظهر توفاسيتينيب أنه يقلل ألم وتورم المفاصل ويعمل على تحسين القدرة على أداء الأنشطة اليومية، عندما يتم تناوله بمفرده أو مع ميثوتركسيت.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>التهاب المفاصل الصدفي </strong></p><p dir="RTL">يستخدم ترايجان في علاج حالة تسمى التهاب المفاصل الصدفي. هذه الحالة هي مرض التهابي في المفاصل، يرافقه مرض الصدفية غالبًا. إذا كنت تعاني من التهاب المفاصل الصدفي النشط، فسيتم إعطاؤك دواءً آخر لعلاج التهاب المفاصل الصدفي. إذا لم تستجب بالصورة الكافية للعلاج أو لم تتحمله، فسيتم إعطاؤك ترايجان لتقليل علامات وأعراض التهاب المفاصل الصدفي النشط ولتحسين القدرة على أداء الأنشطة اليومية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتم تناول ترايجان مع ميثوتركسيت لعلاج البالغين المصابين بالتهاب المفاصل الصدفي النشط.</p><p dir="RTL"><strong>التهاب القولون التقرحي </strong></p><p dir="RTL">التهاب القولون التقرحي هو مرض التهابي في الأمعاء الغليظة. يستخدم ترايجان لتقليل علامات وأعراض التهاب القولون التقرحي عندما لا تستجيب للعلاج السابق لالتهاب القولون التقرحي بصورة كافية أو عند عدم تحمله.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول ترايجان:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه توفاسيتينيب أو لأي من المواد الأخرى المستخدمة في تركيبة هذا الدواء (المذكورة في القسم 6)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من عدوى خطيرة مثل عدوى مجرى الدم أو السلّ النشط</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا تم إعلامك بأنك تعاني من مشاكل شديدة في الكبد، بما في ذلك تليف الكبد (تندب الكبد)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنتِ حاملاً أو مرضعًا</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتناول ترايجان 10 ملغم مرتين يوميًا إذا انطبقت عليك أي من الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تستخدم وسائل منع الحمل الهرمونية المجمعة أو علاج باستبدال الهرمونات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تعاني من قصور القلب (عندما لا يعمل القلب بالصورة الطبيعية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; أصبت سابقاً بتجلط الدم في الأوردة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; مصاب بالسرطان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ستجري أو قمت بإجراء عملية جراحية كبيرة</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لم تكن متأكدًا بخصوص أي من المعلومات المذكورة أعلاه، يرجى الاتصال بطبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات والتحذيرات </strong></p><p dir="RTL">تحدث مع طبيبك أو الصيدلي قبل تناول ترايجان:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعتقد أنك مصابًا بعدوى أو لديك أعراض عدوى مثل الحمّى، التعرّق، القشعريرة، آلام العضلات، السعال، ضيق التَّنفس، بلغم مستجد أو تغير في هيئة البلغم، فقدان الوزن، سخونة أو احمرار أو آلام بالجلد أو تقرحات على جسمك، صعوبة أو ألم عند البلع، إسهال أو آلام المعدة، الحرقان أثناء التبول أو التبول بصورة أكثر من الطبيعي، الشعور بالإرهاق الشديد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حالة تزيد من فرص إصابتك بالعدوى (على سبيل المثال، مرض السكري أو عوز المناعة البشري/الإيدز أو جهاز مناعي ضعيف)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من أي نوع من أنواع العدوى، أو إذا كنت تُعالج من حالة عدوى، أو إذا كنت تعاني من عدوى تستمر في العودة. أخبر طبيبك على الفور إذا شعرت بالتوعك. يمكن أن يقلل ترايجان من قدرة جسمك على الاستجابة للعدوى وقد يجعل حالة العدوى الموجودة أكثر تدهورًا أو يزيد من فرصة الإصابة بعدوى جديدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من السلّ أو عانيت مسبقًا منه أو كنت على اتصال قريب من شخص مصاب بالسلّ. سيجري الطبيب اختبار لك لعلاج السلّ قبل تناول ترايجان وقد يعيد الفحص أثناء العلاج</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من أي مرض من أمراض الرئة المزمن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل في الكبد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أو عانيت من التهاب الكبد الوبائي B أو C (الفيروسات التي تصيب الكبد). قد يصبح الفيروس نشطاً أثناء تناول ترايجان. قد يجري طبيبك فحوصات الدم للكشف عن التهاب الكبد الوبائي قبل البدء في العلاج بترايجان وأثناء تناول ترايجان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا عانيت من قبل من أي نوع من أنواع السرطان. قد يزيد ترايجان من خطورة أنواع معينة من السرطانات. وتم الإبلاغ عن سرطان الغدد الليمفاوية وأنواع سرطانات أخرى (مثل الرئة، والثدي، والورم الميلانيني، والبروستاتة، والبنكرياس) في المرضى الذين تم علاجهم بتوفاسيتينيب. إذا أصبت بالسرطان أثناء تناول ترايجان، سيقرر طبيبك إذا ما كنت ستتوقف عن العلاج بترايجان أم لا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت معرّضاً بشكل كبير للإصابة بسرطان الجلد، قد يوصيك الطبيب بأن تُجري فحوصات للجلد بانتظام أثناء تناول ترايجان.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا عانيت مسبقًا من الرداب القولوني (نوع من التهاب الأمعاء الغليظة) أو تقرحات في المعدة أو الأمعاء (انظر القسم 4)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل في الكلى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تخطط للحصول على لقاح، يرجى إخبار طبيبك. يجب عدم استخدام أنواع معينة من اللقاحات أثناء تناول ترايجان. قبل البدء باستخدام ترايجان، يجب أن تكون على دراية بآخر المستجدات المتعلقة باللقاحات الموصى بها. سيقرر الطبيب إذا ما كنت في حاجة إلى استخدام لقاح لفيروس الهربس النطاقي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل في القلب، أو ارتفاع ضغط الدم، أو ارتفاع الكوليسترول</p><p dir="RTL">&nbsp;</p><p dir="RTL">هناك تقارير تفيد أن هناك مرضى تم علاجهم باستخدام توفاسيتينيب لأنهم قد أُصيبوا بجلطات دموية. أخبر طبيبك إذا كنت مدخنًا. سيقوم أيضًا بتقييم إذا ما كان وزن جسمك أو عمرك أو المشاكل التي جرى نقلها ستؤثر في خطورة الإصابة بجلطات دموية أم لا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>اختبارات المتابعة الإضافية </em></p><p dir="RTL">يجب على طبيبك إجراء فحوصات الدم قبل تناول ترايجان، وبعد 4 إلى 8 أسابيع من العلاج ثم كل 3 أشهر لتحديد إذا ما كنت تعاني من انخفاض عدد خلايا الدم البيضاء (الخلايا الحبيبية المتعادلة أو الخلايا الليمفاوية) أو انخفاض عدد كريات الدم الحمراء (الأنيميا).</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب ألا تتلقى ترايجان إذا كان عدد خلايا الدم البيضاء (الخلايا الحبيبية المتعادلة أو الخلايا الليمفاوية) أو عدد كريات الدم الحمراء منخفضاً جدًا. لكن إذا لزم الأمر، قد يوقف الطبيب العلاج باستخدام ترايجان لتقليل خطورة العدوى (عدد خلايا الدم البيضاء) أو الأنيميا (عدد خلايا الكريات الحمراء).</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يجري الطبيب أيضًا فحوصات أخرى، على سبيل المثال لفحص مستويات الكولسترول في الدم أو متابعة حالة الكبد. يجب أن يجري طبيبك فحصًا لمستويات الكولسترول لمدة 8 أسابيع عقب البدء في تناول ترايجان. يجب أن يجري طبيبك فحوصات للكبد بصورة دورية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>كبار السن </strong></p><p dir="RTL">يزداد احتمال الإصابة بالعدوى في المرضى الذين يبلغون من العمر 65 عامًا أو أكثر. أبلغ طبيبك بأسرع ما يمكن فور ملاحظة أي علامات أو أعراض للعدوى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>المرضى الآسيويون </strong></p><p dir="RTL">يزداد احتمال الإصابة بالحزام الناري في المرضى اليابانيين والكوريين. أخبر طبيبك إذا لاحظت ظهور أي بثور مؤلمة على الجلد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تكون أكثر عرضة أيضًا للإصابة بمشاكل معينة بالرئة. أخبر طبيبك إذا لاحظت ظهور أي صعوبات في التنفس.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأطفال والمراهقين</strong></p><p dir="RTL">يوصى بعدم استخدام توفاسيتينيب<strong> </strong>من قبل الأطفال أو المراهقين دون سن 18 عامًا. لم تثبت بعد سلامة وفوائد استخدام توفاسيتينيب لدى الأطفال أو المراهقين.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأدوية الأخرى وترايجان</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تأخذ، أخذت مؤخراً، أو قد تأخذ أية أدوية أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يستخدم ترايجان مع ميثوتركسيت أو أحيانًا بمفرده عند استخدامه لعلاج التهاب المفاصل الروماتويدي. وبوجه عام، تظهر بعض الآثار الجانبية عند استخدام توفاسيتينيب بمفرده لعلاج التهاب المفاصل الروماتويدي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب ألا تُستخدم بعض الأدوية مع ترايجان. إذا استخدمت أدوية مع ترايجان، فإنها قد تغير مستوى ترايجان في جسمك وقد يتطلب تغيير جرعة ترايجان. يجب عليك إبلاغ طبيبك إذا كنت تستخدم أدوية (تؤخذ عن طريق الفم) تحتوي على أي من المواد الفعّالة التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; مضادات حيوية مثل كلاريثرومايسين أو ريفامبيسين تستخدم في علاج العدوى البكتيرية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; فلوكونازول، كيتوكونازول، كلوتريمازول، إيتراكونازول، وفوريكونازول، تستخدم في علاج العدوى الفطرية</p><p dir="RTL">&nbsp;</p><p dir="RTL">يوصى بعدم استخدام ترايجان مع الأدوية التي تثبط جهاز المناعة، بما في ذلك ما يسمى بالعلاجات البيولوجية الموجَّهة (الأجسام المضادة)، مثل تلك التي تثبط نشاط عامل نخر الورم، إنترلوكين-17، وإنترلوكين-12/إنترلوكين-23، ومضادات الانتيغرين، وكابتات المناعة الكيميائية القوية بما في ذلك أزاثيوبرين، وميركابتوبورين، وسيكلوسبورين، وتاكروليمس. قد يزيد تناول ترايجان مع هذه الأدوية من خطورة الآثار الجانبية بما في ذلك العدوى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تحدث عدوى خطيرة غالبًا في الأشخاص الذي يتناولون أيضًا الستيرويدات القشرية (بريدنيزون على سبيل المثال).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل، الرضاعة والخصوبة</strong></p><p dir="RTL">إذا كنتِ سيدة في سن الإنجاب، يجب أن تستخدمي وسيلة فعّالة لتحديد النسل أثناء العلاج بترايجان ولمدة 4 أسابيع بعد آخر جرعة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">يرجى استشارة طبيبك أو الصيدلي قبل تناول هذا الدواء إذا كنت حاملاً أو مرضع، أو تعتقدين بأنك حاملاً أو تخططين لذلك. ينبغي عدم استخدام ترايجان أثناء الحمل. أخبري طبيبك على الفور إذا أصبحتِ حاملاً أثناء تناول ترايجان.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنتِ تتناولين ترايجان وكنتِ ترضعين طبيعياً، فيجب التوقف عن الرضاعة الطبيعية حتى تخبري طبيبكِ بشأن إيقاف العلاج بترايجان.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير ترايجان على القيادة واستخدام الآلات </strong></p><p dir="RTL">لا يوجد أثر لتوفاسيتينيب أو يوجد أثر محدود على قدرتك على القيادة أو استخدام الآلات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>يحتوي ترايجان على اللاكتوز</strong></p><p dir="RTL">يحتوي ترايجان على اللاكتوز. يحتوي كل قرص مغطى بطبقة رقيقة من 5 ملغم و10 ملغم على 59 ملغم أو 118 ملغم لاكتوز؛ على التوالي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان طبيبك قد أخبرك بأنك تعاني من حساسية شديدة تجاه بعض السكريات، فاستشره قبل تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتم تقديم هذا الدواء لك والإشراف عليه من قبل طبيب متخصص يعرف كيفية علاج حالتك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قم دائماً بتناول دوائك كما وصفه لك طبيبك تماماً. تأكد من طبيبك أو الصيدلي إذا كانت لديك أية استفسارات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التهاب المفاصل الروماتويدي </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الجرعة الموصى بها هي 5 ملغم مرتين يومياً.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التهاب المفاصل الصدفي </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الجرعة الموصى بها هي 5 ملغم مرتين يومياً.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التهاب القولون التقرحي</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الجرعة الموصى بها هي 10 ملغم مرتين يومياً لمدة 8 أسابيع، تليها 5 ملغم مرتين يومياً.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; قد يقرر طبيبك تمديد فترة العلاج الأولي باستخدام 10 ملغم مرتين يومياً لمدة 8 أسابيع إضافية (إجمالي 16 أسبوعاً)، تليها 5 ملغم مرتين يومياً.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; قد يقرر طبيبك إيقاف العلاج باستخدام ترايجان إذا لم تثبت فاعليته معك خلال 16 أسبوعاً.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; بالنسبة للمرضى، الذين سبق لهم استخدام أدوية بيولوجية لعلاج التهاب القولون التقرحي (مثل تلك التي تثبط نشاط عامل نخر الورم في الجسم) ولم تنجح هذه الأدوية، فقد يقرر الطبيب الاستمرار في استخدام 10 ملغم مرتين يومياً. سيخبرك طبيبك إذا كان ذلك ينطبق عليك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا لم تكن المداومة بتناول ترايجان 5 ملغم مرتين يومياً فعّالاً معك، فقد يقرر طبيبك زيادة الجرعة إلى 10 ملغم مرتين يومياً.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; في حالة إيقاف العلاج، فقد يقرر طبيبك إعادة بدء العلاج.</p><p dir="RTL">&nbsp;</p><p dir="RTL">حاول تناول أقراصك في الوقت ذاته يومياً (قرص صباحًا وقرص مساءً).</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يقوم طبيببك بتقليل الجرعة إذا كنت تعاني من مشاكل في الكبد أو الكلى أو إذا تم وصف أدوية أخرى معينة لك. قد يقوم طبيبك كذلك بإيقاف العلاج مؤقتاً أو دائماً إذا أظهرت اختبارات الدم انخفاض عدد خلايا الدم البيضاء أو الحمراء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يستخدم ترايجان عن طريق الفم. يمكنك تناول ترايجان مع الطعام أو بدونه.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تناولت جرعة زائدة من </strong><strong>ترايجان</strong></p><p dir="RTL">إذا تناولت عدد أقراص أكبر مما ينبغي، فاستشر طبيبك أو الصيدلي على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا نسيت تناول </strong><strong>ترايجان</strong></p><p dir="RTL">لا تقم بتناول جرعة مضاعفة للتعويض عن الجرعة المنسية. تناول القرص التالي في الوقت المعتاد ثم تابع تناوله كما سبق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا توقفت عن تناول </strong><strong>ترايجان</strong></p><p dir="RTL">ينبغي عليك عدم التوقف عن تناول ترايجان دون مناقشة هذا الأمر مع طبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان لديك أي أسئلة إضافية حول استخدام هذا الدواء، يرجى استشارة الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثارًا جانبية، إلا أنه ليس بالضرورة أن تحدث لدى جميع مستخدمي هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يكون بعضها خطيراً ويتطلب الرعاية الطبية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>الآثار الجانبية الخطيرة المحتملة </em></strong></p><p dir="RTL">في حالات نادرة، قد تكون العدوى مهددة للحياة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لاحظت أياً من الآثار الجانبية الخطيرة التالية فيجب عليك إخبار طبيبك على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تتضمن علامات حالات العدوى الخطيرة (شائعة) </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الحمّى والقشعريرة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; السعال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; &nbsp;بثور جلدية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; &nbsp;ألم بالمعدة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; &nbsp;صداع مستمر</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تتضمن علامات رد الفعل التحسسي (نادرة) </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ضيق الصدر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; &nbsp;صفير</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; &nbsp;دوخة شديدة أو دوار</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; &nbsp;تورم الشفتين أو اللسان أو الحلق</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الشرى (الحكة أو الطفح الجلدي)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تتضمن علامات مشاكل المعدة (غير شائعة: تقرحات أو ثقوب في المعدة أو الأمعاء) </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الحمّى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; &nbsp;ألم بالمعدة أو البطن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; براز مصحوب بدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تغيرات مجهولة السبب في حركة الأمعاء</p><p dir="RTL">&nbsp;</p><p dir="RTL">تحدث الثقوب في المعدة أو الأمعاء غالباً لدى الأشخاص الذين يتناولون أيضاً أدوية مضادات الالتهاب غير الستيرويدية أو الستيرويدات القشرية (بريدنيزون على سبيل المثال).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>الآثار الجانبية الأخرى التي تمت ملاحظتها مع توفاسيتينيب مبينة أدناه.</em></strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة </strong>(قد تؤثر على ما يصل إلى شخص من 10 أشخاص): عدوى رئوية (الالتهاب الرئوي أو التهاب الشعب الهوائية)، الحزام الناري (الهربس النطاقي)، حالات عدوى الأنف أو الحلق أو القصبة الهوائية (التهاب الأنف والحلق)، انفلونزا، التهاب الجيوب الأنفية، عدوى المثانة البولية (التهاب المثانة)، التهاب الحلق (التهاب البلعوم)، زيادة إنزيمات العضلات في الدم (علامات وجود مشاكل في العضلات)، ألم في المعدة (البطن) (الذي قد يكون بسبب التهاب بطانة المعدة)، قيء، إسهال، غثيان، عسر الهضم، التواء المفاصل، انخفاض عدد خلايا الدم الحمراء (فقر الدم)، حمّى، تعب (إرهاق)، تورم القدمين واليدين، الصداع، ارتفاع ضغط الدم (فرط ضغط الدم)، سعال، طفح جلدي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير شائعة </strong>(قد تؤثر على ما يصل إلى شخص من 100 شخص): السلّ، التهاب الكلى، التهاب الجلد، هربس بسيط أو تقرّحات البرد (الهربس الفموي)، انخفاض عدد خلايا الدم البيضاء، زيادة إنزيمات الكبد في الدم (علامة على وجود مشاكل في الكبد)، زيادة الكرياتينين في الدم (علامة محتملة لوجود مشاكل في الكلى)، زيادة الكوليسترول، زيادة في الوزن، الجفاف، إجهاد العضلات، ألم في العضلات والمفاصل، التهاب الأوتار، تورم المفاصل، شعور غير طبيعي، قلة النوم، احتقان الجيوب الأنفية، ضيق النفس أو صعوبة في التنفس، احمرار الجلد، الحكة، الكبد الدهني، التهاب مؤلم في الأكياس الصغيرة لبطانة الأمعاء (التهاب الرتج)، العدوى الفيروسية، عدوى فيروسية تؤثر على الأمعاء، بعض أنواع سرطان الجلد (أنواع السرطان غير القتامي).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادرة </strong>(قد تؤثر على ما يصل إلى شخص من 1,000 شخص): عدوى الدم (الإنتان)، سلّ منتثر يتضمن العظام والأعضاء الأخرى، حالات عدوى أخرى غير عادية، التهابات المفاصل.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادرة جداً </strong>(قد تؤثر على ما يصل إلى شخص من 10,000 شخص): سلّ يشمل الدماغ والعمود الفقري، التهاب السحايا.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيداً عن مرأى ومتناول الأطفال.</p><p dir="RTL">لا يحفظ عند درجة حرارة أعلى من 30&deg; مئوية.</p><p dir="RTL">يحفظ داخل العبوة الأصلية للحماية من الرطوبة.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة الخارجية. يشير تاريخ الانتهاء إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا تستخدم هذا الدواء إذا لاحظت علامات تلف واضحة على الأقراص (على سبيل المثال، الأقراص مكسورة أو تغيّر لونها).</p><p dir="RTL">لا تتخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. اتبع هذه الإجراءات للحفاظ على سلامة البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعّالة هي سیترات توفاسيتينيب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي كل قرص مغطى بطبقة رقيقة من ترايجان 5 ملغم أقراص مغطاة بطبقة رقيقة على 8.08 ملغم سیترات التوفاسيتينيب تكافئ 5 ملغم توفاسيتينيب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي كل قرص مغطى بطبقة رقيقة من ترايجان 10 ملغم أقراص مغطاة بطبقة رقيقة على 16.16 ملغم سیترات التوفاسيتينيب تكافئ 10 ملغم توفاسيتينيب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">المواد الأخرى المستخدمة في التركيبة التصنيعية هي: <em>لب القرص:</em> سیللیلوز بلوري مكروي، لاكتوز، كروسكارمیللوز الصودیوم وستیارات المغنیسوم. <em>غلاف القرص:</em> أوبادري أبیض.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">ترايجان 5 ملغم أقراص مغطاة بطبقة رقيقة هي أقراص مغطاة بطبقة رقيقة مستديرة الشكل بلون أبيض مائل للصفرة محفور على أحد جانبيها &quot;SP04&quot; معبأة في أشرطة من الألومينيوم/الألومينيوم.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">حجم العبوة:</p><p dir="RTL" style="text-align:right">60 قرص مغطى بطبقة رقيقة.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">ترايجان 10 ملغم أقراص مغطاة بطبقة رقيقة هي أقراص مغطاة بطبقة رقيقة ثنائية التقعر بيضاوية الشكل بلون أبيض مائل للصفرة محفور على أحد جانبيها &quot;W215&quot; معبأة في أشرطة من الألومينيوم/الألومينيوم.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">حجم العبوة:</p><p dir="RTL" style="text-align:right">56 قرص مغطى بطبقة رقيقة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>اسم وعنوان مالك رخصة التسويق </strong></p><p dir="RTL">شركة الجزيرة للصناعات الدوائية<br />طريق الخرج<br />صندوق بريد 106229<br />الرياض 11666، المملكة العربية السعودية</p><p dir="RTL">هاتف: 8107023 (11-966) +، 2142472 (11-966) +<br />فاكس: 2078170 (11-966) +<br />البريد الإلكتروني: jpimedical@hikma.com</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الشركة المصنعة</strong></p><p dir="RTL">الشركة العربية لصناعة الأدوية المساهمة الخاصة<br />سحاب<br />المدينة الصناعية<br />صندوق بريد 41<br />عمان 11512، الأردن<br />هاتف: 4023916 (6-962) +<br />فاكس: 4023917 (6-962) +</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">تحدث إلى الطبيب، الصيدلي، أو الممرض إذا عانيت من أية آثار جانبية. وذلك يشمل أي آثار جانبية لم يتم ذكرها في هذه النشرة. كما أنه يمكنك الإبلاغ عن هذه الآثار مباشرةً (انظر التفاصيل المذكورة أدناه). من خلال الإبلاغ عن الآثار الجانبية، يمكنك المساعدة بتوفير معلومات مهمة عن سلامة الدواء.</p><ul><li dir="RTL">&nbsp; &nbsp; المملكة العربية السعودية</li></ul><p dir="RTL">المركز الوطني للتيقظ الدوائي</p><p dir="RTL">مركز الاتصال الموحد: 19999</p><p dir="RTL">البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">الموقع الإلكتروني: &nbsp;https://ade.sfda.gov.sa</p><ul><li dir="RTL">&nbsp; &nbsp; دول الخليج العربي الأخرى</li></ul><p dir="RTL">الرجاء الاتصال بالجهات الوطنية في كل دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة بتاريخ 2019/11؛ رقم النسخة SA1.0.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Trijan 10 mg Film-coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains 16.16 mg tofacitinib citrate equivalent to 10 mg tofacitinib.

Excipient with known effect: Each film-coated tablet contains 118 mg lactose.

For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets.

White to off-white oval biconcave shaped film-coated tablets, embossed with “W215” on one side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Rheumatoid arthritis</u></p><p>Tofacitinib in combination with methotrexate (MTX) is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs. Tofacitinib can be given as monotherapy in case of intolerance to MTX or when treatment with MTX is inappropriate (see sections 4.4 and 4.5).</p><p>&nbsp;</p><p><u>Psoriatic arthritis</u></p><p>Tofacitinib in combination with MTX is indicated for the treatment of active psoriatic arthritis (PsA) in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (DMARD) therapy (see section 5.1).</p><p>&nbsp;</p><p><u>Ulcerative colitis</u></p><p>Tofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment should be initiated and supervised by specialist physicians experienced in the diagnosis and treatment of conditions for which tofacitinib is indicated.</p><p>&nbsp;</p><p><strong><em>Posology</em></strong></p><p><strong>Rheumatoid arthritis and psoriatic arthritis</strong></p><p>The recommended dose is 5 mg administered twice daily.</p><p>&nbsp;</p><p><em>Dose adjustment</em></p><p>No dose adjustment is required when used in combination with MTX.</p><p>&nbsp;</p><p><strong>Ulcerative colitis</strong></p><p>The recommended dose is 10 mg given orally twice daily for induction for 8 weeks and 5 mg given twice daily for maintenance.</p><p>&nbsp;</p><p>For patients who do not achieve adequate therapeutic benefit by week 8, the induction dose of 10 mg twice daily can be extended for an additional 8 weeks (16 weeks total), followed by 5 mg twice daily for maintenance. Tofacitinib induction therapy should be discontinued in any patient who shows no evidence of therapeutic benefit by week 16.</p><p>&nbsp;</p><p>For some patients, such as those who have failed prior tumour necrosis factor (TNF) antagonist therapy, consideration should be given to continuation of the 10 mg twice daily dose for maintenance in order to maintain therapeutic benefit (see section 5.1).</p><p>&nbsp;</p><p>Patients who experience a decrease in response on tofacitinib 5 mg twice daily maintenance therapy may benefit from an increase to tofacitinib 10 mg administered twice daily.</p><p>&nbsp;</p><p>In patients who have responded to treatment with tofacitinib, corticosteroids may be reduced and/or discontinued in accordance with standard of care.</p><p>&nbsp;</p><p><em>Retreatment in UC</em></p><p>If therapy is interrupted, restarting treatment with tofacitinib can be considered. If there has been a loss of response, reinduction with tofacitinib 10 mg twice daily may be considered. The treatment interruption period in clinical studies extended up to 1 year. Efficacy may be regained by 8 weeks of 10 mg twice daily therapy (see section 5.1).</p><p>&nbsp;</p><p><strong><em>Dose interruption and discontinuation</em></strong></p><p>Tofacitinib treatment should be interrupted if a patient develops a serious infection until the infection is controlled.</p><p>&nbsp;</p><p>Interruption of dosing may be needed for management of dose-related laboratory abnormalities including lymphopenia, neutropenia, and anaemia. As described in Tables 1, 2 and 3 below, recommendations for temporary dose interruption or permanent discontinuation of treatment are made according to the severity of laboratory abnormalities (see section 4.4).</p><p>&nbsp;</p><p>It is recommended not to initiate dosing in patients with an absolute lymphocyte count (ALC) less than 750 cells/mm<sup>3</sup>.</p><p>&nbsp;</p><p><strong>Table 1: Low Absolute Lymphocyte Count</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Low Absolute Lymphocyte Count (ALC) (see section 4.4)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Lab Value</strong></p><p><strong>(cells/mm<sup>3</sup>)</strong></p></td><td style="vertical-align:top"><p><strong>Recommendation</strong></p></td></tr><tr><td style="vertical-align:top"><p>ALC greater than or equal to 750</p></td><td style="vertical-align:top"><p>Dose should be maintained.</p></td></tr><tr><td style="vertical-align:top"><p>ALC 500-750</p></td><td style="vertical-align:top"><p>For persistent (2 sequential values in this range on routine testing) decrease in this range, dosing should be reduced or interrupted until ALC is greater than 750.</p><p>For patients receiving tofacitinib 10 mg twice daily, dosing should be reduced to tofacitinib 5 mg twice daily.</p><p>For patients receiving tofacitinib 5 mg twice daily, dosing should be interrupted.</p><p>When ALC is greater than 750, treatment should be resumed as clinically appropriate.</p></td></tr><tr><td style="vertical-align:top"><p>ALC less than 500</p></td><td style="vertical-align:top"><p>If lab value confirmed by repeat testing within 7 days, dosing should be discontinued.</p></td></tr></tbody></table><p>It is recommended not to initiate dosing in patients with an absolute neutrophil count (ANC) less than 1,000 cells/mm<sup>3</sup>.</p><p>&nbsp;</p><p><strong>Table 2: Low Absolute Neutrophil Count</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Low Absolute Neutrophil Count (ANC) (see section 4.4)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Lab Value</strong></p><p><strong>(cells/mm<sup>3</sup>)</strong></p></td><td style="vertical-align:top"><p><strong>Recommendation</strong></p></td></tr><tr><td style="vertical-align:top"><p>ANC greater than 1,000</p></td><td style="vertical-align:top"><p>Dose should be maintained.</p></td></tr><tr><td style="vertical-align:top"><p>ANC 500-1,000</p></td><td style="vertical-align:top"><p>For persistent (2 sequential values in this range on routine testing) decreases in this range, dosing should be reduced or interrupted until ANC is greater than 1,000.</p><p>For patients receiving tofacitinib 10 mg twice daily, dosing should be reduced to tofacitinib 5 mg twice daily.</p><p>For patients receiving tofacitinib 5 mg twice daily, dosing should be interrupted.</p><p>When ANC is greater than 1,000, treatment should be resumed as clinically appropriate.</p></td></tr><tr><td style="vertical-align:top"><p>ANC less than 500</p></td><td style="vertical-align:top"><p>If lab value confirmed by repeat testing within 7 days, dosing should be discontinued.</p></td></tr></tbody></table><p>It is recommended not to initiate dosing in patients with haemoglobin less than 9 g/dL.</p><p>&nbsp;</p><p><strong>Table 3: Low Haemoglobin Value</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Low Haemoglobin Value (Section 4.4)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Lab Value</strong></p><p><strong>(g/dL)</strong></p></td><td style="vertical-align:top"><p><strong>Recommendation</strong></p></td></tr><tr><td style="vertical-align:top"><p>Less than or equal to 2 g/dL decrease and greater than or equal to 9.0 g/dL</p></td><td style="vertical-align:top"><p>Dose should be maintained.</p></td></tr><tr><td style="vertical-align:top"><p>Greater than 2 g/dL decrease or less than 8.0 g/dL</p><p>(confirmed by repeat testing)</p></td><td style="vertical-align:top"><p>Dosing should be interrupted until haemoglobin values have normalised.</p></td></tr></tbody></table><p>&nbsp;</p><p><em>Drug-drug interactions</em></p><p>Tofacitinib total daily dose should be reduced by half in patients receiving potent inhibitors of cytochrome P450 (CYP) 3A4 (e.g., ketoconazole) and in patients receiving 1 or more concomitant medicinal products that result in both moderate inhibition of CYP3A4 as well as potent inhibition of CYP2C19 (e.g., fluconazole) (see sections 4.4 and 4.5) as follows:</p><p>&middot;&nbsp;&nbsp;&nbsp; Tofacitinib dose should be reduced to 5 mg once daily in patients receiving 5 mg twice daily.</p><p>&middot;&nbsp;&nbsp;&nbsp; Tofacitinib dose should be reduced to 5 mg twice daily in patients receiving 10 mg twice daily.</p><p>&nbsp;</p><p><strong><u>Special populations</u></strong></p><p><em>Elderly</em></p><p>No dose adjustment is required in patients aged 65 years and older. There are limited data in patients aged 75 years and older.</p><p>&nbsp;</p><p><em>Hepatic impairment</em></p><p><strong>Table 4: Dose Adjustment for Hepatic Impairment</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>Hepatic Impairment</strong></p></td><td style="vertical-align:top"><p><strong>Classification</strong></p></td><td style="vertical-align:top"><p><strong>Dose Adjustment</strong></p></td></tr><tr><td style="vertical-align:top"><p>Mild</p></td><td style="vertical-align:top"><p>Child Pugh A</p></td><td style="vertical-align:top"><p>No dose adjustment required.</p></td></tr><tr><td style="vertical-align:top"><p>Moderate</p></td><td style="vertical-align:top"><p>Child Pugh B</p></td><td style="vertical-align:top"><p>Dose should be reduced to 5 mg once daily when the indicated dose in the presence of normal hepatic function is 5 mg twice daily.</p><p>Dose should be reduced to 5 mg twice daily when the indicated dose in the presence of normal hepatic function is 10 mg twice daily (see section 5.2).</p></td></tr><tr><td style="vertical-align:top"><p>Severe</p></td><td style="vertical-align:top"><p>Child Pugh C</p></td><td style="vertical-align:top"><p>Tofacitinib should not be used in patients with severe hepatic impairment (see section 4.3).</p></td></tr></tbody></table><p>&nbsp;</p><p><em>Renal impairment</em></p><p><strong>Table 5: Dose Adjustment for Renal Impairment</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>Renal Impairment</strong></p></td><td style="vertical-align:top"><p><strong>Creatinine Clearance</strong></p></td><td style="vertical-align:top"><p><strong>Dose Adjustment</strong></p></td></tr><tr><td style="vertical-align:top"><p>Mild</p></td><td style="vertical-align:top"><p>50-80 mL/min</p></td><td style="vertical-align:top"><p>No dose adjustment required.</p></td></tr><tr><td style="vertical-align:top"><p>Moderate</p></td><td style="vertical-align:top"><p>30-49 mL/min</p></td><td style="vertical-align:top"><p>No dose adjustment required.</p></td></tr><tr><td style="vertical-align:top"><p>Severe</p></td><td style="vertical-align:top"><p>&lt; 30 mL/min</p></td><td style="vertical-align:top"><p>Dose should be reduced to 5 mg once daily when the indicated dose in the presence of normal renal function is 5 mg twice daily.</p><p>Dose should be reduced to 5 mg twice daily when the indicated dose in the presence of normal renal function is 10 mg twice daily.</p><p>Patients with severe renal impairment should remain on a reduced dose even after haemodialysis (see section 5.2).</p></td></tr></tbody></table><p>&nbsp;</p><p><em>Paediatric population</em></p><p>The safety and efficacy of tofacitinib in children aged 0 to less than 18 years have not been established.</p><p>&nbsp;</p><p>No data are available.</p><p>&nbsp;</p><p><strong><em>Method of administration</em></strong></p><p>Oral use.</p><p>&nbsp;</p><p>Tofacitinib is given orally with or without food.</p><p>&nbsp;</p><p>For patients who have difficulties swallowing, tofacitinib tablets may be crushed and taken with water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
•	Active tuberculosis (TB), serious infections such as sepsis, or opportunistic infections (see section 4.4).
•	Severe hepatic impairment (see section 4.2).
•	Pregnancy and lactation (see section 4.6).

Tofacitinib 10 mg twice daily is contraindicated in patients who have one or more of the following conditions:
•	Use of combined hormonal contraceptives or hormone replacement therapy
•	Heart failure
•	Previous venous thromboembolism, either deep venous thromboembolism or pulmonary embolism
•	Inherited coagulation disorder
•	Malignancy
•	Patients undergoing major surgery
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Combination with other therapies</u></p><p>Tofacitinib has not been studied and its use should be avoided in combination with biologics such as TNF antagonists, interleukin (IL)-1R antagonists, IL-6R antagonists, anti-CD20 monoclonal antibodies, IL-17 antagonists, IL-12/IL-23 antagonists, anti-integrins, selective co-stimulation modulators and potent immunosuppressants such as azathioprine, 6-mercaptopurine, ciclosporine and tacrolimus because of the possibility of increased immunosuppression and increased risk of infection.</p><p>&nbsp;</p><p>There was a higher incidence of adverse events for the combination of tofacitinib with MTX versus tofacitinib as monotherapy in RA clinical studies.</p><p>&nbsp;</p><p>The use of tofacitinib in combination with phosphodiesterase 4 inhibitors has not been studied in tofacitinib clinical studies.</p><p>&nbsp;</p><p><u>Serious infections</u></p><p>Serious and sometimes fatal infections due to bacterial, mycobacterial, invasive fungal, viral, or other opportunistic pathogens have been reported in patients receiving tofacitinib. The risk of opportunistic infections is higher in Asian geographic regions (see section 4.8). Rheumatoid arthritis patients taking corticosteroids may be predisposed to infection.</p><p>&nbsp;</p><p>Tofacitinib should not be initiated in patients with active infections, including localised infections.</p><p>&nbsp;</p><p>The risks and benefits of treatment should be considered prior to initiating tofacitinib in patients:</p><p>&middot;&nbsp;&nbsp;&nbsp; With recurrent infections,</p><p>&middot;&nbsp;&nbsp;&nbsp; With a history of a serious or an opportunistic infection,</p><p>&middot;&nbsp;&nbsp;&nbsp; Who have resided or travelled in areas of endemic mycoses,</p><p>&middot;&nbsp;&nbsp;&nbsp; Who have underlying conditions that may predispose them to infection.</p><p>&nbsp;</p><p>Patients should be closely monitored for the development of signs and symptoms of infection during and after treatment with tofacitinib. Treatment should be interrupted if a patient develops a serious infection, an opportunistic infection, or sepsis. A patient who develops a new infection during treatment with tofacitinib should undergo prompt and complete diagnostic testing appropriate for an immunocompromised patient, appropriate antimicrobial therapy should be initiated, and the patient should be closely monitored.</p><p>&nbsp;</p><p>As there is a higher incidence of infections in the elderly and in the diabetic populations in general, caution should be used when treating the elderly and patients with diabetes (see section 4.8).</p><p>&nbsp;</p><p>Risk of infection may be higher with increasing degrees of lymphopenia and consideration should be given to lymphocyte counts when assessing individual patient risk of infection. Discontinuation and monitoring criteria for lymphopenia are discussed in section 4.2.</p><p>&nbsp;</p><p><u>Tuberculosis</u></p><p>The risks and benefits of treatment should be considered prior to initiating tofacitinib in patients:</p><p>&middot;&nbsp;&nbsp;&nbsp; Who have been exposed to TB,</p><p>&middot;&nbsp;&nbsp;&nbsp; Who have resided or travelled in areas of endemic TB.</p><p>&nbsp;</p><p>Patients should be evaluated and tested for latent or active infection prior to and per applicable guidelines during administration of tofacitinib.</p><p>&nbsp;</p><p>Patients with latent TB, who test positive, should be treated with standard antimycobacterial therapy before administering tofacitinib.</p><p>Antituberculosis therapy should also be considered prior to administration of tofacitinib in patients who test negative for TB but who have a past history of latent or active TB and where an adequate course of treatment cannot be confirmed; or those who test negative but who have risk factors for TB infection. Consultation with a healthcare professional with expertise in the treatment of TB is recommended to aid in the decision about whether initiating antituberculosis therapy is appropriate for an individual patient. Patients should be closely monitored for the development of signs and symptoms of TB, including patients who tested negative for latent TB infection prior to initiating therapy.</p><p>&nbsp;</p><p><u>Viral reactivation</u></p><p>Viral reactivation and cases of herpes virus reactivation (e.g., herpes zoster) were observed in clinical studies with tofacitinib. In patients treated with tofacitinib, the incidence of herpes zoster appears to be increased in:</p><p>&middot;&nbsp;&nbsp;&nbsp; Japanese or Korean patients.</p><p>&middot;&nbsp;&nbsp;&nbsp; Patients with an ALC less than 1,000 cells/mm3&nbsp;(see section 4.2).</p><p>&middot;&nbsp;&nbsp;&nbsp; Patients with long standing RA who have previously received two or more biological disease modifying antirheumatic drugs (DMARDs).</p><p>&middot;&nbsp;&nbsp;&nbsp; Patients treated with 10 mg twice daily.</p><p>&nbsp;</p><p>The impact of tofacitinib on chronic viral hepatitis reactivation is unknown. Patients screened positive for hepatitis B or C were excluded from clinical trials. Screening for viral hepatitis should be performed in accordance with clinical guidelines before starting therapy with tofacitinib.</p><p>&nbsp;</p><p><u>Malignancy and lymphoproliferative disorder</u></p><p>The risks and benefits of tofacitinib treatment should be considered prior to initiating therapy in patients with current or a history of malignancy other than a successfully treated non-melanoma skin cancer (NMSC) or when considering continuing tofacitinib in patients who develop a malignancy. The possibility exists for tofacitinib to affect host defences against malignancies.</p><p>&nbsp;</p><p>Lymphomas have been observed in patients treated with tofacitinib. Patients with RA, particularly those with highly active disease may be at a higher risk (up to several-fold) than the general population for the development of lymphoma. The effect of tofacitinib on the development of lymphoma is uncertain.</p><p>&nbsp;</p><p>Other malignancies were observed in clinical studies and the post-marketing setting, including, but not limited to, lung cancer, breast cancer, melanoma, prostate cancer, and pancreatic cancer.</p><p>&nbsp;</p><p>The effect of tofacitinib on the development and course of malignancies is not known.</p><p>&nbsp;</p><p><u>Non-melanoma skin cancer</u></p><p>NMSCs have been reported in patients treated with tofacitinib. The risk of NMSC may be higher in patients treated with tofacitinib 10 mg twice daily than in patients treated with 5 mg twice daily. Periodic skin examination is recommended for patients who are at increased risk for skin cancer (see Table 6 in section 4.8).</p><p>&nbsp;</p><p><u>Pulmonary embolism</u></p><p>Pulmonary embolism (PE) has been observed in patients taking tofacitinib in clinical trials and post marketing reports. Tofacitinib 10 mg twice daily is contraindicated in patients who are at high risk for pulmonary embolism (see also section 4.3). Additional risk factors that should be considered in determining the patient&#39;s risk for PE are older age, obesity, smoking status, and immobilisation.</p><p>&nbsp;</p><p><u>Interstitial lung disease</u></p><p>Caution is also recommended in patients with a history of chronic lung disease as they may be more prone to infections. Events of interstitial lung disease (some of which had a fatal outcome) have been reported in patients treated with tofacitinib in RA clinical trials and in the post-marketing setting although the role of Janus kinase (JAK) inhibition in these events is not known. Asian RA patients are known to be at higher risk of interstitial lung disease, thus caution should be exercised in treating these patients.</p><p>&nbsp;</p><p><u>Gastrointestinal perforations</u></p><p>Events of gastrointestinal perforation have been reported in clinical trials although the role of JAK inhibition in these events is not known. Tofacitinib should be used with caution in patients who may be at increased risk for gastrointestinal perforation (e.g., patients with a history of diverticulitis, patients with concomitant use of corticosteroids and/or nonsteroidal anti-inflammatory drugs). Patients presenting with new onset abdominal signs and symptoms should be evaluated promptly for early identification of gastrointestinal perforation.</p><p>&nbsp;</p><p><u>Cardiovascular risk</u></p><p>RA and PsA patients have an increased risk for cardiovascular disorders. Patients treated with tofacitinib should have risk factors (e.g., hypertension, hyperlipidaemia) managed as part of usual standard of care.</p><p>&nbsp;</p><p><u>Liver enzymes</u></p><p>Treatment with tofacitinib was associated with an increased incidence of liver enzyme elevation in some patients (see section 4.8 liver enzyme tests). Caution should be exercised when considering initiation of tofacitinib treatment in patients with elevated alanine aminotransferase (ALT) or aspartate aminotransferase (AST), particularly when initiated in combination with potentially hepatotoxic medicinal products such as MTX. Following initiation, routine monitoring of liver tests and prompt investigation of the causes of any observed liver enzyme elevations are recommended to identify potential cases of drug-induced liver injury. If drug-induced liver injury is suspected, the administration of tofacitinib should be interrupted until this diagnosis has been excluded.</p><p>&nbsp;</p><p><u>Hypersensitivity</u></p><p>In post-marketing experience, cases of drug hypersensitivity associated with tofacitinib administration have been reported. Allergic reactions included angioedema and urticaria; serious reactions have occurred. If any serious allergic or anaphylactic reaction occurs, tofacitinib should be discontinued immediately.</p><p>&nbsp;</p><p><u>Laboratory parameters</u></p><p><em>Lymphocytes</em></p><p>Treatment with tofacitinib was associated with an increased incidence of lymphopenia compared to placebo. Lymphocyte counts less than 750 cells/mm<sup>3</sup>&nbsp;were associated with an increased incidence of serious infections. It is not recommended to initiate or continue tofacitinib treatment in patients with a confirmed lymphocyte count less than 750 cells/mm<sup>3</sup>. Lymphocytes should be monitored at baseline and every 3 months thereafter. For recommended modifications based on lymphocyte counts, see section 4.2.</p><p>&nbsp;</p><p><em>Neutrophils</em></p><p>Treatment with tofacitinib was associated with an increased incidence of neutropenia (less than 2,000 cells/mm<sup>3</sup>) compared to placebo. It is not recommended to initiate tofacitinib treatment in patients with an ANC less than 1,000 cells/mm<sup>3</sup>. ANC should be monitored at baseline and after 4 to 8 weeks of treatment and every 3 months thereafter. For recommended modifications based on ANC, see section 4.2.</p><p>&nbsp;</p><p><em>Haemoglobin</em></p><p>Treatment with tofacitinib has been associated with decreases in haemoglobin levels. It is not recommended to initiate tofacitinib treatment in patients with a haemoglobin value less than 9 g/dL. Haemoglobin should be monitored at baseline and after 4 to 8 weeks of treatment and every 3 months thereafter. For recommended modifications based on haemoglobin level, see section 4.2.</p><p>&nbsp;</p><p><em>Lipid monitoring</em></p><p>Treatment with tofacitinib was associated with increases in lipid parameters such as total cholesterol, low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol. Maximum effects were generally observed within 6 weeks.</p><p>&nbsp;</p><p>Assessment of lipid parameters should be performed after 8 weeks following initiation of tofacitinib therapy. Patients should be managed according to clinical guidelines for the management of hyperlipidaemia. Increases in total and LDL cholesterol associated with tofacitinib may be decreased to pretreatment levels with statin therapy.</p><p>&nbsp;</p><p><u>Vaccinations</u></p><p>Prior to initiating tofacitinib, it is recommended that all patients be brought up to date with all immunisations in agreement with current immunisation guidelines. It is recommended that live vaccines not be given concurrently with tofacitinib. The decision to use live vaccines prior to tofacitinib treatment should take into account the pre-existing immunosuppression in a given patient.</p><p>&nbsp;</p><p>Prophylactic zoster vaccination should be considered in accordance with vaccination guidelines. Particular consideration should be given to patients with longstanding RA who have previously received two or more biological DMARDs. If live zoster vaccine is administered; it should only be administered to patients with a known history of chickenpox or those that are seropositive for varicella zoster virus (VZV). If the history of chickenpox is considered doubtful or unreliable it is recommended to test for antibodies against VZV.</p><p>&nbsp;</p><p>Vaccination with live vaccines should occur at least 2 weeks but preferably 4 weeks prior to initiation of tofacitinib or in accordance with current vaccination guidelines regarding immunomodulatory medicinal products. No data are available on the secondary transmission of infection by live vaccines to patients receiving tofacitinib.</p><p>&nbsp;</p><p><u>Lactose</u></p><p>Trijan contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Potential for other medicinal products to influence the pharmacokinetics (PK) of tofacitinib</u></p><p>Since tofacitinib is metabolised by CYP3A4, interaction with medicinal products that inhibit or induce CYP3A4 is likely. Tofacitinib exposure is increased when coadministered with potent inhibitors of CYP3A4 (e.g., ketoconazole)<strong>&nbsp;</strong>or when administration of one or more concomitant medicinal products results in both moderate inhibition of CYP3A4 and potent inhibition of CYP2C19 (e.g., fluconazole)<strong>&nbsp;</strong>(see section 4.2)<em>.</em></p><p>&nbsp;</p><p>Tofacitinib exposure is decreased when coadministered with potent CYP inducers (e.g., rifampicin). Inhibitors of CYP2C19 alone or P-glycoprotein are unlikely to significantly alter the PK of tofacitinib.</p><p>&nbsp;</p><p>Coadministration with ketoconazole (strong CYP3A4 inhibitor), fluconazole (moderate CYP3A4 and potent CYP2C19 inhibitor), tacrolimus (mild CYP3A4 inhibitor) and ciclosporine (moderate CYP3A4 inhibitor) increased tofacitinib AUC, while rifampicin (potent CYP inducer) decreased tofacitinib AUC. Coadministration of tofacitinib with potent CYP inducers (e.g., rifampicin) may result in a loss of or reduced clinical response (see Figure 1). Coadministration of potent inducers of CYP3A4 with tofacitinib is not recommended. Coadministration with ketoconazole and fluconazole increased tofacitinib C<sub>max</sub>, while tacrolimus, ciclosporine and rifampicin decreased tofacitinib C<sub>max</sub>. Concomitant administration with MTX 15-25 mg once weekly had no effect on the PK of tofacitinib in RA patients (see Figure 1).</p><p>&nbsp;</p><p>Figure 1. Impact of Other Medicinal Products on PK of Tofacitinib<br /><img alt="" width="603" height="421" src="data:image/png;base64,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" /></p><p>Note: Reference group is administration of tofacitinib alone.</p><p>a&nbsp;Tofacitinib dose should be reduced to 5 mg twice daily in patients receiving 10 mg twice daily. Tofacitinib dose should be reduced to 5 mg once daily in patients receiving 5 mg twice daily (see section 4.2).</p><p>&nbsp;</p><p><u>Potential for tofacitinib to influence the PK of other medicinal products</u></p><p>Coadministration of tofacitinib did not have an effect on the PK of oral contraceptives, levonorgestrel and ethinyl estradiol, in healthy female volunteers.</p><p>&nbsp;</p><p>In RA patients, coadministration of tofacitinib with MTX 15-25 mg once weekly decreased the AUC and C<sub>max</sub>&nbsp;of MTX by 10% and 13%, respectively. The extent of decrease in MTX exposure does not warrant modifications to the individualised dosing of MTX.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>There are no adequate and well-controlled studies on the use of tofacitinib in pregnant women. Tofacitinib has been shown to be teratogenic in rats and rabbits, and to affect parturition and peri/postnatal development (see section 5.3).</p><p>&nbsp;</p><p>As a precautionary measure, the use of tofacitinib during pregnancy is contraindicated (see section 4.3).</p><p>&nbsp;</p><p><u>Women of childbearing potential/contraception in females</u></p><p>Women of childbearing potential should be advised to use effective contraception during treatment with tofacitinib and for at least 4 weeks after the last dose.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>It is not known whether tofacitinib is secreted in human milk. A risk to the breast-fed child cannot be excluded. Tofacitinib was secreted in the milk of lactating rats (see section 5.3). As a precautionary measure, the use of tofacitinib during breast-feeding is contraindicated (see section 4.3).</p><p>&nbsp;</p><p><u>Fertility</u></p><p>Formal studies of the potential effect on human fertility have not been conducted. Tofacitinib impaired female fertility but not male fertility in rats (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tofacitinib has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Summary of the safety profile</strong></p><p><u>Rheumatoid arthritis</u></p><p>The most common serious adverse reactions were serious infections (see section 4.4). The most common serious infections reported with tofacitinib were pneumonia, cellulitis, herpes zoster, urinary tract infection, diverticulitis, and appendicitis. Among opportunistic infections, TB and other mycobacterial infections, cryptococcus, histoplasmosis, oesophageal candidiasis, multidermatomal herpes zoster, cytomegalovirus, BK virus infections and listeriosis were reported with tofacitinib. Some patients have presented with disseminated rather than localised disease. Other serious infections that were not reported in clinical studies may also occur (e.g., coccidioidomycosis).</p><p>&nbsp;</p><p>The most commonly reported adverse reactions during the first 3 months in controlled clinical trials were headache, upper respiratory tract infections, nasopharyngitis, diarrhoea, nausea and hypertension (see Table 6, Adverse Drug Reactions [ADRs] based on all study durations).</p><p>&nbsp;</p><p>The proportion of patients who discontinued treatment due to adverse reactions during first 3 months of the double-blind, placebo or MTX controlled studies was 3.8% for patients taking tofacitinib. The most common infections resulting in discontinuation of therapy were herpes zoster and pneumonia.</p><p>&nbsp;</p><p><u>Psoriatic arthritis</u></p><p>Overall, the safety profile observed in patients with active PsA treated with tofacitinib was consistent with the safety profile observed in patients with RA treated with tofacitinib.</p><p>&nbsp;</p><p><u>Ulcerative colitis</u></p><p>The most commonly reported adverse reactions in patients receiving tofacitinib 10 mg twice daily in the induction studies were headache, nasopharyngitis, nausea, and arthralgia.</p><p>In the induction and maintenance studies, across tofacitinib and placebo treatment groups, the most common categories of serious adverse reactions were gastrointestinal disorders and infections, and the most common serious adverse reaction was worsening of UC.</p><p>&nbsp;</p><p>Overall, the safety profile observed in patients with UC treated with tofacitinib was consistent with the safety profile of tofacitinib in the RA indication.</p><p>&nbsp;</p><p><strong>Tabulated list of adverse reactions</strong></p><p>The ADRs listed in the table below are from clinical studies in patients with RA, PsA, and UC and are presented by System Organ Class (SOC) and frequency categories, defined using the following convention: very common (&ge; 1/10), common (&ge; 1/100 to &lt; 1/10), uncommon (&ge; 1/1,000 to &lt; 1/100), rare (&ge; 1/10,000 to &lt; 1/1,000), very rare (&lt; 1/10,000), or not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><p>&nbsp;</p><p><strong>Table 6: Adverse Drug Reactions</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Common</strong></p><p><strong>&ge;1/100 to &lt;1/10</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon</strong></p><p><strong>&ge;1/1,000 to &lt;1/100</strong></p></td><td style="vertical-align:top"><p><strong>Rare</strong></p><p><strong>&ge;1/10,000 to &lt;1/1,000</strong></p></td><td style="vertical-align:top"><p><strong>Very Rare</strong></p><p><strong>&lt;1/10,000</strong></p></td><td style="vertical-align:top"><p><strong>Not Known (cannot be estimated from the available data)</strong></p></td></tr><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top"><p>Pneumonia</p><p>Influenza</p><p>Herpes zoster</p><p>Urinary tract infection</p><p>Sinusitis</p><p>Bronchitis</p><p>Nasopharyngitis</p><p>Pharyngitis</p></td><td style="vertical-align:top"><p>Tuberculosis</p><p>Diverticulitis</p><p>Pyelonephritis</p><p>Cellulitis</p><p>Herpes simplex</p><p>Gastroenteritis viral</p><p>Viral infection</p></td><td style="vertical-align:top"><p>Sepsis</p><p>Urosepsis</p><p>Disseminated TB</p><p>Necrotizing fasciitis</p><p>Bacteraemia</p><p>Staphylococcal bacteraemia</p><p><em>Pneumocystis jirovecii</em>&nbsp;pneumonia</p><p>Pneumonia pneumococcal</p><p>Pneumonia bacterial</p><p>Encephalitis</p><p>Atypical mycobacterial infection</p><p>Cytomegalovirus infection</p><p>Arthritis bacterial</p></td><td style="vertical-align:top"><p>Tuberculosis of central nervous system</p><p>Meningitis cryptococcal</p><p><em>Mycobacterium avium</em>&nbsp;complex infection</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Non-melanoma skin cancers</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Anaemia</p></td><td style="vertical-align:top"><p>Leukopenia</p><p>Lymphopenia</p><p>Neutropenia</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Drug hypersensitivity*</p><p>Angioedema*</p><p>Urticaria*</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Dyslipidaemia</p><p>Hyperlipidaemia</p><p>Dehydration</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Insomnia</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Headache</p></td><td style="vertical-align:top"><p>Paraesthesia</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Hypertension</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Cough</p></td><td style="vertical-align:top"><p>Dyspnoea</p><p>Sinus congestion</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Abdominal pain</p><p>Vomiting</p><p>Diarrhoea</p><p>Nausea</p><p>Gastritis</p><p>Dyspepsia</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Hepatic steatosis</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Rash</p></td><td style="vertical-align:top"><p>Erythema</p><p>Pruritus</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>Arthralgia</p></td><td style="vertical-align:top"><p>Musculoskeletal pain</p><p>Joint swelling</p><p>Tendonitis</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Pyrexia</p><p>Oedema peripheral</p><p>Fatigue</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>Blood creatine phosphokinase increased</p></td><td style="vertical-align:top"><p>Hepatic enzyme</p><p>increased</p><p>Transaminases increased</p><p>Liver function test abnormal</p><p>Gamma glutamyl-transferase increased</p><p>Blood creatinine increased</p><p>Blood cholesterol increased</p><p>Low density lipoprotein increased</p><p>Weight increased</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p>Injury, poisoning and procedural complications</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Ligament sprain</p><p>Muscle strain</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr></tbody></table><p>*Spontaneous reporting data</p><p>&nbsp;</p><p><strong>Description of selected adverse reactions</strong></p><p><em><u>Overall infections</u></em></p><p><em>Rheumatoid arthritis</em></p><p>In controlled Phase 3 clinical studies, the rates of infections over 0-3 months in the 5 mg twice daily (total 616 patients) and 10 mg twice daily (total 642 patients) tofacitinib monotherapy groups were 16.2% (100 patients) and 17.9% (115 patients), respectively, compared to 18.9% (23 patients) in the placebo group (total 122 patients). In controlled Phase 3 clinical studies with background DMARDs, the rates of infections over 0-3 months in the 5 mg twice daily (total 973 patients) and 10 mg twice daily (total 969 patients) tofacitinib plus DMARD group were 21.3% (207 patients) and 21.8% (211 patients), respectively, compared to 18.4% (103 patients) in the placebo plus DMARD group (total 559 patients).</p><p>&nbsp;</p><p>The most commonly reported infections were upper respiratory tract infections and nasopharyngitis (3.7% and 3.2%, respectively).</p><p>&nbsp;</p><p>The overall incidence rate of infections with tofacitinib in the long-term safety all exposure population (total 4,867 patients) was 46.1 patients with events per 100 patient-years (43.8 and 47.2 patients with events for 5 mg and 10 mg twice daily, respectively). For patients (total 1,750) on monotherapy, the rates were 48.9 and 41.9 patients with events per 100 patient-years for 5 mg and 10 mg twice daily, respectively. For patients (total 3,117) on background DMARDs, the rates were 41.0 and 50.3 patients with events per 100 patient-years for 5 mg and 10 mg twice daily, respectively.</p><p>&nbsp;</p><p><em>Ulcerative colitis</em></p><p>In the randomised 8-week Phase 2/3 induction studies, the proportions of patients with infections were 21.1% (198 patients) in the tofacitinib 10 mg twice daily group compared to 15.2% (43 patients) in the placebo group. In the randomised 52-week Phase 3 maintenance study, the proportion of patients with infections were 35.9% (71 patients) in the 5 mg twice daily and 39.8% (78 patients) in the 10 mg twice daily tofacitinib groups, compared to 24.2% (48 patients) in the placebo group.</p><p>&nbsp;</p><p>In the entire treatment experience with tofacitinib, the most commonly reported infection was nasopharyngitis, occurring in 18.2% of patients (211 patients).</p><p>&nbsp;</p><p>In the entire treatment experience with tofacitinib, the overall incidence rate of infections was 60.3 events per 100 patient-years (involving 49.4% of patients; total 572 patients).</p><p>&nbsp;</p><p><em><u>Serious infections</u></em></p><p><em>Rheumatoid arthritis</em></p><p>In the 6-month and 24-month, controlled clinical studies, the rate of serious infections in the 5 mg twice daily tofacitinib monotherapy group was 1.7 patients with events per 100 patient-years. In the 10 mg twice daily tofacitinib monotherapy group the rate was 1.6 patients with events per 100 patient-years, the rate was 0 events per 100 patient-years for the placebo group, and the rate was 1.9 patients with events per 100 patient-years for the MTX group.</p><p>&nbsp;</p><p>In studies of 6-, 12-, or 24-month duration, the rates of serious infections in the 5 mg twice daily and 10 mg twice daily tofacitinib plus DMARD groups were 3.6 and 3.4 patients with events per 100 patient-years, respectively, compared to 1.7 patients with events per 100 patient-years in the placebo plus DMARD group.</p><p>&nbsp;</p><p>In the long-term safety all exposure population, the overall rates of serious infections were 2.4 and 3.0 patients with events per 100 patient-years for 5 mg and 10 mg twice daily tofacitinib groups, respectively. The most common serious infections included pneumonia, herpes zoster, urinary tract infection, cellulitis, gastroenteritis and diverticulitis. Cases of opportunistic infections have been reported (see section 4.4).</p><p>&nbsp;</p><p><em>Ulcerative colitis</em></p><p>The incidence rates and types of serious infections in the UC clinical studies were generally similar to those reported in RA clinical studies with tofacitinib monotherapy treatment groups.</p><p>&nbsp;</p><p><em><u>Serious infections in the elderly</u></em></p><p>Of the 4,271 patients who enrolled in RA studies I-VI (see section 5.1), a total of 608 RA patients were 65 years of age and older, including 85 patients 75 years and older. The frequency of serious infection among tofacitinib-treated patients 65 years of age and older was higher than those under the age of 65 (4.8 per 100 patient-years versus 2.4 per 100 patient-years, respectively). As there is a higher incidence of infections in the elderly population in general, caution should be used when treating the elderly (see section 4.4).</p><p><u>&nbsp;</u></p><p><u>Viral reactivation</u></p><p>Patients treated with tofacitinib who are Japanese or Korean, or patients with long standing RA who have previously received two or more biological DMARDs, or patients with an ALC less than 1,000 cells/mm<sup>3</sup>, or patients treated with 10 mg twice daily may have an increased risk of herpes zoster (see section 4.4).</p><p>&nbsp;</p><p><u>Laboratory tests</u></p><p><em>Lymphocytes</em></p><p>In the controlled RA clinical studies, confirmed decreases in ALC below 500 cells/mm<sup>3</sup>&nbsp;occurred in 0.3% of patients and for ALC between 500 and 750 cells/mm<sup>3</sup>&nbsp;in 1.9% of patients for the 5 mg twice daily and 10 mg twice daily doses combined.</p><p>&nbsp;</p><p>In the RA long-term safety population, confirmed decreases in ALC below 500 cells/mm<sup>3</sup>&nbsp;occurred in 1.3% of patients and for ALC between 500 and 750 cells/mm<sup>3</sup>&nbsp;in 8.4% of patients for the 5 mg twice daily and 10 mg twice daily doses combined.</p><p>&nbsp;</p><p>Confirmed ALC less than 750 cells/mm<sup>3</sup>&nbsp;were associated with an increased incidence of serious infections (see section 4.4).</p><p>&nbsp;</p><p>In the clinical studies in UC, changes in ALC observed with tofacitinib treatment were similar to the changes observed in clinical studies in RA.</p><p>&nbsp;</p><p><em>Neutrophils</em></p><p>In the controlled RA clinical studies, confirmed decreases in ANC below 1,000 cells/mm<sup>3</sup>&nbsp;occurred in 0.08% of patients for the 5 mg twice daily and 10 mg twice daily doses combined. There were no confirmed decreases in ANC below 500 cells/mm<sup>3</sup>&nbsp;observed in any treatment group. There was no clear relationship between neutropenia and the occurrence of serious infections.</p><p>&nbsp;</p><p>In the RA long-term safety population, the pattern and incidence of confirmed decreases in ANC remained consistent with what was seen in the controlled clinical studies (see section 4.4).</p><p>&nbsp;</p><p>In the clinical studies in UC, changes in ANC observed with tofacitinib treatment were similar to the changes observed in clinical studies in RA.</p><p>&nbsp;</p><p><em>Liver enzyme tests</em></p><p>Confirmed increases in liver enzymes greater than 3 times the upper limit of normal (3x ULN) were uncommonly observed in RA patients. In those patients experiencing liver enzyme elevation, modification of treatment regimen, such as reduction in the dose of concomitant DMARD, interruption of tofacitinib, or reduction in tofacitinib dose, resulted in decrease or normalisation of liver enzymes.</p><p>In the controlled portion of the RA Phase 3 monotherapy study (0-3 months) (study I, see section 5.1), ALT elevations greater than 3x ULN were observed in 1.65%, 0.41%, and 0% of patients receiving placebo, tofacitinib 5 mg and 10 mg twice daily, respectively. In this study, AST elevations greater than 3x ULN were observed in 1.65%, 0.41% and 0% of patients receiving placebo, tofacitinib 5 mg and 10 mg twice daily, respectively.</p><p>&nbsp;</p><p>In the RA Phase 3 monotherapy study (0-24 months) (study VI, see section 5.1), ALT elevations greater than 3x ULN were observed in 7.1%, 3.0%, and 3.0% of patients receiving MTX, tofacitinib 5 mg and 10 mg twice daily, respectively. In this study, AST elevations greater than 3x ULN were observed in 3.3%, 1.6% and 1.5% of patients receiving MTX, tofacitinib 5 mg and 10 mg twice daily, respectively.</p><p>&nbsp;</p><p>In the controlled portion of the RA Phase 3 studies on background DMARDs (0-3 months) (studies II-V, see section 5.1), ALT elevations greater than 3x ULN were observed in 0.9%, 1.24% and 1.14% of patients receiving placebo, tofacitinib 5 mg and 10 mg twice daily, respectively. In these studies, AST elevations greater than 3x ULN were observed in 0.72%, 0.5% and 0.31% of patients receiving placebo, tofacitinib 5 mg and 10 mg twice daily, respectively.</p><p>&nbsp;</p><p>In the RA long-term extension studies, on monotherapy, ALT elevations greater than 3x ULN were observed in 1.1% and 1.4% of patients receiving tofacitinib 5 mg and 10 mg twice daily, respectively. AST elevations greater than 3x ULN were observed in &lt; 1.0% in both the tofacitinib 5 mg and 10 mg twice daily groups.</p><p>&nbsp;</p><p>In the RA long-term extension studies, on background DMARDs, ALT elevations greater than 3x ULN were observed in 1.8% and 1.6% of patients receiving tofacitinib 5 mg and 10 mg twice daily, respectively. AST elevations greater than 3x ULN were observed in &lt; 1.0% in both the tofacitinib 5 mg and 10 mg twice daily groups.</p><p>&nbsp;</p><p>In the clinical studies in UC, changes in liver enzyme tests observed with tofacitinib treatment were similar to the changes observed in clinical studies in RA.</p><p>&nbsp;</p><p><em>Lipids</em></p><p>Elevations in lipid parameters (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides) were first assessed at 1 month following initiation of tofacitinib in the controlled double-blind clinical trials of RA. Increases were observed at this time point and remained stable thereafter.</p><p>&nbsp;</p><p>Changes in lipid parameters from baseline through the end of the study (6-24 months) in the controlled clinical studies in RA are summarised below:</p><p>&middot;&nbsp;&nbsp;&nbsp; Mean LDL cholesterol increased by 15% in the tofacitinib 5 mg twice daily arm and 20% in the tofacitinib 10 mg twice daily arm at month 12, and increased by 16% in the tofacitinib 5 mg twice daily arm and 19% in the tofacitinib 10 mg twice daily arm at month 24.</p><p>&middot;&nbsp;&nbsp;&nbsp; Mean HDL cholesterol increased by 17% in the tofacitinib 5 mg twice daily arm and 18% in the tofacitinib 10 mg twice daily arm at month 12, and increased by 19% in the tofacitinib 5 mg twice daily arm and 20% in the tofacitinib 10 mg twice daily arm at month 24.</p><p>&nbsp;</p><p>Upon withdrawal of tofacitinib treatment, lipid levels returned to baseline.</p><p>&nbsp;</p><p>Mean LDL cholesterol/HDL cholesterol ratios and Apolipoprotein B (ApoB)/ApoA1 ratios were essentially unchanged in tofacitinib-treated patients.</p><p>&nbsp;</p><p>In an RA controlled clinical trial, elevations in LDL cholesterol and ApoB decreased to pretreatment levels in response to statin therapy.</p><p>&nbsp;</p><p>In the RA long-term safety populations, elevations in the lipid parameters remained consistent with what was seen in the controlled clinical studies.</p><p>&nbsp;</p><p>In the clinical studies in UC, changes in lipids observed with tofacitinib treatment were similar to the changes observed in clinical studies in RA.</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Arabia</p><p>The National Pharmacovigilance Center (NPC)</p><p>Fax: + (966-11) 2057662</p><p>Call NPC at: + (966-11) 2038222, Exts: 2317-2356-2340.</p><p>SFDA Call Center: 19999</p><p>e-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa/</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other GCC States</p><p>Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In case of an overdose, it is recommended that the patient be monitored for signs and symptoms of adverse reactions. There is no specific antidote for overdose with tofacitinib. Treatment should be symptomatic and supportive.</p><p>&nbsp;</p><p>Pharmacokinetic data up to and including a single dose of 100 mg in healthy volunteers indicate that more than 95% of the administered dose is expected to be eliminated within 24 hours.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic groups: Immunosuppressants, Selective Immunosuppressants; ATC code: L04AA29</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>Tofacitinib is a potent, selective inhibitor of the JAK family. In enzymatic assays, tofacitinib inhibits JAK1, JAK2, JAK3, and to a lesser extent TyK2. In contrast, tofacitinib has a high degree of selectivity against other kinases in the human genome. In human cells, tofacitinib preferentially inhibits signalling by heterodimeric cytokine receptors that associate with JAK3 and/or JAK1 with functional selectivity over cytokine receptors that signal via pairs of JAK2. Inhibition of JAK1 and JAK3 by tofacitinib attenuates signalling of interleukins (IL-2, -4, -6, -7, -9, -15, -21) and type I and type II interferons, which will result in modulation of the immune and inflammatory response.</p><p>&nbsp;</p><p><u>Pharmacodynamic effects</u></p><p>In patients with RA, treatment up to 6 months with tofacitinib was associated with dose-dependent reductions of circulating CD16/56+ natural killer (NK) cells, with estimated maximum reductions occurring at approximately 8-10 weeks after initiation of therapy. These changes generally resolved within 2-6 weeks after discontinuation of treatment. Treatment with tofacitinib was associated with dose-dependent increases in B cell counts. Changes in circulating T-lymphocyte counts and T-lymphocyte subsets (CD3+, CD4+ and CD8+) were small and inconsistent.</p><p>&nbsp;</p><p>Following long-term treatment (median duration of tofacitinib treatment of approximately 5 years), CD4+ and CD8+ counts showed median reductions of 28% and 27%, respectively, from baseline. In contrast to the observed decrease after short-term dosing, CD16/56+ natural killer cell counts showed a median increase of 73% from baseline. CD19+ B cell counts showed no further increases after long-term tofacitinib treatment. All these lymphocyte subset changes returned toward baseline after temporary discontinuation of treatment. There was no evidence of a relationship between serious or opportunistic infections or herpes zoster and lymphocyte subset counts (see section 4.2 for absolute lymphocyte count monitoring).</p><p>&nbsp;</p><p>Changes in total serum IgG, IgM, and IgA levels over 6-month tofacitinib dosing in patients with RA were small, not dose-dependent and similar to those seen on placebo, indicating a lack of systemic humoral suppression.</p><p>&nbsp;</p><p>After treatment with tofacitinib in RA patients, rapid decreases in serum C-reactive protein (CRP) were observed and maintained throughout dosing. Changes in CRP observed with tofacitinib treatment do not reverse fully within 2 weeks after discontinuation, indicating a longer duration of pharmacodynamic activity compared to the half-life.</p><p>&nbsp;</p><p><u>Vaccine studies</u></p><p>In a controlled clinical trial of patients with RA initiating tofacitinib 10 mg twice daily or placebo, the number of responders to influenza vaccine was similar in both groups: tofacitinib (57%) and placebo (62%). For pneumococcal polysaccharide vaccine the number of responders was as follows: 32% in patients receiving both tofacitinib and MTX; 62% for tofacitinib monotherapy; 62% for MTX monotherapy; and 77% for placebo. The clinical significance of this is unknown, however, similar results were obtained in a separate vaccine study with influenza and pneumococcal polysaccharide vaccines in patients receiving long-term tofacitinib 10 mg twice daily.</p><p>&nbsp;</p><p>A controlled study was conducted in patients with RA on background MTX immunised with a live attenuated virus vaccine (Zostavax<sup>&reg;</sup>) 2 to 3 weeks before initiating a 12-week treatment with tofacitinib 5 mg twice daily or placebo. Evidence of humoral and cell-mediated responses to VZV was observed in both tofacitinib and placebo-treated patients at 6 weeks. These responses were similar to those observed in healthy volunteers aged 50 years and older. A patient with no previous history of varicella infection and no anti-varicella antibodies at baseline experienced dissemination of the vaccine strain of varicella 16 days after vaccination. Tofacitinib was discontinued and the patient recovered after treatment with standard doses of antiviral medication. This patient subsequently made a robust, though delayed, humoral and cellular response to the vaccine (see section 4.4).</p><p>&nbsp;</p><p><u>Clinical efficacy and safety</u></p><p><em>Rheumatoid arthritis</em></p><p>The efficacy and safety of tofacitinib were assessed in 6 randomised, double-blind, controlled multicentre studies in patients greater than 18 years of age with active RA diagnosed according to American College of Rheumatology (ACR) criteria. Table 7 provides information regarding the pertinent study design and population characteristics.</p><p><strong>Table 7: Phase 3 Clinical Trials of Tofacitinib 5 and 10 mg Twice Daily Doses in Patients with RA</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>Studies</strong></p></td><td style="vertical-align:top"><p><strong>Study I</strong></p><p><strong>(ORAL Solo)</strong></p></td><td style="vertical-align:top"><p><strong>Study II</strong></p><p><strong>(ORAL Sync)</strong></p></td><td style="vertical-align:top"><p><strong>Study III</strong></p><p><strong>(ORAL Standard)</strong></p></td><td style="vertical-align:top"><p><strong>Study IV</strong></p><p><strong>(ORAL Scan)</strong></p></td><td style="vertical-align:top"><p><strong>Study V (ORAL Step)</strong></p></td><td style="vertical-align:top"><p><strong>Study VI (ORAL Start)</strong></p></td><td style="vertical-align:top"><p><strong>Study VII</strong></p><p><strong>(ORAL Strategy)</strong></p></td></tr><tr><td style="vertical-align:top"><p>Population</p></td><td style="vertical-align:top"><p>DMARD-IR</p></td><td style="vertical-align:top"><p>DMARD-IR</p></td><td style="vertical-align:top"><p>MTX-IR</p></td><td style="vertical-align:top"><p>MTX-IR</p></td><td style="vertical-align:top"><p>TNFi-IR</p></td><td style="vertical-align:top"><p>MTX-na&iuml;ve<sup>a</sup></p></td><td style="vertical-align:top"><p>MTX-IR</p></td></tr><tr><td style="vertical-align:top"><p>Control</p></td><td style="vertical-align:top"><p>Placebo</p></td><td style="vertical-align:top"><p>Placebo</p></td><td style="vertical-align:top"><p>Placebo</p></td><td style="vertical-align:top"><p>Placebo</p></td><td style="vertical-align:top"><p>Placebo</p></td><td style="vertical-align:top"><p>MTX</p></td><td style="vertical-align:top"><p>MTX,</p><p>ADA</p></td></tr><tr><td style="vertical-align:top"><p>Background treatment</p></td><td style="vertical-align:top"><p>None<sup>b</sup></p></td><td style="vertical-align:top"><p>csDMARDs</p></td><td style="vertical-align:top"><p>MTX</p></td><td style="vertical-align:top"><p>MTX</p></td><td style="vertical-align:top"><p>MTX</p></td><td style="vertical-align:top"><p>None<sup>b</sup></p></td><td style="vertical-align:top"><p>3 Parallel arms:</p><p>&bull; Tofacitinib monotherapy</p><p>&bull;&nbsp;Tofacitinib+MTX</p><p>&bull; ADA+MTX</p></td></tr><tr><td style="vertical-align:top"><p>Key features</p></td><td style="vertical-align:top"><p>Monotherapy</p></td><td style="vertical-align:top"><p>Various csDMARDs</p></td><td style="vertical-align:top"><p>Active control (ADA)</p></td><td style="vertical-align:top"><p>X-Ray</p></td><td style="vertical-align:top"><p>TNFi-IR</p></td><td style="vertical-align:top"><p>Monotherapy, Active comparator (MTX), X-Ray</p></td><td style="vertical-align:top"><p>Tofacitinib with and without MTX in comparison to ADA with MTX</p></td></tr><tr><td style="vertical-align:top"><p>Number of patients treated</p></td><td style="vertical-align:top"><p>610</p></td><td style="vertical-align:top"><p>792</p></td><td style="vertical-align:top"><p>717</p></td><td style="vertical-align:top"><p>797</p></td><td style="vertical-align:top"><p>399</p></td><td style="vertical-align:top"><p>956</p></td><td style="vertical-align:top"><p>1,146</p></td></tr><tr><td style="vertical-align:top"><p>Total study duration</p></td><td style="vertical-align:top"><p>6 months</p></td><td style="vertical-align:top"><p>1 year</p></td><td style="vertical-align:top"><p>1 year</p></td><td style="vertical-align:top"><p>2 years</p></td><td style="vertical-align:top"><p>6 months</p></td><td style="vertical-align:top"><p>2 years</p></td><td style="vertical-align:top"><p>1 year</p></td></tr><tr><td style="vertical-align:top"><p>Co-primary efficacy endpoints<sup>c</sup></p></td><td style="vertical-align:top"><p>Month 3:</p><p>ACR20</p><p>HAQ-DI</p><p>DAS28-4(ESR)&lt;2.6</p></td><td style="vertical-align:top"><p>Month 6:</p><p>ACR20</p><p>DAS28-4(ESR)&lt;2.6</p><p>Month 3:</p><p>HAQ-DI</p></td><td style="vertical-align:top"><p>Month 6:</p><p>ACR20</p><p>DAS28-4(ESR)&lt;2.6</p><p>Month 3:</p><p>HAQ-DI</p></td><td style="vertical-align:top"><p>Month 6:</p><p>ACR20</p><p>mTSS</p><p>DAS28-4(ESR)&lt;2.6</p><p>Month 3:</p><p>HAQ-DI</p></td><td style="vertical-align:top"><p>Month 3:</p><p>ACR20</p><p>HAQ-DI</p><p>DAS28-4(ESR)&lt;2.6</p></td><td style="vertical-align:top"><p>Month 6:</p><p>mTSS</p><p>ACR70</p></td><td style="vertical-align:top"><p>Month 6:</p><p>ACR50</p></td></tr><tr><td style="vertical-align:top"><p>Time of mandatory placebo rescue to tofacitinib 5 or 10 mg twice daily</p></td><td style="vertical-align:top"><p>Month 3</p></td><td colspan="3" style="vertical-align:top"><p>Month 6 (placebo subjects with &lt; 20% improvement in swollen and tender joint counts advanced to tofacitinib at month 3)</p></td><td style="vertical-align:top"><p>Month 3</p></td><td style="vertical-align:top"><p>NA</p></td><td style="vertical-align:top"><p>NA</p></td></tr><tr><td colspan="7" style="vertical-align:top"><p><sup>a.</sup>&nbsp;&le;3 weekly doses (MTX-na&iuml;ve).</p><p><sup>b.</sup>Antimalarials were allowed.</p><p><sup>c.</sup>&nbsp;Co-primary endpoints as follows: mean change from baseline in mTSS; percent of subjects achieving ACR20 or ACR70 responses; mean change from baseline in HAQ-DI; percent of subjects achieving a DAS28-4(ESR) &lt;2.6 (remission).</p><p>mTSS=modified Total Sharp Score, ACR20(70) =American College of Rheumatology &ge;20% (&ge;70%) improvement, DAS28=Disease Activity Score 28 joints, ESR=Erythrocyte Sedimentation Rate, HAQ-DI=Health Assessment Questionnaire Disability Index, DMARD=disease-modifying antirheumatic drug, IR=inadequate responder, csDMARD=conventional synthetic DMARD, TNFi=tumour necrosis factor inhibitor, NA=not applicable, ADA=adalimumab, MTX=methotrexate.</p></td><td style="vertical-align:top">&nbsp;</td></tr></tbody></table><p>&nbsp;</p><p><u>Clinical response</u></p><p><em>ACR response</em></p><p>The percentages of tofacitinib-treated patients achieving ACR20, ACR50 and ACR70 responses in studies ORAL Solo, ORAL Sync, ORAL Standard, ORAL Scan, ORAL Step, ORAL Start, and ORAL Strategy are shown in Table 8. In all studies, patients treated with either 5 or 10 mg twice daily tofacitinib had statistically significant ACR20, ACR50 and ACR70 response rates at month 3 and month 6 versus placebo (or versus MTX in ORAL Start) treated patients.</p><p>&nbsp;</p><p>Over the course of ORAL Strategy, responses with tofacitinib 5 mg twice daily + MTX were numerically similar compared to adalimumab 40 mg + MTX and both were numerically higher than tofacitinib 5 mg twice daily.</p><p>&nbsp;</p><p>The treatment effect was similar in patients independent of rheumatoid factor status, age, gender, race, or disease status. Time to onset was rapid (as early as week 2 in studies ORAL Solo, ORAL Sync, and ORAL Step) and the magnitude of response continued to improve with duration of treatment. As with the overall ACR response in patients treated with 5 mg or 10 mg twice daily tofacitinib, each of the components of the ACR response was consistently improved from baseline including: tender and swollen joint counts; patient and physician global assessment; disability index scores; pain assessment and CRP compared to patients receiving placebo plus MTX or other DMARDs in all studies.</p><p>&nbsp;</p><p><strong>Table 8: Proportion (%) of Patients with an ACR Response</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td colspan="6"><p><strong>ORAL Solo:</strong>&nbsp;<strong>DMARD Inadequate Responders</strong></p></td></tr><tr><td><p><strong>Endpoint</strong></p></td><td><p><strong>Time</strong></p></td><td><p><strong>Placebo</strong></p><p><strong>N=122</strong></p></td><td colspan="2"><p><strong>Tofacitinib 5 mg Twice Daily Monotherapy</strong></p><p><strong>N=241</strong></p></td><td><p><strong>Tofacitinib 10 mg Twice Daily Monotherapy</strong></p><p><strong>N=243</strong></p></td></tr><tr><td rowspan="2"><p>ACR20</p></td><td><p>Month 3</p></td><td><p>26</p></td><td colspan="2"><p>60***</p></td><td><p>65***</p></td></tr><tr><td><p>Month 6</p></td><td><p>NA</p></td><td colspan="2"><p>69</p></td><td><p>71</p></td></tr><tr><td rowspan="2"><p>ACR50</p></td><td><p>Month 3</p></td><td><p>12</p></td><td colspan="2"><p>31***</p></td><td><p>37***</p></td></tr><tr><td><p>Month 6</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2"><p>42</p></td><td><p>47</p></td></tr><tr><td rowspan="2"><p>ACR70</p></td><td><p>Month 3</p></td><td><p>6</p></td><td colspan="2"><p>15*</p></td><td><p>20***</p></td></tr><tr><td><p>Month 6</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2"><p>22</p></td><td><p>29</p></td></tr><tr><td colspan="6"><p><strong>ORAL Sync:</strong>&nbsp;<strong>DMARD Inadequate Responders</strong></p></td></tr><tr><td><p><strong>Endpoint</strong></p></td><td><p><strong>Time</strong></p></td><td><p><strong>Placebo + DMARD(s)</strong></p><p><strong>N=158</strong></p></td><td colspan="2"><p><strong>Tofacitinib 5 mg Twice Daily + DMARD(s)</strong></p><p><strong>N=312</strong></p></td><td><p><strong>Tofacitinib 10 mg Twice Daily + DMARD(s)</strong></p><p><strong>N=315</strong></p></td></tr><tr><td rowspan="3"><p>ACR20</p></td><td><p>Month 3</p></td><td style="vertical-align:top"><p>27</p></td><td colspan="2" style="vertical-align:top"><p>56***</p></td><td style="vertical-align:top"><p>63***</p></td></tr><tr><td><p>Month 6</p></td><td style="vertical-align:top"><p>31</p></td><td colspan="2" style="vertical-align:top"><p>53***</p></td><td style="vertical-align:top"><p>57***</p></td></tr><tr><td><p>Month 12</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2" style="vertical-align:top"><p>51</p></td><td style="vertical-align:top"><p>56</p></td></tr><tr><td rowspan="3"><p>ACR50</p></td><td><p>Month 3</p></td><td style="vertical-align:top"><p>9</p></td><td colspan="2" style="vertical-align:top"><p>27***</p></td><td style="vertical-align:top"><p>33***</p></td></tr><tr><td><p>Month 6</p></td><td style="vertical-align:top"><p>13</p></td><td colspan="2" style="vertical-align:top"><p>34***</p></td><td style="vertical-align:top"><p>36***</p></td></tr><tr><td><p>Month 12</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2" style="vertical-align:top"><p>33</p></td><td style="vertical-align:top"><p>42</p></td></tr><tr><td rowspan="3"><p>ACR70</p></td><td><p>Month 3</p></td><td style="vertical-align:top"><p>2</p></td><td colspan="2" style="vertical-align:top"><p>8**</p></td><td style="vertical-align:top"><p>14***</p></td></tr><tr><td><p>Month 6</p></td><td style="vertical-align:top"><p>3</p></td><td colspan="2" style="vertical-align:top"><p>13***</p></td><td style="vertical-align:top"><p>16***</p></td></tr><tr><td><p>Month 12</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2" style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>25</p></td></tr><tr><td colspan="6"><p><strong>ORAL Standard: MTX Inadequate Responders</strong></p></td></tr><tr><td><p><strong>Endpoint</strong></p></td><td><p><strong>Time</strong></p></td><td><p><strong>Placebo</strong></p></td><td colspan="2"><p><strong>Tofacitinib Twice Daily + MTX</strong></p></td><td><p><strong>Adalimumab 40 mg QOW + MTX</strong></p></td></tr><tr><td rowspan="4"><p>ACR20</p></td><td style="vertical-align:top">&nbsp;</td><td><p><strong>N=105</strong></p></td><td><p><strong>5 mg</strong></p><p><strong>N=198</strong></p></td><td><p><strong>10 mg</strong></p><p><strong>N=197</strong></p></td><td><p><strong>N=199</strong></p></td></tr><tr><td style="vertical-align:top"><p>Month 3</p></td><td><p>26</p></td><td><p>59***</p></td><td><p>57***</p></td><td><p>56***</p></td></tr><tr><td style="vertical-align:top"><p>Month 6</p></td><td style="vertical-align:top"><p>28</p></td><td><p>51***</p></td><td><p>51***</p></td><td><p>46**</p></td></tr><tr><td><p>Month 12</p></td><td style="vertical-align:top"><p>NA</p></td><td><p>48</p></td><td><p>49</p></td><td><p>48</p></td></tr><tr><td rowspan="3"><p>ACR50</p></td><td><p>Month 3</p></td><td><p>7</p></td><td><p>33***</p></td><td><p>27***</p></td><td><p>24***</p></td></tr><tr><td><p>Month 6</p></td><td><p>12</p></td><td><p>36***</p></td><td><p>34***</p></td><td><p>27**</p></td></tr><tr><td><p>Month 12</p></td><td style="vertical-align:top"><p>NA</p></td><td><p>36</p></td><td><p>36</p></td><td><p>33</p></td></tr><tr><td rowspan="3"><p>ACR70</p></td><td><p>Month 3</p></td><td><p>2</p></td><td><p>12**</p></td><td><p>15***</p></td><td><p>9*</p></td></tr><tr><td><p>Month 6</p></td><td><p>2</p></td><td><p>19***</p></td><td><p>21***</p></td><td><p>9*</p></td></tr><tr><td><p>Month 12</p></td><td style="vertical-align:top"><p>NA</p></td><td><p>22</p></td><td><p>23</p></td><td><p>17</p></td></tr><tr><td colspan="6"><p><strong>ORAL Scan: MTX Inadequate Responders</strong></p></td></tr><tr><td><p><strong>Endpoint</strong></p></td><td><p><strong>Time</strong></p></td><td><p><strong>Placebo + MTX</strong></p><p><strong>N=156</strong></p></td><td colspan="2"><p><strong>Tofacitinib 5 mg Twice Daily + MTX</strong></p><p><strong>N=316</strong></p></td><td><p><strong>Tofacitinib 10 mg Twice Daily + MTX</strong></p><p><strong>N=309</strong></p></td></tr><tr><td rowspan="4"><p>ACR20</p></td><td><p>Month 3</p></td><td><p>27</p></td><td colspan="2"><p>55***</p></td><td><p>66***</p></td></tr><tr><td><p>Month 6</p></td><td><p>25</p></td><td colspan="2"><p>50***</p></td><td><p>62***</p></td></tr><tr><td><p>Month 12</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2"><p>47</p></td><td><p>55</p></td></tr><tr><td><p>Month 24</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2"><p>40</p></td><td><p>50</p></td></tr><tr><td rowspan="4"><p>ACR50</p></td><td><p>Month 3</p></td><td><p>8</p></td><td colspan="2"><p>28***</p></td><td><p>36***</p></td></tr><tr><td><p>Month 6</p></td><td><p>8</p></td><td colspan="2"><p>32***</p></td><td><p>44***</p></td></tr><tr><td><p>Month 12</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2"><p>32</p></td><td><p>39</p></td></tr><tr><td><p>Month 24</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2"><p>28</p></td><td><p>40</p></td></tr><tr><td rowspan="4"><p>ACR70</p></td><td><p>Month 3</p></td><td><p>3</p></td><td colspan="2"><p>10**</p></td><td><p>17***</p></td></tr><tr><td><p>Month 6</p></td><td><p>1</p></td><td colspan="2"><p>14***</p></td><td><p>22***</p></td></tr><tr><td><p>Month 12</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2"><p>18</p></td><td><p>27</p></td></tr><tr><td><p>Month 24</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2"><p>17</p></td><td><p>26</p></td></tr><tr><td colspan="6"><p><strong>ORAL Step: TNF Inhibitor Inadequate Responders</strong></p></td></tr><tr><td><p><strong>Endpoint</strong></p></td><td><p><strong>Time</strong></p></td><td><p><strong>Placebo + MTX</strong></p><p><strong>N=132</strong></p></td><td colspan="2"><p><strong>Tofacitinib 5 mg Twice Daily + MTX</strong></p><p><strong>N=133</strong></p></td><td><p><strong>Tofacitinib 10 mg Twice Daily + MTX</strong></p><p><strong>N=134</strong></p></td></tr><tr><td rowspan="2"><p>ACR20</p></td><td><p>Month 3</p></td><td><p>24</p></td><td colspan="2"><p>41*</p></td><td><p>48***</p></td></tr><tr><td><p>Month 6</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2"><p>51</p></td><td><p>54</p></td></tr><tr><td rowspan="2"><p>ACR50</p></td><td><p>Month 3</p></td><td><p>8</p></td><td colspan="2"><p>26***</p></td><td><p>28***</p></td></tr><tr><td><p>Month 6</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2"><p>37</p></td><td><p>30</p></td></tr><tr><td rowspan="2"><p>ACR70</p></td><td><p>Month 3</p></td><td><p>2</p></td><td colspan="2"><p>14***</p></td><td><p>10*</p></td></tr><tr><td><p>Month 6</p></td><td style="vertical-align:top"><p>NA</p></td><td colspan="2"><p>16</p></td><td><p>16</p></td></tr><tr><td colspan="6"><p><strong>ORAL Start: MTX-na&iuml;ve</strong></p></td></tr><tr><td><p><strong>Endpoint</strong></p></td><td><p><strong>Time</strong></p></td><td><p><strong>MTX</strong></p><p><strong>N=184</strong></p></td><td colspan="2"><p><strong>Tofacitinib 5 mg Twice Daily</strong></p><p><strong>Monotherapy</strong></p><p><strong>N=370</strong></p></td><td><p><strong>Tofacitinib 10 mg Twice Daily</strong></p><p><strong>Monotherapy</strong></p><p><strong>N=394</strong></p></td></tr><tr><td rowspan="4"><p>ACR20</p></td><td><p>Month 3</p></td><td><p>52</p></td><td colspan="2"><p>69***</p></td><td><p>77***</p></td></tr><tr><td><p>Month 6</p></td><td><p>51</p></td><td colspan="2"><p>71***</p></td><td><p>75***</p></td></tr><tr><td><p>Month 12</p></td><td><p>51</p></td><td colspan="2"><p>67**</p></td><td><p>71***</p></td></tr><tr><td><p>Month 24</p></td><td><p>42</p></td><td colspan="2"><p>63***</p></td><td><p>64***</p></td></tr><tr><td rowspan="4"><p>ACR50</p></td><td><p>Month 3</p></td><td><p>20</p></td><td colspan="2"><p>40***</p></td><td><p>49***</p></td></tr><tr><td><p>Month 6</p></td><td><p>27</p></td><td colspan="2"><p>46***</p></td><td><p>56***</p></td></tr><tr><td><p>Month 12</p></td><td><p>33</p></td><td colspan="2"><p>49**</p></td><td><p>55***</p></td></tr><tr><td><p>Month 24</p></td><td><p>28</p></td><td colspan="2"><p>48***</p></td><td><p>49***</p></td></tr><tr><td rowspan="4"><p>ACR70</p></td><td><p>Month 3</p></td><td><p>5</p></td><td colspan="2"><p>20***</p></td><td><p>26***</p></td></tr><tr><td><p>Month 6</p></td><td><p>12</p></td><td colspan="2"><p>25***</p></td><td><p>37***</p></td></tr><tr><td><p>Month 12</p></td><td><p>15</p></td><td colspan="2"><p>28**</p></td><td><p>38***</p></td></tr><tr><td><p>Month 24</p></td><td><p>15</p></td><td colspan="2"><p>34***</p></td><td><p>37***</p></td></tr><tr><td colspan="6"><p><strong>ORAL Strategy:</strong>&nbsp;<strong>MTX Inadequate Responders</strong></p></td></tr><tr><td><p><strong>Endpoint</strong></p></td><td><p><strong>Time</strong></p></td><td><p><strong>Tofacitinib 5 mg Twice Daily</strong></p><p><strong>N=384</strong></p></td><td colspan="2"><p><strong>Tofacitinib 5 mg Twice Daily + MTX</strong></p><p><strong>N=376</strong></p></td><td><p><strong>Adalimumab + MTX</strong></p><p><strong>N=386</strong></p></td></tr><tr><td rowspan="3"><p>ACR20</p></td><td><p>Month 3</p></td><td><p>62.50</p></td><td colspan="2"><p>70.48ǂ</p></td><td><p>69.17</p></td></tr><tr><td><p>Month 6</p></td><td><p>62.84</p></td><td colspan="2"><p>73.14ǂ</p></td><td><p>70.98</p></td></tr><tr><td><p>Month 12</p></td><td><p>61.72</p></td><td colspan="2"><p>70.21ǂ</p></td><td><p>67.62</p></td></tr><tr><td rowspan="3"><p>ACR50</p></td><td><p>Month 3</p></td><td><p>31.51</p></td><td colspan="2"><p>40.96ǂ</p></td><td><p>37.31</p></td></tr><tr><td><p>Month 6</p></td><td><p>38.28</p></td><td colspan="2"><p>46.01ǂ</p></td><td><p>43.78</p></td></tr><tr><td><p>Month 12</p></td><td><p>39.31</p></td><td colspan="2"><p>47.61ǂ</p></td><td><p>45.85</p></td></tr><tr><td rowspan="3"><p>ACR70</p></td><td><p>Month 3</p></td><td><p>13.54</p></td><td colspan="2"><p>19.41ǂ</p></td><td><p>14.51</p></td></tr><tr><td><p>Month 6</p></td><td><p>18.23</p></td><td colspan="2"><p>25.00ǂ</p></td><td><p>20.73</p></td></tr><tr><td><p>Month 12</p></td><td><p>21.09</p></td><td colspan="2"><p>28.99ǂ</p></td><td><p>25.91</p></td></tr><tr><td colspan="6"><p>*p&lt;0.05</p><p>**p&lt;0.001</p><p>***p&lt;0.0001 verses placebo (versus MTX for ORAL Start)</p><p><sup>ǂ</sup>p&lt;0.05 &ndash; tofacitinib 5 mg + MTX versus tofacitinib 5 mg for ORAL Strategy (normal p-values without multiple comparison adjustment)</p><p>QOW=every other week, N=number of subjects analysed, ACR20/50/70=American College of Rheumatology &ge;20, 50, 70% improvement, NA=not applicable, MTX=methotrexate.</p></td></tr></tbody></table><p><em>&nbsp;</em></p><p><em>DAS28-4(ESR) response</em></p><p>Patients in the Phase 3 studies had a mean Disease Activity Score (DAS28-4[ESR]) of 6.1-6.7 at baseline. Significant reductions in DAS28-4(ESR) from baseline (mean improvement) of 1.8-2.0 and 1.9-2.2 were observed in patients treated with 5 mg and 10 mg twice daily doses, respectively, compared to placebo-treated patients (0.7-1.1) at month 3. The proportion of patients achieving a DAS28 clinical remission (DAS28-4(ESR) &lt; 2.6) in ORAL Step, ORAL Sync, and ORAL Standard is shown in Table 9.</p><p>&nbsp;</p><p><strong>Table 9: Number (%) of Subjects Achieving DAS28-4(ESR) &lt; 2.6 Remission at Months 3 and 6</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p><strong>Time Point</strong></p></td><td style="vertical-align:top"><p><strong>N</strong></p></td><td style="vertical-align:top"><p><strong>%</strong></p></td></tr><tr><td colspan="4" style="vertical-align:top"><p><strong>ORAL Step: TNF Inhibitor Inadequate Responders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Tofacitinib 5 mg twice daily + MTX</p></td><td style="vertical-align:top"><p>Month 3</p></td><td style="vertical-align:top"><p>133</p></td><td style="vertical-align:top"><p>6</p></td></tr><tr><td style="vertical-align:top"><p>Tofacitinib 10 mg twice daily + MTX</p></td><td style="vertical-align:top"><p>Month 3</p></td><td style="vertical-align:top"><p>134</p></td><td style="vertical-align:top"><p>8*</p></td></tr><tr><td style="vertical-align:top"><p>Placebo + MTX</p></td><td style="vertical-align:top"><p>Month 3</p></td><td style="vertical-align:top"><p>132</p></td><td style="vertical-align:top"><p>2</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p><strong>ORAL Sync: DMARD Inadequate Responders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Tofacitinib 5 mg twice daily</p></td><td style="vertical-align:top"><p>Month 6</p></td><td style="vertical-align:top"><p>312</p></td><td style="vertical-align:top"><p>8*</p></td></tr><tr><td style="vertical-align:top"><p>Tofacitinib 10 mg twice daily</p></td><td style="vertical-align:top"><p>Month 6</p></td><td style="vertical-align:top"><p>315</p></td><td style="vertical-align:top"><p>11***</p></td></tr><tr><td style="vertical-align:top"><p>Placebo</p></td><td style="vertical-align:top"><p>Month 6</p></td><td style="vertical-align:top"><p>158</p></td><td style="vertical-align:top"><p>3</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p><strong>ORAL Standard: MTX Inadequate Responders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Tofacitinib 5 mg twice daily + MTX</p></td><td style="vertical-align:top"><p>Month 6</p></td><td style="vertical-align:top"><p>198</p></td><td style="vertical-align:top"><p>6*</p></td></tr><tr><td style="vertical-align:top"><p>Tofacitinib 10 mg twice daily + MTX</p></td><td style="vertical-align:top"><p>Month 6</p></td><td style="vertical-align:top"><p>197</p></td><td style="vertical-align:top"><p>11***</p></td></tr><tr><td style="vertical-align:top"><p>Adalimumab 40 mg SC QOW + MTX</p></td><td style="vertical-align:top"><p>Month 6</p></td><td style="vertical-align:top"><p>199</p></td><td style="vertical-align:top"><p>6*</p></td></tr><tr><td style="vertical-align:top"><p>Placebo + MTX</p></td><td style="vertical-align:top"><p>Month 6</p></td><td style="vertical-align:top"><p>105</p></td><td style="vertical-align:top"><p>1</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p>*p &lt;0.05, ***p&lt;0.0001 versus placebo, SC=subcutaneous, QOW=every other week, N=number of subjects analysed, DAS28=Disease Activity Scale 28 joints, ESR=Erythrocyte Sedimentation Rate.</p></td></tr></tbody></table><p><em>&nbsp;</em></p><p><em>Radiographic response</em></p><p>In ORAL Scan and ORAL Start, inhibition of progression of structural joint damage was assessed radiographically and expressed as mean change from baseline in mTSS and its components, the erosion score and joint space narrowing (JSN) score, at months 6 and 12.</p><p>&nbsp;</p><p>In ORAL Scan, tofacitinib 10 mg twice daily plus background MTX resulted in significantly greater inhibition of the progression of structural damage compared to placebo plus MTX at months 6 and 12. When given at a dose of 5 mg twice daily, tofacitinib plus MTX exhibited similar effects on mean progression of structural damage (not statistically significant). Analysis of erosion and JSN scores were consistent with overall results.</p><p>&nbsp;</p><p>In the placebo plus MTX group, 78% of patients experienced no radiographic progression (mTSS change less than or equal to 0.5) at month 6 compared to 89% and 87% of patients treated with tofacitinib 5 or 10 mg (plus MTX) twice daily respectively, (both significant versus placebo plus MTX).</p><p>&nbsp;</p><p>In ORAL Start, tofacitinib monotherapy resulted in significantly greater inhibition of the progression of structural damage compared to MTX at months 6 and 12 as shown in Table 10, which was also maintained at month 24. Analyses of erosion and JSN scores were consistent with overall results.</p><p>&nbsp;</p><p>In the MTX group, 70% of patients experienced no radiographic progression at month 6 compared to 83% and 90% of patients treated with tofacitinib 5 or 10 mg twice daily respectively, both significant versus MTX.</p><p>&nbsp;</p><p><strong>Table 10: Radiographic Changes at Months 6 and 12</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top">&nbsp;</td><td colspan="5" style="vertical-align:top"><p><strong>ORAL Scan: MTX Inadequate Responders</strong></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p><strong>Placebo + MTX</strong></p><p><strong>N=139</strong></p><p><strong>Mean (SD)<sup>a</sup></strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 5 mg Twice Daily + MTX</strong></p><p><strong>N=277</strong></p><p><strong>Mean (SD)<sup>a</sup></strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 5 mg Twice Daily + MTX</strong></p><p><strong>Mean Difference from Placebo<sup>b</sup>&nbsp;(CI)</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 10 mg Twice Daily + MTX</strong></p><p><strong>N=290</strong></p><p><strong>Mean (SD)<sup>a</sup></strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 10 mg Twice Daily + MTX</strong></p><p><strong>Mean Difference from Placebo<sup>b</sup></strong></p><p><strong>(CI)</strong></p></td></tr><tr><td style="vertical-align:top"><p>mTSS<strong><sup>c</sup></strong></p><p>Baseline</p><p>Month 6</p><p>Month 12</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>33 (42)</p><p>0.5 (2.0)</p><p>1.0 (3.9)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>31 (48)</p><p>0.1 (1.7)</p><p>0.3 (3.0)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-</p><p>-0.3 (-0.7, 0.0)</p><p>-0.6 (-1.3, 0.0)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>37 (54)</p><p>0.1 (2.0)</p><p>0.1 (2.9)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-</p><p>-0.4 (-0.8, 0.0)</p><p>-0.9 (-1.5, -0.2)</p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td colspan="5" style="vertical-align:top"><p><strong>ORAL Start: MTX-na&iuml;ve</strong></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p><strong>MTX</strong></p><p><strong>N=168</strong></p><p><strong>Mean (SD)<sup>a</sup></strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 5 mg Twice Daily</strong></p><p><strong>N=344</strong></p><p><strong>Mean (SD)<sup>a</sup></strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 5 mg Twice Daily Mean Difference from MTX<sup>d</sup>&nbsp;(CI)</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 10 mg Twice Daily N=368</strong></p><p><strong>Mean (SD)<sup>a</sup></strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 10 mg Twice Daily Mean Difference from MTX<sup>d</sup>&nbsp;(CI)</strong></p></td></tr><tr><td style="vertical-align:top"><p>mTSS<strong><sup>c</sup></strong></p><p>Baseline</p><p>Month 6</p><p>Month 12</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>16 (29)</p><p>0.9 (2.7)</p><p>1.3 (3.7)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>20 (41)</p><p>0.2 (2.3)</p><p>0.4 (3.0)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-</p><p>-0.7 (-1.0, -0.3)</p><p>-0.9 (-1.4, -0.4)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>19 (39)</p><p>0.0 (1.2)</p><p>0.0 (1.5)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-</p><p>-0.8 (-1.2, -0.4)</p><p>-1.3 (-1.8, -0.8)</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>a&nbsp;SD = Standard Deviation</p><p>b&nbsp;Difference between least squares means tofacitinib minus placebo (95% CI = 95% confidence interval)</p><p>c&nbsp;Month 6 and month 12 data are mean change from baseline</p><p>d&nbsp;Difference between least squares means tofacitinib minus MTX (95% CI = 95% confidence interval)</p></td></tr></tbody></table><p><em>&nbsp;</em></p><p><em>Physical function response and health-related outcomes</em></p><p>Tofacitinib, alone or in combination with MTX, has shown improvements in physical function, as measured by the HAQ-DI. Patients receiving tofacitinib 5 or 10 mg twice daily demonstrated significantly greater improvement from baseline in physical functioning compared to placebo at month 3 (studies ORAL Solo, ORAL Sync, ORAL Standard, and ORAL Step) and month 6 (studies ORAL Sync and ORAL Standard). Tofacitinib 5 or 10 mg twice daily-treated patients demonstrated significantly greater improvement in physical functioning compared to placebo as early as week 2 in ORAL Solo and ORAL Sync. Changes from baseline in HAQ-DI in studies ORAL Standard, ORAL Step and ORAL Sync are shown in Table 11.</p><p>&nbsp;</p><p><strong>Table 11: LS Mean Change from Baseline in HAQ-DI at Month 3</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>Placebo + MTX</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 5 mg Twice Daily + MTX</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 10 mg Twice Daily + MTX</strong></p></td><td style="vertical-align:top"><p><strong>Adalimumab 40 mg QOW + MTX</strong></p></td></tr><tr><td colspan="4" style="vertical-align:top"><p><strong>ORAL Standard: MTX Inadequate Responders</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>N=96</strong></p></td><td style="vertical-align:top"><p><strong>N=185</strong></p></td><td style="vertical-align:top"><p><strong>N=183</strong></p></td><td style="vertical-align:top"><p><strong>N=188</strong></p></td></tr><tr><td><p>-0.24</p></td><td><p>-0.54***</p></td><td><p>-0.61***</p></td><td><p>-0.50***</p></td></tr><tr><td colspan="4"><p><strong>ORAL Step: TNF Inhibitor Inadequate Responders</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>N=118</strong></p></td><td style="vertical-align:top"><p><strong>N=117</strong></p></td><td style="vertical-align:top"><p><strong>N=125</strong></p></td><td style="vertical-align:top"><p>NA</p></td></tr><tr><td><p>-0.18</p></td><td><p>-0.43***</p></td><td><p>-0.46***</p></td><td><p>NA</p></td></tr><tr><td style="vertical-align:top"><p><strong>Placebo + DMARD(s)</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 5 mg Twice Daily + DMARD(s)</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 10 mg Twice Daily + DMARD(s)</strong></p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td colspan="4"><p><strong>ORAL Sync: DMARD Inadequate Responders</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>N=147</strong></p></td><td style="vertical-align:top"><p><strong>N=292</strong></p></td><td style="vertical-align:top"><p><strong>N=292</strong></p></td><td style="vertical-align:top"><p>NA</p></td></tr><tr><td style="vertical-align:top"><p>-0.21</p></td><td style="vertical-align:top"><p>-0.46***</p></td><td style="vertical-align:top"><p>-0.56***</p></td><td style="vertical-align:top"><p>NA</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p>*** p&lt;0.0001, tofacitinib versus placebo + MTX, LS = least squares, N = number of patients, QOW = every other week, NA = not applicable, HAQ-DI = Health Assessment Questionnaire Disability Index</p></td></tr></tbody></table><p>&nbsp;</p><p>Health-related quality of life was assessed by the Short Form Health Survey (SF-36). Patients receiving either 5 or 10 mg tofacitinib twice daily experienced significantly greater improvement from baseline compared to placebo in all 8 domains as well as the Physical Component Summary and Mental Component Summary scores at month 3 in ORAL Solo, ORAL Scan and ORAL Step. In ORAL Scan, mean SF-36 improvements were maintained to 12 months in tofacitinib-treated patients.</p><p>&nbsp;</p><p>Improvement in fatigue was evaluated by the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale at month 3 in all studies. Patients receiving tofacitinib 5 or 10 mg twice daily demonstrated significantly greater improvement from baseline in fatigue compared to placebo in all 5 studies. In ORAL Standard and ORAL Scan, mean FACIT-F improvements were maintained to 12 months in tofacitinib-treated patients.</p><p>Improvement in sleep was assessed using the Sleep Problems Index I and II summary scales of the Medical Outcomes Study Sleep (MOS-Sleep) measure at month 3 in all studies. Patients receiving tofacitinib 5 or 10 mg twice daily demonstrated significantly greater improvement from baseline in both scales compared to placebo in ORAL Sync, ORAL Standard and ORAL Scan. In ORAL Standard and ORAL Scan, mean improvements in both scales were maintained to 12 months in tofacitinib-treated patients.</p><p>&nbsp;</p><p><u>Durability of clinical responses</u></p><p>Durability of effect was assessed by ACR20, ACR50, ACR70 response rates in studies of duration of up to two years. Changes in mean HAQ-DI and DAS28-4(ESR) were maintained in both tofacitinib treatment groups through to the end of the studies.</p><p>&nbsp;</p><p>Evidence of persistence of efficacy with tofacitinib treatment for up to 7 years is also provided from data in the one ongoing and one completed open-label, long-term follow-up studies.</p><p>&nbsp;</p><p><em>Psoriatic arthritis</em></p><p>The efficacy and safety of tofacitinib were assessed in 2 randomised, double-blind, placebo-controlled Phase 3 studies in adult patients with active PsA (&ge; 3 swollen and &ge; 3 tender joints). Patients were required to have active plaque psoriasis at the screening visit. For both studies, the primary endpoints were ACR20 response rate and change from baseline in HAQ-DI at month 3.</p><p>&nbsp;</p><p>Study PsA-I (OPAL BROADEN) evaluated 422 patients who had a previous inadequate response (due to lack of efficacy or intolerance) to a csDMARD (MTX for 92.7% of patients); 32.7% of the patients in this study had a previous inadequate response to &gt; 1 csDMARD or 1 csDMARD and a targeted synthetic DMARD (tsDMARD). In OPAL BROADEN, previous treatment with TNF inhibitor was not allowed. All patients were required to have 1 concomitant csDMARD; 83.9% of patients received concomitant MTX, 9.5% of patients received concomitant sulfasalazine, and 5.7% of patients received concomitant leflunomide. The median PsA disease duration was 3.8 years. At baseline, 79.9% and 56.2% of patients had enthesitis and dactylitis, respectively. Patients randomised to tofacitinib received 5 mg twice daily or tofacitinib 10 mg twice daily for 12 months. Patients randomised to placebo were advanced in a blinded manner at month 3 to either tofacitinib 5 mg twice daily or tofacitinib 10 mg twice daily and received treatment until month 12. Patients randomised to adalimumab (active-control arm) received 40 mg subcutaneously every 2 weeks for 12 months.</p><p>&nbsp;</p><p>Study PsA-II (OPAL BEYOND) evaluated 394 patients who had discontinued a TNF inhibitor due to lack of efficacy or intolerance; 36.0% had a previous inadequate response to &gt; 1 biological DMARD. All patients were required to have 1 concomitant csDMARD; 71.6% of patients received concomitant MTX, 15.7% of patients received concomitant sulfasalazine, and 8.6% of patients received concomitant leflunomide. The median PsA disease duration was 7.5 years. At baseline, 80.7% and 49.2% of patients had enthesitis and dactylitis, respectively<strong>.</strong>&nbsp;Patients randomised to tofacitinib received 5 mg twice daily or tofacitinib 10 mg twice daily for 6 months. Patients randomised to placebo were advanced in a blinded manner at month 3 to either tofacitinib 5 mg twice daily or tofacitinib 10 mg twice daily and received treatment until month 6.</p><p>&nbsp;</p><p><em>Signs and symptoms</em></p><p>Treatment with tofacitinib resulted in significant improvements in some signs and symptoms of PsA, as assessed by the ACR20 response criteria compared to placebo at month 3. The efficacy results for important endpoints assessed are shown in Table 12.</p><p>&nbsp;</p><p><strong>Table 12: Proportion (%) of PsA Patients Who Achieved Clinical Response and Mean Change from Baseline in OPAL BROADEN and OPAL BEYOND Studies</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p><strong>Conventional Synthetic DMARD</strong></p><p><strong>Inadequate Responders<sup>a</sup>&nbsp;(TNFi-Na&iuml;ve)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TNFi</strong></p><p><strong>Inadequate Responders<sup>b</sup></strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:top"><p><strong>OPAL BROADEN</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>OPAL BEYOND<sup>c</sup></strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Treatment Group</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 5 mg Twice Daily</strong></p></td><td style="vertical-align:top"><p><strong>Adalimumab 40 mg SC q2W</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 5 mg Twice Daily</strong></p></td></tr><tr><td><p>N</p></td><td><p>105</p></td><td><p>107</p></td><td style="vertical-align:top"><p>106</p></td><td><p>131</p></td><td><p>131</p></td></tr><tr><td style="vertical-align:top"><p>ACR20</p><p>Month 3</p><p>Month 6</p><p>Month 12</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>33%</p><p>NA</p><p>NA</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>50%<sup>d,</sup>*</p><p>59%</p><p>68%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>52%*</p><p>64%</p><p>60%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>24%</p><p>NA</p><p>-</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>50%<sup>d,</sup>***</p><p>60%</p><p>-</p></td></tr><tr><td style="vertical-align:top"><p>ACR50</p><p>Month 3</p><p>Month 6</p><p>Month 12</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>10%</p><p>NA</p><p>NA</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>28%<sup>e,</sup>**</p><p>38%</p><p>45%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>33%***</p><p>42%</p><p>41%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>15%</p><p>NA</p><p>-</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>30%<sup>e,</sup>*</p><p>38%</p><p>-</p></td></tr><tr><td style="vertical-align:top"><p>ACR70</p><p>Month 3</p><p>Month 6</p><p>Month 12</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>5%</p><p>NA</p><p>NA</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>17%<sup>e,</sup>*</p><p>18%</p><p>23%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>19%*</p><p>30%</p><p>29%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>10%</p><p>NA</p><p>-</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>17%</p><p>21%</p><p>-</p></td></tr><tr><td style="vertical-align:top"><p>∆LEI<sup>f</sup></p><p>Month 3</p><p>Month 6</p><p>Month 12</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-0.4</p><p>NA</p><p>NA</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-0.8</p><p>-1.3</p><p>-1.7</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-1.1*</p><p>-1.3</p><p>-1.6</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-0.5</p><p>NA</p><p>-</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-1.3*</p><p>-1.5</p><p>-</p></td></tr><tr><td style="vertical-align:top"><p>∆DSS<sup>f</sup></p><p>Month 3</p><p>Month 6</p><p>Month 12</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-2.0</p><p>NA</p><p>NA</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-3.5</p><p>-5.2</p><p>-7.4</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-4.0</p><p>-5.4</p><p>-6.1</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-1.9</p><p>NA</p><p>-</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>-5.2*</p><p>-6.0</p><p>-</p></td></tr><tr><td style="vertical-align:top"><p>PASI75<sup>g</sup></p><p>Month 3</p><p>Month 6</p><p>Month 12</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>15%</p><p>NA</p><p>NA</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>43%<sup>d,</sup>***</p><p>46%</p><p>56%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>39%**</p><p>55%</p><p>56%</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>14%</p><p>NA</p><p>-</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>21%</p><p>34%</p><p>-</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>* Nominal p&le;0.05; ** Nominal p&lt;0.001; *** Nominal p&lt;0.0001 for active treatment versus placebo at month 3.</p><p>Abbreviations: BSA=body surface area; ∆LEI=change from baseline in Leeds Enthesitis Index; ∆DSS=change from baseline in Dactylitis Severity Score; ACR20/50/70=American College of Rheumatology &ge; 20%, 50%, 70% improvement; csDMARD=conventional synthetic disease-modifying antirheumatic drug; N=number of randomised and treated patients; NA=Not applicable, as data for placebo treatment is not available beyond month 3 due to placebo advanced to tofacitinib 5 mg twice daily or tofacitinib 10 mg twice daily; SC q2w=subcutaneously once every 2 weeks; TNFi=tumour necrosis factor inhibitor; PASI=Psoriasis Area and Severity index; PASI75=&ge; 75% improvement in PASI.</p><p><sup>a</sup>&nbsp;Inadequate response to at least 1 csDMARD due to lack of efficacy and/or intolerability.</p><p><sup>b</sup>&nbsp;Inadequate response to a least 1 TNFi due to lack of efficacy and/or intolerability.</p><p><sup>c</sup>&nbsp;OPAL BEYOND had a duration of 6 months.</p><p><sup>d</sup>&nbsp;Achieved statistical significance globally at p&le; 0.05 per the pre-specified step-down testing procedure.</p><p><sup>e</sup>&nbsp;Achieved statistical significance within the ACR family (ACR50 and ACR70) at p&le; 0.05 per the pre-specified step-down testing procedure.</p><p><sup>f</sup>&nbsp;For patients with Baseline score &gt; 0.</p><p><sup>g</sup>&nbsp;For patients with Baseline BSA &ge; 3% and PASI &gt; 0.</p></td></tr></tbody></table><p>&nbsp;</p><p>Both TNF inhibitor na&iuml;ve and TNF inhibitor inadequate responder tofacitinib 5 mg BID -treated patients had significantly higher ACR20 response rates compared to placebo at month 3. Examination of age, sex, race, baseline disease activity and PsA subtype did not identify differences in response to tofacitinib. The number of patients with arthritis mutilans or axial involvement was too small to allow meaningful assessment.</p><p>&nbsp;</p><p>Statistically significant ACR20 response rates were observed with tofacitinib 5 mg BID in both studies as early as week 2 (first post-baseline assessment) in comparison to placebo.</p><p>&nbsp;</p><p>In OPAL BROADEN, Minimal Disease Activity (MDA) response was achieved by 26.2%, 25.5% and 6.7% of tofacitinib 5 mg BID, adalimumab and placebo treated patients, respectively (tofacitinib 5 mg BID treatment difference from placebo 19.5% [95% CI: 9.9, 29.1]) at month 3. In OPAL BEYOND, MDA was achieved by 22.9% and 14.5% of tofacitinib 5 mg BID and placebo treated patients, respectively, however tofacitinib 5 mg BID did not achieve nominal statistical significance (treatment difference from placebo 8.4% [95% CI: -1.0, 17.8] at month 3).</p><p>&nbsp;</p><p><em>Radiographic response</em></p><p>In study OPAL BROADEN, the progression of structural joint damage was assessed radiographically utilising the van der Heijde modified Total Sharp Score (mTSS) and the proportion of patients with radiographic progression (mTSS increase from baseline greater than 0.5) was assessed at month 12. At month 12, 96% and 98% of patients receiving tofacitinib 5 mg twice daily, and adalimumab 40 mg subcutaneously every 2 weeks, respectively, did not have radiographic progression (mTSS increase from baseline less than or equal to 0.5).</p><p>&nbsp;</p><p><em>Physical function and health-related quality of life</em></p><p>Improvement in physical functioning was measured by the HAQ-DI. Patients receiving tofacitinib 5 mg twice daily demonstrated greater improvement (p&le; 0.05) from baseline in physical functioning compared to placebo at month 3 (see Table 13).</p><p>&nbsp;</p><p><strong>Table 13: Change From Baseline in HAQ-DI in PsA Studies OPAL BROADEN and OPAL BEYOND</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td rowspan="3" style="vertical-align:top">&nbsp;</td><td colspan="5" style="vertical-align:bottom"><p><strong>Least Squares Mean Change From Baseline in HAQ-DI</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Conventional Synthetic DMARD</strong></p><p><strong>Inadequate Responders<sup>a</sup>&nbsp;(TNFi-Na&iuml;ve)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TNFi</strong></p><p><strong>Inadequate Responders<sup>b</sup></strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>OPAL BROADEN</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>OPAL BEYOND</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Treatment Group</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 5 mg Twice Daily</strong></p></td><td style="vertical-align:top"><p><strong>Adalimumab 40 mg SC q2W</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 5 mg Twice Daily</strong></p></td></tr><tr><td><p>N</p></td><td><p>104</p></td><td><p>107</p></td><td><p>106</p></td><td><p>131</p></td><td><p>129</p></td></tr><tr><td style="vertical-align:top"><p>Month 3</p></td><td style="vertical-align:top"><p>-0.18</p></td><td style="vertical-align:top"><p>-0.35<sup>c,</sup>*</p></td><td style="vertical-align:top"><p>-0.38*</p></td><td style="vertical-align:top"><p>-0.14</p></td><td style="vertical-align:top"><p>-0.39<sup>c,</sup>***</p></td></tr><tr><td style="vertical-align:top"><p>Month 6</p></td><td style="vertical-align:top"><p>NA</p></td><td style="vertical-align:top"><p>-0.45</p></td><td style="vertical-align:top"><p>-0.43</p></td><td style="vertical-align:top"><p>NA</p></td><td style="vertical-align:top"><p>-0.44</p></td></tr><tr><td style="vertical-align:top"><p>Month 12</p></td><td style="vertical-align:top"><p>NA</p></td><td style="vertical-align:top"><p>-0.54</p></td><td style="vertical-align:top"><p>-0.45</p></td><td style="vertical-align:top"><p>NA</p></td><td style="vertical-align:top"><p>NA</p></td></tr><tr><td colspan="6" style="vertical-align:top"><p>* Nominal p&le;0.05; *** Nominal p&lt;0.0001 for active treatment versus placebo at month 3.</p><p>Abbreviations: DMARD=disease-modifying antirheumatic drug; HAQ-DI=Health Assessment Questionnaire Disability Index; N=total number of patients in the statistical analysis; SC q2w=subcutaneously once every 2 weeks; TNFi=tumour necrosis factor inhibitor.</p><p><sup>a</sup>&nbsp;Inadequate response to at least one conventional synthetic DMARD (csDMARD) due to lack of efficacy and/or intolerability.</p><p><sup>b</sup>&nbsp;Inadequate response to a least one TNF inhibitor (TNFi) due to lack of efficacy and/or intolerability.</p><p><sup>c</sup>&nbsp;Achieved statistical significance globally at p&le; 0.05 per the pre-specified step-down testing procedure.</p></td></tr></tbody></table><p>&nbsp;</p><p>The HAQ-DI responder rate (response defined as having decrease from baseline of &ge; 0.35) at month 3 in studies OPAL BROADEN and OPAL BEYOND was 53% and 50%, respectively in patients receiving tofacitinib 5 mg twice daily, 31% and 28%, respectively in patients receiving placebo, and 53% in patients receiving adalimumab 40 mg subcutaneously once every 2 weeks (OPAL BROADEN only).</p><p>&nbsp;</p><p>Health-related quality of life was assessed by SF-36v2, fatigue was assessed by the FACIT-F. Patients receiving tofacitinib 5 mg twice daily demonstrated greater improvement from baseline compared to placebo in the SF-36v2 physical functioning domain, the SF-36v2 physical component summary score, and FACIT-F scores at month 3 in studies OPAL BROADEN and OPAL BEYOND (nominal p&le; 0.05). Improvements from baseline in SF-36v2 and FACIT-F were maintained through month 6 (OPAL BROADEN and OPAL BEYOND) and month 12 (OPAL BROADEN).</p><p>&nbsp;</p><p>Patients receiving tofacitinib 5 mg twice daily demonstrated a greater improvement in arthritis pain (as measured on a 0-100 visual analogue scale) from baseline at week 2 (first post-baseline assessment) through month 3 compared to placebo in studies OPAL BROADEN and OPAL BEYOND (nominal p&le; 0.05).</p><p>&nbsp;</p><p><em>Ulcerative colitis</em></p><p>The efficacy and safety of tofacitinib for the treatment of adult patients with moderately to severely active UC (Mayo score 6 to 12 with endoscopy subscore &ge; 2 and rectal bleeding subscore &ge; 1) were assessed in 3 multicentre, double-blind, randomised, placebo-controlled studies: 2 identical induction studies (OCTAVE Induction 1 and OCTAVE Induction 2) followed by 1 maintenance study (OCTAVE Sustain). Enrolled patients had failed at least 1 conventional therapy, including corticosteroids, immunomodulators, and/or a TNF inhibitor. Concomitant stable doses of oral aminosalicylates and corticosteroids (prednisone or equivalent daily dose up to 25 mg) were permitted with taper of corticosteroids to discontinuation mandated within 15 weeks of entering the maintenance study. Tofacitinib was administered as monotherapy (i.e., without concomitant use of biologics and immunosuppressants) for UC.</p><p>&nbsp;</p><p>Table 14 provides additional information regarding pertinent study design and population characteristics.</p><p>&nbsp;</p><p><strong>Table 14: Phase 3 Clinical Studies of Tofacitinib 5 and 10 mg Twice Daily Doses in Patients with UC</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p><strong>OCTAVE Induction 1</strong></p></td><td style="vertical-align:top"><p><strong>OCTAVE Induction 2</strong></p></td><td style="vertical-align:top"><p><strong>OCTAVE Sustain</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Treatment groups</strong></p><p><strong>(Randomisation ratio)</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 10 mg</strong></p><p><strong>Twice Daily</strong></p><p><strong>Placebo</strong></p><p><strong>(4:1)</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 10 mg</strong></p><p><strong>Twice Daily</strong></p><p><strong>Placebo</strong></p><p><strong>(4:1)</strong></p></td><td><p><strong>Tofacitinib 5 mg</strong></p><p><strong>Twice Daily</strong></p><p><strong>Tofacitinib 10 mg</strong></p><p><strong>Twice Daily</strong></p><p><strong>Placebo</strong></p><p><strong>(1:1:1)</strong></p></td></tr><tr><td style="vertical-align:top"><p>Number of patients enrolled</p></td><td style="vertical-align:top"><p>598</p></td><td style="vertical-align:top"><p>541</p></td><td style="vertical-align:top"><p>593</p></td></tr><tr><td style="vertical-align:top"><p>Study duration</p></td><td style="vertical-align:top"><p>8 weeks</p></td><td style="vertical-align:top"><p>8 weeks</p></td><td style="vertical-align:top"><p>52 weeks</p></td></tr><tr><td style="vertical-align:top"><p>Primary efficacy endpoint</p></td><td style="vertical-align:top"><p>Remission</p></td><td style="vertical-align:top"><p>Remission</p></td><td style="vertical-align:top"><p>Remission</p></td></tr><tr><td style="vertical-align:top"><p>Key secondary efficacy endpoints</p></td><td style="vertical-align:top"><p>Improvement of endoscopic appearance of the mucosa</p></td><td style="vertical-align:top"><p>Improvement of endoscopic appearance of the mucosa</p></td><td style="vertical-align:top"><p>Improvement of endoscopic appearance of the mucosa</p><p>Sustained corticosteroid-free remission among patients in remission at baseline</p></td></tr><tr><td style="vertical-align:top"><p>Prior TNFi failure</p></td><td style="vertical-align:top"><p>51.3%</p></td><td style="vertical-align:top"><p>52.1%</p></td><td style="vertical-align:top"><p>44.7%</p></td></tr><tr><td style="vertical-align:top"><p>Prior corticosteroid failure</p></td><td style="vertical-align:top"><p>74.9%</p></td><td style="vertical-align:top"><p>71.3%</p></td><td style="vertical-align:top"><p>75.0%</p></td></tr><tr><td style="vertical-align:top"><p>Prior immunosuppressant failure</p></td><td style="vertical-align:top"><p>74.1%</p></td><td style="vertical-align:top"><p>69.5%</p></td><td style="vertical-align:top"><p>69.6%</p></td></tr><tr><td style="vertical-align:top"><p>Baseline corticosteroid use</p></td><td style="vertical-align:top"><p>45.5%</p></td><td style="vertical-align:top"><p>46.8%</p></td><td style="vertical-align:top"><p>50.3%</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p>Abbreviations: TNFi=tumour necrosis factor inhibitor; UC=ulcerative colitis.</p></td></tr></tbody></table><p>&nbsp;</p><p>In addition, safety and efficacy of tofacitinib were assessed in an open-label long-term extension study (OCTAVE Open). Patients who completed 1 of the induction studies (OCTAVE Induction 1 or OCTAVE Induction 2) but did not achieve clinical response or patients who completed or withdrew early due to treatment failure in the maintenance study (OCTAVE Sustain) were eligible for OCTAVE Open. Patients from OCTAVE Induction 1 or OCTAVE Induction 2 who did not achieve clinical response after 8 weeks in OCTAVE Open were to be discontinued from OCTAVE Open. Corticosteroid tapering was also required upon entrance into OCTAVE Open.</p><p>&nbsp;</p><p><em><u>Induction efficacy data (OCTAVE Induction 1 and OCTAVE Induction 2)</u></em></p><p>The primary endpoint of OCTAVE Induction 1 and OCTAVE Induction 2 was the proportion of patients in remission at week 8, and the key secondary endpoint was the proportion of patients with improvement of endoscopic appearance of the mucosa at week 8. Remission was defined as clinical remission (a total Mayo score &le; 2 with no individual subscore &gt; 1) and rectal bleeding subscore of 0. Improvement of endoscopic appearance of the mucosa was defined as endoscopy subscore of 0 or 1.</p><p>&nbsp;</p><p>A significantly greater proportion of patients treated with tofacitinib 10 mg twice daily achieved remission, improvement of endoscopic appearance of the mucosa, and clinical response at week 8 compared to placebo in both studies, as shown in Table 15.</p><p>&nbsp;</p><p>The efficacy results based on the endoscopic readings at the study sites were consistent with the results based on the central endoscopy readings.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Table 15: Proportion of Patients Meeting Efficacy Endpoints at Week 8 (OCTAVE Induction Study 1 and OCTAVE Induction Study 2)</strong></p></td></tr><tr><td rowspan="2" style="vertical-align:top">&nbsp;</td><td colspan="4" style="vertical-align:top"><p><strong>OCTAVE Induction Study 1</strong></p></td></tr><tr><td colspan="2"><p><strong>Central Endoscopy Read</strong></p></td><td colspan="2"><p><strong>Local Endoscopy Read</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Endpoint</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p></td><td><p><strong>Tofacitinib</strong></p><p><strong>10 mg</strong></p><p><strong>Twice Daily</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p></td><td><p><strong>Tofacitinib</strong></p><p><strong>10 mg</strong></p><p><strong>Twice Daily</strong></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td><p><strong>N=122</strong></p></td><td><p><strong>N=476</strong></p></td><td><p><strong>N=122</strong></p></td><td><p><strong>N=476</strong></p></td></tr><tr><td style="vertical-align:top"><p>Remission<sup>a</sup></p></td><td style="vertical-align:top"><p>8.2%</p></td><td style="vertical-align:top"><p>18.5%<sup>&Dagger;</sup></p></td><td style="vertical-align:top"><p>11.5%</p></td><td style="vertical-align:top"><p>24.8%<sup>&Dagger;</sup></p></td></tr><tr><td style="vertical-align:top"><p>Improvement of endoscopic appearance of the mucosa<sup>b</sup></p></td><td style="vertical-align:top"><p>15.6%</p></td><td style="vertical-align:top"><p>31.3%<sup>&dagger;</sup></p></td><td style="vertical-align:top"><p>23.0%</p></td><td style="vertical-align:top"><p>42.4%*</p></td></tr><tr><td style="vertical-align:top"><p>Normalization of endoscopic appearance of the mucosa<sup>c</sup></p></td><td style="vertical-align:top"><p>1.6%</p></td><td style="vertical-align:top"><p>6.7%<sup>&Dagger;</sup></p></td><td style="vertical-align:top"><p>2.5%</p></td><td style="vertical-align:top"><p>10.9%<sup>&Dagger;</sup></p></td></tr><tr><td style="vertical-align:top"><p>Clinical response<sup>d</sup></p></td><td style="vertical-align:top"><p>32.8%</p></td><td style="vertical-align:top"><p>59.9%*</p></td><td style="vertical-align:top"><p>34.4%</p></td><td style="vertical-align:top"><p>60.7%*</p></td></tr><tr><td rowspan="2" style="vertical-align:top">&nbsp;</td><td colspan="4" style="vertical-align:top"><p><strong>OCTAVE Induction Study 2</strong></p></td></tr><tr><td colspan="2"><p><strong>Central Endoscopy Read</strong></p></td><td colspan="2"><p><strong>Local Endoscopy Read</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Endpoint</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p></td><td><p><strong>Tofacitinib</strong></p><p><strong>10 mg</strong></p><p><strong>Twice Daily</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p></td><td><p><strong>Tofacitinib</strong></p><p><strong>10 mg</strong></p><p><strong>Twice Daily</strong></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p><strong>N=112</strong></p></td><td style="vertical-align:top"><p><strong>N=429</strong></p></td><td style="vertical-align:top"><p><strong>N=112</strong></p></td><td style="vertical-align:top"><p><strong>N=429</strong></p></td></tr><tr><td style="vertical-align:top"><p>Remission<sup>a</sup></p></td><td style="vertical-align:top"><p>3.6%</p></td><td style="vertical-align:top"><p>16.6%<sup>&dagger;</sup></p></td><td style="vertical-align:top"><p>5.4%</p></td><td style="vertical-align:top"><p>20.7%<sup>&dagger;</sup></p></td></tr><tr><td style="vertical-align:top"><p>Improvement of endoscopic appearance of the mucosa<sup>b</sup></p></td><td style="vertical-align:top"><p>11.6%</p></td><td style="vertical-align:top"><p>28.4%<sup>&dagger;</sup></p></td><td style="vertical-align:top"><p>15.2%</p></td><td style="vertical-align:top"><p>36.4%*</p></td></tr><tr><td style="vertical-align:top"><p>Normalization of endoscopic appearance of the mucosa<sup>c</sup></p></td><td style="vertical-align:top"><p>1.8%</p></td><td style="vertical-align:top"><p>7.0%<sup>&Dagger;</sup></p></td><td style="vertical-align:top"><p>0.0%</p></td><td style="vertical-align:top"><p>9.1%<sup>&Dagger;</sup></p></td></tr><tr><td style="vertical-align:top"><p>Clinical response<sup>d</sup></p></td><td style="vertical-align:top"><p>28.6%</p></td><td style="vertical-align:top"><p>55.0%*</p></td><td style="vertical-align:top"><p>29.5%</p></td><td style="vertical-align:top"><p>58.0%*</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p>* p&lt;0.0001; &dagger; p&lt;0.001; &Dagger; p&lt;0.05.</p><p>N=number of patients in the analysis set.</p><p><sup>a.</sup>&nbsp;Primary endpoint: Remission was defined as clinical remission (a Mayo score &le; 2 with no individual subscore &gt; 1) and rectal bleeding subscore of 0.</p><p><sup>b.</sup>&nbsp;Key secondary endpoint: Improvement of endoscopic appearance of the mucosa was defined as Mayo endoscopy subscore of 0 (normal or inactive disease) or 1 (erythema, decreased vascular pattern).</p><p><sup>c.</sup>&nbsp;Normalization of endoscopic appearance of the mucosa was defined as a Mayo endoscopic subscore of 0.</p><p><sup>d.</sup>&nbsp;Clinical response was defined as a decrease from baseline in Mayo score of &ge; 3 points and &ge; 30%, with an accompanying decrease in the subscore for rectal bleeding of &ge; 1 point or absolute subscore for rectal bleeding of 0 or 1.</p></td></tr></tbody></table><p>&nbsp;</p><p>In both subgroups of patients with or without prior TNF inhibitor failure, a greater proportion of patients treated with tofacitinib 10 mg twice daily achieved remission and improvement of endoscopic appearance of the mucosa at week 8 as compared to placebo. This treatment difference was consistent between the 2 subgroups (Table 16).</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td colspan="3" style="vertical-align:top"><p><strong>Table 16. Proportion of Patients Meeting Primary and Key Secondary Efficacy Endpoints at Week 8 by TNF Inhibitor Therapy Subgroups (OCTAVE Induction Study 1 and OCTAVE Induction Study 2, Central Endoscopy Read)</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>OCTAVE Induction Study 1</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Endpoint</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>N=122</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 10 mg</strong></p><p><strong>Twice Daily</strong></p><p><strong>N=476</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Remission<sup>a</sup></p></td></tr><tr><td style="vertical-align:top"><p>With prior TNF inhibitor failure</p></td><td style="vertical-align:top"><p>1.6%</p><p>(1/64)</p></td><td style="vertical-align:top"><p>11.1%</p><p>(27/243)</p></td></tr><tr><td style="vertical-align:top"><p>Without prior TNF inhibitor failure<sup>b</sup></p></td><td style="vertical-align:top"><p>15.5%</p><p>(9/58)</p></td><td style="vertical-align:top"><p>26.2%</p><p>(61/233)</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Improvement of endoscopic appearance of the mucosa<sup>c</sup></p></td></tr><tr><td style="vertical-align:top"><p>With prior TNF inhibitor failure</p></td><td style="vertical-align:top"><p>6.3%</p><p>(4/64)</p></td><td style="vertical-align:top"><p>22.6%</p><p>(55/243)</p></td></tr><tr><td style="vertical-align:top"><p>Without prior TNF inhibitor failure<sup>b</sup></p></td><td style="vertical-align:top"><p>25.9%</p><p>(15/58)</p></td><td style="vertical-align:top"><p>40.3%</p><p>(94/233)</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>OCTAVE Induction Study 2</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Endpoint</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>N=112</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib 10 mg</strong></p><p><strong>Twice Daily</strong></p><p><strong>N=429</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Remission<sup>a</sup></p></td></tr><tr><td style="vertical-align:top"><p>With prior TNF inhibitor failure</p></td><td style="vertical-align:top"><p>0.0%</p><p>(0/60)</p></td><td style="vertical-align:top"><p>11.7%</p><p>(26/222)</p></td></tr><tr><td style="vertical-align:top"><p>Without prior TNF inhibitor failure<sup>b</sup></p></td><td style="vertical-align:top"><p>7.7%</p><p>(4/52)</p></td><td style="vertical-align:top"><p>21.7%</p><p>(45/207)</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Improvement of endoscopic appearance of the mucosa<sup>c</sup></p></td></tr><tr><td style="vertical-align:top"><p>With prior TNF inhibitor failure</p></td><td style="vertical-align:top"><p>6.7%</p><p>(4/60)</p></td><td style="vertical-align:top"><p>21.6%</p><p>(48/222)</p></td></tr><tr><td style="vertical-align:top"><p>Without prior TNF inhibitor failure<sup>b</sup></p></td><td style="vertical-align:top"><p>17.3%</p><p>(9/52)</p></td><td style="vertical-align:top"><p>35.7%</p><p>(74/207)</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>TNF=tumour necrosis factor; N=number of patients in the analysis set.</p><p><sup>a.</sup>&nbsp;Remission was defined as clinical remission (a Mayo score &le; 2 with no individual subscore &gt; 1) and rectal bleeding subscore of 0.</p><p><sup>b.</sup>&nbsp;Included TNF Inhibitor na&iuml;ve patients</p><p><sup>c.</sup>&nbsp;Improvement of endoscopic appearance of the mucosa was defined as Mayo endoscopy subscore of 0 (normal or inactive disease) or 1 (erythema, decreased vascular pattern).</p></td></tr></tbody></table><p>&nbsp;</p><p>As early as week 2, the earliest scheduled study visit, and at each visit thereafter, significant differences were observed between tofacitinib 10 mg twice daily and placebo in the change from baseline in rectal bleeding and stool frequency, and partial Mayo score.</p><p>&nbsp;</p><p><em><u>Maintenance (OCTAVE Sustain)</u></em></p><p>Patients who completed 8 weeks in 1 of the induction studies and achieved clinical response were re-randomised into OCTAVE Sustain; 179 out of 593 (30.2%) patients were in remission at baseline of OCTAVE Sustain.</p><p>&nbsp;</p><p>The primary endpoint in OCTAVE Sustain was the proportion of patients in remission at week 52. The 2 key secondary endpoints were the proportion of patients with improvement of endoscopic appearance at week 52, and the proportion of patients with sustained corticosteroid-free remission at both week 24 and week 52 among patients in remission at baseline of OCTAVE Sustain.</p><p>&nbsp;</p><p>A significantly greater proportion of patients in both the tofacitinib 5 mg twice daily and tofacitinib 10 mg twice daily treatment groups achieved the following endpoints at week 52 as compared to placebo: remission, improvement of endoscopic appearance of the mucosa, normalization of endoscopic appearance of the mucosa, maintenance of clinical response, remission among patients in remission at baseline, and sustained corticosteroid-free remission at both week 24 and week 52 among patients in remission at baseline, as shown in Table 17.</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td colspan="7" style="vertical-align:top"><p><strong>Table 17: Proportion of Patients Meeting Efficacy Endpoints at Week 52 (OCTAVE Sustain)</strong></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td colspan="3" style="vertical-align:top"><p><strong>Central Endoscopy Read</strong></p></td><td colspan="3" style="vertical-align:top"><p><strong>Local Endoscopy Read</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Endpoint</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>N=198</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib</strong></p><p><strong>5 mg</strong></p><p><strong>Twice Daily</strong></p><p><strong>N=198</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib</strong></p><p><strong>10 mg</strong></p><p><strong>Twice Daily</strong></p><p><strong>N=197</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>N=198</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib</strong></p><p><strong>5 mg</strong></p><p><strong>Twice Daily</strong></p><p><strong>N=198</strong></p></td><td style="vertical-align:top"><p><strong>Tofacitinib</strong></p><p><strong>10 mg</strong></p><p><strong>Twice Daily</strong></p><p><strong>N=197</strong></p></td></tr><tr><td style="vertical-align:top"><p>Remission<sup>a</sup></p></td><td style="vertical-align:top"><p>11.1%</p></td><td style="vertical-align:top"><p>34.3%*</p></td><td style="vertical-align:top"><p>40.6%*</p></td><td style="vertical-align:top"><p>13.1%</p></td><td style="vertical-align:top"><p>39.4%*</p></td><td style="vertical-align:top"><p>47.7%*</p></td></tr><tr><td style="vertical-align:top"><p>Improvement of endoscopic appearance of the mucosa<sup>b</sup></p></td><td style="vertical-align:top"><p>13.1%</p></td><td style="vertical-align:top"><p>37.4%*</p></td><td style="vertical-align:top"><p>45.7%*</p></td><td style="vertical-align:top"><p>15.7%</p></td><td style="vertical-align:top"><p>44.9%*</p></td><td style="vertical-align:top"><p>53.8%*</p></td></tr><tr><td style="vertical-align:top"><p>Normalization of endoscopic appearance of the mucosa<sup>c</sup></p></td><td style="vertical-align:top"><p>4.0%</p></td><td style="vertical-align:top"><p>14.6%**</p></td><td style="vertical-align:top"><p>16.8%*</p></td><td style="vertical-align:top"><p>5.6%</p></td><td style="vertical-align:top"><p>22.2%*</p></td><td style="vertical-align:top"><p>29.4%*</p></td></tr><tr><td style="vertical-align:top"><p>Maintenance of clinical response<sup>d</sup></p></td><td style="vertical-align:top"><p>20.2%</p></td><td style="vertical-align:top"><p>51.5%*</p></td><td style="vertical-align:top"><p>61.9%*</p></td><td style="vertical-align:top"><p>20.7%</p></td><td style="vertical-align:top"><p>51.0%*</p></td><td style="vertical-align:top"><p>61.4%*</p></td></tr><tr><td style="vertical-align:top"><p>Remission among patients in remission at baseline<sup>a,f</sup></p></td><td style="vertical-align:top"><p>10.2%</p></td><td style="vertical-align:top"><p>46.2%*</p></td><td style="vertical-align:top"><p>56.4%*</p></td><td style="vertical-align:top"><p>11.9%</p></td><td style="vertical-align:top"><p>50.8%*</p></td><td style="vertical-align:top"><p>65.5%*</p></td></tr><tr><td style="vertical-align:top"><p>Sustained corticosteroid-free remission at both week 24 and week 52 among patients in remission at baseline<sup>e,f</sup></p></td><td style="vertical-align:top"><p>5.1%</p></td><td style="vertical-align:top"><p>35.4%*</p></td><td style="vertical-align:top"><p>47.3%*</p></td><td style="vertical-align:top"><p>11.9%</p></td><td style="vertical-align:top"><p>47.7%*</p></td><td style="vertical-align:top"><p>58.2%*</p></td></tr><tr><td style="vertical-align:top"><p>Corticosteroid-free remission among patients taking corticosteroids at baseline<sup>a,g</sup></p></td><td style="vertical-align:top"><p>10.9%</p></td><td style="vertical-align:top"><p>27.7%<sup>&dagger;</sup></p></td><td style="vertical-align:top"><p>27.6%<sup>&dagger;</sup></p></td><td style="vertical-align:top"><p>13.9%</p></td><td style="vertical-align:top"><p>32.7%<sup>&dagger;</sup></p></td><td style="vertical-align:top"><p>31.0%<sup>&dagger;</sup></p></td></tr><tr><td colspan="7" style="vertical-align:top"><p>* p&lt;0.0001; **p&lt;0.001; &dagger;p&lt;0.05 for tofacitinib versus placebo.</p><p>N=number of patients in the analysis set.</p><p><sup>a.</sup>&nbsp;Remission was defined as clinical remission (a Mayo score &le; 2 with no individual subscore &gt; 1)&nbsp;<u>and</u>&nbsp;rectal bleeding subscore of 0.</p><p><sup>b.</sup>&nbsp;Improvement of endoscopic appearance of the mucosa was defined as Mayo endoscopy subscore of 0 (normal or inactive disease) or 1 (erythema, decreased vascular pattern).</p><p><sup>c.</sup>&nbsp;Normalization of endoscopic appearance of the mucosa was defined as a Mayo endoscopic subscore of 0.</p><p><sup>d.</sup>&nbsp;Maintenance of clinical response was defined by a decrease from the induction study (OCTAVE Induction 1, OCTAVE Induction 2) baseline Mayo score of &ge; 3 points and &ge; 30%, with an accompanying decrease in the rectal bleeding subscore of &ge; 1 point or rectal bleeding subscore of 0 or 1. Patients were to be in clinical response at baseline of the maintenance study OCTAVE Sustain.</p><p><sup>e.</sup>&nbsp;Sustained corticosteroid-free remission was defined as being in remission and not taking corticosteroids for at least 4 weeks prior to the visit at both week 24 and week 52.</p><p><sup>f.</sup>&nbsp;N=59 for placebo, N=65 for tofacitinib 5 mg twice daily, N=55 for tofacitinib 10 mg twice daily.</p><p><sup>g.</sup>&nbsp;N=101 for placebo, N=101 for tofacitinib 5 mg twice daily, N=87 for tofacitinib 10 mg twice daily.</p></td></tr></tbody></table><p>&nbsp;</p><p>In both subgroups of patients with or without prior TNF inhibitor failure, a greater proportion of patients treated with either tofacitinib 5 mg twice daily or tofacitinib 10 mg twice daily achieved the following endpoints at week 52 of OCTAVE Sustain as compared to placebo: remission, improvement of endoscopic appearance of the mucosa, or sustained corticosteroid-free remission at both week 24 and week 52 among patients in remission at baseline (Table 18). This treatment difference from placebo was similar between tofacitinib 5 mg twice daily and tofacitinib 10 mg twice daily in the subgroup of patients without prior TNF inhibitor failure. In the subgroup of patients with prior TNF inhibitor failure, the observed treatment difference from placebo was numerically greater for tofacitinib 10 mg twice daily than tofacitinib 5 mg twice daily by 9.7 to 16.7 percentage points across the primary and key secondary endpoints.</p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td colspan="4"><p><strong>Table 18: Proportion of Patients Meeting Primary and Key Secondary Efficacy Endpoints at Week 52 by TNF Inhibitor Therapy Subgroup (OCTAVE Sustain, Central Endoscopy Read)</strong></p></td><td><p>&nbsp;</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Endpoint</strong></p></td><td rowspan="2" style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>N=198</strong></p></td><td rowspan="2" style="vertical-align:top"><p><strong>Tofacitinib</strong></p><p><strong>5 mg</strong></p><p><strong>Twice Daily</strong></p><p><strong>N=198</strong></p></td><td rowspan="2" style="vertical-align:top"><p><strong>Tofacitinib</strong></p><p><strong>10 mg</strong></p><p><strong>Twice Daily</strong></p><p><strong>N=197</strong></p></td><td>&nbsp;</td></tr><tr><td>&nbsp;</td></tr><tr><td colspan="4" style="vertical-align:top"><p>Remission<sup>a</sup></p></td><td><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>With prior TNF inhibitor failure</p></td><td style="vertical-align:top"><p>10/89</p><p>(11.2%)</p></td><td style="vertical-align:top"><p>20/83</p><p>(24.1%)</p></td><td style="vertical-align:top"><p>34/93</p><p>(36.6%)</p></td><td><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Without prior TNF inhibitor failure<sup>b</sup></p></td><td style="vertical-align:top"><p>12/109</p><p>(11.0%)</p></td><td style="vertical-align:top"><p>48/115</p><p>(41.7%)</p></td><td style="vertical-align:top"><p>46/104</p><p>(44.2%)</p></td><td><p>&nbsp;</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p>Improvement of endoscopic appearance of the mucosa<sup>c</sup></p></td><td><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>With prior TNF inhibitor failure</p></td><td style="vertical-align:top"><p>11/89</p><p>(12.4%)</p></td><td style="vertical-align:top"><p>25/83</p><p>(30.1%)</p></td><td style="vertical-align:top"><p>37/93</p><p>(39.8%)</p></td><td><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Without prior TNF inhibitor failure<sup>b</sup></p></td><td style="vertical-align:top"><p>15/109</p><p>(13.8%)</p></td><td style="vertical-align:top"><p>49/115</p><p>(42.6%)</p></td><td style="vertical-align:top"><p>53/104</p><p>(51.0%)</p></td><td><p>&nbsp;</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p>Sustained corticosteroid-free remission at both week 24 and week 52 among patients in remission at baseline<sup>d</sup></p></td><td><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>With prior TNF inhibitor failure</p></td><td style="vertical-align:top"><p>1/21</p><p>(4.8%)</p></td><td style="vertical-align:top"><p>4/18</p><p>(22.2%)</p></td><td style="vertical-align:top"><p>7/18</p><p>(38.9%)</p></td><td><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Without prior TNF inhibitor failure<sup>b</sup></p></td><td style="vertical-align:top"><p>2/38</p><p>(5.3%)</p></td><td style="vertical-align:top"><p>19/47</p><p>(40.4%)</p></td><td style="vertical-align:top"><p>19/37</p><p>(51.4%)</p></td><td><p>&nbsp;</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p>TNF=tumour necrosis factor; N=number of patients in the analysis set.</p><p><sup>a.</sup>&nbsp;Remission was defined as clinical remission (a Mayo score &le; 2 with no individual subscore &gt; 1)&nbsp;<u>and</u>&nbsp;rectal bleeding subscore of 0.</p><p><sup>b.</sup>&nbsp;Included TNF Inhibitor na&iuml;ve patients.</p><p><sup>c.</sup>&nbsp;Improvement of endoscopic appearance of the mucosa was defined as Mayo endoscopy subscore of 0 (normal or inactive disease) or 1 (erythema, decreased vascular pattern).</p><p><sup>d.</sup>&nbsp;Sustained corticosteroid-free remission was defined as being in remission and not taking corticosteroids for at least 4 weeks prior to the visit at both week 24 and week 52.</p></td><td><p>&nbsp;</p></td></tr></tbody></table><p>The proportion of patients in both tofacitinib groups who had treatment failure was lower compared to placebo at each time point as early as week 8, the first time point where treatment failure was assessed, as shown in Figure 2.</p><p>&nbsp;</p><p><strong>Figure 2. Time to Treatment Failure in Maintenance Study OCTAVE Sustain (Kaplan-Meier Curves)</strong></p><p><img alt="" width="605" height="351" src="data:image/png;base64,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" /></p><p>p&lt;0.0001 for tofacitinib 5 mg twice daily versus placebo.</p><p>p&lt;0.0001 for tofacitinib 10 mg twice daily versus placebo.</p><p>BID=twice daily.</p><p>&nbsp;</p><p>Treatment failure was defined as an increase in Mayo score of &ge; 3 points from maintenance study baseline, accompanied by an increase in rectal bleeding subscore by &ge; 1 point, and an increase of endoscopic subscore of &ge; 1 point yielding an absolute endoscopic subscore of &ge; 2 after a minimum treatment of 8 weeks in the study.</p><p>&nbsp;</p><p><em><u>Health-related and quality of life outcomes</u></em></p><p>Tofacitinib 10 mg twice daily demonstrated greater improvement from baseline compared to placebo in physical component summary (PCS) and mental component summary (MCS) scores, and in all 8 domains of the SF-36 in the induction studies (OCTAVE Induction 1, OCTAVE Induction 2). In the maintenance study (OCTAVE Sustain), tofacitinib 5 mg twice daily or tofacitinib 10 mg twice daily demonstrated greater maintenance of improvement compared to placebo in PCS and MCS scores, and in all 8 domains of the SF-36 at week 24 and week 52.</p><p>&nbsp;</p><p>Tofacitinib 10 mg twice daily demonstrated greater improvement from baseline compared to placebo at week 8 in the total and all 4 domain scores of the Inflammatory Bowel Disease Questionnaire (IBDQ) (bowel symptoms, systemic function, emotional function, and social function) in the induction studies (OCTAVE Induction 1, OCTAVE Induction 2). In the maintenance study (OCTAVE Sustain), tofacitinib 5 mg twice daily or tofacitinib 10 mg twice daily demonstrated greater maintenance of improvement compared to placebo in the total and all 4 domain scores of the IBDQ at week 24 and week 52.</p><p>&nbsp;</p><p>Improvements were also observed in the EuroQoL 5-Dimension (EQ-5D) and various domains of the Work Productivity and Activity Impairment (WPAI-UC) questionnaire in both induction and maintenance studies compared to placebo.</p><p>&nbsp;</p><p><em><u>Open-label extension study (OCTAVE Open)</u></em></p><p>Patients who did not achieve clinical response in one of the induction studies (OCTAVE Induction 1 or OCTAVE Induction 2) after 8 weeks of tofacitinib 10 mg twice daily were allowed to enter an open-label extension study (OCTAVE Open). After an additional 8 weeks of tofacitinib 10 mg twice daily in OCTAVE Open, 53% (154/293) patients achieved clinical response and 14% (42/293) patients achieved remission.</p><p>&nbsp;</p><p>Patients who achieved clinical response in 1 of the induction studies (OCTAVE Induction 1 or OCTAVE Induction 2) with tofacitinib 10 mg twice daily but experienced treatment failure after their dose was reduced to tofacitinib 5 mg twice daily or following treatment interruption in OCTAVE Sustain (i.e., were randomised to placebo), had their dose increased to tofacitinib 10 mg twice daily in OCTAVE Open. After 8 weeks on tofacitinib 10 mg twice daily in OCTAVE Open, remission was achieved in 35% (20/58) patients who received tofacitinib 5 mg twice daily in OCTAVE Sustain and 40% (40/99) patients with dose interruption in OCTAVE Sustain. At month 12 in OCTAVE Open, 52% (25/48) and 45% (37/83) of these patients achieved remission, respectively.</p><p>&nbsp;</p><p>Furthermore, at month 12 of study OCTAVE Open, 74% (48/65) of patients who achieved remission at the end of study OCTAVE Sustain on either tofacitinib 5 mg twice daily or tofacitinib 10 mg twice daily remained in remission while receiving tofacitinib 5 mg twice daily.</p><p>&nbsp;</p><p><u>Paediatric population</u></p><p>The European Medicines Agency has deferred the obligation to submit results of studies with tofacitinib in one or more subsets of the paediatric population in juvenile idiopathic arthritis and in ulcerative colitis (see section 4.2 for information on paediatric use).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The PK profile of tofacitinib is characterised by rapid absorption (peak plasma concentrations are reached within 0.5-1 hour), rapid elimination (half-life of ~3 hours) and dose-proportional increases in systemic exposure. Steady state concentrations are achieved in 24-48 hours with negligible accumulation after twice daily administration.</p><p><u>Absorption and distribution</u></p><p>Tofacitinib is well-absorbed, with an oral bioavailability of 74%.<strong>&nbsp;</strong>Coadministration of tofacitinib with a high-fat meal resulted in no changes in AUC while C<sub>max</sub>&nbsp;was reduced by 32%. In clinical trials, tofacitinib was administered without regard to meal.</p><p>&nbsp;</p><p>After intravenous administration, the volume of distribution is 87 L. Approximately 40% of circulating tofacitinib is bound to plasma proteins. Tofacitinib binds predominantly to albumin and does not appear to bind to &alpha;1-acid glycoprotein. Tofacitinib distributes equally between red blood cells and plasma.</p><p>&nbsp;</p><p><u>Biotransformation and elimination</u></p><p>Clearance mechanisms for tofacitinib are approximately 70% hepatic metabolism and 30% renal excretion of the parent drug. The metabolism of tofacitinib is primarily mediated by CYP3A4 with minor contribution from CYP2C19. In a human radiolabeled study, more than 65% of the total circulating radioactivity was accounted for by unchanged active substance, with the remaining 35% attributed to 8 metabolites, each accounting for less than 8% of total radioactivity. All metabolites have been observed in animal species and are predicted to have less than 10-fold potency than tofacitinib for JAK1/3 inhibition. No evidence of stereo conversion in human samples was detected. The pharmacologic activity of tofacitinib is attributed to the parent molecule. Tofacitinib is not an inhibitor or inducer of CYPs (CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4) and is not an inhibitor of UGTs (UGT1A1, UGT1A4, UGT1A6, UGT1A9, and UGT2B7).&nbsp;<em>In vitro</em>, tofacitinib is a substrate for MDR1, but not for breast cancer resistance protein (BCRP), OATP1B1/1B3, or OCT1/2, and is not an inhibitor of MDR1, OATP1B1/1B3, OCT2, OAT1/3, or MRP at clinically meaningful concentrations.</p><p>&nbsp;</p><p><u>Pharmacokinetics in patients</u></p><p>The enzymatic activity of CYP enzymes is reduced in RA patients due to chronic inflammation. In RA patients, the oral clearance of tofacitinib does not vary with time, indicating that treatment with tofacitinib does not normalise CYP enzyme activity.</p><p>&nbsp;</p><p>Population PK analysis in RA patients indicated that systemic exposure (AUC) of tofacitinib in the extremes of body weight (40 kg, 140 kg) were similar (within 5%) to that of a 70 kg patient. Elderly patients 80 years of age were estimated to have less than 5% higher AUC relative to the mean age of 55 years. Women were estimated to have 7% lower AUC compared to men. The available data have also shown that there are no major differences in tofacitinib AUC between White, Black and Asian patients. An approximate linear relationship between body weight and volume of distribution was observed, resulting in higher peak (C<sub>max</sub>) and lower trough (C<sub>min</sub>) concentrations in lighter patients. However, this difference is not considered to be clinically relevant. The between-subject variability (percentage coefficient of variation) in AUC of tofacitinib is estimated to be approximately 27%.</p><p>Results from population PK analysis in patients with active PsA or moderate to severe UC were consistent with those in patients with RA.</p><p>&nbsp;</p><p><u>Renal impairment</u></p><p>Subjects with mild (creatinine clearance 50-80 mL/min), moderate (creatinine clearance 30-49 mL/min), and severe (creatinine clearance &lt; 30 mL/min) renal impairment had 37%, 43% and 123% higher AUC, respectively, compared to subjects with normal renal function (see section 4.2)<em>.</em>&nbsp;In subjects with end-stage renal disease (ESRD), contribution of dialysis to the total clearance of tofacitinib was relatively small. Following a single dose of 10 mg, mean AUC in subjects with ESRD based on concentrations measured on a non-dialysis day was approximately 40% (90% confidence intervals: 1.5-95%) higher compared to subjects with normal renal function. In clinical trials, tofacitinib was not evaluated in patients with baseline creatinine clearance values (estimated by Cockroft-Gault equation) less than 40 mL/min (see section 4.2).</p><p>&nbsp;</p><p><u>Hepatic impairment</u></p><p>Subjects with mild (Child Pugh A) and moderate (Child Pugh B) hepatic impairment had 3%, and 65% higher AUC, respectively, compared to subjects with normal hepatic function. In clinical trials, tofacitinib was not evaluated in subjects with severe (Child Pugh C) hepatic impairment (see sections 4.2 and 4.4), or in patients screened positive for hepatitis B or C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In non-clinical studies, effects were observed on the immune and haematopoietic systems that were attributed to the pharmacological properties (JAK inhibition) of tofacitinib. Secondary effects from immunosuppression, such as bacterial and viral infections and lymphoma were observed at clinically relevant doses. Lymphoma was observed in 3 of 8 adult monkeys at 6 or 3 times the clinical tofacitinib exposure level (unbound AUC in humans at a dose of 5 mg or 10 mg twice daily), and 0 of 14 juvenile monkeys at 5 or 2.5 times the clinical exposure level of 5 mg or 10 mg twice daily. Exposure in monkeys at the no observed adverse effect level (NOAEL) for the lymphomas was approximately 1 or 0.5 times the clinical exposure level of 5 mg or 10 mg twice daily. Other findings at doses exceeding human exposures included effects on the hepatic and gastrointestinal systems.</p><p>&nbsp;</p><p>Tofacitinib is not mutagenic or genotoxic based on the results of a series of&nbsp;<em>in vitro</em>&nbsp;and&nbsp;<em>in</em>&nbsp;<em>vivo</em>&nbsp;tests for gene mutations and chromosomal aberrations.</p><p>&nbsp;</p><p>The carcinogenic potential of tofacitinib was assessed in 6-month rasH2 transgenic mouse carcinogenicity and 2-year rat carcinogenicity studies. Tofacitinib was not carcinogenic in mice at exposures up to 38 or 19 times the clinical exposure level at 5 mg or 10 mg twice daily. Benign testicular interstitial (Leydig) cell tumours were observed in rats: benign Leydig cell tumours in rats are not associated with a risk of Leydig cell tumours in humans. Hibernomas (malignancy of brown adipose tissue) were observed in female rats at exposures greater than or equal to 83 or 41 times the clinical exposure level at 5 mg or 10 mg twice daily. Benign thymomas were observed in female rats at 187 or 94 times the clinical exposure level at 5 mg or 10 mg twice daily.</p><p>&nbsp;</p><p>Tofacitinib was shown to be teratogenic in rats and rabbits, and have effects in rats on female fertility (decreased pregnancy rate; decreases in the numbers of corpora lutea, implantation sites, and viable foetuses; and an increase in early resorptions), parturition, and peri/postnatal development. Tofacitinib had no effects on male fertility, sperm motility or sperm concentration. Tofacitinib was secreted in milk of lactating rats at concentrations approximately 2-fold those in serum from 1 to 8 hours postdose.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Tablet core:</em></p><p>-&nbsp;&nbsp; Microcrystalline cellulose</p><p>-&nbsp;&nbsp; Lactose</p><p>-&nbsp;&nbsp; Croscarmellose sodium</p><p>-&nbsp;&nbsp; Magnesium stearate</p><p><em>Tablet coat:</em></p><p>-&nbsp;&nbsp; Opadry white</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p><p>&nbsp;</p><p>Store in the original package in order to protect from moisture.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aluminum/aluminum blisters.</p><p>&nbsp;</p><p>Pack size: 56 film-coated tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements for disposal.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries
Al-Kharj Road 
P.O. BOX 106229
Riyadh 11666, Saudi Arabia
Tel: + (966-11) 8107023, + (966-11) 2142472
Fax: + (966-11) 2078170
e-mail: jpimedical@hikma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                26 November 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="data:image/png; base64,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&#x2B;IDx4bXBNTTpIaXN0b3J5PiA8cmRmOlNlcT4gPHJkZjpsaSBzdEV2dDphY3Rpb249ImNyZWF0ZWQiIHN0RXZ0Omluc3RhbmNlSUQ9InhtcC5paWQ6ZWZiYWJlZjYtZTMzOS00NTQ3LWI2ZTEtY2VlNWEwODEyY2JlIiBzdEV2dDp3aGVuPSIyMDIzLTA3LTEzVDEzOjQzOjI5KzAzOjAwIi8&#x2B;IDxyZGY6bGkgc3RFdnQ6YWN0aW9uPSJzYXZlZCIgc3RFdnQ6aW5zdGFuY2VJRD0ieG1wLmlpZDpmYTVjMmE1NC0xNmNkLTRlZmItOWUwMy1jOTI5MDgzODc1MWMiIHN0RXZ0OndoZW49IjIwMjMtMDctMTNUMTM6NDM6MjkrMDM6MDAiIHN0RXZ0OmNoYW5nZWQ9Ii8iLz4gPC9yZGY6U2VxPiA8L3htcE1NOkhpc3Rvcnk&#x2B;IDwvcmRmOkRlc2NyaXB0aW9uPiA8L3JkZjpSREY&#x2B;IDwveDp4bXBtZXRhPiA8P3hwYWNrZXQgZW5kPSJyIj8&#x2B;p79H8QAGr5ZJREFUeJzsvfd/HEW2Prz/xmuZBcns3Xt37/eu0sgRHCQbkzPLssuSFlhgyTk4KJhkMDnnDAYHwAZjcABjW2GUs2TZsqTJ0xPkiK2Zfn&#x2B;omVJNpa6O0zPq58PHjLornMrPOXWq&#x2B;neyViSTSc1xHTgwG/z&#x2B;Kdh7c7STWyx2jtYSQE4L78ABCadLO7AhnG5pQ/wu2wI4cODARlA1TefxnJ7HRXMA4DSxAwcOpjIcBcCBA7PgMAzNcKrOgQM&#x2B;FMcINYAzshw4cADgKAAOHDiwFHlJQfKyUA4MBNZDcqLDOCpETmPKNt9UKKMhcBQABw4c2BRTah7P49VaQynsU3COJFkR0nHSc&#x2B;DAgSFD21EAHDhwYBjQWYn1mxXeAR9m15XTFhbDqXAzAGrVmXAc2Ae27XWOAuDAQT7AtlOMZuRfiXIFTs1PBTitnN9w2teBIhwFIH&#x2B;QrwPe5v4D&#x2B;VrtKMzzTpkKtZdbcFrEnsjLdsnLQjnIOkztV/nUaR0FwIEy8qnH5zHyvpns4/2c91XtIOsw5EsmOY2pUEYHKJwWtxiOAuAgB6DtwjsHijC23mzYCjYUSS3yoAgOdMLpA3mMKd64U7z42YWjADhwkFeYCvNprpTRGjlzpTamMvgnUx04cODAejgKgAMVcBaw3AXZdga2ptMxHDjI3VGQu5I7wKDqvFZetnseFMqyIjgKgAMHUwIa1gDBaSj/rJt5fCX/VEOutFoikci2CELIFTmNRa70Ip3QVswpUjl5CUcBcJCfELmE3m7QLKf&#x2B;AqpNYWqeyrBboewmjwNVsOAeLecksQMHDlhwFAAH2YGz9piK/LPKOxCBcwGuNUgmk/a5k8qBg5yA4aPAGVY64SgADhyYApscAFUMkIt7&#x2B;rky7&#x2B;eKnHaD44rgQCfs0xlUOVI6cGAgFDuVowA4cGAkcm4ehwLnnOSWIUc/eZYfDZofpXBgQzhdiwOncqYCHAXAwSScMZ/3yPsmzvsCWg&#x2B;nSo1CLu625Styq1fnlrQOcgWOAuDAwVSEY5DOYzhVbX84bTQV4LQyBqdCbAVHAXBgPJxB7sC2mJr3FznAoKeV86OH5Ecp8gkWtEieNXqeFUcVDPHddRQAB1MLU2oXPl/nx9xdKbPbIvnaH7IF8frMj&#x2B;7k9B97wmkXB4LAuoqjADhwMBXhrBkiyNHjv2phfwl1Iu8L6MCBWthkUNhEjNyFswPgwGo4g9aeyOn9Dcs6VbZ6L5mvrcaRrYRxkBVo&#x2B;F64AwcOxGHg5z71j0pHAchtOPOyAwd8WPxNaLsNSbvJk3NwKjDvYR&#x2B;LwFQTwEF24SgADnIJzoRlGZyqVoRTRXkAnY3o9AFrMJU/cW03eQDsc4&#x2B;cPesnJ&#x2B;AoAA7yCs5nrQRhn1tQrPT8mVK9wj4rtH1gQwlZbnssUXPazc&#x2B;BAwf2gaMAOMgx2HAJ1wCzL6PM&#x2B;v0k9gG/gHlffKPgqBMYRMTTXATA8m1eAw4cYHB6LAc2rBxHAXAwdTE1d/&#x2B;NtSBmZVvW1MQTiQQn/Rxt9JzGVK5zY3fqpnJN5gecFpSdSjAOjgLAhNPJHOQusN5rmcOP4aNGJEHHKcKBsbDP5G8fSRw4sCecMaIZjgLgQDtsNfCcb&#x2B;LY2cfd4qt4BKFHTdIWNytlt0&#x2B;F5zTUbnbZrdrtJk/ew6lwEgZegulAPxwFYOoCjChnXGULOVrzZtCdHK0KW0FRxbJ5JdtcPOuhv0LsqXWbCgu8Og2sySnSKA5sC0cBcGAwbDup2VYws2Grgmv2S1bl52OHIhslg6qLrexQcAcaINK9ncY1A3lTq87FDxB23gy3FRwFwAGOnBs5hjMtoxLPLmOzYcrGipRbrv/WnL22D&#x2B;wpoSGtYIei6Xc5s0Mp7AC19ZBb9ZbHpcshUTnIbikcBcCBA&#x2B;NhzajO7tyhLffsHil2YFvYsK1tIpJNxMhR5OJ1ZPZscXtKlXPQb2c0sCEcBcBBNmGfOcVKSexTakHksRkpd5FnlaynOGq/paUTU9C33oEDB/kHRwFwwIOzvBkLpz5FMJVraSqXfWrCtn5xTld0QMLpFfkERwFw4CDfJrU8Kw4Vhl&#x2B;7aZ9Ks48kJiHvCygIAz/W4cBi5FZj5Za0DiyDLgXA6VVmwKnVPICd72GENyRYII9&#x2B;ZwkNsQwsl2Z76lS&#x2B;hiIrF8JO2do2HFO8Jqd48XMXTsNBiFeFswPgIJ&#x2B;hn4c50woHFtzDY4iuYtl9QVnvLYYIwLl4NOsFNBs2VN3zvs6thB1u8bd/gypKOBVuuZgKcBQABzkPVRelo9DJC/NyespioTBtzZ7Va&#x2B;XSaM8aEIfN5eeLZ3PhzQa/&#x2B;Ll1Ay8K65nrFO9IDsyGnis6HAXAgQMHugDZgOHk2P5O0jYUyYEGWMwLTTUe69n2zPv&#x2B;zCmgcxGcgymFZDLpKAAOHJgLi&#x2B;d6U12exLm&#x2B;hsRVpWAexcnjtTm7ByrMhp1FzYpsdq4QtcinsjhwYBM4CoB2OFOSBTC2kq1kjVOhe9itjNmSx271kOswqj5zvT/Y8ECCAz1w2k4DVFWaDWvYhiJBOApAvsFWvc1WwuiH9R4pqjas86y2qTC1jIKJ59CRUFZg/SWdCmfrddaeqRBvGjuXwmzkaxnztVwODAe/qzgKgIOpiOye/8vdI3SGQ&#x2B;1Zwzxe&#x2B;fKpaLYti20FU4X8KIVNoKcyp44VJl/LZRnseS7cUQAcMGF2N7XPMMhjZFfZSBpxiada8Ivs9DrNyIOqy4MiZB35UYf5UQoHuQW79TpHAXAgBLt13FyHU5/2gZ6vfal9peEQs2Y/HEMOaudcR7X&#x2B;nkc7I1fktBtsWG82FMlUTLXymgpWZToKgAMFZNHrOi&#x2B;nAANvwrEsR5Es7OCdLwJA9&#x2B;15T6J&#x2B;x24DczQwF3EYmKNIUobXqg3HpghIMfjed4aLbZN6EEfOCZxdONVlT0whBcDpgiTyu05y8Q4Nm4uHIifOwqq6vslYb&#x2B;BchHgp1G6b2OGAdX60kR1gn5o0ZJvLStin6gxBnhVnqmEKKQAOHDgQgd2swhYjKwXMxTq3iVQ2EcNY5EShckJIBwD52lj5Wi5r4CgADrRA7e0H9t8Z5ztn5&#x2B;sso6pcOs8T59/dR2iJ8rWHaICehrZ/NVpcOssqxP41L458KosD/bBtf8i6YI4CMNWR9S6oBzktPAtZL1S2BLCzhmDImV3DY&#x2B;mJaB50iqQ5OrX/2PBMs86&#x2B;ZIci5ApsUldqrWM23w&#x2B;0gzufA0PgKAAODIbFx/iykosqz3LLkEwmVXFowwm3qQuDNauOnZUQo2Aevchi7YmIbap4mmvVmt1R9Jh&#x2B;zvnNo7CJGA4MRE53SG2wifCOAuDAAR02GaIOTIVm85uV3cOkvATLYrbqZZnaYFlGZrSXfqPDVFBupwhy&#x2B;nquqQwNV5OZCkcBcGAdDOnZeTYT2dDfJs9q2AzkB5ey52WOedz9zC4aqtE5n8PTgOxq2g7Uwrz6tGdLGStVMpl0FAAH9oLZztbaYM/pICeQrarTn28WPXFt7gSMQsP&#x2B;gA3vWbIMNhFDG3JC&#x2B;JwQEkMuyuxAP7J&#x2B;xN9RAFJwRqCdkVutY8aBTpNMztqOSKoqoOFWYRFynFsdRjPyuJgGdnhb1ZKthGFB58fyFJFPfnQaEs&#x2B;JPoAhF2V2oAhHAXBgKbJ1Q4hNYBP57eOJaB9JNCCHlA0zTrrrjMj/1mzeQO0hE7Vp5mWliSBXCp43ukHWZcu6ALkLZwfAgS6Yd6zNcBZlpV&#x2B;gtss9zGa91tQAmYs2q63O&#x2B;1uyuyrY043eAmiQU0P3sFJvsT&#x2B;MPbQ9ZWHPGWNqtlpWjstPQTgKgAP7Yqod5VELi3fMbVhpiUTCyktLxRdpG9aVgTCqdFl3dTU7rpVpZjcjByYhmUwqNmJutXJuSZtFGKjPq03KUQAcOKDDEDs9NYDOzQE94Q1JR/NRgaz4/k41WEBkNfdSwVMuVGUvKzcviZc0n7q0nctirGxZLKk9K9lsqexZavvA4vpxFID8Rw4NOStPCNi2WowTzKYFFISxPuKG1Gp&#x2B;3P4pCLsNEEPUZvNUUAuqC83CqK5ot1Z2IAg7NJwdZBBBTshp7NEgQTgKgANTkBNDThAmlcVuxx7MYLfZTdO2Dhg23Lcxj1BmZSqwMlO&#x2B;84biW3OE4iGfJmez4dSVrZB1G5Ae6LQ&#x2B;aJafE9FRAExH1rud4bADc7WeculnSCJenjrT1xkgW0gqfbfIzrDY9Av/tGdrGrtCW7AlqNmfTW1gW7WXTp8u8ZQFA&#x2B;T0AQxxGOjtzYmbN15SDsxGXikATk&#x2B;1A&#x2B;zcCvaRTbNvcXaLkC37rn0aLr&#x2B;RW/WcW9Jagxw9tJAV/4epBhtWkVq7jx2KkF0rnrH4nfVZ5hOcqsstWLz15iD/YKBR2WzY36qqbR/PEGMndTuOlZpNGtQM2GE710oY28T2KbKeXUGLS2H2TrhNkBOmurzaAXBgKqxxPJgKU4PNYWcPEw6sP6qRc1WULajy&#x2B;nBq1Q4w8HgJGsyCxhX8Zoh5PjNomjrdvhXTZ71yBlF&#x2B;w5D2TSQSOakAOJ3bDFhfq2Z435qdlBkmllzcBpXzayc0KxBZp62sB1OPYegx1fPTyS26Y6WoamtGg2yaCa4q/m0gjTZpxFFjmXFdQQ51dRao1ZIH5cohwNrOSQXAwdSBKtuhBVlrC&#x2B;/MblYiW7Wd01tk/GQ16&#x2B;pWsnOMWNh/0NlK/TMcObqRqAoG&#x2B;qQ5yAp0tpeBJCErcBQAB7aANWZ&#x2B;cToi7h9sJSyTwQ6FhTBEGLhUWzzj2xM6u7d96tCopDRr7&#x2B;Z5j2QFrI5hniuLKmEArL8xLA9GvYGzqAUZiUNPdrnerPoHQoYCkOvV4cAaGNtPTN39zPUunRXbUlYqLVdaKlfk5CBb9N22zMACLUI8lgW1ZEPrhkkCKDKkrBdcFpvk1SqoerZf7FAn9oRlY9OyJnB2ABzQYWoX1GNP0rZeKk6seWzJM8m4a6V3hyro7BJqY1lpOzcwEethvdhTwQvFENhQJSDBFyl3PySSLSg2sYHfYtffnezcIc3oe9aU11EAHKgAf53QY3LL1vC2fmJiKTA20UBsOM8CmC2YbQuuGSzTYE7YBTXo&#x2B;fnXgorIlj5p291Ia7Tx3KWzautHM7W1zLRnCEy1GdkZjgLgYBLZ3Qo3XIzcypqTu7ErdO6uXlnBFCms2r6X9663ZhfQVGqbxTRzJXf90NbKJpVaUbHXw&#x2B;YVszYwmAjss9uT6304VxWAXK/3qQyzVzL96oeVPiS5a9g2w/qYx&#x2B;PaDoRPf9biTjVoGD0LtuH26bxXXQTBahR7dry8zBfNWs/&#x2B;udoAdoAhJN4&#x2B;mgCEDUViIVe/A&#x2B;Ag52DslERlITkx62EwnItodvBQTNmBUTDb6ctWHUD/ThRcUEWS0qllZXfxNnXc2XxX1m77G3Z2i7ID1BY2h2ixfWDeoIDN4SgADvIfLFaU67ZAW1E9W0GDOU2td6zi5r4q7ptMQ4MwIumbEYUT3dR&#x2B;xf/UqyqfpXzt/w7MhgVm&#x2B;JzunLkovP21FMPtO/mgAORiV8szGOIMoz9Bo8DnYYbLZuDmryFRyOhqXT4U35pkY7a&#x2B;2yj2EJ2Nq7lExuoSFlesTaZ0QV1CfxvpT4qVTiKRsLIyTcrLJv0BwCgHM1sVShBGyWwI1c7FCrQb8kEBcJB1sCyaBibOT3BKzQVUbkfUjzp7tv4ZmZTKvEbJSnNb7KXA0iIsY&#x2B;Tc3oUHsEYMo0LmK6ZUDeRNYS2eWCyITk3HJu1lBzHss9XgKAAOTISxg80OQ5cPQ7iv2cU0yfouGECPuTQrXhzUNSwra7a4Um34jpwhKVigQoivrGqzzhudUzAvPV3dPvyGBRsSUxHYZyNO50Rkve0gh1rZSjgKgCmwSW&#x2B;ziRjiyJbABu5XUBNXfJJDMGoH3MBMrU8nV/LFYJQ1nb/jZ4fCAhkMZ6KCCRroFJQrsGCjxrKZx85bl/bsIZZ1eCt1S0OqGk6M9mw4RwFwwISpXZbk3NmaHO0wMnXOg9Rp0fC5UoO9H3tlB/6dQ0qmqWKLJMgRQK1sdvMX0hZeLcxIX2Rcm2R5NcmWkce7K4YzYzuzST1glchuu0lqLQvW2wJURXQUgKkIC6w1DjgwXPPRkKllcfWkJu7zo2G9NJwMGZu&#x2B;BchWs5okgKl5iTe3Wk0vizuE&#x2B;ucE2/JR1pC3XlSRTEWksowK27ZNrUSeFZ9VHEcBcDC1oHkfWQ9tNeqbO&#x2B;Y52KhdorKyjsqZNEttXLWvdMKohV9z&#x2B;CyuYdbbvdSmKZiR4aZ0owqYKz1BT&#x2B;4a2kgPxbe4lrStRLYS0m7ApLXb7gEf2vQubQsixFRUAHKrTzvggG88y7qB01joFIB/e7raKIZDgxsJ68&#x2B;s6yrWwJ6OEzq3XLKrEhu1Naq5FPwRZ&#x2B;weizjFzOkRZP/9Vc3RzS5aTre7ZiiWWueyKFir1njwTkUFwIFJoN45nYvLCZVK2s3lQ//2vUgi2XLS0EDi7e84YaWEWBOTy4l57hDi5JizV6ZfixPkvoabDAzpumolUUUXtKnK9p&#x2B;3AWxiO9cJTtNMZd5vyKqXLWRFS2RFB386CoADK2D40qJtv0wb&#x2B;ObMrE8r5sHKVUcV7LnGa7AfYz80s17DC66z6U3dO9KzS263bqxfHkVrBZYFtWlsUi02ESNHYRNjjfVABbCD24/m/U/FBBVLp7b4jgLgQANssV9piPVa20Smx8apCmr1HKqhV60YttoWoAIU0/B51iho7gD8syIWL7qcLDSvstqGGJpdfpg/LVBFzNg0s8Pg0ga76X6yEXtc4hlZYK6yVfVizW3Z1pbFlaCHGAA4CkAewrJeaAEP0BPd7Hqwg7EBwsC1PPOVCsZmrGHepF0j8kmS&#x2B;yFkPeu0NhJmuM6WlbXQAli/YWL/fT/BOhEe/qKv1EI8FzM0GbNhmRqZxeimpoZBcallzaK2gk14CwpHAXDARE7MYrmeu7Gk2WxonmcNKY4ZioSBELEy2rwImrMzthtkq/OblK/FRE1QS8kh/qcnRyuHv/hD/bazXNSL&#x2B;DBv2rES1nRLowruKAAODIM1FnErNzFNnWSNXZ4t9iggrdT6BTCjCKSE1hg4LU7cJAH0d9GseJzr3ArISksZblzXk2BO2FP1wwJtPFs8z27LhyG52LATCq4mqqiRlZ4F2hUAGzaGBuRHKSyDiI1TMQWjhGElazaPVJWRGcJgEwQrCw3ziOZqtHJRVEzZSvoiSJGzpR2xzoSYCvNsYDqZPT&#x2B;Afs2QuuTr6Y1mVJGqsqgVXnGB0ElMbTW3ozCWtPGr0YI6yTlkd5/HyuyMFcCiHQCnjzqQs&#x2B;QHYrZuYF7ielYmDSu3uGAGxuWnoEfFYpFvzf0ntzoPNX2YiwWXTGdrp8W8HO28imkYKeIzif4tBUNgnmLJT8ee1nQ9yOmpLP&#x2B;Q1OESphOOC5AD7dA/1Dl2MivFyIlMrVEw9IRUxULIwJy7fQyESPrUbql2l0MDJ&#x2B;asBAZWi4gqaPaChNWPGdmZR1uzSHFM3T2gQrBp7EP7TJJErUJr2Ypmn5oHsJs8hkODQmjbOnEUAAd2gd0GCYuhCgbWE8wQmLcQcozugqyLqgaIL7G2un9JA0ylcdQqzS1KQbVVJ9OwLF87w3BebjiLNTYRO&#x2B;RuzWaguBj5ihwqoLGimldw1gLqKAAOsoC8GeHmeb/wA1M/ukwGU6XD6BePGt1sQy8K69O3LR9Vtf9gUgrUNHWyKJE9Q22vdAY2Ctoy5SvSFhREc8UaLluuWwfkXFgfzdtec2AlHAUgB6CfhOmXwW6zqgYaYYj9hmP81pym/SHOqCzb&#x2B;MZiYY2rk2EYbtexzLQDoO3uHawOLfj8FmtIZsvUakZ2VKqk8xZIw2djQ7zvjKq9rJBLPQuK5sTF2zG/1xcRaPgUACuuSWZ7xaXQho34O9mWYuU6nCoVhw3rSpzUUrmdTlOrseufIvvkZCdOGRXD24RbmJ2X4AJvN4ushvCyyYqNnWE3awgLdmsdxUnG1PFi6raDNkns1kBZhNkmhqzAenOY2nSm3A4An7I4A1IQ2tZ&#x2B;tYRS8a1lFjtBeQRfCYptam9UrGpWPRhly1SESWxAbR9Tm7g1c4ggm8kJvUs8F0PuDODLMDExYWzK5sEmq5WqqVLtdMEPr2FFMGrZIvWWHGoOWXgCMRzi9nKjYOxOphly6tnc0BwSYMopAFMNNpmVFGEgubdzkXXqFazAVs7mhkxGelwgBPc0zAD/6IU4DDcBCvYrVjBtYmiIhS3GFqj0GkYT/619lCK1kpinqxtuodefuHn8UqeOYYFnHRX8NcJUm5TFykaubNBphoF1mA8KgJ0JHwt530dJqG0m87ReDVA0AhmbsgUwPF/9H7c3PLBa6Px0GuuJIZKQyRrOJFSVxXBDI7XyBQ&#x2B;7axZPMCJG/XVqAhrUV07PFDyYbpnBNV8h2Nms1DRMimsNzJPQ/uuy2o1io&#x2B;gimU4&#x2B;KAAOpiD0r75mG18NnIb0yyyowKiyEplqNMJSgImYYT9TWy5UHnFLrdnLuTVLPqh/Va1grGA5dy09CaNU5WwZPqxBtnb5RGAqec3K17vNgDaxbWgb1Vn/dm6&#x2B;XFIA7FyPZkOtK6TiK4sr0z72Zj0w2yqgP2txiqBHqRDsb9a0keZG4XvuCprDNexTcX6Ig1TVrGGH2pQZw4Uxe0lWOxipvI0Mw0pWw8ED82ZUtFsa6J2sTRhxmLQhoxPUrmKTRdmBWhi4ohluiNSGXFIAbAUNC39OI7dKYd4moH3qQZUk9hEbgF&#x2B;34tKapGPoYeQ6Lf0muRNQ8&#x2B;KfqeXvU6sdHXoonTYaKtgiNjTvmb1ZBCGoeCj2SZur&#x2B;lgiaMfQYDujhhEftuKmHDKktut9cwW5cimqefqbxV/pkR0FYIpA5zRnMbQtJxqGpTazukybnTWsFtpMthoWYLW0LLvKrTWWbDJ9zl3RaHMDr3TzNEwOSPcbPakpgiymzuu0YXSTXFpZ8ljfyc2Yb/XQDqPmQGOrggyWdQqoNlkDNeQsLsQ6p1wLJKcuwWZnOhUwJRQAp6/kFuzQXjqXOs1F0MOxNN9Gp3l1l9krt8U8PuswSitQzIXzp6lQxdrFjfdYeJ0QzDcrfIK/I2GgWVGPfqVqs8WaPm8sBGU23Mpr54pSlE2tMmMGbHg2wBBkt1xTQgFwYAH0TAe09Vhh/VaVHdfuYszws8YkrEHHyOKusVppBcNwViOqNsInXuJZawBHL1Kk8va5ksgoZN1qK26NtlW98aFHb9eZYD4p&#x2B;eJzr4i5xOyunnUjvSpjk87cjaUWaoPxd4b1SGLUXq6etdVRAByYBStVWxGaazg9ErESqZ0jNNtayLXBJutx1mmfYDqWdY&#x2B;sQLB02iiy5hXIKDVeM9SSOYtVCPEpNFvfnFasHFuNAhZgN9AgrYZ5w3r7C0C2jnSrgogMebAbkEgk&#x2B;KWwpoyOAqARmkmeA7UwaiSYRCBYPUGEWxgriSFhNETXX0aWPUlxlhQEXxWkys85IKtTxbLGbGZUasbqkyapbYpjTe3ATKZhiLRqoZ&#x2B;GovXDGUHaRnSurHciU4d9ysLvvUYpV2YbxfSkI95XzVaxsqVgWN8bHQVgSsPwDsfnUnkAnUsjSSy0Te6CdN9wC6tImorFESHchpji1IYUrHNyEdWftfVAJaFeAUkNKQidx4VNBVpGtYIZzjz0MzB71q3iw6xIIhjGAt1PrXji8hhlNFFE1jue9QJkyyhjXkkNUwCy3hsUYX8JcxRm3F0lyKQNzBEG09NPJrmFJZ/FNSQ6lQianTsMSbX966FZGr5Rla1pnRNRbYWwErT5pMe3eupMQUMwzeHVpmZe05ja4ui1odi8ob8pNQOOYlOtBsZGt/nAJGF2RZm0mmtIX3OO4rCPSVSFApBzXda2yNeaNHaOMHaQ6LmNRL8xXiSiYNboWmsrEwi5AGvT9Pix&#x2B;L7OJBUw0BTNP/eWlTldQ6baLvORuVWn&#x2B;fPMhtgCNOSrPzr1Nljxzmx2ofTkKzLd8dm2SD3orBlO1gaqIvonWFtN0WRIzZYFDbFEYPYsapLk1lxfa4bwtnABMmkucKCIvKxhKlHj36HOgbFLl6LJmUruDWkm8YsRzbNNcpQcVapXMplEFSGTdr0NoV/W8FeZfWgBVpQZbEbwMhD&#x2B;Gf28nIXsADuzTwya9VKLQZ3ENNNoKwti&#x2B;AxvrPD6a8O8ZSvrKZgHWygADrTBzh3LWHCWBzMOiQq&#x2B;ogYTsZDpgVqTNkb&#x2B;MGMtNGQqmv34X43lZM0RBoOxH4BjBRasMUGgMmu2A4nYXNW&#x2B;1aN4wObOP9NMknvQkITdiCmUZ2JiIrs8mPpbpn3uLeu9xQIBsAqxoNuwqp2vV&#x2B;uZarSFN6Pys96jINSuPgbmaIhGN&#x2B;UUAPt0HRvCqRwMgmPMAvcPEY6O/bAM/FrSozBok8EM8DcZ1M7FFjMSCJTW88k9px0N4RCqaowIYGkPt/4yGXG9y1izLmYdMNxmbBKyLhs6ZIyqtHw1POeuVNZzfZNyQWNNOQXAgVpoJnDZYjmC0HA7nqIwOq3LZhjIWenb5xySGVBlmNfcixSJmvBGkGHLj7EWPmoUbZqwtv6GmpMNX4BFeDZL7dGm8hnSiBbDYmHMyy5bBE7DkLRVB7Ah9JiZdGZEvjXK/qVBABGR&#x2B;MhbBcCQbbUpCMNrgDPBKXqlc4QRplZMGVRFEaF6arPQliM/FicdEbsvK6IqI6jaOUgQ&#x2B;o00OkkYvzdynsB8qSno0cTQBPWko81bQ7BFqB3SztZlQdm0KULiWRsejNr/DdEJ4UNqwe1ma9CjJGu78k6Q5dttIJgBxUlYZ4fU1rh5UPPaipCTCkAetJYDi2GBoYW1vmrjSaz0zQOfGajVH9RCUMfQTF9E1BhVm0L6bdLmESMRhYQVS08taYDIJ2yxvmfsQKAqP6p6uxnyoG2RLdai&#x2B;X5nccGs1A0sWAKshFGam/1huFVCT/g8g00VgCneKg6yDvMslIrGD80Gqkl&#x2B;nGkYFl/5DCmpNk0GYw8cn3uMp5rKxli5szJCVRRWFzLK5G84VPV5Qc1WQ77wT1VX99ptyVBVP4I3dJlXRlNVLCwXU7MwFYoykwegdYJMx2IzUFZS0JCIsdsp2uJqmOSzPgqy9iGwPFPHxWGTAWYNRMyudoOgwV5VGBHKK5K&#x2B;uB1XMCMNMMPEok1CVmDFa&#x2B;k1qFja1AxsSeDfhqkHqkgwpjuJkAyy&#x2B;KRxGgvDKqzZHwnmWM3VDhlFXV0kcVXQ/EUFmVZwa1YKPu8xZKHXMNyob1U1qDZoTseamyRklRLmENnAYIbkZmjI2a1hc3cAcrf3qILhQzfn6i1bArPWG20rt&#x2B;ZSCFr7qKu7sVVn1E2a1BKRTwTdRUztHtgXHnSyf2oAfqcSL52eDqYtIgeCTcNSEsgw5G&#x2B;RlNUC9kx&#x2B;c&#x2B;hvLG3hNUNDt6TCJB6J1qoGHmkBTPoYiCA4S4Ci7cCovmoeDGxxzaNef9ZoOhpsQGphcW/Ulp0uBUCQ92BR9OSYLeSo2BaAuvZbU12GfNWL9dyCCYKTuCoWpcGyxWopVVlzbmhhZSrSZOIHUkUy5cTSFl0RVGJt9oggs&#x2B;M4UOkXRu14wYTRYKRXG1JRJzFEGVOUwbxvDihmBzU3w/uehilCWzBjdTmZMfY1p2PeoDZkkGIJ6gzMWdw1mOH42Zm9vFoc0Q5Zs2DTMwDZQs75q9gc5i1CMjIqjGo1M6Z1VbObIUsdJxFTWyGLCRqrrSlyd22OudoqSjEvkav9&#x2B;TKo5cdkXppv1DXpin2Turp47tTf5J/kcyyusUopRwBV0DmgBKHq9l5OFjpvAeYQX1Xgu/9ZRjy0zVRZHE0Y7CMJBHVCzroYgpiiCoANu1GuQLMLr0lMkZWsGX5ZEIpSkb8Fs1BMTXwGN4pAYOkIrog6bWwQip4q2R3LIuoB57khtcTpNtQ0zViiSKYruC6SmwMi9wJpC6A2GLRfkNGNEsYCaOB8ppaOuh0kAkFNNes1b4gdxzKo0v9NLYJ9mtIorc/&#x2B;MEUByPtaw2Dz8lovnlqdOOuXYJB56c9O3Cyqdrk1w4yH2QjVWoXJdBSj65nuSSFF9EADG1cR6K6XzpLqPzos0sH4Ww2CJFJnDxGE9ezEpJQNVPn4Nn60K2p2saNmJxjeJBjbE7AOL7juYGeQWFHQJ5xzSmZM9ST0J2s3zmO2PGrTN&#x2B;/wm/6&#x2B;jcKmOwB6Ks5uXTOHoL/a1abAmcF1tmMW2YAqG6Fas6VadwtWTaIJUpcrzX4drEz1EA7NColm6FmJzdDQsCdqK1PnF5o4taFKP&#x2B;d0Yw4x5fBdVr76iZR&#x2B;j3wzoltGdPgatR4FwKiLCkQCC64jxi43iiqWgYqfnnSMTc2oYKpCagM/fbIz2JaK6IdNFQAHRsEmnc/YGYefi2IYcaaiOFOIPFc78aFLLCqGYjoYlaeKIULXRMplKkHhJGKehyWrkvXoHjYZfRj42h0/IuctaQQVqToNLoVZP6mV9WbVo0vrDGwlSDXPtqJCaFsyWIHtsGIqhjRWTvs3sQ2hudc5CoBdkCv9XpXBTxzGOgYYq8Grzd2Qt&#x2B;Iy6zHV82GgFZ/fOuYVQVVSfKunBpH0CK&#x2B;H8WT3YmKWwV7wyK/aIuv5sACWndnqKwdZ0WoE50mjNkNU&#x2B;cmYamKQkfFlhrJk/9Vc5xJpWQG1ZcQ3folEV5WvgbuF&#x2B;itWFXOwQgHIusFGM&#x2B;w/jPMAFlwVT6avedJXXJawH7B0HAFYNYDGYi2W5DJGjaKByvPDo4Na8wBXpReJ3CUlMnFrLriinob95l9MTkbEuoT4oWGd95wYAk73EIzL71Ea7guybCmdmJhQlAGbDajpZPcae50BRA566Z&#x2B;FNOTLAitrtDXFY2EBqOPU8P5JQtUNBCwx8pX25GK5zJbZ2QHIDYj0A5v3bw2c26i5Sf/Mq2hCoAZQZXIwREJMGHGOiMY10A6a1HeGVbHCWU&#x2B;MNROqEkxDgrDOzRvCfDXG2FxICoU1DVUGzUxO5zUyJsEms7GGqtYjuU6zgmCYJO1D1AYKpmqwqBq5yTRUSUVqyFmHUcJou1JZDwzpojYZ3frhKAAObAQrr0NWmxd5tItjkxZ8zvlT0OSm3zInPpeJU3lOphg75FtMWdnxZVY7OxvS68xWOTTEIitTG2EiY0GXHsMVIQNT05&#x2B;sftjQwi0expB6sxVtFYeG/qlKE1CcvfnuUtmtVQ12JQ2AiedoFzIcZtSDowA4sDsMXL/RpNQOJ6OmYMVtDYuNdrI&#x2B;pihr8veQM3UwC6Z4zPbGAt96LafF5iyB1DtABPdVNLSjYnfiRGHtPFAfclx0qIc1xcWgpqkHqrox584WM7olSyQrj21otiiL201IBVKVtVtcHpGsRVJWrK7sQs8wz1FYI78qE57&#x2B;ldoMiKuRJBwFQAjZNe9lK1m1MFYMPd1aJBFZJVGwBoZrO6wykucyBVd3DUsRC1YSLM3gu/Krgp4NH1QeQXWCI4NaNqZt64D6kFMJrC2FJPtABfbcwBGtdurQ1ppkmlnfzTBJU9Wmb&#x2B;hMR1vrsBRjtbnzReIIgw5wnZqJxXxU7fDPFkwVSb8SC2F286lWAGzSfrkIp&#x2B;pMhUksTW14nUZcvoGQnxeHF/L5CqvqWNlpcCsycJpLIjZ4ca8kaNoHcVkRDWGQ2sx1qmxRqnKXGc3NMX5zUhbv8BoICr8StL3l50hmrbgLpJiano4kot1RlXlqXuJDVVUdikilP4pmRRedqaxcdsXrUNUUIRiYNa1xIHI9l07NTdv8oDiJiSRiB9jcf&#x2B;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&#x2B;smBngPWagurbTWlXrzDJ8qqpFIUiZ8g544gMwamSbfHqBp6RpXXVCopCEPYiT3NJRwB&#x2B;M0tftJGVQqWgdSZOVDbh/nhNU&#x2B;SggoDlru2AWj4DGlBjtogovIJRjFvBhbJ3ah08ucQsKmC2fwkR15CW4MafkuDLLyoc6zdWZmIdVqSYDDWpzE150WukXwTI&#x2B;sJ1VyNpqa2M7Ck1ZOOoJJDkjANzSdOoFHDqlotF9UQ0OdqjxTLjBYUjMsHh4cJlheWzihyY4E5g9pXs7hka56NYc0btfJqOG6kLSlDoLa7msdPzKC5nBKpMrWIBNAPaidBx7LF48vY7Oy7AyDeSxxog82r0T7iCUpCkn6&#x2B;OYE12ZHUSq2cgld/8PkNSwbBiS8r189p6zOCVh9DZqR0SFEOKgs424ifTFAbQH9cquZAvsW6LqqZ8KtdcZQJyqYqjGJEjiamf1oTGYD6a0BbwQWhbXLjNLQ2wbTdmaMhHda0z&#x2B;rhaotj6mSr9voBWZPOnCR23bUtu6pyxJ6IR1dVFRZo/pphXwWABTvXphnI780HQYppUoubdKRPhOULJst5yMkFA&#x2B;dclyE2csGsRdI0kLrJxNJlhmOoqsrktz7LsgibW72aIRqMCI9HF/G0NmOQiugAalMTiaVY20ZxR/GIIj1Ns0pDDaDn9EJS7Dip2Z1K//xmYK9W1OdNWvgM1DmtBHUXndOL0DlKsbOxSoROtppLnUMENfcUAAd82LbzabP6mM1QVSGRSOjfYaeGp6YsG6f&#x2B;8ec78qE2XoX9yaIs2mwtakUS3KlPcD8pQI3Ol4SaBeuVfsYmqELrOSupDaxS4/WcudaiNUwuw3rGGrXysXx1DjeRgcMaLKoS4aegLS6Ho2PdXrGWRJwGxQVDMxVXBUX0DVWMkHxFNStoaA49M4&#x2B;GyUG2yopqahbiPSGL0CmJNp1ZFaauAmCfXqIW2ZXcKOOEGaVQu/rqTFwbNTHcmVKnjqTAzxjBBF&#x2B;pksQaiFjg&#x2B;HETaYhEUZujWpWAv5ZTNQGqbPrbgk&#x2B;hqKQQJfqsRLSRFRFVjYSe2sDiqtK4sCrSQJQNoXTYfKK2K4pLok1Uzd1AM8wbFNpyURzp/NXZjANy1oC0H2mbOVkwfBrPIlQJM3UVAAeWgT8rCRJQxcTFw4gT9wRxrx/KY9QamUjulSQ2ykWkEsxOKSlj5ixYBJG9EZ2qgjZiBH5w/Hf5jEeVzJzFSZEYqVWxjF0CdYI6ijVUnWIAPrNh5UtVmchgHNauTaMgc6e&#x2B;FUwWDanZIVvtfMsPwD&#x2B;Ury1NWcycLx5dBCdPnuQH0OlAqLNENkSCdo&#x2B;wBiimYLjewmkdo5aAXIGjAGQfudVjdMKCqdwQ6M9XcGuY1AGMmu8U1QkWl1JVdpEdA920SQVvxqyYakEySEHhOfqPNtMRZ3EV6VpYdDIMy0&#x2B;DTJnTkdSqZBz6LthLUfpuBh0nBcNi6RkdHMVDPE0W1HKXiYkJVHHSo&#x2B;HABAVT0FaZ4tCgUHESUaWZC45Z6kNttWHSKUHBZAX9wchlRdWqZBkEzRDWZ21SKzsKgAPtsLPqolM28WVMlQEDW1QA3WdxR7XKANewIRReVRbo8qnZRqLBoonCQKOjISmosnxrMAqyHHiYWSgZaMnOqcF4T8lXaTGj9lVtnECPmqQIRfKnVgXSLAkJ1s4bNZggLDB2auj2Fi806JageQNBQ69GHwq2vqpM5cyya0iBdZjNcLAWDmO7irYlUkMP15CLIek4CoADCkwawxbYe8QN2HqWOm2TjsjUgJVFc0OgygO0wbBCiqfJykj8HJustMaQdau225DLJCsvTrNiXiXUBPVoUAb2Um2dBO0hKPWnpkb2W1h8rB44tFgbjzdv&#x2B;SRT1lCT&#x2B;hmVYBaGKGak2yEnpKBg2sQQTFO/QmIqQTTwCI1gRoKwhh8bCI5g1mgUHJjBKGSDNHOdDapLAbCmM9m2y&#x2B;pB1vu0bKGxx/oW1EY1BIOxqCE1LpXiUw8DkIEF5cR0Hioh4yQraKMSJA16zJxkFmRVq2pZtaSfKgM1Ov/Ag9oOxp/c&#x2B;QKrBecshKp09DS0tozUBhDR0ES6E7Vl9a/HVJ2KL4Z&#x2B;9q8hvEimilOlbRfxZFL17VhotdingOKKqGJ0PWs9NUedlaOzaGZkbWVzs3Q5Q&#x2B;DsADjIPrI&#x2B;e7LAZ5D8JZlDRkWMrORbRSpPzUjEKsZ5KAh0rtdjX2StQ6yya1Nm0IeYJORZQH6aWdLklZclVWNKcanWf6YCay&#x2B;M1LKItWI/0eYIQc2LfKjNUsCJpVNOtfOkyDEPYyFi8WGp0FQIKuSKgbXZVrQhW8uZUcRdMZgiJRXpBgbKxpGETI2xw2xWk2m2CFgD7QqAWnFtS/IcZBGCpFY/zCBqIjY5s53UsUlN1e6EnKawpCO4ZvrIUjkUuQi1J5CrDmmV1OCigxJ3Da4OnD85ZjAqNPuckPWsSBOprSxo4mL1Cr6RWNwfj5O1YF6qkrWbYc&#x2B;kaVCVMkNVpfix9HsVcuJiLFOwLIqdX60mQKqsqqKzAuvnhXpUX3uCOuFr4JniEcVbP1egVmBnB8CBddAzJvVYs1iLiiqIb6EKCqM5R0H7vbYdfwAWmxTRechYHAOzohUWy5o/ubPeKhI&#x2B;fqFIrsanBTAwf5EWIQQiNjZW7mhj8fMCIal&#x2B;TYJLsrbVWlUUwZCCTakqa6NAVVxJlVWxsRQTp45TbIALpoze7SNOf5PE7cBqnevMax39pNlYKo9B7WypLRcsL1XLB6qyClamUbVEnZGsgbG6ljbJDdf3bKoA5JNeax/knDoLoMoqQC5sJBkV0ftZJElQ5omJCSgqfyU2CqxpkVobIsSXyghFxGCxf21QtP8JrgdqdQY&#x2B;MLKClpF/PIAFvleYKu6rqqOycqQ&#x2B;V3teAk2Qql6qkkEtsK0tLH3NG26CKhmrFTSMDp0Kv&#x2B;IASRLHwcWhSFJVzX7iCoaiGCKysaDBdKJZclXyGD6u&#x2B;dlZkJdiCuK9xRqoytT&#x2B;jMsUBcCh7&#x2B;bB5nWrjTVqy0hW6frCSkTEoiYoBnw4GVfJLMdJmePzoDhFCq6IagOQwQTTRIsjToip2z580xSWNYcVqaXL4l1LvJUV3VqoX4cV6bE6Sba2/qMqmOYURBi8tgGimKAGSqrWTwbtmYq5ZGU50D9hKgbQVi5VBwb4eakdwqzoRpFp/XOUgV1Fv4IEoW2uUJWaSSxcs3ppthiqYNMdAEHYX8HKAxjFGs2GohjaNisxw554doKyGWu7UpuRIIwy2Yr4rSqmRtUKsKZBF07MPG&#x2B;sA4CeKCz2L8j/OAHQlEX6krgWxw8mDrXMBgI7cEJ9JZg1NXdtigH/CSRA5vF1zfVp5ezN6UV6OpgG2qf57A0/BfFtLjQYnJQEp1mOXQMAem3ZZGnWAKMcbjVH0bCRq&#x2B;hcYMPmyLICYHN7dq7Dgg5nbBbmkVRWYMsc&#x2B;3QWTZXpUfHwgKBTATVxxSfU54qLtFrTIKgTcGmPCPtBy665LRSNheA3qqLA33o2ECA9EhRArb2Q/6UIVUDbgmwXRe5CxtUWQFY54jTsHGZmwat2lguHTglJ5ZafgoHshJ&#x2B;XoE1dXGnRsItCjWVsn&#x2B;FD7TwjODTQ8GhEPV1LBHyHOpaE&#x2B;sVQVSeKgfUrfoKvBANkHTwFwBrp7V9HDvgwtQVJpw7D06TCDGOnSDC10w20qScYHxNQK6FmFgjXIf66y1&#x2B;oxKmAtgaiLmP0IhMcQnMtwaaBljkN/IkKtMUFl1ujiAK1s6nq6jrzwsDvGIIPRWqSSrZUc&#x2B;vk5LCV2VQV635qu00qX02HUkiQ/Z9TcPI52UCK7nlaxaM0qx4yqtjJ1RJ9ObOMagUTMd9om8YNWfVY2heZBbVRTKITGuZG8Yh6Ms0uctsFKI9h/66TLeixY6mdqcWXN8WkZGLuY6Wjiu6IiMShvCIEDlMtFKuFQ/c5UsFlg198cT1HsI0SxGfUqHKyFFFM7RHZyqfmJVIcVqPDFiEXV1aXQ19xuIJuKqbg5sTJ3RBmYNT&#x2B;HucKMozJaVBQRUY6f7pQrEM&#x2B;O&#x2B;RPJhrcWkSgZyMOQg&#x2B;tNxCahwnWduLzKgtob9HfcCJKheYhxlJ9&#x2B;RCf1bXIpClTY3ugBmVSDwxTAOwwDvMYTvVmHdqaQNzwwDcIqdUH0OcipIRDuNUKoy1N8fQ5SouiXqRtvWG5TqldGKgNwdq&#x2B;J1dxMh3Fh3xQKQKWjvj1u3r2jrAfsspRIL6nxx8C/L6kKlkNoxgCvXlTMCLLF0iDV4mIH4Wqni8y3vkzmEguasGZRliBWeo0X047Q1F1MaNcgmtiMvMaDEP27RX3CW2iUlqGXNoByFZfzAnk6AREQnwEGmIjlMWYASc6NqfwrTjiyaKsSLNsIiGpCyHnoG1SzbfDWAski/LqGY9J4upxA0FasqmlFnHS4LNMTncSNJqSPSeRSGANqlZ14TQxa03lm6X5/Yej4fCTVezkgl40HJVMBFTdj0xTZFyjjSiYu4hg/D0N&#x2B;FtR/9cwYLGCixNx8c0i7LlahYSTMtlq2KDmdF1tdcUSQzw6KQlLzmzBKGFYY0rtdKdfDGMT1JkRJ1guKQA5irzRMfTAmjHGGf&#x2B;C6wo64QrKzLLgUkGuSUklp3mZxp5FMkVLwSGagpLz33I8ZETogp4JWhVjIGtDxMJNrT1t&#x2B;xiKnUrRfCsi8MTEhCzT2xfTtTgeUBzykUjgCptiK4sMCpnmdaBz6lAbXZDdqkrWPLKllvsaBX6JFAm3qgmW2j30lEstHTdW9SLBGtE6206Vn6fhEFS5qVFYDzUrcg5YcBQABdifvlsgofWVIOh4oGGWEUwQ&#x2B;82yiLMEEGe6qnikYkNg8mgwHbEUBkEJxSHiYEoNwGn0ZDLJudAGbUSMIVEpPqtc2N38LFUKk4RfSxzrJlVUQzbEVcUVyZETBq0HtAVJdqKKHXKQTAN7iP1gxeX8KWv1YKZGR4cqRnapnZC8Y8ooYoTJIKLImUSjDSf9rMSxJ6TBghVYpB7EBRaZlsWVYXGLkjUru&#x2B;LiaD3B0LDMmYTsypB9BcD&#x2B;DNsmsENn1QbNawZ1/jVQEmNTSyaV6Qt/ahZXG9TyM2rKqkikiJMudaJXJPrG8lS1UUiXGz6LpQaAHE5zWURUWVZVU0vEF4akepweQnZRkQ4pmAWHo5MPE4mELDNpkGLX4jM/kQQFE9em7KmCKuadzHSnVtVLdVpwsbfGDn9BGbQRcSgwf7uPM9AUB6DaV7LAgJI1rQWKIfU0E/VrhqpyFw/MmRgVszCwK5o0xNQGVoSCAmAlOzcjL0e7gHCqAkLVvKDWWCLC5FiSkORS83omstBS2Q&#x2B;L41LFwBYhfhYcFcIQi5QiBzUQ&#x2B;qfsJOPEgkhViGgaGlYg6q4RX4yJiQm0kvmrr8V2RyoUVRcopIgHBbW8rEog01HLHfkPYVtgIEtkDdS6b4lzYrKqRUa6WvVPMR1qfWrQQg2B&#x2B;FynTW0QTFwkd3EhqVVnlBhqo7Cmcf3CZBHZ3wGYasjLbmQ21E7Q2tYDCGxd0eDeo2qx4RjOqWmK1waL0pHmQD3ODCxyz6JKMtuHXhW7YgkjJjgdIp2H467DCjmR/mCZ2jWMT6kV13J&#x2B;n5S5ihkMAGXWs2qyupmgJqPZqKk47jhVpGj6FZSBD5YGwk&#x2B;crwxoJt/kABQcevzExYeMYlKsuOJJ8WmloL5EVUL08O8chalapU3qyqihrScpk4ArAHaTL4eQ3arLrYbTsB7oKaC4JqCWSfAXJEFyIyIkH9gihK3cipJQ9QSWnJrB4b7YQ/LEhaLyY&#x2B;w6JFxeOlti&#x2B;QiJQJH/KcpGJdnUbRa0Y5DKiXimGTkKVJ2g6VRbGJEOpgGaxVOVtQbdkpOLYD2THUNRT4PdSYQlU4VPTVMGLVuCShTLvsCKAiPCwipqHYoKJ18qQ0CdzxUneQ1ZWA&#x2B;&#x2B;AUVRizNQQ8tWDRiL3NgBEL&#x2B;L2oENocd0ZKwkEJZ5IyQYH64iH7KIC2cRZcWiPhfURvgGUeorFuulCsz6EybC3w/R3F6auSPHDIzOSyKGQ4wcUBpXqdXSUTIqnKQ1rL40MTFBBmC1C/aDZDacthBfd4X0ZDWeHtoAu5kIb&#x2B;M0sapXkxtE7Ft3RYYV6vwjrr/x21Exd8W9OG0RWZKQVYQ2lh6VEm16cooT72ykRsSqYVIV4esVrKZUnHMElWG1ZdQDwV6tLVmTVnO1MueQbqBLAdBQ3ca2UA5VdBYhXufmsWFtKVsQi0OgRSZKzUMAXRs4Dhv89KmrPlwpqWQafcKy87FYOF8GEhlrodhQFckoKXZEgRRGpOz8FNAf5CpOJiuyrusxSiXS4IQkq0vPME8i&#x2B;0sk/UIZLUtx4pgnYbL8ekOfU9dm8BxmpKiS8TuGyCs0Nf4soVg0ReIuLg&#x2B;Zsoi6pWFo6AdV9eKD0ytYYVi6hLFgdQO055OjQLCtOVEU5wHRAggD5GhsfWqj8maUTmeapuokRiE3dgBErGsODOxqFvdaPRxIMDoWXoQn6ReME9iQCU78oZIwvOgc9kl9JUK8YMqsHRLOYsaxYXPmXCpf5xQErtOsFTeZTCYSlB0ALDopiYxoC6pIDEt&#x2B;mVFwau4a&#x2B;B&#x2B;MyBo4rMDkW/4oVmXI5EurNh0yTT5d1r&#x2B;6Ax2JbGiRRsQCcBqa33mwXmr28irOdwUTQYFNC9psBAYG0wD9y6548VmTD3/iYmWHgnoY3XrmZgcVQg&#x2B;skUeXAuDQ8azDaQKdUDVViaz6ilMwOvNSl2dFQx2HhHGM&#x2B;jLBelmpieRIysx5yAefJbMyRdd7rF00mzCxiFS7ssymqhx1SJs8/ERYYTDXCLU6p3gwztgheT/Lys7v6uLiCSrD1P0HxRwFhzz6p571m&#x2B;yHiqmJZMci&#x2B;tpEFRnpinOpiAyC&#x2B;zP89AVfaUtBVV6oyUNQndYMfnUZMu44gUUMQEbpPPoHHStlCMN3xuygcthlB8AOdZEV6Cm4vkqzXYWrGsNmdxgN2&#x2B;syb&#x2B;LTSDhYK4QIq&#x2B;PvCFPDJxIJjjvypGBiE7f48kau8UL1L1YorETijNxY1UgVqLxB0ECOrYgkfSQHGmsfhpUdPEsgUgq&#x2B;gRkTQ4PpEaMRLPVMQ7LYb2p/xkYivz&#x2B;whq0qJY0/QEgdDBOMs6nFKQWZnSG8HGs7VVYJVpqc6JzWUZya&#x2B;Bubgr3OGp5jrFlQVecUh8gepoakyGbid2adfENcFVSVrGWgKwBZFwtCgyRG9X6zK8E&#x2B;lWx/2LOu1NqB0FkJs0RSV0H0FcdNRTFfDByHGaqRQ4TZkKxC0V4C2B7J3tA/Wd6lbEULB3WuN8SOiCaluDwoLqL8VsCCsbgpn6GyBBCn3YIJkq8M4RCKcbUtFmhfEvGN4eeSTEOthOQo0FZ7nOlCEJypSc7sAKp6DlVO/it&#x2B;Eax3xeEIxpkkjZVTT2oifkGqEjRpXeZQdnLqE09EMKK2WOTqpicvy2CXHQC1yJbriwrzJA027w1mQ/OINS9rk8wbihCfyMTBMv7JNN6GviXpgsjuLSt3DOihZDIFvl7BAVNCTbqB&#x2B;CsZmQRIBSZTECYbUMXPOIEVVRpSv&#x2B;KIJMup7QIN8xvHHiwy6o3qb3zlRO1gp4bi6FoYdeYzaarqqMpnw8DFCEuEs73A11T5&#x2B;o&#x2B;gSPBfPUVDZdB2SpVliOEH4zxUfCVntimrGjkyaFjOxHdE&#x2B;VGw6JxhgiWiOAOYqkFliwDYBLmqAOQ9tHX6bOlF4jBkmGkrpuBQ53MIVnhF0iNecHLq5Bsz1FYpi6moEpKaIDU18Q0HKsmjclxx0yxJWcRdF6DAHF2FHxdLRzFftLDpMMp3&#x2B;GjQQHTCqC0UrJZEhh4nwQTjwEMSucedFREVQJDkyfT2yqCbisXn92q&#x2B;CsEXiZoFX9/QkL7O1ETSEUlT57IiMqYEJ2TFXPg6ElWn4guGxtVGZ0XmN2GdWbRciumQw0FEBuspkP1JFwcqFAA9mr2xsEmN20GMrLeIZQKoykjbNMpZHamdX8/yyef01Od8siuiqKDmZ1YNYBKKdHIqR0fFVlxaNK/rSbY/Okt&#x2B;wbz4hQI4ceIE2aAaTFkcpq5zkqEu7fAhZu9nsWdVimIymZS5NUwlUvzOJk5QqKZTzmBnjUeq/iC&#x2B;AlJrFSU0WL4nT54kpVLMizWyFEeuHv6qmIWihiByJkdQGMG4GmqJLKxgpYkXR2RiFElcVUMnaYeCFNPhJ2sIEVJVydTc9VARwYq1km5Zk5fpOwD5ylCzXi4HxoJFqal8RUOCIjSCuiZxCJNipvyIpISshQGs2ZwVizNX8gkBVslU0z41I1hXk/pMEmPMGYyQXLQEKbs4yyGtueLVRU0f6w/i3U&#x2B;QWMBqoTZfIg0yQepzVTwAZs2vySTNRs7qbJykFKuO7K6MKElZyaUkqeS7whrgWOdH/6WqN0lEpYcDgVUuVSB7hQaSR&#x2B;3DMtFYnClLvw6jVkVRBEtRFBzRHGBTjch6JIKEVqc&#x2B;xbwMYd6cZC0GP9985XumKAB2MI070AYNHT0Pxoa4bU8xHf2JUBMkubIsvJTqERJjePzrX&#x2B;BiL0hEOA8FW4SsDUUVggqMWfKrVA/3pZaOY8qFYHF0xbxkBnUQpry8lNEisEJq5kaCz6nyC262sAgibGJtRm7xt2RSLA8iVqmpEQW93hW1I9YwFO8AnLhkJcOujuarh07wKxwb7xpmbzhvsCpcRPgkw01LfGBybEb8KIqdSjA1bZJoblm&#x2B;piSIPOAt&#x2B;jElzgBkq6XNo4PZFcNAWFMiM8KjS5Qe/YFBMjQuRTIys0PIwiZh/kPWqk&#x2B;SKqpxCCXoLJrOkpNjjCQrEGsO8BtuYiQIvxdMcyBzAXE1KCRUus&#x2B;JQkKVXQotmuDiSqWYLIUEE4naQ6j5kp0Ti6JYCeJDjE&#x2B;b0M5AyszRxLCCGDuliJDdZPoj3&#x2B;TY0aCQYLWk2dZOV6gYOxWKUpEpa6vnZHr/iiUnXwbFTMUZObV6qdE1bKCJpMOvRsH9MbWCiQfWECaJ6OfYKxEF2wGKKaEAQKjVpE3Ny6SUxc0GOjPKLqjExaiUBZkuRyTsCUdVEF8M0LWNIwZJYkSWOs6KwgdZHPQJdUbmrEmCSy&#x2B;WLPXbkywBOMnyn5BJCVrlqTZd1lrF2l5QZNuckqpSCTB&#x2B;aawTBXV2QvuMiOmaNcUlEglUc&#x2B;awLlblo5JABolRSc1QmwiHNKPSahu2WMrYkGRpcUbNtNqSUqxAzRJqsKCLS0VNma&#x2B;Y8bVocXk0aIbiUFyJtKVJPuS2jq5p3wFPATCkEgXHktNgVJgxxnTCcLat&#x2B;NaaGtBplOIXRE8RICUiuTUpj3kzMlVvUdUZoPz8TQD4kPNJMjIWa5FAjaYkX8QMdSw6RfZDvjKWTCbBsc5kkvfRJVJs9Am/m0FR&#x2B;dWomJ1M61foD6wDiNvYqJyerF6W2Gg98NVIantRuytMWYRnyNzurYcycnIkn6O9lKXvkd2YmqxaJZnadVm9hUyTGl2xl7ImHJZg4lA7T4rkwhrd1G4pSM3FwSmRyMLKkVCtKmXUukOdHMzjkHYjV9Zjau0AGAtjqbCViZsEnQNV/LZmFkXTCbV0loyidukVAZ8JKQYmY3HSSdJ2V6kkNUHzysAovsxtUxbBJakGnzJi3AJ7ezLTa0IQIsZ&#x2B;TAAsdz77QU3L/HrA&#x2B;JBIH0BlxiqTo1ZRiFciIRMtyCKFZIKCQrLSxAqC/Wb1DSrQRkkSziEiMosPdmonZKk9ip2KBb72qyopwXQEibsiDSXNFuIl5WsRVM5NFVID&#x2B;ImzJiiOCUOwqqnF11NMVufXlhoaBlsyOJO2nlYwKbBJKdgf5ioAU6EGSUzNUouAnCbQt1lRx1lWEBYt4//J4mfk3E3lTJz0FZc3FmfFCBOZsggXYRFxjsD6W5NvC6fKyck6kekfQo0oKI9iIuRvVbUhzvI5nQ3TLuBvFkNVTF&#x2B;z0VRR4afGAm5d/KZBu6VIpSXVbJho0GrQ0c1nPOJkTs4sJgeCfYY140FqiMqmthLEp3TNxWHdIsof/oJycmgrCf4aQd2WUSWkYLuj4RUHrIhKxg/PF8kocm8efVc7p&#x2B;U3fuewVethUp2rHavmZZpdcOpB8f4&#x2B;9AdJ41hrp07ZOBDcA2WxT&#x2B;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&#x2B;slMKz6aLFxiYRhAifjrqJ6m55eF/1BcSSPHHWwCjJcLMmOqowuzddjmbUWeR7VAg4ci15hyMuJkgZUI/ubTdyywYI58PkTNjhWFVxWaGLm4zgZTo3JE2GSY5PBTwSKJk6VOZDqDyYyKVYQqCkVtVk5eIjSXfJIUcOsin2OjktpPdGoOrMDkn0bVPzpdkNmh/UrxqwUiky1/TJHCsCIKzioiUFwLtBkF8hh0BcDsijAwfTP0Wm3QKUkOdT79ooqkwPrmlBmWUUNSYIXhT8rU6UmzwPqVEEWCSw2M/slpoEQa6KqJ8UVqjhylAibIEl6xw3DshVQ2Ro1OyiwCKlcTCS8T1m5yUSfVDFYDQVogvopTRSKzIBuXxUoTSu5hMEFyQLH4pf4BRQojOBUkCN8MxRIJdlT&#x2B;c1XTIza4WEXjjD5WMLTdWcmK6KWcqlM7Y5AzLZ8a8s&#x2B;osPJFEzeEnFDFJkWidlFOg4osAfz6EVy5&#x2B;J1fc59nSSIeSw9yiK3xkRsKgH1Yfg7BKPYsZ7e7K5k5GZGUrcLU5/xFAjwmo5O0QwMFhLHIqVxV/avKHQDyD/4sLzPqH8uR1ApY7BZlCVDfY5HOBG17gVQnOIDVSxImxYKTwqARqYs9SQhYIonkKKMNxD1&#x2B;zZGBlSCf6KMMlSOwCH1H32IVKDOYB5XdUtsLVSeoObIkZ4FDfKmDVHC06iQ9amcD1pMk4xNsisyV1dX5XUg8wQTNn4eaoCLTZWXHCk&#x2B;&#x2B;0jO3cxIRj8uRlhVeUB7xZFW1LGmOYaWjbVTKbPn5OqG2vDQjJ5QEW7sAKcIoxcD&#x2B;CkZOdCY90NMEaqdIFhQndw7DwMKQbECQBcrchVmxCCREPG5V2cjVSqLWeqeWfHAIoqKcVPWGo/OQxJRqNaeKzSKOWAD4nGMVFuETHKWLDMySnFM0jlGc&#x2B;uEzQbFJJLmGZFSHlJF2J4uvipdT&#x2B;yHfns0SHgqJ/uAUR0Q8Tt&#x2B;QBYa84jwmUka0YgUnK7IzUHsUtR&#x2B;SXVFRS&#x2B;QLwwqjdprl6BKcP8XT5I8aTrIJpfPB6CtWZcJmIvsMR&#x2B;tjpYZFxOwO&#x2B;URy7E8pAXJbAcgJqJ3oswtjBRMcBtqmbM0Qoe&#x2B;qZBBZ/xSNZDCYuAkH/a2KOivaz1CuAyOS9wJpABYXGv6xBUaRv/KXN5gIlcbBHKmLNCsWNST5igRJHDkKnmLWqt7KRFtTK5asimQa/MQ5krD&#x2B;JPPFOrPiPY9QPBlpAuza0ASyL8TqHliyLNZFViCqzlFVOzIRTp0kaB9noNY81WeGZIQaVD7BPsx/opiUojKmYcoVIcSsrsjXnFWJwQI53VGjc3iwYkk1rJXU&#x2B;YeTGvbw5MmTgpmiQ0NQS9QJ2zIro2BsAR0FgAdFpqgnBT0wsBPYf8BomKb5a6RRMogEI6dvvnVEFUSoKlVIav2wyogeQFRcNlimONaSg60NGiqHz1PR9NPBMDagfHk2J2WZKDtWtbLSmgpJMCuYhiYWkZzk0KhgHHmoRIR6SpWqV2BF4LBklk7L0RhF6AtZFk7Niwx8Vk/gC5AgbNiqGJKi8kmOcWphBXUArN0F&#x2B;6TaiZdaA5wD0Bomdn4psC6nmD5/eKrSP1miYv&#x2B;yBoUI&#x2B;N1SURL0t7gM/PlZHPYnKixoUGstg6MA4NDcBrnbQRVhh6IJXuGPPeUHo85NBJ&#x2B;j2AVVqR/iRFZRJOxPcoUQkYqkDoLlUosEe&#x2B;M4SXMrV8XeVAFLhFRpyDqkNgSVdaFmYGq&#x2B;KPdSpHRoRI6ljaO0kCs0i4CSsfhIh1HQZ9R2RZnRVVigKgByZiOiLQIN52rKSBn4JPdSHHraei&#x2B;oDVanIgPzcxcx1auao0gXL07nZ22MoPqVKuppOKgNjQqvx9ZOjcWf8fhJkYuL4pRi7J4GJyM78ARxZEVau1URrgBYKV/W68Ik87wDEWhoff5ikMXWFLEUklMkSdFYb6mpwS/ssLJWtBXRrOM8sshSbFgGbBahRyOK29tYsbAwKP8Tt4&#x2B;Sb7XpgaQ9VZWpjPWK9IrhtAVLJD4dlNWs4tTcMdqEAShdVMKHRseILzkiUPoo3r4i&#x2B;wN8IoW9VWSuZMp8NqY4APlNLK50UZ9oXos5ibCqCJNf8IZTvgykYmbgcsCZYGW2Iq1fAFZS8DnLWU7OnMFY8rNGEH/uIt8avpRnETpbzVZlEUFu7wBYxvksblc92VkjqsUVorhqakNS5YavIkTkhNMufxLkkBUYnbUwcBYhDinXPJrEl1vIgQD4KyvJDDCmiEXnfHyHJaHicUlYLZi5lKrwyNwlE3tFpXHoZ1P5nA&#x2B;TMMG&#x2B;eUPm6nhJwqbLERtd8jnshKpyoIoZDEzNlxSPZJb8/obKRh3g&#x2B;ucNxd9QAJmoN76mQR0XaAoJ2vlXsqoVAdMkW4Gjq7CGLYdlcmJBiFwJKp4pKYCs1FGxdoFvtfUZVYKpiigoj4bJXGS2waCt1Uio0gfU1htfJdOviljGQs2AAQpAzik9gsj1cuW6/EZBVT2wrBqaVyYyHc0shM8CFdPElnny&#x2B;hpMQkxOcU2JVUCWusKRAc2dGp1ctvlSYSs99UcymZRlhTUDVUVYOUKQgdn5KptR0Sdk7qwOxumHZEhOFxUsslIwuvBkdDIMYxQoL/9o02MqHEsS/eSAD4yaiJAY1hOWqi/YXqxcVIE1QkUYEkdDoKrKrHSStA9ikGHUvhJJliUba5rlREHvRCZjCdanzJi0&#x2B;V1CUdqswHCSrapEWS&#x2B;&#x2B;eVBQAHKx5Ab2lex2O2OR03qqdWBQNEUDOYuvyJlrG7oocqzFrPRlxsqh2K9IRsUvjiLdZ11nQT5ksV6U9CRpt8GgkrPSZzFXLFiC4W1MNWmjHJFTHKqcVPGSCKhxqX9S0&#x2B;fUQ5JBv8jwrGBkfaoSVSaILFntfOZBvk2cPPFbLHx8ZGC8ZUewu/lwJDxx8gSnIIoSyrRypesvwXmClkVx3AlWO2Zz5YwC&#x2B;IAqPz8jfuWzOhUrC8XwEIJUWBaexwTzFQlGhmE9UdXE5FRPhiQrUNW&#x2B;jTioOxjiNIBaENYsql94Vn3qTNYBH&#x2B;p2AAzvo3kMm9eV9eKZnaM4G4YQ4SUQiu4KVGFYwUiGzdl2Z8VlrTecRRp5pUALsFcoq6PeB4oyJzQiSm4U1RvFhyxQVyYoCdUGT1231GaK1T&#x2B;rINSyowsqq8moTUAVmyw7NTqLPmJ1xQJfSE7tCRLHZDIxcezIsbD/2MG&#x2B;8I6v/F&#x2B;s9r10/dgTSzy15Z5VC3zvPxba9U109MCJ335TJIt8AgcxWV42Y1MUWzwYJxYqMMm6OFHI2YbVvTnSJpU&#x2B;3MvqORAa6JpiI3LS59ydig4r7AmaGjk/8MUQCaAYmL80sCwvCcLHj99LNfRhVvOJNCtn6tA5t2sbVtrAags9/lQ2hy3OAFjZxllEPhVT8UuNEKYun3rA2WPVlhQnNfFksQVAjDMpEB2S2wlOyug5Y/QtUwFIZthQWenDH5iFmCWVyPMkw9MgmUxixI66SKtdkASNdoLUgVMhHE5D5gIDUPPlPFRiNujbpJyZhUgxsTQxZpM48dvJo4ePBr2HOvZI378f&#x2B;Lja/9yVY6sWjFUXj1WX&#x2B;GpKPNXFY9UlY9XFnurisepi7&#x2B;t3BDe/E93XffxQnKqCcorGH1PUuNTeQgbgpEytK1h8Zk0xysVKViQYFfztPg1TIraXwnnLyYsqidq9AlUWB86rpNLmDDbBQggKgAqsuASQqh3VnEQONJYAGqZB/dAwEDBwnLL4w1xnvhpgW33AFgqAPWF9m9m2l&#x2B;QZzJ7mRNJnsVW&#x2B;eyv6W3EJpNoFSQHg2ia4hoFg6HFVLH3x5QQrEba6U51wWJSLmhe2mlL3xNGsWUyOQyXJ1Fi&#x2B;Q/yyY2KLB2b1BJbMrLfoK1bDkR5T1MAi7Z747diJSPDwyL7x9l/D373refMu3&#x2B;oLvLUuT3WJt6ZkZEXxWHWxt6bEU1PirSnxVJf4aku8NSVj1cWjK4tHVxaPVZd4nz7f/&#x2B;Vzofa9RzwHJhg3yVC3yDgFx4TUM1FQexHWsoLWB6yniYA/MFn&#x2B;e0nuvgF1VPIDy9xqFBkmrLciGrhgvsaC1d8UJwFBKG6DUMUgdyDRJ6yJFLWRCYqaYDhbooIZaFDn52VIFvkNuysApo5Vo/JF135zxJnS4Buo9CCZNLK9xK1T2noXlouMTH9wlkfDkPsS6ALPmVL5TAWdc/lUNZEGmRSD&#x2B;jBnc8YSpWAvJJ9zap5aM1TfocnwCeVKYCFJO5nAiUhlgZyIHOKLveI/hP2BnzVZRUS/nTh5/NjRsP/I/u5444/Shhf9b941&#x2B;nilp9Y1urLYU13irSkeXQlYfsnoymJvTcnIyuKRlcWe6hJfTYk3pQkUe2pKRlcW&#x2B;2pKfDWlnpqSserSsZdvDG3/Mrav&#x2B;/iRw6zBwqkfmTEW0OGDjgiyS7BSZlWIOJdiKTBYdmQ7QiEVBzJVeLLPyAwimEROx7KYovgWMVX9oJZCsUoVJ2FqpnB2UttYMLA4JSXzwsSjTpXUTGVak6FFSBIHWtCQLNnI36wnpkJVE4ikw7K&#x2B;mZe1bWF3BUAtcqvBTBpIismaR6lhqiKSGJu1IZWpNhHWXToyMdWqnUYVZ2qOrQ5LRCYWPOy3Ikfnr2osMsRf2jETFBkFTZxkmayI/FkeEwCNwqF0itFRRkL9gZZCkUGS4FcvlQIqp5mZDsYSksmU6xSUmZMsmULqeWJi4vixI76R8YF26ddNwU9Xjb5w/Wjdmf7aEk91sae6eLQ6ZdcH//pqSzzpP8F/oyuLPdXFoyuLR1aWdj7karhn1r5lLvDKl1YJQBjPU&#x2B;cGP1oec2//bTyWzFQ7yapW3MoQtM1zakPxIdY9FBNkmWy1yckfHawZQFviVEsEJ5b4EEahqvPz00&#x2B;KXYtMDcOfaeXMYUtGUSVqUpM1XVVe2DJElUHDK1mpM2iGsanlPXgKAEsLtGEV29/0zloAcg5TQWxsala11oo/FxQJG4ZoLCobZnEdVhiU8yXZPgBkOlTeyVowSLFZBSF/Y6w0kUjIxLWPpMwgFvbVUiovVGxlzLRJpYxYeMHVncU7mdWlpKuwSoFGIbsNp3WoTcNpwYkTJ04cih3xj0ba9/h/&#x2B;DT04WPeZy8fqZ3nqS721Zb4a0tGq0uAD4&#x2B;/tnSsuthfW&#x2B;JL6wOe6hIQDDB7X01KH/DUlDTfN/PJCxdcVFZ1T1Xl2uvO6Hm4YnhFaco7KK0t&#x2B;GpKPHXzvO88EPzp8&#x2B;NjQ78dO0qtK7IbsOqNU6ucWlKVDvZQUTCRaYSUijWoWeOOz4w5ZSGjk76CrHypQ5g1m3E6M0sqFtQmhdUqZx7AZOanxnrCN1dTA6uaHOArw0mUiBIlHkyPGPwAZNlFmiA/kG87ACZBfw/QMDEZmHtOQ3DDjkM6Nc9u2HqsOJWrMvNTF3gNcira26jPKWswm9DLyGqXEYWWIGNFpBwz4PBIajp8rka1j/LXPJkgGTALtX2GWnwWsSaZNKuk4vMGq&#x2B;qSmaDKI5Ig9bcsy3IicfL4sWOxyJHh/njjVv&#x2B;Xz3rfvMvz1DmemgpvTbG3psRXWzpWXQz&#x2B;A279gbpSD6D&#x2B;NSmfH/BqZGVpz8Nlu&#x2B;6Y/fWNc9ded&#x2B;bn187/8vp5W2&#x2B;d23TvzN6Hyw8sL9t956znLpl/9l8W3zCv6oXLFu34z&#x2B;z9y8o8NSUjK0sOLC8/sLwUuA95qot9z/3V/9Xz8f62E&#x2B;mDwmiV8opD1AAML9hG1IZGaovpJM0aXNTmY8WlisEKzCH6rNQgXUPHsuBISRKWdXEBOIJhswo1sGJvJ&#x2B;NC2wErC2xKZEHbNEJGxPLicH1FkdDisFIQ7G9YJQtub4o3hCBYlaz2uf4ccwsZCgB1trJQGBORNwXJClhUkgrDx7YGYCucntYnV3cqy8foNX81kjMnUP3KCZkydYLmBCN5iapWVlywwZLAYj/ogoFFQYVJZrpii5A5xdrAElGsN5m7vFEXaZYwZHbwXxExsPTRgugcg4qNOzExcfLo4SP&#x2B;sfhgZ2jHOv/aZz2v3uJ9YtHBmjkjK4sPrigGpv3UEd704V1PyrenGBj4oQLgrSnx1Zb0PFy&#x2B;&#x2B;qKFF5UtuXLmkmcuXrD&#x2B;hnlfXT/vvb&#x2B;f&#x2B;eSFC6&#x2B;oWHx3ZeVTFy785qa5nQ&#x2B;Wt9w/88vrzrinctH8Py&#x2B;5u7Lyg3&#x2B;c8cKlC&#x2B;5bXPXNTWfsX14GbgoC5wQ8Ty71vHl3ZM/mowFPgnZ1FbWMqtinSO0laXsOHHA2/RQnFv5D7LnixC7I5FhGXGqpqVXNJ7vaZFNV51TxOMZpVmegmiFYsbSxZE5Vqxr4guRYfDiIvxWMpWfhFo87lcmhiTsAxi5CDqxH1geG&#x2B;PyuNimOrwU1X8GtTJK86qxD6gKpuOQLMhU&#x2B;EyLJAWrdEV9Q0ScsIbHfIkSW2oKc3KkpcBg5DMPcMFEqCFVg8arjcwWyryaVrn5XlJAfKzFx8sThQ0e9w&#x2B;GO&#x2B;uCPn429v8Lz3FVjqxakTuWm/HZKJm/pqSkZXVnsry311IB/Jw/y&#x2B;mtLwKnfsZVgi6DEW1Oy8/ZZ8//3rOmnLb1zUWXnQ&#x2B;XwbMDIytLW&#x2B;11f3zj30aVVs/901k1nLv7mpnkHlpf2P1r27U1znrhgYdX/LS4sPOuOhYs6Hiwfqy7x16bkGaud43vx7/4Pl/m3fhzrr494&#x2B;w6H&#x2B;0&#x2B;eOJaYoH9KTFv9kF1XoRrZRJY/Y/D7OWssZz5PYuFFejJ/oKGv0OKjZVFk/NS8qPuE5L8cedS&#x2B;QkEadFgRwUYBFBibVVj7sYKAafLnamrHI7MW1B6xt6yJi6wZzgKqFoJKiAOdsNoFKBcbUjPD0BbY8OgmQWRhUIVsFZPPtFjgTug8i51iFqoMV/yI1KLxbWms3LEE0TUJRBdRD7AVi7UhQBWPtP1j8sjstQoLQBUG/sSiYE&#x2B;wm6NI0iPT6o1VLvJP6qIulqByTfLNhFh2yWTy5IkTx2PhYwf7w80/h795zf/ug75nL/bUVqQc7oGDfnXJWHXx2Mpif20JvLgzfUi3FDwcXVk8srKk&#x2B;2HXL3fM/uGWOf2Plnkn46bCH1hRtvnmOTefWVX2x7NuOrPq25vmDT5Wmrr&#x2B;v6bEV1syvKLs6YsXzSg864w/nbXuhjPGqksOrigeXlHWcp/rh1vmtNxf4a0p8TxROfLsFaG1TwV3fBls&#x2B;ibYs13q3xDqejHYek&#x2B;w8a8h99&#x2B;kjseO&#x2B;rZP/HYomTjJ6nsstsfhN2g/xLofNRbH&#x2B;AqlovZwfsNRZZOJrkUmS6WY2EYEK3cRqdCH1G0Hct4QnPpEGkXO7PnUsqAOPyzx5MxRSaooIjJT08eQQC6eoipC1GT5nVam9aWk2KEOqpyK5RVfC8APzr3&#x2B;hsNA46ZgR7UnLFIAzK4jtRMHZyLILdi8CPxJWScUy64YQHFuIh8qyo/NayzrC3XdxVg1Jzt0bRDZzYDCcNZLNC7OPxipUcuOvSV5LZYRtYqoPBgSdEz3oIrB&#x2B;hONxVqiEokE5NN4VbBBr1uluKgA1LpSNWRUdV2y7IlEIvHb8WNSIDbQLu353vPZU75Xbxp7&#x2B;gJPTcokD/x2wFleQPd9tamTuMC0D27w9NYUe2pK9j1W1vaAC7jme2tKGu&#x2B;d&#x2B;ezFC&#x2B;f9acldi6o&#x2B;&#x2B;ee8rocqDq4Ax39LxlJ&#x2B;OyX9j7p&#x2B;uGXOUxcuvKJiye2LFj978cK1153x021zd/xnzpfXnXF31eI/n37WPVVVP902B6Tpqy3zrL5w7Pl/&#x2B;D&#x2B;plnatD7ZuC/ZsDfWtDfe8FGq9J9R4QaRpZrC&#x2B;PNLkCjeWhxtdofpyqdEVbrt/fHjDxOHRxMljivUmE52WU71JRBPmROQMQ/6sNTExwSLQVHnIV8m0I77ifpF4x&#x2B;No8tBAjnY29GQwdQyKZE3qJ6SSLy4/9SEyNfFmPCqShN8Xv49hwohYjvjdUlFCMlMyoqJRSRv49caPayrnMWpE5AqMUQDyr16oMKTn2a2u7CYPCnHKJfhQcJlnLWMk4MpHsnCdExl1eYYrNyk/FIOMKGg7xJ6Ti02S2OYmE4eLOsZLErSzjIILP5WCJxmaAzU1VkT0LZU20cmcQK8T7wYcOVP/42o4LKKpuMSiHea3I4eOBDzhtt2&#x2B;rZ/7v1gdfPFq3xOLfLXQPF88ee1mTYm3pvTgipKhZWX7l5cfWF4Krf5j1SUjK8s8NaXApafjwZnPXbrgH7MWrzhn0Q&#x2B;3zOl8sPzgitIDy0t/vXPm61fOv6hsycXlS56/dH7jvTOHlpUC7QKeHBirLmu93/XzHbO/un7e&#x2B;/&#x2B;Y/9JlC16&#x2B;fMGbV5751fVnNN83c/Axl&#x2B;/JSv/bdwfWPh3cuVZq2xLq3x7q/TTU8WS49cZgwzkR9xmh&#x2B;vJgfXm4oTzqdkmN5cH68lB9eXBvebihPFTvCuwtDze4pOa/RnueOBbYmzw5LicnsG6gdmKkVjtrmJBvYXSS0GPGaXLCYfUBKjiSkAOTLz81I9YukwZ9Q4NWwBGVJRX4wTc/U1uKFYy6FvB7FPqKvy4ojm5FqF1VqSMCnXv5PV8kL1ZgtYxLT7VMTahTAAR7MISIFjvVoKr4KOvKLoDY6CypTSprykJdKa3JXXDbgbVmk3yaZehCQa5enKVOzlyZ0IecVY2aJhmMuorDookkNRmMWDVRziooYTKZlIk7Q2FGMq0yUSpGrtxUqx7Gkzi1yq9hOTMklhpriSV5GzUjtFyJ347/Fg3FDu471PpzaMtHnrcfGH3msrG6eb6aYm9NMfzsriftyu&#x2B;pLu57pHzv3bM&#x2B;&#x2B;ecZr1yx4MXLFjxz8cJHl1auOKfyy&#x2B;vm7V9W6qsp&#x2B;eXO2asuWFh9buXGf80dWlY2Vl0y&#x2B;FjpD7fMqTu/8sLSxdfOWfzpNWe675vV/XB5&#x2B;wMV1ect&#x2B;p/Tl15ctvj6uVXrb5g7&#x2B;FhKkRhZUTyysthXUzKW3lUAf47UzBx7&#x2B;oKxdx8KbHwx&#x2B;OuGQMt3od5N0sBn4c5VgaZrQ41nBfa6wg3lwb3lUqMr3OAKNbjCDa5QvStY7wo1lEuNrmB9eajBFdhbHqovDze4pEaXf3eZf09ZuGGm1HLtMc/3J45GZFmI5rJ6L1r/iUxfILQjwQ7MSYfVdmgjos&#x2B;x8KilIJH5ITMWjQP/Yrd2spZ1ar7kACeLiQwfoZUQBsLu8&#x2B;XwjSQCRa2DkIonGes5OU4FFxpytGKTEhaAM7sKCkmNohiXD22x9EC8hh3woXcHwPq2z10ojkzFkEblaCXMk4FPIkWyVpxEWAHIBUPDfERdtmFq5DSNrQqsVV8xR8VqQRdvmVYJKL1A0yQJKCkzGYDD5jFmjBIgUmbqQog&#x2B;FIlLSkjGRcmc4moq2BWpmQrKxkoNDTwxMTHx2/HD4UB4qC9cv3Vs7fPBN27zPn3uWHWxtyblouOpSd3Hn/b2ARftF/c&#x2B;4nrrbwtuOmPxvVVVG288o/6e2W33V/xwy5w1lywoLDxr4f9b8vxlC366bU7nQ65vb573zMULLnEtuXZO1Qf/OLProYr9y0qHlpV9ef28pcVnFRUuuXrOkgeXVN23uOr&#x2B;xZUf//PMzodm9j5SfnBF6ejKlKO/J3UpUOnoyuKxunm&#x2B;5//mf&#x2B;fewLevhOu/lnp2RAa2BLveDbc/LLVeF26sDNWXA3IvNVZIjeXA6g8ovtQEuX7q33CDK9yQUg/CDa5QfXnKHaihPNTg8u6eHW6987j3u4ljAc6ETHYJ1p8awLIcU0OinVBEWiw1dNxx&#x2B;jAmmEwwVEbWzIFGiideb1QTBktCVkj0T/FJG52sBMegeMr8XQWWMOhvTqEUV0lO4tRXaBdSFI&#x2B;VIKfLie81WYl81TcyFADNTJRfO6rqjko78rX2pwhMGrqCW72ac8cSEV/vOblr6NVUWk/l3/w0WVJxisZhulRugYIaBv2XugaQFAEuvax80YKjJkB&#x2B;DSQyTxKTOXLiojnygaVMTY1SIka1UH9wsp6YOPnbkUOHfKNStzu046vw5497X73F&#x2B;8Rib01Z6kO8K4vHqic5t6e6GHj7&#x2B;OtSbjzgCG/rAzMfWLzojD8v&#x2B;dcZS164dEHNeYvuW7xo&#x2B;dmL6s6vfP7Sha9esWDJ/y1x/ffSjTfOa3ugYt&#x2B;ysoZ7Zr142YIb5i2&#x2B;Zk7V8rMXrb5o4V2VVReXLX72koUt98/sfaSi/1HXgeVlY9XFgTr4Qd&#x2B;0DE8s8j7/N//7j3i/eyfUvDXYtVXqWxfueS3Y&#x2B;lCo6dJw4/xwQ3mwvty/pzywF7j3uCJNrmB9yskn1FDu31MW3Avoviu1G1BfHqovDze6Ys0Vwb3lUbcr3FAebigPNZSHG12Se1G45aZY34vSvg3hkT1ScOTwoUPHjx8/efIkp0EVJwRW35aJXpGgecfB8PyejwmTpO0MUAejUs9h&#x2B;sOgGwus6JzEMX2YOrNxIrLyQpPF5lhs1POlxeqfo3JwhEGjU3OkTlPYb8WRzpcHu6sAnsSQkRpTS6tYcyMpj1rNSq0YIumrVW&#x2B;mJvAdAIdq2wp27q&#x2B;prqJJQs2md0VorDG2TYW6kHMWMKpIqhYSxdSo6SSTSTjpc3beOXwUeyViByXWMPq5BcFCof&#x2B;KbGWQzIk0H5C8ilx9WVyKrBDq4p0gzoGwiiYT1c5fUDlrP1ku8OeJ3377bTwWH90f6mwKfvee58PqkReu89TNhtfwA6IPTP6A3/vSln5vTYmvpthfWxKoK/XWFHuqiw&#x2B;u&#x2B;At4NbSstPHeil/umL3n7jlN987sfMj1yTXz71tcdeuCqjeuXPDJNWe&#x2B;c9X8G&#x2B;ZVXuGqevqihQOPuXy1pT0Pl9XfPXP3XbN/vXNW6/0zOx&#x2B;qGF4O3IqKQeJjKXnKPI8v9K65wv/5k4Etb0tNm6WubyMDG6TeN4Kt9wXdfw81zA7Wlwf3ppz4wb/BtFEfOPYE97rCja7Ankk1IIQY&#x2B;8MNrlBDOdAEAO&#x2B;PNC&#x2B;V2u6M9Dwb3rdBGq2XgqPRSCgSiUQikWg0Cv6Nx&#x2B;NHjhyBagDaMTgtxe9UMuLKgtp9OZ2EatAF/6Lna6nycCYxFOioof7mRyFfiZghqCJRxy8rDBoAPMT0FiwRzGhCysMfj3LmTE7un7CKxu8wrADUP6kVS9WpxDUrMhF&#x2B;JRgCs3mm2uJPWYi6AFnQJ0SA6bW0ALaQkwWbi2csdBY2u9GtSZm1zpEKA3XFVVxpMIgwGJlYIDFNL5m5Z40RHf5CwuJJIsKTwRKJhExkxPlNLvbUlZtkCZPZZUanyoa&#x2B;ErdCobWKuRnwS5dMJE4cP3487Ivt6w40bvN89&#x2B;HYG3d7V1/grSkDV/J70iZ2eEc&#x2B;OGjrqS5OfYh3ZZqUg4e1qZs3gSOQr7bEW1Psqy0F/jljK4s9NSUDj5auumBh2R/Pun7e4q23zt1z16yf75h73&#x2B;Kqhf9vySNLK3seLvci6Y&#x2B;sTH0AGFwf5Kst8VQX&#x2B;x&#x2B;f533t377PnvD/8F6gYUNk4Bdp4Ktwzyvh1jsjzecF61Nm&#x2B;2B9udQInHxcaXed8nBD6j4fYMIHln7gzxOqd4UbXFJTRbihPNLkCqXCu6RGV7jpglDrHaGu1dED34ZH3VJwJBYNx&#x2B;PxWCwWiUTAD0mSwO9oNCpJUjwej8fjR48ePXHihJzZf9B&#x2B;gvVJaq/DeloiDSxMknZCndPZ0HxZvUuEj3J&#x2B;QELJT4fDaFlDG&#x2B;vn1G6PqhPUuYKTL5oR9oTaKFiABOGHSZ17qQ3EGvicHEnxRB5SoXifpmIArKPC5yKqXdZBzqIOWFDYATBJbdLZMJa1a251ICuv0bUtNG8OIuCZpkAA/gTNYpBqQV3wyLfoE6p9mpoUdZFGI/J5CQSV8ZN/kisfua6wVh2SYKEhWQUh&#x2B;QRVSGourGAsNYxkIeRDKqXAiAj6g3wFF7ZEInHs0Pi4Zzg60BHYtcm7do1nzV/9T501VlPhqy3xpb7AVQIM7b7akpEVfwGkH36QC7BwT9rwn3pSUxxIf50XpJPeNCjx1hSPVRePAqed2pLRlcV9j7q&#x2B;v2XuTWcuOesvZz10VtXH/5z/7U3zdt81a&#x2B;Axl6&#x2B;2BNwWmnbvKfbVlPhXzfY8Uel7&#x2B;drQumcCO9aGW76P9G2NDG6M9LwQab9fcp8VbqhI3dLTkCL3wfrycGN5sB7h9w0pF3&#x2B;gAAT3uiJNKRegSJMr6nZFmlxSkwukEKyfHWw8S2r7T6jnxdC&#x2B;b6UxdzR4QAr5YrFYPB6XJCkWi/l8/ubm9q0/7hwc3BcKhaACAHYDgG4QDofHx8ePHDly7Ngxsu3Its7sRJNOF&#x2B;xgRBx2MNbIkrnTGjSQs1LGSDY6iOBg5DMqbJiQNgIOWHSZHG4cPYcqBjWw2ufUUqBDkgMRGkperSFOXuGcQD5kBVYF6lqm2ArGgpW7IalNcag4BCw4f8HAmuQxHvaRRD&#x2B;sKYviAONrGvo1b21aKDVTlu2HE4WfJj9BAPKbMuIVQi4AilZk6nSMsUmO/JjCg4ZP/aYoDwoaDosnoT9I1itnrvpoYJQBYBJSC4vxJHFQZSPzRcHacydLDVMgxwhLaYThJyZOHj98KO4dkbqaQls/8XxUM/rKvz1PVHlrSj3VKTcef23KdQd&#x2B;YAuY86FF31ebegJc/AN1pb60IxC4xd8PL/VP3wIUqCsB7jrgtADw2/HXlvpqSwYfK/vu33O33jq3&#x2B;&#x2B;Ey&#x2B;OFe6E00urLYU1M29uTSwBu3&#x2B;Na/GPp1fajlO2n/L&#x2B;HeTyLda4KNV4SaLg03zA43uMLpazqlRhdw0Ae//XvK0nb91DU&#x2B;kSbA7MtD9eWBPWltIa0zhBsrgvWzgw3nhdvvDfe8JO3fHPG0RsOjESkEXHq8Xl//wGBnZ/fAwNDAwL4xjyccDvf3D27Zsu2ttz/54MMvmptbfT4/MP9Ho9FwOByJRCRJAoqBJElHjhw5cuQIxqTRDiDS5UA3UBzj1FdYDye7GfYnZzSR0yw5bNG5hW8JphY8ifjBsxgzNSLLmYcThYokYhMRWZhAAOzGIZnWZPxJjCMJFoA1FQguo&#x2B;QOieJySYohbtdPZu7xYonwUyaj8KF5DlcLC7KwLaz&#x2B;EjAf9mwJwTldMYwezZUf16SNGp0wuzXFV00RsKQVWadZ1FBxylOceVkLbSIxISulj77FdgaoEfkMBiOy8AeWJroGkLlQlzp5spKTaCKsWpWRtYEMQ/6JyYm&#x2B;YpnkWWWnyoCVV3AVZNlc0aQmTp48Fg3HRoYC9Vt9m98be/1O33N/9T&#x2B;1OHVdT&#x2B;rSnhTh9tQAT57SMcSoD9x&#x2B;0lb8NK1PkfviSYccJAwIlt4rSHkHBepKRlO3cxZ70zf9&#x2B;9LfA4akf6y6xFNT5n/m3OBHywKbXpcaN4e6t4d7NgR6Pw91PiG13hSsnxfYWx4Ebvr15YG9Kbs&#x2B;9NEP1bvCjalDumm3n/RZXuDW3&#x2B;gK7i0PNbhizRXhhpTCEHafL7XfJfW&#x2B;FBraLHk7Y&#x2B;GxiBQOh8PAhD8&#x2B;Ph6NRtvbu2pq16xbv3lvvbupqWXb9l8&#x2B;/uSrN9/6qK2t0&#x2B;fzeTzelpb2Dz5c&#x2B;8or723Zsm1gYN/BgyOtrR27d9ePjnqi0ShQIWKxGNhAiMViJ06cYJkqsHbkdCcyADZwOGSRnz5VNjRleOMnhyKjrI5T2CTBCzEkMq8iJeVhPaQmiM3JrJ0N6swgYr1OJBLJRCJJHIbmVyk16yTDosHJmgzMmq45MySZFAuw&#x2B;fiCKSaiPzC/OA7MQIYCwF9K8wNmcGWL&#x2B;bexxDe3oGgO1wajurrIdIzN5podt1hLIytwgnCJge/I1BSZN5oOWCnFuQ5kFZPSZvJ&#x2B;&#x2B;C&#x2B;pCWBUnly3sOpN0kqHrp1kplgVkSQMgErdZFmG2yOoqNR6IB8mk8ljR48eDvmlfT3&#x2B;Xzf717/sfeVm3&#x2B;oL/LWl/toSeHwW/ADXdKa4PvivtiRYV&#x2B;qpSRF6L&#x2B;LhA3yBfOmrNlNeOunP&#x2B;vpQ7/90FG9NSaBu8kNgIF9fzaRvDzhGPLKyzLdqtmfNZf537vVtfiu0e0O4Z4c0uDnc/0W0uybY/C&#x2B;pcQ749lYoffeOf08Z0AHCKV&#x2B;d8rTVP8X7w2nqD77bBQIE054/ofrycEOF1Hyx1H631PeWdGBLxNcZ9h&#x2B;QwqFwOARP8UajUbe7dcuWbX19A4FgcMeOX//xz3u&#x2B;&#x2B;/6n0dGxYDAoSZLfH/zooy&#x2B;vuPKOrq5eSZJCodDQ0IHvv9923/21r7zy7ocffrFr19729i6f3w/PBwNIkhQMBoFqcfz48QTi7oJ1HhLiUw2VDaOdltTqqSOFfI5lQdo4qKSfM0VwxpqcWRvUCWpiYkJmXD2ECYAqJKzKQV&#x2B;hxeGoHNRyUcvLX2Gpkw9VWmrpOFKRyXL6mExTPAwBa9LjAGtWsmZYGqYq5D3zMQnKtwBpq1nxac761CxDMi86pRmVb3aDsoxV1D9VgSo5OYWhKwG5oSyYvqKcJEllWZuoix/GDFiFYknIIrhkXEi4WWQFDUbmBaPDAKxtaFmWwU1EHOIiE2snWgSSzKFRONOjYnWhKaM/fvvtt2NHDh8OeqMDHd6tn3k&#x2B;fXLo&#x2B;X95n1oaenJ&#x2B;aFWpv640bZIvQd33oeXel75Rx5/m92lqXjq2shiQeD9QDNIMHhB6b5r6w&#x2B;2C1KnftC4BNAQYeNLkDxJZNdf7wtWhz&#x2B;r837wsub&#x2B;L7quXBjZL/R&#x2B;FOx6NtF0XcZ8pNbmkxvLA3tR1PZGm1Bd5g2l/HnBOF7wK1QNnntS1ntAFCPyONLlCDa5wY0Wo6ZJY1wPh3rekgzviwZ6o5ItGJGCVD4fDBw&#x2B;ONDa17Ni5&#x2B;4etO37Yun3fvv0HD442uVs/&#x2B;HDt229/0tbW2d7etXHjd19//f3XX2/ZsmX7pk0/rlu3ac&#x2B;eBkDxo9Ho9h2/7tjx6&#x2B;DgvtHRsVA4DHQJ9HagUCgEFIBYLObz&#x2B;Y4cOTI&#x2B;Pg7vC1KcZ9CBQO2TLAaZzHQgwQKzNFKZNqbgQ8wqT44map/n/InlRdr7yXKhxaemjwagjndW&#x2B;ATxUTOZmDdQDUrEtMSaKlkCoD/IGQmbtKmTkkyrMf5vQSFZ/ZCaMoAFhwzRCgFwmL2pUOEClEMtIT5QVQ3pqQY7tzg5uVsD1toj2JEUpzbqpjNnfSInfVU7zmgsaiKsxYb1ippdkr3FzGLbZABYCVTKQhImTkbMOknngiXIr0Oe8Ayj48njx45EpfjIUKD5F/&#x2B;Pn3vfeXBk9SVjNS5fbbG3piRYN0nx4TFcT9pZ3z95S0/K0g8VA0jo/XWl0K4frCsNpHYPStJe/pPbAmktogTqD6MrwQWdxZ7qYn9dKVAAAnUl/tpS/6oK75orQp&#x2B;sCPz4SahtR7h7a3Tgq3DP61LHg6Gmi8MN88LARae&#x2B;PNzgijVXQB&#x2B;e4N6ycOpqzpSxP7g3dVNnyvW/yQVOAEtN5aF6cFW/K9RQHnHPkVqvk9rvjAx&#x2B;FBvdHvH3xyRfPB4FZ3MlKRIKhSKRSHd376efrrvr7uqvvto0uG9/Z2fPDTc&#x2B;uGHDZkmKhMLhUCi8ffuuBx96fNnyp1c/81pjY2swGPL7A8FgKBwOA98eAKBLAJYfi8Wi0ejhw4fBQ3AMIBKJHDp0CJwPDoVCwMsIRDx06NDhw4dPnDjB6sOsjsQn3OgrmeZLQ6XOkN7BrTmM8JGjicpT0bdkRlDxwLbUyK0JViWQVJhUFZKZWopagzGaAmtaIMNzAkBgApBneeXMaucoSDAjcrOCM72IQMSKJPIn1lLahFEMrxhAw5rrgANzzwCoWjjFYWdiaiX49TBFaolct0TCoxCZYUnjB2aN1gDBmZRcOAU3wbFEBKXF6Ag1CmvVJAUgjVtUIfnLDPqKXMhhFMy8ilYX9hz7jZVCJtZv0laKZkE2EFojUIYTx46Oh/yRgc5g0w7fl8&#x2B;NvX6n59nLvbUV4GBu2nKfOonrSx/YhR/kAkw95e5fXeypKRld&#x2B;ZfUd7tqS3yTZ3CL4fWd4HmgbtJTyEtc&#x2B;wOS8temKD7MDiboeWJR4NV/&#x2B;T5cFtr&#x2B;Wah1u9T/Y7h/Y7jz2XD7I&#x2B;GmC0MNc4HTTiBN8UMNLqmxPNzoCuxNsfxIU&#x2B;oaH2DRT20LNLqCe1M3&#x2B;sM7&#x2B;6VGV2BvebjxzEjLlbGuR6SBj6Kjv8ZD&#x2B;&#x2B;JRf0QKw1O5w8Mje/Y2fvXVt99999MPW3ds3vzjzp9/3fzdj598&#x2B;tVrr73//Atvrn7m9W3bd/X09v/44873P/h8cHB/b&#x2B;9AW1tnfb371tsee&#x2B;nldzxeH7TrQ2YPHf3Bk8OHD0uSFA6HfT7/gQMHfT4/8PmBscBbsBsAFAaAI0eO/Pbbb6pWN5Z5mD9YOA85NA72cKpvBusJi3arXcTR8UvdJyRHGTUvdOiRExTLVk2dnVh/olGoDcR6ImI94TzEwKn5iYkJkdWHn4tiCqoWOHL6FZdEf3gHapHlD4Fpa&#x2B;A87hYi9Z&#x2B;vzF5nsyrOtuL5ilDeRBpy5voqnim5iSG&#x2B;tItkjTJjMiTVJEZlxugTju5BlRkjylRpEzQXauIhXXjqbgBRIgrPIOuK9TCZuX3BZ2aTJGBiYmJi4vjRo&#x2B;N&#x2B;T7C3zf/LN96vXgy8fMPYk2f76mYCb3tvTTFg55B2A8s9uHjHU10cWlXqq0054qec&#x2B;GtLxqpLgnUlqWv7U9/tSqkK/vS/3priYF0pchIAuRg0fR&#x2B;/J33HP0gEfAJsrLrEV1vmf7LS/9rNgfXPB3Z8EWjeHOrbGhrYKPU8F2p7INSwEPrwgIv5o&#x2B;7UZ7aiblf6Hs8U6Q83lMeawYne1M2e8Ctd4DfYMQjsrQg3zo20/lPqrAn3vR0d3RPx90WlQDQiRaPRYDAYi8W8Xl9zc9v&#x2B;/cPBYOjTT9d/9PG6gYEhv9/v9wcGBoZ&#x2B;/OnnO&#x2B;9a8cXabwYHh3bu/PX773/atHnrd99vq69vGhgYBOw8EokcOHCwubn1wIGDQJcA/wITPvTvB&#x2B;Z88KO1rfPddz/99y2PXHPtXStWrt6zp2F4&#x2B;CDw&#x2B;QEJQtcgcEcQVCckSTp8&#x2B;PBvv/2GnY1hDQEObZp8kjmIFMNn5kV3XUPVAHLvkUpkBUGOF9YeIEnWySpSVD9EnEZUUVLqAOfLgE5NfAHE9y5UPddGDMiNI1aOrDkWmx4F8yUTEVRm8pX/ZAW/Y63cAPq7VI5Cw5TnwDxgs0NWWkdxfkfB2cNFUyMDZ4TJyEt00if30Fm5C4qXRFQIYl2fDECmhi35rOygIwEahrrkcBYeLDAZEeNA1BUrlWAygaVD3dAnRZqYmPjtt&#x2B;NH4tHowX3B9nr/1s887y8ffe4f3tUXjFUX&#x2B;2pSnvrwen5fTTH8Npa3ZtJm75l005&#x2B;01nvTZ3wDdSWB2pLRlcjB3NqUbw8g/ekjwimiDz/m5Zk84DspSaCuNGX7f/biwKs3BDa&#x2B;HKrfJHVtC3dvig6uDXc&#x2B;GWq9O9pcGUw74kMGnz6nWy41ugJ7ytK39KRc/AG5T93wk76&#x2B;E3yIF2wLBOvLw43zQu6rIl0ro/s&#x2B;lkZ2RwIDsUggGk1Z4sc8noGBfb19A339A35/wOfzb9my7a23Pv70s/Vud2sgEIxEIsFgsH9gX2/vQGNTy7LlT7/xxod&#x2B;fwCcB4AuPcBZCNB0wOzBb3DZP7DZRyKRcFgCT6LR6Pj4OPD58Xp9P2zdsWz50&#x2B;eef8P005aeUnj2jTfdv3Hj5v6BwVAodcUQSAEoDPDeIaADgLeHDx9GPWSonR/2PbJbQvYM/&#x2B;QTXM5bzlqfFNCl&#x2B;UBLAZ9gw1nEsMISTyYKSB37/MSplaPKSSZJHERG00G3ozl0X5HF8ltKxmwNSvsYrLzEZSBqUqFjCDaH4HOdm076I&#x2B;Yx7HUNqDZoaFe1KopJXUcxWc6mpKpYNlHJBJcWw2ubtfpqy1fVgoE9FMkCW&#x2B;E4djjBGZzPDLAoGuZubHlmrRzpxHFmzzANZlBtkh6R3CJB&#x2B;O5jJUpmQkaW6swEcW2HzBQ&#x2B;OXny5Mnjx8bDgcjwYLhtz8ENb3jeute75q/eutlpE3uK3MPDu4D3Zxj&#x2B;0wdwAWsHhn/oDuSB7kCIr38gzfX9taXgELCvJnWFPzDkA79/X00qO0D9oTuQr7bE//gc3zMX&#x2B;N65P7jp9fDuDeHeX2IDX0f7Pwh1PRNpvUZyLwWmfakRXLhZDqz74PO6wL8/3OhKXexT75IaXeFGcKgXmPbBJZ6pG/3DDa5gfXlgb0WoYY7U8vdw58rw4Jdx755YaH80EhiPpwg0IOJtbR1dXT27dzfs2Lm7obF5/Ybv3n7n0x&#x2B;27jhwYHhkZOzX3Q0ffPjlRx992dzcNjIytre&#x2B;qb7B3dDQPDg45PP5gekdGvKBaT99YEAC7j3wK7/RaDQQCAwODv3408/vv//5F2s3Dg7u83p9KH2PRCI&#x2B;n7&#x2B;1teONNz&#x2B;86JKby2deVnDaWVf/86533vm4sbEZBA6Hw4cOHQKXjcKvCAOtA6ocx48fp/oFcaZE6ngn7SAJti8iykdJJNIuN2SyIiQ7kelZJwt8H4bzJ/oQG91U0w9rT0BQAD1LTJJxYRFLGGwKUkyc9Qo4/AjeeUo&#x2B;Fy8yNjnLWr2AzMbJkyfBD507KibBJqSLj5xRAMjZhx8&#x2B;K7VvuFQk57AV7CkVgNoOoyo17CFr8WbtenPqja/ywemYXP&#x2B;om&#x2B;Dk9J1kG5/S0vLsavwWJyk7jII&#x2B;J6OQ6zr2Fks2menXhBUTaxdq1iLkHn2O1I88MTFx7FA87vdEhge8v37n&#x2B;eyp4CvX&#x2B;9dc4ntyCTDng4t3POnPbwVqSwJ1KccecAmPZ/ImzeLgqtJAXWmwrjR9h09x2kEIJDXpwQ&#x2B;Shab99NX7xambPSePBReD/8ApXuBrBD4UEHh8tu/5KwMfPOz//r3gng1S78/RAztiQ19EOpeF3NeEGish0ZcawYFdF/jCbtSdMuEH9paFG1Ne&#x2B;5Gm1H2dofrySFM5tPEDj6CUj1DjzIh7abjlhmh3TWTo85jXHQ3si0oB7EtbIyNj27b93NbW6fcHmtytb7z54bvvfdbc3ObxeCVJ2r9/&#x2B;PMvNj78yJMfffzl&#x2B;vWbWlo6Ojq629u7Wls76hvcY2NekJrH4&#x2B;3o7N6&#x2B;Y1d7e5ff749EooCUA7s&#x2B;9NEHf8bj8UOHDo2Neb/99odbb3tkxh/PLTh16bnn3/DSS&#x2B;/s3tPo9/uhcz9AOCwNDg59te6b&#x2B;&#x2B;&#x2B;v&#x2B;fP/XVh4&#x2B;jkLK//&#x2B;2LInt2zZtm/fEHpDKIgVDAZHRkYDgUAoFAYbDuPj48AviMXXsT6MDQ30B7WHk3&#x2B;yYlFHgbidGCSFejCSw5ZlJpfTvI0zR8mZUxx5uBZWoMiCy5KQE4u/dsBJgFqfWOUrmvCo9YAF4EyenFJQ51IsDNX/ynDKQUouvvnACmln7pFDsEIBcJpKEdRJVlUKeVDJ&#x2B;iuBk5RmcAzwKOCqANdFReHJuR5LTeYa1dDoLDrLzy5dNIpZHRUD&#x2B;5OzrrCKTE05mUziNnkGR0cpuIwkRWdCmaoXliO1Zkg50UYHVrdjx44dOzQeG9kf6HJ7tnzsX/uM9&#x2B;UbfU&#x2B;f66sr99eWBCavyyyFH9gCpH/SDyftfA/Yua&#x2B;2FHy4Fz5Mu&#x2B;VMHgIGxwCCq0qhZz/4wm7K6T&#x2B;tRXiqiz01xWgW6I6Bp26u/7nLQ5/Vhr5/S2pYH&#x2B;7dHuhZH&#x2B;r7QOpYFnJfHWlK3dUD/HkA3U&#x2B;58TSkL&#x2B;ppKAcuQCm3n8Zy4O4vNbpiza5Ikwsa/sEFPlKjS2qaF2m/Ndb7dHT/Bml0Tyw8HIsEIxEJ3rQTDktt7V1NTS2BQECSpFAovLfe/eprH6557s3duxv27x9uaelY&#x2B;&#x2B;U3L7z4VlNTq8fj&#x2B;/77bVu2bPvm2y0vvPDW19/8AFx99u3b39nZEwgE/YHg&#x2B;vWba2rXnHvedf9XfNFVf7/z&#x2B;&#x2B;&#x2B;3AeYNFACPx9vfP9jQ0NzXNxCJRKHfDlA/fD7/jz/urK5&#x2B;dubsK06dcc6ceVc&#x2B;8GDdd9/9NDS0H24mgJDgNMKvu&#x2B;tffuXdc869bvppS0//47n/&#x2B;Oddb775YXNLm8/n83p97R1dP2zdsXr1q/&#x2B;&#x2B;5eGHHlq1deuO/fsPoOeMY7HY0aNHUVWWQ82pfZIaEoK0BQjyXUiXM0YckhT6nJVmgnZghpSNNZlg0mKSJAl3RE7RqDc3sAILSkWtfBE6S5/NMp/wgdU5mSkor&#x2B;JsLCKnBkulqvAJsfBqk9UWV08uuQ6KAiDeHY0WhgmTWii7ezSKtgGR5zkHVQUxq9313WesYfeZRDLT1s66/ZPMFIme8TuBeALAqVxRpyLXV/icZB7oK5mxIGE8W7wIVGquSN&#x2B;x1Y6kL6So1Goh9ysSicTxY8eOxKKxkaFwZ4P3qxe97z0SfOWG4DPn&#x2B;1bNgtdleqpTdBwa9QFBD8Bv5aa4ePFYdTGqEniRu/Z9taVoUl7knK6nunisOqU/eNOnfrFDw6hPka&#x2B;21FtbEXiqMvDK9YFPa4M/fRxq3yX1bosMfh3ueS3cfq/U/LdwQ3mwPnW/PrDcA2M/PLwbaXIBMz94BZz7paZUAP&#x2B;eMuDe499TBj/ZG24oDzQsDrfeGu56Jrp/gzTWJPn3RaXA4cOHwc054bAkSVIgEPx20w8//LBjYGBfV1fv2rVfv/Hmh1u3bvf5/LFYzOPx7t7d&#x2B;Ne/3fHsmtd//bU&#x2B;FArvPzDc3NzW2ta5Y8ev4Iu8wWBwzOOJRmNg9wDw6ZbWjiVLrys49ayCU5f&#x2B;vujsr7/5YWRkNBqNHTp0KBwO7613P/X0y5defsuf/t&#x2B;FF1x04wcffjEwOBQMhoCjP/gX3PbT1NT60stvn33u9b8vOnvemVfe9p9HPvhwbVdXr9/vB749IHA8Hg&#x2B;Hpa6u3g8/XHvTzQ8WnHrW/yu&#x2B;cPbcKx5b9tRt/3l0UdU/QPS/XXX7s2te/&#x2B;mnXw4cOAh9iiRJgs5Chw4d4lwbyur8mBWcStZZIGk0PzAZAM5UqMVa3KDLCcxfEFkDX04Xh8yFnC6oA58jOUsYbPOBOgtxhBfPlDqB89sOvfiVlFCVPHwzlhn0iboKwFeGZ&#x2B;dAeQeAqvjaB1aSeAPzykp9Gp6pqqlcFEnKxGoS9EzEGDizLfqcumyQ6VBXDv5KDzUKcmccTROzn8mINZ1MWWT7NZmZAoiVzFwCMe6eTNvpWXMLqVpgFZJMJpNJPAuZUW984VGxT5w4cezo0XjAK&#x2B;3vD&#x2B;75fuzbd0ffesC7&#x2B;kJPTTlC3FN&#x2B;/Cnen75KP1A76YQDr9EELvjButJg&#x2B;nofQPrHUnd6Tt7eA88JgIygI5CvpmSsetLtx5&#x2B;&#x2B;Pgi&#x2B;BWqDZ9Vc7xOLPM9eGvjymeCOL0JtP0oD26R934R6XpfabpeaLw3WA0s/&#x2B;CxX2lm/oTywtzzmdoUbysPpi30iTamvdAF3IHB&#x2B;N5y68KcC3uUvNboiTbNCjedIbbdJvS9G9n8b8bhDvn2xaBhY&#x2B;b1e38GDI909ve0d3T9s3fniS29v2bJ9eHhk//4DX3/9/fMvvPnpp&#x2B;t6evq6u3s3b/7xvfc/X7du08aN369bt&#x2B;nrr7fsG9ofDAaB20wsFhsaOtDe3hUMhgCHBs&#x2B;jCPx&#x2B;/7Ztvzz4YN3//uWi6actLau4rLpmzY8//jw0dECSpGg01t3d&#x2B;/nnG6&#x2B;57t6iP5x3SuHSpedc&#x2B;&#x2B;ya13bs&#x2B;DUUCgEdIBaLjY&#x2B;Pj4&#x2B;Ph0Kh997/4s//d3HBaUunn7b090XnnH/Bjc88&#x2B;3pjUws4YwC2Djweb//A4JYftj/y6FOnzji34NSlBaeeNWvOFf&#x2B;85q7Hlj311bpNLa0do6OecFgCh5LBFaJQhQAnmD0ej8/nGx8fhzQa/uAPCnRgQrsviM4nymhqrAHCGj6JTAf0zBmDOZVREwSxqBfni4hHDZZh/07iFJladZwZlZxwyLiK6gQ2KeFzL5Ejlj5VBkwYTB8jA8O3qKpGncBRMTD1kpxXBSdYPqxkQbZlsNmFwS5AJtWysSzfhl0hu3sRdoO&#x2B;BuKZOlTlSKGtWsHanEWXbdbGQpLwp2edA4OLMfmWSgvIlLE4MFlyOcGWsSTbLkUSdHR1wRIHyaLVhbUCljW67CWREwLoQ05VANJ/dDwe83sCnU2Bn74Y/XiV/&#x2B;XrA89e6K0t96eIfmn66p6SYF1JaFUp/IyuF6gByNlc9NNawGV/eHlp10Mu930zm&#x2B;6d2f&#x2B;oa3jFX9ADwcDzB54ATt/Hn/oTfMMLpDy68i/&#x2B;1DWgxeBksKe2wr/67MAbtwQ&#x2B;q5N2bwy3fR/p/T46uC7U9XSw&#x2B;RbJfX64cTag77FmV7ixHFy0H2oAJ3TTV3OmST/8bhe4qh/9bhdUGCRwEVDTeeHW2yO9zwUGv5bG3LHQgVg0HIlI8CpM4Fqzbduu&#x2B;x&#x2B;oW79&#x2B;c1dX7759&#x2B;5tb2n/Yun3Nc2&#x2B;sX7&#x2B;pu7t3ZGTsp59&#x2B;fuWVdzZt3jo6Oub3Bzxe79iYB3xdC3xvC17dA27eBInDW33QS3jAj7Ex7969TU88&#x2B;VLl4qunn7a0uOySO&#x2B;5c/sXab/r6&#x2B;sFd/2Njnu&#x2B;3bHv4kSfmnfm36actnXvmlQ88WPv1N1sGB/cHAsFoNDo4uH/Dxs3/vOaugtOWnnb6udU1zz33/JtPPf3yps0/wn2AYDD09dc/PPTw4&#x2B;eed/1pM8750/9ddP0N9y9fsXr9hk3NLe379w&#x2B;HJQkeOYAXjAI1IBgM&#x2B;ny&#x2B;ffv29ff39/b2dnV1NTU1RSIRlNLBTkv9gXVg/rlbLCI1ABaSOorJP7EBiG0soOOL&#x2B;htLE82aurHAV2xYICuQhAYbEHUuEk&#x2B;HIzlpu&#x2B;FLopg4mZcFTEPVQkn2GQdWwnaHgMU7d7Zg0s4X9Tf/oTj4u6uKIG9S1yOMZRBZ/LhMGg8vsm/OykhVMM4mMlVVwBZg0mQukjtnUxtb76lVl0SAxUWfY7&#x2B;puciZTYBHYZuv4JJMXflA3EQicezYscPRSGRkKNDRMPb9x6Mf1vhevTmw&#x2B;mxv&#x2B;lO48BytH7mox1Nd7KlOOeHAi/M9acf99K0&#x2B;xSMrS/ofLe99xNX1UEXXQ64dt8994fKFu&#x2B;6cu&#x2B;P2OZ9ec&#x2B;b3/z5j37JyT00JOKELvr3lry0J1k0ye1/N5M2egckP9xZ7a4q9q2Z7Vl8QfP/B4Oa3Qnu/DndujxxsjAVHY556qee5cNNZwGMHXMITa64Ip132ww3loQYXckl/yr0HUH/g5Z/6IFf6MAC44z/qdoUbZ4aaLpHa/iP1vCDt3xT1tcckXzQSgm7x6HlZ&#x2B;KmsvXvdd9y5fO2X34yMjAHbeTAY2r7j16uvuXfFymc&#x2B;&#x2B;OCL1raOsTHPgQPDbnfbuvWbBweHgLc9&#x2B;mUueKsmdNkHuewb2t/Q4N6w8buPPlr79tsfv//&#x2B;Z19&#x2B;&#x2B;fXPv&#x2B;w5MHzQHwi0t3e99fYn/7zmrtNOP&#x2B;e008&#x2B;97vp7X3n1vdbWDp/PH4/HPR5vQ0Pziy&#x2B;&#x2B;ddXf7/if/72wfOZl/7rxgXff&#x2B;6y9vevgwdGtP&#x2B;5ctvzp2/7zyNq1G4eHDwYCAVKYAwcO7ty5&#x2B;/U3Pvpi7cbGxub9&#x2B;4f9/gB6BRA8ewCUmbGxsdHR0X379gHS39bW1tzc3NXV1dXV1draGo/HyY6KckGSxSYzVXfqwKFatbEUyC9JYWmSQxUNhv0JJwfsCyfk7EG&#x2B;IoEF5kzXUAsi32JZKwbDcidfsdY&#x2B;6qYNdZbjZIqmw8mIFRcFvCFHUUiRtkCBFkqkRFguhsMmtDBHoV0B0NmiTrNlEVSGZAbUTi4Y&#x2B;PYtQ8CRUFFmfgADKxlbEjDzmEwswJh4LCpAXWlEZOZP9KghE4DYZ8AXdWpZ0FywVYdcWWEsTAeAROfYkSOHgj5peNDf8qvn23fG3rzH9/INvsfP8KTv2/HXlXqq4fHc9MX8dZM39APq70l/iNdXW5r&#x2B;2Fbx8PKSkZVl3ppSf21J7yPlay5d&#x2B;N2/5&#x2B;69e/YHV89/6uJFv941q&#x2B;GemXvunvPjbXM&#x2B;uvrMLbfMGV1Zmnb&#x2B;KYW3f4KMgnWl8DNhKQ&#x2B;fx2cFX7jS9&#x2B;Z/gpveCNVvCvfsjA5&#x2B;J/V/GOl&#x2B;PNxyY9h9cbjricjw1qi3Tdr/baTtuljzPHgYN9xYLqWu8akAbD5YXx7Ymzqwm/LwaYAaQuoan3BjudQ4K9R0SaTtxmj/G7HhzTF/RzR0MB6LwKst4S2Z0AwPnOOhO40kSUND&#x2B;3ft2rvlh&#x2B;0bN36/adPWb7/d&#x2B;vkXG7t7&#x2B;oaGDrib2957/7Nt234JBkN&#x2B;vx8Y4OGF&#x2B;lCdgAmCg8I&#x2B;n39gYOj1Nz688qrbq5ZcfcO/7rvjzsdu&#x2B;88jF11yc8GpS2fOvvyGGx/4at2mcFiKRqO9vf1frfv2tv888t9/Pr/g1KWVVf&#x2B;orlmzY&#x2B;evIyNjwWAwGAx2dvZ8/vmGG258YO4Zf/v7P&#x2B;5c89wbPT398Xjc6/UND48Eg0FQOrD5AMz5oMjAWQj8hh8cAKUG1D8cDns8npGRkcHBwa6urs7Ozu7u7o6Ojubm5o6Ojvb29q6uru7u7vb29s7OzvHxcXJgckzpWLdHxoLG2YZF6VgDEBunrMAYqJoJWVLFdMhEZIbtHN1ZpXJfLCOOjiFnNg05t2cWCn&#x2B;I1pXa&#x2B;RatN452R53kZW6TyTQPIirQpPiaiSxQIlXBFGVzoAe/41euhqpn9QOddEozOAPVgd2gqg&#x2B;Y2pRU&#x2B;k7Ov8nMhYe/xlBXO&#x2B;pKz1qKSHLPEpiyCUBc6kxda8mC84XBSDxZIqxQaC5ofVLXGEWpUAGSiKaRSCSOHz9&#x2B;5MjhaNAf6GkN7twwuvHN0dfv8j33V/&#x2B;q2b60/T59IU&#x2B;Jt6bYl/4&#x2B;F7i4M3UpJ/jSFvJNLmCMD9SVjK4s9aaP6h5cUfbxP8/YefvswcfKfLWlg4&#x2B;V7717VvP9M5vum117/qK&#x2B;R12ButLhFWUDj5aPriyFF/8H6lKG/0Bdiadm0vnHW1PsX&#x2B;UKrLnE//4j0o4vwns3St0/Sft2RAc&#x2B;ifc&#x2B;GXZfEnGfEWooB/fwpJz1G86KdD0c2vdN1NcpDW0ItT0iuRdBc35KGWhIfbIX&#x2B;vmAvQJw8DfUUB5xz5aaL5Pa7432vxYb&#x2B;VHydcUkbywWhYQe/IA3aYZCIejrgn0SC1zqD7hyJBIF5n9gTQfsGVjVwR4C1BxAavBTu4cPHwbUv76&#x2B;&#x2B;dPP1tfWPbds&#x2B;dN33LXy9D&#x2B;eP3/hVes3bB4a2u/3&#x2B;71e3yefrj/9j&#x2B;dNP&#x2B;3s6aed/djyZzweH5BBkqThgyObN29dtnz1wsqrf190zh/&#x2B;54Lb/vPY119/Pzw8IklSLB4fHR1rbescG/N6vb729q716zd98cXGLVt&#x2B;crvbAoEg/DoYOLwLhQT/Qj8l4NM/NjbW39/f19cHSH9vb29nZ2dnZ2dHRweg&#x2B;93d3c3NzcD839bW1tLS0tXVdejQIZnwEiSHD2dwYUNJzpwHsJDUQYQFJncGsDDYeGTNJNSIpDD8NRovHeMH9U8sHepv7Ak6h6DF5JN&#x2B;LB2OLqGo4SQZzcd/qBlYGeVMI44h6VN/O7ADsuACZJ9OYLiqKhjeqAFsn5q0DAYWWTkp2vok1nZC8z5nZiS5smKWYM9XVZfmLMkoEoRfDUbTWZKTBUGyoNB3GIbYMcgQD1Me4NuTJ0&#x2B;ePHlyPBoJHhgcbdkT&#x2B;OmLsY/rfK/dElh9XmDVTHhzjjd9fjeQvoQn5bKfJuVj1ZP3bKJWeU918fCKkuEVZS33V7Q/WLHn7pk/3jbHfe/MnofLd94x56fb5vxw65zX/jp/790z0xfylHiqSwcfKxtZmfqwVwD9HFj6IiBPdTHQRnxPzPe/cp3v8ydD2z6LdOyI9O8K922IDX0hdawINV0RbqxMe&#x2B;a4wg3lwfoycP9mqL485k5z&#x2B;qYzpY4Hogc2St6OyIHvI52PhhsXwe/1Sk3gus/yqNsV2FsOrvYPN1SEm6&#x2B;MdDwY7ns7evCnWKBnPOY/fGgcMPVYLBYKhdBDt&#x2B;DuGuDrArQC6PoC2Hw8HgfEHbBk8JEsQJchmYZWc8ieQQogo0AgOLT/QFNT68DAPqAn9PT0v/3OJ2ct/ecphWcXnHrW9NPOPue8G3bs2D0yMtbW1vnJJ1/deNMD009beu75N6xe/eq&#x2B;ffv9gWB//2Bf38Dg4JDH441Go2NjnpbWjtdef//ue1bW1j23bv2m9vYuoJZIafeeAwcOPv7ES4sq/1FSdkmZ69Jbbn1kYGAIiA0/Kwav8YEfFPP5fCMjIwMDA8Cu39HRAci92&#x2B;3u7OwENn7wsLe3t729vaOjo62trbW1FbwaHBw8fvx4krJLlurVCcLVh29IhkNVnPpzJg0yGGqHZtFc1syAKfykSCjzZnFfKABp9UenETRH9E9BNUBmT4zoc1YsbKqkzufUSiDLi6VM9geyBkT6iUyrQGqfEVny&#x2B;DWpNi5LJP3BHGBIKQCskcx6CCGyFaUN2rqdGZIYC0E&#x2B;pzcXe5Tdnk3Ah7jMOkNyBh0/fcUo5NTPsehgE70CMyA0gURi8k5nVdMIxgbQ1TSZTIL/oyZJNB24dJ08efLEiRPxgDewr9fb3jjy7fvD71f7377Xv/rcg3UL4MU74JxuMH0JT/qbXPDq/WJvTYmnOuVtD&#x2B;h&#x2B;sK7EU10yVl3qrSk&#x2B;uKK0/cGZ&#x2B;x4r63yo/Ksb5v142&#x2B;y118357Nozdt4&#x2B;a&#x2B;utc3bfNbv3EVfXwzMb7p31612zux6qGKuGBwlKxqqLQYLQ8O9NXxjqrysLPLnQ&#x2B;/zf/J/WhnZ8Hqz/Mtq/NbJvc7j7pWjXI1LzpVJTBXTZlxon/fJThv9GcD9PebjRFXW7Ik3lqSv5GxdH22&#x2B;KDK2LeBqk4W2xnrpw4yJwwT9IIdwwK&#x2B;y&#x2B;SOp8WOp/L3Tgp2hgIBr2xGO4LR96tIMfhw8fPnz4cDgchoZweOoXUmR4KgC99AbyfnhIALJqqFeAXCKRaEtL59OrX7nir7edc971V171n7Vrv&#x2B;7t7Y9EIqFQqLOz&#x2B;/MvNlz&#x2B;11v/&#x2B;KfzC05detbZ199084OLqq7&#x2B;379ccuddy7788puOjm6fz79v3/4XX3rnvAtuOGvpNVf&#x2B;7T8/bN0Bnfj9fv/YmNfv9/sDwe&#x2B;//2nVquera559evUr69ZvOnDgYDQaHR4&#x2B;2NXV09ra4W5uG9y3H2gm8Ati8DtfXq/3wIEDvb29fX19wL2nvb29ra0NcH3wBFj3u7u7gT4AqD8IAM4AgPADAwPgJlCUZYJT/hiXpY5ZjEry2SeZCHVIUqNDVYQ1&#x2B;YAArPsJsALKxDyTyTUnv0/MKjiaAqkPYBNUqlyZfJcMTE6A5ERK5cSkSkCGwcKzalKQG3C2aFg5kuE5m04AHPWATF&#x2B;bDPxkzUMuMhMzYOIOgB6aq0ehpII6Ms3uBNj8yyFh2lJW&#x2B;9YCxQPA7IpVm76B8lCXB3JNop5eIDiuQi78FYIsVJL9jXoZWXWoSy/1OfmEXJIp0rIHL8kAMhKkCUYmdezYsd&#x2B;OHz8cjcQO9Ht2b/F/9/7Ya3f4nv974PG5gGFHnig9uOIvwK8mfYFP&#x2B;uRuLfI93dqS8OOl4LoeYI8fqy7215bCnQFPdeneu2d9c9Pczgddv9wx&#x2B;5Ur5v9469xNN899/&#x2B;oz2x&#x2B;s6H7Yte22ObvvnrV/WdnQsvKDK0o96aO6qKYBru8M1pWGV5UG6kp9tSWBp88KvvdAcN2a8M7PpfZtkf4fpcFvon2vRjvujbacG3HPh/d1AiO91FgOLugM7i2TGsuD9fCiHlf6Rs7yqNsVaiiXmlxSYzn4tle4cV645brIvrUxX0dsdGe077lQ83Xh9ofCfe9Gx/ZE/X3RsEeSwtCWD0h5moinHHVQ&#x2B;gsJPbyZB17KiXrFQKcgaNFHv4GFuvWHQuHR0bFwOEMGvz/Q3t71zjsfX/HX235fdPaf/&#x2B;/Ca6696&#x2B;WX3wHXgMZiseHhkc3f/bhi5eqqJf8EF/9XLv7nu&#x2B;99tvXHHZs2/fDSy2/fetvDf/if839fdM4N/7r/8y&#x2B;&#x2B;9nh9YMsCXsMfj8cDgeC69ZvvuHPZZZffctXf//PQw0&#x2B;0tXVBhQSEh0WQJCkYDPr9/tHR0YGBge7u7ra2NkDuW1tbe3p6WltbOzo6gJ9PR0dHa2sr0AHAnxDgz5aWlvb29vb2dhCrra0NKABJwkOPOsDBD/LYKzaK4WiVaUyXyqGxYMlMnVxmTEfoQEYf8sk0JgDLbCHTJiJqzWAaEXXCwQpFJfHUyY2MJch3sbiY/FBlkjMbTjFlskGpuQuaUNXQenqtmgTBXBwqrweTCoBRPY8HAVpvGUmlwbCs0TlLcwc1oyr4nBJ7qChAVhpLc5/hBNNga5e5SzUfiuFZOwbUNRILw3lO1UD4UVB5qCs9RxLSciazV1C6SMmknExOTEwcO3r0yPi45BnxdroDv3zjXfei5&#x2B;Wb/KvP962aAy/kGUtfrAn88gN1pfDLWfBoLwzgn/y2LvDPKRt4tLz1AVfr/TO7Hpo5Wl3a96jrlztmNd47u&#x2B;NB18475vx8x&#x2B;zt/5kz8Gj5geWl4JBAsK4kUFsKNhY8qZuCSsHHuXzp3ym/o8fn&#x2B;lafH3jn3uC6Z6TdX0udO6LDu6XBjZHuZ6Jt14SbqsINKfM8&#x2B;LZu&#x2B;gjv5I094KKeWDNk/C4QAPwXBpd7gs91Nabu64w0uWItVdG2v0d618T8bdHwSCSwLxYJxKNhyIah9w48dAvt3JAHHzp0CBJ9qCGAiOgtnOD34cOHoes/1BzimYhEIkNDw&#x2B;vXb6quWXPFX2999LGndv1aPzIyBjUHcGNmb&#x2B;/Au&#x2B;9&#x2B;duVVt5/&#x2B;x3MLTj1r6dnXrHnu9V9&#x2B;2ev3B&#x2B;LxuMfr27u36dNP1z227Klrrr37ssv/feFFN1540Y3/vuWhldXPfP7Fhq0/7jwwfBDoMEC2cDgMlRywUzE25tm/f3j//mGv1xdBdBsgZygU8vv9Y2NjQ0NDg4OD3d3dPT090K4PnHwaGxvBn4Df9/T0AEt/V1dXS0sLsPH39PR0dnaCUwFtbW1AMXC73cAjaHBw8OTJk0nEWQWAY0onxxF17IiTVOyJjHjaYIYzUoHnzMYsUsufwLFyyZnKiSKocw4f1GBUS4diyqjuxCmUeHEUqw5Nn/VQ1TJNWrX0gOwwtqJDDjJcgKggv/2Rx8huAfO&#x2B;egFENhZNUusFjSKCS6/iJdzir8iJkp8CK1mURlBTpmYkZ664WEhMbSAXNlpZ8JBYsvxKTiQSJ0&#x2B;ePHb0yHhECh0c8rftHdvyyejbD3reuNP7RCUw4QfqIJUvBQdn4a38wKc/WJe27qcv1vSlrtQsHl0JFIbSgUddnQ/NbL2/Ytedc3fdObvzoZmtD8x666r52/8z58DysoHHyoB64Kst8dWm0k&#x2B;fIij1pWUI1E3eATqpXayaHVhzkf/tu4PfvBr6dYPUs/PQgZ2xA19Hel8It/wz1HhW1D0zdbl&#x2B;Y&#x2B;om/slrNxtSt/RE3amrPIFuEHWnD/Iin&#x2B;sK7C2PuivCDeUxd0WwvjziXiS1/TvS9Zg08F50rD7i7z8UD6OfzYJG&#x2B;ng8Djgx9OGB/v0x5GZPQJ2BIf/QoUOAUsMoqM4AdwPSZ38jcA8B1Ryi0ejBg6Pfb9l273218xdeVXDq0qolV//n9mXffb9tcHAfzAtk0ds3sGHD5ssuv6Xg1KUFpy7945/Ov&#x2B;/&#x2B;mh9/2unxeIGm4fP7R0ZG9&#x2B;3bPzg4NDS03&#x2B;Pxer0&#x2B;8KEA&#x2B;PUAqJPAT/BCn6VQKASyA&#x2B;b/cDgcCARGR0cHBwf7&#x2B;vrAsd2uri7g0A8BLPc9PT2Q1vf09HR3d4MoXV1dQBMAxn5wMKCltRX86O7uRrWCrq6uEydOkMOKOgCxYcsamPA3pmxTWSl1l4CcKCBQYdCNCA67xeYW6uYAqSpwdA&#x2B;ZPTeSehGpSgmyW5ZI1LjJTOsMS2ByCmXNz0mGFkHGwiBoHmJP3cpxWT1TMwQXXEPycoAiwwVIZIzpb3JVxChHweG4JpVRA1nUn515u296UqZyXzJNcQMJKwBWCdq2EUTCwxlQUVlKZt4gzhcAW2MSidT9Ieh6nJzkIpNrPIyOAU2TzJQaET6fmJj47bffDh86FAkGggNdY407xza&#x2B;4Xn3Yc9zfxurne1Dzu8G07Q7kHKzAffqlHqqi0N1KfYPGL&#x2B;nOu3tU1MM7u48sKKs/9Gy1gdm9Tzs&#x2B;vWu2R/9c8GuO2ftuXvWa1cu3H3X7M6HKlrun9Vy/8yhZeWQ7sOLepAPdZWCE72ButJg6oxBsbemOLjK5Xvh74H3Hgh8/UqoYZPUvyuy/5fowMfR7rpI61UR97xYcwXwxQdXbYILfMJp537ETT9l0Qdm/khTebihPOae/EAveBtrrgjWl4cbXNGWpaHW26Wuutj&#x2B;L2OePZKvPxYJQt8bYNg&#x2B;dOgQcLaB3j7wi11ADYA3/EA9AfrtAMUA3v8DjsCix4JBsqg&#x2B;AL/kdeTIEej2A&#x2B;//AamFQuGff95TU7tm/sJ//L7onL&#x2B;UXHLLrQ99/Mm6vr4B&#x2B;M3dQCA4NuaprllTcOrS8pmX/fFPFxT94dzzzv/X/Q/UdXX3AeUEu5k0hnwqGOX6qOoCJAebG6FQKBgMer3eoaEh4LsPjucCgg58dYBXD2D88CAvuMUfOAIBct/e3t7c3NzS0gKP/3Z2dv6ya/frb7z35NMvr9/wbVdXN7gJtLOzE7gPHThwgBwg2G4AfIWxQ&#x2B;qwIgcdfI5GQX9j391D/8VYuExMeliyipwhkXnUAQsgaKBBA8N/T548SS2g4uKryC&#x2B;pKcBvHbDYPKuKZDXlxdqdVRAsX/RP1MWIXBCpa6WigiS4ouUNnctj8BQAmeGWZzgM7CiW0ets1RUJcZcMM5IVCSmYlIZb/8ULpWLXVSykymrH12AAxSInM/cZSGZPisHZMQdrAM/2k7keoGstqlpQlx&#x2B;MNFCbBiU0oGgnTpw4PD4eGBvx97Z7f9nk/fJ5/5t3eldf6Kub6cc/lwsu50nZ8uEd/F70s1l1KT97aIkP1JXsX17W&#x2B;dDM3kdcXQ&#x2B;53vjb/BcuX/jmVfPf&#x2B;8eCX&#x2B;6Y3XDP7MZ7Z7nvm91478yDK0rT1/4UA0IPjw7DbwUAX6NAXcr2H3pyTviJWb5nLwl8Uu3f/IbU&#x2B;lO492epb4PU/5HUuUJquTbavBBw91BDedSd&#x2B;tRu2kWnItxQHm&#x2B;ukJomP7wVa64IN7iiTS6oJ4CP7wbrUxf4AIefWLMr1rIg1nFzuGN5fP8X0bH6aHB/PBqKIWQd8HXgzIOyc&#x2B;ASg91sA260hN4v8FoeqBUAJQGz6ENlAJB1eNtPLPO2UKgAwH/hD6B&#x2B;tLV1rnnujQsvuumUwqW/LzrnwotvXrb86bff/vjd9z595ZV3r73unj//30V/&#x2B;O/zVtas2b27cdv2X9o7ukdGRlHqD0qNJh7N/BYvlAr8CSz9Y2Njw8PDPT09wDMH&#x2B;O0A3g/u6AT&#x2B;/VAZACwfHOEFp3ih07/b7QavOjo69&#x2B;yp3759Z2trW1dX188/73rk0cdP&#x2B;&#x2B;PigqLKv/3j9p0//wqigL2F7u7u/fv3gzMAMkE0Se4OmRlnjLOUf3LMYiMaI7KYaQCATA0mQpJaFjOWaeSYSuupfBp7iGatuBxgucjE3EVG4exOYKIKqhAc2RSN90nCr1JEzUBBrjisKZ2lzJCBFcvCrxy1cPQKA2H8IWBVzcMfGPy3nIwUZTDEwDyVoe0TXaZWHT9xtS2uajbX0J1YCzMrsMgEzbK00RNhaLBoSJbCQC4wSWQHHC1aMnNHIpFInDhx4siRI9FQILS/39ve4N/25dinT/levt7z9AW&#x2B;ullp3570HZ01JcG6UnBJvy/l2Z9y8oEX&#x2B;ATqSqF53p/SCkpGVpY13jur/p7Zv9w55/Nrz2i6b9ZPt815629nbrp57ufXnrHttjl7757d8aALXu3vry1N/yiBn92FKkSgrtRTUwJ9fnxPnBl4&#x2B;drQZ7XhH96TGr6MDO6J7v9R6nlZ6lwZb7ss3DALGPLBh3UjTa54iyvS5Io0VQTry6H5H3j7hBomr/eJpK7pTLkAgURibtd4SwVwE4q2XBhuuVbqfjo69FnU0xQLH5DCPvSsLWreRs3zgK/D6ztRRo4GBrwf2OxBYJgypNGHDh2CVBu91Qf1LILP0SO/aF7gFQwAHnZ393399Xdr1rx&#x2B;193L/371Heedf8PFl97896vvuOPO5c899/rWH3fu27c/mnnCGLr3oLwfaCNAVHiND/yU78GDB4eHhwcGBoA5HxjjwZ394KgusM2DW33AnyAYIPrA1QeY/KFi0NPTA1Jzu5s//Gjt1dfccd6F17/3/mf1DY1PPf3Saf&#x2B;1ZFrhwoLCytKZF23YuKm3txfoFS0tLa2trR6PBx1urIEPRhB6OxB8y2J7JC1GhyE5OVCmCIHUsNzJ6YLMXSZIp4jtDHuLqUDYlEUNTy0yK0GZmKKp38xC8yI1E07iMq1CRHg2NR3OLK0N1Lg6l2&#x2B;R3qX40IGxMEAByA9CnB&#x2B;lsABkRZk6UDmJkxOx2hRQUG1UinEVA7BmPWp2VIBVnxogSZxDUNs6LPKBiq3IG1AjGckkJiYmJiYmjh49Gg0FQvt6g627D27&#x2B;cOyzp7xPn&#x2B;9fNctbN9sPb&#x2B;JPG/XhId3UJ3iriwPwUh1wq09NcTDl&#x2B;ZNyzhmtLtu/vLztgZnAh2fPXbM&#x2B;u/bMtdfP&#x2B;&#x2B;qGM9&#x2B;6av7WW&#x2B;ftW&#x2B;baefucjTfObby3Yqy6xJPSH0rSn/uFHwRIbSmAZH1QjMfnBV69LvzlU&#x2B;Gda8M9u8P9P0eHvokOvCl1PCC1XB5sOANw91hzhdRUHmkqj7pdUlPqCG/6Y1spfSCSuqsHXMyfusMn0pT6aFe40QVvAQo3zow0nxttvzHa&#x2B;1R8&#x2B;BtptCkW2h&#x2B;NBCOSBBxp4LWbgLJDZQA9UIvpBihZh7&#x2B;hbhBDPsGLGtGh7R&#x2B;GRHk2ZNhQZ4D8Hu4/wN0AdKOAVEUkSfL5/Pv3Dw/uGxoc3Hdg&#x2B;ODYmCceH0cPFaCpYbsKkPHH08eXgYfP0NDQwMBAb29vb28vuJSzt7cX3M0PnqB3dIJzvZ2dnY2NjfAez97eXsD7gY9Qa2trX18fCNzX1wfs&#x2B;m&#x2B;/8&#x2B;H8RVcWFC6YVrjwr1fd&#x2B;tnn66648t/TCiunFVYWFFXOW3DZ5s1bwBFhoDlABYA1hJO0e7cwezz1ztAE4oZH2uYTyE6CyLxBGrlZdBbLi7&#x2B;qkrlzqoIsBTUKh8fLtNmYfILuKpA8Hv2XWnuoVsaSUGaA1OhEaInibZ6C3EYtBdJMmVRFdHQDU0FXABQpC0e9Nqlt1PY2y7qIZcMGQPOuiLZkqaYLzXnZZ9zyhRdctziBzdAnDbHoYIsWmaZIzWC8H6acROz9J0&#x2B;ePHrkiBQM&#x2B;DsaQ&#x2B;6dvm/fGXv7Qe8zl/jrXL7aMl9NcaC2xFOTuiw/UFfiA279af9&#x2B;aPJPfSQr7e0DbfOe9Fe6fDXFY9UljffOevCsqk03z2t/cOZn156x4rzK1gdmdT88s&#x2B;PBit5HXJ6aMl9arwAHA3w1JcG6kmAqx0ntwgcPE9eWeFZfGHj7ntDGVyK7N0Y6fpD6f4oMro8PvhVpv0Nynys1zoy6XVLacT/WXJH&#x2B;kf7wVqMrbchP/RkGPjwN5TH3pMkfOPwAz/54syvcWBFpXhptu17qXhMf/jrqdcdCw&#x2B;OxcDyecfMm6tIDbPCHDx&#x2B;OZ97aCe/pxzxzUHs5NPyjPv0wCiD3kKyj3kTQ8I/6FMEUDh8&#x2B;DPUBoKvARCCJh0Ji941CUaG2AGk9erkQ6v8TQ44uAJckcFV/T0/P4OAgsO7DL/LCWzvhFf7wK109PT0dHR1ud/MPP/y49ssN9fUN4C3QEAD7B75AwMUfxAJP6hsa/3nt7dMKFxUUVU0rrKyYc/Ebb35YddZVBUWLCgorpxct&#x2B;tvfb9v58y5wbADsJHR2dqJnALCBliS86dAnHDLKYpzoqzTVTMg0Ik4OdozXUpUKanZYImQYdD6RM40aScKTBK0Z&#x2B;Ap1c2fNb/ylh&#x2B;QzcnpCw5QTqHqR8yTmq4npANqs&#x2B;1R1RVHJYZVIZmzda1tZyELph6IkHEJiNuzDXgyE3h0Aw4mOnlrGxqqG7MzgbRogqM2TwQTt1jphavoGNgFrIdQgP2oTwrJgtQI/NVI8/isyI9ZKTy5a5BNq4qStUSbGFJoFpvYfOXLk2LFjhw&#x2B;NB8cO&#x2B;jqbDv7y3dj7y4dXXzG6&#x2B;hJIqeEPYFkPrSpFL&#x2B;YHTvzhVaXB1GU7qTO4yIZA6Wh12f7lJf7akp/vmL3rrtnDK8qgx/&#x2B;&#x2B;ZeWfXnPG61fO//G2OUPLyrw1Jd7qYn9t6hO/8BO8/tStPqmPAYPPhIVWlQbrSn21pb5nLgy&#x2B;e39w48vSrrWxnl/CPd9GB7&#x2B;Qel6Itt8Ya70cOPbEmlM&#x2B;&#x2B;oDxR5pc8ebJ3yljf&#x2B;qGH/jpLuD840pd2dlYHqovBzpApMkVrJ8dbTlXar052vdCfHhzzNs8HvXGomGU78LrOCHTxSz6gC5Diz5k55B2o4wfcm5gdAeONNC3ByXZ2CFayM5BgvBAMDS6A&#x2B;oPHsLnkNCD8KhIqD4Ds0MVDygJegNpFPl2AaiZSCTi9/uHh4fRKzsBa29qagKmekD6AZsHfj5AAQC6QUND47p1X9fUrv7XTfdUnvWPa2&#x2B;4Z8&#x2B;eetQLCKoQkL6DC4KAPrBp89bZZ1w27bT5BYWLCooWXXDx9Z9/sf6iS2&#x2B;aVrhw2mkLy2dd9P4Hn7W3d4CbQ&#x2B;Emw9DQEDoG&#x2B;WybHPioPsCaOcnAZBYwAMqb4f05KNXDPkFFTkoyckBWJmZdTBhS7GSmboP&#x2B;oM5OaGCqgoFNXKzo6ESHpoMmhf6JVgJaXo5zLJWUiysq2NLPXyixSsPURcWuIgjWekFVQvQgL8m3HcBTAFj8ySjoT9BiddBAx3fWSMs6t9YvQHaVKEHLiiGJK5phZGKmJlcm6grKSg0LSU0Zi0I&#x2B;T&#x2B;AeOxQlgZSKZAzwzyORsDQ6PNqwI7D9K9&#x2B;HK4Mv/M3/9Lm&#x2B;VXN8qY9tlYVXpb7Ci/JvYIYHt/f4kI9npUz&#x2B;6SO/B1eWemtK9y8v2/6fOZtunrvxxjO&#x2B;uO6MkZWlwytKf7lz1mfXnrnj9llDyyp6Hynft8zlry1pe6Ci6yFXIDM1f21JeFXKv8hXk6FvBJ&#x2B;YE3rhMu/b9wS&#x2B;fV2q/zbS/VNkaHts4LNIz/PhtjtDjedFmlzgHh7A5mPN6eO5jeWIGpC6n0dqTGkI4YbUp3mj7pRvT8ovCFzVDxSApgsi7f&#x2B;Wep6LDn8X97fHJU9ECo2Pp06pYp48kBZDez/k38BMjpJ1SKkBaYabA6iNH5wVhlsK8Ju&#x2B;42nARFDHG0jBUQUDev6gn9CCMqO/waYE6vaDpgP3IlDdAIpN7k5Eo1G/379///6hoaG&#x2B;vj7wmS1A08FFnNDGnz6h2wEeonZ94Mrf19e3YcO3cxf8taCo8v87beH/d9qCa2&#x2B;4p7GxCdzlD/4FAB8BAPQd/At8ijZs3FRScWFB4aKCosrT/mvxE08&#x2B;t3vP3tXPvnrmoivPOf&#x2B;fr772bpPbDcKD7IBzUSAQAGMJY9XoCCUZMJXOJtJAA2P8DyPE5JTCyRT6GlH5MRYYm2pQmROJ1G1jZHlJycliYqCqEMhv3vY1a12gzsxyphmIFC9zUhUFWWPUQlHDU4WEwO4/1UaWBLPD&#x2B;oy2xB1YjwwFgNRutTEni9U1bbzcWHC6srG1obZpcnG/jMNEBfMiY6FGGiyihmkIo&#x2B;8sgk6tBKpBK5UOseMvKB5rsQTTssxY8FhrGPqDsPbhaoAsy3L7T7EPHwo9OT9QVzK6shgc1YXf3409UeZLnaAFd&#x2B;qXAvd96PQfXFXqTX2uC3rjlHpqStoemFV/z5xf7pyz7oYzfr5j9oZ/nfH2VQs&#x2B;&#x2B;Of8726Zu&#x2B;WWuWPVZfuWlW//z9xPrzlj152zux5yjVWXpmh9bUmgDhj1U04&#x2B;wPbvqykJP17qry3xP7XYt&#x2B;YSae1TgU1vSPXfhLu2Rga3RvatC3etDjVdFm5cGGlKfYIXXtUPfoQbwde4UjwebgXEm1NuPPHmChAg3lKR9vsvl5pcUXdF6uYf93mh5n/F&#x2B;l&#x2B;KHvwhHugcj4zFoyF4RT3KraPpS3jgD1QHQG3waJQocgzgyJEj2GWdaILwCaTa4whQWo/&#x2B;GU1fuUMmAiQBmgk8Qwyfo7oElBxTHiDRh/sVpJNPKBQKh8MHDhwAHBp14wE3bIK7OIHtH1zGD8z/wPMe&#x2B;PGDb/HCu316e3s7Ozs3bPz2j/&#x2B;7tKBoUUFRVUFR5b9uvs/tboZcH1wW1NLSAhyKoOcPyKirq2vHjl/&#x2B;9o/bC4oWnTKj6tIrbvrm2&#x2B;/a29ubm1t&#x2B;/GnHzp27wKVA3d3dIC/ghtTZ2enz&#x2B;dDxRR2hkElDDoeGpDJ1xRkDA5wfWPM2YTVQWPIShJ8MzAKdizKLTJntMZEwRjsZjTFnYp9MJqdHcrfh5MmT2FuYBZSZ/BMrI2wvkSWMSrI5CyiZLyc1UrEUX1bUQjHNXGQj&#x2B;Y3fsVd6FVDbEXMOOnUMndHtoyhbI4l4VzFEHsFExKXib&#x2B;NybGbkQzQwWFf4fYl/JjhBeO3LmcsJupKhbIMlYSKRSCYScsePJ56ff2j1zPGnyg6u&#x2B;MvYyr8E6kqGl/8F8O&#x2B;x6uJgXUlwFfxyFqD&#x2B;k273/tqSseqS/ctK9j1WOryivO3Biq23ztl&#x2B;&#x2B;9znLl34/b/ndj008&#x2B;c7Zr90xYKNN87ddefs/kddQ8vKgUvPWHXp8IoyoEj4Jp3409fzpz7OVeKpLvbWloaeOdf/4tW&#x2B;9x8ObHor3PBtuP9Xad&#x2B;2SP87UscjUuvNkeYL482ueHMFuLIT3tIDvXckYLNvLI&#x2B;6XeOtFVLT5Ae8Ul/scqd8gUIpNaACqA3jrTOjrZdEOx&#x2B;M9q2JDG&#x2B;N&#x2B;rpi0hiw9EN2ixJiaPw&#x2B;fPgwpOPAaQfY7FF/&#x2B;lj6Yn7U7QcY9Y8ePRpPfwQXGPhRgg599GEA1MQ&#x2B;nv6GANxGAA/RnQGoNqCx4umDwuPpS0iBvR8a&#x2B;NHdDDQurASoWowj1/ZLkhQKhQ4cONDf3w8s/fAoLbDuA5cecLEmZmIHX&#x2B;mCOwAggNvthhsC4DRwV1fXunXfFP33WdMKF00rXFRQuOjmWx5wN6c8/nt6egBxB4d94Rd/4TeAwSbAp5&#x2B;tu&#x2B;&#x2B;B6uraZzZt/gGGAWoDuPYHbkEA&#x2B;dva2sLhMDnSUaqNck2ZwXrRiOhDdDbA0kRt8BgjJOcBbNLAVA6&#x2B;mYNMmTqrcIgyzIU19WHSYmLwp3e0WqhpsvKiFkEkBY6KJZ41fEI&#x2B;hOqHqtxF3pIyaEjNVAphnm6TXZhXIqEzAGqpD7WnqhLL2OgA5PShk5ebodJoKKlaA4PFMHwWME&#x2B;TZO0mi0wrnFlbhPFThZEz1zbyB1VPQMJkrFXYKj75hL3hgFGBJMNRQW7&#x2B;Xn5j6ckXFx9&#x2B;9szIkxXBVWWxJ1Ou&#x2B;aFVpcFVpb70vTq&#x2B;2tTRW19NSaC2ZHRl2cEVZZ6akvp7Zm288Yzv/n3G&#x2B;1fP//Ta&#x2B;XvvmfXNzWd&#x2B;/M/5TffO7nyoovvhipGV5YOPlXc&#x2B;5AKf5vVP/pc6OgzM/AHg8wN2GGpL/Y/PDbxyvf/9h4I/vBdt&#x2B;Vbq/zm279vY4Pux7kek5isiTTPBmd30LZyTzvqhhvKY2yWlP8ELP8QL7&#x2B;tM3&#x2B;ST&#x2B;iYXcPQHqcWaXVLTwmjrZVL7PbGBN6Mj2&#x2B;OBrpjkicekeDyDamO&#x2B;9fDAa5S4qweegsW8bgAguUffQhqNUvYjR46gXjTRaBR4B4EfqLEfvVtzPH0TKOreg/kLkbJFkWPEaFLjyEcJAOB2QRxx7h8fHw8Gg2NjY8C9B7B5cIQXHuQFtBtcpwPu4gTcGjyEygB4C&#x2B;39YAegubkZXMcJrvTp6Oj47LOvZvz3koKiqmmFCwsKF9159/KWltaWlha4AwB4PKD10I8f/AkvFXW7m9va24FfEFRRgGzgyAHwJoKfDQ6FQtjQ5lDnZDIJBzXyBI9CEnQyJIu7TxJimhjYhTNUwk2VhJoLqZ&#x2B;giWC2DzIMNn1RE8GKSTVqsGZRqszYEzRlapXyjUHYE8wio0oYwUz5LSKYvjgEJRFc0/OP2Wcdeg8Bqx0zqqJPTZhN6AXrXJC4s4ZxTo3VDFGp9z2znkwmoaa8cD2mxmLppeIbC9TljWYtooSHm9fUt/SHw2755cXyG4vl1xbJr1UdenZh9EnXyIq/pOl&#x2B;6YHlf4EHcPctK&#x2B;952NX2wKxf75pTf8&#x2B;czTfP/ebGuT/cOufja85c968zv77pzK9vPGNkZdlYddneu2fvvWd2MOU4VOKvnbzv35c&#x2B;vOtLnxYAJ329ta7Q6iX&#x2B;V28MfvFE&#x2B;OevYj3bowf2xg5sjQ5&#x2B;KLXfH2m&#x2B;NOKen/oUV2PKpx/a&#x2B;8ONrkhTebTJBa7oAa9iaZUg6nZBoz5QBkCsYH15&#x2B;rafuVLzJfGeh6IDb0dGdkQDvYdi/lg0DGg9xoOBJR69wx5YylErO3SDQZ1/IMlGfWMgRwdMGo0OvIDQG/HjyNX&#x2B;EOPIEWFUBwBxUX8eTHtBfYfiadcglNzDDQGQMjglDKsC7AnA3MPhcDAY9Hg8g4ODg4ODgDSDK/mB2R5QavDVLcCtoWIA7&#x2B;kHTj5NTU1QVQD6AODozc3NUA2AFwEB3eDDjz4/Zcai6TMqpxUu&#x2B;v3pVY889jgk6yBkX18f2EwA9/8A7QIoA2DzAZB&#x2B;cNM/9A6CJ4bBRaJwCwKkHI/H5UwOShgdkiggRyQtAuTwxAglx/ZMZbdYOuQrdB7DNhJZcw3mk4PJgNYDRzlhCSMz1iBMj1KsELTgWFwoHikJKSRVGcAqh1TYsHRY9aCIpNjRcCr0EDNWiczIy4FOTCoAfDsla4KgviJT4zzUA22dW1ua2mBN59Ygs0nbc4b4yQhCLefWmR0nZb5ZRXHPl4xCDcxRSJKIaRD6sPKRpPkVMGRgTgWp36GD8ndPy6&#x2B;cPfHy2fLLlfIri&#x2B;Q3Ko&#x2B;sme&#x2B;pSTnfR54oB0dvDyx3fXrtGd/cNO/L68/45Jr5v9wxZ/Ax19rrz/jg6vmbbp43srLUW1Pmry311RanbwEqhs5CwLnfX5vaAQDnB8KPlwZWlQefOSf87j2hDS&#x2B;Ff/ky0vlzdGhXeGCD1PNirOvRsPtCqWkuuHQ/3Dh5DDea&#x2B;jqvC3jvgH2ASFN5pKlcanLFWyrAxT5SY3nUXQEUhnBDeTS1IQCu&#x2B;XfFWubF2i6VOh&#x2B;JDHwYGdkZC/RGJe/4&#x2B;HgsNukoD/37MdM4pM7x9K32kItDcgxvu0dv0kQjokQc0mjUTg/4N7h4BzXPowoJZPDALwha7tEthRhyLyfUENDSwewOHz4MwoTDYehoBDco4A9QOuAmFAwGR0dH9&#x2B;3b19/f39PTAz6y29raCvk34Nngo7xtbW1gQ6CxsRFqCGA3ADjzgC/1AvINr/oBVn/UZg9IPzxI0NXV9eFHX5z6h8pphQsKChdNL6q6/8Fq8DFg9DPAwJwPeDz8oC/IFPj2oGhra69vaPzppx1udzMQBnoNgdT6&#x2B;/sPHz5MDi6MzpKbgZDIcsyoaBgsBerAR4np5OTAmMHgVgCZAqqlUO3iKEUmJ89JGbhCkvMkVhUaVgeohFCVGZLUsiZw1rSPPid1JM46Imi255SOv9qKrMX8tYzzSrG6BB&#x2B;qCuBAEBp3AFQZRzFY0HiCHChbUOV6xBkh&#x2B;utcbVsY2HaqjASycGFVWblk9joE3pGBqbYfzmqkKDbJp2lRFGZJ/nJIBXUIk7WBpkzWIfLnCdnbJ39yt/zmufLrlcdfqJJfWjj&#x2B;zJmxp2Z6qovjT5b50vfwjFWX9zxc8cudc365Y273wzMDdaXgcs&#x2B;RFaX&#x2B;2mLp8dL07UAlgbrU&#x2B;WBwQRD8SoC/tsS/ambg2Qv97z0c&#x2B;va18K4vpe6d0f2/xAa&#x2B;iPQ8F&#x2B;24I9Z6TtQ9ExzADdWXh9MGeyntuhNrRr/PlfrqFtABJHhVf/qAL3Kvf3nUXSG5q6Jtf4/1VMf2vRcb3RH198Ui/vH45I2ZKKuOp2/gQUkztNNDIz1wv4khd2WiwbB9gzjiLg&#x2B;5PmTVkN&#x2B;jHv/jyHWcqB6CqhBwiwBoC&#x2B;gxXChJLO3HD3MEecHDCVHks1/Q4QfIAJQE9DtiY2Nj4NbO3t7elpYWwPvRS/cBw25LA5jVAZUHjB887O3tbWpqgl43gJSj7Bze3oN&#x2B;4heoE9DDp7W19dXX3vn9H6oKiqoKihZNn7G4dtVzXV2T0YEHPyT6QBj4L0wffBlg2/adn32&#x2B;vnbVc9dcf9e1N9zz6&#x2B;69wE0IyON2u8GOQXt7O9gBkLlcXEZYIzoYBadQvoUOpenUKUWRPlKjoBmR9JrQB5jGCCgAdb5KZHo3kcGoIlEB45K1iqVP6mMy7Wtc2G8RAbAfMq0nUEtHTUoxU/FFigqWYCat7A7MQEoB4M8RsrBbAl/rZYURhLiyaGCXyhtd0/BhZqtxq0EYVl9N/cg0UwmmSc6JImszPwz2JWDWIo2mKigtZvGS2WsGi46gjsLHjx2TTxyVh9vktXfKry458uyZx5&#x2B;bL7&#x2B;&#x2B;NPnCnMiTFeBmnmBdibcmdbU/IPfgAtBgXWlwVSn4MgC4IyhYV&#x2B;KrLfalrP4l/tqSwKqKwHOXBz5aHtr0plT/TXzgl&#x2B;jg1tjQl5Ge58JtD0aaz5IaZwHvnVDD5AWd8WZXLH1JP7y4E17eD27ykdIf34U3&#x2B;sfSx3/HW1xRtyvWskBq&#x2B;Xu0e2Vk8IPY2K/x0GA84o&#x2B;lHXugnRvSa2jeRqk85O6omzt65Be63MQy79cfR&#x2B;7sjyGnY0FIeMr26NGj0BUH&#x2B;giBYFBVgLZ8uAmAfaIL5f3xzEO6IAXI5lGpUMBKgInD1CRJ8vl8w8PDwJcG&#x2B;uujl2zC&#x2B;3mAsRy63wAA9QC8Bbf7gwCQl6O3&#x2B;kD/nLQ9vg1SdpgmPCfQ0dHx&#x2B;hvvTS&#x2B;qLChaNL1o0e9Pr3r8yRfcbjdItrm5GaYGrgMCcqJnAKDSsre&#x2B;4bbbH/5T8XlF/72koHDBxZfdtGdvPfxwGPRZAqLGYjEwoFDfGJJzY3wdG62s2QYEAOYwLAx1SmHNA&#x2B;SfLDpOFZg6k2Bsm3J7QWbpkplfPaeyYVIB4NgskgwPGSwXksCgKWP1z1pTNJv8SAnRJ9QKF1&#x2B;tRBbNjDCMO1Un3wvvSIgEc2ABtOwAUHu5oK7J&#x2B;VNtt9BJQG3FX20F6vxu0qClzs7iTcOfWKn9SlAXxWZhasqs8Ip1xSfZnKkcW/4TiUSah2fIgx5jYOVFbWVqpqR2oaDeJH6Te3bJH94qv362/Gql/ErlxAsLDj8zN1hXFqwr9dYU&#x2B;9NndsGlnOCGUGDgB4qBL316OPjMOcGX/h74eEV48xuRps2RgT3RoR8jAx9EuuvCbXfHWs8HtnypsTzqLocf5QUePtHUod5Jcg/YfzD1dV6XlP4ELwgTb6mAGoLUWBFpOkNquSbWsyJ&#x2B;4IvI6N5D0oGo5ItFI/F4/MiRIzHkzG4cuTkH8HvwI4Zc7AMJNPSZgeQYvkKt/lBbiGce50UpOzTYQy0CZf9A5QAOOeSHAmAYVAy4gTCeeVkntPpDBQPe5wO3BUCp0SKDTIPBoM/nGxoaAkwdfk8XUH9wNw4g7vCbXJ3pi/zBvf7t7e3g5h/gwwMSAYwcXsOPHvkFPyBlB3Z3&#x2B;AkwQMGhZz9QP4A8a557raCoEnzH95TTK5959tWOjs6mpibo5AOE6enp6evra21tczc379lbD3YDUHf/Xbt2n3/RdQWFCwuKFhUUVV56xc176xvQ4wR9fX3AT6mnp&#x2B;f48eMY9aeOd8w&#x2B;jQ5AlMhisxZ1mlKcHGRZRhV70kDAoqTk1EpMVhlvMQINH6L&#x2B;RagiQSoPHMsFyt1hLmia2DTLmfAV53bWXMqCwvyZWQTOcoAVEH2oNI3zsqZWJkdOFhyKZX/QFQA73KwPYRL1VOydplaC4vg0MGX7wIIZwZri85cEcn7n22zIuMyFmTDjYVQA/U1NCn3Obw6OQsJKPAOHQ/LuL&#x2B;XP75ZfWii/vlh&#x2B;ZfHEiwujT1ZAou&#x2B;vLQbW/WBd6nNd4Cxv4Im50iv/CH&#x2B;8LPLDe1H3N5F9u2P7f4wPfih1PBxpuzHaPB965qQu8GksB2b&#x2B;UEN5YG858oFecLS3PNKU/oaX2yU1ueItLvgcvEpvC5RHW5ZG2v4V7amN7V8fHd0VDw3Fo0HUdR5lxijhhm9RBox684Pw0NcfxgVPjhw5Arz8obEcpg93DGDWhw8fhieGUTcb4IcDwkMDfDTzu7&#x2B;o7xDUW44cOYLew4NtFKDSwrzgQ6hdAD0ByB8KhcbGxg4ePNjb2wtt3tCEj97dCdg/0ASAC01jYyO4Mh9euwm1AmBxb25uRg/1wgO4JMWHh33BwV8QHjrwAA0BMHsQa81zr04vWjStsLKgqOqUGYtWP/tyR0cHONELxWhv79izt37LD9vefufjx5Y/9eLLb&#x2B;2tr4fZdXR0uN3u3bv3nnXO1dNnVBUUVRYULrzuX3c3N7eiJ5WBDxJI9vjx4xw&#x2B;ig5qhPpP8kJ0JKIh038mM/&#x2B;UsREt06Yy1oSGpgl&#x2B;k7oEqp8I0lwsAFVvYaUmmDK17Bi3ZuUrExM1CJlkqDTUfNHKUQtOeTl/6llq9a2heI&#x2B;lQlA8O5OZ/ABzB4BUgjlqsaxmTHJCws&#x2B;Mq96cIpLFhpx&#x2B;6qlImAQTMUoeDvQnbuwOgEhcA4e6oI1fbZochRDrbKybLuBDwS0v/tqMPUmkwVE/qOViheFY11QgHpD3fCZ/cKP85lL51Sr5tcUnnz8z/Lgr/SHeEl9NcWBVReiZc8Jv/Dv01TPSTx9IHTvHh3bG9m&#x2B;O7fs42vVopOWqiHs2MOoDd51QfcqcP96SOtELbuQEZ3zB93ehkpC6jL&#x2B;lAtzRKTWWhxvBQd6K1Jd6m8&#x2B;Kd9wQ6X4iNvRp1NscCw3HY&#x2B;FD45P0N54&#x2B;zotSf0CjAWuHDvexzIO2MCRgzOhDVCuIIRfkQxIPvXTQP&#x2B;Pp6/PhD5ga6nIDtREQC&#x2B;xXoCoEiAVu94dO&#x2B;WC7AO4zwGMDEFCRGEfONMPTC5IkBQKBkZERYOyHd2UCyze0kUPveejNDyzrbrf71917Nm3a8sab7z&#x2B;75tWff9kFz91CXyDgrw9SBhGhsxB06YF&#x2B;/62treA6IBAX3skD7&#x2B;8HIVGPoCefen560cJpRVUFhQtP&#x2B;&#x2B;OS5154HQSGmwDt7e3ffvv9v26&#x2B;f&#x2B;78S/9cfM60wsplK57s6OiER4qBM9LWH7edufDy6UVV04qqphVW3nDjve7mlJ6DXhME0jx&#x2B;/Dg2ADnrLHVIkiZtmWa9Sma60MhK0wI21XAmEzJ36iKOTZKYnqMsmNK&#x2B;NCkkNnEp2yy4oBRHYGeAjMtfklTpIZysqc85WcPW0czfFBPXA0cTMAm/k9WzPbWNoa3xrNmFYBkbeNqOXaFfSFvt2Rlyklukb4tbqjRkx899MjxtCSQXbLikiUzurLKLju5UYE3mfwzjAfmXj&#x2B;T3r5VfqZRfr5RfrTq&#x2B;Zp709Pzgq9cHN7wQ2bMp2rUzNvhTdOib6MDb0c6HIy2XB&#x2B;tnRppcUXcFsOVLaUN&#x2B;6ptcqXs8J6/kBw48UmPqHs90SFekKeXQD27ySW0ONC&#x2B;NtN0a7X0qsn993Ncck0aOHIrE47GjR4/GMg/LogwbuwMHmtgBHYeHaOE1l9AhHlrNUYM6TAoeIYCsGlB29KZOGB08h4oBJPrwbv4Ycu0meioX0npwMSj4IADK&#x2B;IEYqM8S8BoCYVD3Iah7hEKhUCg0PDy8b98&#x2B;eBMONO0DsgtM3eCULaTR6P2bLS0tW3/c/uiyx6&#x2B;9/i7X7EsKChdceMkNv/zyK3qJPiDW8Mwu/IYXuPcTugaBezbBLT3gT5gCvOwfpAA/5gWFaWlpWVn9VEHRwukzqgqKqk79ryWvvf5ua1sb9C8CCsmHH31R9N&#x2B;LpxdVTitcMK1wQU3ds9CvCWgaPT0927bvPHPhFQWFi6adtqCgqOq22x9taU0dVoYnm4ESMjAwQLUFsBYglhM8SjSps0QGFWZPgNSHJI0GmLSCM&#x2B;g7&#x2B;iOjOOnoZO6KpDaReaQYTZLUOjimFlAE&#x2B;Hl4qo0D9R0ip2JsBwYVG5zaItNkqQEi9iBFak5dxVhbPWphGf8RychWLCXXkXEImDX8qB2X2gyk/krdPtMrtUHg6axGCKlKBbcGnG0TY2XTOWVoEEatxii4y8RZivjpkCwZVDLVDoclQn5wh4zCQpJ2VEtIyck0m8F/yfWJul4qYzwgb3tbfvcq&#x2B;bXF8iuV8s8fnAwPxofWxftfDLc/ON5&#x2B;ecQ9Z/LazabUUV30P3CBD/gUVzjN/sMN5eOtFeBhsL4MMP5Y&#x2B;qQvUBhizRXRlqXh1hul7qekwS&#x2B;iHndcOhiLhqB9Hb2cHpJ&#x2B;lGSjpnfAsIHXDeDZkEljf44T9/mA3&#x2B;AzvdDqDwNAHQNmhEoFYsWRm3&#x2B;gbFA87PvBccKBZzzzYDG2dQDliSLf&#x2B;YohJxAikYjP5xsbGztw4AB0jAE/GhsbMT/&#x2B;3t5e1DYPn8MogAq/9sZ7Rf991vSiRQVFVQWFlZde8a/tO3ZCgz0I09/f340AfooLsnPwsS2YONAf0BO30AEJOzwA7PHNLS3LVz5VULhg&#x2B;ozF0woXFP7xrPc/&#x2B;AzuMIC4PT09773/aeEflxQUVRUULiooXPTU0y/Czw/DYwDbtv8898zLCwoXFRQuLCiquvf&#x2B;lc3NLeDoMPwgQGdnZ19f3&#x2B;Dg4IkTJ2RihaVyXDlzrkC3&#x2B;1AFgBzy8BWYfODcQl2eUF5LUltI/WUZn9xIJBGg4gnNRZnpYLSBpbFQdQ9qanLm/IbNdRhETPKc5YC66cFJVhGK9Sa&#x2B;JGlLR3AHG8tRxEQlkpoDA5HhAsTh/WqhtqlI3UPVUDQcLDXaAgjuAOpHzg0nnQKLR&#x2B;eE1Mh9VYK/ZYwuWvAJFp21RipmTVk7CRaCKQnq4B2Qf3hJfuNcuf07eaJd3rc46p4Fru4JpY30MbcL3OQDnsDv9QJCH6ovjzdXAKN&#x2B;vLkC3t0JNYRYc0WkqTzePDPcdJ7Udlu077n4wU1RX0tcGjk0HkF9coDlHlrx0cOyqP0&#x2B;hnwNdzx9KBbVFgA/liQJEHH0ok/U&#x2B;o6exIWfxIIu/vBaHrjJgNrd0d0DzFQPo2OuSlBvgVsEqLQwEegFBE370MsfZBoOh8PhMLi9B/rPQCcWlNzDizghbwbGe3jwF7J2aAjv6Oh46&#x2B;2PCv&#x2B;4ZHrRooKiRQVFC/961S1799Y3NzcDtx/opQNdfeCFP2m//JQSArk4qhj09vaC3QMQDIgBHISghK2trV1d3Q88VA2O7U4rXPSHPy/9&#x2B;JO1YDMBfmGgvb39jTc/&#x2B;P3pVdMKFxUUVRUUVT751AuAzYMcQUabN2/5f6XnF6SL89jyJ9va2uERiPb2dhClo6NjcHCQql2Tww01b6NcnDUw5UzuhTGwBAJy7IuY4cl85bQHbwLxj&#x2B;ekwJ9AqM&#x2B;pJJvk8WRSWLVQf7NAklcqReEvGdi/5FtVQBvIkGQ53Q99aIjwOiM6MBYKtwCRUwz4QZ04FEEGI7ftdEI8KWP5dLZM&#x2B;9oawmzoN3KQ0G8/4EBk90BD3apa3ljCsHRj8bHDGXdUuiCTS2OmSVI7&#x2B;4c42C6Pdclyv&#x2B;w5Tz64eKLvjMNtM4G1Pt5cEW&#x2B;pAL46UXfqzn64ISA1uSJNqYdRdwX0CIo1u6JNrqh7ZrT57FjHrdG&#x2B;5w&#x2B;NfR/1tUfDB&#x2B;OxMPwgLnCwgWw7lnlrDVQGxjNPzUaRz3ihewLQLh5P&#x2B;&#x2B;ujzj/Qtwdc1INS6vG0dz6aFwDw/0H9hUAY9DmUCpUWCgAVA6BgQFclVCGB1/7AFKCLP5A/EokEg8GxsbG&#x2B;vr7&#x2B;/n7AnoFXPfhKF3StAQQaUnPoUg98fqBDDgTK14FK8NbbH572xyXpKzgX/vWqWxob3Wh2qBUfdR8CMgDyDRyNwCcFoGoB5GluboaXAgGloqWlpbGxadeuPd3dqTuCWlpa7n&#x2B;wuqCoanrRooLCRf/156Wffb4OZAHOELe3t3d397z8ylunzKicVrhwetGiaacteOXVd0DKqDr07bff/&#x2B;FPZ00vqiwoXDR9xuLq2mdgDQAvqe7ubnBSeXBwEJDmJM2lBBuD5KRKvkXZKmvCRNNPh0nCf0lySaYP34rMbyhrR4uAJZ5MJmFVYBmBH/B8ILVoRIlwUL9cRhWY/JNaFpnRENToZHFY3D2RSCjdtim66rF0P&#x2B;wH9id/VrcJwXBgFDR&#x2B;CAxC0Eigiqvxh5PF2kK2mL0gTBqQqpLlVBE/HUELiub0VUE8KZHVQrNKLBPWLLhsY6uO/p2iZObeOliTqKY76qosYj9TQlAOvyp7zpNHz5aHFib752V8mQtcxt9UPnmiF17xiVz1E3HPjTRfKLXfER94JXbwu/FgZyw8euRQFLV8g49toe4ukNwDFo7Z1LHv4I6nL7WE/vekjxCk6ZBSo5flA5ch1DNnHLk2B/XhgRZ6sEWAHr0dR24FxXQJWC70m2KQ/aO&#x2B;Pej5AZgOqIdIJOL3&#x2B;71eL/goLzxTC4/zghOx8Du4gOuD23vAzZvw&#x2B;1Zutxve&#x2B;AnYc3NzMyD0gM2Dj/UCUv7SK2&#x2B;f9l&#x2B;LIbG&#x2B;/l93NzQ0NjQ0QL8dYDVHNxNQfaClpQV&#x2B;AxjoBiAAUD/Ax8KAMtDc3LJt284v1m5Y/eyr/771obvvXdnQ0JTWUtruvnc5&#x2B;AhAQeHCP/7v0vUbNoGbOvv7&#x2B;0EinZ1dT69&#x2B;6ZTTq4CucsrpS15/412ofgDB2travli7/r/&#x2B;95zpM6oKCucXFC54avXLLS2tQJ&#x2B;Bnwzr6&#x2B;vr6&#x2B;s7cOAAxxaOckRsrGEmfHQUo79R1kuScnKwY3aBZKanPrb/gE0OJKjTuyJHpz7kGzswjkt9S5WTIznLMoIFg2HQ3&#x2B;RRDVJ5E4dRE74gxU8kjDfeObAtficrMRhO/6OqmBgoz5G5jBqLnpQS1UjQ7mlRNTbM6/FoynpUI8OFEQTLFmUBdOZFnfTJzWL&#x2B;DgCnhycSzAt/SD5Nfi1SMX0kowQaIHONofuYsgpCJDuRJEg/Jgw41oZFRAuoAwl5fLfsu0U&#x2B;eJ7sO2eid/6R9tnx5gqpsTzmdoUby8HhXXDpJ7yyc7xltuS&#x2B;IN51T7T/1ejBn&#x2B;LB3rg0Nh7PuOceeuOgLBw10sOPZI2nne8xco/Z1&#x2B;G/0JoO9AForcccfiAFR5k9&#x2B;vtQ&#x2B;ptfMeSWnkOHDgGdBNt5gOoE6uWPbiygCWLP4Ve64K3/cAcjHA6HQiGv17t//37o6AKZN7Ssgy/1An0AeNEAxg9v1&#x2B;lIf1sXxAXOQjAdeIgWdcSHDjwvvfL2qX&#x2B;oLCisnF5UOa1w4TXX3dXc3AK0BXi7DhQGXqMJru8E1nT4WbGu9AcB0N0GeNJ349ebrvz77f9XdsH0ooXTiyqvv/HetrbUh4FbWlpuvuWBgsJF02csKiha&#x2B;L8l56xb/w3c4gB6Tmdn5&#x2B;pnX51eVDm9qLKgqOrU/6p6/4NPW1pa&#x2B;vr6QNX19PQ0NTV9/sU68AmwaYWV02cseeHFN4FgwPMHXl7U3d29f/9&#x2B;MK6psyvK7ydHJU0zTyDHBlDGzALU/JFTsDy7OEdLoS6dWHGon9aCBaRaHFh5YeExRSVDsck0sYvrLUniyAG/gPzU0DQ5AbBcYGqchYmcolkGNT1TNEuL05wgCnRZdJAVKO8AkL1HJ10myYSq3EVe6UmWBT02Xf0wSk/g2HdNgk67hc58VbFhDjiBWdOuqoxExhRm5APrN3U5VMxOJuqHszSyNH/wSyQvAZyQf2uWg8vk0fPlkcUnuucdaq2ITn67tzzSVD7euiDedlG86/b44FuR4a0xf3c84huPT5JayH2hiR0weOCKg/r/oKwaEmV46w5qXIdGevTQLfgBD&#x2B;lCwo1qC&#x2B;gWAVQ5gFEf2uChtR56/6NEH002nr4ICD1dgCk2UHsBRxGg/w88WAz3GWKxWCAQ8Hq9Ho9nYGAAethDczt6/ya8xxN&#x2B;/hb9ehe88wewf6gDgOeAl3chV/UDEz7qNtPe3r7muVdP/cOS6TOqCgoXTp9RefW1tzc2NnVlfjoAPb8Lbg6FB39BLiB3QPrhxgU8egs492efr/tT8QUFRYsKChcUFC64/sZ79&#x2B;6tB&#x2B;Gbm1tuuPGegqJK4AL0f2Xnfbvp&#x2B;76&#x2B;PuBQ1JX&#x2B;TtmqJ56fXgTOACw&#x2B;9Q&#x2B;LP/jwM/T4AdBz3v/g01NOX1xQVDnttIWn/deSl15&#x2B;E6gHsCra0pcLjY6OUg3zEPzpmkXIqOQVm2HIuQIGIJklNfeMP2kCwH/JKORswwqTIPZCsR/UWhIxqaDSwuxENIQEAiwkKYnIlM5qPtaigKk9cmaz8qZrpYfiMquCKsaouPo4MBAZOwAcnVg8RXFNVw/vpOaiigAppmkSLTaVbWvLlJz0xZEf45NTCk7VYReVih8k4C8tirKhxh5sqYMpcIxJiqsvtiJC66CiqqMbv8lHd8n&#x2B;m&#x2B;SRJfLg/ENtc8ZbKuJtV8S6H4sNvhM9uHU8PBCPBsbjkfHxlIP7OHK&#x2B;FrW4Q04cRwDCoDdyQr6OXnqDagXjmWdt0d&#x2B;Y1xCQB/W2R3k/8OSBrB0GRksB1QyobKBioJoJ&#x2B;HYYUGzAdgGg&#x2B;PATxajhP5Y&#x2B;wRwOh4PB4MGDBwHp7&#x2B;7udrvdjY2NbW1tbrcb3reDOuvDHQCwCQCv8enq6gJcH179CRQDwHHBzkBnZ6fb7Xa73V3pj211pL/vC1WF9vb2trb2Nc&#x2B;9fsrpldNOW3DKjKqCoqpb//PQ3r31wIkImvmhigL&#x2B;BMwe3vMDHsLjB2BboK&#x2B;vr6mpCeTV1tbW0dH5/gefnf6npcA7f1rhwv/c8WhraxtIyu1uufb6uwqKKqfPWFxQuKhs5oWbv9uKpg8OEy9f&#x2B;dT0GYvBLUCFf6xat/4b&#x2B;MUDIFVvb&#x2B;/7H3xaULRoWuGi6UWVv//Dktdefw9WC1QSQBN4PB50/JKcEmPP2BBGxyM2dXDWMpYVH3sCs0hMmv&#x2B;F&#x2B;Chq8if5KPkEM2FwSkEtFLVoyfQ2Lzk9YiFJbkoloHxDEqoPKE6MIixFkYlhAQSvzEaLSV2tyIrKOuwjSV5icgdAZH9HRLWljmT0rVrqwBmrLHBMICZBZJowL3fNmaqVSucEoacJOCqfGUhnx1wssbGgaHcRFJVVTNa6qFLppdsOUUMaJ80k4j0lMl1oxWH5&#x2B;FY5eKc8tlgOvndIGjwUD8djUjgcRg&#x2B;tHjt2DLryozwemNghv0c1BEipY&#x2B;nb&#x2B;qGDEMrOMUs/pOAg5Rhy0T6qaaB&#x2B;RzApaJgHn9mC3&#x2B;UdTx9OGE&#x2B;fLkAP76K3EoHc4QWg6IeEUZ8lUCKQOCpeIBDweDyjo6Pg&#x2B;1yQiwMAZ314JyZg5IDKo1490AQO/HCAfR3ejAndY8DhYHhOF/gIofftAEd5aNcHqoXb7X72udemz6gsKFw4fcbigqLK62&#x2B;8u6nJDRyNwFEEGB4I7HY3793bsOWHnzZ/t/X7LT9t3/FzW1tbb28fFBIoAF1dXfAbXkB/&#x2B;ODDzwv/uGRa4YJphYsKChfc/2BNa2sbSL&#x2B;&#x2B;vvHqa&#x2B;6YXrQIuPfMmnfJ91t&#x2B;hOeP0&#x2B;eeO&#x2B;67f8UpM6qmFS6cVrjwj/979qeffQVz7Ozs7OjobG1re3r1SyCRaYULZ/zp7A8&#x2B;/BwcIYC3EvX29oJzBR6PR2QEJWge/DIy7VDdfsgZI5npKiNnLltUPs0xVciZ8x6aMvwXSZM3vcBX6KeFE7RbfTgzLaaxkDJAUOdYrFaxOkGnO0y7EAFGDzDZSBlkWmsqrp5oZxABJ3dFOH47&#x2B;YHfibQ6aW9An2N/Jmk&#x2B;1pxkIVQxe0PYvIiQVjLdrCgJZsOoQvEtFuLgGHuMTYRjdaMubCzajS4e5KqArkPU0SFiuyITTzD8kmF2ZioAAD45vl5OuEEWwFsG3taP0uVx5MwrSpGPHDmCOr2AwEePHkVDQv4dR1yGIL1G9YFDmV/ehYnEkM/3AhM&#x2B;4PrxzHuBoOEfJgLN&#x2B;cDpH92sgBoLLMI4cU4AbiOgmgCIK0mSx&#x2B;MB3&#x2B;cCtnOU4gNeDl3829vbAdWGtnngLQMJK7xzE0SHUcBhABAeXNYJfgMdADrtQM8i6DUEEwGKRFt7&#x2B;7NrXgN3a54yo2p60aLbbn/Y7W6GtwBB8bq7u3f&#x2B;/Ovb73z08KNPXPbXf89b&#x2B;Ne58y&#x2B;fO/&#x2B;Kq66&#x2B;Y9UTz&#x2B;/cuau1rQ1EAWUBNnsQEdTAu&#x2B;99Au4bnV5UOe20&#x2B;Q8/&#x2B;kRDQyMI8MuuXy//600FRZWnzFhcULjojIVXbv1xO4gFlZD29o577ltZUFQ5rXBhQVHlqX&#x2B;oXL7yqaam5vb29r31DZu/&#x2B;&#x2B;Gddz9&#x2B;5LEnFi7&#x2B;W0FRVUHhwoKiyj/8&#x2B;ZyPPv4CiATUEpAaECkYDMrJBDa40MEI3GX5B2GB9ZdqgU4SHx4Bb9HDSGhEkr5TlIr0fiCUSlHxkBmsgKXVkMQAVQxYeYEUma/YIM0r2mw3ZLLU9DMaiKYYCEIDF2KFVGlFyojFeqk5uiHUzoEgMs4AsKyPgsquIZyAqmbkJTM2AyZVlPgMxZmVFONaYFQguyirxvjCCCrDfBlEnqMPOSIlkYNryWTGN&#x2B;o5CdJahGL158tszdhMJpMnTpxA7eLoRT3Qfg&#x2B;Z8TjilI8ee43H4&#x2B;DkriRJmPc8ZN4gOvTPQY/qonf1QJM/lAduMgBXHNLSj&#x2B;4JxDKv/AdiQ80BSDieeRgAmvZJsSORSCgUGhkZgXfMQw8ZcAkm8FQBLBxe3QPt8cALCJj829vbYVx0fwDsGMBb&#x2B;VFNoBv5xC&#x2B;0uMOLg6DvOzz82tnZCd3iW1paHn/iuekzqgqKKqcXLZw&#x2B;o&#x2B;qOux5rcjfDMwPAAL/lh5&#x2B;efuaV8y68/vQ/LS0oqkx9iqtoYUHRolNmVBW7Lrj0in&#x2B;v37gJailAh4G37jQ1NYFb/E85ver/O21&#x2B;QeGCaYULH3iotqOjo6&#x2B;vr729vb6h8ZLLbwKm/ekzqhZWXbljxy&#x2B;wEgBrr69vuOOuZdOLqqbPqALX/M8587KHH32ipu7ZG/99f&#x2B;VZf//Dn5f&#x2B;/g9LphUuOOX0xdOLKqfPWDLjf5Z&#x2B;sXYD3AAZHBwE1Q5qIxAI8AcRSs1Rqk1150PnXvRrX1CFgNZrLC7MBf0yboKx7SCLzXUsNQDNTkY&#x2B;msuKCyMmaS7vZDCyXFgipMBU4zr8poHMLjtVJRMpDjU16nOR2ZWlGYqAtQQopkYqh9QwGkRyYCUmFQAW&#x2B;&#x2B;c80dPAmenwyKIGKkkNbLhmmRMqrB5hDKF3alNQa8/gLwaqslA0hKALGAnyqmmWzy65Zc&#x2B;vJcwuSC0I1f5HTYpl7lLSDZjJWjnR//bbb5hvD8r&#x2B;gScM9Jw5fPgw&#x2B;gWAOHKIFvrHg&#x2B;fw3DBqboccHSgD8fTpXuzjvvC4Lcx0PH2tEFA20A0HzDUISg43AcAeAtzKgLoEPDEMtRpJkkKh0NjYWH9/P2C6gHCjF/UA73xANwG5h3fRwADwcC16YU4XAvRYMDDwu91uqDkAW35n&#x2B;v5N6CMETgKAkOA&#x2B;TaAqgCO84MbMrq6ujo7Omtpnp89IfVqroKjyvgdWtramHP07Ozsbm9xvv/PRxZfd9Ic/n33KjMpphYsKCiuBfX36jCpgjJ9WuGjGfy&#x2B;&#x2B;9vq7d/68C72YCAjZ398PThC89PLb02csmla4AGgOy1c83daW8m769dc95114HfBBKiiqPPeC63ft2gN1G8DaW1vbbr7lgWmFC6cXVU6fsRh8uWx60aJTZiw&#x2B;ZUbV9BmLp6cM/4unz6g6ZUbl9BmVf/rLOd9u2gKqEW5H9PX1gWQjkQi69Zdk36yFjVOMm6ITNZwoaKQWH&#x2B;wiUxAZhaV&#x2B;cDQB0niB6huYhkDqCWRclvz8EnFmeKqWQt2OwH6QUpG5gzKK6DmkYGqhlh0Zxeg4AjiagG2h9zsAKFhjVUNSnE4s0r/FVXBOLD0CaEvZcGioK04KhpeCRWcV2bCxYkAYvgUhYiYhc08QDqbi6bBMXJwA2AJPXTX5KViMRCKBeuqjt&#x2B;gAko0S9Fj6giBAx6FRH3Ju1OEHJejwdxz5OC5k4dDtHh4PQCOi7j0QMB2oVIwjR3vhn9DNCaaJ&#x2B;jvFYjGfzzc8PIzeq9OZCUAuoeEfPUcLAqC3WwKyDm&#x2B;yh5/3glZ/qAzA6NDRH71qE/5ub29vanLX1zfATIGyARSPzvQZYriZ0NrauuqJ5085fcn0okWnzFg07bQF9z2wsrWtDaa5ceOmkooLUp8Jm1E1vWjRtNPOhJ8NLiiqBMb4aactOGVG5TNrXgUHf6FfPrwVtL29/aWX3y4oqpxWtLhgxuJTZlQ&#x2B;tfplUPaWlpZdu3YvOftqcBRhWmHl&#x2B;RfdsHtPPSg4TMftbr7muruAc//0GVXp3CunnbagoKjqlNOXpLWCyoLCBQVFlYX/VbX47Ku/&#x2B;34rdKkCt6O2t7f39fW1tbUBBSDNdDPYP8pxSZM2RnZJrR79gU0m6FvWxELS3IxZAmosxDTCIpQJxM8Qm0ComgOmA3A4JZYaabQiVxms4GTViWgRGFhRqMoMlgLZvnyoZSCKjBxTqNC3jq9/fuN31GGAPhFZ6amWSEXLvSG2edZYkol&#x2B;zM&#x2B;Fk4426NmYE0nZSpCzqql5GRJGQ3gDy3jy/2fvut/jqK42fweWSSyZNDpYWyRDYkmmhAQCgUBIKCEFQgolgWCb0EJC6CT00Hs1tiVtU7Fs2epbp&#x2B;6uJNu4996l3fv9cHaOztx7Z3Ykyw580Xn06Jly28zOPfc9554yMiJVU02ApMo8cZGzXylKl2cRCpQVutx/&#x2B;uPzVYwyI8WOHHEvNDIyQvX61MyGquHReAauoDctZ0SEmJ7iflT8c6H3cWMBg4pS03zE/XvsUTvBwgedE6BZbuR7LVdjrA4CDEbvgXxYiLlpnHvA&#x2B;piKCxA8DcFJQb9q&#x2B;fvCMSSmRYt/BN&#x2B;GYYBSH9sBTTbsMOB16Ag0/eFIyz/&#x2B;&#x2B;e&#x2B;7//LwW29/mEymUHiAUcFmAkgdpYCYmczf/v709Kr66VUNYJnzp7sfhN7T6bSm6e&#x2B;&#x2B;9/E3T794WmXdtBkgA9RVVM6ZBrY6lfUnz6ibXlU3rbL0/5rrftfR0Yk2NpAYGMfwzL9eqaiqhzA&#x2B;FVX1jz3xfDweh1fasayzbu5PKyrrAdNffe1tK1d253I5tNgxTbOvr/8Xv7xzWuXcaZX106vqwWxp2oy6aZUNEPNn2oy66TPrv3XGxT&#x2B;4/Kbb77zvhRdfj0RaU6k0OP5CO6D&#x2B;B8fofXv3snIAl14B7bu7TrooZPdzn0dSAUN66jI86ZCKMmdZitdJ&#x2B;0Xy3w1zF4h5ktg4bdklH4ITgi&#x2B;r1Me60owu7nsg7r8Ilf0mRnRg3EWnIU2sC4/Xnbo4YUBiirxQaQfACTczz3zEKu62bSctP4EPolAoOMW9kipC3Gm81t5IR48exeNj/Ky/nLPFgVmPgyZXVhHfxqSoTDhuzn1alH0fO4921y2Ja7m0ANEa8qoabiI7rdPuSjKs6F79eImFG4dZOMS6e72UhSCYHGpHbI2prxBnU&#x2B;0&#x2B;atwxeA4SZ18EmntMCEBtdVC0oHb56B5Ao/6jtwDa&#x2B;uMeBToH4/WdO3fu3Llzw4YNw8PD1FYHnWhphl0sgDp4tAWivr/o5pu29OsQ5B4df8EinyYCQ0kDfQaoWT&#x2B;1BYK&#x2B;mkPR62/8Q&#x2B;W3LqyorJ8z96effrY4kUiAhRJuAgCYBisgRVHS6cyDDz9p&#x2B;QDUVVTW3/OXh2D7Agbw9jsfnnraJdMq66bNqJte1fCtMy6pDv4oMPvqc3yXV337QssZoKGics60yvozzv3Bu&#x2B;9/mskosL2AQouqqul05rHH/z29qm7ajLqKyrpTZjY88dSLqloq09q69IK6a8EMqaKq4YqrftXV1YMRfiC&#x2B;Z09P3zXX3QYCwMkz6k&#x2B;e8b0Z37ro5Bl1FVX1ld&#x2B;6&#x2B;Lt11/7yN3965tmXP/7k845lK8CKCdKEoeMvRAECGSCXy&#x2B;3du9cCfrZlC7XUyDEKsjSXjLAU/C/O3GKxCDzNSSsnMg2pvsw765Mqv6jeXZRkyiIHJymlaJH7VobYOEpKlKm6SDJMYL/SlulyKfJbdyHBC00ipue&#x2B;uuPFz73RlGDwX6HyTsAcSfkLHjghkglgcdHQ8Nh3DKTsYLxf3lf0S3VRq3gnlzf/5ZRhnGjCo/IoLpL2PYm44jLssYqXJZNep1W4hVNcIDkJcKyuvaTHKNReae8Otn03W7&#x2B;abdjssQYNik/1&#x2B;hgjn9PNo2m&#x2B;GEUH9Ppo6oMXoTXYUqCW/ZwFkWi6Q8MEYYwgajKEssquXbt27Nixbt261atXZ7PZbDaL6nY04kccCSptgOPgjEtxvGrF7lStAD40xn9/fz&#x2B;VJdC&#x2B;H41z4CI1K0IpAjcT8ACSBKdSqb6&#x2B;/tt&#x2B;f&#x2B;/0qvppM&#x2B;oqKuu//o0L//38a4pS2qAALTiaAGHA/lQ6fd/9/wTLmelV9dMq6&#x2B;ff9w&#x2B;FJBZ46&#x2B;0PZ37noq9/o6Hh4hvuufdvr77&#x2B;zuIloSWN4UWLQ3/7&#x2B;zPnz7m2oqoe3ABgZ&#x2B;C&#x2B;&#x2B;x/FxlGGga7/8c9nIdVARWXD10696Nl/vwoCjKZpLS3tswI/mlY5FwZ/4y/uAEdkaAGqr&#x2B;zqvvLqW07&#x2B;&#x2B;pyKyrqKyroL6q599PEX7vrzg/c/&#x2B;Nhbb78fibZ0dCzjZC10RMacaJqmgURkGMaBAwfgA&#x2B;YmrHRWFol1EPf9i0haPKZX6Cx2UW04CQxMWNaRkyCyd9I&#x2B;FO0bFFwL4pjp6i9KFPQWHZj4rsQBYztOCdrFAYjDY86MWnw0UdAqEMsop3ac2vRS3om4qEqc9Hi8aXLVglN0LHQSnTxIcOo&#x2B;MSiVmSTOJZkwRd1JyqScik3i1&#x2B;z0RF5e0fH73KXqCi8ljwc59e7l8cdtaHhswkzZIZWFzuJIRkdHJ4aDi8Xi0aNHxzUkF9APxAm60lnp&#x2B;MYENb9Y2EnAmCQaZes3MTbKVq9ljKUzuXjSKFunUCjstXIAi&#x2B;68aKbPad85M31Ro4&#x2B;wfh&#x2B;J9YmCARIIFZzWH/X9NFQRDgObgqidq1evBqU1BN4B&#x2B;AsZrDi8Tm33FSsnFwB0kBbAiJ&#x2B;G5EfATU35YaMA/VPRpgiDBQFRO3hoGU16EM3DcTTaOmfudRVVDaWg/pX1zzz7MvQGT5RMppYvX/nZwiWffLo4kUiiQdFf5j1SUVUHqHpaZd0DDz0Owgo0&#x2B;/Y7H1586Q0PPvxENNYeTyRVVSObEumXXn7r22d&#x2B;f3pVfan6jO/9/o/zIb1XKpUC1TuIH6l0&#x2B;pF/PDNtRl1F1dyTZ9R97dS5L73yNgw&#x2B;mUzGYm3n&#x2B;S&#x2B;3IhHV33Tznd3dvalUCh/cMIzOzpU/uPzmk2fMqaicU1FZd&#x2B;Mv7lixokvTdJSLwM0X3h4cgDM0/GQoGIA5kGmaBw8exHlEJ6mzYF&#x2B;g66ZUFc1BYbzOTRY2Bvg87UnSPsauO3MATndQEPwNCjKvAO6JXDiMi7YCDuia4sT6OJ5JEXCRMHYn6YieOsldZZmkFNOXBfpOP6h7sUmhcUksU/QlJ9sOgNNP6/5jS9UVYhmni&#x2B;P6niblg5bOZ6QJf9lcLKNjGarTAuCxpPe67ATK/UDuUopHSeB4cB8pxi0tpaOjTJBSnLh8SSY85hFOQB72/gLFLkTtFHfL6Us7LivBjl3s4G5m5uEsEut6/uWPduzYU7be4cOHMeUWovy9VoB/sN0HgA4OwdQNl0oIaJPDGfHTyKHUBRn2B&#x2B;h2ARUwUEhAsWTbtm1btmwZGhoCNT8Y3oD3KjXThxiUmEgLjOwx3xZa8KuqCmXQGQDt&#x2B;DUSyB8bAYt/Kz&#x2B;uAr7CcBGALNrPoNU&#x2B;WBwBGqZKbjCPAaT78Seff/OMS0rW/FVzq2uuXPh5E8gY0Vjbc8&#x2B;/du/8R668&#x2B;tdnV//oob89jUFI0&#x2B;nM3X95eHpVHTgAVFTOeeChx2EMUCYaa29qjqRSaXgzoIyHwSiK0tXd&#x2B;7s/zDt5BgQRapg243uXXXFzT08vzVAGJjfJZHLegr9bPgB1M74596VX3sRX1NQcOcd3WUVVw8kz6qbNmHPLb&#x2B;9OpUqODeAkoGnasmUrGi76ecniv6rud39c0N8/AKH9OXeIXC4Hlk7wSjEjAe7GwA7PQWsHgAkqcClWFoV5uD4yMsJYUSwvauiZgGhFKYKRMGWo&#x2B;OAU/0XLTIgCZXclvdgyE7hcWQjLgQ3KlJzEIe7FiqCfMcaKfKqBMrKH4ENMh0FHPl5diTv6OhZmK61bdmDjxQYnEktM0bGTxAcAaFyfmtO0x9OyH3HReX8TySUR&#x2B;njJve4ENMRl6dgnxmQhrWMfiXsL4x1n2fJffmWDVHkj3mIexC0RxFPlFteUtE0xm6at4lhT5bcUxH7F48n/dYqH2bIoGxxke0vwaCCh9/Yra9d5tQg6fPgwKvVpGFBq8EO1&#x2B;NSAB7YRIOXw3r17Dx48iBZEuD/ARe6ndVFaAOsjaATEiW3btm3dunXNmjWDg4OAbgF/Ywz&#x2B;ZDKJsDgejwMuB9kAACgCfQzUQ91qUS&#x2B;uWPm8uCD9hmFAOE6IB4r7AKjvR&#x2B;9h7JEaDg0MDOAuBGjEAY4nEqWY/U3N0fMCV06rrJteVf&#x2B;1b1z0l3v/1t8/kE6n4/HEn&#x2B;95uOrbc6fPbIC7Dz78ZCajwNhSqfRf5v19WmX99JkNEGDnn4//C92XVVU1DBNNaHC08FogluiLL73x9W80VFTWV1Q1VFQ2XHzpDR0dnbqVqziVSnd19bS1dbz9zsc/vvo3EJ2zonLOzO9c/Nob72GUz88XNX3nzEtOnlEHzga33/nXZDKFSn3LUXiFr&#x2B;YKsCCaNqPuwYeeGBiIo8yGIhMMVbFyq8HrMk3TMAwI/gO7N7lc7tChQ/jRigoFqUJaZC9UPhfnu1ScYMKi7HGyi21KG3HBA1YBR9YhAmgv/n70CicYSB&#x2B;BXuQepyxkd&#x2B;fh4pv0wiEnoJF0H6H3rscrokwi/f&#x2B;TFr5yQZPGHQZUim/c1brM4ZcWOQjETinbb9nWnDrluZhr/oEJ04QbmcBU/1LRZGFBL&#x2B;9hEmWwyfq93OVeSiMjvOWYk9hAD6RlHBoZq&#x2B;Xw1NZF&#x2B;krtqjVJHeetgMmk0YMsk2GaDmfZ3Jp3Pwj39Knr1m9hjCX7EitX9O8/eNS1CXbo0CHA6ADEMV4nWNujVEAdAMCGBzcE9liR&#x2B;DkTf/p/n5WZiyr&#x2B;MYfA7t27t2/fvn79&#x2B;jVr1uTzecMwILAmIEXQ4qP1Dmeco5KQ/IAXoTDa7cAtjPcPF&#x2B;EU9fQoNmBrGCMIdhJA5KDDSKVSaK0O0gj6EsBeAY0IBBgXwW5Xd88j/3jmnOrLqoNX/PGOBa1tHXArnkj&#x2B;4fb7plfVV1TWT5sx55RTGx57/HlU4adS6bv/8reKqrnTqxpOnvG9aZX1jz/5HMBuHAYEz4FtCoh0hImKVVX95NNF51RfPm3GBdNnNkyvqr&#x2B;g7rpYS3symWpfuuyTTxc/9vhzv/jVnfUXXveN0y&#x2B;uqGyoqILg/XNmfufit9/5CGQYRVE&#x2B;X9RU9Z3vT6tsqPzWhRfUXfPY4/9WFDWbzYJ4A92FwrHg&#x2B;VdOs4SEF19&#x2B;w9rESINVDwY4wj0KMPWB3wi8IODRDMPI5XI0jAQQBaAcu&#x2B;N08LSWlF2IrIPWpceixoHuFRQFixqxX&#x2B;xRKn7YxiPgY/GACdiA6jIo/nbB4kVBpcgJVEK/tr7cIY0om3Fw3wV7OClDRTgkdGwTUaTte1zLuBbExYXSf0sB91WBPV9pKgkA4/r5i4Ktnoso73EmeCQRApZtnyvgRbvv/uV9Rb/LyZ3G/0Wt/LHvzxQKBSaUKSthMtkqyOlaOJ8QTquEhZ3sU50YsTgeUYHHjWSsQNExjjh3xdaLsJxzY8Nbx2E6FJmusFQfnOzevT&#x2B;tDEVbuzZv2ckYO3jgUCSy7NV3o14aOnz4MNj8oMIeYPrBgwdp2l0IBEQNfqjlD3oGg4fxPpIMGBT80AWq/Hfu3Ll58&#x2B;bh4WEA/aAejsfjGCsTUTsAfVBjU6t6MPtRrYS&#x2B;iIZhl4CKCqi8RyN&#x2B;9BaAugMDA1ALdwYURQFIDcXANgbrosyAAJ0aEcEtLpQn3X/o749/&#x2B;NHnny9q7urqAV24oigru7pv&#x2B;e1fKqoarPA7c59/4XV4AkgacPtd91dUXTi9qv7kGfXTZzb887F/o9SB4opqJR2DTlEA0DStvX1Z8Pwrp1fNmVZZX1FZX3PBVXff&#x2B;8gddz1w6WU3n3neD0459cJplZC6qwEydkE&#x2B;gVNPu/j9Dz5DSeaTTxdff9Mf//rAPz/6aGF7e0cimUQ7KBiGYRj/efWdb595KcQb/dYZ3/9sYaNqhT9CUy7cLoBbSAD68RuA3YDR0VEUxXG1KtgNfoqCWT/3nyNmx4giWysKVjT0WArfpWo1kZkw2ZorYmUn4qCtuBUgHQ/Xsv3lOCqSXMQG8cGdRuvyLOMtQ9mpl5WIIxHQe6nlsbwTunORQ8pWn0T6L0KR/wfkaALEPJgriOWdmnLphSOnPRQXWXnUMtHmypSVNKR8xAmBuT7XBIOZsnIv2fvHPV5O4bG8k1pissBf2RakS8LxoHGxswlwTLFNl&#x2B;1CF4laHJj3d&#x2B;iyZpdtQRQPvA9g3DSYYW0dcKjpQ88&#x2B;9/7adVvgNBVPh5qXLmlctn3PIcfqdtprZebav38/mPSghy5nt4M&#x2B;ANSXF&#x2B;J&#x2B;YjEwK&#x2B;KCC&#x2B;3evXvLli1ffPHFmjVrAJVimE5QvactUq3wmoCtBwYGANfCXThA/T1gU9guyFipfFGiQOMcKA/KcmqOAk1hX2jTr1pOqwhMQd5AzI0HUAxt2eEiTSuG3aGtC&#x2B;B1fGpd1/v6&#x2B;n9z693Tq&#x2B;qmzZgzvar&#x2B;lFMbnn/xNXgOuPuH2xdMqwS/4bqKqrqnn3kJRBT0adY0DRA2jA32IkAoUlWtrb2j4eLrKyrrKiobplXWnTyj/uvfuHD6zLkVVXNPnjGnomouRPevqKyHeEEVVfXTKutOO&#x2B;eyTz5dDFhc07REMtXXP5Cx3glo7jUSSDSTUW757d0VkK54xpxrr/vdyq4edOfVrFwBaCIFQkvGyrMGun/8ZVVVzeVyuONdlvmgDMCtFxziF9evYrHIGL/ASfkA16Z4y0v&#x2B;cicRQhwbJxig3p0&#x2B;kVSQcF8upWVcOK1UeuG6lsJr7nEwqin&#x2B;975GOGkqJ8ZXJyCZTD4Dl9GJ6WWKxkUniZ&#x2B;LNIMGp3Fksg/UaU&#x2B;A1vWINlyyeHihCQOdCVDZqX4sVBZKHj9M7CI1TcDQbbLG6RR2aVzbAk7irstdL427V/Qy5nF17fwrOH7z4kpGv17uFTl9XaiVHK8w6ZWKR1lvJ1u/Ec5Wr9kYa&#x2B;vrG9Csu2xZZ7wrMQxnK1akvDQ5OjoKgB60&#x2B;GgXhJIAKvthfwAMeKjdP2j6Mc4PHGzdunXdunVDQ0NU&#x2B;44W9mgNMjAwADsAqBhGqxtqYKNYybwgNiXgYxr2h0vvhZbxipVmC3T5IIGgDTpUBFyL0gJUxyRZKDDAkHB3AuE&#x2B;XAFcjoGAqOyB/q/U6AVOV67s&#x2B;v3t902f2TBtxpyKyu997dSG/7z6Nlo9ZTLK7/4wf3pV3TQLpj/9zEsYuxN2P6BTeCJd1xVFTSSTbe0d73/w6T8f&#x2B;9fv/nDvef4rKirrpkNmrsoGMPSfZiXlPfnr35teVVdRVVdR1VD1rbm13736F7&#x2B;868mnXuju6UMxBt5PLpdTFCWXy4HJPnmByksvv/mds38wbUbdyTPqTjm1Yf59/1AtQjkBJAcqqGDkU&#x2B;oeAP8HBwcLZCuyaNdwO4FOepGDy8y&#x2B;GHGqZXdAOS7YyuFsBO4cu0BMXBC2QD0&#x2B;HYc6xOGJ7KvsQiAdAw7Vi6jgvnxwZdyVj2VJzPvmPjaP18fV2rGz9ykl/ZeWTmLljBCkTMEFH0wi4ZwsuxMnTd7khTzOT/cGJ/YeCsRoxIlOjNB8vD1XxvUyx9WU98LjfZPH&#x2B;ubtqwuzLzzHLtmSfhzXP3GRZg7rH13&#x2B;JRzApo2TuyJMMu3czjra4XDvvoNN4RVLmpbizUP79q7dvIcxxgojCWVYT6U7uzNeWuV8eTFHGBzTQD0QsB9MelDTv3fv3u3bt2/dunXjxo2Dg4OAqqk6HJXWOomWo1rhNeEu2s9AMB&#x2B;M28NZ/CP6R7SNwB1RPkgRiDgRkWMgfxomCNTSsHWAfSlW4CBsEC9SjwJ0DsaMBGgUpJJgRBD6Bu2UsLW&#x2B;voFf33oPGN5Mq6z/2qkNL778hq6XDGwSydRtf5hfUQmZgOdMr5r71DMvwnMBnsZNhmQqtXJld2NT5IWX3rjrzw/88Ee/PLv6h1//5kUVVfUVlRB7tO7kGQ0VlfWQFAwQ/7QZc06ZWX/GuT&#x2B;86ppbHnr4iTffer&#x2B;tfVlPTx/q/mHwAMrRfB/ih5qmuWJl1&#x2B;IlofsffKI6&#x2B;COIMlRRNfeCOdcs/LzRcmJOqVaeAYT&#x2B;&#x2B;Dsi7gebH5XEFFq1apUoRTvBU/GitBYjuvOCg0UNI5CdyRQ6FLyKGw5OgoT0OsdPRIgvtsNpJZyuuLwBTpwQ63Kc0IXoq/AiI&#x2B;HL54qJ&#x2B;lOX6mWLYWGPJY&#x2B;FRTt9clP0/4NOcponQAisjxNoc5mKHudM2X75hyrIgzl6B8HHSewpO4CykSXH9cY8TuOyv533piarO46O/UGcytOP04u23ukzplXcFw&#x2B;Xi9z6zWyChET5x2F6&#x2B;7CLnGwgHZUL63dajCeNdm1hagoO9&#x2B;071BRemcuvgdPhTPKdjyJYsKsnFQot6&#x2B;rXPP66o6OjoP6HrQAM14NYn8sAcPDgQUjRtXHjxi&#x2B;&#x2B;&#x2B;AL13IDhMMQ7OoMimIZbmFgXzX4yFoGJCBjtoHUNWs6gbIDKeMWKwwNG/KqVDxgzAYNfL7U7QpkBe1dJ4CAArwhYNZJnAJP&#x2B;UhyP7sK0JAJcTdPAKokWhsZ7evquv&#x2B;n2aZV1oJWv/NbFr7/xHngba5qWTKV/&#x2B;7t506saplXOmTZjTkVVw9PPvAi967qeTKb6&#x2B;&#x2B;PtS5e/8eb78&#x2B;979Lrrf3&#x2B;u/4rKb18CkfinVzVUVM6pqGqoqKybNqN&#x2B;&#x2B;swLp8&#x2B;ce/LXv1dRVTd9Zn118IrLrrj5D3fc9/J/3mpsCvf29aNsg&#x2B;IQbqTgAWbpymQyqVT6b39/&#x2B;hzfFRVVcysq66ZVzplWWXfKzLoFf320f2AAHhZgPbolgA&#x2B;AbuVghjcMXwhcBzHJMIzBwUGqIxfnbFHmdeO0OeB0yjEQkclQRifCfXEGcasqshfpMIpykyS&#x2B;HU45Qm&#x2B;5j4fjeNIqLtKCywM63eXKTGDBdVH8eRQSXIbH/couDboj&#x2B;7IrwgTW03GVn6ITQ/IoQFI2wVynBPd9O5ELjJOK6WJFWszjBtlkUUHYyvSYF9ZLy&#x2B;MaiQvTP64zbRIbHxez4y4eJ9B/Ikn8nrkD9&#x2B;&#x2B;czhf3FpzW0aKDZk6K8pkwQ/Gqt8cdJw3nWPMStv8wY2znrn1vvtu8fsN2uJNOqkp29bqtpZwAa4ZXf7yk0zRy23cfLhw5&#x2B;OnHofzg2rLNFwoFtP/BMJ0YEWjPnj07d&#x2B;7csmXLunXrBgcHIf6MagXhUaw8WWjqo5DQ&#x2B;6oVLQdAcCaTQY07KrNRQa7rOqB2qILQGWQAlVjYU1sghPXUaEcjHr2opEfNvUIcfHE7Ai2RFJIAGMUPAPqwCQDaccS1VP1P9x9UEjuImhL1D8Rv/MXt06vqTv769yqqGr7&#x2B;zYtee/093DMZGEjc/Os/VVQ1TK9qqKhqmD6z4U93P9DV1bts&#x2B;YoPP1r4z8f//fs/Lrj40htOP&#x2B;fSr31jrpXwqxRO9OSvf6&#x2B;ism76zIaKqgYw&#x2B;JnxzYtqLrj6F7&#x2B;868GHn/z4k8/b25f19PYpigIuBPBftRJ7UT9mwPHowltK6ZVK/ebWu6fPbKioqq8opRCuv&#x2B;qaW9raOqjND6j/QV6CtwSiRTabRQcGgP5wDLLNunXrKNCn0I2uMjjvuPC&#x2B;jNhDSpdOUWVAyzB75H44kK6n4souHjgBa3cOzEF2J5lBfDQpxMcH4QYjPojLdTqGsoOXXnev5RRGoiy&#x2B;KtuvtIz4JbhU/8qFsJyiYydeAJBK8yKJIEz63ctBgyu5p1P1ro51Jw/lPel3PXZUVm3Dyr15KeOY2JBcFoZjQcwe2YeLasF6V&#x2B;V/yrIr3ATI6QM&#x2B;xmYnTGX1T9LJhW9SXAMcpHoPKF8Ykpe5f0y0fojlTDjcs/fgosaOaEs3nO7esX14eG08mYXTfbt27tp7aO0Xm44U2dFD&#x2B;5cuT0Rbu1uWDnjp5PDhw2ACBFZAe/bs2b59&#x2B;8aNG1evXg2QDpXl6HqLbrWo4weYm0gkaFx/ipLRKwBxNooEGONftULcIEyHU2qiA2XQRkUl0X4yJKg/2qVgEHq6LwEDQNN/7BotjlTiTIxGMvgfXHJBQoAWYJgoq6BkgkE8dV3v6xu48eY7ps9sOPnrF1RU1s/41sXvvPsJDEdV1d6&#x2B;/lt&#x2B;&#x2B;5eKqnpIAzy9qn7GNy&#x2B;85rrbfvijX55x7qWnnHrh9Cqw6a8DFA7JBE6e8b1plQ3TqxoqKuu&#x2B;/o2LzjzvR1f95Nd/vueht97&#x2B;IBxpgSS&#x2B;YNCPibdU4n6dSKYGBhLwirLZLO5d6Hbq7x/49a13T6tsmDajbnpVXUVlww8u/8Xni5rR6xezlYGYBJsApmmC0Mi9EHAJgIN0Or127dqC3fymQI7FmSiVDcSLnAYdr0vd6rjWsM1CYVTaFNeIVBJwwt9i13a2XyjK8H1B5l0gJa41ab/SRdYFLou1XAbjZUWWii4uQy3bgnt3ZVsQ6cusNfty0lf6jUl8ADzWRNP8CTw/l3VPPC7a0yF5&#x2B;WTLImyP5PI4YpsuvGBcLTPPkQo8khNWmxgdo25A6sXBcfljaX/S6Bjec1miz&#x2B;gl1JVLF9yCJAqZ7psk4hpmL1ykH49tdSzayOpl3EJ&#x2B;eUr3s4Ufs6QCZ4uWLH3j7UWlIR09/NnHodaeHJwub&#x2B;384JPYQDrPGGPFETO/ljEWTyoH3dQINtq1a9f69euHh4dBQUv15YoVax8dczFiJhrTi16zqGjXrTg8HExHwyHVCtZJzWbQzAa3C9DvFq1KVEKI2tG4BTYWqPkQWi6hjIGbA&#x2B;gZTDOOoakMYlw4Rdzf29ffsWzFBx8ufPzJFxd&#x2B;3owvQbMyjsFzQVO9vf2/&#x2B;NWfplfVV1Q1VMz4btW35r7/wUKQN3Rd7&#x2B;ruufW2e6dXzZ02Y84pM0vGPBVVc6dV1ldUzqmoqofUwqfMbKioqj9l5oUQSqiiqqHyWxfOvfjnd9z116efeenDjxb29PTF4wlLVioZ5YPenb6fvr7&#x2B;N996/ze/veeOPz0YjbaBpIRiFcpIAPF7evuuu/4P02bMmTbje2fN&#x2B;sFNv/xTU3MUfhF81ZDTF8A9qP/B3B/v4geAx1By7dq1dKJRTF86li2OBbsDLlZxn&#x2B;8UFosLa1nNPSzHIvR00eZw46ScRCohiHedoLaLNo32xY2WylocYIDCoqeW2C/3INwYJmUVKzh7boiDOUZyepYp&#x2B;t&#x2B;hsR2AEwzCxoUpPSIbpLKKbSdO59S&#x2B;R6HZafvCCQG7v3Pvgtm4FA/jrTsB8hKgxiN9WWSD8ZB3QdF9LZRSoVCAz0z8dDlNntiUVUC&#x2B;uHILD7dm21YL69gFBxwTHT3Mtm9mA3E4W7YimUiVNgS2bVy/aHH7xh0H4XTz5m2pTPatD1v2HykyxgZ6E9t37TVVY/eBUcbY0vaVQ8Pr3LtavXo1AmtAsf39/ZgniyrgOVMZas8DQgJuGsB1sJ9BRT40iPp4bBOuwAYCqN4paqdiAKj20S5IJQF/EMJCYRptJpFIQMIvDKQDAFcl3skwPLQL0kl4UDjG0EOJRPL1Nz744x33/fCKX5153uWnnnbxf159G1XdKF3ACKFKd3fvjTffWVFZD&#x2B;E4v3n6Je&#x2B;9/ym&#x2B;gZ6e3rv&#x2B;/EBFZf0pMxumVTacMrOuZOdTVV9RdeG0GXPAyn961Vy466u58qZf3vnI35/&#x2B;8KPPWluXdnf3oCkO&#x2B;hWgVAMmRm1tHZ2dK3XdSKcz/3ntXV/NFRVVDTO&#x2B;edEfbl&#x2B;QSCThVeDOBoL7dDrd29t31TW3nn7O96/&#x2B;6W1PPPn88s6VGB0IxAYw8lFJyCb8NvL5fC6XgwJAmhW7CdwMNm3ahNMHJ6NTlDMmTEkklMbF9QI1dOJ6V35FcFDkc124HzOHZY6qDssiAWRr4v6D0&#x2B;NIT921cqIUIf53ijVChTdp1yJrLchMlVykDunTOX0nThX/K/RVXMH/d&#x2B;gkZv9KnGajywQri7a9bI0xMkvpGLzICaCcoCqKskOSEjcnuWFzIxnXZ&#x2B;0&#x2B;D8WXyTV&#x2B;jAp4F5Tm/c0cywCOhbyD6ePa6eQSVY95&#x2B;a6cNsrE1pjr3HQfjJScbpWwiHV3ku1Hc0m2tmTKv3ffwVhrT1&#x2B;/MnYzt3rlQGkHwEylFjUuHVq3A063blj/yn8&#x2B;ev29liOMMcY2rd8wf95TTbEel8F98cUXiNpRd45Bb9DdNmOF6kfYjQCaBgJC/TdIBalUClN3gTxAxQlunwFaBk9frn2IIopX0HAfACvdNNAsL1407AHEr1pG6qrlbYwGMGC5jpsMmACYGv2jRVD70mVXX/vbisrvTptRN71qzvSq&#x2B;nfe/ZhujGDuM7Q&#x2B;6u7uvf7GP55yasO0yvqKqrmnnnbJx58sgrcBZf79/Kszv3Px9Kp6y9IGvHsbplXNnV5VP31mw3fOuvSHP/rln&#x2B;9&#x2B;8OVX3mwORfv744oyprBHiynUzaM5U2NT5M4/PTD3khtuvPmuULglEmn54Y9&#x2B;PX3mXLDmv&#x2B;a627q6e8FoBzA6BvOxPobkiy&#x2B;9&#x2B;f4Hny5bvoIG8wEZA/tCSQA9CuA/SFCYAgzePPSVzWY3b94sgmNE85AiALE93uXwIkJ/XLncNescueNmKZXVHYhKBxfXAk7FIBVjnOAy1wgnHTnJIfRFSZEJ15EXhsydiu9civLFtd6dz4&#x2B;XPLbwZRASpui/RSUBgH70HAiGci4fq3uScHdm4XRrvB&#x2B;lu6LCqTVuWkoacUglKG3Ko5zD9Ts6OjrepAcuWhwn8MfpAya2/SL26PIrSwfMHH7iLycPgmG7RJgd17DlwL3cDq8oykqlU&#x2B;mqM0YOS6PTksktqNaBZJWVd3fstHaQdbazXfsZY6MFlh9cmx9ae/jICGNsx5ZNyaTW219KC5BK6ebw&#x2B;qG1JRfhpc3RF98Mrd92AE5Xti197d1Qe1/uqHNXW7duTSQSgNgA4iN&#x2B;Ba15f38/5qBFcIzAHY18VJKON2MP5QnVKeEGAtrbgN8ttAOxfVCNTdOHAfQHeyTq&#x2B;0s3FuLxOGYIRhshkEagC2wQVf50iwP3DRQSJAfHuXz5ih9fc2tFZR3k7Zpe1fD8C6&#x2B;iaISqcWgQZI/u7p6rr7kFMnBNr6r/9pmXfPLJIlVVwTU2k8nEWtq/f9lNFTMvmj6z4eQZcyoq606ZWT/jm3PrL7zut7&#x2B;799F/Pvv5oqaVK7t7enpUVaMYGoE&#x2B;GvxgJP5kMtnT03fDTXeARHHqaRc/&#x2B;NATL73y1szvXDStsv6UmfWnzGy48eY7&#x2B;/r68QfC7Q7E7vANYB40eOFg8wM2QvAas9ksbBaBCAEDQ2EARosSF8oJmzdv5uaRE0sUJyzycwTNThzYfr2EpMUpjMufdHHBWhxqFztyx81iRdoyfTo6SCmEoOu10&#x2B;OLLYjCCbO/Xu6KOznJWk5jdq/rzlcnUeE4YXJHWcejxyk63sTvAHAfsXekCBVdygOQ4uatS4MeOQizb5tiL7SRcc1ql&#x2B;6cWjgW9aeUN0ltPLjy8vdzbGoDqVB37KoI0eVjYvxiXLW8FD72RxPJ6WNw926XUsF5i7xItGUuK7fYmpScoL94V3Y8tg8waTRssg/fZeYQnH2yMLakqWPv3hKsV5T8p40r4XhNfnBoeI1ilrYL&#x2B;gayX6xZu3lbKUbQQHp49/7DueENcLq8o2fz1l1cV&#x2B;vWrdOt&#x2B;JtoywHKcmqTg/gbVPIUu2OsT3QGQM9gGh2IaqxVyzofU02hCKFpGuj7YWNBsyLzUN9itC9CrT8a30M7uEWgkkzAmhXZU9d13Nygdv/oOUBNVqBrQNiqqq5Y2f2Tn956ysxSpq2vf6PhjTffR3sbtH1XrAQCiqL09g5cfuUvp1WCNX/drMAVkWirapnC67re29f38SeLfnXL3XMvuX7uJddff&#x2B;MfH3jo8Vdfe2fZ8hXxeMlfAnA/Va7D2ABto9yVsVKeGYbxwktvfOP0i0DwqKicc&#x2B;vv5j3y6L&#x2B;&#x2B;9o0LK6oaplfVVVTO&#x2B;fdzr&#x2B;DPQoN4wntDHA&#x2B;twbvC9wBV0OsXatEYoHgFbcBAaME9hJ07dzIBytMrMMFFaAiEU5Uu0yJAF48Lzjt&#x2B;eF20RMJhSP33KHTmHkRE5&#x2B;JyLC3gHQBIW6aSEn0EJ2nBiT0WZbs0THjV41qb6Lty6ZqrIv0SvKApJ34uFis7jCn6SpP4kcjDgHqhsp&#x2B;LdLvAe3UvPeI&#x2B;qVQvOynwjnYqTchSVn/vZe4xwijLihkT2CsYL50wXiCi2/8KGxK5/KS0OXZsnwujo6Nl5QF8M17ES7IOiVd4pVqhUMo/WiSlxaZwGS4Wi3QPQZQWyg5v3HRgF1u5gm3YCmf7DxxubF7e3ZtmjLHRI6sGV/VbFkG7t&#x2B;947bVPOuODcKql9cHskL56G5wme3oT6cHhVesPjDDG2N7de19/9ZP25Una1Y4dO6giH23iMeA9gkvNcgAAMQDwPUb&#x2B;0YgbLgJiaq&#x2B;POJVa/mj2vLlYHnrBi4jUM1Z2YfQ0QFGB7i2guTl9BMUeUwjhqWoF7EfNPfo56IRArli2fMWVP/nN9Kq5FVX1FZX1Xzu14c0334dR4bCpnltV1aUdnRd9/4aKyjqI4XP5lb9c3rkSDaXUUtyhdHd3b0vr0qUdnd3dPT09PQi&#x2B;U6kUWt2AWJLOZLq6egbicXyB8PiAxUEwSKXTf77noQoIH1Q555SZDU889cI773387TMvhbBCv/rNn1es6IKo/NQ4x7QI1fx0WwAIwgqB1ziYUeHzwgBQ0oOgnzB&#x2B;dMAA4XDXrl2MsGi6joiaafgvurEW7M6ytIoUoDMZcHfSZFOOIV2bnHgCdsSVt7EUWQHskUPGLmsop5WQDo&#x2B;eSjG3E7CWtlBw3251Jhd1JCcMiIsR9&#x2B;qY8Dt67N2dpmSA/zUqCQBOH8ekh4YVvzAvMr147H7RpamCReItTlB2moTHQhNQA0sHMOlpyyaclwRoshjQsZM4Eu&#x2B;PJl1mnDRGZZvl1k4vJF3LxZax65GRkbJ5sqUrjbsSSIrs3XcYJnnl2LGZLW9nW7fSa7v37GeMFQuFjvaV7y5cBhc3rFr13sexnftLL2Tvrl0ffNBsrN0Np8vbVr75UWzzrkP4grq7laWd8W17DmOze/fupQYwaFeDkT01K/wOKpjTFqGlDWfVg/sGqF/XSaZeULGjSwAAfbgFtvhUeMANBLiCqn1U9uu6DvGIAArT1nDwVB6AhAMAdlWSeQDfABxQ31aUZ3Rd7&#x2B;7uveLqW6ZXNZxyasO0GXNOObXh7Xc&#x2B;xG0NFKUQBBuG0dQcObv6RxVVYALU8Itf3TkwEEfhBM3uUSzBN4lo3rDS9Oq63tKy9C/zHvnZDXc8&#x2B;PBT8XgCNfSI4K09k8zv/7hgetXc6VX1p8y8sOGin4UjLYlE8vEnX7jx5jvm3/ePtrYOdPlFLT6q8EGmAgEAZQCdhHgCs35q9G8Qons&#x2B;KOBBsCDdCtK6Z88e/Ajp2kRBOSeij2m7irZlUbpycVOSU&#x2B;pzTIPb8hVxfFGwEaL9clxFBNlwF4WcwpjbEuOIlhSfyAmpO90VyzhdoQPgOpWOUFqAOy4KuzpMWBG8yxJOWlR3JZpLs&#x2B;NdkU/MCj5FJ5IkOwBFQRsqzkbvsMYdtVO5lsP6LgBIMhPGuannlPxcWpgbrRQeAXnB9&#x2B;MF8WV1FU63pBB2spB6WQA93ureHSFc1gApieZMHj9d6eO41B0XCD6WpxAboSuxUwsFu6&#x2B;wdPUSV3GHsfP9TjYV2Y7tbDDPtm1jjBnm6i/WbqK3R0ifqaS2tNfE0yPkPWlJtTG03PxiO14Z6Eub5uDmXYfwyo4dOzD&#x2B;D&#x2B;bVAhSLNv0I8fE6WvtQAJ2xgmxiYJ/&#x2B;/n604cHdA4T1YDsE2BF9hRXLNRYNkBC7AzZFxKzb83ypxHuVDiZjBf6nsgSGvgEQjHKFQiKEapoGFaEA4NeOjs4rrrrFSshVV1FV//J/3k5nMmhCg3sgpTBKivLk0y/N&#x2B;OZFFZV1FZX1FVUNjz3xPABoxNa430J3EjS7oy2MPxptvea631VU1k2vqjt71qXvvvepZlleaZZLA&#x2B;Lvfz33ynfO/sH0qjnVwSue&#x2B;dcr6TRsnmjd3b1wrFixevCNoRgAPWI8pWQyiY7CKkmHDAIDin8Y8yejKBlFaWlpf/udjxWlZOiFXgQwyL179zrNWVHRKyLy0jwpHTi2gGtr0bIU4lCjVEcAB1CGqhhEMYPWwsfhFkpuJOIjc48jvhb6OJIB2NmauGSLL0e8KA7G5bpdhnFngHKJqyyJssqk0BSInyJKJR8Ad5tvqb4ciAMQ7jBuXPsJJazmLdcvBgKSjtNdSeDydN7HOS4aL/hj9kcQ77qrgV0GIHJVl17cmxKH6t7OMboreCH3780Lo0dyX7fEksxZGnRRLDkNVbr&#x2B;cRVRzLM9tUwVJF23RBwgluSW5&#x2B;MD/RljjB3YzTqXsl274GxJU8dHn7bgzZER8oCFEUMbzA5vhLPD&#x2B;/fTZo4cPvT2m5/350relru3b1s1tOrJp98d3rgby&#x2B;zevRtwOejOwYMWdf8DAwOiDh4RJ6DGeDyukQQCGSviJzSCQgJIBdRbgOrmQRiA6gDKIRSpardux&#x2B;0I3cothTp&#x2B;sAgCBb9qD0wJI0cTGuiOqrExwH8ikUANN9W7o7TT1d17&#x2B;ZW/nl5VP72q/msz66bPbHjiqRcVRUWJAncYoNPWtqWXXXHztMr6iqoLKyrrai648rOFjYoyln0MlevUakixXBHQ4j&#x2B;TySSTqTvuemD6zPpplaXMAM89/yoF4ph5F2oNDCReeOmth/725EcfL0okkmiiA8b91G4HiLr2gtpes7L8giswNfRXrAhLdP8BrsTjiX8/9&#x2B;q/n3/91t/de8Mvbu9Y1qnY04RBdyAAOE0ubjeAQ590nZUyJVgNRcUzp0oX12sXecBpvruvTe66CXc24oLjxVrUQJfr0WUDQXyEooxnOl0R26SCgahvkso2Lt0x2bO7aDY9Xjx&#x2B;NIkCxpSscgJI7gMgRQNOJE4JhD5O8jcnb3iUyJ3UxsVymVBc7vKDl81GJzbkpMt3Gqd710515eOcKPxyedXjDQ2Eb/U4pRAv&#x2B;4BYgGizuJF4Bdm4EJZdIZzIkY87q6AKhcJouY2UQqGAD0WXc/AicMnuyV2hi6L4YYufk2zSSZbGgrB3N2l0YA/Ll5yA25b2LGpavmFjybL/888j2XzJ63ft4ODTz77Xl1kDpzu3bX/vw9D2XSV34a1frGpp7UY5LG8ORWMrtcGNtJ/169cPDAwA1Oay&#x2B;YJalxr/YKAedO5UiVk/oGrdyv8FsgGa6YM2HaPlYBUUMDJWpFGE7OinC11jcCG6q4ABQFEmARCPgoFqT09GZQPU2VOjf2rLpFqJgTNWbqzlnSsvvfzm6TPrp1fVnzKzoaKq4Xd/nD8wEEdjGOwxmUzG44nHnnj&#x2B;m6dfUlFZ/7VT51ZU1f/qN39e2dWTz&#x2B;epuTzmXca3h/Y2KCYZhtHW3nHZFb&#x2B;aXtVQUVl/ysz66TMvfPOtD0AKQsMnHAD6aeCWCMhUeMwZ7oNHB4oQmhXrCc14UBoBTb&#x2B;u6xDmXydhlDKZTC6XC4dbfLVX/fWBJxb89Z/PvfCGpo3tt2CnhmEcPHjQSYnOZPpmugxJAS49xqYE3QE/03ENFTmAXN0uCB50MNxqTofBXNkFV5FqT2gLRZnTQqGcg6xTL1KW6I4l6FOLON4JrJ9gaC79isZVwImmQPn/MyoJADiv3MGcVNYX2ZAY2hJyD7m0LPIFl5FIYxTgf&#x2B;mWpUcZw53GhQKlY3Y/nlinx0LSxaAwIUDv/g7LinnHg46xR&#x2B;&#x2B;5qMcKF/mVycsYaNAnjy6/jjPRigrIlZfi&#x2B;9JFu3gg9sVdlC1pk72SHdnP&#x2B;paxdBrONm3Z9crrC9eu2wKnO3fuibX2HDjKGGM7tmztXhmPdaax6tZNW3rSw3C8vLXziWfeX795F97VFFMdsoVfPHDggGq5vYLSHUzqEQfTbL6gp6cBeXTiOIuiAqJtAP3UNxcMcrA10Jcj&#x2B;MZbAHlBolAtk3qM86ORyP34H4zmcUg0ZQHqntESCQUGtC8CwQP134aVWguFFhhVV1fP9Tf9saKEwhsqquov/P71i5eEMxkFbYpUVc0oSkfH8r8&#x2B;8Nh3zrq0orJuelX99JlzK7910X9efVsnQUKhC0iRmyFRTdGeh24&#x2B;tLV3XHjJz6dXQZaA&#x2B;h9e8cvly1domgZBUWE3A&#x2B;UWw0peBhgdpBcIZ6SQuEm6lRIB5Ry6J6BY6XuhFjoYoBZfUZRcLpfL5dDQX9f1vr7&#x2B;x554PhZrT6bSmYyCqYJR6oDBHDp0iAmYmCIzivid2AiF&#x2B;1wjKDaI&#x2B;8NwRbSDddERcMNDvEu5gYtCwU42biOieQ6Fc1IEeVKJqY93qE1HLhVmpCKNeMyNoSi4X3PHAiseO55AnI8pmqJjoZOcxHE4kE5RJE4C5qTzopA/nBZ2Qle0BazuLpRTecBJEOeey/2KEwijjU9YoihbfbwOvqIeYlzVPRYYb7ICbMHLO3chcU1yabwsTBe79igiHm9yETbctTViYalPmFRiHzslBcZWKVexgdyygY9JI1Nna0vhO&#x2B;NJs31Z3OqtsLKzt72te99BkLiKnZ39n4R6QGG4bcO6dDyTUFdDWSWuhFt6ejKr4HRYTUea21Zv3EX72blzp0q8bwGpo5ocADp6i8JdNAFCrE99A&#x2B;Bu3IpRQ0E2xvBBkxsUM6BH1IXTqES0fTRG0gjpVrJevAsH1MwGxgmbAygbIKIFiQKHRDcN6BaHpmnJVOrXt9xdUVV/ysyG6VX10yrnnDKz7qab7/x8caintz8eT65Y0R2Jtj359MtXX3vr174xt6KqrqKqfvrMhoqqhl/&#x2B;&#x2B;q6enj5qmARG9viKKOgHrIyx&#x2B;XVd7&#x2B;3tv/6mO6ZX1U2vqj/t7Etfe&#x2B;N9NBOixkIoIGlWEB44wOcF&#x2B;I4tK1YQJyovqVaUUrS2QiEQfiMA/bqux&#x2B;PxbDaLMYgsu6ySpy9aHJmmmc/nUdIzDOPo0aNFh71r1GRxF4vEht5FqhdLFuzZuDiB32kY7kRWH0c1swtc5p5RFCFoLSbwZwoSxALi07k37kQubFOs7s5maQF30OU0AI80gSpfRZqSkSaFTmKygIMuNuWWplOy6rvMK&#x2B;967jJI5dioUCgUC3J&#x2B;URDsLKUtSBUGUt2ty/tx70IsydF4kzNMSlPsOE65cTd7jF/ChN&#x2B;898bd23F/k07xhSTSVLkdXu5U&#x2B;MKLWEI6ZpencFcNHCsd2c8yKbaxZKtz6NBItLV70&#x2B;aSL&#x2B;/mTVsbmzt3Hih1fWD/IXPtLjgeOXLkgw9CsR6wHRo9dOBQ85JYc6cKdzs7el57t8lYPeYTzBg7evQoAl&#x2B;E75rlrauQIP0Ytwfcc3Ur2j3a7aCCH1E16vIR&#x2B;qtW3i7E4gpx86USCBZGzwE02deI5ytCdi69F6rz0fGUi1IKj5Ah/ru4F4EgGNE5Og9omvbAQ49DJM2KyjmQsveUmXMvqPvJ9Tfd8etb7v7JT28LzP5x5bcuAlX99Kq5UPjyH//680WNihXJFHckVMueCmUkQP&#x2B;YJYDuGHy&#x2B;qOk3t97zxzvmv/b6u4lEEoxq0N8A7OwR6yP4Nkh4fpQNwNAI91Xgefv746&#x2B;&#x2B;9m401o4m&#x2B;1BleWdXW9syTSu9VUDzIMWhZwV0genJwuGWxUvCumHAHgK&#x2B;ZHyxR45AumqJzhtIqvtwWZgo4hcboe2LPIoTG3BUaIpDlXHiaDmJQiRxW744RrzJEOVXIu4XLzI7iyvYdw&#x2B;k43EbeVGuoZM2JUUCIjnJVxNQqLlfnywp4stAx8m0&#x2B;CtKx&#x2B;lHtPkASKeW&#x2B;zcqzk/gFMhixPDGXGGnKe3UF&#x2B;UjTi&#x2B;FY3Bi/P5x2RdJ23dSSJQnu5UImkuJA&#x2B;O4octgnIbhrpCQDG3yPrJjUfxP1jC8bwR5b8qlrhfozxyySVByFKRd81J7ES89PThtR6rEslvclo4958z2SqHP2IpSrM&#x2B;9&#x2B;w6uW78ZAwHpip5JZrbvLeGno0fG8vxuGso99&#x2B;riVZv2Msb27dzx0UdNyzsTm3eXSubNXGN4RU9qFe3n0KFDqqpCuB70iAVgCggVFe1oDoRIHU/BuBwqgpkQEDaokphCiL81Tevv76c6e9g60O0h/AEE0&#x2B;CSNHj/wMAA6NEBYsKmBEBqVLQrJDQQmsVT8QP01tgO3VvAvQIs9va7H59&#x2B;zg9Pmdlwysy5p8ysr7BS/IJF0PSq&#x2B;goQD6oavnbqhRVVDTO/fdGF37/p408W0SA/aOeTTCZRYtGJZwJq9AFbwxuOxxM9vX29vX0oBYH2HbC&#x2B;ZgX0BO07ykIgS0AkH5TTTNMELT6KGYZhvP/BZ4HZP/5sYSO6Q2QymWQq/ae7H/r9Hxf09vXTjwF6R/cAaAE2Llau7P75jbc/&#x2B;PCT&#x2B;DhcFrNsNnv06Nh3K7IXipKlqmv3hZUJ2BQJIbLVckl7JbIjpw18blmRr8iCsEGXM27YBbtXgxOKla5uUq4r0ZXY73Iv1qlTl&#x2B;vMhVGXI/GtTmDJO0Z8PIHn9bjATdFXiE5i3sANJSdsh4DeVqBYEgm4ue1xkmNJ77lp3RG8k2wgOC0UmXMgF&#x2B;5ZJjwVnWbUcdO1l0i05zl&#x2B;s3rC6vbJfQnHVZ3g5e3Bt0RXfa66i/CG15jzQuhlK3y84xdVcdYVT80eEw0Ps0wp29e27bs/XdTe05eB09VDq975qHX/UcYY279nz8cfNg2vLhkLbdu4aXD1Rj27Dk6Xti7/z9uN5uB6OD165GiosTW8Ikv72bdvHxrBUydgwMoAT1XLE1chcfHB9xQDaGokzibG80ETf9WK/a&#x2B;SAJ0I9xUrligQWuag4Q2UwZBEmqbBwKj/K3gb61ZKLEVRoHEwbaeGPfgUXPgdhOboDgvPjlIB3Fq6dNm1P/vd9Kq6r53aMH0mYP36iqqG6TMvnD6z/munXlhRWTetsu5rpzZUVM75&#x2B;jfm/vTnv1/4eSOa2gNSR9iNA0AEj28YDXJMO&#x2B;EWDW4UgJ09BufBBwFJACE4FMPnouIBXP/gw4Xn&#x2B;q9YvCSEHWWz2a6unpt/ddcTT72oaaV24J2bptk/EF&#x2B;0OPTsv1756OPP4/EkPJdpmr29/Zdf&#x2B;at/PPpsKp3GHuENQF&#x2B;5XI5bFnFmFUlyX7va3s0wlVmVOVArgtSig4IcB0PBOoXmXOOccooWoJ26K8WxANeUOCRxwEy2RhQdNvNdWJzTOuiktmcC63NfSelLcII34hIgteScrB2DLz99dUf&#x2B;1aKT3L9dQC3ih86BbCm6kkJ2mgpErOJFpKaKBEpSXuBSpmCPi1y2NfcRSjmOC&#x2B;gc1/ctVVR4BF7IWU7kjHJno&#x2B;MaySTiy7Iwd7zk9A2UjQrlndw/TknLY&#x2B;Vty7nYsKRB531zmSBBCh9nndCOnXvbOwa2bS8lTupdtiy8NIl3167b0tmj5QfXMcaOHjqUyw73dpfurlm1ZtW6rXG1pPLftmHd4PDG7ftsMlihUAA0Cap09OJFn1Q0iUHAilbj1HwfrmAeXGrTAiFBVeISAN7GaKCPkgM2mCHpwFATD1fQ65eGoME9B9TfGxahHp0OAEZLxRuDRLinPgk4gEQiASA7k8m8&#x2B;dYH/tlXfe3UudNnzp1eVTetsmF6VUNF1dzpVXNAJDhlZv3Xv3HhRd&#x2B;/4YGHHm9t60BLG4TOGL/IIAkEMBVXKpVKJBKWPX2JwJUWjXnwcUCdT3cPcE8At3FQVMAXAsISWPPj5sbrb7x/dvVlTU0RtNVRVVXXjda2Dkg6huKcruvLO7vuf/AxX82Vp552ydnVV7z73icgTuRyuWXLVlzyg5uefuZlwzByuRw8FBpoaZo2ODhYEKxo8MBJhmdC&#x2B;SJZDjjYDcQhy6K9Om1NRNuo13PhnBy5w30mY0cuAgA3DBcjWxcY4yQRMWGN9rK2lgUGjOeT8hbc77r0dYKRsXt3DovLFH1l6CRxtlPG4TIt8Yq7Uh&#x2B;TidCLYhUnu2eQQHAvsmxkdy9zZmJl8GG5N&#x2B;YypLJzQ1rAXZqyM4hxdO3lihtNuo2HMzmpSSaFXJ7a4y3v7829pLsMLF4XtUTutXCl4di0KKw69UgLiwfSxieNto1l/soPftHS1rt&#x2B;QykKUH8yl1Jyuw&#x2B;UOl2&#x2B;tMfIrt6&#x2B;&#x2B;yCcrli68tNwHxwf2L0znda7ra0DQzVioXZj2BYFaGRkJJlMAkaHHQCIAoT2KghVVSskP7rkYtwY1bLs10kWLVTzq1Zu3QxJJKxYKQVoeQxHgzIAlQpQt43uCiilUCEBjPt1Ej8nQ1JlUcsiaArKq8RbAO4CXles2Ecaibg/MJD49/Ov1V/4s1NmgjdwHYT6OWVmw9e/eeEZ51728xtvf/zJ58PhWCJR8ojI5XJoTYT&#x2B;BugDgLZSaJKkkYhA&#x2B;IwUzUMOLxQbsBHcT6B2/BkrjCmG80fjH5A3YJCv/Oed84I/Rh8A3JPJZJREIpXJKCgHJlOpBx9&#x2B;4uJLb3jo4cf//uizgdor/3zPw&#x2B;CWYJpmZ2fXJT/8xUsvv5HN5kAUgefCeKCrVq0SwSi3LBaLtvXRMqO3TUMRVeMVCt&#x2B;5YkViBcRNOyd9jbS8iJgpui3ytkZj5HSRvgGuL45rOTEx6RMxB7LdcgitJmIV6chpGRddpBcYU36oZAz/z/D3/7PH&#x2B;fIT7wOAxy4I2Eu7FHw4zYqyPYoT22kLAsvTAmKDLvEWvbIJ2cjdWnBWihRdtwg8ojT3iuLC4ELutuku7NiJXFRHE6DjxBoKhULRWbZx2TnhOXK54FFclXJrgORXw0&#x2B;64MFtpmwBJlu/y5ClhiwWi2zSQ39ylFXZQC87epQxtnXrzk2btw&#x2B;vKlnyDGXzg7nhQcvx99DBw42hFQfBWO/ooU8/DqWUIWwmkzIWt5WcgNcNr3rr7cZQ29juAWPs4MGDmmXEr1pesAjuAVYiFgcQDxSPxxGa03D&#x2B;muX1i0gdDVoyVkR/UGxjrHpqskINdajpEQfKaTEallSxMs7imFXi2ov4XrGC2aNXMQohiLwpaVZwfd3KGpZIJD/8aOGCv/7z6mtvvfgHNzVc/PMf/OjmW26795F/PPPue5&#x2B;0t3ek0mmUQ6Br9IIACI6YGL114YWgIZBOHAMQkWO8Jorv6UYKPD56BWBkVdwbUa08ABjJB0Wvfz33n/PnXNfa2kH9hlvbOh546ImbfvXnBX99tKNjBfTb2BT9/mU3vfveJwMDAz29fX&#x2B;8476f3fCHgYEEjLZ96bLz5/zkpZff0HUddgBw58EwDBBdpGI5ZdccxGd2TuKERznmULQTIyAVV2d6LI5qXOs&#x2B;I9o6bvWxnAPdljxRDSdeoV5z2L5HSI2wxAXBC4/vKACIj8m1xsgPV1ZIEOu6FJiU1fAEbyZM0ZeQxgQApylRlqhaQpRKue&#x2B;eI6knk/iJi1IEx/ImMHJxHjrpM9xb8HjRKReYyHE8tina8TvtokiG7krHI0ev&#x2B;3NJezz2fQARo3spJiXvdcUUNk4VXWJtcXXHPhL7Lr&#x2B;4OHEDcxqAbUJ5mC8iJhCQwWTLA8MG27yJ9ScYY4UC27vvcG9/SZG/ef36N99ZMrhhL5xm9WxfT3LPYcYYO7J//9LlqceefkvJrRsbsHUwcujQ4qaOTHYt1xV47qIhPuBLDA2JV6itP0gIqJ4HxIlh&#x2B;xGIYwugA0bzG7gLNv1ofkONbQDsogocG0SJAo1ecJ8BoS06EnBoXiNRhhSSHguhczKZBLMZ3fIQQOCOLeAjQK14PNHV1bu0o3PZ8pUrV/b09Q2gDKOSVL7wBjjgDpp73FsQLfhRONFJkCI4BrsdfEy0/NGtXL&#x2B;As7E7lDpoTl/VCjeUtujJp1&#x2B;q/e5PYi1t2OA77370/R/eNPt71wYvuHrmaZf845/P6bqhatrf/v7Mb393bzyegFf68N&#x2B;euua633X39EGPoVDMV/Pj997/BHcn4A2g58OaNavFZY6bs5y2i1OHua1cQkQg7n/Z1RMZDk0TRldMF8bCnTqJNCio2HiLTOGCzhKiQlAkcREXS3K3RGWliOnF8mVHMi4cIq0rHedk0RT6nyLG7QBQgbtAiMkM&#x2B;qVMRLTSowcu37qLPp4LjEMHZptjrnpc6bE4TvdRla1Vtnd3HOwOB53w4riUAV4Kj9d1QVzDvlQkfWTvm7Bl9fpiLxOQSLk13nsLBQ8aI3cxQKrHclJrcehfWndyKNXPhrJspMAYO3RopHNlAn0ABo1sY2jFoaOlHtet2/zW&#x2B;7F95FfK5dYYX&#x2B;xgjDFW6O9NHigFAWIbh/OvvL6IywTMGAM1fzweB2iuErt/lSSowjTAuD&#x2B;gWl68WFIn4fMB6qHJkE7M96luGwUJeh0FAMTEkKqWwnFFSOgLMNe0coTRnQe0pNetYJR4BTE0hgRFQxrc3KACg2Y3u8cwl4j4VSsjGPoMcPIDlqRbBLrlmYCeAHAM2w64UQBIGsPvcL4Z&#x2B;B8V/FAFhTd4cNzVAQ29auU&#x2B;e/zJF75bf21HR6eu69lsLhxp&#x2B;f4Pb/zzPQ83NUffe//TuZfc8Ktb7o4nkvF48qZf3vnEky8Yhgn2UY/8/amf/PS3K1Z2d3R0fvLpkocfeeabp1/y3vufwFB1Xc/n8zgYTdPWrFmDnx&#x2B;3luHyKgoAtKSoNsKK1L2Y9sKVd6KyKV/cm&#x2B;JUA&#x2B;7D4J6Cgx&#x2B;0Fofs8Qp9b1TCcRq/VMAQn4jDQtIHkfJeUX6Tkvjzccfir8w16H2p9c6cv4TL9xQdV3I0ASKT0/ZNUDsEZv9MpV9PWfDtckuEQYVCAYbGLEzMVaEhDkZGRgqFAsZdEZmCqC3AB&#x2B;SuOA3b&#x2B;4OMjow4teOFHZclsZiLgrlQcNM9lx0SlQy9jMSdjmUkE6BJ4XHuo3JZ87gC5Au0rTFcCzS0rthUsVgs2IXksqMtFotUZe8ul3JlipNq2eVISj8Lhdmho4yxQpH1x41oS8/w6vWMsZ1bt7a2DwwoQ2V/yO2bNy1pibetKEUT2rRu/bqtewdXbeCKge4ZkLpmBdlE038E0xCyM0Py76qqirZDiqLQmD8aCQqE&#x2B;n4E8YjdUffvpM6nOnvOxAigJ5rNoMgBenHFiosPeBdwvGaF30HxA/9jOEtMZ4bYGtqncXg04nhAQTw6Dcfjcar&#x2B;x0xqKAPQnQdUjWtWzB86KvT9zZBkW9CRaZqwW6JbQYQg7A&#x2B;kYkATf3QLNiyCjnK5nGGYyWSqc0V3JqNomv7IP565oO6nnZ1duq6n05lH/v7Mz274w/LOLl3XU6n03X95&#x2B;Lrrf9/d07tiZfdF37/xkb8/k83m0ulMf398wV8fDZ5/xR9uv&#x2B;8nP73t3MCPz66&#x2B;/Kprblm8uBk9jEFMQsFy06ZNjIjT8B3ikuoE&#x2B;ywBwFaM09CJSgTk1biuFex5wYDEU3FZd8fEzI4HKDfjOJsIHuhLADOfosy0yWmo9vcjuSvlZk4onMlYNJB7YED3K5TKonkHMOZY3omchnHs62BhnAv9FH0Jic8ELD0VeQFOA05QprIBd3F0dJTJ7ASwcS5VoXS4nH1F0drxlA6ea0oqMDgVdiHpZkXZ6eTEMZ0KWxzqmGapyOaApB4UYj44GIq0rq0XonlyGolcLjr&#x2B;HGRSoKr8x/X203iRbJlsnE4rDXNet4oy3wAnlRLOHbFrUR9WJEo1cZU9LvJAVmGvv8b2H2aM7T9w5K13m83sqn37DjHG1LSyrH1FKrtx3&#x2B;ECY4xRq&#x2B;KjRxRtaN&#x2B;&#x2B;kkNwcXR049Y9&#x2B;WweXuWBfQe27tyXHFC44QK8hjCampXfF0CzTgK/ADJGd144RTiLlv1U6Y5qZmqLj/ZFWBhbxrroTwzoViFhMbEWdg2jBQdTRPCmlcUWu0ZpRAwWhDZOqFkH1I4afTSp14izMgJx3crpC&#x2B;M0rEy6VLtPhwG1YOMFHHmpyh8eCsx44OUAjAbrHRw8qv81Tevr6&#x2B;/p6YOLaHCFGyPQOA4P3Iihl3Q68/QzL99w0&#x2B;1dXT2Koj78yNMXX3pDV1evYRg9PX1XXPWr&#x2B;&#x2B;5/TLWiBt1z799uuvnOeCLZ09v345/ccullN73w0ptPP/vKH26/LzD7xxVVdcHzr775139&#x2B;4qmXPvhwYUtLO&#x2B;y1ZLPZwcFBEJxyuRzsS6xbt45bUqXCACOmMtzyigvK6OgoVi4QI/6C4AxAO6LfP1nleS07rSKF4&#x2B;J/UbRwWhxxJE7gWzoMsZjYgjjOssS9eVoLr3AHTv1Ksbs7tnFnwuKpx2dxp0nRhX0l6LisUP8vqLQDQOP3o&#x2B;YYIw/YPpSijQuUrlkzH064u2NVZWp1jx86NyE52C2VPdzZkJevn0ZBxdZsJknOLk20I5HBiVxGOtqyg5SjdlkBrmWnUy9EeRlWn3CgfS&#x2B;T0yOMpiSNozyuFpxqeawrLrQiiTGyikWbMYBLC066LumwpbfcZYNiEeN72uuOU9c1QdoyzJZ3weHRkcLg8Pre/pIifyib/eCdz3uSg3C6NNq&#x2B;aHHb&#x2B;o3bGGNH9u&#x2B;Nhpe98HYLDqinq79xSXvJCOjIoUxaV/RVXFfZbJYm/MLA&#x2B;ehuq1gRexSSUQuwLIQPQhMXqtjWLMMhqAgl0QGAQnnU8YPqHeE&#x2B;NdShmwnUWAhdBTi1OkoO6NKABkIAheGRoRgGAkK8TqNtmqYZj8cxkKVmN9DXiIuCSpwQ4AoGUMI2oQBGFjJIxi7cCsDHB6lDtaIPAehXrUCiyVTqw48WtrR2zL/v0Tv/9ABEHEK0DaIUevqib4BhOVLDU9w7/5Gf3/CH/v64oqjz//roj3786xUrunRdb21bWjf3p08/&#x2B;5JayuGQmrfgHzfdfGdPT5&#x2B;iqA889Pipp11c&#x2B;a2LTzvnB2ee98Mzz/vBTTff0dgU7e7ujScSupUS2LAC/&#x2B;OeA7S2detWceKIoJMJiyxe5MCxjcgtacmCYPgnag3EsXFY1mkdcRk5LtOiROFEHDOULot0PBNj8mXLSxuX/l4ux&#x2B;6tjWs8Ujr2Z5&#x2B;i/zU6iTMUgWk2KrMo4ACHy4RnXqRkV/GAsgm8yOlEpfCo6EHNz1yZlyhpSAfD7G/G6UGQnNL90i7wtyjaObjTU3hRgUg7dSexWZfGj1M&#x2B;Qub6&#x2B;OPia9gOebdet1PH&#x2B;3TeoTB&#x2B;zJJA1K47WvxFhxgg0qnhNE6nwlLMcYJkADPDjCyz3s2KruTS5QOlBy0UunrVtFHy5V29ZpOq5z9c3Amny5fHm6PdO/fD6x3t6&#x2B;qPrDCw1ebQspbOJN&#x2B;VBRZRGY&#x2B;bABRJ05xfqDKHMqhZxwKcVQ9g3Hg8DsAXbWPQxobaDiHIRhGCugUr9ng&#x2B;KomVqVlxh9BuR7MscKh5Pd060EiKAwzOo5DYoBoxRlItl2VoCmG6QWL5a1a&#x2B;MLwIUJg&#x2B;EaJ5&#x2B;I8JDaCFwcFBaBOuwxPBJgCWh12L9z/49Fz/Ffc/9OTcS26at&#x2B;DRRCKJcoimaVgFGoGnMwxj5crup55&#x2B;sTnUksvlUqn0XX9&#x2B;4Be/unMgnkinM/MW/OOqa27t7u41DKO1demcuT/91S13t7V1dHf3NjZFf/rzP/zxjvvSGSWbzXZ19z7/whtPPfPyhx8vCkdafvTjXz/2&#x2B;L9VVQM1P74W3NZQLU9lXdfz&#x2B;fyOHTuKVsIvXLOoro2CXW6hKVhqfjpJ0WbGBSWLCxanrefatMq45NUqOtXiyEkbKD4yfTqXZt3kH1KAlnQanoM0NTYA2YOXeUZ39svsP4cLlV0f3YfElfSoVZwsmhI/vvxU2gGQfkN0znAKe4pZpRXLahS48sw&#x2B;pcVPRypmuAyeXnf/EPGuKGC41JpE4rgP90rtGw4WihUEGPGdc&#x2B;R0d8IKEo9qjAlAw2NBkxOoWxgdKfMSXNv0rnfx8uk6LVTjinPnMgbxLrdSiku7dPKWCh&#x2B;/ObJtC9u&#x2B;kW3eBmfLV6YiLaUNgW0b1i5pXJqxFPnJvkQ8rg1vLLkIHzl0ZOOW3eD3M3ro4PsfhNs6x2x&#x2B;jh4d6elXuUEDYkOFOmfooll2O4CS0SoG9dxYEbXLqNdHaE53CSiIB302eglbXgOSuD16KepOnIJsapIE0guVDbALNOLHflEtDV4EAJTRzQB01RoxyIFXkUgkTJJLCzcc0KIGxgy1oAAEwUTpQrccplGswn7hidCBAd8q6u8BOqNdk2maL73y1s9u&#x2B;GNTc3Th502dK7rQskjTNIzZD9sXsZb2gYEEtPnxp4t8tVd/&#x2B;NHnmqbF44k77rr/up//Pp3OpFLp3/9xwQ2/uGNgIKHrRvvS5XMvueHr32j4yU9vu&#x2B;EXd86Ze91p5/zgvvsfVxQ1n8/ruo5bNW1tyy76/s/fefcj2HlAsQc3HDDOKVxJp9MgADCicUMcD99k0e6gL/7ngHLRbvzD&#x2B;OnMsFlxOhdIXasxfjWRhvcQR8iJGQjomf06bYS7yNG4&#x2B;HnRIUCnOzMUX6/HkYjvtmwvQFJ444SR6C/u0v4UHTv9D77hk9xvi9IzN72LggKS2RkQTWk&#x2B;MYRKC7ijT&#x2B;&#x2B;/n8eReOE&#x2B;LvGL3HmoUzGOEeAL9FjdfYQcZ5&#x2B;sLx7bQZdrlzIcSX9EsK2Srhku8t6xSA5lqWzjTiGwyrbpJEp59Bqnc5MG4XbvlNsGEb2QaQsTWB0ngQ7sZbv2M8ZGRll/3Mjlv4DLe/fsyxhrXnr1s137RxhjRw4fXba878OPQ4eOFBkrNn0eXtY5sHf/UcYYK4xoxuojI6WPZ&#x2B;/2reFQ&#x2B;4quFNfPmjVr0JAdsTuARbDbQe01GrSAYh7KQ/RP3AEAC/6BgQHA1mB7Q1E72r0oJEUXtIzqdjjGCDwKyRlM20H3ZRQVaDuGFf4S1c8oFaCkodgjBaGgAmiV6q01TQOZQbdskLARAL5UZIIq4CFNR45vElrDvQIYBuJjANDpdKazsyujqOjyi88FFVPpTFd3LwRiQgfleDzx8n/efv3ND5LJUsTPDz9aeOElN3y&#x2B;qAk6fff9T2q/&#x2B;5PGpmgul4snknfcdf9vbr07kUgmU&#x2B;k7/nT/3EtufO3191997b175z96ju/yr50611d71VXX3DpvwT/efPvDtral&#x2B;FvAg3R19zz48BM33HRH/0AcgT7uVOBGBzwdxAIyDGPPnj3Mjuo4mbxo7Q/Qu2Af6L48cQUKZEuwWG5zgJv1HF8qCpardPDi&#x2B;LkRjgkDpDUv0NzjIlUQtkqsRsa2TbBHfBDx6bimmOuaLkIj92XISbMpLgFlWe4UTdGx00ncF&#x2B;bEj8QCRWJs4zJDnL5jJ00nE7Qg0mHQkt7nm/fkXy40XhOjYzSSwda8xCTl3qpHDOoekB5JGmiIOXPeE0zcRyi&#x2B;NCe3E49ke5muHsDj0gzhkLAYjYDBPZTLjyuK6PTUttQJZgbYPpakn5N0WZJWLPuY46BNwyzWzNZuYIwdOTIabe1554PwkSMWZygU05nBfUcYY2zb&#x2B;g3bNm&#x2B;JLc&#x2B;AS3BaW93W1rU4VNouaGpeauYg5GKhLbb88yUdzbGeweF1tKvBwUGwzEF7Hs40Hw33qcUO4mYooFum7dQaHspgpBpoB44HBgZ0Ibw9bg6g7Q1KCNQbGHXk0CAo/uEWGroAgW8uNo6mOJjxAJ1ldSt/FuxIUGlBI1nANBIyCMUkjRjxa1aQUOo3DLsQuLFAn1cjcUhBAIAhJRLJl155&#x2B;&#x2B;prf9vevoza0oCKHa3qs9lsIpFMpUtbB7lcrru77/If//rBh59Mp0se2P959W3/7KtD4Rjsz7z73ifn&#x2B;i/7bOESwzAGBuK3/m7eb2&#x2B;7J5NRFEV54KEnKr91ydm&#x2B;K7995vcvqLv2xpvveviRp957/9OlHcszGQXFFcMwMhmlt7f//Q8/u&#x2B;W2v9R899qPPl5kmlkQmTTL&#x2B;ggO4FPBTRKQkfbs2UMnmjh9EK1iVDo69egM5eaNqFOg0B&#x2B;oYNfc0zIOs1hy1xr&#x2B;GJviWJZ0vS7KBBinJDn0oOig3ReXHo6DyR5H3pGURD7sEW84/TQTGMMUTdFxIj4KkEhSMV0q7nvHAZTxYVNSRbUT52Kymc/37iDbFGV7EdY8H7PClzpCiMSJTB5topil1JdcL&#x2B;fX607e0W2RaETGJRqdeGYlf1HlFEgiSQXR8Q5mDBwXygTMdqIJdyodhrQwB9ylZSQruu2VSgAKN3OP47p15BDLm2zxYjZaYIwNxLXWpf379h9ijO3fufXDT2IpbTUU3L1jxxtvfLYsPgyniZXd/YlsanArnO7fvbuzKwW2fbu2bn3qmXcaI13rN&#x2B;&#x2B;iXa1evRpU9RgFSLei3QPGtSBpAr1XOat9ugOgkUCiKC0A7KMWPgia0dYFSqKnAYwHdhhoYdygUElYSTTvoQpyzqAIjYUUKwUvjg3talBoQSxrkEA6iLwVK9Y&#x2B;lEQ7e514&#x2B;uqWdRCYxQO4p/sboqkMRu43TXMgnrjzT/dfdsWvV6zsplINehSArLJiRfdf5j3y9jsfQ&#x2B;B/TdM6O7u&#x2B;W3/NAw89kUgkLQHgncDsqyORVmj81dfe/faZl7762jvJZDoSbbvsil/ecddfU6m0YRiNTZHb77x/3n2PvvTKW9FYe3d3L/pOoEiTz&#x2B;cNw2gORa&#x2B;46je&#x2B;miuu&#x2B;PEv333v41Q6gw&#x2B;OFlbw&#x2B;NR3HLMCww4AY84QliymUg2LFMFTWEzrcrzCKTJEWabBkZiiB6/b&#x2B;FKRH78L12KeGbvTIs7xNLEXp7vHor0q&#x2B;94mkVWWbWoCK&#x2B;MU/W/SSQW7bUlZ1FsUFMb0a6OMBmejmBtVMi1lagMsTGPzF2U7D1JpG6IY0YvcxMBx0j0H&#x2B;hSFQmHEit9PHwoMXbzPMZHz0sd04obShCxepAIax4k2yC0D3tkENOhRSHC6Pq7cW7bPwPt2ijcXcCc6fkzT5UPlyriU5HzEaRn6xY79yg6LHwfrpaFmHUrysnexWHIInnxJYN8O1t3BsqVQPyu6kt19KhwfOrBvzebdm7fvh9PNqwffeDe88yAMoLC8oy/W3rfLOv34w8ZPP4ts2r6PMVY4fDBjru/tTe08YPtI1q1bZ1ihMMHmRyVxftBWBzXZaDkDgA&#x2B;07AhqFUUB8Aex8KmJP9rbUF9V1Z5MAIthKmK4BYE&#x2B;0VQJ7XB04lmL8JrGGhI3EDjZQycJhrFH3coXBqIRbmXk83kqI9ERorIfwTpKIxh5EwIuoaU&#x2B;XIT4nrlcDnYzYANB0/Sm5kg40qJppQRh2WxWUdSVK7v7B&#x2B;LWqbKkMXzGuT985dV3dMuNuKOjs&#x2B;7Cn/390X/BILPZ3IsvvXmO7/LPFzVrmhaPJ&#x2B;67/9HKb18895Lrb/rVny&#x2B;69Bfn&#x2B;q9Y8NdHwX83m81mMmpvXx/uXYBcgfIe6vUbmyI3/fKOJ558vq19GXgFoKiTy&#x2B;XgFEUaeBto/5PJZA4ePMicVwE6kZmQmQsMgbjJyLELUUMnrrxFYiBEm2KS6TzWo7g/L641NklG9oxSMYDa6mAxJxAiXuQKALnwW64RsbD0tGjnwNLyXrg9V8AL/zy&#x2B;CpcpOlH0pZLNxnwAaGh/JuNHTGZyI8EEVmEpKHcah8AL3LgbV0YEsiJCohclrKowKkXb0k494uaijAu4vAHxlpOGg6PR0VGMxE&#x2B;lI4xhSuUlKcdxfyLvXAzhqcd8C7RlMXq0SMduTOWdJNzWvv5RmsDAnOypPBa2RiTR2LkvTk7tTOy61exxWJb2bGfpDFtbytobjnU1hTpHobfRkbalvbv3HIBbedV8/6Pw4LodcKrn1m7atGVwzWY43bLjwMBAeklrHE4TKdPUs9v3HiE9lXwAQLs/MDBADW90K8q&#x2B;YsXxpNAfjOZRPKA2OQi4AVXTLMKIkmnsUbgLSBENiuLxODrmotRBETxVqKMFEdomQYNouE93D9DgB3pETK/Yg4qi2T3KJzSwJlwE&#x2B;I5dwIOD9wLKRfikGKATNeWYVNiw8nkpVjoCGDng72w2axjmhx8v&#x2B;vmNd8Zi7QCmc7ncws8bz/Fd/tbbH8EeRTqdXr585QV11z759EvgB5zJZJ586sWqb1/8l3mPvPHWB/MWPDr34ut&#x2B;fuPt113/x0t&#x2B;eONtv5//7L9fW7q0E8OPwjuBnwCELk6wAcmqp7c/nc5omo5piUG2QeMrdAMAEQL9KEAqOHDgAE4lLgEOBdZwAJxcRM/8qle6bqsuFqaaoMLYwlHGx0y6yIoKCKwiRatFYr/E6TJody7rkXdO64LmvSzf3tELJwh5X&#x2B;JdfPO8VJ&#x2B;iKTp2OokGki/rZioF1uIVTo&#x2B;O12mwMychgTkzhbIlHfGxoISQakSYoKGngxQZipTFiGPgnrpQkCNdrjpt34Xrjf0io6MuvyDXjsvLF4ckHnsB695pAk15qeKREXv5hLyTVL6SjkTcaisWiy4u1Gw8cF9UblmrVLFI0gZL56z0hfwX1p6De9lwjmWzcNbbry5u7ty2vRTqJ96vLIn2wPGWDVtCjW0DeslFeN2qNe&#x2B;9s1BbtY029sXmUsV1q7945&#x2B;O2Dbtt8b6GhobQ&#x2B;Eezcn4hjEbSSQYABIKo2kcQD6ICauihqXQ6DRZEOgmND3AcISMgZuyIquFpQCFU1aNlPLUv0qw8YhqJ1Im10FWX5gJDKQL6gn7B4h&#x2B;Gh&#x2B;ZMBolxpJJUX&#x2B;BsgLZDdNiYLgBHqxNPBhwhgm/dip1vmmZvb3802pZKpU0rH/ALL75xQd1PItFWfHULP288c9blb771IQgP2Ww2Fmvz117xl3mPDAwk4onkx58s&#x2B;sm1v539vZ&#x2B;ced7l3znrB9&#x2B;tu/aee/8eibR0dfUuX74yo6go6hhWeFPY5QADHnTkhefCDRCNuETjBwOiEYYfhbronADCDMgDhw4dYrZliDFecc6oxp1OQzETsCPXkm3fkZu2ZRFOUW3kncdS6aVANuppI1Ra4JYV6XWuijgk8dRJ6mDemFjZ5/WyNBzjwjRFU3SC6SQOc9AZy4goL6L2kZERJzZB5QRuegNILdpDHAhbnHLrlwIxb6BdeHHuxGIi6JEGb7E9l4MKH47xBUq74EgqdWB1bmxOUpbIKKV9SYchFSqQcYvyA/2JxwWOjxFJT2Ljx3Uk0hWOOUwK8fU6pfsdl2xGL9LxuCz5zsV41T6VhLky9o9ZkhzgWKm/iyVLZj979x1&#x2B;&#x2B;dXPNm0uqfmXLevr7tew4MDK7vbekqiwfvXqUGvffkvFf2D3Tjr2VH8yo67ifoaNGzdSe304SCQSuBWgOITeR5U8AnTFCtWPxahjMYoQaOuC&#x2B;njcUkDpAkPpYy006wcET5MVqFYIIN2yvMeSVIHNVYfkxyixGFaEU&#x2B;yUyiF0kNAv5DjTSYhPOIAUwqDdR8sfjISDkgYegNkMQGryaOoDDz1&#x2B;y2339Pb1o2XUE0&#x2B;9UHfhdUs7lsOQcrncx58sOtt35Wuvv4uDfPOt98&#x2B;e9QP/7Kvu&#x2B;vMDt9z2l&#x2B;rglQ0X/eytdz58&#x2B;92P//Xv/3y6sDGRSKKoA3IFgn7U5aMBj25FMtWItwMcAGE78KSDg4MoRUAjWMw0zaGhIWj/8OHDTNCIi0gaFwUpgC7a9OgSuV3UR7isMpRBceVFJsC5JjtheiZbxOmpqKqAQuJdl&#x2B;VMXBbFwtwq5lJASu4M2fsSI7Jl0bDTIx3Xde3LSf&#x2B;Dj3y8iQ8DKgrWcIDTBmkMdtsVz04/UkHwOKR3ndA5J59w&#x2B;NVpzsNToKTBFZMa4ju9AbFxTm5xaUEcnpzfCcTp8svicqp0kTbokbg1piDYobqMeWJ9OflMH8cA86T3YyHum3d6LdyPIgpg3CItTgHx2GlNteF7CXBnFtKwaRDHxk&#x2B;uiIkmxGcZu3LMH56cNm/Cw5XdmQ8/iY31O1roj&#x2B;tUeMLhHtx/cOHC2OoNO&#x2B;G0JdT&#x2B;SeMKrBdr7X3/g8bu1CDtZ9OmTVQXjjgYtdqIdEH1q1u29RmStRd121gLr6NDLdZVrKS/1M0XBQyApwD3ATuiDh7NeABPo9Yf/0NhGAO3k6BpGgB9VLRrJGY/BC3FHQl4asDrJgnhj/YtOvHlxbdnkHy9KEWIWBl3A0D8UBQloyifLWxc0hhWLbeBZDJ12&#x2B;/n//rWe5LJsTCsTz390kWX3tjW1oHyxvsffPaN0y/55&#x2B;PP9/T0RaJtL7/y5o9&#x2B;/CtfzZVXXfPb6porLr38V/Pue/TzRU0DAwOGlUEM5A1FUUAfb9kXlZIGqFY0UpQEQAxAUQFjfaKEgLGJ0NcZusCQoHgK/7PZLKjPxr5nmQkQnW7SqSe9jhe9rG6c1MHsEx/vShcgejoqZDRnDpKAuKbQRUeKy4syrz8nhzQXjCEVh2hhdzYuvT7eYl7acSozBX&#x2B;PH/3PvtuTpDMHqOxLGRkZkc5wrhhyB1GHQU5tWn&#x2B;RWYjASLwi5VaivsQLlbWGcrrroo0o27tTgaJMeey9C&#x2B;4dukhraGzKOXtQ6cXLU3j0AeDIi32nix7oOJELyy4U3Abs9FtwoqAwFySCFv28vffF3XWRD21LL&#x2B;mLq2JdJBzDGWocK40cYlqGbdgAZ4mkYebW7NhRsuRpaWpJ66tGrG6PHDo8VrE4uu6LjdpQSXjQsmt37dixZmNJHlC1ofVr1n8a6qVdrVu3TrMolUphHB7VMtmn5j3U0t2wTPmpaT5idLQg0qyIPSgzYMwf3FsArTk2YpDYO2AyhKCcmtHDNgKCby7nLo6cuinTiD1UBkDtPqj20Q/BsJIJAEFTaNEO9vpUSIBR4dvDkibJHKxZvhO4R9HSsvS79T995l&#x2B;vQDuQBOB3f1jw29/dG4&#x2B;PZR97/Inng&#x2B;dfHY21Q5sDA/EHH3r8a9&#x2B;46LzAj6&#x2B;&#x2B;9ra6C392ru/yiy698e13Puxc0dUcii1btiKdzuDegmHF5s9auYfRUAfRvGEYkIo4ZxEKRQjuVSu6EcoMmhX8FFrGZMCaFasUvUogjhBlsBwCLsg07kVin8ORyEnGVjrcnbO3j8U4GQP5f9G&#x2B;549UcI5ASpvlwoRIV2Qp3xBfi3TVRqhAGaOoARTflVQNx5GT4MS9Onpd2o6XVUm6gvzPgtEpOvF0EhNce/FDF5XQlD3RPUf79dIVJlMwMOfvmxPuxfGIJOUXzD5dxVE5Ee2IqjS4aS&#x2B;Oh9rEjwoBK6VOCLRBMQaRO9QuC5Sd1OreT5k3XonED9hZ9cJ15KSkmSyadG2KdDFz&#x2B;UTLkhfsLsps7mo8p2ZxaccrtDyvCxTFP2e1otsTTpBGWGwJW7kSTnRjeHjV&#x2B;sHh9XDa2tH3yaL2o0XGGNu7fesnn7Zt230Qbpnx/rffazK/KCF&#x2B;08j3dHYnzVLFXHb14iVLN2w/QHvauHEjVbGjGY9mmc6DRRCo1dGKBgogQEfTdhQVFJLUFu34Aa&#x2B;j56tu&#x2B;dHirgJkmVWtkJFccB7Yi6Cm84inAXeigh/HppPQnKizR2yKpj6ovOc09&#x2B;CDC2pyaB&#x2B;V9DrJEQYCAyJshL&#x2B;mPXMwSAUtLe0vvvxWS&#x2B;tSeFhFURqbwudU//DZf/8HRYVUKn3zr/90x133x&#x2B;NJyy9Cu//Bx8487/KXXn6rrW3Zu&#x2B;99cs&#x2B;9fzvXf8VV19x6/U13XnzpDX&#x2B;44/6nn3mpfelyTdPhhRtWNmKIzKNaSY4R36uW4T7ubKDVPj4&#x2B;lEc1P26A4AE8bz6fh/cDewt5i3TLH0C3giCZpjlqT/0rZb8cOqcH4n9aEUjUuOEyzUn1Yi9iX&#x2B;SUV5PTwUO/XBUXXsT1xQk/eCxGH6EVvUB/6QC4Kk7iBK3ivn5xLY&#x2B;LvNc6Pvz2f5GmZK2TmB1kFIUM5Gz8KKpoaaxFRQJMNpHricKGe&#x2B;8FwXSSw&#x2B;7SEUpBrRTWAxeTAndpxFJaqyxAx6Ywxij2xel4pLZA4iNzz8I9DhfJlGtfOjDxFXG/oxNJ3617GY5oF/g2XBQt4xrPMZEMN7NjZiJOkN1l5Dg9x34&#x2B;18ky9iVLQv7Jfy/uQ7JfL4oRro4LJ9UTLJ&#x2B;DwwMHj3yysGX5igScmubw0mW9ew8WGGO7t&#x2B;8YWrtNy66FWzlNW9LYpuRL4YOOHjy4qGl5dv1uON23c3tPn64Yaw4cHnvwrVu3ItY3rMCdumW&#x2B;jxF&#x2B;KFhHvE5z/cIBVsGKaJkDpwZJ44UWOzqJKQQl0ZQImsJ&#x2B;AW4mEgkMKEQN9FXLlRaDhGasVLsoeHCDMQwDw92gPIBbExD7COE&#x2B;Yl94RdgauhejeY9ipU7LZrMoh8Ctp55&#x2B;sea71zSHYnAxnU6HwrHq4BUvvPQG5h5LpTI33nznb279S1//gKIomqa3tnVc89Pffu3Uuef4rrig/qdnzfrRrMCVf7zz/misraenb9myzoGBhKKAmJRevCQUibZBzCIwwYLeQcQyrdQEYPpvmubg4CAUQNkMjPhR7MFnR0CPVkO494JWQGgjBIgfngi6y2azq1atGh0dZQTycguZu5DP7Mu0SHR1EAM2SBkOOR7bouQOxBa4JZKKHE6BIqjYI23ZSVuEMow4ZqcROo2TI5c3yZz5s9iRy7ov5ZNSRczEyH2Qx0Lewy5N0VeRTnL5gd31ASK29j7fsLx0YmB17i6HrbljF7WER&#x2B;JakL4ZOrYjR46IBZid70jFEpSCpBvBzML9IsvzTjRynAvnKkvuvR89epST7spYi3oQD45lVF5&#x2B;QS/teCzPLX7yTov8ByDyffFn8i44OcnJ3O/CrK/OCQ2IjRcd9gqYbYJ7mvITpPBizAMAlExn9&#x2B;47yBjbvWNXtCO580BpeEpKSyc16P7IkSOR2PJwWxJurc7l80Nr0VioPdrRtjx52G5JsW3bNjTvQSW9YaXTSiaTEMBHs0fzhKS/VN&#x2B;PenqFZPNFGUC3ooLiVgMidZWE0qfFTCsGJRrPYEX4T4P96yTdL5aEBhGPohigWS6tqNjGZ6EgHv0BqB8CjYGD7q34ONSgCE3/qWZd1/Wnnn6x9rs/aWlZCgJPNpuNRFrOOPcHTz/7km55GvT09P34J7cGz7/q5Vfe&#x2B;vSzxn8&#x2B;/vy1P/vd6edeNm/B3&#x2B;/40/233nbv40&#x2B;&#x2B;8NnCpmQqjQNWFCUcaX3iqRfeevvD8&#x2B;dc&#x2B;&#x2B;hjz&#x2B;m6gYicvgS070ezHM0yuMLYo2jujyIErY7PRe2CcLeBnuLWSi5rZLWeTM8nq/NJiq25WVYQt&#x2B;mE0JlO042K69hywW5Jyy2vYndcFe5K2ZWdK&#x2B;NFbSStJR2J01NzJUXO7PLGnJ7FC0AXrjuG7vgy0JdnJP9TNPkr4&#x2B;RRyQmYQhCnGSteFE0SuTkspgBDcg/dIwVJYuREW3lXZCP1uaRcZswOx3VfgrYptsyhdlG/Dmy8rImO&#x2B;BM4QXnOiFCUJaS1WLnNChyAkyKHNuLUhVQkm7Chv7RN7xWPpVNbsUnSiOBazsrtb9CPjS7eUnnbXeQTV0p6V1w&#x2B;ES44YQ68fhyWlgLrX8n6&#x2B;62R2O5t2rKbnirxdFOHgqdr16xT1uzC0/alfYtDJVOigURuy&#x2B;btazftodW3bNmC2nog0P2D2Y9OEmYZViwd3YqJScP&#x2B;ADpUrXj5OknphTAd9cGcQQ5AeUwZhvIAtgzjwfK4Y4Atoz09KJ4Br4POG9EqYGUUG&#x2B;AKyBtoBw/jhxaoIIH6e9woQNyM1VEWUq1YQ4i2UVNumOY/Hn129vd&#x2B;0tKyFPFxU1PkjHMve/iRpyG4/squ7tdef&#x2B;&#x2B;s83541qwfnjXr8vMCV8wKXnnF1bc&#x2B;/uSLff0DAwOJeDyRSCQQiANeV1X14UeenjP350889dJtv5&#x2B;/eEmIvhOUhahMQh1zs1YuYS56D1wHwiqI9aFkLpcDzwHYTKAGSIaeMTPLjL53M0sXKNGf6C3fX5dfwc0mBO5jc5A44Eo3frkp78IYOcTPcRLKFhjh/Nx6JHIqJ5EfGYLL0iAOmFuXgcTNfG5UeMy9ImnLtN&#x2B;ig3bDfczcsKU/x/FDe19mHDlFX1EiUYCEL5vTIovfn9RQHqjg7AkqLS&#x2B;yIadsu07aBWl3OELQVTsjFcnUQjW8C8QpFosYz8Hd80lal55K5S6xwbIMTnwKRn4Ozt&#x2B;g7CClbmcTUo3ISTJ4WWJap2bpsuFk5iRedDJ8culIeoW2wK1Px8isx4unXXofW6Vka1tpOXRd8NwfnHlYNSdI61excDPE99m&#x2B;Y8/ipuWbNu&#x2B;UFmxr7VLzG1xaWtzUsX7bAcbY2lWrspqZHbYV3rFjh2V2kgJJgAvYj2Y5KknQC9cN4kcLt3AHQLdnCQBYGY/HdRIbFPcZdMu3WCHZvqA7DBaEhjooh2gkvj4YFGEBqvgX1fN0gwJN/1HfTwUGbAHALrwZ0zQBf4ONDWYpxv0EaoOEslNJADDMx594Lnj&#x2B;VbGWdgTQH3z42TdOv/iSH9z4yqvvPPXMy7//433&#x2B;2it/8KNfvvTymw889OTDjzz97nufti/tTGcyhgEdZeneBQzANM3XXn/39TffTyRSAwOJZCqFxjkY2RM8AUDCAVsg3A3A9waUz&#x2B;fRggjqYgEQAKAMFRLAviiXy&#x2B;WyuqEOpHsX6z0vq0v/lAr/SIv4E0vOM2I&#x2B;I1b3Rb6XZvMt2lX7zBnm4hJmQ//CbjnwN1yY4BbHyYvOqyFd78QembDPwAShgqtYFNyCsSNGmJV35smVdAcJ9BTLS6UmJ6XkBJi5UxXpUD3KSFM0RZNOJzFX0wIntO1UHkvSUxfNPbMrhul85rpzB/qclOIuq5RGQqrQcEYFu/sUEhfyyGkkeEscMLBgqZEM0MjIiNiLC3EluYSRtAfsSNqIE6rmxu/UglgXslG6771y7Xtk5V5o8pGoKzktNrjGTNiMclzPLv2unFYyj1or&#x2B;/XSV4qqP262eh&#x2B;qV9q5jX1Rct4tMhaOdUViXV&#x2B;s2ywW3L//YEdnAo73bd08vHosfijsHRw6PLp2y17G2NaNG99&#x2B;p0lbtZ1W37t3L43kg3p30NyDiQ7&#x2B;x/0BdALGKqDzTiaToo8vBOlHQQJKalZAT1TkI8I2LJdZLsMAmuCjghkz/iL6B8yKoguCWrrhQDX0Osm9hYUxbE4ikaCyBIB&#x2B;7M4kwX9ABw8usCgz6FYoIbRoUlXt7/945rzAFZ9&#x2B;tiSdzqRS6aUdK&#x2B;66&#x2B;6FTT7t4VvDKb535/dPP&#x2B;WHDxTfcc&#x2B;/fGpsipmlmMoqqaul0JplKd3X1hCOtD/3tqeXLV3L2RdYgDfAAHhwchCsgg6F8AsPDLRq0UzKtBF4gG8CYs9ns0NAQ7hKABT9AfPQrQA/jXC47mM&#x2B;aap&#x2B;ZWKx0PqO335IJ16Wba9VwtRGtNqI&#x2B;NezTwtVa9MI1&#x2B;f4iIbpS0BmKk5RTc3DKMimApnorpzWRyVZ5rilr8vElkauXsfl02KCgj4/FOHTuAotdQDO2IO3X9THHQcei6PEO970os9zbHG&#x2B;ZE0AnYBhTgpN3spkAMQGHFQTmwuxaZLpByWTafSmaZwI6Eec8aiwASgKkpuOkP3PRyizm5AFMmQJXjDl8lJyHpcuHK&#x2B;r&#x2B;y3KfstiLCSKHWNKprpP3Ais3/cre9fJEzIHpM9l6I354XuDyhJGxd8btsF66MV93OcpD425Ko7J8UywgveKF/xaLRZhhzPrRi3SjQJh6x4vhHjyEh6vXbHj1zcWpTG5kROjryKGuFQP9fcrhAmOM7dq2tamlb8Om0l7BpvUbw9EVm7eWTIbWf7H&#x2B;s8Ud&#x2B;w/bGtm7d69uBbfRrPCaqN1XSXxP1Z4oAOzpdWK&#x2B;jyb7gNEhaCb1JNaIdywq9bF3TP4FWm3sEfcKIGoNuJaiNwIKDxjSHgh9c4Fw5ABwqR8wNewxDAO6BkkG5QGUIhDKp9NpFDYMw4hE2558&#x2B;qX29mWoIIfYpiiEAM5OpzN/uvuhGd&#x2B;86Jbf/uW5F964/a4HLvnhL75x&#x2B;sV/uvvBN9/68IknX3z19feisfZEIolx9A3D6O7u&#x2B;f3t999190O33HZvzQVXhyMt6ISQz&#x2B;fhYfF5AZfjbga8NNDWg7MvInjDClsEV1ASQMMeFHVoIH8wDCtZAWUNXUub6aXGwCfK8n/obTdp0bmZ5oAWqVbD1XrUl2rypRpnJZacp4VnKaFZSrhhwxoFZmKR7LQDUc5ZKNjWCG6WiUstLqmo&#x2B;8e5SdVbLtI&#x2B;heDCAu2mpy&#x2B;SsB9wQRRO3BmF&#x2B;wildaXriPS5nK57YVzjZW7el2lK8vF7AAleBjBFU&#x2B;REY2FAnaaQi1JWxPQUxnF3EXyj5kDao3cU5W4gKLZQ6tG&#x2B;NeHOkgr2NMOcTkUKVZGbi3dd3qQTOckz0lNRm&#x2B;LUrzuVytsf36UpqTCDJUdGRopEOJSSdx05FQs9VnHpwr0R6a8jbiWJ7XgJByGWcfoa6et1GHB5QatItYYOWxbWeQEaLNh3&#x2B;V1WI1zsj59258jRQlN4RXefIt4a6Oz6bEnnv/&#x2B;zaNvO/Yyx/Tu3fvBxqK19AAvs2L5jRb&#x2B;Jp0NDX8TV1bSF/fv3oxevbvngIpRH4A5oXrfy8sJFFABQE4/2MLrlL2uSADtUGY&#x2B;wGwEl3uWsdFQr9zDa0mCb1BbIsJyAIfA8Sia0IwzTSTX9dLcBRQg6SNUe50e3rIkw7H0mozz97Etz5v481lIK0m/aSdP0TEZZtnzFy6&#x2B;8ea7/R4HZV5/ju/zbZ32/7sLrf/HLO158&#x2B;c3e3j5d1xVFNc2Srh0fyjTN9vbOhktuevrZV15/84NX/vN2IpkCKA84Hi348bdDCx&#x2B;4DmPA8YO5jmm5/KJDMJY0rVS&#x2B;eIAdWUJC1tRTejJm9r9lLF&#x2B;gxn6shGq0sE&#x2B;P&#x2B;AD6a2GfFq5Ww9VqaBYca&#x2B;HqVGO13nLZlvWl2FYi53Q5EJExzjuU2KWsWPTUwoUMS3LMhwPH9o6ggO26iO9dIDuXbcAFTtABOy1/dpHJLXGQ2IUTcW9ycnUcUnFOWmaKpuh4UykMKH7ilDVwVBRsARmZePa5aiUNILr2goMXL8eJmDC3qXzCMbiiq30FlQqKFsfiGyw50Y7xR26QTv1yB5S4zQpuMBxjlYoxRYc8BszOPmgxOtpRwdbICf5ySwKzs0iP0hdjDH5pl4rSpqQOBhw5wU2R8Ktzbmoc8FSOxV03ZLy3xrlzlA48NFjS7TnH52FszE1Z9omOLWa45Fu/u838gGucfm/idekwJp0iLd2ffBYTr/etGHjznab&#x2B;5OCaDdsZY8WjR5Ysbnvrs2Wl0Rw9uHJ5XyozDGeb1641FCNjfEFbGB0dVUlYfUDzgN1p0E9qTkO1/qhfV63wnajmN6wg/TSFMKjqMVMsOgNAdctORlVJEl/qLYAoFnE/tQ5CKA84FbT1ppUZALcX8Ni0nHfxGE1r0ul01p4/y7TciOEKZCWzjH&#x2B;0x598Yc7c69ralpnEeUDX9b7&#x2B;gVjL0jfe/ODeBf&#x2B;44upbzvFf&#x2B;YPLf/n2Ox&#x2B;//8Fn/3n1nSWN4b6&#x2B;AXi3Pb39iWSKRu1EGaO3t&#x2B;&#x2B;ddz/u7u5Lp9O6biD0R5sogPVZK88XmPtDGH4YIWwUoC2TruvgD0BjfaKnL5UEdMt1OJ/P57K6qfVnU2Gj58VM251q9EItOkcNVevRajPm06PVRrRaDfv0SLUe8ZkxEAZ8atiXaZ6lRfx6xKe3XLFt82q6q8wtIqOjo&#x2B;AHZU03yVY5t0xLcb&#x2B;Lsp8WFld/aYMcB6DlaRnYXZf2666kH5edJMegijJ&#x2B;6M6apKuqU0cT0NxJh&#x2B;o0PBeakgSm6LjSSdKrnKEhzrGi3QaRyfAixxHsIENi70HZENcmV7dA9iXhVNw85UjskfbFPYgTuKEjtJcfZYJ&#x2B;xQlFFWSZWRCKjY24aOM4HjUW9j0cSwzwsAXhpFVyryJ9urHX5WmPePJVIFJRzQuqLtv1uBansiMHBO&#x2B;linRGWBdtjRQFidHepmT9EycpvVl25AJWOL4L1f4DRz79vFXqBJzoT7/y&#x2B;qLoChXe0ZF9uz/6oFEbLLn5rskPvvtRZFl8GMuvWJmIdeVpC3v27AEP2kQiAaAWVeZoh4O2&#x2B;MlkMp1OY7geitcNw4C0ABAtFMoA&#x2B;gftOwJo2iYCfcT6QKjCh9Z0y5heJ8GCUqkUmKmoJDARDAlD/qPyG3CtVsqzW0p0YFoRPE0rY5dpmjR0PejU0aIGqgDUxgeBBh/5xzPfrb8uHGlRVDWRSHZ39y5pDD/779d&#x2B;fes9cy&#x2B;54azzfhi84CfXXf&#x2B;Hh//&#x2B;TKxlaTKV0izH6EQiGQq3xFqW3nPv35799yvJZAqNfzQrXClG70HbGzTX0YjTM4b7pJsPGCPIJOFTs9ns4OAglkcxAMqD8DPWr57J631q78f6ise11huVcIMW8WWaq7WIXyvhe78W8ekRnxquVkLVSnO1Ea1ON52rNFfHF5&#x2B;Xaa7WItXppllaxKe3/nzntvUcgObXhUKBrnd0itFpLud4FtnWOLvPMVcAu6a3xAURB1woFJzCBnBjo4MpOFgBuaxxZZc/Dg/g&#x2B;5SNQa7CY8J7Gy&#x2B;5V5c&#x2B;gvQ9uBP9OSZMU&#x2B;LEeMmLjvIrTSfBjBZRIIeVmWxWM/JJjdozZ4lcpuBgUYC9QNgfjkQeRKswfoLJv2/qqEDRP16h10sN8YJNkT4dsrnR0VGqV&#x2B;ZaFoZX&#x2B;p6KzvHyUU6gP4H0oZiwfjjxXKfq0hZFAQCHKgowtGZZ9jRe/iU&#x2B;jlNJ6a1jZ5deeinTkf0jF5viNiXELmzfpCA5lH1FHpeNsUnh3KAUN4hDOk60d&#x2B;&#x2B;B5SvTurlKvLV5w6bIciUS69y65whj7Mj&#x2B;fct7tQ8/ajLyGxhjB/bsWhrrbFqWxvKHDxwQ83doJHoP6vUB&#x2B;0ImLIS/NEwQwm60okFPX7SAT6VSYHiDiYTR/AZMVjQryr5Osk2hjT64q6JgAB2BmMFJJjpxTkB1PraJ1vAI8UFEQVMflDegDABr3e4aAbiZWslrVnwhVdMee&#x2B;K5ym9d/Od7Hvr3868/9Ldnfvrz34NT74WXXH/b7xc8/ezLny1s7OuPA76HBMOGYSSTqcefeD54wbV/&#x2B;/uzgfOvfvzJ5yEoD9W&#x2B;I0Y3rIifNIAP2iNRbT3exeqKoqAXL&#x2B;zAYAHYK0BzJtg50XUtZ2aMVFt24J3syoe12OWJJQEz5jeifjXkL5n4R6rNmF8NgZuvX4v4jKgv3eRLNVZrYb8S8hlRvx71Z5qr9YhfCVVnmmbpbTdv27KOyVY0Zl/XKLPlwDqQC3bH1Yrj2Lj4Fix1HlYvlrRRBcacK9p751iB02LNZIk1pSWlUoq7zMAvWERbZ6/oCXNToUsq5HBCl5cheaRxL9ZTNEXHTCeJWgQRxQJxCIaz5oe7NCYmLUyrc/AXGYcYhKso6CGkfJC7ywQHYqokYAIqErC4DeVLIS99Rk4qYGMM0ca&#x2B;aTv4zmkX7iyeEhfK04ndiNddGLRTlbI&#x2B;AB7xJR67j5lSUSZwcs9utX&#x2B;sfNP90yo7WttDkR&#x2B;6tL56cBjw/mJ5/C27a79k/ejSD1i20HLHThsIJ3i5&#x2B;uDjyMLFS6W3du/am8uv2b73CGOMjRzJDq3L6VllqBQvqLc78fZHrVh47RdfHLCrdYrFIoJjRVEGBgZQQQ4mN6CHhgOIDYqoPZ/P06CfaEGEmbx0ktgLwTp0BIY6mpVRWCPZiHUr2y6URCt8cPPFdqhGHGQPjcS8N0phN8dyeCEyNkjcT2gWKmIsURg8iAHwH81yDCvrFjr4QjMvvvRm5bcumvHNhtPOuey84FU/uuo38//6z9feeC8SaY3HS&#x2B;kUUJGPAk86nbnv/sduv/Ov0Vj7Zwsb4/EEht2ESD6m5ceMxjw0Kj/ESEXgnrVi9uNQqdiAiB9eIz6jSVwFcrmsqfVriZje/bK29E9G6&#x2B;VqOKiGqo2oTwnN0iM&#x2B;JVStR3yZ5vPUcLUZ8yshnxo6T4/6M80&#x2B;LVJtxnxKyJdp9inN56UaZ6WaZimhajPmSzXO0iL&#x2B;bEtAabl1144tjDANO3YfLQoKfm6uOU29orCTIPbiZOsv5SRFu7K/WCyyoq19KVpwZ1wFEh2Ou0WJLpF2Vu/Giu1cyxEnuLSAnUoBDFeXXnEf2KRro9zpBHc3RceDTsyPeJII8XHyuExLIMTWNEoPVRgzu0LCBfyNWnmpRLWHTJofg9EuHgJIdJZSnkXHwyc9EEQFEcUyO88V31VZkISCigcsNVYAhzrWtbNCAneTXZouEFssWrfgHJOHc8YVBSruzdjBpVyJwpELFnfivJzHtlNrkrfhqtHhqosLmBNJJS5u8C6rptPLF59O2m9RotTnPkivmypOM8up/KRTscjiCb1jeVx6d6A31devbt1T2kLs601&#x2B;&#x2B;nk7RPo5tHf3shWZzbvHdhcPHz7KjfXw4cMAyk0rNS8k&#x2B;qUOvroVAAcxN6BtUNVzyX0NK38WYnEwAYI9AbRFwabQlh3agWKAxVFgACyLJuxQ0rCScNHtCADE6CoAYwakDpbusJVBg/fD8OAKGimhmwF2igc4MITUhmF0ruj6xz//9eDDTz32&#x2B;L8/&#x2B;XRxd3dfKpXWNC2dzuDOBlXqQ61kMtXb29/fP4AyCbopI3xH0E9lAyqN4OPDz4HFaNJflA10XR8cHATJbcypN6sbmZVK3yKz&#x2B;2m9/Saj5eJMc40ark43VRtRnx4BoO9TQtVaxJ9qrFZDs5SQP9sSUEL&#x2B;&#x2B;OLzMs1&#x2B;pXmWHvFlmquNmF&#x2B;L&#x2B;PVIdbrJpzT71HB1umlWpnmWHvGZMX&#x2B;m5Y49u7dLATcecGovDm0zuxJtbKEhyLUo6OOtujwy5prFuiIMsFYSfqnl&#x2B;LzLWmMtuOWVXFwjHCrgVrSCbMdD5GAOL8RxlXcZQ9kBO1308rAuF79sdLzZ/hQdbzoJY00innaB6dLpXbBvUHLVRRzMMRG46zS7irJtSm4yF4vFko2jbL6VRUvcyMXRioWRBzmN3OniqJB/14ljcnyWCS&#x2B;WG49LMQcGx2deo4MUhycyVnFzwOmWU0Jo6e8ixZriB/YVoqIHFzeXoEDc7&#x2B;vURem/t50B7tPlynDT06mvUvWxAsf3d1m&#x2B;MpVWBqW3Er0D0bb&#x2B;hDI4MsoYY/Huga70arh1eM/upqZOw1wDpwd3bnv/g9CBw7a3fejQIbDGMaww/KqVzRdQfiKR4MLzG8QlF27hPgDgY2r9r5IgoaDUx3YQtgIWx1g9KDaAR4FmZQzAxjE4j2bFCMqSVFagzAbADebsIL2ggh&#x2B;9hOEUkD0G&#x2B;EdtPe5vZEl0UbDeoUb2MIB8Pq8oajpdclOGLppDsQcffmppxwoUjUwrdy&#x2B;a36hWruIsifuZtaLuYARPVOFj&#x2B;i0ogO8cnhTeMGcvlMlkIH6/YSXtKkkaespIL8/GP1U7HtDabtIi56thf6b5PC0MzruztEh1ptmnhHxapDqxeJYWmZVp9uuRai3sV8N&#x2B;PeJTw34lBOp/nxHzm7GSIZAanqVH/EpztRbxmTF/qvE8LeJXQtW5znsPHtjLBL0yrg7cggiTemztk60y3MxlzvoX7hbPYx2sfEWeTNdiJnAMXByZsN&#x2B;OMEM6kbl&#x2B;mX0hc5cuxLrMmYm5kIvaq0iIiW&#x2B;P17aU6fcrt5B9GcjjB/D/3nZ/skjuBAxUGC0Fk6EaCBF8ixiXm/N4i7syOjoKJkOQppcJvImqHLARUR0iIg/OmkhEP7KxSRQGMh5XoNxNGAnfo5PGQqxIu2Z2o8mxd1Io0HWCjk0UtJyIA/TcLQo6HXUe4/RUdnFHxvfpVMAqJtegSx/B5dSpzXGRZFGxNyWGuKVVnPqlb567JX1FzHUdpd9noVCAT8e6YheeXbE&#x2B;aadUV3QZOjG0bfvuWGuPYQ6Lt1avXtcY6ty8fT88WGOsf8VAyc23eOTQZx83NUU64XTnlo3LeoyhNXw2McNyrsX4P6ibB89gMP6BPL7opEslAbTIByW0QSLfo0IdQCpaCoHDLgdkdSviEDaLhjpoiYRbB3CF&#x2B;iSAZQsGCIJbaAQP7WDqAHT/RbMiw/LrNQjRbQEsjIAen51KAgDTNU2/d/7fz/X/OBSO6VaMHXApRtU&#x2B;WOMA0axkhmVhhXsm8MgogaCTLvooY4ouNOiCwtAgGBTl8/lMOmVqA2a63ex7Mxn7UybyEzUc1MK&#x2B;VJMv1eTXIn6luVqP&#x2B;jPNs1JNPiXk1yPVmWZw4fWrYV&#x2B;m2adHqsG&#x2B;P9NcbcYCRiygRar1SHW2xQdwXwtXaxG/FgGtfwAsiNRQtRauNjofOrB/L3543LognZLWf8lyVrDbuNK7dBEUe5EOgDmIB&#x2B;I6KC5h4hURr0sxvViAklRV4bGuO3Hyicuy6HJ9XH15J5flT9raMQ5viv5n6SQOuzC7iYWLLtAdvBYKtg1KahfEcR&#x2B;K6el1JnAKjrOIggHsZjjxC1Eo5EAz1pKGK2V2/mVjjsWiC/gWRy6GRi0KcpTTlKaSCddFUdhbkA7JOybmTjmzH6nS2qllq8EC95tyopoTF3ZaM5zEGPdhcGW8m/RwZTxGBxpXECEnkomy/ELrFOfU&#x2B;5eJvYjvEL&#x2B;x0hnHGY6/SJBRh&#x2B;KpbGt7n3jr6MGDO7btGN5QyvY1tGrj6lXr9h4qPUJ764rXP14KNkB7du1ctWaLpuS4FgBHxuNxRVH6&#x2B;/sBK6OGHuQBCAmKhvsgEqAu37RyYwEmBj9dSCiGeWezVopZFAaolRFuAmgkpxjibJRJKEbPWvm5ABMjoMektrgPgDID6vJVK08w9gjXqdMtBvlBSQDv4tjQqgctiEzLSziZTL319kf/efVtDOyDun9oAfcB4HFQMU93A0BsUFUV/6NnAlo0ZUkOryxxU6b7CYahZbV&#x2B;M9msrfxXpuW3euyidJNfK6nwfWbMr4bO0yPVWsSnhaszzdWZZl&#x2B;qcZYeDWphnxnzGzG/FvGZMZ/SfF6qqVoL&#x2B;9WQTw37jKjPjPn0KIQDChjR6nTTrHSTz4z5002&#x2B;xJJqA26FQDbwqR0PHzywj3570kWWTGr5olOUKWik&#x2B;iZahltwsXGc1/Q6rjXcIugCx8syZ2GJsa0m3F133ZC4WnFrKPeMBbvajlaZXADN9TJFU/SlpVIeABF9Ur7DMRq4Bcp7jj3ROVawEyO7nIyAb04AoIOhPIVeRBhdLBbhAg6eG7aLLzITuCqXeZdyEHEmc5yOFhadg0VGxgXpp4W5g9K7sgNWaYx/930PZl8DnEpK0Sp9A6XRksCmUh4q/mp4OubI6&#x2B;pERX&#x2B;&#x2B;ot0/RHwoccBlr4yLylYXvy7urvhpTaAXsdhYU1LlmX1ri/TLL1G2A&#x2B;kwimRD7L&#x2B;hglq/YdvipuXLVqTEWxvXrm9c3JLJr4fTVH9i0aK2bXtLdv/vvvZRn7oGC7eFWj5Y2Ml95aBuRysgNP6hGcFQN49hc9BOHdA2&#x2B;gboluOvauUHAOFBIwF/0CII4C/E&#x2B;qSNAHwHEQLz/mr2kEEoFcABNIU7CRSR61ZA/Ww2i8kNAHwDdKb291ARkxVkrWRhhj0hABVCsBeDuBfDdkQ6PZYNDTT3FOijRRCm2kVhA4/Rx1q3YoPqJCgQ7ifgf7AayuVypqkrmUROW6n3LzRWPqm2/U6PzdUiPiMaUEPVSsifWFKtRwNqyK9H/UbUb8QCSshvxoJ61K9F/Gq4Wo/4QPGvhEruv1q4WotUZ5rAIdgH8UD1aMCMBcyY3yjVBbgfUMP&#x2B;TNMsLVwNmQGMqN/seurI4YM4lTiECl&#x2B;juPBxcJayTVgO6V1aWOT54oo2Xt5Ix8AN1QlPF&#x2B;wGTtK6YkcuXEUUFUR5gNlfhXQdZzJ2WrT0mO4jmXR8P14uOukDAJoUjdUUfSXoJKeJx80oOsNF&#x2B;CjCOO6KFLKIvTDBfILjDmOuxjKJBYohjnf/jqEKZ55&#x2B;9OhRKadAjkCZF/bIbcI6Yf2CfXeiWARjCrn0wvVeFHQVMFSxJHN4207MgqsiLcYlf/DCIPA7OXLkSIFQ2YrcwMruM4xrVE7jLBRIflzPGwj2d&#x2B;VJ5KDv2amAOCPKdX0cSToX3L&#x2B;l40ShaFe0tXvtuq3irWHd/CzUu3l3Kbzn4YMHY8syB0cYY6xw6MCAujqVMg7Dr3r0UKipXV&#x2B;1jWsBMkahuU7GIsMKu2maJsbj55T0/f39uuWPixmCUUeO5ivU0p1KDrrlP4AoHwMBmVYAHFTVY/tZK3MtwmVoCo3yEazrdqdkvI4AOmul9AKLeSijWzQ4OAjODBhNX7dHHYXHhEia0Ozg4CDtBZ6dGuegmIHYHZqloTmzVlBOuItAH035UWDA3w5ocHAwmzWzRjoTbzf738uuuN9ceqMerQULHC3iU8MBPeJTwz41XK1F/HrEr0f9WiQAnr6g/jdbgkqoWg379KgPvH7NWCDT7NfCfiVUrYb8WsSXbfFjKgA9AtA/oIR8SsiXbalRQ&#x2B;cZUb8eCUD&#x2B;LzAiMmN&#x2B;beWLhw8f5iYRt&#x2B;TRoBpM2KkuCmovZldCMTsgLgphbWhf0ovi8FwQsLU08OuIEN9MAglEsYeU4SGHvTv5sN0fysuzly3jRCeMJ0/RFE0WlXwAOGBasMNrZhfuKXAXoT8WoCFu0CIIUR3XLBJtkBsGJ3gAf&#x2B;GyB4h4mpL4jEV7L5SJwCC5tyG1DuIewTqVqMBdhiodBrNzUpH3ca&#x2B;du4LXi0It8aGKRIISXxdzJXyNXJhOl5&#x2B;DDmBkZIRbnwTUWxSvS10LnN6PdNlwEkicZAnpdSeDsdKVcmIPnUpOuxy0/dLCaUseZ1&#x2B;0Cm6NuMB3OiTGGHUV4A7oaVHYWD9OtHxlaklz5&#x2B;EjEu8uLZNd1q3sP1S6taJt6TvvLNlvMYahL7Z&#x2B;MTi0Y19JPDCzq2JL&#x2B;WhC&#x2B;XyeqvkBBIMKHw2BMNoPXKdm&#x2B;lAXDX64dpDoPgDidbwCjaOXMMJrtJxBcx1qlA9YGT19QTCAsYHFERgXwV1Un1OjIDqSLAmrj83qln8wVkdzINgogKdGvI5bBHAAggE0a/kGaFR6MYjjMq1CM/ui7y/2i4IEkWc0JdVlJMNa18va0jvU6A/0aDDTDB66AS1SrYb9WsmI36eGqi2N/iwj6lfDvtJWQMSnhiClly/dBGE9Z6WbqrWIP9daY0Srk0uqk0t88cXnGtGgGp6lhHypRvAYrlbDPiPqV0I&#x2B;PeI3WwJ6xK&#x2B;XtgL8EAJIj/rNvje5/JWIbu2Q3ab&#x2B;tzH/YrEoxBXgVuSi4MNGi&#x2B;EqLMgVkkVtrKliUVynuHmE4&#x2B;TgOLcrPsbH6LI1GWzEIwAQ0QUj7/C/Re7Mf4qmaNLpJGZXPI/aM1sxMotAs&#x2B;4kfIsH3FwSN9Qo3AGdR9FueoQtcEYvUhBDK0qYl6yiyAVsTNBuhcns7IMJjJWzIMKRF&#x2B;xBNrmXID5C0R5ftVgsiK&#x2B;OWZuqlLEWiW8uXKft0FfkEsTTaVTMbiIlLirYS0mKOHqEyX50Fx7nnf3hK3LaDRAH74Wov7v3WuMtTz9UrnerQBkZgDFWcEvKVn48&#x2B;JjcD&#x2B;outuHdsYvOKrdJp9VrNn7euGzdeskOwMZVqz79LJyxsv9ms6uWD4zFC9qwbmNWyx8qnRX37N6TSmicJAfW5LoV6xM17ugOC2IAKtfRVgcz7&#x2B;pWEE9U6qOvsGEPLgT/EYKbpbRTOnZH9xBwbyGRSFBUDeKEZehi4nYBFS3QA9iw/HfhIurdQa2OKJyq&#x2B;dGWBrMO61aOLd3y/QXVO/xHlTxidNg9wE7pAXpEmCSKKPUf0DQNogNBCyAtoJqf7lTkcjnTUPPGQDa5WF/5tNZ2qxr5nhELJpb4tXAg1VgN&#x2B;v7kklnpplnJJedlmn2gmM80&#x2B;9WQT4/MAuCuhKpTjSAe&#x2B;LVIyTdAjwbUcLAUESjkB8lBC/v0iA/sedJNs4yYHyICGdFAprk601ytRQJaODBWMhowoj4QMNJNs4y&#x2B;d0dGSrKpVMsjXS&#x2B;o6awNghcKKB7QhcOa4KXGaRm6nElXUqnkIPKKQqHAGK8rFJE9R6Jk4sQ9OElD1Ow4VeSekbslrQL3vCxAUq4rRSP/XVliiv5H6BiFxtIOgBRiIoh071U6E4r2bUecwJQN8eDDYlKMZMyl7AxV8mUfG8IKiXCftsAIt2V2eEpruXiI0uqlMg6vonTgIE5I&#x2B;2UOvEZq8S9lc/ifk7K4p5ByYfENwEWpIzWzQ38n&#x2B;Cg&#x2B;C73i/oO6gN2yLN7pN5WeFouO/qyi8OPF6GjszRTHEaaJ&#x2B;265fguWItA2bKFTjtx/F7FwUfZNctXpt328F7yRUdbdq2zZulO8dfjAgSVNHR2JIbySUYcOW5&#x2B;qaa5a1NixZ39pB6Bjadc7H8a4rOODg4PUDVfX9WQyydnnwCnuCWD0GyyPpjuofdcImZbrMKbxQhSLAga16c9aObNQL46aeDSyp9URRiP6h2Mrv1VJwoEDNJfHMigMUKAPmB4aV1U1mUwCHAe5Ah4HsTsOWLcb6KNqH/Y3OCEB9P1UDIDYo1RAApsiwzKayufzhq7ns6qRWW4OvK93PmK0Xptqmq2F/VrYr0X8RsynR/1K8ywtElTD/myLXw35jGhADftTjdUQ2EeL&#x2B;MxYUI/6Ms1&#x2B;M&#x2B;ZXwwEt4jeiPj0CGv1qNVQNtj1KyKdHg8lGX6n9cLUe8RtRvx7xpZt8emQWVDRjAS3sTzehz8B5etQPmwy51oAeDehRnxnz5RKfYbpMZiFFkUdxnFYE38hMRD5P&#x2B;YwN8tslf24VHiuMcn6hwBhvyVNw3vErWulBpTzZSSTAZkUgIWWD3mjivMipI&#x2B;kIxz8wnlw2kKdEiCk63sSHARU/Qaf5zBE3PShHc0IeFMrTXkROIY0VIyUpgKNqlTHAanErJ9gtDkbUSVDjHK5TTq7gzDpF1la0lOhS3ifdNabVuZEUrSSOTjyFe&#x2B;HSZ&#x2B;eq4HM58WUnQEwkkBFGZCpOOJFKMtbjOCq5pdiXE5NEaZBZP4r7gJnsnbgvY0635MWcJUb72GyDFz82KXSALTWnYkzQqxUd4ocw5yksHcxxoq6edGNo&#x2B;a7dB8Rbh3ZtN7OrD1kvTB/o//zz1nXbx0qmk8qLbzbC8bKOviTxCQbK5/MA8anhjU7cdg0r2o9OAukoigJWPYBWaYJejCWKoTlRZw9A37RyACOCh3YwshCa2XD2Nig2oBkM9GuS0Jm4TYF2R9gCWvIgpMbARKiPR5iOkUMRiHPiBPoHm5bPLgpIVCQwrJD8CPTBVQA1&#x2B;nCKQghsPsBLAPHAeiG6mhlQB8Jq18va0ruVyGV6NGhEfUooACb&#x2B;umWBo0WCWsSnR31KKKBFAnoE7P6DRjRgxvxG1J9phhCffjMWALMfLRJILpllRH1aBHYJfGAylGqcBYGA1HAg01ytR/yZ5upUk1&#x2B;LBPSoTw37Uo2zoCkQDIxYwIgG1JAP8gTr0SC4ASghnx4JrtbCViZEm0peRPbcslK6bmF38S4T5qlUJJCS9K5LFekqJi7ltB0OEjgx8LLEPZSoH&#x2B;FOyx7Y/9uehetxwlR2p3qKpui/QmMmQCUi/AUuwGTASSI1vCa1i1YbY7ygYLnbUvhesMKDcpieDgbs&#x2B;wuyLdHC6GihMEqboi1YbHRsGqPuXwp8mYARacgCTvwAopmDkaSqZSe5iDY7OjrKirzeF4k58Hdu3wbvlhGQuCvlOB086dGjR&#x2B;Edcr8jqWvzkC5YWmocP5f2WBS0HMdcjl1KmTVdXL0Tt0nitP1Ff0H34XE/iut4PG0OcI1Lfz7&#x2B;V3De1rdeEQ9EpA8hfYQTJgAcOjyydt3mJU3LpHdXdqe6exU4TsYzixYv3bXnIJx2Leta1r5SHdrCGBsdLaxatf71tz7fYRckVq9ejVY3YG&#x2B;jk9A6CKYNK6I/Fk4kEgDKUbWPPr7oM2Bahv4oYxjE/h5OIfAORBFFyx9qr49AXCNZgQ17kH5OWjCsPACI41FVj/F2MJgmavpNEnEfcLxJQgnRU7iCZkhomQMDwLp0l8C03ADwiXCQuGuBw7O8fnO5nJkzBrKpZn3FE1rbb9XoxVrED8heDfvVcHWmuVoJ&#x2B;fRoQIv41bDfjPkzzdXpJp8a8qkgFTT7jGhAC/v0SABC&#x2B;uhRf6a52oiBk65fCfkyzT4lNCvVCDH&#x2B;fUY0kG7y6ZFgcsksJQTtV4OJvxLyqSG/HvHn24JGLKBHAtkWsPOpTjf5ko2ztEjAiPoyzX4l5DeifiPq16M&#x2B;NezPtc4eVlskGhBOYe&#x2B;M7GGpG4PRDvOaHots0DvvxSmPqyq3fSHtxb07e42iWJ054AGussuAucLSdrwsl9Kux3XdfWyTW/6rSP8Lz/hlplIY0FHBpFgqxHMmNEwm93N3xWnGwV&#x2B;gUSH4D2U3yIAoJuY6RRU7HRXtGnEnd&#x2B;rkXWBj0KQdcc9O5HfFoi2rYsHBQGJ0dLRgf/BCgYSjEbY&#x2B;pC2Ibw8b4exKsYpo10QfDVC&#x2B;1aZE/y0CX/ori0IRfY0uZjOjoyPMMip1KUbxN3fg0KynmEVly0yAxDfs9CWMFXNOQsns4&#x2B;S&#x2B;T/rduuxsOC3SovhRpJtpMnghZRHHm3bs3Ot0a80Xm1dv2MUY2/jF6o7lA/3KaryVUFfvPMwYY1kj298Tb42tWN5n2uquWYPxdlArn7UC4etWcE&#x2B;DhOIxLGN91crLi9AcLe/RPQBSiQG0RSdg3GfQrZj9VHjALqhZDrX4163IQlxhPDBNE4x24AoF6AjlTRI&#x2B;CK35QTDA0D0ovRiGMTg4iLIHjhnj8KCaH1qjPsH4fuh2h2EYQ0NDhmX6j&#x2B;ZAg4ODhqFpatJUuvS&#x2B;D/TOvystv8yE6rRIrR4NQLAdsKqHQJx6JKiFA3o0oIV9oO/PNAfVUHW2xa9HAmq42oiWUDuo8LWwz4z5tLBfj/g1MPKJ&#x2B;IyoXw371bBfi/jybQGwJlJCIDMEzFhQi1RDYi/Q6KthnxqqNmNBIxpINVbnWoNaxJdqggFUZ1v8ZgwiAgXBDzjXGsyEvrs230VXGXfOg&#x2B;tLia&#x2B;SKT86OsqY4&#x2B;pDF6ZiscgsZwFslwkrsm3hsy&#x2B;RTGBc9k4FhY6gIxBlEnlFx/cg0RLikFyYKsfuCsKaxdUtu1g4jXZi3O/E8MxjpymY/v&#x2B;VxsKAcrOLs0Ec40GMMcG&#x2B;pSgo4MUvRooLuTIiiKEopyBT4VN&#x2B;R/sVgTsW5roTAZNNRCHhz8WHEoUBThxi9kmOMYsKfGSeYkEYg3TWSbneGAfnOXuBsk7xQSSSgzBmJuP&#x2B;7oB&#x2B;XMsb1x3&#x2B;WNwAmGxHxakXF8FJwnOFtWG8/M5pYNLurM/VrbBsreXbcX8P4nIuDhhuisOgA5I&#x2B;AhM&#x2B;vP/uSta4pIXzDWiPLksPbpEWXriw5cPmvoP2V7J69Wq0/uds9E0SMMewh97XNC2ZTIJ5j0bS8eqW5y5NYQu&#x2B;xdiOacW/z1rB&#x2B;xHTo1BBcTY1B&#x2B;JGqFsR&#x2B;kFxDjnIoHHE2eDLi5sVNKoPSjuA72mcHzTjQdkGDfoNy15fI/m8aGhOlATAdggNh3K5HEpTXC8lSUFJ5JRlWs/rWsdfjLartcgFYFivhCDgps&#x2B;M1QCIV8OBxGK/FqnRIjVmrEaPBiDgjx4NKCG/FvEb0aAS8mmRasjam2n2mbGgGQuA8GDEIJNXsJSiK1wK66mG/Xo0mFwyS4&#x2B;UzIfSTT49Gkg2VutRnxH1G1FfqjFgxIJ6xGdEA3rEn2n2J5f4tEgw1xqAuEPg&#x2B;6uFfVokWNqdCPsyzeevHexjMkmeOWjxXcTsAq&#x2B;MowEhxlZhkS14n7ZFomLj2pGe4nIsdsEtzePlse6qkwnwHxgbhRmsXNRp0QHPY9dfFaA/Rf9rVNoBgP8FO46RWt7j/1F7lMyi3Z6nWCyv&#x2B;y9YxKy0Yjgsic2PHfRTRItE2Q11XRUV3iLSknrHUrmCPj7HFLjBSEuK3JZyQHdjdBdeWSjY5BOXoXKgH4uNWuF04MqIJaIIWzSFgrCQSJ9FXMykxcSLnDQi7YgJC4lTy07WO/TluPNlu0R3rCoQpx9RKquMTRlnoQKeBcUD6VzgvvNSs0X6Y/HxwiVPiu3YN8dsPcrEjEmnVDo7vHq9eH3bxk3vfhQz81/Iaw2kNmzZjad79&#x2B;zty6zmyqxatQpU3eDLa1rewHCKaBWsg9C4HzcHwGgeM/6qqgpGRCg5oFk81frrJIUwegDDFRwMTbZFtyZ0ko4ATHegMBxTRX6WBNrH5&#x2B;Iseag1TtYiuILafbiFOZLRdgi7gCRf1NQHXoiqqkNDQxj7iDoWm1YCAV1TTK0/mw6ZPc/pS2/XYt9PNvqNaFCP1JqxgB4NqOEaNezXwv7E4lmA4DPNATXs1yI1SrNPCfmVUl7eoB4J6NGgEatRQtWZ5pKJvxapMaI&#x2B;M&#x2B;Y3ogE1XK2FAyAJaBG/GatRS7sHASXky7YEjKhfj9SoIV&#x2B;62Q&#x2B;6/3RTKZ6PXvINKIUDMqKQHSxgxgJaxGdEfXoUuvCVXAUafVrEp4TAqcCfbZ37xWDCNjHtCw0jOi/7BHdkWU4oH8/wojXBbWxBCvGd&#x2B;pJWtN2SMX/6XNK7BUHBREu6D8NdkODuSgtzjXjZMfZCE5Nzpuh/nE6wrDjmBMzNQ0DkHOgvEr2CiKdFjMtkVkO0FuJ&#x2B;tEuhjrkFXsMxBliZjKFw3E28iE9EpReOw3KPxkHqAtFw0PLiPKeFRcxaJLkRmPOvTstT83S8jq4IYLTjBMJEBsdfKdpkOWbfrHB4zLGfaexlCii2SDZY4NjmpUp&#x2B;wYJgjlUg2x3cdc7Z1&#x2B;V5vdwS14mJLQMuMhKSh5bLswBOWOL367hhuPGU0sds7XfJ9I5CC04L8/Gm9Ru2Pf/yR0dH&#x2B;H6PHDhgDK4fSJaserZtXL9&#x2B;25iJv6qY3b3pPYfGnmjb1p0H7T/CqlWrdF2Px&#x2B;PJZDKZTIInLgb3BGgL6nME4pzOnsbuRMEAzf1Rcw9hQ1H7jpgetxcAGYMtEIgf1KOAGujDngNuOMA40WTItGL54z6ATsJoorMBwHr6LCCBoHbfJFF60OhftwIHQeRQcGCArkH9D2NDUSGbzQ4NDdGNglILWS2r9WaTi3O9z2dafq1FG4xojRKCtFyBVJNPi9SasYAWCZoxf7qpZKkPGwKZZp8e9YNVD6j21XAw21JrRP1GLKiGA1ZI/oAe9auhgBIKGNGAHvUbMb8SgsD8QTVcq0eDWgTCffr0iB8qapFArtWfafYbUb8ZCxixUkR/NRxQQmAO5NMifjMGfgX&#x2B;bIs/2xJQwwEjVvpTQv5Mc3WysVqP&#x2B;jPNs4yoL9sSzIQv2bbBZA5zR&#x2B;Rp4tpEqSjMSiR6RVpRBNzUR8tC8/yqQVvmmhQDxEkJF1OxEXpdKi1wC734UGJ3ZYu5vKJyjzJpdOIZ6RT9/6DxfjkiG7E5AVu3iwjKmRD&#x2B;vygD5YywLUB41PqcU7syZwDBYVBu6LQ6jUlPu4DbBbtXA8WpXJsiAIUQorTZUdnGCDjFciNHqYnCVu5ViI&#x2B;DLUgZYsEeAgjVsTRqKv0FC4UCs8x&#x2B;qMAARbgx0Frocg04nvvJRHJh0PhC6LJBN3mo8GOVp5KD1/izTs/iVLFI&#x2B;5XpnETyKAmMS2Bw&#x2B;sjdy5crM&#x2B;o0BvE6HQCVEIrFYkn8kK304hdrOz7Oy9jmLTs/W9SWSOU2bd4p3lW0wXjShPENGdk9&#x2B;w7v21kqpiaUV55711yzw63xzZtBtY96/WQyCfC3v78ftNdoIwQ2/fF4HBEz4F1qgo&#x2B;&#x2B;udTTF&#x2B;1nMKkwJu2itkMoLaCEYFoxQHGjACMRYcvU9B&#x2B;1&#x2B;BiFE2UGDLNDw24CHEfZA8NuYptZkjwYAg3BMZj6wH8aupTbRtCtaKSqquZy2ayRNjPLjP53lKUPmO3Xa9HvKqEgRN1Rw3496tfCAQjXk1zizzRDmq2gFvEroRpA5GCro5eS7PqNaEAJ&#x2B;dVwQAv7EothZ8CvhoNGLGBEg0qoOtsSNGI1ajgAwUC1cNCM&#x2B;QHBJxt96abqdFPAiPrNmE&#x2B;P1oBPMMgP6Sa/UfIt9qkhvx4NQDJgI&#x2B;rPtQaNaCDT7FNDAS3sz7ZAINGAEqrOtQZTjWB6FNAiPstYyK&#x2B;3/mTbplKwWg7O0rWvKPjacgyqMKaH4leBgrUuYBU7XJY2Yls&#x2B;&#x2B;NXEPlpKdKEU77qDb&#x2B;kSTwfjwpOlbXpnp8fI6sfbxRS&#x2B;n6IvLdlMgJgsyCOHsdCnE4WEUgGrlmjIUbQCbjKCIeipFJfjxZGjR0XtAu2FKpixS6fyyGQRWEt1G0UheQrPCgVwz&#x2B;g&#x2B;Bhlw0b7twFwVzGiKQ/vCd055vQ2v21k/SAdSxwbuPdMXKBU/XMhWwAbfbcdiSgf6MrnnxZJFYVOFDu/IkSNYnSsJ8g&#x2B;S09Bpw9IiqI3zviqIS1FZ1l8ks8ZJhUYeULI0Ov2s3HRz6ZqraBv/2BXm9KJOGG3fsXfjph2rVm&#x2B;U3u1aEf843A/Hu3fs7F7es6Irs37rPjhtDK2I50suAVktt2497x6wfv16VKgjOgfASjE3mNmgqwBmyOISeHGeAzTWjW6F8TFNE50HdBLXH/X0gPjhGMP8Y&#x2B;M68UvW7R69aNCPSb4gtRbGFDLt4ThNK/cWdUsAcI&#x2B;RPan1P6B/NPcHlX/WykNM0/fCZgJsCOi6aupJM92aG3hTafuj3nKFFrkg0xxINfq0SFCPBtNNtUrIp0Vq1LDfiAXUcECPBLQwWPv4Ms0&#x2B;NezXIgEtEjAsE3894ldCwXSTXwnVGLFaLeI3YrVG1K&#x2B;EAqkm2DQoufDqUZ/ZElTDQT3iV0KQtytoRH0A2Y1Y0IgFU01BJeTXwoFsC7gR&#x2B;5KN1dkW8Az2mbEaLRJQQv50kz/bGtQtOcRsCRjRAMQV1aN&#x2B;MxZUw34lVA0RivSIX48EjJa56fDVZvczenzx1i0bGJW0ZYRMXkTDUFEQ2uXVuSuMLFXS6W/jAAL&#x2B;LtjD8bkwNyrJlAo7M3ORpHfHJQx4obILHC6&#x2B;YsteNDLjHY9IHnuZoimaMI3tANDP3frox5gFj7EYY6UZXkAjck6dIPWnKRDDG6pZdzLTF71UxVlB8SLinlF7XKMxXbgdcdKRIFHMKkWi4jBElwNpAa5iwTLd4d4D0NEjR2wv025/xSnXrcZtspD432nYdEjcFW45obYi9h0GiUQHXwXida4LuiyJ75kbhdMNWmvUClQKjXOrjlSisEm8DhtTXK1xSQVOvU&#x2B;MpK8Or9CvmlYpjFqiBfdoRJLnoIaIIaTEC8YCaJhcSqZzvf26eL1w&#x2B;FDb0t5NW8cCBH32afT9j8JJcz1jbOu6dao&#x2B;jLf27z&#x2B;4YmVi7VZbNKFt27ahjjyVStH0vVQRjiH8MVgQRPYEoAx2NQjKsRgib5QHTBLDB0QLAPSpVArt7HE8oFyHjlDdrpPwoOgVACici70DFaEdTPWF8knWnr0LCMJ0gtUTbDugKILF0FLIJIE7UaIAZ2LTNLOmriSXZ/oWG93Pae2/UaOX6ZEacIpNN/nUsD/bUqOGa7RIrRr2a5GgHg2oYR/Y0ighvxHz69FAuimYaQ4kl0CCXp8aCpgxUNgHtUhJ727G/KlGH6QFUMM1SqhGB3feiN&#x2B;IBpKNPiPmV8N&#x2B;I1YDnrtaJJBtCeqRAAQCMqIl255Mc7US8puxoBH15VprMs2&#x2B;THO1EStV0SN&#x2B;PRowoN9wKQewGg7oEX&#x2B;2JZBp9qcawQvZl23xm631Wttv9RWP5tNNptqfNfVsNrtjB92JsplNFsZU4EU6DblZXyxyyvIiR0zgD06QGguLWieOh4gNYjFRAyXtThwJt2pzYxNboP2KZdwZrHT5c&#x2B;mXPrIXnubUu9PbmKIpOt7kBXKcxOlKpYCYke/YumVjNwx5k2CJUSD7m9L5ViS6YQ5HcvACIa84S6WArEhU7/QUjXxQSBgdHWVCVnNm5xrFYhErImpnPGdxZBmj9piV1msZE1Q4TiHljKIsJFbB7nCo2E7RDl5F/ot2ODBImutg7NcsUBqlv0J5TmdHqE4faMGyR3J6dm41kpK4EyV&#x2B;P7QFJ6eCgrDXJPJ0brQeOb7LMil5LrtXvcsC6WUY0lnm8lbFRx7X6jgpVGAs2tKdzuSldxN9ya7utHU2mupPJVK5NdsPMcZYkXWuiKf01XBvVX5VMp5Zs3Enrb5161bDCs2ZSqUgeRZq2VHjjmp7GhUUUT7nXwv28aLHLZjFo8U/lERnXMyxhVkFTBJWHzN/mVZOABwGmtyAtRKmDDOtUKRojASjAnEFqoBVD&#x2B;0O9f0ayYJsWrnAUE5AaQcNigYHB3M5M5/TteRSve89dfnDautN6eYLtEhQiwSVkD/dHADbej1So0UCajiQbvKlm/16tEaL&#x2B;I1orRYJ6hG/Hq1NNVYbUZ8ZCyaXgCl/IN1UrUdrtUjQjM3Wwn4tUqNHApnmgBEN6tEaJVSTavQZ0dlGNGDGfFrEn27y69GAHvEnG3161A/w3YzVWOY6QcwDAC7CesSvNPu0iD/XGtSjQTUUMGP&#x2B;bAuIGYFMM5gb1aph2JoIZFtgc8BHZYNc&#x2B;6XmsjvyA6/lldhgNmkaqqIow8PD&#x2B;Xx&#x2B;aGhoz5498MnhAgpMle6FiiCeTlhuetLVE1suiRb2qU1XWwrZsSmuX5GrOzEBZr8qLeOCtr0uHw6Dka6DE0bex8LQXNYjUfbwgs/GRZNowuROx5Xnn7CnmCJW2gFw4AgyZmRTE6JGvyhTJUr3zpgdLxYESxWwwseSHHvilA1cg7QRGBWaVRTsOmaE8ozZIq9zXIMe0&#x2B;0LKjVJfbbGHtX&#x2B;CKVjwU9AystcAKLtDTjgNlxaRGAnbdmd0Y&#x2B;SYEH07XG90&#x2B;eiH8DYsf0uN2xx88QDo7QJkNLngt9szEBrdHTUHnWKI3GJla5e9OsSa9GS1EPGpeRouaWL/oKuq2YB37OtQLHImO1XLt0lTYmfJfeZMeGjpcfHdW3ojxtmjk/iC9S0KPLS659CcM/t69eG2lMtHXG4NXrw4MEDB7XBku3Qvt17P/w4MpDbRqvv2LGD2uGAzpsaAiHURhseegXQOQS4xMg8UBKif2JsHzSj5zYEULkOjQ8ODlIHXzTXgTYh1ifuPFBre5AN4EBRFAzkTy1zQAAASQMO0FUX3J0xRxia9KCFDzUcovZCtlxg6aVax71ay9VK&#x2B;PxMs1&#x2B;LBPVIINVYDSlytUjQjNVkmn1KqEYN16SbQSSAGDtBM&#x2B;ZXQsFMs18NlUL6qGHw3IXNgYARC2gl/F2TbgLlvd&#x2B;IBjPNPjUc0CJ&#x2B;IzZbaa62Ivb4QamvhoPpJl&#x2B;2xQ&#x2B;JAtJN1UYsqEcCRqwWdgDMWADy&#x2B;JqxALgU61GfHvWbLQEtAj7BPiPmTzf5zZhPDfmtQKKBVOOsbOtsI1qTbbtM77jT6HnFTLcO5zNDg3lA/PAxrMmb5oqWfOvC3du3UjgOnx89oBi9tAlPiwm1KHvHwt6BMj1FBRCOTVzWOS5Rdr5zj&#x2B;YiVLg3xVVBbi8KMNKK4oOIxZzY&#x2B;HiR&#x2B;qTwwOPKSCeXpiD7pNMJ&#x2B;/XHTIDEiSTyCxvysy5iFQ5fFh02&#x2B;AoFm9pbbKrgGnCATn6EVlSxDegfFSq0MBYo2GGxiCCdnoVW4Zg13EKtOQe7xRdFGSLeKlqNylwpxvS1TmC9YCFdPAVpqlikbRfEJ6UG6NyGCS&#x2B;iOAg8VoNjv5pVUfKiOLAuwOIynJp7b4zwIFEMkNp32bsrvzUspUI5aa1sR1hXnCP0P&#x2B;&#x2B;mYv&#x2B;WvDMLKeCgEwSuS53O8dSl2RNAqUxWer2va&#x2B;D1T1bC8aH9&#x2B;3fuObRz5&#x2B;6hDXsZYwd27174WbS9Nwd3D&#x2B;7ZtWbVGnPVZlp98&#x2B;bNiOwBoAOARiddjA0K9jmalbzWtHIAo5pctQhOKW6G8jTpL7oZYKweLv8A2u4j8oZ9A/DT1UlYfbiCkYigU4hPSrcIMAMAihyGFboHXXVRWgBbINOe2RdN/3Vdz5pm1tRzRsJIhs10a0kUSXyuR2er4Vo94jdiNUZsth4NZJoB9AfTTX49GjRjQT1aa7YE9UhACdXo0VojVgvigRENqOEAGAXp0SCE7lFCPi0cBJEADH60SDDV6Ms0B/WIT4/6lRAo&#x2B;4NGNGDGApnmoBnzq&#x2B;GAEvIZsYAeDYL/bqrJr0VKcX70aNCIBs2WWiXkz7YE1ZDfjIGCH4yFgkY0mG7269Gg2RJUQgEt4s&#x2B;2BLMtNbnWmmxLQI8GUo0Bo&#x2B;1qs3NeLv5eXltu6slcLjc4OAj6/nwum80kV/UtG1zyqvHc7wcfnjP44l37d&#x2B;9CTozzFzkkmt0ya7uVkTWIMlIkceUdu2Wx&#x2B;mJxLM8Mx9ULRDVGWXRRYCzSdUdkINzCJ3IMjgs5rWUi0R45numO7524btlOC/b37zK2KZoipPFKjP9FGnMCFgErZ7ZOozdiyUKhgBCBgmB73bGZxuFamMZHjx7luIlYjB6LkJoOW0T8yEnxFtc&#x2B;FQloO0ViMzNK4pNSotCWyiEFIXwQ99S2l0lYJ/Rrj5lToMieItqC/bm4fukA6G9EeV&#x2B;xUMBATzzvdtFVO2zvwOtgDlqBkZER7Eua8tZascaGXbAsprxY3kt/IHwQbsGQPt3EuLz0qxA7dSHui/XSUVEQPuHAbUvK4Qflfm4O8UtXaNnyeSIWyD17D0qvdyztj3UqeGoYQ3v37MkOb2KM7dy04f0PIxt3HoJb&#x2B;/fufe21jztTtqQBu3btAuyeTqep6h3&#x2B;I4xGsxm4hVH/DXuAf9PKvYUm8mgIRF2KweI/a2XaQrt5EEKgMLYAwB1083BskDieUIxa/&#x2B;sk6CfaC6HCHgWSrJX/C12QcbsA/sPIQRJAIyJNVfNZLaf1ZBOf6yv&#x2B;qbb&#x2B;JtV8odH9nGHo2Ww2l1yohM/XIjVaxJ9q9KnhGjUEhjQ1arhaCdWkmyDyJtjcB5WQXw37lFBNphni/deasYAZC6TBtqdktxM0Y/5Mc1CPBvRojR4JquFAtrVGi/jSTUEtXJNtna2EfFrEr0V8etRnxgJqOKiGg0oIjHP8WsSfbT3fiAa0SI0VEhQa95st/mxLUI8E9WitGvZnmv1GLGi21GSag9CvGvabsdlGNKBHfEqoxoh912i7Lt/1QKb7g6y6cjCnAeiHVzeYz5vJ/vzKluzHz2af&#x2B;8Pw3&#x2B;qz804fWnD64LxvD718z/49pZQU0snOoXkOpnPF&#x2B;EVEULeXFl&#x2B;Z2MDIZJduxjL5HLedUuHB3qkjUSFBXMj4l2Bfs6QrvvvIJ0xfIQw3RVM0YTqJ2f0gS1CSwN8iiViPxjkUheO0d4c7I4LRBcfFKDalkJ25wiMR99Nb/HPZa&#x2B;H1MeBYLCLTKchyFZNh2KQa6ajwwbmLHL8etQgHiUPC62PDE0aC/7GwaEBPCYpxw6bBXrkdEu5FFezaF5Gb83WLYw8l/gT0nXDyErckiEFyikT5JG6YiE8tVrcq8kZoXBn3drgnciwjUyO5B8&#x2B;WyScTXpbw55YMoyjpyEly&#x2B;G&#x2B;qwbZs2&#x2B;10a/CLrVs3b92xq4Ty9&#x2B;3Zt/Dz1o7&#x2B;PGNs/Zq1Hd1Gbk3J5mfTcP6zxhW7bX7pbN&#x2B;&#x2B;faDIB605aPdBNw&#x2B;&#x2B;uZAZAAIEUUMgaouPsBuvaCRZr2llxoWm0JsWcTlY7ECbGCkfQvujUAEiB9ZF1T6KGWixg6b/aM0PBUwrlj&#x2B;6/GIyMuwdJA0glBM0TVNVJWtmcupypftdbdn9Wst1ani2Gg5mmmuMWI3e9byiKIODg9n4x6C/zzQH9Sik2QqCPKBHa9Xw7EyzXw3XpptrtXAg1ejPNAeyLbXp5lojVgN5fNWQ34jVZprRxTaoRwNKKJhtCWRbgka0FKHfiMIOQ60RCxgxsDUKQi&#x2B;g8geXYjMWNKK1erRWi/hzrbVg/a&#x2B;F/ZCuS4/49Wgw2zJbiwQzzT4jWqNFAlokmG2pgRbMWECP1qSbAqmmi7IdvzBWPDKsLMnrPYN5E2SnwcHBwXx&#x2B;KJfNJ/v01s/N958Yfv73gw/Mzs07IzfvDPMv3xpacFZu/tlD950z&#x2B;MaDB/aWvM9dxHVkqhTpSlC4BabpKuy0BBcF/mOBbPncF8szwpGkSgFpO&#x2B;K6LK1lPSO/8U4LiLjfBRKQMpLCYkXxrpMWbNItXo5dXJmiKZoYnSRa41B4R/XfzK6hx4oF2X4cN13t87lYJKFykG1xCQc4glsQfb9Agg6JqBERISNYlmDuAkLSohUMtGAPcEaHgQ9O2asoaYjiDffsHLin1&#x2B;14XQLxCw6KfL4X&#x2B;6/gThyI53sUNE/05dCuKTd0F4QYz7tL4XoKo6MwHKvMqFjFGpWbw7QTv5YOjNk/eLzIZ9QS10tnGh0dLThs0ZSOBXeXcY1TStKnkA/Y&#x2B;h2dFnUvxPdSHAtH6AI&#x2B;JotSmVxre5/01p7d&#x2B;3du37lpz2G8cmjfvi07DzLGdm/fsWHrLkMvxV83Vf3F1z/ftPMwrX7gwAEA05j6F1T16KpLHXyppRA676LWnzoSoI8vxspEsM5hdIT4NPMuhfV4jEFIIbwmmAPhpgRa8CP0R/EDo4JiLTA9QsnEsPIP5HK5oaEhtAUydMXQBpT&#x2B;ZqPnJbX9di12hRa9QIvMVkLBTHMJW5ux2dm&#x2B;l0riR/wDLVKrRWrMWA0k9DVjtammGjNWY8Rq1HDQbJmdbgooodl6NGBEg0bsfC1cY8TOV8NBPVKjhGrNlmC6KQBqezC8MVtqzVhQj9bokYAeqTFis41o0IgGjCj4AwRTjQE9WmPGavVowIjVGtEaUN7rEb8WKW04qOGAGasxY8HkEr8W9hsx8CeGXgJ6tCbbUquF/eBLoISCerRWCwfNljnZZbebXY/n0416ZmUuZwwO5letWrVq1aqhoUFT17LxrlzHksEPnsj940fmX2uHFpyRn3/G8H1nDy04S73724Pzvp2bd1p&#x2B;/hm5eafl3/nn4YMHbIY9hQL69wtzs4hE&#x2B;bATkOU4c&#x2B;nUyqniDuhpZ&#x2B;JFWqVYLIpaAG5IRbt&#x2B;kCtZFHT5Ijktml6YlbjClq0ie0b5rXFxS2kLUzRFx0KT&#x2B;zmdNGoP38kpj0cdIAudnzhFObMQcBjgYKv9wNqjtNpE6YIJ7AwHNmqP40mb5aoUizaXU8pEisXi4cOHRV1CgRD3porE3wBLMoGXSTc6OHZGXwhzZLKS56LVQW5x8crgLo6O2lITjN0S3yeRoAr2LRonlkpFMkkX1rvCK6NWtoQRe8IETsON78GJ7brcgtvM/qoZ8Rjmxi8O2zuJvyCzXh0nWHIFRkdHmeA1IQ7D/VRKBcuAiivP/S7Spmzj9Nb1MWxNjIP27D2UTOdWdmfEW6aiL1vef4iIb3u3b13aqTDGCkeOhCKdHy3sgOs7tu2IRFfEtXW0&#x2B;tGjR3Ur7j647ZokU69JAm6iqQ/Y8OgkiCduDoD8AJsJiONBPACFPYJ1ivJ1XU&#x2B;n0&#x2B;g8kM/nAeVDvB0K0w0SVghHiPsGJUOUwUH4zwkG1Gk4SzKF0XxhuVxO19RcVjPV3myqUe18yuj4o9k6F6Lu6JGgFglqkVolFFRDPiMW1MIBLXK&#x2B;2fvK4GB&#x2B;cHDQHHg/3TzbiNWABT&#x2B;Y3OjRWj3iV8Oli0ooYESDZiygRwHK15gtQS1Sq0f9qaZgtiWohGrUcEnHr0VgM2E2ROpUQgEjVpMJBcyW2UZsthkDZX8Q8L0RDSihoB6dnWrEbYSAGatRw34w5oGgn9mWWi1Sq0dLYokZC2jhoB4NmjGIEFprtPwg0/L7bM9TRqJ5KJvIZY18Podyl6mpqzL9udbPVr//iP74z/L3zTLvPd2897Tsvd9W7zk9e&#x2B;9p&#x2B;fmn5&#x2B;afNTj/jOy938nPPz0//8zsvacPfvDMkUOHxFWDMnwpEyja1U9YkkLtAtkopg2KPJljRHYOyWgvYhlrQWe4vMLtAtHlcY3zTdmjgLhzMzpm6Tjx&#x2B;BgV8&#x2B;7DcFplpDhhAkJCWZpc2HfC6Cs67P8dOgk/Vvv8kWv1OHGcoupRe4oQ5EcUXFLWhtdHuRxhAubjeBkVOQoEqlIjELFTWpI2KxL2Ati6aKXcYoTJUt7HPRS2MBaNngybewTxDfP4rDBaIJKVyPu4N&#x2B;nOekRmygjQp6fMgaXK8eLoKE3MPDo6isKG7ZclkhgZPC9mYElmZ6&#x2B;WN7NtU2VkRGLsxMszZAzu6N/2KdLx2FfEInFl8WgRBMW4fAhScv8Rxedyb4oRaI7gQPr41ArIHR&#x2B;IZPssjyfHD0VXLutMqPoq8dZqXXv0n6/GOhJwunvr5lXDa8NtCSzQurRfzW&#x2B;C45UdnW29tnCihw8fpm67GBEIPQHQhgeKAdRGqQDi5QOORysddKKFjQWE11yzID9gtB&#x2B;IyEmz6tIdAzTmgXYwES&#x2B;OHLX&#x2B;tCL0hYE&#x2B;sySNF3eqKspgTs9rXdn4R/qKfxjtN2rR72Zba83YbCUUhHS8erRGhRCc0Ro9WgN29ka0Ntv/RkmWiL9vRGvUcCDTHNCjgWSjTw0HUk1QssaM1RrRQKrRr4ZrjKjfiM3WozVq2KdHa7RIDRgLGbHZ6eaAHq0xYkE9WmNEA3q0Vgn59EgpVCjsAOTbarVITbZlNggYRjSgRwPZlhrMF2bGaozYbC1So0WCBrQfCRix2WZLbbIxoIZ82dagHgnqEb8WrjZjNdmWWqPl0sGVd5q9r2QzbabWPzSYhf0QEKhyupofWGmEP8i/On/wsaty91UPLTgjP&#x2B;&#x2B;04fvOzM8/Y8395wzOPy0377TcvDPy88/64v4z1bu/PbTgjMEFZ5v3npaff0bukxcPHTpEPzxxpROnJ&#x2B;X8jCy7CKA5yM5hZbpcOrE&#x2B;jj3SNZebaCJzwFWPKyOuKeJCJl0HRcBwosiTKDIFaqfoeNCkm5Z5afakEbvKv2AFjuRmNerdySwdpbdcUEKJSQmKDbDoQFzCCOPg3IhFiExVCKOjNqU73YhA/C2Ois5nbvAITDmWhKIODkxUk9se2QL/pbpjb4k32SzY4ZdNUCmMcnfl&#x2B;EzgtlRy4FYRmkUYPRC4F0hNvGiDnMjBBFyLjwb8VNyxwXc7KqSdpqOlbxUEjNIpWcmcVgjqd&#x2B;FlFSmQ35QD7tLq4pqHzz4yMlIsyKccfAkFYSLQBse&#x2B;XvuWBVdS7NehR2HRKha5da5AZFrSjlwotc2&#x2B;E708s0Qqu3XbnqMjkn5z2TXm0PqhL7bD6eeL2pauVDLZUujPI0cLjLG9h4qMsQM7tzaFOnfss9l6HTx4EAx7MPIP7AAAoa0/WvWg6Q5Af4DvmMALm4JjwPSc5wDaDtHYmuCEkEqlIFIn6P5xGOiZgLb&#x2B;4J2MvgdZEp0T8/KidAHDw6y9Q0NDGAIoaxpZI22mWrTu14zlf81Er9GjF2RbZmeag4kl1ZnmWj1ao0dq9WhNusmvhmv0SECPnq9Ha/To7ExzjRquVUK1aver&#x2B;XzeNIxs/AMjdr4SChixYLo5aMZqUk3BXGuNZSw0lvbLjAW0cI0Zq003B83Y7GxLLfgHZ1sBtdeq4YAWqdEjPvD61SKzsy2z9ehsI1qba60xojVmS60eATkkkGn2mS1BIzYb9gG0SDDfdr7ZMluL1KrhoB4JmC0XqGG/Hq3JtQb1aK0RC&#x2B;pRnxmrybV9L7f0Gq3j3uzA&#x2B;1qyzdRTYNw/NDRU2odRU/ne5dnGN7Mv/zn/9x8NLThrcP4ZgwvOys0/Mz//9Ny87&#x2B;QXnDO84IzsvDMG55&#x2B;Rn3fa4IJzhxeckZt/dn7B2fq952TnnTF839nZe7&#x2B;zuvGtEUuvBB8ex/&#x2B;5VUnqjsUYKxT4fQNai/G8Rd6XvUGJ/M/1K/Yi3hV5hVBM0qC0C3GE4nicFneXAUyApO/BvespmiInOuFirRtJogAx&#x2B;ycuVToWCCFb4TgRloQLcErhJtcIJ0UU7YmosLWiQ6pdkYVJtQtcFcRbNMZRsSABagUiF&#x2B;HpyMgIB5UK9pQujJUi29AH5GQyEHgKoyPUaArrii&#x2B;f/gQcM8IDam6OQJ8uKszm/&#x2B;rIdjlVtwvQpLecjODhJeNIKOAuCnF&#x2B;OHszOD169Ci1Nhkl3swuy9sokQfEsYlVsExp80dA6uKr8CK&#x2B;u69VRQuac3LIuNqh4h&#x2B;3QIorNLM9jjNXoj&#x2B;uJZZwbZ6Y5TCZzq5Zu1l6a&#x2B;MX67ft3L//UGkM&#x2B;TXbGGNrN2xnjI0eOBBPmZs274Rb61d/MaCszg1votULhQKkAKMxN2mkfwDQ6Nqrk0S8ALVRVMiSLLli5E10CwblvaZp1LwHCqNBjmElGUAboayVoku3IpNCAFDE/aaVqwtawzie1HUY9xx0TUknVhqJ5sTSJ/Wlv9Vbfphqqk03&#x2B;Y0YIPWgEgqasdlg8KNHZmvhICjszdhsM1ZjxmZnmmvAkl4LB/Te1/L5fD6fy8Xfgyj7SqjWiM7OtgDUnp1vm23GanKts7VIbabZn2z0a5Gg2VJrRGtyrRDUf7YRC2ZCQTVcm2kOqmHQ6wdTTUEtMtuI1mRbz9citaDjN0oZeWu0cDDT7NfCAS1SY7bUGrGAEa3RIkE1XGvGgtmWmkyzz4gGUk0BPVJjRP1qOJAJ1Rqx2dnWWrP9Z7mVDxr97wybXVkjbTn05kGSyWnK8MCK7KJX8y/dNfjIJUMLTs/PP3Nw/hlD951j3vud3LzTh&#x2B;87Kz//jPz8M4cWnDW84LShBWet/uvZxr1nDi84Y3D&#x2B;Gbl7v2Pee4bxl9Oz887MzTtj1X1nDIc/pIuaE4KX6he4&#x2B;UtPuQTwTuoJp4vSLoTuxmaKE3B3AhIuA5CiC5e6XpiM&#x2B;&#x2B;M7KVDKOrC5DGyKpugrSifR1Z374jk/XbhIdbHgUMvIvCoSZTM1C2F2OM5ppkHfz2nTCzL9Op3btGTBstkQnThFoFa065gRBYoAnXpE4F3cnaAQdgzaEoAoshXOAAYvjo6OMmskIyMjAIbpg9PNUyJa2OAyEA6yOBbEidtC4X8IJjBiummL73x05GiRANMx7C71jiCt0TL0O6GDpz&#x2B;cEy5HSYbZka74tkt1ZZwa9yucoDx5nzJVmf0HLbsY4GaLSxlh7ZHIG2VJiu&#x2B;5u1zjLuXhnkvJ0mm5BX5yafUXG&#x2B;NJY0QmamW1bFePitN19ZpNjLEN6zcxxo4e2L8k1NHYUvIe3rNt89qN29NJPp8AqudBx4&#x2B;OvOgEDP8x7j5E&#x2B;czn8wDQ4/F4lmTLMknKLd0KzA9YPJlMYoxO6uNrkARbcAs6QgdilBPAmp8G6aeOCjBCHAY6H49F/jFVLd2p9n5krHxMb/&#x2B;NHmtQw4FMqEYN1xqxGj06W4vU6tHztUitFqk1Yuebsdlmy2w9OjvT7Ddjs5ONfrOlVg3XZJr9ZstsNVxSwGf73wQzJaPvTTU8WwnVGNFaIxYwW2absdp0s0&#x2B;P1maaA6mmGsgKrEdrkktq9GjQiAW1cI0KOD4SMGIBNVwDGwhKqGRlBJF51HDQjAWUUCDT7DNiNdnWWhAqjGgw2xIwY7P1SCDbOtuM1erRGiNaq0X8enS2HgnmWmdnW2qVUI0Rna1Fzjfab8h2PTqYXmQoK3UtXcppkM0C8NdTA/kVsTVNr&#x2B;dfuH34b/X5Bedk552l3nPG0IKzcvPOzM0/OzfvrPz8M7L3nja44OzBBWcNLThzcMFZ2XlnDd93VnbeGcP3nZmfd4b&#x2B;lzPz80/P3vudoQVnDd939pr7zx2cf/oXHY3USawoLLgcU6LAmhoo2ha&#x2B;UvlSC9is/W6RNkXJHeYW7eHX6Khs29SuWgYnnkCXEpdaTlowceRemI9YhhvGl5&#x2B;&#x2B;KuN0of8Hj/D/g04SrhQRZeKPhCCGMpGCLMkUlB/TGcuU1nDMiQeM1EUsPtYsFSRIRl5bX8IIOTsQWrLEp6z9BGDKlDWI0gt9RotT8xsCR48eZZYel2PW9OVyzUonAw&#x2B;miXzCmFzFXrCU6FDs8OHDYmHuVygUCkwmD4iNi2Nj9jcMH82oldaA64gzKKKfFteFGDW1YG0RiCMRRQWXwJo0mJI7jY6OuV7QYYijnQAVSYMFy1BKXPzoALgFkpO48CIjHzb0RNsUpTLp9bLuvCfe8gdp5659kZaVI6OSZd6ID3zwYWhowx443bR1D2Ns7ao1IO0lEtn2Lg1uHdq3f9GSpe99FKPVjx49irAeTHpM04R4oKDap6H0qck&#x2B;WOaAqKBbBLF0cKOAc9WFoD2gwkeXAKwIxvq4P0DxPSboRTfffD6P4gH15UXLfrgLuX41ZSCrdGo9b2sd95hLrzdic/To&#x2B;VokYLacr4ZrIQB/urlGCfnN2Gw1HFTDNSXr&#x2B;dhsLRI0Y7Ul65pYUI&#x2B;en24KZJqD6aagESsp2kEAyOWyZu9r2VaIqlmrhmt0SO8Vq9HCgPtnp5uDEAYU4ntCqmCzJQA2RXoUDPdnG7Fas2W22QIyyWwzVpNpDmoRkFJqtUgNxAbNhGq1SDDbElTDNdmW2VoE/ID9aiighsHlYHa&#x2B;rVaNzNHbbzG7nhhSmrNa9/BQTlUV6xXl8tlsLtWf7QjlF76Ufe73qx65aOj&#x2B;6vz80wYXnJObf9bwgrNy884YXnBGdt5ZQ/edO7TgrOy931n117PNe88YWnBWfsE5&#x2B;flnZeedteb&#x2B;c/MLzhm676zsvNPz88/IzTvdmHd2bv7ZgwvOMuedNbTg9PUrI7iUMEH3jwe4/hbJNriIgwt2ZRm3YNFjUdlBV0wpbnZXKDCBP1NFDHNgs&#x2B;LDeiFuAfVeUdqWVGwoyLY1Jpcmpf2vNG4&#x2B;3m94iiZAJQGgINOFU0G/MKb1H0PqUv0xl1WK4y8iW6GIn8d8ggZdHCSFmNjyyMgIsFDonfrjMjuiArJJBXadR4GonK1aYy&#x2B;HaxnFBmwKRwtiBtqxYPuEcY8Nr2jfUeHeQOnAEjlEgyjOBom&#x2B;KyrGjL0NEsAHewT5wWkAnATCme5I&#x2B;SmHnuk6AWOgTzdmeiSLryohB6/xgiB4cIZGXoj7LMdbV6yFi7p1y1ZGqlpj9oXWy2gZmRQU1ksXVBcoUJ5KtU4Ef9&#x2B;1e/&#x2B;Onfu4i4XD&#x2B;5ub2p967sPu9Bq4smbNJsbYYG5tkTF29MjKrtT&#x2B;Q5bMeWBvONz52ttNqazNCgiN/sHQHwNuggEPIHgMBorh&#x2B;dEUB&#x2B;PwoAofYDrICRhsB23xUeVvGAZkBEP9PVTEA1BOo0kPdocyAzoSoJsv7ACYhmHoGUMbyCttRvdzWvstesvlevQCsMzRI7V6JKBHa4wo4OnaTPNss6XWiNUC7tejNUooCNp0PVqba63RIrA5UKuXfGpLtvVaZLYRrTX738rlclnTzMXf1aO1Srg20xzQIrVmbLYeqdUis7VI0IjWmi01qcagEoL4/TVapFaLzNajwUxzrRKq1SK1udZarVS&#x2B;1owFs621ang2yCFKKKhFaszY&#x2B;XDLjEEwotp082w1HPw/9v77TY7jOhfH&#x2B;e98H0vAhokdZ3YXzCQAksqyLFmSZUu2LFmBwE6nGVDytWT72rJsf6zgawUrXisQuxMBZhIkCAK7M9M5zSyYRVESI3Znuvv7Q3XXnA47AClRlnVZDx9wtru6uqq6wnvOec8puY3iCJWVNqF00AEFlH76Ou3eT6gP/aN2/k518Iht6aijLMuyLNPQVGdw3r5v0/rBP1r/&#x2B;GGzXlWPH1CPHXC4Bat2QDt&#x2B;QDv&#x2B;VrN2QD52cHj7QXP9D8z1txjrBxDtx6wtybcfMNcPqscXtOMH9ONv0dcP6OsL2vGD&#x2B;vE/sGoHzfUDxvqCxS2Z628dfPat2vrSk&#x2B;fum84W29jSCpavbLkdTlX8wwcpSC0diW0uUU4izc&#x2B;Qfjs0SmcWmLg7p/z5bwz/3O8dqSUxvWbun&#x2B;aZJuYvhumSM7eV/9GQ/c30&#x2B;5HmjOSrEkAzgQJ9QBlH1BQ4/zPBzX5oaZoM/5Kx9nlA6zkF4eFTq0wMteyHgBONB7WNSfxQHvCATQBWFRWIeTVB3CDrAWMIRtvp9Q4ux0Ekn&#x2B;BWwB9BXAm9t7cLD3KHgBvlx0cpxwwXkctpiKSnMT0NfAv&#x2B;HEhwgrWFixqmOaGUpWuPxWgK4op/LD4FYJiFJadOLoNDywda7dl3yRqHPtDlJMbDNB4J2wMJ50nQddJ7W2Kgxl&#x2B;R6I2MB2PzJR7OKFE&#x2B;rlKiAml5GP7lxU0l&#x2B;6nqswQAPzNz4jOlO&#x2B;R1CgyvN5nW43ff&#x2B;&#x2B;izz/0qcf3l53/&#x2B;nW8372w/8kJWmKX7Tt175uHtu&#x2B;7ffjmKEqpr9kb3kZ89/xLMhjA95sdjBg7698KFC0hCwMQefBoAAt/IHxdydeCZXNh5F9sTcHAeTN1BUfnRe1VVRU66UDDAan78J6otzolFBVXpa8Mz2vkf9e/9m0Hvw9vNa9UONWwRF&#x2B;5ECntC7RBKm0A6cqVNKh16e7Osdim5HSLvYYtQOqTaQfp4YtAkhi1S7VJKh0Tc&#x2B;v5mSekgjE4PW9SgSalnvxkeOvbwV9QOOWyRwyahdrG2nta61PYGoXaQCr&#x2B;M4n5eOEn2N5HLL2INUVqPGrZIrUfLbUppl5Q2OWiWh63yoEkpHQLF6tk6SahdUmmXhy1KblNKh1TaZaVdVruU1iXlNjloXa/e8xfqmX/Wt7umdsHQFRTJB53Xa2qKvX3WuPtO/Rufs/7uDw2BUo8vDG8/aKwv6McPWLWDxvqCcuwt5voBs7aoHHursf4Wi1tUj73F4hYsbsGuHTBrB431t2rHD1q1A0ZtweYWjfW3mLUFi1u0uQV9fdFYf6u1/habWzJrC&#x2B;qxt9jcQW196Ylz93lxVZrv&#x2B;35KWTYfECfmb3p6JhA/TImNA6f0dpnOkFisMl/hz9Wm7wf9568q6fV8ToHplG7alZeQtVS&#x2B;5gqka/JmejP9jqSr0qAngREx4kzAlDRmhclPpQDAprQyGEsaGCpNJhMMYf0oLA8&#x2B;CAw9iIBvYoZ7KSpLAiAGWRSaaRxhBzFTxiyeKdLi4z4J5QHfT5fsx7sUlzCN&#x2B;6360bNQMw15oh7AczgzTn5c8QNfNPsT6ZwAgPaBXIf6MN2N6VGRAM0oBOcEx/L3/XST04MK4Wz8xsQukpY3ghTaxt0V89CIvB1wRwXxlNj5puAAYDgUoTwQZY9D8EjEutINCWa7AtVXQq6IsmW/C36115fwKMrc1&#x2B;dubymQ8cYLA08/84tz59Uf33l34vr00qudO0995RubxujZ9FNn7n/sP7998r4zQ8t5MgiCYLLbad77s&#x2B;de/OXLMbETn5&#x2B;FovUj6I9QNYyqCYNsoihASGDAYfsxRkemA4jakRlBAyH5YbBOdAgAFjNwaCDkVYx1/CguEPToRUR/Xdc0tT&#x2B;8cM/2g99UHzix3Xn/oFWV28SFk&#x2B;Wtk4jbU0Y6&#x2B;&#x2B;3N8rBFKR162ELonOpvEkqHUjq00qG0LjVoohj5SPVOKR160KTkNoE8AeQ2JbdLwxatdGitR8ptZtgilA6tnv2Gruu6rmln/13tFAdNAgX8Ubs0MgUgQUJuU/3Ncn&#x2B;T2NpA5gXywkly0KTULiG3CKVDowpoXUrtkINmWelQWpcYtkilQymdErIJKB1K7ZB6j5TbtNIuD5uE3iMHTWLYOard9xn17P9Rtk5b&#x2B;rZpGroenqJgGoZtqOa5h/T299SvcfoX3qnzpRDQ80tGbVFfX9SPv1U79hbt&#x2B;IKx/lb5GEL5C8PbD9jcQWN9wVz/A7O2YHMLJrdk1g7a3EH1&#x2B;EGbO2hxy3btgHLsgMMvDm9/q378gHL7Wyxu0Vg/4ApL5vpbkauAVivubJ9Nb68BsNH5cSNtADY1OFZhhmmcMwkfzFxeEph7P/A9B3bPvXsZBcF8AuF&#x2B;ldmvwnMXqCt6xfxsmcLD63jpm2m/9KZQ9Mal/foWqm6vAuyXmH40uh6edZUBevzo9NzUWjYFYV6C&#x2B;FyCUGOmVACepgk4gvA3&#x2B;p3gkQeQ9hNG64&#x2B;FEkog9QBwbzDpP2HHTPwJp3oac8OqJroo6kAfuZwmFmVYsQSIh6/2/dCwgPNnrKcpGI1lidBFGETbxCcbJIDj7FuDlsKtAnZpEMRY7AFg6eAOwX&#x2B;iusB6wsrDrzxJbWOhZAWizaIWB6mEwT2E9bDP4wLhvOU7c8XHr5jDHfJnbN2ZPSo9A/EVGHUKc8Pmv&#x2B;KydU5UeL9TjTM3sCypIzuof&#x2B;rx3952&#x2B;OJLu089/byijdO3enedPXX/&#x2B;bOPJV17gyA49/D5b32nfc9ZFf156cUXzpw3H7xgJbIhvT46yhfR/TG/XwFHbiGOEPYKwLF3MEzHUYMw6MdHB8CwP5CsjwP5Y0AP8T32LcYXUZyfiOqjaMoF&#x2B;Xxn8OBXlHtrcu9tw3Zl0CT6m5TSoeUWpXVJtUNtb5T1Ho2U&#x2B;lsbpNKm&#x2B;5tEf5OQ29SgSUaOv5TSphAjSG4TyDFA71Fyi5TbJOLVbG8Q25s0Qupym0Ix9ZHRYHDmP1RVMQxDPfOv2xuE3qMu3EkMW7TSJuU2AugkYvbrPWbrJDJEkKhKWo9R2pRxitreIFAMULUT8oLULqP1qPN3EmqXGjTDEwC2N4j&#x2B;ZlnrImdfSr/rbfoDgvHYN9Wt044lm4aB&#x2B;scwDEWRjWFfP3OX0/qO9dVj&#x2B;l/favBls7Zo80tm7aB2/C02t2DWFkxuyaot2tySvr5grB&#x2B;0uQWztmjVDrr8QWM91Oub6wfkY4tGbdGqLTj8kssvmrUFs3ZgJCzrx9&#x2B;qry84/IJVO&#x2B;AIy8qxA8qxt6rHD&#x2B;jrC&#x2B;rxRYdfHPFvNaRDPzOGs&#x2B;UUzbi4u13m1gNX1zkQOQBbKr6bkApgNpxg/vDPK8O4iUUj/a7L4ub5AsaVXE&#x2B;LRnMen1/4nPwJeSDz1b&#x2B;p9CYmfn3pd6fffndqctl0FV59EtAN5/CBtjixVKUhHVy/EoX4gKuz74uic52gche/IiJyeOl56O9zgmy6wX4UnghXA6rPUfn4dQkEnKkl9TwPXcAF4mLR1SDC93t7e5O9vSB&#x2B;8iuspDcNoyF5QOeNy8Q8HwBGgSd0Sm2Puxon3Cj4NROrtu/7e3szoSV8F&#x2B;A&#x2B;pfeYAAyMRM97cWuMH52qhsB9wlqCbSPwmILZkPNn4haEtgmeDG5gNqKFz2KKVJxC5oNjpxPPZjYK9vysc7JErERKa&#x2B;Oici4vA8zLkzILeNMMoSj53tmtFGJIm1bCu/8NmrCtgXXm7DDz1uOjnXseyRAAHh8/3jx17vTdZ555IfysP/vlq7bpJLLhQ7sQKV8Fx34hEI&#x2B;9crEpAGniEaCHJgL8A4kTCKknQv2gPFhUwLE&#x2B;kQ0Bnj&#x2B;A2T747bqua&#x2B;pQHTwyeOS/hvf/w&#x2B;DUR4fta5G2fnuTGLboYYtUOsyFO8tym&#x2B;xvlgdNatgilTaBYvuc&#x2B;0l52KK2N0itS8ltZnuTVLv0sFWW27TSoYct6rGflLUuvb1Jal1a6zHIGoB4PsMWub1Bal1ya4O4cJJSO7TSofVTjNKh1LPftCxL13X1ka/2N0m1Q&#x2B;o9Wu3S/U1CbpNKhx40Sa3HqF1S7ZTVLgo0RMstUu1Qaoc2TjHDFqH3KOMUFQb0bBNymwrZRC0KeRooHUI/RSsdyjjNqqffM7znmP7Ydy31jK4OEMMH1cGyLEsZ2Gfv0X76Nfvr69b/ukVfX3B5BOUP2tyCcgzF6V&#x2B;0aova&#x2B;iISAyxuQVtfsLhFk1uyaget2qKxftAVFtVjSIu/YKwftGoHbG7B5pdc7oDNHdSOHzBrCza3aNUO2NyizS0Z6wf09UWzdtDilpTjC0ZtUVtfNGsHDWntZ5aSGHWJnWUKdGH7TQG8MsPdFuSfh7nT6zP&#x2B;AeWBdIYgtaenU7rm&#x2B;&#x2B;P7GAU3LdjAl85WrXDbmmeaSD9&#x2B;Jdled/7MRzKlhTfT71l6Haq638EKXJWGSnD4&#x2B;nHtKYbOwT7KhgRmhUtGiF&#x2B;jVSZR&#x2B;729vZC/nmVw8ICyHN2dTqc4yk2iApClA6uN8Stk2qBHE7AY/4sexK1GdBeUEz2L3pWGU1gAQOIBaleiT3Ah6XXTj9/CiB8/m0kUwX3leTPTQRD/jrhi6M/d3d0EgkffAsa/z5TlcOUxqsbfBUJ2WCvcSxBwJzY8XEisRXGIn0Sx3kwcCh8EIhzoXoTOw8OVcSHom0JCUSZcjq3pc/dm&#x2B;Mlw23HPe1kyc0zOidLkshGHsqI2wYYn3rJvOftsYPvk9ZP9H17Zdwv/DaaXX9l97vkXN1v3pyOBei/98qc/bFk7P898cHtLufvus8&#x2B;9FPbnk0/93HWfSOQxDAOFAIIWAHz8FrqytbWFY/VgJwEkOWCgj3A/ZgqhPEhtj4MC4TieSDBAFgDs9Qsj/&#x2B;DY/0iZrat9tX&#x2B;/fPaHw3sb8l1/Nuxce&#x2B;EkLbeIQZNAwXy2ThKDJim3KLlN9zdJuU0rHWbYotQus71JDZrkoEn2m9SgSSptenuDHDTJQZMeNJHMgEwB9LBFD5rEoEkjLhBS8Os9Rm4ziLKvdOitDRKhf7lNym1K6TDquR9almXo2vDBL8ltanuT6G9SF&#x2B;4soTg8wxaphBYDSutSShsRjUIGv9wqI1cEpUOrnTCYj9yi1C6p9ehhaxaKVOlUtLs/oD30Be3c90zljKEr6CQEy7Isy7JNwxxuWY/cbf3kK9qXP67WrzNriya36ApLyrEDZu2tVu2Avn5QPXbA5Q&#x2B;atYP6&#x2B;kGLW7a4BX39gLl&#x2B;wKgtOPyiuX5AOXbQ4hbN9YNmbUE/fkA7ftDlF/T1RYtDaH7J4pA8sGBxi9rxg8gxQD520OIWjfWDxvqCsb6gHjugHfsDs7Zkc4sjfsE6cd3PXWO/aZJYYxO/E5MOLqfpR/AVuJOmFhM/oYpKVyO9/uDFH9YE5kzo&#x2B;NJr3Zw/Y3tEfH8JsnbJOQ0PfgfS70g1fu/Tm4LW60i402YUoPQakaAl4MmZoBZAQIlS3BXV9&#x2B;In&#x2B;&#x2B;Ia4AUC098nkwnizKRJL&#x2B;mFDD6b1jrgx9Gf2Ek3AAuNB45IxI3aj3qOi4VK&#x2B;rRSBC5hcK2crV/hIhpzXYUFwA6BFUu0PRGC05tOPECkmQkAkXUi2GeqwB7G/YNPZsiUNHAbcQyixMcNZut1hhgZSlzeFMqT6QbCKiXSXvw0TWjDgX8m&#x2B;FeJDxrEByosLd3k&#x2B;CtiKn&#x2B;cwc/qZNzzeEikpV/cqMw3wtqmnwIp2m7nqPnD6/utmBmQIj04M8uE6Y1bkV9&#x2B;ZfenG/c&#x2B;8miGBWDvlVd&#x2B;cuc99z2WJPag9OQTz953/2NPPvsC&#x2B;vOhB88/9HA/kQe76mLHXKTjR2gesvMRsQcJA1g3j1x4sRsuNgggbg&#x2B;MDoS8jRVwujCm/SBlP6YPGYZhmqah64Y20Af3Ko98Q71fkHtvUzorchvp45lBi97eJNFZvHKbltvU9kZZblHDFjNo0kqH0bqU0qHlNiO3yUGT7m&#x2B;S25v0sEXLbUrtItmARkSgCyeJiDVEI89dtcuqXVppI3EC4W9qe4NU2rTaoQdNFGyHVjrssMUqj35fVVXLMtUz/4xkBqVD6aeYYYtSO0j2oOR2GFFU7SLXYbq/SahdRu8xgyahdQm1Q6odWmnTSpsYtqitkyQyRKjdq5W7/lR54Avm1k8M5awi923LsizLdV1N0yzT0LbOGfd3zB9/xfrXT4w&#x2B;f63JLRk1FJRzUT2&#x2B;aNUWbG5RW1/S1xfN2oLNI6rPgnJsQV9fUI4vyccOmtyixS063ILDLxvriw6/qB0/KN/&#x2B;FnP9rWZtSTm2YNYWtON/YHEL&#x2B;vqCVTtgcYsWt6AcO2hziza3oB4/aHHLZm3B5RfUY2/Vji/Y3KJ&#x2B;/K1GbcmqHTTWDyp33PLs2IbTKnMe7bdKwwUkyFoh00LCfqqKxL6TidQz0Xn8&#x2B;mUA7pw2JuuZrN5sQ5&#x2B;zZ&#x2B;1Xcub1y8Lx9Lqd&#x2B;ZY3Yf2b6fcpXRWA&#x2B;Iz7zbrEnN9PW5DWDXj7WwkSv3G2NMqBCx8OF5OJaD2grUfrJSoWGR9gAJkEUoRIdD&#x2B;4nFheEwAdrmV4sUasFaRd9lIpXSzUQ6fMFLHM8PFIAIDa7tBPNsiC5lgYA5KMF0TOZL4f8qmwSIZrmxRX/IxTdQMAoFG3Y7V32lQCH0l/1kyUDOuAMHcmXveipqGEPxYcjZ7nedMJ7uHEDpeQDeCeBBPiMsEr6Y0z3cDMlP5S6XIS5SdNJWDGQXpV5k4GX5SYpIGP2f/zN79Unstt&#x2B;b9m2t3zfrpx37M/&#x2B;2Xm3QfuP9&#x2B;657HsJyeTZ596&#x2B;t&#x2B;/Hcb&#x2B;f&#x2B;zs1rkLxviJmLnAsiwY6R/H1cHngmGvXBiWB7N60FP4MGDsM4DFCRw2FBFU1OjI3jByDggkiohAijJQB4/Ij7X6939JvedTSu/IoEkNmpTSprc36EGTltus3MYwmlQ7pNxmBk1ia4NUOgzi8ygdZtii&#x2B;01m2KKVNpIEyEGT2d6khi0aQX&#x2B;ti3A5deFk6AygduntTVrpMNubSCvPal0GafqNU&#x2B;ywRahdRj/FKh1GDV2HGbnNqI9&#x2B;L3QCPvMluU31myicPyqBUrsUUuSj6P5Kh1S7jNaltR49aNJKhxy2SEQ3GjQJvceqXUbpMEr3pkHvj41Hvmxst0z1nGHolmk6joNEI9vQ5Ufut&#x2B;9vmd/7O/UL71bFFaO2aNQW9fUDRm3R5Ba14wuukDO5JWN9wawtGrUli1sKOf38knp8weYWbX7Z5pe14wcdfhFJBRa3qB1f0NaXLG7RqC1pxxf02pK&#x2B;flBfX3T4BYtbGt5&#x2B;0EAeAsKShahBtSVtfdHmlixu2eKWLG7B4Zdsbsniloa3H5BvP6geP2h84b2/fPqJYDZBwn/hFgD3IPxvECR3nwCsZnDVmrM4zO76frBPFL4gNXn3EVGyQwnNkSgy86TrMOfBdM50HWKPp6wob1x641Qeb6b/6elyarv/5nQVVjbjhOFaJkhNoHww5WJH/3opD9cIlIbmgkncczQAwNSLItxjOIgBNKxGoiUJbX1USS&#x2B;NOzHlIogvo5jhE8SxFMo/mUz86CKuGC5zb2/v0qVLPiDYJKQID7B64AYAJQfYiqy11YcpTZ5B5UMCPRIMPKDRh52TtrFellUGpRf4OWb9tk&#x2B;cSs/zJnEpKIawwceF/eN7M2kEDb0gRuJHo3E2JhFMT8h1uDLT6QQNCC8ybiQ&#x2B;YkL8SFjAPGCWwXkSnw921H4dGKRiEM3v&#x2B;YzdCwzRhP3NS4ncMCaSH5/RV7LZJ5qT1a6oqKwt&#x2B;TebfvXCK9/6TnO883R2JSfeQxdGmbcMzbnzRx3FCWMEPfPM863emWd/GQsainTJ29vbqqpeuHAB&#x2B;/4ikQAjdaywV1UVHgGGiEDI8dQ0TfQbh/3BlgF8whfODKP&#x2B;y7Js6oqpPKKc&#x2B;9GF0yfkuz4id24ctujtDaSDJ9QOM2gyegiama0NBP1ppUOhQ7LULoN0/8MWo3RCsK502GGLiij&#x2B;tNalkeSgdpG&#x2B;fyYtqF1a7VBqh5Lb9IU7SXRr2KLlNjNsUXKb2ToZloOIQ3KbUtq02qWVDque&#x2B;4Ft24ah6Q//k9yihi1q0CT1Hql2mP4mrXZZpcMobUpuI5sDqZ9ihy1y2KKVDqX1aK1HaV1GbhFar9JvHdbv/6zx6NftYcsy&#x2B;ooyc7bWdd3UFEfpm3ffaXzzc9Y/fNCSaIdfko8dNGuLiNavry&#x2B;atSV9fdHhFo3aEorbo68vIqCvrS8atZzJ5/XakllbtLkFm1821hfM2pLFLVncsllbtLllbX3BFRZdIW/zOXSUL7pl1hYcftmsLbr8os0vWdyyI&#x2B;RMLo&#x2B;4QMb6QXP9oMUtIT9j9fgB&#x2B;RiSHJb0L/7RC88&#x2B;HQABIDFVMxcNuFXhK4kMQRbvPzENZ0&#x2B;lxIbEs9CiDnecVJl&#x2B;4l3zVRiZtbryPHOKvfI3zn/7mzj&#x2B;zfS7k17fNnpZCJdIVwUABE&#x2B;nMV4KxkMeCB3jx/n9cNny4qwYhEumkVsthiae5yFuRrqRuMBZMyJDAWR9ZAF9H8OgNBjygR4avhHDULi6JSAUBIIQq8G2Y79kuHQmugiiST8uX&#x2B;HM0&#x2B;k0iBo7Bc6suM&#x2B;RjAF7zI8y4XL2dnchTIffJQiC3d3dS5cupbcQz5vCpxLNnEbBW4OUMns6nUxT&#x2B;vu49OjFdpSseNLwT3zaAG4&#x2B;LD8RQDYcsdOpB0B/EASTvT0/XmB6f01i8bjiPJZ8H4/Y/ZIPCFHpRu2XEoMN5PcTFc5cDnwwpGPDOEs8zqzz/OrFcl7OBRDlQ/&#x2B;7wmJfRzp9z7mz55KelFeSnnr2BUyxev7Zn7nO44kvOhqNEKxHvrZIYX/&#x2B;/PlETB544C7iBWGLAWL2o4tINtje3sYBPaGLMDYgoOuWacqDR&#x2B;ULp9RHvqHcV1dOv/f8yVWEvBHUHraoYYvpb9JKCMcppcMoHWp7kx40KaTg7zeZYYsdtmi1yyC8rrRprYeQPXoEIXVma4PSe6xxKryIzAWDJqV1Ga3LDFvUhTsJrUsPW4zcptVu6Om7vUEqnVBaGDRJtUurXWZ7g0a8I7nNGhd&#x2B;YhiGqirKg/&#x2B;AUP6gSWtdSu1Sajd0AFDaJAokqnRIpU3pPVrpMHqPUruk2mXVU7co93x6eObr5vAuQ9uybVtRwvj9uqbZhmacf0Tp/MD8j4b6N&#x2B;8wRAoBa5dfNLllg1s2ags2d9CoLSJnX4vPO/yyzS8Z6wsWn3P4nMkt29yCwy/otWWLWza5xcHtCw6/YPNLBreMQgDpxw9a3KLFLbr8gs0dcIVlo7aApAibzz3yV8vq&#x2B;pLJLdncgr5&#x2B;0KwdNGoLI2HZ4hbHwqIrLBu1RX19SVtfUo8vGusHlWOLTlj4svGlP3/hZ8&#x2B;kYTdKfhYzELMKk1L9bDJml4azpde9tCCxn8yQLjBRk8x0hTB6P3kmXZMreWm6V9PFzn/jZdOb4sF/Y/qf2/lXXvPXit3Tb4ElzLc84JwhBQj9EQusDpSLGIQlRPxogUnGaIfoczqdBkFMfZgQG/B1uAxh/JeIUp&#x2B;Yw7g&#x2B;e3t7yJ8VXvcj9wOIwiG0xe&#x2B;awc3p1Pf9uBuxj3sDx&#x2B;HBrQi7KFLtQwkq0VGe5yXOivIjK4fnYZV0LGAOxnN4BYwU4T7ODyD7dAo8E1ATJpMJNAjg37g0FMsf9m0CdE6juJ&#x2B;4MnBIYPEDXsddgR6cTqe7u7sztD2dhoegpQwdaSjsAe8R&#x2B;NXQmXRwqATxFLYCEKKCfbaEWQCiucEocB/udzedrgRe/6YK9ObZEJAVK8NYkZ53c18XTsRslB&#x2B;hjStqya&#x2B;R3NHTp&#x2B;46m3nr/vvPpQ8JRmlw7rEHH3rsxSjw/9Zj/e98v/vkL2JOF&#x2B;g4LQTi8UleyIUXM/Ux7Qf9izPjGP9Io2&#x2B;apmma2CaAQv3A6J&#x2B;GYQwGA0UZ6soF5XxTPvNv&#x2B;gPHh91bh&#x2B;01rVcZNMlhq4IQ&#x2B;fYmLbeZQZPubyK1PXbYDbX4/c2QFyS3abnNal2krSflNru1gTx6Wf0UpXVJpVPRutSwxajdCgr6KbcpuU2bp9lhExXI6D1GP8UoHWbYYtQOhfJvnaSUDqH3aL3HIGS/tUFGvCBGaaP6sNpj/zUcDh3b0s78b7VDy21G6zJ6j&#x2B;5vUoMmrbRppUMOmtT2Bgo2SqohQaiinX6Heh&#x2B;nPfpNY3ifIl9AYXxQPB/bttXhtv3Yg3bvh8q/fMr6wtvsE1fLx5cdftmsLejriygMv1FbcvhFo7ZkrB80uZy&#x2B;vqgcXzK5ZUfIWbUDRm3Z5pctbtEVlpXjizaHKECohCWbXzbWDzr8kr6&#x2B;oK0vOfwSOhbA5pYc7oCxvmDVDurrS50/Lf3NrezHb6w&#x2B;&#x2B;KlFi1/W1he09SWXXzC5JYtbMmtLZu2gyYXRhPTasrF&#x2B;0OZzI7FgcUtm7eBIWDK&#x2B;9Be/eu5nQWrGwQ0usX6ClGGETyYQWgeWHMQN2ri0TGCNH4R/zktJ7UP6vg8rkygfJS&#x2B;1F2S9J2N5ueyD&#x2B;92CpaVjvr2Z3kz/UxIE&#x2B;oll4UpkgKsS9j74ZALHh5M8jKYSMfizVgpwjK6H/ofJGGkgjh5MkHxwZljsFKQgvrpBhXEAVkkvro1GtzLDCwAk7QWQ0wKQKM4WE2/ACjsrMA7fQR&#x2B;CgKrTKY4yBJsc&#x2B;H4Q&#x2B;JAvBPcGiIZDQIY6HMhIs06LgD6W5dJWWvh7Clhb&#x2B;O40Tmfy4sIArCRMuJ&#x2B;nkQsEHHZRaUm7E9Sg40d8ZESI85eCwE/WPHoWyzkTIJiFnx6IQ0EWCQrfTewc0IAT7J8SpxkkEuqxvb1dNDqxjQK3LpE8IHjDswIyOzOscDYyAG3JCpiL/4pdiUZXes&#x2B;GK4bv&#x2B;2lhIKMOv6H005P3uKMnM289fvFpxXzqZ794JX3r2Z&#x2B;90B8YP9w4g/7ceuTRO3vnEnmeeuophOYx6MeMfBx/E8cDxQ6&#x2B;yC0YRfiBBwKgB/H5vujIsFD3rw214SPy2R/07/1r7Z6PK72b&#x2B;pvkINTrs8MWff5Our9JD1uM0maGrTAsj9Jhhy1m2GLkNtPfpLReCL4HTXoQZqCVDqN0GLVLyW16e4MctpBUQG9tMHKbPn8n2W&#x2B;GUsS5n1CDJq33WOwtMGgxWq86bNFaj1W7zKBJqx16e5PWeozSYfVTrN5j5TardGj9FGuerigdFokcSodROrTSrVr9O03T1HVVf/jLwxatdRm1S29vEkiuGLZItcP2N0mlQ8stetheVU69V3vwjsGZb6vb9xn60DIN27ZNM5Ke5IF&#x2B;5i79J1&#x2B;zv7ZuNK41akt6bcnm8zqXR&#x2B;jfEfJGbVlbXzS5vMHlTG7Z4HIhq4dfdoVlk8&#x2B;btUWTW3L4RZs7qNeW5ePLFrc8PLZscUv6&#x2B;qK&#x2B;vmhzC9r6os0dNLmcUVvSji86/IIrLA2PLVrcssMvW9yyur509hPFPySv/f8duO7W1WvPfHrZ5Jat2oLNLdn8ss3nzNqixS33j&#x2B;Wt2oK&#x2B;vmRxi3otZ/E5l1&#x2B;0uQW9tmRxSw6/rP7TJ1954VfBbPpcVqsd/vD2J&#x2B;UGWetwVlFAbxUHzdPU4oPne&#x2B;x6fBFIvyUdWmAf6SK2sCcaktnAzCbPmpMlGFyuDq8z/TrP/ren/9GV/38hzRFEX4cjQeY6kIifHiALAEp&#x2B;HCwGcT1EYnGBP/aS8QpjuDmBvwOwvkCkheAaVhVDBwC8/E3jNJ40MIVVTTgkRNhr5kMM0XBiNUyg3mnksYDXuAQCRgl6&#x2B;uJFFoJmDOaikJQ&#x2B;DioKewNy3DE4nk6nASgkKfbFvwu0VODaQjeAaSR7wCU&#x2B;YX9IX4cZcPdOAQc99iEin4rEU7AouNyjKyi0a&#x2B;aAgR9u1l3hu2JRVjFjCsqZQRD43nR3d3eOai2N&#x2B;6EQCHsYf5fMaRbsIyckZDmcE70z8ch&#x2B;cz5RQ1DUvltdul3BbAx7&#x2B;O9EsemjBjI7J/3vG5ou7U4feng789Y99zyiaKPnX7iUeTcIAsUMJYfTd5/5wY9PJ&#x2B;6Ox2OksN/e3sZnfuGDvXCgHnxML2L&#x2B;oKg&#x2B;6IBeBPExpx/mNE1DU/vy1r3que8r9/&#x2B;1fOp9Wu/q7U2EyJkLJ0m5TasdRulUkCZ&#x2B;2GKUDiLYMMMWE5F8aLXDDFpsf5NRO3R/k1Y6zKDJDpq03KaVDiu3K2qXVdqM2mUGTUQTqigdVu3Sarc6aFKDJqN2GLXLyO3KoFlBbxm0GLlNaz122GK1LmIQ0Ui6ULus3Kb7Taq/SaldVulQeo&#x2B;V21R/Ex3pxWxvIJISOWyvaud/ommarqvKg3&#x2B;HzAhal1Y6tNKmBi1a6zFajxl2rut33qc9&#x2B;EVj6yem&#x2B;ohlavgAZlVVNVW15L72QMfe&#x2B;A/zXz5h3nGdzpeN2rK6jjxrUWCfJXV9GQX50WvLZu2gxefU44tGbVE9vmSsL2jrOZtfcoS8xecsbtHkli1E/hHyJl/UazmTW3b5ZWP9rQ6/rNXyDr9k8TmTy9ncklFb0NcXTW7ZrC1b3LJRW9SOH7T5pXOfJN9N3vAHCze&#x2B;9&#x2B;q1C8eXkafvWFx2&#x2B;GWHX9aOH7S4ZYvPa8cXx&#x2B;KSvr5g8TmTW3KEnCug0pZ2xGXja8LuKy/PJmO4ZMXM0Xg0Qu1YYsdM/A5TUiYPgnDiB/h3YsCnX/q6Z3EmCt9vGU9IEXOFClBsailOFwvvvtZWzM//Rq9sb6Lz/8Y0X6n3u5PS9UwAiTl34Z8w51UQZyfmjxcPqpMsKAW&#x2B;Z1A1VWk/SgkRBC8B&#x2B;G5axsDLJXgwVC1DrXBCYEClZvYI4ntg/TS&#x2B;i&#x2B;F4EEFkfDoB9q&#x2B;dhj61e2kZICE1eV54pgHm6EOsj/7AD04mkyB&#x2B;ABOWxPw4uRzlSSi5YevAqjp7NgE9PXCOQQImxmqYUiwlIL4PMCLmICUGQ&#x2B;amgiUx1EA8EhIqeVzJhG8x6lXcLh8OdH/fPcD3fXzuQTrh65jun5BdYdNmgnFCf3a5XXCaZXBLvCLquonnhXGKovyp/TJL/NhPJsls7PwMmZIDyJJUZP52trGXXt7XH&#x2B;PcY8p&#x2B;jZ9OZnVTBtoDD1z42QsxEevpp5/GR/zigD/4aF54EQfxxGQhFAYUnuMb8X9UdXhOH9wzePCrg7uODzu3DZosAtzDFjVoMsMW&#x2B;pMdtli5zahddtBk&#x2B;puIxE/3m4zaoeU2O2iy/SYzbDF6rzJsMdubtNJhUfBNuY2o/wwKCap1GaVT6W&#x2B;SapeV24zcZhGg7zfprQ3kv8uqXUbvVdQuq3ZZtcPKbdo4VVU7jNZjtS4yC1TkNrW9iVwCGGSCGLao83eSSH4YNCmtxwxblNZjQ&#x2B;/e7oq&#x2B;dVJRFF1XtQf/RutVkG1B7bLDNmvedYN1/0cH9/9v7fyPDeVhXVMcx7ZtW9d113FMTbWGF8aP3jv4zj&#x2B;qX/4L63M32ELB5Jb1Wl6vLdv8sllbNLllV8jptWWHXza5POL5aLWcyeUsbtHhcza3qK8vmbVFo7Zo1JYdoeiKBYtb0mp5k1tC7HyTWxoJyza/bHMLRm3R5gs2t6QcW9DWl0wuZ3FLNp/bEZctPmfxyw6/bNSWzdqSK&#x2B;TPfoI&#x2B;Wrj2LYs3vevqq7eOLTpCXq8tW3zeEfLaOlLwL43EnMMvq1zREXIuv&#x2B;DwOaO26PLoRLBF5fiS9a0v7L4amadSqDdTOxDdykbSmfkT&#x2B;3gmCp&#x2B;zBOEdLXMuZ6oAYlfw665A9f7rYO603HKFD&#x2B;6X5ihZr2RFfTO9mWB648YMxBtX&#x2B;JY5Es5VQYQ1AW/HT2kRYsx&#x2B;qJCAZXmpcD0BwBC4BN&#x2B;fUTK8uFbbA/F/kP4YNhLFeIH19ADtHiJv3AR0ZXd3d3bQWFQgxppwvcP1SVsbIDRHP7CiHcsSsO1eVEKCTzWJTiRIrOOzF6VOPUtga5h838dxclCUG1xyZn78RiiYoZyZrYBCEexz9I0icWh2snIAgvZ4wLcBljABzsRTQDry4hwneH22Y8VpSPiL&#x2B;EAlNk1JCwEwMoChsu8&#x2B;ARsYgB3l0qVLk0nyfK4pYB8FQOKdUzju20QlAzB60w9mQoTXsdtljqIgCIKUET8TPaSf/e3gfpRefmVfO6k60M4/upUpHLia&#x2B;aPNh/Cfzz373He&#x2B;13WeeRnmeeaZZ1A8H6SQxtp97AGMHQOQSwB258V3o/Cg2nCwPbjwoHp&#x2B;Q3noy1vdv9hu3jBoXSO3mX4TQX8WxdVB/Bylw6odethm5TZ94STT36QHTVbpsGqH0nqs2gmzRSQfenuDUjvssEUrnYrcZuU2O2xX5DYzbFUGLWZ7k1Wj60qnMmgyWreyvUnKbUbtsFGBjNJhlA67tUFvnaSVThVdkdvM9ibdb9LGKVZuM8M2ExH9abnNbm2ET2k9dtiiL5yklA4zaCIZozJsrWgXTuq6Lg/7&#x2B;kNfGLRY4xSrnbpBvecT6pl/NvubyuCsaSBjiIlIU6amGluPaneftH7wJeNLf&#x2B;rccbUrERa/bNYWLD6vHEdIfcnk8xa3rNdyRm3REQpIna&#x2B;tL1ncsissu0JuJJVQKE9HKNj8siPkEZQ3a4s2n9dqOb2WM2uL6vqyyeVtflmv5fT1JYvPWdySwy86/LLF500uZ/EFi8/ptWWLX7aEkrqet7lFR8hb/PKZv6zcXLjuDxZu/MA1h7aPL1v8sl5bGglLFrdkcrkdKW9wefnY0gMfJ7/8h/RDn0KOwjmzdtARchaf12s5g8tb3//yq6&#x2B;&#x2B;isdbYv2HCS9Zsb14fwCdCcQzn4K7Q&#x2B;rV8wD6lc/9TDg&#x2B;R6iY//gV3tonfxDsD5J&#x2B;zcr8v5z&#x2B;p6jMgyuoKhwerztkZ5pa8&#x2B;t30a8TP/TKJ1EoAMB7GDr7MySdpH1j3AnRVQKX&#x2B;HEmvRdXVwcAocJ/MZJL0HUSzYgBJi/mUZCmUsGFEsG1sFH7VAC3MSEkeJFTchAgPo4fREstBM2JY6qg5IDqBk8li8hFYV8l&#x2B;DZIbsFH86YAWfjn7u7uFBg0YDYvpqT3cBsTyB5&#x2B;owSRPbUPzTgwgCgV1hZcmcFxP04nxaYb&#x2B;KUSsXpmEkgkLeDS4EjzPM/3vQT&#x2B;9iIeVJRhtuEl4mDCAYkU/&#x2B;mRsP9cukzUVNQDl52KUYYUGghHV5LxlVkIfGloG7lc6IzEp88sLbqYpAok/vxtbpOPPCrrxsXMW6&#x2B;8ute7&#x2B;3zmJ3nCGT/78xc15xn058&#x2B;f&#x2B;1W6Q5977jmE9ZFeH6F/fGQvovcgGQDRhJCcgCSBUDxQh4ZydvDI94b31vvdP&#x2B;63rlHaoWI&#x2B;OjSXHrboQYtROuygyQ6aTL9Ja71Kf5MdttitDUbrVftNetCs9DeR6p1VOqzcZrdO0v1NRuuyWq/a36TldmXYotVuRe1WkG8AYuer3YraZQZNZtBk1W5V6TDbm8z2RmXYorY3EGuf0XoV/VRV71WGrSoqPJIlGL1HqR1kiECWBwbF&#x2B;dG6lUGT6G&#x2B;GpgYUV1Tp0HKbVbvVQYvtN2m5XdXO/9QwDMPQtDN/r977GfnMV43&#x2B;KdscGoZu2zYC/aqqOqY&#x2B;PPugeddPle/8vfWlj1iNNZPLWRwCynmztmRxyxj0m1zB5PKOkDO5nCPkbb7gCAUUvB8p&#x2B;G1&#x2B;yeJzBpfX1hGTZ1k9vmhyS3ptWa/l7RDQF7Tji2Zt2eZzJo&#x2B;eyrvC8lhcNvmCXss5QkFbX7L5nL6&#x2B;oBxfNrmcXls2uJwj5B0hb9SWHvp49erc9X&#x2B;wcMOf3LDaXy9YfM7ic8b6onLsoM3nHKEwvH3hwmfpT199PZm75vPvXDl3LGfUlrT1BYvPW9ySyRcsPjf6r39NHE0Ikg9XA7gHpfPh33iZmhXhgwhg89au2eMoa3AZc1/mU7P6JGqSWef0hniFaX6xibpl9th&#x2B;MsCb6c30W0uZmzjUtF62hMsO43QUn8uWeVUCpiSEAQgo06sS/gEzZIL1BBvbAwm/NzPgD6bBTOKnC8MKYDEDg0j8FFL2onKmIBAKTsj0ATkkOA80U3iRaSKILygz5ITaEj2bsF1gA0tCVAiCwAOxeoKs5RXi7FnfRuXsRkE/8SEGCBLDzoFsoiAIsA4b6tpxIzA6xx2I2wutItGzE1zDIKJmwT6BFgmI3X3fDyKXU4Tg092Ou24aeSwEqQS/eOIK/BP&#x2B;8IDVKAgC1IF7e3voKGU47NMvCoDQBbNlgun010&#x2B;XjIOown00&#x2B;a0hdS1rL0zXFmZLi3MBEIQCMF/Sj2fjjySw&#x2B;K0qyXTzcd28&#x2B;MzPfvUan/O3zve31J05OZ599llE5kHncGma1u/3ceB/5BKAzwNGhwNomqbrmir3tf7d8sP/sX36uHL6PXLnWrmNKPjsoEkpbWrQYuQ2I7criLozaDJbG/T2Bq12mUGTfeynzPYmi&#x2B;L6y5HAILdZpcNq3cqgiS6ygyY9bDNKh9nepLRuZdhiECJXOiySBNQuAvTM9mZF6bByi9J6lfN3UshPFx0chgQStVuR24zSqajditxmtzZo/VRFbjNbG4zaYdUua5yqaj3kPMDI7erWSVQrVu1W5Tar9arDdnXYYvRTFa1X1XvMsMUo3TVje9NxHNu2Le28qQ8URTFNEwXxtCxLG/adwXm9&#x2B;0PtG5&#x2B;3//4PjfqaIxZNvmByOUcouGJRPb6s1woGt2zzBYvP2fyyfHzZ5AuuWEQgfnhs2eLztpC3&#x2B;ILD5yx&#x2B;2ebzRm3Z4nMozo&#x2B;2vmhyOUcomVz&#x2B;sc8Uda5k1JYtvoBcdR1&#x2B;GYF7q7Y4EpZtoWByeb2Ws4W8up5X15fk40uusIzED5tftrhliy8atZxeW7r3Y8xa/sa3LFz/sRurW8eWLb6AfBJcsWBweZtbGt6e/8LRaw4s3viWxcOFwnXf&#x2B;DDpCMsWn7f5nM3nTC7niMXRxjdnO3TctunHp3xiY8UZMteZYB9kMNusU5LAPhN8noS/H/iAt9LGzytUE8xHNoltaH7KlE&#x2B;uROTIzPPraGHfTG&#x2B;mK0/7EQdekyUBgzfMnb5s/qu8GNUkGREf5YPXPUzsBsgPQmQvYr0nKDeJtiFaDoT7KO3t7gaADpRAnzAnKgfz4zNRYKKc6XQaxDkkUCSAPwIARjF69mdhMWPXUTnYgxnXFiLpSMfjB3HDyGSyBwEirj/uUlwOgvJYTIIQGf1AV/YAxQhmw61OXIFDB38RPwokCuuD35LoNFRQAFy3Z4&#x2B;A4EC4S6GNDHYy7jQ/irsfVTXmL47lmSAOwcPf8aGbMDIgR/NwUPkeioIapVm3JFwsoqrGTHvxSZGE5mjAzXyUs2YBdITAVzwgJycOXkhLiYndDv7pA/EPfjs8BmbGEFhIGnnE&#x2B;zPRhAxg8QZbA156ea93&#x2B;uFJ1qroDgc/e/7ljBtBEHheu/Og&#x2B;uQ&#x2B;d4MgCIIXX3wREX4wuR&#x2B;5825vbyNJAOn7h8OhaZqaqphaX7nQGT74r4PTH&#x2B;&#x2B;3b0G&#x2B;tnKbkdvofC50Ghd74SQrt1H0fUbtMv1NWumw/Sat9apbG8ygyYYgvoOO66LlNq12WLnNyu3qsMX2N9mtDRbRbJCefthmEXZXOsiLF4F&#x2B;RukwWq&#x2B;qdCrbm4zWq6jdFbldQU7AwxYrtytbG0y/WVG7rNyuKB3GOMUOW9gnmEHOx3K7ovUqSqeytYH0/RXkWCy3K/qpqn6qIrdZvcconYoWSh3XDnvvVe/jhme&#x2B;pckXUPBTFMHTcRxd111TNx590Gx9V/06Z3z&#x2B;iCUS2vqyI5RGYsHk8o5YtPm8VsvrtWWTy9l83hHyjpCzhZLFFyw&#x2B;7wglR8jbfB6ReSw&#x2B;Z/M5m8/bQt7klm2hoBzPyceWLH7Z5PMOv9y/Pbf5Mfrv3rHysWuuPvMpwuRC2cARCoiHY/MFg8ur68tjsWDzOXUdMf5z2vqyweVNbtnm8yaHaELL8vHlkZBzxcJdH12pLl/3lsUbP3PLilrLjcSCIxSNGjombNnky9//wBqzfN1bFm5469JNf3nT1Q9/pmhyOZsvGFzBEoomtzwWl93Wd/cL9OHHlUpwgb2iOZWCuXBjwhn2e3WWDO/7qUfmg&#x2B;nEgnxZvH7l0DydEnSDYK4IND9dYayFKy/w10nz0d6b0sjvTsrU/QWvEa/jhApJf985pWUinP2e3U&#x2B;z4HneVRA949t&#x2B;Ssm9t7eHI68HAL0lsnmeB9Ya3/Omk1hM/RmmgSQQqGvHpeGnItSSoWZAmHU6nQZp/0jwL8SdiFSDvHgxsMaknVAIiYDs7JPEw/gkIPtkMoFHdHmeFwQ&#x2B;YuQHAHaDtsSJLqGhIjxsCwJNBIVhb6M80AYC4ele3MEgfBcG1uCsgAkIzIooRrgOkB0E&#x2B;f0eIOGgauPPHASBF/f3Ta/R01kwpdlJC9PJZD/FNhoQfpzcn&#x2B;y6mQToe3GOWUKk9jwviD&#x2B;IU0ySSVTBS1quoCXH9/1pJEJg1&#x2B;GYL40XG&#x2B;ewqMRrMNMp0UAvbhJJ/073WfqHn2pgxOrJMP1NJpPQOBPNnMzy029GDdnn7m8yOaOnMitx5szgnDzOfMSbTO9/4PzDj2lzin3uuedmZB5Nw5F8kDuvqqrD4UCR&#x2B;9rgoeGjP1If&#x2B;vvhqT9WujcP2xXEzh&#x2B;2aKVNDZrs9iY9bDHbG/Sghbg6SG1Pa6H/bki&#x2B;V7vITZZRO8jBl1Y6SKNfkdv0oMmoncqwxVw4SW9vIA8BdtBi&#x2B;pu01q0MW5Vhmx22EN2fkdtsv1k1Tq0oHVbpVNVuRe9V1W5F7dJym9Z6lUETeQYzwzaSIlbUbhXF&#x2B;pTbrNZjlQ6rn1oZthitV&#x2B;k3K/qpFbVbVTsV41R12EKhQlm9V0UZtN6KfuqQfs&#x2B;HjTNf0B/7vrJ9v6b0NU1FZhPDMEajkSlvm4/c4576ofUfkv75o87nrnOFJYsvWHzBqOVcsYA4Pxa3bAsFxMwZHs/rtZzN57Ra3uILFl9SawWLLxhc3uCQTSDnigWTWzZ4wqgtu2LRFgojqeQIebO2ZHIFg8vf9wnieuqGpfyRd7LXPvbZMlLzj6SyxRdMLm8LBUfIO0LBFfJGLeeGxoSlkZhXji/afM7ic46QN2uLrpCzhZLNF0ZiQV3P9T5SJXM3vWXheu4dKwZfMGqLBpez&#x2B;eWxVNDWl41a/j/evXpz6fq3LFx/I3uo/RcFW8hrtQKSYYza8lgqKMeXH7/3ZGxWxqE5/PPKgeYckJ0hnGddT5eTlvCxTIIv71d&#x2B;Kmd2ZWLV3j//rJd&#x2B;t9P/iEr&#x2B;P5vmC6L7pdcH5V9rgjhzfj3T9bnCGkKbAEbCeMSGJwEHENhFNYOYwI9ze2JgHfBtYGkQhgYRVPWAxteLh8ucodvoHWnciSuJJI3pdLq7uwvVFbioNFL0wLsy785eB2LLQDjrRSch4P5Jw1OYOY0dMfgOIgNF4lvioEM4eg&#x2B;Wzbw4kwQOFw8ojXA5u7u7iSBOWMseBBFWm321DLgZRBF4PM&#x2B;7dOkSbIuXBtMptwcvep0fjxOaqDb0xPCAjcKPH1wQAe5YnKhJJD9kSM&#x2B;TvcD3/EieSQxF2Bue502jZk5CN4ZkS3GCEgUckKgn9/Z2g5nfQljVuQfNhEaqaRbHCU9aP3NpuLJdJ2xy&#x2B;NFjfID0Fh6JBP7sUurV8V15ljMIsov9zSZn9NR//eSuF158NX3r2Wee/&#x2B;Xzv/zlK/sui3eevOvxZ7NPCguC4Pnnn0d0fxzSJzrHVzUNuf/Yaf38D&#x2B;T77pBP/4ncuRpR5wdNenuDGTQpBN8vnAwP7UKk/AsnaaTyHzTDKP4IvmtddthitzfYYZsdNJlBSOOpbm0w2xuI7cOoHVrtIpRPy212pstvV&#x2B;Q2q3SqSqdy/k5G7bDDFqN0KnK7qnariKJz4SStditar6p2WBRlKFTh96pyuzJohj4DWq8itxGNpyK32WGronRWkNZf662gouR2xTi1goQHpcOqveu1e/5MP/O3&#x2B;oUNdfCQoSumaaiq6rquYRiWadjytn32PuMnXze&#x2B;8lntc4dNoWzyRUcs6bW8XssZtWWTWzK5ZWU9b3AFR8ibXM4WihZf0NeXDK5g8QWbz7sogidfMLi8LRT0WsHico5YRG4ArlRGlCGTL&#x2B;pcfngsp9XyNp&#x2B;zuCWDy5/&#x2B;OMOWbnrr0s0fWLv&#x2B;/O2kto4wfVFdz43EkskX9NqSI&#x2B;RMvqCu59X1ZWRPQK66llDUuYLF5w0up68vqrWCKxaQ8WHjgxVi&#x2B;cYDSzd8/t0VuVYyuZxWy7tiQa/lbG5Jr&#x2B;Xk2wvffO/KrfRN//hHlcHxZaOWcwRkZ8hbfMHkcrZQGt3f2g8cZ4JpP0zZaotfLyXNwvMFj2wgvo8g4QFVGnw2XUL6Clyf52dObyVzip1//fc1/b/W3teaEpgBAuXfbEpovX&#x2B;dhEvYr6jM63B2JED&#x2B;VWnUDv8MggDrjyNhBXvBznB5uE7F1RsoJYQHiPDSsBVWdzqdBgBezy4CsO7PZIAgiI/4sCFxrXAkhMzYRFAXjl&#x2B;B6wyzweUMVgY/Aha&#x2B;AAG7CYi1H2fRxLA7zoyrnRBRcGUw/wfKHljSwHXDsBs6AOAGIhWvDwwa8FtApA4ejBm8Qs02Nr/EqUSZHzo9BKfT6RTQ02ErMH0ogbaRCIQ4PFg8QyYdXHnsCzGr8CxzjIAER8s0Ee42&#x2B;kD4E8QkT2BpwSPEA/YT2NhLly5F88KHFcNjKa2eT3yU9JTG4wFuzH4kTeGahwQnPKISU8/zgvhharhK&#x2B;HdYFPA8CeBsjeksfxu6/yAIHPdJy3ki89aLv/jFnXeeuvhchmyA0q9&#x2B;&#x2B;aJiP7Pf3ZdeegnR&#x2B;sPTvhRFGZyVz3f6D/7b4O71Yfftwza7tUEj1I4i5aPY/P0m028y/U1q0ETevTTSrA&#x2B;aKBQPO2xXBk12e4PuNyvbG7TWq6odRm5XtjZYpVOV2xW5U5XblfN3UoMmq3Sq/U0GgW&#x2B;1w2q9qtpdkdtVhPv1XkXrVS&#x2B;crMhtBNPZQauq9ap6b0XrsWp3Reux2yGVH9kBqnK70m8iEYIdtli9V8FsInQggNarYBdkrbeiditqh1G7oWVA7qyqvZvVe/5Sf&#x2B;TLZr9lalumqaMzeg3DUFXFsW1H6VsP323f&#x2B;VXrXz9hfu5Giy85Qt4WSnotb/IFR8iZXIj49VpOr&#x2B;X1WsERcgaXd4SCVitotaLJFyw&#x2B;b3JLllC0haIj5EdiweILOleyhLLN512pjLT&#x2B;rlhyhKId8oJyBld0hCJS7dtCqf3nDFW88cDSTe&#x2B;pXv/YZ4ojMW8JRVcsOkLeFQvoKYT7DS6nc0WTy1tcbiQs23zBqOXU9Zwr5Bx&#x2B;2RXyRi3viCV0dEDzgyu5pesPLN/8hT9c0bm8zedNvmhyBYfPmdyyxRcdIdf/bK77MebCsbItFLVa3qwtmbUlbX1hJBYtoWiL5OPn7kebWjAXDcMtGGwZl7EMwFv7SAvJbTeI79SxNfMKUmaV4JKYrn86zcHx0VP&#x2B;nL56TRW&#x2B;kjSnh3999PZm&#x2B;q2l/yl0qSuXCqCOOHFrvzm4X4IlXBXEteAJ&#x2B;kfyNWCNwEg0mOEkoCYH6uQ0XA6AqgC&#x2B;PdkGP8YAwaA2AOsLROcQxwfQkSB6F4JEEMEktLNpEIwLCeKSQJCSl/CzcIXF0hHUrGMA50U6bFxhaHbACYJ4&#x2B;JYEsE705CuvvBIADg/OdunSJdxvMQoWQJDTiFQDPxkuOfpqGRsANE34wJ4A5S6MlWPWBt/DZeLhgaUCz/OCIMFXmX0pLDN43jQA7YJjCV1JoHMvNfeQOAEezdZyTSd7WHrB8mdmziu/7kPVezzt7u5CUdaPHxyBxleqqhmrAOiWtO4/BiCQPzcecvs1xI/saeiPzDy/8XSyeX/mYcBPP/H0oxfs7Ge8vbtOP7w7d6X9&#x2B;c9/rmmarivK4JH&#x2B;I/9XfehL/VMfl7u39Jsr/U3ysZ&#x2B;S/U1ya4OS2yjoDTNsUXKbGTTZ/ibV30TnYdFym0Yx&#x2B;xFtBosBKCin0kYOuJV&#x2B;k5HbCMRXlU5FblfkNiN3qkq3qnQqSgcRb0LIjvT9wxaK2BOaC4zT6MEV5A&#x2B;g91a0Lqt1q1Gcn5VBq6J0qnJ7RemsqN0V4/Sq1lvZ2kB2AOQVwMptVj&#x2B;1qnRWlE7FOLWidqtKZ0U/VdV6K0qnqvQO6/d91jz3fxzlnmH/Mdu2bNt2HMcwDF3XTU1xlL56X9v56df0L/2Zc8chWyg6YtHgCrZYsvi8JZRsPm8LJYMr2ELRFUuOWLb4orxeRIp5Zb2AaDzKesEWCgZftoWiI5ZsoWDxxdAywJUsvqjXlm2hoNUKYbxOodw/VhocK9hi2RaKtlAeiUWDy9tC6ccfYYj8jQu5m/549frtY&#x2B;WRWHCFPDoq2BHyyMKgrS9v3V56&#x2B;FPlRz9DDo/nR2LBEooWnx9JJYPLI9dhR8hbfN4ViyMxPxJyP3jf2mLuhgNLN/3t&#x2B;6qWULT43EjImVxueGzZFXIukna4kskXdS4MKzSSija/ZPP5kZAbS4WdO1af2no4sYwHkQYgCIIg8PGKmlixo4TvxkzxiR8oJVCF511GfkinBIK/bM504V7WXpb5bOaDid&#x2B;vqfJX8pb93jinkDdlgP93UmoG/SY1XNNpRmlx7PHrFB5qnDNNHIm5cBW&#x2B;B6cxJDoHcWAdm9WRddJPKcV9sLSlVRpQ7oE9m6DEYCAe1idl5kMyCUbSfnTSE26qD9TkUFzBOvtJKhomfnUm9PdDmWHGEUI5gwhCxWwUKUo9ajjEtVDc8iPSCzYdwF7C/Y/LxG3Z3b2U6E8oh0B1csgqAVe86E1&#x2B;VCvIvMfQGVfABycbICA&#x2B;E8AikhLsHPS5ELhP6N2hxOKD8hN3oeIcxR3Clfd9fxoN9MRHxDslErES0D8qMMYd8iL9ve/PejuII&#x2B;DUupCkNsGcPuAmpVcQ/N1DW8pksru7G8RHY1TNEByA7RA62wS4o3DrEvM8zTpLtiWlRdgP9yd3UwhBZnaAN0oY&#x2B;OWvXj53Xt9oPZB59/wF7annMywAr/zql&#x2B;5TLyj6vChAL734C&#x2B;XR7/fv&#x2B;Zxy&#x2B;v1K94ZBk5Zb1LBFDVuM3Kb7m5TSoeU2NQjD7zDbURCeYRvRexApiBk0mX6zIrcrwxby3GUHzQo6eTdy&#x2B;aX7m4zcrgzbrNatDkNaDhISqoiBI7eRi20FE4TQLaVTRTIDOmmr31xRu6ElAWYYtpEuH6H/VcQOQkr97c2q0kE&#x2B;ACjEUEXprOinWL1XVbpV/dSaevod&#x2B;gPrzoVv6v27lMGjlmmYponC&#x2B;9iWpSqyuX3Our9l/OBL5hffqYssiqCv1RBAL9p8zhGK2vqyLRT0Wk6rFWyhaImEwRcNvuQIBVsomXxRXS&#x2B;4YtERS45ImHzJ4gs6V7D4osUX0RFgJl90hKLBFZT1HLIAIFK&#x2B;Wit/649XPnrt9f/&#x2B;/orJ5Vyx6Eplk88bXM4Riz/&#x2B;E2pp6Ya3LF7/J4euGxwnHKFk8YWRkBuJRVcsOELx/GeL3/rg6l9cd92tlRvfs3rj/3kfJR/PjcSizedMbtkRS65YcoX8ToNwhKJyfNnii65Y/MEfXbOcP7yQO/ql97NIwW9weZMv2CJh8QWTL9t83hFK6BUjibT4os0XbCGvHF82uLwrFuzG6rPqVmLIJaZSxjIyHz2D7QMWlYld4HT2o5SuRnrpgHkSWB8q42C2BGq/rAwwpx9gvnl35z/72vO8mX7/0m/fLJCO8zEnpSF75kU4u9MSKcQAQbzJmeJrKABAlUN6Dqf1qSECBgkDJgi7YbXSqxt2vYWIHHnTwiUGw&#x2B;Ugfi7VJIs27WPlOgidGRUQuSUANwBYbfyWII53Z5JT3M4ARQUMUn1gJUAMmWkUCB&#x2B;KJbiXfKBDxcfKYjIJrhv&#x2B;gUWIIBUlJv3hcE4gckyh&#x2B;gl&#x2B;JqQ&#x2B;x82fAmq7F3kSJzH6dBodUjYz7&#x2B;BOhnWbTqexQ3OjTwxlADwG8Pfdi4Kcwk&#x2B;c&#x2B;PpwGEyjQx5gZsx1CfPv7QVBgBwkJpNJIigqHuqXLl2CIyFhLYGxp0I5JCUxxmqVtbUneiCRwnLiVp3ETEw8gmqa2OZhhml0rjA0NCXyoJpDmSrTAwGNX/Qrs/5vUDKsxx9&#x2B;VBlffDZ961c/e&#x2B;axR7dHT/wy88FfvjTdGc0TAHZfemrYefuwRaFQPMNWSOU/fyfZ36SRP24kDLDoSCxE&#x2B;pfbbL8ZBtRHJP5&#x2B;E1H2EV8/DOCztcGq3eqguaJ0qkg9jyG73GblTlXpVOVORW5XBy1G6VSVzqrSCRX5areidKqD1orWQ4B&#x2B;VelUhq2K2l1VOkwE9FfkzprSqWpdVutVlM6K0lnReqvortJh5XZV7bBqd0XtVvtN5GNQ2d5EVKKV7fY7lHvXzce&#x2B;tf1ox7FkTdMcx5FlGYX0MVXFOPeg3vmB9d0v2v/wQedz17tS2eRLOpe3&#x2B;ZwtlAy&#x2B;bAklgytZQskWSo5QsEXSFop6LWfxBUsomHzBEQoGV7D4oiOWLL7oCHmLz7liyeILBldQa4WRWLSEsl7LuxJh8UVTKO&#x2B;Iy3otp9VCycESCj/5U/YQcfOB5cOfuO5qpUboXNHi8yZf1msFi8v/6E/ofP7wQv7IX15/g3y8MJLKllC0uGVLKO5IhbOfLn/2xkP5/M1vXbxxsXBkIX/kZurG3sertlDQOVSrvCvkXLFk8wVHLFt8YSyVXKH0zfdcfXD55sX8zV/5EOtIhMnlHKGIzBQ2nxtLRZ0rqLWizhVtoeiKBVsoGVxuLJV0rqBzBZPPbwvXPmfKiSGX2HQSt/DP1JV0ntlc9sEWHN7Kmr94JffnAuv0EgHFhvQKAy/Or3BmhteaObNi&#x2B;115TWLJm&#x2B;nNFFyZzHAldiEYIPHKC7ySkvEwhmyLdIGZFwN0DgD6GwJNuCpN48gPrS145YJiQBIdAuiJ34r/nMapMjBDojG4Ppgtg8GHH189sZCAs3mplO4OjCNhhyZ55ABe&#x2B;5HXFATx8Cn0ImiRgDxvnMGPOxPDdTORGSFLfIgYrs9kMpMW4OeD9pPJZOJ5M4C&#x2B;t7cX&#x2B;YN6icpDaSHxTfEn8GJhcDKcv/HjuF343yD6ZPCNQVyAgUMCfjL0nim0U8VriMpJMGEmIIhnEJ9OcGTAyuDB46XtTnHjexBtt7iLZouFH5MkE4e4RR7muNqT9A6dEOpAi/bwYdvJ6ZN1GF8AxnOi5lH1steFWdelZgGc0Xg1SFf1DUq//NUrP3/&#x2B;pZ8/n&#x2B;HLa8hG777ti8&#x2B;8lPngiy&#x2B;&#x2B;em7LmlOyt/v8sPv2CyfpYYsN4/E3EeeHQVF9UMj8x&#x2B;4MT9rqb9KDJiW30WG6Fa3H9puM3GaHrer2ZkVus/1NdtBkhy160EJh&#x2B;9lBq6p0qii&#x2B;p9yuXDjJyG120Kqq3Wp/E8X6rEZhOlf0XmV7szJohkE/td6K3K5qvaraXR22V&#x2B;VORW6vKp2q1q2q3RWlU1W7COuzand12F6R29V&#x2B;s6J0qnJnpd9E72WVTkXrrandVbmzovVWjLuuV&#x2B;/6sP7g5/XHvm8oZw1dNk3TNE10bpdlmoYytC88YnS&#x2B;Z37ni/Y/fljhKXm9OK4TllC2hZLJl02&#x2B;5Ioliy&#x2B;aXF5ZL7piyRaKJl/Ua3mDK8jHCw4CxHzeEfKuWLLFsiuGMUBtPm/xRYMrmHxZWc&#x2B;bfGl4vOCKJVcsWUL58RPkSCq7UnkklVyJdMXSWCxotcI/vPvqhdxNB3NH/uZtV6u1kivkTb5o8bmRVDL5wnc&#x2B;WFnO3XQwd/jPr7l6&#x2B;zg1ksqOkHfFsiuVLxwjP3fb9fnCkbcu3Xhw&#x2B;fBC/paDuZsWcjf/47sPuWLZEYomX3TEoiMUlHUkxhRNLu&#x2B;KRYsvf&#x2B;1d1y3kjiwVbv4/H1lVa0VXzFt8zuYLF&#x2B;tFR8jbQsHki/LxgiuWDC4/Eos79ZItFHWuNJJKJl92hIIqVHaUPlwq4XxJbJH4tw9S&#x2B;lZiAM&#x2B;ZgPMfzEw4WyL/ftcDACGCy2GXK6xDJkLAty5bPlzY5&#x2B;d/M82NVPHrpt/O1vBbTleCzmFKoJH9ypxEIfwTORObexDhWJwf5kHbNAzcAhMs5yr8C2PNBJILIs10bA3KUvlHvIsZIIMIL42E0LM4gCasOpy6eDJPgecrxKb4dQEguHvTKQ7DEoC1IF091GSsE4UCTxBfPrCyGWvQ/Rn73EuUjGcULtCLol5ChhU8/gy9C58nMJl5poaFT4FDdgxbBwF6owc00FCbjssHuHdmA4lKmODywyuTyQQ4N&#x2B;NooRj9R8Nr5t6afkUQRNlg/CW0pcUtG7i2cJuEgyrB14I/PM&#x2B;bAINSNH98OJgDcFZxemvx4tFRvbhsCYco7h8vZC7hP9Ho8lFBQRB48bdD6SK4goQ3/sRFFAfW95P9MHsq3kWwIQlJwMvS8YNhk2HQyHwpfjX6/xtqFmh1HhzIdvr6y794/lcvvvrUM89nPmWYOw&#x2B;eTapgYfJ2f3l&#x2B;8&#x2B;3DFr21QW1vUIMm3W/SF04yWxuk2q0obXprg1Y6KKoPi6Lj9zdZ5PiLQvtvb2JufWXYYgZNZnuT6TcZ5IkrtytbG0jfj4j&#x2B;odpe7VYGreqgVVU6lX6T3dpgETlH6630N1e0XlXuVIatFaVT1XqrUXye6qC5ovWqarc6aFaU7qrareqnVrXemtJZGbZWrbuqcmdFaTNKp6KfQgIAi&#x2B;QEpbumnzqk3vVH8v2fN7d&#x2B;rA0fsi0NOfU6juM4jq5rtq7qj9xrd743&#x2B;g/B/OI7dbGicYTJl0y&#x2B;5IpFV8ibfMkWSq5YNkOyft4VS2ZtyRHLtlC2&#x2B;KJaKzpi0eKLjli2xbLOlSy&#x2B;4AhFgy/pyG2XzzsiwsdFVyIQHQi5/5p8CRF&#x2B;TL44kkqOWHaRMy5X0mqFb3/wUJW48ePXXXvfJ0hbJFyxaPEFSwhJRP/5wdV84ealwuHP3nz99jHCFgmdKzlC0RFL3/hAdTl/80Lu8J9dc90/vGv17dWbFnJHDi7fJNxyrc6VRlLRFUvjOoGcidEbTb40ksrqev5r77jm4PLN&#x2B;eLh//xT2hIIvZYfHMuZPHIvLph8UVkvGVxRrZVMvqDVCiZfDk0KQsngCpZQlhs3P&#x2B;Oa/j48cqjL2HdmAeQNF/ZgNu/i&#x2B;fc38c2bBWi1zwLfsDT49ssW66VW2sS&#x2B;HMQX8znVu5J0Wbg5R4ZJp1&#x2B;/Pr/f6XfB3fa1YvE3rvBMus78EiCC3y95WaL1/GIhgJlR6&#x2B;PE8ul0GjoBJyAXHvQQxaIfaKlK4Jj0D5ghA0bEF45pPFoOfAX2i4VQxo&#x2B;rIWGCEDldYVxOYvXEj8B/YbdgH1OM2qG&#x2B;PFbmDA56sD8x7sdNgA4POPME6Xj39jwQDBS/ZbK3h7Fymg0yjeS0aUToDyLGywxAx79Uop9hoxL/4tpOJhMkWYUN95NLObgShu7BXTTFLtEgPJEXi2YTU3RNoxCZ&#x2B;EvOSHXe7NmE9Saq8B7uz2k8Pg9UoqdnEW71q6&#x2B;&#x2B;GkQ&#x2B;volZh4rFpCY/8i9PyMCJhIS9wI&#x2B;1Mdh/8oPZFItkBfOkfBuSG3Pqwdjm58VPGgI1SUoRs3KuQBJ449JLL&#x2B;/e98DW7m7GS/cu7f7ovzoPPapmP&#x2B;n5d526v9k9u1/Je6/&#x2B;Uj71R&#x2B;fvpAZNWu2EUT63TtLIDWDYZoYtSulEZ2N1WKSbjyL9swjxI6rPsMVubbDDNoPcaqM4nqzareinqlqvIndWh63QGXfYqvY3WblT3d6sqt0VvYcO9F1FGv2I87Oinzokt1cQa0hus2p3Veshhk8Fcfrl9sr2ZlVur&#x2B;qnqshvWOmsoLtab0XrVrXTbxue/qh&#x2B;5m&#x2B;NrU1bf8wyNcuyDMNAPB/TNEy5P75wxmp/1/xazfjCOy2RtIWiwZcMvmjwhCMStlC2hJLGlWyhaAllrZZzJNIWyo5YtgQCUV/QLVciLaE8lkquWHbEkiUQpkDYQtkRCUcsGiFVpmTwJYMv61zBFMpIwLCEss6VbKFoCyVHLKGAQiZfMPmiw&#x2B;fGUunC7aW7PsE8&#x2B;hnCFooGV7CF0kgqW1xuLBVdsfTtP64u529eLh6tHb1BryGlftkRiuc&#x2B;S767euNC/sj7V6978K&#x2B;o/u35v33nocXCrYv5m7jDa8p60eQLjlh2hbwtlB0hPxKLI6n0eINwhKLJlb76rmuO3XTtf35wtb9O6lzREQq2UFDXcwZXcKXySMi5QsERS5ZQHktlgyvYfD5sglDQasWRmN/523c9/8Q4OTH92PoTXwlnF4PUpIuVET3ig4RvBUESo2eWH19D5un&#x2B;LytOwCtprD8fc8NXz19YMit8hemNzv9mCn6/Ou117HFpWD8FzPArKQEDwkx44AFa8nw5HBoTIPpHhVwF147wINgIV2Fg6nlJBJ9AXQkgFYES34&#x2B;HAQ3XmljsF9/zfLRO&#x2B;DO6y8xVN0gh7CnggWA47gFVOjICeKFFYuYM4AGteRBAGvSMtOMBdA4B4hSEp0RvwRkyv3EAjAkY6aLqQuAFxQzcZNzqKSAUBUEwjeSHWGd6HmKx46oikg&#x2B;UagIwghNvnMQDU&#x2B;LCEerF0B&#x2B;q3v1UbeHK7oPBE29mxBaL1ySIzF6QSxNEnwSKnTizN2OoZ7sU40dgu3DhWBJAjcLjLVErAL5nPCs/Mlh5qXCf6JWwJuHAmAnuSRJO2C3TaQBiH0XDyYfPYhNQEJt6sWmfueB6nhfgZ&#x2B;OROvHgDIvyL1MapEIlX/PbXest5wnTvph5S5XN1qlHf/VyhmrkkYcvdO56&#x2B;OksF2GU/MmL250PDVvs9gZy/GWGLVrtMIMmfeEkjc7n2t6gtzaQpy8bHdqFA/WEsfyVTvX8nazSqQyarNxm&#x2B;pvMhZOI8IPi&#x2B;ldRyJ1Bi1W7Vbm9qnRY867VYbsqd1YHoStwZdCsDturWm9l2F4ZtleVztVqd1XprMrtVblTHbSqw9YhRApSu6tyu6p1q3J7VetVh61V5DGsdlf1U2vmXYe0U0eN&#x2B;z&#x2B;uP/Kv&#x2B;lZLHZ51bFPXdVVV0QFnjm3bysB8oC3/&#x2B;OvWP3/U&#x2B;uvDpkgZPGHwZUsoWwLhiGVHJEJcK5RskdA5whbLI6ls8mWDK9pC2eDLjkjYYtkWShpXRAQhgy/rXNHgCjpPOGLZ5MsjqWhwRVskEMNerZXGUlHjymOp7ESK/JFYNHhiJBXl9ZLJl1EgIFcsRTGCyhZfcITC9nHq0c8Q5z9bNriSKxZdiTC44qhOfOuDVy/nDy/kDnNHrjP4kiFQjlC0&#x2B;MJ/fGCVLd5QLt78nQ&#x2B;tjaSSfDz/lT9cXcjdtJA7/E/vudbii1YogRRHEqFzRXSMlyMUbKFo8/mtz5YH66TOFWyhuCMVHJFwRHIklUYi4gjlNa5sCyVbKFlCWasVTS5v8iWLz1t8QV3Pj6Wi8Tfvfv6pWfhaP6Vfn5&#x2B;8rNmXudl7qQUW5szEClBvEoCVPHua7HcdZIDwPfONrwNRXbZuXlaXztkgXtMb/1vS6&#x2B;6l38H0hirpf530m&#x2B;pkjPgxUAmyeDs4YU3ilb8CxhuETnpzyocpM/NV8B5GtxAmeiCivAfUxp7nBVFgMgw38W8fKN0x3goiiAyBXZCapaiQtBYfprDOkbY7iPAorDOuLSojrffF8glubGIpRAAXo70oqs8e5vBge0Wi38I2RvLGBByHPI2cGbAcAr8lFKtmHQ76wfM8H5kgJns4tGUQyXkQJWOBAVcpavwEf6NYV/uhTIlakjD&#x2B;&#x2B;NFJw7icKeCf&#x2B;VHlMbAOu246jfoQdXhMhAv7Ic77Twzuyd7MSRd/ax9Ip/B7wWbiYbO3twsG1WTmUBENJAiFw&#x2B;qmTr4LgOCOw3VBMQDWBM&#x2B;FxKiG3wKWDK/Al&#x2B;5euoTNF4ltFT4bnzgelKbgi/AETEh96TOMcYIOG69toXwjd82fPfer0fjp9PVfPfvMf357w3nqhcynLpwbbqnznIC9vZf1e/502KKVDiu3GaWDDspFAT0pFEof0fSHLXbYrgxb7LDFqB12e7MybFcunGTldnXrJIqtifxuq1q3qnVXzv2EHbRWkDpf6bBab62/Wek3V5FGX&#x2B;2uIIKQ2q0ivb7aXVW7a1q3onRWlc6q1lvRT63qpw4h1pDcWVU6q0iK0HsrxqnqsL2in1ozTq8NWshWUFG7h9TTb9fvv9149N8t&#x2B;R7b6FuW6bquaZoGSprqyNvqPRv2T79q/ctfyuI1jkRZQsjzQfB9hALvCEVHLDlCSa2VTKFsi2VLKJp8yRbJcZ3QuZIjliOXgJItlPRawZWIkUQ6YtkRSzpPGHzJFkqmQFgCgWJluhJh8KTGEVFQ/5ItFByRdMWQ/GPwhMmXHLFk8mX0uMaVLb5gCeULx&#x2B;h/e9/aR6&#x2B;/4R0rN33wmhu/&#x2B;cdrGleyBOLxE5Qrlb/xgepi7qalwpG/ftu1GlceicXHG&#x2B;X&#x2B;sfKnb7pusXDLbdWbH/wryhEKSq18x23XL&#x2B;ZvWS4c3vwo44rFcT1kHI2lkhNGLM3bQjmKUFR84gRlCyVLIFyJMPmiKRCuROzUy0qtaAslZb3oSKQjFC82CFsoISnClQiLL9kiafIF5YsffPEXP0cjzY8r5mHC0w3kjCF1&#x2B;Dv5YHybmA1sIAkEqT3uCtN&#x2B;790vZQK&#x2B;TMPk/Mqkl8orqducPnwzvZlg8iJSwPxscwSYhCpwPtf/ShA/zoOLnQGt&#x2B;Prwmjw3Ml8dngQM72GMkl4poGCAkZbvx&#x2B;jXAQA0vu9PohNt4fUEQMdmDlCmn7n2QfHAB1IHygMNHBhKQgoKXArxFSi6eXGFPTRBQDNKrGIAa8IXBSlPDoyzYR08z9vd3YVvRC&#x2B;bPQUEJ6y0ht8CCzZY8e9jiSXe8Agi4syzzoT9ljj0F3f1HiAgRYh2gpT1UyD4QqKR7/uodUGE&#x2B;IMgQO&#x2B;NtWJWAT8xxHE5cBRNQBRUD2BufHYYVrfjrka4PgAjJ7ZJoGEQCgyx2EqI7TOJwqd6wOaTrieQ2aawLSjKJ2yaB&#x2B;RqPIrgaPF9P0hZ5/GtRDmzZ31/pieIR&#x2B;mBgyoxC2DCLQ1fEXKKYgDCA7WN0EyiK97A7bY/tBRtnHnroYe2L&#x2B;gZRwQEQeA6F&#x2B;954Py8cr1L/e7HlA57/k5K6aDo/sz5Oxm1y/SbTL/JDtus3K4&#x2B;diczbDFyu7K9gdyFK/1mFcX9xCfyDluVrY3qoMkOWiv9Jqt2V7c3Kygaj9xmlc7qsBVG50TBgpROtb9Z0U&#x2B;tIQ9drbdq3rWqdtcGzRUkAxinV1E8H623Ypyqyu3KsI0yV8zTK0p3TeutDForW5urg847rDMnzMe&#x2B;bSkPWMbQNA3TNBHVx3Ec29SN7XPOQ13rh/&#x2B;k/O8PW3dcawqkzhXVWtEWyiZftpA6X6JNgXAk0uAJVyybAuFKZUMgbZEwBdIWSrZQtoSyKxGmULaFoiuWHbGMSPO2UEKsG4Mn5PWyI5YMnrTFEMdbQtkSSVsgQsa/SLhS2RQICz0oUY5IWELoZOyIRVMoO0LRlco6V9J4&#x2B;kd/WvnDQzcs5Q8vFY4sFY8uFY4crdzc&#x2B;XjVFonHG4TBF//9A1cvFY4u5G8&#x2B;8bYbBseLI6ls8YXuX7DX0keWS0c/fv21D/wVtX2c&#x2B;fr7r7mePrxUOPy&#x2B;tRvOfIp2xZIllCy&#x2B;aPJlRyQsoTSSkC9yyZXIUZ3UawXEaHLE0uMnKFcsjsSCJZRtvmCLZYMr6lzJ4MuOWHbFwkgq6VzeFUvyetERyyOpZPN590sfeflXvwgSi0Y2VS&#x2B;24cJs0bq6j60vS6mP17pEBpSmcZN19rR4vZS/zGU8fX2/AhMbwZUj&#x2B;F8T6195A38H0&#x2B;&#x2B;rnPNaDQj74expFLPxysu8kvGAgThENXOeTQD35L4fpSuXFiBDO1FgIgOGpujKVfHSggS4DMDKklhEcJ6EnACBLC420R0J&#x2B;IXfhcElSgDnYc3sxEtpeQPAvU7ULcKpMzg7idjnQVwmwbrtmAI7LtXgBFXRKEF2fgAWVvgvbhQqAoP1sPLTqe/7e3u7&#x2B;BOEJU9iPZkwpODvGrNU4EqC1d/DnRg5&#x2B;HrTCf7T8zzsfIwyp8P/ex4wEcwA/ezrR58&#x2B;GUAJD4ywnlm7jud5&#x2B;IsgH4PZEAIkolB8ikbjJPIe8QEOxtXDTQtxtp9ynIjIZrjmQeAn2oheHwAX5EwRJTGSk7tXVEKStBe3M8AJFVzZ0uN5Hnpb/OIUShSRPcf3vWmwz&#x2B;F3IE5ZbNPdrzII919JDX/j6amnn3/0nJJ567GHH/tJ51zmracff/Lpn73w&#x2B;NPZQUJRku/6lNYLj8gdtNB/le1NenuDkTvV7U122EIx&#x2B;xkUyP/CyarSqcidqtpllc4KouIMW&#x2B;z2JjtoVoct5OOLWPsrwxayAKwiP2C5s6J0VoYtxNRfVTrVfnNF7a5pvVWls7K1gawBh9RuJaL7r6ndta2NinGqEkUCXbXuWtV7Fa13nXL6veZDd&#x2B;iPfU8f3O9Yqq7rpmlqmmZZluM4hqq48gW191/Gt/6X9aU/UaVDBk&#x2B;EvBqR0LmyKVCWUBpLJVssm0LZEQmtVrRFwhGJkUQ4ImFLlMGXXYmwhJItECZftkTSFsujOoWcXDWOGNcptVYcSQTK6UiELRTdOmXyhVGdHEkllSNdiXCkUISwhfJIIlyxjLwLLjZIVyxZQnFcJx0ROQ&#x2B;Udb5siSRyDPjOB6tHKocX84eXCjcvFW5aKh49mLuFJY/&#x2B;&#x2B;E9Xd&#x2B;oEkhb&#x2B;5Q&#x2B;vXswfXsgf/uLb1yyRtISSzhX/5b2HcsUji/kjROnmd6zeeFv1plLx5qXCYap0&#x2B;P9735rBl9VayeAKJl90xFKI7IXCqE64Ytnii3qtMKoTThjyv7hTL7ticVwvj&#x2B;ukJZQtoYwIUbZQHkklgy&#x2B;7Ejmuk65YGodRjMoaV3a/xr38y18EqTmeuffP5t3&#x2B;eA7n2Q9nZ16EW/B&#x2B;j8CS05t7&#x2B;tmsdyXRjweWowQYuELMCtcivClnZtuvhPQj/y3L15vpvzG9JgX8/MzePgF8YYY51&#x2B;FdqIEN4uIBxK4YWuO7cHfGAC/xdqiwhnARXYmdBIxRvh/H&#x2B;nDiTUOcOkOHuGiMuqYRrRmCIYhEE7M0mtsxBJ/O46UYF/AL4beEmeMykB&#x2B;pnKfAIIDFiQB8Toz7MYDGYDTKEBJdsPoWKqeDIJhiho/vY2CNc&#x2B;Lq4dompBrY/0jqSXxCTAFPVBgPrBkI9gEsBo4Br776qgdsHbhDoNwCG&#x2B;4DLlMA6EbTqDdxP8Ou8ICHLjLF4D6ZRD7HcPji6vnIdWM63dvbxWcpBPiuN5MB4HfxvJjFBvZGEISRrHCVYsYZPynExjanqAOxiAiHJa6b789CIQXxLSpxKzaqwVcOItsIegYPDFDPpJZ9ji0i4YGQXowSKgG46FzRvhjvigRieEOTaV1sdx/KvHXPXWcumBlHBARBYOl2s/3gM89lE4SCIAgCT7n7U/0mq3SYYYsdtiilU1G7SJEfUvP7zYraZZUOOqaX6W&#x2B;iI3tZpYPi/KyEBKFWVe6sDJqrcrsit6tab1VuV4atan&#x2B;zur1ZGbarKKi/3MEUoKrWWxm2VvRTa2p3Te1WtN6a0lnb2lzVT60hRpB&#x2B;alVuryqditZdGbZXtjerau9q/e73Kfd/Xn7kO6byiGMblmVZljUcDi3L0nXdMQ3rwsPm6R/b3/kb50sfcu44ZAnlwToxblCGQNki4YhlS6QskURuvihMp8ETtkjYImkJhM6VbZFwRcISypZAhmwfkXAlypEIVyyptZJSK1lCeSSVLOSPK5RtoeCKJVMgRhJhi5QjFEyeGNVJWyRHSIQQCZ0nXLHkSLTBl12pZAqEKxSQyOGIZVciXLHkSoQlkrZI2CLR/PPqzZUjS4Ujt1VvuuO2a//h3dfcyN6ymD&#x2B;8Rh9t/vkhVyzZQtmViH9&#x2B;z1qudEuudOSO267pHysO18n/&#x2B;5HV6&#x2B;mblwpHlwo3LxdvXcjdvJg/vJi/qVg88vm3Xd0/VnIlciSVTaHsSoRWK46lEgpAZAikK5ajHii6UlmtFXfqhCsWTb48XCd2GpQpkBfrZWW9OKrTBk&#x2B;otYItFB2R1GrFUZ00&#x2B;ZLJFVC4JOffpVdfSo49PzXRZhtEljQe/Rv9SG2R6T8TyB79LxMKe1mqhETJaeyS&#x2B;fZ0IXgRm78&#x2B;JMpPrzDxi1dksngzvZlea9oP2WcOrSlQaCYeT03nZJ4o5lZY&#x2B;H7zy4sU0xBCJyq538xKiATTeIDK0AKASA5eTOGa1ERCsR6CGwzasLoRNyZJ7/ZnTOggMscEAP9BEB&#x2B;A45YgEsUgA8NcD6QA3IKtwGDXR4peHx/QO/UBodwHFBfsG4p/Q1EBaXOnk2Rg05neOvCh/zHC8VgQCoIAcWM8QMWB39sDCnsP&#x2B;Al4QFSAgWjCj&#x2B;rHpEBszZjhSN&#x2B;H56/hl/iRWzMSb/zIh8EHo22WfTIJZhyeWYwjVCBA5J4XyWwook6sJtEQxN0ScVf8cJPzfR&#x2B;ImjhnEMea2K8gwFGDAGLGBDDcLXjswcEZ0n4mk6gavh&#x2B;XIfFox&#x2B;JEYnaFXRWPjgXbGI0fcK4cmBc4J2IiBfFTNrHIFz01Ux&#x2B;i5ofxhcAikn47rD8UM9BT&#x2B;xGIw8y&#x2B;F/g&#x2B;&#x2B;rjRKjFHgffGygAvvbw7kJ3MW54X3LsPz&#x2B;e&#x2B;3r0nT51/8Ow&#x2B;MYKCIAgC&#x2B;e7b5TaldtlhqzJsI/SPTuRFB3Wh0J/M1gbz2J2s1kPwvSK3K9ubrNxZUbsr25vVYRiNp6p2q8P2ar9Z7W&#x2B;uKh2kwl&#x2B;ROysofn&#x2B;/WVW7K2p3ddBaHbaQd&#x2B;&#x2B;a0l3VeiuDZkXtrgyaVaWzovUO9ZuryKO331yV24eG7eu0uz&#x2B;iPfg3&#x2B;oWfDLcetC1d13VE7LcsS1UVQxna58/oze8Y/9HQvvCeUaNiCaQlEgaPAD1pi5TGlTWe0nnClUiDKyGQbYukIxKOSOhc0RapkMwjlmyRtEXCEklHLINsJVskNK7sSqQjkqZAqrWiyZcsgTD4srJedCUijAoqEFgeGNVJS6QcidL5siOWRxLhhN4CZVtAvsJFZCXQOGRwIMZ1Uq4Rn7zpxuXize9YuemeT1Z1njx/O/H&#x2B;q29YKhx&#x2B;36Gb&#x2B;scJRyybAmEJ5Bffce1S4chy8egadbh29LqPXX/DTZUjy8UjS4Wjq9Rhsny4UDxME0ffuXrzv7x3dfs4MZLKFxskOrxsJJUciTD54kgsyuvlx0/QSJ5BPYDIPOgIM1csO2LRFssjKWQrjaWiE/pLlEcSIR8vWHzREgidL5t8UecKzre/cOmVVxKLfHzoekEQ&#x2B;HHzYLTzXl7Hj3Mmtub9no3Wz9kJ93EEfxmIn06wOZnCwJUoX/cr8DeVfgvqiTcTTK/1o/&#x2B;mEmbtJlIa2SfQyPwyryRbkLULJ15xhWMbl5PG&#x2B;uk6ZEnI4RunONJjAg1CJ2AEpQOgSvcAlIcoCuLgACCqaeRfiK9gejqk&#x2B;PsghE6QOsIAX8frFPLXDADvxY9H6YHV8EA4IFymD7x1PSASwFUPCwOwGtOIMYYU2BiqYjiOf4BCImU/eirME1PGwI7yosMBoijy&#x2B;OuGTcCZIyWxDxE5ANBTFJXejxyjp3HB1AMfdzKZ7EaH7HpAwY/hOxwAWDrCTQjFkqh7J5PJq6&#x2B;&#x2B;iqs0mUXXAXtSxJLCTZ59a9/zI&#x2B;a656EYVB5my6BXz&#x2B;ZzdLZaqFPHhqPIMoBFpimG/viQZjAtYZgjOHhwG3Hzd3d3J1kHbKGf6H9YVR9TyYfjLWZHClLJ87wg8DJXK8xZgt9xb3cXSVNBhPunwCgXBCDKVtZuB8RaKIf4ePrjEjIT1Fl6kb5gdj2S3PZ7/DeSHjmn3nVPNs8nCIJnnnku87qi2JoxenXu0m089PlBiz1/Jztostsb6ARfdtiqaF32/J30oFWR28gaUEEH8crtqtypqt2Q3z9sVfXeitZdVTpVrRdG8NR6h1AwUBSOU26vDlvoBIAqwv1ab3XQqiqdVbW7Zpw&#x2B;JHfW5PaK3F7RTyHcj9g&#x2B;Vf30YeO&#x2B;T&#x2B;gPf8nY2jTVc7qmhGf0mqZpmrqmObpinb3P6X3f&#x2B;HdB/cJ7nEbVEpDbLqHzZUsgDR45sBK2SBsCqXGEKZC2SEQBdghTIC82qJFEuBLliOS4TrkSafIlVyINnrSFsrJeciRS5cpqreTWqZCsLxKuRLsSYYuULZIo3OdIIkYSov4jqgyBnApciVR5yuBL43p5VKc1ruyIpCtRozpx/hj7w4&#x2B;sffkPr/naB66&#x2B;6xOsKxGWUDQFciSRd39y9RB9y3Lx6J9ce8OZz7CWQPQ&#x2B;zl7PHs2Vbv3n9x7SeGpcJ0y&#x2B;/NCnKx&#x2B;9/vqlwuFc6UiudGSpcHipcGSpcLhUOvpXN1xz8qPsDz5yzdf/qPKTP1s591nCFsmdOoGYSK5EmAI5lkoXGwRi7IzEosGXLYGwhfK4Xjb4os5TdmimKLsSMZJK4zql1oidemksldA5Yq5E6Hx5LBUtoahx4eO2UB5JpP6tL&#x2B;6BIB5w35n96Yd6hwROhZkT8rmfEhLmYdy5IsH8lEAVmethIg9eSNO30vmhkiLdqCtMaUnmt5P&#x2B;u2DubzNdFvX&#x2B;Nt&#x2B;VYLFm&#x2B;sJeCUy/wmrM8ShIvAX/iXFv5qSAv/2Uxi1R&#x2B;fQjABMmFZEYs2WWBiEoAiRXJdA2BtkYGkIsGMRnO0aTGNxgBDyNOBvRKpAkxycwJYDdMc4TbBXWdsNmQ4EB49ppFH/GizsMBGB9gbBsAhw0IY0&#x2B;7IT4&#x2B;QCQsYNfNyNXYXlmhul9XFX42aaR1hwLMFNQ57C2UR1wBt/39/Z28QjDzQRdPWO0g2aGVgII7rEINAEHVOFHEnejMqcIOiPRDn902JAp0NNDUQeODS&#x2B;ufUc1wpXH3gh4tECN1HQ6mUL6ih/CdDwMppOJH3G0UGnIUJPYI6P&#x2B;j42lIELG0&#x2B;nk0qVLYLAln82ctyhhvlNsGicoSdGz04gvN4liIsExH8TV857nYReLxKrkRfQzFKg0NEhAwRvMAg9II7GpDYAI5mjh2ZFYVuDClLnuvEGpe&#x2B;rhV&#x2B;YD&#x2B;aw02Nb6W8Nnnn95Th7lvhPDVqj4R5yfrQ12e4MZtCpyG7H/K&#x2B;fvZOX2itJh5c5Kf7Oi9arD9oreQ4Aekf5X5fZqv1nReqv95orWWxm2qsPWGiL5DNsrcmcNGQSUzur2ZlXtrcnt6vZGVeut9Zuhs&#x2B;&#x2B;gtTJsr2mnrlZP36bd9xn1zJfNflsdnrdMA/H70aFdlmFYcl97sGdvfNP46jHjb95mCKQjUZFymrBECsWsNATSFBDip5QaidA5wuU6TyJobgklgycMnjQE0qkzGke6EmGJlCWQtkhpPIGcgEcSaQiUI5KmQFhC2ZXKrkS6ddrky65UtgTClUhE5tmpE5ZAWiKFwneqtZIjlkcSiRyLR3XKkchRndIF&#x2B;kcfXfvI9TfQ5K3LhSOl8pF3r12/8eerrkRZQskRif/80KFi8aZc6ZZy6ea/ece1j97O/PXbr8mXbr21evjev6r215m7Pln5yvsPffLmw7nikaXC4VL5CEMcKRG30OWb37V249&#x2B;&#x2B;67ozn6ZcsbzToMcN2pGosVRyxLLBl906ZfDlsVTUOAKBeNRGR8g7YsmWaFMoj&#x2B;rI9EGOJAIdfmyLlMmXTIFAsY9csahzoZ3ElYhxnXCEgrxecISCWisafNkUKfv7X5ruhQIA1u9AtArVVYmVCky0bJpN4vd8BAwRNkppjJJZAr4&#x2B;Z&#x2B;lLXE/gmESxeB3bD2BlLnTwVvqNry/N77ErTL9NiPx7mX4jnzL9FdIoHO9r84u6rA/AldQka7u/oqEC344ljcS0hZAV3sV4DF2ZKQdTj0fnAMTjDMKC4GIE642wVwJh41rC&#x2B;elFOmaMyTwcFd4PeeoQ5sJe8CKLgQ8SVnzirsEWBrzKRBWbYjCEKjKNGxCCIIjyhJkQDsOEb7gEp8uH7wUvnSV8HX4AfBd1qxcdQYB0/F6kVp9Ad&#x2B;QQN08TCB7LFegAsSlgVU2BJgmaL6ZRCqJDA6aRF3IA2Gazc4X9kLg/yxnV0AcH2eDKT0BAUi&#x2B;S3LBZYApqguPthIXjEe&#x2B;nhCL0lSMP6cToSowcPLT8CKyjWwgZ76GoRDP2ERCA4bCE0UjjJ9n5EfkqAAp13/d9YFPyvOQMT&#x2B;/rXtTwAG51vh8A1f7s8fjRb3CogPF5&#x2B;QV0GjG70HOp&#x2B;z68GJuMcTUkvgh7DGZ749J9D2w9el7PvHV3737DHGXeeubp5&#x2B;574PxD5805JTtn/17vrQxb9PYGI7crg1Zle4MZtqtbG4jlX&#x2B;1vsmqXVTpVpbuKHHzV7sqwXVW7q8P2yqBV1XqrcqcK4vGvqt0VpVtVOqvDdkXurCCLQRTbZ03rrVp3HVK6a2p3ddiuIvSvdq/VTr9dv/&#x2B;z1mPftJX7TH1gGAbS9COnXsvQrcF5&#x2B;6Gu/ZN/M756u/3XN45OVC2RGtWpUR0ReyhLIOQaYYukI9HIixdjcYMvIxqPKZCWSFoi5YplnSfdOm0JhC2WHYlA0oIjkW6dciTSlYhxnbRE2pFIS6RNgXQl0hQoVyJ0nkDY1xbKOk&#x2B;M6qQrUZFlgLAEFESIciTSkShbKOo8afGlkUS4UlmtlTSu/J8fPHQ9eyRXOpor3ZIvH80Vj&#x2B;RLt3BHrxus02OpZPDE/Z&#x2B;qfPDam5eLh5dLRxny8Aevu4EhD&#x2B;fLt6zfcu0/vffqv7rp&#x2B;psqhwulo7nSrfnybWvUzf/8vmu&#x2B;&#x2B;cG1L73n2h9&#x2B;ZPXsZyidpxyJGteJcZ22haItEhcbZY0rj&#x2B;rIvbiMjv4dN2hXIhyx6IjEzgl2JJUdsbTToMf1siORJk8YPDGuUyOJNIXQSVrnyVGdQp0zqpOoN0ZSeSQROldyJMqt065EjeqU89N/T5wEglICesKtM503iC996ZwJgJ5YcILQuBfbrdLVmI&#x2B;GY5N9/&#x2B;bMbci8V8A1J50tE3X9RoDjG1rg72X67Sh9Et8iU&#x2B;2F/QwvW1rC8y2REuMtCXezagUfSQ9dqDiGf6Zf7UUUaIzNcMnp/JnyQIKhNImf/wVfhP&#x2B;cTCZXwRkbKZjDSPDBTAOdVBZCyAWheQBkAICew8yQMDMBjqQYNyPUCxXJPgjVjzSyPpAW4F0M4vGz6Dvs7u7iYjHMwtWbgrhDE&#x2B;ATDNEzAsceUOF7AI0lOhBzNqAYEDozgHrOwNwsDP/sBF/4OHoQ4mZcZ6jEDfskEsnQLczzQT8SfQWHI/6gfmgFQuLNLAh9AJb&#x2B;KYhBBPs8qswUdzKWRFHP4EOOo1vhQPejR/DOFMYVReMQfCZcMvrYe3t7IZknFewVd6Mfk1jChqen4iSibAWAPOP7Pv4uuBzcmbjr4lGD8GCIHyYQWTlQzcMxGY9&#x2B;G4R0KQ/H5MFMp&#x2B;l0sreXpBCE8xGuO/HxH6MkgQRnELwetiIl9KJ7cYEh5DglHp/desM20e//326rk&#x2B;0E/PhTv7j73kdkMyMS6FMXn&#x2B;gPrYcfMy7tv2GZD//vQYsdNJl&#x2B;szpssYNmRetVB62q1quoXVZuVwetleiE3SqK0K92V1A4f6W7IrdRPJ&#x2B;VQbOidFaUzurWRmXYWlG7VaTv13qr/c1VpbMWhfFZQecDyJ3VYXtN7lwr9945uLumnv2WrT5oGbIsDxH0t21b13XbNJzhBefMafvH/2b&#x2B;y1&#x2B;anz9s11ldoCyhbEu0LRIjiUSn8JoCYQikK5GORCPSvyMSjkTZIgLxtCWQlkDYEq2H8XxISyTdOmMKtCFQtkSpHDIgkIZAIXw/btCORDoSOZIIjQv5PGOpbApljQ/lAcQCciRyVCc1jrCE0rhOjOuEI5bHdQKx/22RdEQyPDxYIn/0p4eOVo/ky7cRxOHr2JuL5VtzpcO50i3vv&#x2B;bImU8zOw3SlhiNK/3oz1bfvnY4VzqaK922XLx1uXi4UD7KULeUiCP58i3LhcP50mGSOPq&#x2B;Qzd&#x2B;98NXWyKDDvbSufJYKrt12hZKrkQZAu2KZVOgxlJp5wTriGVbpCy&#x2B;6IiEJRKuRI4b9KhOjSQSGTF0nkD4XucpWyQNnhjXQ2uJLRIXT9CORNhCyREJjSNcidK5sinSZhQv1RRQVFNyp066G9&#x2B;axE&#x2B;Cx6Nun0kUJi85jzLwtw8m7P4PJvMnVgA808G/&#x2B;xkiMtIc&#x2B;JV4/DKQ8XVpEN54tcOb6Y1Nc4br60gYIuOUmHHzpYX03SnwnU1Ar/1eneaH4z/T8D1RQ5gNztAA&#x2B;PvBBuKcsMwZmoqTk2GeqxLvhjgmsUB4EYvAA4rtRHswAsOVg6gRg1RcIHyFF3EYZggvSjgbxHOwE30AyHxg05hpu6EVwPf9eBMwIoTvQgdIzUBb3PEAYl/4L6bZoPwIyUG9NYbF6EAxVB7sNISMMcTEYd1RJSeTiRfXtaNmImw9mYSB&#x2B;TEhPgBwEDP1IQjG&#x2B;HW2tUQs/FCKuHQJ19NPSCYR8sZfGn8mrPIPMfdkcunSJfTpJyDSvBfzD5lix2g83mCP4T6cTGbSFz4NzY&#x2B;cDSBvHheFPyXukMneXhAEyKMAd6nv&#x2B;7439UMaUswrY/fSJVzCbC5Mp54XLg27u5fw1MMTDDU5ZNV7nheXxX3f2929hAVsdKizD8xlsI3A2jBzQw/A5J/x0CLLBhyZUX38ICKq4T5E4N6LpE3ce0EkDe67ZyPrUORfDgQnz0utjL&#x2B;p5LhPmvbjmbcePbPVHzpP7XPc7wMPnL/47ItzSnbP/euwXZHbla2Nityuyu3qsMWqXRah/2G7onTXtjercruCDAKDVmV7c2V7o2KcWhm2q/3mitZD4flX1O5qv7nSb6ITwUK4r3TW5Paa1jukdteM02vG6UNqd1XtXave9cfK/Z8zz/9AvnDathRN0xzHQVQfwzCU4cAenNdO/0T77t&#x2B;b//gh&#x2B;8SaXCNMgTBFSuUIW2JsibYE0hAoFEffFAhbpFSubAqkwYcaeksgbJE2BcqRCEckdYGyBMIWCFtibJF0JMoQSEdEfgK0KRDjBuNKlMbTKDDoqE5bQnncoDWeRrGAxg0GgX5LJG2RskRKqZWtUACg3Dqt8tSoTqlc2RFJXaANnkDSyMUGaQiUUiu7EvHYscpHr78hX76lQh35h/dcf/oTFfG2G/OlW/LlW29dOXr2M5TBE6M6bfGl/jot3XpdvnxrrnRLrnRLrnQ0VzqcKx3Nlw5XqCPvXrvxxG3XfPdDK&#x2B;dur9giuVNHghCBDhdDvsi2UB432JFE2BJtCyVHIt06vSMVHaHoiITFlxyxaIk0OuErJDvVKUsgDK5oCNS4Tuo8qXHliw3S4EujOmWLhCNRFxuEK5a0WngGsM4TOlccNVhkgVFqpMGVdJ4Yd38wW2NnEnWoDgj2VzHul&#x2B;bDfbx14t9htn24xfiSlzIL&#x2B;GC/TtzaL2UsO68F4c0v/M30ZkIpQf3PRO1z/kwPyCshBaWfmsaZNjgDADbZZqsEjofzC6VMmTnxO1EO/p2wEnjAEOEBbHwVxkk&#x2B;OJALvx7Cd3QJqp8hJoMqc9xs2CSM6SF8hHcTinlcdQwlYbfCDBC&#x2B;ByHai7H/8XUsxiXsDLhuQYRdfBDkBN6dTqcIKl26dMkDOvUg8IMAnCsMeglHWPIiGwseRgjfh2ryLBENPTsFxBuM13E/hM2fTnHQpAAzPfCnAZ8MvWsymVyKkP00EhvQU5EmftZ7&#x2B;KNg31nP87B9AAJrVGYA5NQAqPankdsDCqCE0T&#x2B;ShbC5wI/IQtGVyTRCxIkBBickfgrOwFACwXniJqwgIoDNRnuk40clBhFdzYtCWmGJDnckyonaix3WE3MeuDijk9EmM6EE2EmgKTPupIunfXxPnYaHlPm&#x2B;j10MYxUD3RXOuOgre5BT5Pu&#x2B;l6w2nOYQQ0QPZJgO4tneqF283X3o/oe2M28N9CdM62LmrUsv/ur82a1nfjXv6MSL/W/0mwjus8NI8Y9O6h22KugcLq1X7TdXhq0qCumj9VblDmL7VNHRXcNW1Th9SOmsyu2q3EE&#x2B;vitRFKBVtXtI6ayp3TW5e71614cH99St7R9b6sOaOkAOvbqu27atqoptaOb5h517T1rf&#x2B;aL1jx92T6zaEoWAqcETGkdZImUKlM6TrkTZImGFp3fRtkiZfNkUyFGdtoWyI1GORFkiZYvEqI44POSoTjli2RQpCz0iIFIQqfOkI9GjBjuqM6M6PW6wtkghGo9SC4NyOhK506DCaPcS6dQrbp1xxLIthYVbAunW0YOlUZ0BsgQ5kgi3TtsibfCEzpe/8aHrWeq2QvnoHW&#x2B;/UeNZWyA2PlZdpY/mSrdew95y8mPV88fouz658h9/fPWf33ADQ96cK99aKh8hiKP50tE1&#x2B;ui7126Ubrvmhx9ZO/tZ2kSBTSV6XCdHdWbnBDOWyo5EWkJ5XC/v1AlbJMZ15ItMa7XiWCqPG7QrlkYSOZKKY6lsS/S4TtlC0RZJWyhaIj2q0&#x2B;M6cfEEOiqYdCVCrZV3Gowj0RdPsKZImyJti5TGkShakVYrIu7TuE7bYtkQKEMgLaFki&#x2B;UnH2hBAmc4O7KQLtxVE3nC&#x2B;bUPPn5NuDmLSpFtWEhfxPt4Rm2vOHlZQsKcl6ZzJtJlDAv7p98PeeN1N/&#x2B;NS7/BKl22KDycIObEIHi/AjMV5xDSJFLmUJlMJokXoU15Fzj9Byl8nwDMc8qHlcGq50RtYXPwI7sR2zmImyNmqmTPuyoAWArXMvHKxJUJIND7QC&#x2B;OgQJGybjNEIunuQEQaAaQjAEa48HwMnEyzAQwy3EfJY6jgtUIgDkCq8OjOiSveHHmUgCQmQc4S9MIukVClD&#x2B;JTpbFBfqRqt4DvpVTTNiaTHZD901/FvwefJGoBzwPRBTFnYDy7&#x2B;3tQi0Ovg67wgOSAMbZM1EhdP6c&#x2B;UXgluLehtJOlBOcQ&#x2B;wnhUNcDQgoE0gdovDZtIxGajg9QAgp&#x2B;OlxPX08dQE3DM7McCxhB4PJHnrn7qVLoSsIkv1A9bBUPBOuJpPpJDa6UJnTuISNEPkkThWD9pwgCLBDQlia5yHXbdwEXHM/TukJgO5w9icQ5oNItY88H8Bsm32RIJIHPCDxwtKwDiOx4uD67Ldbpy/&#x2B;BtMLL146d149dz4joOf44rM/e&#x2B;bZTIxvDrV//feN8c&#x2B;yjQMojba&#x2B;FUX0rw7bFRT2BxF1UKj&#x2B;7U0WBe1Ru9VhC11BgfxXtjZW1O7asF1Ru2tye1UOT&#x2B;pdUbpranfFOL06aK0OWqtK9wbtno8aj3zZ6m&#x2B;a6qOWoVpRUlXVsixDlbWzD6it7zvf/YL7jx8wRMYWSVuiXbFsSyyi0JiRtj6k9UuMwRNunRnVabfBajzyA6ZciTL4ss6TlkjpPIU4MJZI6RwKmknYIulKlCMxbqNiCJQllC2BcCRq1KjYIjWqUxdPMBpHOBKl85Qjli2BNAV61GAtoWSJjCWU3DprCLRbZ5AhYlSnXKns1mkkdbgS4YjEqMG4ddatM&#x2B;MG60iULVE6Vx7XKU2o/OXNN&#x2B;dKR6&#x2B;r3HL3JyqjOmkJROvjayx5tEDcUiSOvufQ4T&#x2B;74eYb2JtY6miBuCVXOnJL9cjfvvPab3/o0Nfff/V3P7z66O1VSyARx2lUZyy&#x2B;6EjUuMHsNBBdh3DF4rhOIfOFic4aq1M7DUrnyuMGZQqEzpVHddLgSxcbpC2WdYE2&#x2B;eJOnRjVKZMvGQI1kkquRCGykFunDa4walTGDdoQKEci5HUUIqlsirQtkojsZInIeZpBpClLpNw67d7XCsCsSU8fL2suo13sCicUKDOZfw56TuCSeDnJaf76pvZlsTvMs9&#x2B;SklkHH9hS3kxvdHqDZAz86RP4Ff9OvxdC/DklYwSVLjYxovxII554HANdjBvTdYCQck6tEkUlKomvw9omJkWEbKfpMjG8DLKwfgIrwikfHgSGoVX4PkA9x23zo5QoIojHhIHtxI6kM4gW/UbviZo3a0aiUzBwjPdOuDgGweyzQayJcfmsNKyxCHskdGnF4NiPMyg8kKJOmOFOCPUgvsdNw6yeCeCdR4A2xqrHdfAhYSbu1gxhethez/MjyWQac2j2sBcB/Or4T9wzOLDmNCLk4P7xsE4as6qi4QErD0dLOCTAwMCFIBMHHrt&#x2B;RKkPwNxG9UHq9iAIJmjYgJeGJ0jE46V6wFgU9fzsyC0kO/i&#x2B;j12Q0yE1Ex0FRxGuwO7uJRSnKAj8ySQ67znqFvwglhN8ULcgohjh103CE3lDLhAybuDmQOEeuwfg6YDaDpetmaAVmiCBygGQcOBQAJMoY8GN&#x2B;S77SVk9jUV8f&#x2B;Ygnrz&#x2B;hiVn9PSFbePlV3Yz7vnByc7ZX2Xd&#x2B;dnTz3VPnzWemHcS8JPqfyH0r3RWhu2q3GbVTlXpVIftqtpdQcE6EfpXuytab23QQg4AyBSwhnwAUKxPTPRXuytyZ007dXhw6i8H9//D8NxJS9&#x2B;2TN1xHMuyXNc1DMPQdV0eWOcftja/qX2t5vzDByyJRRF7LJHUBcaRKIT&#x2B;3TpjiSRi7Tti2RBpU6BNgbQl2pFojSPceqjvVzjKEqmdBmWIiNlPOvXKuEEjwcCVCFdCxH1S5&#x2B;mIO0SNG6wpEAZPGCI7alTR9ZFEoPieKIr/qE45dcYSSFuiDYEa1UlbYkZ1xpXoUZ0eNRhTIDWe3Gkg&#x2B;wM9qjPILjGul13kFysStkQ/&#x2B;OnKTexN&#x2B;fLRj1x3/dY6Y4vUYJ36h/dcly8fyZdvKRC35su35UpHiuTb8&#x2B;VbrmZu&#x2B;fThmzY/VjVEdtygHj9BmyI1kkrjBm2HJg7y4glmVCdHdcoQqJ0G5YjEuE6bfGlUpxyRsEXSrdOWSI0b9PhE1eJLbp22kJO0xIzq9KhOumLp8RO0IxKhO2&#x2B;dcsSSJdK2SIzqjC0SjkiOGsyowWq1/KhBO2LJEQmdIwyBko/nbZHYaVAqR7sSqfGkLRTMO643v/xx&#x2B;0f/elEbhiM0jl9jWCHaRwKgm4RL3GuaVok92ttnhuKdCC&#x2B;AiZyZTwX7zPH0s/uVljBBBNFyCgtP55lTtzfT//Q0/&#x2B;MmAPdrKjO95QVZAxgKDAlFO8yT3jcRH2QXGOETr8NII8gSaTwQmiUBRXBV4XtxOTgDRDjwFsS06Tk1RRQgCNpwf8FKJGSOhCTgAf0ufncM64dIZaYV9lJSixdpPVFxEOFBTTl&#x2B;HC9b&#x2B;IoXoc94K2a4E/YyBrJQTsCmDAi1cVW9mcAQxsaJtREIXvgiXFVn1YAcqoicA7kr00iMS1yMGuh5AIJPYwFPZ7AVDxf0ot3dXeiAO&#x2B;soIBF68UN8vRhjag&#x2B;bX6AIBOUBz4sFnURyGNyEkOnD83DPTOGoCCJgjb9dKMZFVKK9vd20Uj8WR8j3I3J8SMXDpqSoOvjogGA30ovjjxhEcHYaOVTgb4fI/ZPI4Thh2kMN9n1/b3cXSTt&#x2B;ZKcKIlna930cvD8xt6fTCZQZcGeiykwiNxLUtqTrObAYTCKXANT78C2TvV1vOp3EA1ulWpBx3dtnqfU8HLwokSFDa/gbT088&#x2B;fMHz/RffuU1x95&#x2B;8P5HH9xy5mR4XP6vYQud1LvSb1bk9orcruinVpVOGN9z2F7d3qj0N9mtjRD6o5D/6HBfpbuKjgMbtNaG7RX91Jp&#x2B;1239058aPvhv6vmWrm7blmlZlqZplmXJsmwYuqX0tYfvMX/6detr68YX3mEINNLx2yKlcoQl0pZA6gJtS7Qt0RpHWiKlcoiyz1giY/BhGB&#x2B;EuS2R1nnSbVRGEmkKlMaRlkgjD4GdBu3UGUeiLZF0JRKRfzSeDJX3IuIRUaMGa0uMIdDIAmCLJCLwjBthHdw6i0J8uhLpSJQphBnQq3We0njKlSidpyyhjGLgOCLhhHWgXIlExeoC/b0Pr5aIo0XilnccOvyND1/37Q8d&#x2B;pt33nhT9ZYCcduR6tF3rN1ULB&#x2B;t0rfcunLjHW&#x2B;77vt/snbheMWWaFcq2xJrCsS4QaODzByxNK6ThkCNG8yowew0GLfOuBK1c4LZqRO2xOzUCXTmADJ6jOqEypGWSI3rlCmQbp0eN&#x2B;hxnXYl0pWQBEWqtSI6k9gWSq5EjCTyYoNy64xbpxHRCJkybJG6eIK1JVrnSuigA0cojOukeeIa80t/4vzkq/q9Lb1/XlOUp556KhplMU5psP8smwLLbfhkFi8ocWvOj/Q&#x2B;jn97ccyRrlKiJjBD&#x2B;qn9WpQoYb8l4gqXjit5y5vp10m/hR7OfMXr2DvmVBXOI6xaxTpQuFvNGZNYBzdNMUS8FN8G58TTKoH4IUKDuB&#x2B;ifAiM8Vsyyw8iKIgZKF48Sk1CrsC/J5PJVYlmYMiOH4ZtwKXDOZ9GyfARDNcwiAmiBsFPAnFkAuQl1imsZkY9jp&#x2B;a6aeBpQMlzEeHogJWtwfBTDYI4owmD7pGxGWeaBH3AsCUwNehjIFAJq6bH/HFPfCl8cAKcafvT6Ojx3CXYhcT/Bb8L&#x2B;63aSRReJ63t7uLguR4AKnjSiKMi6cH7v&#x2B;ZpAHkYC86ynfWxiiy0Kw&#x2B;cdd42BuwZChI4PETHr7reZOIYY/HIfrz5Zdf9qMpsbu7i75FwgQRvSLGd8KWHzSSggjl&#x2B;8ATAxWIT1cA6wWKvbOHFotpxDRLzNLER0diiBedMI2HdzATVFBdolcHQRAF3/RTCxCuvB&#x2B;x9v0I3EcLWYaiwos6BIsW&#x2B;PfsCIUZoStcQQKgHpj17YxRAN7iz04V8FIBT4Pg9azgV562&#x2B;tZAcdPXf/HcL&#x2B;65&#x2B;&#x2B;HpPhvBq8///MGHtn91KfsuSk9bXaVT3dqoDFuVCycrcpvVT62o3VXj1IrcrqrdlWGrovbWkDygdKpKZ1Vur8rtitJZGTRX1N6a2l3Telfrd79Xufe4fObrlnyvYymGoeNDu3Rd15WhObhgnTlt/eQr9lc&#x2B;bf6vWxWOdkKGD2NLlCUQpoDC71AaR4zqtM5TlsQgxT/yu9V4SuFISyRtibZFypEYS6QtkUZ33UbFEqlRnTEFCjFYdIFG5&#x2B;8iLbjKUwZPunXWlhhbpJQaMWpUnXrFkWidJy&#x2B;eYBx0HFidtUXa4NFJXmVHQnH0aVeiUDwcQ2DcOu1I9E6DtkTGEihLJC2RccTyqMFaEqNy5XGddOusI9G2SFxskLZQHtfp9sdXPnbTrYXy0QJxS4G4haKOlskj&#x2B;fItRfK2Q&#x2B;ytX3v/1Xd/svrND179vT9ZPXt7BbGMXInaaTAXTzAXT7CuRNgSPZLQYQKUKbKOxNhCeVwnRg368TvYnTphS8iHmBnXqVGdGteJJz/H7jQo1GOoWyyRdOv0qE5cPMHsNOixVBrVKY2nHj/BjOskslc4EolEC7dO2xKNDhNwJcqpM6M6hdql1MqmyDgn1pwvfcj4zy/qd91pDrZs03BdFzl1PPnkk0EcYUAZAK&#x2B;Q6E846xM/ghjOTqowcEoAGm82W73Z4pAS1DOn7WUzeHFokl7B4A6Vzj/nFemcv2Z6Q9el/0EpgUd/F146H3mjlB4PYC7MfuynycqsAETnHtguvTgEha&#x2B;GIxmrfb0s&#x2B;B4Az2BYB8&#x2B;bBfoLQEjMRCXxspBAmIlZjNMUqAhhbdP9hl93FUK3uIUYFieWJz/ir&#x2B;Bbic7C2TDc8YHwgMCiD0ycqAhUEm6/l4X74aqRNiMEEZbCOGz2OwzFOMP6Ee6MLZcJABeHgOHnCYKI6oANsqAfMWUf9wz6E19HDUPVhhexmh9ylqLHJxijYwEp1O6Do3bD2PZ7e5j6NJ1O97BjMSDKe4CTg&#x2B;swIxdl9QCUJsFu4c/&#x2B;xEJFXD7GowXuNHDmJPYerFOfTCbIwDINw9HE6jCJvJyxrIull7D8SM7Z3d3F3BsPEFSmgG01ibmOzHgsU8TwAV7g&#x2B;LofIelp3IV9Ep04BgZtOPaQJ8DupUtYVQ9nEJ6x6M&#x2B;kbSHkuc3mIMwMBr8fkp0w6S6&#x2B;4wazFXA2033PixT2ycxBtEJNgRIi/NyA8wZLTszW4A3YvHFyx0//8oVXdvcyyj//6LDZe2S/B2XV0ayMCKE4PWl0lA6K8FNROgj0o3BAq0qnMmyvyu2qER7Qe0jprG5trGi9Nf1U1Ti9ovWuVu/6I&#x2B;2BO9Sz/2nJ9&#x2B;tq33FsWZZRHE9d101Dt&#x2B;S&#x2B;dX/L&#x2B;PFXjH/5hPu/bnLqrMzRbp22RFrjCFOgbAnp6ZHLLGVLtC0xjkSi0DoaR9giOWqwI0TZFylLpAyBMgXKrdOmSBsCbUmMLdKWSBsCZQnI65d268yoTpkirQuUIzFu5BY8qlNuo2KLIUPGEGinjmj6tCtRyLXXrdMjiUTUIEtixg3GqTOORLoSZYjMqE67dcYRCVSUW2fGdQI5AKCwpBdPMJZI7zRQbWlLIF2JOHt79V1rN&#x2B;XLR/PlI0Xytnz51nz51iJ5S5G8dZU5&#x2B;tUPXDeoMZZAahyhcWW3zo4brFunXIlE8N0UKafO7NRLpkCg8KY79fITn6vuNMhxvWwJxEgiTXQCscQq68VxnXQbrCWxlkjbQsmSGEcsj&#x2B;vkTj0MWOTWGUsoGwLtSKF4YyLaj0SoPGMKhBUecky7dXZcJ3Ya9MUTrIm8JkTCrK&#x2B;O/79Pjv7rn6x7N1w5tPOMRqPRaOS67mg0sizr&#x2B;eefR2PMj2OdBMslNmeBhi&#x2B;RJ4gvPulNMwBmvUR&#x2B;/DsNldKzOJ3Bi5sv9kv&#x2B;fpEW938wgSggGHgz/d6kOUN6ToYgC8h6YFvH/&#x2B;KRmYbUfpweAsF65nj2wDaKi0oMSwjE0yM2LdJDbWDiRYndFuI335&#x2B;BLvxGbMrATYCRV3CT/TgfJAC8iSAIrgJIAuJsbxpXzAdAo48hFG5SEAlDIXjFkV6At6vvz/g8uCvh94Blousz4Av8UINoccHAHQNuLy6E4fLhu/AgQLQtXLiPIOZkRqjAjYKl&#x2B;b6PhJApUP3i2sLh4kWOlVNgdZrGT8adgX58rlOKp4QbhTsBA1D8mWCX4rfANRTnh5uBFwpImB8eO5kYfXNceS9ec1y9IJidUYW/y2ycRHgRD3HMC0KUlclkgpXluOexoBIAgwNuL&#x2B;6W0DKDWgcEGw&#x2B;IGVggRlIcAvGoDdg2gm0dnhfGqA39IrykiTyIrApBbGtEc2yCPk0QBHuRuDuJzDghjg8/0&#x2B;zQaITXE9ZD/I0wKcuPW1TC&#x2B;bW7i0lficYGkZUBs6F8359OZkGikNgQViN02Z9isQ0vHAHyx4ivpH5ElMJVxVFZUdmwl96INJkEDzzU/8UvM870ferJn7/44is/fynrxKXJ5OfPPme4z8wp&#x2B;Rn7HrVTuXCygqL6KJ3qYz9l5E510FoZtipqd03rrein1tRuVQ2P7lpVutepp98j39fQHvuhun2vqQ9t20I8H9M0VUWxTMO8cNa&#x2B;d8P4wT8qX/xD6/M3GyJtS4wtsQi&#x2B;o2A&#x2B;yOvUFEidJ0yRRXAZsYDQmVyGSFsiPW7QKGa/KVCWyNgSYwiUI9FOnTYFwqkzukCNT1QskTZF2q3Tjkiiwm0J8d1JVyIcKXIslmhHog2esCXaEumdExUUS9Sts7aEHHnJnROsI9FO5MU7qpNunbFFCkUZchuV0YmqK5ZtdHhWnR43ENGIGjVYnSsjtozGU7ZIGDw5qlNbx9lPHj5cJG/Ll4&#x2B;85&#x2B;ojH7/pxnddc&#x2B;ttq4dvWzvaeNt1nY&#x2B;vGmJlfIJ9/ASz00B2BsYWKVtiRnV2VKd26oQtouv0Tp1Ap/M&#x2B;3iAskRzXyXGDHTeYnQYzarAGT44b9OON8kgiNZ52JerxRgkdYIzEqic/x1hCeadBIcuJwZc1nnLqrC0xOw3KFUtarTiq045I6Dxl8qVRo6LxjM5TpkDqAuN8/sbR375r9P2/c&#x2B;/&#x2B;ibH1qGXojuPYtu04DpL6xuOxYRij0cgwjF9EAkCQ4s9AXBLso8LECx3OlgbHCYVLYrXHL4Svnv97vwxXkvACMv/BOXdfRzXSd19rtd9Mv5GEAcmvUwh8PA2O0&#x2B;&#x2B;CF/Ek8oCWLQA6SlwIRDKznRfMMrztQtECvg6&#x2B;K93q9J9pKQI/jqc5hp0Y0CYQXbpwWJ90i6aR6jPx9quAwn4meQfxCTwFOj8faPGxYQIlyDqCnQLrnViSYD/6QFeBEfDsvd4sTSaTaRQJJ9GD0Xs9RNpBkA5XYBqx8GdrLqhb1MUzfI9NBzPsFXcT8QDARfkjyw66EgPimaAZ9wPmVPhAFkoo8qGePj0lMPTHIg2qGwo1M51OA39WDYik4cjzZvSq2ViEQwpVYBIh/mkUkH4al0ERur306qvoIjg8a&#x2B;bbimXCaTykaQAE5SCSbjHjBZ1eHEQHcgVBMJ3E4qJiPb0XSThBXPKcRHFUsfgBpyhC7eEnBhaeYCYYzCwAqO2ojdhSBOfRJIpDiieID0RlvAKg4Y&#x2B;G8gxnBzOFGS4QVQO3fQ8f/xwN1CCSGaLHYyp5L8tKiJwcwAicKRVmYwzhfhCeFZaA3utjW8obvO8&#x2B;/Ogw8/rzzz3/0IPnzCd&#x2B;lXXTf/iR/uY9gznFPuPcp3TWBq2K1qvKbVZuM8M2Opp3bdBa0U9V1e7VcmdF7a7qp28w7/2Q8cj/lh/9sS6ftUwNYT7E83Ecx7VM88Ijxqkf2d/7e&#x2B;dLH7JOXK1wFIKhpkCP6pQpMpZIORKNztsyBVLnSUOgLZHWeDIkvdRZU6BciRw1KqZAWhJjSzSinodhdhosUtubAu3WmVGj6tRZhaNDNr9I2CJhiKwtIWpQqNi2RcIUaQuh6gbr1FksAJgivXOCvXiCdeoVW6R3TlQdibTFsh2GFiVGdWrUqKBTgcd1cudExW2sXLyjMmpUHJF065WdE4xTZ2yJGjUqOw0K5XfrjCMxtkQbAv29j1zL0Lfky0ffdfWR7l8eOn&#x2B;MOnv7ykOfrjx2vKpy5MUTKGwoYQr0xRO0K5GjOjlu0I&#x2B;foAweuRRTiJlji&#x2B;VRndw5wdgiMW6wT97BWCJ18QQzqlNunTGF8k6DduvUToNG7g0mlx83mFGdduqMK5VdsWSLZYMnHj9BjaTyuE4gYckVS6M6/fgJShdot05HHs&#x2B;ULdEoiOqoUXX&#x2B;7t3Ot&#x2B;4Y33fS2T47cmzbtmzbHo1G6F8U02k0Gu3s7IxGI8dxTNP85S9/GUSzMjE7IOCAv/Ht9CNANealZ&#x2B;JlZ18mNM98ClYssxD4e07m&#x2B;SkRQD2Idhb8Z2xJ3L8aV5J&#x2B;90WC9Pr8u5x&#x2B;TZQPy0mO/FRKjJAADDyMbmGGBGr3s5T0AcBOcGxAGJzW7cLtGL86gfEwQoPiBy4Eg9v0hIWmMwg7p3EqeACmCWTu4LolWoppOB5YhbAFIMRGEBQmxIt07&#x2B;DiZnwMz0s0GCt0YX4/7jeMOwLjbA/0FHwQdmKQkopCJ1doAQBBJ/24GAQFDAyaPRBEKEChPAFbC48z3NG4&#x2B;X5kGfCjJgSRXwh&#x2B;dhpRblDCMf7RbzjgpkDywYNv5gwatRcfjRwAp&#x2B;HJZDIBLCOMyxG7BlqgMHCPckYnf&#x2B;3u&#x2B;kDHj7110XVcQzxt4MgJMIUmCPb2QhU1asLe7m7g&#x2B;2HdwKG/qGRvdj7aBEUEihZ9D0PqSIM&#x2B;3dvdDYIZnsYDGJ7VhUeg7/tI6gCTxENKayhng9ESDphZAM2UZ3AQbdV4J8bGBy&#x2B;SoDB9C7wi7MmodpH4CpqGcfwkCncbvS42JVFRQTx5nrcXD9zp&#x2B;zPq2iwIUupgL286O/8LL1v4ayYzx3vYn3WIF7/1Bm60d93z6M&#x2B;ffyF9/aXnn3/wEfnFfbakVybBpbmVev6Jx5TO2rBdHbZX5A46wXel36wMW5WtjYrcWdlq3qje/TH5gb/TL9ypbD&#x2B;k6wqK5GNZlqIojm07hmadP2Of/i/rO39r/v377TuuQWH7HYm2hLItUjpPaTyBWPsqRzsSZQi0I5KORJsC5dZZR2IMgR41WIT1xyeqiAhkS6wj0WGozTprS4wlIho6Y4qUIzEofr8lkijupy3RlohCczKWFAJfhaMdiRk1QuqOJZJOnXHrjCPROk&#x2B;PT6zYEj1qVFyp7NZRxCHaEQlbJEYNdudExZboiw1q3GBHderiCdoJgTiB9P1jiTAEOjofgLIl1q3TrkRaIrlzgrl4R&#x2B;XiCVYX6E/ddH2BuIWm3/bvH7xB50mnUdV4yhIJVyJGdXpUp22J2WnQOw1qp0HbIjVuIK4/bQr0TgO1kTZE5uIJetxgRnVKF0KDw6hOWyI5lspunXEkZCsgHLFkSezFE4xbZ1WeGjdYA8lUddbiC5ZIqBw69oswBcoQmJFEqhzytSBtkUIOAApHunVa/&#x2B;tb3W99zmp/13jsjGPq6LC28XhsWRZS9huGYdv2eDxGwZ2QGIBGyC9&#x2B;8YvEYEugkwAgBjh//f1hOtyPgpQFAOfZb7T7UNi4Ak38nITLmfM6L4Xe3ky/nfSbwujp0uZ8R/i5E4/gWwmEOb&#x2B;QxEsxrMqsDJ4aeCMLgLUNPgixFt7BMTiEMC9dGTjdME4LInCFZyVKGKwmCsGhWaZAysW/4Y4M92KMMNGfCAp6EfxOvMWDvqzADOKhcwBgiRjQYJztp8ghPhBKPPA7AMp7L&#x2B;4ekfgB0TYuAdUpiNqM&#x2B;wXjoWmKqoUvTuI0d1gybPBkspcAwSH7Im7iyRy7Hkg&#x2B;GENwQGN1rwe0vF4k8Eyio69wCE44sHA/wFg9kR1gD9OTLkVnBaR7bxodcItR73Q6RUDZi4IOwYZ7noegMHoW8eYTk3MaF9KmcWsUCDszE&#x2B;pm3J6oe6dAnIPWANT&#x2B;IJj5qoZWjki5BeWK6OIsKhSqf0jlmlV7gkJtYuV3NPr3IopOSASC56bhd&#x2B;G&#x2B;QnDf9z0k9oDhNxsnmByF&#x2B;iAxj2bz2fexq25i4niw4cDQtLe7O40MPngd88NmxrXy4eCcouuTyQR7L8Q3daDzC&#x2B;f0TDT14s76HlaoTGZkwfhCAfWUMyoULvMNTZd2py&#x2B;8&#x2B;Oozz2YF9PSDu&#x2B;45&#x2B;9JcT9856RdPDYzT1yrdNbVbldtrg9aK2l3Z3qwqvaOD038lP/glY2vDUM9Zpq6qKgJ8lmXpum5pin7uQbP9Xf0/GtbfvlsXWVMgLIF0pJD4rvGUHYaOoU2BtiXGFChTIBELSBdoRyJtibFE2pYqGk&#x2B;5dcYWEUZnDIGyJBYFrFRqhB061JKIr&#x2B;I2Kk694tZpW6QckXTqFeSfaomUK9GWxCJhYHSiis8MNkV6VKdGDRahW1OqOhJlS4wlkm6dHTUqowZjS6xTZ0d1etSoIvdiN1TkUygAjiWQCHOPT1RUjrBEEgXJGdVpFAB01GAciRk3KEei0MWLJ5gzn1m5uXokX77lusqRuz5RtUXKEhm3zuycqIacIokaNVhTIHYajCORyH8AmS8sqWIJ5YsNYlRnkKZ/JJUdiXz8BKWs5x2xNG6w4zr1xAlqfKJqi&#x2B;ROgx7XiVGjYgslR6IvnmAsgdw5wSAzglOvuKHIRDkSOZJK4wYzrpPjOuFKYcxTVPPRF241v1azNr7hXnjYNXWE6RHVZzweIzX/eDx2HEfTNF3XXde1bRuJhTjziy&#x2B;&#x2B;GIQLfvLEzMzfifUE/8bLSJCYmFmbF845B6jNytzn7pz5kjnZ4UUPbJT7PYV3wP3eldkV8&#x2B;v5W1iF3oj0W9b9//pi2K8pWiSAVmK0pKsHr8BXY7CeLjyN5SCMxptdACwGMaSXUqhPMSk6LvRiTDUFEc&#x2B;DrKGY2UBIJ4E6flw9hPWnMZ0gQLCgD6G3AL4FpYIp2O6vwm/FdfLCg1pBSPJ4m6cpEdD3Y2ryIM4OgvWG8CKIrAGYe4D7GrcWfqrM0sJbQGjBQAQLYRCj4w4NcEsjcc2PgvBAcIY/JwZJETYK1e1BhIcwqML/YqX7FCDvCaCRAM33DJCBfo6Qbpzj4UUv84BfaRCxQTAbx08YZwA9YwrMYTib53nT6QRbLaZxJ2ZsLgiAjt8HpoBJRLL3IuMGjDI0jWRrWCb&#x2B;HLieuJf29vb29sLpBCcedkWYRmx&#x2B;3FI8gdHoRQYZD8Lc6F27u7t&#x2B;3E6FDCeJ/k/NNw93SxD4KHIRHl0YeXteGHoINxmNFsR0Qld2d3eRCQJ30TQ6ZRkHIwoiwQC3F&#x2B;bHhL3YsoJU&#x2B;1EIKd/38SEMaIbiSYunZxAdVYYPWp4JRXMs8vAAZs/zvCnkGsGV4Q1KG60HFM3NvPX0E0/L1tOvr9ifP9G/sHFdv1lFZ/cqvaPKvbcbj/6fwbmWLj9qGLppmui4LtM0dU2z1KF57gF945v6V4/ZX3iHLjCjOmmLpCGg&#x2B;P20GYbloQyBdCTWEimFoxyJcuoVSyQVjnLrrBsp45Ew4Ei0W6cNgdR5Ug2D/zBOFPzHFulRg1V5xhYJW2JtiXEkxqmzbp21BNIWQ7X9qFEZ1RlHCklBpsg4UigSOHVm3GB2TlQskXYkRucJU6TtOoti4RsiYwrkxQaN/ARGdXrUYFG4T7fOuhLp1iuOSBpiBRkiTL48ajCGQI8kwhBZt8G6EnHxBGtLjM6TowaDPA0soezWK65Etv/y6ip9tFC&#x2B;5Q&#x2B;vOTKosRdPsOM65dbZcZ1yRELlwxPExnXarbOIrP/EHYxTZx6/g7l4BzuuU6GTsViKpAtaF2hTIC&#x2B;eoA2BdsXyTgMF7ans1AlHImyJHktlU6B2Gkx0KhlygKbHdcoUWbfOovBK4wZti4TBlZCDhPO/Dpv/&#x2B;slx&#x2B;9uPb52xNXnkhgm59mK6P1L5o9&#x2B;apkHHX8wKcxznpZdeSmAUvNbNtqQgCEIz4IywlxiicJNNJLwMBvvPPj/um7tfOZm/wyvAMyrzFfNvvaHLwhta&#x2B;OtOv5u1et0Jb8fzs6VpovDx/RLGXQkImwDiiXnkxbcqD7huwukAQYIfV5viRxJwAheO1edBnKsMMQOGK/jWFJgX8N6NN/S9FFMDoSaMQmF0Gdx1WEKAGsz9engKdK&#x2B;wtnivvwpXFIoFiUUEAnH8Xf34eVVBEGDVYwKgY9SK8&#x2B;MaYNbHJIps4wN0gqE2Rr0YWkHqBXoLxje4o&#x2B;EK68XtAwlRG7YXrsh4BEwjkAglhAngvoeZU8g7zIwdgqNqe9inOR6lNQCqbpgN9kzgzxqC&#x2B;gSPZt/zcORKfHLZdDpFavJpJC/irQipo7D0CRPuZ9RM7DONehgBdFw3PIouXbqEDB3TGHvev3TpEi52EvkxT0Oajed5YdT/9EibRP4euL0RzWzXi0xGyHYRRPpv9F4vpNPMRFMfDB48frCo6XnedDoJfH8yAc7rkTw5xcaBKJCU5033osj6qI8wi2Yymezt7cJOxg4VYd282BQNItyPPrkPAAGqjOd5qPpYUg0AJwoZeWZWKd9H5aNOmCCJIuWz64dlhitRbJdKaRPxRJj5CfjRv74fei9EkUyDNI/5t5V&#x2B;/sQTJ5sPWhd/8foef&#x2B;Fnutw9ot/1LuXezw4e/Lq2fY&#x2B;pD3VdQ0pcEyVDs&#x2B;Rt/aHT8v/9V&#x2B;srnzU&#x2B;f8QSKUsg0Bm6KkcYPGEIpCWUbYm2RMqVSJ0nbZHSeRJFmHFCPTqDHHBNkdZ4ypJYW2IQfEeK/50TFbteRVDVkWjE1TEFyhArowbr1umLd1R3TlQQ&#x2B;kchOw2RGTcqTp01xKolEKNGFUXu32kwSFSwIzFjVKfcBjtusJbEjhrM&#x2B;EQFxe1xJMaWGIMvjxqsIVBOnR3VKbdRderMqMGY0oojEqZIWRIzblQckRzX6Z0TFadRHZ&#x2B;omgIxbjA7JxhLYkeNituouA3WEcPYQYiw9P2PXENStxXJ2/7shqOqsIIi/Dx&#x2B;B4tMBE6d1dHRBCIxqlPjOjVuIHGFHdWpkUQ8fgfz&#x2B;AlqVKfGDcZtsMiq8PgJanyistMgR3Xa5EuOxDx&#x2B;B&#x2B;uiI3jFsiXSukAhpwW3zph8wRKKKJqqIxKmQDoiYYmUi9yXG1X3r292/r9Pu3d&#x2B;1Tl770hXHNvCiB9hesMwkHYfkfuRs&#x2B;/Ozg7i/2DLgKIoyECEnn3hhReibSKcR3DgAS1DkHl9vyv&#x2B;7CCOGQ8h88F9SogJ9jDNmcIJSWZOgvAoXeYbukr8nsHuOQlKdK8vXRbNo3Ql3yuzMunvnvl1EhfhUxiXQlAexNEa3K3Sj2MQjNH5DFFAPJZlXvPjGyLGSAlPPFgxHN4DlwAzTLNkmEQeqPjzAHj2Z5ruUBhItAiCKFjVAAhvuIuugvKHBwSAKdZ8x&#x2B;ku8PWJPsLrgg8QAH4cgV10lioGiInH083Dd2EFMO7H2Aj/xprsaRTdEncNbnxslETKdagpn0bODHFzUGhbmQJWPX6vF9GlfHAFjyqElwNwXgMcfLMSPM8D/pc4J5QI0ef1Qc1Qd/ogyCnuFgy79/Zmen2QMza1os89xbsCjLaJrQe4RYm2T&#x2B;PGB1jVIPIqnmJJJurJvSjwP8bcUPaYgjmA5JBJqN33MMJGn9b3vcle6LoQ&#x2B;SrEwlWhjgrCqb4XgBj8PhqWoQ4Aj0NvOp1GZw97cBgnvHD8kPMT6xAPhOuZLUZRdaPh56MW4XUES8VBxPva3b2EqxQEwRR8Izx39iIV/l50VFn0qmS8TjRU4HQIIiEwfMrzJnuxFXwm4c&#x2B;m9hS9YJYprrb5b0wvv/TKkz9/6ZnnXnx9j7/w/OPquf9rymdMQzYNA3lzqqoqy7Jp6MZgy3rolPnjfzP&#x2B;7TP6526yJMYUSFOgDJ5EETltkdR5UuPKpkCaImWJtCPRhkCbAm3XK4ZA2RKjcSQ6Zsut0zaiu4hUGOgGEXjqjFtnEHC3RMqSGFskHYmxRMaSWLexOmrQF0&#x2B;wbp116qwdngNAjBoVJCEYAmWJKHgohYJa2iI5qjOmiKSIituojOohd2hUZ5x6xRQoW6TGDcYUGadeceusXWeR4cIWKeS5O24wlkBgMwIKh&#x2B;/W2YsnGKfOmiI9qjMX76g6EvX4HRVHoi&#x2B;eoC&#x2B;eYFDUzvEJducEM25QboP97keuJqhbS9Rtnzx8ZFCr/v/Z&#x2B;/d3SbKrPBDuv2rG3XUyLnkaG9vj29iMdcGoBWMbPGPGM57xeKDrZEZEnuYm8BgPjMHGBuMLtvH4wsWAQEhIQhJI6nvVOScz45Z5qlpgg7q76mRG7L0jvh/evd5YkVlVagks1HyOp5/qPJkRO/Z9v2utd61VpUGVTtbzoEoneRJdL4I6DcpkgmRe6/kkn926vP3Mah4tZyereVjMb9XJM5vkj6zmYZWGmyxYzyaISbqaBRe3b&#x2B;VJePf5W6uzZ&#x2B;7eDsr5M2UaVumkTAKftsxLUyfF/KROb5XJLeRNK5LJavHHy//nr2z&#x2B;/d8vf&#x2B;NjxZ2X8zwH7sdV1/V6vb579y4gPilAV1dXdV1DzY87r66u4ANAh&#x2B;D1en15eQkKEFdfP2KQjuCXX5hHmKN/BPof6ekO/tS3uTFI0vd0TxTXeedI0/f46wAqPa7kJwg2T6jM44r6A992vsavd4jvD64nD8Qj&#x2B;1y/6PilGqc&#x2B;8kW84bjw48rwGz29&#x2B;yMqEae9cyO1qV4RVmnH&#x2B;CtrwgKpd9cvIghhrawKs6HP2eM&#x2B;0RjMHbnnEggRNWnJpFO6S93MfkwrOB4FDTidc085BfoPGmyMoWOfO5KQ9BiwQ7X8R1tGJ0ESncKyGojz8qpZFazd60sI9QY1tulEnKA292CAD4aZf7LaRLe6o91YIvSzQYCvhu/sXyl5sBvQpnHQXi&#x2B;KiR4dT4GRottIMYP/amPQUDdxVOX87igRyrOk&#x2B;JuR363TDfQuws7tdju&#x2B;0Xv9ChmJFdDaYt&#x2B;Bir9uJPiSNx00/qIwJjN71BBMBPatMaZzQ/hRJ6wwgHLMKzwIuwQHb7/fQzFPIhMwvbTYy3XU4usO55LDpVG&#x2B;FakS7&#x2B;JGcHQe&#x2B;5E2Yn&#x2B;gqaFtGm0dIkXnYMvgzOyU6axXvi6dNrs559QiYjVGrCdlThlZCdTawyfa6egrzA3BOdf3w9bjQL6SzvMt15G1UOB/SSfgJ1wvv3Tn0y&#x2B;uvrJndzc3l5eXZG5cXV3dfe2V9cu/&#x2B;fpHfmb50z909YPfulr80eXs5PL2M8uzW4jOiay9q7NbV7dvXZ0ht9RJngSXZ8FyFoD6v5oHCMa/mgXr&#x2B;ckaksNssjp75u7zE/D1l7NJkYB5H6zn4XIW5km0mgPih3kSFWm8PDtZz4PlLLg6O8mToEgmy1lYJAG09UUSXp5N6kWcz26VaVwkwXIW5klQzCfrJMrnJ0USXJ5N8iSqsti77aZRmU2Xs7BKwzIJ1/NwPYf/cVCmAf4t5pMyDeosrLKoToP1DPH&#x2B;wyqLV7NJlQZFOq3SME&#x2B;CMg3r9KSYT4okyJNwuwirZJLPnqnSYJ1Eq9nJajb5p3/5j9&#x2B;a/Pd/5OQvfPuf&#x2B;tN3b0dlGtbpZHl2q0bQzxQh/8NNdpLPb20XwdVZUKWTfPZMMT8p57dy7xUdXt5&#x2B;pkgmRRrV6aRIJkUy2WTRchbAt2E9P8nP/ttNFpTJrXz29L3zsEpulWmQz04Q46jOotU8uF5MVtkfW/7dv1z827&#x2B;/&#x2B;sQvXi/vrteruq4h&#x2B;JHnQ&#x2B;YPUnoB32sWEB7J8xxfAvdfXFxAWoAw8PDhw14ZwzHf9P7jlJXSExQVNdkpRHIwaZ3CRrpwfR0ZFr4EyH4nkPpRIP5LaAEOfmJtH4lQ/3DA&#x2B;kcOx7uoDo8THr7k6LiDs0Y9xUP2oJzh2HrUlD5uxbHsdyAG6Af554GVTCM63ka0ppfnASP6oH8OHtRCBY9UQPZufNTiAhokdu/VYndjKpHGgU7pZPkIA5Doi&#x2B;BQt71t2yEPgGEURQW1O7UHmTF30FoLGKC7X74/DNrDLmCnsHBC5IN&#x2B;9G1WPH7V5mH4RU4YSj4YeI3vOeT94QTtCJ2p1&#x2B;/GjJFe4ihZFcynE39KyCrWmuN8sQTfBOL4n4d0in/FtwgfZuAIERk7BZr1DOhk8jXNXtfQiWhBwErWDasEvVQnZo39fm/GftJGAvN7ofMwta3vfPCCeiUCuaF1jB0phHgllnDQWVuN6Y2i63A0vZPuaAEMvuBaVLDC3RoWgEwbWu5oKkFjORDHIiIf5EKyCoWPJHVvPjHok16toFZkd6N8dmkZoJAgAyqe2ZLxDWMktiZ7YE7Ri5T2wW7IreZ/6/seNie9TXSC9buuw0ZlxiZdfb&#x2B;sv2Ef79Qq/oM6v8tV9WrxO1/Zs13XeQHg8u7d3/jE6mM/u/qXP3D1d//KMvu6O88/szw7WZ09c3X7mYvnn0Fgn&#x2B;XZM1cwApzdWs&#x2B;euTqbLJGOdzZBVqnVmb9tNZssZ8FqDn15sJ6H6yTK58D6AdLxLmeBhO4JyjQskLA2DYtk4hXz83A5C1bz8Ors5OIMofonVRav50GVRXkSlz5LF3JXTdazk8uzsEyCMg23i0h8BiZwTc6TaCkphNfzoEqj9XxSZ2ExP6mzoEyj5Sz0SXyToMri5SxczoIyDfPZM3UWVVmUJ1GRhlUWlklQJpM6C6t0UqZxmcV5EtZZVKZxlUwkL9hJPvsjP/mX/8StyTc8ffLn//c/&#x2B;6cubgdFMtkuYsgMVTJB2t1teiufT&#x2B;5&#x2B;539TpxNQgJBzt0pDGCtWZ0&#x2B;X86c36UmZnGwXQZUMkYKqNKzSKJ9PqjSsUxgWgquzCTL7ViksLU&#x2B;vs69b/9/fXPyL760&#x2B;9eHN3VfrqgKyr6oK8B0on5h&#x2B;uVwCzTO6f57nr7/&#x2B;OhL9QjzI8xx3QjBYLpcQDFCCN811Xd8pUCUUwV5k&#x2B;16r9B6lFPcH65Gi/eAePan14euroCjRXy74fuRP3aOq&#x2B;sgbHlcyAcMf4PUHXoGv/euRXUTg&#x2B;7h7COGOfz0&#x2B;KTR2JzbQM/wAiB58IFbWmJil9aLL5vdWxTXpjwC9rkA/IkrQybPTxbI3DsA6VKtOgrjoTtP5Q1kZXQ1NENCiCJtMyz/BoT70uczZIg2An4LjoFP2EY6Zb7O0Xy/yAyFGf/PID53a4PxPY/ZOp9IL6MfZbBmkwQThtb&#x2B;MWDIm3uhxOvhXA2KNEVXzfQonoljfX2NGEAv0EXXkm04ZJQDi9Yzhv72yq3osTO&#x2B;Qpuk6ZxSLhp1JGcCTZ7wu3FiFtq1yWSbOJgOn73v8IvX3Fmf0pVF2nvHUIS2q63uf&#x2B;hcVbhR6HiwVUIU3DbullZRSbdu0g4ZeBQWSqc95YiXhgDUGCnhiXCup0xD1aMj7K1YRatkpKhgJT9R1ru8HM4sYOiC0tCAUYRCxruDY4CXkgfdlrbW73c6vEdbHtGQfoe/HG9PIv6VX530nsx1tIUOJO4XsJsM&#x2B;6Cu537cSAJc9iSazJ2XTHFlL9U7n1L7MVeDUnkvlhBiF7Cilg&#x2B;wVUkb3ByIAPPzimz/9s5/8&#x2B;K&#x2B;//JU9/vabX7z4/GcuPvxvlj/1A8sfeO4qOX3l/3pmffb01e2nl2dPX509s5rdurz99OXtW6vZrRWdfW&#x2B;fgMq/OjtBDqx8Prn7/K27z5/cvX2C7Lx3nj8pEmT2nUCLD4rO1czLAFezKE/CYj65uB0U85Mijcpkcnn71nIWlmmYz4Myi4tksp5P8nmwmkdlGuXzYHl2kidRlYZFEhXJZDUP8yTK55N8fmudhFUWI4JQkQRFgricXrtfJvA2DtbzoMzidRKtZyd1Orm4HVRZtJ4H1WJaJkGRBGUSVFlYplExv1Ulz5TZtEjDIo3rLC6TYJPe2i7AJppsFnGVRVUWFUlUZ1GRBFdnwXYRreZRmQR1FtZp8A&#x2B;e&#x2B;2N/5OQv/DfP/Pm/9Wf/u9e&#x2B;M6iyqEh8ONEyjTZZUCQ&#x2B;D0CZBHUa1MnT2&#x2B;zWZhFdnd2qklubLFjNw3x&#x2B;Umfhah4W85MyOVnNozINtxmcHJ4pkqBMbhXJ5O53PlOlPhsaOiRP4&#x2B;sf/MDlT75Q/vovVhevlkVeluVmsymK4t69e5vNRuv7yeZfLpfI5wWGDxD/5eUlxAMIA/AKAO3n8vISBoHLy8uyLGFNggWAq8&#x2B;fRDLxNKYZBAC/NkcAXR/Q&#x2B;s7jJOL9GG07BZW6QVXxiFVwvEUcF6shnX5wOCufWJknvOWRdX5kJfHhWNn5JV/9h&#x2B;86UNM87jroz0fKfo&#x2B;79M0HKFnfdnCoPbIC&#x2B;pGD4XZHOLMfC4ed4vT26vDqxpq4fjzBtI5YAwxdyAFu7sfHdK8OQV1bHs1suPWekIMOccxHGLTvvYcWw9h1kp&#x2B;Ui7obqByPCD1ElOvE1NAqD1hW2EmyUd1FqPxTTkXX4ZGvB5gK0ePXs/E9Hx4zFjSA5ofRI2NDBgEK4WmnhTDVAKcwfa&#x2B;CsNrBz/IQ/QggsxrKaPSJChlmhB3C5/vLKO0&#x2B;ZBiyQYjyWX894fwICaTuFGWCQ2ska6yeat66QBcTSdxrpIHWGmtaiobsH0v&#x2B;vshCrUo7YO1IhOVnJwIMRaxOGUZQArA7Ven40otPImBYSbaFOgoYHTJaOzE4WBGHEFQHhfSDsHsYUMiJY41UnjuAd/nonAMdv3OuV6CfPaBXF9Azdxn6afR9DxDfNHuZva0Ww6SrOyxgtd8NW4YAcR/bBxJUP1ZR&#x2B;L2gaaxyjqfHMP/VW2Hfa3Dg9y8VlqfTPB90KH/qZZPquiFhGd4rS2bIWMwVobab1r9g7KWjN3HaEPwb/yCuj/7a5&#x2B;7/7lcUCvThW1c/&#x2B;NfWi69fnz298v89s54989p3eMIPqDvLs1sXt28V81vr2a08Ca7OPLi/PJuszk4ubk/KNLg8mzCZ7nIWrM6eKZPJanbC78skWM3D9XyymodXs2A1D1czhPQBL3&#x2B;ymgWXZ8F6PsmTsMrC1ewWJIQijVfzaDnztP4qDfMkRCTQMvX&#x2B;wVUarmcnRQov4Wg5C1ezoEiiq1mQJ/FqNlnPnsmTYD0PquSkmJ9UWVRn0TqJyjRaz0/qLFzPwzqdFEmwyQLQbADQqxSeBsDuYTF/Op&#x2B;fVGlYZ0GRAJ1PqmRSJid1OkGEn3x&#x2B;UqcnV2eTMjn5if/xTzx98hf&#x2B;21t//m//uT99dTZZz25tsgAyzDZDt5xsFnGZhmUS5vOwSE4QjKjKovU8rNNgswgR&#x2B;adITjZZUKZBlU6WsxOftGv2R65uP72eQ964BRZQff51yw&#x2B;9v/qXH1r98r/ZvP659fISsB7wHUp9wH18hi6/KIrNZgPfXwb0pJWgLMvr6&#x2B;uqqgD36RZMYQDuASQRHZyhbkyu6/th0Tml4NcL0SnYpD/zG76Cq5ILk3t&#x2B;PwaL3P8PSjuGbo8Ec&#x2B;/ktnfy08ENx6LCkx/8cl/0/w/XkzvhGM3/HvtcF6UxxhPK5EIgxCL84CHb&#x2B;2k2KLP7IwZRp/T9Gtnri&#x2B;pdfnBjLKqlgoO6HQBXLZ&#x2B;w3/A4NYa8&#x2B;aA&#x2B;VrjcbLLm/BzcqbFZd0RKP1jaVnGzcUN7FA3SKXzoBIg&#x2B;pRGtV/GqXubz3CZ0d/N9HLOD0p1C9voe7k3UleqhRSPJjWGzORJd19lxbrbuKF0CUTg/aIzr&#x2B;&#x2B;Jo9jiBaASXfd8TQWI2dKomfT8kdvVij5Oonf2gYCbhxyrkJNjUsmJ9P9gxfCtkQsCLV78IqJoOr3pWIZonO/wA9Pt&#x2B;Vk7l7EYi&#x2B;05FZOJ0RH3apnGCwgGLrRKHnCcCtbqqFELUN4dJ0Jz4WDOejxbbOm16gxAiLiVa2JMpJGQYZUY3auGxQ/q&#x2B;a/Z7xdVprRKcUKbPq6AMfEDPmKLdYHQz8JTgrmHEYEWHB&#x2B;t5Sl7M6BhIR6F5ThJzkCi6oxOz2rvhcSGD23Uc2BbBf/AFJ2rvRUrv522tHQRRFYxrECF8lVwHkVhdnbyMf/eEHUdBTr6a18d/7TcuVve/smfNW797&#x2B;d3vyecnV7efubr99PLs1t3nn7k6g77/ZDWbLM9urREFfzZZz07u3j5Zz06Ws8nlbe8ge3V2Agb/ah5e3n7m4vbER/efndy9PSnw4HyyOoPF4BnYBPIkLJKgzqDFD4o0zucnAOh5EtZZnCdg8iBkfrScneQJcH94NQuvzoLcx&#x2B;&#x2B;PVvN4PQ9X82A1j&#x2B;osXs6Cwqf6ulWlQZHGV7OoSEKf5GsOjXuYJ&#x2B;HlWVBlcZkGZRrWWVylPklwmZysZpMiCcs0BMknT/yHTRYWabhd4OYgn59sFvFmEZZpWKZhkQTr2cm98/B6ERXJBE34sW/&#x2B;E09P/sJ/e&#x2B;sb/s8/&#x2B;6fzBJShEFr/TXaC1m0X4SYL4LxbpcH2fFqmoSRPuFWmQZWcILHXxe0JcifXWbiaBWVyss0m&#x2B;Xxy9/lnNll4cRZevPDni5&#x2B;YFx/5N8XLv1muPLhfLpfQ&#x2B;oPYgy/rukYkn7Isr66uENCTrr2I9A9zAUhid&#x2B;7cQTTYuq5hE3jttdcgJ0BmAPSnE7AxxtrBGE5LpjYqq5n4JRg1&#x2B;sxVEn5v7ZDs5eDU1o9bpTXTv35Z0PmRksPj7vyyvn/C9Q7f&#x2B;FW7rELS767roCef3JAnzEP90zsZHS2XEigSBLLA42KtHc1zAZCdLtk9ytn9eDno8okMWQ2Nld0YOusaWtE1A7Tot5sxkUG/yClvVQ2J&#x2B;SL2z8GdumSiR7bIjIkheDVvwGWUlpyCylM9ucjjEXUKVXdjnr1V2NEqhfEIiwtV0W9RHuqpyC3yPfGHniUaB&#x2B;ODflCLHxog6v2OF/&#x2B;0452R3ziy&#x2B;Mdi4oFG3IqMhbaQc6KL0jXsug7tbSUrFvvQKmI9saYQbAbqWy9&#x2B;sex27PWsgJ6&#x2B;bdu041hUxHZE/9TTd53TnrL73c6pFF1t20KJzv7vhHnW9z0QeDcIvnB&#x2B;UPwrEQOIg7uuY82NT4KGivke9ix5kRIpOKFAShSNhCLVK02LKM653W7Xy7NGbCOCdS3ZSnoEpXuFz9cNFiRrTCcVsCKX6oPTSk4x1odWQs5tfzMnhrIbOq//GBT5vQrM14mtEAuqPzC7&#x2B;emthlhJAsZ4h90eckLf970Xm7GS2Oc9ZeDOQ/9WEtU5kZO5nFEtadAgZqPysor9inZ/EKfjJz7&#x2B;&#x2B;Y9/dvkVP7760Detz56&#x2B;uv3M6uxp5IJdz275eJHzW&#x2B;vZycoH9LwFg8B6Nslnt&#x2B;4&#x2B;fwJG&#x2B;53nT1azE0npNVnPvNvuq98ZLGc&#x2B;BVieRFez8OJ2cHkWFklwdeZlgDIN4QCwPJsUaVgkYZVN8/lkOQvrLFrPJmUaF0lYpdF6Hq3nITIAlGl0eRaWaXR1dgsF1llUpNMijetF7H1zPWU/LNJwPQ89xSgNl2eTMpvm88lqFuRJXKVBlcVVFhVplMPykE6WkBPS6TqJquSZMgnK&#x2B;a0yjaosqry7cFRnwXYRl2kEDf3F7UklsP7yLFzOTqo0XM1ONtnkhz/w9U9PvuHpkz//f/y5P3M1C&#x2B;ssyJOgSKMyi6t0sllEZTLZZF7Hv11ERRLU6UmZIEznpEpOtosQMkDuLRXBvfMon59sF0GVTso0qBdR&#x2B;aG/uPqH31H&#x2B;0k&#x2B;Vr3y2zpdQ28M9lyr5uq6R0gHqf/L1i6LYbrdlWUIeILOfVgKICpAc8BTCfa7VdXl5CWcA8H9WqxU3/16WFY&#x2B;nXkEcCAmcjdgy3BEk6sfgplfUiOEG56z69Xiq80s77BvvSEmva35c2uO&#x2B;d49Ch4/88ktW4F19fblN/goKf4e99LiaOIU49XUw5XqFrfnNcDyN9dn9Y7AlMYZ&#x2B;lgXyERauEY6&#x2B;U6PTR1aG&#x2B;E0/jkvjxl6mNyvfiQZdQ0pcQHG621mChgFc&#x2B;wdev/pZVokaWP12LTkcNE033KpIj/zMhvSyS&#x2B;jheEoX4ZR20/ds1/EUH8ZSqMwahzklzOkX6z/ZsP7I0WEYZpV1VfeCrnTL5GeiENVTTWMXQt5edJ&#x2B;OceiPYkJZdTklkGnxTr4fJiJvZhuBOzlgUNUL/d0zs/GoE&#x2B;x4MMYDAFUeKk75oVulzGYPdCo6ql6iHeVI56yKRuqc8xmkrbdatG1LVwEDe5an&#x2B;BtrDJ1i23EmYxTFQRnjfjizepKPMaYX5g/eZSScUe95Ml4OGYQK8eVtJacVdNxtO&#x2B;QtttY2zSCTsOF0gbV2QMNO6ewp0nAttW3bM/Bo2&#x2B;73&#x2B;17moRYYoIzHRyc3c1NgAl0uQl&#x2B;fpjGYDBh9aX7btugl45OF2f1&#x2B;34qA1z0qZIdT2yILPLxTbQ2dwu7dWG7HKCrZoOMO1Y2PE6vWEdT83ZjM5pxjdcAUOq75f&#x2B;nr9ddWv/qJz3&#x2B;FDzc3y&#x2B;//YD67tTx7&#x2B;ur2M6D4L8&#x2B;eXs9OEDYeFP/VbHJ5Bqw/uTo7gXZ/eXaLavurs5M8icokWM/D1TwsEiT8CpezIE/iu7eDyzPv8lsmwXIWruZBnsRI3eXz/s4jhPFBPJ8qjVazYDmPEb5mPffRci7PgiqFsj9YzRHBM0J22zKNLm&#x2B;fLGfBahYUSVink/U8rNLJah4u59FmEW8XQZVGG7jqZtFydlKlUZmGVRatk3iziMs0KpKoSkMkHCiTSZVNyzRazU6KJNguwjI5qdMgn0/W80mZxpssrNKTMpmUycl6drKaTco02CxixPTcZNF6Hv7wB/7kHwv/&#x2B;7/5Z/7MT/3Vr4eHMZIAQP7ZLODxHFZpuFlEZXILDsrbbFImk&#x2B;UsLJNgPXt6swhBjqqSk202uXcer&#x2B;cnZTYtvuvPrH/4rxc/9xP5b/7a6s6rdVWBkHNxcVHX9WazgYYexB5o9HEDdfz4crvdAusDx2tTAJ0EQO&#x2B;Bsh&#x2B;PMx8wrQogGt29e7eqKq5B67VXAy&#x2B;5Hysp&#x2B;9EeNYrD0Y8Xfq&#x2B;Ud3qfGcoholI6u16t6AOQ546Q3JOvg8ffCdb/ChD8I0s7&#x2B;P4PgWDwDq93Mi5PuGeEtcZ3Pq6fj38aDpRHjcLBK/qxwUqP1Miorgoh2ua7iND0CXWwpnQ5xHUskPdrMEmUQvYv0RcuM47b3iuxgapb4kC2kfCs6zpALKsi8VNlqXGURnRsby9yAmrVSt06Yde3YzinwT2xB18hAM9Sm9kiClCnBCAjzApWS&#x2B;1Bg7DVKSFB7zt6FLmp&#x2B;doo11KYOPUA9DqkzBDSxNfeKB9tjqXeLjUEod&#x2B;Dk8D5B5KJHct8/J6onX3HYdOCl4x9K9CHBJ4hcaMbp&#x2B;CVoR1xmToxffBd/GCFkUXncT3PeDboMT6oPBTVYB&#x2B;Rl&#x2B;KshQMuuTqgYB24TDi4RvjChznnxuIpRCPUWKZUx2UzEsyEu8&#x2B;pj5KhrSeRCS2RdklVG899ovygdxnaEJzr&#x2B;q7b7/ethM&#x2B;TnwamEIeOc8Nvf&#x2B;JvDe27j6I13qc6kVu4Y5phXbYC3H1ndkrOpiyEp4aEaNIJWFlO0XM7pW7nzqLFQk4biB&#x2B;yGgfCWCcWGOcs5Rm911vJIT0s2EECd054VlzCnPzodW6m1ge/smp/6DQdqP&#x2B;qX5/&#x2B;2Cf&#x2B;3c9/&#x2B;it92i1/4Fsunn/m6vbTq9mtq7Nnrs5OXv/OW/n85Or2reXZrauzWyCirGYnRQJh4NbKB8u/lUt8zyIJwNFHSNAyjYokKNJ4NZusZsHd50/W8/DyLFwn8JQ9uToL8vkEkXnyBJkBkAdgspoHZRrkSYjMABfIlZuEZYrHwyqLtwsE3gGJP6yzcDUHgScAJalIgjKN1l7THxZJUGan6yRez&#x2B;FhHNZZdDUDIScqs2mdhUUSVSn&#x2B;Q3KACOVXaVAmtxCEtEzgHhAUabRJT6o0vD5HHoOTIgk2WbhdhOt5UGcx6El1FvzS3/ijv/i//LEXv&#x2B;N0nURlMqmz4N55VCRBlYWXZ5PVbHK9CIokLJPJJguWZyfIXYC2L2fBNpsU81vbRbBJT&#x2B;DtUKZR&#x2B;T1/Zv0jf7P8mX&#x2B;Uf&#x2B;ZXq&#x2B;XdTV0DeQO7Q6PPYD6wA4Ccs91u8edyuby4uACURz4vZPsis7&#x2B;qKoT1vL6&#x2B;hnEAHsOMFwTRAgIDmEWQBC4uLiAtqKOq7yWWgF6DPEQ0CJBjzuljmhvL4dyFDk7OE31Gc3ux6oTqxxrTR6JGoiX9DT/1YyKQO0KQjxRacLVHzrvH28VByY8s579eT7g0Pu4fNcQHOP4Jo8k/Hwmyjy8OWafIF/oAdWN8qGE9UZbGabyNX1J&#x2B;4Fv0nwQbfd&#x2B;7sVbajX3qeL8d684P&#x2B;lCDH92BhOMsZIAWCohqyNor/2BCJraxlSRirJLW/PaDw94owo/uIqeiqujeYLfzEQkDqrkKSv7QvaB70H&#x2B;pUO9xJbgBsXf0l8RA/QAsnG6AnhMau&#x2B;sxZttoizGKfXU8k473RMEuHaGbVVKmRtUad3YKnOkJxwisEBsaif5ux9KhG8sbu91OBxjtxyYnp/A9wWunRDXGi2xVOCMjlx1ffAtGgi2CeAD1s3OW7uf0NLASfwa/9qLp7ca&#x2B;Kda0PIKc4NSOo9l1BPRd1&#x2B;33e6vS/TZNw7j&#x2B;nRKKJJdAwzOPrfCLXHIqc9pYJXAK6LfchjgPKQJZO6Qp4M7SH&#x2B;wC2oVDVaBTHvp&#x2B;Cgk1n4PC0w6Ggk64QJTg&#x2B;XbZOzprByEKVeB&#x2B;g7GwPlqUnyGctB0iEckkUbO3wzpnMzlGxBkkz3GM&#x2B;n6E5tlkN1CGBu0AOrMnqe8PQgD4tU&#x2B;9/vnXN1/x4/kP/693n7&#x2B;1PLu1moHh43k&#x2B;F7dPVrMTsPyXZ0jyFQD6X96erBD982ySJxGCbBbJ5O7zzwAoF6nP17ucneRJsDw7Wc0n63lwOYvyJFjPJnefv1Wk0Wo2WScxgvas50GexOskKtK4SII8CYpsuppHF7dPqjRczaM8iS5n0Xp2UqZRPg&#x2B;rLF4lMZT94PHn80mRhnkS5UkEEr9PJZYEKLPOos1iWmfx5SyG4r9KwzKb1otpmYbF/GSzmC5nYZncujxDmFGf8AspwJBda&#x2B;0ljXCTBWUyKRCvM4vqLFrNQxCKtouoXkwr710QITXvJgvzeVAi8H8a1VmUJ8G9F&#x2B;LVbFJlUZnG1&#x2B;dxPj&#x2B;psrBOvctEnQUkBd07j8vzP7b5kW8v/8OPrj7z0fzua0WeE9zXdQ1&#x2B;DmP2A4WD/Q9AD0oP7i&#x2B;KoqoqonnwdhjkB4IE8D3iBTExMFwFmDJMs4xWq1Vd1yjh&#x2B;vqakOIAhHFL4QmofyVM0YeyU8LAwc3HX/bqdOv7HkRHvpq75cEbD2p4UGc3xoLcefr/AhidO&#x2B;fve8l/yK532D96fA8eORYPeqVW579OodiD2aL/1PhNv&#x2B;sAfWkoxe81UOR7tTzgFN/BKX64Jt4cL5NjiM/XEWdrANmLxpkwkr1ELTORve4EqvaJwaja5Rpn50A7iW8oD7AtrCprSGEAnzuBi1aiD7HhRlGPWBOiNbT6KVZIA18OjL6blWbRRlkc3DjIkca7/BPolvezKCJFKzR3jrEVeYgFOimXqlaj7Dt6Dz2A&#x2B;04kM9gWeoZKlH6B5pK5iofqjVH&#x2B;MBvGYgD7F7BSdyn7kD1MPlLXOXLx8RnqZJS22&#x2B;3QTAoDfhqpOhDxa8BnlaGHPdd13hSljwFYMJqmgU3DDsKYDx7ayXRkwxmpSkuohvF2VAJmo2x8mKBWPBC0Hco527Zt3/lpgFYchOH3o24MKkAIbq2kSmCkf78d2J4yqnOOebkVxu3Eb0atkxbKb713OEYTkiXndweRo4zBjBpmIzUB8FuQnvO/ys5liZ5RJSQyU6SaQS84XiOOe5CXVbpODAnOs6dkF7NClkMV&#x2B;I1T2xaHmAvHWguv37Zte6H7c0/s&#x2B;57hTftu2NA5ozrFOPoqX/d/660vvPE7X&#x2B;nT3eqH/9d89vRqduvOd/yR1dkzVXqymp0U8xME91yenazObr3&#x2B;nbfuPj&#x2B;5PJssZ8F69sx6Prm4fWt5Bt18gDD/V2eTdRIuZ&#x2B;E6iVazoEyjMpnkSVxn0Xo&#x2B;Wc9PqiwukuDu8yerOTTcuAHx/oMqiy7OojyJKyDyZJIn4dUsKJLJauYD85dpnKfTdRLlSbieh3ka3z0DyyhczwPkyl3PbhVpXGVRnQVlNi2z&#x2B;OpsUiRBnk4B4uEHvJ6fbLKwSILVPELJVRoVaVSmUZl4l1z4FtdZlCcxfIKrNKyzuMxiSAVVGtRZUMxP1vNwNQs2mefzFEmYz4PlbJIn0WYR1VlcZ9FqdrJZRHDz9f&#x2B;mYY7ISLOT1TzYpLeqNFjPvUEgn5/4eKMv/PHV33lu&#x2B;a/&#x2B;7r3f/Mj6tZeYrRfsfAbyp9vu1dWVVucDrAP6b7dbsPnzPNcxQPEB5aBYwnqCe8YJvXv3bi4XRAjcfHFxAUECpCPI6U6p&#x2B;niYisXyEVx/ruJ&#x2B;wEaHClqjDIzctbjyDnQ9&#x2B;NIqtdfwriMEqRUu/VGklOPrcd&#x2B;ryg9ywpNf/RVc5sgk8of7elyncYw0MLWPEj71NSAThaD0qOnS5ESzus/1r92RPp7F8kXD/D&#x2B;aD7otnHvu6GJN2IReMZA14O7GSlj9UkImIg17FC3GiQ60V2uhV7AWX&#x2B;rUvLpWlsFgSAYGg1lpnPk9/2V36T9pW6DKzyk5p5VLS0T4rAUDPXxP9Yr5oxvWj2Nr6tmgQZUTv1V2dzfWKAw9rgK59EfmmwPMDditBx711d3tjlT1g0pYzAtoGnXDbIjxqvTB1gMC&#x2B;hiyW8Hcxg1a8FEmiINOGya6ohVx/Fg99xgXGc5FAcejSYkZNkxrO1QAlgej7ESamYN5STaRUWYNymxkklCooxxCqN0NgTsHYcBPWclDgU7T87jTfBjB6MPUGgey5WIDFKbM0KqwQpAf/CqVMcWKYv39S1UyZggzzX5vfPwNv6kxHlGr3DNEt933vc/n1YnfixU/Zhlru9/ve4mfy&#x2B;XV0yG46/AKVqMXiNy2rbXe6xc4G28Ea7AfCHh&#x2B;8ssmJQFDRazXO6ZRQWwxTL1EmAXHqXPe4V6vI/YGfz0o06rw/8aYXnES5P6xrb/rjllGX53LNPa3f/t3vmLng6u//396117QfmYny7Nbq9kkn0&#x2B;Ws0kxnyxnk9efn8AbGM676/nk7u0wn5&#x2B;UyeTqbHJx&#x2B;yRPQoT4hCvt1dnk4vmTMg1WZ7fW82A9D9bzsEij5dlJtTjNk2g9D69mEVLwIjvYOonyNKrSoMqiq1kEFtByFnhQnkZ5EhWe0hPAXRhSR73wQf3LLN4sIu83nMX5fLLJQASKqiwq04A0oTqD80BYZxEyhVVZCKmjTKMqDYok3CzCOouKFI4Nk3oxXc&#x2B;DOouqNNxk4WYRb7JJPp/UWVRn0b0FkglEdTrZLOL1fLLJgsJ7DId1Glyfw9kgrrNwkwVlGm6ysEqDPAmrLL4&#x2B;j8pkUqVRmZyAvFRn4fV3//Hyh/5a8VMfqj/x88XrL1VFDuy&#x2B;3W7J8CELH9gdcHyz2ZDZf3Fxsd1uEQAUKB/AnZ/B7dH&#x2B;AJvNho68uAd2AIoKyPkFOwBEAggPTBoAs4NTKEQfkW6APiPtpv/16DarzIn8SUvax0BKAzseuHasoOU9PMsOcNXBpevwzpH3CPQ/qthHvuv3eH0VBIOvsuzxDl93vP0SBH/JXx9X4ADnxiVo8UD/5JSgqxG/npM8iXgbwYBeL/ZIejmoDGevHRsW9ILSogjxnsauvZyMB6YnnqS9wvQaUuJZHcWfqAmwjRToXgBbK6HAWBO9A2jFN8EDsQolgU5F26ddAkpSzS/Cv1Ao8xtrrRcAgDk6weIa8bNyrBkFOC0hEHjpZ/vxzjXgjK7b7XZ&#x2B;wDxW9oQHNqDv&#x2B;77zHziufC9fNFRjzDPT0p4UMoBptsKO9S76ERIwBsw9JspTCKPQyWoMPfaI0JN9r2xDdtCCOyjmWX8tyzLDrlPkME4yYzwZ3Qm2a5qGKd6k8qgJSGaNaQdHVWTj0jdbbyhgq4f5ZMVptRcqCw1PKG1kDRA5wSn5leXLvPSMt55ZAqDUN6Zt293uBlaa/W7X0kcZoo5Ma65tY0zbNob8IlJlIBarGjZNQ3uClpKtMqdY8oikF7qxJQqNQxykTnGEOnpXO/qae8GGpXHicdSsHRwJHCWxrtNAv&#x2B;u6vh82rLZt27aBaKcEFT3TOlRMbW0W7fKtx8QzI2IAtJUiztrR5u75/SMqkRPXHbYOz/6BWAA&#x2B;8osf//gnXvyKH1/9g&#x2B;/M57euzm7def7WanayPLu19ME9T5azk/V8spqdXN4&#x2B;uTybXNw&#x2B;Wc9O1vOTq7OTu7cn63lQpNPlLIRT7Go2Wc3D1TxcJ9F6Nimz6Wp2sk7iIo2XZ5N1Eq&#x2B;TOJ9Prs5O7twOanjcplGeRFUaredBkUTrJC7TeJ1ECNpTZdFyFlZpuJrdEkp9dHUW&#x2B;HD&#x2B;6aRIo&#x2B;UsWCdxlQbLeYgwQcDZKBkuuVdnkzwJ8iTcLqJ8Ptki6H4abQTfV2lQpGGVRmUWF0mIV28WUZlCdInyJCyz6fV5fL0IfMj/DCkCwiqdrGZBmQT5fFKm4XYR1otpPp/UWVglk3V6WqVeGtlmkxzZf&#x2B;e3Cu8BHG/PUZlgeXYrT6I6DdZpvP3BD97/6e8vPv5zm4tX6qoERQeYG7p5fADJh9F7CPGB3ckLAuKvqur6&#x2B;hoxfCAtgPrPm5EEADcwwo8m&#x2B;TDzFwQDVonZAPjh6upqu90eHzpOn6oHCnKeMo&#x2B;JO&#x2B;4UTuqHM/EQuh2LCvps4tUpNeo7vIgBnnAPs5Me1OH4zvbIH&#x2B;C/Xrwe2WNWSYaPvEHfo68nDJkGSxxf4rdjEVGD6V4hKA3u&#x2B;b0GUXzjoH9UZ6IZU336/hAfE3cd9MDB0awV5/2YmaPbRdTKL1mIXrCtZHzS0hdbZJQ6m2CYZ3SvhCtLlZw0ip95s446Y8ciEIENdaD6dUZhAEIIp1A9m2aETP6UHumD2aDngRmHI2UbCGt6JfGoOTFyBmAf8RtfY&#x2B;f6ftBJuPGlnhqsMxR6WL5VAgD/HM22kUJ6lMOZw&#x2B;zHyXqWsxV&#x2B;y6i2Q7IwebVCjd04vtXB5HbO9Uoq1YKdboVzzoiQR72&#x2B;E8MCRssO8HVgoR0r/jl3mTHXDc8O0iSqDacF5P8yY88KWBgacSDGr23TWGmdlgQoA3Qiv1qBm0pa8dCTIUdbcSnm4FpxBug6qskHAZejY4XTQguJx9BtayU3B8A9i0Iw/lZ0&#x2B;RRXepWCwDkHeUNMXkM0AM9Z6nvIRX7OeybPKHSAV5YrHprMyWGFUxDC19iu0KnDbuUcJTp8ZRRqN8LLl&#x2B;k3eJxzhnuVPBweBo2IEAlEDvE1E&#x2B;HHbwJdZySbm3MO8W37ngFG&#x2B;4FZNd43&#x2B;q/69WDX/&#x2B;bn7750p/7KHq9&#x2B;PFnNbq1mk6uzZ67Obt19/tYK7ryg5s8ml7d9Dt2r27cuzybLmY/1CSoOVOybLLx8/mkJ8B9CqY9C8gRK93A1m0jirSifB3l6mifhKomXsyifB3kSVVlcpxPk2yqTADE3qwy8/7j0cD8q0rhI4zIJVvMgT6Iym&#x2B;LxIgnzBKl54zKdrueTMos3i9MqDYs0XifxBmr&#x2B;NKqzuMriMgnyJNieny5n8XoeVlm0XcSbLNxkYb2Ikasrn/ukAZtFlCdRlSF8Z1gkYZnFpU8WFi29DBCuZpMy8dKLdzNIJlUWbbLg3nm0nnmSz/UiKpPJdhFV6aSYT9Az1d/5ptVPpPmv/H/XF68UqyVo&#x2B;iDqQNF&#x2B;dXUFbT0cc4HLIQAw0v9B6i7cQ7YPSTsonHm7YCK4vLykhACbAGUMQH9YDJbLJbMC58oPAQnCwEH6rd/6LQ2bMNN4UOoPGrR1nT/yOmWix&#x2B;XUIdIrWNYfatyGS4vx&#x2B;qBRTNHHErj7I62zbsg7v975tvB730AO8Mzv8TJfXR3/4y49pk&#x2B;Wmh7ZdXqSHHzojxD88b/6QDmGWJzGGusTAPAzF4J&#x2B;LyumASvv4RIgsuLrDqCUKFJHxqtOHGD4YKeCanRKMNCsY43p8QHgB61jAtljYM1WEBAeA1S&#x2B;BVevgDHqvBfmsFNYd4QrlMBGTHUAI9k5hGRW8CFRnM8DQL2dnhMHA6wbyTuBq9x4/Nh3ej6xKDbYKO61nri&#x2B;W1WCVXYi9LiUbAYMpElmzumq9uNED065ZurKcE5T861/JX4igmQX91JFNpyzkw3nvBEltOH9vFNDZ&#x2B;cGrxGZIoOIclBtAFwCdCtsFt&#x2B;TahrppdiKp7lTb2I/9BK4ynnu08ClcZILzJE2Z601pmn2PEs4HaGi5pdWkv7ipUZNRNB&#x2B;QKfhurUya1kmetcMeH3wQ3ASipQyQzf2G&#x2B;klNQZe1w3O9UaMKkYeH0Rnvcb8TNN&#x2B;OYL7ZY34BWaMcfIrxQYq6fV8872NhAOyrfjXjRz8bac2PggIjrjBmE4F/OlFXBl29tF5MMioaCx7rBcUgjEdGcEgqPsVNHhNWTXn0T3dsM/&#x2B;AVCAcNVfePiVPbj6p9&#x2B;3mt26PJtc3kYsy5PV2S1otZezYD0P7t5G9P1JPg9ef/4EQT8vZ1GRhBe3Ty5vT5azyXLuY&#x2B;YUiY/juZ5P8iRezYOL2ydFGq3g7JtGVXZapbhTIuokYT4PVvOoSKeXZwj2H8E&#x2B;UKVRlU3LNCyy09UsWM9OvJFhHlRpdOf5SZEEeHWRhOtk6mWDNK6zqMqmdRYX88nVWbBZTMsUBKGwTII6C4p0WmdRvYjX8&#x2B;DqbLKah/UiLpNJPg82WVSmUZX5FATLs1tVFiM98GYRV2lQL&#x2B;I6DdazyeVZWGeROO9ONxnsCWGZBkUyqbJwm4VVNt0ugnvnkDeiTRZuFhH8B6p0sn3hdPP3vqX8iVn5y//66sVPF&#x2B;vlvXv3oLkHk4dEfITqR94u5vOCUn&#x2B;73d69e3ez2UA8ALi/urpCIbAVkMADcA8tPn6l/n61WpHto3OH0SuAucO0zwANAuv1&#x2B;u7du7BF/PZv/7ZG6rLuLBX8DLrAzaHrHMmB7jGYXg6mR1Aj&#x2B;MEd4WCNq7ipOob&#x2B;G/M6DnDkcQX6MZh7JO48rsMf4utxuPwr6ITjkT24niCW6J&#x2B;0Qu34FX6&#x2B;jaeKBl0HjxyLBBooEvsdgHg3RsBOnWUHj/DXXvE7WII64EZnKD/3Y7vBQU0OauvG0o5T4XfZP&#x2B;g9In7yangbq00o0h/l0qFgwLdbJQb0osJjCcRavDiCVmlI2efE/WzygDqsbdsWyln2J4HuU7oBnfAEDjraChGCfdSrxa/rSrjGG/gnK9QpSfFgmImG7RjfW2Uz1R3BYlmmHgkqiZ1SQrMOBFL6pRxyhQ7HCmk12O5I1GHX80VGWQwOnh0GVXChnkAO3Bjo451zg2wwCIK4wNPA9&#x2B;0QvpNpy3ww0AM0rItySiQ4WKWUVbhWnbUIJApJrNnvW5VTrFUpsaR83xtGyjfisW6FfWSM8USg/d4DX2HOGGMg/OCsQoD8TomUzg1RL614GMOn2VpDea/Tthr4gkvWMyfuzuwNqzxAWHMnggGlR0jS9CLoVOtUN3qvDyvuDZ0wnbquM23btg0oT8i30AtxyChlhhPJtkcAQaVE8eVjxxw2tXEc8a7r&#x2B;07LADJYMJj4rAidWnq0ACCiUed8uCc3nAcDB88dnhx&#x2B;qT4SDXyNX9f/5v9BKM/1/ORqFizPnhE3gGA1D6/OgnUSXd4&#x2B;yZNoPZus5yereVQm4WoeXp1NoB2Hj&#x2B;9q7tNprWeTIo2uZsHl7ZOrs6BOJ8t5XCSTIgmLZAJ8X2dhkYSreZTPJ&#x2B;t5eDULL2dRmUZFEq7mATJzldkU6vw8iYo0FgEjWieneRpfnU0QjWedhOskqrJ4u4g2WVhkp3kS1VmUzydFGq3mQZnGqyTeLqJ7L5xWWbSeh&#x2B;skLpNgNQvKZFJBVEiD9TysMwQJnVTw9E2j7flplU4kX290fR7XGWKPRlUakckDz4EqDessrLMQcZCKJKiyaDULEOMf6B8JievzP1p96C9u/sk8//C/Ll/6jWp1eb3dkpEPnTpU8tDTUx9PpbvW4oPtA&#x2B;StFf&#x2B;QH5C&#x2B;l2IDvseL4LYLcwEZRDQgwOaAB/Ev3g7RgvnCGCwIH/DTf/7P/5lHjLWDJN8L8tZgy4ltGRPSKLcxfWIOq16BS31i8t9OqHy9Wq0aaR0cx4&#x2B;7eEb3j4GeT1jv3q/pidfB40&#x2B;WJX5fWENPANBfU2XiYoc8eV/V4zjorY7u6cbHQa&#x2B;07/r7gznGPx/5lgPcfFxgr5SYxBVcCJ0ivvdKxujVWc/KUHAlvjJKQa7xm1Mki17B3Z5kaRk1Pm5F8CYesEK/6YXBr6DCCAe2yrXXSlRxNwbP/Jc90CqXA7yulctIeEkKDERcfLtz4xNf3sX7BRQNyBM/PcWth/3LXtbyAKurZ4OG8roQ4DC90eg72XEHM&#x2B;agN7uug4pYDzAV4R5odoOdhbOE3XcMxKEw9qhR7aFaWlKywUBJ7watvzUS5UbXmaIC59AwxZV6lQ3vxKRgREmv5y4APdslr0YfIkKLdyFltffi48umWbm0cWAQ7bsOqbWITZ21QOFWLEJ8tRaonHO73Q7eJEDS5LvzomYdMokZxF&#x2B;j6VWUVbRQZ5UXgZ&#x2B;HXjVuHXJpKfmHT9EcMUwntdHo7kCVOm/AMOx/YwxkEidAvz/UnQyssF4o&#x2B;72YqnxDWiRbaJ3i8&#x2B;kZYq3xTCGnIv2PY7za8UJzVikPrOTltRZu65jVwzRmD3ASOp&#x2B;xC4N1sP31fe8tFf2wC3c&#x2B;wL93HnDaOazrqPJ3I3XLQELru4Hy1L/brs2/&#x2B;aHl2clyNrm4HSDsTz4P1rOTfH5yeRYilP56HlzNgvU8uLgdLGdhmSBCTriaB0USVml493aIOJ5FMrm4HVRpVGXxxe0TOAkAKK/nQZHGF2dhkYR5EiJU6HoeLOdxmUar2WSziDaLGDSbPInKNF7PgyKN6kWcJ3Aanq6TaDUP6yzaLOAwEJZptJr7VxCXF&#x2B;np1dlks/Dpe8s0rhdTCBJlEtSLGHT/Mo2qNLy4HZRptJrHCP1ZpUGRRHUagqJTL&#x2B;I8iass3p7H20W4PfdiyfZ8iswAVRqu52GexGUaL28/fX0elUmwXYRIC3C9COsMZoGoSKPy&#x2B;/6H/Mf&#x2B;r&#x2B;rn/8nmxV8vV1fX2y18Z4uiuH//PhJyMUsXwvZfXl4yJg/i/fNPqOQZ35PKfobqv76&#x2B;ZgoweAPjM4SK5XIJR2FweK6urpjxF4p/fIBsALcBMo6KokBeYbog08iQ5/mbb77pt2V1wFllXh70U93oGu5x/iygRZczlqeVnsb68LVaDFDg5njyd92gJmAJ/NWOUaNTGgH3Za7338vO8BUg7K&#x2B;Fjej3RWLh9YRO0PiNn4ejcOyATgh08KBVoubxN5xU/XhWaFzn3PCl1hH3CjhpZo4GYzyp&#x2B;6Np5pSFnGV2KndYN&#x2B;ZWGKH68EWPg214lsKMUQ51rEmjwgNalVpYtdoR0phR3BTvDeyUoNIL8gTpWgGnQfxoRE1JKE9oQUkDfCEKDL3yRbZHjBW2CDV5ajjyxyRCjocT/Mq&#x2B;tmPhr9cSpPQBqMycppwxB4VwL9OTtVdygq&#x2B;08djFKqRulSChZSC2iKCEKls9ofWUYh9ZEYz0FsyqdiqWos4Ly02c3WWpQhaIhho1Y&#x2B;113/tQkkaZljjGSh4YoeRhkgnri&#x2B;/diz5eTV/DKQhHW4aj4lQjZQiniwfZZvBPMEIfapumbRsW6GlnznuREqRawdNOpTrmU4w3SjG02e89nKWVTckG&#x2B;/2e/dYprpRTMYKsIhQh8uZ&#x2B;t7OKidSJ7YWS4X6/A2VITmVE7BH5ROpmoZ4XdqARR2E/qaTXnLhtGBUDuBdbWzsQbdXkl1ndi/OGWpyKYNb3fr6pbzhvHWKJKkUI5YFB8BFzCn6Ca4RzggO6jkYVSIBY651k&#x2B;GqbpnO2bRqakoTZNSQP5pKhhEkTwbvruv8f/gESeBUI2D&#x2B;brM6eWc1OVvPwauZ59qvZyfLsZD0P5LbJcjaBin3tI&#x2B;7TBzfycTmT&#x2B;OpscjWLYQ0o0zBP4nwerOcBgoQCsudJfHkWrObheh4WaZz7kKDTMg3LLC7TEBmF88RnFsuTsEzjMg2vZgj8H1VpmKfTQpIDwFCwmp1UWVykMYqqs3g5CwuQ&#x2B;FNo98Mqm26ysJjf2mRhmcarORB/sF1EpU8oFhTJSZlN6zQo07BKTq7PoyL1wkCeRHUW5ElYZ2GVhVUW5fNJlQbbLKjSoM5AIpqUWVymQf29f3bzD/&#x2B;P6ud/ovjsx4vLO2WRA7tv5aKCH9gacX4Q8wfCALg6VM9fX18j7j6jAAHxo1gUAkCP&#x2B;yEhwMhA4j7v4TewPzC4JyQK3Im8YJeXlzAdQBjAzXfu3MHNjBn6O7/zO9youav3SmPFrYanJPd5Hii9YI6DU7gTykGraL7YMGUlPtofgGDeHeHj4296FWDxcbc98qn/etFJ8gnXlxQP9JnSjwWA48E9kAZxHQMtO&#x2B;giB4zLmaYfdI8X8DQKoi2rVwKnBpO8k7OdJbMabgyRNa7jRXyv36KhuUaYvEffb5UQYpVe7ABi8Qzlv50y4ANr0arfDLEQ5ehUpGiEveFwD3BCuc4yTyhEAgUKxDVUqSl1CURTB6RukCZ0H1KGASnoKT0k3Jg4inq26R7p/SZi2R6ZXh73D1KXqgqxCFCj3NMdjxDnAQeGEhVHmtuimriDp0jPJAaDyta68WbqlLWhGwcXInD07x1RvrxQ0asdmcp4HSNfCyTc6LUKh3Yc62GoJ32SVSJjf6gjN6IgZ88YY9q2aWQC4aIMMFoYxjhnm4ba7oGSZMWbFneS&#x2B;tK2bafyMwyMVRk1mbW73W6n&#x2B;031jDc&#x2B;YPFg3Rhl5LLj&#x2B;K3a/sXhgHjD1WLtEA6Ic50D55Qs0Yu3rp5ynQQg4nwwEjkUZZKJ1CnevxtBaiY0ECtB14F&#x2B;07Zt33VOYhYNZhaagNTbnXNmMHr4CS4&#x2B;64OvuUzOIRkFuZq9SJIca&#x2B;8PoImPQunhxJDh8xPb948EhHUINGspwxvODS45NKTvOgSVcuOS&#x2B;0edQ1/jV/0zP76enSzPTu48f3L39uTyLFjPw9XsJE&#x2B;iPAnKNFyenaxmAYJj5vPJ2qfIjcs0XM2j1TxYJ9PVPPJK7iRYz4N1Ap19kCcBIvNczZCuKyoSBNYM8yTOk7jwOXfDMovXSVxnnsSP2Px1FhVpvMlCfFkkkzyd5vOgXpyWWVyk0XYRVcjpm4X5fAKGPej7V/O4yqag35RJUGSn63m4ngfLWYiAQojEv12A8e/D/JdpWCRBlQabLKoXcZEE1&#x2B;fxcjbZLOIijfMkQMbfMgmqLLo&#x2B;j7eLaLOAWBJusgC0nzIJNll47zyqvvtPbn70f6t/7se3L36yuLq7qSuwaAj38QEwGkH6wcvXPr737t1jfB5k79KBOBnyH7LBnTt3GLafLwKbnwWSawSpAPegTFoGUBo9fckdojsB&#x2B;D/4jNxhNAJcXV198YtfPMAcfd9zo7MK9B8cT&#x2B;qo1Y5Gbjgv1cFtBUkYMdjyfnw4QGbHwJQHJU&#x2B;o/onBZB750yPvfIf3vJOb/7Bebgyvj/uWMqR&#x2B;hJKk/l5PFZZ2MA3ckfBmFfQnzCM04k&#x2B;cxge11TItMU&#x2B;vBFTOVd5AzG2UHpOnm4YWB&#x2B;Ce4OdgCXQqWAg/dJI/yynduRXlugafXDhGooywcALaA/6PNm5YhTBROBtO8UC/VMM5/ae&#x2B;WD2jOBG96BEaRa9gG83Y&#x2B;mHE&#x2B;AB0ZIVhgdo&#x2B;pSG1Gws9/JLzhi8jvONUO9iwOtFr9uP9i6U5ZV5gk/Rk4r/c3YBvzNimQ6mAZR6MDac&#x2B;g584JQ/1/RA5pxP9pdayAFjrGYlrv9vhw0Fl0Il6zKhnNWbE5WBRTdNQIHQKkfdqL1YTYpDhjDHOx1mSHLR&#x2B;PrWQBBoh&#x2B;WhRZD&#x2B;kprJ6vQ0EGJn90MobiSmLorquc85LqG6guA2LhNexENWJRawT11j2KsOS9kIYJfimC0QrjsuqpcZbiNq2bdu9iB9oO31qERsUPdMpE3wrBDuRi4Z&#x2B;hrabMNpI1i2Z9qPQmc6rK7AB&#x2B;aignXDxW8W986p9mRld1zXNvpNABMa0bdv0PgwPuf5&#x2B;TqCdeu/oxBu4E7KZnxgtAwoNJ7pMfu&#x2B;2zuXZC6&#x2B;gbZte9lAhy3mhiEvVGoOKUWzoxAsfywfzH3Pj3SgAbH/&#x2B;J9ezk3w&#x2B;ufP8yXJ2spoF6/lknYRFMlnOJkUarmaTPAmLdFokQZFEjOuP0EC5OP6ukmmRhBe3J4jEj3j2RRIW80meRKu5Z&#x2B;MsZ2GZBPCILdOoSOMcqa/gd5tO10m0XcQI17OaR3Adrhen4PlUWZin4ORML89OrmZRmQRFEpbZaZ2F9fmz9SKus7heTKssLrNnQeuvsjhP4lUSV1l4NYvqLN6cn27Op9tFVGYIAQQSUZQn4fZ8WiRBkYZ1Fqxnk20GH&#x2B;iwSKelTy8QVllcL07X82A1C&#x2B;ssyOcneRJdzcIiCaosXp//yfIHv&#x2B;X6Z34k/&#x2B;QvXOfLTV1Bka9jd0LpDq05OPTX19fM2qtvXq/X&#x2B;B7wervdwtkXFCAGBQLDZ7lcgvaDm0HOubi40Hp9FEtkT1djiArwGUDoIaYYYwmkA&#x2B;nHwReC&#x2B;QKWgQcPHujzjsiAmjVK&#x2B;K0y6vaKbe88lsKHkZLOKmzXqyP1&#x2B;FerOHtaU9YfwU2N7/k4ZRXe/Ei8jhOBf5ovh7Hz7pUE3kkz3RhzP&#x2B;F6XA&#x2B;zY/Ws0E/h0iUo/PMIB&#x2B;5&#x2B;PGEI6qzyW&#x2B;UNxAwH8Ixw8WBSOeUTqKerVbjZir6VC0RLBaw5UazuZ76ulcPUKKOBBoG6qp2oenuB41ZBfCIr1lZrIfksAJJOUsTKEOS0Qglxiv5AUNpT4yZUH8JFIwEYD7QD/JOvwwfezJZSf8q2eAymcD4ef4pwTXwBRxYTTZrnoLpBGalIw8BJSjNNoY2laaRODMfZ0w/7o&#x2B;0EPuqZrV/djb2B6aFoxs4ZLNwqjheHuZW48r5p4ymiPz&#x2B;OU6Vnpxl0q0a/kUwY3kwEfzDdySbnuLLTCPtaZeLRcq12Tudqb5UKvxW&#x2B;ftc5RubhykFgR6c4Z5jHncxOzngnRB10HQCulcmqLz&#x2B;rxuaFXh14VnAk5ZP9fm&#x2B;tOx5ZtSMMZBtOM79UgKCbhgIPRBuqsY3yS2aHsHrwP/avM62g8MEhwQkrRlXe4b0HfaUzcHWobdNYGXc1A4ccxk4MArKvmX7sgmLatsfU4tpULjp6tZLw4&#x2B;gzMOgXjbXeBcJPP&#x2B;eliH5wWbGdZCamRCGr2Kv2reQCU/PNeOKQ0hv178Lr/q/89Hp2cnU2KeYnVYoctMF6drKaBasZM3wFq/lkPQ/zJLg6m6xmSAIQlclkNY/yeVCkUZ7GZRJenAVXZ8FqFhRJWC9OiyTIk3g1h2Y9KrNTZAQDcR/M&#x2B;8tZWCSTIgmKdFqm0WYR1YtpmQZlGlRpCJMCuD3Q6FdZlCdBkUzKbFqkEdJ&#x2B;ecpNGpVZnM&#x2B;DehHXWegjimYxfY5X83B7Pt0s4moxrRdxlXp3Bej&#x2B;N4u4zKZ1FsGXt87C7fl0NQ/rLKzSSZ5ON1mwWUR1Fm0W0XYRFUm0XYSrWZAnYX3&#x2B;7OZ7/kz1//719U//verXf&#x2B;F&#x2B;sdzUFXj8QOdg6m&#x2B;3W2j0EZ0TvyKADzg8EAyur68Z6xP8H7gHUHigRKEzf&#x2B;m0XBAt6CgMuwH0&#x2B;pAfmESM2b4A9HEzNPowCyA6EN2OAfeB/nEh&#x2B;E&#x2B;e56&#x2B;//jqCgb791luE&#x2B;Fg&#x2B;XDxyxg1nLrcOHsedYglSqdnTv&#x2B;7QO99fdgzfeS5gM&#x2B;&#x2B;P4KPTFBGlvnWikzq&#x2B;&#x2B;ZHXExY&#x2B;m9Z/pZx4vvfLkiseeX0VNii28fhdRlHC9Pf6oHzyZY8g/sGXrIAGG05dGnTpChjFvHBjCNer41tDqYN79FnvFExiV2hBF5rpVjGoOeepa3djYNMrCgYPTQ0vnQAnojI3Pi6bkWviQD0yolm3gwbZdwilFI0KjDFQhvJdpNwQzROtdRLF342lL4oWbTvwkFFDEHWo&#x2B;mRVW6GIa4zHb6gDJSBHiEXexgCPT1ml1EdGoY5kLIlJogeeQ8K50qu8Br5JygYxkr2OXJ47JbR5hKGYT04hXatAP8dbo3CneDhWSUtOiShsnVVz1zIsA1dFN8w2SlG9yHb92A9G41SuAYV6JRy&#x2B;NpuICtgqWcX/Khx653xAG0oFTkZU7x1WxEoqvDmaLNlPcZkWvIwkzOIc9cR3IGlMX&#x2B;EjOUG3bdtCAWzadr/fW2OsZAlo2/aRTro&#x2B;yKa0HT2z3&#x2B;1ayYfH1/kOHyUxaEjFIZGG7svsbSs&#x2B;ysa0&#x2B;/3etJ5fZKRuXFHtkH/Aa7Kd5FlDA6hgb3ycIuEgtS0Qtt6npFe9UIFJ7dekepbja8nYU1tDJ2sbD1Gp79emOG&#x2B;44fgXuw2d430mMi8VWAn&#x2B;0wGRc/4bAx9ifcDDXQeDKAwfCcLbdZ2USWTQ7PfdoFyEDDOYSjrxeLGKIvguuu792s8sZ5OL27eKZLKegQI0QQigIglW8&#x2B;Dq7GQ1j5azSQ4SznyymkdVGixnkzyJ8vkkT6frJFzOgnUSrucTJPO6OIvWSVxn0Xoe1lm8miNSZ7Q8O9kuotU8Ws6jIp0u59N1EgP6F0l0eRaU3l82Rox/kH/KNAShv8riMg2RRww5gxHRv0jCIoWJYIpUA9tzsP/DEmJDGi7n081iulnEmwUsEvF2Ea/n4TYLigSCQbRdxFXqUX6dhdtFvMmi9TzcLkIE&#x2B;SnTsF5Mq8UUYX8259Myjasf&#x2B;mvFP/&#x2B;u6pO/uLl6fVN6Lj54/CThEPRXVfWFL3zh3r17EA&#x2B;AswHKQfVh6H1G4SQRH2geFB3ctpEL7CBKCCQFMfQnPmuXAMoJRPPMDkazg076i6dgZwCbiLQiMJFgbSjL8u233&#x2B;5Vfh875CIc4D4hiGzIfn/T4L5V8YKsUtVpbUivsD5x5zEswwcNTO2YaNRTHye60oOV4h4vAzzu&#x2B;i&#x2B;Hub8yceIJ1zsh7vN6J13B8eU3j6uzHsQnv9GO4b57lETXy8i2whEQLDaMNaGzPQLuvQLZB9jmAG0TcXVKRXvwCq1xJ5A7qAnii7AaXBq9yANGcYBZQ57sLF/XhCjIjYkxRESEzp3SoHPIWmWg6JWlhTdYZQfoZTlTJLDinGmVvtJLOMILOtafspmUjnQoUkI7gHaCQBbOujmFwzUkw1ue0iOtx7VX0lI/3jJ00fpB9oXuJj1B2TbSmnvRu7O1vTCJh1eMwzxxXzsQUjnDetm5&#x2B;Hiv8kANKLwblOtG5ZigzNQpK4dToo5&#x2B;qu&#x2B;dbp0TlTBBsB1xs/wOy17i7O/kFdr0g7nMCc0VpUvmnOi6kXzPx&#x2B;nRapWnyzCBhFjP5cF/JUBnixbJmoGTgwjHRz7Z3nuBYrQiQeFFWMaA/lb5&#x2B;/pypJMphBhjmmZvxZ0D31pPBPRiuu8fzmzjL&#x2B;jL4e3Q9x0wuiFhSa0iNNZJnFNrhwb6Y9tCThjWsDXMHjAsJ3i&#x2B;ejlNwrDaQage9hdjDHF/2zSdz/818o/vhe/bqZ29UzIeFv6Qa6xzztq&#x2B;H5LysjTOf8gwXTcSDNTaH&#x2B;C&#x2B;NYO1wblRLjMualnOjqQgNMSJI0H/bru&#x2B;8ImfX81DyeEVrOdBnoQgvayTuEgmeRKvZpPl2clqHubzyWoOZ9x4PY/KZFKl0cVZUCRBkUbrJNpkAXxhyyTI02meRGATwYt3NY/zJNospqtkupwFdRavkyhP4tU8ypOgPn&#x2B;2SOMyjco0Xs6C1TzM50GVRZvzZ5EgbLOY&#x2B;lRfabgCKM&#x2B;iKjutsvjyLNwuppvFtEijIo3qFCydeDmfXp9PqzTaLE7rLKwXU9gKqizyAkYSbM6fvT6fbhZRkUyqLF7O4yoNr8&#x2B;nZRouZ9Emm9SL6QbQP4s2i6hI4yIJ8iTM/&#x2B;631P/8uzYf/9nt1etVsaaqHsgeNBv8Cc49CDZaAQ8ITk9fBv/BBwgPyAxQqnS8lCu0Rp&#x2B;SA8QDOhtokg8&#x2B;MLQ/LAZaYEAoT2B9CgCUGegHjBv4FggJEA/AEXr48CG1Gz0dd6gyk/0Z0Q541qiFaXnMEWZRRcJDthNjda94Pk5vHY8iyurJr2/oFV7Xt1l7&#x2B;Ct3dV2UO1r7&#x2B;oYnSAL2icD3D/x6gqTxhJ&#x2B;e3Kgv2WR9g97SdSdzWA8eNErv7pxPMESo0KswFWasNDxAg70i6rDATulkOxURnpBUPzIcJcqE3ilVJo9dfVs/zi2gZ3sv7qaEi60wdYmwnXPwS2SBGq/zXxoEnEqNZ8foi&#x2B;tFD0Er2VE1gqcg0YzDd/K9Tjn/MH0qXwe&#x2B;vhE9PREau5SUbD5Is4MGkNQ82rFdgoQO59yQB0BPCH5mL3NINODux2oDK06ZbozROxVrnx90z&#x2B;o/&#x2B;WpdH9Se14A8RElPUc&#x2B;vBGVG6EVj2nndp5P54dxYQur73jDckBot1rAXINX3Q3P8MIiHpciLw1TAh0ZFyu9V3gfWvB0FERp4HXhQHqcTRGsFcrmx/M3jgfPVOZ/itxNWCeeNtYM3sGnbnfSzlazATuxlfjH73h4lJRBde0vgjpK7gdo&#x2B;RCKif7OR0D2dMOqMeKD6OnjvC0Mw3XoazOBFJ907sNS8GpveFBICFaYMPyLiF2FMu7u56eVd7ZhPZakVkE4xrSpBrVhujkTM1lrrW2roiuAk4Bcb7sgU6joQbCDwGNmSaKrCcMtLrbWm771rcq&#x2B;wghB&#x2B;fJ8YYzBnsPM7ZzsP0zve3PfiZdH4QEzcAY3ECeUB03cdyVF0JHDO4Uv4K&#x2B;C/vu8PRJd3xfWFT/0S0H&#x2B;eBIjsmc8nVRquZyer2QSkf/jyrueTfH6CwJ2r2SRP4&#x2B;UsQMbcKguLJCizaZnGuQTbWc5OlrNoOYOX7fTqLMiTKE8iqOqvz6frZLqeh8tZiMj91eK0SKdVFi2TaZnFiK&#x2B;/XYRlGubp6XoeVmm4Sk7zNL48C&#x2B;ssrBfPFmlUJNF6HtaLU5SwPZ8WSVSm0WYRr5Ooyqbr&#x2B;WSzOF0n8PGNN4vIhwfN4s1iuj2PEd0foXvKNFwnUZ3F9SLeLKabxXQ5j67P400W&#x2B;NwC2bPVD37w3r/6vupXfnpz56Vy7QPvbDYbkPh1Bi4N5cGlgestCD&#x2B;awAOqPUhBZA2BMkQDAm4GTQiFaJ&#x2B;BSl0A4jA4aG9jnRoMLgGg7kAYwGdIBVTwA&#x2B;hfXFzcvXuXIUqB8mEuoNEAYsDdu3eLojhA9sMRpiI9WGthecaGrHVSNB10yv2xE2eAXmlG7aNUwhQVCOackjF4SvJs6vveKuDVP&#x2B;pMwfUEHE&#x2B;1JXfmg8v&#x2B;HoC&#x2B;&#x2B;fL5P1/W6w7KfwKy/7LKeWRlOCUe&#x2B;QjvJGw46Ez9J8eReKw/5Ij2/KZXqn2iNdzAx63ooXsF33nisGRdQ8IkN3ac7caab6dC0fPEJ2DoxxkMNFxx4rxO2NaMXOz8RZTP05Nwn3ICERokBHYCb6a3oVNkYHzDSOi6ja1cWO94HN9r9g7QbC8iEwE6XnFzc2PUtmBE39/IxVawja0HYIata5U1gGpKJ5F/BImZ3W73FMej64bku27sKmEZ8VQlC9N93UjQsaO5dRiCtB&#x2B;r5xW2HjF/eiUn9CJo8k/iS6uFM2OMsg1RShOlywivs4sHsDsW71Aatd1Gqd4RCtPjfkFLAHCcEJyd3ZEZAR4CHBI9xnwLZx7mih42/mrU5KbEQoBoJCSOUywx3Kn9GXTFiOlluXoa2X6/R4EccdbEKBlaT6xObtOSK6dm63X/eychj6Q&#x2B;g5UGc5jDitbt93v8jXuETufNDE5ZJ7EC&#x2B;Gwrmb&#x2B;sKPiNUuF3ztFn2gEHWxWMyPeAc84hW7H1dTCtTHtIZaj8SAawhhiaNek9QPfj5azP6sD&#x2B;7/ue8Um5qzZNQwKSUXfiNtkQqWDwhRsDi4fH6x6aq4CtB3NVGER&#x2B;EHmuODe0CxYG59lKNBQMZ4zfzZ0jJelddH3xlU&#x2B;B1p8nUT4PyiQo0zCfn1ydwfdXQnAm4cXtYAXEn8WreQwf3xqq9DRcJ9E6gftvWGXxeh7mCN&#x2B;Zxsv5dD0PyjS6moVlGvtQ/UlUZKcg9hTZdDWPkK&#x2B;3XkwRgWc1D&#x2B;AKnCdBncVVGlUZQoVGm0VcZnGZTfN5AKMBsHuVBuskRB6xOouvzoKrWbg9j&#x2B;ssKpKgSqMqDesFfBKiOos3WVSnwfV5XGdhmQSb89MqixEmaLuItufxah7XWVSmUZ5Or7//L1T/NNt&#x2B;5KfrV35zefF6Xdf0voUOHtT87XYLSUB73AJG60CZZONovE56PcoEWMe/DP9PI0ApF8A6xAn8Ck9cuAXTYgD4jp&#x2B;0Cp9vB6xnoE88ghJQSUT/pIUB2YJzuWAfgPzQSFwRo3Ry3PAHXb6O0KWifxAAdeJkz2ORi477ifEa35EYP6jG5DIKFzqFAvml/tMq7n5/BKaZB&#x2B;aRC&#x2B;oJQsJXfOd/6YstfWT&#x2B;soPe&#x2B;HIvDUtwHYwLP2vNo372CSXrY7cfS1/cnPkKjmyvhAGiID1ztNLQCd4lYOMc5kVPQo0KzDhrqryoP/ipl8lMoExcx/oc4F3dY72ojLki9vv9brej8Nw0Q7BEDWYIDsdQSuCEyAMg0xPua2TPVjtR26N6CADaiuq973tUD&#x2B;wd3Ilie&#x2B;VDT7jPF2lTAweapgBjzM3NjVWyRKtiJxKaclBQ7acOYISeAZx/ehsyyhpAVE3Eo4VFLTx1Qmbi2Kudy0sCWlxjBST50uCZYMfhfYZXC5QHAOrV/ngw6TmVzdgw5MTLs&#x2B;8RpdHwhn6Qmzv9XvxK&#x2B;cEIU4W7PHuDzWTDuftbZfmyQ4pcozTcFjYBEME5aZzM1F6F2Wok/3ErZHoKKnh7o5j3oqpuEZtfw2g/vWQOcSVAJODgGrLo2rYRXbtV4krbNIKYLSe3c8NQctW14lTAhY2iOmUyaiQUvVV6Ao4xrTokt6ATWnGQcBKtyNKyMYTAV94sOmi3JEYwyq3HqaCo6EI/fMZAbkFnOHE24nwYznI1LXmuyz44iLVGqQwbCZyKDueuB72&#x2B;5&#x2B;L3CP6DMr1s6UQAsENNTKcGmi68/eg08sKA9RXr8BYnufCUgp82AUkp3/lsZV87h/o7vL742m&#x2B;s5tDlh9D0X55NCh8AdLKaBUD/l7dPEBUUbP4ymRQp0vRC0R55An0GHX9UZtMyDXMECQXbZx6s5lGZRnkCsk20msdFGnraTzKpsqjO4ioNyjQq0/DybFJlcZ2F6/S0zmK4EJQZXhcXabROYuQB2Jw/W2XTPIGvMOB&#x2B;WKVhlUab89N6Md2cn9aLeHP&#x2B;LLT&#x2B;SON1vQiRUwwNuffC6XYR5EmwWUzX8zBPp3kSVmlY/8B7Nj/&#x2B;Hetf&#x2B;pfblz9V56vr7QZafMB0yADk4YD5wzg80MEzYxeRPcUGKP4pJ&#x2B;AGqOTv378PmwAKZ6AeiAR4kKkDNpsN0nLRaZgxQ/kKFMvgocjpy&#x2B;qRMnR1dXX37l2YMigYIC4Q&#x2B;EXwNEAMUHoeayPAdrvVWkAuc32KGcUzppBAjI4IDY3aqagnkvWLDcH/yg2nHwdO4VnWjs3FuDqlAeX9/LdVtGx8wIs68eP05/X4aiX6YfsoJfojv3zc9RUD7q/y5Y4EoUfWXDbV4U984NAc//TIYp0C8cQVhLAEIf2Y2UGI1UhSoF6GngUS2h2gcyKBA0m1V/IG8R6BplOA7QAN9uNgHqxGryCcEV9bo/SqnHIa0RFU2DEznsukUyYIcmm4GAmmCaXQClgJzJAGp6WC3wncx503NzfU5bVjU8Ne6xnbFjYEoj7uA03TUGZgK4zkA&#x2B;ZtrTJo4CdYD9iN2gjAKYHCOSg&#x2B;EZhTQi27nrNHg35CQwAeTiYnQN&#x2B;I&#x2B;yDHnu8mT6AXlKOnYz922HVjiaoTd&#x2B;FOSAgAJewLvoXFGnUN26SyavUqZhNbzRdZ8aTkQtIzmANAIYOThvHdW6WAb73v7GAJ6Y66yAroH9TPwrfphN&#x2B;paNmWheNpjCvlTq5SvYrYB9ZysRne0bZt0&#x2B;yh&#x2B;4c&#x2B;3ghNX20ohosHdbbCSxrkYwgMVvyYpZnG16rhksC6olHCiGuvUYIBlO5OHZZ8HWcs/QTMWIIf2HLKmxmPtFJ/Hpni6iDRgUTickru7TuJn03emvVJsppmb8QlWteEA2ok4dqwy0iIUkziXgzxrCQeGW&#x2B;FbU/CmHCI&#x2B;743jBEma9P4VM0GzH7o/p3It3YQdH0E0s6bleyYd&#x2B;Rk&#x2B;Lw/hvcT8DY6xhHy3SG91InY9jXN6D2&#x2B;HqxevXM7XM4mq9lknUTL2eTKJ&#x2B;oK1vNwPQ9X86BMJnkSrWYeYefzIE/C9Txazz3Rv0iiIgkvzxDNM1rPwyqLr2ZRnoSIyg9cvppH6yRaJ1GexsgzkKdxkUISmNYZwv&#x2B;HRfZsmcab81MG5ofPbp2FVRbn88l2MV3DGSCLN1mEbFx1FhXpdD0P62y6nk/qBcwU4WYxvffCdLuIqjS8/12niPaznoeb89MqC8tsWiRRAcrQfJInMSwY&#x2B;ff8&#x2B;e0/&#x2B;lvXH/4Xm5c&#x2B;lV/dBRBHAB/Q&#x2B;snsJ0cff/LX6&#x2B;traOX5J5k/iLhP1o0O6UMRAqD//v37eBF&#x2B;pTGBmnuo&#x2B;UnBh6oe4J7MIsYeBWqvqgqxei4uLhjUn&#x2B;YFUHroPUyaEGp7cXFxeXlJqYABQ/EBNoSiKGQn72gJHLY7dXC4sdulHeft5pdUx3DS6sOrG7P/OwH9/NcfHnaUKx3ldIrSrUvujzyMnwDH9U&#x2B;E&#x2B;DyP9E&#x2B;PFAC&#x2B;doD&#x2B;IwH6Iy&#x2B;Y6PtHVd6N5YGDP9uxtyEG8FjW6sfmF41YvqxLJpIj0NI/8SzmgagnxuM&#x2B;cKLy2OqVmpVzhsCJB4oba3uJj3m1EvqGPQOAyxcR3gBINCrLKnFwr3I6EbgDAdLbuFUxvglXdrvdzc2NU/E5WkmqxdXHED1aNtCotRcZeABtY1o4tP6tUIv5wSrGP1WZeBHhu47rT1mF7CNKQbRR4EuaJvDNU06xaHrllM1GUjYwzJM1puxbFda9U0OuB75VpAXsUhqFs&#x2B;uHvUl5I3DHPPgXV6csA51zIF73Y8h7ALn0FNSbrP5glbtGJ&#x2B;QoqxyFzVjC89OoG7iVA4ZTIspxozTMciLz8HjwlZcvud4OZA&#x2B;y1TkhAMI8LPXhnzAnBpRplXO6G8cS5WyzgpGxdobVPjgfDzJhqyxiEBWGzzJx3SCpG90PmNCc9ehwmOq8l4y1cAlohRLnnGvFfd4oadgYs5dF0jnXtoMA45QqnQ1jG51ziOFj2ka6i6kPhNLTto0k7kZLnB9WP4HllDe990Xx8YuchO3nPIfVBbCbC1XmzCDXcUZxBlLMkN3WU4k4Ij3P164zMigicHojFfl&#x2B;LWQMLFswf6C8V4sR7aemQIC&#x2B;7cT3GvcY8ZfwpCCp8LvouslfXyZfVyD6p4fyQZEEqyQuJcz/ch6t54EP4zMLV/OoXnj6TZGERRpBeV9mcZlGRRqWqdf0L2dA53GVhkXqyUJwCajSaDULK/9IfO&#x2B;F0yKNi3SKiP4ItL9dTKtsWqTxZjEtknCzmFZZtFmclmmwTkArCjdZcO&#x2B;7ni3SuErDzSLenk&#x2B;X8&#x2B;lqHm4WU2QZK9Ngs4i25/FmEdXZdHs&#x2B;RX3qRbych1UWbxZhmcWrebhZRPl3/anrf/x/bf/jP15/8hc362WR58zLSw/d1Wr1xhtvMG8XNPSI6gP8vdls3njjDYTyJMufSbIY4YdwmQF5GDiIRUFtj4vJwigPUCuvHXnxFr6I7H9&#x2B;1op8UoOYOwxhPQHo8SV4QeQXXV5eMhAQ4ofiKRgW0DQrWidsOOS79hID0SpPNtlojFE2SW4CrVJ89Mqczj2Kt0HPQrnCqkwvZkzGMNRu9D0ff8IaIXa0Ktj38fXItf8l8f0TXv3kWj3518fd8CWf4vUltzI0rflS4YOsAlQcr0eWxu81tu6POPFWyWbtOPdRryS3Vvj3uDTGoy6SpyR/olpqgH/jEJwsh6rGg&#x2B;nk3KDB5Mzhe3uFOXUDoUykgKRxgp6fFCy5WAjh2MNQShL6U8KBwAOCUNu2Dx8&#x2B;pJqV0JmgiEMGSaOV2Jq9CBhEQehGLmddIGG31803TdM0sBjwS1aVgAo6eyOcZ1wUS6zKXIbLKlmCL9XhRPErXvQU9xcZsEFi0wP2yC&#x2B;tEkY1eu6VZYqTCT&#x2B;hHp3i9KsJ5I5nUqesRbxT8NOhnrKTyym1B6ejUdpfEh50JXvvEb/nfs2qE/Fbbzrxjs6y7ZpujOO5sA9WFEfFqjKHd8nQOmUg0&#x2B;YbPsix0ANvBuW3v82NQ8yytwFDaVEaFpjaQYwElADrBh2ByWoFN/dgcMk0AKPGiSSK044BdtwA94f1ud/vPaxXUTLacWBQIwQ7mfTDrHNsKtC/yAN97729nRJmAMeNMfv9jguMXC8rPQCiP6ct8boTHnyLOEIcwUH8UyGAVOyFbjDUmGa/ZxgiJ5KzFWcAXaaV6LSUqfq&#x2B;B3rwTDC1nr0ZR&#x2B;2/fd8PhSjjGx4zQpODLQhNI8GsE92hUxXzAowiDqGByjdAYhZ1zok/tN7W3xXXTXmxTP/o5dkknwdlGqxmQZkE69nEhwOaT4p0ms8DqMnLNM7TuEiiEjSbxSlce8skKNIpmDnLWXB1hoS7cZFGSNq1WZzmSYxAQ&#x2B;DngHB/eRbCVbfIpvXidHN&#x2B;WqZRuXi2zqIqm1ZZhGTAwPdFGufpdLOIyjTG67aLqEJWr0WMbAAQFapsig/b8/jeC9N6MS2y6b0Xni2SiYQEjbeL&#x2B;Pp8uppNyjSqv/fPbX70b1z/zI9uP/ex8vLOVpxuibbv3bsHpg0jddLrl3F78BNTbiGcP9A5cTnsA6T9gAikVfsMHwSt/LE8wD9ZNwbzKSW0P6lEMCNAaIH3cKnSDmhnX0gjdEiAvzKegjHhzp079B6mDIOaIE0YRA4INlTaKRzgicJO2c&#x2B;58VrR8PGz3sd4otmx/qsZs0l5Q9/3rXqqHStWiTLdmCx&#x2B;cJGQbR8TgoZ/vkNI3Srla/97dgAwX3W7gT3C7vrzI/vw&#x2B;NJQoT&#x2B;SBA5wf6u0jTjoe0XU0aCF3DCnrC48MfXbuX&#x2B;z2M7bboeJQfTVj/ESMTenXKfMAvrQ57taRWVph2h&#x2B;I8cYjW6BE3aSdJVv4TTm2&#x2B;lnT&#x2B;gCP11WAPaBVqKJaICHteYRiyIRUVkOLSqZORqGaaBvhMtgyI&#x2B;w1ooGk2APN&#x2B;92O5K90Rv4phUrRCO5e3VEoEbxt4k0KDlQQmDd6KmMByG9WMVoegqIyilzTCuGFYxlp0yHvcw4DkOvID5ngBsrJPiNRsOdyongxnIk4VGvaDz9OBEDyfpOacQP6kPFZ6&#x2B;IcVw8gnb8hOtUbohWIroY8dpuW58ZiquF84AWJd1MvVRkB7d62HDnw4cPndLcW1GuC4rtSRojBERNONc72eX95i7acS0TGxGLW4lPD7zou07mWSPBp3jkAPfj9GqE99&#x2B;PNA2Gk8womxROOOJaNJ9BeAwie3oEO/hMW5m8lpK0EsR9B7aNUfYyYN&#x2B;28XvBbrdrxW&#x2B;7F8MixRs2v5WkXYC/xpuPLNct0HzbDqkVuOpgBun7HsRcdi9HUG2j3oNZH9sI3UM7gJEoPbycHepgRCbpxVXGSIwj1UuGinZKYpy6rVIIWeUs3onUaozp&#x2B;06QvPWv8zGC/IPGtGqLMM56K4FVe2gnVgLnY4k6a4y15l3nBPx2eXmZfL3Pt5WGq9lkNQ9Xs&#x2B;DqLFjPw6tZuJpH6yRGbNA8gRtuuE6iIo2KdIqcu0UarZNwnSCHF1L8RmV2mqeIyh8g8maZTavF6WZxitiddRZTbECkTtgQyjTYnJ&#x2B;WPpTnaZ1FZRoXSVQtnq0X03XiY4lWWVym8WaB7GAxKlOk0fbcF15n0SqZVlm8WZyW2elmMd0swiKN6yzank/zJNp&#x2B;99cXP/zt9b//kc2nfrG8&#x2B;0q5XpUSax&#x2B;kne12e//&#x2B;fQTkqSRqJ4C&#x2B;RuEao0MqKFUCLwB3cPqhLIcfLRA2Sf/b7RakfHCHGKGfQLyS2P9024XfMBg&#x2B;QOcQAFAZgHUG8i8lFYA2C4Dww8ieUOHXdX3nzp2qqlDPy8tLiBCQYfhqZgWGEQAhRMFfQrZvLD2eEbLePUozSlHVKht9o4j&#x2B;vTqInQpDx18PbuBGqqFJrwDc8WnVq5hC/QA3B36LGweM587/hDX1OJHAjAlIj3uK4L5Vet8vvZLfcTW&#x2B;gkes4kERYPR9j13w4Ga2j52mP&#x2B;ii2FLq7HQdrBIPDorCgB7/ysuMFef7/b47kvcOEC1hHhEgjRtGVHJGKcJZPo5s8GeIQ1hJQE82rRMaPYrlr0boD53wajSkYad1wuQhDtntdqgtPjhR8DFuj1Uq81YpZIlCzTi4J2EhyRRWAU7eY5VmltCcXyoY4zRY0o&#x2B;Tr3Fzc8P24s5GeQOzhuwlaveJeFvxW2hF08/Gslg8&#x2B;BRHtBdsD9feXuWR5SyxgtcHO9c4RFQv3occcu44GoRZFS/8YDaTeMCtrVeGngGmKA6Sf&#x2B;l4eeBqx5EQWE90QSu6dqt8AGRujfCcpXit9mvOG8WnH80k1hDDRTy62&#x2B;06kTs5rq04S/EpPWmcoCvH08B6uOaUqMN5YFQQq06IKHhkv/drDM1C9fbC2sdi3kuyJ07i1hPKrZ5G7EDOKk5o1FwL/U5JJr5LSVkTURg191aV8UHIXmrhC&#x2B;u/8T7B1DfLkjNAyUYJ9PyXMht47a2SvjpJitw0DRLhdZ1EYTJmiBILxQOVc0O7DNplBofmltyY4azFq6UEPOiELNRJaB1ORRRlheQGlpETchoXDqYpJyHMFL3PMKCsbbLLd4rgaJTI50R04Z&#x2B;dc9gerKU6R3t9dXgF1rUbpHrnjo6ir/Hr7XqVv/CnkNm3SKPLswmy9hYDsz/K07iWfFvreXR1dgJ/XFDzl/M4T6fIyXU1i&#x2B;vFdLOYrufRdhHnaQwHXEgCZQaGT1Sm4XIeb7Joez6t0midnJbJZHseA69LZt/p5vx0u4jrRVyn4WZxWi/iTRZV2WmdxfXiFNE/xZE3rLO4yqZlNq0Xp9fn8fZ8iv/KNEBMzzwJt4tolUw3589WP/jN93/mR8qP/3z&#x2B;2ovbTc2oOyD6M8gmqTVQzAPf0zUW8kCpEniRZI&#x2B;fgO8Bvmk9oEGAgfkZnVPHFALux0/379/nn9C&#x2B;a&#x2B;YPGfyXl5eFulAy5BM6JVNtz88QSNhSVI9GDKYJA&#x2B;0HjCA2EwIAxAb4DcNcoE4KnID4c9jieF7IqTfENyTU0Kce8ZmV84hH2xBDQq5OtminAka7cegIbk3Yjoj59CnMY9opMyOuTpjrrQQwwffmSDGvCyGk01j/&#x2B;JGv/nWM&#x2B;w9qZY&#x2B;2tYNvDu5/XKPcoNDsDm4zchHk9KJu71VH8VkNYNirHFldSeryZZfu9Gf2ALEGp8qgRlRHBipD/TRD0xK5ERjwRaw/FdJGKV6tqD4b5Z5LBI&#x2B;pZZQ23YqG9MGDB5jnnqcgkxmadXYmvmlVDiWjFJ2EK/y1lTA&#x2B;QG64jTCP&#x2B;ITgR5dgRVN5EJWIdXPiWsASdB2MCFpsAvEVW8S3NEJY4ttZWiMkIn2PpwBxDnFPaYVB3ku0e4xoJ5eRcCvsBT2bOV8JmjumQ1LMAfWTwh/SR3gf5yUv1pYkHP7EXU937uFWqN7IGvYK7suDg2XqYM&#x2B;1EvTKCsemEw8BrgenY&#x2B;MYTF8vAGDu7ve7VlxmUUIjITs5Y&#x2B;SoGFS5Xu1KCUTgLKVSbu6Qv3EnRequc5xknXJibhWsJ&#x2B;DDNBMt9mCha8Vsp6cgZ6ET4xdd2nFZcYG14xwZ7G1t2MIEFxxvRfE/LC2nBJ52LInxpeD/NOK&#x2B;3HWd8e7UDTkwOtpGIx4FmAKNJDzmsPJff5QqK4dpW&#x2B;eZRXvIdeIX6yAKidGg8xKLtUb4QoDRxpi9qCt8/CLpGQ/clft12ygnLef8XG0aKPWtXLLJ&#x2B;qpC2iGqwJ193yMFMtcmV7QV2dKqrMxG8hVYqRtmOBaCU2vNOwG/C/MAPLhXrV74s1dnk9U8WM2jfD5ZzyNk48qTYDUDYycAp7/Kpqt5WC9O8yTK03idTOssgnfvZgEZYFpmp0UalWm0nMd5EteL0yKN1/NwOY9z8H&#x2B;yaZ5OEfK/XpwW6bTIThkDtEwhBkRQ4ddZvFnERRrXi2meIgFwvEqmRTrdLKZwJ8D9ZRpen0&#x2B;356eM8Y&#x2B;AodvzuEjCMo2qxen1D/&#x2B;V/CcX5Sd/oXr9pW1VQNdOv1vQaaDCx79QzwOUX19f37t3T6vP6QMAiI&#x2B;IQIz5w4j719fXoMhDy07yPZE6c3jhdTAIAH9DkGC8nbIs79y5A6QOQE//Y3r64gMiEaEapCExVTDDg8ICUNc1QnxSwc/qoU&#x2B;A/qnsX61Wd&#x2B;/ehZUAgUEvLy9pTLh//56RSNlYuURmPPLETas1ijyAW3tFEDKis7fkFagzoldcbSMKVMxq6nEb4XPqKB0aQVI8oF6273scIo9cL9T9a9BM7U//Dqjzj7se98Z3eLnf752HBXaPt2rqUSBS75WC9bhRreLT4xuNT/S7NDrXJeg9v1dBMzW21hJdr3Sa&#x2B;hWcPLqqByjIjY1Ifd8TxLPtrdKOE&#x2B;D2IhayZ1rRUutHOJOpsCe2wdoZhBDF7eGBaIwBq4KIRZN2nHPUr1vFzCEGaBVfwIg5wgqEoCZ&#x2B;L1cnjgqt4kG0bWvtQMwmj4gf6EXA93YqXUA7vti9zZjcwZoQwxD7aWxGaeGgDhQkhjwARlHz&#x2B;7FAyXnDAdbqB84/jdQ5HfkgJyIf6ZT5UmN0InU/IdRbOPPMmMLVK&#x2B;2FH3uh2eg38imqTtX6MYQvhsFnUKAK4dSqjFqN5GcBhdoqT20r49oqh26uE/5rhOPBGrD7WtHfs&#x2B;H&#x2B;fmUgI0NdknkNhwqgJ71LWVvLScBINVJVT&#x2B;ARJr0T7lPjs2iZztHf3G8N5PDYwRXdt1QwqwWiN0r65ALmn0bAupx/gxgg4TsdQDwXZ9u2x5KDaPR9rCTIVzLHDKwH6E8K6FatCqO4gI6WjRYJudrWa/GNdL4fKaMktCEUz5GRzgpExgYB/Z8bjEV&#x2B;3hovJHhrQCve3hQ8yP&#x2B;hx23f99YY2KGsMaDftOpXOvboBYjjAK22Iksbn&#x2B;TOi4JGUjRolY/eT61nKMnB1nVCKPKLwr3bBID&#x2B;7d9Zfvc35PPJeh6Cq1Mk4XIWrufhahbkSVhnQZVFRTIpkrBKozKbFmlcZtM8iao0KNJ4OT/N50GZnW6yKE9PAcqR3itPgiKdbhYx0gVAWiiTIYNvkYQSlidA9i4k6y3TMPcexgjieVovTjeLKXT8ZRpXi2erbFotplUWbc&#x2B;f3Zyf5umzm8U0T6fX59N6MS2SoEyj7fm0OP/64kPv3fzUd5W/&#x2B;v/du3ptUxaMtwMnXbrqEiUzjRej8RCd379/H/gbNzDQJyPwkJ8DYwLQP2D0F77wBTgS4O3U&#x2B;hdFAWED1Hz8Wqk8wSDzaA9gvk5z/flIoYhMKBOVpNMwg4riG3yJzyD005NBywCkEsECwBRgIBohptBqtfrCF77QKnXggYrOiKtVj&#x2B;jp1lLv5pTCvlX0V32C9P3ojOBWTBNur4ip3LW4R3VdBxXAXgIb6LOmH2uUHwdeD65GecFie3nkOsNefVDO8TdPeNHvy/WEkh/50xPQPx/R3WUVsu9Vhxzgon7sj4GL2EY/zrHrlUzSSBg9/az&#x2B;wKGnAED4RIBHWEVNJW64ubnplOaxV7YF6kk7FRDTCuzuxwwlq3xkewmPY4RlbSXBEZnhhAc4lAGF9xLknnMVMJ2KeUIpSB0yyb2WnU1rld8t39JIXiArAoAT50PcwzibDx8&#x2B;RJWM8vElgifmprRAnMMlj&#x2B;bomlilseXj/KlpGnI3tOhCoQLFwvpBgwNBiC5Ql/wUx6/rul4BfasEPu44hK2c4nrsO6WP74Uyb4S6AMDRj11PWkbakTp0Ylzo1EWsTPmvV4ZIShG97IC80ynfRD3pB7ijpYhuEPFblS2rk&#x2B;gNnD12kEk8ftJqm1Zm1V5FXdBgS09Tvp3FGmWWZW2hsm2aBr4QRmm&#x2B;O2H&#x2B;cHT7scbaGLOT9HKDjCEcJKfgOxGbnnl8aq8STLSIMENTlxSOM4xaaqOsY4StVklQ7fhPrvwD9s6wXyhVQauMdHrSC8j2M7Ub1N6W/1LZb0RW1D3mF4/k4u1F7vWihegDnDKJOJENGHSo9bJZO0iqHvq7oW7qPLbiHk26DvvQ3wXvc/Gvdf5gVvkLZQ7IDB/i8PB13P6M5x2JoE5UMcwr51REIFbVSjnDASJz1Yi4jvIgAzzhvPwavOwX/1Pxve9ZJ6Ew&#x2B;8P1HO62cZmGiPMjUX0QyScss9PVbHJ1NsnTuEjjIolWSVxm4PkgDxcI&#x2B;uDuh1ezcLOIPbhfnObp6XI&#x2B;hYbeJwKDm&#x2B;/iNE/iavFsnYVlGlZZuFmERfZsmU3LbAqhokin2/PTOg3qLN4spvUirhdT5CbbZkGdRRvvMxDW3/vniu9/7&#x2B;aff1f5kX&#x2B;zee1z2zInyC5VRi0q8hmL8/79&#x2B;0DM0KADXgOR379//969eyxEP0saD&#x2B;n42sWWjsIIJAqkDoY9eUS0GyBIKEQRwHRWD4gfenedfYzet3QUps2BnsSluoqiIO//wMgAywBlAM13YsmoGDMMLJdLeADj83/6T/8JQnunNkzn/GdCBKeiiTdi4aSQwLPSEAIqAyZBmz5/9Yam9zcnZj29VbYSsN8p0NkqLb4dY1PihGYc9KYTzbH2CniyhwAC0/VjJ9fjyx86v4fLveO9yDxGaOkfHwWV0P&#x2B;4knzEKd5BI&#x2B;pwUNX11Sm7TTtOC6DlQBauMT1bapSDB6cH&#x2B;tAqeN2Ok4Tq8PM89wm3OJF41DYqbCAxoR2pk3pC3kZ5G/Jc26voNBpVOiVs4Oa9ioFjRI/Ok32327399ttsC9ERvuFb4JlghNjDknkDtf5Yko0iTegHe0nHeXNzQydd3kx/XLYd0oIVMYPyfyPuxRqp8xunxI9GGQdI66Dowl5iTcAaYlHsrgMZwOcBIM7uldCmp5SVVEedsPCtiHG8TZcDKKPFynbsj8hNiuON&#x2B;/VUIP6m/y3nt1ZpgLTNyYcJ4sayipOAKhQMOINJ7O7EL9iJVpXUq34czohToZfNEWOglShGxepxyulZL2PKNkbpVslgE9DpBwx0EascTSjjElA2DdxwB4tHO4D4Fpr4VvmJ8i3C&#x2B;vbWACeJCxrlGdwNBo1W0ObAtOOJIifNCNBrTbnzzuyN5VODMmAQMAA2bx4&#x2B;NF6KGDmytBJLh89ayuLGgPoiZpmGcqP0j7jC0AShzsiGJBn4Lo/DE2E8aJdAz&#x2B;JfPxkoHw7CnuGOD9kGpRBJe78ZY4Qm5EPyW1/BphV1Pue8QAFDZT87p9nvKU6jN&#x2B;gT7CxCIQ0WGCtuuw5Csvg2&#x2B;LXZtr4fvH1JItOpaLne99cOeYU7absXP7p3kwzg3vqd/Hu&#x2B;wTv4JkGRThHls87iMg3LFO6/QZVFVRZdzaIinZZZfHE7qBeniOxZZ3GBlFtZiPxcZTZdJzHiil7NYjjpVlm0PT/dLqLN&#x2B;bNlGteLU&#x2B;QEqLK4yE43IP0vTjeLeHt&#x2B;Wqch3Is3i6jK4uvz03V6ullE984jsImKNF4n03we1ItnN4vo3gvTzSLaLOJqMd1&#x2B;/3uqn0yqX/5X16997l5V1FX5xhtvVCoSP/P1gk8PDT3gOxx/cUH5DWSPm0HN3263DPoJ/2BcdV2/8cYbEBiA0QvJBQaMToEBNgfUhHLC3bt3USB9eUtJDsA6QGePn66urhhpFPYB0vTxFubnIguI6nyaC8jzYYRQeg&#x2B;T&#x2B;l9Ktq9CkhCTUwRHYfoJQK74rd/6LSIkq65WPJFaUhCxHtXxZJQflD4UfAlKG8KTrocqQR5vVPAQbs4ERm5wSxiwKTf8YVE4H/Ucte3HCJhH5MH9B1CYx8TBimuOMoW9E6D/Je&#x2B;xjxIkeLg/&#x2B;Sl7hPJ5rB9c7CieEWaMg1lPDNlxK/So8U&#x2B;OkRYPWhWNhx&#x2B;soDV&#x2B;f1Bmr7SiB53PAg8qr&#x2B;VJK26BDx8&#x2B;1MjYSKROq5RKVomUVpxQKTMQB7Yi1fCzkzA&#x2B;7CiraBecxpzqmNLQx9PrFz8dsF9a0f23StClst8o90LibC46/ROTBnAptW0LNtGg4rS2Uap9vIgX20hTBisDnMly2rFXwMEjvtNU&#x2B;eiH5hHXnrKNlh/YQOfcU5xJel/o1QJrFBeQv1oVAFjDd72PiDLfHZev9QqdMkU55wRoj8KJsigMPNEkJwpLVhh0MAK4ISWWE8TjWc6NCr5ux3YGO2h2LSEytlWCRedG&#x2B;wVbp9nYA1BWcqRcQ0oIjopqy3CD9wSVbd2oOgDH9uKLY5TwoxcPaiVkkqaV9FitD3lkeRJwFhrFB9XOnc4503qSD1eRMW0jK80oHhF7cjiBpExi91ZZqUBn4lpFT1LAc57R1PR9B7aM8zT0wWRhxP2Xwg&#x2B;nu&#x2B;4QK6Ztrgr0JPYwYwwSe6EFaGCLgJs&#x2B;lxmRsZdqGHSM93Rd5117IasYUHQk2DCldpEkjZg&#x2B;ZOxaNQcM&#x2B;xOOxX4VWJ8Does6f6cIWlamC9eaEfumLLdBlYjloDX9nTi3&#x2B;Hus9fYH3iGSbd91vb/ZRxTFunHi5PBuuswu/9D7EdtnNZ8W2XSVTPMkrBfT5dnJ1dkJcvRW2bRIwjKNV3MfmpMh/IsUubTi9TxazX2WgHoxzZOwWiC6f7Q9n9574bRaTLeLeLOIS0QBWkzL7BSB&#x2B;evFdJ1E63m0PZ8WaXTtI/lERfZsvYhB9bk&#x2B;j6/Pp/XidLOIyuy0yqJ7Lzy7mk3qxWl9fpp/15/e/uPv2P7yv6xf/GS9vqrKgopwXoT&#x2B;jOAJog5U4JqRv1wucTNoPCTlA6CDYX///n1QdBjwh1l&#x2B;S4nySYMA0Tx18Fo3T5RfFAWkCzwFCUEbCmC1oGofj0A9D5o&#x2B;4D7dhWHEoEQB&#x2B;I7YPjQasD64E369yAawWq3u3LkDeQBYH9W4uLi4uLgg&#x2B;19zin77t3&#x2B;b&#x2B;5LWd3IPNIr3z83EKq18JzZ2M4bvjcQlxMztJKOItaNwfDz&#x2B;5VgZgf7Rv9ZaTTdVqlygvf5LebviakS9zW8O8L1Goscq8N/fyynEb8fI/rgtBAP6Vyfon9i6fYyxQrfLPUrScAKX&#x2B;Q11MccPEhD3Ih6QTGJlpHAPhsYpnMYHOYLaDqObxnussAnwJ9wIe3U&#x2B;8iAm5sas0PiV5beSqtKIBp2S3s3NzcOHD4lPO&#x2B;Ub8/DhQ1J6mqaB1KGnPWplxHpAgMv&#x2B;caIbbVU4o1ZRmomVCTAIxFtF5Tdic0BVG/GjhSK/U9nHjgUGqt75714CeurvtRDSjOP/&#x2B;P5s24Pu0lKKLkELNhRm9JdaJqEk0IACxBnQKzTfq0QPGpVSqKVx3yjngU6xxw5Wmh5m7ilGMVJapVC3TJCk&#x2B;Da0MABL9WOh4uAG7qRcAHwR68Ol1Y0jHenaWiVCWFG&#x2B;spJEk74542huTnURtl0G09SFd91QuEPEGJmyfq/soEBqnUMQGHHAsEhDu&#x2B;eQO0VGIsZ1OmGWgPsRMlYyD7&#x2B;UBfmAj&#x2B;z3e9Fe&#x2B;9nTtg28WrlHNKLa57ucBK90wm5yEhG1bdtmv/dc/7aBzAYE6VXf9JcX2YlQfre7GYhG0ntW&#x2B;GZ&#x2B;Sih/biPULKMC6OIbJzKD51kJH3G323mgD9Ddel0afA9QZyNKelTDeUX&#x2B;kOfFSg3pJYKqNSRfidzC6SciGW0IxkoJsDiofvAD7S1XdiT09oO9yEuYsAY4md5OqHHG&#x2B;JCdnFdczgYe/xaOg07Tk2C5gRThvX4HDqB14iXsHqU5&#x2B;1q&#x2B;ih/81nw&#x2B;KVNQ/yd1FpZptJpHRTrN02k&#x2B;D6rMx/Ap0tiH7U&#x2B;jVRLnCe6JC3HPrRandTatsul2gUigU9gEcGeZxlDql2lcLU7XybRKozoL8/T0cjbNUzwOk0JcZqeQCvIkLNKwSCMEAoKFARLC9ny6/dCfy3/0/6x/7sc3L/76Zn25Xq&#x2B;gxSeiJTOHwToZapOxPgHiyeShwHD8FMA3HXy1FEFETo4&#x2B;w33iwkupcUc5NAtQAQ&#x2B;mUCWB/8nyZ8nwVEb1aH&#x2B;4uLggJwcPlio9sBYAGNsHVH6KBLgHeb70PeQC0RkApgA4DTOpGVIBrFar3/md36EA0DaNVfsPcQZgEGH6bnfDw6UV&#x2B;95&#x2B;7PDXj2PrDVu0gn1Yp3vFGLZKy6MPCCJC3NaPD&#x2B;JeKbCP0XA/hsLmUSLB4672SJH/hMf1edqKSbZ5fMShg6ee8Png4m6s7yHUNgqP8mb2Wz8G4hp1GEWFoMJe7hyo1zrVFBA2clQ1wtHCvwwkjwcpChLLGWN2u13XdUzB2avQ2E5iOd7IpQ9x4sVedN6YpSjQjbOOou2A5p34mhM3NkJBwbsEObRvv/02SThW1Li4AQx7ntTkRLQCjRqlHSfsZiFWMReINJx4AHNZ6YOSEhTJ9KwAUgL7IP3Kh8co4L4XF4VGFKC8WVsJtCRgRMjZj3P36iHQL9W3NeoiGDu&#x2B;U9/TjCUc1ucpoAenEvf4A9wOGj5OMooEfd&#x2B;T06&#x2B;08/7iN71KxUWk1akYo72ir3GAewY5ViBGg1pOwQEKK2YOISDZ28ZL9h0aJdB9FIao6zrTDqFsBBAPMGhoHrZF2V6dMOH0swIQh8lH8jelUrX/DkF4APSJG7nX6J2aC9Uqp3jew9lmpbfhbgVo26qks&#x2B;7ANCwuzo0Kj8XFica2iuejtRGtRBnCZLRD3E&#x2B;fypff7Kkt8J2DrjO6vZrQogUMLDfnXNs24vTje8Ar0oR41wl5rh1e1FqVFNCJ5cQYhPz3fb7b7ZSM07YiurQq7JLe9ZymDClupVO0ok74VZZ9Z1pPp&#x2B;k6I669rbDpqLMffHDFY9iJEMV9mZYWWk6GxWs9yx&#x2B;D6w8kazEVRZywoEvJHmqs5Frm2qehQ9OBpBUwC3jeAivZdUPy4HeZG4Bt6v/nr5VpjMie9WK6WfgQn3UWlmlcZ9Fq5hOBrROv&#x2B;F/Op&#x2B;t5WC&#x2B;mq3m0WcSXZyD5TKssXifxKjnNU/w0XSfxdhGV6XQ1x7NxkT0rpoO4zqIqDYskqBenVTatFs9uFvFyPt2cn5bZtEojeeS0XsRFEiLoZ5nG&#x2B;Qt/avX3/mr1H370&#x2B;qVfry9evd5ugeZJ2qF&#x2B;fbVaaTdfzf8pyxK6fB2Lk1x8aPTxOHT5AOsMtE9fYQYRgmGBEUWpuYeCHJ64Oq8wDQgA&#x2B;kD2&#x2B;nvUn4p82hC0/AA6UC15A2iCII7HDcDoiD2qaT9kCuEqJFUwxQ9&#x2B;A0kAvr&#x2B;4IDzQcwAcpP/8n/&#x2B;z3nL11gFwY8RFqhnHWXdja0ArgRyo5LLCEpEdwNMkKEjsRctAYNELCHOC4wkNe&#x2B;qnRbrgs7zTDuHFBpsArrfffhsfmiOSzzE0J3zvj4B4q&#x2B;Io6JuN8qm1T9QpaCBuxmFGDyrAdh3fY9RwHFeyH3sDm7HXr35E38af8CV67&#x2B;bmhl&#x2B;2KpyrrhIL2Ss6bi86eA1krZi19yqUha4zpUEKDDzEKWMQRXAG7vf7Bw8eEG7yBgIzCi2oEtF8JwEDeWgSvFGeIcrHdGUCgYc3N4AKWmxgD8gJ3rbKMPLw4UMCIZ65TBTQCmkHD7799tvk5BBqGzFENEq5/vDhQ75oL/pBlqmFDcgYWnohlNdCBdXwfAXlh2YsbhkVPQWPsCiCGeIxdBT&#x2B;JA5Eq2&#x2B;kM1kB/PnUcMwrx1a9zNT3fv1za&#x2B;AmpRGwU/6L6CzZrYZ4PgpIW04&#x2B;7kpWaSghXphxZjUrbDZiL6fMF5y1znNXRgE9O2Xc0CunFxmazfQ3j5NsN0q/vt/vONsGfCahEnuxyZqxyocIUh8G/NIqJY0V/norVHUrsJLiNV7OajsV8pmt46sbCYtpTNt1&#x2B;L4VSO0lCkBMLnLPTjFmD9FfHUVcflZskUZfhLM&#x2B;7L2xdlRPK24EVnmkWTv0FU8vsQF4TrxRor9/1veAX/C0P1DZ1opu3kn8H2q&#x2B;G0nK7ZRWY8DpknoCEoX1QizyByufFmXxwOPcnsj58WwrfxsTEYhtAWMNrYxfPkyF5vn06H92Arf7VqwBXedQtwPJthUCG1edn/YQttUy77qu75yE&#x2B;vSCtwgGgwjq/fTFidmJ3YCd780XMqP6d9PVVf/v3yjSGA67PvDOIlrNQ&#x2B;js8yRaJ5GwcU7LbFqm0yKNl7MwT&#x2B;J1EteLGMm8ap/uN66yaHN&#x2B;uj2P4SGw9vGCwPKHg0G0feFZiBPbRVRlUZ6eVlm8WcQbzws63SymmyzK02mVRUUSbRfRZhHf&#x2B;54/Xv3I36z&#x2B;7Q9tPvuxbX61qT0QBxhlZMy6rkHdgQwAlE/mDyE7ADTjZjJKJv0E4PJbScIvAGLEAz1OB0Zf3lLSgek3QmyA&#x2B;hw/aTcDlEmCkPbZpSABWr/OHAygD9kDLB2yhsgXovWAXgFoRS1ZC8jsh3UC6cCA7wH6wfCBGMCf8NTl5eXl5eXrr78O2QDlf/GLXwQMMoozwGPRKFc6vbMZpe7RBx/Xu5xBe1o4CenMmDPdKEZEI5aEXunRrdINE9Mbhdp54FrBl6zP41YRARM1esfFPuE6gOMaRj&#x2B;SMsTKmLHYwF&#x2B;JmPvH6/6dcw8fPuwf48urn7JjlN8&#x2B;isBjx1YROxY2tOxE9NJImBrgUf124mAG&#x2B;Aa42vsspX2v5BAAff6L6QSVGVtnJIZmL24ATlwOCGrxp1Vyi1VqeDl3BhgD3NyKvt&#x2B;qwD6N8H8IiAnqGtFG9&#x2B;pEw0rhs41oVLWt7MGDB4DUBL593wMHv/32250Q55AfYK&#x2B;ylOJZDDe6FB3uxnFCVU32uuYa91PBT9TeSk5f8naOYd6BKHUgAFBgaMQIwC5qSZ2Ql2rEr3OisUrHJTSKLPQUIRrRDGeDoUeIG8kDRgIREj1TIcEZRkkAX9Is5VGaptEreYBLRcsk8uAAHN2Y2MPvubwFytB24ZkMumJG1LeMxe48chpEGpbGqWPH4lCrDEkDuiXxRpS1hPutaHHoizmyniiMxfZSYrai58aDRlTarIOG3wMAHUsFPH44y51ntPvWNd5pzJubWzkwGiHBO0WCMj4plQyNaZ21x3JRIyYFijf7/f7hgwcy&#x2B;xlgq93tdrAbcEPpuk44NpjoLX6lB4LOqsbdDU3g8uBIUXRhT0K28WtSAoM2EiPIDv4DI/GM/dkqAc9Z23edEI3EJqNyDnRCkMPKEi9A8cYGoUtNFQwNQL&#x2B;Vf/ErY/AjxVfnUwtbInX0m56ccJygGEaDj5OYs81&#x2B;77SOX2hLlD1831qLmEGtsJL6zmcqMAqsOGEEPQElfG1e9Y/&#x2B;rTyN6yxcz4MiBUUnypMYgTjzeVik0XIerZN4c34K9j&#x2B;Y/ZsF9PrT1Rw5faPt&#x2B;WmeTtcJwvyf1gt8iHPkDE5jsIDyNK4yhAyKy3QQLerFNE9gSYjqRVxnEVL/Xn/Pn9j8yLdXP/2D9ac/fH31&#x2B;nZTk59DlT/17lCfA&#x2B;NSR665PTpSPrNu3b9/nwYEGhP4CnoJQ7R444036GtLcg7DhkKLjwev5SJriHUm80fLD2Dd0EOXQTxrid9PIwCbxiRcZCsR2ReSrgst5ZcI3o9HAPoZ7fT111/n46gPhA24DQDiX15eXrz26vozn15&#x2B;8hP55SWoR6j51dXVF7/4RSOsgGac4NMqzbpXTAj9mobKdqRC8rsWdJZd1zWNP&#x2B;zdmBbIA9cJw4GqkF4OOytonie&#x2B;VU5xVqhE/IDV8eDBA33QHyN1q9gm&#x2B;lg/htS9hABqjowGreiVDnaPdpwctz9StFM80Mc3byYwtZJt6nGbwIGQcAzrj&#x2B;vMzuyVpHTway8g2IqW83FVPbjefPPNXgkwB43SFiGjEoQR&#x2B;HZd1wqFqR1zkFCaniFd10F5v5f0FDp2PlX1RK7UylvBpqwJoHariCsED865tvGpAKyIAVaU650ETdHUl1atI8EM5s033wRLpxWzA1AvggIZUY0TRAGmE6GhZDyOpYTG7lQa3b3iDuFXft8KqYb13CsiPiUTmhr0bYwlevAuCgAE67QG0HTAnaQRCwaxDbF&#x2B;o0wHzZgj5E0rDx8&#x2B;ZRWsNyq4vj7ICS45a/dCmdJ7hxuD&#x2B;F5tNIQsvaIMWSHSOPLyBayYcTYToCvqWZ2gjU5IxtgZWTJrgs8Hy0Pw0KCilmtAirj2&#x2B;70ofT147XUuFboOqzhZukwIHo3ASivAvaOrDd6qEmmxu3wfiqDCKmH4reIdUebjChwqr6g1EIi1FNvJAlACwxBsx4h7QDsW9NsB0Yovr8w2AllWlfMKk9aIOgrVoDTIjWO/3wupXmLrNqOLlJ7GeyAMrUATmiFh3kCq83u9CqzJijUSBso/27ZGrJN&#x2B;UMAWc84OujSJzSdpEUHp4TpCmCCDXL/Od4UTnz8rogJH50CKk03QZ5ywKmSTVLu1hO/OSgAnXx9OxU64Q9TKYxFh4nUCz92I2wOvAKNifRnIGI0YQBDp39N&#x2B;MNzi9&#x2B;w8Nwiu0l5seJdRgPq&#x2B;/rHvWM/DdeIp/oWP&#x2B;ROXaYz8ANXi2ctZVC9OqyzOk6jMpkUSITRnkUZFdpon8XIeVVlcpNP1PCrSOE9P6zQs06hIp/ViWqRxnkT3Xvg6JOWtF2D7TL15YfFsncVVFpdZvF3E1y&#x2B;cVtl0s5huv&#x2B;vrtz/4zfW/&#x2B;v7rz3x4c/FqWaypvydln8gbkXAA9MnPQdh&#x2B;AHGq1YnjdSItBuYnWK8k0L4ujX69eJxcIwgM5BQRo5eS3JfPVpJjSzsnkCkEywBsGlVVQfteqkidQNu1ckoGvQdsJXL6IVdQ5V9K5FP6BuAe/ItvUA6Y/SD2QP0P8wJcfqHmL1955fUf/fsv//Vv/fz/9Fcu/&#x2B;W/qMW74PLysqqqN998Ewd&#x2B;I7RG4JVGdOrt&#x2B;FKIZzgEucVRNcAdjEhrvEWMAkzzHOzHWBaLn8jAjZXcPIh75U/Mg5Ube/8o59e9Cg0kp2FP6aJ/fBifYwU/TjdNeukexavhn/pXXSXeqbGvvs0opbj&#x2B;5qBi7siagT4HKCKeobDRKqO9rrNVSnekr&#x2B;pVP/cqkCvAIshCRvTcWhayQuBphE6jMSWKvbm5efPNN4mSrbVvvfWWUYmodrsdHV4JDHiDUfF2nBiWcTzBS5Vf8jIiEREkEJWSbdGKTYOHIPyAdyp9r1HRNjFAaJ0V8QCiwttvv/3gwQMjQfFbCZdJ4YEtAqAHyKb40SrFOS665LJAyj8E3xpno/c02QafUT1G6Oe/rXQ126tZOq3S32uxoVUsIP1lo6Ss9sik0CihpRHHhv1&#x2B;/1Sv3Hr06uJ01FuAEdL5XsyI&#x2B;IynBlgvfq6jvUYUA1wPFGQJ0EldOLRISMD&#x2B;XgKW6w2uV4oHXeFuzJPjOuGeyFoNm50U6EQdwkWon&#x2B;JuS6RFmwYQsJMYRG3bWuk0Q3SudPO9SD4srR2sCgNwHMwUij9jlIraWiusHgOEaiXSHGcAtMIaBDdNI4xxbzf0k69pjMHyHnT2ZojFa9oWLupMoMuI&#x2B;I4UMuccoLiXN5Dgdmxt4EIyimQvoJynGvxNB1mgVU4Oxpj9foc&#x2B;lZXTcFNolJs//kc5xHHT9Dk1vY6t2e89vUfF7sQI7na7Zr&#x2B;HZn2/3/V9j/r2fS82kxbyDJZuK0kBW/pwEzRLP/q4TFIfI1ws5POykqnaaEaTimJkRTptJf&#x2B;AgHiPvznl8N5O2P&#x2B;QPp0MPZYupb5OsjEIz8eHAJLj3w7UJsD9ruuFaySTeTA&#x2B;9O&#x2B;qa/NPsnUSrRO43sarJC6y03UyXc3jzSIustOrWbiax&#x2B;skWs7jMo02i9Mygwo/Rr7eMo3zdApJACGArl94tsqiIo3qLMqzZ4s0rs&#x2B;/rspO6yxezX3U/3pxWqVBnUXV4lnE/Lk&#x2B;j/Mkqs7/2PbvvL/6qe/bfPTfFa/8Zl2sCbsJmgGsybkHJtbM/vv371N5Tz4PA3oCMUPrj0JIymcQHnwDcg5eh/sryQRMpT7KJy6nVzFEEe2IvNlstINvqZIAMEQpKftMU0D4TuMAgLt2DibLP5c8vsD0dP9lkB8KEgiBStMBXQvw7MXFBWE931gURf7aa6//39//0nPve/m59736wfd/7uw7rl56ESLE3bt3y7J88803gVIapZ/TiKQRnRyhvBXgRbWIFT1R27b74ZsRec85Z4w/RDTa6PseWw4hfqeiMfqTTkXfphSxH0dex&#x2B;og6Cem12uHJaD8fhy/vxXqy&#x2B;PQv75YcvOokEFO2TcOfqIMcFC3buDNjmwa/ZGEwC/dmEOPZ7WIYh7FOGqEr0sIq/EPn9IdjtsIwXkDIRPrxk3YiDBGANarQOe4GVF0nFCX27Y1ZrA8GImlQ1zoxG8En&#x2B;mk24hT8ltvvUWDAyE7Ot8K4YcAHS2iJwCEBD7VNA04POgofN6LN23f98DfkC4IcN9&#x2B;&#x2B;21iXNwP&#x2B;WEAufv9gwcPUAEN6B88eIBn4czARrGqQA54KQQJ1gclHPD4ob8nfYh4Yy9Xo8wI&#x2B;nvC&#x2B;lbsJ7xBmwi0VLAXXwh8c2BJYD/oJrOXaLJoxl7FxpiHDx8&#x2B;Reze0/VW0W/0mqEKQU9lp3g4XEKUBPw99jAPQC9ZhChNEmc7AtJH6TBYQ15EPOpxA0zmxPNYNkcBpkrS4MpvhWMzACaRaAVVt62Kz8PLKpV/KyRv3t8qLbgldUcgOCCac4fgvlXRhBrv&#x2B;OX2ey/1thKq0oqIwlWq3BiEcKb8dK0i/PTi88Cq7iVtmUaZflrv984N9hPKM81A0x9sDZheVj47UYrjwtv2sl&#x2B;ghtLqhqK2rLEHRqIPWdh5BB9TDX/z8KFjQD2J9kPpwkGKELvkXtyRrRy0ThlVWinBGHNzc9Oxvc6RAMPHG5GRzEBp8w7QmBedG/KkGMiWfuhbNMQKIudAY&#x2B;q6wR3CWyTk2Gj19LCSL9kjdTtIp9ZayDOQIqCtN23bd950ZsTzGFXqeKhIjggP8SWJXt93MNZrZwCuVFoYuq4zxidw8CF334UWgO1PLso0upoFRRKWWVxl8TqZ5mlcZVGZxoj/s8nCehHnaZyn8WYRrZLp5vxZhActs9MymxbZ6eb82TqLt&#x2B;ISsFlMEdQfcL9anNaL6SqZlmnkM4IlUb0A3f&#x2B;0SILtC19X/8D76p9M7v3av6/vvLQp8lqINOTYAKoCwiLyPek0EBK22&#x2B;0bb7yB&#x2B;&#x2B;EGAOgPJT3jXWoKDWn9laQHxmcICYycQ&#x2B;I&#x2B;uUb4l/4AtB6UkqC3lkhBkEaAxQvJ9Uv&#x2B;DxA2tP5MFcxfkWGA9B5deRYIsQGfGea/kqwCKAQNoZsvGT6FpPrS9CG&#x2B;EYx/OCjDHPHKP/&#x2B;nr3zbt3z&#x2B;g&#x2B;9/7YPve&#x2B;m59776/N9ev/IyCrlz505Zlm&#x2B;//bZWXhilm7RC5u4FvWFl0evRMJC/yABM6ehEW7QXhkPnDcv&#x2B;OAOpkvszX01hoxWKEQ/Bhw8fGsG42JR2uxGfk6e8lfDwvAAQAeMa8UI2YxoMLn6pleK4WGZ7xCw6wOtGqJ688xivu/HO04rmkef&#x2B;sDl3hy/Vz7ItPP2NUjLyTpLsrbW/&#x2B;7u/q7HQcScAFpsjmwPvJ6hFchi&#x2B;CO9FCJ29ONeS4tKIrt0YA5q7LhmjA2JtL2EkdiquJV0gIORQAiSaxFsePnwIUE70DNjNmQncj3Io9aFKkEm0gQLlvPnmm1bxcxox6WN6v/XWW4yG2YjansCXfhHtmEKzF4X9IAY8fKj1&#x2B;k3TvP322ygBuN&#x2B;qlMCsG76haYIWPP5EIwa&#x2B;0ZgbleSzreB4mjh4mwb9tE5o9K/hPgrklxT4tTjB7uKXRvwl&#x2B;PkpTrhG1ANGNNZE56J0H&#x2B;Wh6I8EBnxplC&#x2B;8U9EzFVRt&#x2B;asdexsTwXddZwUVcZU6SsNSkF&#x2B;oCn/3yhzWKf6MFj80aveblJgjtK2DPWNUeqxGRWw0innSERAp1jWFAd5mvW518CQmaLZ2FFQek0&#x2B;RTEbuBxzClvF/WsSMHyzCjUSJccKYMqJ351i0onRneB/BzTo1gVf/t4LXCdCtznIgJ8QOkiiiW6ggPE5Yg/vdzgpXh7Xq&#x2B;97KmrMSsAj6eLSPOxfFCUggvddmedFCnXneodmJJsZa6yQCKVrPgdbvdYioo8PnoXylEYeoQLGBkUCtTJW9WAlFqPRDaWXeDgx7Zym&#x2B;tt5ehFVjhkkroHwwHUghMjNtB49AZgDwMlIzrFDjXREwL603Vbmuc23TIMSneFa03pTRttbnIjB933sDQuesGfI8dBKxlP2DevYi3IIc9S66tv/0u4p0WqRhnk4RC6hUIXqW8ykC9pdpXGWn6yQuUh/Hs8y8KeD6hWfzdFpl01Xi3QPqLLx&#x2B;4dk8ibYvPLtZTKssriQN8PV5XC&#x2B;meXq6PZ&#x2B;W2bTOovrvfGPx42fVh3&#x2B;qfOkzxeoSCBv4ntAfMJSI9v79&#x2B;6Wk5SL6p86eDgAI1Q9Ar8ODAqxDQqBXAN5bSB4uDbgBhWEKoAmiktigjL9J6YI1YbF0tIXAAGGGJHsUdf/&#x2B;fSbfrZWHMYPtsHB6O/B7qPkR3R9/MnsX3YXRLk1DooMv72cFUAgMBRcXF6Ablcuruz/wfZ977n2vfPD9Lz/33pc&#x2B;&#x2B;P67P/YPLl5/HQ4A8AEAF3mvUoE62Wm5ge92Nx43qHjhRgWEuFGp3I1kqLSipyekMGOtWdf1hGgoh1QNXNzeCJ15HJtxQl&#x2B;rFHy9SuGEP81RdjA71qbrq1Gq/U6lyjq4x4zdBnhMsHyjuAm9guwsn12hfwXytoqN3I/hvsbZB9fv/u7v8vNeGCmsJ0/nXgJK8uZW8ngS9LNphCJ932MESfXBmFpr33rrra7r9vuBj0CM2ArBtW3bm4cPGc2T3euGXK7ef9eqWOHUFj948KDrup1ElOqVGteJJR&#x2B;zZS9av6YZFHY83CHuAnoSDQOF9yLVQHigrYOI9gDeYFZzthPuA6a3FKr3A8hmGoGu6x4K1m9EE//gwYOHotpHCCAjooiReFwa1u8HMl5LXE5o3iiWAawKvGGvrp2KIrpXanu&#x2B;Tt/JP1sJ3YMP&#x2B;yOzwE7cFVhnI5oFiFg3KjuYfrVuYNu2TxFByp4wOLwaFazgGD0bZS5UiNfqb7geBqitODmiKx0sAPiyU4IBaC2d&#x2B;FYSHx/IDFzqnXKsAfuCrRP5oRG40naC71lnqwSSXmXqJTTnNiQ7bEdAxh7z1HYVPZOrBS81xqgwjLbrhkj5QIpdhyxXg8FBb4J8m1OuNs65VqXWsp6YbmF&#x2B;4a43qrAgRdbQSBCbViJ2CVvJr1Kr1PkoZy/qeWv9nJOzrRUppTVQM9B/QJwNelpL1SZi6Q8ktksuM/&#x2B;sNLNV8cXaptnvd3LP6AQ1bcv9i21vFUUKj1iB8pzDg5nCCwNtI4LQXjwNKAUBoEMC0Zuss55703cOphtrDPhC&#x2B;0EP5x/suw69i5C1wq2SfzHozlHf74Qq5iR8kNB1gOk9m06kaEvjGlYHXoFHYKAQ/b2Vwq2Fdw3XMpQCWCOdI6eIkwcSBSuGz8dH6dfytf0X34ekv2UalWmEeJ2I4r&#x2B;aR4VX2E/hAVxmcZ3B5XdaZtMym1ZZDOZPnk43i&#x2B;nm/HSziMtsWi9Oq8V0e35aptF2EdaL6XIe14tpnSHz17PVh77h&#x2B;h/975tf/lfLz3zsuswrAfSgyxOmAygzlKfWvkM80D64xPRA2ET2gN3EzbVEvHnjjTeojIfIQbIQIDICASFZGPE3vXtRT5omSDdiiCHNDsI3JN6UEqiUDaGevpbQQJQ38Ov19fXFxQUKB0b3pPyxkwB1&#x2B;ShQc/ppNABjh14QOokYA/7cvXuXrgjL5eqVV169&#x2B;OxnX/nbf/O159732W96z0sffP9rf&#x2B;N/ev0Xf2G1Wt29exdlFkXB&#x2B;InYExj304g&#x2B;HlgEK/MgRqdReh8nET&#x2B;NCp8CgAiFPaBVLymKWpVXp1Uhs2WRen0WThBGLDk4u1tFVWU1sEyIJgEcewH92Hv7sWLbjuUHXth8&#x2B;zEgdmMPB6dyCvGwo3ZGl2ZV4ipNZMCvGvdTuUlxyIiGkdDfjJVulgEYxqRlp9SFVl2kD2h0RHDFrutVqHT2OW82KooGD69G6acpxe0V3agV9Z8ds&#x2B;R50DtRlhNG71TcGHy52/E8NVqd3I7zkRFc0lGYQBNTHQ8CmpM2s1da9r1E8qEcq9ksexVOp1E0GC1g7EX1rtXze&#x2B;XzqmG3BsE7IcprrTzfSPC9V1YF/SKN3b2CXz2yG9N7Doqi/MOn2BwtM9DU0IioRlFfN5x30kVhJ8ylg3s0&#x2B;m8ZBYhAnJNbFoZizhy5AXHJ6cXGuc6SCcq7jmbKTq897gt62eslykLaAbMOcosHQ4r37CT8GbcPWgnYRivCg&#x2B;4Brs9GKScE66OogQLEGCnAr&#x2B;wEK4Zdo/TxvW&#x2B;p4E1htnRdJ0GKOt7ctm3fd9xkG4mY69yBpOE7Y79nDHgB9LJxABxba/f7XecFd5LjLbcD691tmTe7Aeg3SuhqPaRvhk3Enx8tqy0Hm9dMtG2z3&#x2B;&#x2B;9bONFOMueZ3AATAPQZJ3sWXiWG4oVwI3OR7EUFXAKdsKYagRbt&#x2B;J74Ovm6UB&#x2B;a7BUqgl3yAz5RIzGtdyOGwn4Y2HMaRoE3zRC8jHD5U03OJIlFqpt26bVvSePWNEOWiE7caE5yQ/gK2laatx7ibRD/I1R6kXdYqUmTs4kqz1GxE0ZhXcIvNvR7jeITNYazq5WSEQY/U5kDNzaiy8Kuqh/lC7ta/na/usfLNM4T2JE/S/S6XoeFmlcZVNE678&#x2B;n1YZPHdPizTenJ96Ak8WltlpkX1dtTjdIPNXGpdpXC&#x2B;m2/OpD/d5/izyA9SL09U8qrLT6nv/QvFjf7v6&#x2B;Z&#x2B;oPv/JzfoKyJVZdQmUAX&#x2B;heAbCZlJenb2LQJyOAVClQzcP0Ay5oizLL3zhC/QeBkuHRdHxl&#x2B;LE/fv3qa1fLpeoDwUSevRSqKDXrxZUKgnYT8kBaLuSlAKlpCao6/ru3bsIXUq&#x2B;EwUDBtqnLIF&#x2B;Q&#x2B;ouMPVBIsKLIBiQMZXnObT4TAVA797Ly8taoojiV77x8vJyvc4/&#x2B;9nPf/RXP/7v/90vfPpTv3nx0ouvfd93v/jN3/jiB9778rd/291/8c9WFxcQaZASeLVavf3WWw05xyqB0V6Rho1yVcRye&#x2B;utt/SBa5Uyz4iqDyVABmiFvKcPILAynPhrarRKjdjDhw/feustq9iwBPqEwkRpVuFp7MNE&#x2B;YStvPohTvdIhOCpqgFDO6bf8OKX9vF6hOE28bvjicl/KS04hfKJUtqxV4MbX7zfjX0OdYHcJ3sVDogV4DHKVlN1xZOlFdK8MXrXHU5qygx8O2F0IwRXnlD8dy&#x2B;2aCemg70ikVNU4BAbY3A&#x2B;stgbFYZ/p/gwGiIT9BMKa1isJQcj5gsi5r1StCvAOgBu4lfKJwegX6NbqeGeqFrfhn8fPHjIEg4eB9FI1/xAo79XPB/geEodGq/rZymE7EXab8VpeK90&#x2B;Vo82ElUHy0G7JUdoFF6fVaMvaffeCyr8PPNzc1T3BR6pVDnHmFE4OYU59ZgFbjX&#x2B;4vz1PmGgjVXQie4WZdmx2KDEdZ1p/wN9J2AKR2ziQ0/DVjWygLyO91hzYdQiawwV50ToN0yi60Svq1KgujUbsu6OSUVsEkaSDmlBtANZF8RzXcqQZVGn1bFtWwQp2hsO2MfcNejBVm09YNCve97snrIe9nvd06JMVbwpRE/6d1uRy2NtQwLa1kOxZLhYJNoP8aYpvGOuk4FmDKSp3aPWEBt23oy0nBANoPO3hhjMMH3&#x2B;10z3s6cRK3Rx1LbDioHD2FFLGlFuDGi7eYQU7CxVsIEkVemEnwS/qIf9vudRHDyvcSaQ/1vlUNII&#x2B;E4LQdXbLtu4JH5WdQ5SizeU5lPsQM5LsYYeF03Qt/iJCRFis4JHWV&#x2B;oZMZCVjkpBOdr9CQeM6N/x24cCIm2XebBeCNn/kHeRLWWVxl0yKJ4KpbL6aFp/1MxTgQF&#x2B;l0A6yfnRZpVKTxaj6tGMEzjevF6WZxipvx4HoeIvvv&#x2B;nv&#x2B;h/qHv7X89z&#x2B;yfenXN&#x2B;urWlCy9oUFhmb8SqjSiacBjgHlN5I6F/dolTwROTPvAgRDHtBUfuj1dfgdOhDTuRZ3EqNrh12KH3TzJawH4kf5LJlWAjYWj0Bnz2xf2u2hlKxetBXA2RcK&#x2B;0rCB0EwgI5fk3kgNgDKo58rCTDKgJ4wCNDtmKFCX3n51U9/6jd/4T9&#x2B;5Jc//LHPfvbFu3fvXl5eFUVx8Su/fOdD33Pn7/7A1Ud&#x2B;ZXX3Tr5eg/xTFMXFxUVVVTh0nQQdx/VQ2BrY5IXx6GWDG0lX5JwDyOCJ0EiqJmpb&#x2B;r5vmj2PMCO2V6zfnQpy0kiARe6KPHmbhmnOHWBKL9C2kZBoRKKi3Gn1ialXEE&#x2B;3XundWTceeb2C453iFLTK6M3bdPOdggeWGiIltHSSaYsQHN3VS1Aadp0ZyyedkOM15jnQzbHV/djpthv7B2qkrnuY4EqPBQark0g&#x2B;rdIK6dO/GXi5gy7fisqSYoAOPsNvGqXUJ2psxQKwH4eI0YByLzwWjVO1Fn8/RN4bTAfAx04yFhMKExxTnGhFXS0/&#x2B;ddxLexVxEyiXjYBEFzjclZeK&#x2B;OJqjVY3yujgSbq7MZhdljPG7nYV4TmWnjYi4yka6Jv0wD9QE5g3fSduIzIThrcgxPFBX4ghzRHTCrczBF/qhcLVHekqON575Q&#x2B;Xs9&#x2B;q4h0nnAyjg&#x2B;llzp3Ci5a/KmFB7xXL29sISzEQ3BSLIxxbthHuBNxUfEbvZIJ5z1mkvwA6l/LSwsGYGi0KqMK8TRvZnOoOSaO5wcWKx1i9Iu4lnrFJNH1V4KZFDXYlP0u0Kpgw3y8VR5gWu9rzBBMU&#x2B;9H3IycJNZFeweVwMgNYAhS6ySuMLC7lUyBwIhg2BNwN34faaXVktRWNByNUmlA6&#x2B;9E/2FoSfC3DdR830V0tGgbiIggMBnZrbgJ0huBcJb6ibYZ7CHA633XgcnTKBvFEGa09VF9TNta43k1nYSKsirGDudDA2Yw3Xl9fJ5hiD0p31pYMCBrtUqn6Jw14i7SSeqx/b5xTnA/YAHdACQYkRaDnRvk7Vayp7XioKKmrumcE8F68K134o5vfVRQ7wnwe4HjX/3r3n/4h3kal2mcJ2GZxvXitMxO8yRezWOk7N2cP1tm0zIV2SCLilS0&#x2B;4vTzfmziPe/WXgi0DqJtot4szitF3H1wtfXf/&#x2B;v1//hR6rf&#x2B;Eh5&#x2B;fpmUwMZU4MOoj/15fS&#x2B;JXWnVgm2iIw3kqmXuJ8gniAbkoN2Ai4kCRcQs&#x2B;YXkW/zxhtvsHw6EuCGSkUHogxA2YB0f7wajr/4Bq2gy3IhKYqRTwB126jMYgD3AOJ02yXRn3weShrk/OBmlMDcvbBCgPxDEwFJUHwLjAB37tz9zKd/8yMf&#x2B;fjP/uyHP/rRT1xeXoEOhBCfcHS4fP214urq6pVXlr/&#x2B;ycvPfhbZwehJTLhjJdqJEet0q0wBViI0HKhFifloW&#x2B;S23KhgaK1E/tEkIqxrohl&#x2B;zxDpvfiG9qLmHw470Zo7UfMTZOuDG0uGcF/q&#x2B;Ai3n4PDyB7wV8dBLXuldNdGe6tQvjHG2oFYT1miFbV6L6ijVY7CvXCfiPPsGLd0R97GBBXE9Frc0o/3Ihexl6Sedjhc1FG7l5A78CLVHa7xgB2C7HWNIvCwKD7FtvNXDTSJXEET5/TTkFoLG40KV98q9f&#x2B;g2hNHBR27c6801ge8FCIELXjw7QSvRtm7NGlHw2KtBUfYn&#x2B;bIT5cigf6ereAc8Ch8LAPodzVC2oHvNV/NZ/W7KJa04ufQjLn7LJnCBuOHatPBAScKo3Dg&#x2B;9uoQEYHUgE7li1CCdw9MIhPOaHO&#x2B;2U2RtLwXOFa1XjaKDtXp6J2ClR1XKjErHpOc/H3j7ItWLVmuK20Qkw3WuWpIwgdOfU6iSLq1CX70cg/eBCBlM8Dl/eeEXIk5BY3At7JalilkzBKPd8I4bL17HDIRaN8wAKmuT&#x2B;KB7CUL5087JtN46GtQEVfCLdCzEUnBKdW4s/o93J7EmDt/YAbpUVolWZiNw7Xw7caM0T44bLvxpGqhfkzyswnoojZ7W44uDc3N81&#x2B;14hlEw2UgBgD78gOUlDz8MED7H24sxXqbdsO7PZGBRhGCfs9m9NK/4k7gW8plk0zHijvY42SG5WzkN3rMbc68Nhe7L6ouaSf2yOOkFefe526tZL0hA9qy5K0vRVR2YCUZhleVqA51oJfX1IarRZcv1ynmE487zFUKJaMo97LuqbvINtYZ23vfN5lpzgD75brC7/wk1XmOf3LZFqkUbU4rbO4TKNqcVplcb2Yltl0ez5dJacgAlVpBJLPOpmu09Mqi5fzab2IV8l0s5jW58/W3/2nNz/8bdt/&#x2B;/eqT/9yfflaVXpeO&#x2B;A11NVQtJPzAzBdq&#x2B;xaRPkbidgDSg/uZGR9ZOai/p6OBFCfE/1XKmUvCUWQCqB9x4OoIUn8sFHQIZhAn6YD8G1qCdapZRUtFTBHGPg2/BUWDCr4SxXhh6YMAHrCd/oxA9/XEimIIf9REyJylklNPwqhqID7Ly&#x2B;vPvnJz/zaxz79q7/6iRdffIl5AOCuAEFiuVzmV1erz3/u9f/vp1/70Pe89je//fJjH63rGhICqncjIcy5EWl0wj2ZYHQnhH4NCq211PPh&#x2B;HcqMQv5GL0YBwZlk2QI1toZFEjDAvFoK&#x2B;bNfhyioxV1EnE/HuwVNuCZZZVqvznKD9CM85X2Yx0/IYG&#x2B;rNKvEzjyT2IG6sWM4tNq28JOot4RSVPzaJWan7V1njHb6LPeiS5fTt4h9GonQfH14bITz&#x2B;xWeetyj23GcejxVCespL2yC/HBveR&#x2B;bsbB9dVZ5oGpUbLige55L9EtNe7XqJ3acSLgVrSHzL/bqrj4aDWL3Un80J2i8RiRFna7HcIBEdHuRT2va8g5eYB9W3F1JQlnr9T5BOuQCuAZDDW5ru0BXG5U/H6WvFNsmUaxm/iZFThA6rsjNf9eUXFYAoE&#x2B;h0zH7SFeb5WcRu9qdqauG1vkay6iBTtcy1Eo7Skr2rteWeJaZaczysGlU94qRrg6RoUL5CLhgneDe/FAs2m988rgO&#x2B;/GRj0tb&#x2B;ia8F1c9rzHHrEY9d6h1fCd0PcboVRSG07pn0EMndJA6N2tUYp5bhweNQkHEX9ir7HjbOqExWoD9c61zjPLB56fEY0Rt2DHqEqyJ7IyndiUGxWnhT0PjLgj0VC5oylA7IGpU8DdiTqBXKC9ChIMOA6GjCe4tz6YcSshQY3Q3K3Ew9lLUE5cNHzvFTWI/dCS9iqZszjcjRgiKLdZRYiUvbVtlc7MiqOCF1GEtr5XzlJEyfiJDhjO68W9pwRcF1qxFbClrY/z45OIWcmo4KyV/vc9bq1t2wZhXlFLRk8yIvmw21vlJ032jrzLirBhKC2ISOC9cltOFSVmtBIDF98jn7EP46O5bUIAs&#x2B;KC3Pc9TBNUHJBAhYVplDX/3XL9p4/9uzKLAfHLLIZ2v0zj7QIhfaZ5IqH6F6dVNi2zZ6tsejWLqzSssmm1eBbOvpvzabH4us0Pf2v1U9&#x2B;Tf/zntlevF&#x2B;s1iexkyJQqeg&#x2B;BLF1mSegHYwe6c1gMyPwhnoYxQVP5axXIX7OD8Cd8fInsmbJ3q3KKweugVgnCSPWpJYYPRBfq8kkTQmnwrEX1QDraSExPgG/2gzZooBMobNQqQdhG5TNmMB/GKkWxFCoA1uFnTHCvTQrL5ZI5fcuyeumlV37jM5/7jz//K5/4&#x2B;Gdee&#x2B;0O4D48BMgRqqpqeXm5fOnFy1/6xTv/7w&#x2B;99B1/67W//IFXPvDe1771my8&#x2B;9lGECoUNoSxL4gCjbKGEC61sUJQNCOaoQmpE57qXjEI8Gqy1YPBzk3RireVb/EpUuuemad566y0q/nsVCaMVbkyvNOt7Fe6Z93Cf7FWIHkLhRmmjGzHhEos3oyRonvpixhSgwdA9diC2QqEhoOnFXMC28GhoFdUHj2vA0CumfiuUS2KARthW&#x2B;BMYt5e0yr1yaWgH84wwh5W8x34jRufGvpOoO/yGQg6RLhFeK04CnCFEck7IuvuxC&#x2B;&#x2B;BDpiTcK9INY3S6O9U&#x2B;Hxqi7WCmSAYkJqa6Z3Sf98IIgcyvrm5AfFdw9MbycPFV8Aowc94kA7Ee6Wz16pxFrITK8R&#x2B;HJufoJmEnJ3SxPMR/rpX3KGHDx&#x2B;ivtq&#x2B;QXyvYb3ult1u99Zbb7FbWomaupduZDnsQ/YV66ClCwpaOzEL3IxdIDBbDgwIxCTNkbOBFm&#x2B;eIqzUWnOCb4rFRNVO2PwEZxoH0yBAdE7Ijj8bJU&#x2B;bI08DxyyDShruFInQekH8UY/Lr5SPtYRA3MyVrxGz3GLbdjAjaDzN1as3Smut5CWzB2jVWm8e2YuyebfbsYu0DqBVyhU79LMxyt6i9whHR8&#x2B;2bdumE1GEpfFf480jDCkwiiTgxCVouFPpD7CTQS9ONIypaURecj5KtO98Sh1WOELWk879YUYRArIBd4RWqf&#x2B;J1M0glbWQLvSRY0TY8Jua9AYU9kDYXvDAaSQBvzA0&#x2B;i1WXmyNj4iMjuKRDHkMRd3c3ADQm8H00bI/tVpdMLRP4taK5t5I/FMrMYha0etwxI0H7tZ6/O3BeiceC5bRe6y1ErpU&#x2B;PcW8oMIF54E5ZyFa69j0gw1mZ34qOCoA6bHMGF2811yTHrbAjvQDeYF5RAi5pHfZ4T&#x2B;X/i699F/X2dxnsQ5Qn9mcZmdFulplU3rLKyzKVyEl/N4c470vXGeIq5/XGXxOj3dvPB1&#x2B;fe/v/xXf6f81X&#x2B;bv/q5bVVq1T4AOvTHwPFgpAANM7VWPXb/BeDWHBuA70r56R6E8OevG4nQD40&#x2B;4fvB/ZAl7slFJT1V5gigyUj/uB/InqIIfYgpvTCBQCWRQFEOKsDgm1uVLIw9ALV9LZFP&#x2B;Q11/3Sc0Jl94f5LvwgAfQgPDAxKE0rh0/0uf&#x2B;M3PvcLv/CRX/iFX/34x3/9zp27oAxBkU85JF&#x2B;vV3fuXH38117/8R/7/Pz25//yB17&#x2B;lr/0&#x2B;Q9&#x2B;4yuIBPo//9XLT3/q4uICgYbQKGI7IpW9EBuggzeiMeX5jT3hzTffpLqkEVXxjYRBxI6K4w&#x2B;bdi8hvJ0brMqywAcmDNGoPqZ53JsjIj7ZAU7p12hV7sdpqozEH3RjCwC37v1&#x2B;3ytFuBPFoj3So&#x2B;FxBHm04nrHc0SbL9q2ffDgAaH2gV7fiMqyV6mveiUzsG48vHgi73a7veh0WElW1ahcsDxYjVKcDTo4CQytRYLd2D1Dn8iEgKR17RR8JLbT&#x2B;LtRtP5WtPWtpAhgTEwC6FYsUVofvBe9Ib/Xv8IGRdy5l&#x2B;g9LJOBOIndWzniqYknwKVKnrXluxrJEcZi90pxfiOsd/5KZg4V/4TjrA8K5514I/A3byD&#x2B;1iD7QGDQBgd&#x2B;3yp/A6Qboz0B9diNjQkoASkI2BX67Y0yg&#x2B;yVFKcryZ&#x2B;0/YFtZ2X0n6wz2/iUpRx8FNunVxGBelHhO6reJe0rkTHACkEwPvdCpLOKOdd3gzsBrmagMjsu3U6ofiyhFyqhQu2HLECnqDvWWsbf7QfzwugGqwQJyjDWc5wG/x52iFVq&#x2B;E4RExuvpDcHwgCxbMtsuBL4jJsImww420m6Zb/XiBrDiYtCoyyGxM5GKY2g9L2RJHkEl1TGWBXeB0KCdP6QdJciUyN/WiVjtHKkWTOkMLMqpsFe8l3vVUxrK0F&#x2B;rLXA623bdiBZiQCwF94RzzAP2emOI0jaOQdNPF7Rd51E&#x2B;Bm2QsDQm5sbcJOM8THsETZUCzlOXFmsKN5M28Iu0zb7RhXINjp9sxdOwIfxx7D1ELlt9nuJ0UGKDsbNe1ZY6yWKxqdds74yvEdZY7Ae4SeAfdZJMFCkD3OD9aY1Y/OUlSxdRmIN7fd7Cga4R085aw3N894y5s1KIrR3nTU&#x2B;mKn1XtReaHRylr&#x2B;Lrt/&#x2B;&#x2B;M/WiynU&#x2B;eD65&#x2B;lpnsabxbTKpuskRnT/KovrRbxZTFcJeEGnZXa6&#x2B;f731v/svP7IT68/96ltmZNVD5UzI2Ae4F0CVq2qhzqfpPkD4r7m5dOtlpwf5vxiyE78SQsAqoQ779&#x2B;/T4wOlTlIRIhEBDzNX&#x2B;EAwIqBawQRAgAd2Jp&#x2B;w7AhoBCYAughoDlOGqnD1oHm4HtWgD67hcrepY0DpVzatgC7BAQPav3hPLCpN5///Euf/MRnfvZnf/HXPvbJl19&#x2B;dbVcUZ6B6QD3F1dXxec&#x2B;e/Hv/u0rH/qeu//r//zqt37z559734sfeO9LH3jvy8&#x2B;97&#x2B;UPvv/z3/QXX//2b7v41K&#x2B;DngQPhLquCQW4Je5Emws8ASwIBQq/3CveYytK2aZpblQ6Uh4T3I7sOBvrThTMQL37/Z4aOg2me7GjtnRgk7VPeAoRpRHvWB4NVHL1cgpzt8FqasUgoL/ZKxMuK68t7Tz9EZ&#x2B;eKrBGmE74HRtXM&#x2B;bHyynpekll1YjxAcUSbfdyoO92OzSk6zrKEgTuPFUJTvq&#x2B;342V99hdUQLPrJaBJcS7l2BGQ3ACTSq51ena6KHkN6wVQd5eLADWWswfnVsXKJPCQyMBKDVO1Xj3QE&#x2B;8U8x7guMD4aFRdi0N7jGlgZ4BuFuh&#x2B;rDahK2NxNQn2qbwQzEADQGA3gnJ58GDB2&#x2B;99VajCDy6/iiQOb92SpfPOmv0rOWTG9HEU7rQJWtJiaQjtpH3P1Rpg7U9QYs3/LDbeSmCldfvOpCjWKCaSPu9ojndiAWGotFehL2HDx8&#x2B;hTWpQfYBrnWK6c5FSxBgrQVKJtanLgHPDp&#x2B;VDbFXbruWVoWuI&#x2B;C2XuIfeC8E5bqeHp0458Y8ELyFdbCi5NbV2O/3HbIgkZvuXWeGfBmi7xyqzn2WAoCvjyjRvUK0EyV904y3y&#x2B;F1gsa8sKSQ7qBTZ0M6lbydzTEqIg3/xU6NnWgv9gcPRq3hVsKLMNF6v2p/Plkv4AF/&#x2B;tzACuYa1SVe7ytvsVZVnjuaAFxjxY4pO6SKB6w2TSNeto1yP9hLHB7ctt/tmv1&#x2B;t7tpJaSmQHAKYjC731hR2ONEMXxL27btAOj7ITimH1bZVQ0cmiFs7SVBJgYR89B6/wEvODkAa2OgUG/2O0t5xkN2JvgcvDJYcxpP8BI5//bk/fcSZQ&#x2B;zDquYHH0WDlDurMpy7T2MfcW4goymzw70IdimWich/x39oa3pez9FvGTrJQcfWcibL6x5d0UC/eLnPlovplU2LdOozuI6Qx6AGKl8QQoqkqjMpvXi2TINN4tp9aFvqH4y3fzKv65f/c1NvibjBUidWJzhawDESYgHMiadhjp&#x2B;TX0hqUZzh6jC19IC/Xeh8qcGHb/C2gCOCt5FowQU8/QA1iCePBw2hEYAPMifDlwFkDoALSVPCXFOmZALoJwxQIHgWRqj9EBhT59dhvGpJEFvofKO0Q2A3ghMELZer1er9Z07dz/72Rd/6Zc&#x2B;&#x2B;tGPfvLFF18uCu8HjBuGCELLZfH6a8tf/IXXf&#x2B;gHX/1b/9vL3/KXXvmWv/TKc&#x2B;977YPvf&#x2B;m59730Te95&#x2B;bn3vfyB937&#x2B;L/3FVz74/s9/&#x2B;7dd/MZnQP4B4&#x2B;jevXs4qlul5if84mc3RE1oCNahZUc8UGKmRrEdCEBvJK0sUbJGbDhMAUp6YekQgu/E5aAVPzG/x4nk0CilNXdUrBSlI/DnFE862So988eKRr9X3sD6bGLFrMIbRlwCnHM4cAi4exUCqBXvW/y02&#x2B;16BdAB7lm4U74BRBHUwWmszyNSN4fHUyu7ZS&#x2B;ODew9/RROYQ79zc0NqkkUwTFtlYIfYiGgHt57I6QUjT5xPZDkVoSArXCH9NzjKx6qCPSkvjBJMDHlgwcPNI1eY2Xef3PEm3845v9oSA382irLgwbZWroguMc9SANMqE3/gZ0SWhR63hEo0&#x2B;5BCeRmYN0MivxHAnpCeXQFgTilDtSENgR9adyvTSIHMpXmJrFDdkoaAXzn2xvleazHBW1plK2AMsODBw92SsJE&#x2B;VrS81GACKA1SaBXMWcoEjzOaEg03HvL2pCIt&#x2B;sOJQQrIJKGBa5J7CwCl0cOOk6cYqkkIEY/sCd0StgwStXdK1tkp5hFBzYB/gukOIgQKmoB5Q2vulDkH3YXt5V2nIAduxUgYOf7w3Dr5CbOTXAn3kutStXUKnsujxBW1Xp7i8fTHDI7Nk0SnRvhxHcqGQLRJ7e8rusIl3c7&#x2B;P34uukte&#x2B;eVGYMfDwwLe3EeMoqdb5U7MhBk28htPI1GiYpV0IPBd41mhx3xK1E&#x2B;amLEmcYw7I867Xa7HaPr&#x2B;B5umqbZu4PomaKJh1SADu7EB10a6/G3CBJt2w75BISDhO71lKG2Rc5jj9StPnXadr/b0XFl5GYgApW4GtMoMbzC6ewEbQuhGk8R8eOzQ6RUL8R6UQTCAxzzO5mpKL9zQk&#x2B;yPvUvOoEZhzDf3LvND/h3P/dRIP4ym27OT/N0isA&#x2B;VRaXaVRkp3UWF2lcn3/d5gfeW//Y385/8aeKz/96na&#x2B;YsgqgGUCwliRW0JQz1CYpPaXEx9Q&#x2B;vuTSAMFTi09efi3Zf4FxAZQhNrzxxhtk6ZAuDz9g8H/wFDXx23HkUCiwYRyAkzENF0TnaCNZPfjzjTfe0IQlhtin3MLmQ2bQJhHSfvgvLB6V5A2g7h//Upe/VSmEGcSTKnz4&#x2B;NLZoK7r1XL1uc&#x2B;9&#x2B;OEPf/Rnf&#x2B;aXPvGJT11dLelIXUlWMthG8GH5K7/80tl3vPyXP/Dic&#x2B;976QPvfeWD73v1g&#x2B;//9W/8i5//wHtf/Kb3vPSB937&#x2B;ufd99i/9xZe&#x2B;6T0vffD9F//in5WrFRhNtLHw6G1Vdp6bmxsrbJNeaOWAI845/Nq2Ldg&#x2B;gI8ACsCFRlQ81EAR3WJ7xz1GlN9O0oRxd&#x2B;qV6r1HhB9leN/v973QY1qlfed&#x2B;TijfC5&#x2B;HqnQjcshOUuHux8ZkK0QgfQprk74Vo4cVs7k24PPU5uHLo5aHci&#x2B;QgN/QCsEh4LE4nD5ybraibOLZSnSF2/Zin&#x2B;E9PMuA6vRACAQfKK&#x2B;C&#x2B;1stBhhh8LMyfGkrXgE3ira&#x2B;U/wcDcEhLZA7/lCCz1JtTKx8I/QbnNdvvvmmxtmErY1QVihUaAi&#x2B;U9pxig03YxOBtkjoL3EzITKLAsgG7scNN0qpryH122&#x2B;//fDhw7feeovfkFWPB6m254uInvW/B72q/2Qbeacufye2AtT5wEiyF&#x2B;rUca9qNTwlDb6XHaVHhBNAfTMIbJQNdF81QiVChTncHK&#x2B;neoW5eU5jmWlZGUH/9BLlv/o2M1YPC4HQIwfuVr248vRiIuQ6dyq2AJcfX8Fv9D09I/dYa0zbiQujZTxEpahoVNgW7obcWQjg5EXWqbiT3PKsCPc6eqbouQf/fesrbxXQbJwqgZuOU4oWpwC93NbqGiJKJjdBKHqdoFEtq1hr9/sd2tcqLY6lmlze1Um2BG707C4tHuzEOLCXl6LHdsKu6aQhZrAYtKwJSUqt8O/xSic8e&#x2B;ecV64bs7u58fwWpXTBW25ubiDHgMbTNnsR4YwTipEyIzTGmN3NjROlTiPv8gp4Uc7xAAPmxgltxLDeKOTNs7Bpmv1uR1DeqgjNnE64GTSnnWRE3u12xvg0DhRF2rZt97udihlseAZbKzp1B3OEJ9tQLHSuF4OYGduFfLVlIvmeNwYUIPE49&#x2B;p8vSJM21qJQ2UQflQRzGQ4Wr9qrDWQCkAuMsZnQXYONLx3y/X2679RZXGRTsvM5/mqMgTxPC3TuHrhj28/9OfKHz&#x2B;rfv4nys99sl5dAL7qQDfEtdopFpi4UMlu&#x2B;S&#x2B;Q90byc5EdxCj4uhCtmAfKJ2UfBCGWxm8A6OkMALhPawPpPRQ5KMZAutCOyNp2sZUUv3RK1oIBnRNgYSDQZxehK9BGTX/S7CZgfXoS1ypkELE&#x2B;gu6D1YMsvLXK5svQPS&#x2B;//MpHPvLxD//SRz/5ic/cuXOBSuJB1AE6e5oj1uv1a6&#x2B;&#x2B;&#x2B;vo/&#x2B;fEXn3vfS8&#x2B;993Pf9J6Xn3vvb3zTez73gfe&#x2B;/MH3v/Tc&#x2B;z7/3Pte/OD7X/qm93zuufd97gPvefm591786N9fXVzAVxji3xe&#x2B;8IW9IvUCl&#x2B;&#x2B;ULhabFSz&#x2B;QGlG&#x2B;CEabtqxRylOfYD7G3G4spKWdSd0nb7vbyRkEHdd0f2NUiX2fY8XffGLX&#x2B;xV9Ewjdmmt39lLfP2dxBfqRZywQtbn/rMXgpB7VLT7hw8f4ozejdkpPOC4i7ZKp84jRm/arJ4VAUMsEp1TlN1WDB2dcj7UpzauvYohsRd2DQ964ioe4hw74mmW04oCnlh/vx9Swex2Q7ZN4r9GeP&#x2B;cOWrsvOa4HefDIqxsxowRjSYfSmxKgshGyDYHeBdPUQ2/H/sAHCBRlgCOjUaoGqz7B8f2BI/R33774cOHu5sbAPoDM8LNzQ3cah8qe4V&#x2B;SyNBPG/GSve9UIakc3b8EyXwdRqj41e0nSr5Bw8e6m5k/VkC26Kx&#x2B;8OxXYJw/6HQeA5K40DoHYM92ag4p8eF46emadg5lAwp2Og24t&#x2B;n7KBQ92CaaLtXOvte0XUU7B40EANoEGR8ANyHQowRZOzL6ZVvvt6PKFd0KkuAEepePw5TgEVFIcR6ZwOPa72moev6MVPQCxiKe8MNwioXIkFye&#x2B;0Nieq1os8mhiY26vveyu7QK1aVVVmKRQDwmn5rhginlA2sFX9K7Kdt2yoqDvcsdmAraYYJRp0b1Nj7vfgeYcNVOolWFCpOkCX3NaeqBHDaep2xadt2d3PTto0TrbtRceX2wmjkJtsMNdnjfiHl&#x2B;5Xj2eRCH3IqpI&#x2B;uqlHWAytC1F75G/CGVjySB5HAmxp86gCf4attoSBvmma3u7HWwosXULj1mcUaSHF2CAfkvQK4BDrvmeBP5b7vPEXHnwQ3vg1D/Oa9F9IkTcHNzUOYehiRCdPPiP8GfhUhzTP42yFUlBhVWvSt9xCgkr5hFmSeuCK0S&#x2B;BXg7Y50fr3Xde2PsIpJgPE7JYUI8YU8laaljyizr2b3AB&#x2B;985nq/M/WqTTwgcDPa2zab043X7Pf1f/2N&#x2B;uf&#x2B;4f15//ZL1eVUIxB8gmB52BbkjIIXFFq8x521bSe&#x2B;FXKO/pg0sSUamy7W4lEzCRNB2CIQyQyVNJKCEtYxC453lOEv9GMovBK4D2CkYBoj8xa0VBhQ0h14iIn1So1WqFqkIlX6rwoNeS5Ji1ZdIujfu32y1yBh&#x2B;E7NR9Ql9qEHiqqn79tTsf&#x2B;&#x2B;gnfuY//NLP/dyHP/e5FwH3kWwB44IPCA2EZy8vL0sJZvrqj//YKx9830vPve/OB9//0nPvfe2bv/GVb/7GV7/tW149&#x2B;47Pf&#x2B;93vXaevPht3/LaB9/36gff/9Jz73v5f/lrF5/&#x2B;FP2Gr66u7t&#x2B;/T&#x2B;CFHQ8oai&#x2B;XMYakZ&#x2B;cc0HzbtkQkbdsi/Ty2Rx52&#x2B;AyEil3u5mbH26ic5isIjlshW&#x2B;J1fd8blaYQZyjU1RrdItZQQ19VFaeu7/udhLig5EAMjTO0EZflVvFwtJKLvxryY8UFQgkGg/oPpyF7slUGkOGAUAe6Ef0dZC02lkctj&#x2B;OdxGP1&#x2B;6FKVy/bdaMVQEbZRgjgKI9xEI1QblhnQLdWDOat0Nx5UYNLRG7FwkBw/FDIYDthpGhhgNB2N6aFaJR8IxxxQlKyXDQOvhEn2v04gg1xP26&#x2B;ubnZCWB9&#x2B;&#x2B;23b26GeD7Ex8TKD5Xd4MAjlsp1/TjoQDsJs/O2iA0aRusm405tlMBbWqHWsGTMClokNKZnAwnENb5no1AaRaCHSszgsLJMfH777bc5ZHtlmdmp3MCoFUcBe4WuTyPhE2/EXNMoj45WBR1mtVvlUOEpQApmj4JpEt8fgng7OM7yTlxcOU6ZFL2GUtatUSp5PtirYGTUuBP6i&#x2B;w&#x2B;FK4F&#x2B;k4CnJN74CRBWKOy&#x2B;vV9b9oWv/NdexXjjOUb5WxghG/N/YLw3QO&#x2B;rmMhgska7mWCmw2goSpnoMsDQYo2d0huoEQsL2Y4736NLh2FZhKa9xDcxgnZo1VQmBKL9RFvxMgrHgVGtB08LUDxxwdzRA81jMYj9Rd82wDsopk7sb36HpbPfgOV6EB83JAmq&#x2B;KgtYq9I508SBdUtO/3e3oGoyuAa3uGTxVxwpBLIzoh6nWgrLF2kNCg78avfd9Z621Ew3Gi5AFr7X6PjXsn7W3wqx53L1pYn2KMfWi8qcdPhq5z3tNXvc60DWC9DLoXaaxgcaDwztvGvGcCCifJp3OOcYQ40H7hWCvjPmSiMWZIbyyx/4UaZAxMcKgSmXh9/27yAditXy0XzyLEZ72Ybr77T1Y//Neqn/3H5Wd&#x2B;tV5dbjc1kHelQmdSPa8TdQElMxR9peLuAwqDzLORuDfMfkV4TV9eEnuAnsm60UXhZlL/N5Lzi9F4NpKBS4sBLIqex6DOa0Suy4S7MJF6LUm&#x2B;0EAaJWh5oMOuFmBI3WEryPWH663uFtzM0q6urhARCH8CtaPCtQQmqut6uVy99OIrv/zLv/ZzP/fLn/nMZy8vrzgQEBvo4IvHyUqC7h/RP6uyvPjxf/TiN73n7jd/46sffP//j7o/fXItvarE4frr3i9vxC/ibVx3nqpsYzPTzNgGjIF2Y3C3MWDM0BhDgxvb4KHmW3cec55TKeWgzNSUqZw0nuk550jvh/WsdbZ03RE/IKLdpaio0JXOfJTSWnuvtfbS7auz119f/&#x2B;3PrH/vX7ZXVna3Sttra6vf/MbqJ24t3L66fPvK6qfe2H36BLmiYBonJyfOFPtV13BmbtcUMhAiFCCLWaMJqfEAoMeXahzH&#x2B;NyGVHSkplaSU/GfmfrLiFOrABryPO/1emMTUY3jjKIoYe2m3&#x2B;&#x2B;nJgQzpJg7p/BGHEYAAN9RAZVLKRXzGRU&#x2B;aeqNAWJHQtLmd7NwOY&#x2B;oJY5Ned4ulnGKQuRFs5kunbCKhe/OxGYAFeknO2JXwfIWu2Joxq7hd0r8TT9qymCJaOG1tzKkvdWiPb0uDjDk5Lher4fX5frFwjHryiIYgr9AwMqlUTzlcFgo7FURF6Ds9/vAzRG9tlhsyO0IgMZxPAwC4WyIiAJqe1SKxhameILwtyQ62imWtyeld0MTnSmqILuCbUGI7UgmpJMVd5oC7tqOrdOD84jS4NimaIllCzoj7BcHCd5SkBZTs9dOLcdQCV/3Lpq0FuDm6kYExq6gc9QhiQPEZhIwPnuv4fM9Vj7P5Mg9vTIeF0xAC9tHTigqdJia6YBjCv6E5u03xXg8ZsZ6oSDyKNmE7SRm&#x2B;onHIkXZNdWfqLY5MoGbMHdafpJOWoIci998vZBPjEZMFDa1hJT1g1cTUXMe6piUZkS7Qpqmcezz2lwRmZIJEaZEqylbEzj9ZHI0IPChvqwTX5x2mVnG8QRzOoNzjoPBJkajXO2DES3FKmlkrB4552Jo&#x2B;vnlhaukXeiioaKv/obssChipOaBbaYmtxgCktTzE5fa1E6miUVsbUOi4&#x2B;hYiKIoTTn70GcRhGoseC7k&#x2B;U9RsMmMTQKFf0BzVPpVxQEQj6JQv0&#x2B;6Wfw0eolULI4Rx8gjItnzn&#x2B;qcv8GK0MFvQsr19ROV&#x2B;6HFTn0b0CJQhYSEIU0dpgdkkO/7K49ehz8vlA9T5pmOcvw4xWwiedcB/kZw5KlPKGKEKMkGLkbqPzy0x/CWommQ89T0OcSf&#x2B;v9JBP8ffITV0v7v/39qX/z/HvzFz&#x2B;5/96uHM/f3S6sH&#x2B;9VDTsmtM9JeYF3PbSxP0wziFSyWWB8CcczHhQcXdXTJcmQdrnNgls3zwdBcxO/I8ttut61bQMFBR0dHR0dHMgbUaD5umAfq7jV6kUUeBMel0gFSVwcAGzxkPqkidw5M7qfO&#x2B;vDwEFV8m/AjdoR3UfUXuFcEp2y&#x2B;sv&#x2B;qA6BC/u7u3vLy6v17Tx4&#x2B;fDYzs7ixUTo4OJSOaHd3d3NzUwn92LiG/oJU7PBxeHi4t7Oz8rU/W719den21fU3rq2/cX39C7&#x2B;9/fIFZg&#x2B;XofZ5/mzl5z61BpnQT76x9t672NTm5ubOzs7p6WlKMbfjAKOAEo6Elcg8z0J6K4FisZh&#x2B;v7rdbpqmKuCpuh/RM2orMm6y&#x2B;B1yvoqj3N&#x2B;xVo1tZibWJk3TgLIcUIWYYXSRUY3rR9BNphgL4OJPSd/2ApciBvbnIwiCzNSnHDWlcRw758GAfkH03SKMm7H6E3KIbMa6nr0agNT8ksz166Ofy5TqLCEk4q0iqjKgASPi71fE4rozDQGdtTCiFgPCFsKzDMEDNf7sigeq8BxNyWkMXoyIyCMjvLGye9WJh8Sd2uZwOOx2u1EUDQZ9wMR&#x2B;vx8aGAoYbQF9aOy5g4FHwPhnEARhWJS3LcwVGQAbCcOw1&#x2B;sJFtuF7an1er0p3CwWoSOxaB5wP2CbQkviLyVgiyAw6hrtC8vjIbIhpiEcjweYmHoXOnj8X1dAt1jIPjCtD72oqxSYMQhYUZTDYv3IdEte/VTYjoq2H5meEvbLDsCk6VblbWnoVb&#x2B;39CA10Tq5aRfknBWQ&#x2B;eI0iHtRd7drqWQ&#x2B;8qHp/nDIvBM1FvJXlDnAGJYhZOZhD0871bdPPhkYjNMcT/KfYi/8ghhzIrq2Zr&#x2B;V8DzjvC192SW&#x2B;LcvpWuRItjKRUmytsgTwVkZGBDxnv8RxnKNiAqL3ZuVU5/u7mWWJ0v1NVk9Ky3KhQS&#x2B;kLGnCOjo/D8XldaZwEpuJfcXr5mtXFohEMwFMb1qkLgwDxx9FnTLArn6ZLAOMC4NEmjAYNI4iQPnY2AB0aDpIlOQFZxONK0aFjGcE7oHBAilL&#x2B;4nP/ve&#x2B;ZDCNLMsQWJSSSOQ5ne7Oj0fAfU/IkfB//ALllBjpRzQuYgGZAoQrZtlX4vsJTusyyRTQHFIcdQPyLBuPR2majkn2Uq&#x2B;SSpEcqsuLz67oLrtJGf8usix10PrgMLLUZakD1h&#x2B;PRvyTzP1nK0ky1gI&#x2B;Eo&#x2B;k3Wh89ysHLz6oba0e7O4I&#x2B;CLKU1NyD5iOf8DwfshUVMvH69ZrK8WLpEEA2UDYNZPVIwW8qu&#x2B;YdSUlD961gh9LPGyKjmKFxAHABxqT47p0ALVaDQGg2hEoivaCJ1gGWwaBsSmf0PzY1QX0dQH1Fmr5YCA4ZWB6jN/C6&#x2B;oeSPODFWu1Gmd17SwsrNy79&#x2B;TBg6fl8rYdxQWgD6uAED/oBP4PRiEvAQRCBwcH2&#x2B;Vy6U&#x2B;/snb76sqda&#x2B;tvXN/45Z/fm3lZ5TgCbGr7xfOlT725dOfa0u0ryz/7qfLTJ6IQpVLp7OxMv7gC69FklAoe&#x2B;I1P2N/HKvxlHAmXOA6URSXP4tHRaBSyqBxF0Xg87vf7jlV/fbXiOxDsIjHaRX21JrQWBJNZ&#x2B;/h&#x2B;GNLNLLic0wiXpulgMMiyLAzD8XicUH&#x2B;MrzV9jQt2ZzQMONOasL93ET0Gwj065pDT0CJmRLoifCKJDYbWKhkL89qj7SQAOaVmtm4QBM4V82qiyTGuuqq2yBpTbJ1T0x8wH9OWXVWOtWvFtG8KQQqyh8ZXim3GdPcCyQGY4hNCUF7UqoeTqfn41Amkhqx8mxWL1yNj4UUtXJ9Vi3GlyRHaFqwHfMdD/AHHCWyKHoVFsYPBAMRAWFYr6okaArggMgngxV6vh1dEPESi2MwYREbB/yqvEMS31MuyGi2mvoq2r6PSNcTpBF4WVVy6iKoqfMZwHxOq/6PJboAxQhRfIJbvqR8SGI4XGH6lExEneQ3wYmzENoK/&#x2B;kXMGCzoTIZArpl57AmowZczscQCfbOLolgutO2cy0ejjOEGQCDau76Yxsb76&#x2B;crZRmQSW5KCzoYPU&#x2B;N60D7tf/Hikkcq1pvuYRWxEaAdUbEaimLuxlLnqlU0exjJOyTZoaoeFDoMZwXEY2Zw5hSrg3M6kyyzdgMQhd0S4xqM6FOhuxowjCgb9jMcwDnXIIzGmkciXOOcNNfBdKb3LeVvUXVfqsC2efkAHmWQfGYMrY/ikLV0RHiWRw5fx5iTgjGd7d&#x2B;ZlLTOsA3GiRVKRfDfjMK5XWy/NVJhKFRUkoSzRDw8qeEEhqf4YPS9Sh3zo/mFY9ypnQkspE6V0SO8g6qHp/xbkZhKNmPmFKaFiO0kslhXgLrCacuFFdMCbOkqi5JkiTGX1meZ7izgvKkLh6b8&#x2B;b6tB8v33c&#x2B;pbRQ9qPTBVUP/qbUi/OWHvsZ8Z2BYkgeK4IfiUee5wd7uxK4Q14C5CqkLhG/RckqhAOYAoUr4lNUQRJ8leetYcCO8hWGtkoe0ABAfwH9QwYNQSEDFT5AP44frQYpaqzZt2amBR8fH0MpdDiZoK8ehQy7&#x2B;xzCBbyOErs8DBL22GUsycHhqcAvgtFgxmid1mQ8AYKvMddIFGhvb&#x2B;/Fi9n33nvw7jv35&#x2B;aWtkpbeF2SIXt3cCJbW1ty/QKpK/oTDEQanvLGxs53/nnlE7cWb1&#x2B;dv3Vl5S//YqdSKZVKSvrfrlTKP/jewq3Lc7euLN26vPqZX9tbW9WmyuUyhnnFTOEY0gAQmeGsGZU8/X6/1&#x2B;ulzPEUbHWMsxS&#x2B;x7pRFDmXolgmWG97C5FRnkyVfvTFgq8N/63LP&#x2B;GMwpvcCPrHlNH2&#x2B;33xloyp82Ag/X4f5CGkckmI3FEwk1JvY6mF2I6uj8qFEdU4jv5jAB0crQXojtF20WTakq5Gamr2&#x2B;i2OjNcWiMpeTDwCqrMEUmOqXgXTBbn0upV2JJPZrLbuiwWsoMXCfQBEweUwDAcsKltIp4ryVIE5iiII8bUjoVhV37XxiPL6bqcTUjIkWIz7PlW5Hw4HQv9DI6C3YF0fXeFgnSPWstohLANWMFVNx&#x2B;v4M&#x2B;l0OrFJFppqNahjIAIQhmG/3&#x2B;t2u/aUxZp0raLCvRBOncvQqIyEoXVxdC6R8WQL64uKaGu2g6GFpwiJ/h8blZc&#x2B;Bgk1Zj8yBCmmcDoMwzjmdTBnFNs5AJjMJS0&#x2B;BQaeGIxMgV/cIKXuReAMXyy2gi4Ubuv9YzN2wBV14lz1AOxGFfSxZm4T5k41EOw/06JY7uxedDyC&#x2B;1psZEKCU4NmoGRA7VPb8ReHZ51QmTNiUJo9GAi4/RmxPSqmEbORKsyn4PYC4TFHKJdGChfNOces34x2As7A8qaQtHBuFEFjWB3cCe1dHZXK3kmSgM&#x2B;MJnNCdd1UVFfRGhtOjCIzDAN/PNCXw19lQnVgDyB89xVo/Fx4vsexAELwcRSlKOrEMehHzMZ6RiCe5zmK4hHMA0D8xMqeFDCbCN0J3URdHx2eKzIxfQKp/jSyNHXGFuJ/6JJYXQIBbp6RyfMBvZlcjBc2wVzehAQAF1P8RFX2jBdddwO7YM8hduzGAPRL6pMavy/&#x2B;yyh8orZfs5kdeVSiy4VF8jxHyA&#x2B;O3/9R&#x2B;z/8jOG2dB18pAjAaDSStxWQEQofxdQccHavPABWHqMVDxjer1o7HlCcH3C4L7A1GgJNjt0FWrUafWFi5fxYrY4MwbYwD8EMRncho1PtBWs2AEpGT0CSJDkZGpNjfadyftQQaHK4GNT/2kiDkwGUEVQzEf4Q5dsF5PrFPyX72d3dxeDkw8PDSqVSKVdmZxcePXr&#x2B;3rv352YXUfKXQMjO8EKpHluDPVcvIq5n308C3kaHp1KpyElcKZdX/sdfr925tnb7yvonb&#x2B;88fICqP3oF&#x2B;9Vq6eWL1c/9xuob19duX125fWXlT/7bbqUCelAul3d2ds7Pz/F7nHLClxA5oAaE3aGREGTGeCqogb9G/Irjbz1h3AcWw190YKJCBCwSGoL1RQeAgrqYILJK2sLuwPRBEIzHY&#x2B;w9pdQ&#x2B;DMN80jKr7&#x2B;2UbWEVuVHU06/t1C&#x2B;OZRqZKfbZn56IAxOcKfOrVjqkrBmXF32SZNJGKdyv6r6OTd&#x2B;fKskLzSemcI7/p3SmCQI6Gq&#x2B;F10MzsWFotOyOw6GCV6ylURQNTDUXxywkZzF0ZHyuApS2vh5SnKNjFhIFqrbQczAYdLtdC0BFD4DFRSTsE8F0LGDr4h5f9vuGIQwBuNFZAPK2e1GnYmprsiLYVsZUy0I1eFuzD02Z3zKBkGRmaBwFA&#x2B;NPCI3BQBdfUwiGwyEugD2vwPR/LHwPw8i2ICIzhDhgR8X&#x2B;nVr6Ye&#x2B;a/WdgvA2W/lkGGBmrgOVO&#x2B;mzbKzkYDF4bs0yeTep8NHcDDX2BP/ywjyfHdoyYLiINekbNT8ZkIUHtEYNHU83joP0AIGNsQoFyYy&#x2B;GA1IIWzjG6n9ylufFOiwZcK4I0c8LU7KP/gVug&#x2B;DeXAe/F0cJkGokrohl9J0BQK78f9NASI3xVDhM3856JWcZRkQCvKLQ9xsYp7JNxIBOfHEmFkkXQDBTNShNU2iucOtxyo5pxLikYRhmZvZWmhbcQBc8Tb1OCRgRfzOFsihN8yzVGN1E0wqxNfPly0054n6QgTihjiXkSBT9PJBvOG9x5RQt8gov5c8NskeFXkIa1YHCMMwnwnM85HX&#x2B;7vijLdo1zkEalHByXBLHYRDAeJDxdnolT&#x2B;LniOW6XhhCx9kIXtzv9&#x2B;syZX6TZmRZmvlof6&#x2B;ooQGg8Ct7EZEs4M4VdIXTwdLUjanE041LmdOqveQM9ffv4nNOC/uo&#x2B;MPMsf1sUsCWmf6S40i7HwOQ/w88ACIVZTMVNVMzmf3CuDWG2askXzNTb1HvxwZhmbVC/zrTOaHqEdqWdKfO8V7aL3A/oDa0PYcmTlR6esl7QDNES&#x2B;RXts7dGhNFwQf0Yo22Y3QnDpm7L2V/3ftud7AXWWx1QSyrqRkTM7Q9uoyaBSY2hR6IpQeLi8szMwvvv//wyZOXGxslzV6QnkeBS/L44m7atNADTmQ75JxmXCIcM/JDS6XS/vra1m9/ZvGN62tvXFv/yTuVu&#x2B;9rhHC1Wi29eLH1lS&#x2B;vvXF95faVtTvXVj5xa/Pdd0QnyuXy7u4u0JXQoYDFcOh/1wEv8CuOdkFEmy9rLEkYekE8FhOUB8YBpMZvfM7&#x2B;bWjk4I6qUSBjfYsOBoMcI9L5APTMIddJEiiI8PUIAqPquDNtT8dSVEhjJb/JitcTFmVwJNoLUPJ4PHYUxjiTgKlKVjyZkRIVcTqJML0qwdopngOyZ2yz4DCA1bSWoFXE0n5CozMeQmBxnAhs4bI7Yw&#x2B;wQC0wCpCBkbAL5IVhaNUviuEHvLanYOu&#x2B;wSvJOVjSwk2heWxTfMBC3sho2cUB8Hq3W&#x2B;hnbKU8NH0GIctutytJD2rz&#x2B;pD3ej1geq0VsMavlgJWjIzxFyVt8AcdOf4vMwD3XrAI7QUbtBxpOFl3xyn7dz3ZKEr11iusfenFITsSdo&#x2B;6ZbgCuI4iLZYt2OumC27pR2C0THEcB4F19w50YS3r0LkEph1kmczQ&#x2B;E&#x2B;CyTyiXq/3moHXxYjvMYf22bcEx3PqmzNW6DMjp8lN5q6EAePJGODUZOxkRoQDID5mnX7EHFKLdPPJ7CDHfIDcqIxSI8ofk&#x2B;EUgLUwVqZCP7YnQNbhD5i7nph1pQNOpd8wIN4Rm2LFkfc5xBm/jPIJA0ARaOAXYxyqkHFu5UPGehXHMfjQcDjMOIpcjKX4ujcIW4Ab3&#x2B;K6gCxAF1HHolspL4szYaMAuClZzSjP4yiKab0ajfJE01JoZsLmE8lsgL95Otp4zm6G2qz6RkZwfsjSjn5sdDtjJuvHcZSxlK7Ggt9yksRxFARBQpCNY075y4bDSIoRaRPTypwZUkNwz2hOcU5akIHLsTX0Omg2iMg0FI3q7SK6S2lalPkz/r3lys4juwMVsas4kgE8xvxTRA8kY04u7RkOdvB8Urom4pSZaNpCCISuAlP/MQU5zzN5mr39gMT4xwPk/70PZfscmpm7ByYsv26y86EFwsKSsGtJpd/YLCBtBDgYaNvGbmoBCfpV7wedAE8A9pVqSO4CVPo1HwCYG1tWZr8WVvdAMiRRERzh0dERhEOokYszqJ&#x2B;AgnqduT143V4KXR&#x2B;A8kM&#x2B;cAoSWeFMsYCaA0D21Wp1ZWX97bfuPn70YnFhBagdaBtPKpWKmIBE/3ARHBwcAI7jRViB0feo&#x2B;sHAu2oaKMV/e3t798XztZ/91Mqda6tvXF/9&#x2B;M2NP/uT6vr6zlapNDuz/r1/Kf3e76y8cX3ljWszt64u3ry89nufL6&#x2B;s7O3tbW1t6f/6aU9MhrfQdhiGeZ4H7APEcZyYwr&#x2B;wXRiGqMQHGO9lAnPw849vOQH6iF/LFlFF9AY4kxQEWIzDy7JsyHAhPVRqEVWITGB/khRFH52g4zeJ2g6JqeXrpPS6XhEyFuBWsT&#x2B;hRkinhssVMMBRux6yG4Dn2jLO2hZN8c8hbRjJ5EzWkJqcyCQyCXIlk95csYiBGRMbUZ0v5GeXjIx02zJDe98H0tBT/WKhZ5fwWrBVBf5gUmcigY0Ad7fbFQoXkI2iCGhe28TygLZD1ozRkej1et1uV5hY8LfX6wXY5mCAf&#x2B;L1wHQqhsNhEAyxuojQkCYEi&#x2B;MJjicsxVhMhmMhbB2hVgxMc0B7xythGEIONMVn7C1Tt2T4StVfVziasFBPiKCGk06DoSm96xjwAdAedYv1wRBxEj2zVMGyEVERcYYBG0chXRO2DIF3X9Of&#x2B;ng8TjknaCzdzuRArszkb6YG8YAS&#x2B;LeK6nsxslegPDXTs0da0Rh8U7qEx/DjcrNjthGI46XP8TVynYj2Igl1TgGNYytgNDm0PDdKIbEFPFG3QU8IbxIwBK2i/eKfI5M7JsxNm2YRogrXQQwlBqXqGa29klsI7aVCq2YOQEIvV2p4jpaXlsaZqBlhO1XBPUbHtye/drWkmEMcx3Azozas79aCX6GqrRwh4wD2O82yjMNu9AHDuvphiziQS&#x2B;gfKB/4Hmdhho45/cZk/HnwDQTPEJI4jsRtYsaD4kxxPWN2mXHwunR5lsVRhMscMNJOMLcAzYwDUkU/SZI89xLVnMIkEBt8ehNK2pK48Bnnee6SuPicMFSq4Ce8j/pQ6XMCsVPGAXbiRdL2oGCfkN1lvjY/yqjeyVTC9wFB/gkmG4xHI6&#x2B;GijWKDuQ2zTJPJ7zDGIm9vuvinesfoYdAf81k3UwJewRtlcZjJS4NM6HWStsBrFGtV7EfCFsWW8B0sIIpVY8eMgSLKkDqc2DmCktIAwOx8LptO2AkMOKD1PeocXqxLkKdSUQq&#x2B;YtCCHZjGXh8FRy0zzHGUkYBoNtWhvYCloJSPVNBD2ZnFx48eHLv3pPl5bVKZVtRnjIPqGkAd6&#x2B;sDiAbpVIJNXuwCGmEFFGK87X/BK84PDjYvffh2qfemL91ZePOtZXbVzZ/6hMrv/tba1/64tJnfm3xJ9/YuHNt4ebl5TtXl25fXfmFn954791KpVKhSQBdhX6vp6I14HVo8gfxo44/ZBXX1QTg12aeMydDW3AcFOAoVQdaRVhQp9OJmNgjkJEyjChkYTtNU/QEcHj4khkMBthXQFYQBAFk/amJfEj49Y4vW7TNhWhTKot0Xjn1QmmaBsa4jG9jx6p8yFTNlJFHtt4ZGRuuGAJEGgLuCdPc8VaapsPhMIpjXToVTXH6oluWVOgwLBkQjOOuC52G8FZosnG0okVyAl7&#x2B;pJhMr80OiGtVbFY9eArqWXkMIL5F2IKnYg72LUBzrGWfCPHr9U6nEwQBiAE4g4WwaB3Y1/HodrvA5MLcOAy1CzqdjniFfViWMjAPECFwBmF6rAKeMpys3&#x2B;tc/AHwKul1oH&#x2B;V2wPTmrD4XtzAXnDRCTYQhvZ1cSq9OPUR0s3FSanHYhG8/cD4j9kkUfnf3eJgUlY05OQEEYzQqIbCMHwtp0pHJVgB/TENwVY3b/&#x2B;vOr2&#x2B;UMY/Sr3jcbOZ8SEwnRhfL3BgPim8we/xyIQRaY&#x2B;CUBQce9aRMBFF8Gg0GsVxpI2oAI9aOw4mZppyxgHGAq85Pc1jM8HXuh5ZdGdgWRwXvmTnAHPll0iVYQogbuusNFvrXuCorKhGuFy/CpbemAsbA8gW0J/F/rwoBnvTwojfzpEpz2S&#x2B;0ex0Kcw1UQImR6CbQE&#x2B;sjmQe2Tb0CXE&#x2B;wdPnUQRB4JyXwicUs6Zp6h26HFaQkJZM/TMMQyQseciO2n4UOedltomZhS59DpC9LyZx4K5jgT9nt915pVOcpiliQNUwQfE7YenIsdmdZ1nEocj8dNCBkEogG7kkifiTgwaCBFriW/qkRd455z&#x2B;u/n17JOxrIes2z3PsAh&#x2B;MLE2TJB6NRkIYsCB7fT86MLhTWQYcn2VZnqViU2kRz&#x2B;r/inH8QPhQFmVZNuKohCSOMw8RPPfIP1IxoHme23J4jdNnBWolnrHFflsOt1J7gPVqtQocr9WBwo&#x2B;OjhDwrxdVs3&#x2B;13i/acHx8jCcQ7lt/QoN5/6rQ6yAPGU8EPgDCIFk/1sVcMLwiwY8kOjIeoEiv49znsGFgaLU&#x2B;tOShSe/BK/bwsABYE7azt7e3urr&#x2B;&#x2B;PGLt3744fz88vr6pk4Q3APqphptygdmCPH29jaU&#x2B;ugtgAbAQCz5/gHHAKNvUK1WK5VKEeyzvQ3&#x2B;sHf3/dLHb2y8cW3ljWubb17fvHN17c615TeuL9&#x2B;6svnxGyt3ri7duTZz68rKm9dX/vZvDhj9CZpRLpcPDg6AM1CDV50PP&#x2B;kJI9UteAUgHo/HzjmAA35pKEfIAaaHNNGGodf5REZbIuwIDIGvBWGU4XCY53kURXGcqKymvYuiCOInSTIYDFSL0TdJv9/P6ChwZhZVwADTkM0BnWbAkrkIQBAE2ElE2T3OVEA5ZE8jMiJmgbDICKCHLOfjRTEQrWVZk1TgBcYylEnVXL0rUBhT7TMsEh69XCemONusGwZB0Ol0REssutXG8TmR8kdXIGAhWYJ4cYyBaSz0&#x2B;/2eEcQPjSJFmB7o1srlUbkfsJwvhqDnYgWqWOsw&#x2B;rQCC7XLvGvhb7fbVWdAPMED015vSIWPFQthYQFW7V2nHBgljwX6fSOC0sITpEUHMBiEoSr9BdfSfR8avjQF3LUL3WV7vvYE7R0MzDyE0LgFxBnEDPuTSaP24ydmGBgyqbeGxkWg07Ef1MErQqMwDF/LJsdaCYyOOfBrTO//2CQF4RtqTAFMxqm36gA4k98v1D5m5tdoMl10LMEPc4TGZmRYbiaI5ZSImM0yDZQeA&#x2B;Ha8aRsSXKd3KSRqmiNZZIkQXyKYFZmsDuOUCflmL&#x2B;eZYWiKWHGsEB8mjrxE3/YdKCKBuioHH2x1HynKdNUnOyqRvQSUe9oiU3ODgleF/rPjG0gYW5myoZGQrENyZWZomV6vnFczDnPaHhQ7dxWqZ1zSRxBKwImlDLkB8wExAaQtCj2xzGV91MZETQb4DBQ4CnMZIkGC2Sm8xAEga/0uyTLZCRwTsmnPHiI/mP5E5JkNBol7GwkfOScUgzJk7y/2GMURbJcc8vFoLSMAiR5f1GqB1PISCwh6Efuk/c2qJFFt0MUhZZjJN54UAwESM1cXq/8oc9Ygq6UCaRexpNl2StzgsEf0tQlxpMQKZcDAiTPKBM0ChAPmqUp3eJJQnb9UXmozC9T7yEn&#x2B;FrpC6rR1hIg266K5WoOWF1QjXH7svMC&#x2B;&#x2B;7v7x8fHwMEA&#x2B;iDJDQYHFSr1TSmtzGZy4njQTSQjvCQ6UDiFcgAxRPsHf&#x2B;sMWtIeUHwKkhTpO2oJYJTQw9BV0bdkgPOFEO1XmAdbymdE90AgfKNjdL8/PKzp7OPHr3Y3Cxvb&#x2B;9MJS/hUJUBqhI&#x2B;RP/A9xIOWW2PNQdvb29jYRwGaAAaC4ecBba/v7/z6OHqJ2&#x2B;v3rm2dvvKyu2rEPws3r46d/Py8hvXl25eXrp5eeXW5a2v//n&#x2B;1hZYBDa&#x2B;sbGBJkC/37fAOqEQXyXnIZ2mSZKojEcgMnDUtKBiKiRB3BwDOelXAH9vlkvoe3s4HGK&#x2B;b0SZO4BCTtUQtgAkGjJwE1Qh5mNAh6tq/4EJR0/YYWBtLBsyq1RFfUGlkFoa8BlV91U&#x2B;D0iTVEZVI0UQR9KmgOodAXSVORMOSbW4vNvtBZPJ8aGRBul&#x2B;6WgTDmSNGdQD1Uef0ZmhUV8IogmkDpnwA7RtEeTA2E&#x2B;xWSXVCPd7kEcyIBantwT6heb1aQmCAFp5rNXpdFTdt5A9CAp3rHA2mAA&#x2B;Fajfw9QuSC28DiDu4bghA1gX56XGVECFz4CtgIIVGPaCnQ5NYX7AeNC&#x2B;sQTIbaxjEBAXV/mRT7RNSyGGZD7iD33ql3RI9ubqhloWZAnqFGEQLrf8LZjs8NhyfmhSm&#x2B;wHLKIJODDNioAdxeEks1W3KmIQk8jwa6mZ/zUeodTtR4GqCYBCPp8XoHxMZX9mZgjoiUrm&#x2B;eRDdWg81CXAF9WY40W0sEfe5ADIMp8yIaQG2o7ZuEiNnwFwJzOOZJVpbc1euHZsxiJmjCcS6NFZm/2mU4V5r74g1M6NCCpnfJB254GvS5xDTL7nJNpsQrtnYsROUJvICIFvWP1zAoibrBhdt4TFEkFVwGIJvuM4ltQEm8WXO2AuVOz6gYnYts6yjEXrVLRnyNJOTD8KB0t5PKpKc5ZlEI3AAZwUAwcinRe&#x2B;oLU7/M4J5urH1bPB2Hu/MlM4z6lSRVsjQ64lGwtxrHVjngiEsw5dBUezskrjKsPTwpFgLIBjT9&#x2B;rlGJle&#x2B;c8eGzQuHiJzgHgY&#x2B;Zn4zCyTAwQt9Xjezp6UxIG/5kXw9TPdvExsLI35zI/&#x2B;SvLYIXH0SroE3Oj&#x2B;eHJfTuroDdJ4j2IoK9F&#x2B;yvPsuyjNAdgPB4LN9tKvArtQNI1RlKq0o8ati3kYzuq04sk1Jm6A&#x2B;VPg0k&#x2B;4hXA1upCNBjPb5mG1Qupmo5tvtqC2N/fF&#x2B;IHYVBDAJi&#x2B;YUaYSUHUbrfr9bqV/tfobBarwUYaZgawwL06EijYgyegQt&#x2B;gZQK&#x2B;2&#x2B;3tndXVjXffuffB&#x2B;w8XF1erVZ/nA9CPJ0DzsgfggXI7iAG2DCgPhgCHALaAZJ7Dw8NSqYTOgJ/2xQHAiAStVCoHBwdoCOwuLq7/8i8s37m6/ub1pVuX1&#x2B;5cW7tzbfnWlcWbl3zszydvL339a5X1NeUIwf6rmQMWDYR0AvQZ25d4L6&#x2B;PmxSCl0oBX3Sqv1rmoG9dFaTTNFWhPWVqguUewyAYBgHK9lEUAWjGZgAtQFVoNP363giNkj6clB7pvIYsgQ8Ggzj2gUKBEfCEVNKzqOQphGP3YGCmrgp44dicmZoc&#x2B;BhEBwiO64An6FQAe6keb7cTcibUxcWFyvZ2XwEL0gJwAn/SjQijW1uqdjSFLAVhCbWLor40Lfo/XtG7tggN2Crp/BTqFYpV/V64XBV0C9Y7nY422O/3u93excUFjtPqc3S&#x2B;Wr3T6QxY2sc1EdruDwZ4RVAbLKLb7egKBBT5WPew5QMDdiFU/g/YIRGxEVDWedm&#x2B;AZa0ZEB/QfZ26KGt2U3h/7ry9g7qZoVmNjBWjGgJ0McgMB0Ae/df7Q&#x2B;IyQxIQgLT61DvaGg0Ztrs0Ni7Lc3QW7gCkVEH4W/8NZX5x7TbjpnGg&#x2B;I6C43ZaERhD&#x2B;3CFtw7I1pI0xQLY5vYeJqmY6O8B&#x2B;qXIXjs5w2PLXNImYqTe4&#x2B;B0fdTJI0VczMPC&#x2B;E2Kk6PzEAAIX5DV3IJmXSmqZFCZa/E8qR&#x2B;ptJYJyKMxXW9GVeTCoBwccqC5KIKOfsGArsCvjn5iXNuzAUMvk8Qq69KD&#x2B;5AJt1o5v0DI052xIGpxCtqYYmB4F3ExkLKZH2ganwX6zhxu4Mg8EokU49P6VhA3yAtmglxzMQJ/5OQZb5BgRG/I14o56CrSSl8TxVdF8cgCZn5nKC47mhjALZNvRjdWw6SJI6jMApDfKggSUrYdlDlTAZxlO1xMMC7aJqo3eycG2NaM4lBwgxvKJGcdxTIPxdnxtqbT6TKutQlI9la0hQdJIBv7BC3NqSJGeaElEjd0kg1AXTwZHo&#x2B;SgiqoZTvZoV/HdAhSikTStM0S500RRnN6z4bFIleJADgOlw40Z/MR&#x2B;UBfN9sNhE9Ka9t3fhcJfuRTkYAHeIZlMAh15EuSPocVdyxvM2lUU9AXKLdbh8fH5&#x2B;enlrdv8y7YinAsqAciv7EAUxZDlA7b5gkooYJI2qaScbWIizJkKwIeG51QYcMRQVkV9neJofKClyv1cvl7XsfPn7/vYezs4vr65sNDiaTMQBnp1WArUG3sJjE/TATS8ov1&#x2B;/W1hZg/QGHi6Far6YBMvu3tragEcJGdnd3t0ul7X/8&#x2B;6U3byzcvLx8&#x2B;&#x2B;ramzdW37yxdPvq2hvXVz55Z/23P1P6wfcrm5vVanV3Z2e/VGqQZuzs7OD/w8khRCoJ68cbhWQHVQ9LrZ1OR8gbv/e2qg1oC5iLDTrngOdUDwa&#x2B;R5u0x2CWXq&#x2B;XmORNUYiEA8UcBTABI/CBp1lkSVVz7VOOEptxZtipkAdwZJqmOGVh4tAYTwOTPa8aqmBWSDXO4JXQHsLfQnAClCMVhC6OoM/QKKrtA2hJgFViiT7F2Ypy0mXsUwBjMeirFd8u0XZI06pgqF1MG9GLAyPLsexFiNyiUk9XTLG8T5sv6u6DSZGP7qCeWCze7Xa7Xd9D6HQ6eMuepmVEU7vDTR8Oh&#x2B;ASVnfU4wJiTRag4wnIg30Xq&#x2B;BF&#x2B;9mYgv4DU54XZLdw2a4ecJiATlmXcQpGW/Jgj1N3barePzRzxLSYEL9ow5AhqoHpA9jPg209BYwh6hujsHC//XOwf1b6jA2Y&#x2B;KS/Cyyu1V8Tzp3Q2FAOJLicpumIPYGEmR4kBr6Eb7cg4IhX4jgeM7Qnp5U2MyEzqUkTGrNIL0TOYmJh4S2KndTNa&#x2B;FcHgPG9lOu7yeJFKSCJ&#x2B;6PBNxDU8OIiMfjUWJmbGUmAVMmXUc9jA5DkLrAXhx6lZmY/7RwD&#x2B;cJ80DVTEBjJCWLkOYqMTNxU19lL1zII456xVkQ4HktDZX0MqSmanqmFH7wahMRkrapIaBCckpnGO6y1Pwxl1S9xxIG1OmL2M3UdwBy42P2UhNvXPZ6HlzJMAw86rVDssxMMXCDUZ4zhsfHOAAc515SlXjBOt1pIfvFIJwxqVGapkkSY1iBr3z72j/ksIks6RnTfgCBE8b1oMzPe&#x2B;GNGWA7uiM5Y2RjJP35H2kQthgfxZyJTHzXfwz8dpNE9MM7pAn3wYX8cAA6WHA1ADQy38Rwqbdk&#x2B;AEIozxzBY9iGlKhSqL7mZIqka4sLQzEWerGDP/9SDwkgq9NTp6qMZsfbwlS101cj3Q1B5zSher&#x2B;oZkUZlVA6BWoZq8avAQ5SPnEKwLlmgZg6&#x2B;6o69ugT9ASFftrZlaABDmq62N1UJ1Go9Fut2uTA4wViqqLgFo&#x2B;wD1eFArXpauZOFRK/KtbW&#x2B;Xnz2ffefveg/tPFxdXdnf3tGXpebRZKyuSuEhaf8zzwisgG5YS4PD29/fL5bJUQFtU7GAjmCWsCV9YHcFBlfm59b/82vrPfHLh1pWV21eX3ri&#x2B;9qk3Nv/wv6z80/8sz81WtrZ2yuXSixeb3/rHlT/43a27H4BF4FGtVodG7iIMCmAtHCDZLjQS&#x2B;NoxdW4faCP5BCDdxcUFYEGSJH1Sgph2Am3WmSzOIYf4CnkHTNFxzgUcD5QwD0fPcZwJ5wpBRhLSMKaqrX3R1rnjGAIkr3fqm4K3ME1E0T&#x2B;Ll0NhYrupgLJvqqQmIhQFpNTf8AcWRRA/hIxDsZhei6G4rn8K5QPPAUyrAm2ry0MjCLFI2mpysEHgY9y4odHw2EuB7diie5/VcaF5IVp7eNopgDtesShW&#x2B;BVnoY8QTk2gFnvps9GB5f3x9Hr9fv/i4gKXIjD&#x2B;YBEJbVBHqMYC/i&#x2B;gL4hvt3BxcYEFLNAfmkq8var2akwh/iHbCL1Jn0DftFb6k34D3cFupwMO059s2lgaYO&#x2B;&#x2B;XrfY3W5fCwdGsTMYDBQYGpjeUWAaCz06JUIzBiEwLnD93dknwXTbwZMK/e2HFLy9lrGoP&#x2B;IvtArkY9MTsMRAQH9M3C9Nf2q0PcD0I/qJc6uBAdQej&#x2B;ExJT7PtDuCWj7n8qpSq9QtliIUntAWKYZgKYRQsoXgMY2bjsgs4x5zM0kgYR5/wUMmTQWOM7ws&#x2B;venz21yhCoz8pkpiZOyboEC3JvCubaJBUKm44uMiYok1OX7XoCQe5I4Qn9fJs/SlEMWWYT2R6jZZMLoKbNuUoVUOpejIE0dCOCyo85Ev2pqEXlWk3q3K3aaePtBRp4AxVExoNcR4Ko/kBL4qtIsBoVDjeM4orE4ZWcDPBAFdUdhjLorgNdRGCL0JonjKAo9WXKFICchMUuJoZ2PEpKCC62PWNoq560IEuIDsUdQN2FdR&#x2B;9synEWfDA4lSlDqXOOA9Ryya5cEkWRL9JnaKqktFwnvBR&#x2B;GkYcRfLpelLh74sq&#x2B;r4t4688PxiO48BgTcadRZqQ2gtOqU2eRX&#x2B;UHoChqDQfmoFfQKKA1PK/yjCgmjoK8JL4oxivJ3iuwVuS90jrD6yPrdVMtKVVE&#x2B;G5gj4BneUPls6&#x2B;zqh&#x2B;4GAZfxuTLmcZEqwFuW6m7VodlDiPaE&#x2B;NwUfiNtJQ2XzPer2&#x2B;v3&#x2B;wsLB89&#x2B;6je/ceLS2u7u56tiBxv4RG1kexu7urBFW1StB7QY1f&#x2B;aEaPoBlrHwIE75Q41dfAomfivavmDFekPRUKpWdzc3tB/dXvvmNzb/7281//W758aPK4sLW5mZ1dXXzrR&#x2B;s/8l/W/7ZT61&#x2B;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&#x2B;7LIfpTnI69viYXIBfTFCnIOP7aHrSdyFOgwUEoXnAU21SBgaNaTwgng8afOVEjaM4G8MDaY3EzOeAI2ZfwrdPCC0WIMjihTjQK7C&#x2B;pbvE4my7KY0wBCRjEEPlai0Eq5JAnNfHUoVbBiSr1&#x2B;GIZAqzjmKAplg&#x2B;UBJP4BtbpvgzjM8dXZxTF1&#x2B;QTQGWvVjg0Z0QCvgQENQHk&#x2B;LbwO0L3EPo0uFt&#x2B;D9dZeMRHLKCxkWnEcCTHr/jpOPfNciAX&#x2B;LE3jKPQTx5Jk5FsEaerTQv34sIwTeXXYOAx5hlOyIwB6bGqU53EcZamfaObtyPi7IFlKvZXf3xEyKOM6KPQ&#x2B;cRFGxZELmTKF8o&#x2B;S/mc8HkvrAqApLI78HIHUukkEshwAdW6gZDAEFfVhrq0zpF8aoaOjo3a73TD5nvLmwhJQr9dPTk7smDDRCRXv5R/AMVgbMfA64j61GFC7JSqHJk2oyaAhnaO8BPI3aw6XiAFOU8hb6vxSqfzkyczbb3344sVcuexhd6PRQPVduZ&#x2B;C78rltHaLQyarSuqjgQDK/lcEJ&#x2B;iBZgXgeFT7x/KyB8AVIHMw2AJwfLVaXV9f31hf3y6XDw8O1peXd58/W/ubv1r&#x2B;zK&#x2B;tfPL2yhvXl25dXrl9dfXTb1aeP5OgCCfYN01/aPoHZvCT6osDJq50uz2h9h7ngg3Z6x8ycx3fVKjKA/2oOaAy5GBycpOCaLDlKIoAYcEH0JQQHpUMEl9nwkmS64AkXFxcYPux5zNFRo24igqWtkDusb6JQRSileRGLwZBaBEkdiocLPAtdB6GYRAUwfmBmYo1MIqOnhlVi23iKg1eefSpzu9RqSI8qvqxwCuWB4AWfLQl9sEr1etez0NVlcZVPvd3xGB6y38EnfXEwmVJ&#x2B;W0hHKygZyQ3FxcXr&#x2B;J1nbI2i4q4Svu2wyCorSW1U0tC7L7Ec87Pz9UZsBdZ&#x2B;x0YzjZ15XuvtEHsXbYtEX8ipiejtWwbRDdRiNwSWt2RqXs9MKV6/A0GRrczNM2r/mQ/QZ&#x2B;HgE7xnqFV9gDwJKCvWstbOq0/MRxnZGJ/JPgJgiBiRFgcx2EQvCYQL1g2ZrV&#x2B;xMQbAVPAZ2qBRuMx4bkB31mWKbLHQvOxaQJkHhzkti2QejNAoe9PqQuykBobdEZK5O0EPAWPZXleU6g9YeRRavoAcgDniCzMC0bkkRMjjHIzwGtCR2RqzDiELCtaEwXrYEkYuFxcK2eQiijTmDxH6M05N4aZgXcqK9AnHyYoU5QAcnBs14dj2mo3q9eOZtaIwyZ50RLUvx1Hg2mxkD42UYIoDKzxNCWgjKMojn3AQkYLMivEjP831AK7Rv5MKpTPnkYYBLhZcimYC&#x2B;ARvFoZsU&#x2B;9iFm8d4oohRcZRgJwj4hoO4pCiHZckkRhGMdRTre3c55gENAnomIxFTgSwERh6PtLcoPEUTqZ8uR8AyR2zo1GuWaExXTd6RLRxMwZwLQZeOrifNNG19AliSA4/jCsiN/fdBoD0BAQi8g4RVjszpN/EoOMJCHz4UU&#x2B;g0hWZjxBW&#x2B;PHhuX/XQ/haRlq5Xatm&#x2B;m/wv3qEigOX2mYwNlA&#x2B;Q3G8rTbbSBpwHS9JTCNeNDG5LAw1OOtXRieV1kLDjhmGNGiDTPwS5L9&#x2B;mR&#x2B;ERZomGAfYOK6if5smGDQOqcH1MwUYUF/7AvYF5qmcnl7aXHt3XfvP3r0fG1tY2dnpz45Lwy4/JCTBIDva7Ua6vSopqvNgnjNKem/qIIwPYjEPqcCK6doe3sbBEDyoUqlArE&#x2B;pETgAHiCXZdKJRiCK&#x2B;Xy3srK2r/&#x2B;y9p/&#x2B;b21n/nk8hvX529dmb91Zf7m5ZVbl5dvXVn99MdLz59hF3AU1Gq1hOkxAaX/wAcD08oXsB4yBEalYvx4n5yc9E08fELvL&#x2B;CydQcOh0Pkhar2GTBAPWA8jnYNnD1gJjo2cnp6im9pQRO8CKqAdsGAlWlbiXzlMIp9id4ERn4dx7FQ8pChOqAWfZOEKGQsbBROmiNtrd2CJKB57GJAy&#x2B;n5&#x2B;fnAqGukYBlODmnyqPSV7HzgReLUCWcttiPdiFoW9sgFziy7mMKpAq9CulYzc3FxAYjZ7XbPz88tLBZ6thxAF0E1dTyRRv9/V93XkUyufqFLLaCvV7DM&#x2B;fm5aID4A6C/yEC32&#x2B;36kyqq/jpUHYwp7fctdbHnKLIhyqRrYv9vL684sL1oQ3YJ1DEYGmGPbpYh0tMqnV7PXz1b49enXZsVf7DMfzAoeAJ225&#x2B;UbE19sAsF0aT7XO75PpsSalC8SjzQLnhNIFWV&#x2B;zzPx6OJUn2WZkWN30N5X9KzaNtCbREAVcQzo&#x2B;&#x2B;fSgrKKfXxxX7W6WOGERVLThyDty8DsYghjEY&#x2B;vMhJfpPneQ5eMeFaHjM&#x2B;SP0BT1cMeAXQsVxIq3gJkEJ&#x2B;WHH3tASg3zF&#x2B;kbxFwCszyBWwKxUmU6YnwaUm4wJKGixYRDZNoGemhapIzvKtywxczvN8TJLjGJmccl0A2SAI8E&#x2B;kkfrKUJIAHPOMEvwsJexdSB9FfTlOtiAtQLH&#x2B;UnBOe0a1iSvMakkUhRmbD9iFtqx2hBAwCvPD4VB3MCU8jeModS70p4OxVmnEkWFZ6svzOXNFkyTOszRjVFFKRZl2F3EyccSkalXNdR3iKMrS1Hqa0QFImByFVP48916LiBnb8g9QKJWmXi3mh3nltGfofo1HuW66wwBmm8qXpXEUpc6h1aLrgyN01FM5djlSb1couiVZmiIfydGhnnqribcag8UK/TvfN3BxHI8&#x2B;Uk0Azd6yiToqb9vJXIDmSt4E1rScQaC/bpI0AdalmUH1/eTkBKV6oH80ByA3sm0BK7/R4cm5i/3Wme2jVkOj0Tg&#x2B;Pta7iu2HtAabxXFO5fTjgQMD4pdSCBfE8hZsoVqtbm/vzM4uPHny4vHj5yvLa7u7ewLoGrwliZGlUsjsB/RvmKnA8hbrsAHTVcIH69jnxGJYCEAGUP4HjodeCEn/lUpla2sLz0EYyuUyojwxOAyG493d3b1SaeOfv7X&#x2B;m7&#x2B;6eufa4q3Ly3euLty8vHL7ysrtq/M3Xl&#x2B;4cWnuxqX1X/yZnaXFnZ2dUqmkoCFfw&#x2B;t7G65z7uzszKI6gBIBoyFDJ4EkoJPpm&#x2B;TB0FhIhZAEXgVZAoa3ALD2XxHNA/sOqWwBHAeEtVVDIGw5fYE&#x2B;VdPtE9GGTIjHAYRheHZ2BpBqYdaATQnBL521RfkiEn1K0kFROp0OqEiv18OR2dqzUCCuuaTkXVbfceVFGHBswpoWvveMgnxoJCtTgLLX63UNZOybmr3F&#x2B;trL&#x2B;Tl7F37VnqC86t9dltWBbofsHeEsAPototUq&#x2B;kRZlI8X8X8ccOfiotPp4O7o9YuLC5y7ML24k/6P47Rr6Yr12GfAifSNIOri4qLL48E/7emo9i/sDk6gwxA9ENHCbdU/9WkR2cBZC38PTKFdCw9M02YKqevG2Z3arVnaJi4xGBTi/p4RDglw44Lo71SfbbWtbM/B4ntBfB0PuluRmf&#x2B;lZUT4LXnQHz7&#x2B;6oPJsXGvpZTnpqkHxGMm8atyn5oqvmBxbjJ8BNMFlAVh8Y7zkgD/&#x2B;ng8dsznyQqvcKE7GhsbgDbIUmvRLhBqEQkZ&#x2B;RDMQmwzfiWrlATA5/CMfVYpyvkTM4B1Cqqmj0Z55oVJeT5twy2GQJkadtF8gO7cNh&#x2B;yH&#x2B;UG1r60Ka&#x2B;69sXiJGGQvCrBgtESsWi2lxfVIMBHKJz4HsVpeZe1qYgxc7Eds8UHCIlMwwn1/ZK1EDH7BEzUy3NSF3wOPMRkwd4xWSilbN0W8mEGSDgGElsd0XYsHy12lhiHdMwIPDoI/OVShqmjsyLVPDIsk8QYJOx8MGgM43LqXBAMYZ/N/NwrzBhORqM8ZqZqFPkZMLYRoXub&#x2B;kZERKlSGkfRSAZfZnj7crxxOKS09Dn7SJIxk51S&#x2B;SLoRUZ8kCcezicm4d04jhH9qQ8SPgLwJ2Re0Z&#x2B;kyDiKY5x7psRVEo9U4jEypdTrlyL8leHC/hiA/L/3cXJyItCp6nLTBPwDlWqc1lQ8jggDoDmQN&#x2B;rcgvgyBkjhI1WP3AVC2w3OBobDVfsFEFevABtvmqBP2wGoc3yvxEjagp1NJquAiIRowCFT/JW1L5GSD9/cq64srz58&#x2B;Ozu3YeLi6ul0pYaDlLy4LxwSaXe0WYB0DHG65DTiOW&#x2B;gJ5HY33xfyyMVoBGtuldvI7NwisMaA6lEKI/9/b20BmQGUADBHZ2dqrr66t/9fW5N2/O3bwMK/DC7atrb1xfvHFp&#x2B;fbV&#x2B;ZuX529dWf&#x2B;ln1v&#x2B;6n/fWVsrl8vQ/2xsbDQaDYFRq6cXgIO4pUc5QRAEZ2dngAsshQ4Bvnu9HmT92BToAZoAFnIJfeoJsJStputIhHI8ZhoOgyBAjVmYVVXPbrd7dnbW6/XOzs6iKIKWQ0BtYKyuQPkdyvEBtYWcVJKfQtVSQHUZtakqZo/G0&#x2B;FwqAKzgPJwODw5OcGLp6enurZnZ2c47DAMBXMHNKEKUekiDFjDliZEEpqeqYgPjOKlz56A&#x2B;IOq4P1&#x2B;//z8HDhbGL1n9CdDRuVYuIxjwwYBysUPDUTuiVn12azgFjpaHstgIzgXLIm9XFxcTF1JsQUcP5ZRSR5nCsx&#x2B;fnam0xSyt1xL5ERv4QBwMDiSrmlWgJD0TIOioCs8NdwRQX9LXcRYRCHsX8QUYRO76zAFtUcpv47nVTqtWzYwXSb7EcIuLNy3Hy1fBTCJsWILXTb6hib8p2cmG4gM2D9qbaHPaCn9MzBeF4kGw0k/AMg8lnktZ2E&#x2B;5USwMYv0gNRjYnT8NNoKugiAquPOTOMCpECvIKNghpmbvkg/NmV1ZwbZClJbrD&#x2B;mHCg3ah9nZng5L6qZ0M8IxxORJ6OJNNKipSAqkhVW3cJUmjC40z4E0wuQ7blQKnyZSoHtTZVpFIaj0SiOE7AICXIKNzCdl2QmPuDSGY2QM2p7saDUa&#x2B;Uj4vXCC6HrlmNSLIGmM8qftMh0L/JGAeIzM9NARM4TDx6tK3RZHsgmPtsnAyTFBZhS&#x2B;0hwYucQh0GAzSh1J4pCiOnFRpxzQRCkzB3KsywIguFgkMRx4icYJHgdwB019agA4l7NLwlNodJxCYbpAn/7lgvF7iQ8WV5k9XiSIKdsHEf&#x2B;IpgBDo7x/yNmhtJvHDqN3WXikOPcYh1eHPsJx9T74zOQetl9kozyQoc/yrPxeOR9C/4ANOMsHo1GsjrALYAmg7hlzvBTdSEox8JnKR2PvGhtRHyPj3vOfpDMCSCcHy0CcH5&#x2B;Dsza4OirOj2ysuTKBwwpvKJ&#x2B;6gz2ARlQ3r&#x2B;kO0DAwu54yxba7R7lDFZmqIr6egsUQn5cHYA8u3UzcQz9BDUZrCHB0gZ0HurGQ1ytVhXRI90Rzbj729u7c7OL9&#x2B;89efL45draBgC0&#x2B;iSHZuyuKvoA4tIXgZxYBA/srj4AGgigB5rYhT4A4D7OVOMCgOzVQwCsL5fLeBGFf6D8jY0NbEGjgmEb2N3d3d3YWP8ff7X25o3VN66v37m2cvvK6u0ra29cn7vx&#x2B;tLtq&#x2B;uffnP9t35z4xv/Y&#x2B;fF891KZbtS0erlcrlWqylbXb/Zg8EA2EuI/OzsTCgNIBXlPZIEX54HRBCIPDo66nQ66A8IcAseTZUDBVUFYVEOxz8FoIHMgF8FFgVigBqF2qfqnYKJtt7cN5Xp/qQgGyBMEgVcKFwBwf3hcHh6empF6iBCAlsBh&#x2B;wKkmI7YFlCnFhGCA/XFm9p74CzuDVA3tojjufs7EwVbnEJwWhdup7nThPkwcLijpH0AMELqQuwaoMdk9av6yOIjM9Sh6L8Dh9YV2chItE1Uhx1SLSK7Upd8IEPJ47QwnHbcFA/oUfiqr3onzp3SYN0xy3t6RjJlmU4U1fSMoS&#x2B;4QmdTsHB9Mmf&#x2B;uzh1ghJD4xSS6cmtK3Ptv4cepMNAd0yyz0GRvFl20Ei3rbV0DMSf/012T9bxQDIWtBhDFffR4JOjDMTpbGUwPoHAjOc7rUxdTVGMuEhXW6cAGMz0ktwHz&#x2B;WhWhnUvKeUdgzJm0QkdCmBM0tthYKNz0EzzeSyaHFQMCFhp6dCs8lssw2EFJjFAZy1V4A3JGe6bfPaQOqLmecsao9CoU7MxIhNQ/tBZfHYnGxHa2uErv6DLkR4id04k79E/zBekBTummFOwn7PKzPOfsd6D8zc3P99SS/Al53RiaeEWpjg6jZO1NfR51Ye5EeBSr2KXaBEjskKKIiOqQCfWZZFIWOQfh4TkuxB9NhGHjLL8viYRhkWeYHBWR&#x2B;pJdLEozicvL4ehaRes1MAfd9URyWgziKFPeT52ARTmyEJXmM5fJNGHEbtTIy39xwjpp7jEBWP8HvIYlhmYDJ2HE0mHMuxS44RieOopgNgZx&#x2B;cAn0pc/BJ0NSnzjyMh4QS8dJFM45WIGdo1U6yxL6uSGOUqxsRnqWcaY1jTQJOYjve7BR8FGyAZyfnwt2H5oBWBKpC2QLeduSP0RBrR81rFcy&#x2B;jqThbARbUHgXuV8q7exeaC2MyDpzlTqvyUDdVqWdczS4h8yzt8Kk3AAwvpWCgUgfnBwsLdXXVpcffedB48fv1hYWAYoV7UeKB9PGo3Gzs4OLL&#x2B;gTIccFACALm4AxQ50Plgdu8PWENQDOgG0LZ5Qq9XwFoiBhnNB5a&#x2B;5ARrZCzESqMLm5iYAP7asgcE7P/jeyk99YvX2lYU711ZuX126c23l9tWVO9dWf/6n1r/y5b2HDzZnZ3d3diqVSqlU0n43Nze3t7dbrZYAgWQDPepzVLME4B4Oh&#x2B;12WzBaVXPBviHnZHUoaIEoH9gOxW8LGgSk8C6AIIDRlPTi5OSkY/ClKTZPyFH6RhHeN1mQAmRWueGPnMAO4ENlZnsk2iz6DygG23K1BXxAjWdnZ1isz8FY&#x2B;Ke6K6A3wPuA&#x2B;2dnZ5APab9d81DBW6C5y6K&#x2B;MKhAvEW6lnWI/FiYblexwBqnM2C4p8XT/X4fq07V7HWEOEi9K4oiGtPtdlRr12FcXHiuonK7Lq9aFh02B/Tu6empCAM2eHF&#x2B;rnvqXyGUF52wx4y7oJbFFB3ShQIRmqIoWMuSE60l9NzpdvQpmriznY5eEZ6291GE8NXnHTJGVfpFQQX9LTEbGNdyb1KYZJcB&#x2B;O6aWW8q7feNWknbl7Cnzw6h4P7ADK0bFLPDizELIeO/FKjFAkHhaR4Oh6&#x2B;NOdJrPB6PzExZQbFscixXSi0NfimBwDKi/MyMZBqbdkFWKG183iiAmmiGELz9Zy63gBn&#x2B;hSgb7DQ3MiSB4zRNpc/J2cpQDTJN01Gej80kgamd2np5nufj0Wg0yh219bmZAayeQHHikxOCMx6Ycy5Ni&#x2B;zOzMPAggwI&#x2B;6oEO&#x2B;L8L3QAnFkeJW1ffc9IQgiX0zQTfpXTlLDN5RTie1BIPb34CQ4YsBYnhZK5wqRTZjtOVpGdgDvEOZbnRHTBAlni1MR5Ykr5gU2hUxfPwTapn3HiDxnnD/gryTI8uJy2CfSJXpij5MmH5VPeg&#x2B;J3zMm&#x2B;6DaoR6HYzcRPOwYNSyFDypUS65U/EcreQPHcSGx5AuYJpGkhc0qZrEoW4e&#x2B;1Nzl4OkHFlIPZOqQE3yuRis&#x2B;Pn73gP0u8lRyEnPjonpTiIlbu8TFL/JLGewAegs&#x2B;Y5FJaJct8kpLOKOEYB1oDYucSKAw/Ko&#x2B;TkxMBd8XqNxoNyG/qJt7eSm6ajN4/ZJS&#x2B;ILiUP8rVkS7IpnlKrtPkNAAJ9LWLQz4k/lH9HnuRdgivyJ6rUCD1CnBG6AOggq740boJEpVGqE5ncLW6v7y8&#x2B;vjxy0ePnr94PlepbNdqdbU4NBmtxgkA4BVySgjrC&#x2B;Kj9o&#x2B;rClyuZXCEkAmBRYgnALsjqAcFfjQQ1DFQmA9UQKjNb25uQmsEn4CCgxQWVDCHhYX1z/3G4s3Li3euvbxxafn21aWf&#x2B;/T8535j7X/9U&#x2B;XF862NDZT8oUqqlMvblQr4xsbGxs7OTrPZlCSgS6EFqnEnJyeoIg&#x2B;N91G4s9lsovLaYyVY8BeKF0lrBJIE5QUihcNUDj8ndAMgxrvtkxNArtPTU1smxysXRjKuAxZIspXprtHzAGX2J4UftohegEWjdcGZ4tgkLxHutFhQG9ETi6RVriYW7Nlqt9AqUC9QkdDnFAosoCfpk65kx5SEBWpFk16lCuJIOsjeZP3bVtyn/onVp04WLKhjavk6Kn0wLCs4Pz/vdjoXkxcQ7&#x2B;qKqe1gD1ViKt1HrSLOYBG83Y4lLfosWeqiA&#x2B;5SuKULJQGV7uzFxUWvN5FupAXwZGAymromFkkL9PkYGC94t9vt0EysD7CW0U3sGw2SLf8PaCPBrembFgFgvjZruw3C7uIneihKSz3D3qSsv9fTjAs/9WLIKRavPAZqGuDTLns62MJrY2r9BabHRgyT2vG3k5r4MZVC4/FYpWUrxLeCfunF1RbIWJ7PzXBfVY7Hpi&#x2B;h7aB6L8hebIcHKdSYU8CDs5uC5lM9B7sjdQxyE81JBU4qDsDFUr0&#x2B;oqDIFXOmXCGYIeATB0jNhFTvnswyGQMy&#x2B;Wo5YAtrxXGc59lolBt6AJTlKLjyEaKiKJZj4OClgfEAmnIdH6YEaqQAnyxT&#x2B;TybvALOdD9sb8GD70LT4gidizgjIGOQCj8Mi3V3Xz5PYo0gIF3yMxZi5tyLRCWExSjrx/QQC4xCkwNxEe5UIizr3RGYEOwJSUpzMFKGsGUsFoZhyueuULoXPoQoiuDrzbIMMv8s9b0a34pBBynLIMTK81yzBbCjnKSruBqcYYzPTcr81swnjYLkBLqbzrkkjrB&#x2B;zCvvkiSlLzkKQyB2jidzaeqg4/faJ5OBm2qaWhxzsRiqqrSYaJGRWrgoCtM0zf0IsDTLUjiDf2xw/t/&#x2B;QAcAiBNuVIVgCtru7e1BJyMDq1Xs4LkcAqIHwP2Q3wigA&#x2B;XbUQAC903jHrb/bDKnyGb/iyoAZ7fMgF6dDqC8fMwtPgDT6ybvX&#x2B;GhONlarVbdq25slJ48fvnh3UcPHz7b3t7dr07EdFpqIf4A&#x2B;iErBVQ6doIYUL7meUE7hE0pZlRUwQaGYi3cAkR/4lBR79dQXlAFdAw0OGwqclR&#x2B;gFKpBMNApVxe/&#x2B;53lm9fXb9zdf721fnbVze&#x2B;8Dtb77xVXllWiBA8xOXNja35&#x2B;dL9e9Wdnc3NTZiAt7a2ms1ml0ksR0dHU/48CW9Uv9fv9OnpaRAEwm0XFxfQvfTpgzw5OUEd9&#x2B;TkROAMxVpBRuG2zmSZVoD79PQUGxF87DGZ8eLi4uzsFFhNHAPcQ3VfgDbsVIXzzqRnFKeA/gOOB2c9Bd1wBbAdsA4djCjBmSkPC02en59jefElHYxK1x4oc13B7gujkBGGVtFaDMQSsL4RlGtrF0bTov3qyHGEXaPsn4K/PxIrW2phOYNuJe67pT0WZAv6i7T0er1z7lr7wgGI5uHJhWnO8JNQqICwhSniIdKCD4ylQ7hu2i/uhSU81Fx1tAVdW&#x2B;xFfxTdSWXUhZFp2YPpmaQdHYb9vPWNat&#x2B;C&#x2B;57xc19QHnZh1FMq8OtjoA6b&#x2B;g8yFHdZ5rd/8n1q57qG7ave3&#x2B;l0rFDQUhTs136B4PVgcqox8L4CAHpsNqrhAE4gJWGAGNDMJFEKcI&#x2B;NUEdYecSBX&#x2B;OJ0WBpkiRjQm37ljUJiDYAz9nNjr2AKNPygrwC7omKoGbdYjEMyuUsYZXwsX2Bch28WAQr5f6BBawp1ucb8qgg3pjaZkK9h92jIDuCUwABpfIXvMvV0GCCkJC9S5LRaKRz9PZWnLWxXuiyZNJxEU2iRM19eQVOHDNQyFTvgyAYccwwgHPKKWNeMeKSQkxFRUpE5EpaRczqVeBej&#x2B;ShJChBTHMt5w9QOOSVLYLv0kRlWRZFYTLpmXaa&#x2B;MuEyiSOAV5RofecJ011tXX6rN&#x2B;HjsX1mBPBsPpoNGKcpeYKJyI26g9IGcVGhHon/tpGUeSSOGMnQYwOm1XDQR8zeTZwlbIsizULmT4EnJePK8UM5sxPFsNZx3xLiiDIhMYjz3C8edoVw3pzz4Qz8Qpd5Dj2hgR2A5I4jkd5EQHkOKAAxniyR4enICf4/48R0P9bH&#x2B;12e6qQjwq9cLMiLxtmIICF&#x2B;xLeoMCPFxHDb00CeEV8oGWm/wLQNxgipCBRSGismB4bF0tpmOB/iJH2zRAxbcQie/UuwCtQGm8wBOng4GBrq7K4uHrv3uMP7z5aX9&#x2B;UaMdKg&#x2B;omVggHU&#x2B;UDdX0cBsaKAXljRzbmH0gdNXtojUS6kPMjfA8UDiMBsLs1/mLj2gUigOQAxiqyc8gfLJNxrVbb2dra/PKXlm9fmb1xae3OtaVf/vntx4&#x2B;2SpvVahVBn9W9vcr6WuXJ4/W//svF3/jljT/8LzulkkYHlMvlRqMBiAPUe9HpHB8f29LsBUX5wDreDEAUDrR0cnKCBYDPut3u8fGxtiCgj70MmFPZYYW7P2mRPD8/b7fbwNnCf0CT2KZYAZDZ6enp2ZnXhwwGg/NzDwf7g0Gv12u328L6PdbIhVPb7TZe6P4oTTme4MBwAAJ//X7/jDwEqwj&#x2B;Ck32&#x2B;32hSVtUFqTWiau8LaTbo&#x2B;bEHgk2ohPpG1/shdEFCZjqTPucS2Wp17lR4dvGC3YnGD11ABLn6F7o0yJeIaxvGx3ot2iz56&#x2B;U&#x2B;XUZlc5kP4QgZjqSC1Ppv5js3ogTXhS0p9Ptds/MHv1RcY&#x2B;dTueCK56fT3sDdF/svvAQ/xFxmoL1F6ax0zUq/PPz854RI1nCiceQ8VPiDML30nENzOji3uRDnATXXC8K0&#x2B;MV9coCM0Ogb1KzepOWAyF1GWP0sLhfL8ocHEwO4NN8QGsgDpiapRdxHV4D1rdNgLGZAwBYOfbL5AKyqqMLZ8dxPBqNgcIFwS2mF8S39GA8Hqt&#x2B;jPJ5asr22gigbRiGUlwUGzFtCjvoSsxBpXFV94GYM/OAKgZHMubEMWHflFV8FnGdjj/jeGBdK1xHkYopJqMtp0YyZC8mUKUU/NqIY3xkSjU/NR4ewGkLceRNpdhsGIYyqkKt4YzAJqUaBDGjuc/V8dfNUYGTFHGfLorC2E998vNiU1p1JbyJoghY3Jm5YziFMAySJEYrShTFyU5gXM7AxOgeiDN4nU8Yxt7m60c3pKzZi1mR53iJPKiCv8ZkfUmSZGxEGN6SRpEPHUKdPuHkL6h6vLxHo9DSFCV/RwUOnsO95xKMOIiYuhSmpA4qn8ORkHFgguPuqM6PMYoLDynvfZfARxXFqVN8Jy84/AD4zBjy44kBlxmNRt5GTOl/rsHAmAoMkQ8cwGwOJJQPZd4ZEns3MAdR4yBFHuI4&#x2B;jEC&#x2B;n/ro9vtAgEfMh3fFvgF31sc7CWIjxx9QXlAfBXv1QRQnGiz2ZTcyC4Aky74hjoGCgsCbRArsHIjmW7b7bZSiZoc6aVTEGSv1&#x2B;tA5Ohm6BhAIXZ2dleW1x89fHHv3tOFheVSqWwdEVix/sqQ4CYnoE3p&#x2B;&#x2B;kYrirzZ3t7G9uRkXef03yx8e3tbViHQVqsyEcjAsANUOb3nQpOBgArUKYnjmFrawv1fryIzH5BfwmBqqurK5/7jbmbl2evfWzh9tWNP/qvlY0NeBh2KpXSzMvVf/5W6Y//6/xPfWLxjetzNy&#x2B;vfemLe5WKlwNVKpVK5YTqmrOzcyB41INPTk5OT08FYYGNgGyEBU9PT4&#x2B;Pj4FFANm73S4K/8fHxwIuR0dHwqkW4WEXwHntdhvSINCP09NTvNJuty22BoXAMuhdoGyPY8YDSNHqwuFbEC5E&#x2B;wLHjyeAbjhrHI&#x2B;YDM5drGOq6KumwTn9tRa26qKpdSC8K5wtTG8rxF1CQ5EHy1vQ4tClU60XTEyVaR3AhZHBoNJ/cnJybuhcx/QrtCNdVS1jK&#x2B;u4eqqya3fAmdoduJAtqOuQcPziCfaiabF2u623VPu33AYvqkOihw4MN0iv42Ds&#x2B;dqbiEPSlceHodPpgBL8SAJwfn7e63UvqAWyZOacDZaO8TnoE9KjKQKrnJuWizoSeCIa8ypbEN&#x2B;zHneV3q0cyDIQ8yjmOYgeiCSIbOiQhsOBUgHEHCQlEri3Vf9C5QOIzyeQHtnU/wHdBV0TOYqNvCbX7FTo55hBnImfDzBSr0CynzHngKXsCYz5z0zR/karI6Nvzmlieebtg74ETgEPUDUWSY0BwJcqCZ3HzPvPTJ9B3lY8xqaVoQprnmUjmh&#x2B;cEb5b3kI06UdEScJhuiWcAPAKoBeKTdMUWK141&#x2B;fhjKQYkQXT0Yxh68oxc36oDsr8wCbGR0q74gvdztfaibkTXROB44QKGemFJhmIn5YVUwcPbVLMFE5sGbvO6KNQ7dxfJfoicFQ6gJzHbwrmCSQryBqyciDHmQZiJp6csJGSe79yKh2Rr6M7h3CbRCN&#x2B;xQeiKE3TMAig&#x2B;6fJ1Vf4wzAEw8GVBH8QSeCnJVOOfhgGuBdwBkPznrBRkFKhlNFN7rmZc6nz1tvEJwhF5K4KsTXKriyNwhBMA5c3ZmST5640DLB14AdT6CMnZimHbsZeE1T&#x2B;zuh5Yg5bwN&#x2B;acwksB4kyZ5E4xBaY9xKgYRCFniSnaZ4Xd&#x2B;qj5QE4PT21lX7hWsF0lfwtaLZJQRLEox6PVxB0AxSu5UUS2u22YHSDk4Mbk5N6sYDtBqiob7X&#x2B;U06Avb09tQiU6C/jgXbXpPHg4OBwY6P08uXCe&#x2B;89ePz4ealUrtXq6mbUOftMuB/r1iYHh0mLryfKTQIBUF1f5wKegBK&#x2B;UoZQp8dZ2KRObEGKIMD9fQ7/gihI4v7NzU1JhsAcUKSXBgn9BE0B297e3l1cXPmVX1y7c23&#x2B;5uWl21dXP/cbmy&#x2B;elxfmt&#x2B;7fW/7zry7/8s8vv3Ft6ebllTvX5m5eXr19deNP/2RrcxOb3d7eXl9fb7fbp6enrVarSznEycnJ8XH77Ozs6OhIkOjCCHJQmG&#x2B;32ygunp6e4poDzrbbbbACQChsRGi1Q0nM8fExABZAnrYsgA6sDyA4GAzABPAiMD0WFmo/OTnpXFy0j49R8j85OQF/0KY6nc7x8bFaFjjBc1Pm1y6E8/RPHB6OEHRCqh5VprFfUZFzymDs6tqXzgU4D4cn5iPIeG6q6SpC411sTVD4wpTndbWL8rYp84sGiBuoMfIqZzg3D/HDqXPEKzgXz5QI1gGzbfdA/OG8kEtdaLOWFE1xGMF3vW77Fbjd56ZhgruFAwMBa7fbZ6enJ&#x2B;22rgw&#x2B;BkDGlmDYw9BedE2EvLF8d9JmrYXFx4TmO5MPdicKWtgxvaALZZ4S1qvJILxulUIXVJdZXD40cyosxB8wgtMD/clIH9uCEILvMQhIe7duYPQQsBd5iBXmK4iv5FBYftVYiKOoR4&#x2B;BegV9Tgt&#x2B;DRjeVujh6xXy9iVwjnbCkglV5mOPVgtnsGMqv4WV2KwQ&#x2B;chMBEvN1N7xeOw1Cf54/Iu5KfNbeK2uBZF3MflLcJbhJM5uxPY6xHCcM6ZY43bQ7sR/JCdy9BkTNxvoz5KtgGlm/L5a3RdfTeOigMWGkAjHs/WRaRUto/qrR9uFvMTfLwi1dXgJi9DsD2S5X7fIy4edVAp&#x2B;&#x2B;W4hHM94bamB8ZBU&#x2B;DiO44jtiJQmVCcDLverhXVBdP1yP5c3cs5hLA6gOq&#x2B;uC1l9d1ws8TcxQbk9MTN0JeuHpihVvn7qSJAS9hwS5xy4nr8ajDkKgsCTLjIfuGPVWPBCncSnncpB6wpdk2ObKNVivKFesRNHkYI7/SfB0yzf94h8bydh6myaeJe2Q8cgZbsgjqIwDBw5nyRJPh2VYqpcnNYfrY8qSjVaLstAM5zM35A2xbFvSoQhyE/uA1KTOI7yLMXwtR8fnv83PwaDAcCoKtwAu5Lpy7mLxEyL1KUOUmfg&#x2B;PgY0M0G&#x2B;xwdHbXbbWxQoUBYAOhKiym6R&#x2B;5h7dFW3CHpUfG&#x2B;wckAOFpwD4F&#x2B;wX01N4C2d3f3nj6def/9B3fvPl5d3Tg4mBhOPJUFpH9KvyQXgWUIKvkD/VsDAIC7Zv1aUb5cv&#x2B;gMCPdjayjVyyEgyzI6BtqyMoXgS65UKnAGH5iJwjDsqlegMJ/N&#x2B;bnl3/zVzTevr9y6snr7yurHb67/1m&#x2B;ufPbX5z95Z/n2lbU7V5dvXV6&#x2B;fXXtjWvrd67O3by8/hd/Vt3dRQDo9vZ2qVTClQdCPT8/Pzo6AipCoR0A6Pj4GM&#x2B;BtrUkcBs&#x2B;NoTFngCoPwAMBErQbDaF58APUebHNvEcRwJh0vHxcZ/m116v12q1gNKw2Var1W63sRbuLA673&#x2B;&#x2B;DeHSoHQLCvri4QNkbq4iuYC1QBbzVarX0CjZyZiRMONN224N&#x2B;bAGAGMevSzSFnvE6WIHULOcsq6OFYrmHGhTC4hfsM6g0LhQuHnI&#x2B;WUrH7i7OCyQ9dWw6JIFsgXWxlwsjixIPsSREeFd7x3WzNXVbVtdD0B&#x2B;XTjzw7Ozs4mKiJaVNnRvhGVbUhcUylmtdmPaCOh7akRQ&#x2B;XXp8RZnEUi5e6aiIqepMsYtup4M5xGJrHRoDut3uxYUH912jbuoaF0rXWClU2hcl6HY7XW7t4uJiMCjEORcmdFU7RVvgwpgQbD/BVvr7E/GjE1Pk&#x2B;mZKgCiE5Qm2S9Dn&#x2B;AKL9YdmYoAefR8MGkompPBQnybE1sFgMAjD8LXcxPUkJmRTYH08HqOA7evirFKjqAnq4Iwg3tfXvdimwIg50zC15Cvl&#x2B;UIno92pL5ErpibzIT9jEgnh76K9wH5FRiG&#x2B;gLs9O6DSMUmLxdMqYeZeZaSESr9YUuBvoltiqZHpQqB27oy1F&#x2B;fi6JEV/DWUwXs30VHR8SRAbdR2Z5ROadcWiBeHyoHHic&#x2B;u8bGYAJOj0SgMQ4hPxItoDi6C/6HPEWKOMZqX2T5eB5Xn8h74ijJvSs4PSWrERfaW2QAcf0ldYeH1heUw9H7WOJZkiKV6uod9I4E9BH95/YywlJ4EkIowCGQhGHHSAiQrsgQoAQknlRGmi57FdOum1IklvE8pQ414lxPPL&#x2B;LYOReGAQYvOBEJGj8gmEFKqZfRxBFFVj45FDIqqZt0VJg/gBJ&#x2B;yosJd0TGUQCOQa4ZzQNgRKM8T&#x2B;QNoLAK9AZ/sVmqWcLecpAo&#x2B;BWzjdESSeFh8G0BP0s4jn8sUP7f9&#x2B;h2u3UOplUJHyBYVXwgYLwoXRC0N8riFBTGwkB71lTQ4oxesQX0Fo6PjwHllctZN9FDeADyapVDM9hLsp&#x2B;mGTRmj1MHj1bA7u7e4uLK/ftPP3j/0dLSarXqz7rBFCMV9VXsB1634F6leqwC1A6QXWfyaY1jBDS7V2aAra0t776tVBQzCj8AgD4W0wxjXArV7/EucjzlAZBbF1uWJwG7RmKPeAJ6CFtbW6VSqVKpVEqljT/9ytKdq3M3L2&#x2B;&#x2B;cW351pWlW1eWbl5avHl57tbV5dtXZm5cWrx1ZfH2lcVbVxZuX137&#x2B;tc2Nzaw/a2tra2tLWBlSLyg5oK3BDgbcFYQH2AFkjDc/YuLC&#x2B;BysMHz83Pwt7Ozs1ar1el0wb6wkfPzc2xTz/FEpXcBu1arhX/i2IDIhfaKkn&#x2B;noyZDp9MBX0VH4uLiotFocF/&#x2B;XAD71BYQfwD8xQLqZoD6ipaAzwihYhd4VwgVp4NLJ7yOtYSqBfgs9gX6xPEIDeOo9H/bTBAxuKAW65wNE&#x2B;FUi4YnQLMxeAhe4xVcGSwmJtOZFH3pxQvKotSE0fU5L/T053ouCoFz0aZEdc6NweOcbNO&#x2B;4nF2t6uDEfh&#x2B;lXGhT4VLfUZu1jG&#x2B;CHsBhcVVkj812rDOZDCRFjilc9oflemo9Hq9Dp&#x2B;fGTuyDs82ebqTBmvbHOgYK7av7kPMw9q5VEaq9E9hegvoEc7TmTQMvNoi6DFjdDA5R0/CHmxQuH84HNhRX5LuSMbTNQPpsCT2IptBx4wmsMYALODnAOBnr8DoJutG2FTIOeG8sGxS028r61mWcTbARCroiJN68zyHJnuyS5BlWZokTgtbvK5Dwo7GJA&#x2B;ZVEDmeFQX13EmSZJR7KRtZpTu2Dmsnoqgumwk7ELbo2LuQQadCQT6ebFVL9EBikIDRFeSmD61nYERA09zo3rSTkWifGck9VMRHPdiV9RmBfdJn1J0LxxtpgKsOHW1DrDumPIwHHhGS4P0OaGPu/FSHF/Ij0Inh64vvafy1yKYPzEEQIQKVxtGAsmfoKQX/XBmAsDU5DIcAHo4yNXBW1DvBMNhYpy&#x2B;OHJAbd2yzCec&#x2B;mq6qvhia54OBUFGHuItKGy/QI4P6qCifhSGXjrlGYu/a0zg8W5gGAZSP4rY4UKlaQrFETmnv1P46GS&#x2B;LeBykY84hicEtoTUxwRlGUc1o7cQBIHc5BGj&#x2B;r30CJKezDepMJUsy9I8z/LMkwfofBQtauX&#x2B;jpFWSRxJdwRK9GMC8/&#x2B;ex3A4rDNUR/BdQFzVd2V0tsxYLiwpTI8H8B9q5BL8tNvt/f199QHADfBE/EH6IpXwm6&#x2B;kjoJaiIEccOyu1eUDNNeZ699gGOjq6saL5/NPn8y&#x2B;eD5Xqeyg5C&#x2B;8rrBOAG60KeQ8btAAjXfh0NW7cPHC&#x2B;HvAUcEK5ZTUR6V6QGeg8FqtBukOZPpYBoqdnZ0dawjG1iQNajabKPmjqK/oIQUN7e7uogOg&#x2B;E6MBiuXyyAeEAjt7u5ubm6WPry79tlfW37j&#x2B;vKtK/O3rizevrpy6/KL66&#x2B;vvHF95faVuZuXV29dWbxzbfE//&#x2B;zCl7&#x2B;08fQJGAvK/1tbWyBX9Xr97Ozs6OhYnRzcrPPzc3v3ba292WgAwZ&#x2B;enh4fH1WrVZ8f1WiAEkjBhU8R7i/MJ6KXaiIBPVs50MmJx6/qJ5ydnaGH0Gg0AI&#x2B;A6rrdLvgeAOgxH2A1gvX4v5ob2KyQK84ORAXACyBe4FWsQ7V8IFTRJByhJE&#x2B;iN9zvhDFAIiXxHxybCImtNAuj42qf0I58fn5&#x2B;MgnBheDFItSgUN/jlHqkCyY1nYNCEIgL1uuJrgB3dIZttI&#x2B;PL4y2R2RDVXm7O10lK9&#x2B;yREWUQEX3H3m0U8zBY3Fef/EBu0cRBsnDRMDw7snJyZlptlhhlfC6qILtJJyzkH96eqr&#x2B;jFoKF8ZWIQSPJxcmoEmv9Oiu7k1GAPVM2NQUpr8wo8os&#x2B;h9yNnbPGAZECQZmFt75&#x2B;fnADBDoTcaG9kwQUNf4m0UAbPlfbmAb66kuwcXFxYBRQjjCrpmajC3LW2zdxq/Z/J8sy0Z5PqJAP6NAX2V7FFOdc2PW5gHjxib5xxbsUxPw75wbkWm4YmQshgQ5WA8F6C0r0EZGFNukk8H/hUNAoZwonJvcz5SP8Xj86o60zZTyaGwzkT6&#x2B;iBUqYv5VRoU7wBIVQXCkdvpESxMEpG1qeRwDLcseowNZ6vR1KUBsRhp5pi2Qw1iQDVgPDToJgEYBeF&#x2B;yo8xD5f9Y8hXt1I&#x2B;DTVHMppolVfOBDtc0CAIAX2fsAZCXABlLaITD8yopMwrN0fTsGC6J7ocX5yTFUF4MA4b0JZdGpYg5SmEglgsWwDoMwySOHDsVGUaGxXGeZ5ivwQI2Dl42jBgOAfABWGBxQRLyFpxLxnQjEC2U5HFnBN9dMXYATmU/ZyA1EVJFtZ6UA&#x2B;5qfIp0obCucwmobBJHiQ9HcqAG6D6hq6HmQIKQUCnfOKAAW5C7GpffMVA14fCEKIryLJUYzDemSH1jjoRTl0N//v/3PwaDgZC9SvhWPyNxv2A3cIkkN0LwMgHboE9V6JXgCSAo6IYlW5wIpoaA9DbWyyu3gAwJU3mgKvmzk1Db3t59&#x2B;nTm4YNnT568XF/flOYevQ46AQ7UJcCLkO7gfFHsFyvAdQAuR5G&#x2B;wRG/hybyHwZfrI6Na&#x2B;KvpvPK5gvb7s7OToOzhIH14fRVfwDr1mo1DffFugD6WAx5oAoS1dBfvLi&#x2B;vo7&#x2B;A&#x2B;iB3MD1/f3Fb/zN8p1rCzcvL926snb76tzNy0t3rq3dvjJ768rST39y9fd&#x2B;Z&#x2B;Wf/nF7fm67VMJOMQRge3t7a2tLnxCBchGAg4MDDYLQR6XOnNZDE9sKXI67gycibycnJ9Y73mg0Tk5OxD/1OZRTXPIbYHTQV3ADfMzOaDOAy1y9LK2Ij6IvM5&#x2B;cnJycNJstoUa8qzo3VldNWpBRhEQQv90&#x2B;0YtYDAcjMwOeizloa&#x2B;oh4HUQDx2DxDOvIu9zNkmEp8W4Cm8DN26Zg07WrmtZimC3PV&#x2B;tNdVqsDV77BdLCoWLjeAtETNoeNTluKA63/5/ilmdGRKiS23fFbGxHQyB/lNjfrBESOtamZkYhV45M/2T8/PzC9MoOKOgyFKyLuzU7EucTVoydCTnRhYlEqjnXWPwPTd&#x2B;G1ELdQO08IWJMbUkoWsSObtm2IU4wGAyElQziSU60rqdyShSbb/X6/b7Ezk/EhR1MGGAw8IGk2PILKDvcqZBbzJ&#x2B;FD2BoTEKFyZgYd8xB/dKCyToD9OqhfWAGhLhmNp8Jv4gxJAasDsySJ0AugDuZp&#x2B;p6t9jU&#x2B;xXvZa6Gv5zIo9y&#x2B;mFJTpIkAItafmSy/wWpLUQGe0lN5Z7vunySS4RhmBXTXn0HALhfR5hRN692hN8UVVgxs4N0XkLbQJmyIeiwUyMEEoZ2ruAAOjsJ6LG1KIrCIMCKkerWSYKrCFifMA7IMSOS0JORUEhJyjKdmvaS57kX3E9ckyJJBvQgpacZcp&#x2B;UrQDUpwmCi0AkUQhQHWBoXeQoCsMwjGOhW6dTTjliOWRhHnIgXE9mDZkqvnNRFDHXSJcx8c0IDlXwr3guFNueQxLHSRypeZLoymRZEATyS6QcFxDHsTce&#x2B;L8dl3kaEsdxNMppHTZWaWif7PWU0ikKQ6zrqUWKCFcfS&#x2B;qJFjE6mic5hwHjqvJvLR15u7lzLvHBRN7BHOcMHk2di8IQB4N7JIHQjxfT/5seYRhaAgC0BGB9eHgooF&#x2B;tVoGlsFi1WgXcV21eawGHtZglKp1Pw0zskr8WT2zSqDUcA0dacZHSQsE3AC4B6RRRCpi&#x2B;s7O3urrx6OHzx49frKys7&#x2B;/7ar3C&#x2B;4GkNVj3wIzuAu6vVqsQJh0yer/OQcLA5fgnYL32jsI/0P&#x2B;UwdfSAKV8oqsgzQ9ENeIG29vbNY4GwxYU&#x2B;IPjBw/Bi6VSSTmhCOiE4AdqHwR6gg8cHh7CBIwGQqVSqczNLv38Ty3evLR468r6G9cXbry&#x2B;cvvK0k&#x2B;&#x2B;sf4rv7D&#x2B;9T/fvPvBzvr62uoqpgHAaiwKUS6X6/V6ZXtbR4hcI9zBs7MzVPHFJ0UX0SPSbbU2dMUuiXaKeuH2ocSOz9Lp6Sk&#x2B;JCrYi1KKfJ5QbgSID2GP2ggw8jY4a0KNJqyFhU9PT&#x2B;v1&#x2B;unpKRoC&#x2B;NRhI8fHR0K0aAKojQAAqrSrU/YWTult0GInfKjzIF4B0ImDPKWISExmakcWlJ9Q&#x2B;SMSIlIk6mJJi&#x2B;jKFIU4YZKSPVS8IsRsbQyWDtlddJitdMquwhmtt6IKWFeQ11KFNp0hZq0T0bBzo3qyhX9dMTwsFTk/P9Nl13YE1k9NbwEHLLh/ZvRF5&#x2B;cTFOWMgxrOzON8Ui4lMtCmmfjMxEBhme7kLIhzY5y4oCdYdEh8QGqiCzPD2LcILoqHavAGlPu&#x2B;AarsnckRe5L6iDD0jG/Yv9It5lX3zHyJTqfT7XZEDKbwuiUblgxoO&#x2B;o29E0eEVYVKxhMZP97i3AwmR30moroEtWMJ&#x2B;f&#x2B;OqPvz6m8n&#x2B;oMSEFuAXfik3wYB&#x2B;QVLr5AOGaXQAcwBd&#x2B;x3/F4rEK7duSYQ6/lR6PReDxSLVzvuiQZM85IqN1XlON4NBqNJ40BKXsLgtSZmQ2cmeo&#x2B;3/UQfGx6IEL5OJ6kGIKWQlcTR9F4PDJsxNqaNQQqFesAXJaF1x8JD0agX7hcHMPJ&#x2B;1vojpzQtm4rdC9eGZWmaZpGVNgrlVKUBrVn4fuEI65ipnCmLNsDzcNUANAPnJpnWRRFYTB0lJt7kY&#x2B;cx2EIBIxdeEW7sUg45tXgXIbDoXiLFx0lhcxGKNwx1N&#x2B;5JAqDqACpPjUoJfyFPQDQGZJ6bzPwvZQwjuMw9NgduNyRhCDxE1fPpJ164X5CURB2DYE&#x2B;q/MRPi3YLBT5MZP&#x2B;0U7JmP6pVo8nGEkyynNquvyw3oTNHDagCsGPI0sDcM/zXJeOLDESJUt5wUHMsizF&#x2B;WZMuErYlgGLkGiKJMLzKPwxfiQecRyrPF/jBFzgLaAZ1fiFqAC7gaWAbLCALe23OE9XGiF5fIX78aIESADNELEIER5NmonlIcYyagKoVLy/f7C1VXn08Pn9&#x2B;0/nZpd3dnYBIqc0QsLx2KB4iMy&#x2B;IiSiDThOqG6A4GEJEKKtM/BH2Z1A9vIBy0VgN2IXAJ3Y3t62zQSshUG/gPJ4sr&#x2B;/DziOxaTnKZfLtVoNIiIpkfAWlkE2aLVaBXyvVCq729ubf/X1zY/fnL95ee32lbkbl9Y//ebyH3yh/P3vlV&#x2B;82C2XtysVLLy1tbVTqVS2ttBqwAbX19fh36CJuXBQ4HWJsuocv6CPWZ0hTrgjuJ5YGJ8iCH5wiUQSdOtxy4SGFRuF19UdUu2/0WicnZ2h5F&#x2B;r1ZpN7ydRH0AbB17X51wHg4202&#x2B;3jo2NtGSRBqiH9OaidBaqAv5fj4&#x2B;PT0zN0JICnm81mi/8E0MRiUkxJXCSlEMiALW9LAqQSuxYWLG4zFBV7KLbJt1SABxoWrzg/Pz&#x2B;dzGISPsahWtoAHHxE54NYQbvdPqFPA6/A2yA0r86AsLhwuRomOgtZGiTLsQzEXhwsbNsX2iZWUbfBkgGheS2v1U9oKugwAsjSBj3HaXZM3Cc3Czv4xdR&#x2B;LWE4oaPD9gGE7CUoOjdaI52mGgVAzyAGPZNkaiVDQOoA04N&#x2B;/5wjNSQi6nH6WM8MKxC&#x2B;705mhgrf26nA/UlTgdhF30SFXkwOOvBSIsqBLNDvcUiwGgj9HxU5KrOBUkFfy02UvoD4mMGdqk8r/dOWyacK8AoPzbJC&#x2B;577GFCnJoPK7WNCc2HrMfU5gt2vlvPFNMbGQIy3sEHHJHJ7nIkftoV6f2406HYQUpFu5MzIW5yhQH/Kh5y&#x2B;qRHSpMaLbLmQM0VWyyIk2VdDg5TKW4R1SKIfYkd8MROSzjS9OMsAvnUFtP2UeT7KulEhWRwsLYav&#x2B;Yupf6akGqgTe8YFJmNMvf7iQ8JkOh6ZUWTBK5xlWZLECvARk0l99yBKvLQ9yzkil6snAvHD4VBYH7DVso6E3CCm&#x2B;sUlSeQDKzV9LHYmRwg&#x2B;gSRJwjDIlWnjqYgXz2CmgSdRURTRKs0blMU&#x2B;Wscl3oEdoRkSRZEMCTCfJHEMN3bqeYgnDNgpeNeELQGfN9oYUklu0jRlLmrqHIZCoA2SOhcMhxm7Z3mepS4BjSG/SlKXjEd5cen8BfEnTge870g4/k1hNHIsZkKzOBhClnrC8BFqAqRp2uRDNWzgthbTeFRJbdLgC&#x2B;gA0&#x2B;0UPWhNZvi0TchP08z61QKHnA0sfQjWstVZACkg8imHgGD99vbu/Pzy3Q8ePXr4fGO9tLdXbdA4a&#x2B;v6am6o6QG0quR&#x2B;VPdrJhpVeBS7hnAf8BrLqJlgZ/fakB&#x2B;Be&#x2B;l2ZGDQAiQwxVQvqyBCqg8Mvtjs3t4epPxqIByYkFAIfra2ttBSkCcYryPBE6yg0Whszc6u/savLNy6snbn2vrtq6u/&#x2B;DOr3/n21vLSTqUC8rC1tVXe2torb5WePV355jdKD&#x2B;7v7OxsbGxAUATREQgAjhmGY9gM0GzBiYCuTKF/QeTa4SHOxlImmAewCm6KuAGsF0dHR6IH4mliC1bMpuSoRqNxQhnbEYOk8EEVdm&#x2B;ZMXNiBVhGcB&#x2B;dDeDRI0ZdnZyctJh89Wr/4YSgX4K34&#x2B;PjRqPuFzDDMfCQGElricw0my3sC4eELdhKuVUxCVsLrKO/gYfkRoaiFOom8CvbH9BDCNu/Tje2GhenVMXosNtMTNIB6y3hcouqtSRWbLfbJydtwXQdwOnpmY751MiQzmi2Fsi2PKo9aWmwfEkcYII28HROJsNnz2nCtmzh3EQh2YaGlRud0aFhWxa2pSC9ELgEUDLf8W91zVQ4GQNOGdJ6bsaoSeIvw4AeHTP2WAoi6zfwINuMApBoRwRAy0smxC7ERcEHjP23Y4YQa4OkAT3ZheUn7nQ6/f7E3DHLPfr9nlJB&#x2B;xwE1u12ERb0WsaoHzxy&#x2B;nRHhaZ/WpGfJMmY1uHUtAXSH5X&#x2B;iWpoZt7S9vO8kPiP2XyAWAUOA1GRVyVDqJXi3dRgSttVyGlBlus3Z7Qo8BnpjbPuAu3IC3KyYriYs6FGJmV/CqCbI/FgPaPXU75Px8hIYyTwRCVl9L5gfW6GdmWSKqnIzYVzhguxZJumNLnqmgg3O8a/FOfsnNhFRgiuF8HrAKOxIapxvLhf&#x2B;F5SELEXR&#x2B;SdeCOs7yGgZC6Pr6RWUqeg/h0EgQQtKRsFOIU8y6IoFLuIoRfKc8BfDEHzAiE0KIrwpZSrRxg05s&#x2B;UJ66rhDgmjB4TtI3JnWLOLkhYFPc6HI1n9nfBp&#x2B;LkWZbEUZq6MAhSWrFjZunEXvYU6nKh8B&#x2B;GgV8mRSSoQ9JUrhgf51BsxymHYeCSZDgYpLyJ/uCdw&#x2B;SGhPN9XZI49iXS1EFf5NhzQNpsksSpn/bluz2jPANjAakKgwDPYy&#x2B;p8o0IuiwSpCHlk181/zc/nHOSbgtgqXTa5IhfqX2AogTlW2YyF6qqdaaCHtFYrJqoIH6DPoEWh4VpGWy/xnlYFuvbxgI2W6vVdnf35ueX337rwwf3ny8vr1er&#x2B;5BwAM0fcJYwcmnwXMeA7ezTttvi6GJgbhGMpjEB45gPzAxg7AsYF3sEsMYlAsoHxNc/QSHkKsZje3sbKBkhnkDPeB2mXqB8yH6gSoIaR3usVqulUqnZbMIBvLm5KcOxtDqo3Pta/s4OVECr77&#x2B;3/JN3lm5enr3&#x2B;&#x2B;tKda2t/97d7OztYplwub5fLG7Mzm&#x2B;&#x2B;9O/elLy784s8ufvLO8ls/rFQq2AIGgZVKJfgKREJqtdrW1pbEToDycj&#x2B;rX1H3kay7Mo7jUuMcddHwMcPWcLPQwDngjIV2uy0&#x2B;oIX1YQZr1U2XrkzKMXxQj46O9vc99WWLgG0HvqKPboPBsti41R2pLQaQXaer/mhSkqTPv5iDqIX6A9ggFhbxBrWYwutNhvC2Wq1W60jFfq17Qm8D/o8Cv1oW7ePi0TIBprZE3aLN2r57ZEJ&#x2B;Bf2B5rGWWgHiDGp9WFJxxPAlW4bHdnBUdguiBKI0x8fHEv5P0RXLE/CWugegE7YLcUJp0wn7AOowaJuvEoYTk816ZlwEJ8Y4YXG/ngt5nxvLgQjDSbvdYYDsuQlr0u6ApG3Vv0NvMSCyCIY1CYgGaCMXZjpBYRLgRqC2F6DXozc5VUCkwsp4&#x2B;mbWgQH3XWD3wcAbhbGuyvlS/oAh2HnGHTNOWOqgLv3KGlmAJ0EQdLu&#x2B;Y/BaZkT2GAgMJJSbOQDjyZlcY6qAsJYK4WNOFB6ZkWFFIT9NU2pdJrX&#x2B;XniDLeDVMXM8c&#x2B;PfVVE5Z8uiKG/T&#x2B;GsNwWNpmQh/nXNQCrEIWrQXVIlP0xR8QG5ODRhW30BqH&#x2B;enqxZRnjodytyLknZmUHhK8zTLw8TtCBId5aaQXPRntPeYyY&#x2B;O9Wx5DzJDMFCZHo1GKFRnnA5rsDsL8xzlm6WKf/Fw1lHU4WhawKUbTcwXm5AJeUDJIFSrF0LNPp2cv&#x2B;v3m6WIVNL1SQzJwagsXE85lYGPtaQrGjtZIkuAn3WVUFKfWvoBe2vCjP8sy1B996ImhxTUIAgCLOmosSF65pCsJEnozU3YXih4FOy2SRIFAUrpEPag6g8yAGSfkCogp8gfoUv8FfZ7CZPYx3EKrCdJgiZGxqFjWZpGUZhnWTAcgndhFYH1PM88GfONAo/msywDapeqBw0fMhl/N6H1z/N8PMod5/cV1mcMB/DDpxMwpR8jpv&#x2B;3PgCwpDpQRVb1&#x2B;CaTNKXst8vgN1idAdRrpYoBagfSEpo/ohwIqyjMR0IaZZJaWgKGACByeFjb3Cw/ezb74P6z58/nNjdLDcZ3Hr3iMRBSl9ng8PBwe2fnsFb77r&#x2B;89fLlPNiC0KHVn0BCg0PSddBDwn0cNkrgWFhw3&#x2B;JUyavwrq6S2gJyF2DL0O1A0I&#x2B;qP3A2gLs6BngFMFrWXuBsjRGAcB9PsLCfHVapbH3vX1ffuLZw68rszcvzt66s//AHe3u7lUplf3t7&#x2B;YP3l//ubzc//7mlT95evX119trHFj5&#x2B;c/3uB1Af7e7ulkql9fU1MAEU/hE0BHER2Mvm5qY0SID&#x2B;OKqDg4PtnR3QABGDra2tOkco4JU6Y2HBK5rG5C3ats&#x2B;wVPAxXPkjYyW3iF9r4b7ooy5TuMiqCOcxLcJIvxWHbBjLe92MsZviA9LCNY1DRgoi7Uvov0UNkrC7ugr6gxJeP2EfwLIFu1jTmxaOLWHQ6kdHR&#x2B;fn58dHR&#x2B;pm2O8Bq0dSd&#x2B;LEdBsEmv2laB0J3IOWaIFjCpwsB2i322dnp8fGFKE9iinhwIDstWXbExDxAAHQ4VmAPtW7sAdzYmwJ9p&#x2B;2n2AZy4mRBmGxDoevmXc9K8ADPRZV/W1vocvReLb7YcVUFxyLdsahYNZF0DNjpPWWHl2TGQodl9wCXp1vQn7OzEwD2wo4p4FB1l7p&#x2B;&#x2B;HoVcdACwDu4wAAx7V815iMKeg3EUDsD6DYr2aCJElqNQy4EdADSYN6Pqi0NxgU&#x2B;h9vAhZqH7OQr3q5yvNj6m0SquptXVmA3uJ6SyFS73adEPwARoxGoyxNtaKN/bE7GjPMfgpnZz6LM7d9A2x2xOnCKRGto7BH&#x2B;BsHA4Rqa/kiGOIeCcfc6gRTk86Z&#x2B;pjFAt/b6&#x2B;OtwOwD5LxiQt46FwlpbKtEaDjPcyXSxHEMUgWyEVGnLr&#x2B;vcLlWt5edSD2WVAPthZQ3JTX&#x2B;Y5y4Ggipc6lLsHxM0Y6UTplR66u4LnIS0xGhY8A2c3MjpBqXYgf0BsAUcN2fBOf7ehLAtCX1E9hMSAqy4Uv&#x2B;iXNJZvKIEHbpqMbBYYRBAGzteYuK9HGMdE5U7sMwYLqOpyi42rGPRXIK7UH8fxgEEcNSoyjExFyAcmB3T4qyFJn6chh72zGbA6jiA2ePRrlLkhF1QaBAsk949wJq9kmS&#x2B;uFujl2IxF9D8knE&#x2B;0jN78eccWupH0HtVWFBEKTOhcHQuSQKw&#x2B;FggGuLO6XgJvzFfSQeQRAI5QAYtSYzHFXba5jMH0H8/f39YzqDLXRW2VUFSIkxWnyo6o/NChxPCYqsXqhWq&#x2B;3uVhfmlx8&#x2B;ePbs2Wy5vK091hjbf8TUoKaZGia4hlrv4uLK3//P72xslL7wB1997/17Wlfwsc5JZzoq4HUAU7wI0Uudk7mwlyoH9wKj73NeL&#x2B;rfUvkDrAPuK7sTGFRGCJviL89AqVTCxlVlV7gQ0La2hiK9LMV6gnFg2ObW1tbm5ubGd7&#x2B;zcOfa/M3Lszcvz75xfenPv1p&#x2B;/Gj9X7&#x2B;7/pUvr/7CTy/euTZ/49LcjUuzN16fu3l55RO3Vu9&#x2B;gAECq6urVc4D9jPFNjcVMKq39vb2sDxeUd/g4OBAg8nADfAE/0erBIYHkRzQpHK5XK83Dg4OcPr7nMkgjlczyU544BL5G9dsgnHhw9CgC9z&#x2B;U6wDq&#x2B;j&#x2B;inuon6DGET4nr7aMjuinl3AIz/UnoC2o0wVW0PZKpOJP5sRYmQGIVbDH8lb8I7JtK/1WMnQy6S4Q0LfoHAtb4C5iYB86ALEIwvhjrVUQA57FsbFlHx8fYxVV2QGadTBTYp42VUNtJhrZJ8cG7utoxZfUOlCrwTIQNQ10MG36lUVjjo0XWS966G80RSr8n56enp&#x2B;dQf0PMC1kDx/FhclxOjEmhDY9HmIOZ0xMOjPD3cQ0YPYVfJfOR52Bc2YE6V15eS8YHIT/Q5wjIiGzgTYiZzCW7HALUvJIRFQYhXu9DlsBfQ4guzDjh6VxUiKQtQLjFf2zO2liRjSQXrEOgX6//xp&#x2B;lZXpmTIVJ6ciHwB3CtljAZABVtbHwty2IZDSS2Chfz6R8Z8CHI/H4zF9qBlDP8fjcZ7nYRhmtL1iI2NmibrCKZumpsQex95o67zswdfOE1P4x/kQ&#x2B;k/bi5UEmnrwnekYWLMv8nn8jthnSDhMAK&#x2B;LFeg6M0/TZWk6Ho&#x2B;4WV9Qhy8ziiJoMFLqXlIjzU/NljPK9LU7zMkCLNb5xsyazE3PROX22FtO4&#x2B;IOkgaojq4itM5ahXO9ggp3TkuJqehPjNCKwlBHJbtqSpJgWURMGwBBvx&#x2B;US707ivEF7RGG1qRbKZekUE&#x2B;NJ0E7TeLi4ZyLohDcFWBaKBa2XRxkFIaIeU0YqakPhqPNF6Zh4G81FnRSiQ/SiTK6rhMOXwPkZ8MkDP3oXxdFISrrYERQMaVyYqReiOWr8nE8yjM/fiGO8zznNLEE7AXWBf0tuqSI9Mm8lxdhRw5Sfng/YKJA60nTwSJqrkCH8FZstEk/NkT/b39MQXOhBOAqK12wim0AC8W0CyKrTqkSfpNxQGomqHugt9oUTANI1SYNu61Wq1rdn5lZ&#x2B;PDu4/v3ny0vrR0e1qQCkmm4SXOwAFmLLtJWkQ60W6vVHz56/tuf/&#x2B;Pt7d0v/MGfvPf&#x2B;/SNGggKigf8Az&#x2B;lgFFjZbDaFuYHsW60WoKpg6KHJ/m8ZyZCQMVQuYgVW/S8oLCQN0Ax3L/ZboSu3UqkAcyv4XxhaAaAQ/whJowOA11GeLz98sPiTd&#x2B;ZuXp6/eXnhxqXlO9dWP3l74c0bK7cuL926vHzryurNy4u3r87cuPTy6k8sfvL21uNHm5ubYBGlUmltba1UKq2vr29sbJTLZT9crFIpl8ubm5vQEaGPoYYG5ENTJ4JV8Dg4OFxfX9/e3m40Gju7u7i8ckcoQOmAc9lwWeTfgBwI3EkyrePjY1nMBfTxIW8xa0iwXvwBtw90q1arHezvy7XSahUfm2azWa8XtPmAwVAiovggAWLiA9/iaGptwfJkad5EhkUb9C62gw3qE942BgPRIeF&#x2B;&#x2B;8eLv7g2BUhHHOXWot3ZVgG0Lur6XrFzcmIpwZF5iFS0jcBJpf0j6nbaRv/TarXOKNQ5NoFFAtlaWJV4Afszk&#x2B;t6YtJOj4wwSVzl2KiSWgyB1UGKaZwz50es4/T09ARqIhNhdHx8LFuCFpbHQFYBUQhgaCx8PpmU2jaJpVPWAtX&#x2B;28ZIfWacx3LrnjNB6NwEj&#x2B;qBw1C9X1X/czOm4JxhRILj8hgAzQPxa&#x2B;P9SZ9A1zQEBO6l7emYMWpqGgwGA/QilAEqKZFdFzPCoCDSi0b24/sAg8Gg2&#x2B;2oFYANvmaVNhn1OXylwJeZybpRZ0CtA9WzsbpFuilH7aqTINAppRD3m49GvrQ&#x2B;5pTfbFIx7yZHC1Mn4w2RIw4q9sH8RMy5wccpRT4qaadmFpUF645SmZTDtnCmKUUmKGZPwejEw74i61NbJnJO/Fn7wWGp3aZ6CwmGMeGwiVmB3hx7Do5qdXvMEnF5uGz0RaNRbg8sMQGUKRXeICeWS6D&#x2B;PcWvEuI/EIkkiR2r8rrvxNuxvMJ0yjrHIV8JbyvE79qdpvmyBO5sKKfK4eBFdBF4uf8oz5VnWtCPwgHsWMuPnPNwFnKXPM&#x2B;jMEziCKKvxE82QFR/CM4WMDIVyhZ88KIwBLiHVTeKIu/ljSPnir4EmAldB0kYBnEUYRdoUAwHfdxFlNszanvw5wb2BRuxY5STLkVxW5NYE4jDYBhFIYYVgB7EUZRlaRiGqNb7z0gcR2Hgb1AUpi4BwQD4D4NhlqbBcAh&#x2B;mHimxMnKvmnA4FTnxJmTOA6CIT4EOPIfH57/Nz8s5jiiJ1KFTEEHIQBAKBEAAYv9/X3oki3&#x2B;PjYRQHWOFBAuOeSYLVtHb5p0/9phbXl57dGj52/98MO52aVKZUdFVoi8LSpSsV/QDdCqVqudnJzgyeLS6t/9/T&#x2B;/8&#x2B;69z3/hj5eXV0EAoCFpGlfxESciS3kioc4Bo36anAYA6YtC/fF/uX7rfFifLp7DlSvwilXEHACIgW6B7JXdKaAP0K/hvqVSCZuyHQAlhOIVAXHg6a2trfLK8vwf/delN2/O3rw8f&#x2B;P15zcuzd&#x2B;6snDn2tLNy0s3L8/fvLx04/X5W1eWb16evXVl&#x2B;Td&#x2B;ZXtuFjAds4SXlpZKpdLGxsba2tr6&#x2B;vra2tra2trm5qb4wNra2sbGxtbWFpoPIAziBuAwpVIJNX4so0QjEBuNNsMTcR6IoyqVChgauhxTQxg0Z&#x2B;2AeamVSgWfN41exkcRbMHKt3S79QrIm33YLpN8C/oQiiHoob8O22eQgK1Jk4B6Ai367JvG4YCdimYfGZdO06TxqvzfZi9OVf9jauixPP5ARMKPOOWjRU&#x2B;/9m6JhN2aWoWiFupCnBg3wpH3SU&#x2B;Ii6aQ&#x2B;tHRUdu8LjJwRGmTWgo6Qb&#x2B;6kSe1Wb8/PT2ZbE20j02ImX1RnEHwvW1czm0zHeLcBK0W3MD0E9rt9hllRVL4HDG7yUqAhPJPTk4EwcUuIGlC1d8aiC8mZxvLHiDzsVX&#x2B;qNgvMQ&#x2B;4Qde0CM6ZLupbATQcyzqgzoC16spC0GU0kGiGNRDLH3zOSWSo5RsdkX&#x2B;AXQwGg/Pzc7ECayyWiEgOBImIepwUJlbQNdmjr41N6Kek84DI6eR8ACF4C9y5QDFMQI0CweUsmxgupoJ0xtlY9sXU6N1t5Vjb1E51YBlBLZCTLL86C0FM53ycER6JF9yPRgwDtWjeANmJecMJA38kqpliJkCfhPVeG50ywFEaDOFpVKaLKj7Df7TN2GTjsEfBFoRzYRhkxomR0Bsg7AvsKCH&#x2B;iCOEcY2jKHZ0I&#x2B;QM9S&#x2B;GHhjrgnMY1us5jEuSMAwc43po53WxT8OM8zyHdB4DwibIDHsaStFxzuVsXKRFL6XQKQVBkCQ&#x2B;VBTXMAyCOI70SYk55Aso2ANbZYCSiYEAuCKu3rtv8YmBnVfKImxTYpiEsaH6f&#x2B;jF956I&#x2B;up&#x2B;7AUzMdVEKbs6LklSl/gNJknqEnh5MS3YFamjxXwxXRx1HrBkQuNHEHgBkiwcIFpOA4NxJZ0DTE&#x2B;SOEvT1CUyEKsjgRXxh5rQKg0KhwPOsqKTA6ZB1hRrg44zH2S89vqr5KPUAVCBsDWZwX9MbQ8KjQcHB6gpCnZDD61fU4CGY5p6W4zNsURC8utjE&#x2B;wjkIHNttvtZrO1u1udn1/58O6jubmlg4OaDq/B2cDtdhtYDUdYrVZbxv3ZZGCRWM3hYa3Van147/EXfv&#x2B;/f/8H7/725/94fWPzc7/z5QcPn9U4u1dUBNiuMRkbCkxZZyKQwm2E8huMFhXilHpnn1n&#x2B;UP4Ad&#x2B;KfUMMDgEr4rqo2it94HVlAelGC/kqlgoRQ/FMCfb2L58ruBG0Ai9ja2iotL6/96Z9A6rN88/Lczcsvb1xevnV5&#x2B;dbluZuXVm5eWr7x&#x2B;uybN5b/y&#x2B;8t/v031x48WFtaBApfXV3d2NgolUqrq6srKyuA/qurq8vLy8D3a2trwP2rq6tbW1vr6&#x2B;urq6tra2t&#x2B;/HCpVCqVQCTW19d1FjhIdBLQqQCx0T&#x2B;pONqxPEreYnmO9VzXVsynxoEMuH2671btY3NpdfcbPhm2JX4o7Rw&#x2B;Gw0zuk7LiCdIGlRjSK7Vp4nH8hN7OPXnA1JtNUh6HDGfVDV4QHY9b5iRfJbV66/PPzH84VVGIdx8bBzJrVbr&#x2B;PhoClg3GYRq2w4oNUi8BGbSmlQb2o1M43sesDoDtrEgNC8Urs1a7H5smg/tdvvoqMhx0tfFCSegyXhw&#x2B;kq46rFpbkihdDaZI3Ri4oMkK5Ku6VQTiI3fQA0BdAnOzYhisY4zRg&#x2B;pD6COwcXkaGQ1AYDdseVerydZ0bmZNCw4Dr1Qt9u9MOKfTqcDgQ4kRrLzWg2PoHzHbE3iIqvbASvAuz3OBOhcXCC3Zzgc9noT88iwTJeTg9UZ8AGmZuSwJQZ9k0b6Gn7tHHGzcLbQsIgBgP6Yw8IyzgkW6BcWx2PMzFDU8scUC6lqaLX4qdHBWyCOPQJw2wjIzDiGJd0hCvTO0Ywjb4mtvX59TOm/egiJH1lQJAgJLrMoXmRxZsRGljg5lyguSdVWcY&#x2B;M2YspA&#x2B;y1osfo3idQlO0tCSnuS57LwlucLET8pB8A0MR8HLzlvFsUdXfb8GH3o8iMd16aUmjZx6Nc8BcbSTnBN01TnDgue85EeTHJjAbZmFOlsPcwRE3dN1iAQp1R7IRhGLH27yT1cQnMx0raQfG7&#x2B;GyYAWe0zLKZkGXYVMzAUEddEOlVMcg2ogUW/8VRWASAxn5aWUy5C6B6xvhRFMhjZn1ia2EQQLYEWIw5ZbESkLyru1D2Z6RJSRwncRSGAe5AwrXiKMqzNOVsLxTg5cHN0jQMhoVZIvFjEPAxw1kriSg1BCNJ/Kl52U8UOTp6cVNCTiRI6R5BwyGOouGg7ycecEJCksSpSwb9fhSGYRj8n8fx/&#x2B;7HkUn3F1AQIkFR31bxm/SwCkYITEioUOf8L5AHaR60Hf3QigPgsbOz&#x2B;/Ll/PvvP3zxYn5jowTU3jAmYGmN6sxntOIHvL67t7e0tHJweCgxz/b2zr987&#x2B;2t8vY77374u7/339959/4nP/2bX/2zv/3kp3/z6bOXLeMVtuV/YD5b5QVcQ&#x2B;Ffohq83uTYYKyFICAE/qAqL3W&#x2B;eh3iA9C0AGgC1kO9I9E8NgVeIfkQdDiAv1D1SHMPuI8n2DJq6hsbG5DcqDS&#x2B;s7Ozfv/e4qc/PnfryuyNS8u3rsxef33xxqXFW1dWbl5afuP6wi/&#x2B;7OJX/tvme&#x2B;8uPX9WXl9f&#x2B;/731l&#x2B;&#x2B;2N7eXltbq1QqGxsbCwsLS0tLq6uri4uLpVJpZmYGrYCFhYW1tbXFxUXwhLX1dXQDKpXK4uIiegUo/29sbJRKW2tra&#x2B;AVmlmGo8X/S6USmIAmnVmGANqDy1gul&#x2B;EtFgeTx1pWCpNKtK9XhPjFDQ4PPTPU6oDs0nFJX4SN4EMiR3LDeFFkS1DXy7IC/bmp84aO08HkoAkspg8PmmkNBp6qSzDVfxCqVlEfyFUfe8nzWq1Wk3RCf85THbyaSVMVu2bLoqm92JaFuH3LyJmOOWTwhBbnFl2/XmJkaIZdpTWpQhQJkdD/SLlJpjVx9KPSio6N0EibmlIc4SEyMMU92iQe2uDJpKW4zQEL2MwRE5ba3m1c4P5zjhs7MUOFp4D&#x2B;KYcPWPiu53gXW&#x2B;sy5Md2FazOx3cPKASSSUBV9g4zOvXAq5YzqL2AtyRDujDRQMDiHfOutP5a1/5f1t6pOKALpoVa3C8DcRiGvckRY3a/vV7vNVT7BNfGRso/pg5HuDydDPq0qpWs0BGlwt9jUAsCdEzdyrJsPB5NrZ6/8rAvWhCMV0ZU/wugpwzCZ7DQRHIOC&#x2B;durDnHBtB7bJ1OnA5WkXcZ0modkphDWrQ&#x2B;/I6hUdExx5TIO6&#x2B;P912CjNFDOkcRhnxS6G&#x2B;TQxMzKhiOT3ESPJBfZPQ8PlbII2nKM8hbHAmAh8IaDiArqkiXVENRhLr7RGaoK4rNTpsVAQCaTIxfgiSHC9N&#x2B;mnIMma4AcDBEOBmJnEhFEkdhEGTM9smg0uEIYTAfHVXMQj5YEMAu7gvK2zHVR9TiOxlwoyhEBR2XKArDLM3C0LOpKArjOPLtAo4ZBtDPUvRqEgzSgmMhpSAqikIravKgP4nFssiIYu8lSBL4ldkc8OX2LHX4/GVZBukRbmjCNCfYxMlJDI3UAcSxSxI4elOXcAQYrQKR9yQUCqU0lUk6S1PKk2J0BiCyAjGAZyD&#x2B;SEmAjkxcCX4goZmp0VArjRBeOTo6Ojg4wG&#x2B;YaoS2jCc5QdOkhWr70jaosliv13d2dkub5UePnr/91r3l5fX9/YMjk5lYrVaPGeNo9T9K1LGdgdm5pT/72jf//Ov/sL6&#x2B;eXhY29nZ/eDuw4ePnv3Sr35haXn1n7/zw6s3//Ovf&#x2B;aLf/DFr/6vf/7e/PzSXrXaYOCpfJztySwjJfwAfqFmrFLxAR/gACrwSxcEWH/AUE6J&#x2B;xGTL&#x2B;0HqAUOAxuRQVbYFHgX9WwA31qttrGxgaI4FDWS2ksvBDqhVoDyQKHj33n&#x2B;fP4Tt9dvXZm/eXnp1pWFG5eWbl&#x2B;d&#x2B;cTt9d//3eW//7vKy5db6&#x2B;vlcrlSLq9/99trv/2ZtZcvS6XS8vIycPna2trCwsLq2tqLFy/m5&#x2B;fn5xdWV1fn5&#x2B;cXFxcXFxeXl5eB9Uul0srKCsjAysoK&#x2B;gYQKYEwkAxsoiewubm5ubkJ2dLm5iaOGQcMTzNmEVgpFLgBJqnJgY1z14pqF0C4JTKA2cNVTkiQx8PasuU30FqHnGYgfqgPCZYUG8Sn19oMWrQKHHHgdG3SZ6xegZpR&#x2B;EtsGCeAtqZtWg5Q5&#x2B;iMI43QrtdrTN9CP0F/kvpLl77o1QaCHjoGW6qfel1NCS2DdfVtIGRv6/RaAJhbXz6qIIiWqBOIZU452&#x2B;GY3EDURf9s0XB8zMhUy4jaJgBUdMI&#x2B;sZxBBoB2u31iJEziAGdmwJm2cHp62m4fn5p40JOTk9NThqWSGLRN2OjZZOJQu91WOf/chIdaGiDCIE3/hRk1AJ5gcTze6nQ6FxfFNADxAav/ubg4F1Wwan5h&#x2B;gszc0CdAa3enRxv3DEKHxEAlfxVyGcVvyftkJoJqvpPWRTkTu4zOOi1sanTK8wny7Ixy/Y5pf/j0cjXg1HL53Og&#x2B;jGlQdqgsPJoNALwVdNA6DObjPoRah&#x2B;NRphvpYQfYO6UnEE6HPlNfY/COBBwNqltUGAxwtM4juVAyGCAZOk9pdTHFsvVEkEHQFRBLmTUoS23SalQx5kmTM2nYKbY18j0HxxNxup7UO9R2BiAaKXnUaY&#x2B;M2r8fTQyfWbY0&#x2B;wrmO5oUfBNEgJ3nbuHn4B6ZDW4O85k9YhF5EyEpGfU8ArW8ll35/VR2R70gEg9K5iP5zxE835QFy4pLk7GjxA9r5EaJjFHhqXGjOHdtGIjnLpl4ThGjDkqglISCTyyLB3luaRKANBJMV0Y&#x2B;vpILmeobBybVCIJw8HAI3V6kWEq8HKmYuRZlPmYozgMA4/FZQBg90Y8J&#x2B;OQNWirQm9gSKIwyJhkCn2/TyCC5YC5n7gIPi8VFIKlfQxBSxnh6qeVhYHzrMyfQhyFmDUGw8OPB8v/ux7AEMfM5GmYZEPB9OPj4ymbbJMOwhZF//rFPT4&#x2B;BkMQPlA18eTkRNtptVr71f3NzfLMy4W7Hzx&#x2B;&#x2B;WJ&#x2B;Z2cPKwpMWHxT41wnARRsqtlsNhrNmdmFhcXler3&#x2B;5OnLb3/3rYXFla2t8rf&#x2B;&#x2B;fuPHr/46Z/73A/fuvtLv/K73/yH73zmt770ta//3YMHTzApTCAJmF5aIOxd1V&#x2B;cCKC/gKDojdCbcn4sdFMZHhgUONWWmZF0ucsQfYD&#x2B;fQ4XQ2VamUK2P4DSPmreQK7AuHgF2Fqhn&#x2B;gYyHELsQ28AUvvvL1w59rMrSszNy4t3bm2/J9/duG/f3nr3oelpaVyqQRIXalUdl&#x2B;&#x2B;mP3Fn1n41f9cWloU9F9bW3v&#x2B;/Pns7Ozs7Cxw/&#x2B;zs7Pz8/Pz8/PLyMpoAMzMzq6ursApAKbS0tIS&#x2B;ARZYX1&#x2B;HhxjaIdgJcHg7OzsYN4ZrCD6A5gbeVfrQwcGBTg2Dk23kqJoellmpYbKz400UEF/hsu9sb/shynt7uM5VP&#x2B;rY2wPqHNgMegZigM&#x2B;SWgEHHFyAjhCWsaTi8PDw0MjPwCEPTRiRTAj2b0Gl/Xq9mFV3yHyhOqdfa0XQjEnL8oTECItZcN8wKbri&#x2B;W3jXW6Zwd4tY1TANgSs9QUiIG5XUSfBcgMcv8RIlmOoidE08iR8XRyZBuNUyV/dAz05MeMR9NaRUTe92is4mnqQUgjZSybkY4K8UsjPhhNn0JInZtLZiRlPJgYy5QaWZ0BdgrYZfix8LwsB8LoeMgxosQumA2GzAuVSBFleIanPxSsJQp3JFacWEA2wvQJZCGzyj5zEUv7IMyBxf29ysICaBupXyAygJoDvAGQU1o85BSwtJgGnKaO7kyQZE&#x2B;Kr5j2i8deWwG03QIAPr4yN/h77HVONY&#x2B;M1WXf3eA41eAvBcz&#x2B;92I3ZnUgni9CCoRbIKqEIx4xdJ6ygZxPjApT4Pj0CLGWa0GQZ29ekpVxPJsf3JlTpAG1nhpPkKplrlrBhGumkFSHLsvHI25exx5QaHl351GcWYftKhuEW1KAgkE3TQuZUTH/LsgyaEG9ETskxIjc5P6G47hwFkNODi7cAZIFi7QdmPB4DcEdRlHvTLUYXe6mS0x1EdTkMoygKggBQHvVsMZyYZfs4CnWbIgp&#x2B;AItR5GZN2jGnsuBjWerGoxE07plxU4iqZRxzFnMml6PFmdqbSDE&#x2B;&#x2B;HjgBGEtiDm9AUwg0WTfJKEoCJv1Y4nlJUh4jv6AWfJPOClMDRYvGUriOI7gn878cSbBcJimKQYYR/QniJl41B5FODBcZy/39wlFEe6mS5IwCMIg8N2kmPX&#x2B;MEw4/Kvf68U&#x2B;IygIwyBJkigM4vijRAD0Q4hSOgqE1hhgtf7tdhsc4JhSXbxV5xyAplEPV6tV/MAjDKdFVy6AxczMwqNHL2Znl7e2Kru7e02mdmLJo8kYE1sBbfuJYw0RgHqj8dU/&#x2B;8aTpy&#x2B;r1f1qdf8v/vLv33v/wfzC8ic&#x2B;/Zv/85/&#x2B;9f/5T5/&#x2B;1E9/7qt/9rezc4urq&#x2B;vYFzYFcAakjkKpUJrFT9a2K72&#x2B;ZPrNZhP1Y1kCgO&#x2B;h1RHmk1wH0LNGr7Bi&#x2B;xWWD9pQqVSk9hHohKZIWnZAYdTOpTUCREaBfN&#x2B;MEgPelXimyPB57935N24sfeLWyu9/fuW73954/ry8sQFQvrq6il7B4gfvr/72Z2euf2zh1395k7V/oPPZ2dmXL1/Oz88/e/YMBGBhYeH58&#x2B;cLCwtzc3Ozs7MvXrxYWFiYn19YXl4GMQAHQHbQGh8Q/1Qq3hKAVgD6ABsbG5ubm&#x2B;vr69BcKSxofX0dTzY3N2V72Nzc3N3dLW95AzEWkHxIZmLxAbEsvlK1oix1YPb2qrj&#x2B;eFfODTRhcOvxIdE2G3QOCMTrVqqRBeoIeiAPMXC/Jah4gpo9lsHfVNN43736iMq32isz7/C61R0J36u9ZvtpogoNzjuTWEirHFHkY5uEVg2oP/kGLQoNEyx2xBHLDc5AODoqDMfqHugLp8kAomMzULnRaLQMf2gRlIMVACg3KStqGZ4AY&#x2B;7R0ZE8DLb/4NkFI4Bak9KjYzoTdDAtM0jBuoEp&#x2B;GkfHR2dGR0RyvkewZMACNbbToXV9IsMnE2OPYbsB4d6fl7MGrN2ggtOFMaTUzOEWKBfUqKLyWli5yZyVOqdfr9/dnY6hftRcbecAQtgGkDHDC0Gdofap9PpdLl61yQIWZSvf2rWmLwBsvzawQLWXvwasVciRC4aoFK9mgCiAQmy4ameH1OOnxnlzHg8tnBZ4D6bUNdkozyHIqjA/ZNR&#x2B;jkD8mOTupMZ2RL&#x2B;SRW4B&#x2B;U4HmJTwVEfYZ5lmS//c3VBfGH3nDZiiwWnKIpK1zpmwOiEGu48zzPm3CdWp2R4i&#x2B;C7byyYTSWcewWICZYl7Y0eSGRPOIhKfmpclkxZpVT1OKLejEbbjPH5KVX4jk0SwPGcNgxg1uFwkBRYNhHnUWMHC8ufrc6DLrgeCc2mGVsfoZcA&#x2B;VSfiNJ56OAtIqfg3sNx9lXE3HwmaaKpW1mGwbeKxZTmR66AxEzGjeM4DIZxHGPecOxnhzm/ZhhGHNeV&#x2B;PG3Cd&#x2B;L4kJKFMdRmPjF0LJwQNggP&#x2B;BjEFYl7JykqVMnQl2LMAhweEo4pdUhDoKhVwcV8VBI5gmB9dFyAXCHiAh3BTSlcFZgSoB3SHtbcxQEqXNx5M8XZCyjDT2OoigIYo5NCIMgiSMgfmicMCo4GA5/nIj&#x2B;3/iA3OXYjDpSEQ6sQD33htET6ydcWiBVH6UwbjabKp7hV3l3d29tdfPhw2cP7j9dXy8B/xxxvK6qfU1mF&#x2B;qHXPig1Wrt7x&#x2B;&#x2B;/c690la5yRTRcnn7a3/xzV/61d//52//oFQqf/73/vtf/c3//NtvfOvazZ//7G996dvf&#x2B;eHs3FKl4pM6gYEktzg0M8JwGNJvtDhFGJdFfEBKcerIq/V6HaN8xSigJ9nd3W21WqABwIUHBwcoV0tGIlgpWTmgqpaBW1f6dZkBrMcX&#x2B;FUSI6UGAVVrLfmDEZjjnbj3Piz95V8sv/XDtbm59dXVarUK4X6lUllZWalUKuvzc7Of/9zCrStLt64sfeF3NhYXd3Z2FhYW1tfX5&#x2B;fnZ2ZmXrx48fLlS8H9ly9fvnz5cmlpCa88f/58dXV1dXV1bm4OboGVlZXFxcWlpSXsaGVlZWVlZWlpeWVlBYh/eXl5a2treXl5dXUVPGF1dRVQHrZjmJhxOjgL2QAUJ1oqbUEcBc5QKm1pgHGZ/AfxRGBlIE7qouiWyU4gR4doQLVa3aXPGDcIVx4IXuTNphIp7kktI9xW2QzkG6Y7WS/U9Fkt6IGih0zDQfj&#x2B;kFG2sgSIKtT5kMSoztkXaoJpYdsbbEzGDcmlcMSRZyoceH5C3SA2IjKvZVgaKHwIngSYUsIRPc0NxgofGz9As9kEDSFwLwaNW7hvDwzfeKpZHNGYZCmHyMmRERQ1eWD43hMHMH7oaV/Bqc8ROraKoLaZjHZisk1l&#x2B;ZUh4eTkBH0BBYmemPxQPY7pKgZhsPZiWX6nhEAgAOeTD1X9Udw/5&#x2B;QBKfuxNZXh9ZaSizz0N8uobK/Cv7oBZ2aKmfUKWxqg0r419Ur/Y&#x2B;3IsA1b6T9oQ6fTeW1s6vqj0cjWj62GR1jcuUQOXXEDvIshu3w&#x2B;tnB5bARC4/EYeZQjquYBVyfqyty&#x2B;Y36oOQBni9&#x2B;E43mmLB2N6SXit3AZ&#x2B;5fIXnX6jNImVdyxnZhBk5aWiMNoF5CdaL9C8BhHkFC4b/eYGnVQnmXQhUPWkmcZzih5RYhP4BvZ7YifSDGfeP263x3gHfQcmWJSs4x6oenwJUBV0aSiiZGmXk00OSItNtk4jlRN9C&#x2B;hXVgKH5xCkkjF7vstSI13SVGDVyspkyuAU4QztkHQsUmdU4XecxUT&#x2B;U/hU&#x2B;K1/oVL1a/riN15PIlzbjgcpjRGh7TnynbsUy/p91WdXq5i8RMQAFAO59wYOjT/UhIMhwjSCTl0DKzScZWEDMdreJJklPtgH9T41W5IOPYroX05SZLMORiXdZXk3JXNADODw4BhoGHoGwKxDzlNnYvCcDgcgFPx4xpgSRi4ISLCXhj5moZBMBj0g&#x2B;Ew&#x2B;khJgI45nKhpogNV/zvhzB3ACEsS7CoCBPa3VkW1ZrNZKpUf3H9678Mniwuru7vVw8Oaft0FWdrttiqmTQoApKw4Zuro8sr6p3/mszOz87u7e8&#x2B;ez25tlR88fPb1v/qHP/7y12&#x2B;9&#x2B;Wv/&#x2B;K1//emf&#x2B;&#x2B;wv/9offO3r35ydWyyXt6tVb8o8OjqCnkceTVVJj46OINQWoGlyEJiy5FtMbwQ6lLhC0ApQr8a0fkA61WsB9MvlMk4Ksg1pTlByBtAEZBdhEO6HRgXideV7AmVK2wNMvLa2ppnBO3wAGaM5gLI6tlZaW9vd9m/ZwFCvINrcWPz61&#x2B;bevDF7/WPzNy4t//7nS6ur0OeUy&#x2B;WVlZUXL148fvzk6dOnL168ePb06czMzNOnT2dnZ589ewZXwLNnz2ZnZ1&#x2B;8fDk/v7CysjI3NwdvwMLCwvLy8tzc3MLCwurqKkRBKysraAtsbGwA96&#x2B;vrS0tLeE5QoRgGGCjYANHUiqVcFS4DiAMqvqDM8A2jWuFF3HZ8djjDGNBeRX11S7Y5dBlsQIwLtwytAUOTPoTmkW4R0D8Xv1lRkCAKx7s74s92h6UDsDyBKsL0vK2h4CN15g06jG9cRIL1uMDXK/XDw8O7F/EAf8pTF83RnxpfqSX0x9ya3IsIBazLgW7tbYZhNxqtUQKjs3UZCFvba1FhZJtR2gzjcKHMBF/pK8mtCnUjhCU19nh2wa4XF9xYgIqzOuoTjlE7Ggy0vTV52dn0PEXFmTxB8sNrCLo6OgIYP3E04CJkcNA5MccXyA&#x2B;IGMxTMNoApydnR1zaxL5WH&#x2B;w0L&#x2B;6AdZkjMfFKxMGAOKxupX6aAEZgk9OTtBSUA&#x2B;BNt&#x2B;exfTqJMg63OO4ABsYqoX1f2l&#x2B;tLBMw68JoKvYn&#x2B;f5eJRbOJ4z8j8ttCtOSUFS2tgBAjlH&#x2B;Y7HY9XURS20Ll5RKCc05WIOWZqOuf0xw0l5wEUBPucoXCuhQeldMFRO0IQRluPxOJ&#x2B;cCsz6OnkFAeiIRyioLT1PCg1PkshXgOMXnRCIt/BdYwqARFPTndD/yQ1MbD8aCCa9B0eSUnzvjFoppUAftwawLKHvM89zW&#x2B;P3AJJsJKX6C5mb0uEkZppBWgwOA0b1sqKMwvHUtB0KemAuFL28MSYhxAzx9OH0SSJDrZs0KiRsX6QsdYdhaAUwvIwuJHJN/aRkpf34z1iapgCmRX6okfvnOf0BiZ/LRpLj7cuJ9O5RFMdxEAxhs05i9i7CEBFMMDHTkJD4KcJkdwnbLNhXxG1SlI/xbRDYxFEY&#x2B;Lo7qA6dA7LtirKKBCZJEoVB4o8/QnUfnt2Y3AaeXe9YSBKMIQNJwCWCcgwNBHgG0ApI4hiKIAiHgmAYhgESWv0gMO9zCILgo9QBOKLJTzgetfxms6kIIIl98dtT5&#x2B;AhK&#x2B;dtUQ7UoIug3W7v7lbn55cfPHj2&#x2B;PGLcnmnXm9ody06hvUjjR9mYZQmp4/t7&#x2B;8fGavizMz8p376swuLyy9ezt9645feeufDUqk8O7v4Z3/&#x2B;tzdv/&#x2B;IXv/S1d969t7VVqVb3rZIBdVkI7lXmrE8OfFXuiuqUEuoIxx9QsS19jlCaVWzjRXQGVJgXPcBaEPBI1o8zBZijNt2D&#x2B;EOmEineRzoiTMMFJkZVW2YDaxgAYUDhHJ5ayGZ2dna2Hj/avPs&#x2B;6vpwBler1Y2NjY2NjdLGxtq3/9fs7Wvz11&#x2B;fu3n52bWPzX3piztbWyi6l8vl1dXVx48f37t379GjRy9fvnz06NGTJ0&#x2B;ePn16//59lP/n5ubABJ4&#x2B;fQpvwOzs7OLiIlzC8/MLc3NzKysr&#x2B;Cc6A/AMzM7Ogg8sLi5KJgQ/ANgLwoJAFXA8G3x3Z2dna6u8vb29uLiIHCGhfJy7hhjgYsoqUN4q7&#x2B;7u2NnGclFrWhnsBLibVU5rloIINM9C9iqTW6vMeMUyen5Aq4l6OPiUHhwcHJIJiDyAMU6RBCD&#x2B;OolovVbDn5AaAocmkPSAYUR1WoTlZhb3rpmHXrSrNGhTbk76g9FVEEavmwyApgkFwlrtdrveaNRqteN2W/pDAf2W8RVYHZFaBEdmF5bStJg/5rG7KfzbSr/9kmmZiQrNZrPdPha4t&#x2B;0CW/jXidj&#x2B;QNtklbZYAZFqSO&#x2B;i/t&#x2B;edB4faYgBByGfcdIwAL1wv5X9yExsQb&#x2B;K/QD6R2aomToDP9IV0DaDh22EqK3xn5lwoYuLi86kXdgW8kUAuuZhgfuFmT0sG0Cv1&#x2B;t0LlTX10OEwXqOofW3YaDSC6mTgEyh1wBSNUKLPmD/YsryuUZ9SbgP2iCImRkVjdy3fl06BITsUyryx&#x2B;Ox9DAS7XjYx6hNxzLwyIwTVkMgy7IxlTyO87nspiQrAkrO0nRigJGpNJPbpBMaffIZnY5A1Xg8BiFRQTrlfLTMHqWB7KIoulYZ5UYoFKO0n7EbI5VIVrACVZcjSOoFrwH7HNfyEvmJBRyeYOPYqrQ9bKqgDB8L7ktBNBqNnOIpE18jV4kdhWfHBCGgUnxC6HPgfCgKV2wPAQ/cvsSLuCaik2KuElG045yLohBipERDlJNEonkQFWF3ruUDSZ3ENl4sFAEH56zuA9FGNAwMh0MKzJzXvscRjhm0IQiCzJtuQxzqKM&#x2B;jSDKhSBwDPEeafoeYziQpwlj9c05Ao/qInNN7hQHiE0b7Oz/fIIiiiHYLJ/MDCvYJiApcuZjbEEeFFgh3h&#x2B;jfucS5JHMO7l46KEJxLTwJwwCK/&#x2B;FwiBMZDof6HAbDYRiGQRCEYZDn2Y8V1f8bHvpp1I&#x2B;T&#x2B;vLqd6szoJ9V&#x2B;wstWIBfysPDw3q9sby8/vDhy2dPZ&#x2B;bnlur1iYgSlRLBJVSxE7WwVT29cnBwsLu7V65sLy&#x2B;v/eRPfWZmZn5jc&#x2B;sLv/8nd978pS/8wVc/&#x2B;9t//Pf/8O2nz2Z2d/f0026LjgBVdYarCFWoyt6k7gggSfVR2QCsYBqIrVarQdFR44io7e3tFtNd0M1oMrMI9WPVgFFdBuCrMZYeYAu4EEDT2oJR1gU8hVIIG1EaJhJspHQX7gdYB6&#x2B;AV1gSmo319dV/&#x2B;sfFn/7kyle&#x2B;vPbeu2sL83IRlDY319764dLP/OTz668v3ry8eP312V/4mbX33p2bm0NzoFKpoN7/8OHDR48ePXv27MmTJy9evHjx4sWHH3749OnTx48foxvw/PnzmZmZp0&#x2B;egBJAHYQlUfhfXFxcWFiYn59Hi2B5eXlzs7S8vAwVkIYMLC4ubm1tgRisrKzCS7BBxwIES2AFIAnQBZVKW5ubm6IKuizqY8A2IEuxzBKaT6yOAQr/WN2mtU79E9sBMdjjSGYheD3BvT7gxGLx0n0zxAA3/dDMlj7g&#x2B;IJqEVfq9UVC9nu7u6Cp&#x2B;HS1Wq0qY6xECQ7ZW2u1fLCv7Q8I4leNqV0yISmI9FeGL4R6rdakLaFpHAi1Wq1erzXqdfW&#x2B;9IePvyn5eexXSmNy5Fmr5SchNJvN1iQrQO3AonnbKBD3wPeKOpNHk8FEKmHYVfB92KQBWsaDlhEXHRfTCY6Oj4vpaS2GDrWYcGrVQUfG3Gw7ACr2H5usoWMTQ2ThfrvdPqVv2NsD2Bk44&#x2B;Dh8/Pzs7NzbP&#x2B;CE8QA6I2ayOP&#x2B;KSIBPK2NA8FP9Q2sOViaIoH1QvZDMqBqvfoGUx7iPmv8Wl7x/6AHMvh2u92&#x2B;cRjLJSx1EAjA&#x2B;fn5a8D0FiWPmfyT0RUwniz/Oy&#x2B;kGatNAGAuDI0FiNr9GCx1CVQg12Da8XjsiUeWZZnm&#x2B;/oy7XjS6UsfcDE9N6ODOSt09t7AkNIzYI/Bspp0Mu5G/5eHWDXalB2MhG5d/5jUvtt6v&#x2B;&#x2B;fILvG1/6L5CIsEzOhRc4EqqtTq/wR0dJzHEkSx/nk2DXfTHDOEUrmDC0d8&#x2B;JnPvyex0kJCfYkJZXArmTluUYN6HLRkYw76wE9ouiNPIlUqjiFhNNhE2UH4Y6ZPFBfk5bNlCA1pSwn5rgGgNE4ihDvarN0cD1lJJjU/3jgzqvqN&#x2B;VjK7GLKIzpfMiYlIqStg4Agnv1ajKqjiDCSdMU2BmYPhgO6VtAZyCKQhqXzWgC37swEaXgM&#x2B;gJgA6BpaSGlOJ8fWnfH0Uh/kGdXttMimkJcezNzVEYBBIRQfxDV7Fva3heFIbY4KDfh&#x2B;g/iePhYIAFnEuGg0EYDMMw7Pf7w8EgieOPlgdAsRUtE/0hmG6JgX6Jq9Vqi79eKKdRMtsql3eeP5&#x2B;/f&#x2B;/p0uL6zvZum/nZ6iS0jPOvzaQgVdwPOeoIByAgUm80Hj1&#x2B;9sX/&#x2B;qe/9Ku/9977D37hl373g7sPv/b1b/76Z770p3/&#x2B;jQ8&#x2B;eLC1VWlSJSwI3uCMMBVBgXisVFo1fhzAzs5Os9lU2ItK&#x2B;1VO2AWqs6JqICTAtW1Gx6D232w2VV7FuwDfdmYtqssHdBgfHBwg1QebUkkYIBLwUclCgJ6oZwOk4i1k56McDggLvbtUQBD/eL3QP3zzxfXXl29dXvvZn1z/2p&#x2B;uv/9eeX2ture3dveD5V//5RfXX5&#x2B;9&#x2B;p/Wbl2Z//mfLr39Q5hxUVNfWVlZWFh48ODB/fv3Hzx48PjxYzCBDz/88OHDh48fP37y5Mnz58&#x2B;fP3/&#x2B;5MmTZ8&#x2B;eQSa0tLSE6j7cwy9evJybm5ufX3jx4sXc3BzMA/Pz8wgImp2dXV5etpKh&#x2B;fn5tbU1OIlXV1dxPJgphn8iaRReArgL8KJ8AtICod0BqoAnNCJXbK4oqv47HLOgV/B/qwvCBmXmBsrH6&#x2B;rn4P/gdTuMea1yCgFWFw&#x2B;07SCAfvUKGial6vDwsN5o1Ewkke8/MNtKi0lWJInaLodaHDCeSNX0mhl0UDduGdBa9OXkW7DdNtXyheBtW69pEktbZrRIw4xFa5oVbdNA2xf38PCd5mbtq16vt9vtJg3HIgBqcvoyhBl2ju0D1ouNHJmhyFodyyhKSGQAX4OnHEN29KPml&#x2B;HFljE3H5tpBlZfpMI/wLe0/ooPEnOY8BMbJzFczkL8YBQA7ir2e/IwCf1PT088Lr&#x2B;YeJydngqUyxMsf7AekgDhCYRDXRMSejGZIgpAL3/wFPRXr6BvxgJYiK8EoQ7HDvR6XfEBbwKWhsc&#x2B;VJKX01e17TGhNqvXRT3bv5WmKYdtiQlkxhiQMfrTeYW6D8LPssx5PuAjgDIE8qBv8OqEYMp4hOaRMSpxiJoMjseD5wLTAqaj3JfhM25N7/pXGBZkgbhguo5hzJllhFwTST6iWCAV0ihJZO&#x2B;VUbj47Db4i89UUJTeU8&#x2B;OMhttBNuA&#x2B;IDumvoApFjSLxUNmZyZoUnso/EhVok5EcxfUlbThdFJk/wiQN2pZ0bMC6KiPfOpQYkSeNhq8LZjwPSIuFbHlnhfgZ8&#x2B;5jUqGGWFtgaPKqP6JTaKpsR3V3zwDoAsgqTMh8Hj4IwsSF2CMAhizjaOojCmnyFhURyQ2ts2uBZQeDwZzRnCI5vE0P0DxENMlPkoHkh0qIOi5xgKHB/TqfvhqJjyQUA&#x2B;V1RXKUvTKAyGg0ESR5lzAO5&#x2B;p35sWRTH8XA4zDAamQcvruVi78pAv2I4HCI7yLlkOBwGw6FjW2M4HAyHgygKkyhC5wTniM0Gw&#x2B;HwI0UA8MOg4pZqXQcmkRO/drVazVriAAKOj4/39vZKpa2XLxfu33s6P79SLm&#x2B;3WkX8dot5naAKqrVPdQ&#x2B;OGPNX55xgRPrgZ35vr/q7v/eVP/nT//EzP/db3/2Xt3/1N/7Lt7/79r9&#x2B;/72FxWUM/LLaIZUq8QqC4fGLbhU&#x2B;qpgemlQfAAhJsbE1tDWsJltQCRVNALhGowH5R1FkJSaTWBwhP9KN6P9AfpVKBQQAoBA7hUxlc3PTVvc3Nja0mCQ9gKTQ9gChqhCOFXGoWBELLC8vLf/1Xz6/9rGZG5fmbl5aun114dMfX/7Kl1e/8&#x2B;3Zz3/uxY1LizcvLd28tPKpN9e&#x2B;/69b6&#x2B;tbW1srKys4gLW1tbm5uffee&#x2B;/Ro0cPHjwAB3jw4AGEQI8ePQIfePLkycOHD2dmZp4/f37v3j2gfPQKYBqWbxi4H35iKIIQFQqTABzDaAUs84FuAIzC8A/gwOABWF5eBhnAQGJlCqEbAJ&#x2B;DXMXlcrm8VcaFBTtCB6BU2tLkBD3xo5T39nDXdvlEtX90DGwEE4A7Lj5IQqWyDbyOZfaq1Z2dnZ0dr/46PDjY2trymrFqtUoOoN7RPgcdyKUAwlDn5AobTOS7B7Qaq4XlSUW1Wvcul0JWJM5c56yDusm9xRYazCQVdj88PKzXa/YvUWqiOv&#x2B;m9NdaN2LCoyKotG6/HGyNAD28ppnPLW7QMuZ&#x2B;wfTm9HSzouTfoHwRsLxJGSTKHy1mGEgXpM6ARERqOHhREB3Dail45Q9UQByM0GJYUMtEJ1sDsSzCUgQdFzMEJpoAagtILHR&#x2B;djZlKqBkqBhxIHrQZmipRfCiECeTk4m9VOjsVKhdYB1UQS/2WbzvdC7AXjqdjqzDVhrExTqiE2oOXJhZwnIFeGV/t6vdSTukJaX7V3Jov98fDPqvSWGfUfNjxf1jxvuoWD42IF7V9/F4JG26XncUDgn7ZhQOWYGNo/QoNSYBFarzSZuBBdNekeJ5SMFbtFk8sjQdWZMDA2ckagLO1rqZEjYpWIrjiE6DNM9zvJ7zxFX2Zsk8HY9HAq86PEBDU5f1iUZFTo6HvBot7IvKmLbsOA7M7wsgnmQGPQRffTdcJfH5PH5fuiMo90ovLidoatwI2JROhG8lLklga/a4kwA3zzPU2p0xM&#x2B;Bc4ijKfc&#x2B;hsBdnbAVkDAmVGEaxPKCXyeSAgpj2XyXhKKUUoNY5l6Uu4igu54r4UUDkLE2htko4J1ixmBGzOKUpckUGfxwGgd9IGAZBAJwNiQsWQysA8BdMRiJ44uo4TZ2QNwzEEfN2sFmddcrQHlkLcJxom6hJIi1&#x2B;JO1THIG0RGHI7CNvzPUTylwiAU8U&#x2B;jyiMAjyLIs5wBgipWG/n8RxHIYxFxoOBgkGqGEZ0oNgOPTtjCBQHFAYDNEiGA4Hw8EgY6zw//2Pc46mt5LWYxPdg5&#x2B;Zw8NDWQJUEjs4qG1sbL3/3qMPP3y8vl7a3z9Avf/o6AiYXvoi&#x2B;YaxkSaluirpHTKVvN1ul8uVb3/3h3/399/Z3as2Go3d3b0P7j64cv3nP/Nbf/SlP/6L2bnF&#x2B;YXlanVfhUmVEhsmzMSacfWWCo2C5kIhQDNHtDsL8QO473NoFCAX1PxAbyj2w15cr9d3dnawliTdKN9aQ6dKv8KCh8wJBWir1WqwqOJdmVmBWVFUhiUAHAByIKh9II7HgC0p5vf29gBz5Yj1g8C2tzf/&#x2B;utLt668vPax&#x2B;WsfW751Zf7GpfmblxbevLH&#x2B;xrWFG6/P37y8&#x2B;OaNuW9&#x2B;Y2N1dWN5ubS8jN5CqVRCZf3u3bvvvfce/v/48eP333///ffff/LkCdoCsAc8evTo6dOnT58&#x2B;ff78xcOHDx8&#x2B;fPj8&#x2B;fNnz549f/4c6B&#x2B;4HwRgZmYGzmDV/gHoZ2dn19bWVlZW5ucX1tfXl5aWgO/BAfAWDANgAphWhto/SIKmF6NjAO2QLhe4jY8JYnio/NBwSONFvKLrqbBRNHbwHDgeUi6stbu7C26mtfAJkdNAzQH1miT1Ue4QHtCA4bmH8oeH9Xr9gMaDA842lkBIuaXU/hzUGEWq5sAB02b1B3LIoNLDQz96Dw9rErAcQJsX7rfFexGJhgkYlcyvRt9wi&#x2B;J&#x2B;W&#x2B;avT1oO6szjwp//kdH3689fHYO6kfxpd1MSI&#x2B;2uRY&#x2B;yP3KQk1ar1WxZDnA0mXxgRUEFZ2AFpGUmnckM4Fch7j9hHJBQ/pRt4MSMENbrp6enzWbz3EwRlohIZX4rGVLVX3k&#x2B;IAPnZtiwvAGnJkL09PT07PS03W6LKuB1ywes61dVebQRzs/P0TZQaR&#x2B;9CI/7LwrRv/5v/cTWD3BhEoEuzKSwjokQVZdAgaGvqWBssfuYfEC1ebECMYFMs7dYXAckHY/HyorJiulXvjqe0zmAIveUYl6QMaN6J&#x2B;f0AGcm5grMIXcoNWmbo8luhj1IyzfGdC8I2qaMuLHYXaQi47SvxAf7jLWKdDVpIUnyS8qZ4Ca08v5FQEI7PCEjUbGyIh1JymTSJEmgjxfjin2cfxaG4UgUhf4EHJWURVmhL/IqeV0rZ8rezjml/ANwA9QW58Ii/XiUF/A2jqggwn0sJiTkZjqY6v1JHKEunnGocMSoTTuqOfYSdl9TT2lZFs1Tz4E&#x2B;YDccDjOOdIAnFdfNK/iTxCNXsjLewYTpN7GF/lDDx1EUBENnZp&#x2B;NRj7E0&#x2B;fqxDFsJz5OR75nTykTxeejjRMzMDRJkjAIeGAxLgidBrEq&#x2B;ngbWh3fYQDHQIujIAD&#x2B;1mDQAjaOk/IqoDSNwnAwGMRxjFxU73kYDgeDfhzHMPKm9FgHw2GWpYNBPwyD4WAA6D8cDrCvMAyGw0EY&#x2B;qzP4XAwHA7DIOj3uhQIxUEw7Pd76Np9JB4XFxctPoTsIcVRfcuqa1qto4ODw53tvWdP5z68&#x2B;3h5aW1rq4LKGX6fGszzaU0O1oEiVj&#x2B;fDaMArtVqe9X9vb0qdv3t7/zgS3/85/cfPEUyT7m8/YU/&#x2B;JOvff3vv//DD6rVg/39g1arhbcAKWyzXsol&#x2B;&#x2B;su2UB9Mg&#x2B;xTuOjOgbgLUL8zWazWq1Cm4T67j7HPAF87Ozs4BgA/tBMwDK2uIu6O/oDlUqlXq8DuMsHLF24pB2ChtCNALPu8qHRV9qIsix3OSZMVleg/yrH3AKAYuG1leX5P/vqzI1LCzdeX7h56cWV/zRz/fXnV39i/vrrM9dff3nz8sLNy0v/46&#x2B;3ZmdWfviDuT/&#x2B;w/XvfhvSGtTOZ2ZmfvCDH7z33nsPHjz44IMP7n744TvvvvvBBx/cv3//7bffvn///v379&#x2B;/evXv37t0PPvgALuGnT5/CKAxz8Ivnz589ezY3N/f06dOZmZnZ2dmVlZXl5eXZ2VkwATmGZRhANwCWYjQEQAZAGDBvWI&#x2B;NjQ0lAqG6D4cAGAJ6Amgg7OzsrK2tYUlsFi5nSaqE42UIllsAl1qdAbAFsaxKpYx7hM4MbhCeVznRWVRwf7&#x2B;6Y3zG1gygnCh8zKqms4QPm1zF&#x2B;8ZmoA&#x2B;SHvv0LmNTIJx1Di8TxD/g80Pm3tY4m8yyhf39/VarhR4C5HaqxB&#x2B;aadl1q&#x2B;jjXxBYNymE5wzC32qjqRFRN94A8RACbh/JxXVrIhjiKpOsg3SCy0hBpJaC9QoLytueA2sWLPObfNIGpyu2mZKsRDV1XNvt9tFRS4KiZrMJ0c7J5FgAPJFbALvQkgDiZ5wpdmaGiwH9A5Gron9yUmiKxA2wFwT1SJp/fn5&#x2B;enJyznxPpQlpLZXtLy4uumbyV8fMEzjjHDFb5hf670zOJJZj2FsLaBjodDrDwUCp/&#x2B;oAKClI9mLlhFqfcUEAxgTlqRkJnKYZ4bUfoDtlqMUvpbCjCvZjJv8AnAmCj8djMQ2pjMacPDAaj8aU9JiSs1MzQYVt9QdStgJsW2A8Hgus47AJW31AUEJ4LT6AQq&#x2B;4hEjOKNcUrUKOgu1YbD3VtRiNcjgfpK2ylf50cgywzldXTKqezFyKmPNW/cFT2ZIVAxD8kdsSfspifG5S/BNOI8YTO3bAMZDeqSfgXJamYRhoGdXpHZPy8WLG&#x2B;6Wz9mYKzpkiIQnt8oK8KSck6Hwd05Z8dd/D7iQrHAJxzrnOCdOZdGFjP8d3gJq3ujpZhrG1HnwjgdR5EVGiD4M&#x2B;zAnVL6qvx2b2LerxGYamUVAk3Y5sGI6nnDCICexLhfmYM78yxgFlWTYcDKD5ARuB3gmV&#x2B;CxN0ayAZAtC/yTxA3oxR8y5JMK0YHqcE3YPYKQG4oeUP4rCIBgi6hRVfJAHpPtjs4N&#x2B;P1KlPwxBKoLhMPAl/8AlSa/bjaNoQJLgnBsOBn6LwTD&#x2B;6CSBDgaDZrN5enpa50Bf/MygA66qfKvVqtcbpdLWixfz9&#x2B;89ffTw&#x2B;fb2Xq3mXb9W54oe&#x2B;vHkpB4U&#x2B;/Grrx9OEYNqdf8b3/z2g4fPl5fXSqXy7/7&#x2B;V/7lX9/&#x2B;wQ/fm51baLVaT568/Nzv/DG6AfpxBaA/nIz2x89znVPJpExQBVHlPb2Csy6Xy4DskgBVTZCil2RwOABAGFhBtVptNBqqtu7t7aGHsL&#x2B;/j5quPLvScENfDvCk9gJAHgymKELjIQ6gNBtk4QvbofYPYYnMqcCdvsa/uyskCpgLEAwmUC6V5r78pZXbV17euDR749LLqz&#x2B;xdOvK4o1LL6&#x2B;/Pnv99bmbl2Z&#x2B;9lMrf/OXC5/99aVP3Hp55T&#x2B;tfuufUE0HCH78&#x2B;PH3vve9999//8MPP7x79&#x2B;677777/e9///79&#x2B;x988MGHH374/vvvf/DBBw8fPkRD4NmzZ8&#x2B;ePXv8&#x2B;DEkQLOzc2gFwAzw8uVLGAbABObm5sAHXr58Cevw/Pz8zMzs/Pz80tIy5g3DhABpEORAsBagCQCl0MbGBhREKysra2vr6l2sra1tEP6DDGxsbgL6yzGMkr9WwT&#x2B;htirxIfcF1tVsMpiMNanNyregyMIdlMHASr/29vZ2tj1DwJJ4Hf&#x2B;vMjR2f39/u1KRsfiAlgMg&#x2B;z1yRfKKglHsM9gKHS1QR33m5TMW&#x2B;sdO6zQKiz8fMKGozlQigH4RhjoZRc3EFgnKNxnIa7lBsU2zwCHnElgNUpPhPyrnW&#x2B;EQXkDjcaoXoS1j&#x2B;Vqt8EY3jTPYm4/qdakZm3zom20K6zebYAWcj9ZsNk2KqNqe2sUJ5wPo&#x2B;/NoMozh2MwPtj0BVfRtyf&#x2B;Yw8XaHDKAyNFWq3V6enJ&#x2B;fn58fIz/C/EbVlBYh1Xdh6VYdgI1DWw6EEC2bSl0Op2LCz9JQKlBCvzxTODiQgtYxf/p6SmeQC8klX/XMIFOp9PTVAHie3l/5SgQGShSgFA4x89e6qvmmcr5AKnqAIxNBFBmEuXHLLGrnO047csiWtSlU1POH5sRAVNbIBpMZUXQNtWX0I4EgieL8Znz7lKcVOG&#x2B;FS7XiSi8KDW9goztES/Zd84VeTKUjyeJZwhMqUdrwgJxgH5UuNX3GPscoQmlkCiN6tnaoz/rPDdFeh9hhGsLVJcZM3FOB7A4le5sQn2/NpUZB4V/IItJkxC8sj8Tl0jlD85zUQstjBeLhUHGUHf30ZkBzhySnjEpYs7TcQjgj2MfCpQUMfys2CfOzOLVzY2ZayTon5hY0lGeawFvhnYO7QICd4eSv/J26C7wvMg5FwSB7&#x2B;T4aV8Rj8cJanvhTBiqyp4wvjNhZJOnai7B/8VwkBaaMs80Sbx8CAcJYiPtVmFaiCL2B6I4ipIoUpB/ogV8P8E7fX36p&#x2B;8zxHEUAdPD6Aw1UTAcJlEEdhGgwN/vh8Mh7m8QBNAUhUEA6X8wHA4GaAUMI27tI5QEGgSB1D5HDL6QMseL&#x2B;A9q83NLDx88m3m5uLlZPjg4VBaeimQo8KP8r1a&#x2B;dfo2m80P7j58/OSF1LfVahU/otXq/ouX8w8ePvulX/nCP/zjv9x641d&#x2B;8Ze/8Lff&#x2B;NbS8mqr1Xr7nbu/&#x2B;3tf0bRg26&#x2B;vm9GkKr23jCMQv/1qaKgQiGNGvR8YCK/s0zcJoIONQ4gPrF8z85tqnJyK2ie0E3jeaDQEtpT0AncpZCEqxwJMyxiqCj0Wq3EQgUrI0gJZhcmeGVmlZWBslUBFi&#x2B;3t7WHS1sbGxlapVHr&#x2B;bO2vvj73yz//8taVpRuXVm5emr15efHWlZkbl2ZvXFq4c&#x2B;3ljUsz135i/vrrL66/vvTP/6u0ubm9vQ3xzMuXL99&#x2B;&#x2B;&#x2B;133333ww8/fO&#x2B;99&#x2B;7du4duwN27d&#x2B;EB&#x2B;OCDD549ewaj8LvvvvvgwYMnT54gIwjE4Pnz56ABagtAHfTkyRMMEwATePLkCcwAShedmZlBcNACHzY2dHl52Y4OwAOGYDyBTAjdDBT7Bf3xIjwDaAjgAb4AJobngPvoD&#x2B;CuKVlI4it0bxQ6tM0H7pT6OUD/WAyAXp5vNQ3wQcKd3eOsYtxTfDwOTO6Q&#x2B;gZyCNjNApTLWyxTwW6RanpwYKA8PtvA4rsca7BvZlRblI&#x2B;1mkwFPaST2AqQZLCxVpzDw8Ma6/r6&#x2B;63zn7ZI79kCjwpduKnmnvB6fTK/q8lI0wMGH&#x2B;mbxEqGVOyvTwYWHTHMQIWMY6aiHR8f4zWxBbvYSftEwiFBefUHpozCchjrLSF7r/9hor/EPXIC&#x2B;PDQ0&#x2B;JRNAfoMbDo30t62m1sRM2HM8J9LCNlf4ejAMQWVJK3fgCbGaotiAPgier0tidgjQEq4etFKHzkKJD6H0uiRSDCoGnBr5nCdipYPx6NxvTOFhohU3q3WpqcQZm5SfQfA9ZThKMRAXmeuyQej8diDiknYeWc7JtwDOqY1frEjAsQqhbqJQfI7LlkhTV2WsgkEGwx&#x2B;ng8HsOHEMfjUV5kXLKCLsNAQiyI/blJlY4Qp&#x2B;cShofg4BOiXsmBUo3szTKIsHVqifI3yTeceUUbTwiLkaCaMU&#x2B;GdA7l/3CqpeAtBET6jpk/RKcRbiV37YSnefppxvPNshQp9RkdFIzcyew55lQfwfMK4Rbq8Y4cacSpxgl5QqbxzOw5OLmHrTmbRmeU&#x2B;TXKyqvhoxBiLTEc5Rex/O&#x2B;8UieO4fqAhp6fQET1AwEnWZbFGLHsB4d56wJOAVX5lO9GYZj59NLQUdUTqh6P&#x2B;bsukQ&#x2B;BzKSgFsWhRZFfX4YHLMNVcKZgTcgvijmT2Ht8/d2OoyjEhzwYDvu9nlfth2FI/27qWzehrmEwGERhiJhRdA/iWNL/KInjQb8PgVC/14uiaNDvIQW11&#x2B;sOBv0wCAaDwf8xBH9&#x2B;8R/aV6fTaTHtDmheTYBarb66sv70ycz9e0/n5paq1X0U8luM8FcZTMqfpskFt5WzRqPRbLb&#x2B;8I&#x2B;&#x2B;9s/f/kFpq3z/wdO5uUWA9er&#x2B;/sbmVqvVevFy/v/3sZ/6gy/&#x2B;6Tvv3l9ZXd/hvK333r//hT/4Eyh/ACxazBQS3G9xYgBAvDiArfrXjDm4ximnqPpXKhVV9AGRrZdX6wqsqFdwyPgUraIyPxD5/mTkP&#x2B;L5q5PTZFWC1buKANrd3cVQXoFFpNDs7&#x2B;9LUC5UV6lUgMtRjYZ8xZhZSypIgw/ADru5ubm5tlaenV351j&#x2B;u/tZvzt64NHPj0sqNS8&#x2B;v/sTsjUsL119funl5/sal&#x2B;esfm799deVfvru8vIzK987OzqNHj956663vfve7d&#x2B;/eBfqH2uftt9&#x2B;&#x2B;e/cuWgF4691337179&#x2B;7Dhw/v3bsHSoCYIID&#x2B;Z8&#x2B;eoer/5MkT&#x2B;INfvnyJ19EiwAP&#x2B;YNEAlP/xRExAFmG0BcABwA00dRj0APPFxA00fQywHq0YkAGMWQDQxwbRBJBDAHV9GItL5mHdw5L9bG1tbRszBlo9e3t7ymXC/6vV6u7OzvZ2pVIuozUkKK/E0j1my1qHwK557O9X9zmaAKqhKvN/gPv3OeNMBPKQH2PvJSBprNcn7QGHh41GA1wCr&#x2B;hdeBIE9A&#x2B;ZFCS5nf8/4TsRP/6bEAgdHhwcHhzgUJtU5OtvU/2HmpmOLOKx70cp&#x2B;0L&#x2B;FJQv6ASLAuoPNJgdVGe6qGaoNY0JoTk5kkwqSkF5MQGwixYnFksIZBdmO6EliT8AerPZbNM6hVewBSUCaXl8h0uug2WOOKtYD28XNqGfsAjjRSwA&#x2B;C5ugIXbx8fnkyMCLgwTkGHAVvHxkCugS0XQlBVY3QD5AWQCtkZhM/e3Y3sCth1hRwire&#x2B;BTgJyZF6saf0pFjdXoj1GgZcU9YSBjkdAvqEcUPh6PNSF4xDh/1ezVWzBV8EL6MjJDiHmQxazf1IheUh9RmqmYbd0CIxoPPGqnD7jYFP7JyrHK9mpTaIMpQzNtzV5UYUQWlJFUKJknoeI/RUopCvyTw61s&#x2B;wJylCzLJMQCHE9s4CbL9Hgae3&#x2B;tmhL&#x2B;OIX4ck454Fn4jgrcxmpwQFOUcLBAzExPoXlpnwCXNUMgo4tAiB8rQV0jtb3gbEZpUMqDyShtgq3Wg37ny94K9BT093idGBcOWti&#x2B;kbmZYcCCkotcAigPggQpCw4PBfs89/lLkMIXQh1yucQbGBKJgsDKUHdPGDDqOzBpOhwM8jyPwjDzjosEMFugPDETwRySOjmVjHzPYUxvHIXOwcaQ&#x2B;hlb2BGnvPl&#x2B;ThSq&#x2B;ZAyERX5P0EwjOMoDIao&#x2B;vtJvTgG2gPAXoJgqLlmEPBEYQBugCvm432iaNDvxXGML50kjvq9nlKkwiBAMGiAPkAYhkHwHwb2/68e2aB37&#x2B;Hyf2QLg8HAFpzwg1gubz9/Nvfs6dyzpzN7u3sNn6FxLGCtfrQe&#x2B;DGTmNU6gIHC9/cP/vCPvvbFP/zz//aVv77z8V/9oy//xeFhrV6v33/w9G/&#x2B;9lsHB4f37j/5zG996eDA191bNNUtr6w/fTZT56&#x2B;v9D/AHK9a/Y4YJwK8LloiscEhU4nwgw1sUWWaoYQKe3t7EPxo&#x2B;QaD1bF3r7XY28Na0utjm6jpYhmV/OtMFAWOB&#x2B;hXrRccRooRNQ0w7UsIUh0DUQLUmFGltnxAoiBN0QLu3N/fB4gHtF1aXNycn1/8wfde/s5nZ25enr3&#x2B;&#x2B;sLNyzM3Ls1c&#x2B;4nlW1de3rz88trHXl6/NHv72vq778zPzyNzc2Nj48GDB&#x2B;&#x2B;8885bb731wx/&#x2B;8N133/3ggw&#x2B;A/gH3P/zwww8//BAcAP&#x2B;//&#x2B;DB8&#x2B;fP33///cePH8Mh8PjxYyD7x48fP378GOV/yIEQHvrixQt4hREfNDMz8/jx4/n5&#x2B;ZmZmcXFxbm5udXV1fX1dQ0VBisA3Afun5&#x2B;fxwJyC0gghEo/yABMAhgsoCxRcSS0CyD0xxPQA1xYLLm8vAyiJSfx2traq4OKgftxl&#x2B;Uq3jYPMAo1BDSJbHvbZ4yqySMyYNU&#x2B;e&#x2B;af4JP206LXmS20tz052kxrHZgJZQd&#x2B;WEFNLQV8ktGhqjLBtmYe4AM1Jm6pdYYiveUSBybPVK05bA1/Mvv8p3T/IPkN4y7QWw2akg/oQGiaIYPYo3SD&#x2B;lqomxnGHuibCoKqDOAJcCwI2dcpE1I3Up7gphl66J9PjjTWWi0filC3vimL78UTbJlf6qCJ4CCOGbbzAY6Ojqyp94KzgRUwChB/zKhQeXzRDbi4uFA/QYV8YHfQBhb&#x2B;J3zAKvxja1ABeTJgnguvyxasYB&#x2B;sDhyvFgESfrrdbs8k/4g59Ho&#x2B;KhROAPy/MAHrMTYxPqIBWeYL7QLNKqsTfOfOCOJTE8Uj4Y0lEo4je8cMDPX9Bwp&#x2B;ACK1ZSDm8XjsaD9Q7hAwt5yjufEDCIPaejkAaJqmURTbE8Fio9FImTMZ1VB8PQPEh4QmZtQ9lrdA3Lk085DRswl2M1IUla3VAYjZcyoW5ulo9WmMmWkIBEFA3OunhnlsqllgTO/BweBqixKkHJcGsQ3BamS7HFDUYGExvTAMkZ&#x2B;TeTO0TMAj5upw4q9zzlyQlPXrhD4HcQzsjisWg7Gcz&#x2B;N3IlcF3zHtAUd5fcKrZB3Gcezz&#x2B;728xznnxwZzkBY8D2HoXbPsnFhYj/vFbkAs3kJ07mOC0jR1SRyGgTdb8/qr8O&#x2B;cQ5Mk9wFNXlbkrcAhmwORD1GFJgetAxykm4h1cmmSyDCdpalL4oxJU7YJg5urab6Rr/IPszRleFEYheGQ0wmiMAyDoWNDI/LW4SHeikIfJDocDKIwCIbDYDiIwjAMgygMzYtDXL1&#x2B;v4d/xlE0HAwG/f5/ENn/v3zslQ&#x2B;6w7Eb/fu3EIbhEVM&#x2B;9duzvl7a3Cg3Gk2V/FuTYy/xCpbHz6RV/G9v7wCFowBWrmwvLK7sVff/6Mtfv3z959559963v/v2b372D3d3946Ojr7/g/d&#x2B;4T9//nvff/d3vvDl733/XRXz9OuI3&#x2B;BDRvVjs6ri4/deNbwmPX/gAxD/4GCskrhm7Ixa12oeagz93GdyYr1eFzY65HhUyIcEoaTEgES7Xq8Dq6EKC6iEYjA2LrOvyrHQgtdqNTCEWq2GKvI2E&#x2B;gBCqH8UYA9aINet6k1NrQeLQJUr4Fft7e2Vh8&#x2B;WPrWPy5//nPzb954fvUn5q9/7MX11xduXHpy9SdeXPvYzLWfeHn99cWbl5d&#x2B;6uPzv/&#x2B;76y&#x2B;eb1Irv7y8/OzZs&#x2B;9///vf&#x2B;973oP5/66233nnnHTiA792799Zbb927d89aAt5999379&#x2B;9DL3T//v2HDx/evXv3xYsXDx48ANbHAAFIgDBdeH5&#x2B;/unTZyAJcAXMzM7Ozc0hWhTeAAwYxj8xVkwEAO/ilfn5edsT0DwBiYVADPBuuVyG22Fzc1NxoqXSFhZAuJA3Ga&#x2B;toW8AkzGeoHUgtgDoT09wBTdCbZlKpbJd2dbEMSF&#x2B;2L7L9BJYC/KuH/bs/SG7tAros4RVZBtAV0p9p&#x2B;3t7b29XRlX0IUApldDAN6SAxbgqybYSugcf63sNvjUUasI0p&#x2B;S&#x2B;gbqCah1JvU/Fqpz5LbX9nCOR91MNbbVfWsUPjTjzPAWvivqxmag2r&#x2B;24Kv7k3WEOrOJ/JfJpKxI5f&#x2B;GCR5omUjTo8Ii3LbEQEwAeqHjSZKAb9QmSQKK&#x2B;kcmO6jFQCHo&#x2B;FtGJlSogMwUYb0IGmBLNsfHfrOQESn8R9IgifjPTBioFlN1H9xATQNRhXMmC52dnV2YiQH4p8iDLeFbL68igFTml&#x2B;VAC&#x2B;j/WkZcQoZjHORrAuu&#x2B;Ym18q5oHPDZZ/ipUy87rnEOVemph4W&#x2B;pg1DXnLK9crPOMa1f9eOUYBSv5WxQAO6nlHBoLcmBhBqdj4n0UqWJtsBoBGaSU20fsRothiPlklOTgS0L22rI8zyychfyEAmBEpOwmSHj3zcEcvYTPO3xmJ7Xx002WzBNWaX9jIPVcvYNsEoGry0YEbsreZ6jfyKAi70oQlToOvchpBT/MEoVVyyljSHPspxTkLE6EKaOMFGRPlH0Z4qZaJCj5H7cAQd7ebKBFP9InZYwDCxZ8h8qBIyiO5E6FtGTnOKcnMlFCV0EQOpA0vR15LLhppqmHEUM4UnGoxGm2CJyRwSA2&#x2B;EcAHxi0S/gncrN9GIV&#x2B;6EaytiHSdO0MGQnSXGotExA/4NI09SrgnwIEoQ3hSWaap8wDHm0HtwnSSxNlNER&#x2B;QHDkPv//3l7zzZX0us6dH7gNcmZOWfOzJwZUaRk2RJFSZRFWZG6smyaylm2JSpcW4EiOeGkzgk559iNbnSjc0IsFAqVUPfDeveqFz0UKYqS65nnDEKhUCigq9beewVbJgmGYUwNg9MAEHtAZMIEAGQhZHthx&#x2B;azGeYDKJ&#x2B;MycSazcaj0Xg0mk4NWoKORqP/axOAqzujP/yB3ms2m&#x2B;lmF7qBNK9e15JYqV&#x2B;orsSx7pJOdre3hWLlG//47M//4m9PTnqXl5flSq1aq29uRX7t13&#x2B;3Xm/&#x2B;wR99/Sd/&#x2B;it/&#x2B;dff&#x2B;K9f/aM//R9/c3TUvbi4iMfTv/BLX/u1//J7z1&#x2B;s93oqKYxMJLwLGngnJyfwF&#x2B;K8Hu97cnJCir9O8MXF&#x2B;1IcBnWGAAn955orKFuJbGoeS4wX0cDFxcXh4SGnAYQylPP2ej2SOoClqOM8PQ0bqMBwQGyoAUDpYX&#x2B;XQI3mPydalO&#x2B;heEqi5c&#x2B;UKzoOVatVNKGPjo5IVQfur1ar&#x2B;&#x2B;12o5Avra6U/&#x2B;j3iz/3M9n33so9fZR691Hq6ePMu4&#x2B;K7z0uvPc48e6biaeP4599N/XlL9X&#x2B;6uvllVf1chmtdDTdW63W3t7ehx9&#x2B;&#x2B;OrVq48//vjly5cvXrz46KOPXr16tbKyurq6ur6&#x2B;8erVK5gCIR9gd3dXzw3Y2tra2tqiL1AkEtnb24tEopFIJJlMogCgMhjhwUgKSyaTCBZAVYCnQARCWBi0wggY1h/nBAC1AUA/iEC5XA69fwYLMGgMh46KAoiGIaJAjx/TA6xDATEXRgfgoKFUQzGg27aSd4TaDGlleK3uOnogcXL4hWA7nBV0hBXGHxLGRxQAkHWml5SHhx2WCvjRHh0donDFjEv3IcVMgLwjqll0LTtHB12JyetJEUAFwrEsLCTI/GENwBHB8fHxicSfnchTnDbgL/dES&#x2B;A&#x2B;1VLMcMZgGXARqgJU4hjOElyBZ4xTCUTTX8WRAdD5qZAMr8TZDCcnwno&#x2B;cnNzc3Gh7BAeKASutBhjPAV8j5UJ98nn4YiAUwLa/oDMc319fROGBy&#x2B;pAnDGBtC/vLykIJgTgxtqAGS5vV2yE9UevwXcJ9Qmob&#x2B;/nCvMRx4og9n&#x2B;p2aADCJdlCxygIGeLsy3091Ch8PhdDrlbSiA7&#x2B;/vXwuCgBRzT5jxrugBlMGOMOk9YQEtNI0s&#x2B;/eALIEECQfLpqJ8C1tpUkOijqvZVuJ/jkg2vWVPUul3h0wYf1m2yxvBYuH7HtlHLCrCMkMQKh9n5aBPORYSMLxYLGwhvrNN7qhGr43xBgsPsucpMiZKdrUFkVjYGok9MrRwAxFe60fP9306SAJ/&#x2B;76PHZsLhuaBBXUH/WZwt7h9X/xziIZZpTDXjP17gFTslSP&#x2B;p6hzwHHi4WVUMAhhD46wCFhtlHAo3riTsKBxJKjLFaa&#x2B;LYpnFhXYH50vRbL&#x2B;3LKQjzYLKe9qYICdl4JHq3Ag25DdAF1K6bmxsqO0vJ7noofuCiEN&#x2B;VamaXouBx1q9AFTfEtqj/l8HiwWjipUFGGJbCEIIWSSoWTHrlIX2LOZUtbiKdexTdNEgLHoia35bAZlMyg8oNxYlmrtg64DRYFth9FmljUzTZOuPujf27ZtTg17PofRJxA8eFkq28uylN2nYcxms6lhoMc/t6zJeGTPrdFwaBoGqwtWAv/XwoDHxvzBI0f7x9/XFmzbpjSNFyFcWkhjpRxWnwBcXV1dXFxeSEcKr/3go5W//Otv7kVT5&#x2B;cX7f2Dr37tTxPJ7Ora9n/8wi//n7/99k/&#x2B;9Fd&#x2B;/Cd/5et/&#x2B;XepdL7TOcL0/PjkBPwXvDmqjlPNtYPXSFzUOX&#x2B;gSRHBPUcEVyqm4ISiQAoTzyUqGP17HUlAE3woBjt4FgUGUAUVk8daLAAxCpEQIBTmALQH1aXD4GQDM4HCwRYv4T5jp0ATAso/PDykzwxe/sCPUqekUySATjPa0p12u5lMVL7x96Wv/kbhP3wu/95b2fce558&#x2B;Sj59nHr6uPj&#x2B;k/x7b2WePk48fZz7sc/lvvob9Y8/LEYj9Uql2WzWSiVgX/S/6/V6JBJ5&#x2B;fLly5cvnz17/uzZs&#x2B;fPn4P9v7KysrKy8vz5czB/dnZ2IA/Y29tbW1vb2tra2dnZlQWFAVQB8Xgc2WGJRCKbzYIRlMvlMB&#x2B;AQRCUAIlEIpVKYyZQKBTw&#x2B;AMlAHr/oAnBI6hQLOJZJAxUZFAAWA9VgB4ohpIAkQKYA7DZjyqC1CBgfbykVCrhQY4FKpVKs9lA9YWxQLvdbslYgPoBfOM0HeK3CU6RxgU6oEB5Xwsqxsu74veKBw8lqPhAYqo7nc7p6elhp9Ptdo/k2QflAYcD5A7pSmL&#x2B;SwUCNQPHx8e93gm0CMcSaqGeWJYOn4pgptvtnpwc66M5nXp0Ln7/KBWktX9ypkmHT6TxT/LemabYORGf31PNXEjX9gi&#x2B;D12GuBvsGlCrQOog/70UYQCRPc&#x2B;lKCrosnCuJRPjXzZfwOnnOuzrX4n754My4Pb29vpapQ6zDLiSrJUbMWHTOzV3t7e3t0sZYWzc0ESITkH3S8HAKpC4L5174H6oBYDjdcHAQNA/axJ9XKDfIHYXqcC9vgLeC3weKImHKuh3PNRSwHT6EF6FJGAKCabT6Wuu0GzYPg/oxKKFdpGZ42t&#x2B;Qb6WDUyGzEKDrXQUDUGnBtaR&#x2B;Kt32X0pGJzlIC0Q4gPNyz9QcwaXDXsWJ6wuAm2eMJeEV1&#x2B;ax6xeFtLCV24wywkAxMfskvMj4I1csecHEoPAVw09NF9Ocvo5GVAgGAG9vj&#x2B;fWzw&#x2B;6lBojWEX3qlqNhBOHoD7gbzR&#x2B;BeUrrA&#x2B;38sTRhC44wvfn89V63oh2gBHMWuUDSi/ejbj4XAKNggf5HEj7ccVZyEb/kgiFPZA0RFIjk8ahIfIsWYzgGxP1MYa32eOnZTBiOe6DgcvijfvOLD8h2DXkxwAlDGuYy9832Yi72wWHmQJV2aD31FUfmXsM7dmriPpxZbFQYRt2zNzhhpBUZIcG8/a4qMKPyHHseGmjwpk4fuqZc4YgbllSbSZ&#x2B;i1Np1Q8U9qLuzDah8/PTNC567qWNZsahgnCPWYU9hyCXdM0AdNN01QDL0ulI1vm1BIJMAoGSAIw6MDLcXtqGHNrZk6nYPvgvfAyrAPjf/WfVB2GYRiTyXQ6nf7fEgEb94PO8Q3vju6u17YL/fvRP38Ls9mMFhO89qA5RCnblRb&#x2B;dabsMi663eP1jd1ma/9UnPguLi63d2L/7b//8U9/6deyuWKrvf8Lv/S1SDS9vrHz6O0v/M7v/fna&#x2B;k693ry4UBvBwEG/8Ov9firqzjW3ELb6eHkGlNdZvGzVX1xckFhPGg8YyV1x&#x2B;te5xWDmgOpDhjGu&#x2B;sD6OkeCiB/NVCB1MBOwHQA1DARAyaDAFzMBhsKeiAUk26to6xLDscuL1wIaomYANGQMMGWp5JbQjXS/0Whsb5X/7E/y//k/pZ8&#x2B;zj99XHzvreS7j6LvvJl5&#x2B;qj0Q08S77yZffo499l3kl/88dwf/2H&#x2B;&#x2B;bNCMglcm08kamuruT/5o1osBt5LvV4vFAqbm5tg/6&#x2B;trX344YfPnj1Dyx/CgBcvXsD5B9oA9PshAFhdXV1bW9ve3tnZ2YnFYtQDRCIRDARwAznBuIEaAK6g0WgU5J9oNJpOp0EBisViaPaDCIRwMQ4BYAaaz&#x2B;dhHgoXUaiBmSFQqZSZLpzNZjEWqFarpWIRq3FcgH&#x2B;bkkDcaDSqVTVMKBQKgPjA6LVatVAo1Gq1ukwS&#x2B;AUB5RP900WU1KBWq9VsNPb3wwkAhcL0C8IPCd/y0dER1CDYAUL/B8MoilXwcryWP8tOpwN2UCdMpuseSQEgJKBut9vFal1Ng0yuP2cC/AM80iK0e5raniugdw9lwrGWaNbTAD00zeQgnWltfp4cTrV4Y8ULkvqBLCBB82pnSCMk4ufw8FzLF7/Q0sQutEf4&#x2B;LXmI6RNAy5IXOTLqRumFPhay168v7tjm&#x2B;NCwozZB7mTsEUwgujwwzqBIwLUDHycwmJi/XvJA77RQsRIGdKLBIB&#x2B;VSEoOpCaBtxJgAD4PzQC4nCAkgCShQjuuQw0EyF0&#x2B;nWTnwcUIF31i6kC64HhcAgNAGoDbuQ1dGFDAo/IAHxNgKvPBIIgQFs90Br8rpYfHAjsDqR48AUHPygGQGgRj86H3BtHTEg9oRthszTlJOJnQ10Beukusznty&#x2B;O&#x2B;5IV5muURd4lvoU8DZJc8vlGg1RWcJzghR8gXSKoQP8gagTiZAgdTjrwQvg0Lm/l8Dm6SJzFq3DHyjtD&#x2B;xz6QeOM4jue50jxeCvflJ0Qdwub3bDbzfZ/GlyxzOARg3x0OMx7c/WUFfZ4wn9vhXc&#x2B;jKZArQwNbAqc8EZOIPNd2JDRtPicBSemSUYfMl1gxtkM/UOHScB11Q1NX4xPwC1KjANtWEwPZMiA7aga8BfN9le2PihJTvCPp5SvD07llzS0lfnUcBzUM9p9CAgB5W3Yeswb0yB3Hnlszw5hgBVu01wr7z0xmD2NOQnEIVbnY7enUsKzZXMj&#x2B;&#x2B;LUjlQw9ftOcmqap9sk07TlSfufYB1j7W9ZsMh6Px2NzOjUmk7mlaoC5NbNmpjOfTzEfMAwF92fmeDw2JhNjMsY7w5MYz2ILCAX7v1YABEFQbFzydrV6cDtxne/n5Z7nAYhfirfPuYTgnIoJBoVluBp1Drtf/6t/iCdyP/vl3yiVa9cSkNnrnf7&#x2B;H/7FX//NP37hp77yv/7ib7/&#x2B;l3/34z/5q/FE5tnzta/91p&#x2B;2WvvX1ze8jEnNcMGLHAcLbIxxItGTqFE&#x2B;gkus7jt0JjlE2PMTMSrBpyDPmH1BVAIXFxf4lwJEoiWAAyAbDg2wJgAKOBIAMTqIB5DCToK3AwRzcHBAWpHeWyUOY4MWjwDlE5mRI9TtdlutFlCUAvcCDdGhBxBEcxpPNZvN2uZG6We&#x2B;kH//Seq9t1Jvv5F&#x2B;&#x2B;jj93lvZ95/k3nsr9e6j5LuPCj/2udSv/XL9m98ox6IHrVa73a6Xy9VYNPe//6b0a7&#x2B;S&#x2B;eF3Ez/9hXYmDVYM0DPsfV6&#x2B;fAnc/&#x2B;zZs48&#x2B;/OjZs2dra2uvXr169erV2tray5cvd3Z2IADY3NyMRqMbGxuQCBP07&#x2B;zs7Ozsrq2tra2tJZNJFACYDMAkFFQf&#x2B;AJxDpBIJPBgLpdjbZDNZjPZLIICOAHIZDLQBmSzWWiFC4UCHkFVgCEAXESpBMACrM/CAElkWAHQH&#x2B;tgYlAo5IvFAsXBVFrTnQlrtlqtjqg4QDRqt1owV8XhBaFLSoja/v4&#x2B;3YWA16vVKiqHungWNZvNQyF9YVygU31arda&#x2B;jAhQmna7R5QlAPfjx4xH&#x2B;MM&#x2B;ODg4Ojw8OT5h5YDAga78mfBf0tuI&#x2B;3WUT9GLvs6hOIrix4ztnGgpHMfHxycnvTPNZren6YZPT3vsC7A1oP&#x2B;Ns2cv9cNxr9e7UHD/oS3YheYVhs1Jc&#x2B;H07BOmovp8gLD&#x2B;TKyB9HeXjZ/rSmJd&#x2B;3uh5SFcX11dXoaMIL3zogg/NzfX4jFKZTDMgq6X49txl65BYgZ6cyVi4pvr6zsZBfTv7zExuJNsAbT8r66uBhL&#x2B;Rbkw2vvk59xIljAuE5T8clAAsM4Son9/T9oPZggPZgKk8g&#x2B;0hGCQhfqhG&#x2B;lwoMWBjbR1sP5Aix4bjUav&#x2B;eKQE4gzfSCIFrdpE&#x2B;SxT6/pBPTVXAncJRAn7NZKiIXqN3uubUuP2fM8eRUwFpYgCCRQ1vN9z5f6QQ0K5C4oJb6Ednlavlg4cxClgS&#x2B;DAzbROUkAET9EioIdfc1K31PIWLHz/eWwXiBO3/eZCQUDeOwGdLdcU2YIyg0Tu&#x2B;fJQIZ1l3woF7OLhdLpKjWtKjO4w7btOo5lWb4mbgYqlVmEEgk4GhmJfCpHKDfs4is8as&#x2B;JffWX6E36EEDbtuyk4zgOeCmO4ssrkxzV77esxXJQAAsGTzhapC054tSEkiAQQYJt2/O5ZRiG9NHnarzgOD5T0nDEUCXKDMGez1nz0IqH6Hw2m9lINXZdT3xaOUdyHGc&#x2B;t&#x2B;DPIz1&#x2B;GyMFzAc4DPE8D0Bc7QaF3SIeUAb8cM7h0UbyF3k7YjY6R0avtPxR&#x2B;&#x2B;FNlTmPstwx4SZkTqeKBWTbaMmrqmZm2pYFX86ZaUKqq7Y5g&#x2B;/ndI7Mr/kcNQNI/5PJBLljc8syp8Z0asznc8MwJBlgPBqNpoYxNcAdmhqGMZ1MxqMRhg//pjagxt29frdQbPP2zd30&#x2B;OTmE6/4bst8Pr8RL&#x2B;rz83NeMFAJ6M2ws7Pz4&#x2B;OT8/PzYrHy73/8l569WPupn/nVTLaA69Dp2Vmztf&#x2B;ffv6rX/utP3vnvZ9677Nf&#x2B;p9//n8&#x2B;era2ur77q//v775a2aQpB9bX0T9FcnxKh/i4SzEfZAC8xl&#x2B;IgQZZQ0Te2CbLBrDwsbWeCIJ7vaVUYFywgdT1xiFYE8eamQm1kvRR4dYOxZsFgP5QonmPJbOJRAvKAID2uCm4yhyKk0&#x2B;tVsP6tJNHuxevInUETV&#x2B;shl4yEWez2WytrsR/6J3se29lnz5OPH1cevo4//Rx4t1Hyfffzv/0F/J/&#x2B;PvF1ZV2IQ&#x2B;mUDWfb2xtpv/sT/I//RN7772VeufN2LuPYv/xR0rRaF2Wcrm8s7Pz7NmzDz744NWrV6urq&#x2B;D5vHz5cm1tbXV1bW1tbXVlZW1tDXrfra0t5IWB7YMyAElhWGFnZyeyF8Gz4Aih8Q&#x2B;PIDiEghqUTqcRDgDaD&#x2B;TIzA3AOvl8DnLhQqEA1tCyQqCIKQHEwbAHxQ3ogSF1KBQK9Xq9kM9XKpVsNkvbUJB/OA3gAlshNOChIsDBr9frjXq92Ww2eFe&#x2B;OG6kKaZDmAYA0NO4icoBnfQFoE/fITxBDhiRPaA/HtdTyegrxUnCgRScpANxjMBfNWcA5BQBtZMypEsC9GLg8PDwSPA94TjrZ30&#x2B;0Ov1ut0jPoh6&#x2B;0zz8NH/NrnCyXJ&#x2B;mX6WONWSyHrLMmJidP10d9rr6RD/TBwF1O3z816vdyYmBOz0n4kp0MWyTyhexTXJFAKmP5PUlHMxUiNT6FJlC4RNE7IfqS0&#x2B;Ozu7lXSwm5vr8/PzWy1y&#x2B;Pr6&#x2B;k7gOwsDynxxnqf/z2AwuLu7vbm5vtGCAlANkMp/c3NDvj5fi6cG4gqqw30ShPSaAQAd0wDKBlQLX7r79AIaj8ecDNze3tIdCECfBKGBlh6g64YRGvAaVaRsObOlGkiDnHAZIIbdfVwpffHvJ9ZXxB&#x2B;RaRJcBkFATaQ&#x2B;VWBdEQTBYuEvFLx7KGwVOGvb0jDmQiweSHyB/i7Sql9wNYJgfjoOKMJtSkHiidbWFQQJ6A49qyc2OJ5WV7iCRBW415S7aIGDSKM2KGWPXgygoPqk1iJUTGvHxBa9AXeYQNzXjH18z&#x2B;NeKeLQJ3QXnsgVFKNmNnPU8VeybKlePE98h8LRgZQNfLl6C4XAVcsc&#x2B;yANe4&#x2B;eRdw31iGEy6FkVgtPgLuOWCE5mCSwDiTEX0jX31XteZFTS6CB6zizmSljCuVuhDKDygGbuQpi9OR7HtKvsFu&#x2B;xBfIZ7dtIUpJ0taMFkOcYPi&#x2B;b4kr6HxueS72We0Gt2Ar&#x2B;pNDbe58bjmODa9SUInAzgeNB&#x2B;Ma2vyjBgBZCHJe8KMsUv&#x2B;tGTg/nusyxss0p8ZkjIGAovjPLdPETAAagOl0Oh2PRtgBYzIeDYfGZAKC0EillI&#x2B;mk8lkPJ5MxlNjMjUMX7oM/&#x2B;rL9maq27vj3dXn0YvLAW7f3PT/BRu8vb0FsNYvSNeSY88e1YcfrWzvxK6vr6u1xk988VdfrWx94Yu/mkrnrq6u9vcP/r//861KtfH33/j4F3/lt548/emPnq39&#x2B;df//mu//T/&#x2B;v//9rZ29&#x2B;NFRFwx7knN4MSN152p5gH4RJhCfsQzQ&#x2B;bW9Xg//nkogwIMxPbACSf&#x2B;np6fX19fAAbgqs7V/KmpgGWX0QOMhdQEdRKob0f4ngae3LAXWF4wFdM0AA1&#x2B;xQQW8xP&#x2B;RuIphUmAEod0L8jegHgYCysxHosGAHUEKAhItFAqHh4fFYrH20Yf5z75TeP9J&#x2B;t1HmaePs&#x2B;&#x2B;9lfnRzxa/8kuFb36jsrtTKxbrtVq9Uqll0pVvfqP41d/I/Ohn408fZ999lHv3UerdR6l3HyV&#x2B;7meq2SxgLuDyixcvnj17/uLFC0iBX7x8&#x2B;fzFCziBPn/&#x2B;HDyflZUVkP7BAgL039zcBO5HIhisgWD&#x2B;g2SAvb29vb29eDyOvDD0/nd3dzOZDMyC0uk02EGxWIzmoclkguMC9PjR708kEoVCIZfLZdJp9PtB&#x2B;8FAADQhMHzQ40ezH48gTyCfzzcaDWoGUBiUSqVKpapSw&#x2B;p1UoPoItpoNAqFAhF/uVxB5x5ZCqwTMBPAlwuUT/ugRh1dfhXh3Gop9heGAMwkBq0IPy0UCbqigC9BcjAqAZQBTQl1VhwzLUkaQuBu94j1AMZZB6IzPlJyYXgKHUHd29VcR48OD&#x2B;FThL8RvfoFRQcKAY4OTnu901NFzT&#x2B;WXDyqhI/FgKunYf1jsRbFX/GJxBifaV69&#x2B;miCa7JIANanQoCqHuwJeIDnmmEACYcoA3AKOjk5uRY4fqHJf3lSksHCKU50V1eXLAmkG3LOPog&#x2B;JaC2mPRLInt9Xsr57c3Nze3tDY2DgNHR70dfX0kCkCYWBgbfYLyga3wpOWDvH1UByTzUD9xpCcGsDeANSl8gNPsxIkBj/u72djQaoX4Aav&#x2B;kTkB3COW/5AUB3HM4EA4ENB8hlCuvBUHgaJG9bFtyGuBrtH7&#x2B;S7dNvenuL5v/BCojzGU7nxWCLXaQgUwbOGHQW9esN7xQOuxiP13h2FBCwLGDr1HewwkDY4Nt21ESYT9E0ppFKUE2kbTv&#x2B;/jMLDYIcF2m3i4Th7gRN8wIc6igBcbVZcGLxcKRKACuoy&#x2B;OiCJc2TfSfmwxCyLjxRKPec9TbBdHfHUsa&#x2B;Zr8l9HTFrFB9XVxx0AwUCTrtBsOFLQZwX8Bh3HAZ5G6521kFg6OQvUhL7vuipczHOXZAz8jI7jKNsix/GFjyQfllIKj3prgn7Htj3PdaDHEJNWO4wSU1UEwD2lDrCtdOhGCiaVq1S/rFhc5WHqcIiBGslXR8wi6wYfbWaamAdZFhr2KpEXg4vpdGqaU7ydqj1QRFkWvIxQY4D077nKGxRDAMuypoaBAsk0p3OGi81mnquMg6yZohUBwc9M0xc715lpuo4DvO7YtnL1say5ZU1B6J8pe1AweTBbsC0LlCFrNjMmk9FoNBmPrZlpmuZ4NDSn08lkjMJgMh4jYsw0IRg2zOkUA4QfDOf/k0u5cjCcOJYfBEFgTWeReFUTAvvJbOv72prjOBw345pxLB7bvAIBf6&#x2B;sbj97sXF41G00W//xC7/04tXWf/ryf0kksxcXF/V66z9&#x2B;4VdevlrP5kp/8qd//b/&#x2B;4v&#x2B;UytXVte1ypXZ8cnKjBVjyAtYTqS6J/rjCkWjE2Ton4Ofn5yD5nJycXIpDX6/XgxqYYl9yfFkDsFMIz0GdpXCqZZHiWo4qheQE7AOu8V2x8GfHkc1O8oXY&#x2B;yeNAb77QOcATCDwtCXgaX9/H3fR2aVTJESfAHDAbWgng&#x2B;HDxjDp5rhNIAiMSI&#x2B;axoffTn32neTbb2Tfe5z6wo8Vfu&#x2B;3a6uvGvlcrVIpFfKlbLa6tVn4sz/JfumL2fef5J8&#x2B;zr3/JPX2G&#x2B;mnj1LvvZV85834u4&#x2B;S/&#x2B;mna7kcev8oAHZ2dr75zW8C7m9ubn788ccrKyuvXr2CNgBmoC9fvhTrT2UDimV9fX1vbw830PWHGACd/kgkigcRCIBSAeUB6gEIA6APZvs/lUqB&#x2B;g8lAJr9pP2k0&#x2B;lCsQjLIKB/CohRLUAJALhfKBRA78Hj0BVAMwCUj5ohk8mA9w&#x2B;YDlBer9cr5TImAMVisVwqAehjKRaLpVIRwuK6cIcoCaBEGKyhVqvVbDTFNrSNFXSCEA2gGBkBBI8agP92JGtsXyLJ2u1wjACUTxzfFRfRoyPlK4py9&#x2B;DgQPxGO52DgyON/MMbx8fHXU0TjLGbxvXv8q&#x2B;PJkK4caISiI/Ju1MriDBG1AXq7smykgcGoIq5JyQi8nBU1XB8DI4f/mzJ&#x2B;9eHDOfn5ygJMA44Pz8/Ow11R&#x2B;eac2iv10O3ARthb4JaglPNXAiYHvNVfQhwJg0Rqq0oDNDLAJIwhduzRJhEeXAtWWBYR1f3kuJPQv&#x2B;11APs4lMZrJxABdar9r&#x2B;EBhDrwx2IsDucAAgXSMl2JQYYvX&#x2B;OBfAS9ukf&#x2B;IqiQhiPR7gTkv4HA2B9GoYyLwy3DcMAL3cymeibei0IAk&#x2B;l0oaUdyJ7dfEUE09XfD9D7orWRSZAx6tcbSZAFKvfxabQeg8UY4fk&#x2B;DBPwHVdDigWnDaop8INEn0SlEPPwERbfR8AMIlZgf&#x2B;IPsnLl3a&#x2B;40uXPVACgOWQYM9zXYcsf5Y34bMoDAD6wxAxgf5yPMMhg&#x2B;Y9qs8HCIVdN9x5z1V0FPWO4SDC04cSwM9zaWnzHcMiCofd8zzXpfcRQbwv/J8gCMBI4fFh&#x2B;QGfHJCmXPE1gjjVF72yVrYpRowqacIQ37BhzwKA0wMcdUZcQTRsz&#x2B;eBlAHwFfWW6jH1yUE5A572PNf3PTLyPfGbckLHIWx&#x2B;5mjTCZKswiJFBXVZcwQ8i7pAaXZN05WaRKU3SNwvyVqWMHyUMtqaOWoAMnccm&#x2B;wdV&#x2B;oN7L8xmdjS&#x2B;9cHC0DtliIOWXMZClgqeNhCsx8oH6MA7P/MNOezGag&#x2B;tPsEyUe0vxa4PaY5BYkI&#x2B;H40GEwm4/lshonBaDgwJpPxaASFwKDfn4zHEBVAUeD9m00AEnvZ&#x2B;pGaAAzHD12Aqp2r72trvu/rfNMHcjRcUS4vL/OF0m//7v/84R/9z9/4x&#x2B;fVauOHf/TLq2u7v/KV304kMtfX153O0c9&#x2B;&#x2B;Td&#x2B;5Md&#x2B;4Rd/&#x2B;Wt/9/cf7R90yOehMQU6&#x2B;pxu4wLJATehNhk7uLbh&#x2B;k2OPm6D8MNhAtXJbPOficgYEOHy8hLXe7wRED&#x2B;5B6fiSAgowCnEieaAjgYeiBBsZx5Lpi/ghU6JRm3AKQHWp1cPe/zopx6JzSJ69igYQPQ/VHbvx7VaDfAO&#x2B;BL4DOCv0&#x2B;koWrk0/oH58KqDgwNY0&#x2B;T/7v9kf&#x2B;T98i/9fOGvvl7Z3W1UKq1m86DZLMZi2Q&#x2B;&#x2B;XfrNryb&#x2B;w&#x2B;cT77yZeufN2DuPku&#x2B;8GX3nzeQ7b2afPk4/fRx9&#x2B;43Mj/9o/I//sJjJlEqlVqtVLpczmczq6uqzZ8&#x2B;&#x2B;/e1vv3jxAtpfkP6hDN7Y2FhdXUU9sLa&#x2B;vrq6ilywra2taDS6ubmJlICNjY1oRJH&#x2B;wf7ncAAeoID4nANADQztL5QAaPkzLCyVSvF2JpOBJCCZTEIDgFeh65/NZIrFYi6bReMfUgGWAej0l4pFCgbweK1WKxaKEBazJGAZACkwigddQgDZNB5hDgP&#x2B;RZGGV4FihKcOpKKrS2gA8X2j0WhqAo9moyEBxs39/faBxA&#x2B;DoHOwv98RJUBLkqEPZKFI/eDgYL/dxi8ZNQM4RfjNH0kQga5aOT4&#x2B;Pjg40POGjzWzIJ0dR0VBqEw4ONDLACpkut2jIy2LoNs94iyObCL9b7MreWQoLI5F8Y/3PTs7O&#x2B;6GyR4nkmDA9j&#x2B;pQRQOobqAHJmnnVOxEuZphBKCcwkN0JmE6mQlRMdTjS&#x2B;ktzZ4wpEG/yWlTZyOogXDLv6lkPjB1cRtnBVVcSA0Ic4EyBrS1cD89/LyEsLim5tr4H729fmvXiqgGABqp3PovSQQ38qzuIH6AfY&#x2B;nA8AykNGDPhP4e/9/T3KAZQH7PqzPADcFwrQcDQa3d0pXhDKAMMwdLfQ4XA46PdfI3xfiAZAXaE/AUwDqQSCZXo9VnjQdMdF1PlOCgFARjTyPfH8kcnAXO&#x2B;R&#x2B;&#x2B;KLv2CPeqk9HNrbK8wdCgDCUQaNYgIZQQRSnDjKTQjq59AXCOpkdqz5toFIcvmRsU8O07KkRb3Qjg8JS2pA4YWCB1eykF2N&#x2B;q&#x2B;KE2EBsVZR8FeBWoDpOYc2jm3jK&#x2B;NMBlUQD53jOMHCJwT3NZo&#x2B;3gMvUdpToaCISliVNIS9sEP1ZHqDAhIfnHx65TIktp624Gz5uqXsxCACqu6FL1WH52uSA9/3F77vSv4xPpHi0AtnxprNdIkFDXkcbdhCY34UKqgi5pZFH6QgCLj/7PGrElT&#x2B;03ZbVrNtQH/5gDbYR1LhOKwf5kJbUoFfyAY2TUB8y5rBggkChrli&#x2B;8wV18hxKOedToHCZ7TwR7SCcHWUdtiW19rz&#x2B;WQ8Zr2h0s0sa2aa49EQRp9I9YJfZygGmM3A53EdB1Y/GAjgHfAVzExzbs2mxmQyHk/G49nMhN7XmIwRBjwc9I3J2JhMpsbEtu3vH9v/s5ZaZf/46p/UGJTqR873WXrcajExtAC6vb29uLgsliqJZPbwqPvNbz3/gz/6y9/5vf/5c//5v/351//&#x2B;Z3/u1&#x2B;OJbCSaOjlRKLxUrr9a2ao3WhcXqpbAZYyXKGyZIwVetPSmF0UInAOcawseZNlA8i4oTGQBkcYD2AEFIekEuKwCcJwtBwPjmq3TEnBb7xReXFwcSYAX2QXn5&#x2B;ftdhvQAewIkCXQ19cBFokNJPwA5QPfgzIESg8HAmj6Ammhl49aotlsdrtdtP9JGQLQPJDMr3K5TDOZ4srL0kcfVLOZRrWKlev1ej0WTf3Cl3PvPkq991b0yeupd97IPH0Uffdx4unj7NPH6XfeTL73VvrLXyr8&#x2B;f9sxKKNSgWUGDiBlkqllZWVZ8&#x2B;effzxx&#x2B;vr68&#x2B;fP9/e3v7444&#x2B;B/nd2djAB2NraWltfX1tb29vbW5cbW1tbOzu7CAQAL2h3dxfkH9yABmBnZwfInvJfwH1IfpkTDNCPWQGGAGjzY4FiGLLgTCZTlt5/Op0G6Ae5H&#x2B;18aoUhIMZdbJBaYWgJGCUG6A/&#x2B;Dx5v1OuqTigWAehpJAoBMYXUTBrudDrNpuro4wjTOAhlIYY/aqTTaOAR1nv4OWFNKn3bEkjclmw4zIiAv/VgASoB8AtkXUqzIKwJwM3aAKMD/DgPxZ8UJYdSucgj&#x2B;NnzNslvvIuaAf1&#x2B;jg66EimgoH&#x2B;3i9Ka5QRYRhwLsNLG3&#x2B;9hp6NPAHSpQE/yyFAknEjOQCgClnGi&#x2B;tuXkJAz8R7lEIB9B10NTEUB&#x2B;TznwhdSdCNNXXAuxmUkOp6LtvhSc2TWtb9XD02ZL8jqAfzXqUE4md/d3YEaBCh/tZwgpk8Y6BREb1BWAlzwOChDqp3f74Phg/ECgDtQ&#x2B;52EB&#x2B;s6AeD1wWAwGg01s3&#x2B;F&#x2B;MEU0v1DafqJG4rxL2pgrjkajYbDMBmAbkKvMVrLF5YOuq18BPgRV8QHjX/ifgHiLtt7DyC&#x2B;J91l4GlHJLCB1Bts&#x2B;fvKxV/UveIIRIhM6MySg9hUwJhinweLBR&#x2B;UfVaVgBPmFSy0QoLI3ueWXTH1h0USe&#x2B;rcDcdZmkKwhe&#x2B;JqhipUthxYvGF7ztaX1/1xf2l93WFGqTAum1DUKEjckfY/8Ssim9kK6d8voUrA4SQIo9QNlp2irOQL3MMFGDAx&#x2B;ypA3P7moICC9So&#x2B;sfBzrA6ovbXETmvKyIBV&#x2B;3YXBUG8zl3xl4OJpvrpHzH9jxvodJ/FcJW8wpPKjNHCgzPAzMKPB8Fvl0XMNpRCbs2fiHKm1XGOODtgLw0ZxyYOnSW7wllX6omUxr2pmkquyHhQeGQOqq4CmG05AAo5A40b8mgAygc2B3HH98Lhb8A9LOZya8Mj6BzD3fOqWFgOOC57mQywU5iNdB7UAOMx&#x2B;PZzByPR3PLMs3pfDabTg2MC6aGMZmMafo5GY8RBTAejZD8ZRiTqWGMR0NrpshDEgIwNQylDbDnD3vz/1qLHwS7ySbDf8u5uv5srnTkf/I133XRbePYXrq4uFxZ3f6FX/6tp5/90urazm/&#x2B;zp/9xBd/9Ys//ZVf&#x2B;pWvffNbLzLZwvHxCXA8WlnXElR5Jr7Xl8u2Qrx6nUrk8Pn5eafTuRT/H1w4L0UEDDOf6&#x2B;UoYnT3ie9vbm44kedgHd0&#x2B;8nZ4ee52u1iHfAP2/LAF1S88PgZeubi46HQ6V1dXIDeDgKTjfjxO5gPp/l0hNwMSAa&#x2B;gBuiK5T/XIRcIkAjtf9QP4F7TxZ8tf/JJANqKxSKVpmjPqw5xs8m2cblcbtRqjXq9nM1WNtbLmxu1cqlSqdTWVrOfewoD0NTbr8feeTPx7qO9J6/nnj7O/vvPZn/9K/kPvp3b3a3XaoVMppjNggQPyJvJZFAAwAXo&#x2B;YsXyANeWVlBNjDMf0D3h953b2&#x2B;P/j&#x2B;A&#x2B;PF4nIY/uE1rICD&#x2B;WCy2t7cHWTCGAAD9SAeLRKLJZDKdyYACBJUw6gGEBwP041lAfEwDUslkNpvNZNKgBmUymXw&#x2B;D0ZQTrhD8ACFNRAtgxgUUCmXISMmJ4phAnAaBehntgDgO26AFFQXfj8a/9AHYz4QKoObAPwNTgzQyMd3jafI&#x2B;2pJPBlqCcaNsQBowUTo4IDCANSKujvQ4eEhDIJCQlq7jeEAZwiA8kpnrKxFw7Aw6o9RtWLAddjpHB522LOnjxBchign6J30&#x2B;DelU//PJFcYGmNAfE1wvBTGd6JldHS7XQoDzs/O2PtXOoTlUAKuSY1BVwspI&#x2B;tPP12wxuBJ6VTzNabAF6c1fWiJZ3H&#x2B;JO5/wH5kB4QdfRQJNEvQe/kUcV2KNRCNffDgAx3wjSykA7FTgzdC/57tf76EvX/AfYYA0D8UaJ6TBLaW&#x2B;v3&#x2B;vRiDUh6gXIC0lr8Qivr6wukBEb9uH6SnAvf7fUwGKAgejUavkRUdAIVrklBfCNxAt6TXc8FlUl&#x2B;H7WdHW3RxLYsHplwphD2fe9KVX2goH1AP9vM6U3&#x2B;xUG76gVCY2OYnQKeqARsMpGAIgoB6WVeEyITdnhibsldtC8j2NYK&#x2B;F5J8wsmE4zg6O8iRfrxQoXhYFEmGTW4WUZ4XMnb0gsEVIyMMHVgXsfGs7z9zuzhAcLTvhUWUw46&#x2B;0N/1DyI2PLb6GLKIKkOoQRg1uK7DgkHD7gDNtkQCO8LqcQX9e&#x2B;HBC3PEHPlNUo&#x2B;uiPUzM1DyjzlkrODEg7LlOg&#x2B;PPMk8tnD08bQy8bTVtxA27EWOjFpFaP3y6XxfZQuglW9Z6ptncWJZyA0AtQaWmrKKI3MAlcNg20qBMJ1OcRTmcwvwH81&#x2B;sHfs&#x2B;RyUG2zQloJBfT7LspUAwHIcG&#x2B;yduTWbWzNzamAgADUCSgi8BPpdkINQbMCs05qZk/EYowNVhFjWdGrMLcuYTCbjMdZEU38yHhuTyXAwwINzy4LGF3MAy5rBWQjsf/CLJuOxMR5PxuN/Ocb/fpbr66F&#x2B;t1DsfL9bwHUIFwzA8bOzs/Z&#x2B;58u/8NW//fuPvvBTv/qTP/2VL//Cf/v9P/zzaCy1v9/R7SlwycEjONeTt6oPr9m217lGbHFdSNQAro4sAC40g/&#x2B;eFu91Kaac7LSdabEAuMoeHR1hU9gO&#x2B;Qnn4vWB7VAegNe2Wi18fFx3UQ90u91zzWn0WDM1B6AnWD/UfP3J9T&#x2B;UlCWMHdhbpZ0LCokDSXhF4BcasUCNKAy6EvCEV6FzjJApIH5gUGwB2BEwDhSgdrtd2VjP/PpX4p97L/MfPlf54FvVSqXy8kX6/SfJ994qvf8k9e6j5NPH8XcflX7&#x2B;Z4v/40/za6vlbLZarZbzufz6WvYvvx7/vd&#x2B;pSowusO/a2tq3vvWtV69evXz5EqMAWABBB4zbOzs7YP4A5cP8B/wfpIBhgc9PKpViAQABQDKZjMfisVgslUpjRACIjxogEomk02kYg6LfD0tQGAHl8vl0OkXbUCaFpdNpEP1RJ&#x2B;g1QDabwTqIAsC4ACtjJpDJZPL5HFKEAe5RGGBo0Gg0yqUSMgfK5TLgOF1T8/k8c8SA4GEDykgBDgdU179WazabMBtl3Bi0Adgs2v8wEgWgb9TrIdyXmUCr1ToUu9iDkP&#x2B;zTxFwq9UM8yK0aOE21cMHB/uSXc1x1oEWNMEJAJZut3twsI&#x2B;iFugffzXczpHY3eq9fKhraEBEdhD5PKjbFcXu6Kgrr&#x2B;3Kgnc5kjIAf2ig/On0obPT014vNCM6DrMF1ExAB/E4P5xJGYDCgHKjU8kiuBAXUf0p8SQILUd5YrnQPIKuhRXJf4XWH3ZSqDFgP4UES11dwHqDwJ2YXlhDquUPgH6tJQaEHJ67O1wRGACMu8vTgFsWCXQEolaYjX&#x2B;a/6Bf/0nXIK45kNwAvkSVB/f3ZAHhwZH4/zwIBNDrASgBWAO85mlu&#x2B;gDHlmXppJRAz/nSxgIE3J5Q81kksL9uiylKoCmAA4HXQJAMBwg77lq9oQ8QbHHBD0Q84As9HU1W6oMDqQp0WTOLHAG4HuOfVJ2wUCSchdY192C6L5x4VUJo&#x2B;2xLyKsnrBuUNwrCAtnL5ITbBNDnVIFBB46Q8jmKAUgV9Ox6oQ2RVCACollFuEIf8pZ0Gio6lxb1rvBnPBl0&#x2B;JKioLvueETVHK34PrrvruMEwcKWBGIJ2Q1lA4445fNY8ZdG7O9LZ139Ahc&#x2B;5gnyvYceSsvaZRWq4IvPksfsLTJ2MDqYz7ERz3PxH6s4B/HDcy2FV&#x2B;1GmOHgiozBlg&#x2B;CtyOzi5kAQvSfA4u7rgshLww9MS5wJJ9hLtafAOL4aKDczBXR3zLNKaYNlmWZpuk4DgxP8V7WbDaZTFTml2laMxPAXTKAQeKfYkIADS4IPLAMcmwbAl&#x2B;ldTDVBADDh6lhmJAFI&#x2B;jXNA1jgl7&#x2B;ZDJB&#x2B;x/mntiIMZmAhmRA9WtMTBMkoPHMnA6HA5gFQQ78A6D677bMJktbnkys7sn1D7JBukDgYgCiy4cfrbz&#x2B;&#x2B;Cd/4Ze&#x2B;9od//JfbO7F6o3Vy0qN6DEB/iZ96c0ML0XNx3&#x2B;fY&#x2B;lZiBDhn0EfYGI6zg0WmLKsCXarLsgGtuAvNng93&#x2B;RF4GdZfjsch6UMBAJrQmXiGgJYAxj/pB&#x2B;fn56BDtNvtE82EBAtNEjlb6GgLORXtdpsUC7RRCaoA1/QbwC58lnMAtGBxQ1eLNhoNtIQPDw/JG9ExaDuZLPzCz6WfPo6/82bs3Uel3/vtcrGQ/&#x2B;Db0XcfRd55M//e49SPvJ/61V8q/MPf1VPJarFYLpVK0Wjp44/yv/nV9Bd&#x2B;LPru48hX/2upUEBfvFqtxuPxjz9&#x2B;9sEHH6ytrb148eLFi5ew/YEl6IsXL549eyaBX9uxWAzkH/T7MRZAU39nZ2dvb29HhQKrFdDOR84XQD8qBCB7zAcKhUI8Hs&#x2B;k00D/iUQc3f1YLB6Px2EJxORgyIWpFigWi6gHioUiBwXFYjGdTmMUoFxBSyU8QogPylAeAWGlUi6Xq9VqkAgzQ6Ber4EihY1gSoD2P0A/SrJyqYRZQaPRwBgHLwfQLxQKDdGEUCLcbDYPDlQmAAPFIAagHZBy/d/f5y8ENUDn4ADAHaSydrvdarb2RS3Q6RzwVagHYCjLlWkWdCgeo1Sr49nDw8PjbvfwUEkFjpbrXg4HdLhPfhHWwa9dgXjhCHUZOXx0dCheusfiqAt9Aqj/&#x2B;INVBCFVOahq4fj4uNc7oZS/1&#x2B;uxAMCfMB8/OTnBmiT&#x2B;nZycnPZ6xP2YBALun2uOn3rXn4wgnLtOFIOod6GlBHCFENnLGYx1wu3t7ZmWPcwzJ06VnJ1iyqr3XHiyxQxWlwsT9FMurGYIYvdJIiig&#x2B;e2yKoChYIwHVlD&#x2B;/r7fv9cNRgH1&#x2B;5IrrDr5TP4SW897LXKYpQLUwywPWAwMh8PR8uNDkQiPhkOOFKATGI/HI3n2NWA1WGQ6wttBazMIAt2TR/wrF1jZkzAvxR3icECL8WKP3xGnUb5LIFWEqgrgRqp2JnDEGwf1A7klC820FM/O5/NAa9gvFgsS7r3laYanORSRMIMrPbrDnGMEIhIIJAaBxQl3zPc9aetL6aIVJHitq2WQBUFAPowOZFlysEDyyGJ3HFrccGDCEsIVEhSOD3G2q81JgGn5IDZNUhBBuStVQbBYKMKMDEaoUXacMHYXXBqpEVxHZizgNalBgatSxnwRG4jvZyiNoJLYg1RDgWwVSKymEJJBRt2z2B8prQVqLcuyHMcmScaTgsG21ThC6X2FfaTyJWT/qawglFe2p6gGWYG4jo/QaMfxXMdStv1QP3totDvKhUl9KZgqkJNjmuZsZiqF7nw&#x2B;tyzf9217bprmbDYzJhPHccDvn0mar2EYEAy4rgtnJzD14REkQwATvHzDMPAgcLkqNixrMplA/2BOjZlpTqcG2Dsw/Jlbs/F4PJ0ak/FYXIAMw5jA6geKAnM6NYzJaDg0TROPIx9gPBoahgGdwMw0LdOcmeZ4PJqZJoxB8RRmCJPxyJxOfxBQ/l2W07O7m/ESzf/g8PJ&#x2B;8i/XHJMYSk1YLl/&#x2B;z7/43z9&#x2B;vhZPZLrdLi4JJycngPi8COFCcnZ2di3J84Tv1LFRrIZL1K1kDAP9E&#x2B;uTzIMbpPjzgnqpuWeca658HAUAl59rvt1oxXHaQOL&#x2B;heYOhBUAHag1hC3PuSQQA8R0xa2cGkd2GYHj2yKXJMO4I8FMEDiiBoCWF2oBDgd0eERtpQ7XSPbQQ3&#x2B;xwbIYzuxrMcAgluDZTqfTqFSSv/Obhffeyjx9nHj6OP3&#x2B;k9Sf/nGlXC5/8xuZ959E/sPnC3/6x6WVV9VMplwqlXO58s52/H/8WfzLP5v60c9G3nkz9uT13NPHyd/5rVwmAzRcKBQikciLFy8&#x2B;&#x2B;OAD1f7/6ONnz56trKx89PHHKAPg8b&#x2B;xsYEhACS/UAVsbGwo43&#x2B;h&#x2B;oD9j64/7sLlE&#x2B;gf7H9w99nvz6TTMAWKSmzw3t4eA8KA1KEhxiP5fA5UfqxDkUA2m0GRgHgBuAaFRqJSGJQEr&#x2B;sLMgE4BFAPVirVajWbzUqyWIlVU7FYxLcDphBjBHRtQKVSAXZnwYDHq9UqVAEY76D240iBLP92q8UfDLr4uFuv11k5cGKAmGEUqLSW0nlBnY4qUw8ODg41NQsqXiB7KgQ4AeA6FBnjNodgrCWOjo4OtVEAOXKhuVCnw8a//mfS0VII&#x2B;Fo29U9PT481EtHxcagDJkmP0v8TWbqi6e9JdMCpljNwLoY/rBlQKoha4EQfCFD4eyoeQSwMqBs&#x2B;1&#x2B;LDHvAkz5btRK&#x2B;W4wIuNacgnt8A&#x2B;oHpL7X5gE7sEQbQ1b2WAYzT8u3NzZ1cApQG4Obm6uqK6l6e5EEEAlzHIEBv/2N9&#x2B;m&#x2B;St4P1CdzJHWI90FeZwaT&#x2B;3A9FMICSQMl/MQQQSQCCxmj835cosVstYmw4HL7GlrMOHPUGvKfVAOx/E&#x2B;Dqr2I7H2wQT5r3bGMHQcAmPSsEwvQQb0kLn8h1oc0KfBEbAK5J817lixGCczWOEUC8gX//UmWiJQPwtqsZIvHjc76hyhhhB/liDIqFm/LFNxMFxif33xYLUT7uhgJW6VJrfqOyb9y&#x2B;CrIlVUZvlvOzYzcCKX7UgQXqFQivuO/C8HEclaNM5oyj1M&#x2B;O53nWbEZ9tj7c8FQtpIoxqFpZHdHSh1Ae0Nn3VbceXC9XkxN4Gm/H1VxH1czHU7Qoads7srdh3Bu67Avfo4BYzQpsVSewVPAlFdiRJDXUD0w3w5gCtTG&#x2B;ViJ&#x2B;rOx5nuvYnqSPBYsFBgiGYVBa7bnuwlc/XWUTJOaevsw0UPwAr4Oxg0GB6zizmYk4XxXEa0wsy5pODfDy5/P5zDTtuWVMxubUmMlsYSYa4jksRE3Tse3JeIyaYTqdgsMzGY2mhmFOjel0apqmMZnMZrPJeAzzH/j/zEwTSt9Bvw860NyyxqPRdDIxp1P0GBRByJhMDWM0GkIGYGA7k4kxmfwAIP&#x2B;7LZP7&#x2B;xDsO5Y5&#x2B;0HthkgMpWvERx&#x2B;vfO03//j09AzDXwJ6EkbZhdLb&#x2B;WwynYl5BRE/&#x2B;kY6OwiUm263yysl6wfyhXq9Hq9quDSeig83NbvnWrwOttmTAKCuZvSJazBAP&#x2B;UBuGqeilsfZgVoK&#x2B;osYcKRsON4fHx0dIReIFnOgCn6v0fiCooXIqiLYgB6d1JDiX/r9XpHon8hCGaeF9rADIfqdDqwnIf3vyKBNBqlUgnQH1VBtVotRCOFn/qJ9LuP8u&#x2B;&#x2B;mXn3Uezz7&#x2B;effXxwcJD88MPEX329srdXKZXyuVwlmSy9eJ79g9&#x2B;L//i/33330d47bybefj319HHinTf3nrwR&#x2B;6M/yGYyzMSNRqPf&#x2B;ta3Xr58&#x2B;e1vf/ujjz4C&#x2B;x8LHD/X1tZ2d3dhBwQuEOx9IAAA7kc9AD9QMP53dnZisRjCv&#x2B;jtg5UxAUDNkJLoXyqD0f6nQgAJwWAEYUqA9j&#x2B;qgkwmUyoWKfaFNiCVTOZzuXK5XCwUwPnJZLKZdBqK4UqlUioWM&#x2B;l0sVjElh8UAxgIoPePWUGtVstkMigGwPPRgoTLhUIBDCL6ioLt05LwYBDAMBNo1OuVchlqAUB/EP2J/onsa0IDw&#x2B;&#x2B;Hzzbq9Wql0tbUwLCURSMfPx5Kz/clSaAtjCDUrhgYKHzf6bAWJaBva2liwNMcc&#x2B;k0IRiJHsocgNs/OgoNSQ8kqqwrDf5ut4soMWyc1ludTudYpg38k1dUveWMMDL7T05UkXByctJTSqHeqRbzJw8qmVBPefuckTTIOv/s7OxUhoo4q/BkdXx8fHJyTLYP11FkoeUhwPn5&#x2B;YVmZMxuCMsAAH1sjUMAPsX5KocA&#x2B;g0u13Rkvrwk9R/4vs8Br&#x2B;YQihO4FAz3wgsKtQH6WFivAcD/Ib0Ht4Xeo5QA1AdDVIB/v0M6mLZgVsDGP9n/DAdA&#x2B;BfQP4qQ8Xj8Gi51gvFsoltC0kAj/AgUdvXyQL9kck2d2OML4HbERtMXDomGrUPc7/v&#x2B;YqHWJ1IPggBDCdlbVXsEwjVCs9yTOcCSOlmo/CQyAefRZsfTEtA8LY34ATR3tXAAvtDX8tGIg91PEH5ciQybi0F&#x2B;IJ5CgJj47DgOtvju60AZnX5biitXggUWi4XuS6keQTqyfEH8vNxzNNFJxAcpRTFqZONcj5WYfLQweMGV8ZErbqpzVjUSmexoB0f4RRLE6ziu60AEwuNMW31PBg4A34548vA34Ev88JygWdC8KB&#x2B;c6dRwXYdTCynSbA8&#x2B;Qpzt2LZtzzHKAKyXqQVguiu2QpYPpyOIdB1nPpthU7PZDNgaGzQMw/M813Eta4Z3mM1m1kz5&#x2B;i9kI&#x2B;AXgZplTqeYMKAeoFePZVkA36iXdM8fKICnhmHP4cw5JYkIO8MoABULMJlY1syYTGagDM1mCAEYjUb2fD4cDKaGQdxvmtOZqdK&#x2B;DGMyGY9Nc2pZlor7nRqQPeBdIBWYW9Z4PIbedzIZwxIU5B84gQ76/5JMrn/OMrq&#x2B;6V5LyIAzNz7hNnRz9v05gbJ5HxYAz9Z&#x2B;7w/&#x2B;19nZObpEIICiL4VS4UzCuXDe1wk8vV4P160bCRjmhJqyAQ4Eut0uBW2nYgBKPRwFcD0x6T/TFtJeLyQXDFdcPII5O0f8APfk7lMT3BV7UNqDEPqDkQyAroMYdhDJ2CF44rOHImqEZSdwEt4Cq6Gn22g0UCrgQY4RSK5Aw7ghJo&#x2B;Hh4fA9ED/eFOYzwDot2Sh8FQ1oXe2sz/yfurtN&#x2B;LvvJl8/&#x2B;3C7/9uNpksFAqNek3BxGKx/PGHuf/ya8nPPU2/82b23UfJt1/ffvSpyNtvxJ&#x2B;8nnv3UeydNwt/&#x2B;ReVslpqtdr29va3vvWtj2VZW1t7/vz5q5WV7e3tFy9ebG1twfcTjH80&#x2B;yEDSCaTIPqL5X8EnX60/4H1wQKKSGs/nUohBACOQMlkEqCc6J9&#x2B;oBlZ0MUnsocmOJ5I5HK5fC6XTqdjsSjAPYPDsMAvqFgscpIAy9FSqZROp&#x2B;EC1Gw2gdfB7EdFUalU9E4/jIBKpVKr2SwWCqqdX6thfkKXIRZUyBdQGcOSB4yCAc&#x2B;ii89sBxg9tduKBcR0YZSLnYODeq1WrVTgCkWnoLYEzGFNkP519A&#x2B;dgPII2t/vhFT/ffKFUDngx8/CFb9JbL/Vah0c7IPzxvJAMfs1BtGhpAtzOADEj78sWJeSYncorkGHod/uIXv5rNJJ/efUDjrgrqRzHB0dncocgBrfbrfb03h9qB9gSsrHVS9fZomnpz22EuAU1BNvHzb&#x2B;zzVrAaqNQY/ESexcLET1uaU6B35iCMBWyLmYKRPxs4Ojt2bwIP3&#x2B;1XDgUgxD5SlKCNj75/rUBugQHzcoD9BJQUT5tzc3wN9s89/e3g5EzgsQDwdPygZIE9KNfcj84Q20/PEYZQa65JeGQnpV8JqnZWkFn8j3DVutFO8GQRAE8hIht2gvV6BZGyMEGmR3tWwBNoNd14Woly1pYkFSUHzh1RCCs7XPKmW5PYzP5YMj5Alj3hMdsCPepo4w7HWGOtq6Cw360xfV0yg6xPqqRAkLhtAAhyMCj3LeT4wpwh3wfU&#x2B;o&#x2B;Y7wc&#x2B;TYfgeVsx&#x2B;KE3zFv/J9F415uJF6nljQeI74/wSihcBh12nxnsha0cvHs65MZnzft&#x2B;25J3oMHnBPy2WzbRvRyBxNKBK85hnq0I9IygYQb/gFSTKuIoB5rsuZA0YQtiQEA517guy5WVQvaL1LWWs7UADLXWxtNjM9zfgIxQYOAyg0jsQA45NiZ/ABZ7MZ2DuemPjgxwMSP3YMyWLI4pV1bLwp6DScHaF/j/JP&#x2B;XVayqUHtH57riK9ptMpRgqQB&#x2B;CA&#x2B;J4HCI5SwZ7PsZqpqPqGYUym0&#x2B;l8PocpEOoHQ4z/YeXpOg7ce2D3KYaeEw4KMJSYmVNzOh0Ph&#x2B;Z0OpvNjMnYsqzJeIRksfFoxCgA2ARNp9PxeDTo90ej0feFwv/5i&#x2B;&#x2B;4d8MwZcz9TutMrMV3evg7L2zzwFfn4uLi2Yv1r37tj09Pzzg4pqMcO08XktSrewddhc50iikEKj9pqTfLPtZs8EMoDMSvk3ywAjYCXx007EFJwoX5&#x2B;vq6J3nAxPcX4uV/cnKCwQJba1wZuOH09JRUexQJlPl2Op3T01MwgthxRPFwenoK7AL9Lp4CDEIBwI4mDIJAAWqJMyN5C/i3Uql0u11lzSlpXx0Jb8KsAGUDRgTAZ4CGQPAQAIBcToNIGlBWU6nkL3459vRx8rPvpH/zq8V4PJvNQj9aKpWqsVjia/8t9sNPE09eT737KP72GztPXo89eR0FQ/ztNyLvPUl98ccrH38EPApnzFgs9sEHH6D9/&#x2B;zZs42NDbT/P/74483NzZWVlVgsBvOfaDQKwg9I/7AB3draSiQSTPyNRqMA9yD8wPAnGo0CfzMhWEX/xuPk8OCGNOzF5CeVymazYAQBvufz&#x2B;Uw6nUqlMF7I5/PJZDIeiyE1AKAfm8JL0qlUOp0uFgpgBKGpD5ExssMQFoYyADi&#x2B;UqkwnQCMIByrYrGQzWSwfq1aw9AGDqHlUimXzYIIBCUAtkP5L&#x2B;o3fLm1Wg0&#x2B;P1wfUQP1uir2VKqA5AO0JCWaYwSdBSTygUatVjvsHOqNfDL&#x2B;aSLEHyG8htCex1329fEXFFKDtH4/N9uRzR4eHh5oTDZOwA7FeJQlMcqA4&#x2B;PjA6ki9L8dTgB0jpCqFlAPCNDv9U6OtCQB/o1TzX90dITMAbzqiCHEEiLGPsKpOIf2lnOFT09PGSxADiGeIh2x1&#x2B;tdijxJREpqeqDVAxdU9KoCQFhDF&#x2B;KX8ODkeSVubDzHXl1dLXX&#x2B;r67u7m41cfANXX30IgGi4XuJ8uUjQPwU&#x2B;97hWc0dSH&#x2B;W/CIYg3IdrnCj6Q1I8ScXCJwflAN8ltJhqH51dyBJDRuzDKBhKMsJNQEAEgLwYjdaB9O&#x2B;kHD4lKuc9X0&#x2B;y3/1vrsX2jv6bOfjNknVhPgElHNJnPU1MhLdhIh6F6Io0N9d7517Wp4xywbC7oBiA98PNFMjX1J1UeSgMAiCgN33UDur7bmvcXvwjnNp7bOK0HcvENoSa7DFYuHqfHotlZmfkZ/LVq7zLnCtK7peVTnM54DvrsYIwnMLEWe74vaji559LQkYCzv6/L64e57MW&#x2B;y57YuxqScHQa&#x2B;OALuDhY&#x2B;5xFxGHJzGOLatDrXvewx6o/2RprJwRHWNWYpHopemrcAtXzyIfN&#x2B;jINuVIF58Bb7vzS0rCAJ05bUpkFoHHW5HfD&#x2B;V6ZBtu647m81guORIiC&#x2B;qI1RuoN/goMMdSFUvyCJwHNM053MLcwBYA1nWTJGF5nPXdQHBHceh7z4GNY49h0GnaZrI9jMNw2LjfzrFaMK2oe410blHfjBsgiaTsWlOYeMD4TKmAXDvVNXCZKKo/6gElMXnCNDflOiAyWQ8NSZQGGPl8WgEWbBpTmUUMJlMJqgKxv9mBUAQBOXq0VHvFreHt/fz&#x2B;RLcP2gefF&#x2B;sIOkMXXI6XCrXi6Wqzq7BdQUncQD6Cy0Bh3xWXWr2QLhGks&#x2B;leNtdicaXc3AUIbiMkfePgQMNf85lIbNWrxlwHdXJsmgZnpycoE7Alsngh8y3J16cIN&#x2B;fnZ1xVgC6DtqTwPrtdhvzAQD9kMp8eEhrfygHOB84PDyEmc&#x2B;RRP&#x2B;yow8JLyALOT8k&#x2B;mObgF8EZOzjAl2BBEKVMMoDmNYDJtZqtUI&#x2B;V9vaLP7vvyl89GF2bw/0D4X&#x2B;E/HkV345C3Hw22/E33kz8fYbkbc&#x2B;E3v7jeg7b8aePk790s&#x2B;n/&#x2B;av0qsrGcHZ0LxubW19&#x2B;OGHcPvZ3t6iHgBd/1evXq2srEDUu7u7G41Go9HY5uYWVL&#x2B;7u7ubm5uxaBT1wN7eHh0/YfAfiUTQ1FfJX5ABSBoAxgixWCwSiaSSyhEIMt8khL9SAwCRg8GvpgHiEJpMJrPCGkIBAKyP6QGKBCwgDrFOAKsnn8tBIZBOp0uSFgwdcKPRKJWKpVIJyBvuompyUq222y109FUNUC4D8avev7IVKoPHValUms1GrVoF3C&#x2B;VSk1Eg8mCwgCygbbECDQajbZWJ4Ry4WZzv91ut1tIk0DggKYD7iBsuKkxzVrNJoYMbYmabgs16EDSKlA7oDjZ19LuKCFASYDlKIwZPkKERafT6XQOOp2Osgw67FArjLAwym/wR6pLAnTBAIcDvV7v8LADHH&#x2B;sMfowT&#x2B;hKTt&#x2B;RRAGy5td0wL2T42OA&#x2B;a7kjhHZg/2v2wCwDDgV4wFFR9RUSWdabgBb/lj5QhM16Wc5Iv5T8UdGFXGhnTCvxGvh6uoKrkFs0ND4/4YObJeX15LHomuIr5eNQbFN4nUwc641s1EaBNEPVNcKi0JAGYMyPUBR/zW1AHXGpOvQ9Z/8fuqM9WmAWP4rpQHEwUOZG&#x2B;irYXmNpB128YGccAkkYg4CdSnVWs6Kq&#x2B;N5HijjrsbdJ1h3Qmq4CqVaCgeWd2cNoEcE&#x2B;Jo0lgg4EBd/vCOBtaL9aMFbpJGAle6JyyRpLXwXV7AjP7Ir/XgddnMywHY&#x2B;&#x2B;&#x2B;ha&#x2B;1yhf3SBXZggLRTQ90g38kI9LiTF/mIB1jh2g2/BRjtS0jiNUYTyhY8QWUJ2jiBwqD2hPLmaeliv07Qqy6NUYOH7riRD&#x2B;x662&#x2B;KAJMeftpue59lilKSPO1wZ4PAbEd225avKau77vmVZs9lM51Z5rrtYLOaiBHC1PAF6jPIX63kuJwNUF3B9FG&#x2B;qPBCffh4u8JFMc8rgNkfFLYhCQM1SVIIvQLwTmorC3BOiZEcxguZzbAWcIGXAqn5htuM4s5mJbxOhvKh&#x2B;ZqbpeZ41mxmG4dj2dGqY06kznzvKy3&#x2B;Gvv5MJgboxKsbc&#x2B;XsCcUwRAL09UcugTVTKuHZbDadTNSDloU1TVO9djweW7OZPbdMwwCOB&#x2B;PfnE4R74Xbk8kYO2MYk0G/b0wmxmSMyQDEAxAWT8aj0XAwHo8n8t9w0P&#x2B;30wBgueqrnAFzNHmQODC33PvZJ1/xTy43y&#x2B;HwmAIDu5MeGsrLpOWv95xwYSOZB&#x2B;if5QT5Pxx8UxKHZ3F5u7m5OdVigHH9Y/MezCLcvhLXvJ7Yd8KoBy/H&#x2B;B7vBcgOrhHQPxULoP2g3gDPh0pBzASADLBBgIyzszPgb9L6MRygCJgCYhQSyhrl&#x2B;LijvNJDH088AtB2IKlMAHC6lpeMcIA/Aj4Cu1KpBDQP2x8ISWEuibYxrOsbjQb4LWCEY0TQaDSye3vp3/xq6snrkXcfJ959FHvnzfg7b8aevL7z9HHsxz63&#x2B;19/PfF3f1tIxNOpFHKssrKAIfOtb33rxYsXr169evHiBdx&#x2B;kAeMG&#x2B;j0I983Go1ubW2B8LO9vU02Pxr/cPtBkhfp/qgNwAJC&#x2B;x8QHzMBIHjQgVAtoKmfTqej0Vg2m02nw3hgNuYpAMiE0D&#x2B;dTCSwWiKRyKTT8Xg8n8&#x2B;lUykUBphCwBoolUplMmkoB0qlIlg9MEXFDZKFUCEA33OAgOMGhg9zwfDaarVSrVTKpRK/QXxHlXK5UMhXq1VOeyAhgN8rfht4O&#x2B;B7CojxU2m1mvx5UEQujKE6ssbabZUuHLp/ttv1egOgHyMFxFAcCKDHD5jEoWaz2W63OtqAS6sNDrrd7oHGL6J9UFcsdPGbJ/WfbJ8DER8faOahtBg6PFQMIhD/jiRujOrhrkRt6FhfuHmHZAehBcCFEJ83GEGglyJcjiVvmAyf3nL6GE6PocmPCH91spDev9DVvZcSHHapmQVdaokB1ANcMDlYktGxDk7a4coXF&#x2B;QI3aqcrzuqBWQecE1kT0x/HQYO3BDQ6&#x2B;j/vt&#x2B;nASgsgG5vb/Hqu7tbov/7MBu4zyEAuv6DwQCVA7C&#x2B;XhIA6/f7fYZ8kXFEdhD9fxgbzPnAYDB4zRVOSBAENOcJFB897KyzfR5IDLCC74J3fd/jU4S55OI/kBR7mgc/ICO5Ir4UCa6QZ/RSQVcpKA7PYuEvFzC&#x2B;tPPJ6sFiCxQDRYRQlRsHbiRODcQDh71bCo7xAlsyqthKJ5sIuFx6ybZtO77WZfdEOzufq8&#x2B;rBg6u6worSfj6irweBOhWL81JWKigse1o&#x2B;loME1icYCN8LynGPH5MkmewoH6wbduyZkvVgnxBnhY9hnwDEIc8z0X/nh8BhRA&#x2B;nS8WsXqJ6ImdEQ4&#x2B;KwFPIthYBrgy5fBExMwj7LqKU8SRjj73sKwZPqzv&#x2B;6Zp8ufnuq7nhuaqqgFv275muIQDgj2ZSz4APiPwt2B7G8h&#x2B;rgD3zLHnrmYv6rnuA8KPLdHO8AwFa0j9hIRVb88t0zThJgSsj4ze6XSKScLMNEfDoTWbQUwMIyDw&#x2B;FW&#x2B;r/LeNCyYfU6nk8nEms2mU8M0DOzSzDQnQvWB/&#x2B;jMNA3DMCYT27LQzsez49FoMh5NRqPxaGSa5mQ8Hg6HmAyMRyNzaoxGo5lpQk88GY9RYIyGA6wwM83hYPAvxfbf3zK6vR1bDx&#x2B;8HTn//C3gzItz8YWE1BD9kxdEhe6VOP8Q6OsCYvr8kD6k21bgIsPmFq6OgPLX4mWBG6wT2A&#x2B;7urpC8wy3yfhnd43XRRQAHPHTf&#x2B;Po6Ojy8hKXbTTwqMk7Pj7GC9HdBNY/Pz8nLNjf3z&#x2B;RgFIgEs4H6HCyL5aIYOOQ1kyHFlisEN6hBmDXnype4CEgMFA&#x2B;AMUeGAHRRZ6EEMwTAPhgMlOpVGA/T/ceeNfgRvrv/jb6/tt77zzKvPNm7Mnru2&#x2B;9Hn/3UfJLX0z9jz&#x2B;Nf/xxMZOB9Q3db3AXwbe7u7sfffjh8&#x2B;fPP/jggxcvXrx88WJlZXV1dXVnZ2d1dTUajW5ubkHvC11vLBbb21OJv4D10Wg0KYY8CdB74nHQevb29mAAik4/UHs6laIFEJ18iPKzLAwSibQ8m8tmMUPIZbP5XC6XU1Y/GAvAtyeTyeRzeTCOcrkstomCIZNOo67I5/OFQj6Xy6VTaUB52oDCMxQKgVQqVcjnS6VSSYqBclkB/ZIC&#x2B;lXKM/CV6YnCNbEKhdgXj6DeK5fLlXKZauBWq1WtVkj60u2A1CBIUgWazSZciSgURpCw7i4Fdj9NZvWF84EDMP61f0H0l1/1fqvVPNAWIv52u43MgX3JGqMqZr/d3t9XFqIdzWKIsmBVKgjJh9wenfdPtf3xcffw8BBqYBiD4q&#x2B;Sf8IsLTAlAKw/1mLFJGxYrIEgAzg&#x2B;htyfJxOsfC6pI7r5T693wttwFSARkZMBGhPrSifInOgfCiivD1fPxFlIqwUudHB/cXFxeXlxI9MAPMunSMu8BqUTJ21R92LNBw6hrBPIGiIpCFifIgEKfx8sHBTc3YWqX04V&#x2B;CryhRggoEsCQO&#x2B;hkpi1AasCKgfG4xFnBVzG4/Hd3d1rrkbsCZZrAB0c&#x2B;37I0Q9EVIrLpI74fUkMCIT3EoSCAd/RFjrquMJrx2aDhXKf5PsSOtPiU/WhbTuQ5i6hJPYTO&#x2B;ZqObKO43iKbENaiKpzwumBFCcL1Tr3QjdP33ddZX&#x2B;kIL7svHTiF6wBPDoj0f9U0zC4mt8oDhH5MCHfXY67I66jArXDmAJfsyv1KLoVwYZ&#x2B;9AIJPluEBY8XBKrT74nBq&#x2B;u6GCb4Wgvfk5EBdnIhwW1aMaYKIb1W1JE9yDC&#x2B;NM61Uspm8eZqVRZ2XX3ptg2VAn4bSv3sONQM&#x2B;HolGWpIgKJt1CSoDVzmoHkePDpZc7qC6UWa7PL7pcwaD04Nw10eyLBwxE/LsqyFxqGaz&#x2B;emOfVcdzYzPVqRCrifS6oXeP/T6RRDA8OY4KDB7Wem2P9zWzn2TCX3d8aBALQB6OtDZAxFgang/xRbm1sWygOAfjB95pY1Hg3p8zOdTOZzpHpN8HLl8W9ZU8MYDvocRID9D4tP3B30&#x2B;5ZpTsZjxH6ZhjEaDMbD4aDfN2QIYJnm9w/m/1mLa9m12pH&#x2B;yPAHCx0mi5SdJMh2AdYvLy&#x2B;hA&#x2B;ZkmXMATglwqcBThPiA8ujuYzmTkOAryb/U211sbuElV5J9A&#x2B;oOUD42iAqE10JcXHHV7Eo4AIfsaPCfnJzo11q2A8/Pz0EMONFSfgAIFD4QG1ASDIA8oE0Es5/6XdAMgPjxOOoBbARUH3RJj46OgMZqtRrLANqiU0zZ6XRKpVKn0wHER&#x2B;WAdi&#x2B;2TDExGsnAgoCV5XI5lUqhP03UjqewqUIivv3FH9978nr07TfXnry&#x2B;9/6T6C//5&#x2B;w3/iEf2auUy0C3fEk&#x2B;m81k0sj/AqLd2dmB0/&#x2B;HH374/PnztbW1lZWVV69ebW1t7ezsgOW/s7MDDQDsfTABgGaX7p&#x2B;oB1ASENwD9ONuLBYDoT&#x2B;bzSbF3R9sHAwBMplMNpvDZtHv58vh8Z/L5VAVoPfPx9OSEJbP5ZAChs3mcjk0/gv5Aiof1BilUkm9SyaDigPDgWKxiPxgWrIC/SNXGPgeh7FSKUNGTIJQQWxDsQ512&#x2B;zcw/0T9UAd/f5KhVJsZQ8l3ztJXwcSAg18j76&#x2B;Yge1W0wWU1VBs9lsNDqdDm2moOhthckAoP20WhIhHAoGJHlASQuazbZkDAPiNySoGI&#x2B;g00/zH33NTkeZ/6CWpvYXIB5bYCWA15KZgz8Z/JFyHfwVk60Hlj97991uF3dVSYBwMQH66N8firHvsQQMMzWMxH3qhnFGYvufYwEKiDlbYMNCUX1OT2X4qc5RqASuxFRNx/04MQrRMWzt6&#x2B;dMnYdJEZeuxVKyruW57tXV1WAw4Ppke6JDdKNcQe/wEm0IEM4EQBzCv1QF6AoBFgA645/q4X6/P5ACQI8F6EtYGAuJZefQPn1C2fhnRphKAiYE931/8QnwjQuhJ9FUIEAHnBJIK5qMGk/4LYFga26HVUQgQl7QTgRBufTkwZvC3QXddrZjFwvVWlaSzWWY62sTBk/YOLjtiLc9H6SZpqcF67qSsYXmOiEpX0XCjLyvh3kFoDCOEjkqBIucEpBWxBrA12hOQLGLxcK254vFAvWGjBfU/MFXtHtfR5&#x2B;cirBWCSn8mgoZ2Fp7xvX90KBzsVh4nhsEC1co&#x2B;7YmdJYKQR1GvDO1EJC3hnR8z5MwCQHZml0sDyO&#x2B;svDrkAa/dkhDSO3qnBxMfmQG4oksG1t&#x2B;UMNgBcuauZJW5i8XtDI8CV1BHRmq4C8BeN0BvQd10nwO8YDj2CaifF3XdV0LcV2WZYtPKIlbnngNOY5jWTOAfpQBONTg4nuuA9gNKtHUMJAhAOyO4wxSPlS8Mw3iA9bjPryAIADAbsAXCPkAIZ/HnE7E7pNA35rNYBI6GSsjf2tmmoYBrj8KgNFggB24v7vDDcwBJuPxdDIZDYeT0WgwGJjT6f3d7aDfR2oYuhE/ECr/p5f5PJi7Qf&#x2B;fRv1nV98f&#x2B;2g0GtECCNcP&#x2B;kNfidEnwDqp/3SNoJsE6gS8SjepwDCBDB&#x2B;WCpxQ0&#x2B;MC4B6dMLb/YStEp867u7sTMeTG9AAXWvTvMUZgW64n1p&#x2B;4wJ9LbgC1wuzkYTiAeoBmoAQiOiIBlAeThy9RtISjo1qthiIEeIW8hVqtxgYnpwTgQAN1YWVk&#x2B;pIXAZFuWxaQQADyqkIKp0k8RgHJZBJeNFgNtBCoSOFXg3/L5XImk8l89GH0h97JvPtm5O034m99Ovsb/292Zzs0s69WAYUzqWTsxfP43/x1Zn0tn8&#x2B;DHx&#x2B;JRHZ2dj766KOXL18i&#x2B;WtjY2N1dfX58&#x2B;cQ9cLuE7Ce9j7JZHJvL4IbMO&#x2B;PCMkHHj5JYQHF43EIbcERAkEom8mA7g8GEcN99Z49iD3xeBz7STugfB4hvvlcVvX4WS1k0mmIdBOJRExkx3pCcDaTKRaKIPDg4BSLRZ0KBaPPXDZbLBarlUo&#x2B;l4OWgKJhMLJUI79SYTEGAo9YKylCEb4&#x2B;0IfKpRIGAmT&#x2B;NBsNfLO0&#x2B;Gw0GhANYzhAbUC1Wm2JLASak6ZERLckWQzgvl6rHezvczAFIx9sgeC&#x2B;0VChwmDs7O/vH4pX1f7&#x2B;frPZ2Fc/&#x2B;A4FA1S8oMQlz6ejKYwpDDg6UpagHKlRVQzcLxSgfRKB6B3UPTrqdkOBb09D6jQa0mk8QPMs7Lvd7tHRIcUAeJb/So1xTMrQgwCBU/ENOzs9RQMC55lzcSU&#x2B;1ShBlPP2lp3NLjTngwtpguhtETUNODu7WHZD5nnyTMyX0dq/EVmXoP&#x2B;Q609Z8I2cwLXezfWVlvKuLIBubm6ur9nXx/CA0wBdHqALfGUCwIlB2PinQ/&#x2B;dVgzITOBOdwUdjUaoBxgVzNZ&#x2B;SBAaDvWWf385D1hpAALNRYfQH9c/oFXCX6JeeHT60ukMBND7GkFoIZpaIldeVnUqiP64L86YaOovJJqAu&#x2B;e57kIKBuwAXXoCjcrPJjSDunSzS3nWYxNdqoglyhOb6K4EDHsiKuDncpfpQ7YY5gDcqyGJVDX61vSKiDWMVgIJGNUMmlR54Dicb3CDyptf3EV10L&#x2B;Q1DZX6FKeJkUAlF0sT1FQACzEDghulS5zxDTlAws/R5C3AuKCfV3tu0Ab3pPP5SiFrsUvBSoCBGN5arxg&#x2B;/iixU7U1t/IcZjQzIPjMl&#x2B;MwmUbVqcYBoS2pyBoAXY74v4EeUBAbpLnOY49nU5935&#x2B;ZJnA/XgWhrKPRkySezJnPLXUbnf75HD8JAGs1lFCW/DPHgTcoPP5n8PykZSca/45jA/qj725ZMwwKsCZa&#x2B;Yj1HY9G06lhzWaTyRhpvjQGRdcfMwfPdbGaEbJ6xtPpFKBfuYXCGgjhvpMJ8L2qNBSrZ6j8/idjVAWTyXgyHo/Ho9FwOBoMjMnEGI/HoxHQvzGZTKfG1Jj82xUAxieN//0faIODwYCUHirAyLrhOJgXCQwE6AuESwiuBFQCsNsELM4hALapK3dxIeSzOsv/THy1yRFCvx/UXs7T8Xbw/sf6R0dHeAtcs3GbFHxIeLER0IrI7mWb/0zzC8K1m31H2oMSprRarV6v12q10NcHOYfEBjp74imd50O2NJC6Lvll7xYcD9q6g8sB8ISnwOxHhxieP5wGgOrTaDQA/ck7z&#x2B;fz&#x2B;Vwu8z//DErfxLuPdj/3Xvr5M3jXABaXy&#x2B;VcIp796MPMH/9h5Ke/EPuhd9IvXqA3D2P&#x2B;tbW1b3/7269evXr58uWLFy/W19cJ&#x2B;rHgLjS&#x2B;MO&#x2B;H2BdsfliCok8PTE&#x2B;nf0b2xmIxwGhw8fEsuD1oxqMMgIQgk05zaJCIxzOZDKTDFPLC61Mn9MsAIAWYjtIIZQMqilwuh7EAvESR&#x2B;QW9QaGQB5rHwUwlkzAYxREmiNcb/GoRwQBe2Gg0QO7nrAblHCs96IOrlUpNpjEQEKPw41dPLhDYQS3tB4P6Ab8x0n6ayzUAxk0YBrSlnb8vAcNUDx8eHiKfuN1ukaJDjyD&#x2B;vKkD1nv/KA9ammeurieGBLkjuQG9kxOMBbqSlKfVAAdhuSB2ot1uF49wza5ECB8eHkowcJjjcSg&#x2B;oaj28UetT/l068&#x2B;u5ItBKIS&#x2B;A0C/khrL&#x2B;j0xI9Zfjg7FueQA4AYZRKfCFDo/P4e1KE99RPm9Xu/8PEwdvri4uLg4v9AcgdjaF42Tmrji3HilBQVwlnulmYcC63Pky2vB5eUlEDyNgG5vb6&#x2B;vrgDZMQcg9Cd1R/F/NLKQVg&#x2B;o9Un4AV5nIcFkgPvlpQ9GkDT&#x2B;dYJQ6B/6CaEw5gD39/ev6Tg4EAqQo1K6lGwXrVDgLazjaUwPIldfIgICTUnsiVFMIMJWdtBRPCw&#x2B;QQTyBeKTm4TGcyDG&#x2B;cL0cJc609L1J7mILqWBVocIsHNCZI891IyGQlyOqkZz4AmE/oQPS/SvwLoCuKqRrDgwtAxCrSLjC44gXNdFv5y43xX07wiT/kGp4ClquyV7Ih9cWD14ZG5ZD4yG8KW4EojLOgoHVipAHFjXp25bMDEa4dZsxta7I/8CoKvKB2Y&#x2B;FBlL0K86gFKGPfgqfU1&#x2B;7Uu2msc4Z5SjJPPI/MeTV7GFH6oIlE5DYXT90NnLRQvGFxIbjO83nB5g92zbhqGnK7IH6fHb87kFhA8GjmmahmEgwMuVuQGO21yYPDhKIP2b5lSBfhVW4LjKCHWu2FOOY1mz0Wg4m83s&#x2B;VwxiFAmmCZigBEwjOAz1aefmahSEBQwM6eI/kX6L&#x2B;TCSAMAfWhuzWglZM/nSAI2pwbSf1EAAPdPhUdkTqcWnIjG49FwOBqNzKlhjMf9&#x2B;/vJeDwYDAzDGA4gABhOxmPc8L0fNKLrOy6ONdd1v/3eeSrb5F3LXMoFOO6cfs8NYsBKaS8GxyRxouGEawDv8rKBNXFhw4Og6fMqcq25TWO2cH19TVo/yEIsGMjbOT8/R1P/QpywOYjAxRJvyhHExcUFBLunkt/JmTs5uKcS64sSIuy3iRqYliAHBwe4gVIBrj5HmtsgO5fADWzwA&#x2B;5DMHBwcIDhAB4krR9lANhBoGRALUDBbrvdRi/26OioXC5TttsS&#x2B;3bw&#x2B;6HrRVeYEVQg66PTDGgITAmrSrbJ8/l8tVxO/dZ/jz95fe&#x2B;tz0QefSr6Ez&#x2B;W3duDP325VMpH9krf&#x2B;sfkf/m19c//0O7jT6fefbT9w0&#x2B;TL19A/4r2/Obm5vr6OoYAa2tr6&#x2B;vrW1tbAP1w89yVBXLeaCQC4S/KgGgkgnICqgAge7TwQRCCBiAaicSVCDiWyWQS8XhGIr2wJsg5uVwOLj2kBqHNn06lUK6kBeinUqlCIY9RRjaTAVkfCmDY&#x2B;BSLBZCRUAulUknop/FGhXweLP9sVsUFAPQXCoVSsQhaEUoOzFIqlUqlXIYPKeoJlAelYjGXyxYKhWw2W6vha1SOQFAC4FsG9R&#x2B;0n2azCcfPeq1WFmNQ/FowJSABDLVBq9lsiCFsvVZrt9sg&#x2B;sPkhyUlDYKUSagUn61Wqy03IAVG8dBqtcAFYpN&#x2B;X2LFHrgDHR0eopzodMLYLyrg6XOFPxzlhaVyAEIof3R01Omo1drin0sqP6A2/mBZnNMhFC8n44hEPn0mcCR2n2p60Oth0HciE4CuFjWgVL8SNUhODzmEOOsA39MjiCclAnq6/egKAbKJtFNTGA&#x2B;sUL8YiV6LNxpAP9suHL3i3xvNx5m4n6dlnKjZ9KEU&#x2B;EriBSgCZhsIFwXKhSkVu5OcAaJ8cn5EYHZ9v1wGsGGPSkBn9TzQCWDNWwkX08sD9PhRIVDyS7IQRMNKBIyrHTvogbCAAspDfeWmrzezdajqam6VAVXCAJeC4xU9RjMa8sTF5QEW9EXD6miCUf4bolhtPsBSgXf1rnmgEYFckY3iU6sqQl7F7ejzB71G0jk03DiOj9bt1sTNgsWBWVkXAWkT5vK4eVLM6FujrMJhIx&#x2B;IXzr3&#x2B;EQ4aDzash3wW1TRstCqL1fpLlRNRY6&#x2B;tPap/VXqjkBLRXC0oQorK5QN3HM0/sNHVLNcotY8xZ5yXTdY&#x2B;L5wclB4&#x2B;D7dpURELhoG2XcV9&#x2B;uI6td1XcuaSQKDzT3EnAH7Rj8oYem4ZGTBSsgVUpDneYDa8CDyXBeofeH7pmki4diyLBSHfK0i7tt4KWC3KdWFjUQz7PPMNBEBBm0xuD0YXxhw6Zkac8uazUyUGJa0/MejodgNWePREOz/ibDwJ&#x2B;OxY9v2fD4aDlkqTBAOIEafGCYMh8PJeExyP/LCyOSZGoZhGGPwfywLiB/FBhIIYfY/mYxHw6ExHsNrDB5BmBigWhgNh8r9czgc9O/Hw&#x2B;Gw35/Nvh8vnu9nKTXPefvw4LTSvByK4uBysEQNOj3/3lpkUjxvbm44CgDiv9HSZHC31&#x2B;vpYl/9mnEtQZUkFGEjbNJTZ3Yj3qC9Xg9FBfpJF1r4F65t1&#x2B;LdeS4uoria4nE08KgEIFMIV/eLiwusQCIvUD6vxCeSGYTLOR4Btjg9PQXKPz09pdk5OnlgHTSbTcoDgGMajQYnA81mE1ihKbbreAl6olT37mtBqu12G9pQGLygpwswF4a5yoKUWYqAwQVSyFJ8acAfoYFMs9lEC1xpUnO52H/99dTbb6SefGbnyeuJz7&#x2B;f/fCDfCSSXnmV/bM/Sfziz68&#x2B;&#x2B;lTkyevbT17fevTpxJPXdz7/fmF7GywjNOZfvXr1/Pnzl69eIfALdP&#x2B;trS0QfoD7of2NidUPjIDo9x&#x2B;JRDKZTDwewwRAPSVzgL29PZDv8RSwPhPBsplMPB5HxC/gPj09k4lENpsFiEdfP5/Px2PxoibMjcfjBYHpSkycSqVSSYh6k4kEZgXYODKD87kcmEJE86q&#x2B;KpUQ6VWtVHK5XFEIVzkJEOCgBmag9VqtXCpzUIPhDEA8VqhWK9VqBQVASb5OFIdo/OstfzyuksIajZaSDYTS8HKp1KjXa/IS1BiNeh1&#x2B;QbXl&#x2B;RKp/OjYw2S2KQkARPns6zdUMEWNLX&#x2B;sKcyg9r4YjFL8e6Ali&#x2B;GN9BeyQqBUAP3&#x2B;4&#x2B;Ou/lq2&#x2B;anrZXGOP2dWCOT8HGnaAK7TFUzPGSDg&#x2B;7EkhOitfdYMXI1jQ9Xv7/XAFMI56gRdf7Eb7vUUyuf08kLyCkkEOte8jLGqOiVqzB&#x2B;cOdGFOZce/9nZ2Wmv90AcDC6Q0m5pbRT2ejg60BXA16ElKBr8NzfX18Nh2KQnz&#x2B;dWHD9ZBtwvx4RRCXyrmYHS9oe8fzoOUSishAFSSIxGo4GYArFs0LlDffEguru7G2orsKJ4zRGNI6557HPjxlzyWdmBZk9auA9hweAtL0JBWRID4KlAKoGAxkECcKV2oOnnkmsoAFyg5hVLdQUBt9q4wFz2&#x2B;DmvcDWErb&#x2B;pJ8wWV0Phan&#x2B;WrZBQP7jL2V54U18bcbCFT8XCQjPhwSEMggAUGuWTI0fPldvYZXxIoF5Xo7n7spM8vAtRDkBv6vueeiutBc6PL6hdzUB0tQBNflzRUruiafb0JAcZdMgLw2&#x2B;fpHmtHnC524pP76r3dZap/B4b//KUqnagLxctBMYsNo1f5Rdmh6aijm3PhYjvyQuVomDh&#x2B;3PB7vjW0Fl3JKoMswtHNMrz&#x2B;RzRuYzxwmvNqTGbzZD8Be6&#x2B;&#x2B;PnMkc&#x2B;FTAAoktliVzQeYUw5jjM1DHENsufz&#x2B;WQysUkewmxhOhUW/tSUBSldIPDMZrPhYIDmvaF8eKaWZQGUz1SY10xZ9Eynw0HfEjHxeDzCjbvb2/F4ZNtzNvuNyQRi3&#x2B;l0ivCB0XA4GY9mpjkejSAdRst/MhqNxyOYkGK1MQLJRyNjPB4NBuPRyPo3KwC6F2P97u39lLdH5lImgDX73nZA/X6fs2C05O/u7gCmgeCvxU0CTR1AfJ1LytdeLPtsksN6LVFfV&#x2B;Lv&#x2B;UkpMKg7F5qpBUm0gPU9SfI6F48gdvpZMGD&#x2B;0O12sfGTkxO05NFXQ/tf5/iC/Y8LNvuIgPt4CYoH9hTRqmcPEki9Vquxgwgcg24l0AyYPIAj4GPA/hwTADp70sUfPV1Af5q0oLkLnAfkJ3SSYrVaBWMHvBEMBKgfxQoIpQJ5HaTzUqGQ/uM/2Hrr9e0nr&#x2B;&#x2B;99ZmNtz6z87n341/64vaP/NDek9d3nry&#x2B;&#x2B;dZndt76TOLJ6&#x2B;uPPhV58vruj30&#x2B;8vIFGuHA4nD6X1lZ0Wk/TPAFMyceiyWFsq8HfiUSiUQ8EYvF9nZ3gelVplciodr/qVQOct5olJwc9PIB2RnaBZ5PMpks5PPg64P9XywW40gRFpY/2u1F2B&#x2B;lUtlstlDIZ7MZDBCU72daOYSqZn&#x2B;hgLZ9qViEnT8IQaViMZvNYK5SkLCwQqGQz&#x2B;fwCFS6&#x2B;NZQhKAqy8h8gIx/fGtcAWVAESIB&#x2B;U4rovpFL79SUXOharXabrVAMWIyAHXhHAvQSZbPQiUM139VAEiRiQKAQgKyhsjsJwmNdDX4jaIGbksScLvdxpTg4GAf3KGDgwM0&#x2B;CmPIUdOioR9PL6/v3983CXb5&#x2B;DgQI3c9vfZwhcCXofKYJbf&#x2B;GuFQ9fRUWgTdKIxfED7ES3Q0ZFkeNMO6FTcP3muIOlfjQgE&#x2B;/d6PRk3qmY/qYPs65&#x2B;e9s4kKIArKL5Qt4sb55Jtcr5sdnyhmaGdaYko4VDg/BwnWJ5LcVqmWOtuueWvLaE7EKE/pwe4cSvG0LhEAO6zB0RKz7U4C9EgiJpgXfgbFgRSHACmYys64YedfmJ98oWoHu737yn81dUF95p5KKTArwVBADhLSKdzTojsCeOCIFhoj3PNQLS/gbTbidoJtX3Nq0eH4ITvgWQPuxoZxpehgSd8cSoTPO1Zvpfeevc1&#x2B;grf1JXcAH5G1ciXyQDeK1ATDNYeOhVkrn9AHbPqUmY5knLcUJMIalfJU5Qji1ZBWfgrepJSxAZiauRKHi33ip45QRDQxpQVC4&#x2B;JK270gOn8LGRVcWVWCAvxEmWlwYPA2/iAZA3JPEEJOTB84BeqviON9oOdkR&#x2B;AqojoLMTfBmcIvlSheK0yUPK0pDBWNctyDie0DdWIW1JloT2vEn8dRyV/iR3QfG6pb9l1AZcdyURzlbhgLo7&#x2B;DjE92u3g8c/lX4wUXNedmSbGM5Y1w1ubkvYFTj/ifueqALBs20aPXzl1zmYz0/Rc1zAMZfgzNSTzy5xb1mg44F1m8aoo3/l8Npsx0msyGlmWhY7&#x2B;dDJRHkHT6Wg4NAwDzf7pVBUM/ft7WPpAQ0wT0pk5hYx4NBxYsxlaDXD9h8zg7vZmNBiMR8PhYGBOp8G/zbLfudTvHhyEd2fG2LGXqEfZVOW7b200GvEkjgsJWP6X4jDNaYBO/adK7Fr8QG/E9Z&#x2B;CAajTbm9vSSLSR9UoDHBh4/XmXDJuYOVJpS97Zigkelrgjn6t1V0ycOnF4B56O3QE9/f38RT5AygSgP5h838gluRsK9LhB11J8nwAjIBa2lo&#x2B;FyxKwMlGjxOEDXh6kjVB0xXdFRTYDh1WQDF4eqIwICJEQ7fZbIIXjtFBJpMB6If2FDQVkObRuq7VaqlUqlwuZ599vPPvP7f15PXY40/vPXl9950342&#x2B;/sfPWZ3Yef3rnyRu7b31m8/Gn9x59auvxZyJvv7H&#x2B;M1/cfvkSAcD5fB4agPX1dcR&#x2B;SdRXlJY&#x2B;Ozs7kUgkHoshBwDUfyHzxFPSyFfM/ng8k8kkEol4PCaFQAKrp4XZD1JQKpnMZNIMCANqT0oqMAw6ocGFciCTTmezmbwy/czA0DOdTudE6lDI55NC38/n86giFFEnmy0W1AJYjwFLTnF&#x2B;8plMBoperIDH0dTP53KlUhGpaTDtKamU33KpWEQSsJJklMsYJoCpDzEwdLow8yyVSjXp3FcqlWKhUC6XK5Vyo9EAd4g2oJj1iDWQ4hXhF0jBAH5amBXgQTL4W6IspuUUKwF05VEk0EKUPqH8GcuzDZr/4A8Bv3DQ3lot2ATp1P99OGjR&#x2B;erw8HBfHgl5OwcH7P2T&#x2B;s&#x2B;7x8fHIA7hr4/8n9PTU1QCx5IVwMb/kfyrTwbIAsIMUMH9bpcWPmQKCauwe6IZiB1LLMCppAV3JVrkRMKDT8PM8hPh/Kh2xgOIf77shnx6enoZYv5zBeGl5Q/BFRool1pAGMenl1oUwKVYBomoVxE1Saokb5M8n5ubaw6KFe3n7o5SYNzu9/u3Uh7ca0EBaghwe0u6Kf6lBZB&#x2B;oy8JYjr018cFLAN4g8/eK&#x2B;aPSgdjefCar4XgOuI2Q0BJljyLBLrR4yWE0Q9mCOyCE79yaywe5vO5xjUK9bgLic0iKl1oTpeBjBSCICBpRNcZi7A1DB/gdgLhxgjXJeyFewy1FUmopxGTPCGZSKM9lNty&#x2B;/pTi4UfBEopoTwZZzPWM66anCwY&#x2B;uvSm0g4RXw7BaY9D7ASe&#x2B;yJN6gbhicsjVkWYh9EuyECX0cEAK52ePFN4tn5fK7cjSB9ltsYQehiCQJxx3FULpvjaCwjl1Qu/ErgZ&#x2B;8w3ze0aRI3Vam2xJgIMx8eZxmVeEo0jHIi4BctOmxPEt8WmpYAJURY8Ei33hGPJj1YAEQaR4oBX4mhHdd1p9Opx7xqBcHVhMGS6QEs91EDuOKnNLdm0&#x2B;kUimFrplTFaO8jPcB1HHByHMcZj0aObcOfBw6h1mzmua5pTrGOejlqDNu25/PxaMTBAnj56OjPQfKxLGtmTiYT0zQlMkzJjiEMsGaz4XCAUsGcToeDAQYFyPIFLwjTAJQWxmQynUwmoxHQv8oIG48H/T7yAUD&#x2B;Gfb7yA2AGhi8oO8H1X8fS7F&#x2B;enNv8O71rWFqxJ/G0W14x5pt79TKtePvsrXJZHKt5cnf3d2RCMTHQ1KpqMRweeAs&#x2B;EJC6alFI&#x2B;eHDSqszx4/r2FXV1dsfeGKdSam19SlUSUMKI/rKMoDevvwQosFF3sO2XFdh7qA1&#x2B;xjSQAF0Af&#x2B;0N0D9ZlAV/KAdRYBcA/AN10&#x2B;2bkHWgKWQnseHAaANrwEJQEa9gD0AF5AbMrnUWK/sBq6uYVCAbQQNPgB&#x2B;kE7KZfLGAuwzVwsFtFHV6yVVDL5zX&#x2B;M/tRPbL7573afvB55/OnM269vvvWZjcefXnnj30Xf&#x2B;vTa489Enrz&#x2B;8skb2z/zxfif/nHk2bNioQCuDkA5Ar92dnbQ149Fo1D6IuuXGB2gf2dnB9T/ZDIB3L&#x2B;7u7u3twfOT0qoO&#x2B;lUKhGPJ&#x2B;Jx2vwXi0Vsk/79WDkajVLam0wmM&#x2B;l0LpfN53Kg8kO8ixpAke9zOcwH6NwP/k&#x2B;pWKTLJz4XwL2i8udytE4KF4n0KuTz0PIWC4VGo5GTlUkuQtmAAGC0&#x2B;avVCjIEikLsQfGAbwoFQE10HdjJspCIsALHAmjwF4vFalVNfqAnhrMQBAHK5EeFA9Ta7TYoPc1msyY5A41GoyWSgFar1WioX2ajXt/f36/Vqk0Jp2NQAO6igEUpKz62oc3/0dFhp3OAaRgKDDwrjqJtFszNZhPjCNptdWRQgJqh0&#x2B;kcdlTsF/F9V5z&#x2B;jzgQwHxA/lrR&#x2B;z/WjEFZzFMBfHR0xGKAgwU&#x2B;daQRhI4/YQPa1aLEjo&#x2B;Pgebxjj2xDSV8xxBAR/YoIcAqPJMkAQw0z87CNIAziVrXexwXAuIvRd3LUoEdlouLiytxbyPXn/NYnN4vJEfsWuz/cYa/vb29uQkRP3VWVxL2whqA2rCb62syecAdwhBgqfF/d7tE&#x2B;7kLF5YKOsufXkDqQdEDsAyAYljNEO7uKPmVecA96EP9fv&#x2B;1B0pTT0sDCJYtQR/09T1ZyIGRJrRadNWpH9KBQmtObJ9zAHSjifXJ7fYFOxLX&#x2B;r7vOGEnXvbTo4On7/tBQBK8yzcKRGf8QDMQaCIBQb2K58N2OOoKYv0HnXL6EbFI8H3ftueBVhF5wrRhERIWNvIs3hFZue6yeFeXQLCYwSEKpHjzvLCX70voMonvgdQYn1QGu2IkutBa7Nxhfl5XaDaO&#x2B;IHqd1Vx4oXFSRAE&#x2B;I5YR&#x2B;EF&#x2B;PiByljwFouFIxkInnT6ffEX8sRlf4H9pFp6SSah9kR&#x2B;IeonRBoVBcq2sPDxe&#x2B;OxogAXvyv&#x2B;gFEwwGSJ4bv4ovFyva/PCs0wDE9U2q7EA8/F91P9O59js2D&#x2B;gDgE357JeGwoyD6D6ZA9nw8GA/T&#x2B;x&#x2B;MxqDhTYyLbmTmOM51O7bk1NYzxeIxmP4uQmQlWv0oAMKfKuHM0HHL/4TU0tyzAdPT9sQ7a/GqeMJlMxqPZdCrhX5ANDDFAgOR3ahiT8Wg8HBpiCXp/d4eCAXXFvwjef&#x2B;8lma6ZVtjmb7ZO9GfbuvDXtqr1E/O78oBGoxGBPi5X15ozNK8WbA7R5fNSSwEDXr8W439defbJrj8QP5tSdApCd1&#x2B;nydLhDppgXOROJPoXRH99SkA53ZGEeuLK2ul0zs/PdStPQHndlwNXdBQG9B4RkkCXLH&#x2B;QgtC/ROOfhB&#x2B;Y/wBLAdyQmMH&#x2B;KIz/MQpgJ5UqTDgIgRcBrkVDkn3ZNm40Gtlslvxv4M5KpcJEqrK4&#x2B;KMYAG8H7P9CNpvc2kz94z/Ef&#x2B;1XNn746avHn9556zObT16PPv707pPXd9/6zObjz0QefSr25PXtz72/9ZVf2fr6X2S3t9KpFBA8nHzW19d3d3fX1tZisRgSu2DwD8I/pL3JRCISiWxtbaWSSRCB4rFYJp1OJZOxWCwei8FzE5UDmDxg7ADNw44TaD6RSOSFooPbaNKDDgTCT0qCe3X7TniAxmKxRDxOyI5NJRIJuHaWyyXSeHDoMEMgvadcLqfTKSD1TCZTr9dFK1wso3lfqYAgVCwWUU7gBsozlAfka1XK5UK&#x2B;gO8CBRveSDB9Uc8FowK4UqmUSyVQgDD&#x2B;0WO/0OnX6WR4pC5hwHhQlQEsAGo19PvBSWtKfBj0vpwMNOr1ZlOR0PCrbkhiHTZerzfaUhu0Wy38mZDTD6NbhfIP9mkBxL&#x2B;aA0nK6yj5r0L5h2K2e3x8fCCuQR3lpdvWNcS43VFkIVUDIFKg0&#x2B;kg9FfLAejq&#x2B;J4RYyei8cWCNU7EGJTQH5173ED74PRUiw0&#x2B;PsZZCxpiNDUI7o&#x2B;1UUCv14PXJwUAvTA3QOmAz7UJwLksp6IKYCWApgn6LHh30oFI76ECmE0cHe5fSRfmRssKuJT4F6Xa0qIeqQZGnQBwz2fJxb&#x2B;&#x2B;vr67vb1jhaB5g2I&#x2B;cCtzAMqC&#x2B;/17dPFVnaC1/4H/&#x2B;xLuq5v/3N/f32lsIv4rbkCD29vb1&#x2B;ilCIAYkLXveb6Ieslox3WRLX8vxHBLNCFXgpkCjaOvw6NAExsstIxeVyg9NBh1xZiSuJYQPNBGAa5sMwgCVwKAXelOE2eHeF28L6kQ0AsSfgTiYwJcVyPE4x0XmrsRSCn&#x2B;soYYFQXAPQ&#x2B;ao7n34OMsfB8uNI6kpPHI&#x2B;H7o&#x2B;r&#x2B;QHGLuv6I/qU/h8shw8UMmDL8B1xddhCO2M&#x2B;h2c31wYFxxMqVZkyP&#x2B;rQtNoDwX201&#x2B;ajxoO&#x2B;pY8UfieZLmKwl0vrj&#x2B;cyLhKcGu54Ricam1NGlB2Ol31SRkgWpHG&#x2B;nY8ilQYJDI5ftKCRAI6wyPeJJwPJ&#x2B;r/AH49GOAQ0C/YIXh2ADNrusCrGPgY6ukYUdR/Pmg40CPq9w5p1NLogDk1&#x2B;rAixNcIMOYIJ7MNE3MCtCeBztoOjXoO4RUL&#x2B;zqcDiczUwQexS3xzBse26aU9NU8lywd&#x2B;DeAyHBZDy25/PJeCwEIdOeW6DyT8bj0WiIYgDzANCKgO9RMJiGgYkBTIcmYh4K85/hYDAUa4N/uwLg8PBCp/kUK1392WWbUP/lTu27uxFNp1OccHX2zr24uenecNeaPShO8efn5&#x2B;zxkwJ0KZ0ngv4HDhUk81xoCwk8WB/Qn&#x2B;IBvfV1IXG/VAJcX1&#x2B;z8aYLBq6urojpL0QofHFxgTLg&#x2B;PgY5J9TLfmLQIHUIDyIxuT&#x2B;/v6JpA6hawgoRhklOpSwBMVAoFZTEkmYBVUqFcCpXC4Hxj&#x2B;jmpQus1YDxgKHB7AvJ36RKADy&#x2B;Xyz2UTyFKAkagA0v9nShukNxK&#x2B;lXK68s731u7&#x2B;d/vKXYm&#x2B;/sfv2G7uPP739&#x2B;NPJt9/Yevzp3cef3n30qdjjT0V&#x2B;6J29L/yHja/&#x2B;xvY3/zG9txePx0ulUiaT2d7eBpV/dXUV2V4w7Af5J5VMplOpyN4eaDnQAe/t7UX29sDwicdjiYSy/89mszvb2/F4HEODaCSSSMTh8AOwDsZOLpdLJBKpZBJa3lg0mkwk8C/tOzOZTDweT6eVH2gmnVb&#x2B;nqlUOpUqlUosG3K5XDaTyWj2/4V8Pp1KgerDyGRwgXKi9y0WCmT/FwoF1B7YMhQC&#x2B;XwexUCpWCyVimj84ymg/Adt/mKxCFYPqotioVDI58HmEkGwKgaazSbRf6VSKRWLKANC0UijQbdQCQ9WinAUA3phgPkAIT4UJgyaoKEQygaGiIlb/8GBFl&#x2B;NHy2KWwy79vf3WzLmarfb1P7iV42BAJ1/8Hiz0UBdAf07u/6g/YSPiCRgX/LCyK9TxCFtfHfYCfUA&#x2B;AM/WhbwHGnpYHgF12RrX2cK4TygeEGaWTDpQ13t3xPJ/IKIWI0FTk7OtQnk&#x2B;fnZaa93hhjgszO0&#x2B;MU&#x2B;6FRPDtYnAMT9p70eT54XYiikP0LNFRs3F1IGXF1dXV5eyPkZFP9LDgcwm73&#x2B;RKKL&#x2B;jds5YSu0JgasBjgmpQH6Jpg9cjNzf39/WDQp8b3XssLI9bH1af/iUXnCNEpSF/o&#x2B;j9Y1gEPh8PXdJ1uIHoALg8QtuM4qAIWmluOLaQOrUXtEVqxBetLo1pXowYyEwiWe/MPRhCOeHqS4Q3OCWcRalUB&#x2B;tx/8lW&#x2B;Y8HAcUQQBK6gW5YriP5l4JQv1B02xZngK16Z6KMvCYt9MQgiXHYFYqojoEkI8OFUScZJgjYicGVuEIQQP5QmE/UuJLVA8LEGc1kVCGrnaAWianbTvYfUpnDUw3oJccKianCIrX0JDfCkkKB0WEoRlQwQLBYg0viajNsVXa/v&#x2B;7aWmowjiW43ygDR2ob66UB8WvlLYG3pSUyYK9Qp6JyVRSm&#x2B;cikYPE&#x2B;Fdjki//V9D9MDePVgBxzbnk4NkHBQNoCyjwAvsHQcMfv3hA8mhj&#x2B;OLR6d6NaDvg9ZLVxB5/M5AncdRRyawdZTRQTY9mQyGY9GaO3jWcMwTNOEL5CKDJtO57JLyAowxmNrNpvNTOXnMx6D5NPv94Ha&#x2B;/0&#x2B;cP9kPJpbljGZDAcDWP1gg6gQUEiMR8PRcDidTJAO1r&#x2B;/Hw0GLAwm49FENAOT0QhPfVfg/S9f5jO71ghBf620z9vG2Hqw8vZe1f2uQQGz2exaM/gn3&#x2B;ZO0r4uJGsGlwqy&#x2B;TkoODs7oxiAQwBejchSxSXq5uaGrXoOB84kL&#x2B;xc8gHwWgwKAOtxmYQ2AEpfdPrZ8sclHCUKibNnZ2e4cqMqQP8e1F6af4OnC6/u4&#x2B;PjVquFFUD0Pzs7E1KButKLqfkh0BgUh4ea2T9Fk9KFbaFIAMsIwAvQjR4s7Xa7VCop35Vmk/bwUJECtMHAHk1ooDqa0gD9gzSCfjZIMtFoNJ/NJj/8IPXf/9vWj/zQ9luvR976TOytz6w//kzi7Te2H31q&#x2B;81/t/boU1tv/ruddx/v/dzPZP/6L2MvXmRTiokPfW0mk9nZ2VldXV1fW9vY2Njc2IhC7xuLxaLRvb09QPNEPK7yuZJJdPdTQtDf292NYLVYFGUA4sAwH4hFo4VCIZVS&#x2B;VwA/QDucAiF3jeTSSeTyWKxAOZPVnr8yPAC8k4kEslkAtrffD6fSiaRDwDKTSGfJ/sfUD6fy8VjMYQBFwp5pSLI51E&#x2B;FQqFdDqNdn6xWKxVq7lsFlIBHGd08dHjr1YqeBa0fvTyK&#x2B;VyqVQslYocKYCrDxZQPq8igUvFIiYJ5XIZwgN6/GN4UC6Xq5VKVQydFBlMMYJUjhjgu5IL12qglgHi16pVQP9yuVyv15qNRl3JgmuA8qxLwTprC3GIP2NSffDjbGp634ODg0ZDzQfAJYL7J0uIELKL7c/hYYct/GXjoH0KA/BHR8TPx49ED9BqtbqaPgeoHephanUA6EnvwaDgCAwiURdAjMxi4OTkpNuVEuLoCCQfnmdUndDtInqMQwOeHNCJQA1wdnaGxr9uWdbrnVBFgIIBnXtdznRycnJO3j8iwFTX/5xGCJeXlxQPEPfrxQA1AJRXoQtzI22aq8tLerhxZstKQBcDXC7HPqI2oDiYGQKKESo3NLmvUiGjJCDnBzcUC0gVAHf09xkMBhQSQPILks&#x2B;dpAKjDNBdRHXBwKDfv7&#x2B;/h233a57Y2jhLytcF&#x2B;8euxpwJpMtOdKsaydrKfKFutWmLazvxH9ZBvxyPBEHgibF6oAWTsRjAS6S1r0TDgeLMzAlY9WmDViOEi2LaCEWeYF1NBhSOXEiTW3Xu2ckOpJGvw264&#x2B;/MIwLwoCAK8HKpW13UWWqTA0pGUu94DzQOnEMuOPY5iroefNyTGeCHOtjXH/YBTF0WXUo77SqsQyhtUeWBZFgYlrFW8ZYseVGWObSOWmD8ApTrwPBYneDmLMaUKWHBqodbhwrcAs8uWQDpPMpvRFPekzECRZIeBYiIWlykQKh9bcnzx2R1NMQyKjm3PRfsrxYGjNAB4U66JQy3jGt/zPHM6RWufqmLXdWcz0xUZBrhDsNYxp1NuajabOY4NR3/Hti2V7WV6njedTh3HtmYz255jHXCH0FVfmhVMjZlpzufz0WgEH1LTNBEvwMgwYzKxJCgAoV1A/3PLMowJGfxTY4pYgKkxgeMnBgKwFTINA9QjvpxWP8Z4rJz&#x2B;h8PhYDA1JsNBH9qA4aA/6PdHw&#x2B;Gw37&#x2B;/uzPGS149/7rLce/meqw6&#x2B;1srsfDx84cxwDub6ZPL77Yn0&#x2B;mUJ3qcaq8kFZiXh&#x2B;tlP2md2d/v9y/F9Z/N/vv7e9QMV&#x2B;ITyrF1r9e7FsPQC8m5JO7Hleno6IiEHxJ18CoWDxzKn5&#x2B;fA/efynKiRXii90a1ALk9uoP4st9I&#x2B;CywQbvdhqEnmpGqSSk9SEATuJjTCp3a36OjI5ArgI3I3VfosFLBU&#x2B;jgQksApJhKpYDvqfIE/6dWq4GCAkYK&#x2B;tng&#x2B;YCFAlY6aD9g0eSjkcyXfnLj8Wc2Hn1q9dGnd9/4f&#x2B;JPXt968/&#x2B;JvfWZyFufWXv86Y3PPl39xZ&#x2B;Pf&#x2B;Mf0pEIrDmh9I1EIrlcbn1t7dXLl2urq6srK1sbG9FIZHN9fWtzc29vLxaNoiWfTMST4tmPyQBc9hPx&#x2B;N7ODrUAqWQyRZGvgHuQgpLJZCwWBYMohSiAWCwWi2IFevXkstm82PzD&#x2B;B8S3nQ6nc/lkolEKpnEx89ls8lEgulbiA7IpNOZdBpmnTiMyUQim80g0LdUKhXFrBOzF/T&#x2B;y&#x2B;WyEgeLCLhYLORzOXb3s5kMWvXVaqWoxL4VDGcymTReVa1Wa9UqmDyoKOAfCqwPfA8FMFaAVEO5djYaaOcXi0Uie2X5X6&#x2B;XSqV6PcwOY64wZlMNSYxuNhqQ/zIlAL9S2P/XlVVoFZyihvgFtdvtRkNlUFC5TtJaOChgdEC7DT1xp3MAmlBjuVTQsT4VwNjUwf4&#x2B;QgNaKjb4oNVqHWpReh1RAnTkQZ1HdHBw0Dk4YEAYZMFqPiDWQLQEBeg/EcdPAnTFF&#x2B;p0cN7QfcNCjyCRAWD9ngiElRRYhAEoGPDyc4n9klHA&#x2B;cnJyRnyAYSmSGODMzH4P5ecRLzkUoJQeM7kPBbnT7L8eXZFaUGSz&#x2B;XlBSG&#x2B;SAXOFe1HTu8E&#x2B;g9KAoJ&#x2B;FgAPSgUd6&#x2B;u&#x2B;nxT16n6geDkVAqGKVzxGIeTFXQXoBwOKg2kJOgwt/yUYeDS6u7sDb4gcodfQol6aAyzYCdY7zaE3qKNZfwI0u8sKYEHJCjrrgB6Iy9e9dwToB4KGAykz9G16WpFA7grW5w2P8WGLhee6qj&#x2B;9jPjZgLdtG5/UFnKIq1FHyNjRP7UnXBT9gGiEfunBq6woXz8atKrE&#x2B;jQSDWQEsVATDDUqQWnkacIANsKBX3m4PBKNhNvjy1DCV1MXGwCU3yxKFP3TeTI6cCWyAIUBDoXvK8W27r9E/O0K2x4teZQlLAup/eanwGs8bRKCkZGHoUpY3risXhyJAYZaIJyZsHPv8Hiq6QdqTl8ZBKkJA&#x2B;YJYArZEsvguq6SaFMzoJC/jQ81nU5hE6QYWVIgqR2bz217DioOrP2xR4D4&#x2B;CCmaQaLBWYCs9kMW8N8AxMD05zOTNOYTLBl1AOGYYBEpNj8lurxD4dD0zRd1wXoh9IX/xrGZCJkHsMwBv0&#x2B;zH9AHjKnU6iNYRgKuo5hTDAZGI/Htj2fioMnJgaT8RhDBriGAfGb0ym8/yej0bDfH49Um//m&#x2B;hpRX6PhcDQc9O/uMEYABWg8Gg0wHBh8bw/&#x2B;f5XlSFP91irNB88eHN8G33UZjUbo4qOdf39/jz79lXj588RNjS/uApSzyYQuvm7Fw6uFzkylSKAniTnnYvept&#x2B;2xAtlEPc3l&#x2B;lzos3ivY2m2sbXPXj6uvoqDK5JfNvu7Wvov1If4VxwGw85it9tthc3LQxISCEQAa2jYzyEAqReg94DWD2QP8g/wYqvVymazNANFR5&#x2B;9fzB5sBpazgCm6CijHZ7JZEAsAYZGkxv/JtfW1j//fuLJ65HHn1p5499tPfr07luvxx5/evvtN7Z&#x2B;8j&#x2B;u/&#x2B;5vJ54/yyWTkUgEcwMYccbj8a3NzbW1tc2NjY319c2NjbWVlY3V1b3dnWgkEt3b29nejkYiyXg8srurGvmRyN7ubjwWS6dSMWn/p4Wvk0wmQfjhU9lMBpAdK8C6J5VKxmMxtudTqWSxWMxlsyAIgeIPtgyieXPZbLlUYmAvyh449uAQ4ZFKuVyrVuEFhH4/aTyg44DppDt&#x2B;KoZPPg&#x2B;NdbFQgNACTX3Y/sD&#x2B;HzAdm1KhYKUinX/K5TJQfrVSkWdLfBy&#x2B;TJVKBci&#x2B;VCwqS5&#x2B;qqgiQAVyr1cD/wfioVCo1GorkQ3solAFYuVKp1GrVSrkMZ5&#x2B;2yMppDYRZgQLxzSboPaDuNJuYENTqtZouEmAOBX7h&#x2B;0LxJ5OtqWLC2uz6A/gjWrgjiXhtLSQY9H3UA6re1qKCOQHAymoQJ/6h/BvsiIfo4eHhET3&#x2B;xcsL6B9lvD4rgAaABYBuCaDLBnoiADgW008KfzEQoOkA2//Hx8fn52eYA5ycnJydnXL9s7OzE/ECOpdsYE4AeArFwFOUAGe6dJgnyQtB/w/8gvTGCvg9OhvzSm4pEZdotG40kzeF&#x2B;JdlYAT9ugj4WlLA8Ox9GBGgekm3WhYkDf412s8d75IOhO0A6EMtAKzP/hQnAID4YP6gAGCYgHr8/n6AHABc6nwxAA3EeB&#x2B;dWgFvoWe/jhFVU1w46EqTKqgaL2FbNyDZRuPrE&#x2B;j7YjDqCU1CcGpAV5nFYgHYpFcLaDMTX7KoIHBcSDyWUhgLyg&#x2B;CwOG0QYSntq36yoGmB/A1Vj1zdkNLI2oYPC&#x2B;QI0DSEW6zz60/GGoqPI/ZXvq0ZEF2U7DgbvCweBpFnsc2nC2EPq0E8WFVIJMEO0wg9hRFx5dyQistlAIBcwMOHLyl/r3yj8IBX/hLcJ/EKn5TrpYi7AqnHxwbHAXuPwpUX9yQfN&#x2B;nVkT/RtCMDxR/zKfTv65t8ERJomYF9tyez4NgQXsl13XtufL8gUeQav&#x2B;H4W62aZo0MprP557rgY7vybHGN4h2vmEYc40CZM/nM9OcmaZtz4Hd4QI0t2YoJ2amCZGAbdtcB3Jex3HQrbesGWoSaA&#x2B;m0ylUvdOpAX&#x2B;h8Xjs2DayfsEgAjsILCAQeCAYGI1GTO8Cax8encgIYyLYcDAwJhPDmEwnE&#x2B;D&#x2B;0XA46PeNyYTPTmRTg/v78XA4lTphPByOBgM4hwL6D&#x2B;7vB/3&#x2B;PwO9/yss9bJOATKGehTAYvEdXrC8uK7LhhCbOrgsXYk5NNE/LxUw9&#x2B;QVArAe9B6d7s&#x2B;BNa5VumIY17me2Pzj0nVzc9MTX39cMq&#x2B;urujYTdwPPx9cuSkaRtsM/XtKe9vtNq6O5P7iEg4pMIDC4eHhxcUF7rYl4Qg&#x2B;gF3J/eGarBCA7EH0JzG6IR1WDARo4gnIhQdpvk5/T6p7Dw4OACXR9IV7T6lUAsQvStYsAC76/agNSP5BSYB/gbkjL15sff79zUef2nz0qe3Hn95&#x2B;6/X1dx/Hfv5no3/9l9svnm9ubECtG41GQfV59uzZxsbG1ubm6srKqxcvVl682NpYX19Z2Vxf31pfj&#x2B;zuRvf2YpG97c3NWCQSj0Zj0UgmnU7CxTMazaRSMPNJJpMxiQIAygdTKJfNxqKRWDSKyF4MB7AO3HvisZhq56dShXwe5jxw8slmM3AXAk0I6uFsJgP/H/D8C4VCIh5HjVGUwQjIPyiTMul0uVzOZjKclqD6yufzpP6T2Q/bzVw2W1AOQLmSOHhCRpyXKgIYvVatVquVgkwYwuAFaerXJeGLfv8A3xAJ6N87mELlsmL7YDRUljqw0WjUJS2uKrawNcH3BOtqBQkKUCnRtVq1Wm01m2plGE/VahwaLLF9mk14g/J3W5WhRL1WwyCMJkKoH/bb7Wazhb4/0HxbpQi3mSFABy1s4UDpDVTyF42A2moa0IF5aEfLEua/&#x2B;FvuSK4wwgFQG&#x2B;BvFtidxTxZPRj6UR4guv&#x2B;lSuDk5KSHIcDx8eHhYU&#x2B;igsUXNDT/UX4&#x2B;YhfKUwfVw1QYn52d9XonOC/1JDRAaX81J1A0QThJuCDFX8qDC/ECWpIByKwA58BL3f1TmEJXywGOZP/fSEYYT/JXV1fXVBRotm9E/9di&#x2B;a&#x2B;PkW&#x2B;1xF&#x2B;Ce5j8sKNE9E8FMHF/OD3QXqu7/XB0QDUw1h9o4cFQBYxGo9Fo9Jp2vVvoCNUXn5nFYsEwLumLM85WRJxSFSykx4wtsv8dSCUAjIh2MrEsnmU7Fm/hiNjUdd1AcGrAMAGhiLAxTLxomqY&#x2B;HKCcNAgC5Bl7mkjXF4PLxWJh23O9UAnEM8eRlCj2pNXLNT2xq9F1BCw6gVbzeNKTdkSUvNBAvytccwBBX7Kx2ALn&#x2B;gTTxOKulofgypQDhy7QXIwEf6s4LVc9i08UKpsXWgqETv4JxQN&#x2B;mEJgz&#x2B;eQPThajlg4ppDj4y7bTPmaMsFxHPzw&#x2B;PUR2fNrdTUFsxMSeGyfeRTaoAAlgaMkxWp0ANo9HUJhJOoJKWihRMCoeyUxACWKbfsy0gG/31fEKmc6nbqS7&#x2B;tqX5Zt2/O5hZIGzXsIIWazGdS6GDigMY9fLxrz9hxpAFMHvv6maYpz/2w2Q1AAhgNYX7X8JxMDMcCmOZlMEPgFacFEmP2j4XA8HiNaGPWAOZ0iDgxWP7OZCa7ObDYjs58lAZA9pgEQ/sL/ZzKZTI2JYRiA&#x2B;JAUQ&#x2B;mLeYFabTQa3N8P7u/xFG7/cyH897X4QRAEhukMhO5/edm/vTcMIf8PjCXTn&#x2B;PuWad5MJt/t0qAPE4QLnFVAEC/EPc3nvGB4DElOD8/v7&#x2B;/vxAjal4kIPzCiOBGfELpKcHrFi9aZLsCtZ9rUV&#x2B;cg6PxTz0AqwvMB9jUp3EQLoqk9mImQOotm3x4dslxvNMhFtGJCuAb6GQGrEaw0tSyfmnzD/ceGIBWpTsLKAZrGlKDwD5vKgP4WiaTaTQazO7FjZRKsCqAoJJOp3d3dyGZhSKWBHf4fuZyudTqyu7n39999KnY22/sfv6Hdn/rv8e&#x2B;8Q&#x2B;RzY3dnR2sSYrOq5cvV1dXV1dWtre21ldWNjc21l692lpf31xb29ve3tvejkcischedG8vFokk4vG93Z1ELBaPRQH0E/F4PBqNx6KJWCwei4FbLxyhRCwWSyUTcOCJx2LgCKWSyXg8ns1kMCJIiaFPJBJJp1KJRBye/WD8A/RDoZuD3DmXA&#x2B;cnl81m0ularZZMJHA3mUzWalWG6YKdjx5/HhSgTAbyaMXvr9XQcS/k80zmymOMUCiUxKkTJVaj0ShJ3HJF2v8Nzd1fTQBKJUXrEbgP0g6GGHyqUi43xAS20WjUhBtW0xaAeNxoNhqlUhFYH1UodMDVagWdeBCQUJfCbErVALUabamgCMazHAKwSKjXalD3NlUQWAOZwW35A1Bc/0aj2Wx2Dg4YGqB&#x2B;/PU6uvpYVdHkwPM5OMBLFKEff1PNZrvdhvhYp/pQWgOkjpcfamM3sHQOhRi03253Op3u0dGhsICOtGzgffkbB4nn&#x2B;Lh7qln6gvmDRj5tf3raglMTNQDHmnEQCYcnEgPck0yAk&#x2B;PjM9EBswbQ2yJ6DYDXQu97vmwBhNuftE3DCfRCswbCgzidkkh5uey8DNKmqIGvqAFg&#x2B;/9Sxq0852O5vb29ugrHBWT&#x2B;6LgfFwLSfugnQXCP9XX4TyEviUCUB&#x2B;jMfsXqub&#x2B;Hv8&#x2B;9lvXL3j9wPzXBKgjMdV1bYLG6jAqiQuOZcDNgPbDcudchvr6mr9UDftjMDoEp/e81sO6RWaSXB0SHC61vp4NFwkRqdjmCkM1yC4pw72iCAUHSDneVlYCOvwMpaaRKIdtewWK0lgMtvkpD3gsWJAFLrOW&#x2B;OG4L1SQkx2NNovNAyEYgWanvDsQnT7lqyjbDlAZPaE5US3uey4gGkKb4XdPOX4f7D44GSE2e7gPL2kbWD9RUx12QIKUt3Kj62dCRSTTTrqhyF4uFlpu2FAoG4O8vxxg7ogwOxCWJfkrQDWNTpjkNJ1oSXob6BLAeYB14Wlz7Ldu2LWvmybgGhHvgfrj&#x2B;owQFu8c0TVQO4BEhMQDPep6nWD2OY8/nGAh4nodZAdhNmEKgr4&#x2B;tgfo/nU6Hw8FoNDImE/h8os0/Go3m8zm8/EH9V&#x2B;Qf06R//2g4tCxrBOXudGooWr&#x2B;E/orVDx7EdMEwJtimMZnAzv/29kbsPsdTYzIZjfAUZAOQ/ML0s393h4nBaDjs398PB4Ph4N9qAvDJeN/b&#x2B;4klpgCd7pn&#x2B;1HTmnt9Zk4fa4KXlRgx89EYOTuUE93SK4MXgQmK5cEInNehc8wkl9MeUgJcNXqJQTqAAuLm5OTk5YVMK12BSYB90&#x2B;judDi7/lAqQwgvTT93WAyUBLsO4bAPZYyCg24MCkQBRUPtIDSILA&#x2B;h96wxkbbdpjQI3FbAjaASEFi9wGBqukJAC0iG7F2wQPJtOp0kUSSaTaAkjQRbuN4jHAgsIBPdCoQDuPoqBWCyGRxIvXkQ&#x2B;&#x2B;27kS1/c&#x2B;qM/XP/7v4/u7ABqr6ysxOPxTCazu7v77W9/e31tbWN9ffXVq831ta2NdUL/9ZWVnc3N9ZWV3e2t3a2trY2Nna2t3a2tWCQS3dsDBSgRjcZjsXg0mk2n93Z3U2Lqn0mnYuL&#x2B;mYjHIRXAXchzc9lsNpspyD6rHIBEAqQgRPYW8vlioQBff0qEQdRJJpPg4kMBDEyP25VyOZvNptMpqH&#x2B;VYlhEw8lksixS3XKpVCwWQLgqFYuoK7BLqLKy2SzAerVSqVTKxWIRUB51XS6XJbgHfQtyXkX4yefzuRy0vLlcrlwqKf5QsVAsqsBgwHeQlFBUVCsVNTgSVx/UCmjks6lfKZfB18c6jXq9XCrVSPSpVKqVCjv3yg5IpgEYIGBWADHAfrtNv1rUFYDymBiwrG23281GgyS3QymP9/f3a7UaSoO2tpDDU6/X98MIvIb8xYSxACilWW/zz02UBu1DLsImAm3v5PgYAgAmBtDDRxcEs80Pph8cQmE9xAEC7YCE59PF9tF6oNiXg0d4iirPHxlRUjPQ0yKBT8XpH&#x2B;x/KoOxqcvLy/Ozs9PT3tXlZU8iz8mHvNBi0SEboFMCNQB6AcCnLrV8xgd&#x2B;DNdiAXQtHv96JaDLAIjvQzHAdbjc3d3dSuP/TqLBri4vifLBEdIqhNv7MBngTqcGQQH8gCmE9cnmx&#x2B;iAJUFfGEGDfv&#x2B;TamCUHCoHQEB82M5nz5ujAL01TsWwq5F5gCy5GsWRgeb6v9T/FoBIZBkEgectZfTqfB4dBLN37i1bapLFBII7m/R6d1a67TZhseuEMl9HvIBYBihG03yu&#x2B;C2CmDXrnqWgX73aASAOqUSyKFN58bJcaOUNXgu20kKOpy691T&#x2B;71hoPc7V4uAis&#x2B;QVx/YVkEutfmS8SYUecmkhw8qVHTl2vJ4fOFfytKjfWG1o5ERZpjsNfF48es7pYbDCmwP1O8vFFuEEPbjyeEgkoE1Ul7PY8T5ya&#x2B;GMQLpN6R0fCv/CTQNQDpyi&#x2B;hBbT7skVGTTeFDXAdDr1PQ/yXNd1QdOfzWbz&#x2B;dx1bM/z2PtnCADdQqHxtazZXHS6GFbA7x/5wZSsQPI7M01ViMxmYPiA0DObzQDVxel/Cg6SY9vGZALKEB43TdMwjPF4bIo2AHMDczqdTMaoNDAQIJRHLx9wH8wfNPsJ9GET1L&#x2B;/Hw2H93d3o8FgjLGDYdxeX4M1BHeg4aB/f/s9yPf/4uXq7OK7&#x2B;PrsRvInp3f6I&#x2B;F04DstnufhRMxz&#x2B;qWWDE/ED3Ew6wTefUANYrVA1unt7S268hfi8kk2/9XV1cnJyd3d3fHxMQmsWAH8WlL/Dw8P6eeDJhmabVQLsEgAXwhzA1yJccnH47QMooPH8fEx2f&#x2B;MIgLLiM6ewDTAImQzd7tdduvpmw64jwUkb/Tvm80m7fnRowXzB7gTD2IaQHJ5pVIBHT&#x2B;VSpHwA88fDAGy2Syt7tHyr9VqYPIAK&#x2B;dyuXg8Hl9f3/7rv8rHolDfKgudbDaZTL569WptdXVtdXVrY2Njbe3V8&#x2B;cbq6uba2tb6&#x2B;tb6&#x2B;trr17tbG5ub6xHd3Z2t7YiO9s7m5t729upeDwejUZ2d1OJRDwWSyeTyXg8EYvhbmR3NxGLxaNRkHvi8Xguk0nE46QGoZefzWTi8Xghn49GIqDmI&#x2B;g3Fo1mMxng9XQ6lUmnC/l8Jp2OxWL5XC6VSsHGB2IAbArmnuVSqVgoxGMxZPSmUynUCaD7p5LJXC5bLpdqtVo2kykVi/l8rlwuwzm0WqnQwbNYLEBDTP4VdBdo25cg4M3nAdwVmtekw/DuxLePL7cq2l&#x2B;MF2qi81agv1YDgQelYLFYbDYaFOO2Wq1atYrqgilgNAiqawFztJPSWWcNYZrRwVM8pupwEcXvuSEvQ3XKTaHrj2lAWyLt2OZnSdCo1zEKaDWb&#x2B;5IewOAL4G/m4rXbbfhvAui3Wk3dCRRqAaBzgHj8/R53u/TwIQsIpQVW6HQ6mAKA2a&#x2B;HAaNNgEYAXt7roWffPTzsdOUt8HZqFHB4CE0wtb8wFMI5B45AAOJKDdzT0gBOQu8BfT6ghwDogmD2OPi4YvWcnfVkpMCSgE19DgEuReyLM&#x2B;GlpChyeIuzMPyC&#x2B;HKquXiuppEDOD88mQO4Xy&#x2B;HuvBKoXN&#x2B;sNr9/f319ZX&#x2B;YCj5vbvDS&#x2B;7v7u7uljTBlP8Cu7Mw4MTg7hOBwVqnf0BSEEYBDApA&#x2B;19pAAh5nWWvek8jrAeSobsQ309eIxfLLj2Ed8SdwHCLxcK2Qy44QbMjKDkQGPrAwsXTKOncEwWdFzBkl90WjBtodqIKZQoK5ydiBeIuUd7DnfekrR6EJY2Yk2rZvTpnJgjYnff0o0ocrN&#x2B;mMhUo3JVDyp158KXgWVcIUawKNGQfjlkWas/VgQ2746i1FgvlKLpchnEqIp8odCLyJSaMhyucnDBZWfYZbwwiDV/rC9bXxQa&#x2B;Np0QOO5g96RA4MjCpQjBk&#x2B;mBYuy4YQgX4T6ISRwSeIwFeOAWJUfPFQqWLakUoNmYQtbXsTgewRuhnPNc15rNXNedWxZEHY5tO44teuK557nmdOq6jgrecl0AekwqoHMwDMOez&#x2B;dzyxYGEd7Lsmaw9QR3aDKZzOdzIHXHsYUdNGPLn&#x2B;18BAWg5Y9yAjlcU2MC1S9wv2EYpjh7GpMJTEVRA0zG4/F4POj3pxMlL0Y9gNrAkNrAnBoWZgWTyWgwGA4G93d3w&#x2B;Fw2O9PxqP&#x2B;3d1kNBr0&#x2B;9AADP8VNQCmq99rN/eT&#x2B;Q7vji4vLm6mvHvUOb4dhojfdYOLm&#x2B;&#x2B;WSOD7Ps77OINzRnwhUV9XV1f9fv9KvP91Hwm2hUi8uby8BN&#x2B;G42PCfbyL3qOiVcWVRIPhQsh3ZyVwfX19cnJycHDA1r7uwXd5edlut4H7Dw8P0a6D3vdc8sIODg5oJEouEK7rdDw8OTkBO1klEEmnH2gGvp9sbcIXCBCH4sj9/f1CoQCTFiDyZrOpiNf1elEMJRkHWyqV4NUI8IdiAJR0GOHTxwbdejDOU6kURcDRaBS0HzS24/F4Pp9HyC4iupCqCzoQoruQwru9vf3i&#x2B;fPtzc21V69WXrxYfflyb3t7e2Nj/dWr3c3N3e2tyPbW3vbW3vb2zsZGbG8vtrsb2d2J7e7Go9FUIpGIRSO7u7G9vdjeXiIeS8TjsUgkk0qlEolUIpGIx5PybyqZjOztRSMRNP7zuRwo&#x2B;9VqFSvEYrFsOp3L5Qr5fDwWy2Yy&#x2B;XyOpUIqmQQLqF6rIcq3VCymkslCPp/P5xLg/IAXJEKBbCZbLpWyGTVbgFFPJpOBkT&#x2B;ivlCMVcplUIPKpRJqAITvAuXnstlSqYh5Ag44a7NSqVQulZrNJooB9WCxCHzPwgDt84o09QH64ReElGay9mvS11ci4EoFrfy6tPDh4ElXKEwYxPu/XKko01gQeIDUURBAGQx2D5UDdPRXP&#x2B;9mswbzH1H9tqSc4A&#x2B;7qS2NRpMqXpEbNGj7g38xUqCioNVsAu6HDCIJwuMMoStJwPttpRY4FH7d0dHhwcE&#x2B;3XvQ0e92u&#x2B;1Wq91qdUU2wFKBMz0qeYD&#x2B;0XRHR6CrIgI6OKNgZdQJcBdQeWHd7unpKXyBqSjodlW1gFMWRgfQ/mJNcg7PJL4Qa15IOhgfAXxHF593T&#x2B;V8eHZ6ilmAzuwHH/Ls7Ozs7JS8oHMx&#x2B;gRtiARLntJJyyR9aIn0rwUIXF5c3EheWCgPu7qSYBiJAwsTwdQjNH7QqUHA5Tr5h8R9eMc9eISsISoHdNA/HA7vJHSM5B89NUzPCYYaONQA0BQlWGb46LAy0OQBeAn7taTuEBA7wmuXy62rXi894EAAeiCQmtiXFQKxO7fgCtWbu0Q8R2sdn4Qi4Z8oJBr6SLr8OLjBhjTp6RS24l9/uaFO7YFi76jbvhp9aEWU7/tQUesFlRdiREcguMdWN1Cppy2u5A2zkuFTvmb1o1OJ&#x2B;Ky&#x2B;n4tlJQPeT1/ZFR&#x2B;hAE5EaLovu5cS/XuaxgPEelZc&#x2B;lsEUlXOlYZbtNQiMMCkgER813UXCzWVWqoAVdvedj9B3/KE4MTPS50xhbkup0Ci6wAj3xcjINjtezJWmluWJ9JzV5vY0EFIzQrEUWo2M1n4gdTjug79eRzHsWaz&#x2B;dyyrJkrFrS2bZvTqW3PgeyxP4o&#x2B;NJvN55Yt2WEsBuz5fGoYyAGwZZ4wU8Y&#x2B;JmYIk8lEcXim08lkbMnGmd41m80wK8AQANMAcIQMtPkNwzCMIfw9JxP0&#x2B;wH9TRNuocZkPLYsy5iMJ&#x2B;ORIiAOBvT&#x2B;V&#x2B;z/fn82NQaYDNzeQgDQv1tqw/9Ai2Hq92zL3YxUhqIBiKwkS5UjPmtavqlFf/nu99AB&#x2B;77PZj/P3br2l40fXRWAE/qVpDziSsOz&#x2B;blEg&#x2B;ESwjYSOT8hgVVMKm7Ejpp0/5ubGxp04HpJei7gO5A6ID6JvFgfSOJE/P7R&#x2B;0dtQJoQmD8gBaH3T0CPF&#x2B;5LDlGj0YBOgGKATqcDf0ZmJAHN0LQReAi4EI&#x2B;DMYLtg8kD2jewfqlUgpG/gonSfkaILxA/MGtc7PZBiAcRCMaauVwOIVxIw1UiYFnW19dXV1dfPH/&#x2B;4sWL1VevVl&#x2B;9Wl9b21xf39rY2N7cXH/1antjfXNlZf3Vq8j29u7m5s7mZnR3d3N9bXtjY29rK7Kzs7u1tbezE49EEtFIIhqNRSKJWCyTSsWi0UQslojHk/F4OpmM7u0lE3FA&#x2B;UQ8nlZBv9F0KgXwrWqDeBy&#x2B;nCgDctksmEKFfB6JAZl0ulQqgg4Uj8VQQhQKeVj7o&#x2B;aBkw/mBTjaWaH6IOQL1Kl8LpcRun&#x2B;xWIRxZzqdLooLUD6fL0kBhvIACBtiANj4QBsAv51CodBsNkrFYqPRKBYKxWJBMXsKhQpAf6VSKpVq1SqgeZW0nGpVsLsS&#x2B;0IZTNBPnhgsPpvNBrv1eApiXw6a1AxKuECK2NNstNvter3G3n&#x2B;9Xm&#x2B;3Wg1h&#x2B;RO1t1qtZrPB1ZqNBolA0Bs0pOUPIlCI78XBsyWJ19iUqhYajVqtti/VMscFrWYTLLvQDBQTtlYLPJxWS6mHlelWpwPHXeb&#x2B;Avrva&#x2B;FiHfJ/QP7Bf0eHR5qd17GYeIpNqLT8u90TCf1AmhgNQ/ng0dGh7vhJezGeak7EI4g6JfJ/OBnA7BGDSpKFTk9Pj7vdMxX&#x2B;hZSAHle&#x2B;EMcz3KUg6vQ0lAtfibXahWYAyhtoylxJDgDOwDzl4hSN4QCJ&#x2B;5QIo7/D1j7P5/q5WtcAPKgHbq6v7zFY1laDCFgXAFxroZMDAe597QZlxLiI9O/v0dQHOwiVw2g0AgXoXu4Oh0NVANzf9/v914jm2bnnxY8tfKLGQNUJdqDFLREQ81Vc0GfnBgPB2dqWCfiUK6h&#x2B;IxAO&#x2B;yfhPm4TJRPxBxolCSgYdBpfYryWeuRBsBCkyyZ6EKDDHrbAFWRXM4ewAHA06Sc&#x2B;7DLvJaSs6J42XN8Rnv1CSZlDux6PcxVhpARB4Gnpud6y7pkoVjfqIfr3pOnOEiuQ0svXBhT4tKhVtAa85wnjny8J4MQvgyA2/gPWHuK/pH99vigxOH4BkUbFI4gyRBn4aNEHesmBgQ/xPR63LMvXTDwdQeQhX0lmF65kVDuOK1sIvYyw45Y1w6dzXcc0TfWWiqHkoI8OOK7a6rYNkS61v6rMcB2AftM0F76PyQCyvcD5gXgAA4VQBT6bKe8g24ZlJ0g7tm0D95umOR6PESkwU3JeyzAmkAFAhADBLr190LKfTqdw8MdT9nxuGJPhcGggtdc0J5IahhVgExRmeI3Hk/EYVH7UEhANTw1jMOgP4PLZ7w8Hg&#x2B;lkAsnvaDgY3N9j2tC/u7u/uxv2&#x2B;7c3N/27u1B88gMuw1HgeIGG5G9vR/2xGqYdNLtBEFiSbWiMlvr9RxffO5D4TmJ92dS/lRwAnOVZCaA8oHkz8T1ewqvOpQRGQit8KcHyuFzpthWcX&#x2B;PiRKs7tNDYLcMlEM4/Z&#x2B;KuzdAc0oTY3qPAF5fz/f39Y1HjodMPcA9/QBKFaffJ&#x2B;CHwIuhdCJ5PW&#x2B;z/0enflxzfcrlMpS8dXeDPAzRPvhCQZS6XAxSjqw80ptgU2vbFYlGZ6IuZJqxs4A2KdRCqlc/nYaifTqf39vYikUgymYREeGVlZWtra31t7eXLlyuvXm2ur6&#x2B;&#x2B;eLG&#x2B;srK5trb&#x2B;6tXaq1dbGxuboACtrGxvbGxvbER2dqK7O7tbWzsbGzubm4loNLq3t7O5AdAf29tLJhJ7O9upRCIeiUQje7HIXjwSScRi0b29eCyWTiWT8XgO2V2JOIg6mVQK2oB8LpfJpAv5fCqRSKdShUIhnRJj0GQSiBwiYEgCaN5fKBQSiUShUFAvTybTqRQqq0wmAzfPdDqFuiiRSEDFWy6XcrlsPp/PAPGXikugP58vFNQXlFdUq0KxUCiXSxXNsx9NfbHyzCtKTqlULpfgoI/Gf1nie0Hoh2coRgIoDkEQwl5hOgRY3261MAaoC&#x2B;1e1YcS6FurVhsNBfHr4tMP&#x2B;n6lUla6XmGjgfQPq1A1WKhWgdRViFi1indHGYCYMDxCTlBLYwcBu9dqtXq9Rud&#x2B;wPp2u91oKCdQyGbI76/XamLr2Wq3252Dg3a7dXCw39KShvEXh3UOZIV2mEPcoWuQ/odJFyD54z04Vn/Lh/pTUjPsn52e4rUA/awWuBpig49Vmpgi7ZDcfyzpATif0ANUOQKdnPARfcBIYQBqjxPNlZhVAXg&#x2B;Ygl6eqIFA&#x2B;Psp1aTf1VEAOYAWj66QP/wrj5HPZckx8vLyws59yoWkPRceN6&#x2B;0qyBBOhfCfS/5hw41AnIC681b1C6DLGRj5WpE&#x2B;A69/f3fAnqAfD&#x2B;geBvxP3zXqA/Kwe9VLjT0sHuJS0Yzy4lAQd09fE8vQzwpCm&#x2B;EDtLPKU30RUfxg3lreQI6UUC2qVYR0E0ra3OfdArBEVBQStdODmuptBlEzqcHlAsq1F0PtkCF5ztu67SwvrLoASr2fac1QWBvi8GRFyZlYantfmB/hfiPapA/0IFhLmaXsJZ9vZZiByW3XpP5iTcbXTT0ZAGxiUXPxA1hXZo0R0PMX0gAWquyIIDUYDwswMfL0SvjGY8hxvs8cvehvEOAM0oJzwB5b6qJZYkCqw0XBH&#x2B;4oeE79Knwlia&#x2B;vwB8OA4wuph2cMvayFqYJX163mOY3sqGcDzZbjEusuxEQdmo/BDXSGxAy4iDkT1O5WX2J7nWZbF3YAGgMscyl3btoVHBOK&#x2B;SjywbaVLsW3HcczpNGT1TKeObUM67JJ3JJpjzCvGoxHTgqeGAc4Ston2/Mw0HccZj8eTycSyLOh0Z7PZGD3&#x2B;yWQ2gx5gNJlM0NrHpqD3BfSH7Q/uQh8MHTANglAVwJPMnBpTw0BmMAYC4&#x2B;Gwf3&#x2B;H9v9oMOjf3Q37fd9dou78y5fb608&#x2B;xj/j6&#x2B;NzYynZPBiMQgrQaPq9ixDqq8j4R5PmQnzfcLV4YBuHlj&#x2B;6/riW3N3dgcnDTj/aVGI6ET54LV5AVAXgNt6UJqS4ZFLjq8N90mexGujCNOpWoTy9HjV/uHijISeKw05bsro4EAAaIOkZj1MDQNwPjFUsFqEVJhgCbQPNWqqE8S9wf0vhvCoceEAcz2QyiPKFlz/oOiARAdmj349CAiR&#x2B;DAHo9oPQrmQyCQ1APB7f2NhIJpNra2urq6ubm5srKysb6&#x2B;svnj/bWF9bX1lZffVqe319bWVlc319Z3Nz/eXLzbW11ZcvV1682Fpf31pb29nc3Fpd3dnc3N3aiuzuJGOxvZ2dRCyaTaczySSEv8l4fG9nJxGNJmKxfCYD0k4&#x2B;m82kUmmR&#x2B;eK/dCqVTqUy6TTGAribTqVy2WwqlcSUIBGLQRtQLBTyuVy5VMJLcrlcJp1OJhPK/CebTadSxUIBWBw5A7lcDocRHXrkdoG4Xy6VEPCLWQH8f6rVSi6XLZdK9VoNPftioYA5DEoDcH5QvAFwo6NPa3&#x2B;gedQAjXq9oDkFSa&#x2B;/AsRckZAvNv7L5RIludxOVZIflKFnTe/xq8yvWq3WkkET4LX4&#x2B;dTxg8Q2W61ms9GolMv1eh0xXtLUb7JIqNfr&#x2B;/vtZqNRryuKkU74qddqdaku2u02MrlarZbq6&#x2B;/v082zISEANMU6POwwGLjRaLTbLfTd8YfTEkKdIv23WygWmmIWhAc7WgJAR8qDjpoGqERhanvo3EXj/464AJHYQ2PQw&#x2B;WsgKOjo7OzU7YMut3u8fEJioRut9s9OjqTlHEi&#x2B;BD3h9KjENOjB4ETVLfb7fVOzs/PqB84kVIBcB9CALiC0gy0J6kmqAquri5JZbyUdgm6IRAMCPnnkuxKNvs5KNCZPMqYQRTAOu3z8vLiSs7DLAYoD8C1gMLiazEPpXiAIF7YPtfXWijYtWYYeiuiYVKDyPu/kxivOy1IGCvdLIUJ3N7d3Y1GIwwWBoMBrIEA/ZEZTIOg13yNMR9oWJlNWZJk2OLlCr6m36WPpL5msMwmInT2hGURhAb2ClMKXlUtcJ00r&#x2B;N&#x2B;TgnITqHAl&#x2B;&#x2B;40Cznsa5sQYkB5K19blBr5zNO2Pe1SYinyQncMNHMlua6txAlq&#x2B;M4fFO9iCJ6dpUPpu1LFhvfXW/SeyJTZkWhhxN7YXM9PKqE7yyNQM7Rj78nVB&#x2B;22AH3XY2dxQfVoZP9YZ3iaRgdaFxZxGpFoP8goAAVphRdAsR9dxnBLxbqZxYsQmMf/t50WpEqz2S8gymN/mNQxZLnoUhzNFmC53lomfsyH7BVC9/lnoDK7whYxwIBrm3bmDx4rjuZTGzJG57P57OZieIBNCqlE0DIF5J9bdtGxNh8ji2jGGNtgBCAyXhsqZQAB3QdaHkty3IcZzKZzOcWHgT/Hk5EaPBjegDqPoYJ8B41DAOMo/l8PhwMJpOJOZ2OhkNjMqZN0EjIPzPT7N/fgxcEHTAqAVD/Af1RFUwm45FWD/Tv7vr394P7&#x2B;8loODUM4Oj&#x2B;/f2o3&#x2B;/f3VHx8gMvfhBN/VPPXXQOuyc3Dx4050EQBJZpX91Pv8NrlhcagKKpf35&#x2B;rp&#x2B;vURicSVIYED&#x2B;d4HCNuRLbn4uLi8FgcHV1BQ4PBgsoIbBl/gtVANpa15INTLsMDAHAO8LF9VL8MXpird3TAjgxxwefh5dz9v4VP/j4uNlssqtHi89arYY1D4UzQJ/Bo6Ojuigp0XoEvgfewg249yBWqaL5rgBrAe6g7QqISToQFKLs92ez2VQqVS6XwepBTxqGP5FIBAm78Xg8Go0Wi8VoNJpOp4H7d3Z2EolEMpmMxWKRSAQJu8&#x2B;fP//444/X19dXV1Y21tfXV1fXVlY21te3Nza21tfXVlZ2Nja21tY2Vle3Nzag/d3e2Njd3NxaW1tfWYlsb0d3dzEZ2N7cTEajezs7iVgssrsb3duNRSKJaDSdTMZjsUQslohF49FoJpPJpJKpRCIaiezu7KRTqWQ8Dn0wCD&#x2B;FfD4RjwOOIy8sCyvTVCovyB6DAnTugf4Vvi&#x2B;XK&#x2B;VyKpUCzwdjhHQqVS6X0NdX&#x2B;l3EAOdy4PTDGghG/khaqAhDP5fNlssq&#x2B;hcZwEW1qDwvxDAXC4VarVoQmW&#x2B;1Umk2GrVqFbMCTHuqYtQj6tsqKgQQfpQ2oFaD5w8wNJ8iIYe0H8yOGvU6ZAN4vFwuNxqqx68GAkL&#x2B;AchuiCC42WxWZAsA9DQAxbSBamBSg/jzFiG7EvfWalUSfg729&#x2B;v1eqfTASUJQLwZCgkaVAYDzaPAwJ9MU0UEtBTEPzhACdGQ7bQlbBvmoaoMEOENu/5IFz44OGABgD9qwHpyhDqdDsg/DAGg5Re0&#x2B;7QEQKyYIvxoOmDIlKUMODqWTHHygk5PT09OjrGRY6VHCrW/OnFRNwICyudZ6/QU66hz2gUTvi7OCfHPJBWYDCL&#x2B;i2HpmWSH6b6iUANz0EqN1sXFxQ1Vv3LGJqsz9IGQuS6FW3gtNcG3Yv9/e3tzfa0oo9cyItDzv66vr&#x2B;9ub4HkbyThC9idkgDdQUiPAqDzzwOjz8FggEEB4L5yARIDUJB/bm9vWQ/cIwkYlzoCfUe7Ni80uryn8XCW2&#x2B;FhBNhCLHe4mi8dcUf8f0IgKNSOIAgU51v4P3g2EMCq7yTeTieu&#x2B;Br5BMmpjrj&#x2B;L7S84UAzLdW72g4T0LSJhAadPelYu/yMhNHsfxPa&#x2B;oox7wQ6L0FeovbhEx5KAlVDD1OCe90jaCEddQXAtekNqyM0jBdaMLAnkb16XAA&#x2B;hoaSQ0N9Qm0OHwiaIXIIxGyVxYNQ7aV4CCuK8NlAaGMLsYhdaJwivDX9f/Qjb1kWj7BHUbKWX6Y78wRh5LMqSxZyrMCtpzsQ6i6pXBxrNgOC5w7b0p7Hath5x7axPp7GmpgAoCRQAwHHUanAMoJAppglpQiIQI6EoOFZ2PvMZjOGAZvmFKMAUPkdx4ZfEDA97IYQDYZwXzEeVXrl6XQKa39MACQBwIKLv&#x2B;QNTzBSgDXQaDQC3B8NB4YxwUDAMAwgfvw3HA6A&#x2B;4eDwWQyNiaT4aA/GY369/dg/yMAGELh4aAPa2JOAO5ubx17uTP/gyzltn7v/Cok9gyu7&#x2B;4m/u39DHdvLq4evNTxAscLvsuCAoAnYvaE2NShXIyTAb1tf35&#x2B;fn9/fy7JNeju93o9FAm4BB4dHfElPQn/Ojw8pLSAXX/0utDRJwsWVzuI88AX4hWR2oDT01OCAAoAjo&#x2B;PW62W7t8HDEHeP2ABGv&#x2B;gABH9tyX3FwhDkSXq9ePjYyCwg4ODcrl8eHhI8g&#x2B;KAYwFYDQJLxeYwFTF5xFlAJr6sPTBQAA30M8ul8t4Cqg3k8lEo1GYe6ZSqa2trWw2u729vbW1hQf39vYSiUQsFtve3n758uWLFy9WV1a2trbWVle3Njc31tc311We18baGng&#x2B;Oxsb25ubO1tb0b297Y2Nna2tVDy&#x2B;t7MT2dnZ3dyMRyLxSGRveysRjSai0cjubiyyB&#x2B;FvMh5PJRLJWCwRi0X29gD6oQBOJuKZVAr5X&#x2B;jrq05/IpGMx0H3T8bjqWSykMtlFf5PFvI5uIImE/FSsYhkMagCSsVCKplMpZJw7CkheyufLxWLlXIZlj5VzE&#x2B;KxXwul81kCrlcsVBA4Bdyfwv5vFJZlErFYqFcKoHQj3IA0QHk/9RrtUI&#x2B;D&#x2B;9O9O8bjTq8/Ou1GsoA0I0qEvFWleTeVquFyqFer&#x2B;PZkGDTaOB9UTDUazWQ&#x2B;2ncWatW23D1qVSA&#x2B;JuNRrvdRj&#x2B;&#x2B;JY49UJig2gSGB1O/LHkCnU6nXq81m439/f16vYY3AugXnW4dpYKe8AVHUehzm80GHWkxZIA4uK1QvlL6Ki6Q4HjsIQlCYNBREkDeP7X16MyjfgA0RyIYe/ysFg4POwdCw4Mf6MH&#x2B;/tHRoVIRdDrHx12i/45k/R53u0eyoDuAocGhmAKpNr&#x2B;EAygukHgBMSdYqgLVWWAu2Iny&#x2B;&#x2B;&#x2B;enCiREqA/dQLwACLXn/QeOpj1xBRIwXqtYNCNj3lqZZ1wdXV5fn5&#x2B;qRK&#x2B;LnWXT5B8rq&#x2B;vLy7CpLBL0QMQqT&#x2B;gCV1plm7XmkPotRQMgOZXmjHojeYcx34/YT1wPPtH9PbBI&#x2B;D0a&#x2B;1/lgQ3t1pe2GAwuL25oQYAxQDMgmD1A4aPrjO&#x2B;vw&#x2B;1vywSXlto2JT4DND5AVjXOT96Yz4Q8K2uqTQIEoCrwWuFqgPNG9RxHBpTBv9EQjBJO67ARE&#x2B;M2wMR2hLHu64LNg6v4twat2NLFJRHo31VkHhL0JyQXfTHOr&#x2B;Ib02wy8MSaMZBnmZaH4iIOdAFDJqTEt&#x2B;UYoMHxzmQw8jd5jZBsyFYDyTSIdBqG1eTOrB8AiU/fC&#x2B;B0ayCFpq7Py1WWSRwkuP7frAIa4kgWHDuwaGEXr2grKKOwhNikmwfj3nUmoezC99jEaUjb26fAxl816gNFosFMT1Xtm07CBbCnvL5IN7Ums3Exsd2HAfoHMcZYF2JdEUVIJMQFx19gG&#x2B;wdNDsx3bmliViAEtqACUpRuce0mHHtqeGYZpT4nt7PjenU8dxDMMQFe8UImOkB0A/AB4/3xcIHr3/6dSArz/cfgxjMpNwYDUcgBHQZKzY/5PJaDQyp9PhcIDcXzT&#x2B;Yfk/6Pcn4/H9/f2g3x&#x2B;NhhPhBakVBoO729vRcDibTkeDAVJMRoPBzdXVdDL5brj7&#x2B;1raB4Ed9ix65wPeHt4uJY6ZplM7CGuAdvvke26btB9caXCGBaWH6J9ne/J5LrVUYOp3uaA1xdWA5tHNupIwYKxGNM9rGFtcvBBeSbYXroi4VOPCiesuQoXCi3Sv11G5nkrOCx8PCgNQKsABsNVqgUmMTiRIyXgVW/igNKDjS7pFu90Gsgf5B26esPJEOBR6rmD4ILI3nU6DTwKCClg9qArA/IGDJx6kqT/MQFEAZDKZ9fV1tPy3t7cB&#x2B;hOJxMrKSjQa3dra2t7aWllZWVlZWV9bW1tbe/Xyxc729vbW1vrq6vrq6u7W1vrq6ub6&#x2B;u72dmR7e297e3tzEzlfe9vbWxvr2xsbkd2drfW16N5ubG9vY20tDo0vVL/RKIj&#x2B;mWRyb3c3l8mg059OJlPxeCIWSyYSiXgMjXywehQFKJlMxGL5bDabyaD9X61UYApUKpWU&#x2B;U9Omf/kstlysYhAX5KFCvl8OpXKZjOolMDSgdVPqVSE7SkeQdBvoVBAYZBXNj75TDqtODyi8a3XavD7B9CHpU&#x2B;lUoF5f6VSVinLuVylXC6XSgXJ7qVWW&#x2B;f9A4WXisV2u10ul8rlkmq9V6sPSoWKkH&#x2B;QsUXPKAXuGw1sTfnMVqvw9Gy3WpUKCEI1sHpowQl8XxfzflU5ILi3WqVNJ008UQa02&#x2B;2m8rrdJ10NhS6mAagBGpJqRzYRauEHBkGdTkea/e1OR0F2xPei0S5eQC0hEbWgQtYT9/b395XwV/IByPjf329jI&#x2B;1WC3&#x2B;eqCU4ARB/ni4rgX3J9GAZcHJycqgSgjsHYhZErTDOA8wQ0KE/b&#x2B;tcoBNRInW7ioJ4otg&#x2B;KjiMvp/UBJ9JIAnoQ8fd7nG3KyOCMBGMd08kN4AWQADl0AWT/U/tbyiykts3NzcXMh/AcOBCg/7kZF5qLkAQ795oFCBdFUBZMBW9N9fXN&#x2B;LlgBHB1dXV9bWYgSIQQBUNN/di9cOxs64B6EuGFyS/wPRA/3e3t8PBAOXBYDC4u71l&#x2B;FdfFj0kuN9XkWGveVr0r6vRu/UGLbvdvs7S1iYGhE1s3wZhS96VHryaBgQEi9oQgE1fV9O5KhqGHQJ9vpd&#x2B;kaZ/jo59sbAFjmWxCOcJHrShgk3JC/cpV9Dkp4H2KsHioVCBSJpteH5S&#x2B;WghAWbxCWgeyFQh0FhJ6B2ztNC/COJsfhH4IGi8L5bLhsVywpqOwl2NyMT9h7ABlRH3mSIBVzhavsb&#x2B;EjQfHj0WEgsthGGxWHja8VEvXyyCYIGiItA0G9rPMizSsEvMAYBNk6PNFgJtMkBGkC/0MHs&#x2B;dxz0&#x2B;D3a&#x2B;JCvBTiOfj&#x2B;2DmKSu5xIYIskwBIQjx8P8sIQBuYh4cuaQXuAfXOl2U8bIj0WAIjfdRzbnoPlb8/n&#x2B;AhYDZHALC1Upq9F038IhbU5gBj/owKB4&#x2B;d0OrVms&#x2B;FwaIlKGEMAPA703&#x2B;/fY&#x2B;wwHo&#x2B;xWSURHo2m0&#x2B;kYYcCGYU6nw0Efzf77u1uY/yDwi2Fhw8FgLM7Dk9Ho7vb2/u6uf3/fv7v71ywAiuXgPvQV7c/CZ4Y3d&#x2B;N/2uh/dDe4HH2PbX&#x2B;yMcPmza2W/0IJL64cgOw416vekrBCSc2nEwW6/jTKuL6&#x2B;7na7uG7d3t72NKNrfQ6g5HeywOUTs3hAfyxnEhFAwg9u4NKLMoAcX7gNQv7barXQjGwoGHSArj&#x2B;0jEAYTXFkPzk5oXEhUNzh4SFavECNyPOCiWexWIRMEzi&#x2B;VqvB5AfmPwCdyjSmUoGDJ4YAIPej5Z/NZhlHpet9d3d3Qf7J5/O7u7ubm5vb29sg&#x2B;q&#x2B;srKyvr&#x2B;/s7GxubGxtbW1vb&#x2B;9sb29tbm5tbm6srW1tbOxuba2trOxtb&#x2B;9ubW1urO9ub29vbEAJsL25Gd3dRT2QiMWiu7s7W5u7W1s7W1tJsfaPRSLxWCwRjwH0Z9KpXDaTTacRCJBOJtH&#x2B;TyeTiVg0Fo2mk8l0KgXjzngsls9lGQgAfk46lUqnU3QIBc7OpNNwEAJBCv8hwbcAYk82Cz/QTCYNHlGlUoYREAS7GBFA4wsLf7gDIVYM6t5SqYht4m6lUiYRqCC6bchzAevR&#x2B;wejplattppNtY5YdjYUk75WrVTqqq1fCelAlYrqowN21&#x2B;vFYhGd&#x2B;RDr12p0/4SEAA6eNbp/VqvtdrsBKpDwzZoSJo1RA6S12JTC7qpIqNWqVWBurA&#x2B;wrvx5Wq2G0gzIrKHRaLdbSg1cr&#x2B;8Lgx9/BQcH&#x2B;3gvePjgT6bZbO6L5w/&#x2B;fFqtliL2yL&#x2B;gEonwV9n7NBqNTqdzcKAM/gnfldVPu41&#x2B;PHD/8XGXAl8U83gJGgGY7HWPjjAzRDLA4SEkAeGrBOgf0f0TpwVFKTw&#x2B;7p2cHIqQQORDx2jbH0sMMAS&#x2B;qApOT3s6j/9ESwU&#x2B;oZBJoL8MAU57vd75ueL5XF1ensmCdgm9PrFZnCHPJOac8P1SXnil&#x2B;SwLLTPUBNNu4UqzYiMFiFR&#x2B;tcLFxc3N9Y34Pl9eXl4Lvr&#x2B;5ubmEy7Mw/ukCdLP8CF7ev7/HPfTHOGrmv&#x2B;jr31xf9/v9&#x2B;/s70fXesvEvJFW8UBkKge2jOv39Pm7rOmA81e/3VQ4AL3hE4XzEtm3XDRF2oJGFWCRw5bDxzF6vBvr1K6sjkQLsDS80dS8b4fpmPaHEkIfzwKie0B8rsJGvU8bZOPck6hib9YQMo9vdEEfy5b4qaWzCcZYN7Hb7QgeCnDRYHmgsREvtiR/Ogw/Ir4IPckRAkpVeDLhKS&#x2B;AIPycIggCaVF9eqx8iV5vM&#x2B;EL31x&#x2B;UQk4RbEBNkUPqOCrMGE6mIa9JdnIRUurh/b9YaKII&#x2B;qJK/oPv&#x2B;5rGGscWON6ROAhPqzd8Df3j4wCXi6GqPgmx&#x2B;cWxZmAxqSYMbrgAl4MLhJa/67rI88KhsCxrgQJgPsdTqAE8IfDg0AmOV6ZAnufNzKnrOAD0juMAakvJoax7VBawJYuyFZrDYghjAUVBQhUhnH6lG7Zt254DrI9Go9lsBtSulMQw&#x2B;pmMUUjgtePxeDQcTiZjlQ8mw4HpdAphADY1GY&#x2B;oBh4Nh5PxGLZChmHc391hIADV73g4vL&#x2B;/B&#x2B;0H7X&#x2B;sPx6N7m5vjclkNBzACGjY74&#x2B;Gw&#x2B;8Bvf/5S6ESNA95b6gnA8ympeYl790Plkj//dOLy9vvIQOg3Ao30Mi5kTBgntBJ9Mc8GidlskihAL7VjP9xTeL1Bpcl8n9ub291euuZOFqgbOD1Fdgd3TW6AGEIQLEdbfWg2EP7Hzyf09NTNPiBGIDv8UhLmMR0BG80GiB2V6tV&#x2B;H7C5wcdX7B9wKNot9vI7UK/P51OYw4AIji4/hgOQCsMSg84/c1mE97zlUoFZj6g9VPpS3f/ZDIJT08kgmWz2Ww2C6pPNBrd3t7e2Nh4&#x2B;fLl3t7e2trazs7O2traxvo6PH/w7Mb6&#x2B;vb29vra2vbm5tbGxvaWivLd297e29nZReN/Zwe3d7e3E9HoztbW3u4ObH/ikUhkZyeTSkZ2d8HmT8bj0b29RCyWTiTI/s9ns7gbj6nCALreXDabiMcy6RQcP0Hcz6bTaVEGI&#x2B;s3m8lkM&#x2B;l0KlWrVrOZTLFYwIO5bLagyP1FKASymUyxkM9ls5l0Gn39YiFP785UKgnQHXblJa5LDH9yUBfk87l8LgeHfsgAGo16TfB6sVAol0qlUrFaqZT/f9b&#x2B;69u1NLsOx&#x2B;rv84NfPYb98Bv&#x2B;ybItU6REUWqSzc45565OVV2dqjp3pXvuScg555xzTgfACYjbD/Nbc3/AudUkJe1R4xSwsRPCBeZaa4ZEnG48GBQAr8NUJ5VMplJJlIiA6eDJqH48FOHZLIn4JWmWZwXrZwT1x&#x2B;OxdCqV08x2lBM/xLi5XKFQSKdSOdHxAuunJaVLV56USiUF6LNZFCpZ03Q/dzrUUvOATCYDB0/Afdp6qs20IQCtP/GvqSRR2aDs0/sf25SKRXb9lQg4n8/ncrVqFT4/mmNQvlwuV0Rnj3&#x2B;8tNsqSQSYkgSo3r8Z7ovrYbMftxta4De/EJQwoFarlMun3B7V2qdVAEg7&#x2B;GZoSCJYs9lE/cDNUDNUq1WSgpqnBqC6hWhTvtNYCbC1r6uBdfKPOP1DENzHF6Zu899utzvtNgaqWDnUdL1tsRPV2T5dzatNaP99vX2jU4BOFMBKFdATRqjZNmJ5cMIRkrmxrgGghGCo2QFR7zsU2x9dFYCF1kA6ymeGAPO/gPsnMkmYTqevsTeMHzxia3bNjVfFAjw8PBiGAQRFnowhHdyt6F&#x2B;fFww7YWKcnEiB8hNLFsK7jWTEHsVn09C4N4bWUzeEfELGDn/IzwYaZ&#x2B;ML/RXgFfLJGqoKMk&#x2B;9F14K0aShZxocTS6Qfg1bCfbSyxV21vci5zWERnU4HHY7heC3EpfGJ36UBc/vgBReJriJIvmgVVY8lyGi3ufH1N9lBbh3u&#x2B;PxcDyqsQPJP4DPBxE9H04nRbyBFwFQWD842Dt7xgUcDhSG4rxPT0/w6OTHUZVkQunR6x/UWk&#x2B;Pj6QGAdAD5e9FqYzK7SARv4&#x2B;Pj6zcULfgOvnZg/xgJwUMOD&#x2B;qPICR/9MTdgd2Fxr/49PjIzQArCvgAWoyf8y04O3D/T0&#x2B;tPfSv98qA6HH&#x2B;/t71AP4i2AvHAEhAJgkANOvlsvtZgPGP9j/EgcmJKL7&#x2B;7u7OzB5lkL352HXq9V8Nl&#x2B;rSOAlioG7xeLh4YGyYJQBd4sFfD/pDjSfz&#x2B;eC&#x2B;Bfz&#x2B;Xg0AgsI55pOJrPpFAXDdDyeTCZ3/xsLgN3euDfb/uPx3ZNWR&#x2B;vG/8vFqtm7491Zu3swjPu/Kkbo9XogUELphZksfg&#x2B;wht/FZAGhTz8YDGjtzBGzDvdbknHTE6c5/MVxyPvH7hyOVyoVDBBwTMjpxCmvzV9i3sX0nyYb5PWym0gEgJ/zUqnUbDYBXNC5ZPsQ5ASIAYClaANKqk80GgWkA4ajFU8ulwsEAnCSQYMff9Hpx2bwZAwEAnCu1D37Ee6LaQAcfhDs5XA4IAyw2WwI8Lq4uLBaLH/5y1&#x2B;ur68tFgv&#x2B;vnjx4sWHH4Lxf3V1ZbNar6&#x2B;uri4vHQ67w263WizXV1d2q9Vyc2O3Wm9vbhx2u81icdrt15eXlpsby/U1EnydDrvb4QCUDwYCYPyDyu92OjEHAInf5/V63e5wMBCLRNwul9/nwxDA6/F43O5wMBj0&#x2B;wHWmQsGylAyHg&#x2B;FQmj5&#x2B;73eQMAfCgZRDKDBz5TfSDgcDPhj0UgsGg0FAwjP8nk9eMGTQvFPJhIg8UfC4bi84mAEwdUH0lvsTjdPbJZKJlFmqBiveBxMfdRv6XQaJptK75tS0t58PgcODBr/7LgzqAu8&#x2B;XQ6RYifFh4/ZKypZBJVBI6jqPxmAZBhkz6XzVYqFZwCgBnq3ZyoeJUlqDp1KpvNSFNfqdXxAYYjUC6bLYpvD&#x2B;A&#x2B;2vD5XE7wubqB2kBdYSaDaVhe8r/A5MmJ/w9qg2KxiL2wcaVSwTWQzMMtWQ8UJe0LIwI4&#x2B;gvEV95BKAOKkhZcq1Xr0vinMyh5gOTzUO2D0QFpQnQIYOO/XqvV67Vms1mv1RpSEuimn9hLmP1mQFi71QL5Rw8qIVkfA8x6vd6WUQCqhSY1AKoGUCnmjZNosBZdRNsyBcD3IVS/UiOoyQDs/DkZ4JdwX4z/0afRpQLcZnia3a7oQOICxH7QYGA&#x2B;SokwsTuAOG53xUJ6rHmAsqnE8mD8zPxnpDymh/qRB4PBdKpMgYD7Z7MZtuEZaQY6Ho9gAYQjKw2AYRjbUztLYCCd8nHUGOqEvEexqmSPnOu3pr2PWQbo&#x2B;/L4&#x2B;9PMKePMLkaQIhE5KgS2brfbzfEUZPMaDCHSENxvN5ujANPn5Q05HuxPczRhnAqjVZUiQWA62DWk32y8yj1pJ8aaB3rSa/wrbKP7oytMryeXaWadB12ZoDnx8wmyxIIcWZD3bq/NZKjl3WtEIFW2acIDnlGAOJUPWgKxFoi2Px0y8H2UM5z08vWP01HEBuzBc&#x2B;VGQtMIyuX1POivKhlHW3EjpWhBSk11dkONYlR4wpNi7&#x2B;yAqnXyD&#x2B;oNIHLDMJ6eHreSMgZCDqJ8GQKASmDz9PQgwV6A9ZgbYEoAqfrT0&#x2B;NutwOPB89XGXo&#x2B;Pt7frx8fH1arFTXEqB/u12vwfDBDQM2As69XK0QXbzcbmPqjhMAuEAmAMPTw8LBaLlEA3N3drdcrFgYqzXexgNUPPENn0ymjwVSywN3dcrmcz&#x2B;dQAiwWi8V8DqC/mM8X8xkyAZAgpnyBptP5dDqbToeDwWJmMvX/V5f52AjFeC&#x2B;bb3J0uJwvN3tjMTYJQt3&#x2B;3NyvN0jnX&#x2B;Eiqi/4Ou5L/gvtOIfi&#x2B;4kfjPF43Ol08FWrvt/HY/5I4HdFby/pg2YSe/DrhTkA7/YlCZidMBCE8IsI3XBNsnWaYpOH5lZZJH00/6H1Jyw&#x2B;YeuZ1wJH2dgDpECb0&#x2B;xQ5vOAcfBjQceUvc9sNgviPogl7PqT8Y8uPtAnlKMqiyoS4UPArz6fD5uB/Q&#x2B;dQDAYdLvdLpfL5XLB0sdms1ksFqy/vr6&#x2B;urq6ubm5vr5&#x2B;8eKFxWIB8&#x2B;f29tZms1lub29vby0Wi91ut9tstzc3drvdcntrs1hQADjsdrfTcXN97Xa5PC4XAnqddrvToVz8LUgAcDjwn8NmVYjf6/F7vS6Hw&#x2B;NyeVyuUDDo93hA5vF7vZFwGLQf6IBDwaDb6USzH1reYMAfjUQSsRiEv&#x2B;lkEg3&#x2B;gN8fDgYj4bDP5/N5vZFIJBaNgu6fSiaDgQCCkf0&#x2B;bzgUisiCGGBY90ATTEt&#x2B;CHwT8XhSItVQDiQTCRj7JOJxgO9wKIRmf1ycf4B4U6kU4r3gxYliAPaa6VQSg510OpVMJPAhQY8fmVmYDik7TpHqplMpQHNwY9KcAwC&#x2B;a&#x2B;la6VSqWCjkslnIeWnHqctwpeWfV1x/SdcCVQn&#x2B;PSgzyPCBGX&#x2B;pVIIraLlcKgoKB58eaD6XzeZOqf/YBhFdeREDaFA&#x2B;Xyjkc7ksDp6XCQBOiupad&#x2B;5nnUC1AAg/4OBJBVKoVatQ9xbyeVH9qn4/EDwr&#x2B;ZIkgkE2oIQ9IvMlg79er5dLJdQApVIR3xXl0/Z/s9GoSII4gD6IQzrpvyZxwuIWqrZsNhs4Ahr89Xqt1WrqbKKmWR6oYOCWZP1y&#x2B;MlRAGUA/H4Dzie4h/c/vhUVBUgOojaQZj&#x2B;&#x2B;b7tsygjo12k/fQl5JM9zMOgPZBu9hY&#x2B;fAMq9htrCbtFQRALj8RjuQGd9/TPbn9FoNJG/4J2OhsPpdDqfzaArIKxH/hcKBvB8TmKARUswk4W5Adj9NSVU1TA0YBkbzARbx2dsn63Wst2J3QpBJEga0BNLs/lAaHgQlLzVfCdJYjkI/YaMnd2p5pVlCdE/OSHmAOGUy0SQzTU70afuha1EGMprY8N&#x2B;L9QTafMfdWCNcoSQ0TidP5ivrYZZDSVKBtrEcGBzOC0AzMLgeNxqUWs60sXGp2MWvKTHrYrEMkiyN8SqaCfaDK1OMLbb7V5eQ71MOmo1jHEqVNhL3O9ODV40/bEaR&#x2B;zMwAcZULDeMCsHTedgSB2lv/IshGiRdDi1ITK0Km4n9QNruaMY3W6envQUM6iHDzJrOopgYLdTnkK06l&#x2B;tVnsJAsATB8kHx0eIL9A8FcDQ&#x2B;GLUsBOPUSUX3m43QvlRLCb4BT08rNdrNPiVrgBWPw8PT4&#x2B;PSBADax8Gpirxd7WCHgA64xUiw9ZrJRRer7Fmu9msVivofVEYrNdrlAooCZZ3dxAAICVgsVgsFovJeIxJwkxz&#x2B;Vze3c3naghwd3eH76aJhAEv7&#x2B;7mNBubTlkDzKbTwWAAJcBHgu5/71LOGYU27&#x2B;Vrw9WD&#x2B;TUVieTTlZHuOcr5wKjTzZcGy/u/lgeMXg5&#x2B;TsgCYhefMl/&#x2B;BkA0NhqNwPBBqQDVL10jntNSqTOjhx1ZQPilRH8Lv46g&#x2B;mAz/O52JGUT5QFWovGvO4GiCYeff3EIqVPpC68ecAnYiTQlldlsViSVOWnWplIp1AYpWQArYe4J7SYoQFgA5SESQOceZB7Q/TEHQLCX2&#x2B;1GdFc8Hne73Q6HA9T2QCDgdrs9Ho/T6QwEAnD0f/Hixbvvvmu321&#x2B;8eHF1dYVY3/fffx&#x2B;IH39tNtulFAMYBcCR02qxvLy4cNjtdpvt8uLCenuLIcDN1RUY/26n0&#x2B;lw&#x2B;Dwej8vlsNmcdrvb6fRqnX7Y8gR83qDfHwwEgOx9Ho/X5QoFAjD5CQWDXrc7HAqKD08Eo4BYJBKNRNKpFGYCoPsr9B8KweY/HA7H4zGY9APrx6NRFA9o24ehiAiFQB9KJ5NQAiBmC5m&#x2B;UFOEgkF47MCoJxQMIsMrHouFwyHUabDoQUmQyWQS8Xg6lUwlk7lcLhqJ4FFy/cHdTyYTENcid5fpWul0CvraYrGYFf6MEtEKcM8JCQeEGWD3bDZTEEgtqtwsagMYgII/g05/TqZVuJtn&#x2B;K46ppIQZDMZhAAA2WezpjsnQH9Rsrdycp35fA7IG5OHgnD687lcpVLJZNIFIQLl8zkQdfDU1Iwgq5ZyuQQzH/h15k2nf4X78Y8IxJ58PlcEuC8UkP6rW/XjhaI8AA/Q3V&#x2B;Z/VeVPWhBZL5KwlsqKX5/pdJWgL4qoL&#x2B;kS3u1sLCyuAGpyUBd2geNRqNer9Xr9ZZ4gJKOqKuBa7VaQ4YD5ohSCwLjDfr90wiInXzebrfbCD/hd6M&#x2B;AUAJ0e/3mQKmSD6oFtptdmFOXEFlDoDyoC99GaYBsCQg84c1wEBb&#x2B;qIMHiiDfxUCQ53AROj&#x2B;Z81&#x2B;VAV9iZAfaSEAUyH6i43PhKUC7jITgLaeujaAcwCm2Uzl72QymU4nU9iA6sDaMIyDmOToP4Rkm&#x2B;jw6yCZuASX7NQa4gJkGKp5z0MpzKp1tfW6AncpzyXWBAqkspM9XR34YmPwOnRcezzXlZqYcifcGL0/bZzWGwT93EXn8BhaLq&#x2B;0/4/6cXAdbIEbEkTAYxqGgdJIvzDDMLbbDVLDtGHC&#x2B;ciCz454muBeR/lmLbHfo8oCWKe61ziB7KrUMfRqUMPZfLKsRg6wEtKGEjgg0sp4YXstfsvQQuK01IX9DnEEuy2HFcDTeEOVQne/h32&#x2B;GgSJI6d&#x2B;rq2geXMKoZUHB3jzizYXZB5shdhdDAd2u&#x2B;3xcKARkFYPK0WvVD5qFKDQ/&#x2B;Pjfre7v78HhWkndd5emYLCu/Nxs1GCXtB41uv1drsF138jaV&#x2B;Pj2o4AEkA2/zg/IBWBOo/SEdPUjk8PT2tVkscFkye1Wp1f3//IMoBlBCgGK3X6&#x2B;XyDqafKwkPXoL3D&#x2B;3vYrGUUDDcnc1m9/f36P0z8wvlgVkhzGZQAy/m8/FwiPUjMTT4K7D737fM58binvcK&#x2B;Y/09lktTxj/x70xu3ta/NUCAJJffM&#x2B;yS8QvVvw8sELgTAC/Dbp3BDtVKBL6/X61WsW3f6vVGo/HKBjwIyp&#x2B;dqo8wLi8Vqvxdws4Hr9/vV6P1Ft9po/OHPYF1sevci6XwxqkJunKQtCF6R1EqSIZ/&#x2B;j&#x2B;gvNDYxa0k0EHB7cnJ&#x2B;aJEPgioBcLagBoA4LBICW8GAWA9E9873K5IpEItL&#x2B;w9oezJ6S9Nzc3oPq8fPny4uLCbrdfXl7arNbLy0swf25vb68uL&#x2B;12OyYAVqv16vLy5ubGarHYbbbrqyu7zWazWpVswGKxWa1Oh8PpcFgtFrvF4nI47Farx&#x2B;122Gx2mw1SXZvF4vd6PS5XwO93u1x&#x2B;8PtdLsB3r8cdDgXh6UlMj0Y&#x2B;LPzR&#x2B;w&#x2B;HQnT9dzud4PYA&#x2B;iPty&#x2B;/zRaORUCAQi0TC4EclErFoNBIOJeLxWCQCt02spKtPOpWKx&#x2B;M4SDgUikTCDA6DAjiZTITD4VQyAYkFNcSZTCYej8GkH/4&#x2B;COtlXC7SdjHGwUNQFGSzgPWKYyMZz8lCPg89AJQAdIYFQT&#x2B;nHPRVMYCqA/rySrmcVgz&#x2B;FI0ys5lMKpUsFos4ZkbCdxWHBzA6m0VyFocGmUyaD6mNYd8pLXzKfPP5XEEI/UXA9FKJ&#x2B;mCg/IL8K8jlMBDLF4tmzz6TQQRYrlQq6pjeRPNU&#x2B;opZJ9aXSyUcv1QqVauVqhj4lEoqVg/EHqUYBuiX8C7S86qS9lU2NyiXSkVUFPV6HevI8UPhQJv/WrVa0eQBAOU4rGr212p1yQfAFxEKADYalPOPyhqv1qrVlngQM5ZEsf/rdQ3xm6pflBP6GJPt/6ZSCzRbKllMJQPoegCeomsmBnS7TAU29cHmKKArnB9&#x2B;zXa73X7/RAbAr2ud9N8RUwcgfvCG&#x2B;rLgKx0/CkD/zI0ZyjQArj&#x2B;4PRKFAEhBrB8mJ8uYZQOZ/SMJ&#x2B;WLmFwhCZ4UBawaw/8ejEYy4cZzRaPQaEbAO6QwNwxFKGs&#x2B;YMIbw2veC6jaaYw82Iyg3NKiKeF3iXW5JXtDJ77QgVIJRQyONGIax2225zUba5DzI0&#x2B;Mjj0PuCmEij0wAevaogGGTqn44HHBGs6oxL8k0VOUBDc1S02xs7/fGM721zgXSX/Cj9MU3WurtXsTH&#x2B;pPVF3Tuj8xv1mYdqECOp2HGx8O5otcsG07X8Iw6sgfg5qfIrLgY/XZUyQMHjTq11wIBznYEItdFApvNZi&#x2B;FH//utGGCNiTZU3HBMgP9e2Bx1jMHbZyClADF2t9tN5snvNqoOp5Mhx/JFd5sdjtFSIN7D7ZHMx4eoOjTbzZP2&#x2B;2GoF8FBUilAUCPggT8ftCK0KdHmYCCh7Y/mAnsttv79fpenEZxOnT2kUBMg3&#x2B;gfxH7rlEhPD48LO/u1jIHgDvoarVc3t0t7&#x2B;5WqyUwPYj&#x2B;iAiYTqdQDy8WcygK5rPZYrEATeju7g41w2Q8xi6z6XQ2myEnGMNKuAP97xQB7/ZGvYWb96undv/EX2g8WlQbY9zePD72hmZKwHKxKjb&#x2B;FSYSvnl1fwZ89aNphG/2vpYFQwdPSIEp9m00GpSaoYmlC39RD&#x2B;AnBwUAGD74ncPxCfdp8dlut9GWw9wfejvcxk&#x2B;jTusviv0/mD&#x2B;kDqNZiJ9q1ADCilbSRrKuuYZmKdRWwuUdLX80kuHrH4vFYN9Jeg&#x2B;KBJB8YE/JfF&#x2B;v14u/fr/f4XCA5Q8zH5fL5XA4gsGgw&#x2B;FwOByXl5fvvfcejH1A9L&#x2B;8vHzx4sXtLQz9X15eXlosFrvdJkqAK9QMNqv19vbWZrVCCeB0Om&#x2B;ur50Oh9PptFmVBsDtdNosFq/H7XA4PC6XGxafHg98frxut9/r8bhcfp8Xkl&#x2B;vx81wX7/PF/T7g34/OvShYBDkH5/HAwMfKAGikYhKAvb7VFBXBPpdf8DvD4VC8OQJBQIg/CDJC2b8iAHGfAAhuzD4R1hyOBRKJuLRaATd/Xg8Hg6HQsEARMNg9SSTyXQymUwkouFwNBqBCU88FgOZJ5fLJZOJeExtmaGmVvz7M5k0Gvz4bKDfDz8fJdgFMyebzQq3R8uAS2czGWRBSH88mxGdQDaTgQY4JzrdYrGQSafRiUfXH7SctKQH5MSysyCu/Dnp2QO74/NaLBZMkr2gfzTX8YEnz41ePYVCAcUAjsBqoSjMH7pwkiCHCgGAXtr5&#x2B;VKpCEd/7oUzQgmArUvyj5FKm4IMAXQbH/wF9i&#x2B;Xy7VqlY1/EIT0Yr5Wq6EeUAWBHKGi4X60G6gBqInZf0kyQ8gFaggRSJ8G1LSUABQGzWajJutJDRI6UFOI/k3WDPT84TQA32x6Clj71CEUut62GB&#x2B;zVNDLALqCCtxvd9rtrpb725VCAgY&#x2B;XKm&#x2B;oiX8q3tKDSIjiG0d1ACDwaCvhf72JThsqBzkFBdoPB4PZEe2&#x2B;fGzgvb/mVB4oow&#x2B;J5wY6I2n6XQKNj9bVCD2zOezqRQAEPsOJctSVwlj5XQ6fQ3k&#x2B;zPCOuH1fr9H7qwhvj3so&#x2B;PBg5Yaq46joVgdQwOjGc/IKvp5DxqQ5Wb63YOw5&#x2B;GbfgZ/D0IaQb1B30YTKqjnZdKQpGW&#x2B;5fHpznnUKpmj6ZNjVkoGuU/yskhBck7&#x2B;IaA/CBrmXU5aiK1ZBR2E9LIT/jpxM4suEqgOpm/SkbgWJdl2u91ud1xD7G5olRJHKzwsN9PvGjJg4ZuivZtmVUCKPF7Go8hF8Iqbf6VgUEx6QH/E9ILAIwUDtgRFRz8aSWL7/Q6tdKqouQEmCTgapwTg3zPdd7fd3t/f813Ap2uz2RjHo3CE9kDq6lXa7Q77/cPDw363E9ueB7KDtlzEyUdVF9BDQ0ms&#x2B;QWx649iY7vdgsmz2Wyg38Xdx8eH3Xb7xBrg/l5JhB8fEf0LyhA8OuHtg6oA7X8Y&#x2B;0AA8Pj4OJ/NAP3v7&#x2B;8hBgDxB&#x2B;x/GPsgKGApLkBLwfcK3KPBf3c3m81wdNxdLZeL&#x2B;RzoH97/AP3L5RKmBIvFYvm/0QbUMIz&#x2B;0Lh7Mgzj8WH7PNhrxy&#x2B;S/aZcNU2BDucbvmLBF6hutkDdGKk7A&#x2B;F34gaVABga6IxS7Es2Kn5Czsyqe5JSCT0xWK34tTMdM5pNfSzQarXwk4&#x2B;fPfzuYlyOqqBcLsPsXxf5ZSTiVOci53K5ZDIJIyAwvEE8AKZPaJbtYPmjrw/&#x2B;TzQazWQywWAQsV/w4vR6vagE0uk0PPuj0ShoPy6XCzUA5gCA&#x2B;NT4hkKhQCAAOhBSfm02G0A/iP7X19e3t7eXl5e3t&#x2B;DsXN1cX9us1uvr69vbG6vF4nI6b66vHQ4H0r6sFguYPw6H4/r62nJ767Db8dftdnMCAMcet9MZ8PtBE7q9vva43R632&#x2B;NyYr3H5Qr4fJFQSFH5g0H8FwoG/V6vz&#x2B;cNBvzhYNDn9bLlrzg8wSAs82HaE4lEIuGQ3&#x2B;8H3KenZzgUZPxWMpmEHhdrQqFQJByOhsPhcEh5dCYSYPZDWYH&#x2B;PeB7SOS/iURcNotns1kl8I1E4AsUj8cltDeZTCTo8Q&#x2B;nUfT7Eb8Fh82Mau2n0mLdjySvlKTwok5EOQE&#x2B;Pwg/siYLd0s4fkqvPatvmU6niip8V3lvkkCP2gBcmlKplBXmD8C9QHCF47PC&#x2B;cnRkCeniD0VoH/psufFoBPdegwK8FAhnweHp1qpUNqrlL6yGfB6QUy00E8Hki4Vi6VSEUAfRQW2AUGfXj0oD9D1l&#x2B;pCAXpsVhDrTzxNPAua/VekYV&#x2B;r1UDop8c/BcTyzx/IXln7l5kOJsNDFA31eh2yAS4KuEuKMHA/rT&#x2B;rag5ZBWVRyYJl8EgVL0A/uENqPtBosOvPIQBMfpqNBsE9iDvYQO/0A&#x2B;63261Opw25VKfTabda7baiCUk90O4K&#x2B;6etuYViVAD6pWkWJEnt/JZGkTAcDvta2AvWcD5Ahs9I0gCUJEBcQfXNGP070Gx/2OkfSNg8/4IGhPAvIPih3Aazn3MD&#x2B;dVVsV9s/&#x2B;sKAeaIvfb09ISfOuLOo8h29YHAQfwWifjBISFuNk7jgUntwLH1drt&#x2B;usOpM/1&#x2B;txVEviPGJQQ/SNt7KwQhQyC4QGeTMMNBAaH5QfGCzLLkORoGiiU6Z9HybExxJLdkv9&#x2B;DwUJwqb0gTEswJxtocW8ltkxH83hdzPdC5gacS6AmYeYuRwGGMPuppTaeQfzDKb9oLwub64bIHtRrJaoAQ6vl5FkcCaMPWgUIoo7&#x2B;dHBnoyVkHTR21k57gkeEAZ9aLeG1NQwD4Fh9Mo9HQ5j9AOusec4&#x2B;TgD9e&#x2B;28&#x2B;/0egJ4KAfTm9/v95sls4csQYCfbbDglwJBhpzkLwacfUQBPj48PD/c49f16DXzPgud&#x2B;vUaUrxIGPDzggNhxv9spTo5MD9arleL9SBWhcoIfHmA0hGJgeXcHNcLT0xM6/SsogB8enp4e74XlD04/CDxo&#x2B;d/fK7P/xWIBLQGg&#x2B;Xw&#x2B;Z20Ae1DYCmGv2Wy2XC5J9Be30DvlHAp/sclksVhAMzAVmtB6vdZ5iv8G&#x2B;P1vWIbDMyDv88b1u0&#x2B;nJj/vXZly4Wa9/a/WAJPJhOxMXdqF72XSMdkT4o8HjTtRObTF8Ie/K1AL9E98qRX0R&#x2B;8fvzr8aZTfuXapVGIUAGm7mACYPn0S3tlsNjG7Z7Ow1Wqx988WZk7EkWD8A9kguBdMIbB9MAfICHUblQCa&#x2B;lBhQoqaTqfB9gGZB2x&#x2B;dPrp9oO4LjwUCoX8fj/8/m02GwK8wP9xuVw3Nzd2u/3q6ury8vLly5dQ&#x2B;l5eXmIUAGt/tPYvLy/h7wmWv91mA9y3Wiw3NzcWi&#x2B;X25sbpdDrsdqvl1nJzY7NaHXa7y&#x2B;lAHBhO4HG7L1&#x2B;&#x2B;dNisTocj4PN53C6nw&#x2B;H1eDxul8ftdjocMO1xOR24yoDf7/N6/V4v8nojoVA4FAr6/fFYDDrggN8fCYXQ9YfBfzgUCvh9kXDY7/OFgsF4NBoJh8DpR7UQjUTCoRBuK3&#x2B;eaCQUCoK4z7GAPBTFDd7GXWwGx89MGk3/BIxBs5kM8Homk4bJJ4YzGPUA1ePNTSbisPhUstx0Ki2P4h3PKLyeVuFZuSxuZyTENyNJupgAoOyEJyZweaGQT6fTuVy2Uqnktbhc5fyTV7A&#x2B;B89NoQApnk86XS6V8IGUtN08duGoiu46FLKjVAAWhyQ3n8vVarV8LgebHWZyoWSome38UrFYRJAweD7VarUkQV1QKQjVR/374mSAHX5U3ZAEKJJPgVFfBY4U2LCngU&#x2B;pVKrV6sznovWnqAvK7OWDUERZcKlY1EcBZUkfE7iP2YLMAWoqObheq1UqqvYA&#x2B;x8FBhbV2hfTT9oB1cQFCIygeq3OLyVsxr/sYrC132g0GABMhg/6IC3ta5AaKhqp4R7bKLrql385E9Af7XQ6SA4Gpj/zamPvhl/OxPR9SYInaWcwGADNjzSjT04D2Pgn0CfuHwwGmAfgt/FMHzwcDjh8Jr2HzH4d9GNKANkAZvWTyWQ2wzZj5oKBMjSbzZAx/NpRAqT2Ev5lnKpjieaJpLdinak3iRWtRRZQJnan5pWcKhia1vZMQsBTGxxHyOSBwFEfDhzFIpMH3EvnmDlS2Hy/3x8PGrw&#x2B;HUdICWG678tYQ2FQPn1cxk7T4LLjrr9WivatsmZ5tYftqSICy0578QleqT/ma6hXO2fXLJXbRj&#x2B;gXt4cNRCvjyPUO64R6Pen7&#x2B;NBmDx6LXGQzdRKIQfp1Rru4908Hg6Q1eKlI0VKa&#x2B;HvdfjO6z97Gc2iSDrtqpqSSoNrqDyWOsE8C3n5fKc40tmImQ8&#x2B;vQL9lZXnCaFovwfxBnw2ePlvNhtsjGb8QRyBkCGAQz0&#x2B;Puz3&#x2B;8eHh/1upwj9CAJ7uH98fEB2LzhCHCwo3A/QLxwhsIMA00HpkeBhxREC1YeJAevVarlcYmKAlACwg5QYQIQBd3d38A8FGYhzA5QHsn65RlmwXKLNYPr8zOc0CJrNZneyTCcTkIjQh8CO&#x2B;iftf3KZzYzTeVsuW&#x2B;Pt7dMun6uuV08ftXepOf2oh7Dgmx0wHcNWwH1Cf3wpE9ZzaMupMWsGMoV6Mi/udruTyYS/WG3JuGGpgN85/PzjlxKMf/6C0u6TLFsaflP&#x2B;CzYCOojkCEG5CwCU17KKkslksVgEsCyXy&#x2B;B4gOQTjUaBEXO5HCBjMBjkBkD/WEnzn1AoBDdP&#x2B;PRT&#x2B;EsjfzT4wRGyWq3w8rfZbLe3tx6PR4l3Ly/R5r&#x2B;6uqLGF4De4XC8ePHCbrd/&#x2B;OGHdrsdJQHW397c3N7e3t7c2O02PATbHwh/HbD3cbttVqvX47FZrW6Xy&#x2B;1y2axWm9XqcjoddrvH7YaDp8Nud9rtbpczFAg47HYF630&#x2B;QHmkaIUCgWAg4PN6QoEAnP79Ph9WCtAPBPx&#x2B;j9sNQg4a8&#x2B;FgMI7c43AoHouFQ6F4LIbbYOzgP1p5gs0fDocTkqUQj8eTiXgymUB4Avw6k4k4yoBcNgthQCadTsTjsVgUpkCpZDIWiyWTiWQiAcNNGP9DR5tSQu0E6j0AfUXrV0aZGcgD0mLFAyNRFoe5XBbaX&#x2B;wlxj5pJP&#x2B;Kw34ul82Wy&#x2B;VioQAjHCUxF2P&#x2B;bDZTLpdh1JNnzzufB&#x2B;2egl2YaUJOkFeUfbWZkHkUyT4v8B&#x2B;InyVBVnP8FFVAvggKUKFQFj1uqViE6BZtfnHrVw6emUyGDXVQ/MvlElr7MOEpmo66Cq8rAl6xWJLYXb0srwhvh/heDQpKJeBySvmp/MG/7qIEfuGfPNW9csBKWWLFgNmrwvyB4U&#x2B;lXG5ILli1Wm3IcABraPIDUlC1UmlKKKFO&#x2B;5HJAIYGag7ZbDTqQgeqixhArwFoGNpSxv9Nru88o/sTzbfEC4h0IBgEtWUlvlSVL1Cno41w4f/ZBe5X09pebyBuDZgJ6DZu7P0PJBmA3&#x2B;e6DAA/BOZAQLr16CVxGsDygM4/pACx5QQvaRKBxBV0ioHARNK&#x2B;WAbMJA&#x2B;YxqAnGoCxWQlMxuPZbPYakBbJOSbCk8UQX3n8Ih40&#x2B;odaoxlrHjRTTswWDuLno/&#x2B;sbrdbWMvz&#x2B;Gf96aMw6SF75aK3t49aJBaRNzGxju/1DrdAfNP4aHd6Uh2U7F4liuAF7DSh8IExutpkw9D67vLsjobJFzJb&#x2B;OTP7DTf0jMqDkXVGuvmqF/58zUk2uvbsBg7aOXETjxJD8JK0j8AhoQtEEwfn7H2lWOpprrWCwZ9Y8qjt9vNXuq9Az34T8OYZQ5wZDufL&#x2B;BOWftvd8Kf2Sq/zs1exjubzRMrDb6eavIgd7fagsJ1s9kcDvuNLBzvwJ4fa8DmlwCy/U7oREzs2mppYtutSg/AwdH1x5Uji5d8oQcxEcJt7AWFgEwYHh4kCkBGBfewDcVwAGnEAPSE8iro9&#x2B;EBwF3tdn&#x2B;PCmS9XsPZ8/HhAS5Aa7EKnc9m9/f3q9Xq6fERUcErEoOWy6fHRzCClsslehIoIVBXQBsAh1AUBliYZz4ajV6Fuv&#x2B;dS6Gs3ysXKoOR4hfdPx4Mw7g/Z&#x2B;SpZTn713KADQNfpgD9oPeQ6oMFPxJgYeKngt/pfSZHahJhTI3pXIEfJ/zsAfFjY/xk8jaAPpteeLTdbpfLZTBrye4F86cmnTnaAqIZyZ4iaT85MQNFO5NtfjR34/G4aaaeTqdECYquP6g&#x2B;MP2Eb0woFIrFYuCjA6q63W6QfLASXv4&#x2B;n8/lcrndbt71&#x2B;XwOh8Pj8YALdHNzY7VaYeh5c3Pz8uVLrATjH4Sf6&#x2B;vrlxcX4P/c3t6C3G&#x2B;5vSXct1osTqfTarVaLBbAepfT6XQ47DYbigSr1WK1Wt0ul/X2FmWA02H3uN1&#x2B;r9fpUGMBoHmP24383WDAD4jv9Xj8Pl/A70cOQMDv83u94VAwGg5LzpcnFAxGwuFUMpkCVI9F/T4f3DzDoSAa9jEx2lf2/JFINBLBTCAejcaj0Ug4nEokIuEwevDRcJj63WgkAmQPCn4um41Fo5l0Gl1/RgWHQ6Gc&#x2B;GYC/XNKkEomE4lEKpWEEz9c&#x2B;RWTR9n8qJjeVCpVLBTS8P9Jp8HpT6dTDMNCy71SLqdEHoCCIS&#x2B;9fBSZxUIhmUzAdx/OP4V8HiAbOlqT0K95bgJ8w2xHYXSR8wLcFwSy45MMkE0xLmg8RTGrLRUR3as0vqUS/zUUC4W8ierz&#x2B;aL47VCbi&#x2B;KBdB2TPpfPA38DqdPnhwoB/tNDNQ6mjdpe/oKfI3r&#x2B;aqVS4Y6A&#x2B;9VKpVartiRyq16rVasVRH5VKmUWANwFR6tIvi&#x2B;&#x2B;KxQpv9Eol8uqAqhWaeKJc3dERKSI/iL8JZ&#x2B;HlQAWwHBl8tNsYghAga&#x2B;Q&#x2B;BuU/pL3z4gSBf2177rnvCB&#x2B;berbUDfFHj8Z/xRQ4XuVNYOSCGuRYez681uaj6L9rxN4dFOg0ehEEkBhGFv&#x2B;JIiibYTfBZ3ZL1wgk&#x2B;U/1MKA8UOpefmrXcYK358YB&#x2B;m7jCWghuMCPETlADp0rxk6atTa/Owxs4Gt962JsA0N7Z1uoBUPp&#x2B;phLEoufDwSJ7GKIBTWELYyoTdOo7s0ZHk8Cl1ev5KzfrZhFhs7HaAbWkVBHfOByWJSwOhomO3kw2kznoc6e622ynjn5NXTZyAn5Zb20FEjBR1MoyGzx8&#x2B;agS&#x2B;X/ndvvrAnElseU3/Z9&#x2B;L4yXMpRYc6/lbr7R94TF4b/6onK7MFvs7Y7aBR8/US7qwI5N&#x2B;zp6nVRbqsWdH0OVLAdQI8H&#x2B;VNBFJn2XAUp1e&#x2B;egfJlpbjKD8iRIwBpB8OB&#x2B;qAd7sdQDwqB6L2rXiDbqUyQX2A1r5K8tpsHh8f6UlKQj&#x2B;KBIgBcHe32z09mVEAWLmVYDL6&#x2B;dDVB8MBqH4fH5QYQFF61uvVcklZ8PLubr1aLe/uaP5zt1gsFot7JQtegxSEocFiMedKqAXW6zXa&#x2B;YD5SBVQmuDZTCcUgWvEKSQ65RhH6t8b/zPLaRVRyeSCyWZn9GgYhrHbVYtN/dHlzAwCa7Snf80AyDAMw5jP5xwC4Csb36o9jQkK4im&#x2B;9/G82CIaiEs0KgT2k7ALOvpdCa5HDcBfOHb0h8Nho9HAr1StVuv1ejTSphgO8B1tOfT1OdBXEEr4ALlcjl26UqmUSqXy&#x2B;TxzmkD4gc9PSjm9ZHO5nBi8pOjjCTQPvj4jvUKhUCqVQtxvMBhEai8YPqFQKJFIgOfj9/utVitqAKxxu91YY7FYLi4u3n//fVL8gfttNtvNzQ3&#x2B;Wq3WWykGrFYrHIEwN7BYLA673W63ezye29tbaHxtNpvdbof3P/LCXE6nD619pxNEIKvVarfZQO/xeb1up9PldLpdzoDf5/N6PW6Xz&#x2B;MB4ScYCPi93nA4HPT7PW63z&#x2B;tNxOMBn0819UOhRDweCYeT8XgkFAIFKBaNRkIhEPHj0ShoQgGfLxgMJhPxSDgcDAajkUg0HE7E4/D6TMTjwWBQ5XDF4yAFZdJpWPunUskkOPepZCaTiasArxgQvxJmJJOI7KVfUy6XA6hPJZOFfC6VSuVzuWKxID76Cu6D1QObSwg8gN9RIaSSSVB3sA3I8XTmyYn6tqyscoqg8sOQBxZA2LJYVKyeonj4SN5Wjn16vW3PG7TUxJbKRbRUyudy&#x2B;XxONeQLBTS86d5DmM55QrlcQrxuTTyviNc5HECbX6l4CyoIDGQeSAjyIhtgR5/iYI4goAkuk5BTKlWrlbIptK2gRJcjFGkKVJKU32aziQ58WTP4pyZYZwo1GvVqBTtiIFBEYaBkwfKXhUH9NNWrVlPmPw0B96wKaCyGFgNZQIr9I0tDgoHrkj9Yk&#x2B;TyZlNllrMugNIXkl99JgDPUB39E7i3pQMCon9PRqYQ73YlUVGn/VA2oBv&#x2B;ENkrek&#x2B;7jegVXRtw9jUO4D4YDHraNGAo&#x2B;TAmw2c4hNP/UMsBwPf/wPT6HOIu6T3o36MG0Nk&#x2B;I60Y0HUCz0sCkPvB/KFZEH6/8FOL2btuGKoKAC5E/4bGDzmDldzyoOUA6ByVM5S515w6DU3Fq0M9LDzRXsLIDCFbS1vaNIzXD3hWmeiXunmW18vzEsrq3BtDmwCY9HQN3IOnzleAJ9pqXkm77ZapWawf&#x2B;FoJkDUJKigoFLv9tJbQXzq&#x2B;nrrT0VkBoJ/FOAHlJgvr7IXiDb7v5NPrL7X&#x2B;ZHmFh8PBOBrG8eTgFE&#x2B;zVBAK/gn7fy9pXIT&#x2B;B9GZ7CVomXx9Qwo/OTs/aTvC&#x2B;q0w&#x2B;MnV2YnseLfbUd2xPTX8UW6eh8PT4yOuBUd7eHhglcOpwnaz2e93SO8iTegAgyCJJ0MAMIoBXMPDw8NBBgvg8YMGplg9T09I&#x2B;wJ2VzMEGQLAM/Th4f5&#x2B;vd5utxspMJSND/THkh9Mcg46/UD/cALFNACcHxKE7u7uUBJIJMAaob/LuyWqgsVioeYDIPpDDbxcEs3rsgGlBl6tlsvlfDabatlh8/n8/v4eX0aYB1CThJLgf6kGOG50GUCzNRxrlJ&#x2B;XtpS&#x2B;7fVt8CD/pPrd0XPF8Nlyd3cH4S95n/jOZU8IvRyOjAea2T&#x2B;HyPSSa4pTNdE/f9gA&#x2B;lEAsLOlk1bB4wdfiD/G&#x2B;sQff1ED0H8jl8uhigCXgAYsGAhEo9Gi2J8D/YPeA4iPZj/IFcCUSObKZrNoOft8Plh8gkEOXxoIf1EAhEIhu93udDpRJ4DiD/8fr9cLo0&#x2B;v1wvS/4sXL4Dv0eO32&#x2B;1Wq/Xq6sput8PMx2KxoNmv&#x2B;vq3t5bbW7vd5nQ4LBbL1dWVzWazWFQN4HA4HHa72&#x2B;1yuZy3t7fXV1egAGECALtPj8dtt9nA9vF5vQ6bze/zuVwuj9sd8Ps9Hg9t/r0ej9/rhdVPOBT0&#x2B;3xetxvkH4/bHQmH3S5XPBYN&#x2B;P2hYADiYDT1o5FIKBjweb2hYDAYCJh2/uFwOBQC5ycajYRDoWg4HImEI&#x2B;FwJBSKx2Jo0gP9o6hIJuLhcCgaiSQTiUQ8RifQRDwO6j9oPIl4PJvJZNKpTCYNqQAkvJlMOpfLxeOxBIx60ulsJgP5bxbOPskE8rAQiGs6/YsSlzm&#x2B;6XQqn8vB5KegGvkZcPqLhQJ8fhQtJ6/ysPI5ZZFJro6y3SwWTzF0oVqp0KmzWCxCH5zL5UqlYknidauVCvcF0wYDhKIgd6J5kuBhIgQWe7FQgJt&#x2B;PpctlYqg26A8QKgWkTode8qlUrFY0Bz9C2Xx58nncvTqwcUQ7qMEIllfJgNqG6B20eaoy68hq0vY/OVSqapkxOaUoCIJAFJOVEncJ8THP3lUQZT&#x2B;kynUkKwu6AEq5TJNgejto9bU6wgDrkqeIDaDuAjsoGajUavVIOpt0BVUAD0ORiGvbmagKwEA63UuULPZbMmUoNVqtSURpdVqISEYEJ9eQIT1KAk67Xa3q9sBddrt9mDQV6VCt9vtdrpayq/g/g4BPf/2dY//4bCv&#x2B;Tvzhrotpv7dbhfIG9aigPKqhTQYEMqT7g8&#x2B;z5k7EHlEqA1wY6JtQLaPDApUwhdPN5mM5/MZSgI8qvkFzUej0WuHZ&#x2B;3qreT47vcn9BI2sA3p6LNvvXkVr/0MLxp6G1gbNeyFznHymy4UIMK&#x2B;/X5vHI/brSkYOGoeODg4Bc2GxvYR3GnaawJ/HzS20uFZMvHBpNyoDXZayBdQoaE1vPfaEXhqrAcU3ms6B&#x2B;3ajoZWPh1k3qI3/mWsYRZL2JkW/vqpDbMwUPoNE2prswXuoq7jcD4ToEhDHU0rAo/aQ2dzG72cOGihAXJVu72Yge5Nbo/YLpkJxKrfjw3YiedlbMVcaCcEqr2Q/k2WkYjFD9qhdhJ4zMJMxQscDsfDAeCbA4GDlG3H41GEuE/o9z89Pm42yPF92kphgCb/4XA4qrHD01YFACvGv8oF22xY1cC9Z7vd3muk//V6rQ8KUA&#x2B;YhB8IBiRU&#x2B;ElzBaXpJwj9gPVg74CrAwIP5gOK6L9ePzw8zITkwyEAuvvYBnnAZ&#x2B;EAWJA/sGJA2GwGuK/UwIr4M1&#x2B;v1wgMxgL&#x2B;D0cE8/m81&#x2B;tNp9P9/l8D4x&#x2B;5bI14mnfWdyf&#x2B;Qrl0ibc3j4&#x2B;pYnd&#x2B;9yB3N8l8968fGt&#x2B;w7OLoXR92bsanqS7A6PxhwHqq2XSHn470q3BAvSTAEWhMQQldU8KASfEvl8vdbveM8luUrF&#x2B;gAUCZnFing4SAaQAgfkmZEirjFEXvzmQymQwMfICsoOBUNPREAt19kHzQ&#x2B;Edcl8fjAeJnqpfH40EBgF2sVqvb7QbEv729vbi4uLi4uLq6uri4uLy8vLi4YIMfJQEUwJD83lxfezwem82GRzEBcDgct7e3VosFa0ABcrlcNpsVZv8eJIt5veD3e71er8ftdNhB5nE6nX6/3&#x2B;/z2e02l8sVjURcTqfb5fJ5PbT4dLucMPOBchdJvX6fNxqJOB2OQCAAw59AwB8MBELBYDQaCQUDdOEMBoNxhB2Ew5FwKCn6XfB/opFwRPg/iUQCHf1kQm0Dm85EPB6PRkH0j8diyWQCbj8oFUDdQSAAJgMk6BcLhaRSCyRg5ZnNpLOC5hHWC5fPnCRtwZETDj6KsJ/NooRArx2MI&#x2B;lw5xCzhbt0zwTxJ5vNVisVhuOiyZ3NZFQ/Xig3YAHlczkQ7tGqL0l5gL668vOB248aMhQKhQIAvWIKlcHRr2B9pVzGWADoWVHqIcDN58tldYSy9Nrr9ToJOSYxSAvfpTaXPB9sWi6VyqVSDZpg9Pil0U5ErkS6MiigJLdYLBLBk&#x2B;1TVwG9pUqlUqtWSyrwq1SVrK6qtuA4denxo7qoS5ovV/J1qNdqjXodHv8sCRS3R1S8Nc3sHzLcqhQJeKGazWZN9L74egKU1yW/bY3hU6vVOp1Oo143iUHCDiLip18QsD55jzT37Crr5C5tQPG1CRYQ6f7dTqfdNguDtiSC4ftW&#x2B;X5Kj5/mP1z4BU72Tq/bNZv9/X6/359Op12JiSThh8XDQNhEFIzxR2QoSTgD0ypULQjqGp&#x2B;IgIc6sWcymUynCtwD62MiDU9PfboOks9UFpD&#x2B;sRKy4NlsNp1MXjNEeosfPLJoyAsyNLfHrSggjVe13k95LKoXjkfPNt49Cx8wTt17DKkxtlryFNE2NiDoFCh5NMRjB9SMg&#x2B;SU8RK3p0Y9ZgEgVKKz52KQy6RnEWhQnmBxp5ci0sA2BwLqpGavXUfhPP6ZzMAQDe5OMgS2mh0nMf1&#x2B;vz/sdYse8w0lENc78Xx5tyLRNsTjlc9dKW7lCcr7ckRtcBQMzecrL75S/fJNfGWRcFb5HMQ9liXEXpTHBOuGSL15UsyIOE3abbePDw/8fD49PW41uv9WU&#x2B;6S0A/KPkc3iv2lTP03dOXfqTRl04&#x2B;VMwRMBjZ07tdYQOjNg/eDHYH7n4TSg4u5v79/enpEUx8VyJPOAnp8BL8fbp6bp6d76e6f/WWyGCXC4PxQJPD4&#x2B;LDZbJbL5WazgaKXiF/LAlPon0UCZANE/Druv7&#x2B;/hwz4Tvx/lpIVAFgPOhDKA8B9dNNhUABBLXoYOiXR&#x2B;J9bXt4YGaX9LWcrg6X5L8hr9esbRmJ5/e56fWoS9GxZLBY0XCMRCN&#x2B;zbP/wB6DVamEg0NPCIzEu6HQ6vFEul/Ejh1Y9frE6nQ5Me/r9fqFQgOMEfwgrlUqn06HnD2oA3gW8qInrP37voSkEWYK9TNqhZLPZWCyGGyBtozWbSCTAC0oCTUq&#x2B;LzS&#x2B;0WgUzX7g&#x2B;Jgs8XgcgV9Q/YZCIbjNIAQA6D8UCjmdTrD/7XY78P177733wQcfENzD4hO0/pvra/j6Q/WLCcCtTAaur68R3&#x2B;v1ejExcDqdLpfTZrO5nE6rxRIKhZwOh8vlslotQP&#x2B;oFdwuF8QAGDt4vV6/z&#x2B;f1eIKBgMftcrtcPq8X8l/g&#x2B;Eg4HItGMQcIBgIOux0hvgG/Hz486OjjP4D7WCwW8PuVZjcajUUiMOCPRaOBQCAWCUM0HAmHE/EYuvhJdPFjMTh7RsPhSCSC28ziRQhAIpFIp1Kw5YnFYmTt46FMJpNOpaAEAHxPKQOfDMY6yOtNJZOJRFyoPhmAflr&#x2B;s/1P4C/9/jza/CTwsAZQlp0w3snlKhXlnlko5MsSYVtUzpX5fD6vGPbFImgtOnkG/69UytDRArOCe6M&#x2B;uplMsVgoFgpVYbvBYr9Wq5XUNKyKDzPqikq5XBH0DyNO3RBHaXDFTZ&#x2B;XUatWyREql0u0uCkLdqcvEP7R8W&#x2B;9VquUy8VCAUUIlfeoydHdhwy3WCxiOlfRTP1xzVDvYE3lfClXRZULEK9EusLjr1QqDZXvW1ZSXfHwaTYVyCahn98VFbEHbTab7XZL7/ejr19nBFi9XqmUG/V6o2FaEbDl31IZwzVY&#x2B;gCjNyRBTFf6niiGZSCA7j5wPKcBFEo1m83uqf1/UyySUShIv79N6j891jhKRYOmKwnBZAT1hBSkJFsi3MJ3Pnoxw9OEx6Hm/jyQUEjeFUWBOUzAT4NyB5LdzfJAJgOU8KIKwHBgIAFhyu1HFr0GGGsJX4wCIJsII/expAFgm9cMDUoepBnM5rHeYyb21UHk4RmH5Hg8kvatQ&#x2B;qDZvvINYZh6DLf/Sm3x9B8PA2tDjkDwYDg3EbnLB3ESl9v558djXd5zfoTPzC366SZvT/bly8d4fJB8ci3oKrrZzFOdQK8WkMbsxxNQGzCZR6cuFl/YXn37PU8aswcHucoC5&#x2B;1&#x2B;X6dOiMZGhDnkOG5KJxPSq9t8Nx5EIBglgEsS/ai7hDXJpMUxG1Yohz2B5apFGnsTN&#x2B;qE8&#x2B;fI41NNcPTg5CvdprOGHMGTgAgxsXGJPOwosCb&#x2B;/jwoGz7N5u92P8/Kc/&#x2B;x4eHB5YE2Iv6YHj4bCWEGB19evvg7nq9ZrAXtuFwANgd2z8KxF9C2vvwwDSA9Wr1KEnASv6rJ4Kt1&#x2B;v1&#x2B;vHhAZIAFAzK6/PuTnxClWbg/v5&#x2B;Lpx&#x2B;bAN8b1KDVqu7uztw&#x2B;kEQ4iQB9QDmA3rvnymGOh1I/2f171gKZUO&#x2B;OZbzO32YGHLHlto//Vt7lLefNsf16vGvH3i1WuHbFl/unMOC8d9oNND1AXmULR9sT70vNWE9iZ1nnwk78seJImC0tVAeNMTWs9PplEol/OxVKhUK6aj3Rb8QCL4okUPFYhH6y0qlkkwmOQoQInW&#x2B;WCzC1QfKTuBI8PgjaEjH4yD9o8EP9B&#x2B;Px91udywWg4Q3EAhEo1G0/EH6j0ajsPZ3Op1OpxNt&#x2B;6urKxD6Ly4u4On53nvvwd6HKB9sfrvdDk6/1WKB/b/dbr&#x2B;9vcENi8UCJQDqAZD7YervcjodDrvDbrfZbDfX106n0263u90ut8tltVp9Pp/T4XC73U6n0&#x2B;lwhEMhl9PpcrmcoAy5XLD8d9jt0PiGQyGP2x0KBdGhh0IgEg4LuT8SjUSCwSByvELBAMj60UgkHouGQyF4gwYCgWg4rJg/4XA8GkUXPxGPx&#x2B;OxSDgEN55MOp1KJlLJRDQayWaUb08mnda9PqEnTomBj6ofksl0KpXP5VKJRDwWVUT/VBKcrmwmAy8d6AHQmS8Vi1B9AG3nctlcTlnsw4k/k06XSiW49UNxW8znURtkMhmsQd9d6W7F7DKfz6dSKdQGZVGfM&#x2B;4KvHzY9ZTLit9SlEZ&#x2B;Til0CwzPKhYK5VKxqMXrloRUk8/nymK0j6Y76gfw&#x2B;0vFIlQuRfmoK6dL4eujoU6Gj1B0CiU5CCUBTNitSCu9DsZdtQr2UU3Cs&#x2B;CuQ0Y&#x2B;CTnQJFTEoeuMW1&#x2B;VpjsKk4rg/rKkd6kKv1pFcx9kP&#x2B;D9umD9SkXtAkJOtVqtVMowACUzsNVq4ZprwuCvVMqC8s2GgowOqtyMSB02AzqHh3T/ugR7NRqNel1tL8BdSP8myjfLgIZ4mnGqya5/QyICTFJQq8VI4K6WB4xvUQXuO91WqzUYDOD0Se//rh7J0ulQkUVjnxPhb7c7EOu2brfb7yt3oIHkf&#x2B;FQk8l4NByOx&#x2B;NOp8OcL6UPlqnx8DT9V6f3kESqc4G4oOvEYkAZAY1GbPbr8wEaAeEnVQbUJtzX3YEwHBiPx6/tpeWpg7mjGHGi/cmwKp2kjhXPbxyPx710u/U&#x2B;9EGRNwAiTRy/0xrqBNzS&#x2B;DdpJzsteJgrzwoVvZI5YxSwSOA2hqY6MDQiDTH0XpOo8jg8rH4Wkyqj9cW3murXpOBrWti9RsjZipMpHzQU0FeNf70jzme03&#x2B;9RHvCCj6dw3NB4QfpdvP58v4xTHC/r1byFM5Dj8biToAY8l4PkHOvVCE&#x2B;33W740glJTL0OW5mK6BXdUQTHfDv0a9tp/rD7/R5iXKJ/tudZOKmSRuZIyGo4IGJMk/&#x2B;S2bVXrkEbzHOA7E2qkhC6&#x2B;PlEPhdSvfaiBobDDxz6WTNsRPKrZgsPDxhLsFRQhJ/Hk2W73aIA0OuEe5UN/EQpsOkQKv6hQPeYHnANKgEaBz09Pt6LLxCZPLDuwVgAdcLj4yNa/lT3cjKgIsMoHb67QyUAxA/cvFqtJpMJnX/wvQOfMvU9NR7jWwkHwXQSiWz/K0s8Udxu1QevXu1z/fzuFX6g09lfOx2eCHmZ0&#x2B;kU38K0VwN/CbPgrljR6T8tmCajEsDvB7bEMJo/S7TUoMaOv4W0vOAwnSN49vsLhUJdonyBwJTpyikFOZFIqKYpXRdzOTj/wNgHCVCI9AKmB/rHQ/F43Ksl&#x2B;Mbjcb/fj7uQ9vr9/kAg4PF40FwH3d/hcHi9XgB6YPqLiwuLxYIG/61ofOH1CWQPBTD5P4jshZzAarVC1IttLJZbm81qt9vsdjs8Pb0ej8vpDAQCmADYbTZojp0Oh8/ncyHW1&#x2B;tVMgC3OxQKuZxOv9/vcjoDfr/P53M6nWoCEApGIxG30&#x2B;l2Ov1&#x2B;PxyBfF4vJL/hUFBNBvz&#x2B;eCwWDgZj0UgiHoOhJ/hCwUAgFolEIpFYNJpKJqIyEEAFlUmnodxNJRLw7YlFo/FYNBoJs/0fi0Yg640K0R/tebD2s6IAzmWzmXSqWMinkok8RNuZDLN4C6KfzSh7n2SxUEglk0DMcAuFFSb4/QDoxWIxr3j8uVwuC8gLEjzqCshwi8VCReS24OFkxcOnIG73lNJWNGEu&#x2B;voQEgBt5/M5QGo1udLM9QHKoQRA556MmlqtBkBf0s6Fz3yxUCiVipVyGetryMcV0j1UsGWx9MFdlATNRqNcLtVrNdj7VCQYqy4JG2Utc1f5&#x2B;Qgjv16rqSpF&#x2B;vf1er1aqVSl/CBvh378RbD/BcRXKhXJ1VLgu2ba9ptyAjCFcElCYVLtfFYXPF2lXAY0B7au1&#x2B;vVasWE&#x2B;zITqAubn19BNQkWVCj/lI5Yl28u/K9&#x2B;SgTqtNtNqQSU3782E2iYFQLNQBuNRoPW/q1WC/SclpQB&#x2B;EbVExLb7XZfkgFIxwfu74nZP75me9pCoXCv12u3W3T1wdG6ktXY7/dHwyFqgOGQTf0B1yt8L0YRkAeMxAKOo4DJZDLU0P9I7D5HWjIAR83D0&#x2B;hJmoEOh8OZOPxMp9PhcDAaDfU0ACqJKQI&#x2B;XansgHTK0GuGQHBdP3rQyDYE2YYmPNUVmfv9Hsxm7o4bxOgEapILpkCt/kOrt/mV9kDri&#x2B;swFxsZ4lnEpvjhrA0sCNuQ8FriSGn3KhS7F&#x2B;DIKzHxtNY7V9sflY8NLvKgRXoZwp43nnX6eZF6mbHTrPqBjDm&#x2B;2Gl6aEND1YbGnjK0eoC9cL1xztf2qGUPE/ofNL2BoRVpeJTsIB6ZvXbDBOUnRdfxeOQwB5hYTqTg&#x2B;NPTk4FZinlAU2&#x2B;9l7Befsb44ujDDT7lvZobHBlYttVi0Vi87Xa7zdOTIRXI8XhANaVqtt0OMgCUXtvNhgnTZOrzyOj085OG&#x2B;YCqE0RPfDweHyXn6&#x2B;npEdB/Kw6h5PkwNphYfy8hX1ulMdhsN5v7&#x2B;3uofiESIIjnetKN9FoCG6xXK6QIgzXEBj9QPsYLxPFrSQDgbIEjAmX5v1qhBqBgYLm8m81mUBWzNmBJsFgsppMJDg6sf3d3NxqN0HjAShQDSAdDbQCnguFwuH1mGvbvWh6fDtnqRN1eP2ZydfUxO1UZUAE8X6rCYNRtnR/q8XGgLXqfRlE5p1NOAJrN5kCywPoS/dtsNtudTr3eKJcr6UwWs2W6A3W1xF82tBri7s8aADi&#x2B;JtZ7hUIBjX/&#x2B;TgNGYAiQlbBSNl&#x2B;h&#x2B;gUgoFl7qVRKJpPlcpllAOyA0uk0uv5Q&#x2B;sLdPx6PX19d/eqX77zxm/fC0bjf70fWL5hCIPwEg0FUAh6Px263Q&#x2B;PrdruB799//324&#x2B;oDtc/HiBSoBtP/h9WmxWJxOpzkHuLnxejw2m81qtTgcjpvra&#x2B;Xnc3t7e3OD2yrty273eDwOB6S/dpvN5na7nQ6H3W53u1wul/L/dLtdLqcTDH4oE4KBAOj&#x2B;kUjE7Xb7fb4AXD69XnB&#x2B;/D6f3&#x2B;dD&#x2B;x&#x2B;tfaT2BgKBYDDo9/mCAX88Gg36/bFoNBwKxuHyGQ4D6INBBIYPTPpVTG8ioZr3iUQ8Gk0m1Aa5bCadSqZTqUQ8ns2kc9lsPBaDr38ul4VzP1j&#x2B;qVQKwVjowadTqWQyidogk06Db4PTgetfKBQyGaX9zUhuFwYCWJlTJvpmm78ELj70tcVCoYAPUgHU&#x2B;VKxSANQWHCCr4&#x2B;Gt6Lml0r5fB4wHceoihVmkS120P1LxUI&#x2B;Dw49wH2pWGw2m2UcoQybSwD0gtm2lyIBaJscfRyZ5Hvh9SBRq4jCAAi7IGG6QkMqAP2XKLeVI1REuQtKT6PRQAlRBS2nWq2Uy7VaVQS&#x2B;ZdCHsAHQe6NRp9IALflKpQLZMUcBkB1APNBsNuG&#x2B;T36OkggLs7/ZbGJL&#x2B;AJTBAzxLkcNgNSKtwP5L3YX6k6jUReKf7XRUHnA5PbwiwgEId6WBr8y/2GzH2ajuEvcX6/XsG&#x2B;r1cJtGhbT7rPVarXbLdr&#x2B;sOWPlc1GA2WBHualf22SEdTWYhOR8gs03z21/pRxq0Swy9HgIjrU8hyJ48nsH41Gw8EAHX706dHrH2nmP6wNyAUdS0oMpMBmv380Go9HE6HwowAg20dr509OVw5nsxl&#x2B;g/S5Aa32sA1LAvTX1Aay2WvGafNbWBMmC1xHxnq/diORqDpq1EGq8QxWysoT&#x2B;a9ajsfj8ahbcKJJzAcNwziIf8dRMKJeVPBc7MSzW0xQaDxj2hy0UxBbn5FzzAGIdiK92332Kumb6SsVij3NQWNldTx/lQ5UUOhSipNiwzDYR&#x2B;f1ny1nb4F&#x2B;Q3vfz&#x2B;XahODH43G/25Hljy798Xjc73e0Uj0eD3IhB/M1PKhKydCmSUeN6C8lkFkZ6vWVPg04SA/ekIpIL2l0Sv1By3JGix1InQwikWubnx/V/t/DHWiLUYBeTqC1fxBjUAD3A3QfYl8L0s7hcIAFEC0&#x2B;AfpRJKzX661eBkDDQKNPyQTY7/eqVX9/z4IBCwn9pv3/0xP&#x2B;As3TsQeFAZg/rByA4zFD2G23gPjYjAUALIlIJSLdiIIBQnyUAfACUhOD9RpeQNQB0xqIMgD0/ucSGQZxMAPCQA3CQ/&#x2B;OGiBb0O/NnnX0G61RsTnH7cV8pT/UqpvzgcV0&#x2B;v6to9Wb6xtsNpu&#x2B;GDu0Wq2xuDVz9jrQ8h31EfNoNOp0Ou12J5crfPji9vNf/M7f/N0nP/ZPX/rVb/5Uq9UxFoC6l57T/EXEjxMa/GD&#x2B;QACAJllVQr7wSw9YIyaADeIeeJ4gNQmgH4x/PfEXkb2IlEqn09FoFBSgZDIZCAQgUg0GAhaL3e72/uqtX7z5&#x2B;uvf/uGvguEIrH4CgQDI/T6fLxqNYmIAtB0KhdC/v7i4eO&#x2B;994DaEeX78uVLsPxRCbhcLhB&#x2B;FLHHorC&#x2B;y&#x2B;WyWa209YSNDy2AMFVwOBxOpxM9fq/Xi5IA&#x2B;mOnw&#x2B;FwODAQAJ/H7XKFQyGshCwB7P&#x2B;A3&#x2B;92uWLRaMDvj0QiyO0Kh0J&#x2B;ny8ajUTC4WAgEAFxPxikL1AqmQwGAnD8jMWi8VgMLv6hYBCyXWX9GY/HotGkOPYkEwlE&#x2B;cZjsWwmgxto4afT6aT496cSiVQyEYtGkcNA7n4ykYBtKywv4dqZSiaymTSSuZKJRC6bzefzqaQkfGUy0Mtm0ulsJp3NpGkBBLgPdlA6lSqXS5D5YmjATrMaCCjnngwVt7lcDlT&#x2B;fC5XrWq0ewHTOrFeRWgVCujxl4pFEOVLxSJ0qEqVq/QARdDkyxJ3VSoVlXWmNO8xEwDvX6ViqbTdQq1WRUMdV1IXk01AaaiNFW1GOvRs3pdK8NqvVaSiqGutdDlIWSB7mZpgHAP/KpVEB8BduEPU6ujt&#x2B;ZrMFlAhSIHBG1WwpID1URSpxny9DjGA0IdUHDiKDfgC4xRQC/BvtVpttZq1Wu1EiaswfQWahFZTbdDpdND&#x2B;p3UPCgO2&#x2B;dnLJ9BHvVGv15uNZqNebzYbNCxm8QCYfpYDgHoDhP5OuwMOUFuz9gfHsqmv1Aj97XYblkEA&#x2B;m0taKXTbvckbLHzLJGdrkHiBtTrdrtDLdjLVAX0&#x2B;z0JEVNtezH/EVuIYbfb7fW6Ay0oZjgc4FeDvxQYI1MAoNcMuAsS6XAwOGPzM5SGXH8S&#x2B;vEo5b9kBKG8oPOPHhaG26/p6PzsR5egihSL4/Go0ppOiTGE2jvhUZxB0o3E/eprDK2K0H9xCUNV21gu5ihCTP0it5oVKSCaPis4g/sfBZSPsuiH1SlD6miakNTQSoW9DB&#x2B;MZyWToTmZYvutRJLJS6dmKZrA96g9eh7oy5f67Fxn9RjfIBoKmSOFj6h2eFsP85LyyTRc0jvxZoV2MGPdTl9wKWzw3m23W83tlMMW1gkHLQwYkB2I/BTBHwyUJVqxtxeWzkEEAzvR9aqXxcwf2LOjzyoIn8/9nnSiLWsAfAgfheqzFWcnNv7J7cHecObh6EDVDKIEAI7X1bqwBgKOV7Sipyfa9eApCM9HgfJHrRLYbDYPD6okgGE/qgL28nGcBwkZoA0oBw56JcANWC08PDzcS7yA8gWSGQJkBrQTXSwWo9EIhB9UBXT&#x2B;QQEwHo9n0ykUAhJUPmNyIb6SMANlzWD8W5bJVL/XHZzudaop6HQn&#x2B;t16taNtuU8WOoZh6LrgzWZz5vOjUznxY4Av3G63i3qA1hC1Wv3lpeUTn/raJz/zjZ&#x2B;/9bvf/&#x2B;GDb3/np/&#x2B;X/&#x2B;t/eHFxw&#x2B;kwf6hgZAHqP35WFWe3VmtL8hd&#x2B;XBWbttXCrJ9yRrRsgflyuRygifJlLxQKYu2PGgCsnlgsRs8fKH3B8wkGg&#x2B;j6B/z&#x2B;P7z9zje&#x2B;9q1v/eS3kVjc8vLD7/zobZ8/6HQ6A4GA1&#x2B;sNh8MulwvtcIT4IsH3/ffft1gsQPxWq/Xi4gJS3ZubG6vVgq4/yTwI&#x2B;UJTH04&#x2B;IALZ7Xa4/qMqAIPI6XBQIeD1ej0ez9XVld1mc7vdlttbh8PudrnsdjtY/g67PRDw&#x2B;7xepA77fT6/32&#x2B;z2TxuN6IAvF6Pz&#x2B;sN&#x2B;P3g9gSDwXAo5HQ4gPuB&#x2B;AHrQ8GgDDoC0UgEGl&#x2B;ohFEGRMLhaDgcj8UA62H0KdG8yqxT5XMlk7D0KRYK2CAej8VjsVw2i6AuYH38l0gkINtFKC&#x2B;IPTD6BM8HguBEIpHPZTPpdCGfQ8GQV3b7RUhm0eyHm2c2k6mUy/lcrlqpADdnMmmVsyvRXWjwo42dz2Xp0gMOD/jlCKbNi&#x2B;1mtVLJ53OFfE5Y/YVyqQRr&#x2B;ZKWn4UOPZjoBPQg55SV4aay/SHznvqWqrK2VCetlMuNRh1ryuWyeOcrMUCtVoORD7r&#x2B;ZbjlSpGg/u1wjFAq6TQbCHOrcoUKjqtQsEJVuvKKYyODAnTWWWygQgDUVpyfagVUopq6W62JMhj/nAHZQRk6qRMqFdQVNbHpZC3BXgAUuoDUHBc0pYvPLdFEQBu&#x2B;IYJdlge425BrVnC/0airiYS5l/CIqtTvcmjQpJ8/1cCiA6jVam3h&#x2B;qMSEC6QKQ9oi7qpLVSfdqtFsa9uDKruihRYofkz8x&#x2B;h&#x2B;mAbInp2/QnzsWW/19M8fHosA/q9HoE7thkMBsD3&#x2B;pRYSYH7/el0Coc3lgoC&#x2B;ofk9vQlGWAoQb80ABpp8V5QEYzHY&#x2B;47GAzGdAcSETAuD7&#x2B;k9Pun9Sfu4qcWJcJ4PH5NR70HLfbLEJBKWHYGkQ&#x2B;vcs3XOC3mQXbCEQe82u9PVJ48o76jAtmicDU0xKxfm075MDT2Dq/E7OVrfkF7zWTGMAzw7A2tbNBv8xmhS70R&#x2B;K49qf3ZJeG2XsnoQmf96WwZkqW9egT6R80bxzhd&#x2B;MSfD1jwOhsnMmtzEHFSzwDHiwunepqn3J6zF5&#x2B;4XN6&#x2B;PS6SLDLWOZuNyoFmt34v5kgA6/xEaSB&#x2B;p79HeA15OhCEcAHswesvOz9R&#x2B;mLWYJrZKCYAdGrCbZYNe&#x2B;YqbLcw7EcXnyUHof9OWw6HA71Bn4QFtBGez3a7xbhgI5ShJ0H/m81GoXMNlD9qcl6KfZ&#x2B;E9rNcLh8060&#x2B;wdVgwUBgABK&#x2B;shEAlEjEAPUO5HopeHIcDBE4AlN//3XJ5t8T2FAErHfDdkl18hf61aQDQPEn/tAfVv6RADcKj5EE&#x2B;Pv4rIl3DMIz91khXeW&#x2B;5OiH6Z7InQWB3ywf9bjpZ0u/euJNnx95sNuRo4ttzMpnAoJNGQCwMsKbX6/X7g3Ak/u3v/vSLX/7ey0vbn/9y8YMfvvWjH//SavN87gvf/ca3ftpoNKkGRr9/NBqhAYYfUf13Dj&#x2B;x&#x2B;F1Hy79yyg9m55URrXTzLErWb7lcTqVSqAGwPQTBmUwGZJ5IJJJKpZDFe/HySll8upxv/fyXH374wRe&#x2B;/INri/3qg3e/8/qvw5EoKEB&#x2B;vx8s/2Aw6IbTjs3mcrlevHhxe3t7dXX14Ycfot9/cXEBa/&#x2B;XL1&#x2B;yKoDwFzFemA8gpctus8Pc045sr9tbHNbpdCItGGwflAFWq9Xr8fh8XpwdqQIet9vv90MQ7Ha53C6X3W7zeb0QAUOo4PV4nE4HonmVT38wGPD7YWQEOhCmAWj5J&#x2B;IxdPcTsVg0EoE&#x2B;2O/zRcXkJxIO0REonUqlUslYNJJMxCOhUDKhYrlYDCTi8Wg0klEOPiYdCHac2Uwmk0ql0&#x2B;lUKqmXEBm8g8kkonBz2awS9WYy6VQKd/O5XDqdRmM&#x2B;Dx/PXA4b5PM5WOnn8/lsNpPP53BbGVmWS/VaLS8k/oIk7BbyOXTKiyLABScHxQMEBuh/i&#x2B;q3AK4/mTkwsy/IXtVqFZrginBvxC&#x2B;/ZPJ54GrF7nxRzQRqYnZDlj9WQMpcVl6ZaqnXFa&#x2B;mVq0Wi4WadOsVvadcRqmgsHu9Bo2vGl9I/57MH6iKUVQ06nW8aBWR4WKAgBqgJgb8lPxiL8zoyuVyvVZrNhqgCdFgB7i8qrn6VLTdyfcDyhcQr0z3O&#x2B;12Qzz&#x2B;6/V6s9kow2qs0dClvSTz4C6&#x2B;VfTjmJY&#x2B;tRrExDgR6gp08cEgYuceX1moHwDxSeWvVirci1uihS9y4bo4GTRJ&#x2B;seatob1&#x2B;VXI0Wi30&#x2B;l0TBYQoT9APOVVahoAd6B2e9DvdySqRSj&#x2B;ahRwxsmUln&#x2B;vL4kuyrpHXEGJ9fG13&#x2B;/3oRAg&#x2B;ZP9ftYDJAUNJQN4IIHxw&#x2B;FwMOiPx0pPPNKywNCwB7hnU19v/2Pj&#x2B;Xw&#x2B;hknoZIL1&#x2B;vbj8Xg&#x2B;n1E6rCeFvUb8qrWZzZbwc/R5FCsVQ&#x2B;oByDFpC/Mk6kxDw6BY9NY7&#x2B;&#x2B;L6Yc/ORWqHYRjHwwEca0PCsAgrsT9w2F4x6U/sR4lK5Qme6Er19rxhHA3DVJrqEwPphZ9cHg8FD3huCVsYglT9FeaheJFar33HSYJhnBBy9CvniQ7M2Doc0G/W3ya&#x2B;quYBT98OeQUUzUmvZPSKSBUJpwWY9habTXS8Djvx2QTUPqrXVhV1B5GAH7VngTefrzafL2XEHNHs90rmsWMQr3yQWADoub8HeWVU215IOGqkcDhwg53YieqfCuX/I6qAjfB/SM7Zbjdw&#x2B;6EwAFLgneRbP0guGAcFDw/3CBDQmULE&#x2B;lT3ktzPI6Dtj1KBwJ2wHv1&#x2B;soNwFz17egSx0w&#x2B;2D2ODsTEKADKLwAW6u1uu1&#x2B;v79b2uB0AiGIUBq9VquVSOQysxBqXDD4YA9AldLpfUIc3ki2yxWAwHAxQA0&#x2B;l0uVxCMDCbzf71GuDh3rg72aZYavP23fJc&#x2B;Hv/0c6fhXLj&#x2B;crxeAyAPpEo336/D/KlNvwd4TsXvxzhcPxTn/n6D3/0i1/&#x2B;&#x2B;s8f/&#x2B;RX/&#x2B;FjX/z6N3/8f/yH//79H771q1//8e//&#x2B;&#x2B;cLhZLqNmnBwPiN5HidLnidTgegv91ug0AMdMIMIOljwv&#x2B;kjMAmMLzR1wexB&#x2B;3/pETDwuoHmyUSiUgkks1mw&#x2B;Hwmz9/50c/&#x2B;QVcgFzWm6996w27zfLlb/3M6fFeffj&#x2B;L37xtsvl9ng8mABYrVaLxQLa/eXl5YsXL4DvmdoLLa9NcnydTuft7S1kvigJwPi3Wq0K4tvtGAsA99ttttubG4fDDvTvcjrtdrvX43E4HE6nw&#x2B;f1OhwOl8tps1qDwaDNZvX7/QG/3&#x2B;N2BwMBVZ/If06nMxQMYi&#x2B;3y&#x2B;l0ONwul9/vDwYCgYA/FAoFgwG/zxeJRKKRSADuPX5/VFGDwmD2R8LhZDIZDoWiysknatJ4wOZPJjExAKyPRaPRaAQxXnDmSSbi6VQqEY9lM5lsRkV3JRMJePAnEomkRHpls9lMOo0tM7JxToYAgPjZbDaTSsE/J5/LVcqlXDajEhuKxUI&#x2B;n0mnkeALja&#x2B;S2ObzqtcuxP285OMW5G&#x2B;5VMIcoFgs5HI5AHoAWUyi4PMDdA5/TCXPLZWKoj9Bm7982ryHSLcmrrWNRgPcnmKxgPKjXCpVKmXgY4WkcQSy8jErAMqv1SrlcqlULIOBU63WNDheLuNQJm&#x2B;nWq0Ui4UqPICwWblchIa&#x2B;VJI5QLkOPWujgauuVMq1mhh91uu1ahV0F1QXnU6nVCzClFN17qtV1XgXeI0yvioYXzx8arVaFYx5zECI8iEmRnkDMF0VnS7KBm6mzPjrddRpgN&#x2B;6Kyjrh2ajocj9ECGUy/W6kvzq3B5cZ1u6D1I2KEEwoX9bZEjC8q83NOcftY0Y&#x2B;LRarUa93tLCv1Ab9LpdVgVE/xyEYt&#x2B;OmH62lNFnuysSXiR89YXgr4N49v474uDJ2gDf0t1OZ9Dvq1GAVA6A9bgNptBQ7DvB7en3eoPBiRp40O/3uj26Aw0YGaYXANL&#x2B;B8rX2UHs&#x2B;nOX4XA4nYpU4NQgiJJfPERjn8lkQqqPrv3VzUBZS&#x2B;ieodAAKNIDkZYOE5UUWOYA2&#x2B;1J9hb/7unkeDzu96q/K/3yA37Fj6KRJTWCOmMBfKaOEws7uDwXawAicv0yeBBDI&#x2B;sbmkPORmPg7DXxg3Fqn2&#x2B;cRs/qIws0qQ0NBOv1D0uOExChDU9OoKomA&#x2B;CTJdo1hNckUQAmIteRPa&#x2B;NLxTfQZZYrMcMGWXob7Q6ndQhhlkgnU9U5GpPpkbmX5ntHIVtv9/vDYaR7c9et6OpSNaISWrIIIla3IXTAL5iehnAugifOhyK0H&#x2B;z2YAQtN8rScCTBG/tRHl8f3&#x2B;PozFhgCUEGDvs&#x2B;hO17&#x2B;kQutttNpunp8f9fv/w8HAQs9FHseSnEgDqXlQIhPj4q64HcWCrFcD8er0GBUd3F6Wud7NRrXpAdvKIiOxx5XiIdCBweO7v16p4eHhYr9eLxYLFA1UBjw8PSw3o09cf5QS5QOD8gPEPuL9er&#x2B;H/M51O7&#x2B;5ULAAY//QgQyWAbfBlhFOw28Gp6L9SAzw8GKecvnTBLAAG7f764RXaGMMwHu4WZy6gsXj&#x2B;&#x2B;WY0/MGX&#x2B;GQygRiA3&#x2B;IQeGEs22q1vN7Af//Y53/z9h/fePOdj/3Tl997/zKVzlartZ&#x2B;98fYXv/z93/3&#x2B;/U98&#x2B;uuVSrXVag0lIKyp8jLrIAJBDMDeP36DC4UCebcFITHDuoT1QE5YFinhf&#x2B;fzeSh64d8Pho/f70cNEI1GYf4DIW88Hg8Egm/8/Ndf/sp3L15exeNxx83lpz/zjdd//PPf/umF1&#x2B;sNBPwul9Pr9bpcLljr&#x2B;Hy&#x2B;Fy9evHz58t1334VjD5A9WP5w9QFdB5lft7e3dpvNcnsLF6Crqytsic3I&#x2B;0d3H/6hXq8XuN/lcqkMgdtbp9OJfj&#x2B;2CQQCbpfL6/UGkS7s8fh8PhQMwWDA6/Ewnszr9YaCQZ/PCwJPIBBARi/gPgqGcDgUBOEnFPL7fLFIJBwOQwEcDoUYDhCPqVguOPbExNwTjfx8LheLxRLxWDQSTsTj8PhPJhKpVBIkH7T289lsLpvF&#x2B;wKaPpS7mXQaObUZSWRLp1KFvCLwwN4HwgCg/EpFkfVB8slls4VCPp/LlUslCfLKFgt5gHIUi0Xp00ODm8/nq9WKstUvlcSCs1QsFOr1Wr1eU5SearVSLudyuVKxUCjkgdcL0tEHpx/G/EUZTIFgU6/XcWaUDaCwK358rVYVe0o24MVgp0JDT1QCgPgoD6RyKKJUqFYqFLOanXhYfIprZ00it4rFYrPREAJPCcC93WoBVatrkB5/rVZjgi8OXK/XygLEG2K3j2pc8ewV/lbGQVWh66BMaEqSrnD9y&#x2B;zQg/PTFIdNOHXWpXkPAM01qBOazQbrCpQfzWYTytkqSPlSiuhzAJDmm4qy36DKiFC&#x2B;odn842kCx&#x2B;MyAMn53aUrAQDodXkA/&#x2B;oL2YyYADRV9K/cbrXQ2sddvQZoNpvo/VNOQDcFCoVJ6YGGoCu3ler3dDO9NgC473a7gPmcD5gWovLQcDBAtLDA/j4gPqYKI3GIhk5X/Vh0u6T&#x2B;s5FPmS/YP&#x2B;jlj0X&#x2B;O51OkQaALWmZPZmYCgHaenJoQGGAPmPXpwfT6XQ2m5ouQMSLhOlEfoTpB2HsEKPvnlHJDRGEcndDs/05wbXnlHEFfA8akeOVv9zH0240L/7El&#x2B;a0lS5d9t3xaEaDHbVoMBkdnKSSUa0r/WmNnPNMMsHloKX2kkpuaGWG&#x2B;bpJB1ove7Ru955Tjq0Wf8bnaJwGeBna1AIFj3bZJ06mR62EYyOfx9zvd4Z2AWfPbrfdGgbPZVL29avC0&#x2B;Dp8Ox2UlDtNJ3GjmY&#x2B;WircXtTDhqavOEg9wJa/cG/2PAVHQ7y7E/2xeVipHvUPpOJrCfonUWcnQoKdpAhvZYFbKB4FHAf6pzsQS4jNZrPdbPWVQPN4FEUI/IKA75/k9na7fbi/f5SQr3spA9Q0QDr6itMvDCJa/XBKQD9QXADb/ELyWTMyjCrhh4eH5d0dVoLijwkABcFg9YgseH0vlkF64i94/8D9oP1wR4h90fvHF5ZOBEKdgG8xfuu98t&#x2B;aWi4t&#x2B;r14zsz3vZ9MfIHcZKLigfsjUwOwfXi4P/0XHPLHCuWevubp6QmcH7ReBoPBWIJX6B6NnyKUBza75xOf/sYbP3/n&#x2B;z/8&#x2B;Re//L1gKNZoNLDNz3/x2y995fs/e/OdL375u/gp4jS8qeXjUAxXr9dzuRx6h&#x2B;i5oqsKrE&#x2B;1JQKJYHICN0&#x2B;0/NPpNLS/1PjG43GkeiEWKhKJ0Ok/mUze3NxarfYPP3z5tW9872tf//7P3/qN2&#x2B;12Ouzv/OLnv/vdn&#x2B;x2h9vtRtoXmPdutxu5vO&#x2B;&#x2B;&#x2B;y4yvBDia7FYQPuBqw&#x2B;QPWoDwH0MDS5fvry5vrZYLNdXVwgHgLOnw&#x2B;FwuVxI&#x2B;YWlz&#x2B;3trcvlstlsdruN5H6fz4fcMZfLFfD7oev1eDwK&#x2B;tvtXo8H&#x2B;bs&#x2B;n9ftcuHRYMAfCATisRioOxAARMLhUCjkcbsj4TC4&#x2B;6FQCBm9oWAwEY8nkwkUA8oFKBpNp9Og8aDHn06n4rFoLBqJR6PI9opGIolYDI180PrhzZ/P5eDon0wmYcwP3558LpfNpDPpNKB6OpUCwz6byWTTaXB4wNGH&#x2B;U8mowj9KAby&#x2B;VyhUKjXazTpR3teQnmzjOUCuFe&#x2B;PUXVv0cLv6qsLUslyeXFbZL&#x2B;CeXR5QebBRAcQDlvZuvmVbau&#x2B;O3QA1SJU8tldPLlRrlsonnlvg8JbE0QLeC4wsq1Grr4QOHokyMll7pYNS2QeUVDcqwwLsBtsIya4nTZbDbV2KFSqdWqNYHwINiDR99QfPpqvVarintPWdmGKtkASUHg2QN584zYBri5Vq2SOi/y2Vq9XqvXatWqasm3Wq2a1Bgtad43hMfTbDSaouIFHMcZFIgXwUCtVqNdD56BsPRVddBsNFotU5XbbDQajXqz2Wi3Wu12q2OSdkzb/nK5rLZXZmWthtgW6&#x2B;oCHBYYvdVS1QVQPq&#x2B;Zo86mlvzVEiJQRwj9HAVwXABdL45MKwX2/gHfO&#x2B;12RwKDRezb10cEXENzIRKEdNzfZ&#x2B;IvlQDyEPg/APH9Xg8/GdQK4yElERCa0Eg5h/ZA60d5oJN/JqIApghNPToajWE7oRlSc5uxmAWNtEgB/JgyGBheHLPZbCITgP3Dw4NxSsIhPf35r&#x2B;0pk&#x2B;fEe1HHi7qcAAs3IE41NPo&#x2B;ttHPSIL1/rRHftLXPx4N46hrhfVC5XDYH4&#x2B;GjmVJPTfpQ3JkaY2b0WaG1mw&#x2B;vbYTur9&#x2B;YcCIxrMqhS8aXub9bqezblhp6OAV&#x2B;MPc5xkXS3/KhjYZQEVjNvi1aYAcXD01vfDgeTkNMF61kC1z8n6dzhPO6hlePC&#x2B;Ar/lB8zw9nuY/6B&#x2B;VgybtpeR4q2m7MTQg5t5p/B8ef6c5/LC7z5eOw4Styr5Q9QOB/k4KgJ3okgHcN09PpAY9ioPnnowgkc4TjhP6A17zYtjj58bL5XK/31Psa04AxAjo4f4enj9PQv7RXf9RBjw8PKCe2EiYADlCqARA/lFrJBkAnCKUE3iUMcDs&#x2B;mOX&#x2B;XzBJOD1eg0vIAp/GRGwWCxWqyU9QMERYtcfIcGTyWR5d0ebIKUbFsuCv5YTnMp81CP71Z3TneXdTrc/nH8kB6hSatT767OVIzF17vV6KFFg&#x2B;IPv844YxrVarWAo&#x2B;o8f/8rb7/zlJz/99Te//dNSuYL1&#x2B;B36zvd&#x2B;9uOf/Oozn/vmH/74ASyryfhXk27J&#x2B;cJvW71eL0rvE2tIbIBlJ0B/PB5HPQDSP3g&#x2B;YP4kk0lk&#x2B;iaTyVKphH4/hgNBkbQ6nC632xuJRn/1m9/97vd//slP3/rs57/5tW/88O13/gjYHQmHHQ6Hz&#x2B;cjSwcNeyh60eO/vLzEbXjzw9Ln6urKZrPd3t5C4ws5r81mg4ePqg1E72uxWNxut91udzjsNpvV5XKhEvB5vW63y2G3&#x2B;3xeuIv6/Sp3zOf1OpAMYLEgfhjmnl6vx2G3BwMBMHZ8yrM/hEFBMBDwej1&#x2B;ny8skWaI&#x2B;goGAtFIhI6fsWjU5/Mi7TgajYTDYbT2VRpXMgkGP9g7/JuIx1PI80ol0cjP57LRSAToHxJeOPAk4nEV0ZVJl4rFTDqdTadKpWImk85mM/lcLpvNKHt&#x2B;6fonEwkg&#x2B;0KhgDY/SgJl8ZTPl4rFXC5bUfhecXhg9VMul3K5HNg4tWoV3X2kaymBLWuAcgld&#x2B;UIhX1W8l2KpUKhJXxz0G7Tba7Uq2/AQxWJfVKdlkdWiU14pl5tibAV6TFXtYhL3qyDol1XPGytxFghn0Q4nzaZUKlZEPlvTsrQaAsdxVSo0V&#x2B;A&#x2B;pALVSqUhcttKpdKUPreIYmtk1TebilFTVZG6lZqUGKZ9/um&#x2B;dWn165MBsvkVPJbtTTJPrQbnHDUlaDQa9Xq73ZK9mngi5NlXq9V2u93QWvW4QoqAVateZLV8qKE6/bWqVCBnNH1dEiD5wSYpEbQcli5NJedtw/OnIbklrBkI7gH6afJfF2kBW/46ZagnAL2thSQqc89OB71/2vx32u1Ox6wKFPQXfK/bhqKjj6/fvqS1wOGHdp&#x2B;6bHc4HHa1LcXu38x6Z&#x2B;qLDuJNG9DxiPoBSshMzx8RmA36fbaWaNYJhg89fEaj0Ww6VQpgqRNUbaDRgUajEZj/jArG7yntQWczkxr0GiEUbmw098&#x2B;DRiYhn8cwDBir7zVuhnFaFQDxsFNrdq&#x2B;1brGOAg2N0GLCXM2Z9CAumdvtRofX9Gkxd9cMN/diGI/jyRxjh&#x2B;eqN601dG62oo8m8&#x2B;dECMvXBAu77MdTmE5wSWGAPhV5nky81yTL&#x2B;itpXpjWw&#x2B;Zy8twPosqVCzBeVZ/oKzktOdvyeGqpdHbeRy1XwXxGpyUBe&#x2B;36Bwl0eX4S1EunWfvzbSJp6qAR&#x2B;tnRZ&#x2B;WwF9IOPoes06QEMm2seLUb8fJnJx4tf44XeGScaC8lAXZhHYKaGcQhHIoMIsD3w&#x2B;FA/g8pQKgQdFLQVoKH7&#x2B;/vHx8eieAfHx&#x2B;3241eFQDNb&#x2B;T4j2oCcE/9wMPDw/39A64EjkDKAkjMQB80NTCeAtk&#x2B;kPkS36PxD2tR2gSZvkCy2dPTE&#x2B;E7rf2Z/EXS4d3d3Uz1Hab4alve3c0kGgwb42uOXQqdL0R70I/MCEvEjMXq1Q8ZxmBhlrKDQac5MiF&#x2B;v9Fe379inKgvJHTim5pTYLZ80FhKJjNf/PL33vrlH77ytR9&#x2B;53tvFopl&#x2B;gWNRqNSqfKxf/rib3/33n/6z58IhWPK7U58LXCD5B&#x2B;hGVQLKh6owkAlfRTAiCV09HO5HNeA6w9omMlkYPhDxj8a&#x2B;clk8sMXL7/0le/9w8c&#x2B;9&#x2B;LF5Rtv/vpfPvnlT376qx//ly/&#x2B;6U/vud2eUCgEuS04PwD97777Lix9Xr58eX19fXFxcXl5BdxPtx/od9nXtwnKRz0A/5/b21ubFQY/FofdDndOq9Xq8XgQ2uVyuXw&#x2B;n9vtvrm5gUjX7XYjphckH7cUCQzxhc8P3EjtdrvDbvd5vXD7CQYCbrcb44tYNOrz&#x2B;WKxGIx9EvG4z&#x2B;sNY14QDHjcbpj9o9&#x2B;fTCQi&#x2B;BsOYyCAHN9wKJSIxwj9U8lEMpkg7s&#x2B;Ivz56/BnYrcbjsOZEFm8mnUZvHhz9dCqVy2aymUylUhEv/zzUuwLoi&#x2B;joI9UL7X&#x2B;A/lw2m8tmVacfPH5YahYKsPopFApFldhVAvOnLMpaduWLktIFH3qyerCyDJ59uQQ0TJvOeq0G&#x2B;azirKsMrBK8OOnqA/gO0F&#x2B;v10sI4i2VypJxC0CNzrrub1MVNTCoPADNiP1q1OuoGRS5pVbD3KAq9CGVblup1FUyrtIhKPQvzXyUCtii0WhUq/DaqoPlX1ct&#x2B;yqd9eFag5Y&#x2B;oXZN4ro0Jk8ZRQKLgaaWqqtLe5WpjrBuyKrHmVXLXxr5LWUBXKVUl4tA&#x2B;QZMdbQef6Ner7cUKUh5DGiKYbT7ie9ZANTwHYVtOhIA3FHGZYqWA30waUU66Id&#x2B;F7gcML0rdJ0W4b5mCarQPETA8q3Y6/VMPwRpptDkh/MB7Kij/H6/pw8M0MJXWB/4XUYE/X6/1yOa5&#x2B;5abSA6YFYIXDPQgh2VkFdcoXWLCDJIxfNnMBqNptPJYNAfao185nzxyPTDIG8HHSiUKCbdX1yAYAqkM/71hcXAdKrSwV4zTrWkhma&#x2B;CfaC/lv4ym79XiOoCPQ6yeKF06UOws4OaJi94ZOetGFi1hMrTKwkLZ6QV00tTlrXR2JiHZgS1O5OgbiaSxxNerp&#x2B;JcSsJ9j39EnplcwZbtYvQ68B9HLF0LrRhobR9VdYvx7sftjvRWt7PD&#x2B;RNk84KbrMqzIzbp&#x2B;97Ory9ErGoEr4tNl/kL87zRGVj0ICIBIRlSPB4wBbs7TjR/Eobjz6q3TSs9deKL5o2Gx3WjMYhgFLH3PYstsZklnGWZMhMhJKCDgZEJXz1pwziB5gv98/PirqDscFT0LlYRmw0ew&#x2B;t5IAQMoQSEQk/1BzzCNw3yfp5WMle/&#x2B;kBoH4gyHAg6SAUWHMQQRtiMj8Ab0HG6AeAO6HQuBR8gTWq/V6tcL2MPIHO2i5XN4tl6vVarG4m02nhPWA79T1UhxMmhD9QBUvaL7AZrPZHF&#x2B;OJAW9eg5QqxgNRd3Z3T&#x2B;UGiP9wccHUwc86rYDGVMh0G20&#x2B;rNXxAPri2bENkb/Zjweo/E/kQiYYrH8ve&#x2B;/&#x2B;Z3vvfnDH731la9&#x2B;P53JY/5LJZnN7v74J7/yk5/9&#x2B;gtf&#x2B;k6xWAbXv9/v41ewWq12Oh2gllarVSgUyAIqStBpXtJShdVcgh8LUD6sPBOJRKFQiMVi4P/E4/FAIFAsFsECgnVPOp2OxmKBQPDy6vb7P3jjz39&#x2B;7ytf/e4f/viXn/7sF5/53FcvXl6FwmEY/MdiMZJ2QO8BsQfePhDpWmS5vLy8vrq6ubm5uHgJto/NZoNBp9PhgA7Y6XRiLxwTuN9isQD0&#x2B;3w&#x2B;oHaXy&#x2B;WBiafD4XI6rRaLE3ccDvT&#x2B;XS6Xx&#x2B;Nhvi/4SIFAIBQKBQMBn88Lf1Kf1&#x2B;vz&#x2B;VA8oGAIBoOBQAAvSywWhSV/IBBIxOHeGYGBTyQSCYeCoANFo1FY8UD1qwg8iQSyutLpdDwWSyYT8Vgsm0nH4zHIdjOZdDqZ1BN50fvPZbPpVFK58mczqARg2QkiULVSAXE/p7j4xXw2U8jnc9kM2PkQAYO4T5vOYqFQKipDHpHMKlINOv34xBCRk6&#x2B;P2rKqTHxgy1Nq1Ot0z6yUy&#x2B;XSiWc/taTQ3TabjbJ8JkGUh34XMFxRZQSUA&#x2B;4XiwVcWqVcbrdaHBSgK16TiFwIhWUUUCLsVlpYwffk&#x2B;TSlbV&#x2B;tViEb0PWvIM4J8q4S/dek9U7wjTY5bhFzN5Xxbk2l59ZqKIQI5YXZ0mKlUa1WIZzVCDt1PiNS53X4DsoQe/ns6NfE20cIRbW6mhUoDo9G7zFJ/IDRQO3U4LY0k1CeC7i/0&#x2B;mYDB&#x2B;B8s1msy3aXOJ4nqgtXpzS5m/jIuv1eqvVRAkhRp2mDKDdMqn8mrRXLa1Wq6sGEeasoM0ZgqgC8A2JSSzgvtD9O8Lsb/eI6EUWTEzfbrUI4snh5PbUBkArjG1oBzcU/x9&#x2B;yYPxj18KjouH4u5PSRv1AOwl6aZASOoljQcMWNiGnsl5ccCxnBH9MpJ/yPVnYTAWjhBn6aPRaDIej4bD1/YSd0rkxxvEkTrIPmjI7OyXkmvOGP&#x2B;GhpLPEKqORMlIOWuEw/zno/rNJ2c/ZcUcNEitM1KMU/mvHjmsn0J/sq/cgNMJff3z6z&#x2B;9a9JytpK2y&#x2B;duaAlcPOPzqkOfdXCDkzdOk2U/e9YcGhz0qkzf/ay7rx/koM1z9B4/t9lsNkeZKrCc41M2DDO/mdOh528liTdA5NvNhlFlOLLe6T&#x2B;K7Q&#x2B;b96wT&#x2B;KnbbjZHsnf2e0B/NM53UgYAzdNBiFwgLIqKtt&#x2B;Txy/Kjd1m88Qi4fHxcbfb3t/fg&#x2B;FjVgJPT8T62P1RrEKp1iUiV4XDwwNBPzUGKCFYSOi4HyvZ7MdBCOulMHjQsf52uwXD50HORdbQ3d3d/Vp5B2F73L67u3t8fFwtl&#x2B;vVirEAjAmj0heGP0Dtq9UK0B9lAKH/bDbHlxEmAOT6gy&#x2B;ElYvFAl9bZwqn849mJmLEy&#x2B;oTuL63&#x2B;fIjLQxgttxttY9Ypmgagz49PJVrA/Oxp9VofD5JoI/y8zkAyoBWq/XOb//yzW/96Ndv/&#x2B;Wzn/92Op3DtBptpHa7XavVv/f9N3/0k19989s/&#x2B;cMfP&#x2B;APIYx98FPK1iBhAU1&#x2B;MBMA4adcLiNxqVargd8P13&#x2B;w/JPJZDweh/wXwV75fB4C30gkEgwG7XZ7IBB4&#x2B;50//vrtP/zszd98/Vuvf&#x2B;ObP/j0Z7/2pz&#x2B;/973v//RPf3rX4XAgzReRW&#x2B;j6I73r8vISGl&#x2B;0/1EbXF1fW25vX758CW6Py&#x2B;VCUx8t/9vbGx7HLgtiwmDzj7GAS8S&#x2B;qqPvdDqdTjT7fV6vx&#x2B;MJhUKw9MFYwO/zuVxOv88X8PtxQOgBwuEwgr1wOxQMIiAMWt5AwA9eEMB&#x2B;IhGPSFhvPBYLBPypVDIcCqWSyUgkHAwEkN6FMiCVSEQjEeTyhkJBoH909GOxaDKZzGYySSH6o5GfTCZKxWIiHs8IiR8QH&#x2B;6ccO0s5POVSgWMIHTr0d3HlrlMJpfN5LLZUqGQz2Xh/FMsKDY/Ngb7C4ViLpulASVY&#x2B;Ix/Vux/pbitomyoVav1ahWFAqA5DPvLpVKxkAe7Bv6YyplHRKugwZRKyvcGc4CSbIDGfNkk7VTqgsurytJelbAqN7dS6bTbAPSiVq2CC9RsNkEHQuceQFI1&#x2B;NGzV217&#x2B;tzXGnJHFLGKt4NOPFB7rVZTwbrVKvhFwuqpQrMLpKuuXNwwQaEhy4giXSHniCpXOustYeTXxSwfDHhQelpyNDr31&#x2B;s12u0DeVNci7Pju0KqhSZZNDx7A3b7apcGyDFmP79WYxIwipOmmApATYtGPjg/ZOO0FVGnyWvAu1Cr1TqdTksoQG1hBJlt&#x2B;3a73W5BmEveDuoQ4HStJGi2RA2l2P9SaeBoEAMQy7NmoJKK1P9225w24BrYrdd5QXQKwmaKwDMYsH7oi/xX4XjNAJQ5Xz2xAxJuf384GPR6XR33s5HPLj4Ogh8U&#x2B;vyYPf6RuSiSj0B8gP7pZALzH6Z9MQSAdQU1AJwP4CeM03V61k2n09fYr9WB4NlKQ2v6GhqyJPOe2&#x2B;g1ABD5bnfOn5EWu6BSkWkaz2A3D0ipK2Hf2egAR3je535&#x2B;W38icrXHnWbZuRd9go7InzfRDa2GUYBVvGjOXhOWK7Tf2UvD3jCLmSOBtV4j8cXUBgLHo5Q6Omnn7K05m2wcxAFJa8mbdBoeTZ36GfrXL&#x2B;Z8XnFaABzMRW1AiE8Q/7xG4pY4&#x2B;15yuwz5IOkfA8JxPiO&#x2B;jPhAmoMFrZe/11IIUJkcDiI7xixouz0eDpDk7iVtwFSh7JXF55MED9MaCPnBtAMi0CfFiC18gPK95g7EjXXUTir/09PTVgKAzyA&#x2B;IPsWVkIyB4AcmbSfB8kjQ21D3I/6hAehjxDQPEIGVqvV09PTYrGAQoDePpvNBnwhWgDB6R/QH1tSBoAaAI5AyCFHVwMlAboUy&#x2B;VyPBqvVqvhcDifzefz&#x2B;WI&#x2B;X61WnGCSBwmi0Xw2g5j45KNzdW2In8/mad8dzPUHu/3ZRvvXMD0l&#x2B;c&#x2B;1YIBGrZqqjMaLE2nw3d0dXeHQs&#x2B;lIT2gwGEwmE5vd/anPfOPFxe0/fvwrTqf3bHDc7XYTifTf/f1nf/f79//2v34mGkvA9qcpRhY1Ee1VGCdUr1PgCykwDBwxBADVB3leYP6QApTJZKDrTafT0PjC&#x2B;z8Wi0UiEXBjQqHQj3/y1r988qv/37/5&#x2B;De&#x2B;9cP33n/h9fr&#x2B;&#x2B;Ke//OyNX3q8XoR5wXLn5ubm&#x2B;vr66uoKct4rUevCxBMLHHswAQDv3yJJXnabDbx/i8WCyF7csFpVyx8JAG63G1b96PcHAgHIfL1eL6YBwWAQj/r9fr/f7/F43C6Xz&#x2B;eNxWLwBXK73V6v1&#x2B;/zORzK1x&#x2B;xXz6vF6UPPD3DWEIhsHHi8Ri7/iACRcJhJKCB6iMe/Yrin0omsZNC57lsIm4a/sTj8Vw2iwQuYP1kIp7JZNCDx5pioZBOpXK5XCGXQ0pXJp3K5/PixVmoViqw90FmVi6badTr5VIpk05Bqqv8eQqFYrEAexwVTFsugxKGoC5w&#x2B;mmDA2RbyOerVeWkWaTVZlkZ9wNGQ/gLgk2tWi0VC7jRqNfgz4OWe1UcOXEQpR&#x2B;oVtCORklQLpWYVouzqJBdqGNrCuvDAghhXqqpX6k0GnWlE6jXKxLHi358VXFsqk126&#x2B;v1hmLUV2SMACxeQ/ED0hH&#x2B;ohLgv7iGWGdWEMernmxd07sqHU6T5kL1Gsoe0PFbbLc3Gti3RvQvCVxsihPWA/TXhdmvdLfNJmhCqhPfqCM/q9lsEGdj&#x2B;3arBfiuMewV/sY4sS3W&#x2B;/zbMM03FfcGxQZa6bwwMJHI9W&#x2B;JIQE3w8G7nQ6QPRhBAN/C6mlRpYtHcVJB7yb1UYF7qRY6nY4Y9bTB58FhqQHAAcAC6vf77XaLLP9WqzUcDLBlT5KAT9r/3W5PigTqelkS8Lsa3E5ObgHxlRkoEH&#x2B;/D2&#x2B;fjsQJgwhKAcBAywnWawC9eTQSex9ke1Gnq08DaD03mYzn8/nQDAIbcRxNrv9EzP5nsynnANgeZQLH1&#x2B;yyYYPzJGBDw9N6N/25nFfkmCe0kFcfR4PvhGXYVkoOUxC8E795IjzjGZY1nslM9Y3JM&#x2B;FlnO1JKGmYzJbzJvRRFv2aueNZh57P/Qw362XG9tSZ1NC0yM8v8qwAOLIc&#x2B;YiRC2uVw&#x2B;Ggq6W5ksJgQ6FwKcBOu/5ncxUWWvpbiSPtT98aXCBUE&#x2B;Tun72ahkxLeC7eOLtavdwiL4gzhJ3cZdWn30VVow9AeG1YHh8f&#x2B;eHZSLLvVisd98r&#x2B;X4mAnx4fD8JM2wiNR2MMKT0Aa4z9fo/AL1J6IHsgUwi2QU9PT/f36/1uhykBtsHCYoA3gM5ZP6zX66cnUydAFhAnCdxLB/3UA2zEFZTZYbxBc8/NZrtarR4e7oHvKRXAJGElaQCQAjNBDHAfygFwe6aTyXK5VMXA4g4RAavVajKZLObz0XC4XC4nk8lyuYQpwd3d3WQ8VtSghXIKQt8CwwRODM7zAXpDOoE&#x2B;rM89Q7evdgF9xdJv13vj9dk/Mxg5k/bT6/U4juj3&#x2B;&#x2B;lM7lOf&#x2B;fq771199vPf&#x2B;fNfPsQvAX54RqMRGlTf/f6bb/z87R&#x2B;8/tZbv/gteqjUyaFziWlATTwEs9ksioFqtQorT&#x2B;AV0H6KxSK8UCQZNoNKABZA8Xg8FAr7/f5UKhUMBgPBkMvljkajmUzm&#x2B;voWePrHP/n5V772/curG4T4Op1Oh8Pp9/vj8fjt7e177713cXFxfXV1eXkJlH91dYU5ACK9JMfXZrPZ0LOHftdut1ssFpfTabHcOh1Op9PpcrlevnzpdDrR6fd4PBAWu5xOjAsoMIC/J1z8g8GA0&#x2B;kM&#x2B;P2hYNBht/t8Pq/HEwwGVNyYy&#x2B;X3&#x2B;4KBQCQScTmd4VAomUh4PG6/3&#x2B;92u6PRKAS&#x2B;kPCiHILSNxKJwL4zGAjAtzMcDodCwWgkEomEI&#x2B;FwKpmEAhhUH5juQ&#x2B;kbj8PFP4VaKx6LIpwLxP10KkWID7ZPKpXK53PJRCKTTsPMB6Y9SOQtFgrg62ezmZLy0CyAY5NKJenxX5Jwh0qlnMtmUfihu5/P58rFYi6bLZdK0Aagwd9qNmvVKhO4isWCYq5Xq7VqpVQsoHeronOlToDOFbVEo4EbFRwKVQTsd4BQYVhZlda&#x2B;irJCPl25XK/VOu02RQKIuypLMm5NTHioiy2pbN0i&#x2B;EIg1QDploTYw3he/EtBo57yU4wC2E3HepB8arUq8mWJrSFXqIsLfkNoMwr6N1Q3vVqtsn4gzR18Hhr4oKveEI4Q2vMoSOpiFnRK78FkTzFn6uI7BJSN43c0CWyn0xH1LQoAk6yPoqIuHvx1Qe1gELVEnIsnwi67Tp2n4Y8&#x2B;XsDddqvV63UbWlMf/5POOi5P7U7yjyxNGvUolE&#x2B;7Ho2P3&#x2B;12261Ws9lA5la/12Pvn7Kotnj7sG3f6bRFy2sS/bEa37dUCHS73b4MYFGr9Hs9CnlJ7kcTp6f4P318Y6M2IJQfSGS73vWngQ9toKHKRT&#x2B;ILX8eh1JgpQHQKoExHhgMSP2n9acMBwbj8Xg6NfO/dE3waDRkm/&#x2B;M9kMDUBxwOBzCiG&#x2B;mrVQ5ANKxNaHeWU&#x2B;XQI5/n9NLdDB6huq4vLJXrW/D22cNfiLRI/xetBavoUFtQLHD6Vn4XPTr4dHARD87qV7w7DQ70bOnYJzieH05GYZonBm&#x2B;VvrFHF5FfNKfl3H6qhLgYg274GcXoA9A4Jtz1Lj1vEh54078jlhz6BfMgxOsn12nTqY6e476jkeNOrUXJQbLDzWBOTmjieDPuFIHjRy1F07RRqIeYNZpSFYddz9owvHDQYVUkOTDv0cRY/CjsqcY4HhEksBBLKeIvHf7PU6NYQIKDBB&#x2B;HpHyK6QdpRnY7Z7z/kn6Jy&#x2B;I3B4MFkRf8Eiej8kdEs9QZv1yRxr/Y1agAP1qhQpB7&#x2B;uvVmveVlWEeIA&#x2B;PijXoKVWCSDZ9w6y3dns7u4OJQHSv8DdV&#x2B;Lg2UwphmczDgfwxTQXw5&#x2B;7xYI8SISFjYYjmpdhX1QmxquWM8T/8PhqP6vnS6vesIarZyun0yl7/ydf3KPRYDj8xa9&#x2B;/8PXf/7rt//ywx/9slarDyX5Bb9kg8EgEk387X/51Lvvv/z//e0n4ol0s9kEqgDXH8UAu5LkUmcyGbqVFwoFYH2aeyaTyUxG5T2l02k6/ITD4WAw/Lvf/xmEn1/9&#x2B;rf/8skvf&#x2B;8Hb/r9fr8/8OnPftXl9ni9vi988RtX17eA46FQCLwgEHs&#x2B;&#x2B;OADgP7Ly8sPP3wB6A&#x2B;rfrvdjvVwAbq&#x2B;vr65uQb6t9lsGBcA36PxDxnA9fU1PPudTqdLony9Xg82DgYCNqvV5XQiU8zpdMKvE86ebpcr4PdHIhElCHa5/H6/x&#x2B;0Gmz8UCkUiEXj/h0OhYCAQjUZ9Pm8wEAgGA5FIJBqNAM2HQyFQfaKRSCwWCwYC8VgM0l5wgYLBQDQaRXRXIpGAfWc6nY5GIvDbSSaTyUSikM9nM5lUKgliDzg8QPzpVCqdThfyuXQqlc1mc9lMJpPO5bKFQr6gTDyzxUK&#x2B;VCohkAt/YdYJKj9lu8ViAStrlUomk0HfvVjIq5CsMm1wqiD5MAQO3PdSsViplOn4CRa&#x2B;btYJsWxFOD/VSqXZUC1tHdlXYRkkEbaMrILAF9AfLpYoMIqFQr2msDhJ8HDdEWa5SpuqVMo1xUGH8U6l2&#x2B;026nUwVRQ3ploVLk2tLtT/lrjO14iw6/WmmF1qzkIwwBGSvxj518ScB5wlWnZiYnC2tNst6bUrWg6GDKptr6ldIUVgLUHNLiqHJr32aypyq91u1UUozBuA1NgRRUiz0VCAv1ZDp6AlRBygc75c7M3rTCEAb0hqWyLSVY38er1eq7WE2Q8EXBd5MSA1TlWr1bqdDuE40XxbbD3bYvWDB3Cp&#x2B;HKjSJelgo7vpTZQU1BWF7TmHAiUB&#x2B;UI9vnI8WV1gR3bmu8n6ftY2u12v9cDfYjb9CQNYCDpv3D2xDYDUW2J2Lc7FjSvpgSyAQoGheUlrgvVxUgLjSGmp/0/TX6wZjKZAMfz0aEsqAHI7aH5D9XAVBXrnCJdMGAagGrpv0ux6FAuQGfwbv/M052s6&#x2B;dtftiA8giHk8b8yXH0juxzBKkjZh6KpwM4e3p6fA7Wnzf7cTX6jedXzoXnNfkwp4/qm&#x2B;nnol3SK5ExxhocaOgji&#x2B;fPzjAMEGb0Rrh&#x2B;AeZE4oSrc8IR0tabO5w9hVce/6TB/6xYIt1oL0leB1Ebn5Vh/Gu&#x2B;Sqd8JLO5LyicQwDpuz&#x2B;BGcUqjvXeWR2inxEg25AMh6PUAAeJEjO0GRH4TkcpAICDd7sdOv1PT0/iHwrfoR3gPon7rA3U3e2Wlj7E39xSJ/kcNMoQALqi6wg6B7MIoJ&#x2B;uQRtJHHsS&#x2B;3/sdX9//yDrSfVhLADpQyT2cP3Tk3ILBayn4yfGBbpOACZCKhBA4D7iwCAbeHp6Qj3AoN/FYrFe34PVo1sDLRaL9WqNTj9KBcwK8E0ENcBoNFprc4OFqASWy&#x2B;Wd3KZN0Hw2m89ms&#x2B;n07u5utVw&#x2B;/0ediOc32r/jaDTH20/3q83pN8FiYToLLSaT6eq8lsbMt9vtIv1X5336/KGPf&#x2B;KrV9f2z37&#x2B;27FYEmNxED3xO1St1j/z&#x2B;W&#x2B;9/uNffuoz3/jNO3&#x2B;s1xvg/KBZhYE&#x2B;vTiAvfC7WywWwfzJaUGtUPci1KlcLqfTGbfbk9KWaDR6cXH145/&#x2B;4sXFpcPh&#x2B;vo3X3/nt3/8zvd&#x2B;7PcHPB7vP//Llz/7&#x2B;a//4PWf/&#x2B;nP74VCIYfDEQgEPB4P1Lpw6ry6vgbh5/LlJYg9l5eXL15cfPDBBxaL5cMPX1gtVrvdfnNzA10umDyQ87rdLuH522w2G4yD0Oa/vr72er2gAMFRFEAfoB&#x2B;iXoSLgeQTCATg5&#x2B;Pz&#x2B;SKRCLS88P5HSlckEoGwQUJ8g16vJxKJhMMhn8/n9/sj4XAoFIzH4&#x2B;FQKK6a/aFoNBKLxTLpNLS8iUQ8EY/DQgcvYCwWi8fjyUQik8mA9oO/cOyBg2c2m4XbD/x28vkcErvyuVw6naKDJyS58O8vFgqFQr5YLCAzK5fNYphToU63WKT7PkYBEOlipanQLZVApKnX6&#x2B;juA5vSvR5qXbldUs4z8MiX9Nka3KWQmFsswvC&#x2B;pMZKJaB8oH8MARCtBdDcbDYUvb5SqYNpI&#x2B;xzmuvXazXk5jakPQ/dKvw367WaItJAvVqvdzsdAbq1er3eQYMaoBbSXoHpuLZKuawYMs1mo15Hf1px&#x2B;jkHAMoVubC40quqQNHrTSWuuQswOk&#x2B;Khjd6/4DXnU5HOfBoiVrtdhvTBogWWKi0Wy0UMLwL8xzVcW82pYvfwBNpCwSv1WpE2wTHtWq1g71QV8hwgLAexYZyzxTJrBCKGnht5WprmAmI/1i93VY7aui8pSx6Go2G8u4UFa&#x2B;aVNSJqvWZABcZPrT40nU6Hf1RlhB9kQoQ0LckIXEo8eqk9zDhq3vq9693989WsiTAWAANGlh/YgMAbhkRKG4PhAFUCaOzM9LivQjW6fbG9T0JFBsMOAQYM0aGSB/wfSTOoWjlUwc8Gg4nCu5PKIHj34l4gOqIfyK1Adi29OEA&#x2B;sfG0&#x2B;l0IjZBJ0Fgz2EuIZfu0GJooVE6Q0MYNaqbyz66ji93p1nCZ8sZ4QTyXyI/fdSgI0ugyuPxSNR4NkAwCfcEnacy2YNIP3nk4/HI9ChcMLXIR20xtBHBCZI&#x2B;vUitMJA5yX7PwIHdbqfncBkSs7WTkNqjhpKNj65S9NKC2JqbHbR2Pk9x9uLrbKvj8bA7lSXoZ3l&#x2B;2zie12aGNqbQrxyfKv1Tsd&#x2B;bqQUnT0168EgcM&#x2B;QjpC94X3aahehGXPzl7d7zFKDcALIzKG2n&#x2B;fxstxt2/RWlR1A&#x2B;2f9ope9oGLrf78W9BxgdJHtsv9Hirh8fH7fbDZn3NOEhyn/UPECxEk8Qh2an//7&#x2B;/vFRIXsa&#x2B;zw8PGw2W53Z/3Aa60voz1Aw1BsoBlgkKEbQ&#x2B;h6Hgt8/1cMQAatkgMUC9QBrANQD&#x2B;GYBEWg&#x2B;n6&#x2B;WKyh658rYZ4b1d4sFuiO097lbLO7X6&#x2B;l0upjPp5PJApZB8/lC1EvT6XQ4GCwWC4wC5rPZZDxer8&#x2B;d&#x2B;7Op4oP2wXS4Y5O54gXtnu5vHUk&#x2B;9DCdPWyNkcgCHu417bAsalIsjE98k/b7/Xa786Wv/uhnb77zrW//5J3f/qXb7cH1fzQa4Qe&#x2B;WCq9&#x2B;97FF778vZ//4vef/uw3cvkCemy9Xq9eP6HwNhqNfr9flbgf8H9KpRLce9D7B&#x2B;5HSQBKTzyR/NGP34pEovF4PBwOR2Oxq2vr577wrc994dtv/vw3P3vjF//wPz7zuc9//b33P4Sh5x//9O5v3v7dxctLgGyr1fr&#x2B;&#x2B;&#x2B;9Dznt5eXlx8fLFixdWq&#x2B;329vbly8uXL19eSaYvHD9B47m8vITG9/b2FhQgIHjIhQHxoSKALBhUfo/HgzmA3&#x2B;8PBAJ&#x2B;v99ht4O7D4aPx&#x2B;P2eDw&#x2B;n/L4x3q32x2NRDxut9/vj8dikAegKggE/CgDwuFwAig/HofUIRqNhsMh9vvB9E8lk7FoNJVKhUOhbDYbjUbRqgfLHw6eyWQim8mkkslEPA6/1EI&#x2B;D1vPVDKZyWRKpWIumwFBHzKATDqdTCYRxwvSDtK&#x2B;SqVSNpMpl0pw60eHHjdKpRK0tipjq5DPi0M/EnlJry&#x2B;Xy7lcDoC&#x2B;WCyAbQ8En8/nIIQtF4sQdFbK5ZoIW4GblXuM6E2rVRWkpWwxkbBb0wJiq9Vatap16KvtVrNarbaazVqtWqtW6rUa&#x2B;D/NZrNRVy7&#x2B;ikmPsC3h5SvTTDHobIj3DhS96G0D0UO02mw26BXEBn9dJLZ16V6z6hBWvVjxCCDutNuoQEh8Umfn9ZAmpPXplXRYFjbdm80mxAYts9lfbzTqZM50OgrE418xHTmbYpIDZjyQvU61V418pdZVNjttEd3yL04kO6rdW2K&#x2B;SfEAW/JNGRAoNk6nA0lAQxxCAff1bRS3RyPqNCWKi0Bcr0O6GusG33K9XrclMSbA9cLpb3cF8XfEhr8tzj/k7rOXzxv6Iix/c2OKdFti&#x2B;olmil4V9KXfDxoPVo7HI/CCetLmV5wf&#x2B;vmIoScgPXg77XZ79KwwYHu&#x2B;r3GEWELwrpITyDyBThJg76hKYDgkI4jdfd1zQol6x&#x2B;PRaET//qkW7js9VfqyTsDxTf8MmRvo1KDxePya8QxS6zj&#x2B;7LfwZCxwNig4ak6deu/5&#x2B;Gqsr5&#x2B;CfeWzE50h1M1pCPHza9jv9zq0fd6Tliv9CIXAR9CZ9Is8oxidXKdUIJx1GIaxF/tIHf3rTwdlhl57nF3kGTLmGY/H4/O3gC/s4ZmQ4/Cs5tFPxB75QePWP8f9Z8WhfpDTd8EwRPuhb6a/nixUzMHI8Xg0BdPmrIMVo3pICDmgbxGss0YlHR8VH27j1X6SxICtJEjgsE9PT3vJ7aIpKsIBWB6YJkL7PUA2UTvcSHXF7W63Q5GwlQQxyGd3u92DZIHhWYDNg//rkwRi9N1ut93t1L4PD4&#x2B;Pj&#x2B;T06wZBhP6bzZbJADodaLVek&#x2B;qz3W5XyyVwPLg6eiDAerVGt/5RAsVAHMJI4V7Sx9DpB8tfHWG1mkyUz896vV7M5/ASVfrd&#x2B;fxORALTyRTgHkQgYPoFNlgs5pK3pb4xpWmBrsZiPp9NJtPxeD6b3S0W08l0sVjo/3ayqeJa&#x2B;&#x2B;a4uvK3e7LB4eHKnZjMVNc/Eyu2OxPDMPABfVwvV0/nX3ojFcY&#x2B;orQXw1a3J/D5L37ngw&#x2B;v//kTX83lChgKd0Qe1&#x2B;/3HU7vP338yz/&#x2B;6W/&#x2B;2//4vNPlNfmv7XalUsFvKiS/jUaD/H5QFCqVSi6XK5fLUPei94&#x2B;72WwWDj&#x2B;RaOwrX//h1dXtO7/902c//83f/u5Pv/zVb//Tf/74f/z//I&#x2B;P/fOXvv&#x2B;Dn/3lL&#x2B;9fXV0HgyGfzwd4DbI&#x2B;xbvg9N/eWqxW6wcffAC3H9B7sPL29vby8hJqXdj&#x2B;QOCLzC&#x2B;UB6gBkPYFlM9UL1h2ArXD3AeWPl6vNxQMktiDjGGn0&#x2B;l2u9xuN&#x2B;663W6fzxcKhfw&#x2B;n9/nQ9QXzEw9Hk8kHAaBJ&#x2B;D3g&#x2B;cTCYfTqZRi8MdiaPAjvjcSDkcikVg0EpFw33gMfp3xWCyWSCQSiTicfFK090mnIedNpZL5fB4JXJlMplQsplIpFeiVSuVyuXQqmcvlEK0Fa85cNluBWRMGN7ksGvmA/uVSKZ/PFYvFfC4Lr31MBuCGCe&#x2B;dcqmIsCroccnhQUu&#x2B;UiqhoU3ePAg5ODiKgWqlotg8sOIpl1vSBifzp1Iu1&#x2B;s1cIeYk4XaAGgcKL/b6cB0vyF5W&#x2B;jN0&#x2B;GnVqvV67VupyP0maoIeZWAGAhe8ePrdRxNELbqvpP9r&#x2B;yApBlfq9Uwi1DE&#x2B;mq11WwCsjcFaqOoqNWq7VaLoJ&#x2B;61U6nbfLvIattNIB4hV7fAFKtSf4u1rfExkcoLk3NHJMN9TrVveiXE5q3BXM3xCdHwX0V/t1AuQLQ3u10UEEo6pEg8qa6WjN1C7fAlulp7HkCYpwOrv9YD1E1joAbDAkApm9BvHvawh&#x2B;IrFY17CVJF/i7ISomYnfAf5hv6iVEV0vn7Ugc2BBzVGXqr6K7UDbo35NtsQftdbt4MVkJYHcZCLR73e5Q2EEUB7O7D0Tel1kA/s/KgX/xJT&#x2B;ZTNjvV56eUlRMJhMoAvShATv6ZzMBHBNAXA8EgHiMQwDIf9VAYDRCPcCmPkcEOtEfZ&#x2B;E2Iz0/WAoD3p1MJiMtHpjlAVhA5yLg3TPFrQ4fDx/NliEZ5qO6xWeHOmtXG6ccfR016vu&#x2B;8sh7urhoePEM95/VAK9sYx&#x2B;EGfL8iRhaM1svV9ha5kPH45F2N895ONvtRkfwpPFgl7On/MrLMISNA4YVEfYr2&#x2B;fy1E4y3YyPKIfUXe16jqeyYPNMB9OJny8dN2MHfbfdktqkP3o4HA57U&#x2B;xL4H4G5Q8i&#x2B;TirjvDWsvsODj2vTNC2mUN3EPU2XYCwGU1&#x2B;2No/avFnMBQ6HA57UQ5wS&#x2B;BymngeRANAS5&#x2B;np6edVg8cDgeiecMwsP45lZ9&#x2B;QdyA6zkK4Em5JUD/kxYLQGEAqgUcjDSh1Xq9WNxRHsCEL9KB9KEB7P9Ne5/7e7CAVMv/7u7u7g5qgbu7u/VqPZvNEAZMFtDy7m42nS25DxKCNaNP1AaUDmPHuTAXl3d3ivAj1QIGAmoIMJ2OhkOwg/QaYDKarbQRgNcT32kfzxtXkp&#x2B;n1WyVL5uhAcNu158wTULVSvnWxhAZrZpOp/PVr7/&#x2B;i1/94Utf&#x2B;cHbv/2z3oUaDoftdjuVyvzTx7/81i//&#x2B;MUvf/&#x2B;NN39drVbxqN71509ysVhEAQDyT6PRQMsfCb6ZTAYaAGh8keybyWTi8cTH/vlL3/3&#x2B;z378k7e&#x2B;/4M3Pv/Fb7351jv/&#x2B;PEv/eCHb1xe3ULUC29NuObDyQe4H4aeyO2CdQ/MfBjoe3Nzc3l5yXBfh8MBz37w&#x2B;61Wi8PhsNvtVqvV5/e7XE6Xy2mz2UDv8Xm9wPFo5AcCARjw467DbvfwUa83FovBrNPj8aAwAL73&#x2B;30U&#x2B;8ai0UAgACMjv88XCgZD4vsZCPgz6XQg4IeTTyqZhO1PKBRCBjJc/JHjCxufZCIRi0VB7EnE4&#x2B;lUko18IPtEPJ7JpDPpNMj6SNrKZjOI9IKiN5fL5vO5UrGYz6tArmKxWCoV4eqTSiYKYutZLBTy&#x2B;VylrDJ0AYvB&#x2B;y&#x2B;XS0D/1WqlkM/VlSVltVgo1AT0A52r4K1SScH3qqoKwNUh&#x2B;V6sLcV2s1ohOIZrDeYGalBQrYDajv8wSWi1WrDnV7FZlXKz2axWKi0hsqPJ32w0YIWJVnqLHpct5TnZkKmCQvOtFkqIhrTYVXsbnX6NEN/ptBXQb4m8VdrvAOsQKDcadcDiuuakqQjyysanDjoNsKPeOBcc3Oy0203N8545WqDiNBume4/s22gIHAdoVqY99TrgufBzkIzbIZep2WzCuLMuov&#x2B;O&#x2B;GCe0eh5MShgVPnRbsNdB5Ad85CWZvOPIQPWoA3fYfBWo9FqtbqK29ME4icDh8MK7McX6gRtizQZQB9fdEpjoJntdDqdfg80IvP4uIEuPAakHTPct01OUK/Xa7da2FXfsSuWnaTrkMbDv&#x2B;zx94UgxM10ux52/bviAtRut4fDIYIFgM4nYsqJp6SKB0X47I9HI3y9S/au6vFTQoBfCoB7&#x2B;PePRqN&#x2B;X5UWTAkYDodj0ZKNTgPCqASAaR4FA/wNYp4XqwI0xaSpb8oDTFKQNmPnWUgNes14tjxH7URju1dJb1&#x2B;BU4GCNd7L2S56OXHUfDn1IxhaW9psaZ9vdQKvtW2OJ/MEKU6M05YzuRnGR1Q&#x2B;slKjHmm4X3/6h8OJjuJwaqpzBrKfN8t5l89UntrBME4mAK8sFfSTnr0sJuuGFJ1nDqF4C15JwtHOe9LL5zUQx/N91GdHz1&#x2B;Bo/psqMqED529F&#x2B;zc7yXoVy8OFbLX3gJ9HkKwfhB5MfclsieDSJ6CYqahSCChaC82QQDluBiKeikLPh6PROrb7Yai23vV7FdjhIeHh4MUBpxL7EV2zBIFNQRVvxw4sB5YLpe73U5PD6BJENn/97JwMqCYPMsluUO4ktVqtZHKAbQhXUsA4hD6/dAGQAOwvFtC/gujHiB4wHqMCGDoiYdoFvT4&#x2B;LherZd3y&#x2B;VyucBey9XdYoHtZ9MZ1MBQCFAcjJkluiOL2fxusZiMxv1ebzadzqfT0XCIQHW9BpjOlk8C85233snSrCEvLNFHraJ0e0xG0PLh0B6fmwixy0JjuG63G4nG/&#x2B;s/fP69D67&#x2B;63/7TC5XoOMnGnK5XP7r3/zJN7/1o&#x2B;9&#x2B;740vfeW7uXwBrSn81qL9T1ke2D6M9wLJp1wuQwCKqK98Pq/hfrjURAOB4N/&#x2B;l49/57s/&#x2B;eOf3vvSV77zL5/8yi9/9Vun0xUOh71er9frDQQCaMxD44t2PqD/y5cvwdhBMUBprzB8rAj/slqtbrebrp2g7DscDqfTYbfbnU6Hz&#x2B;dDShd4/Far1evxhEKhUCjkcbsjkYjb7Q4GAx6PJxgIeDwen9frcDhg1e/3&#x2B;8PhMCj7QcH00PJ6vd5gMIjErmAgEItGA34/dLro6Pt8Phj8w8czHo/D6icWgzQgggyvRCKRTCQYioy4NPj5wDoJmbuYq6RSKUD2dDoF&#x2B;J7NZPL5fElF8BaKhQKYWAUJZQO/v1gsloqFXDZblnexXCphZKB4NY0GUmwLyG&#x2B;WDK9sJoM8rHpdwf1GvQ6uDqC/3iCv1&#x2B;vlckmx/CsVxOMCIjfq9VKpVK1W6rVqq9moSrgVAHexWOx2VeXZEGa8Qn4ws6/ViPgbEmilDDqBg8HIr1ZVG1uhxoZyxqzVGvUauu9gmTebqpcPF6CWcE4A96msBTIG4wiUJQBNmPw0hU7TbDYhnJWDA6yrlrjC/MpyRylo2wpLq8qE3fRyuSQ8nBro&#x2B;Cg82tDUyjWDF9RsNtHqJnel20VAlURcSQ3TElq/HLDWarV6kleFfnajUQcC5nwATwCVwGDQr0msb7PZ7PW6wPFtjZPD3kFLkrP6vR4a83L2hgL3Auh5Ok4zSMLRWTQQJ3TEJgjPcTAYdKUxjylBv9fTe/ldseFHNx31AGlCbP/rfH3djAiXiq9TgPK2CIV5CgXi8WSlw8JKgEyhwWDQ6bTZdJdSROl9acuGDVgzqDGC7EV7Hyzd02iwQV8t4/F4oNr5A2H5D1ADDCUnGLwdPkRRL3J/oRTAcBtAnKT/8asWlgG8MZUtOSvgvkPJD2a/H1k68/kcDKIJfUJHo9ls9pqOxQ8mTVw0oKcgci&#x2B;E&#x2B;DNId/aTudvtgO2EwG1SU855Ps/EnUIcOj4/rE6s14UE29NoqleiWH28oF3kK0gyhlaTPAfxfO5nN/TlFK8fzw5L3KwfVj84L1VVTaxenl3k/vQhHkovMM7erMMzQtTz5Wybg/bWHM&#x2B;3NC/g9OkfdUB/EFrRTkxUeVX6Z8MwjL0G/YnFien1MQtLyoMMN8hlYmFAng9APF/kgxizkpxDRI7zksMDuI8D3t/fcxTwqDn8oJf/&#x2B;Kg696T&#x2B;IxoC/JwdDPsfH0C/EW2wOQrY7Xabpyea/KDSYHefYmJ9aMAZAioNJQ5WXX9WBWpWgMb8vSgBJPBLSQ7m8zndhLCBrgwGCwi7sAaYz&#x2B;cMG16KQdC9hIhBEjCfzeDov1qtZtPZarVC2YDhIwqJ9Xq9mCvRLwKA4VFwf3&#x2B;v7Mym08V8sZjPl5IDsJgvZpPpfDqbjMc0NUPbY/kqTbD9xl3qmzqBTKa&#x2B;kvyS3Wr1p3c9fKjfHRnPFmp/x&#x2B;Mx20tv//bdr33jRz/6yS9//NPfVKs16sy63W6tVv/Vb/74hS9993e/f&#x2B;/v/v6TwVCkIT6A0PjWhYlRLBZbrVYulwPpH9Je9P7z&#x2B;Xw6nQZgzWQy8O/HBAC3g8GgxWr/m7/95//xj5//3vd/9u67HzidLnDovV6vU3x1rq6uwPV/9913r6&#x2B;vr66uhcljh2/Py5cvry6vrq6uYfyPCQBQPphCVqvVbrMjbdflcrldLrvdjr&#x2B;I64Le1&#x2B;/3wxKU5p4&#x2B;n8/pdKC7j76&#x2B;1&#x2B;PBLALXCSefEKj8oZDL6fT7/VHY9USjUOjG47FoJBKPx0KhYDQaAfsfYxAIfJPJJOw7g8FgEu6e0Wg6lYrTuzOZzGYy8Xg8GolIYloKqV4Q&#x2B;CYSCQRt5fP5TDoNl1XYcZaKxVwul4YNf6mo4H4&#x2B;D9I/FLz5XLZcUo8Cneey2XwuC3P9SrkErF&#x2B;tVFRMb7EIMj1sN6EKUD34SqVWrSDoql6rdbsdcelpwL6zJix5EHhIlIeeFZycmmr8Vxv1OghF1UoZctu68t2vohKgYSWgWE0ydwGgm2TaNBsg7WABt6QKf8xGvdNuUxRr&#x2B;tKIHX5dxVrV260Wu&#x2B;9NFXNbb7da0Bh0Ox0Q&#x2B;omY0YpuNpuIF2iJQyW60U3VU4e3Zk1v27fbrUaj3hJ/&#x2B;ka9jqYy1qDH3xayuyLQt9u9bhdsm6a4izYajVqtSpI6RiWo29viuM8rqdfrLP7V7ip2V4S20lAnLsdK3iAzHrVBW4A7gCpe9h766zJ/6PV6LAkwH2hxDgB7n16v2Wx2hBWDM3eFJtTpKKwv9Umjrez2FYYWVk/bNALqdODbQ3JOt6t5BHU6qCswN8AalE/D4ZCX0e104OQDj05A/b58ebJgAASXfN82my8d5ebZU5WJ7MJqgD0avV8DUI5L5fRgNBr1et1&#x2B;vzcQ609A9rGUAfhSR8Oel6RTg5QX3EC1/NnCRxkwlgh59u8pGOBDugjYpPpIF5/NfpkMDNnyJxeIhQEzAbABuUAsBsZaEjAG7EoE/LxVb7wKRj8H3Oa&#x2B;GrwmYjO0&#x2B;kHXCptn0YgcBK87zVhz/6yjTENMtoq3Glv9eDzs97vnnXjjWZTY8yeoU3pYfpz1vNkzPr8q7QgEpjth/&#x2B;sPAXeeDS7&#x2B;LQs72QqOS3qXzlnSN/6og/AZnU1j9F30&#x2B;kF/UsazIcDJ09difY/apOWoL6I/1gdEepHAsgHrVeyAbKC/pIZYJ3ElXnN8ZjZPT4e9aRrLMgDIXpWy4OrsdofDAWibVSVAM5THCs0fDjoEZ/N&#x2B;Lx19PoSDPz48HA4HEG9wcBYMpPrgNlvvuvmPSTTa7fQj7LS7wOhaRaGeAooTFDDUDHBWoEP8J0kaXq1Utheubb1egf/DjRERQM9QzgGwF7PAFPV/sVgsFliPKxyPxwtp83Nf1An39/eg&#x2B;IMdBN3ScrmcTqZoWozH46UQfuaz&#x2B;Xg8nownIBhNxQ/hfr1GDbB4nhFmGDeXbv7zeLqb/OZdNx9aL9bdsZlmWK1Uw6lzCtDd3R1nuOgS1euNf/6Xr/7&#x2B;jx985nPfvLU4yTFtt9uVSvXtd/78yc98/b33L//HP37BYnHgN74m3og1SQZtKBik&#x2B;rXFYrFSqZRKJYD&#x2B;aDSKMiCRSEQikUwmE4vFYFPj8/kvLq5f//FbX/jSd17/0ZvX17eBQBB4GhJbp9Pp9/s/&#x2B;OCD29vb9957n0Je5PWiJAD0v76&#x2B;hpOPRHRZQd9Hsx8qXrfbjUGB3W5H8eD1eiEkcLvdcPWBuhd0f/T4XU4ndL28JLT8EdEVDoeDwaDH4w6FQqFQEJb/sVgsEAj4vN5oJBIMBiPhcCQcDodC0UgEZU8kEgn4/clkIhwOoa8fj8Vg1hkOh5PJZCQSUaFdqVQ6nYJ&#x2B;Nw3z/mQSiD&#x2B;byeTzuVw2i9gE2Pgkk4lsNsuk3pTE9GIgkBNLfuXZXyohjQuce/HqKRYKys0TkV6VShk0Hqp&#x2B;8/l8VcJlJehKQmTrNXrIoDxoNBqVcrnVbIAMQ5saiHrRoQfSpQQWQF9seVR3vysEGJpdipekau2jidtsNICJq3K6hjKtbwBEKgTfaLRbLTD9u12gdmVog0dVcJUwcxhipcjo9ToI37VqFUdumU416tXodTtKOCuIEzBaGWUK4wgOpA0pSOqSxtXQJgYNse5B/UNkbC7YuNVCUlWn3e4ITagjSB28fLp26hlhINgAXKOdD1IQy4OGiIObMrJQhB&#x2B;8VkLGV3haphDA1oCqoOIMBoOmPM2Oxo8HrQjVCwsn9VeVQ21ypdib73Q6mDCwMEALH/BaR&#x2B;odGRRAhtsRE09FENI6/cLnMVk3AOa9Xq8rCV/iMmQqfdti7KM38nvdbqfdhjF/u93u9RT7Xz9yT9K&#x2B;uuLF2dVKFyL&#x2B;nngBsdNPT6F&#x2B;vw&#x2B;fTyqGafPQ6/Wo98WO/V5Ph/W9Xg/2/PhdIClUjQJEDDDRDH90Hj/bScLtGbJbr/f8AeKHkvmFR2azGQlIjMjkBIBSYB30o4qg/FfVFaMRDv6aodnen&#x2B;HIM7T3ytrg&#x2B;Cw9ytDsKQGS9F10YK0jV72ZbZxb1pyDdb26OD6TjbKPziKBjXDyv3W4aTzzIT2cGvMfnjFJTi7ydFhxPL17tpy9Dv/qZvryUbuc1VrGs3fKnDY8ewfPBzKn59LfkbPnePboySfnlIbEN/r5rGC73VGwoVdoZ8fUSya9QuCRWW8cNOLQVqYN3BiqCXwmqfc9aFJgw1Bm//vdDrUoNjtK/DASwXan0cK4eFYaKA84UmA/nkWC7u0DShL9/jenycEqDFioRMT6j2Lq/yB0fzbsn56e9mInqgsM6PyjWwkBf7P3v16rLDDwi&#x2B;j/A3CvfIRAELq/50yAC/C90gDc3YHnw6hgtvZxdzKZLEQTjEqAub93d3dgAd3NlSAYGoD1arWYzSfjMYaYi/liNp1OJ4rvuJjP&#x2B;Y08GAz0D1IsUePtu9ks3z9RDPd6M&#x2B;0DecjXzocA4CPhixi/N4lk5h8&#x2B;9oUPL27/83/5VDyeYucsny&#x2B;&#x2B;9cs/fPLTX7u5sX3hS9/58MV1uWxmfoG&#x2B;DIo/ef8KXAoFKBSKvLi4TqfThUIBCNXpdL&#x2B;4uIpEIpFI5Or6NhqNud3eb3zr9f/0Nx/73e/&#x2B;CBd/r9cbDoedsihDz6urq6uri4uXNpvtxYsX4OdA4Gu1WG9vLXa7HXoAsIOcTie4/larFR4&#x2B;PCAIRR6PG7Qf&#x2B;H4GAgGX0xUMBu12O9r/Pp8vHA4H/H4ofePxOAS7YP7A4tPtdoeCQfT&#x2B;g7IEAgEgePj3J5PJcCgUCgbj8Xg0GonHY/F4LBqNIosX/v2JRCIaieAlSiQSMPqMRaO5XI6JaPDyN3k&#x2B;yWQmk0HUbjabLRaLuZxKU85mMii30OPPZbPVSqVcLmUQ2pXN0oUzl8sB5fMvGPzw0ywU8sVCQSj1IPmXVGJuuUzdba1WKxWLgPi0rq9WKo16zSTeNBuU6sIjslqttgVNKhObRl2sLat0zGw2G&#x2B;1WC5UGUDLLhkajXqtWwbdW3pdNRZ5BmxyS32ajUa1UWs1mpy3eNQr3V8W/X8HWBhlE7XZDSggYX7aEhi7OOWZelV51tFTAFnhHJKAr0xuQ1BVPBseXGoNTgpZ40jdFqtvr9ZrNBpAc9L58FK10gvt2W0lXe9DRNpvNZrMnULVeq7Fxzkfb7TbW82VR/XilxG120RXn&#x2B;l4PV0t0Xq1WAVJRZgDLNsxCgjJc5YOJI/fxXKTZjxdEnoWiy&#x2B;NbiPpm1iG4DJjzcONWs9npnMV4qTxdnZNzRssZDPps/7N&#x2B;wFMmO1915anf7XVBKOqc0YdYaXS7cOU356gdZTQ0GAyG0ncnJ6erOX72pX6A3w4OgMvoa4FfuAuMrhNy&#x2B;v0&#x2B;uDro6/d6PQiLyeQZnRh6ml6fVPGaTf3RqN/vTyaqW6/rAYTHP6AieTKZjEYnFv7j8Xg2naIwIOlUx/26hNd8SCsA9Db/VJLCOBufSDrYbKam5jjRax8FAQ/PaTmnyOwoPvcamjQtMgkBAXf0HffCF3/uEyrHOZET6A9xYnC2Rsf9zw/CKoJcET76SlT9/HqOIvY9uyr9mXIWAbzIDcgmen78sxJL1TzPgO8rr&#x2B;3fUmbovfyzvZ7DceNVNYB&#x2B;lv3&#x2B;hNz//FOhTxX0UuTsc7UTEE/6O18HnOJwOOx3O5YEe/HoJMo/vGqKgu47VqLhjVOcjRr4xHn87Xa7EwEA9mVhsBdVBnrqB2HB7SWyl8oByHPpAoSz65QedvcNCSbD/GGrLbirVwscHeB0uAtqEMx5dOmwrgqA6RCFwjQFMv2FpDAAd4iDCOwF7L7b7agPfnh4WK8UF2i1WikL//kczfh78RJF2YC0YMwBZN8VtMJL0QOvV2t8IzFCeD6fz2dzyItn0ykLhsV8MRmPUTAsl8uRdC/uFneTyQQcIUQIsx8zmUz4wbhbPe20j2qrNz39zJ/8ExhPz8PFUFf0ej20eUajkd3u/s//5dPvvvfyb/7uk7l8cTAYtNudRDL9uS9859Of/UYkGm&#x2B;12rF4ij/A9XqdmV/o&#x2B;JbL5Xw&#x2B;jzAvRH2B7n99Y/vZG79KJBI3t7abW1s4HPnww8uf/PSXoVDI7fZ8/ovfdjrdV1fXP3/r7R&#x2B;&#x2B;/obd7gCqDgQCFxcXl5eXLy4uPvzwQxB5bm5ubDYbID6Uu3TvAcMHegDV6bdYrVYrHDydTid4/w6Hw&#x2B;vx4jYWr9eHjF6UBE6n02KxQAbgdrv9Pp/f76dswOfzRqMRr9fr9ysPH1j7h8NhdPRjsRjCvMJo9ofD0WgEfB54d8ZiMZB60ul0Ih4Ph8PptIL3yWQSx0EBANpPIpHIZjK5XBbt/FgslkolwQKCJb9K&#x2B;Eql8rkcSoJ8Pl8qFnO5bD6Xy&#x2B;fzxWIxn88hUQsTgGw2C99PTADyEs5AR07YXkIVoCKxikWY6rTbCojTgL9cLnXabcBr4GkUD416rdVSAbGqO95oAJHDnKfVaoJw32w0Wk1yVGpAcmj516rVdost7oboYDE6qIExr2g8On&#x2B;91URd0W61IAJWPWmt2ECXHVgcULgl7B044fAGBwXofANh12tVsv/hrE/PGX22AExcr9d6vS7ZOMC7aJArHat6HjVVRTSbYDEB10JNi65zU4lo69i31WoBi5tt/k6nTdKRIOamaHO7XUWDaSoWfoeGnjhgU3F42gTKg8GgLXx98b7stNT3gIxKzKDfJmF0s9Ho93p4d6g0IIEHqHkwGOAgbUWwaXOq0Ol08NR63a6GztvIDSA67wpjBtsot3tTldvRuD1dnYiPTrw6r5JDqIFAT5b2KVOfbZGzv51OZzQcdiWuiyfAqIG6Xp3GQ0wPZhGMNaWRr47c63V7Avdx/aPRSCMC9bXuPtyAur1eDzb/UPey5Q9qEE1&#x2B;RuLuz2Y8Bg5k/Os8H/L&#x2B;x2L&#x2B;w0exZjwej4ZDxniRHcSJAYcA1P6OxdlTIwWNdLN/EPq55Xw&#x2B;o9XPeDSayr4zJQJQCmCc5zUd&#x2B;Z1BpbPbpPE8h5XPd3y&#x2B;nCPXownEDxqf&#x2B;&#x2B;zIqoOrkUB0PH18Vaf87IxnZ9HX68D0zGpm90wpe3Lxp8tpbK3Zhn8lr&#x2B;YE1r&#x2B;qFDmINMLc5JUDgcNhd64hVtJV/Zj/6qgBqmKtC37&#x2B;&#x2B;hw0myOWT39lXGNoJZP&#x2B;PrJ5f3ZVx&#x2B;PxUbJ4Da28hAGPIQY&#x2B;LPNOahjtwrbb7dNp&#x2B;K6u2D5KBsVRUyDwCkkNwpG34gR6PB6PxwM&#x2B;gWi6n0h1hfyD9dAG6OfaiXWPHu&#x2B;13W6OxyPtO7fiFLTdbjebLUA/Ds7ZAq2BNrKo12S7oywYiJ8WQGdjBFYIqBweH81EMNxmsx8rIeoF&#x2B;kedgKBfUQIsyfZZLpdrQfmQ9mKwsLxb3t/fT6dTjBpQCWAsAONOOIdOJhNUDqgEUE4A08/n89FwOJ1M4UE0V5TGKdohw&#x2B;FwhnyU8Ri2CWMtBLHf7y/m87/yyecymj399Q2Wy&#x2B;UpEXN08dLy8U9&#x2B;/fLK9n/&#x2B;x48FgtF0Ovfe&#x2B;5f//Imvvf6jX3o8gYbWeOt2u/DxAMu/Wq0CZYLtUywWEfiVz&#x2B;fB/Hnv/Rff/8GbP3z9jW9&#x2B;&#x2B;8d//w&#x2B;fvr6x/OrXv/3Wt18PhyNer&#x2B;8zn/v6pz/7ta9/43s/e&#x2B;OXN7cWm81mt9stFuvLly&#x2B;vr64&#x2B;/PAFGvwXFxcXFxfA&#x2B;rhrs9nA9oGF/9X1NXz90ekHax&#x2B;8IKfT6Xa5EOjrdDqtVms4HHY4HLTtDwaDwPcul8vr9UIY4PN63S4XDP4RCwDHHnj2&#x2B;7xev88HvW8sGgWZJ5NOo20fDocDgUAqlfT7/UD88VgsFAplM5lYNJpOp2OxWCQczmWzoVAonUoVkX&#x2B;cSqVSqWQyAXfOTCadzWTUNCAeh2&#x2B;SCvDKZrPZDPB9LpstFQtKZYFE3nwun8uVSyWUB6ViAZ79uVyuXCrl8/lCoVAsFAqFAnw5G/U6LfmV5LdYLBYK9Xq9kM&#x2B;jZ48Gf61aLZfL5XJJkeYl2rbVbFYqZRQGFYmkbQrhHgaaStuKKgK8cyGvtFpNdPxB0m&#x2B;pNfVWs9FutdqtZq/XU8lZ2KYBt/sWjgbwrNA8HGwailvfFsjebjUbCORqqyioumIZNVqtZq1aadRrsMDHDKEjsBu0IrTwW61mp9OuVauKnt5sNhqNXq/XkIhcxSQRTN9qNtstheZprwlwCNfL4XDQMv3mW2AE9cQCEhdrHqrdamuOlmANqb67UHiwQafd7nTawtJRgB4VDsoJNuZ1bk&#x2B;320WHXiA4CoN6m09HBiCNel0fI3RMnN1qtZrwzex2u7iYfq8HW31cdo/&#x2B;nlJhYDeIcclTwgH7SiLQYcOePJwT/k&#x2B;73W63yfZpndjydKQlr/r6MLppiQE/if4sJIC58TJ25TaxOwuJnkazaWt5XviLIoQU/57od6m&#x2B;VbC&#x2B;3VZlgxwT6F&#x2B;NAjRw3&#x2B;12qdBVw4F&#x2B;r6vGAj3A/74cFv3&#x2B;gcR&#x2B;CTtoQEYQADyb/YT1RPl8FFUHpgoKygsoBykIJFJIhLHNSAoDnSnEGgBbQiusqwXE8t/0BuUBZQ4go4PpFC4dAP9SMIzx&#x2B;7tYLE5cgJ4zT87go47AnlcCQEvAr8SOhvGKUDAdhJ0B8edn5O1XNpX1azhrqOsXudeMYs5O8Rzck33&#x2B;US&#x2B;O3v8&#x2B;g8JnJdDZaOJ5R/z53VeWBGeIWd/xePxrR5M1x92pk9LJZqdS7LMz6jStsyOTZGUe6SBsnFOgf9CGG2ezmrPndfZCnZzitAg5HA5w4TTkjabDj6HJxA8iHthrVkWE3Qc1FzpuNtujDKYOwhCTCcBxK0ZAB02jfDoiMMn3OAglvPhkbsXjHzvqrXoCff0hTg/Q8ufurENYP2ia4M1ms3mQfACcgAwfbANMj/WA7NwAWmFd/quXCgwRe7h/oB8oKgdUC6D7IwIMrCHsslwuV6v14&#x2B;PjgjlfiwXUwzQIwu2V8gCdj0cjEG9QYKjML9EE41tsNpsNB4PpdIqGx2Q8Ho3Gc/FUnkymqAqMf21xuSL63Ur9nAKEAmCkJbRfvLT&#x2B;7X/9lM3u&#x2B;Q//73/6P//jx/7u7z/5jx//6u/&#x2B;8N7P3nj7Rz/5VbUK4aPq0QqvWrlw1Go1tJDT6XQymbq6tnp9gXw&#x2B;7/P5I9Hoi4urv/m7T7zx5m/sduenP/u1j/3zFz756a/&#x2B;6U/vgjBza7FevLy&#x2B;vLyCww9o/S9evHj//fdfvFCGnpeXl9fX19fXN&#x2B;z32&#x2B;22m&#x2B;vrq6urm&#x2B;sbTAPsdjvUupbbW7fbRQGA3WbDDbj4g9bv9XoDItuNxWJo84PKHwoGw&#x2B;EwgntdLlcwEKAUIRwO4280Gg0EAtgRCt1QKBiVuK5oNGoadMbj0DmEwyGge4h9o5FILBqFE38&#x2B;l4vHY3DkTCQSmUwmkYgnE4lCIZ9OpWDeDzOfeCyWTqUKhTw8&#x2B;AuFQqlYhNI3l8sWCvl8PlcoFODZXyoW87lcoZBHuC/8efL5PKS6pWKxXq9VyuVSqQjbTYD7dqtVKhbhx18ulRr1erFQANsH3jhQ5SphbqWMLCoodJuaVybZ8yoqq1pFYx5gHb5AMMYBF0itVHSdekPMN1uCnhXbvtXqdjr1Wq3XU6QUmMA06nUgZgA43G3Ua&#x2B;gl91QbXl0S&#x2B;&#x2B;2KS9PpsFToKyqRaHORMyVyArkSTAYaXVQa7fZwMOi02zINaFPT2u12lWq23W63Wsq7U3r27PG3BYyK3T5AcKvZbOBQXRpeNhs4JuAshdToXvd6PYw&#x2B;sCVnIDgjeCZ4Xl2Bver1BwTv99HIBzm&#x2B;0ahLF7zFGkAKKmHpmFabkpklrw8uCc3vM6iNrVSJ1TaBeKvZJMmeRUJfmPHYF9fQE1lt28TxCsT3pMnfPcnM6nQ6HdQhHTT&#x2B;2&#x2B;2B8G107C7gXlUW/V6v0273TOjfwVY9LYuXXpyDfh9df8X56XZIzR8Oh2jP4wE25rHj0MzlNecDtGjDW0MtAXcfnPKIFNtnMBiNRrAu1T18JmL2T7ivyoZ&#x2B;f9DvA1jjpOzQIzgMXkBTweLwCWL7nwxVsv8J3zlYwG8WOEKU8FIZPNFyABT/BxR/0Q8w5Xc8HuupYWNN/otfVeWwBxGwDug/inPyHK5x/XP8enKQU&#x2B;QKiHa2vBKXSz/4cAaI5a&#x2B;52UFj9aj5gEaLB2LTtcXPz/ucT8L1R03P&#x2B;srLPnvKKHX0i3k&#x2B;HDhD8H9lOW&#x2B;Wn9YquDpuoD/3/f7E/Of5s&#x2B;PyvGp6vuH&#x2B;NLVA7fiqbGb9RB9VaL1yNqKXYUDnKJ4M6e7zjaBsYLfbHUWdbAjzxzi9JA4cdpLhddC4QKSTnZFwdObPQThmpOJQdIuDg03D42/FJNTAYEHEANvtdrdTvXxCf9YJBOhYSTIPuv0UKJPJc6YlIIjfSAYw1gOFo&#x2B;u/Xq9xbQT0gN2Pj4&#x2B;PDwrTA8Tr&#x2B;l1wgYjmFcNH2P8Ppkp4xYpCUX1kmMDj3C0W69UK3zuz2WyOUDBRBs/nc1QOi8VivVqh948rAR1otVzOZrPFYrFaLvFNN5/NQSIaDobj0Wg6nY2GQxqrofMxHo/PPsy93tjYmlJyy6UnkWnw7vDuPJJvvV7jyx0j&#x2B;/F47PWF/h//x397973Ll1fWX7/959//8f33Prj8zOe//d3vvxEKRdGnrAvHAIJO9P6r1WoymXK6PMFQJJPJvLy0/PSN37jdvmQy&#x2B;Yc/vvvy8ubFxdX/8//1D9/&#x2B;7k&#x2B;&#x2B;/NXvf/Pbr19f3/75z&#x2B;/98U/vQwocDAZtNpvP5wPoR4zX1dXVy5eXgP6qwX91fXt7C86P0&#x2B;nEesR1Uc6Ldj6Sem022&#x2B;3NLZv6Xq/P5XKCAgRzTySIodMPex&#x2B;/zxcKhdDgTyTiXq8HfJ5wOAyxLxYyefAX9UAqmfR5veFQKBQKBfx&#x2B;GHfGYrFMWi3g92cyGUD8YqGACUkkEk4kEqlkMhKJILIXnp6FQiEWi2IOkEwkEok4krsKhUIqlcpk0hmg&#x2B;VIJMQtQ&#x2B;tKkH8KMYrFYKZeLxWK5XEI0L4Jyq9UKJAE18ePHZsqOsyyhue22cusvl5uNRqVcVqSaeq1arbaaDT2dtyU2jmg2N0XV2mw0qtWKIrg3GtVKBcC6AhMehOA2GsrmUrFuGuiMggvUaNQRWgRWOvhCene81&#x2B;tCKoDOruLMmH6RTQS4ors86PdpniO4tgHA3e10GvU6MB/MKLvdLoYUxI7YpitZsEDwrVar11Wd9aYSvCpRKdk1TYn1JZ2pLTlT7FjjNUT2U1M5XTYhh20rPo8K81J9d41er3gyUpmAsQN/HfSJm80m4DdP1O12QFLqiZS1Kb74aFqra2g2cRwSV4bDQVf4OsDWXXHVEaq8emXwAvKla8szVdx32Q03ul0qenUtr&#x2B;qy9xTD3kzRAvbtKz7MgC35rpbShSvpihi3qzX72ZVXwFoj/LAB3&#x2B;/3e9KYNwG9kH/6mjunGgIIUUcur8OhAXZBF59AHAB6IAlifenQDwXi91SYl&#x2B;rHY8dupwP&#x2B;j4wCFJmzJ9oAuOuADkTqP&#x2B;W8fakTiPUH2unI3mGDfzQ0z04WvikLlm79cDhkntfoWQywdPTHoAmxZjipB4T0z8TM6XSKOgI/r0T/&#x2B;g2VpLlY8PZrbFE/R6t/HaceDicQ8/hMI8vNdCB4Zj5ztrCZTVCo73t4FdPG0ETMxinyfr7vWV/5GeI/0RafPC9tZKE/Lz6d47MiYSeZCcdXZSHvaebzb1v0S92eOrHqTJuz5flwg1XNv/G8z5e9LK&#x2B;sFbWeutmY5wbg&#x2B;29Pk9pEO3E4G0EYpx8SvNrA4rwAIGB9&#x2B;4PIgvl3qzkvHQ6HvTYf2GrmVKgxwKhhmx8rd5pPP5hFRPB6NUIHHvJ29mIqCqBP6329isBT2IglEXYRpa&#x2B;KHgPWB8Imt4fkfjzKtj2mBKQDrVYr8n8UpUcsQlerNSD7ZrMBRQdNfbKJmCdAqcDybjmbzXAobA8mDwPCUCRMJ9OHh3sGDE&#x2B;n06fHp&#x2B;Xd3cPDw/JuiSHAarVazOd3izuQiLAGGqXZdLpcLterNdoV8PeEnzHUwJPJZD5fMPJwKtEB4/F4It&#x2B;S4/FkOp3OF4vp9IT0PxjduXzZR/nwuj3pmekRaiwfz/&#x2B;1QnWAnw1MeCuV2te&#x2B;8aP/2//9bz/3he98/Zs//tRnvvmJT3398spardUrlQp&#x2B;6tBGLZVK9Xq9WCw2m00Q/S1W53e&#x2B;94bD4c7l8n9598Nvfvv1T33m6y6X&#x2B;61fvP3Zz3/zC1/69j/&#x2B;8&#x2B;fffucPdrsTdpkulxuuPmDbA/ST5ANDT7j4X11dMb3LZrM7nU7QfsDzAeFHqPxeh8MBDx9AfK&#x2B;s93g8SPP1uN3YBnJeEP3B6sH8Ad4&#x2B;4ufjoZ4XQD8cCgUCgWhUmfSDnAPyTzQaTSYTyWQyFo2CyAPhbzaTSafT2Ww2HovBrxN8HsT6lkolJHNlMplcLgtdb6lYrFQqipefzabTqVw2m06l0PKHeLdcKgL0VyoVGPAXi8VatVosFqrVSrFYAGsflJ5KpQy1bq0GD89SsaBMPGHmUxSiPyBzXUqCQj5fr9UKhQLb&#x2B;RC/YgPwcGrVarlUAkzsdNowAlJQst1uiKM8usXNRqOHkFTppnNjQFuUE4CFYPwL76VFSgxQL0sCBGZR59pWXvWtVqvZFUJIS1rX6ObC&#x2B;xJ1SkulXCnbHEwYgJWBMgnTSftBMx5mPoNBvys2Mm3hrgisb3bMIqSFTr8yiFRhse1&#x2B;vwfMTUI8OuKgxKh0LemXE2W2hOjfFnSuaP2NBtnzPb3djs2kX27WDx31SjaVHWeXqgO8UF0tNLfTbhPZywvSpsLYfO7A93LqZrPJZFyQW&#x2B;R1UEMNIGzAa4Hj6Nb3Bv0&#x2B;tiRe73TMnnrn1CFHOe2IMw&#x2B;J8vqin6KrtfDx&#x2B;qtteANbPlMadMWU02z/yxUOBmYEr9oM9QM8Q9VEosunoF/bcDAAd1/eZfNZ63QgGP6MJHuLbPszCS&#x2B;a&#x2B;gNZZATRA/pHqdBntpdwdbCgPKAtD4uQfr9vsvMF1rO0mM1m0AqTVjocDifjMRXAZPNPxMVfrwGA&#x2B;GezKVpdeh4w0D&#x2B;d/vHjiF9GaACoJZjP51DinVCA9q/K26KxCnHYc8wHsKsDcWxrnNYJx&#x2B;PxcIrwFC78Kx47H7E8h7aGsLqfXca5N45xioOfn0UnLL3yRDwsV/4V8cPzy9bLmzOI/Px1fr7LX4fvH1WJ8Wh8NV5ZHjw/3NmR9ZmPfpHqjX4mINGb7vqhcIMVFEH2K6Uge9Mo9kCUb5zOW9jXZ7eer/BeS1jTZ0EHWX82LDoIawjFwGF/2GwUAwcXTPoNxg5gIhH9A4JTELzX9ANCEVKFwfFoYGOclxOA7XZ72O&#x2B;3WvovGu0kF6GWACgnZej&#x2B;4WErob/b7W6/3zMfgER/SgJ4BEh&#x2B;gfKfGBpwf38vNQBoPA&#x2B;nlQBu09Nzu92SCLSWNADV&#x2B;CfDRwYLSAeD3afyDlqt7hZ39/f39&#x2B;t7yoLR70fo2Gg4Go8nmB5g9/F4cnenJAfj8WQ&#x2B;X5B2ye/E&#x2B;XwxGAzH48l4PNaHTo&#x2B;P5m3HrUd3sIrGcmf/AtbrNVs1HXGUS2dyv/jl77/1nZ&#x2B;8/uNfWqzOTCY3EI/qXq&#x2B;Xy&#x2B;Wq1SpAf6FQyOfzyPMqlUoOh&#x2B;vNn7/987feCYXCX/vGD6&#x2B;vrZ/6zDd&#x2B;/fYfP/3Zr3/vB2&#x2B;&#x2B;884fvJphjtVq9fl8YPa/ePHi5cuXYPhcXV1B7IsQX6vVdnN9c3trQacfib9utwdsH3j5u2WBAhhncTmdHo/H6/U4nQ48hGY/O/0oGPw&#x2B;H&#x2B;C9x&#x2B;0O&#x2B;P3RSMTn82EiEQwGQe4Ph0ORSCQWi4HMA0dO&#x2B;JaGQyFUBXHJMFM2nekUGv9g&#x2B;&#x2B;TzuVg0Wi6VIOGFfWcum81ls6lkMpVK5iUhIZ/LgbtfKBQymXS5XE6nUsqvs1gEaQeq3KIsSOlCWlalXIZdj2L&#x2B;5POFQh7cffTdkbALmn6pVASdBmwfqm&#x2B;VyX2jgQkAMrnQqm826lWVVgtOvwrQBXunWq1iRKBgX6NxZrzToeC13QYJR/k81uttYcgAo5t8G83mEhAW4BsQkU6acOVvKXUByg/Qypv9nkJsaNnWazUBu11cjALcijXebko4LnE8WDNtiZTqCURGI78tzjPdrmoDmwx76TS3pVogfb&#x2B;l9LioNBq0euz1ekITarSlB48bzUZDoVMORlqt4XCgGszttsL3bVUXqWtGGG1ba2/L7h3xslSjj67izKAH35UE3H6/1261VGcd0J/NbEHDMgfo8n3Ba8VmvE7&#x2B;AQ&#x2B;nI0lYKoSrw0WFBgBMs2suffQ2pAU63O&#x2B;rRe&#x2B;yd4nXgd1hecn6ZCDJWX0&#x2B;amJxgHsFlxUzp9MZieUOifUcMmBnvCDg&#x2B;YzHY7w4SmUrHX2Q0/piyDMUh/6e1o9H5aGT9eW8yu1HOPqD0UjtPpIoLh6n1&#x2B;2OTNd/83Q9ISMNxbZfMXxOE3wn4umJ7cejEZA9jkDGP4A7DshDjUXyOxVpGSE7NL3k7ej9frT8QfMxnX8kEpi4H7&#x2B;AmDPwIRJotTSA6XkS8FbLb3rlcqaO1Xu9vPu8HX6GAvVKgADuDAo/P8tHkdF1/KcfTd9gI2ZEB00SgMc&#x2B;6gjP/5rA9xWkl1dsxhMRmxqvmhXoG79y/dnCF0r/u38ugXhVqXZ2KL0CeWXlcNbON/eSSz0RAMi7bxjGdnuek6CXYRRzG6c1AEvB55sBB&#x2B;/3&#x2B;91uywkPefwyUjiwIiWI55vLyoHkGcMwqOhVwHy/50lZM5AspI8dQFU6aD6kuswAC4k6ZBax8W8KeZ8FFOwkBECfGKCF/yjrISwGmmeGwH5vWpQyFIxeQ6AOgfmDlaQDAc2T8IMdHx4eEOy1Wq7u7&#x2B;8f7u&#x2B;Xy&#x2B;VqtaRi&#x2B;F7D&#x2B;sD9zBkA8QeTATy02Wzm88V0Ov3/c/enT3bdWXIgmP/smM03WfeYzZisp1sak1QtVU9rSiXVqKukLqmreiSNRhqrqsxkJklwBUgCIAliBwKxL2&#x2B;7&#x2B;74v/cHP8XvefS8CAZBMZelaGjPw4i6/e9&#x2B;LCPdz3P0g7QfQHxwg1rkBWZpR9I9fUuAMaAKgP4AhYnEc43cfqiBRGMkvR01JUwtBLDFCYbh3Rtg4jt988fBsGeLrsmw3QeHFWxWEoihm9SF&#x2B;fXZ&#x2B;jsoQk0OWy&#x2B;WpDjw6PDyEvAT6n9evXz9&#x2B;/OSf/tGf/os/&#x2B;fN/&#x2B;Ad/9Mmnn/83/5e//0d//Gd/97/7gz/7V3/xF3/5Hz/88A5m6N6/fx/iHAD9v/qrv&#x2B;L4Xmh7Pv/8848&#x2B;&#x2B;vjTTz/96KOPPvzwo48//vjjj&#x2B;98/vkXwPrI9Pzkzidf3bv31b17d&#x2B;7c&#x2B;fijj4Hvgf5R&#x2B;4dhF4J&#x2B;UAJ8Adz/9ddfPXzw4BvJ9HxAYQ&#x2B;yPoH7MaP3&#x2B;&#x2B;&#x2B;/f3D//nfffffw4cOnT548ePDg8ePHjx49evz4Mebv/vDoEeZtPf7hh8ePH7948fzZs2c/PHr08sWLR4&#x2B;&#x2B;f/LkybNnT4Hsf/jhh&#x2B;fPnj158oTOXeiCXr588fz5cxCpg4MDSnrgAIYUB2zh4PXrly9fIJDn4ODg8PAQBAC9gtevX58cHyN3FeFL0NW8eXNweHio8xmkqI&#x2B;ITBT&#x2B;j0EIDg8PDw/RBECgJAJwUIAHNAfQv7g4h/mb0nOcHPVdwHeAWtR9Ly8uYAW&#x2B;uro8Pz09OTleLq7gu8UcAEBnxa9X1LQsl8sLjcxfr6Qou9C0dQWCkrTobDYX6veV/6p2iOdEDRzSGsTRoBwOqTQK6sSARKXAvuv1mkKai4uL9WqFnKIJ2V9eCi6EGkTL55dixgXaVoQMM8PZGbAmFDtE54rCFxfa0ABqPNc5X5CNo7kBTQ5FNcwPVZk7UvBXAKyUzWDhUthW8G2F9ZfkaTrwi2uT2vmVsAXqjvg6IOOlvokEypvN2pKi9WpFGL1UCTtr6nLjiysVtCwJ5dkZwJtyJaL8Lf0PFFwLyd1fU&#x2B;kOy6wSkqvFYkGZDRogk2EAkiEJ3Fws6BO4ukKUvkHnUkfnqthSsDIhivXJIqTvsZwOX6omStmgCP19z8PF16vVcrlg7OZyuVjpoF/XxGsS05MD4Jc5Nib/wKpL1O6YmH9K&#x2B;QnuPc9Drj8L/1Dm0EUGj4GjCf1A/0z5DMPQdR3Ot/HUJUDZD2tbrPprwL9cETUyHGWD/8VUYFoB&#x2B;CP7C8Jii48tpJsBOPviDPqPJgpz3Aam9sAbCth7sfuo56H0ZbIb3&#x2B;im3V35DavaveW9tfa9lxiGYdyZGbx35xnT2LvtXpRao70A/YZT7T3bbLMNga2dNUF/3LUiqM5qq7UyTLvZmrotsVuZWatSnNGwgtk7NWzr09q2xfAvoG17&#x2B;7O3lb0gW9S3eTvYc8DI676njh9Zom3bEdD3fY9w0k4DQAnoh2FAhR4741hDVFo6gCkEIkA3AiFx&#x2B;uZ5jkugqF8UBXardFoZpwHASwAWgTWwCYDzc09SiKqq6qrOshz9ARh58zxPs0zMymVZmxyhuq51vFeG86DLUdAtoK4AnQ6WIVgApy2KPIoicAMo&#x2B;&#x2B;E2BtYPgwBWAYn3CcMoDDPMF9OoUAB9KJSgO0LTAJ2BJEmjKApDCQ9FZFAURUEgDirXdT0Xv&#x2B;NClmGCIJjVL8ZxvHfnq0tHZoflxdwAMI5jWZYrTXNji3m9Xl9cXKzX69PT09VqdaYTiCBjuLq6ev78xaef3f3q6/vHx8evXr8&#x2B;OHhzcHBw585n/9e/&#x2B;wd/8i///P/0f/6//YM/&#x2B;Gf/w9//w//Pv/uPX3xx95tvvvn1r397795XX2ut/Ve/&#x2B;tWvf/3rjz766G/&#x2B;5pcffPABkP0HH3zw6aefffjhh3fufPLJJ5/cufPJJ598&#x2B;sknn3zxxRefffYZgn0g6UEf4K6O6b13794Xn38OO&#x2B;8XX3wB2&#x2B;6DBw&#x2B;&#x2B;&#x2B;uqrL7&#x2B;U&#x2B;cHw7N67d&#x2B;9byPMfPsTs4W&#x2B;&#x2B;&#x2B;eb&#x2B;gwcPNbn/ETT73337gxb7v//&#x2B;&#x2B;8ePH3/78OHTp08B/Z8&#x2B;ffr82bMXL55///33T58&#x2B;/f7772Hz/e7bb588fvzy5csXL148efIY3ODZs2cvnj9HWv&#x2B;TJ08Quwl9/7OnT1&#x2B;9eimq/Vcvgfih7Xn16tXBwes3bw5Q9X/54gVClRi6D/QPzT1yfpDQf3h4eHT4BnZb2H&#x2B;PDg8vMVfr9JQjb2Htvbi4OD0&#x2B;xnnw8sX52fnZ6fHRIRoFPGS1WlHiv1wsIPi4uro8PDw8Oz11NhspA19dnp6eIlERftOFmk1p24U05ez05Oz0BDATQA24eblYbNZrzWEUkcl6tVwpHITORIrNV1coAJ&#x2B;dni4WV67jAOtTYX92doYqOAAWwPTV1eVms4ZoZbGQ0jtOKNX3ywvR85yLsOdS822w&#x2B;JUWoUk2gL9ZNV&#x2B;oDfRKoyQXi8W5JPzITTGTHvISpTQyNxd1YuxzJQNorxDcKYwFM56USFzoMCnsCQkKqMZUrYftQeT4F2gjSLT85eVqueSaLy8vz8/PqHtZqKRKfz8shUFdXYE5SOn9UrT7C6OeB0KVPc1sLAG4xm4LdoTSuPZkRH10fn6Os00q/KsrSt4Xiysg1MVU&#x2B;186WucmtYC6Rkr7qxXOb/keBTmo9y8V7sPtyv4Anyz6CYTUWIkW4FfE8eAGQNgLCdKRo4DIyQcIvhWdr13HcV0H3QPCd8/z1ro/nAOr5XSJlQb8U2EPwY8nuTsbq/Nhqd5xnI2QBPkuz8MavBXx246B4u9Jq0MeMjsKDQHP8xAVSrswkf1mvSYzYLgnbXWT5dcXgZAyCBfjdHhO/CUNw3DqAMzw9OzrXWDHIvouvJ6By3avsuhtOfTYZsB3F3r2/R7hOJBoa4b17uL&#x2B;61b&#x2B;VsTc6LzbdmcY8Gjq2fp85uVze&#x2B;m2bSU36cbNwNz9tlp&#x2B;PczmFZjNFPjnsiWL7&#x2B;17OjvP3svtvdC4Q3WsCGccx27nmcxkWqyvc3mWD4zG&#x2B;YDvEnZTlE&#x2B;kzkCnXvVLpBO2MdWqB4CX603APzfeMmv2VurTtm23PSms1TxQLLLcHvoLksDDifhR9e90kgAQORaDV&#x2B;wZgM5Rtm/btoRASClNURRgOCjPN2pKNgmhNer0pWkFxHEMCkHED/8AIj5h/8XrHBKcZRmk/OAAnBNMfVEcx3GcMEoIlf7cnCdJkjAIMBgsCIJUmwPQEcVxHIUhUoZ89QZEUZxlWeDDOyDSxpnPyfO2Bqrbz2pTFHe/&#x2B;MG&#x2B;4qznpuG6rlc6KB4FId/3gVrw4pWWBhEMgpL/Rx9/9v/&#x2B;07&#x2B;4/&#x2B;C7V69e/fXf/PaLL&#x2B;&#x2B;9fv3666/v//M/&#x2B;dd//m/&#x2B;97/83//jf/pPf4UCvEpovoX&#x2B;/ssvv/zwww8/&#x2B;uijX//613fu3Pnww48&#x2B;&#x2B;uhjqIAwiBc6H8z3/Uy3jz76CKmd9&#x2B;7d&#x2B;&#x2B;yzzyD9/1K3hw8f3rt3D/vcvXv366&#x2B;//uyzz7755hsm9jx48ICSnm&#x2B;&#x2B;&#x2B;QZ5Pj/88MPDhw8B/b/&#x2B;&#x2B;mvE8z969AgTtSDQ/&#x2B;677549ffrdd989e/bsyZMnBwcHcPE&#x2B;f/bsKcdvPXv24sULvo7GCEr&#x2B;z58/f/ny5cHB62fPnr5580ZeefEC3YPDN28wKuHNwcEL/eL46OjlixeA9TJd6&#x2B;jo9evXR5rJidePjg4PDg7evDk4PHwD9M9RXOrclfzNk5Pjk5MTqGLOz8&#x2B;hk4Hp9vz8/PTk&#x2B;PTk5PDNm0sN6QfiPzk5VqvlFcQqq9WKyZKLxdWZDMO6vLq6gr6f5fbLywtg&#x2B;rPT0&#x2B;VyeX52toD19uz0SmXol5rSszT5LRwDDDk71P9XqraHLuX87Axl44vzc/QCBAdfXWpl92pxdelsNirpOV&#x2B;vV0Cf2HOz2eCoC&#x2B;NDlZVovi2z2Km5FyQH7Ch1WcQ7ChyXarpGVSp1QRqMcBagcOhktK4s0TGXlxcEyjgbyszAmpSXX2mmDc6E&#x2B;jf6LeAJl1rzXmidHmyKZIBKm6VqV7hy&#x2B;zXFOZeaZoPHtWIbQcrqgp8vzs&#x2B;dzYbeAFTccYarqytIU3jsUoPwYTxAFI/AbtTCNxv2PdiBWcijmPT6U7Ff2eOlip0EoK&#x2B;Wi8Vis1njpqByxIW0C7QQq/dqtdQQHkH5y&#x2B;VasfVCuZDoYcz4LVXILKkCwpsGME71juUYbLGC84DmAdDjaesOy9XUK1iRmQD0bzQK1NTy0ccQY3EQBFQKrddTjA9etKIdonD5/W9iPV1XLLzsKnjMADUon&#x2B;odSnf4J4m&#x2B;XloUthRB27V/egA8zwvDcCMjBSabr2&#x2B;6BL6W&#x2B;XGz7KuHYRhFIf5cTilAN2xUsMxK17vlNGw27XFW1L8Ows6r/jf2Iojwmu3wfsthAO8o2u530op0Z8bpTAmnFhlfV63f7T/s3WfcltY0TYMa9t77uu6V&#x2B;WZWtRep73ZaJiK08yKR93XXvaFfscsQhu0hyrPvkoZZmmT3H2ZaLxXqjKbqP45j2&#x2B;pICuUJEhy0zfT45Kn/abcV/8TZVrrT6BSwSieL4b&#x2B;Q4He6UdzPxgJ7C2VZ8VRA54TypAQW/YtKp25YyKdICRclScjzHP6BanuImEYJSdMA14XwpizLBt2JrkNJniFC1kiAHKGiKMqipHTHpn8CpjdNk2dCEsBkmB2U6CYKojyv6zqJ4yAIcAag/DAM0zRDTBC/Rp8BEwOyLMM8gCSWQCGU/IuigGQoimLQgCAIOU&#x2B;AuWYcCIAQBtRO8EuTrqmimKZ9nV1MI8PGcXzy9PXsc9u2LV1ijubHLVUpu9C8QtgQj46OIPj58u43//gP/&#x2B;SP/vhf//DD4z/9s3/74Yd3nj59&#x2B;uTJE8z0ffjw4ffff//tt9&#x2B;iAP/ll19imNcHH3xA6P&#x2B;rX/0KEv&#x2B;PP/4YM30//PCjzz//4u7du7/97W8//fTTO3fu4L937tz58ssvoeBHts/Dhw&#x2B;/&#x2B;PJL1P5BCfDF3bt3IeN58ODB/W&#x2B;&#x2B;&#x2B;frrr4D&#x2B;79&#x2B;/bybzPvjuu&#x2B;8ePfr&#x2B;gczi/R6jdlXYI0p&#x2B;oP9H33//5MmTH354BI3PM52uhTD&#x2B;p0&#x2B;fPn369MWLFy9fvoTOR2I6X718/vz5s2dPnz17BinOq5cv3xwcQCjFhH6p7r98efjmzeHh4cHB64PXrw8ODk5OTg5ev3796tXJyQlEVodv3pyfnSHBk4n7R4eHx8dHkOucnmJi7snFxQWK9MdHR5cXF5ixdX52dnj4hkp90fZcnJ&#x2B;dnsqcXRXuM4ITZl/E&#x2B;ABVo/BPIT4F6CKV0BKvFO8vLy&#x2B;N&#x2B;kWK6FeX69Xq/PwMkOv87PRCWwQol17IZKhLFlQvtA4N3LxcLJzN5krHVDmbNerxkoO&#x2B;XF5eXrDkvDDKmSutgjuOg&#x2B;o7MSUA0aUSDNwXzrbZbJZE6osFptXKrV5cLBZXy6WQiovz862LLhbQCF1pKg4Y1EpL7BO6XQgDwbVQG5ZS&#x2B;uKK4FgwPZIflZMvTRY&#x2B;Cts41aUao&#x2B;VdUG&#x2B;rkhCR4G8Uvi/EGHBB07Bg3LUKbC4vVfkiunkiYzBAoGdi6yvVPlmlEDDwQlX7mLkLknOl&#x2B;TlUvdvavNbRV1dXV45OruUXV1doKVxNwiHF7gsNxgECx8LAS4Cv0WahPh5PFdJ5kg3iaXBCpB5JuWS9xgcAj0tQuxpnYbFdaydkoVFCgL8LE9u/NomcG8nRdwHWAerRFsM/UZdRK8KSx67XcubNRswGK43y9JQwUPS/UT6wlqm9UzfAMXnQk0aI5XyzJ8X3Bqaj9r/xdFyXzuSSBCEL070pDmjKDnI1ABR/7GgLZu2fmh&#x2B;cOQhE9I/L2T&#x2B;CYRhsdQB2YR/r5fZrKD12wR8hocVMvRpDr7sKYd847qnB71bo9/YoZh2A3RuxFyLW391/dnIWhnnsjL1wz&#x2B;vK4fa&#x2B;hm2F/c1aoHfhRfMY0NkKbjj5Da/svZHR9ApuZikz5D1u3/6sls9XyMGAs&#x2B;1JLEkAtiajwyEQ5FCrwz37HkbfdjAhQiASXdcxEYiafgvu2THgk0cNftT2Tm8EP5xlpiKituv6tm14HhyrYv2OEv&#x2B;yLDs9M/ehjRhnzvMcSqGK8UEqWMJN0a/M80gt30R/1joIDHC8bds0TbM8h/IHpAI7gFHMDMRA&#x2B;VmazcaHYXmID8rSNMuyJI6rsuSsgDzPkzRFyZ9jhmc5QnZ0AL&#x2B;Wqn8UBQHgvaSFhmEIeY/Yi41tAHB/s9kEQeh5vp3hBQ7g&#x2B;wE0l6aTs/Xpf/7qfPZhrut6o1MeXdddGJce1D6vXr3&#x2B;7PN7X3394Ozs7ODgzcOH3z979vx//fN//&#x2B;FHn/6j//GffXn3q7/4y//w13/zayDpx48ff/3111DgIJcTuT2//OUvf/nLX/7mN7/5zW9&#x2B;88EHH3z66ae//e1vkfL52WefQecDBf9HH32E9J7PPvsMM7m&#x2B;uvcVav8I6/z888/v3b177969hw8eYD7XV1999e233z569Oi77759cP/&#x2B;gwcPHn3/Pabwfv3VV4D73z58&#x2B;M033wDQP3z48MmTJz88eoQ1P3z48Ltvv33&#x2B;/Pn333335MmTZ5in&#x2B;&#x2B;wpYjqB6TGv9/lzSeh/&#x2B;vQpvj48PHz54sWLFy9eQKN/cPDi&#x2B;XOE7h9I&#x2B;r4M1n316tXrV69evHiB2Vso2MOkC8H&#x2B;mzcHx4D7h2&#x2B;Ojg5fvXp1fHwEJ&#x2B;7pqUzbZVAP4v&#x2B;h28ew3nOad09Pz85Oz87ExXt0dHh1dXl8dCQ84fT0&#x2B;OhIJjRdXZ0cHx8fHyMC81L9rKz9M7JzobgQOwAKAz2j2r1aLuDNBfLQ&#x2B;r3q1xdXS1NqXWhazuJqCkxcrVaqhbmQgrQGYl5dXgjSWixc5CpK30BoxsX5&#x2B;Wqp5wf400o/zr8Sic5ivRIf6&#x2B;LqCuV5AEEgJgbt6wwmFauoHgn3C8AH0QtwPxaPFcrri4VC6qktsELw6NXVlQZoLnVQ1EKiYxYTBF9JS4CgGcDU2Wykm7G4gsXClsb5&#x2B;InLDX&#x2B;7IAanDmehP/C2mo4HKNr25RSQvzCUYyWNi8tzyQa95NrwfFzHYZeDKq8rnWvL3gsL5PqtpT5eScBkVYLK&#x2B;5V6UuEPBi0E/KbPYU3CoUNzcRXK/a9U379U78Hi6mqzEcPrQqiIDN9lIV9q8GZJa33sm2m478JxHOsEWOvGs631I&#x2B;e6qr3ZbFarpWNgN/cEvhfJjR5r&#x2B;IZIidZ6awD9rNY75lQi&#x2B;DGTv1yd5OVqwV/r/Vtzu&#x2B;BAwyFwqdn9KcVnP0FU/vq3iSO6aAX2dXavo3Bfpa2i4cE&#x2B;KG/ZhB/PHMLcTxIDHEs38LUEgMX1xkyWHbcTcuz&#x2B;thS9Fx2asnp/c/l8JtTZBcHX/fOGMvZs2736dd2Mcdspu/dyO8vYygwddsy1t1zk7hrmC9iRzdzyEmAy&#x2B;t/&#x2B;hkbHLZfEsQMzLsSTW5XRtGAtyfN1i/u1ezNpgcbtEFIK8eUk6sQFxO91bnRnqELTCIJvNVsTp2U1HR9vOhN48kondrWaAsTCv&#x2B;1acBaYLfZTRNRtjw/DjTQ6fKA30UO7R1HtA1YAh4DVFKFdQG8Apf&#x2B;ZTgVmCwJ7osDf6Jjhtm0B6zk1jBAfxCDLsqqqi3yaH8whYkD2OAoOY/YNkiQB5YDNl4bjLMuSJAXWZzcgjhNU9NEWiKMYv0nBB8QtEEU6XCxNkxSJQHEcoy0QRRIfFMgUFfObVFuoaBGsVqs8z3c/1a9fH89e6bpusVjw9y/&#x2B;qF9cXH557/439787Ozv75v63f/GX//nDjz45Ozu7/&#x2B;Dbf/4nf/7FF/f&#x2B;zn/79/71n/&#x2B;7/8c/&#x2B;J&#x2B;//PLuP/8X//qXv/zgm2&#x2B;&#x2B;wazcb7755uHDh5i8&#x2B;9d//dcQ9mBkL4J9IOBB7f8T3e7cuXPv3r1PPvkE0wA&#x2B;&#x2B;&#x2B;wz6IXg4r179&#x2B;79b&#x2B;7Tp4tE/6&#x2B;//hpzuBDPTx3/gwcPHv/ww/fff//8&#x2B;XOM2n306Huk9Dx58uTbbx/KTK4nT1HUFz3P8&#x2B;cvX7588uTJq1evnjx58vjxDxrcL0H7L54/f/Lk8dOnT6Hyf/36NUD/4eHhixcvUL/HFN6XL14cHR3BiIvMfgzYev3q1Zs3b44OD1&#x2B;&#x2B;fAlJD&#x2B;ZkHUHd8/r1&#x2B;fk5BDznZ6ew5cJyjQlrGNT15uDg&#x2B;PgYYZ2Hh4cybffkBJV89GqOj44QLwN8v1ouoaWBtRdCIDgBoI8/Pz87P5MLSeVYZlRdHB8fL2DnPTuDpH65XEBeD2AtEyEuL1GnhDJ&#x2B;vZJEGo5YWq9WFN8vVfoCkIY67kKr9ZB0LzSxR6u/l1oOv5Ca62q1Xq8uLy7WqxX0M2vBvpO3dbVYLJdLz3VRqGbNm&#x2B;oXnFDyWy4vQRugysDOC1mAZuCo93S5XCKPRVJ6TPV6NdXUpdzOm7U7CFtQn&#x2B;hSNfparb&#x2B;i&#x2B;ASLdBwHRWoDcBdX6jZerZbr1YoSF6mjY5bw5SXEQktaY6&#x2B;uriZ8PzUKKFVZTA5a&#x2B;go0tUaPutTvXl5e4upL7ZMQm5Iw4CqQv8O0aoE&#x2B;XbZS19e0TULlpYqglsuls9lYerDSEvuVvHdL4nvH2VAmtFYDLkiC9ha0&#x2B;q6nMqdcEVIvrq6owFmbK1Lc76iDdq0nWW/ndeo&#x2B;ku7vOs5ag/ZZaGcJhrgczGGj37X1&#x2B;PVawn/0lcl96/s&#x2B;av9SzlfQj9uxjl483km9oyzC8g0ifvQleFq&#x2B;TiE&#x2B;VT3qAPa8Kch/4/s&#x2B;ZTkbnRGGbbPZxHEswh7Nt3AlDshnG4GlfdID4P4wDH1frMaOHuX7Pv5Q/sICtXF7fuq4UxTf/dNILDj7FqDYDSexhfNdHH9DlXr3bNsMYfr6BkzP9VvOcN0lbskrbG9h9h1ztl2cPb/9t15lvB2FmImmZq9YxG8f1N4nz0o897&#x2B;uSzMYsb7F/cP2GGaW/HfX3HUd57hRujMYD3FvaMOssWDX0Pd9raiaRf3ODC&#x2B;jrH8cx8bE8BOdcwEE9FTPE9n3KvuhsAdmWREIidlAJE&#x2B;DUhT8aPTGPwAUjpMTvlsKgVes6KiqKs4IY7ug73vCeov7AegB05umyZUVkAAAmkdRVOlkMeB71uMB3PEKEHzTNJl&#x2B;nZutLMtUJUNFUWCXPMuLPM&#x2B;zHIV8dQUk4AZ0D&#x2B;dZFoURooHKskzipCxLyIGwPHQhAPoN&#x2B;o98X1zCQRAkcRwEIXxOygdC3w9QfQmDQNujwe6n/cGDx7s/So6OgGGR79EPT//Vn/&#x2B;Hzz7/6urq6ofHT//xH/7J3/2//5O79775/It7f&#x2B;e/&#x2B;R/&#x2B;x3/yz//7v/c//cVf/oeHD7/7&#x2B;M5nf/wv/tXDb7/FcNz79&#x2B;//zd/8za9//etf/vKXqPR/8sknH3300UcfffzrX/8a6v&#x2B;PP/74k08&#x2B;/eijj&#x2B;D9/fDDD4H4Hzx4ANyPcB6G&#x2B;kP58&#x2B;D&#x2B;/fvffAN8j9AeuHl/ePTo22&#x2B;/hfQIYfwY2vXDDz8A/b98&#x2B;eLJk8eU6T958kQ8uM&#x2B;eff/dd1T&#x2B;PBMa8AxJ/ED5OOrp06dSv3/&#x2B;/PWrV8&#x2B;ePUPy6fHxMUQ7SPF/&#x2B;fLlsSp2Dg/fUNb/8uVLZHQiKf/s7PTw8M3JsWRrnp2dMroHIP78/JyZPFD7wOCL4Vzw3R4eHl5cXBy8fo0MfmiEJKzp4gLpOmdnp0jHv7y8gOX37OwU6B80gGVOZL8gwGchyOlyvV5fag7jcqFAEzVmMzYVAUEEryvNwAFwh9gGkn3gHuBsx9moYeASdX3Ru4vgewHRC&#x2B;r6wJLrlXzhSCCMOIYXKtD3XFdKyzpoyRFFyuVqqQNcr66WOp5ppVIWIP4V&#x2B;xvqr3U2m/VqdamTYjea2eK6LqrFV5eXS3QSALtXq9VyAYCLfzL5UTQnm42o26cCvJKH1QqeiummgI&#x2B;XSylX6&#x2B;Il6RLvBSzOShvWWqLmttZEeWEvygFYt6YLlymWC7EZaGlegOyCevQVvbDLJRQ4vJ31aqXKJekorLWRsRJ38tpgaKFbupJJWL/QTCEsTCCv&#x2B;pTwTPhwcAi5jeBmJXJL9Rvwwku1c2Bnx9mQ1SzNPRINg6IAoC/U2rter1crCeNHY8HzvCgMLaDHu459rhgzulgQx2&#x2B;UECrsXpMDeJy2u16v1T2MQ1aSyOlZ/oBPHwU8gvJVuG9L&#x2B;xs171rBj6fRPevVarNZi&#x2B;bedV3XIUxnuwCUg6J/MAHqgnzfR6XfenlpFHbVEAwQ7zibXVGQ73vI&#x2B;&#x2B;efPLoL2BNgV4Hn50noG/Z9/xfttkMX6mpFVFN4pcVnu6Bt3EGl&#x2B;&#x2B;Gd/XO7s8N1oLbbrnPrOvcYi3cXNjunXTzA3O63ZnB/9s/rBO67t3BdTX23Tj/jUcO&#x2B;0Wl70LzpP1iJjr3W3ubJ3p1v4GCzk7y1OUP0bNfPfWiH5Wvj9rMizMU/ySJ6DeukMqfRyCmrgyIDGU34bKvjw9Ac6HS47zj1Gabb4eeNnzG0BWw9nv/s1YtCRRDURKQTvZHlwAxQbQ8IqzUn1P6TGiEc2OuQAbzCdgTU9rQB0Arc6eQBqvzLoujV86BegrbQuQFFUTSNqIakb5BllP2UGhVaYv&#x2B;y1J6AyHg4GaAsS5TmK51tXBRlluUwBuR5Log/DPWfMbVAyity2g/yPEcrIAxDDgzm8LI8z6MwzLIsTaRv4GvGaBxFvu8HQRiGEboKgYB&#x2B;dlo9T/sD9fbYkL/6zefRzrDy5XKJGg9S8K6url4fvPl3//7//0d//K9fH7z5N//2P/zVX//6X/7p//b//Kf/yz/4R3/0R3/8Zx/85uMHDx4CZ39z/8GXX95F7v6dO3eo8/nlL395586dDz744MMPP/zwww9/&#x2B;9sPYd69c&#x2B;eTL778Em7dTz/99N69e5/c&#x2B;eTTTz6F2ReOXkzs&#x2B;uabb7777jt0AOAluH//PqwFDx8&#x2B;fPjttxjNC&#x2B;MBqvsPHz6EfP/58&#x2B;c//PDoyZMnT548&#x2B;e7bb5&#x2B;qOQFGBez89OnT589Exw89z0vkcT57Blk/Yvgx6ODZs2cYtgX1zsGBqPhfvXx5eHj4&#x2B;vXrN28OMIeLKT1HR4evX716&#x2B;fLF8dHR0dHhm4MDSHlevXp1cnKCoJ6Tk5PDw8PDN2&#x2B;Oj48QzH92enp2dnZxfn58fPz69euTk5Pj4yMofDB0eblYoBh/dnaG11Gtl3jWszOMnYIwBlH6UPafn8t4WuwDry2SIk9PTxdXVxcX50uRuUtCJSywwgo266vLy/Ozs&#x2B;VycX52tlou0RAgJrtS2&#x2B;vFxcVmvYJZFrASOMXZbBxnszSxNsDZ0FJjB4j4UdFdc7rqFbH&#x2B;1QLGzdVysYAifMGKr8DiFQDf1UaLxyADSBGVyy0WSPN0JZJFsSzgJiCU6ODXmFEFMTY0JzqqaX15cbERQC8oGTusVMxNziCKGsXNk8BmsYDwYyV24RVXiMwi7raYAmSWKB4Dkq4k3Ga5RMlcNe54SrwWHshqtUK5WkwO6/V6tfI8TyD7YkG9vgWsjNFcsMuhyhk0XFaqicIbsdbIGmkm6C1sRAMjSpXVcgkdFNG2FMW1/SLlcx2Oq7hW8PfaJHtSTLViGA7edBXesDMgonwdeMJ&#x2B;Dov7i8WViKxWU7oOV6hsYZr/xeK6yzj87TzljU7mwh2hBi/0WHmC53lsR8B3S0oA5L00k33X5uSepvLzWqL79zwlEi4&#x2B;0nACOGbD2&#x2B;TryF5CfEcNwVD8uybYx3IGi&#x2B;xnfQDr66UEyNG0H8wA9nWCr/7x8nzfF1lP4EdRBALge571vwHWs&#x2B;PtqQ84SRJ8zaKYDAJjQXQGgHYR3gzP7Vbfue1i3&#x2B;vA&#x2B;qwGDwS390CW9vd2G3bPvFvanzmGd882nUdf3HvIO23X3fgwDPu6ATdteycK75529kq3zyW8d3ksh7/1/FjJ7JNwPS&#x2B;61j9gORiBO79b65AvshF2A/Z&#x2B;wLpOsqEsY&#x2B;zMNF8KdertoRCj8kmq86WBoME&#x2B;3JlleIQFdV1X101d17g3q&#x2B;DvOT9P&#x2B;wk4v92hqirMNLClfaT10wZghwawJ2BHBLRtW2mlv9XpB61GA3FKAO4UoB88gT5g5p/yJNo6mHoIHBcABY6eoUb5H0IgfkFbMAT9eZ6HYUhxEU6E18ETcGwSx1ma4ltlWVZlJelAcULhUBiGaZpGkUwcwz/RASiKIopi1D9UFhn6vh&#x2B;F0Xq95q/IIAg99UjBdOU4juUAD797uftjyR7xarU6Pz8/P7/4j/&#x2B;/v/m3/9v/9x/8o392/8F3//3f/8N/8j/9yT/8g//Xn/7Zv/3zf/Pv/ukf/emvf/3br7/&#x2B;&#x2B;tGjR1/r9tlnn2F8L2r89O9q&#x2B;f&#x2B;ju3fvfvyxeHk///zzu1/evXfvqy&#x2B;/&#x2B;PLu3bv3Hzz48ssvEeSPDB/4dJHU&#x2B;eTJEzABYPenT59C84MMH6D/Fy9eAPQjqwcbivc/PHr07OlT1OwfP36MBB6I9V/q4C0m9jx79uzw8M2rV68wNxfQH2Tg&#x2B;Pj46OgILl6M1JXsnaMj8ekeHkKT8&#x2B;bg4PT09Pjo6ODgNWT6b968OT09OTo8xEQtmG6PDg&#x2B;PMJxLS/JA/4dv3uB1KPjPz850ptXlyfHx6enpycnxpWRcnuKoq8tLCHJOTo7Pzs7OTk/XqxXUPpv1mmOzYGAFhVjqxNbF1SXcwKh8A2hCMX92doq6r8zDuryA/Aa7QXIDk2vge1JZR9LL1RUgmus4qKOjn4CSPJLgUUSnl1QiU1iIVSWJ4zioqUNQju8L3FwuNpuNFMUZvi5ocknCIIGMq9VyKXrrpey82qxFybO4MlxCJRxL0YsvQWDQDcBdb1R7DVmRANalXHS5bTaFokkvDW4gS9qs146z0babFJXZHwAJQTLmUgvPCwWO7G&#x2B;YqvYKgHg5aYfAWK7wSEE9phL4agnlFd8F9gRc11HllVqNKXaXwv&#x2B;Vgv6VBG4ul3zOuC4JgDwbPRWst7hHcCrlCcuNkZ1sNIhGkbcEU9o6/VpMApIvxPcCTwxglBxgozV7Su1VCLTWPglaKBqY42gtX5G3Rfz6uJabzdp1JETBdSVzUxpQiqvJu5bqAQDKZ81eMfkG1Xc6Adgc2GCY7mrladQmzLVhGKAej/ZvoAocx3HW6xXF/ar52fBy/CdWbkcBkD/YRoFeUZKCXL2Kr6E8WtGfOAMpge/7zmYDgO77fqCUA7UqRf9bOiK19oaumfVL0A/xj2sMBvgiiiLf9xAJiv75L2zlm1/MKtk3yG/sbntfn&#x2B;0/M2juym92T2hlG7MTzpYqX&#x2B;/TxBMA7S5sL3K9jlTsvbXRPLQJmw571rZX9HLDMm5e582H7G1BXP/AVal/zbHb&#x2B;099gJvXwI6B7H&#x2B;N7MdegnV34n5bv8eLfGV2CasRwjmprafynm2E0Xy2STbIQCzraDV2lkqkFrIe3WodN4ZzApqDA6BC35q5Y7Y/QLNvpaOFeSxPTm7QKVWwHQMqgmgp7vu&#x2B;qmpgd8YHyUQwlQaxV8DUUaBt7KmZQlM0UJ7ntTIEVv1xlrIQi3BVVQDiwPTGOVBB6I8gIOD7PMuqspK5Y3kGNI9GgWQQpSnqFlmWJXGC2n&#x2B;SptAmQTiELCCGCwV&#x2B;4Ps&#x2B;YoLCMEySNMsy3/eTJMUvVvz6xnAx1US6juNA44S3r&#x2B;3G3d8Rq9UKdSBIOH54/PQf/sEf/y9/9pd/57/9e3/4P//Lf/yHf/zv/8N/fvDg4ePHj3/74Z2P73z6w&#x2B;PHkOUA&#x2B;v/2t7/9jW6//OWvEOQPd&#x2B;&#x2B;nn36KzP579&#x2B;59&#x2B;cUXX3/99aeffgoOAND/7bffwcULkc/33z&#x2B;CeRejuDB8FwX&#x2B;77/7HsKeb7/99vHjxy9fvkSGDxy6T548fvTo0fPnz98cHKDGf3Dw&#x2B;tmzZwcHost/hgI/PLgHB5rl/&#x2B;LFixcHUPO/fPnm4ODNwcGrVy8R2QmRz&#x2B;HhoeD1w0NE9ByjpI9AnuMjKHMgqT89PUVhHnmaqNCj8H9&#x2B;LrMU3rx5g2m7x0dH5&#x2B;fnwN8yZ/dMLLzgDMvl8vz8/OT4&#x2B;ErDEFFxRZcAx4KzXWqaPlIs16vVmczQPTs/O4MOZ6FTtFB6P5dZUecryWq8vLi4uLw4X1xdwYe3XCwcZ4PMHACjBRL3JezlynNdlmwvLy9RY3cdZ7NZX16cQ2YDIAUog8LmksKbxcLzXIJpVUQs1qsVAt7Xq5XrOKvl0nUcIFEPcVUSE3kFPCfCa8XlLGyLMVSJgVSD16uVDnZdsSS/EG2Ms9H6rpRsMQtWeMVaS8hrHRTlOM5KI2V4LG5nrbewXvNbUJJsgIccZ7MFZLVE7WjcO6XqdKbisVPytNJvLVVJD5IiJXYQDIBI/adAc9XZc/H0NrBGjjeIg2832gHA&#x2B;dmTEV0TvanaB1hPaHvFdoQK/TdqlpW0/o2A48VGp88C1i9N7ObKaISIxRXKy7egriHUXhsBj&#x2B;m3yEOWM5hEo6XmC63XK89zwfoU3wqkXpmRvRuTockaP6At2RGK9MzgZxne06hNgG9ob/C0XdddGVqyVs0PPs7A3yALjgZresaey9YQOIYt9uM8sPSiJM&#x2B;zkRVwZ&#x2B;y20SVh/SzkA3wHZm4XFTgbfW5sEPia7Ol5Hg6wfYNge5skQJ7reZ7U/I3mx9OeAJWuoASUBlEptN8EzHLpaMJwbsB5Fhre0ks69P1oAJO97rSDqRlzMbv9itFg672L3NsxmIP1fUdhSNTNOqK9L96yR3Hdda975QbFzs1nuOX5b95mdz1sDz7Dc9o9ZEuetE0Cd6nI7AZbk9gzGrDebA&#x2B;r5jnth9bW&#x2B;ymj79ppANlo&#x2B;g9W7YM6PeVGU16QslCrQbKO4c6MfBahkQqQaBVgV4HFe/gELFJvNTy00YEGvZqDoe3hbqr1r2EhAMEADej7viwKHsXng1DRVgNGcSE1IdS0D7PzwDOg4g7KgUp/lsp4YLYjiqKoddQA/AbQ5zBQqKrqNBF1EEX/4Btw&#x2B;mo6UAaID7NvlmVVWbHeT8MxoT&#x2B;EQ0kcQwgUhmEM2qBTxugWiKJotVphijAUQbFOHIN86LoPP0uGkAAcH5/81V//9j/951/&#x2B;5rd3Pv/87osXL6GDh3IGE3Y/&#x2B;eSTv/qrv4LC5ze/&#x2B;c2HH31055NP7t279&#x2B;tff/Dll1/C6Xv37t07n3wCbQ/YAgZy3bt3D19/&#x2B;eWXjx49kpz&#x2B;b7/V8NDvECL0ww8/PHv6DHGc3333HeL5v/32W5TqX7x4gTL/Dz/88PLlS7p4YdhFnf7FixcvX746ODgAmn&#x2B;lip2XL19CuH/w&#x2B;vXr168P37w5fPMG43UP37wBygdMPz4&#x2B;fvPmzdnp6dHREYJ03rx5A0H/2dnZK03qPDs9RY0fltzTkxOM5kVF/0wK&#x2B;Seo&#x2B;i8XC8TynKEkL7k9Z5cXF6enp85mc3JyAm395eUlXl9K0M3y8vLy9OQEETqcgbVaLk9PT1Dm32zWy&#x2B;UCbQFk1MCVe352BvftpQbsXOhEravLi41WSQHT1yJbX11cXDB2ExVWoH/H2cAyuFxcCd5aLDzPZT1VYOhy6YpqGQJ9SHGAxpYAbjApSv14vb66uvJhNpxySxxiWXYVcJKlBLfLHChcy9mIK0DUNY6DRgGoAtA8Sq0A0CLdXy4BzlS5JM8h8H3JmXE2m7UIMFCV9zwP9ea1di5wpywtEwK6WtWevL8qLJEsUQGO681Gkl4knmhjhO8mFQcrFv2MvmUolqPKrixiuV4JHQLepYZHHuByiee5mciSVPQ3elvo3oAUQb6iTECg6lKpgrZoVlABrY2Mh0xDaZiIi4A7FyqLhwwGbzfkNGAsy&#x2B;US4jH2VVhTZ6mePl2HqHl6YtzTWZiBwWtjmcAe0kbYyMcDaHgl7SMXhRJ8OKmxEYK02Sx1/7X&#x2B;mEhFXLsZaD5YUC6wWifvOs5GX1grnUCSj2p71LML7A4svtKJYM724C1fU/bJTPjwgbA32iIGEIc8ydV5MpTpW529o6FAJBuU8bga3i//NawA1XppF/iT1p/JE4Eq&#x2B;6Mocl2HmF9Rvvh9We/HH77A9&#x2B;F5Q6/A9/1E/HI&#x2B;hUC/2Kvk2W0C7EWBu4DPYrK9qLfVGUy73xrelpazq1Aar4GPe19vmtq&#x2B;cjMop5iEu&#x2B;0i4L23eR1f6m/nJN7abqHbme3cXx/DPxqmtPds209s/3tx8wdg98y7baV&#x2B;JybIEgn7SaNshgX4WQMK&#x2B;1vlEo25w87JUTsf6E5WwQ/XCb6BSjxNCNy/bVuSHGL9VkdMWBsud&#x2B;B7MXPD00WA6/JyWLkAcZ0FZt3AiPIEWK81xZ/WYfYT&#x2B;F/qfHDFsiyrahovUFXVOAy4Osv2wPFJkozjCJ9AmiSFIvVag0S5f9u2MhQM473UNgClUJ5JD6FU2wDcBUDuaA7gW2mSMlwoz/OiEMqRJAmCRwH3GS1aliXcAmmapWma6&#x2B;iAWGkA9sc/1TAQ5XmRpqnvT6MTPd9HGwG/EK&#x2B;T/C10Ag48AMfHx28OMWfqDfyvjx8/Bkz/&#x2B;uuvf/WrX/3qV79Cov&#x2B;HH350586dzz77DHGf9&#x2B;7dQ13/888//&#x2B;STT1Dmv3///v379&#x2B;/evfvFF19&#x2B;9dVXmLb76NEjfPH06VMU&#x2B;CHoxyBeyeB/9IgpnE&#x2B;fPnmCKP7Hj1&#x2B;&#x2B;eIFkHvz36dOnqOi/fPny9etXh2/evH4taZuvX72CaxaCfih2ME7r&#x2B;fPnJycnL1&#x2B;&#x2B;hPv28PDw1atXR4eHp6cnmL0F4H56egq37tnp6ZuDA7yCaj3k&#x2B;ye6wb97enqyuLrSAJ8TyeQ5PoaYByp8BPEfHx&#x2B;jYH95eXl2drpcLDCf6wy7XV5enJ9fXJwjExMxO9D9o8i/gJhnuby4OD/XsVniuVwsEHqzXq0uLy48z&#x2B;OgKOpbIG2/vLwAChdF&#x2B;GatOHgJFdCluntFDqF4iwCRchqoFi4vLyXWUEXwWtZ11&#x2B;u157q&#x2B;71FnvFgsAAZUUr8hrAdm2qxxkjXV7UyAcRRLbdZr3/Omqr/jyGq16GvPyR1WWLPrbDbrq6tL3NdGDbur1cpRNY7rup7rqgMYFeKN6ziICnUcqHTESIqiqeLLBZEo/knYutIBT3BKsDFCEchaRT5rFZdPdXntRSy11r7QuHpUrBciiFpKnoxI1RewdK62tembaUrUGu5kAGkIrtYqiGKxfKNuVPY3KFZR3cvGU4C4VOkUvibxY9NDH46&#x2B;TaqMUpSvuynPkXQmpFgafbyUzxUxK5dZYQGkFpvNmkRhrYx3YzYSGGyo28PFK2&#x2B;u604qF630u67DdPwNlyRcFGV1Z8P5u1Jx14BOUcI4eKTgV6zBbzabIEBFf9Lh&#x2B;P409hF3oen8DjG6p/n6aAtvtnsFVPHjPGuV/RDuu6ZCH4Zm9rznYTf8F7Yx12zsP7CWz9c5uRKDLLk8US4Fgeu6KF3JbmEYBCAAgeu6cRTBEAxXQKAKH&#x2B;ED&#x2B;vcOMXqYSbwnBtQi&#x2B;BlQeyv4G3dq8LcRt1ynSNnFuPaVvcXmm9e299Kzsv1s/Xv5xu5Jdle7FzrvXf&#x2B;NlOBW9f7rlnTdi8M1fIlb3/e4ND8AljZYocvei9uCfafu2737zygB99lF&#x2B;aO&#x2B;WZ2mf45mGjQIQLOdXmVlY4C/vJFWs/9ZxafQaBzH1nQtSAPIAwedFcDavG0y0Bbcaj5prdn87CTgzI0ZV4zdeCDoBGNGeXco8zcmNag1caKMFVKGUFHiL7X5ukbJn6RCTQJ1VVWcBIxvMuSnrpuu6xAHVJUV/QOMBwWIp9wfpXrlEg3EP0VRZFkOtRFSQXkeRfnpJCsqSpwAq&#x2B;M0gDRN81y8vxQXYRloHcRxDEoAehDHcZZmRVFiAjH38X0/lOnCKdsC/J0bBMFeDgAMcXx8fHl5eXp6enR0BG0MNPcw2t65c&#x2B;fXv/71r371qw8//BCIX2N8Pv3www&#x2B;/&#x2B;uqrO3fufPnl3U8&#x2B;&#x2B;QSG3bt373711Vf37n117949iHa&#x2B;/fbb&#x2B;/fvA&#x2B;4jVh9B&#x2B;xDuA8rb5M2nT58&#x2B;fvz49evXGJcrKfsQ7UDD8/w54Dtq/Jihi/L/69evIOIH4n/58uXJycnBwQHi&#x2B;Q8ODo4kZecQiZnHms8DGc/x8dHR0eHZ2dnR0RGm6p6enhwdHZ2enh4dHl5eXMASIP&#x2B;8vDw9OTk5OT49PT06Ory4uDg5OUbVHFbaE1XzY2wWkvUvLy5OTk4WV1eXlxenJyeXlxeQ9JycnCwWUPuIi/f46Gi1XF5cXBwfHV1dXfqeBzR/dnp6dXV5dnZ6dnq6Wq0uLy9RIFR/J8ysa89zLy8ugBQl9mQDUcEGIhBXZNZwmiL8/ko1MyvPc9fL5XqlOg3O0xVdjUAurTVuQCSgcllLYX5DfLlZrwMdUAq0LeBptfIm3&#x2B;GGiJAlfEBpSreBcrBzGARQ7&#x2B;Dqa/Ufi7hIa64bVVEDBV6JNn0hHQbFlI6WcgHvnAktgTmgyrtyHAftkTVYCqq5Zr4S1CnCatZr7LZmzKK6WlGOxeHr1bQP0CTaJ&#x2B;6U3CK0hGV0VotB3gA6N0ZDL&#x2B;VzrR&#x2B;jxK5aGrEoLHUDgHaM7JsFdVcHb8lnbCr5L/lI16qNAWrfiDiH3t8N7BZTpZ&#x2B;vr1b4HG5M/CVQuBbOV1QKOfpuLkXKdbU2whh8kPCRlr6Q61iOpB89oRbynKUqP1XfXZmNuFqtVrz3lap3BE&#x2B;r8RdXxy3gFbYXAHOxNleF75v12tMwHJb2QWUhgNGrbHh&#x2B;rpBFfVfl&#x2B;Ospzt91zdDftbYRrIppY8J/UF93NhscqOTE4Zrx3yldh4V8VOJ9P9QcniAIwiCAuxcEBk0AHg5ywuBO8AeyBc9zw1B8vdtQXjb8FaP9F6/gv9IomDREfhgEsQZj/GLcp7reO7pr/4tvw6Y3A/fZ6zdX5WfQ8DbX3b7irWD02yQ073LUNUBfQO2MJ9xaJjS7xnXLGIbhNr7h2aU7U1C/7sy7dX27Dz9Fux2SXeazSzV7Y/Od4X7C7tEwEyp5bNHdroFAefdy9fbAL6B2nqc3A8tqzQClCAenIkOwHIDHkhKww9D3Pav7jUaL1lU1mMhR9gRo/y3LsqkbXIuGgbpuWjMCjCRB/MGTH6Aq1d0LfQ4X0HUdaIB0EtqWQn&#x2B;W54HU&#x2B;64DqWDuEHoILPkr46jzLEvTBL0C7JwXBe3FOC0cC8gRgr4oTdMKxoCqQngoRUT4AuE/WAxjSVP2HLKsKEr4BNgKwG6JyoHSNA2jKEmQapqlaYbfinGchGEYmlEpu1og/DWFfByqd8jlHzx48Mknn3z99dcffPDBr371K9T179y5g2j/Tz/9DDGdCO25e/fuDz/8wJhOJPRD0P/o0SN6c7/77rvnz54B9D999gyTdDF&#x2B;69XLl9DlP378GP8F9H/29Ckq&#x2B;i9fvgRwlwK/4vvXukGQ8&#x2B;bNAeA&#x2B;UT40OWdnp/g3PL6np6cQ/&#x2B;iQrFOIfyCphyzn4uKCsv4jnbqF4btHh4enp6cXFxenJycs7QPuX5yfnxwfI2AHk60Qu3l5eQm&#x2B;cXZ6upimWV1h2u7FxcXV1ZWOVl0uF1cXFxcL7IPBUhcXIAyYRbXUdPmNFJhR514vcJLLS8cByFsBsQn8UnC5pl1yuURVb6U1WnhnIRf2pY64WimOBJRA&#x2B;RzQkPZNz3V9z3NdB0DZ2WxczA9C/Mhms1ot5ZX1KvB9IMTLy8vVYgGpie95WAYuLfqW9Wq1XAAHe2qRBACFn3i5XGANhJ7iPcWE3eVSFNieq&#x2B;IQKU6zdbBer11nI1JnFFZdd6VTV6HhkbbGeg285PveQiKGNq4YHnBTK1d04dKjcB3Hc12pXjsbV82hAKyu64JBrVSDvmITQyVGCsfXhOBL9VSQpWgpeqOGabpRNyiiA4iHYYgnudYaOQPgIXSR9s56rcJvhlqu5I7AWzxvY6I5N6qDd/is1O0KkrM2shbAcd/31Mmw8RS5ypuyWeOprlcrPGrAcer7dUk07MrDgSrJ29blA/Wu1WCgfRZ82Jbr9QojrpSvOkTDwkxUIr/WhonwEOOaBcXd6DBdFv5xOU9jNPEtrBNPD5&#x2B;N9VT43wATE9/zWFblHV0PXnQ0rmetpXqewdeJuZ7nJUm8UWk&#x2B;XuRurib8sCTvqtRn9l1oeKjfB3ZnCZ&#x2B;wnqcFTKcJmEuy2J2IP1DzbhSFaZqSDBD6cze0wT3PnQ4MQ1&#x2B;HBoBpoGPwC6OQmTQPb4eMOxXlcQfmWpi4F1Pao3YvesMhP2Z7j17B&#x2B;I41eG6Em7NL99en4N/wT3OqPcfOmJvV1bx1eTe844Oq8PcuZq8OigV1vmi7B7ZCT8HMuPPBswL9rpuCUBVeD72J2Rmv7zB0GvszGvmZZQjjOAK49zs6t5kKv9GJeLwFK&#x2B;5nCR9LIijnMqqqJp&#x2B;pdIJvpyOK&#x2B;75vGpk4xpsaDQVqJfynws51XXddS7FQ27ZDPxRF0fc9Vfi9CqhaDQWSpTZN13V5nneaRtp1XZblhPXA66iygyR0SgCoL4K8x2aPlorg4RYo0SWApVhnitFknKUZq/joA8CCTFEQ2gWQ&#x2B;kh&#x2B;aJrmuSaTKj1Qj7K8HsdxVdVJkiRJSi4hboQ0hRwIjQJYBThpGA0BX/4qBDBUcANAXCwWZ2dnUNI/evToq6&#x2B;&#x2B;&#x2B;vjjjz/77LMPPvgAsf0fffQRKvoo7SOd8/79B48fP4ZM/8mTJ4jhf/LkCf6LAv/Lly&#x2B;fQMfz9Cn8uC8wP&#x2B;v585cqyj86PHz16tXZ2dmBbiZy5wjQH3k7cPHSoftGY3NQzj87Ozs6PFwsFoiwPD8/h1v3HHqekxPU9Y&#x2B;OjjBhF7oaCOuvLi8Rw7&#x2B;4ujo5OZHQzPOzk5OTs9NTZG1Cl392erpcLs9OTy8uLs7PzjDeFQwK34V&#x2B;ZrlYnJ&#x2B;fnZ&#x2B;fIYMftX8YcBcy/nYJPrDS8a1Ierm8uEBoD2bWSnrmlcy3gmMVUYZIoIfp0PM8DTYRbcnV1SXQ3sX5&#x2B;Xq9gg0AJ0RpE9BhsVhs1iuMalpcXQVS1Fw7jqPGSgErYRAoEnIcZ&#x2B;O5LtT/vu&#x2B;t1ytnsxYFvwPtxzoMAvQigKED31&#x2B;tVhgyutESsuASldQTy0pjwXWlTSEikBXwmes4ItJYrcArXFFRi3&#x2B;AuAoMBFgNGidPzY4sx0IsIeojFIZN1Ik7RaaI1p&#x2B;BoaAoi6srV9kDVC6BRqRL0M1iAb60UiPmerW6urzE5XBHa4m1WSqGdNarVaDgSXgQ9DxotqxEDQXFNJozqBxvaCfV4jrMAKw3A9dNHYnJJy0gWAv5KDCLzmSlbMc&#x2B;n5VOEFM0DBC8Was1fAqZXK/Rg1qtVqy&#x2B;g964ExeCXIee1OlelFG4a7XP4t0R/imMS5KmXIX&#x2B;2sLZKCeZbhCPAjq0tTqGV&#x2B;oSJlLnpfHBsmV73/eVLLmbzdqbsvllLBdYsW0gSKNGSIKcyvf9xWLBfwJekwOwrC7aIU7t1b7WYrGgmp&#x2B;mWxba0f71KQHSY1GbdxwnDAPsr592JwgCKG0cx4FsD7zRNZN6VakPJiC1eVzUEoaNyRQKtaiPd1zO4Hko8IdB4Pve9vQbn9A/CALf95IkwSXZAZAGeBwH2wODpw7AbbYdbDrTaezRwe&#x2B;F2jdU8Wcik92jZnjaHrl3wTfj6Xffpur1e2iQ3iaeucXlb2cCvnkHe3UruZnV6a8lGNuKoBuuTli/ex7KZnYXJkddrz5qt6cK9P1U72cUDw&#x2B;0xf5ePbu92XhpaHv6Se4vB7KE33VdL9OOJ39CXTezXgGpAo&#x2B;qdM5Ap3aFqqq6rmfzoTGTgPn1qD2Huq47OU9td8CpcKPiH&#x2B;i6Sr3FOFbNAx0r/a2JEMWLmCjM0j6&#x2B;26iOSEcENDMdEckAXsHXTPYsiyk8NNO5vzw5uwpJkjQ6rACXsAaDqqrLoojjmN6AIi8kmCjLcw0GxXkQR1RVVZbnSZJo1mgeRaILwosYPZZmWRhGQRBEcYyBZSAMSBaCUigMw9pkg65WKyDXV69ePXr0CGX&#x2B;3/zmNxzR9fXXX3/xxRf37n313XffffMNVP33gfIfP378ww8/IE0fLmGAfsr0X&#x2B;nkrNevX0O98/LFS9HcHx0dHBwg8F5K9aenh4eHJ8cn9lso86Oor1qdsxOI64&#x2B;Pj46Ojo&#x2B;PIcE/OzsFK0DN/s2bN8jBx4xbKPjxNRJ4oKc/PT09V&#x2B;X96enp&#x2B;fnZOcJQLy7Oz84kFvNSZPfIkgcNQGgS9oFiB1HumM10fn4OTTYMuyudbyowTgy4lwhOAR&#x2B;4uLjwPBccgH&#x2B;nkc3OIEho1qF8QFsAlXJUoF1nAxWEs9lcXl4A71JC7Tibi4sLVOh93wduBq5FUV&#x2B;MfY6zXCziKNqs10iUYtUZsGC9WvmeF&#x2B;h8UCB535dKv&#x2B;u6aOcLNlXVMcAQ2wKB7wPguo4TKJCCqBooBYoCRrtgH5IWnAdIE7Iiz3XXInzaRGEIHOPpSKPVcgG4NukhHAfeR6wWZ8NdgHhghXA1sCYKj4GAv40UrT3PxTk91/VcGIWX0PZs1Lmr1XEBoFSheJ5IX0hLpP6NIrGqQUADVFUvSn35n&#x2B;t4KlmB5gff1ZzTtbcd4r5inPzk65BGC7oEuLX1eu37PoVJeJcdddiCN0r5f71em5FbeOPWcu9T8D/r3JvNBj87ntaYN5s1zCe4naW4wx3AR/QNsCe8qkIGHAfNK2cyzi7xAQYHw30RtoJsrCQElsX7jaLttTsNt5IeyEYDNCdwr6yA94I31FH/g6t&#x2B;XGiBHP24OvqeshniuS7efYefavUSOCrXYWUdtW22CMBscQgZAlsc5CpWbOM6jpoKhL3gp8zZbMIwALtwlZlQ2OOYV3hfnmR6esDwlAnJkjYbaHgEvqv4Z0LnOqmXFX3pIfg&#x2B;&#x2B;wZm0O9EA8Iw4JRMfMuOCNBV&#x2B;fwz9wuWGC2usuhwF7DurdnfEl7PdS9mbNMM3gkwfRtcvoFR3GZVu6KU647dC1v37nnLR2GR93U1&#x2B;L2dlususZch3NxIuXmpvbEU7y2xT6xgh5vZfsW4TSrs58cafFlZx2689K5eiGvr9nnKe03cH1nFN02GGa&#x2B;YMSLgZkLzmcje9gT4T16RduTeBJX2Rgs06LAwu0Ojk794RVzLqomA6XFHVVWxLYNKf1VVfdcDhQ&#x2B;GC6GfAJQ8jmOR57UMHZNwUus2HoahUK0O0DOeIWJ/bKUfR/XdNIZMKEff0xjAU5U4UI8qiqLQgQAA7iI3KktcEYV8KIWqqsqn61YqNKpoCMaLZSmcgf4EERSpmTiOY6B/rg0Xxc7gJ3GcpEmK34nQC0VRRA6wWq0ODg6ePXv2zTff/PKXv/zoo48&#x2B;&#x2B;&#x2B;yzL774gqr9b7/99rvvvkf6/rNnz54&#x2B;ffbq1StI9on4X796/erVKwhyXr16BQXOwcHB8fHJq1evLi4uINZHzR4bKvGnJ6fA96enp0jdgdrm&#x2B;Pj4RO22AO6A&#x2B;xfn56jlA8qfaiYmNlhyz87OFosFTbqnJyc4BFocVPrBBwDKry4vLzH6SlU3UOmgqA8PAKdc6Vyt80vYczE7abnEyNj1anV&#x2B;fgZAD5x/fn4OkASpzxLRPJeXYjbUDHUwkI0YNxcyVQqcAUjRdZFYT5G3BOSvV6xqCxpbreApXK/XYRAsl0vMKHVoXlytANBD5Po5TuD7l5cXm816ubgC8AX4Xi4Xrtj4QgIOFwH/joO0HF/lBEjuc2Ao1HohdoDQwnE2QeCjkxD4vuuIJCb0fbACFDiBqBSQeZ4rcDzwfQDBjXYANip7cAEfXRf3wifgaFIKCrTsLaCOrlJsR7LMFRLps9oEvu&#x2B;5rjMJPEQfgoI9jAd45J52MAT/ue5ms1mo7cGhZAVv1uSqXMNogS826zVK&#x2B;54Wg5EM47kuGjKOZCxqtMtms1E1ztr6EHC/iIjZbPCU0FpBWNPKmBBQ9KUUfrNeE8G7rrNZSzT&#x2B;Rr28zmaLjahoRwkesmhUpk&#x2B;NkMN4U61/r9crFICxSOBRWKs9mW8lOaT4/IBT&#x2B;b4fBsFqChRaAXriFU&#x2B;Nzhs1qtqOgaNqHH6M15pH5ILPqB4Jj5qSJzJAtiY8bSs5mrHDXoGjrhVb/KYBwBGJvFDWjYp8KOPBZwkvTh8DM&#x2B;HLkRaBS3G/XGWzobl2s9ngWRGv2/9uNJUfGNpVh5irbQHsoD0EjwwEvxbwk04ywOccmFldxOJsBeBam80misJYUzs9z4vjONT5AGQIOAp/sHgVUgWwCxKAKAzpGUi0743//sICoBvAYmfycPaBvGk3&#x2B;y0Iqq/bma/sovBbKpH2btfRAGt1eOv&#x2B;N5TA9&#x2B;5DqPej&#x2B;wx7Vj7emlRw2/v03rtvsG&#x2B;HrTu1uNzuT9nMLn/YfcU6hvt9wygsHZo9bRHkGKvA3s9StzMXrDc5PBZ8j8ox&#x2B;PVgZhEM6gYeTe8CAL3VARfNNKh4ICLHf1vjaiDHsBRiKv8rOafrgBqhvpskRmQpwOyo63M9AqbzvFefA1/BMyeOL8uybbu6riHI0eyginCZWUBoEdjRAXUlnmOag1nwB82gCghuBH4ryzLkh4JstG3bNDUupvOAUxIP3CN9Ao1OMrbLq&#x2B;saoD/PhbFo&#x2B;6KEjbjUgWVN00AUJLFCaizGAIE4jvEMX7x4cffuXdh2kfj55MnTx48fP3ny9IVabyHUMZX4E9bsUZh/9fIV8D0h&#x2B;9HR0Zs3WtRXvH52dnZ5eXl0dHR2dnZ4eEgQD4B&#x2B;okj96urq4uIcavuzs7Ojo0OK8hGReYHS/tnZ1dXV0dERIPXlJQT0q4vzcxTOoea/UoU9knNQ3ef&#x2B;UAqhyo5LIHPz/OxstVpBTQSBEMyIkN&#x2B;Ihme5hCIZ&#x2B;pzVanlxcY4MyouLc/QNNhphido8ziCnury8gsJnuQQMhYbEcZwgEHPhYrGAkNpR5KolYKngAvABgC4WV0EQYNnwUQa&#x2B;FyKkT7PMoViQbPL1Gn/4N5u142wWV1eQEKjQn1DV1ergJgoDoC4A7iiKFHm4nuKdzXod&#x2B;Bri4Tib9UqUCZvNZrMOQ2EdzmaTRBFwvIJvD8Ao8P31eu17EvO3Xq8BxdExABpGeRKvuCqJJuVAedJ1HNeRCv1a40RpIPZ9P00SoHyUz0WjryIZkBYMJV0tl77vi0HCFYi/Uhur6zrr1ZJMwFdMBq35ZrMJFVpJMVuV6BsFfKgWu1a2Tr0Q/KbCWFyFkhvH2aDizko2FsN6vyMtAiFIqIuvdQSskEYVJvFYqdZvNr4uGO&#x2B;s7Ab8qs5pPB&#x2B;s1rfx9jI0V&#x2B;3d0s5aqOjFI6HaaB6lo7MjNqrad1WdhUuDaoKi4DNMokvWofhbtTSu7GlvU1siUgunSAlQHp2ijU6qYuWbKHyic7q5GnNJWYyjoZzSo9CyPXG8vUfbi9io&#x2B;9bXDB/XdaDAoboGFltb/vd042LIVfgcsCcL9rhoqPJ9Tz0APJuKfHzXcXT6ZMBveSblU2iAPiuSDQjxFdMjHUi/RYWP76sUyLNQXn7zbEcABZoBihRsvIIXWfWniCiO419ch8Z2X9zF67ff&#x2B;r7fladfe&#x2B;lrRr1ed/K967lutTcs/q3inJt32AXE/Y3mh59jm93d3ocGSf32URMv2qVeGNpgJT1EluN2HX3YtgTs9oisumZvj2LQbbZPvxOiSsnNDN9zf7YLVHUjpXQgXfM0OqpuWtNPsP0Nnq3TW2bXAuaB3jTKiOmJy8kx&#x2B;KLNIGKhnUX93hiXKeZhGwG3gzNg4z7UJuHM/TAA7PaK&#x2B;AHW7RUxJYCxQnVdY7AX/8lD2DQgOaFGCHvmeV5rPunUSchyOgpwCFRDqPq3bStzwTQqlPFEPD8TSPGtuq6bBsOP67Ks7OVgOAatoEkAN5umKR4AngP4Cc7JfkUlTuWu1hEQ3MF13cvLSxS8Ly8vl8slcDD0M/AGKCi/OD09vby8vLi4PD8/R2EeowNQDj85OYH8Hd89Pj5eLpenp2ewwgJtw8OKL1artVzo9PT09HShO6zX66urK0TjX6mTFrgZa0Md/eLiAjJ6qOpxXaz59PQUqhtxgmoGDigEzK8Q42zWa2TqLxeL09PTCaAvZGOkD0QOyOXEg9psxEfrOpulzF5dg2msNQ58QzC0XK6WS8C49WoFtc/l5cVisfA1VFsk5joby3UcqcF7HmqlK01zXyyuXMfBX83NZhNFkee5wLLisg38OIoIQaSkp&#x2B;U0B3Bqs1mtVlEUUZwTBMFms9Z5PV4YhpDHYMFRGIZB4LsusLUDdbh6GXFCsYc6gvMAvlFHxE0BGvue5zpSiVT5hKjeN2K0dR3HieOI5VWHKmSdhBqJLsJxHScKw8D3kzgWL7KaERXIQkLtAnei&#x2B;u5LAIoDcOkqdJKypedBE7LWOJqNVm0BaFCMdx0nikJRya9WzkaHLrkOn7yv8JGIGUXiwPfxDOFngB4MgSquKcxvtIqPzw87DJL&#x2B;uY0p&#x2B;c6CMapSywt8f7HgPARakB3GBAFnUwMDfLnSVNDVyoYOSZYrcTC4imMW4OqcOKqeXH7twjQiIBvxUK4ge2&#x2B;1kqK&#x2B;wzAc9lmoVlLygOaY5PO4Lj7PHp2yygRcdVnwJHj7PP2cAWcbjwF&#x2B;bOUj5JnMSmnpGKW&#x2B;p7mW1E2ttPuEZ4hPHT5Q&#x2B;NyyZh9FEVsKjjJP8gQ&#x2B;Z9bFldG4249I1G6WEvCnRii9xy8mGwAOZCkdPzIaHCcuAleJAQ5k0j87DKi7cyyXLf9bIhGQaXgeAuu0nC/6fp6Z821oNJgS7UzeD1VA3B8OATa6RQK0ixGvAY5zZf/217eK5bnlPu8k3bmu5H&#x2B;bNsINDZC9Fe6/Zds11Xdss9ct2t45zbyzcV3Jf9wG8bPGUd/1u2/szaeyJ7Sn3WWnFrKPhpN0muzJdsSwPerOsjX&#x2B;Fxvl&#x2B;1KnN&#x2B;DeEgNrLOblyBMYucOnwQNpPLCMYtR6P2E64jhHJUKgB6zot&#x2B;wDyCSBion&#x2B;vU4ia5qmrqqu61ALr3QQmMX0nc4TAKqerMNqCaDkpm07ugVYYmfEJy5dQJVfVbUOMSh1xjAV/5YS0G9QFEVVTv2Dqqpqhf54lWcojbKorhtohJqmaduuYV&#x2B;irqGAyrNs0AFtXdc1bVvLULPKtiaotmKTpzVTliXXSJwGOX7P2gIVk7NXyJ3UrwnoAfEhfbm8vFwspvmmqP2jCsh0nOVyealx&#x2B;GAg6ynafI1aO0PEEZiD8vbV1aV27xeODtQEXsEhSD65vLxcr9e4nE17xDmh/xEpswa9Yx9eBVONUInHn0xeEQ8EJkg8IgAvgb&#x2B;KP6B8uLy8wB9dteFO44vWKMO7MhYXQMrRsy2urkS84YomHhglDAMUzrGGMPAhBAJyBTB1DbZwNhOqdgWR&#x2B;66idoBUVBahogFwd5xNHIae64RBEIZBFIWwCuBvNiuLKJaHUgX08FcaiCGOoigM2UZA/RW8Qqr&#x2B;FAngpFiSMxUyAUECjVMMg2CzWcdxFAYBVotTOZKU4qpgQ5oDeJKr5ZIKpY0KJAKtTeJmpZyp3YyJDzgOnsxKgyDhAxYZVRgEgQ8Og3fKdR2C&#x2B;EAxlwMbg&#x2B;pw8AQ8pXZ4m9A6ELunegCAjEHAXM1ZIgdAKgtzlmTkgnAwh8KwlbqfIR8SpCvjGiTwh/xqM3kSILhaowysWHkNiAmpFXZGGBH8IUr8pOfDbg8L3rQ0hMyeV8CKcr6rYhhcFzxKWZ8AdML6WbUb2idYQrUPoAZifJyMHcJRYY&#x2B;rwi1HXbnsAChUNiNyAaxNvRwfb&#x2B;mt6RYE/nq9Dgz2BZYFueIPpu/7&#x2B;Em0PYcg8F3XQStuo4KrjdIgPGdPOkIeObBr7LkA6/J0NZDU3e5pkClZnuOoegqn8jTkB15hNgFkGpf8yMp1IhX2sPAvIn51&#x2B;gL9K4WY7LzE/aIj8n0geKB57hMqPyENiCT2OoGUiB0AWAiuNQHP0BiBy88hcRn2lfyxdcYVursqnmXv68MwjGa68Nbh2zaGmXLJro1ftBoQfp2m5a3b7On9tM2Bd3pfbuYzb2U7sxuxsPuG5e2yuxlpnBG22XsxIxXE903TMBTIGjd5EkJne5V&#x2B;O2x01gEwK5w8waPm/fPMxP1t2zUo9pv5cazQ043QbicF0QZAYoDwGV6U9KDXycSNcfc2TdO1LcrdvWkX0FLMzgDr2ZQbaQm/7Lqu7wd8lwSm1mHAtCZjQ7GcYqFKzcTW3avthYbWXqBwWguQ2wMC0OrY49rMLmiaBs7muqrqiQIpE1LrApzB/CfOzyeDJgOffykDj5uiKOq6wiKJ9ZU2TO5tvn11XXeijGqnsKM8h2yJs8myLNdhAyn&#x2B;irD36qkuXP6aThbNjWtCqYnpPe3XI76GyYOeanM5gGk67WYDQS0Jxlocn1MLfi26&#x2B;aXMRnUciHMEc&#x2B;uQzs1mg&#x2B;h3jkQFEAANQP2esJ4V0LUOz9LcGsFSlN9AV4OyH0HSWmMfNzR0irR9Q5oBrOxMQ5Qc1Ox9/aO6kXCSJS7naioOFBqeVvgUUwa&#x2B;7/meywKkYFxdVuD7iKoE3Pc8b3F1BZSwWa8DXxQmogdANQ5h4VpiRxE9DPxI4wUFhbtu4HsEHGjxA/pDExHHURgGYeCHQQBJku9JpkcYBJAcAQqTwwB5BCrzdTabMAjW65X4B1xHipoo9ptxpHggvu/DRYCuAvAI1CyBFPcReOI7SiE8ZRoia1HIu1wuhGn4fhSF8AHjlTiOsU5Hq&#x2B;yCeh3H8zyGwW82G4A8R4Xdm/U6CGQ94E4ghGAIGy1do5AK8iAzB7TIjR8cQaLaxEC93JnE7ht8VxRQkJcYfYvCyo0W/je6eJeol6V0tiOACHWOhOPqh3Mlw2vdQKE/f4pBFgPRoEucq2NiLh0NR&#x2B;IT83SUlS/isWn6LCvc6itYuaY6jh80/vgTx4eKm/l7A6uTbo8&#x2B;z7V6313XcaeJE7J5msNDSoCfcTYEmB3k88OgK3e0YE&#x2B;ALv9UzmDvwhcT8yYMRW/jKiXDPlphhwhnkuJgYUTquHc&#x2B;ikDS/UM9yaQI8jR5k0QCl8YvfF/DhfA7JwiCOJ6AOHbjjF5CfBQKpN4vgp8Av1sE32sLgs5g/Fcj7CaUj&#x2B;o&#x2B;bpMBo&#x2B;w/2NZBqHPEbpsCNG4n/9ywWdx2XY35ltt1fMNCtBvWcPvLvXW/vae67vx7r37DYt4KuHePJR971wN/zHaby93yrnffWb7Cp2dRuN2ZQN9W2WcnmWmBbLWemLszYH3YziQFSKYNd6TnWIE7lzGYcNLO6KA6UR9NI8PsI7JLGrXDoGRmMhtQvDQaaRB2A1rFF0VRDMPQNNP0sbIsWe2G4J4Im12FruuIa6uytFV26nC0c1B1JsKIG9ZQGXPwVJjXrkWJ6QB1XVcVroXnRlbA9eD/SkXzpWYWVboqXIKcodER0V3X5XnBmy3LstOEVmEMyklqmZ42jZdumhbn7Pu&#x2B;beezn0kGeL/6BGp2M6pKtEkgNjrnOI3jGLFC/IXreR5GILvqBmOFzFdRLItezpSCooHWWttDbR5/&#x2B;NeaTQ5BBarynjo7HQUXa40lAdPAOVGn9ybPnBSV8Tp8h5cXF4HKal1VLGzUzrjSQHp4dcFD8NddRAsMBXdEPcwmCf7&#x2B;AYDyzxglQK7wkwXKi0S3JDyeFBRXwNmBemSBR7XwPMX8AcEEgU&#x2B;M5bouitCQxDgisnd834ujyPfcKNK&#x2B;v&#x2B;tEYRhFURxFAbW5nhcGfuADEPiu62CcnDbg8Tc4jCL0/X3wBN/z4jhC8o828X2EgXKEp5bqPTAT3ITneVEYxFGUJjHoBxoOuN8g8DEmyHE2wBBQ&#x2B;wTT5CAfhXMBNL7nbDar5RIF5vV6ncQxiEocRzins9lEYchWg69gKIlj3/Mi1TOw6uw6ju97zmYdaq45GgVsPqBpAIV94PthEKBwj48N6vSb9YoQFpJ1TwQenuM4cRStVfvkeS55m68TlzzPc7VKHai9FXxAtC6o3SqmBGASU6nrqhxfwvvxkKHXUtbkKpqFLUHgpsj6VyuRKmmmvqsWVSnkOw4KvQSgDltJnrm6ZCW5/tS08fhzKkmj2iUAswo05Yko3NW6/tSrMeJ1xbtwn6/xywQX9dSYvlHnjJSrlXm6OlELl4MmCm0r&#x2B;3tsvV5HUehpwqanz8txIMbzQqrklZB4&#x2B;oRVDiR3HQSSwOMrR/XVh&#x2B;PrZF/eGj8J3B&#x2B;3jp&#x2B;CMAzxG8BVsQ1vcGpE&#x2B;MLewV0Fc4chLkE0jw92miSeCodCo&#x2B;rBDzt&#x2B;UfhqLKaUyAJ0z/OSJOFfBMR9BkEQaj8EwF0yf/Snnr9lsBvkPYFO&#x2B;PJ0B14Ff4M2m00URVmWTRIgi6tuAHZb/7x1Fqc9g8VzN5//hmNnQPCGo/ae/K2AeBeVvtP&#x2B;P9f2jqu63SlvshfvPrS9HaHrDtm75wypz/Yh/iaMHhX6DyZOZ3bUbiOC5dtZw2F2rG0L7L3BwfgZcMZ&#x2B;23bc6NQwXr1Xi23f951W96uq2sX6BJdd26LqT2OAdQbbdQoYHYammazSbdvCnoH6/aBDhZum6VX5g/M3anEmbaCyRbsBFf7bbc/8wp6NThkbxxFYvGu7oe&#x2B;Jtq2vAPcIPtA0bZbnLO0T93ddVxRFp0SrMVPPiLbBW5qmpbW3aZqqqvO8UNlSX1VVLzKntqrqpm3rqq7MqLW&#x2B;70FBWO/HHRVFAW6DtwaPt1aWJQ0WbbbwOeD5tZqmSj9GkRd8tswj4pgCBBNFUYT5A5BLxXHsum4QhPh1jD8ASZKwMBZIyLQfBiGLOsAu&#x2B;AuKv7uuGWLv6&#x2B;YpW8CfAS0xyl9oX4fReKrQxZ89yP19LU1tNFbcMd7EUI/C2pbLJUQvnudFis98Ovwcx3Gcq6srD&#x2B;INX0q8qGZRb4M/4fibh1ldqBNfXV0qMnDpBIV8f6N&#x2B;VhbFUeIFugLuBAdAHRER2lEYsnwuTfMgiCJIe&#x2B;VPOEhDmiRJHDvOBn&#x2B;MUaqH8Bd/3eMYkF5wdqTl/CSOfd/D9dIkQc9eFL1hGIWh57lxHEdhCKiKcO8oiiTDWzW&#x2B;kYZ7hJIg7rmOgx18hRdBIO0LPm1wCd/zgknAg8q9QE&#x2B;PDYHAD4JAvLxSRhW4Bq4FzIcnFmhHwkwz3YCYgSEIzILWH72RIIiicKOiI7xHur&#x2B;TJEmkSg9HRSbA9DgP0fxGJ4utVivPdcIwSJI4YpSK66IzwB4OGhqO43iudCeA4Tz9kHgmSz6AckYnUoVhuJ4&#x2B;pTreC3lQOqrMMWOwFIsjHRXeazg3HMhd6FoG&#x2B;uV1VQrFICO1qLqu67pRFLoTG5FDQL832tSyENk1ohoCXzCTQNzh0&#x2B;8E/UXh8cfZcgZ9IOJWV7a/IcL21X1LUoENENnTTgJfFz6jrCBU9oXfHvhUk5BjtYER20wdM1N6T9NU&#x2B;MxmExitji3Ao/21UW8A326W8wO153r69ARPhwF&#x2B;03qsyqu5lr&#x2B;ZUc1JksTzvEBzPAnfjfLHD8wELryC3xr4/e9pmZ&#x2B;m3kDTflwVRBHHw9RLDkC1P6B/HMfyYhDgEmmaJgl&#x2B;J8nvEyp/aBFO0/Sd5wBcV5WfITNWW/eeZy8ae&#x2B;ulZ3ir2xdMdPMZ3vr6O1X6uZLbrOH2J3y/a/3kxX772Gdgup/q69fW&#x2B;2dl&#x2B;7cu2H4wZpe2d92akJ9OM3l4RdsaIqy3RffZJTqzDbrNngNP3mjoJw&#x2B;hWLzdnnqGfB6SGQsxWc6nOoXftYh/NPYJanvwXz5broEPZBiGSjOCum2/gcBrBd&#x2B;NjhPG4oGPQWBQpCe0JaYftekhlfW6xj69egag6il1/DCK67AIC&#x2B;6vKo4dQEne6nCg98fCAP3l9UK6BH3fM&#x2B;iTD6RVtzTvgmvrtrVMXSfIvjYDHwZRcE3Tmsln&#x2B;r5H14SPouKUZeUGlfQ3pHnCjg13rtQADTaFTNI4jpFkii4BlEMozKRpGhgRJ/7SuK4bx1GapoHvZ2kqNSr9C&#x2B;BoAEWapkHgR1GEv/FRFK1XK7sDEJVrAitC/MX1RfDhuW4Sx5vNxnWk8R3gL6LyBOBymUdD95swkDU0G9D2AHX5mqPC0rjjSF0ZfzvjKILwZrVa4uRAoqhOoU6MkwOa43/IsAfIgzMPeCJFwp22CzbrdRxHSRy7rgvEw9peGAZ5nuP8qJn5noeHH4oc3wtDoQdpmoA2JElMhqB/s8X1iwxQQUJR5HkeXokjgQRRGPieh4YA/07HccTD2foPggAwV8qZat51HQe7R2HgOI6YDTwvDIIsTeGyTZMkikLf95I4RpU6jiIK9PFuYg18CwD0lNc5nusCvniuG0cha6LARmEYpMpdHWeju009DVifRXllcaK0udB10Rgl7XeFZhyBp/zE0yKxiHYk7EXiU2EPVWgl9lOcB&#x2B;8gGjKuQm0uhIXqjWb4iDFD376N9o6gs0drAuBY&#x2B;yEiCgfxmAiYnh/qGm/Sr&#x2B;tdKL&#x2B;CZknguKp6XFemSYBSOpqGhJaUo25XpuJQtk4sy2aFI9E94lvAe61qmdCdELlE09rnA27jaoEcd&#x2B;1qrV2XNL23LAe4pDFGoiPvr8rhAoO/2QIlcOf7CIribkcA8SS&#x2B;BLDiY&#x2B;X4bCMoygewdg2y5&#x2B;9AYnFPJW2B6Rhw/4DFeX3CrrqBqe3k5qsHdzL2OFImwO8BHkIRDj5gcRQBtYP/S71fp3cFiv7JQ/TRTSMCIBEkDYh0wxXRE8A/QQnwCyEMQ3CDKQVoBnduuf0kpWjCFPyTkG5Q9Hebk&#x2B;zFmru8Yr8f4N236dhbwO69nOc2y3i/FsdtjupnyH0cx32ehBmY3sXHN6zEvrKHCuq/ZtTClv/5OpE012A/JNOnZdvvYa9r4b49s/3szdhLq4E/3K0zyn67p10Yd7Mc2DYxeiP&#x2B;YYm6N37TmfqftgQuFedRUNtRFMTlEfIClY4yLqACgMapKo1Fsp0BgHXyBzhrbVVb1P9V1W6X/KuybFTVM/RD3/Us88OXDFaAq7OZwP&#x2B;ygcA4INiXCd87PYq3DP7QdR1swM2k4&#x2B;&#x2B;KYroKHgh9zF3XtduhT3zg4E6o8bdq8uZ70RmLBYG&#x2B;XTwVWdr3QN9g4gCVBqHSupAkSZ5lSCvC5IE8z/E7vSgK/AEAQ8CkZOzGuLdUf90nWp1K4higE4pw/OWOo4h/oQMRpYjVLNDAOFtnYlfd97wkSVCfI&#x2B;gHCMafn9SEykWaMB1o9xnnT9NkqszpH2n8WY1Uyu&#x2B;qsTIIgigK4zjyXFea9a4DiYKz2URR6DhOnmWe66IJDvUOq2Ly99U46lABwx9m/t2Nogj6HJTnA9/HSVQc7/q&#x2B;J0143w8C33OdQBvxrPcnSRLIMB0g8jAMgygM4yiM4yjWMmAcRWmS&#x2B;L6XZVkYBh7fI99TCuHjlkWx43kob&#x2B;NF13Eg&#x2B;AHCjlQxDOIksgH9ny/KH236A876PhBqIMoB&#x2B;KS9OVh3nDiK8NCmIqgSMPQKAgVPHtM21Ujq8yraBxAkBC7hAz56lC1pdVky4KfmgO9R6uOr4zng2FRe2vMAPn0hMJ4H0bmDib8yuhVZnKwl&#x2B;4rtPC3nU9CC7zkqnY/0gydiEtfB4fyU4kcJUDhUzjad2VT6bXXf1cAcX12k7LdIDwFaKQjr2RnzPAzqAtlwZDosRklIHw9AU8kSKutQf0kapmtaDYTmvkho5L7w3WA70sDXVqGjMkW2HO3lXFWIeSpwomNBH7sfhmGs06xcmfBAhiM/X66Zzot2EJfEnz4F&#x2B;lNyFz&#x2B;TFNbrc9sQ9Bs8L/xEfldMWf4&#x2B;GYsvjpRgInWmG8BfI&#x2B;HWmy6UJlB1kCd9wtj3ffz8ErLzBgMd5oWmLlsH&#x2B;Np13SSJ8UOhv2RC/tKmizdUiamvPRNlGvIrS4opyl7QheZ5JgJwQ/lz7ybQ531L5vbkP231egZbdwDx&#x2B;1zrnVb4The47iErTLzVyfZW02&#x2B;//zvvcE1PZnasPYn9bmfU9uPOJ4h77tKG2bOaXfq67g1JyO53OzPEd/at1gT7WDhoD7SF9lEL5LbST7xuWwG90lqSE&#x2B;BRXouralSR0ht6g93YYOnNeDLC&#x2B;q6dBE620j&#x2B;OMjZ4MMIhKnBGvTSwOG4OJXOuk5CXGphRg1YJizt1RwAZ4wsiY3gVhB60bVmWUOVYhqCHCEGyDRPqlCjmIQSHoIiOXkJ2qvwbNXA3xuyLuyYr6LquUdbUTnbtrtIQ1dYkhNLD0Ki6ydIbdicsw2EiapZlPLAoilKN0UVRyPBk2AnSpCzLOIqyNC2KAn8bKCtK07TI80iNZfrrPgAxkL8T&#x2B;mcgCsMsy0xNKFDBjIe/LaGm2umfSQcVaHAMtpIhh8WfOk//fuPPT5qmUPigsg71SxhOOvg0ScIwBILJ0hTdDxAVX9OvUf1F1TOOYyhBRJWL3TwPkpvNZgNJepomcGNDwg65TpIkWZZRsx5HUZ5l&#x2B;GufJDHAO86TxHEQ&#x2B;EkcJ3GcJMpqwiBJYlTNEbCn3w3wShgGSRxHYZBlGR4LFp8o8cBAH/mfcjY8B&#x2B;yZgkIEQZZlYAuinwkDoHxgRCiLoihiy4KQFBgXYoAkjtGuAbgPhdRBlSSPFGeL41ikQeqvDbQLASGN57q&#x2B;RKY6gagOQjx8QcBiOZhCEuNYmjkslrvIQnUl8WaNernvqe8ZYEWDhpSEEPyJFgLSFN&#x2B;HvgjQCUAZChBga0qqhI&#x2B;ITl3gKe46MGcOFahhVew5uCq98FQNr1B5iopHi4kvom6Nswk/0V4KGALSVP3tFsQEmkkDNKYGuBaeCojmPU1AErerP6HtIAhc18FKfOjj8Tx1gAAU81rYlhEH&#x2B;AG3GJ0aMGJ0n&#x2B;07B3GuU0KO2I6VMuGRCq1SPb2nlACfPQluMjIk1DJEDuR5jjN5edEp8rVbEqjpNo5j1yUrcBydFkyG4Kv5RK04&#x2B;HCJvZiVkchUPXwVGnmGImLZouniD5u6TfxtCWVoivT8YHvTM0cjMWKBP0kSaPG1GD9V7ukFYl0mUY8Bfm/jArG2iPl7nhUcDvniKDERMWpIRRgEcRyhER1F0S/2Qqu9QOo2&#x2B;8y&#x2B;4HYDRLvhPO/x3ev25N/&#x2B;2x/yTi2Cn6QZcsN2y27AbLuuJH/Lna970WL0vfvv7RhsUb4bBfp7X7G1dn5h8TcJAxkmF7CXBvAVwvTBKI5m9GMwNmJ7QlvXtzzBnhNbowoi7DMYLzKhea9aIKpQsCGtnxclsO40/p&#x2B;A3kp3RjEqjFb73m/LivBP&#x2B;FnJInD4rhS&#x2B;67phmByxJAN936NdUFdV3/dN07YNkH1DGtBplpFxBbNYLpykrrB&#x2B;&#x2B;W7btp0m81Dho&#x2B;r/jpV1IvtmsvY2bHRwf36LWqBeeyx8xy3Fwv64Sq&#x2B;qpxm&#x2B;x9dlMZEZMkD7T2ygFrRi8/aFtKiACjtQI4S8UfQNkKEUhqFygzTP8yiKyqLAn4o8z&#x2B;M45pRl/BN7ZlkKHRFoAA7Ed7Msi2NJkEAWDQrMsdjFAh0aEyVx7DgOpTK&#x2B;Kl/xN6bIc/ydzrLUQ&#x2B;9bcy1AWqa&#x2B;ttZ38ecNf&#x2B;9xRdd14yjyPBeH489kjrls&#x2B;DrPgN3jKIrjKMuyNElgrU6TJAymP8BhEECR73leHEdJkiRJzD&#x2B;TQeCnaQrYjW4ALNrYEwW&#x2B;TF6IQC1ApvIsy/MsDPw8z6XMr&#x2B;dBTBbYArW2&#x2B;JsNFK6wJIAGCfcoFCUK8SbiEeGEURRibewecOhPBB6CRxELzUCTh&#x2B;2KNInBJQCnCDNoEUbN1XE2cRRlaRKGYYDYcl0tBFRhEKC3IGKGqdsgTANl10gbLI6zAY&#x2B;KRLMUorkUBMFqtZL6/WQbiGAtoPooVPMidlNYRd2IJ02JQFzO4ox0HAAdx3EYuIR7F83YZrPZbDAUgriQeNdVJEobpadhrGiJUDSFdxBHULMEtowuh6uuAneK90HPY0qTpJKeSn5fGwXE5Sxmb3VCthXtrnYzCPR9f4vJuNbzINxgai/4qqHylVn56jVScbzramiBwxlbHIWrz4GVck/vgjTPUYePlsZdyN&#x2B;5HgJux9Aw6V/5kpkLRz5&#x2B;tB3KgVxXIk0RnMUGDpF3GFiO4eoHTD36OmkLUwuUSERT&#x2B;Vzd9soKsHK&#x2B;iWmSkGkE2hxQOh1ZLiFxXtoTCLQXhCM8zQwVBK8Fe5yMs3vRuWULgg3YcAoDDbMsoxxI5aYJ/4kTUhE0lwDdfhveJjW5rrB6w/488/st6Zbnf9dtBhx3b2q3c3LLc&#x2B;5&#x2B;fcNu2Hbx6&#x2B;3P8PZF3oj1b15b23a7z&#x2B;E93spdGdLu1m2bibcpx6SWsVZ1yz9nnzSerVX/QNu2ndHb2AN3P/PA/7NbsD0BnnbQQQQEo51K7XsN32TDpzfWBfYQkHY6qnalMRPN&#x2B;BxYKW&#x2B;3Z5aJJl7V8FTvDPpzitq2Ht5aWXxjTMPUt3QSkdl1bUc0Tx1OrwIefqtt2zzP7T5NI60SBcFyzpmYvmmauhIeUut4hKIourbtdMHkP51xUHQmgJXcTM/Ztkx5akkYBr3Tru/7RpNM&#x2B;TZRWWSXx6&#x2B;Hvm8toFcRF5kDv1Xrhp4A2ZTwiqbtuq4sikodD0D/CFGtqjKJY4lTzfOqqtgrQN8AmD6O47quMWRNuEKaJkmSqtYIh&#x2B;DvCgzKcRwn4ANpmiQx5r8ClUZqX46iqMhzZNtF2pQA/Ap1uiRwqohjApCHyPe8JIlRzo&#x2B;iCIA1DEOodPDnk5ARqDrLMiD4MAiyLE2TJMtSWNiKPA8lBS/EwlDCj8Iw05sCMI2iKM8zVMNwrSxN8yz1daYmbhmFsSxNoenHAlBrL/IcXQs8rjzL8iyLoijPsjRN0jTJsyyJ44Cx3FEEppTnORA8C3uByOilISM0xpCZhK49rBb9&#x2B;iAIVS5MRJKoExaPGfAAdxGF4i4gKIF7JPCFksnlVMOgZkLBIgB2iax20kiAMgkUFkdyjI6BAhUftdVYuxyeBqroJCMB8YhdiuOYzSJAebz7tKqzr6VleB&#x2B;wMjQKN9&#x2B;KXgIfJWREITk6WthV7CtFXLVB&#x2B;3pmdhK4G9EwAZxH3y3IgubwCDqkrkblRuytQU9v5SWB7yPs1ZplQ6NR0bB8F0FMCoilm4EbV4jvo0weqKg9FBXcDF67Gz2Vozfubdf&#x2B;Q8XrAr6DIFIriLMl7ndCtQDxEoGaEIjyfZW44N30fQ&#x2B;g01F7Nz4brpVImZDNUM36gQbdBCpBpDiHFyWG5v2SsXiqatNN9lckLfQAH12lTBKlQKVNaFy8nM4bqSs30NYo3iBcjt0A0FH8JsQZSBikQBDHsY7lolbHHh7HcYbfz9pDILWgnpNPYKLcZvFavplGBVuGMBGA3ZLnDBGyTrb74u7rW&#x2B;e53YvXbT8TJXiP7f3K8NjegwtdV1&#x2B;/&#x2B;ZXbbO9EDHYJz94D39q3uc0nZHby6xpH06kUJe8W&#x2B;EeF7LuNiL0UzopqxrfaoE1y6Kg4m2DayocoX7FofsYoiPVHw0N2F4miPlDsOEx&#x2B;6HEcy7Ls0D0A0NRafmtmG0MXhCsK3Df6GWJ90oPB5I0SreoVtM5N70HbzTA6sH6vEwysGIakolZpfqPhP426kwHF2SSZ9QGIp1lcx0VBRHszLq3rJtsGi/qD9o469WHbLger&#x2B;yRp1l5srQvcmfcl9GY7p9X2dsCjqqqqdNSa3lfFpkGWZX3f0bctTYy2BQdo1VSd7VgI0iTJ8xz0oMjzLE2rqkriWHhCmuIPQJ7nSRJnmMGcZRDPpGlaVxVkMygahWGIr&#x2B;I4zvMMZV38yUFLARgyz7NAm&#x2B;BsSWdpmmVZoHE6SZIUeT7FzwVBHEdEz5GWzKGTQdGrKkv8xUWJvSxLIEncL/FHEsdZmog&#x2B;J46jKMTfS/xBLfI8z9I0SXCbKAriySR6rTSJocbJ0jRLUyBjCXNNk1Trb7jlVJC7WAvEQhCGsV4xSZLpoWUZgDtuETofMKI0TQHHpeugPXsCaJSiU&#x2B;QCBT6BO1YY&#x2B;B4YBVzPANAotMMQHKo9V5QFvhAwKMSAua2hHOKcQPXHQBtBEGCd8JczdcT3PSWEYeDD0&#x2B;wTdqBIr3glUNGOGEjCULsc/gT6IfIJFe2Jo1SnHFA/A5zo&#x2B;756pwNWr&#x2B;M4IgIOdKYBkG4URTbjSFfk&#x2B;pOT2/OMWkN0LIS2KoZh4yLQDCvB9Io7WdaFjIqYnhohSkFIBjwTwksMTZcz2Qt&#x2B;0NSCITV4cDwRsCu0heDK1ygekAXAeiUAG1XsSLYP6&#x2B;JRFDqcSqaTpFnaZ5Vd1FlbCkCIc8RzQoDuq3TeU6WZMBPzxkG8RAeCb5Q5eAscx0E/iiVzeaO1MUShkSEwCP2crAt47GgAYjeibUHJUWSpQqDNE64W&#x2B;5ApearSwVvDygUL7ZEx&#x2B;JL2a3sgkFf1fqnbCVSHiadN&#x2B;G6fDJYUmVZDmiaBlFpU/yMKIEkrAnuPlWzEZru2A/A7g93XXejHLOA96v23Kaj/VJfbxbVvPcOMe7wHnfhdbre5qEXStzm8M5k/jarSCe4NQN86qjW5QLZdwLKxPVzR&#x2B;bRELnXWCsBmgfuMIbRag&#x2B;&#x2B;3BwjMbrbvtyzO/GBQtDNdyNT&#x2B;eS3CaJwE8HQ0Qn&#x2B;r52GtvdW4IZbzRSRjpgI3xnQLLmGzOIdhwD&#x2B;xPFvhrs0MY9b72Q2gwqdpBNwztghKG0JqLrjeVuSTVpFUDCKm6rnDOE6TFgi7QWmE5LRbTRgyFsvNLKDn44U7ma83OnhBuZOcsCzLejuKlI&#x2B;lbduyrOz&#x2B;o7pHaJ9AkinnmpF3kSDhRVCCqqrKQnJRS&#x2B;kSVDqjQAYYA46jjZCmaVHkZVHAbYzytlCCLMM/C6EEgmhRfQcuB9MoyxKwHk0KTDzIshRkA4TB11ge/K0FCs&#x2B;yrMjzNE2wAPAQiHCyNBX3gmroRRjj&#x2B;0WegyGkSVJXFb4ATK/KEpfArWVpGgYBeAWkOLp4P8X5wzCO4yxLkyRBvE/g&#x2B;3IXacqqfJrEaZqmSVwURYTYvihC6T3LUvQBYKugGQB3gV4EeFeeZUWe56rvV1mXiIXSVJhVnufA9zgJgWmRF0J44jhJ4jRNQIfwjuCp4jZxIZUUx5UOq/Y8N0mSIPDTNEE7BQwtTWK52SjEqdI0iTSZJI5jkARg1jiORDoVhniAgUDwAG&#x2B;xqrzCSB2NrutgzYFyJOjKMAPBQ/vFoGEKdcJAOEOgbAHNBOIqVNAjkT1EiEKiwMM3GNrX3TxN5gm1mg6YBfwNiAZ7gKeyeBRu0a0CXA8nd7smrBs8B1gMpkH4iKaKr2fWujg1P55ok3QiAYDyRITUkCOla1WSiBQEtn4zkM6wCGhjNoGORwDHg9JMUbsXISFXlTPycKbYIhHtOMJAoglkmwlWwY7WhaSIGnRhLcbzEGq5HccSphN/k935KiCc4LhG2hN8r9drrNbXPVkO91U6P32E9LR4jK72GWIN6tGGmOBvcGChiArBQ1UZsQMQyFumTwMDv4IglA7DZB0GOLd8gAwhEgmfFPXxXpNXB0YLpDxc7g6vxxz3a/oAvo4IwG8GqDcTTQ69KQZ0F4Q1lNHfwuN7/Tb3jN68vRN&#x2B;fdditj3wdwCU34la3BJD79az3&#x2B;Nat7nQT3uIxe524&#x2B;1cd/vXcYNRP5/2cHsJfn3di3il3c6JssRgduzsQtzTlvBZjbaUz&#x2B;p2WB5mMXscRwBK29kYxxHgz66BaJi3z6faqH&#x2B;AZftxHCG5sdBzdl1yiRn6hzapN25jAHc2NIj&#x2B;bUG9qibIS&#x2B;6xWxSv67rSkBy&#x2B;g&#x2B;QSXCRTg8h/2FHpzLCIzgT41HXd9X3XTb0aNjpw8qEfbA&#x2B;BTYZGncdkF3yROqVOmRhYAQ&#x2B;0bQ1yBj5YCn54UTI6PsDOWKjHcSzLEjblWsexwUlc6YavcRTzRgFn4TNG/Cg0QiIoKoq6qrIsA1iHeaAsS8DcPMvwpoBRVFVVFHmR57Agx3GUZ1lZFMCvop5XYhAY0I8OAyAshs0VeZ4kMer3aDWgVwB7QFkWifwp0x5CmiZa5wbgrusKkBQVfZxKbk0ND2hr4IRFkQOXF0Uex3FZloAmUP4UeY4vZIhbmoKHFHke&#x2B;D5wOVhQqc8T2h7QGKm1h2EilygwqyvX4KayLKCYQq8DfgLV/EinItKYDiiUgHrxbNGFAExM4qgqSwANwGhAOhyClePJQIyUJomz2aic2IcqCWV&#x2B;MBlZTxT5klUaEsoHElEauzp7GOXDwPd9zxW9UCBGEd/z8O7ww0AeAkwcyTy1AP0NfELoD/FthKKOU3AdB/TPc12AKrGdBIHveWh5AD2p&#x2B;GGSmEdhKBZSH9PZQhyF6jiMIr4gY/X1mhifQJstFMCECvHBIoQ2ILJGYSK6NGQXYCD4Libl6WMUoIymB&#x2B;v0kAwRKaNIDWQcRYjxcXxmB3ka7uT7gHdBEGAHWZjrhmHIKE9q8ckifHUR4Px4gxy9NS2R&#x2B;8TuLMkTmrNM7klCqHhhsSEOODCjrLwph0oSh8JtTzmuFQgZ9EFa9CgIbFwujP0BXhrdP7KISHJ4EaSTkEehl4JmCFxPkSTJyoBeVtnB7cmpFN8L7UFXhLX2QIU9cRx7nhfrTC4qfNBeKIoCQJ/aS1&#x2B;4seh/pIMKJWEcKTNJgPW5T6jRBRO&#x2B;h7jf90HyA21rYAHkA2RlsV4o2msCviXaG9SPeN0OPxJS9&#x2B;&#x2B;it9ld86xkfpub&#x2B;glB8&#x2B;0r&#x2B;rd/Sjcs7wYmcPOBP/K647sTuWHfi9ddcXbpXZ4225Pf3d2t3xbt2K293njQawjP7ISE&#x2B;4Mq&#x2B;2fLs9fqt03GjRbgCWQt8hsZB2TuhRVuy0m4DeoGpvR81nbAtSzQJ1plCbw3sZsA98MgdWsWzonaO40V6hU3W4kOCYkFtXrdzl6l1cG9BPcI90SPoFfrbd/3dVXVsyaADmmGZmnU6Qqtvs4nCRzP1fKxEMGjIVCbYWpA1YMGH/VmOthM/yOsRi3F&#x2B;OcwDBhSJjtoTwPMwVbx&#x2B;V6M49iZKQRkPuM4VmXZNNJCaShMwkm0MyPLU71QXddlWXRdBxUQ5j9gw26FGo7zPEeETp7nNdoOdQ28niQJ6tN5nmGIcpqmZVHAddA0dRzHTdMAeSdxjBp8rnA/y1KA6YTCpCwjwoaWBtqkJIlBDIIgyPO8LIo4FoOBOBySJEvTwPdnWB&#x2B;NizRNi6IADGUID8KU0MZArlJVVTi2LIo8z3B&#x2B;AP1cehcl1FCJEhjg&#x2B;DwXcwXc0sj8SdOkwBPLczwTaXGkaVUWoCVZlpZFkSZJmiY4VRSGcDIkGvAqjReQAU4TS2JW/fGgBN8LdYFrOYD5WG0S4o1G4RnkBKuS3KE4zrOM9l/AaLxxaCygeQINFeRbSAqiJyGKwlinF8FNHsexs9mAhHiuK3IIsLs0BVrFUShRAg/R7Q1ZEcC0Fl4lPAqdKOoc4u26LIrBogRzZXBY4It1Ae4TkCvPdeWWVV8UinkdtoqQEg7uoIJ&#x2B;QGEvmGCiDHAIKFIX/7EwECvqEF2OMhPaGHgGV0v42Bcnp8rH1wnTgWpRcLZQqYjv&#x2B;5a6sDgdYI6BPChZRKwptwHjaAjNKZc3QTqEvFMBXoE&#x2B;69b4WlmTiVv1fWqK0G6QV9TIqxg9tBCfeF2r2iE5WKjJZpC1iGBMHzFpW6DvS6DKGdIAZYmSyxmYANPAaBcpwgm0tB&#x2B;YJlWo4nvceyAq/ChLU5KcRCM&#x2B;0UCzVX/szwhO34QI8xUA/SgKYQfCzwI0eIGRKrEJwHo/LBZWRxSr3zfS/X1VPaEYJI2vIHhPE/B1aGm8ERFa2GS/eL9tF8xdhw7fb/tpi&#x2B;i/D9uO/uS/gDroPbbdT0u/Y88dpTQ&#x2B;7a&#x2B;7TdXi2edzJv6xB85oba&#x2B;6o1630RT4bRnerpkMue/7zqDSVoPneXg3wei2MyYBrdxLlg7RYa8hofbWWN6erdaWt0eTgAn0adsFcMHKVRTvqnxoOs9gJhjsFrMrLVS3Kri3PARAmbPDmkYQPzasqqoqPCjymVYpE7oKfKcA6/Hdqqog98eCx&#x2B;0gV7k945O2j6KTmcryXrdt23VtZ7zFdV237ZQKyjeCLmEyKMJ6YSnsKtQ1KFRVVV2nF1VKA/7T933bgm9MCiWhH9o5oRe5aZqua8dxrDWSqMFkY5nSIJ6NTtoOJZJGoQ4qilzESOIwLrIsgxQMYBpmg7qqmrouirxmMFNZNnUNpU0m4DjHPyE9AqNI4hjmBLQRqqos1fAAJ0CWpijJA&#x2B;Kn0qyowBmiMASSLosizzLlGJHQmKLAmfHdTDB0qmaGBHtieW3TAEDTNh0Efl1VZSm4PEliUI5CpFO5EAahOil6HWhNQLoDyoGrh2GQpXJprgetjzRJ4ihE0yNUVRU0V1La10FgcRyDS0RRlIm8R3A5nNAoGaK3UJUFCJWYKxQ0iKtBlxqp07rIMhAqVD255jAMUjUNw9oB5sMaIbsKuDq&#x2B;ADRPVFQQIQgVkEXKnzJ&#x2B;wfNcNhmQJCstC7U5CzoBTNcgWmBcPBMYx0OdL4GFIQ/KU2sy8I2nCachR1to8KvAOB3AnOrgJDETR9NcCMg2oq2&#x2B;hCwUnROCfo/VXw2299V9K&#x2B;KlKTop9HX2HMiJFeqosn&#x2B;qrAfKT3yNjBShv4I8uJxxTt/kvnvqE5BGikLeQCVVYE2BNkNwFQezQcKQO4AGKMQUgT5lSwSyvqq2AiE5Wyod7Bmph1uYD6J1tExOcEwKQbIRGYeDZ4Zq4S3Au8&#x2B;6PjU/gbYP0CzyDSMKzAQuFuwFFm&#x2B;pp1zCYvS1yGfkdngeo9oneWCLIDQKnEjDOrGRD0Q6xwNkLDY5y/Jpj2O1BqGWH1jgHk/TfyfrVKwbL2f3lzEyDBvQ9d9EAN4K5d9v&#x2B;/G4c/cMv29gffi9xNbv95SuO2r39b2Snp/kWuM15l1&#x2B;Yb/ur/EE88X56&#x2B;YVwvQZ3J9dkQxhMFGk7AbY9djlESn2KvmYNSVs6VrPLJJ9sg6SDQJ9qybvt2v/jW5d1/UqjGFZvTWeWizSZt1ofb1jqbtThc/QD9TGEEPzWlb3T4IAsQrvmjsTf3dGJmRvxypk&#x2B;ikuaWs4A/mGvBH9wJuyHx48Dj7z3iiIeml0NOR1fDKtuqXpf&#x2B;h0wFmjDgrZU1OPiqLA2rq2LQ0jYsdgHCWbtWvboe/rquLHg5yKTKkxrQ&#x2B;&#x2B;O/bN7ft&#x2B;6Ht4Bvh85EDpijSdiogA5QXr5zmA7zgOsBdDHVTpAGOcv66qrmuB0cuiKIuiKHJg6yLP67rKsmwchkpGOFdaOM&#x2B;rsgTBACBG/wH0oirLUr4rYUdpmio/KRCChJ2ByNFDiOMIPgdVOuU4c5okdV3leU5PM0QpRZYVRQ64jxZEVZW4OgzTgP51VaVpWlUl6vrAuGh9ANBXVYVnhfVoilKKp5SqhkraHVlGFgFcTq0Rnh7wOqhFlmV5lpVlkcQR816hrlFMn/q&#x2B;h1OBGiVJksRRrEFDuSqp8izL0qTIc5TViWAiyRSiviiN4wiXs9poyHsypColMRoCFHpBroCiZRLHWZr6WoOHACyKIhS8Ue9PRJkgUeVxFKH1EegllALFkC2FMmwBlCAqigJALU0T4GYQsDAQLQTuTpFxFIjWOU6mCrHvccRBGIZKKmJlCJ7W72OJVQ2lIxFJOZzAjm4BnA23A72NQm0XOFgLwDKKONKxdBqmZHJgTdiLr1OiAEYlHEkhvu7icUlaNdZaNQkDkL1OmKJynXoVX&#x2B;2wgRHSeDpJ11ddDeiWQH/lG3jv2FjQhNaJwKCADS7BrKFQW1LwUaRp6vu&#x2B;mnSxMGjK1Puxvfnqh8FtB2ry5ruGvXBFW78HbdMzh4TX2AGWcU9jc3yNvtVehPA&#x2B;sCAq5kFxTR9AEq7AdZRpBHwa6FLatyxU/Q81QvbDif0IzQnluaf2rKJU2w6qF5qgP&#x2B;U9ibqJeKJYE88YffYWAvBzbLaAd5ttt8z/Ey7jrdvvG6/4kduPp16z7ce8O&#x2B;/EkSjyti/2pqK/i/gJIu3&#x2B;rBzbM9vdWDO2bQdW5ffC&#x2B;tkhMypioHxvT9KrLog7s3w&#x2B;u8EJpBobtGBiFZC0qlav67ptJ&#x2B;DemODRxmh1WPy2/&#x2B;UiAeL1W5MKH&#x2B;esppFezWhmGHdd1/eDbQhYfN&#x2B;YsJ1G69lCTnYU8HbxrfgidOpwRXu0uZaaBwh/R&#x2B;VjfEca09Vhg8WSJTKKWucGAEZbKmWtugz9JEWh&#x2B;p9V&#x2B;aIoUIOn0onyIcudxmHou/lz5vp5a51yg8Y4Lvgwu67ruw7gHfeED6Asta7VmlwDWAtPQ31eTAVlq2mtbdPgn40IokqcRHRHRVFXVa78QchDWRZFXqknATVvtEREktS2qJKXZVnXIjcCT8CeNVaP12G0jeMsS2v1IQCgA5mDXQCXo7kBz0OhmB6vQ3qLhUHRhBtOkgRm2UJyk7KyLJqmRiEfzwQcCa0AOnoh2qmqKk0lOAi4H6KjQpVUSRwLV8lzdEWKosjzDEQIyiL0XnCJFE4DjHw20CFNk6LIwzBINC&#x2B;JdgIlAzE6KrkYi6Miz33fz7LMdV3EIJGB4L&#x2B;A7EkcwZ2MxkikZoYoDCHggUsh0/FqkpIUxxOUR/cmTX0t2UZaVk91uUBsWqSU&#x2B;WhSQw3DWJsJgQLiTOX&#x2B;SGUNQ2YlQQMd0nIN1QTEJJNBM5DxbcB5&#x2B;Gek9kqpJQugn8Zmx5reCIG4jUxBlZtgfTqJZkEmMtvOBx&#x2B;gehvAlngRhMGXcBtPxiaEEpgb&#x2B;H4Q&#x2B;IJidUo0zyMMwHWDIEhi0XODX00oGTA9xnjpSFtDUTCFV056GEBWz3PZOdFGh58kCZNVPS2QE4NC3hOqoJ&#x2B;8RevsUxZwMOXShFwkqumE5mCerKyTQuD2eWY2OozmJ8BzxtuXaCInLhoqQA&#x2B;MGCbUyN1AW0zJVjKmSH1UhxPxfQxUzhVHEZ4h&#x2B;hJUkeEDgL4HUTt&#x2B;ftkNCFSdz90SCeSZwj1xF6mYAUJb4weyD8yD4ucziiJkMPDSPCTV/FAGPQdGOAQX1k9DAG6jLdl58XeNrX9y&#x2B;Pu3ZbuhhP9WhvMTUqDr2MINlyCktqgaX/TGINubybjYZ6&#x2B;BxGJuSxiGHYn/jBLwFULGYScXaNRcHaL8WQV6WpsZIWw3ArvRaId4LDH0KKXijrXkXhVB9AkQvPJr2Bia7UEEeGVqGXRda2b98roEmrW6cnFyPhkFtT3xKVfL9YCZ9H3fqZ6HyHtUWwLO2anzmA2K0eh5bGmf99L3g8Jx6ZbgjWLzhEQC2h7LdiwB6Iysv1PHLQr5fT&#x2B;wZj&#x2B;rx3N/GnzZ&#x2B;rDPvFPNzzgOKLpTFCTPXI0ETdMMSmYGfePs&#x2B;24/Fd324DNA9sGoyyz9a9t26HsELrWidGq7riuKAui7bZpOVUllWQ59n&#x2B;d5N0WjVsPQN01T6thjdI1gGwBGh9ipVObTd12pc44rJRvA5WVZtG2D4jpWSClRXdeozWNh&#x2B;GcuQUZ5rdFGMBajuq/BR5VCcOkGlGXZNg2kI0DMWEBVlugMAItXVVmBINneSFnWdZ3nGS6nzQckiyaiaEpTYH2Z1KCMoqlraHWYfQQsjvPgWSWJ8BmGcqCQn6YJJDpIEMI9ggmIo0CHvmVZmmWZ53kclYCcUA35iUAtRFJVlqmADBgM0kQDhaqqglAKAwZQnqe9O1aQCqOwKLU4VUChPGQG4AzoAik49nAtmBDgsCQIE2gfR2EYeBqnwxJ7rCmHobKLWDUPVFr7CleB7QB3BIEFgQYryWyHUC8dRRFcwoHqbXzVw2hF3BMwzVmtKNKLNTn0NNgHSJW6HeU8JlbS94H1RX3ueWKwNozCSnciTXQlso7jWArqqlmn5iRRXZPPoQqUtquxFdmdaAV4nocBf1LtRvSN7knMiiq1Z&#x2B;zLOC3SbPlKaJIrfR2DwKaEr/YGZOko0wttPV6FW9LNCDW&#x2B;xtdkW77FBNOsmgeqxU&#x2B;2JooklrCxiB4pMk40CN&#x2B;&#x2B;rYT7eETkPETn8jkJA/BDwPJQu0AU4sdUuSnXwtrCMAQXtX7fSHJ7J/geq8Tf7sMT8vypdOrQ2Ut4p0T58tOtzFncTcL8Y6qA9hCAd8V8u&#x2B;DsPbZbHvtfWUn&#x2B;vbc9pei3PZnr8PfPtO3SrRlkv81J3uNTYcvwuwxnlwPYhVmYzkNaE9qzezsEgnt7C5YndNpGEKyp4N7iVIJyMgSeVtCbEbWzfl1rwCXvgqVxIOlRE34opCnLEnvWddX3EyUYVRnPwzsNwu/7vm2AkgX1ci4YCQwhu0WcrYwV25L98H67rkMtQADrjjHaNkxGpQqWs/FbTVOP49htPyXpVMzeyq5rmgY42IJ1PvxeF9aYYcYG7svcrqZpcBMUVvEeO9MGaY1KqlVtz&#x2B;x2mqYZhn4UojKAxJLIAbhj5YOwuYlAjmqAxkeu7/uGVA0XAndqmq5ru7ZVA4ask48IwL1t26LIu65FiiiURSBXdB5L/CimFqRpXVejpleVRdE0TVkW6BgURVFXVV2ja1RXZYkoVanQlyWuAqdAVZZYHr7V1HWeZ0UOxC/SI0qVsDCMUyhEmFSAYqBTkecZWI3kqpZloa&#x2B;URdE2DZhIBY9EnqNCX9c12wtYEugEIH6appW2L2T9Zdk0DfhGWUrJvyxFTQSKUlUVau11XaEQDskT3AuQ2YASgCpEYQjmEMdxmiZ5lqoaPgbQl5Qn5BfleZZJkJEaG5IsTdEnCIIAhuxQw0OyLC3LkqXQLEkAQYIgkOzXOI5lsHEaRxGc1mqBEAGD5KiqNCKXEQcypkAAVhjmeW4rlGiARAwujGPsHGDMc6yZsPA8xHGSJK7rhoGP28f0A5gn4TpQViAqI&#x2B;Ak5OTgNhK53FScZS4KwFOWZb7OGAaQSpLE971EGIJLXsGqf8jCu&#x2B;97nptoyZkS9kjtvJHSGE/1&#x2B;liM7/uwQU8wUc857anoMwh8z3NhwCChIpoEKpW0qChKgdpdPIEESwwZRim9CDeWirLcAs9JawEL2L7ifhAeyrQ8TVwNdfqyugVkT0p6iIMDDdQntvan6dSCuRPGXEZTSk/Ikr684sk7jm6JsU/A6RHpIon&#x2B;43giG2EYQkIDLwGXxwN1kPmExUGWyEzIFiKV47O7MuseRCq8Qe&#x2B;L/Y3Y6PjjOM415jjUEYFcs&#x2B;iv4oQl/53yv2QKxWotiDUCKNIOFfi8/GbIslA7b0mSvH8H4JYY7ne2vR83&#x2B;FkZxS4w5dZv49Trz3DbQP3r/nnz&#x2B;X/W7Ybb37vnbdZ5Q6/pHRiOOQlR5qwP0O80B&#x2B;x3uWDWWW1NetxmIMiT4YuA9ubwKSQUCHLUyi6pBe&#x2B;a99g0TdtOzMG6ckkzeAZbbuchdgdAYdhPbdke6H0G8WePiyVwq2yhFXhCvYac8In1RvLOu7MPczS1f941KVynYUTDMB1F0kKG1mlnxj6NYRiaph007IjUqLbjArqu3bYlkJg1TdM2bW9AvL39VvsJvSp8WpVpkQlwVVDmtGrRZuG&#x2B;V1exPBZdub3xrmsH5Xj2s9H3srBxHPE1aRLN8k1dD33fKfNB&#x2B;Z&#x2B;ug7Io&#x2B;q6rqjLLUn0rQZM63HWvzLMsi7quu66FiAh31HddU9dd10I1BYzeNA1mnOESWssvuq6t68ruX&#x2B;u45WHooZlBKwb&#x2B;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&#x2B;rERx&#x2B;OWwS3RWsF7zQ5GOFnJk5CjuJhSlWUA7pC36QdGxhSyp4EFUEsTqzaP54/UtkvN3qzAH2sIT2RGfeETS26As3H/UIf4yuF6rTCk7i7RVp50DjUSLSEnAWvlnYL2kHJIKNneDsDv//Y7Q7Q/H8l56y3YvspbIf5PuP1MrZi9xXW&#x2B;ciMF2oP4AVlmZft2J83TYvFRYf&#x2B;sYdWrKIXnt0fZMjzX2hnbKHeA&#x2B;IS40x679&#x2B;3rJzGP3Iv816T62Jsi&#x2B;GtE8E1xy5bv2bYCGqNQ7/vezta1PIFFa1t3nwl4pnK&#x2B;cgBC6hn670zfoGla&#x2B;7rlD/qop08F9hy3tU98kU&#x2B;MbIF3yv&#x2B;2JmqJ5yQc57tANM/FEFtTaWOBfqMqKd4LXQqDblyhpVvN5MFtAftGY9q2jwJS&#x2B;M7EQ9n3seu6vut6FZ7xkyCPUUlIYwwD&#x2B;kMxjOPYmpuSJ6CEAfWFTs0DfAJtCy1YDYe8nFO5HEv4XduO44Dyf1WWg85Eq9UqIB8qHX6MeCJg/RpppEWhzumSuBzIGNX3qiz7ritURESJP8zHgsuLomnqsiyyLG2bBgZlNBWaum7bhrp/nB9MoCyKsiyapsnzDMykFJ9A3rWtyocKbRGgbVBAfw&#x2B;/ctM0dV0h1QgKKLE1FwW6EHVVwT&#x2B;N0j4sziL6L8sYqT5iXajSJM6ylD0E1NRzTRfF7AXUy2GuwCMKgiDPM1lVEhdFHgQBVovivc1mRXwqlkqbMnKQ8jwri1xK8klCW7ZMH9OBZeIDjqIiz6IowiKtNwBB&#x2B;9BQxeoEAMFItYkBlBbHcZrIUIVIpc9ZKtEouM1Aat6Bp&#x2B;ZdVGdTzY1l4Z/4zBoGYq2k5nnGunKs/Y0gEJFVoHNVQ8rEVccSaf5ppK0D1Muhm2cgz5Y/NQiyLAPujzU/FFV/BAQFKlvSOrr4g6EsAj8C/FQPhUrYowhAFn0hei2iKaVUrbphGIahtC8UpmPB6hyYZmZFmhGJfkBktOahUZObkrZ2OewoN9bsw5BvVqSvYGO2T6BzrLztaM4kSUCZtFsj3m4QP9bd2UQKVQEVqUQ&#x2B;NXIaqoOslAjYF2HBxO5RJOGYkCGhRo4nLwQj0b6ENqYC5k2JGVdU9bTZUH7jaZeDTIBAHHK1LeajK4xV57P7NRdAOhGryojlfx4Clw5BP3aLtNXwbh6A37eS/3gNDH2Pdf4e3tru9mNw/88E69&#x2B;6vceDfesaum25/7suw8I1W8m2Vefdw3f5mGUgLGnjdKMhEoT1g8rQd/mAzaq0C27bVqcAizqo1ZRPxps2Oiu3VcyqB05wmeCY6JxQlZoc7ANQ3qnmGyVwCkXGcSQRANrrZSxujRp4bzKI&#x2B;r5v20n0Qh7C2&#x2B;xNG6Tb7t4Q&#x2B;HbGfjCO4zgIPRg0qIefB16aN2uZlX10pC6NiXIatHVjz2CfZ0tBk8nu5PmtUsj4EGQ3wv2O7wu4kWaztirLGUfB0IPONbM8k0&#x2B;GVKdXxwhQ/qDjI/q&#x2B;H83HZlA/8Yy2jbZvpiSWnx/5tGAxUzOnwYSBUW&#x2B;8UoXPaJRIZVnCXdBMJoe6aTDHoO37rm2bUkcdN02N9QO5dm0r3oCiqJWWtE3T9x2aCYLv6woe5rap0c1AtR5TF2g4EPVRXfdK3tiUwM5NXVdVWddVpx6YVtzOFWgMjTHYTZsJJdKBkOlZyzw7iRiCvkhYjciEpBtRV2WepUiDVe8BRhYkSRxlSgmqqhR/QpbRog3DAIJEYTnAfzPV1sdxXBSCvLM0kfEFaVpPfCAHeyHEF1&#x2B;E9h9gS4AtW0JX01RGv4mqB85sGYSc6dBlcTiI2kf/B/AUhihbghWgHYECP4wQoDosnaoqOooiTk2WCaaxQKUQOUiYDhFLtVWCaLA8ZA1FCsoF8MUxVghEmGOCNR59FKVSsfajCBOUxIBLOoExatD8QGfFIrqnKftUoovgRL92mSxkJDG0MQCx4cZ940mwrQmIYQDjCJRxvtQku0eT5kqpkcYcMXoIZXVfxxWzgRNPvlif9wL2YovTwJDUOIXGa0veBQBKg0GiVm/SPwqrxNQr8q0p4NVKhgh2yR8wmzzSYVip0j59L&#x2B;RjwP4JUXKofhVaEUINETLkwccUEVuGx8kx04MfCeqsknjiAHg9NAGglk1lpk1BXoFzRpNoByeRDoPN7eGepGqUGIEdWZ1PrAO56QGQDlWW4V17zxjQ39l2A8L7Mcu7&#x2B;dibYeWwrRV56/67u91Y8r7V9tO&#x2B;NT9TS&#x2B;E2p7X7zID1W0&#x2B;4e&#x2B;zu/hZr9v2eZsIu7p89WwIm&#x2B;8&#x2B;ty203ImyB1p6KvKXbltDwhJaZ8L&#x2B;sQ/dGXtLpIF4uvlf8O6orl8tumwn4WqzfaGQkTkLEP0xpQtOYMF63VR2LxbXw83em9t&#x2B;ZkcDjOHJt9pn3pvfS6pSuwUT7S&#x2B;2cYwHUzNCpa8KeGWidHYNWy9Wd6YG0xmtBfG/bIEzoJ6kguLccqe&#x2B;7Uecn8OSWh/BJGlrVdcat0agiiNC876blNTIuoENtfjQedPs1dhvHceiHcdTk02021ffywbF8ht9CK2AUhtO02gUahn7Qd6c17xE&#x2B;7fgC8J1nJsIeh0EESE2jRfpiHIayLEalOm0rvZGyLMYBn6UWvhQAdIB8rKfUWCH1WGMegviYwUkA8eE66NoWk86ElOKjiGELpSh/NHCoqKVTIY0Lck4kAkFQ1DR117Z93xmDQQk8X1dlWRbwGOTalADPQd5RliZVWRZF3jDiKM9BG4DnIQCjgQEcBgC9UTeCho4KWEeTAV0RNB9oMoZJWorWYShhplkGVVJVlpAPZWmK/2ZZWuQZgk2jKKQPONV0I6DkLEs57g2AvigKjCcTW0aWhmFQFEWWJqQiMmYhy&#x2B;I4QgQT6vGRTiPKdLJyKroLRpQEOpMA6DxJ07QocqmDJnJa4BjwnETHSwP54bt5nodBgGYC9B&#x2B;YrQZjMdKEfJ0OlqixAeKihEoJtRQXRZGmYrf1PBdW6UjVRwDNscbaJKqxxtRbyv2jKU5ecK1KomIKb0JxIwimRLE/TVOSmVjnP8TKZJIk8emFjWOA4CRJUq1VR9IYifEiZxeoLmZrFpitlyscD4GkKY&#x2B;x/lqWrpk3KksibZBuRoQmAN7iUOfU4rEzxykmzcMbkcSxjLuSs0EMpk2DGC4O3EeodohExf26SX8Al/AmvC7vmgqaNGRWCurCOhJjXLEW89i4aaGz5zpBn8h8&#x2B;EzQA4E3HYdLnw3wPU1xEp6WTIPXAjcI1SbO7047yDnlB0feSl0tflgSCT/IryUAN6C338&#x2B;Q&#x2B;9m2u37&#x2B;8bNg653O8NNuf3vPf0v6MUMb&#x2B;OK64r2FhnvP8x63QyB&#x2B;04d5h87Z5RGFb&#x2B;F1wxks7rcLnvC30XV0XTdsC5M6o4cZt5&#x2B;SJR78Lyus9rFgRSQe/C8BKKvm3bZcZ1S60mtkEL0EYCXYH2TA0gBLDPq&#x2B;hxxiNOKZTtG8BcQs2FNu1DQNmiNcNq6OmvHsrSSI571Qu9&#x2B;ogn9UpE7O05smgCVmhOw4vyVFvMGRw8IA36uqV47B79KqOz03PcOotKrvO9tkAGZtTc5Su92N6aX6PhFFMoFRgPjQyxsnVxlM/V4aC7iccY80OjGAxMOec9CP&#x2B;jgOEPrrfAysXB5Or6GlWDaSgnD4ID7jrq6qYRiAd0eVLY3aWAAKb5umrqqh70c9&#x2B;TgMeCyol8v7wYkHUuOvsGx8qkRWhFZM3zeNDk1DV0EJAN7bqiz7vuv7btBPMhzPqNZ3bavT0wroh9CskGigpkErAHgXlgMOTgaLAKouFIU3MCg3jeQXFUWl5CHPMyBavJjneaMNBIiIMNOgLIokScqySNMUZwPN0OkKZRxHdVXlGhuKE&#x2B;oYN6QMxXkmM8swkAEnBBAsigJS/oSjmvMcS4V2CAoffBcozQyAk/FtcRRSa5QploFfAtp9VNbZT8BqUWKHCivR&#x2B;WVxHMPQXJUlguGJVxBsinImfOFCFYIA/QTg&#x2B;DRNULjNs8zXcVTAVdAvAX3CHAy/su/7wGQGok0x7YBRKKxitpfrugBciRSMI0hxRNwfRegzJHEMaZDv&#x2B;6BMkcpyPM8lmBY5kIrs8RyAjGMRqwQwNCOxFN/VQQrC0IgRETHpmxRRlswxAoItC6BD3/dSXE6VKkHAEQECskFd4A/AhVi9lm8pYwFFQZ8BwU2RKmSo&#x2B;UHp3Ze0zWkc2PTcKPRXnb28F/oGyZ6G53ieR&#x2B;Jhl5dy7K7nJTrYmwg7YNdi8lqEbE3gutzwiUKLidQICD5TIgoiJORZNGBTUR/EIN5OH0p1wJ9hAhNwj6MIYwftW2yJRyQ7JBzyxS7B3kYE&#x2B;oHy46y6oN9fD4D8bb6FC/baY3/0gbY8PAyStPNeJ7&#x2B;ppP1zM4Efud0S7l&#x2B;3883g&#x2B;z3X9C5nGAwGuu6QXX5iQf91JyQE556EnqOhBKwfY08i7xmxEWSmtlfixZE6om1377ANH22Vd2DupLzYs&#x2B;RMJD07Z6tK&#x2B;s6YbnsdWEtQzNOywD/oVK/OXBcKpQaTjRUij1oAHoahaSbP62gbHQI6p8LzYGrtvEHDMSZNP2989&#x2B;0jeRhVPUU2Ap3SdBfbjgU&#x2B;XpKcUYUuoEzNduInF8Z3DXXlYduWLfvX0NmrMkcxPQreyp2mWciGXAgDkV8gfLPadgrAVbGQ&#x2B;eCaD/MwjJqWa8kn92dzRp7hMFAGZn5qOliQgf7tqugP7o3UCtqdvu/bFilJwiEHnUvdm1EJuJ26qvquG8cBfAmcoW0FsldlOY4jugcaVNWAWgC&#x2B;DzRST7m0TSvz1zAfTZaBAKJWnd9sRLQyEqHCOTGBeOh7wPEOWVh1XVUlpq01TYNAoQYu56qCooalfZT75XXMNyiKPEvhL8jSFBQI2Tv4Agr&#x2B;LE3zPEOjAA0EdgnkzCp5yrM0z3NYk&#x2B;kQiDUSNMtSTEVIkiTP0kSzdyBVAjEAOkf9FWibG4KSZKJzliEItSwL7MaqP5QSnMuWan0dfga0JZI4LopcGwIiX8Zp8zxLNDY0YqppGMJPHIu7N7EIGFwozzKMTVBYL&#x2B;C&#x2B;UIUS4R2QNPCcNGvwYpaVZQHUCxwZaMAOcVWoYp5UhUAiWFIIRnxJcQ6&#x2B;GwRBrvKMSJcBqQzpSqjS85AyepXphyqGiTTmUtRNDKwMRecTa1UePRwAX4Y4hWEI4hfaHH07xXY70T8y&#x2B;ZIAshGmfXlebOYrE31KCVxjmrjmibapdQHPE7Mm8CKfOelBqsmVieZ7pmmCyWXSJspSlvqxbM2yErCuNX1N3jSonWVyfbyiFIrUgQBQ7vs&#x2B;P5bA3BIqpc5jsbKkaRzHaZrA456qd4JF&#x2B;sj4mNNJMhfbHzHcrBKMNI7jfPrhUmSvvZFEk3zxBVB&#x2B;LC6RaQYwC//YHc/8J5sD8BNu7wQ3f6fbj&#x2B;4b7P3W70Mv4j22n/Zteu/bu82TUQSz53XCzXEfGWPrYJcezBZgy/nEnUSi/KftRRCI4zQESQSgLP2O44h9iblNkX7acEJKg7pphNnkWh4N2uPC7BlGo/&#x2B;e3SMPIX61B/JbjYm76Q0FGoyZAS8SLO4uiUcJZ&#x2B;tFpFRpxiiXOioFsmxk3G7dDIancX/2AciLNDZzIjkWuJP2COJvGlTolUE1bCBQGMM3i8vrkNxk9UuGMYJ9dWZrRVFjA6mG1qJ88xg7VUx1pvA/qkqKD7/rtg4f9COLf3TbGVajonxElNpPxajOYOwDgX7XtoPQlblGjj8R0B0B5mozQT4zIl3jDw6Wyx&#x2B;Nth3HAQofvImjOiXAfOgt7ru277ph6FG2H2ScNrKYGttbaGWwQzP1ExpMLqv6Xm3f0pRo6rrqMcwBU9LANJoGWB&#x2B;RQdJA0HEEQ99jkhr8vpKsigigUuA7GhFgFCAYhQxDqCAbQioR4lBlwDBaClWFw2GJhl4fPmlwCfQCmrqmL7mqZF4yxzNHUVRr3CoPAUYvGEUKABFHMqosTQVSIKVUE5BgDwA6AajKZRZbnis8ktp2EuPkvCLU7RiNHEVhpnrlTIfBpUmS57kwhDQti4JCCzQ0iFmLooCVNxO5vKQMIbYoTdM4klkEoc4ZCMMgy9LA9/MceaYCSUOdhJBo4HqqFlKcHzoKvV&#x2B;p5Qc6Vlbr&#x2B;mmm4hNU2YlEQx0BBn0/S&#x2B;nU9sRGdm8LydhQ2gd/Q7JQnsv7lajyJNSxbpHaoCNJs5EiPVwNURhmWjNOkgQy&#x2B;lD1RbhTqoNUvh/QGYw3goic1Xq8g7TMIqIK/gYpxisZiFVXk4imJSJWDWSf0NV404iJmVr5BoGL1MygoUmTgh8nZ7E8MpIe845j8LbcuHZOQlI1OLxj1eHQamKWNDmAceP4FFVVxc9zrhhdkbosLNW8rMQwBAr3hQsp4cT&#x2B;/JaQLnhylKkm0/wBeaUoclKa9PeTALzTtrdgv/dbv2/bdWRgqgfr1&#x2B;9dQb/uu299Mj/ho/uRp3qPe9/70K775&#x2B;7OBKN7X5wdS7hvC8ws3lsaoDCxtdflDp1CtFnhvzGDbLuuG3bgO/F3u538Y3E5wbpdBnsCLJy3RsvOS4ymw2Av1zQt7508ZxxHVrunG9fux7hDGnuTIjqjHL2mG7Go3BtJemv2nJ6zidG0HMY&#x2B;q7ZtwUNs&#x2B;bxtW5hD&#x2B;qm3MNXyB5MvNGiaPi3dZDttK2N3p1aAAn2&#x2B;FaOyOxoVRriBdbRZo0beTs/Go7qus&#x2B;ZyksBOdfl8ILP3C7dJxM/3YlTLMpA6dUH2PWrN9DH&#x2B;s1dnsHm/lFk1zTgM4yCdpdasrWciljINuUHkisqdDpheDC0T9DNsUwDl6xSzbgQhkYfZsrEgg8zEUlK3xhTRaKZqXVfYoVNndmOOEkNBVUEaBOkRiAH6AwgR4hsHylEqQ9j2GJR5nsOF0ZiJbzKGrBBoDkFU17VpklB9JBOOy0IK/GWJ4WIgD0wRLXUcQZ5nZVHUleiI8jyjXgiCnCSJMb0hjmMUy6UPoIAAcUAQ6kDdlOncZfQ0YGuGNwAzBwo1OgipyHM4FqB/AG0opbEQA6JBXxTHMZBrURSxmnETZQUowJeTzSBPk5ijzVBUhm1AOgDAiyLeCFjuBaQGsidgws0CZkFMpYV2j7AVz8P3fbQvkK1EsYoWgGMW9WMVNcVxpMk2ETlMqr7YFGZNDRSCap9sKlD0jEMgVIk0opSVbFwrNuoODk&#x2B;I9MwU00O/lGifIU1TjeqPgKRjlYuo7gg3KAg0VhsGVDSWe0RGl6JIOqH3NzEu1Vi7B2I41vZINGW5iood7QvDbZLE4GOOWsN18UkoikJaOnEcwwKuzIeF&#x2B;TgWaiFmBrUZJBoBxGJ/YlwT8hme5m3J4F5&#x2B;ABgPBZ6QaPuIzwePQj/t8qyYVmTRPwE9n16skaNW1YPdSLDltMKojfJHTihsKtcOnpUkodeX/M4kQP1PUTD&#x2B;W4Hvb7NIvt5fX1p&#x2B;74u&#x2B;3w57t5/kXfuZVjIrRo7XPPnO6LxnBxIh3bxahc7D7M2yIH7cFgLt3uMM4Nod&#x2B;Lo9of2ax84wN5fXqap&#x2B;NHhXa&#x2B;e95SHjKJXZfltV0mtdf9DWAUEqCca4LVsixMSi7AO3nIcLQz2XFGJQ4Uq3Hf3Zqhp&#x2B;FJXKwNXOrAv2aQ&#x2B;qtOlMW2NU2d70QJRUT/jbVPfHcexMFd9SuFlF33I2vsgn1raNLbpzeW3bQPLO5bEOjcU0egv2k0MOIPelhg1KdBpMEBu1fN7LNDHzfPpxHIfeBtrajwq1/iPXZv0AWx/OfR0AabDAAyDMSl6ZPu5zO9AAjdV0Hl0G0LYcNeAjIS0Uu3Pbil&#x2B;8N7aKXiagcT5DA2sB3uBhkNWiEE67MNT/0o3pOhqF&#x2B;76DnVdmQcBk3DRQ/APW422lml/sB1Ad1VL&#x2B;xwTkSuJKG1T3eZVCtToSEqTjCIRFSD8gB4eg9xf25SxNkfFPWwXWgMEB6s5N8jyvBPEX6DYwQQjBo23bIssIiJxV&#x2B;SxNAZHxYlWWqeCYCFGkVVmmqq6RMQl5xstFDPxR2I2vjVgokXTRJBHlT5bFsdCANE2KPCOmEVtwGOLkic5CLqGSyvMkjouiwJlxL2hKIBMJsxTKsoQPGBoSZCKBAxRFniRxWZaJQbcYtIwX8TyTRMaWAbF5npfnuXgYoihJEs9zIx1MhhsEYgs0niiU3MkE0iwUZWMdJpBILT9yXTeOozzPGdoTa&#x2B;hnpDV76PJjkSdNwTii11cBCbT&#x2B;aFYAziK1xlejsNb1MSQhDoJACskK0y3tAbi1gn4A9CzLxFALaqFkyQBouLQDnBePnSp8PCuL3bWOnrKVQRyckAXZvHytdmsDYdLbpGmK6vhkV&#x2B;CILtXtJMLTxBstvawk8XXaAEC/kB81iNuCeqwKe7xxLOcTx3NPXWTMgj2ZlfQoYvmAEdZHSN0VyVMWqfpIYf3UD0HTLFYjCklIlmXg/1x5cvMgsJvh0c&#x2B;BDn&#x2B;qbS/KvAX0vIUa57Z3vcfq&#x2B;uOf2G3Q8&#x2B;wq/0WY0u5F3/ocZlX53ddvD9av2/odzjDuCIF4qu46Oco&#x2B;jZA922iq/qi181ss0vM8lo3s3rI9Su5ukFfs8gh5&#x2B;fqgfYlxB5EDs1shDWD5VJXd7hUMKuvnFwTrs&#x2B;XZ5zC7L2Ds3XvktWZr7rczPe3zHrXYT1BYV9VoYDqCcWbqIOTJgA9wzfyiMwO/bPpN24qIvDWO52HyOYhmaBzHlgZZjfGxXQiSlk7Pw48Hbsc&#x2B;T6GsW2V7NRVs&#x2B;0aG7UYT3y9uoxEIyRu0xVp3fjMM4GWzkKtrf6aGGwK7&#x2B;n7vr1Pzbo69PLFpSZjlbMlGx1hV&#x2B;enbmtoxKgnhzvgvvL9d2&#x2B;LHZtC8I9EUtc04jg2cBp0oiID&#x2B;h74fJ6kU4kqlyQBjQAfvR9f1nUieurYBkQCXwP&#x2B;kgSAxpi1E/5WMM2swWwD5SNJJ0KlkaikGF8Cwgko0RUVRFAW&#x2B;JR0GUQeJBAjI2IaQwk9c5HlZ5DLkWGv5ucr30zTF&#x2B;DO1/8ohyM6HegftiDiOsKREJw0zqDRLZWRYXVWpugig788VzWeSZSQaBtwhPb6ZmnfTFDBdRBSZjDQWoVGqNXWIUoB6If2nnidVWIaWQpalQeCnSRLHYkeGuRngEmX&#x2B;OIrSRIAvivG&#x2B;7xdFQRFOpB4AgNfA94uiUHgnEByu4sD34daIzURkQYpJQkCMngypAt4IvUocaKnbc10Utn1lHYB39JhqJqYgQjocgiDACpmAmajHgIqgOI7KEhPlRJGfqMjeinMITwPNGM0UUxLy4gODB6IaMWUmCmrZDUApnbcA1Q3fNe7DtCiCcn1bkwi&#x2B;c/WvR2pa8JVLiLZeZkfAUBGAQGYaOMs&#x2B;A224oXq18bjAQ2j2FXqm8i2W1eHSJo5nIR9vFhgTnhWtF0qE5JhcQ3XxQp5L4FVhhvRN9gZ9JdVYJ7yJiU4hyJU24zmAFScapytsWaeJv08K0O/h9vsQTLQLB7ndAEyvA77vcfUbLvrWk&#x2B;&#x2B;FcTef/z22m6H/uy5p97s3E4/Zi7PnM2hp/K3724VZKIbv9qZgP6vmDlM/YSqHE8ZRZzI7z7gtSWJBnd/qtUDeGxRIiG&#x2B;dqZYMUPND&#x2B;ZDdbUYDOJ&#x2B;q67p220asSHcOYbGDfQK2jssfFrhF7RO2tfxhGNlDGLcNFQTQqHx3XQf4uE0hWssxxu3GUdd1w9C3Usdt&#x2B;RbYENVGk0mHYcDZUH3nDroMDg&#x2B;eooSgSrdL4qpIBXGJ0YSfUnij1oUJ8tr&#x2B;gN4OKv2iZum17dNpu6NtW&#x2B;DdmfS/h6x/X99shrBn&#x2B;4zTB36&#x2B;23xPM5NYJppPXEJ0R/PD2eVAzV7etaHXmWW8BJQ5stph6A0fBogHOUFdHOdEZ2ZUUsHWSiuft7bRCQBS72/bvuv6TnZuKStqpxAnHWMswaa1DsBGk6HWdgS4ATB7rQlIWMb0Yiv1&#x2B;6Io8PNc19Io0PigqqpKeovR9ID&#x2B;R/y7cQwoDx8BEHaN3KEsk3HImDtWVRI/WhaV2hUkwqgosiyD7xksJdHaIXoIcRwXRVGWBaRQQGwIXQUHQMk8z7OqLGFFEIUShEBpitxPaJDKIgd8z7J8YhdZhvNsxxAplNFRaEgZKssCMhVgIwiQxNKbCLSSICAEEIUhso/AcFItTodhwBwVoDfkLGFnFoCzLIt1Ni3oSqRAPxOvqorymccfRZAqUc0PrkKjsFbrM&#x2B;p5dI5zTMSPmwXgA4jHOXHCQAE0tB9A7Km1OCu7SNWNkGcZYi6ZrZOqX9n3PWpmWH2PdEwB&#x2B;UAq2p2Ib82kktKgUkiPEtWuQKMll9NqemT4ida/Y4QR4W3Ep45W10h5RaLx/&#x2B;CTBPGJpmHi5FgtnCETPVA6QSN1Im0oAHdV48QxzCfxhLkF6LOsDj6WIQRp29GLt8/IpYQY2GK/KOjyPNWHwAYFWRbPyZJ/rrn&#x2B;8TTTWj7tsfqwpe2mdJettlSjupLkFhKg3z0T&#x2B;FmveAMWf9dL37xzt6/efO163veOf/yz&#x2B;t2/vze8BTe/O&#x2B;92le24zHFedd7/7lioPS&#x2B;Fbp/KAlxLBmZHsWQ7qFxES7EotU5Dmlhlt7XwwaTH8J&#x2B;z1bJYzgNneLc3WZydnq1W8QkL/KOB4Dh/Z9RE/b5hBVw26YElD/a/rSl&#x2B;43Gw0G4fGlE18dk4jlBaW9ZE6iJrUGoxI11kKfYNanXYLUX8vCIpEA5vjX1CxCSA6VTX0MZgwvJbjUadeGDbtoZ9jYpxueZRhTfgMK1ynqosO51VjAMBqa2ZuDM2CerdVQMzxaHO3rVRP8f4L38cph2mN7rbOgCtibcS77f&#x2B;IM8O2fqR2fOzKTQVj2IYiPI7DTBFOhDX01s6NLWMMOBCC/&#x2B;d0OZag0THcWD0ENpBfdd2k826FbKlrSG8Mo4DZgU0mKoxDIgBbWrJDmrVQEznMUr1KPzneYYE0jzLQC9bbQVAqoT8WUwaLouia1vMYsOsNO0WFJV4A0RuBG0MhpdlWVaVJbB4XVVJEqMjUVUVoHmmo76wDyKGoigSuX&#x2B;aSM5pWaZJwpkDtViKU0wrkyHLuFBRlBg0ludwMBcaLSqTEBQbYZQBFP&#x2B;o6YJsAKjgVOo2zsA9AHRwcpgKIJdC&#x2B;TPToKFcq7ZNXSOmHSiMJViAVxZT6RPIxOgpKEqSiKChYi6TlnKB0kBj4EyQhymmBSk5Ewqj8gp7A2ArlDmIPEp18ivGtGGFFLGkDI6kbF1q8Bn8tWho4CHo7DCpHAeqj4eShGE70NiAWkhMqgqciBchJQLMRbMCGfygRp7nhWEAlBzHWJiMSyOpwLE4eRiGkKywGA8dlHAnzcZJRQkjaa2Q1oA6EmEz6Akeg1ilQfha3iClkakYXbKZ8oefgVKV8eQhbCDI8pSPEccTWOd5HgQiFko12ijXvNrcfFrYH8D7BCYQyzueSO8okRyhPGN&#x2B;6UTwsunzn5VlmW5vOHNR5EwNylQyl2hvhA/w984E/C549N2Q6zvV2m9ZeL6h7k5UdPPJd8HibbYblrd7kr2n/Tlw/y0L8DccOCsGz7bZi3tPPqs637CG3T1vWtiNsH7cft/HbUHOzec3kHre8bDV&#x2B;sEYK3kUE29m4Hg0FGWgykUr/Sw22xROYRHy/&#x2B;KC7UFIzC3wKuQMfALY2radrYRPzBpbeaAQHi5AcTl3m6B/Nx1rmQZfmX14OpPh02qBfFq8yejkgyKvGHZM252JXiWh0geydYZWA20GlbJ0GuqvrKZF58Fyj3GrQzIRpK0HOI6oNytv0eVp4Xwcx2EQVjl7/uwPsCdgcbY82O1Glt77bSsme3sCXB7PxnXuP51xI/BV89&#x2B;JtOAM0zr7SQs0Kgdgo4Cv6IKHtoU9oMWiBunwiOMZH0blaeLdrlU1BBqGGjw&#x2B;vG3biqNAGgDT0DFojSTkp6qoJmrqSu3FDQzEIAZt23QYk6zHInQI3gNGFUE7lKVp29RQ9kNTVJUlTgV3AQJCm6ZBGb5rW7AF2BRQ1EcnAWqfupYwTVRe&#x2B;65D6yCO40ohfpHn0PkUir9xctbIc7UOl2WZZSnQMPAwjNFpkpRlAfUORDuY5wXaANBPRRDUPphwXBQ5SEtd18BelY4rjnUcQaxuzlzMBilBFKAzDNM4P6Ee5PhRGEoQZCxgNNXCLdzYk0shzzMZp4oBwymxHeF&#x2B;rkZM3/fT7YB/My4tLQqBiUjXgbQp1NTOMAjyLIO3OFWnAQA93gjbWBA9iepwONYt1JzQUEXhODluT/wSCl5xISr7wzDINLoU9C&#x2B;OY9i/E523hTsi2cBiNBt0mmAF/iCDumwDRGU2UoCXMvc0VA74m/VvmCL4NVPtyVgi4xWO4xiTv/AKKBz3ByOBYgrftfgY8BocJtR9ErFNByi986LsQfFrPOFc2VRsBvqaHVLq1kCM8RlmowCT/gjfE00CzfixVpSfpmlVVamqj6Bhy/RnGf/lM8TH4PeFANyAFG/&#x2B;C/ROp7rNznzhrXD8xjX/NPB6iyq8befb84e9B74fFfnx289BRWabxaMzpL53PTcvqe/70ewzbH/NS/Q7nGFWkMZ5xp0nT&#x2B;g5Q/C2yD27BAExv2uvRXrQauAMrtWqDUD26SfwxP11VQPJg71HslwWyy3uHIah74dZ&#x2B;dlygF6Gqk0XHbXLwf/y&#x2B;dhmC4HRqKviAxTJOIX4ihTrutYC9sRD&#x2B;CR3hUaG3oCZNNzN9GTkAeMBNroeROP3fQ9DAp&#x2B;kqEpmvm3pwECAJF5VvneW5&#x2B;AVXmUcR5X3bDU9RmPbGCVhdhgNT&#x2B;u7bhxE6iMymx3aKVec6aYUfM/r97NtGG7&#x2B;dTX7eeG7tt0H2BEIyZsxvdfQ9/fqN&#x2B;iVX8mT2WkHYeXK3NpR5FUo9LfaV2lG/UijITDqh6dVu7DQjEHZpLoF&#x2B;EJdV1AKgUXA0IveBY3FjWaSdq1QC2j3AeWbpoF1GOdHHhG6E7UZUNC2DQI9IWFqmhoSJqSOAtyXZQFBDiQ9YCYAN&#x2B;ASAMTiUdDxxvgXQD/q98g25dfYIU0TuBrgUgBKhr0YgaSo7uvXuU49LtB/kCpmUbAIKpA9TdWjXAK4qwc3SZKkKkvgToI2PIRQFd5ZmjZ1ned5JtBHsCNG6gIlZ2KfyKBTsuVYwdCpRLD7GiKkjALgOEVTJZFCPqThISA7bL7gIYCAKPaH02ABTYxRnE1wCXgaRSG8pFI&#x2B;z1JqirTKK&#x2B;qmRCNNU4b5RDLXKs8zuXfB2DHE/VhnlqZwCOAqgv5Zqo/jIs8hdwrDELg/pfcjTaMoKstSMzoju342DVh7BqilTzfV6B&#x2B;gW0zGVV/HlIlE6T/ODBqj5AS4PORbY8E0dfBYTCxao5D7kxuwOZCZzXYYdP&#x2B;t9EzC6ETfQWDrTEcuhNqu4XOINTYUB0&#x2B;NI0qJksm&#x2B;grMl6nZI9RDhsSY&#x2B;iH59fiz5RsBak0ycPLMcCcv4hf31etPv9Pfdfgfw7p0ut3cHi2kstrPbzcDx/RDzDYt562632W65qt/Ze3R7cjW&#x2B;46oEHW6/OIPgs0vPsfi&#x2B;BRC69V0/22eLm&#x2B;17y2a4bdyGVhSCj&#x2B;PYbeteeMK27eypuFSCe6jzJzLQC2RkaV8Am5EqbaNzM6K4n/45DNNV7KUtMrYgnudUVN2TigxbQvnRoOqJq&#x2B;wKVAbCaIOAyWSQe2PL8/a&#x2B;7O1TdTMoDcBTtbh29hlodNjCaHhFq2OkRlP&#x2B;Z1OI7ZSZOst2XdjMwZJQmt3TTjHMhKtif8b&#x2B;apo1QGYu4Qmp790M8dAORscn0Jk6&#x2B;g2Hv327jmDfYIgywqrdw&#x2B;kYnu0wmJudBRBJr0O1QPa7vcabwvs7TObsTp9M20uKrkB8yv7wRatpoaM8zFaHCdRKtmt2DyR4tJt0R01di6mgqVHRr3SqAEr&#x2B;RVG02h2gWwCiI4QLlbJDzYkBZVnUdVWVRQUzQFGgfk/IjsRSzCZr6loL6jlnnKVpCrVPWcpM4bapgYlhEmDDoTJ&#x2B;A1gFKhEdVRg7kKZpU1eIH0XJv8jzLJUvyqJAVwEVfSBaFIDjOM7zrCqLFFIizSpV1YSYjwvNKVIVkxRc4zjmRORUpBqRFpgF3sEhDTBElwIwE7XjiqsUkzFKRdfje566lyHtCFm5x4YBxgroJRkmCPxcl4T2gnqURU8iPCeOoXgBLhQXARMn4f1NBYuzNhyr0F9RbMw7QoE/pymbOvJYVDFB4Mu0YJmWEKn&#x2B;J4PRmVJ&#x2B;yHhwuOd5&#x2B;pDjPM&#x2B;ZcZlOcZyS45ToyCqUyTUoSLwQVVWJmr8ooijKVQSmTZVp5i7Bt7R6VJbPJ4982FTcAXGmV7eS&#x2B;tiM78VnhX0McCfQG8sNcHUQRb5NZoWS98rSfqSiL7AGyvopGUonuQ4L85pkpb6XVN9c&#x2B;1FMtgOFdNJGxneBKB&#x2B;tKh5FUsSvf8YOwI&#x2B;Bld2&#x2B;v0A/FWq8YR/7rb3w8V23nwpb9xCI/Ne7/c5IyM2fIvvdGVy&#x2B;&#x2B;djegOxxVu9n3ZogUs9sK/0WcPNaE7hXrElYaSEvqEJvkmp2DwcUob6f0hrbPbC3Y5Gx/dqe2e5vofw4jsM2NLeXsMr7cV6/n5Lv&#x2B;aLNHRo4t7gXmc0&#x2B;4jSRq2E7EAnoCvcuV2xlqte4M8qN6wTIGoah09ZEb1Zo&#x2B;Ykljbyjuq5Hk6w6ig9V2BEO4ejZ6ZBxYIumUyGW/cB0U3&#x2B;mp54HopTtN0gK4b2k3OhbCUZxTV2DjGX3vZaLzoR2c9T&#x2B;0/04m7IBCeT0ve1lD3yvt&#x2B;OGUH3X03R916Hub8hAT7dA17a9uoSlY6CKrGHo0XcaJK50EEFPXY/iwQBhEOM1mkfiNmlkEPKgowEg7qerGHQCmBjxobWGilLDNimLTNAQdEGVBgShydB1Lar&#x2B;mFFQVWXbtrAEwLVCyT5GK2CQ2TQ9AKFDmlVa6qngZ8h1wgCAO3T5UOSXZYm5Bfgiz7KmaSDTB87GP1Ear8qyKPKu65hlhHYB2hd1VbG&#x2B;C9xalaUYEjKoHRJMRoP&#x2B;XkNL80K9yFAHCfBPU5CTXLsNzEFCAZXIDPBIdRdSJA4Dn&#x2B;JsWZL6beHZ5bGgClEYQoEDJ2uaSAiMFIPTNArDsihCHaSlRd8Y55ejUqiJktwU1GOVJwFTAqdCpYPnxC4KUKY4sG1MqrGTZjrLDCASxf50y4caRUYxj46BmqfF9YsDYSlONe/VIk7G6uNsEgAaBAriJ3QLR0Q8eWThEwjt06MJBKdKNbxIQXMiOUV6C0zZZOQOnjMvgQYO9D90AuAeYg0bJfKO1HELmE4LRzo1BxJSTVTl9RMoAUroG5BC5DrfOlefjO0FpdqeQp8h18ECEzkESYZ5BmfQ4XSZ6ojwA5skSa40GLTnF7dB1bffZnWp3&#x2B;U2/0twDWJ7K9C8JRK9ebefCc7urTrvvfGfeyV7t9mf572fhN/levZue69/A9AZTZF4GOZ3N&#x2B;xE/WCzFV8ePu5ATAv390Iu4leCy72HzHDwLpHAOul/tWcjBp2V9u2yB&#x2B;NOtgvDPkZwMl199lhmi6ckZtLKb0vhjdthep7YGs30ZIekM0YF3gifpGzaw8G/UNmdfJlmVFmvcUCdBvyLSVR1PiRalj71CrJ3y&#x2B;fcedQSdaszpHghvDi/C&#x2B;VLPNASJHZXOjUkjKb4vfsZmF1iZ5t&#x2B;MPRs&#x2B;u7zM2nCSa/fftwP&#x2B;G3&#x2B;fFzzq&#x2B;&#x2B;6nbWxILifr/cy5HgYdA6GLqHbemLanFHPdy0/bO00mZv9mVYHtOFNqXUws5AQ1SZBw9Zp6tQ4jmVRaOOh7TVLCtgd/QHxBDc15g&#x2B;AuFaV&#x2B;Iy7rqOHWPC9qv&#x2B;LQiaIYe5YliQQFzXSc4ClpIGLt21bxA0RuMNpgABTcIa2FTqh8UEVPsxA3l3X5rJlTCiqylLrvklZFBC3YGoYxoTluQwmy1VllGVpFAboJFSafAonNECMolvRJmVpipxTfgtXl8qoYuWmaUAPKh0gUOhQM7ENxHFVlanKMLIsQ9Gd5XBI9lHfzSRuSPB3DKl6kiQC5vIkSbI0hYwecK2ua4BgkCwkYEoiUBCUZRmFIdhUqmNfU5Nbn2g5Hy/qlOUw1cq95F1qB2PC94WEL1GJxNK1tCOmcrVq05MEsxFg4Q3DED7XRKcHYOdMI1wFN&#x2B;srJBIpnNyJZIZSylIUue/7eA6T11UVOylr&#x2B;HFMBJymExGC4is22UHR9hgBaVMgiRXjLLSBANKioiZ5a4jyLfcopKAusB6qGyEeRnrEyj1hd2IiQdESYUmeB4b6KUo0Q0k4TJJUVUX9D5g26Qcfhf0pwMc7yzIYCXJEVxmWmG8bCfDiu0mAbo/ebtjTwiwLKebH365O/x7b3sN3akvX7nwd8rav/BgW9E4I/vY7/7QthJ8Kx9/&#x2B;QV33Bo3bUPUGEL97aQtn7Z5d1w3XHGWxO7H1bA3jNoLnP4nXCZ1ZsIRJdHanll0QJnb7zsxV8dh&#x2B;mwx0k2d35AnNDsPsnPa6WzhSwNDU0CCdsJqc3uBUPijewuz8PHlnNDPY6IsljJ&#x2B;eMHDV9i8T8gr70HpNXrJuXSJpXt1SlOlyaufl9AY&#x2B;Z5IuqxTqdPSyLGN6FG1vPMT2Q9Jq2wR5MigXj9sbeMg&#x2B;jD7/wOMe9qL86bozZbx5grtH3X7bzQ&#x2B;dbTurukYjtLWMnX3sd2&#x2B;U4W19d/&#x2B;vha0d&#x2B;r4fh20x3jC0Op550J9ZZDT1yv9kdkHfj6NED6ntu4dPly82Td22LRhIy6bWMKD83&#x2B;iQAcH3XTcOQ1VVOIN0EWQ8GZKLqqau27ruZThxCUpQFkWjfmVEfDZ1VZUFPMqlDiKoq6pt26au6krcybhCkWdwMYMRlUUBS3FT10jgQfhP17Vi/y2KNE0ZG5pjenEOnUyUJolwibqGFD7P87quMh0F0MiA5CrXIcRU1UNwAt8tpQ4YuJZlNAFnWFIcR1VVoYaKFWZZ1ojDIWcvAuEz0MAAdBYqT8e9JKqrga8gCkMQA83zEU8wpDViIEjTPM/gZ0iSBOQBTlOmHhE0C/DNc2hOtEgPTCbSEcBWqVgjr10BX6JC&#x2B;UzTTpVQSeplysxTdSQDsEoIkhobmHyPqwCpZ2mKQjjpAf4pcN&#x2B;M&#x2B;A1DGesrLmpN8ATT8H0fn43IxKqCYoE/pJzRq3Zb0Dzt82QwQ3MiBB5IoWKwXAds4aFhmkSmZAG3n5lRzZL3quPtWDWfqIv0ckSWg55SrA0Tth0SzQkt8hyzqJmKG&#x2B;kKJwSvlICtAHDU2BiFE/WHxDpOAS&#x2B;WatgF8U7Vi5IxH0k/A/iJg&#x2B;5f38FpJjHul1qjVH&#x2B;yckMb3iIBej8g&#x2B;2Pg797tBtnotM/PVHS/8dLXXbTf/kv/DpfbAZE38I0bzrALl4f&#x2B;LYqmn/xde4/tXW8W280rn52q364Qv&#x2B;u2W9get3GhBdO8dLdt5Zyufv3nZ3oUO58lrSVPJAJwwcLldhuN9abAv8scCFm2rrut/7Eg3t4aiQor91zeNhqeTAhyQs2ht3X0UYQeg2UL4zgM/bQAlM9HAcHDbEmop84eBbPw&#x2B;QAHvfQM9PMptXCFahNg0OLuBO4NuQJgYrI&#x2B;T9ippMc&#x2B;T&#x2B;LLrusUeW5lEAGK8XZsUd/2OoBfpw&#x2B;APiv2IuzHdO9nbByH0aTrTL8irgHTt/k9/NYOwE/0i3qPYGn/VWaX0yBRwH2B&#x2B;PvuGooptQCJPWB2lX7qwyAadUAsqX2baBgYtznzKPKhqleRWCce8U70YNoiQIW&#x2B;77oSnuCuY&#x2B;FfjL8A&#x2B;k0tfSWE/5cl&#x2B;Ak&#x2B;zBAX0QSMKcOi8CkKNATyPEdrApIhOVNZyNnaFtoeySMS&#x2B;X4O4y92RqeiaRpMGAAhgetA5hoUBRYv04hNiwD5PDiW4aQUIwGRV2WRpSk8DwrXxKuA/kBR5PA8YFpCrp6EzCRvZoI1M5ybkUeRDuQSPBjH9BugGI0RxTRoZllWaA&#x2B;Bkow8z5HpBIURXsd55NJZhmp1lmWI5oTMRtsLhWqKUiSKYjHQpidxDGxdaI9FlEjKDVCDF7NsmtJFXZZlSvUOLqRwM4pkvhvl8TDgsnoNosJsHJITVqbpCqDuBwC0LIV4oGaPJ0AULvJ0VcJQOp&#x2B;qpZjpNyQM9ABQ9JLK4GcJ6sGbAi0Q3Mmgf3y/UpnwUHCatUZUpbYuToaA0blTxV26LkWuwv1CB1ZoAOvkG8GBpaEBOS0EUs4X/VWscyTINPBpFDGScTPLh03NGPq851mfjORKxIGd87tWX5S&#x2B;hwdgVit918Pf&#x2B;1p7t10M994odm&#x2B;t9zYreT/Marcb1vyuT/vnfkd&#x2B;b7fh&#x2B;ju/7kPy1nd8hszGHdvo7mmvWwXB&#x2B;t5/8kCKOrjIvZVpe7jFf/bk9o5mVMSefHbjuv/WQ&#x2B;MaZicZVBfE3XhUt6MX4nUHA4LtIfY8irq2lP3TE9jRGVIfb4RDgw32wdfkBoNm&#x2B;/C0Uve1Q3lVsdNpiCdWTZk&#x2B;BRujCeO3j4sA3S4Sx4zjCDC3BWT5Nk3US&#x2B;6r1wo019btVPF3QTDvYmopXP/5nEF8cD4ryBm2&#x2B;xXXbbcjCT92u&#x2B;535iCS/S2OxG/ND9xpn&#x2B;6GERmzvrxoO12yj3jE6XKR/XVKgPTE5POicjJUzeVjOQzjIP2HtiUHrJH6TyswWAHUa&#x2B;MwgAl0XVeWZVWVakao0EaoqrJr26IoWp0SCBkRrA6SQaSWmFInCYAJoOo/DgNkOVmagoFIjb8oWP4XQX&#x2B;aQmuEhlurwaZ1XQMDFRoEpNygxKkw&#x2B;EyvXlYy4KwtNTsIiAfCBjQT0NYAokWVFPQDCigATHqdgbYrhXQ4FsmkxNZAw3VdYyKvoPAoglEYFAIpmYV&#x2B;namEmrXYWKB5lqZTpyIMAjuWlYeURRH4vupJUJPO1IwrcfX4IlXLJugEHkWsEZClzPEVlpJodifK3ghOJSsAMiZ8BOLM1c&#x2B;KQyBtZ1JNZhJvBAQrUvc8jxbnTEYyQ24eZWkKAAqjhTA45RvseBBVl2XpeW4qgv4A1W6jv0pgCEnVfcE8foBsSGV4cgSARqbFkdKwMcF6eWczvf3cGHMlS0pxP5VObAWQdnL909XFhD15fJMkBouI4xh0CLdDQkJBFNeTJBMxyM0mTbApPiund5lfTHQiy/iByTQhFISNzZA8z97HBPy75ADXXmjnd/d1qO69KcE7L&#x2B;ndj31v1vHz3dR/HdtNb80OfH/rw5y9KTP8rcBizxVnVGEC&#x2B;ibychdAD1MJeRiMtKbXbZcA8FQWUqP4aK8ybCEbGbU7aNfClsDtgmc3K&#x2B;cfttsUxqswg/WsdveakT/jG3bj0CVgIL3WfHl9L48FcufpWyrTnylkttzJZv4ASQiFH2QX9ruWJOy2VvqZSmpkHuVk&#x2B;RU8rU9edjYMB9CTz0r7CYMF3JQhWd41jiNw5GxVs2vx5nWHbuj7vpuj4Tmzet&#x2B;eIYQx&#x2B;7b3/p15zYG3&#x2B;Vm&#x2B;rq0xfX/q6uie5icFgBvfkQ&#x2B;D/qANfdvU4yh9NCxg2GZr6FMN&#x2B;jmBakxtCWIIbmSMd49Pb9PUiPVEc0nGEvcikGtlVrd4DACXZU8V9DcQ66sWSOX&#x2B;DS6GIWiYMiZOX/EYlPiEC4Uoy7Is0GGgpgjrwcmLPIe5GXV30BVNI63zPEcvAjoceHxR7M/h9y0LVSiVyCMidK41EKmRaNSm61qEF6F5UWnPAWQAPQ&#x2B;ogzDlVJgDZgXomQFFkQ0KwgBUBC4xDSBD5bgoQGBy/R8wnFamhQZg3nBdV9T2sG8AW0IqY48F/aOgHsdxXVdAt67rUuKChQHngnKURQFxP82&#x2B;xIiAdpnWoUVfpHp6Ff&#x2B;khVbBaVqlmlzFIZhjFciQLIXOuUb&#x2B;syyNNQDEwzIby4w2zHyQRWRqulB6kOR5DiME4SkoH/weiZlcm6ujIE1T5ATlWRYEfq7mbIBX9BOSJPE9TxOKUtbO&#x2B;UAyoUlmtJkmkCZxjPcXoaixDjfAe0TYTQ19miRIEcUC2E6B9YUgXhpSeY45DFVVJhrAn2UZCBK9B6XOlYvjGESpFCO7dJkMWM/5PNmjYMOBfQn2kfDRmumdRM&#x2B;mz/89CcDtt204cqvtOmT8rtfl6XaR2XX444aLvt&#x2B;35ot598PfD&#x2B;j/tFzobyPZ2HPvO3nqsx1mRfTrznwzQmIllXvOqrP2szejELv40kJ8g7xl523wvVWhv2F5u3zD7knEP1uqXdhgxhSMLBXvyJyGHXs0y&#x2B;R8MrPHMijwEsX8dsNhVIg2I1G4EWgftvYfhqIodt&#x2B;F1mR6UmiE8JxhGJDcb7/FxyU6pS1798SvpLEwyW8kgJ/gfhwxrbad1OTbDofp8L4bVcffmcnEN2ydOgd45nH73d/bH&#x2B;BjhERq&#x2B;9MycI&#x2B;3Xv1vwfZed6Ef6enHoVdtz/SZ77pRmKe8d2gFsNXTNiLvaZu6aZpBJ&#x2B;KxzdWa6RDD0A&#x2B;DjuEDVRjEUiyUQMbktdp/aoGfgbzruh6GPs9zcAYxELctxDk4AOOl4fclpodpGD9EuARUOjD7wsrc1HVZFk1dww1clSWUNizwy/AyMQQXEnMkAwoatAhyranDdgyhUZHnZSFK/bIo&#x2B;r6n5ifTaV&#x2B;YaCb1&#x2B;DwD4ixUDIMsoySOIU8qikIXmAu2LoqyLJqmARrOs6xtW5RFVU6TA/QDvyG5BWol4PhMZfqFSsPBNHAZhJDCjAErKs4M4A6cl6hyXSvHkwy9qkotnOuMpyTpug58I8/zOI4UB4q3GAAayv5EY38kg0bxNEUvALa5xhWxVC8CfQygVVUPHnKqp8pVopNp6wP2gKIoMCEhSRI8c4B&#x2B;RlIqhE3yXIwQURRJFwX1Z9MIwOcnU/ct31AQnlJ5IxYD6F/Ysn0QUJPDHVhTt5r4VL2zsZ7cNnOI&#x2B;PkGYeVFIZaGpmlSTSDNNHYTOwCXS5StGjBycbRnKiuLceeTcEufKpadqVlZ7cLTIOFM84twm3EUkXqRUeR5FoVhUZRKTgo&#x2B;YiEMEkmUIhb2x3YAdv/5c283XH0vsLvN8vbuc/OB733XP/JxTVDp3df8X2p7Dwrx1huZgdS9l7gNjrdA04JFfWUen3/DJejota9bYH3NOiegvEsPdjdK7QU17jOKzGrwth5sRTLXMeG999hpvL/9Fi80OyEvNxq5PCAL&#x2B;Yx9LHJw3487HQ&#x2B;ifBnT1LZAUFzbVFDXKVGtCemf3UWvNf5ZeX7crprvCmzsIfb1cdtzPNrCv3naO0vdMyzZVqBN22Q6hAvGTgwzNXc6kSL8097/rHchL99G2LP7S3X7Y7z3zL/Pm6x/R&#x2B;CEbZZ0pB2Agbt1SvMwK2C0Hn3MDeg6NQO0g6D/pp8&#x2B;GC1AP07YSe2/45veNPWolf6h7zXlsxrVE1JXVds2JAPD0Ldt0/cdDmmbhhOjZS1Ng2xQCRJt6rqqIAXCrDEodtSIrF9UFaB/L7ShhQBpGPpSx4q1MoG4xEcIuUCQHonWvyxQwi8VxDc6FznP877rAP0x04AZpuASYm7uuq5tBUkXhUp7sqap4ZgEFK7FhSwTsvI8r6sK7QV0FSrW15MkSWLlEjkquInm0wNy4WuxH4jmW83E2xtnIQNs4Z/gOTo6IC2KgkkssQZTApeVZRHrnAE8NKI6IDaGupQalzQrEucauZNlWZHLyKdc4KMGfRK7h6FEjqpSJY5jiGqA4wHWc6UuKdP0Ub3WEn48m6ug6DxVkwC&#x2B;BeSKFWIs9fSi9iXIcIjXuWytmos9gM4EgFcZ55xnyIfNNT&#x2B;qKIpKW0CszadqMp4xopypmuyf6EQFBqeCtKQ60Qw5prgpXQOBtax/S9tjEntIG3hflq2xwJ&#x2B;rNz3WUV9s5giyV/pEhkYnAPlwqRFYPDxXIwEX8/syCZjbrOp5&#x2B;&#x2B;N2T3LD&#x2B;W/z4n8F239l9/Ujb&#x2B;cGHrKXSMy45e4hu5B3tz9wA9TeXY9lNTzKfmERM9sCFvTPGg67V2FFc9z&#x2B;WZvhUaLeQf24M7S6e5vjDs/Z5TP2bLxQZwwD0yE767f3S8ctNtXMbPVGtIw6H6U8nUpVQOMw52ByrPZk2D6yZANfAO7MHtEwDMiD5/syHTUM4wAA19ol4dqdcQUII9p51qOucOYE4FHCWnfY7N5Nz3DjT9btZrHvZVz/ZbZ3HB4vB&#x2B;nnZPZ6bxQ78ortMHfdqOqsyWXetoZd6BsqnwQ1&#x2B;3bdNIxZzMTt1udtmKKHOhs7y4HE8Ny3rYQCNaLpB7wmSai13D6OI4YHM3&#x2B;20S/atkG2Ty129gFzzWpNB6qqslF3MVgHXqxYca/rrm3RiyiFG0h0Kc5ZFDmK/QwdgphHcFuRo&#x2B;3Qtg2gdlHkWCoSfkCBAItLRfzWdox7RAUddluQCpT0WQqFkQBeZKmzZhmQfde1uC4E9KmmfEprQkvjQPmZFnFRJxdTssl1YbKNyFF0JnEmHtaCAJFIWqONRJFPfwWEHlhSrok9WtDNJhUQVCUaCJNnWRhKIhBiRgvV34t3WfF6pHGZqQyAk5j/qqoSO1hKJ/iizq3ROjmHLSTaAym11g59VKZ2Ai29A&#x2B;untLdKARtOCSmoi/CJYp5cuz1gJqjTU08F8lNoVE4mEiNRvUtSUJZlmqLDNw4Nn6ndgQeainOCsDtNt/A90v3JGbC35TypdmOgw8GHVt964W&#x2B;iy1KLArs3ev7J7lzoXDSsp5TwnyxTPsnmBnkpl00hENkXPmnY7RfjrX9TX4eNdn&#x2B;H3qbiexuM/o4c4B2uNUNm9r&#x2B;7B95yBdf9/bvu5Net7cds29Xrt79fv8vtv9Qabn7&#x2B;443l9n0775dXzV68eYfrPmncpLq/fcJrfxz2AdxdKL93GXAnjuYnFy/O9uyNNGjrVDt18XGngj6OY99tdSp6c8XZnp2R3e/lM4JdNM8esh&#x2B;7MEj&#x2B;cB5ADfscZneKZzCdXz8qrZn7i9cBzgDgwJgEa8N5PAyj5BFJaAyUDBbBo2lDcTzkQK0ZPLzdQZrTLb4X0xmGfm8b8IZtNiPsOsPucB2A3ne53Wycv73bYJD9/9Hely65zfPM5v4v9atT75OMJXEnz48GWhC1WPYs8UyESqU8EkVS1NYAGsD8Q35XfAo6d0fdeui0vW4HXkauT&#x2B;queKJM2A/ZRFJYoCEKRUhH4PdjV0rJe19mn8OsHaD&#x2B;V4wB9QrgGQDQh50&#x2B;ah1iljoG9gWUVxJ/xI0NTOydQ3JS3O9Ry5MxY&#x2B;mcrSh4sIfwL6gg9iChHAHcDc55lByeJu8mVhIAiI/Bo0SA9w4BDeAsIacQ0oyCC/Tnz5&#x2B;kRQ9EZ8BvxZFIQuqcQ7JRQcDThHjiP39&#x2B;I2gBQNCJD2EclWmD05952yhOPE3TOP7RXP4CemHXv90AsGAn9l5qIb/9&#x2B;QOzMczSgwJNxC0QQ4MI/kcrPY0MKtDSWs65Usrb2xtIKWAoQaP4/fs/sKp&#x2B;//cfAPqo3CQ1DwulR8G0wMeb1sAalMFCaP7//t//&#x2B;&#x2B;&#x2B;//5xzMQSybphGZjSBFpgffCYIJlZ1QvQfcnKc0l0cl26abrfb79//TVIteq6/Oww31CajS4R2bmplqBw8qSvmj1Yow2&#x2B;vqYpuNlRX1zMKueuNoRTKAhudmxh0cWNxg2lyBoW/vb0ho9VgwkJGTY9rvAo3uk0Qtfzff//BmTCNE3uOMZKUFTU&#x2B;nlOaNOvooO4L&#x2B;gFwLRDwMKq&#x2B;NI4jnkHVG8XrIovv3A1ZgM6gn7Xl8iRm&#x2B;gDYd2hYemIaayvj54mFUN3GA3vqXm9nNKtH&#x2B;3xn4ztdfVQ/fXiryEMLsnXfbpio3zdT7deol5vT4O/N&#x2B;7nbmJdBn3c1jTUo35wG6DRtxV2xk6QTwG7v1ZVVzYH16SzIMKLe9AN1kycEFyOo5vpMqmAUJVIL3A&#x2B;hUoGZA6lzJUHfhlIsU4Uy6sBSpOx6wlDaWBd2sWKVHbYNIKhLYbbr/GeKFIZjIqNmXCJzh7W21pD4JWmoaFsm4FcjdN18&#x2B;NYTq6tQjY2Z1w1ce6bzHy82ZJxbGiheOddaBR9nSRLaWoMmUJWu1mabAtKSFnaSzc2AOzJqlbEYQpOKxcI1AjknxZBSVEyfW0WZ4YSSw5oLKEKXqFpBDwb7aZoKfnuP9mLvDwEZhBh922qVPKQx1FKQlBO3LuYc/ByV65zLmtUHtCKgSexF2PEk4bkTwoWjJg/ViY3QIhAQ7JVWBHAZYwDghg9hmqYU4zgMzk0559vtBnyfUhoGYfwD3/3589tpSQEv&#x2B;sNEvv44Dlp8zcF&#x2B;jFlBjxputywV0xAp4TFtRJFKqtMQ1MQrhWmRmXTStKFYUbLYcUZAnMJNUssuJgni/iRpNP/QyA0GFO30cKeMWhlqjvg0laSM6Vp&#x2B;0NCOeAabC&#x2B;hNcum8KTAWS7zAc5OaZtSE96MGG&#x2B;DnpKUYbrcbFlDM1cJNuv1Rg/ebek4k0mMYcAFwAwC035Toz2xIN4Xpc/gvVlUTjw5q4R&#x2B;0lBgqhQ3DTbMwvVlyDi7BTSs8DANoV7OxX7WOUX0af3TOmstfi2SPyumHQoL0rH/&#x2B;/MHN7DTRJyJJDNH/zak2AteKYwgIa/0aGtVNoT9YXryFBo0YxjqNxieAYxcUoDWY2PxgbL8KDRX4/Av0nXhrTxV5otu1wd5CsT2t47z6cYAI3znhT5WDCd89lw62/nWxYaxn2r//Ylmrs1UFzzwmFv&#x2B;dbNkMVX19i246EDqY21ZgfS3dlDrNtq7IPG3Gu8WCe3ufpLlcQBIyjz539qi6jD&#x2B;WflZegvncVSExeshMdi9KqLBb9AzExg8kZ10WCDDIy9CRyiJfGvZAdoddqCKm3CjqivGBwBtgeTvFOEN4ce1idtPuVpu7&#x2B;utnl8kwW/a9AWfMQ0tnxY/QBMryWthd1To9qtRPsLcWtuvh6nEqEjlQ8lyQmLc6sgAhRBg/7DSa3pdZC42pH0yqUAchyTjQ95PwgqRwmGoIUdIFaDUxkpGSRikII8gkCdVIg&#x2B;y9a7UCtTOSvpYCzYFpgoL3w3ALgo2nkhOT7Qi/XwsUiK8AfokQlPQ/uWkC9I5RoguwB3g7xTCNI04QNQ3IOYEbYRwHKBI5pWkc3DSBLATyErH&#x2B;7XYLIbz9&#x2B;QMKEOIEEGNwg1/CSyECwD4MwoGchiBLZOXtbQDpArXPgLQMmRuoizyiSaMREAPw588fnORgADpgNDAoqFNvkk7nPyhsv3//570Tw7NM48ZMpow9AKJFTd9hji5VfC8w&#x2B;m3QRPtihr/dvHO/NbkkwTFrGFNnGLSQwqCBrWqwHwctrwskKkG9w8AiaFDbSKDniRCFk9rOySPG&#x2B;o8WAqNpn8SYSVMS0ZODuSEUmLZ8qgcQp26ZN83gBGYXDhyVWC&#x2B;KliFuydWE8&#x2B;H3b6GWaVQxDfDYAm8McP80TcEHKmCzTqUFFoj1ofAg/BdLQeVH7mTvZfW0eMKg4Sh0mHANoQnjXjoVA7AGr5sI&#x2B;O6nYvOou4bwTQi&#x2B;1/ihXV0zC9fuNj7TZztMvnGyh/fIEza5pyd2/sCnh/hwE&#x2B;NJRe6kr2YXMT94ymtIvbn9zNDW2t21sajarsPeybKHulNSevlQz4WuKNlEAG&#x2B;qEN2ZRkOP2TvrurToo7HwgozVnDqJRAUoFgfK78IAODTAWQyBSwRms04v1FJA/ia4JzrvVpUbMbEtlpT1eywdLKpdrNMBkX3Rbb/rgui2d6u6ub1t3mNPse1fS84/m6deF9X8v5CNb0GtwsGDKpgib11g1lrnZEGi6KaUswQYFFuATOsNlyJlwnAI7tgm/q4MPwDoOlpHLCYNJm6aVzcqZK8akwBqPij1pRQ0SBqZUEsB4d45x0ACzCGlhFABwHewhtR0jlpdqCPmYRuOWsoMItZf74GlwAvKOaHQWFBML5mLMG2kJHIOoHmaJnaljP9p0grHoJWIH8A5Gu&#x2B;D5khNKQ2S42UaDcHj7e0Nw0mssBq5cSzSd8KODggIVgw8G/BaOFUPYJRltSayYnAikxZyGsfxTRPDI1Z4Mukd1ex&#x2B;w/lM0/Tn9284CqA/IMbXe6esknHUhEgwmavNWzqa5vDWYVRuPVSd2&#x2B;2GUxhHiWrws9lesjMxipdsqzeJMXB2NQYJY5UiWXB0kHgzqRpm1QA95fHPnz9Q2N60xgIpSW9aEgGjo&#x2B;dBCi&#x2B;g5cBaAc65tz9vhP63m5CO3jQfEbg6g&#x2B;EROQktcLryo&#x2B;XqiO1fkqhOiEqHYqDFicWFgkWDu4NonucOfcn0LJoA1Uj4JW63GwrPUbfBVaZbAINNJtEQxgrebygATyM5a6ZavOK2Ptt3x1q3sZrApm31/LQPrJsnDj81yp7zZD3Eo7j2a5SHT5rAJykYT09o0y5&#x2B;fmhFltvbj4/a7L9TRNf36pphsmePpyBAdXMmq2ezMZtk1&#x2B;Fa1c8mxNa27IBO12AT/RPa1lptms5mTaR0LJgOLeyeR9Tt1VRzwy6bsYdHzT&#x2B;UXNFaq6XSsm5H4blnzSakjO1WUWW2LW6IrHSOGGOr1YL4vPJm8AenZBjntZlT6pZ3jgdY0XU44bYjeUFqf&#x2B;BJ&#x2B;usvokM5ObcTze6fpjaoi&#x2B;RsNjqiu9Y8CoAebiXvXWtyBal/zvdera01hMNKhlnTG2z4pRTvHdLIil0/RYavZIn2DYwXQOhw0VLi8A/ArI54A3TjvS&#x2B;lJGUuTdME/4BUGHAuSWbSpMXIArB1rQWwPEgAMZC/y1lKFcDMDyUEOD5oreKcs3MOscKw3wO/Bl2BUookLHXMJTpF1jb2Pqf0&#x2B;/fvoL4FmPyDuBHixLBg0Sgc/QCAUwBtMcZBM9OPwyCV0QaJyEQ6GrJ0QgiDQCs3TePt9uYUlsEb8H//93/OuZuw4W9MPA&#x2B;Eh3LIbprmKmDDMAwDuExYOjo6QK9SSI8sQ5NQpwx3HEgRSgjzV86hrlqhbBxHTZg0jeNA/gn6x0wQ&#x2B;fqmUaewQzMSGudFDcSEnN7gstAhJm02/dYywJgh1RKY2KEnDEYnoWNk1GhsmLF1rIFkKi2hNRCdg/s0aiwBgTt&#x2B;U9VhTlsG9f7WhJ6D1jsj8wpKAgNaHMvkOeec&#x2B;/Pn928t4ECWFBC5mcOg3CqdxjCMQiebJuOUCN7Dl4IrC40IjiDcuIga96rxYghc96AF9UZO2Ht09TFpQDtwcBfW39UBOqzcoZCukwNr6F6bg6EPpn1&#x2B;7/pze1LlOAaOz31xz5/lia7utDnDPv8yWU92Pf&#x2B;D6zIjzntiIebh3bg3z217oenzETvlvZ4Ptttd/CHgwGxPpmIupEhJo5yWOTFp79/Th/XwvH7G64L/Q5VjnaRlETNgiV5E/5hzzjOpY54EeD5bXpdoagljB0&#x2B;QioHlz&#x2B;TVsjSjpZRSgikysHd3FZWsGYFmNshcSGFRLhoSWVAWQygN6a4g&#x2B;&#x2B;qZlpeInDBg4RI2uXymwoOleJm3pWV22duDV0cag8GjQfAcKyp/rElS1ypRwrXgLg3By&#x2B;MkaX9SjAHafk5SDzhrZirksEIAgxQQyDmGACpRljRB2RQaC4g8RigCVI9pHKZpgq6CBoh/wOiIDAZMTxoiPU0jiEMSZJwzlIcoAQBTyXkcR1CJgkQ2TzF4N02k92DXNI4jmEgOXgIJSxAi/jRB9xgH&#x2B;B9m/URKKGgpA9LWafRVI/rNa300oKsQWNxAsOBNzPmAcTcnBcsEewH9oaKC2GsVFSKnEBrj/zcNZh1N8Vpa7t0ckOqDgOkbeoADQRH2jToPoCoIXZq5dPDqELBngSSYwLgpJctXuSkTxk3TmxrXSTj5o2k0h2FwbgrBY4i3t7ekCY68pqr03qvNXnpmBkwS1gdNBYtJkilEN8WoOZfoQ6Dxm2ZvjAJq0E2ZS4LdtVwaYwmoG&#x2B;BEbmpBhzOKOJ5rBdoVfTvU60Yl31Mv4jI6LcItl0D5aZMmqhptDWDnJqV1jXL/zNWyB712t7c3bPeavRS6EHvG3mG4Vwhs0/53AFLPAIt20my/UhWOR1lbKA/7fi&#x2B;cOnUKK3vn58mBnsMGkHdi9E9a24&#x2B;Sp0d/6DJ1j8MZN8KjQxyMuLdr78p2M&#x2B;xMzsfQfP2ntZ3v3XX2trcIuPs/5z7TES3rm2dhfi9srsT6Al9MJYG0rAGM58AOwVNYb&#x2B;ymYReQ0Zlz0LC132tosnS&#x2B;1EzYW13Z5tnP3FjapK6c8LKrZTyAaZOWJRH27sCfwdr/uzKj&#x2B;VrAukFiftsGCf6LxuPisrbWpBDbSqnGnZYlSSi8TJJTCAAa6gBwudwqir9xP5ecgoJa0IQqWEfwXKEfM0pV7YI5SVtrSDCKkmR8fmspUXUGE3JQstrsayk08JeSQ/BSFUGVCil4rPk9nXOE&#x2B;wDkUclCs&#x2B;WeVYq9D4rXxaUQQggBYQNOCoHNFO9xHOGfGIYbcpIiRdKk9XfhRoAB/KZld71Qkjx2CRc/iE9jmqZhuLlpuokRfSCRCclYaZKHOoFuMdCglIxxGKZx9IZMwhACwGsoFR1YF9O&#x2B;c4h5eHv7Mymgp3owaeHeYRhiEK6506RGg/COiDUdgg1o7XZOcq1iu/dSEwDZhwzolISksDpjVswRJN4PpHsS6H7j5XZaB5cQfBrnswOcRfk5IGBvEmhiCNq8IVAUbYwylRn&#x2B;CRRu&#x2B;Ta8FiQpOU3hintvNAwf5WtNVJnQ8o8yjt608DNRPlUU6iRUJt&#x2B;MsuHVTeE17Njr5buZ8nOT&#x2B;qYmpauJo0ZJVrgQkgxX/RX0FQhvTZfow&#x2B;oAPGdNPw&#x2B;JTgLuM7OSjTu9PYSPOavjuR0jqpO77rZ8SAU6I&#x2B;evzkPX8bnJfLhasQfvzs9wzcTY7LkD3Jvg8lgMgOtvtrXukbUOrj38WGdeYuv&#x2B;90O3K89OTO9KxAeY2FslaqcwuovOsHqy&#x2B;JuhwPYBtC0tgN7kuNvpdWdB2y0PaMvbo6jVH8BLL0G3FL2yXXVEgjkF93MOUPQzV4zaLN2lFBEgP018VEHwqHXBmLKnsCGX4X9DDtdkz6W24fnZ0mPXhwuenv0DIfjl/kKvjlzx7j43WmgInsqnCXfJRSz3UU3&#x2B;czlhBqxnVR3hQGiadKgpbw03KgqHJeHc&#x2B;6Alw6qkCI0I62y1eO9qrVHzhEoeIZi0nYOvAFZ8uCOiliVmwlOwfYD8gIegwyDDT4yx1kLQT&#x2B;M3ywYT7qAwQtLiHnQRoIBAjCEGUTOQ6gehBcMgtaumaYInAQoDMLfX1DTWVG9g&#x2B;pRzJjPkpohtGAYiVDfT2cVUDJgeYxyHIcYIAzmJHAoZwcAZla0zg0sQliYtKOY1kHTWgqTC7qQZ4h3VEqwVFvnPnz9UUaZpAnGIA02ahhJsn4G1z1CdLQSsA7hh40xVh0bhaSAX5K2kFNqkAX8RHk0/A/wltLU7DSQwOZTmbu2KjeOIEN5Bssp67VDUDzJkMB&#x2B;QfDQwVx0IqpaQgMS5ScYeQ6ynMwGXh4gfmsPtJhwqUoMQO&#x2B;5UcyOav91uk1GrJrm1PGsaMPJh0FxJzjms0jDMlQEQgD4rJzofjL6rABwjhtVLrE9scgZGrz/te4jq7kxOgrZj0Hzc1Ywbzo27Rl0fAso/pJOvkW801WNZA8QP7O25Y/d0jL7l0gG1f28v/uzcBUvU3j/jB2y3Dq9v9r/3ogCQtal1upfMZs7NWmspeV3HgOMaZWyu7QVZZBPS1evfUatXlv2/m8wc2LDhRz3pGDy6VZaug9I17nwI7dhzu9zFUgN3W7L/r/Fz/gW587Ru7V0YmOrGLvnZq4iNy2ueDuG8saaErPaicoVGnhRUpigSnLMgp0m5ujjn9kE0Oqk&#x2B;4jEoubXmpinGgKcJyB01CkBbAm8HmnDSzKT4f5omGPVRQhgZQlmfGxZlVMmgIR9UJQD0WgsgbJZ0pXOkctAkOSAaFaQfDQHuDq&#x2B;V9WqtOSUY4wHcmW8xeOH6j5LGZ8LyBtUWnHMlZzG3ew&#x2B;aPTSQcRx///4PJBaANqHZKFKXSgLTRMgeY0SUKpBkMAHN0CtglNX0qm4cxxgC7MGEp//73//APPnf//7nDUacNBbZljtw04T6uMgWCuWKOB5cIzGKI2Ib8PF2w/IOmrYIuBz/ey&#x2B;2ZPCI6F4A8cmiSc4Zl2MYhpQScteIJgbg/vb2&#x2B;7///vvvPypF4ziyYJnjDNXGn1JC3iGMBV2LCVIxkDdX2XsPMA9T&#x2B;qhZ/FXVmZzSnLjOQfGxuoOEcsNrMSpAJ9aftD4XkTQ9AIj6QBD8qCHRyHbqZYv4BMBxumkaJQL9UUuJYd206NtADwBb3rQenHMO/C7qA&#x2B;LrcG7S2F&#x2B;vMooXK9w26wAcvPE6a/fBD/5598PQ9bnuZN3DHtyxtr29gTaHONh4sNdaH88f9X55KVz99Sj/7po/1A&#x2B;kPNXbeX217SOktWn55IFPSK11jVi69TxW3S1J5ghQGukcILartQqx2S1bHsjefGy4QlWKEY8hSoa9yno8Oii2noZJrrLofwPub63DKkHn8s3JczHwulso3VttD9V4FT5ETrKDfqwCsC&#x2B;75dJ0t/lZN7e3WbnV&#x2B;HKrZC77Z5pRyTBbUeSrJBsx3zmvcGCMklJWw2mycIeE8EMfFBLj1FJY/BhHkdGUleeTtAQBnQCg6yA1J6zsOLSWEqNkJvXewxPAQH/GBwfvSikA93AFkCYkAQOlMLsObbHNFPxmZWIw&#x2B;DkrJt0CICbdPwQvSkLwRYshAKbPeYi8TykyTmAYBjLpJy28ivbWRksvhCT39F4ioQH6FcGTJeLcBJYUQnKBZenWcIYdNAwDlAewZYDCwct3bk5yOioPB&#x2B;AUKgfs&#x2B;gsr/jAAlDMO2CmqhiH593//E6oJKmp5j5oMmPzb2x9SrBDhQDAKiEmETZQ8aE4bgHilTo3UnZBmBxAZVnOuldMQCOdmWg5t7RpuIUoInQ9ggkETkF3ecThiYjLpsf5ea00A4uecZcI3CfygD4FxzNA2R63Gdbu94exu4iqRm9ZrQTqojnRVsY3TiOG3tz8s7IBmaADVgg4Ey6DDTcI&#x2B;ndb3oPLJsXB4jKH3AOxB/LUc2SAfYVPcBUYn&#x2B;zmWzR7OKCd7qsKZJXpUlqbWf&#x2B;6D&#x2B;nnyhL4H2QSvj179skaEh3LQrLcXbqFea2be1KXPPAtF0&#x2B;fXWq3Vnz101m47vbU2bqetB9b1IdbiTsiLSl6y08TaZhMkzf67jYTshcRlg48Jlaqez3pZ1qKG0jmVZ7eqnaPACvFZD9SqjL7I6wK/hHYV5vREhzz&#x2B;BT&#x2B;kTxu6edyJNu&#x2B;VO1j5&#x2B;8vqmdrSs/fVACsb&#x2B;qEJ7K6mvHTRMHHa5rOx/Td91rQ6tRB1kgYQZyYYrQU5/sGQAV0HtBzQe5ClByeBEsKttVoKttdaaslB6oVJPTLvXGuV8QksLBBjSAkKiVT/AIcHzJ&#x2B;cErL1C1IXio7oOSklgHWoGah5nCWk2CspqI7jiOGmOTNpBiCC36&#x2B;UovhPqp4xRiLnNI0jlJCUEisDgPCDjECj5tWB&#x2B;RzwHSA4hIA/nRL9RRkQA7&#x2B;kFkU9ASg5CrhHMH&#x2B;gVIj3wKHumKSoB4BDzAMBMbSaP3/&#x2B;TJOk9hccqYAehxNZ5pRuJtEkbfAgq9BEPWlYKg&#x2B;cJPfobVIuvsXcg7Leb7c3hapiosboXoE4fmtIwDSN43///WcDG9YmdlFp1HTt3KQKwCSkGk0rRJVDfR1idKdXwcBfGQtazTSOb29/iLNV25mwYoPmbw1BMqV6tcFPpHVpVACqHMAGH/X6oqWQx7znJXBSYvkPr8hoGGUk9BPuA/Fj&#x2B;xsrKy8nw56HQSo9Q&#x2B;WYNBMRQgjGdSGwE&#x2B;&#x2B;13Y2t&#x2B;wSad1nX4OBDy0/pZg/HFseD6e3h&#x2B;M1mT4PF9x9y3NunzuG45SeZ&#x2B;c&#x2B;rl5837jtPDYll2ofb6fd33X2IzvfcafvHQkRem5nA0rbdtp5xawdfD9qNrp/h3tRtt6yjdflb0qJvoTGqIvOxelSXUIUaSzLBxJxDSpL81J5prbUrj9BNmBC/ra/dym&#x2B;5r9RteAlmNUaPOsT91SLInykv5SFtbVfFOp6n2au0NLlqc6baqiElKZHwU5bJuJpqX1UT9je5saX/lKLULdY8oaT0aDWPhHsMvJEYY80ZJB&#x2B;AaXoYqrjUKpE9lOGgcb1UnhEx7J2DNhI0erjVGsXDEJOKd24axxg8oiNAZwohtFqhIcB1UGuFEyBoch79X5jxMHmiPZE0lmuaRpjqkfMUJmprN9U0RGLkJtveDjRKzSlJ0wljP1yLXmqfRdUcxqRKAlGpOB9ipIEfhl6QqXismMAxgUkY9uBKeeemacTgzrmUklDADRcfTpKg6WV&#x2B;//efzkFI9oCZOSdieqFFOVRu9syYOcP0SbwKCGDwNio3xptmGkVQ9WjS54vx/nZDQh7GPbMHIn42RlmAwaQZdRo9DHWIP0a9OtRzJvVLcOZ2RNYyQ2PjaJJs/VClckpeXRxA80HDcHEPcFbOUHroYYDCRhSOgXjdnQk1xg/onAiu4L0HbWfQkmc0/PN/Yv1hGBBT7oT4dGNUMY6aFYBDU&#x2B;LmC2oDZ&#x2B;/19gTkIrDYa7&#x2B;Jge4Co80Ge9N7CB1uYvRPgs5tn&#x2B;m0Hn3TDLxudlc&#x2B;71wekoeM7k/3fHA1D&#x2B;7zr5STz8XdG/5uG4D89a4trN/rJ/3TdOKVImOtnBv2bVBnAkx/CvjA88&#x2B;8TMWDo2Zq9UqyJlyn94ADkbC0trOKGrRMjtRWlv5s4hYAbub565SKJoDHG9CuQ5c1Mu1k&#x2B;eymfUL&#x2B;ynP9Ei&#x2B;TT5dNc1LnLafid0jc6tQ2XuWiAJ3eAO5lUG/WKmBy98qdrKUJqpS8qLXEEBoDVDQPb5qzWpV57zylymRHsNPDNZGlEEESHk5KAE/iJUjIMhRzSs5N5OIzOhmKQU4JCLho1lHnnK04BngKYz80ClQDyFpvGxhIbfwphjmjJdIBAX4xWkCZIUj3OQUtBwYIBdZQUoyP0GEcxXJgoBtB7Rk0tTw4OVG51yTKA2ICIw5KLFFG&#x2B;4R50ttArAkOCWMJWmtCjgdFRH&#x2B;DozJpmVuQVTQWdo4xVRfBNGjYseXSELwKTtXYWfxG2PTt9jYarwLN9ii7BozL4gDgtwDi43oR6A/DAJYRSDuT5gAls4XpgWSJpon&#x2B;CqcBDF7jrcdxRJwGnQk3LZI1aOwyOT/ok6j6z58/0N9utxvoW9PsIXGBla4V&#x2B;lMPedMUnFQ2ODevFaAnw&#x2B;OntkPsPpmKZqoSjLpEDq4VnnLQdJ&#x2B;W/KO1GW6dG2fUjK7YGGOcFYB6Ds2Ime00DKr7LIUzCkZdMhB0191pLjpZ/z5zyOa0n0bPJwe1fx5bgs8PvdfsOaLwO70KX6xFPKQ93u3BagV3LPEPqo4forGsdx2r0JANZvnOn3YHG6zfButJru39ecbKCxhdtvSuxbHLx/PoLWTVCTPEoomUKchMrZO1XPFiVsYDAFhzfL3qXIKgHLQsszl23lKUrXTQ/2L&#x2B;6zfSFhuTEzvT7SVfI6tr1/l5at96xfJq6gdgoDxoQmUm&#x2B;VTge26JJjMp1WBUByPQt24l5OiBeiAWd/HRVQQENxTvAwUoBHB4kDk0eI8wYpQJg40/xegR&#x2B;BsCHkAgsJwT8/Qzr2iVal&#x2B;RxH2vVcnA/vdSBliSCAGwolQwKDTM5KOASU7Bew&#x2B;6U60V9CQk7mytYaCcc1K7u5NiZ7mWAt1gHMegSfqD96hgIHyMYQBWvt1uOedJzcaTUpK8cwiYhsNTGdsTUKl3UogKLCBhKGF6SqMHSgQkhZqBYAA6B7zkG5W&#x2B;vWJDKQA8TUF5OMCCKSWhD40j8lFOClihUVAXojWdmgMAOsHopHh9WCS8Fxycc6Jd3GvWmknN7UxZQw8DPC23WflxPCOoAszpJOoWMy8h6aoWxiJbxknizgHzJ9/Gi7cHTdxEGpVzqm9MdBSIrqixzre5TBu9IqLVwGnT0X4wwKg1nrG26uKQohbWE&#x2B;JUK6Npny4UhkNQN4DTg54Tkta8xpN4jetYeAD6d9Np8/8ZnLrpwj6W90C3NSfhoUO6A&#x2B;8gkq0GS&#x2B;vpfRx8xiJ7Uk769&#x2B;&#x2B;e3ZfJ3x7/vpwxoj907BfIJo68e9dt3snH9/Bs11/UMC7srVqTZK1lScRvesdylE0VS3lBVpdY0Po7faAb2ioPsAvurVtdQvA1Isdso6YUnGMYNPt7t6Sws67ljAfPuinu&#x2B;zY5mXcYKf762&#x2B;BHyqMvAXPdDy7HQr/Ny/oPbRkP05Y&#x2B;gVYrnkUUkOazA6QOOhASjMI0jimVGS5L3DDLfsE8DwcDvFtwOMQIA7/TAGKxu4cQWqsw4QPawl4Od0NrDeEHuKWRqBTaxcwL8j5oKbEo&#x2B;UM9&#x2B;mfFYWkvyYS8pQZJhzGSAYWIWLHcq76BsISgZngg7FrrqFUFvJQlDuIP0OBR8oWA2OCEAX5FzK70pgGaAlunyUvlATHhayUE6BgCmjmK&#x2B;A2GwUw48hSmcZzGEWEVmLl37iYlpQQmAu4GLplSm5R0PiJcwWZVUkViAuFqMjGm9BuEEG5S/8thDQleMfSoZbwmJdzTCWBjbYHv6UwYFUDLXim6LNAWQR3SErIM2KBuwPUkTC&#x2B;lMLwBXhddD8TRSn8SLaGOGq9R6VAScBQBOolD1Nk09Fbr9cJaf7vBi0K9yIJ&#x2B;NJtUUZlMdTAsOOlMgdqeaiZOAq/nGgJyakaF&#x2B;LX&#x2B;SHdfJqj&#x2B;9s&#x2B;tF9YuU/8YPd8BFvsAenMOj75n76ouFsRsgqeTatIe2l6DnqdlgyBxQj5q9IP&#x2B;n&#x2B;78a7DI8SgHN9Vz0ztz1Mme1814D9x9EPae4jV1hz96Qs6W&#x2B;2gT1Frzud1y7J0oaonnrNAymWICC4bMVigCjKPLUTR8GXfm7JFIdvKrWXVLWrnRmkvF4o&#x2B;Eiauz7nq&#x2B;638TFLh8gh5/YM/dSz87KuAT5cMe5zNiFWzTOR&#x2B;H3TtK2fxzSW80loRCKBdgYm/mJ1TiYao0q7PyjCSeIAXhSc0pTdOo4cKiJ5eS4YVA/h&#x2B;pYVwr9gKzAOZjDnAOQDfIWuUAHoasuYMQo5w1x2WtFSb2UoqbJmg&#x2B;oGvbGAMQgYC8we4AuIezwjgZAlA0/BgAr04ye8p2nHiQtELea35MTSsUgpQxDjhHkmeiojTiMJypcw7rCYcAoCTOVDC6pBKSQgFIPAp7Myz6JMYAtirVKjLbjJMIgThoLQIBrNOEBUFtAagWGAWOFKwDQpxxpgii/f37d5qNzYKtQZUJag5HoIgsjuJX5LEBPP3vv/8IxGm/J8tfpg3Qr86KEAImM2mJK1ZlxrQHUQAGa2LHIWgJXI4fdAvgGo3jGGNk5s1Jw2qhLznn/vvvP5vYB44X0a8U9wO5M/yAWNwrN8np3rVdn&#x2B;4ahe8IXxb/FW7TaRxLKcivervdxmFQLw3yAgUqD15vXUw1avLWSdMHGQqQfrTOmKb2LNZ736eHXoLHdson&#x2B;uw&#x2B;xvX04Xvo5zPkUWj4BEz8qLP41mbC40X4WwZ7K&#x2B;vVfXpWJx&#x2B;lR/vcc4mcWVtmIDl5Z97V0iGbhHiGFJ/HzSRLHFFr6oyH8MHGRnKErNahGGgx793RWWN4LcYKc5Cn3wxS2j1a&#x2B;SVfJMYBddyutcWF3shFC5i&#x2B;6mpB5FNGkNyopkYE0HAthdpCNZ/7pBHAzZDfZiebjYExDgcpNKa4H8x/cPpjlGSg3jvE9UatG5A0uScen5zTNE0lZ8B0kHPK/K4o9LkB6gXNJSq4OUUNKpD4Y6gEwfsUg5JABuD81lpKERV2c84SZRtCKRnIXkKH6S4wUbDYQvMt/Q9OU&#x2B;CTIuW9TykCQHvvwIACCE5KIAHNRqIjNBllMCV1MdwwDJgkmeWMlwDedVLJ2BPsDsOAnKrMO4mgYae1CLzmILJclNvthmBT0qsAvrGkatJ2OHzUKl3S&#x2B;ThCacGqwlhO&#x2B;z2qCxPyMvIVZ8diwDy1cRykAsMwqH/AY0mxEQemJGl2qIE4LTcGZQyLP0jC0ylq2YVoVD4ibyohoxL3B/Nj1PAD59zbnz/UUkZJCCuw3pnkpE5jIaAHypVSYtWoFaCD1mkmyreMIOh7SvKZvK4//sb8cVK8Iug2mmiQuZn6E4bhNscA0JCwhryKnjei&#x2B;havrn0z1Z4&#x2B;cKAnVJXNsdqCQ3zq075pyN&#x2B;bAC2O79RkDmbyaPvnPuSPugI&#x2B;sMOfJM&#x2B;d83Oo/aM1kCN/3Uls3VZvg3WHVsc&#x2B;wOULPHE4jaO5larIZiYUteWrYNexsHTpbE&#x2B;VG9WB0Gb0T9s/znSF12sf6BxjaBpkuXmaz4XirOWs63Wpxtg9d9pf8ipiawXUogb1ppb&#x2B;2SVlLPqk/ptHoJqCYjPub3O4C0ICEnMNwafGW6XknFOEdV8TBxUeOA9Ua0qpKBeOIcI4kDpACAFsnKYf36LxNvAPAE8T/bfWYLmHji38nFKAs4HGIqj8qiog1B5Y3zmXEmIPZnIR1BtwgVqrUCTggWAwLuAXMBmwuzI0XBFC/yR2fcHlWnbA&#x2B;yymYkcYKqdDOo3ylEiYQYNhuMGaiyIHXknqGtELroujZgJOfM4ZdalEtfB&#x2B;HEdoPt4kOwInB8lzQIMXDKrcEs4BLWl69xog4TUHzjgOcNfQWh/1dGj1dzr5SUN1gXpzlkoIZGExPtibrJoA3DwLrN7MlQoBgNsrcQsMLrlGmgfTLZn0M9oWOtOs12Efwjk0bNexHgXBunPu7e0t6IJY3WAyKsrILENw7ARvZ8J4DKcJl5yhLc30IVHnZr&#x2B;BTdCUtC6E14oWXklQuI6TVhAbhkELgS0/yfObZmmlU&#x2B;/hkgxwD0&#x2B;skfQZBWCzq/Xhdw/ZnN4maDgY63jLoy0fbXO&#x2B;WdvRWz5cjoc4j2J/mEbxsafz/tuyGgh7d6wzD13bf0vwe792JBZmtjk3dAeL2WDdTA2WtXvM&#x2B;aays12b9u1R3RCWd1QFZvV6zin4/sgtcVLP74INYtzI&#x2B;/lO4H7h/rvyNcUN9t6l8426ppkt/AZ4NhdtUNyLHZH624DdOzMZHmyY/E2ftVbJH4qoAC0U0FoL3kuFYPG/SYLRpvEDRdUJ4l20xVMFSAfKjXOORP8GjUBtt1FrCeM1gMuBcF7MJ8WAyN2cs5szb0rlMsycdmK6LEBQySmC4eENLUeDAbxOIQQmqZwmjIW9gybrRP8zVE0RneA8AM/isrAxU9&#x2B;gPcMJnCZQIktEyd&#x2B;gUSWA9YnRwJq/yEtV5kBOCPQf4ninBYxZz5hg0WuqGWgRHHTQEsjjMCBYGVbpwILHWu6K/HXxongHP0MIYZrGnPMwF&#x2B;XVBEeGTDXz4LWEGXUSegwmk0LHmvPB4aHTZrLE&#x2B;hC8Uq2cFIcOSklzpN07geOaP0f9HjjZQXPw3243VEUYlcUkQcaqWoxatQBboLU6iRxYXOLJJFwabm8MhtaqCSPjQKBlUbfBnBFRwAeE18Ibl5Gu0jgMw6&#x2B;ypLmXZeje&#x2B;nWz&#x2B;Rq6i3sO0PnTVmqLG&#x2B;4izmPA9ND8j1eGxpUnZrJ3ggRYx5N8Qn4S/v45Z/LgzXm3h4&#x2B;QRWKcvcf24NGY7979u73dU9f1z1nNoAHevrjW6TibAfQW2hoaQ0EKou58slIp9tbTgifrDahL/aeYZnuCuclRXCV7iJYufufFtTbjbgbv6faSPTnIy7Rqaq77uuVqy16IeVspBpVpbedOalXCj26v84G1zv3zmVJ3NAsY43BEDAOdYyyqDUkJPEGCB6RKQK3VOyffuFphAAZBI8tRFXZ3zQSaiHElG49zKEFQSwFNpUh23ShZiURykYrCCoxA7s8ZWf&#x2B;xEaT8KJW8gpsmuE1iCDT/I26YSDEjPb&#x2B;GjQbNCgodRoqaBe9REtiMCLsvkCW8E7BnA6jRZSEsEe&#x2B;gCTCNPYG5pDcVQr&#x2B;YhKlTOS1eRgY/DkS4KllANMbT4v72509KCbUR4EPIKYJsgz5ED5mmWgsQ7e/fv4OmyHTORRagVVYMCEhBI5UnCQYQBpdoQhpArC4RiVvwyq1H2APSvDqh7AuphtHhNL2Pcx792ygRDnPpX9VG5Fdali&#x2B;YlHyPk6WWEhiRrBUAoIcw2yku0NvbWzLR2DfNtmSviFVgvE6Gk59LH4zztCctgE01aTQBDMT3TmJLMiZpdbmg/ZDAdr8Q2AeC4&#x2B;Ndz23hxuOh1yD7QPfYQ&#x2B;Sd7HEJ9uSksvRQyzPytIr1gY2flidGeXpiH3jgZ2hrixHft/6Wh3P3KbN2fW45OEEenk3VrbZ6HvsndN3h5sR2kKuNX7Q92&#x2B;3JBCD2HcymfXOs2jX3ZmX1h70&#x2B;N2dr/0rGfr95TfMKyW13uyMPGKovBeDF5NzHd/uh4H2CFDRoPfcp2W8XvjvS7ltncjL9U8tF3LzAfJS608AAhAF475WBE5sGHLdlOl0ovfgRY6ymVB/yh47jWDSbEMzkMKITJTuNrM0mqAAOB9jj4aCA2pAl&#x2B;2caR3EIaOXjCDRf5MCEdJ/iPXBTE4ZS8W5O41M0r5GaWB0gtTOFt0opdBQw4Bj0DEVmYp4HpBYHRwTIllIGoBXBpgvtPUgsMmCfoFKv1c2gYESNVw4hIL090teIIV9WQCz3wpaZU/5P0AFApkoxDsOQNdp1mqZxHKBSOjD&#x2B;1UgPlg6uvpapAlfeMboA1YJB6NK1cmTPwxFBLOucA5aGNyNqstcoQbQjwyGEE6VZUMdhyIa15TQxaJAqaVFCIJxTRQscm0U5NhrOxf2ik8QNCdcN9AQ3T2miB8abAtI4lyTJoCQyGHUJqEsEU&#x2B;chaOpVOAq8ztwqME7BvZSHM&#x2B;mYNCeVIz2KURbOOJQWQcC9QX1pge7eR90nfI8YsOcifyd8efSQkybVM9D/uV2PyqbV/&#x2B;H&#x2B;H59Ped8pPLE438gLcUYfZsuHuuXvvSv&#x2B;Tj/AcyrlvQd8AX/3jNxrys2ecm6P7Uzdx/cVEcPeuOtDlj33nVtbfloRbDYVjGYKJHf0p/UE8t5anTN52P2He59reckLyWMhIncsVkvPmJTd7aNTYM4XbaFjzdXaWkNF3kWHRn&#x2B;AnTtrSQHceKgkIC6sanqrqLwhxnsC/cqC3FpRGD2jCjJ4OFkKewV0Bb4NODyMCqi1huBB/S8lo/&#x2B;chTSOBiD9o1ZaSkLN4WTwW7McSWhsLcUrCR7vChithfUe4zRNYGg0UXWi1UCiRu7CRk7kl1KEhwSNAZfTkvYTNRupmyZw2cmwj2rGZvkCQHkARCT4H4eB1l&#x2B;6U6BsMJaXDHiG2NJ&#x2B;jPXxUvdAnAlQxuAeub29YZ4LrSZGpnUCDMValVKG2426h1eCFiZGq3zWWm&#x2B;kztOHQMpN1NphWJxowqmdm6BgQENgeAAUJzPVCPTPymJMvcp4AAQfK0AXrpFw7plf30ueVnMJnA0Zt/wxg/VlYGYcsg3oByDNiX4PZ4I0WE8aS4p&#x2B;qK9SGwx6e4cQNAZA3wvd57DbtQeAOqvb/JnfVxg&#x2B;UNbdKkl30WCL3XTWX7G5Ju2pk9o2Fh528hyafNoI/Y0Q&#x2B;UvJ5rp94JX9kAPP9/nc/bPpLtgYa0X12T6jE6rRwei1tbJVUFxzjW9Q58&#x2B;d9SLf0V5G1PUp2B74qw8jPqEYVPtqW6phnN/u3C/5hnLqttx5fi18R8YeaVktb23xIetdYas7HFoxKUB8lARSp1RrASIE4MCgAIIIIw7eV5NFF36AnFIMEtaJ2SK5J3hEzk2tVQTdWjSSNVYY/B/nJhCQdJKSmAhqBtgjyNWrQDDWUhC5iyDdnBNidgHWgNtgUUVXjOjFuGQNpRhTjKC2IwOSgD3voXUAcaaUhNgjuUE9sRoJ4mr/FugGQJlivN3eCOa8phPFuXuTdT5p9a6UIrLpYyaYlVJERobqArnSPyCG5GmymU9DCN5NUGMmSSzjgODJOGJmG6&#x2B;xEyH4EPyk4a3Qu2DCH5VjE0OAMjNNi4SYQRKtBmo1uNaIlCilOOUv0VdADQELAuv&#x2B;m6oluB2Zsx/G&#x2B;0kTLqlDYA50pgUdk2GV30kL&#x2B;jLdqmd2VyWV8dLTYM&#x2B;FjcwlFWR5RanTpWMeIVUnnDMeAA0qkF3GfRHZhpeDod4cDg8dwq9/tUPT0EdZbTctkWuoummnvDvWo0bZNe2B4z4E6I&#x2B;JEH9d7lp/H7ItvfKZ/iR5UNl7X6Bn7VF4m&#x2B;&#x2B;W3pL9hDyk63aNxUa&#x2B;c4uu2MyLfugT6Ic2honuobj/ktmquXs0xHJK9i1rUq/sDkqtwA669cBeuvp75Nuv3s4D0j/OtrLv4nDrNNO7EeG53JztsT3nrY&#x2B;oQbxvaw1Z/xEXywnAjo&#x2B;2UqVYPrullDKrsogSBsPe&#x2B;6BWfzTkCdZaBdAog0jRoRQysx9omO1p&#x2B;/Tep5jgUgBwRGADsCkGSpoDFAyZKOn/a0D8cc7TNLlpJNyMAYEKGRZljMXfMBhrb0LUVpgueoXGp2rtYRnUYVDJ3G/qQ3nNnqQTCCGEkjMoRlkLEag9OGiTQN3Da&#x2B;JOpuykymENxmFZmAy4GZg1pzRJesyBPgfPUsq6AqOUJLOqhTB84BCgYZ5rEjXnD3AtZgjWkFPe16QW/aiBHKMh5EDzhImdTgOYyVVfcmCySTIlrQXmHK6UpyriSXDSQGSY4akyBYkzHgnf5USoSBhobq&#x2B;gV9eNVVEI&#x2B;mn4D4zr8H4cBiYGdaYGmXCltDQB4rCTrh6uMgMVkKB29gDUlSzeKEuIsOnKt1t63qrKpnNgbyC&#x2B;aDa/03c/3s9hlwUyOLSmn6FB323w2eb2R7WpS75AvuAqPD/A/tw2Ncbe6L44/NRTQDBxrGQevG26uQFJGLiwOGjrBPeNnRuq0cNvm3ua9q6XY7/DmdK92&#x2B;k7NPbrLfFTxXgDVsEw96xvLPSLHRml&#x2B;kxBgKpEHcQWA8cjHRD2NxMJYEWS5CrpSBj8ShbSTsTMLyMZtQHg3k2TjFty0gpfMI1nFQHxpYDNwmDlrFWHcYJAok2DB4qyWaRpgj&#x2B;hArEFrfZFKO&#x2B;9Szo0so7SE9IZfb2XjJOEuZgkSC&#x2B;EldYnAI4T6C6K0T24RiSEMP41aD4lImDwnehbcM4heSgGBTD1yvnxGtJAwgwOcRop600OylJKUAhrfQLA92GOLhALvaUqyRlpBPBwuw3DABWFEB8aFKqVkR0k1zrMxP2gcbew/UvaHO&#x2B;nCS6IOT2oTEyJNPS9cM2xZVB6PTvMMw8KiywIXguQjVGLW5dSkFgJu3Bxh2HI6hzjjRGVZKXlkwXrOyUO4XrZcAVVP3xKaVBu0jRN4AtBKxgWZeDm8g5RdbyjIOBOE&#x2B;DvbuPmsaW3NBxU2ZypR5u9HX&#x2B;Nzkxm3X5TkVj40Fd6yDH&#x2B;OH/UeTkGHMe73ikXAviOYi/awb3XKbd7jQ/AaF/ZarP/VT/F5NBcdN65qpaP4Z7u/ZBLytoX7bi93vL4bc85785nBbM2ofli0YwpdLPN&#x2B;zw/ZzPDXvIe&#x2B;Yuv0PXjub5hdHqrm6HW1upada9lxuLYgh8W0Ftjf9FiYb2PolYUBNAgn6IjNhYBYP9SfyBnZOhCCOykYBdUEJwIIgeyJBIV7wHZPtFEEaAfngtQWkXuUVQHmyb0E2OstdRSANY1PDdCsUES0qzpPJGkCIECcBRgF83V4JbkjGSjEnPsnANNyDnXWtMMnlMMQihisKa4U1KKJgF8qwXYkfgeKBCNoaIELXGAs2it0VVi1RKwa2Bfhx8AGDcu8/ZYKz4yTpJLA4gprKeZZx919RIUnqjs/2kaRxPbSvUMCBWpjcRLII6RQIo8sDK6oqYRQiglMxMRnQkw8AMTaxocod1TeYsxJk2dyfQ7Xjlg0thUaguq&#x2B;UzThIyfOM1SMmuHMX4Ak&#x2B;cJMgxX7lIZQetCqAOB6qVVb&#x2B;DimEy2U6bKpZaIiYH8gwkzAVHJGXmE4Adorf3is01rXGet33q/HOHaA9i6h5iXZoY7H6dNhaTr5KQBfq08rA2ZhzCo37WpQjz6JQBD4aFDlocfrcNDOO8D5cwol9ZhZXs1Ti/RSc38uP1DjduW1bmUsw4oawJsO9B/84GlC&#x2B;KJu71rcIyM7bHJpB&#x2B;1bTr1Zs3v/0K541G5ZC3Hmu1Xy2e&#x2B;D/fSYWHn3WmwXBf3AmNSebAqscL6uZ8YIzP3N0M6QuoeliRLKcLZhZZ4uGC8bK2Cx49nVoODI1gx2II4BJ5vMUnJYJpFTAKKcKFCMKzXWcNwQcWA0ReIH64PKhiSQwj&#x2B;gZxB42HYLig3KcaUxE4MPkzVWgdIbBrVAAznB23P4AIV9QYAWxNY00gPkGewfiT5RJwaiv6DMJo8FKGsqUuRoidoTLMavGOMEd4SgO8sFZEn2LCJ1K3p3abL9JpofxgGFCuAL8VrZS7l7URlWyUwWIIGvyrBxikFyOtClbe3N4T8Js3CRLI7reNeMxHhAg1a/WoG0NM0jWMwrH2kFUJNaFCeOE&#x2B;cES4NlMnZ2WJqt9G&#x2B;7gwpX/Qf56irTFKgzdMDwJWJmgE2mmRE0zQmTd6qXigJns5a5CHnjAoPGPR2u&#x2B;UuJkH9OdQrFlmA7ONxrAMcy7HpcROvn7d23zX5d5ija9kxFlbHbjIZTkmnQqz3nuzzaRx8PIFNubsOHyvfBeKz7vXXy/tvkkcXeU3nIwTfeyqfq0vdjdj2n&#x2B;Iel/NPAI79E0wp1q7BUk9oi1fBXoIy5kjNdVlptd1La/ZO1f3ItP9Nnp1LnpIvubjz3WWHWw8tWwR8L&#x2B;PdD27RlFLbceNrx1JPIIZQFOhTghQKaACCeDwJ6OHEQ0ZRgPXWGuhGy296ZVIaFOoGqweHhxBqkU6KEn5EkaiVhmoqIeJN0Iyl3jmkJ4KSUGslJCWoAkyEoVqTCsVSCmzqQN6VuUpzzjlL0eIo8Qag70s5s5xonIZGEdUwrwQS76Ypa/QwJgBECI9BUgs3rdS0OeeckbIzqieENunARDEKZ7kFKBYQlFmAnHNSDwE&#x2B;AedQvWHSpPVFKfXUrKCoeMkH6iaS1J1rrQn1SMnx5ERZFcVrvlfqP3QICJLWVRK/iokWiBpgwFQ/3s9MHmpKUUsowGSOqwxNo2iCV64e/STsCkmuRFHUxErW6yITxgQ0BpoEqqgFwpIJJ6bHI8bgHHwp0yRl45Iz6YO8FjZ2UnRiVkjwfE3T&#x2B;KutEMAZ8KfuNvtob3z/TvZZl/73hxwCu73p7wNt4dhNcf5b/n5c&#x2B;9BpdjN8yHa72c/BlkcbvP/wj2rzgfLhatJHeXg&#x2B;b6zFURs9PPiontZqzszWeintdnynTbMMc11bTnKP6cfIgfXeuqpkTLRx5rTQF36vKzd1Csb8zuw1jfuP&#x2B;eLUDiKU3kdNfFb&#x2B;JQXmBbS11SU&#x2B;8V5d0YG6BKCmHyHP685ZpQcw2Ey0RcwwK9jLOqTIw0OuIOG7zq0i4w2OjTGoSlNBJQJ2RBZ/KAlAZjK6VhIAPuZMcBQE&#x2B;gAKDgOnttYAXnGsk0wvDtZWOUd9IwXvW6soOAawqP9HlADDiNBwiESREAm0IngJCoIT1Hjvkbde3QtSLywlOAdIEQlKzqEaQ2xKeCqZ8kMgeHWqb&#x2B;C9GjUgAUVw1fwsOYjQIGqGe6c1p5LWUqBSIXjUTfQ8RCVEUc3A74VmwpjsUsg1ArqFq8Xmx1QdKUNH8qboFeA7g3TJ748mrkAbe7KwUIGL1P&#x2B;gmXyGQTIdkXijqksK6plJKRWNHvGanAc3G/aik6A1iZPWqYC3IedE70RUjP729kZlIKvzhP4WuIyclhKT20PjQ9APNoKZhoAB8c9ooehFGlA&#x2B;h3wm9zzmbLawqy238Inq3zKrr11Wf&#x2B;J6JmvzZDeN9ef8GEbYDu3kN890r5veyngoxz6Hl5WvhAh/A47syvuv1Keezp7Wd7DljB5&#x2B;zOvrTOBPKMmttRTh2d/1HuypspvTPnhNtRWqbluLUJcPZueXODM3u3vV8sTK2NdI74H5ZE37w2/Rv/cIXyENp&#x2B;TcKt1x7u3EElg9Qe36tettBuKW6J9mDQGwT8FAgS2/If&#x2B;PRgZXrVoA1QKHAx4tZq53I9j8RVn&#x2B;wP04lqR2wMdWi3Em5KLVCTABwrhaKw0NIYTWKtCbn3MBhRhCqzUq&#x2B;aeUgqDNmZLuUcRg5hGBvwGruVdUHaOUyspK4hcSjsbyLtwLijthdE8paTaY2SyNONSkSeKJJoH&#x2B;AbKDAfeWj2T9A947lOMF/FXU6xCo6jWDTdLgWioYFqwnE06A316Vq6Alir0WH4AqlHQF4GQgHLccG6BnLC/Ol&#x2B;wX/A7KlaJ9PSj1Hy0Z8x30EAnhlZSvDqG6Xp0eiC7Q5dIqEBp6y0XGgQD9ZOBwYlELU0xa7wwqAWcVGb9u4sLDXDhs8Bo17kxeoLBUGJLGbNALsQgC3rOdr3e11TfmDHlmr8OH2m8qA51mcqZD/rme&#x2B;VqReAjxPISKjif8RIdPtP&#x2B;oY19niE&#x2B;Xrz2FM3D/a2QPjm&#x2B;2bK1fqEeVq2PzQWsLqrF5SO/YIM5MrFcMlof0yUzuWRxWg6/ary/xvWn/7efo&#x2B;z/Fl5yQ7jZTUH5YHc8UHk7kzZvMtuDPoD6X6APmmdXEQfIVjlrJGE9EUFJQ01rj6KdpqW8qGCXDS1CBloCrpAfQeOheqCXGSFOCYndBzzBw11IEaNKYHAJM30Kpz5nFg2lQJ3p201RyDprVFBgXM1fWuNBIQggocIaBpIxBjEIHEnZTnUwpKEuFhy5EGgwSySPslVjTK2WfmWEAo2FO1pZSWoEni/yeUdOhkjvkFLOC2BNNfk8QnICna63Ym&#x2B;ZMOAHMHJx4zpkpLL3GH4PrQo3FOVfUWzIJ80cTManh33tfNJkS3QJJS/ASOkcTou29RzEH9IYkVNBjpLUpshs1rBmQ2msFANKNZLYaN8ylpu&#x2B;FJYoxPQYPoDExOl0TzpRsCybrqL2aWMmgVbGpXSDfKHwLbmJZCXFibGcB6pDxybfDbFw/7fFvvRm&#x2B;Vy32bP9t8b3/yE/R&#x2B;9Hzno32obGsnfW4h&#x2B;f0h49asx8A5r9MeMOf14TXz9f5gR6SDkafebh27qv7Q6&#x2B;8druexu2NW&#x2B;rQnhn4WHea3QKdBfFZ2URLh&#x2B;2fsV6/VqzqJX9RTj7pT7&#x2B;m953g3fNC3s5CYdaXSWZwfK1N/0SbWZfuxtIhAIOwTdF/RYIgFN7iATBjFy1HAKY&#x2B;2XoAjtAoWqvkbCAGQIz9McJMC8M8&#x2B;s1aaCxqCiDdGFtrBG1NixXMPZcM/YcaiJQWVtwM6jzgICMWOBZEuO9OVQvD7ZFogZSSpiVNRrLSVJD&#x2B;Uo3fHkSmGKOT7DSJlnWWSlDjccgKRpkNKWhGVK&#x2B;l0AhJ9VhH8B0NMYmZUoPG9cL0btOkgqZCM39A7K&#x2B;OGzSgFkPPfgxGbKvRHY1BRgIXKJg8PPAMMHIgKJeJJvOoBZhZIIxXxGnZNaY8wuEI0vWamwhaB1wi0L6A&#x2B;4HQcTFA5cKUUGKMqJ26BxQ8yVNkVKO5pfe4IXmCzJgU1b2DS0ldYtIbL6ASsD5uR9bx1rZd7etjN412m6jiObjM3iyQIonoTA8P7b2L1Q5UlKensYdaTgK7J07zUfnb1sfvLh9wgc6A5jOdH6WwPB769D1wjMJni50NN7xHnNvUkKvKGnlvYPGjJAePqT2PyVM9vCjof18pukteRB58A1T9f&#x2B;3I0vxXisuNZYFU/tY6rlGtpcy8fG4FqqZSgUfA4nVGEiNUt2k6oLZ83gHoOWJRfEwmTwgRwUIgnGjgb5RTAoPIe3QFeIpzLHNwqsMxk&#x2B;bewYhwBaAHrwlASYaRMyqFKVPhEmFsaFavRVQ&#x2B;ekopBC/JH8FIUeQtMF3Deb1z0fsoXKk56WetlZyiEOZ6xqQ5hRBgpAfKB16XwxVMiyu4VgLKGGOrhdZrOhaCJmMNqvnkOWDa4TVO9cBrbHRTRIsF9JoelLyXoHGuELJoCN9xRkVjCYwW4WkCRzlhr8HHk9QqDjF48umjFmnGLepMhWCvbKKgDCJMEvcV97o5l78kHo2GBCXFE7RoAxY2aCCHV&#x2B;hPxwXWxHYCYQEBpg&#x2B;yhwRlmhXcXV0dgKJRLPo8zl9Q&#x2B;yV&#x2B;CLKX/cR8e9jlIarDbL17R&#x2B;qedZ/nOznvJznu4XjLQYNvhMK/6bS/WNYPwl0TclvegV37bqXvMmqWu&#x2B;7c2CtD/tFAJ8c96HNvY/fMLt5RaqtbtC8F393Nte3Pemeen8k7r6sf5w&#x2B;9nqxLHpPjx3zD7dbfY/0rqyw0812v3fGkWjOegdYErC9fjzknDdwvfNI3yxh7xPIqoR/KieY6K0EDA7DFa0xwWeYPSMj6DxP&#x2B;nAU4kxMF5ApwHLRmcFUXB2z8DRmQUFIt5xhCaxW88CoJRgWae0Ovp06C/r2mtKcOA7u7E8zqYF0urHuA6AVJqyoMJS/FCmY7fdLUnDKooswq6Uc1wWWYsTjsygSjsCWhDLNTMO01fjql9OfPnyyBzVJ3TBP1SCYlLAUJMF5T4mSl8geTb8dpibEYI&#x2B;KqST1iZEXUGgteSy545zDctCx5FlXnQQZ9XAlidyZi8obV05H4QTkLmmJo0ooEQOTkEWHRksZMe3Vc0JHiNExZeg4BkSQE9DjxTBqS&#x2B;mF4Rkl1hqAEKkY74H7AKUgWIMomZF88l4dwnDfcXoe0z7VHcLPVPdYzvAvZTw5Ul8Izsg3WvT2B4PcaH3T1URb9ctrWe2H0z5CndcX15djs6iE30ZmBTo5790Cd2BG4NxSCTVz&#x2B;gGNtrRHZXeuHjm&#x2B;Yw1HOPINMWvCFdvHrUf1k&#x2B;ZSr&#x2B;ROv2oZ9oZTtsh4rts/y0as8Kto8Qnhala3XVSAuyv7HbxjgkXseKBzXEbZ2gCPmICo5g3nSWgNerMrboa20Ke2HJnyeY2ttmkaugJumWivILXA1AKwzNAJwvLXaagU/x01TzpJ&#x2B;VAlIc8QwdYliSPmgsli9iBCQ8NqgwAXcRJE1pDkOXjLMVKEtFVQypq26lMJuCShhRw9SzUBoSMPtBtM1Qhpwmk6o6oLOrYIh9mxVY2iknzSxaUppmsaO2EP&#x2B;T9J8oKJ0KQemadLY2&#x2B;0G7AvOD6lTguBVOWFUMeE7q7mxvdOknDTMB0PWR46mrAwur/k9k5LQoD5JHQD1Zoxa8cC5CdXfwpLy5DRxp73oUYn&#x2B;1rpvtjv6QELw8EFRd4om/APq1kYQ8Nq3vvm13kQbFkDvHdt2kGjV6uJtCfoPDIEnEdV54PUoeDrWiB498Cth99&#x2B;C&#x2B;Jdq8eEyf4re51BKMZ65OLbOxqMqzd58uncOH/xFDvJVjsKTnZsOy8py/0DwwKY8tAJ7NJ4PCT8wo/xAWs6LMqC&#x2B;qxze2wfeuYdsbfUoGvDcXSqHS32PuUDBHEJAhgIwLvbiN9JWzshMG7RaaWgoJZdSwM0GvCZMxxuAgJJklaaJQek0QDOlfbukFHl0M02j9w5IHX0GDTCAXbxqkeMEVUHPIudcawFkJw0Gu0CkwYIIXUSN8dBPxEisrHfyYZKpcQZoK3qF4nLCTfSMsOBoihZnwyZSoFyCImkJolUODxeEtmpa96XScJR4AO/9OAxlrrucUCrLsHeY&#x2B;7JowHQg2z4ErTds2C&#x2B;11uB90cRHrdaoxYYhRR0rVPCg6uC2maapCnErZK11YAOCmdSf&#x2B;gCdHhOJUjmXUkKYA6N5mZi0FHjdEnuA45OmKuIotVYUHg6a9R/qIhur7jGHI/MeoKODUxUFoOqDuob&#x2B;5lk&#x2B;AqzGar6w1m8e3hsD7lkuN2HNupP27JfvgHVgJ3Zsoe/3PgVzz4PjM9rFpkH08&#x2B;RC9gfygpiMU9qth3Uyfc3qqM7ovtfVwYh3R3nu2eeLbufx7Dce86/WVozHtPrHvQ3kMBzM6pJLPlMeo/Ss3y19&#x2B;qy54y1DoWbXMc1mgNFaQ&#x2B;AsthSDm2Ws1fNrIoYb6gTP1YgFEYo6kaV82FxoDMcIC0VdEAjz5aA2ahn6Usm5sTaZeh7sJEMIoM4TK0&#x2B;wATPfi/fM/xOV0A/bv3MO&#x2B;YsAypFbqSrKxy46BGgwxloRDpJjQwt3BCNIVQJAf9tDKQhgEJ2kSMUCxC5L7iAehQ5xUnBKoGBzkqSoM7Mf2g4vBBchK4LnNCT/kolInqap1eq0&#x2B;m9rrePGoGXO&#x2B;Xa7CQ/KVCOmloLJ49S8ZiOFNjUHV2i9XkNbEs2E1xE3CVfMaYVgeE48y5ap8Z69aX6k2VQfNXgXschOs8Q6hoCbw3FmOWfnJq96wjiOUhLB6ACogNYHAVtQ2/3YEws0rTMdXoKTnIF2goC0Oc&#x2B;iKQIwejftchpS2JfFSVXk7pfY&#x2B;jGelgtYX/K03IXFDyn8HyLne777SNqn&#x2B;y747ho8pJKtFZiHYgA6GPRJ8QMvqGRe8v3l0Io0P1N7D/Xywdx5HqnZApeBJDO3nPF3adYrOHsYKpDiauRaNe0PQIKdgK1XINC51taq5YGwcbSRuDEKTFTQnHOuTFVU6ziOwgnJOQSppDuOY60lZ0nXU5QcNY2jqARIjVpKKRlwmSgQzgSyj2Y3AoZQXwRQHcadphE4HgvonCOPPCviF65UjEqGkZrEMDfTxp80p36METgyapEvtKy1Inl/0SxMWSn7VfPkpCTjksVEjSKaygBFKzYkpb/HGJ1TO3cI8Ng4LXxmSfy4gk4p/sKEUR4/VQ6y/zPz/atugOvoWEg4ShJYcmaCMqDYgNoOh4sasZBSGoeBzgHeOXOkchLnTDAZWjnJOEctB9CHQvDQAbwmP02acwmHYy/1hxij947pkqicIDEo1rwvBLb5BNs/Lcq3T&#x2B;&#x2B;6ca21KApfG8vv2vA2jfFdJ5YyVLYC/rpjHzPRrSZ2MKW7/Rx7Oe7KEwfurfOnyqWufDvhFTt&#x2B;do43nnoW9h&#x2B;B7i794pu2B&#x2B;iPM6meHVfNJSAE77e55P3yYSSi7lb/5y9QPS7tZ3GCofFYW6E9gDwZAfDMH7p8QalzIM1phZShJB8&#x2B;aVyrYQcpDJLcOK21rNUAMBZhMRrz6QM&#x2B;Dt6BKJ9iaAjnVQIJgB0KEidJXpQyC5kZlabkDJM/cHfTogpRw1WL0tmrFiuAnTenVDXEtkh8cCTghgJQTVrVkvM0jVWJTEGLIgN6gmfPob1SZepszpeRW6tBz1RKGXjPrKDskNbeousJyntVt0kylb&#x2B;IWeEVSVrqK5Ozru3hP/HeoZSy4trZuh808mFWDJAgVXPsMKJX5q&#x2B;MHeoAQeMKhCnUJGw6qvNh9qVo5ABPJ2koMDk2SrDBKUbm&#x2B;oyGm0Q2FG4hjYSWKl1QKrx34zhqPYqE0hDiDFFlBhQyEVU86DBh2S/vpWYcUlQlE6K9XwdAH8tsMvseoAGa/LtHeg18N7HCAVq1msZdg&#x2B;UTEN9OYAe31O4sDiDC3gf7iQ/5eefJy8o3murflRfHefSMHze7C4bqwlhwp/ExA8d2cnCb1VoOBhI3/Z6GvxWBsGxz8vbe8HYeTHi7wVepJZdcAukydZ5TdTa/47tf/00B6Ow6icrebloh2BKEZnht3lT6Aqnmt&#x2B;TcBNgSi3hOSa3vDQPnTMVgnvfS1Ci8g5yRjAhwn/mFYkQUr9ehtc6AIkP4KzjPwNRA8CToKuG8ECiMQIKsGejBS7HXSLCmsmIIshuqLINIFEJrLcXIZEdoAJ8DmrRWmW&#x2B;UiDxraeSodPlsShBEzV9Z5jDlMAwD05Vi2ZMW001azQB7vfdumrQDSeiZNWihKqWKV430GHJpmAUoKfG91Ro0XWlQmJ9zdqL5iKk&#x2B;mWQ&#x2B;0zi6aapVsr5GjS0WZ0jOuAPVFRDpwZgxt7L21Q8zYQhg7qaaWDCsfauWFEwPJnxTj5m9BQ3nVT9MhHOAdKY4g35JYCqKopfYDCoJ6KdXAO4&#x2B;n3vg/jnj&#x2B;hkpRsU//NLfect0josDyH5mFLFPnFCNzkz4TPuHxEZq7vV8BmD94/LiuPw9cleXvtNy7/BlpODxLf3E8t51IJzv88hr8VFP4pIDufnEfdxjeOkDz8pfVaX&#x2B;giK3&#x2B;bV64GF874T3TrmU3Jrh/&#x2B;yvDNpYgB410c2yw8WbYYYQy68/&#x2B;d9R6wHPH3qB&#x2B;wGQ3ernQJn2XGBQSDHCDwC0nbU0b1SaPiz95CwVBbhiGHaOs0IAAHg&#x2B;sGWQra4uAuEd6fSEE4U6viDhgB7jnRT9BZEGiHMchwICvao0VflFGIIsf6&#x2B;RxMMwIGwX/btxTEqdJ9vEaXldYFzvHFQjp2W81GYdW6vIF0RFzrJfMtw1IQSp71apeBB/E3lzwlxPReS4FL6UrEEIiaoU7rokhJ9REqEq&#x2B;EZA7TRNVeI0pOBAztk5h/K6mBv0MWYrgusj63TJQaJ60FrLObFGGGfF3E1E88DxwzB4LXmmE5i8d1F5X9RSSimDUo/IViLuxzb6Yfo0oOvfeSdBR1v773bkZLPN/jfnticWju8NeqxFzNMwk2lbvx89o9ONz7d9ovNTjS/L4jvlA9WGb3QtDqZqv9Nb7RdK9WaH9tHeW94vVWjrIsPJxtAPWQS&#x2B;z1X&#x2B;crlW5q68xBI996bqn&#x2B;V1J7VGTbbTufKqQfOm4u88mTWtgJi46TMrzG9588zQn5Z1GXRpkp87VNttU65ElRRDReshVKLbbIoTA9tN00iXBSEaLet2oBiDnLKG3gK8kljfWstZ6qaBsQNGEOaMZs6kuGmtBQNJoZMIS4Ts9hjGcQQanqZJqxFLVtNoYoVne3aKUKKwOElt9jnnUpCXqXDaXs3/QRMHZYXm0NaiGswxNxqwAa&#x2B;Rdx88n6geFcH9ivqltpcUkG4xxlbLOAwlJ&#x2B;B7OB9yTt6HIgsPi/5c9jiZbKRIDZSU1uVNVk3oRU3ZXHRPee/f3t6SBkYLKIcC4z2CcbG2dHPRoo&#x2B;jsvqsNPDBx&#x2B;Wye80URKeE1ZEqwirSHJ&#x2B;Ny51z/lXrKUzcPah8tNZWtLVdfM86npfZQrof9uldW&#x2B;v3ej7est57ABqODIT35CFHysfKKxitLzzzgvJ518Qa1TZu7EN6Xiebd&#x2B;/BgY&#x2B;B/lU/O/k398yTp2wH7TWewR8g1zKelZMv3A99L5&#x2B;tIGa2bUxm&#x2B;6WxYQQ0f25nF621jx&#x2B;YbZcy1co5hKAxAMs3gCDj4JviEzI0eL5FCUgwNnM1QFbBiFGDhtGhbFfsO6surSIZP5lF5MaAlV5L8Siyq7EB1A1Alalz/aXF24nZYQAHSVuKmuQeSovXulFcikrKPjjlc7BshN8AagaRvRJkfNMQi9nCnVLw3jnXBXLQmRA0CWkUprum8tRMowjYJbHHLYN3qQglLQhAkj3OJcy1CyLrKhQNutXQavE55JxutxtjhQHxp2lCUARCIADTgciL5lOi&#x2B;4g6ABL8J/WHNIkhWSRNgkcI0NzyiIjv4ZnJmnAWN8ao8Qxa6ks0RkyJXXEdrArB0gqMZZcgYPuA8eHpH63N583IJpFGN/ZP8kH/XbO1En88DR5yMOcDI&#x2B;JdObD9U5Vvq5fXwYQ3dz2nHmyu6nnPyZmJXfK68qzO&#x2B;VEX96G7fRu4r2/gdyjSy7fK7II4oO2djBO9s2LHL8/5GX8tdPtq8/nB8mFxwx/Vz994vZvnYunoWz31eZmdk8c30cnnj5eFsDwc1XbZ1boYSC2l2Z7ZWCNc2SyzNnCdiUPZJABtrQFoNmA&#x2B;9S3AcN5aI9Tj3KClxBBqRX4YLUtcZ9cBYLp&#x2B;0CXmWFGyJ3kGxldYlwnEE&#x2B;JHI&#x2B;C7mP&#x2B;D98PtJrz5aTIG1gySD9rTC5FzbrXA&#x2B;AxzteYUEpgrAQaLsOCEmAS7hgDKXq3jMYSk50J1IpukOtUEEIt52zsSvdCmaH1fwGJbPJjwl/b4YRicc1wKXALMXIqFKfWI5h4ibAzHrPxg1ePq4L7KJsKYtBzMECumek4ax1Eu01xgLmlJBBPeoLHCwmvSAN&#x2B;i2UgxdDSMKZTJowbFgBDwfqKNP46x1vrrIdBpDfxr1HiAOG0ze7j5GLe9Yzf7WYPd87b8ze3r3wdY3wpvlAPFxm4&#x2B;1kx2J7mvbp0HcI&#x2B;qPRfu/4vyIebP4yu43nvwpGxq&#x2B;J80sWM5Xpl6T5uF4Ht8dzLXI3DJB8rl02it9Yj/A/ozYTar3Ny1T2BQW5NUOTP8KFJPwLoEsxC1xQ/QjGlfdRIpzVsEgke8VQDixZpQa9bg4KA0FeBpybpTq/e&#x2B;Mmd6rfNk1GReNcKhaJod8TAIghQwXUvJVEhKCcE7NxH/pUSCEPgwYnumc6DWGoKHQT1rACu1CzKdiooSllIIYRwGywVCA01smouy7Elvwjyr8nxoqoeJnZoeOmy1ZObk0ZhdSZ6jdQPo5QgCx6vT3P9Riftq6c90BXROElxTOkma5lotpUhZA6m9IOSfpHmN6LUomkOJy4je6Mcgmp&#x2B;1FKX1J02DiwJ23vtaS5bERI2wXtZE9c8oIdpJC9uVqOmksoYm8wddLnodkqQB3YOw9vkk4l&#x2B;jVXtg92MTFm9a4ruW64E2h16PuJZNqpJVGNZDc3pGOX6MnPCEfBSUv9vPc/rDJf&#x2B;arG&#x2B;zPPNlP1pWNoKNLfemx74Wv9fvB2MvPJ7JQw32jOh3l2u3QV1mPX9QrgyVl3ypPOjxvrt376DWTACA6QpW2Lb8vtda8SA184QCfc5HFiHnNAXuKSX6AwFkOZAi5tmx0ISPPhNp2A&#x2B;QVmtNUP5sV54TmEJt4BAhCEBsSNejRCPgPU4AgJXaArBd0uRFVBiAG0H9Z73hRjpQFh5R0piEWus0jrWUWoWtjgJSeO2DpcM5AESCrZRN0LMkDtLADBjFUXZNA3NjMslzSilpdmsE4FdqLNM05pxBQAIyRogzCTZq4E&#x2B;47lmRNxn5MQTWz0KQAxNo1lots5&#x2B;8IJCgLGsoGzCdTSgwOTbogfz7KlWEIztkVG4IYRrHEEIMHjmdsoqfy6JVQnz2gwUZhqHoBILmPoLCgxUQxj&#x2B;Kpmn9NYzN0nXQ036Z&#x2B;7UHhQcf3Wr8AHvW6z0FYLOZbd9t571u/7R7s1L9DhSAvdM52N5NctX5rq30YDKzyeHukB8KzS/L0yWbsqdL/0X5qDlsvZHmfGJnOtjvZ8Mp11avqY8k1bzAdflq&#x2B;QdP&#x2B;ZPkJVfy&#x2B;DEvW7BEDlxs2fDhp7UToNamJJm5/46DpH/SN2gRjqB5gc4s5TsnIcWfbZk0hUAcYI4p/Cvwk2oa/L/Oc8it1aKlnXgiSaGhXRnOAVb/pozzplpBKWUaxyps&#x2B;9Bau91uSLuJpeC4UYMNsoJ1/Il6xrZ&#x2B;Qik5KJVfShBoOK9S/FNKcywsOf1NPSFxmRyzaMk2Yu7WGlA7HAU0vaNZyYnQHJoDjNpF47CbybnJOAHQYNAe0F&#x2B;SLCl0VtLUbJi3dKOoQRdF0/5AM8mmfERRDw/T7zAvEFcYyhI8IUEDA7AyDPMoGl8RYyileK1BoUpCoFOCaN66F6BqiobmXDVrFUzxtUUWoCpyZCHuHsgZ0Z6wOm&#x2B;ijapR88eHry30x783BzrWRkSl/vLX5XkD4YE74hWg2yUfLgfEtg&#x2B;UL76dDh72TcPeQVcHRu69F1c9/cr6m/IvMPI/yZX078kPte/c/7Jz997hgpWXb1FAjmrU9bWJENCKPQALyh2rW5TFAQrQjC4szJCQWZOkyGKMpKSRWmtREAkLulrcE7lJqDlQFipHg4W&#x2B;iZtClApQ8wEW2zwlSeEftYQwYCXjTZuCV5w7/meKnqKTIyZOmkGIy2VZKFGz7BOk8uy8GuOT8vvpizAaiJjnm&#x2B;JDgHi4MrhoUMaSVk6gPwE5T4vmA4WBH3ga/UMVcc4xJhuhAjypYjC9aB16OOC1uDVKAaHfSyWyyVZzg1gtsZikq3m2youiGFRViDHC2eKVX8RVTSZMvGnGIXoPbFYiehWaqltUmZpyin5Zh84eRN58v8zNlqi0e6j6xstud61r5s9Ng/reJNfzr4chv103FmFvdvWeL9aBrvJoz9eH8x&#x2B;Rl7vQh062cx1sm88f6ccce2595qR&#x2B;&#x2B;x7Lp&#x2B;TQivkzYdklT8lXPcgv98a4I8YkfyjHT5M9662Wiy/vscGxW8AYY5MyXjXGCPuvTNjkDCjK6tZDJDa0Gcp&#x2B;aw2J/LOJUQYEJ&#x2B;IEFQfQnwNxtjRC409gPmzHAkatJ8UQVfRpsS/fwAIKDVumSQWAqO9JqSeA00HgrxrOM7FyRFkx1bXEDK&#x2B;6BBsXZfbTqoX5gxlVNFChChVnTlWJEaknjOMolH1NnKpG90rYDVjLbDxZc4wGDYp1zjk3xRC8d1R4sAhYgaAlljnzWkrQIIckAbuh1goyj9R5QJ1d52qt8AAUDbHIJldPNbmP6JGISriK8zRkwojHUHUiIf1/MmWDizoiyJtCxiSsAMZCRtek0Re4J2cPAAE0H4M9kIql51F7RkrLzNl8K9kv8TuB9UH/dw88b4A/OZlyD9y8/x393d7yC/nWk/&#x2B;Z8twzeOh867eshngaH9&#x2B;p/rvcnlL6PEvzU91eN/8lnZy/JT7n5nkhd9OuLd9&#x2B;PY&#x2B;fO9qq7cZsOT&#x2B;k0Jjqv&#x2B;zcjktMz&#x2B;0w30LIuyCLBjk9u3GrGqcxKKsQAGE3CcAtTnkazQQQt9bgDQD&#x2B;a60Rz4HM03GHxnGURcgZiJaIvDFtkToHYoyMc0CHpQgiZyCBodxkck6KQHYpOJBNvp1xHKXQslQSkNUbh6G1BhUihJCT8NdzzlBPyJIHPabWSpO/94KbQX2BM8RrQQMy3ZE2h2Z7Tt45F7wrJceIPEJzTdzEENtSxnHArdXRaUopkbScnL0JJ8CEGbEA0B80rtqS&#x2B;4t6DHgbIOkQ4hm8907LtHEdSNb3WhlArfiZq4FFQARw1OgCajjURhhaQFcDVsw596vD/W3LZL5nv&#x2B;8a7KHwJ8zbvIoHbe520k9ja2Jthcs3Z7vWi2zj9Tny9xr0H8z8QsaX/DuyvtsfUwmWD&#x2B;&#x2B;680ffOQ8M/aD8/ef6r09gT152YmfkayYvo/Sfrw8d4XUUACP8Ypbt4uJH0GLjC24yBWnQbSkF1m5rxASwhtjXSymZnbDN&#x2B;v1DFjvyjc7uAs0dBGP/HKgwn84cXYkklXnO26Oxp2YLnBKttXEYqlYCJpk&#x2B;Z2kcJecPVIXKaUSlpli8B/t609phXKgY4zgMM4koRkG3KSnwFRgNIC7oSFSIuUKz5kcqpDYxvLWozBcM4DtG2rbBvSHRKChG984BTwfN6J9N&#x2B;vymhJyioQIccRxHKlchRBJpgMJxY7AT55zUHYNVfhyxCOK60fADwfom5T/OPZgMsN57qE9CWDKxE0VTfCKivcz1jBfMq2A8AFGzi4YQoo6SlawVNaUsTgGnTLdG7wFYPTammsZq1&#x2B;bvzWabKPmg/cF89gZdKyT8sdfV3li8ES0/6u4ENrccy4cjg78PNS55pzxyBZ82orcHb5X3DPSMPH4bm9O5r2k3k2Jiq4cPlq9evUsuOZT9yJmjR&#x2B;ADH5DHlPPDwLxNy9r696Z1bwYAgMJLFjEL6/ItYeFED1hNp/YvHm7LD8O3wGICUW3GbJBzZohw1AyV1UTTwkauwK4a1ChQL6fknUOf4gGoFdhX6uyqjR8aQDaRrzSKB60si/SXRW3ePNUm0RELlQlugbakQmWNhBZjtsJxs9pwegjNBlb/WisSECG4eRgG5jmthnNlsSUJM3GZsceE84oLxeb6rKbqAqzmSdtXUJ40VjuaUrtZk6UmUxKYw0Fdod&#x2B;GCgmDkjXmoZKvXzUQWbW&#x2B;RKSOHxKqkbOEZ6g3g86BlOZ6Z4zQgIehKunLuoB&#x2B;rR&#x2B;S1f28AMpl&#x2B;TR2h3SPmd27flQ20XmnJ2w&#x2B;t5v92Mbd47Q&#x2B;kWPZPKkPlM/u/5J/Vt57L72bj/fhck7Nrju/ZzmPwuf3yWO5R20PF&#x2B;K/pJOPtdm/0BO6IR93/9dau6fJfO4XMbvL8fsJKGrPre0mA2Qn6x8Q8m2KArtu0L2XA&#x2B;39yRQX44hF&#x2B;es4KVSfbZp&#x2B;VFN/zoGkqDrclEHUluaM2qU4lyLEtZYSNW8moCeQfUopp9i0bq6i5DnSIJrgAYYBxBiSYuhSSkpiJkYtKqsy0V9hdQAL8wiac06gBnWXgLlr6EJB10kjlXPOzokxnrR4qEPeu1rrNI3KCJpDaaFjRJWiToOsMRsSw6uxHEKhUfqQ2ObF3J54CXLOVesGgNzVNOxYvRolaQbPpimb6AooytKRpS6FiUEnTfQJ9QklyWbKkGb/pC6BkwXFKOc8DANdDdBqKguBdS&#x2B;UNSi3vzd17r1j1806IH7wQT3zmrt7eN4JUTgecU8Xsj/2Znes/Bwv9d7QDzX4SnmluVzysJyBs2wz33gvcdWPXIXrZve7Oz6ptR5ix32JBbnkU&#x2B;Wlbv6Xka9ejYVy3tf0vf/pvPO1zXnJBTCpYGwKy&#x2B;XHPVtQ21qLIZSSOUO&#x2B;oIik0Q9T&#x2B;LdZP9HUQyCTmMw5UfUNALugKTWxqYkTo4pvAfHKaqsNZtymJQhYcqvqEGVJhVr4N2ptrd1uN&#x2B;vHWBRKA5keaobW5KIHgDHQMK4XqREmpXOhz8A&#x2B;naXAMHLnx6SaCnwXDAu2VHtOm7pBUdBclpWwdHFm7wERc9D0PqisXDThJusDJMnhMzsTSinI9YnAj1oLNKJowrirMmiqcrQaozhEqxF1JWkp36R&#x2B;ibpMSwo&#x2B;EulAwj5SSz8vVtS0s1VzJVmWEVlkuAQxRo0B2IlPVa20bv6/bnlSrBthA16odKrCOVvg8w73A5j&#x2B;kBwv1PlpvBTQv&#x2B;TFpZYfe7fYzzazcNjd8/8fMNanLOP1LH&#x2B;QXMv4DeXJm//oqL2vfKcS0KxOo/vu4YY4UEpvNLTP70yKVgpD155/4gfweimSp0W6M8ORaWxBEcz29DlUVRt4mknq7M5p721vsNYD&#x2B;zIdTVZI2qzKkTMI9KXkcRiocqSUvHMxhC4NUVMmjOgPasUn2EVFZKQiBXCPmtW0qI/ClkaGUKWpWhAgC7c&#x2B;wtStSz2z7aNmGs1aaxm4P2qKzCoZn3IAoUhDe6kgxRjHccxZ9AEWFMs50cMAQI8lItkm65pI3h4px4sFKZZNVGttraqLQzQuXL6sBdGwOOAmEbVnVf9M5IDTNUlUDHBx6bLgjdFam6YJXKOmWWtxyvAY4KL8OkDYAmH3gcUmQD82onP77gNsDje/N4brZK2r7J3XwaBrs&#x2B;KZL/eBq&#x2B;Hg8AsT/Ej5Xpf1nbP9WA38uNszo5zl3ux44U7OnN/jS364fKtn&#x2B;SfI4wv&#x2B;kIef&#x2B;sCjo7TdF06HNBZBw9JAo4E3LYx1xalmPd22WdRM2fyzRV&#x2B;J9TPoNAoJ43ST0n5ke06kwXA&#x2B;gLkdeSFLQHDOmnW0KOsFB5aSOaVaJTQZVmpeHaW1pJwzIy5qKc5NWTL6S4KglGKxlJsYsxJ7AHORBrRpzDFQfs6SMZNxvUWDpGFlJzRvraUYEeBB1SJpZWLyZ7BEyK5DrQldNa123DTmG2daiiRKQlYorQwA1J6zCUfWU5MLTY0Ldd&#x2B;KBCtrQV8NtuaaA/Q3TbpKnYRm/hB8CMFrIiByllBboJQCNlEIcVEIzKLeA2S/vOM7VswRRt9sz6HXD9h63HXn9vbda4MtfJbOdLvefqy33D386&#x2B;V7IdFLrHzStTt59z6H4B98NB4e4p16RdkyDS6ntEvpe3bM91/E6xH&#x2B;PrK4T77wwt25P3/4LXReATh452gGHpspSMzknYG/0/wtr6MtrZBWitbK7dqQ2DNvVMo4UN/i4hqnwRpowaQNYF7UDMyA4Ki5iWg89kqnaa3BBG7tIBPTiYpJeqZCzZhN9YGcUlOuP1GWRCTHUEupBcqDwySLZtdp6kzAlJDsn6QpgHv&#x2B;b0zstdbZph6CV49Ktli5KK8JqJo0/aKcGRxER4pcIwQJaIqkrHHD/FPjBzzmDD2HV5&#x2B;Jg2iqR1YlqD1BYzA0uEDiho0ak5ljVAOyl8UE9NRCCKyHgFNAn9xLbSGrtjaXsFAdZg4CbluwGFu7&#x2B;7gdQucDlCw&#x2B;oGUPe2D9zqy25mOfjc2PfdfgjAKwOZPjKV1yyc&#x2B;QV7rDH53JY4/2M7Lx4npXLNMl9&#x2B;VaxvPyyWt19pZ&#x2B;dBr32r/HCrAXpNtt3KRD77k6LR1ohhkKMErOe65CtUkrqEAzYDQY8qOk9Wytr5ImvgUTFlw0rtS&#x2B;hYDOx2GAIgEjdzPZjbTawMza52p4lrMVzoxINBC/aZWVlBJS7LPmQNTSvA3VdoXLHgG9wJmJOplFUlRl8AOeikFdCetEtJwS&#x2B;i3LsNqo9ZVJ1GHFZZ5mjBHR1U1Nw0n7b5rKsylK5pWFQBuB94BJ&#x2B;jmcmyb4WniJsavNgdSJtXvJ70fkdykFDgcqRfAkYCysBkoHpJSgOySdHhlKqrSI5wRqQ9DcpuRHYd1&#x2B;EdGWsg3ls7LW7BVq&#x2B;49iVdnca3vYxPrrLQe9sZ&#x2B;6pMHt9bO3a7Pbg666LZu6zZlpdHrIJZc8Kvz8nG25L49y2C655JJLnpNPerEcuRYPR8wmWefWoRtG/RX1v9BMXqRWV6y1WABTTHQvx81apIyHQ2j6zTkTrRLFEk0yzwznSQKMjZgClrPZLaOm&#x2B;hFjvPJqmEeyCEtHMnIWLezV1NrNPr331kGxtMxmuAjQvNYSQ2im1HHHZsG4SdMlKUYSG/&#x2B;8YrpETYJ3NcFREHoMs&#x2B;w3uCNKyTnxQiQNOwZpnkHAnDmz/dCUPo0jkvfDnF80UxP59HDyxBiDVt2izyGbms0pRpYOgCeBzhPm/seodCyIBqVaAd0RQTMIIZCgmEIBTeu&#x2B;pSVDjGXLMLdf6wtmt5iruAFVu&#x2B;tt27fVM9Pr2feUhK7xusOTW457u9v&#x2B;wFnB7Qe77k7mvDy0Ypdcciyf9gG&#x2B;btFLfpC87v38shP7ajkP&#x2B;u9&#x2B;zVdHbzMaOnR0Xra6mtk1tgGxY82ZBYaDqRjAxsge01qLUQBoM9W&#x2B;mmL67oxAtmmtpZldIwOx2jEN&#x2B;VFp621ORVolHkARdjFJjch3r6YkLZG0MnZmk3zRDJi08dP0jDBia7kncksmkX/wvtXq3NSsV0SLAHCS3pQKzgs1LBHEs30wwRii/6jDQZk8nowj0ISKZuckfR8xt7DEV/UtkO/EnpHfsyg9CVPVBD4upWTLjaHSWVMFidpm0toCQPncGDSMQblAtdYKtW0RA9DdIvZPvWr1&#x2B;BHaRNXdTb&#x2B;pLdiNnSXS9nYe8ath9I6T4VPlpI6xedQl/44ceJxeTd5zcx6/Fj5jRHP49Uw9KteKfZi8el2IT/nifO39cxLQ70CRskMfWOPytYtgvUVThW4FBB8KWN1oNoPpnv8jdHD8iZSjrc25fSybf3kKokUQuMcQ7GWyA83m&#x2B;RjVsC3sGsTpEgqSLs/AXOXDJEYgLCYjLCeNAzauAC4REwHBQt8MFs9a2rap2tA0LxNVpibaRbKh0kEs&#x2B;iUpEAf3hvZygGaMm2L0zlVD6yLDB3PzXso5WyYP6EDFBCpQWaLawPVprSFFj11qmPkxEPYilAJqRtDqb9nknGWHNlQAEnRxilZLSMqkAq1oHMdfvOqbd&#x2B;ee7tspA5uHH&#x2B;9tJwgw0BMXd8ZSA7GyeXh37KLnLXfHc/Kew78R&#x2B;Lvk78qX3SrvHOh5yP6gS/CRjj8Mjlz6&#x2B;SVfId1tdt11D8pz1re7HS6xdWepNJbNnbgC28Oacrk55yqsnjn1JAWYz00TFRj7o2g5qqbQ2eo5VrchcRzYvJaCNDLLsSSBDPEravRibtaSS9C8PNm5QNWcs1Jt3nAJNMM5r&#x2B;rxaMpXIR8mxsiVp2Gbw8mIGskAiaZgcCGUV3s/0XMMIWuGU/SPBUzGlC4AuBRY0IsSgXhIKSVQxYoRtnwqAPM6q7ujSiHmVEsBYcxmTEopTdNE3g6QfdZY5CoBGPOWJuENiapF0r1UY5rxL82FwDYN82ux9&#x2B;ga4u&#x2B;B/j0sftcoeIBFNgG9XOOdKAXbjLda1/JAb/nYb/9eb2dGuVDIJWvZuys&#x2B;SnM4Zcj8mjtzf5S163Lr6G/9&#x2B;Lz65Pfsqd9HDlb4YxZ/RoSfeyu&#x2B;1K3y3sl88WN7/No8iDk8PtDuJaX&#x2B;WICVm8HHXeAsu7XMkPVsl6SXrJ37tiUSOKskex1l7oE88sVRyy0gstfloGwTTSkuy2tvSB9USy2ZNKSibKKm3gY4Jarm8AFKRj0ykuBps7f4EGb1YphRaNYWcRfJomJgb6gNDOHlnHEU8ywxkes0TdA4GN6AacvSEYXWWhn6HEJTzccie1y7YlSX1lqdiVJzhbKk7emdkIUNVEUyfRG/rL5lhSff6QbtECKvN3YeA2uw39YQSr&#x2B;RPXDjXZN/N/pDYjvfU1SOh36n7eHu8p458J3yzRHSJZ94BZ/r&#x2B;Z3z&#x2B;cDT2XonXHf758hH34TXe&#x2B;md8mVexNOFMh6/oF/1ZrMQf33j5aXR/UAfaJp4h2LM5GsnQNlotuwc3BWl3Mx0&#x2B;WIM4eiM/XRnUW3SlCUJJ2o0Ldc5avUAINRmMeESiXUDEV7DEF5NDS8sCJolk94HG2FZr0oHyibtT9XKXM1EA2etd8tDisRA11prXjJkmhQHCIyCUJbOQhmjiR1o2zlX1YQfQ4AOgOhbnnhShQQjJ5PFqJjCbTgd4kzuTUnIP3mRzCeAu2WBdNN4hmYCPOjwwRY6T6yvIKgUDUFepAEtK1Wp7Ui3a9Pq1qFn28aeeTt8K52E4N3eTX3muEF3Imc6OTOx9mClkksu&#x2B;YvylwHWORbiuwf5h0DkZ57sP7SMrywnLvE/dKWe8D698wNtX1APjS4oqD&#x2B;k0qzbWeu7eVa1c3cW0mbyYNrOSZ1vhgEiJnmtaUUXARnt5jQXc5g0vb1zbpFrKKeO75Q1Oyc7YT1gO2eectbKxCmlzKrGGu0qOUxTUuKQrKH1PECFUC9BlLxDughafisZbWQuaVyMH6CYsOZiuEkIkq61hiCpV4HRYfsn4kfPAOXWVxA0aqLNmlhlbS8bFRBMfAUXhOEQdEp0UR8w&#x2B;yOsmdcaRcGaJj7iSs6VgNcfWmvJ3nOsb/65Vh72gPWeAnCgSDwqm2r93lmfH6Kb4ZlJPjr/L7PWXHLJu2SHGvTXofarB1&#x2B;&#x2B;X/72Cv&#x2B;r8tiyf/iDsOrwug2elM9&#x2B;RdDKubFrPwaAjJS1aITxfQvmelzLbqdROWvIaSMKVwt01chaSEoRSHqaxlYrMta7acxa1SsG34wiQdZKY2YezUJj&#x2B;fSYDXA5TjxJObAZVjFUl0CZiYbW68MI6aoxBpZ53xiTPbPwS0Rks6J/W7KNDgdWJ6BuYP0zWWulMe6CgF5dB5LynzZ&#x2B;HMsg6QWOr1XYO5ptiVgfwcGYXjYpQamukC/UlBrE&#x2B;wF9IuYApKNfzWh1m1i/2zj7WeTabN2I95SKY1mj/w5eb2oXdobHfd79Uzbenegll3x3&#x2B;VQE&#x2B;REsuEsu&#x2B;Wy5gwL/dljLvyavYPnqLYOPTMmwawQgbp5Rt3GhD6yslrQidwLiuz1807hZV0RuMcZvWGZrM5pAN1u6Hbrp5Z0qCrOJOucGOG4UmKoBtd2ZrqZawOtBMhxwbNoyi4zNFsOsl/a81r4CBmDUUhjQzI3E0DHG1ubeioHUVWF60tMMkpSpMdCZBzIwAAqJbhd9IJssnzI9jRtGXtHWqiYyksJcJOzAls91Q9RB1bIAReO2i8YnVJODVQqBrYF1OUzRswnE2zu8aXvT2JQ9f8LmJO928gTa2PQqrNv8dRzz1ydwyevImc/q594w6Lwb4hNGPHkWL/p0nJ/Vt&#x2B;d&#x2B;vPj0jqVHVH9PvvUyvq50oPbu64LGXfzJ28PyeT48Pr4oIvRqeCZS7yYGE3tTyMnD2WyN7JspmNV2VoC08qb1tqz5HIQWGrlryZbgRCt112dVs7cNVOB85gmzuIHpJ&#x2B;d8u91aa865qhkzhYNUa2tzas6m5Qt4Xlb9KCZEGIGzKCVmmVTNOCJyztM0ZRMtzSQ/TVE4bhCrjMErAqxYcvbO0cNQSsm5sIZA0dhfMHnkEFNNDNoC8b29CtCImLOoGuXh10KL2iLw8Ji11XzPEr/Ybs72LljfUf52/9zsZNuc/6Dn4fygmx09McoXyOcN/aJY6pIvF/uwHBsRnpMPcdlft&#x2B;t7ZO2hveSfkPP82FdRjb5IOmv6mYcC3PG2emHePXATpu8eWOv6kA5wE4WLIXkZr7w5kM0F1JXXxQ9oAk3pKOt5zqgS34itFVNQG9gnqfksccWk/m32NghAZ&#x2B;qkbnRCzdbaNE0I6hWakCYUajORZq4jhpILthNbCk0h&#x2B;5z1XyF6waya6glQIcC5YuJOhm1gV9bEQdK/dsQIAf2t65ASGEpZCVd2uaBFVCV0wcuRUwrezwrAlpOoUFHosPXmj80Pw/phuPt0nHdE3D38eOPB9oc6f49cX9D3yLV6310&#x2B;8gquzBafNdAHy8tO7MfJ694DnXyXeX6wvPBD2trS&#x2B;mDfMOeJD9ZIv7FrH6XUWldlB2aqz54CANiYYowh2HjWdfrOtTBBJ&#x2B;FvfxZKTKK13sYY6AQyDfN7rH2Zkkn32QytqPMSMB0QreRAz1wTrjAN8LTlg0A/Q1PD1M8pSSEwY8WepolBw1xwzof9A1gnSeQ/XxTGFtcqGUJxOapRGKDMsCQCvQEhBPh2Qggg/VetD8BixlkDKsgg4tB1mUqIzCLqD1VZQBuVgDcvz0krOHWGzb19dYwdS9KesrHdZ50pa3t7D8Y67v/F30cfJf/IaV7yNfKxt9OZN8/JEU9P7HocPl0edqs&#x2B;JT/8zXbm7F5yBWoVsPtSF&#x2B;j9k&#x2B;nu6o6Gfix5B5SvtxuotwF7bJoTY6ffZCmXro2dZxcLa/qfK86ClL/Xf86Z6Nn2AwibDUOG0bHjOHZTYtBwMUJyjprthVnEA2FxB6imKb3WwlPW0GSh1hCsF6MV2PBZGvvRwObsZ7ohyc&#x2B;ToinvUGndT5r4n50UDXcWbUcJS3JkKSlFTdk5V0SekxdpZAVRPi9i0rIDRasTcFAhZcmC519lBcpp9W9Lan53FdfulU0Gzt6fstYrt8OmPAffuZprjeKMdvGQJ&#x2B;GSSy55HdlzK//Dcq3GJSKf&#x2B;BX7Nx6652IdgeQ6k3bX4ODY1gS78E/8XlcTW8chzP0sI5INZ92w0kshXcQi&#x2B;LVYho&#x2B;EInhfNN6UQatFef8MhFXcv8hG2hSyN0PBJ&#x2B;c&#x2B;z7WNhTff2mzvbwrBixBpVBPA4UqFkhVTJgw9IZYvBFxqgXWtxVL/SymtIdm/JDmFIT9L8iLB2YTE6k8YizpMim6PIcYY7BoidAGrBzVjmqY6xwfPbCuj7YgqFed0rsmW/rWQnkUAMIFfd98FVAn4e93CNuaPM&#x2B;qvdVt0G9cKRne27HzX4XBEQzrrXjipBlyKwSXfRV7tXt2g9b/YDC85J9dV25ODlbkW7d&#x2B;VDk1ZODtvNOjQml9p/l9Dsg0FYAW08pKdT2qNEHVW&#x2B;gmDBDZHbPysbLE8LMTn76yJhvD&#x2B;775Ks8nf1AluCixh4bZp8mnh5ijkL1ngXutshG&#x2B;tgYivu&#x2B;Y0mk29K1lrKWRTjEwPET2nS75pMS2jk7mRZbnYhhb6vKxmUJbRuWAooU3H&#x2B;ZH2OduqcNVUJkZ7lngrqkqllH51l9Oa/Nfm/7UcI&#x2B;kOrK&#x2B;Psmfb/bh7yEOCEznjbTge69XA0yWXHMpH3q4nb/4PfEY&#x2B;qCtrofi3whO/pXz5O/Y9t9n1RfhY&#x2B;acCiAmp636OoE2ez7plj230tlwjRbZXW/XSJ2AqcNmN3Y89AZLd29vBaFYEY3ED2vLtWVuzvZ15a63kOSsoZZ2zqFsBxvW21qc6LaWkGJnrk36GpFWBOZypbrYZGTI7EGwyUBs3zPjdpl4R&#x2B;BTAGpqmEZi1Kl8/pdTaPLRxpMzVG9ocUjxHUHjvGYUcTCxHjFEUgDWvZk2e6Yg0B7T7A5P8nl3/IYv&#x2B;o/KQwX69FA/1/IPlpPp0ySWXfLXsvjP/wWf2Jd/J3/lCnP/MXd&#x2B;I52T9nHYwepMW0YRGEg60prWJVpn9fR2ArpkFeNxIFH6sCXTdUgmhQR0nSOTKs4MlnqGu3Vg2EPl48tWUMCOUTynFGLDUXcBDa60uPSpd5&#x2B;T2sGdrxQe8brKq8/aOt9Jaq7V475OWAqhqoWezaiIBkuEUNc1Z1BQkd4G/zegVTXQt11orpWLgpu6XYRj4vVgEAe/pTNTMugbWlXOgM&#x2B;zJnvdg76j1HDhoWcYtYEt5BMo/1/JR&#x2B;TEKw085j0u&#x2B;SH7Mnf/aci3yj5dveon//rTXmK&#x2B;Th95Rx5h7k9vzUOcWPnbqwRNOkjWcnXcJipuZNh24t8tid4VVXqCcF&#x2B;b/DcPrti9iVkU6FIdD9gHhYiyDyJG7M89QcDUuFIxxHBFOMCfcNKfTZjqQ&#x2B;GckjU8tpRSa25lNqMheScNfTIyrxbpljkuWQsWIRmAFZUQdMHbCzgFBwLVWBH7Qe8AZMnCZkQloM01TCEEyHUnnec4CtFZ6Oqy/aUTftOjz7l/ewdt2/WoSr9pOOIEDh0DX/mDXgaZ4yXm5Fu2Su/JO9911j/09eefKv9SF25/M69xgHzqTf8DVs&#x2B;&#x2B;0/0y3w56Z8m77u5JXGfcPkDdFoXafUvO5uGQK8WtrDUl1Hu3BMvXnbmPcLCzA/tVcPdPibU7PpjG40CvGceRTY3k1a43Luhp4gmgZDXSe58NiYQKdc5vVidKWbHarLUCrJP4uWpkL0N0SfuyB7A2DFq1WttA31JyPR9vkP8022IA/bNofTDhpAqKisQrKOKrjOLZWaym/eNkOSDjr9W0GoHPFO5Vg3cmmFrHeop6gDeWp7T/tsnfZ7cJdsHnYJZdccskl75CfobZ99Fl88Zr8hEvwCvJqLCbivE2Iv7bAHvypG0&#x2B;pCjPb57BoQFUaumDZ5TytS0Fg63JvZ/9NKVV1COQlO1&#x2B;GU2N0XpYT3qyP1tTSb7cQf&#x2B;cU7cZmgC6s7NYhALpOrUj&#x2B;s8g&#x2B;xEBkLgi4N3TjANPC&#x2B;h5QMyGlonlL4anImr4TPUg61Cy7krRPVcuEZXVH2MmPw1BNRISNaXZuossCvcEnMKcBPVAAuH0zsU&#x2B;Hth99fs7Y&#x2B;PcOfOKoh/p56FzY&#x2B;J26&#x2B;CWvI6/2MXgZefTRu9DJz5aT13en2bve5D/JcfED5XqFfr3cXfNNzNMBbmsjX7cHbLWBsBYNb/bZlhHJ3S5rxl4XXFPTe2gsI6AWZ5nhiuvBA6FRJA38nabJzmGtP1gVJanN/kD7AnAHPEZifktsWZNcYozOOQYA1KUWAR0pqmeAA1HzYQlhq67wfyo8zBREr0KtlXs5pV/zAHoynUpw4AJb73o/AeBuyzNdPa0bbCo2z8n14rvkdeTLbbTbFoR7B/1wNPZX3gnXi&#x2B;gvy0ff9j/D39LJDzipDuc9JJ/KYupg8fmlLls2&#x2B;G5XpXX/hN2TjoLNsWhBtiEQHQ3EEo2YRMjOra50AKJkmNvbKphYmf0zB6mWOWq5GV0la9Z/Ox&#x2B;y7YtJy1OUss&#x2B;ZQIuIys8hOocqZeH3Wo2xmJ79c5Raivce0&#x2B;BaaQ6iqGW/5mJh7K3kZSEwq7XsXkPjCjiG&#x2B;3aZ2G7vCdlSMY9CvO/2cEaRePSlczClS36MXNf0nfKViPO6WA/Jl&#x2B;dY/MCrc6qrk/SGz5FvfCs&#x2B;&#x2B;hxtWQP/pp752e8B2/973m9f8G7c5Lh3wuyTD/UJ0dQ9fSEq7pWMk0vqf16Z1SEzGNUffVJ/3Fd1xuhVefzNqAd88Nep9IWEo8wiVgFrJgCaM6y12oRdvO6EzkXy9qSypUphYijg1XlRKCF4gk8x5OdMcG&#x2B;PsgZ&#x2B;4HXvveT2ybnmzJW0MRWy1LUibCDnvDYxcPK7WYCsRsLp8vfB87bpFrh7VNt6hr&#x2B;AS/N3zWPvH/0CQJd8irzvvvrxt&#x2B;WPP8HPk1cPVz1hXbrkks&#x2B;WsrQ9dyKAb0WV2e6ESSpNbzNSNNLFJT&#x2B;kJHRHof&#x2B;DHta7bHBt73BYxgnwz7Vf4tgEYAF97zeoVTZWKhXbKW02TyTnHGNwznV6EeMccp/ttDdYW62mbFVvoLehaImxZhhBrS1ylW4yrNoqj9OvDpevkfomcD9P/jm4kN1GO/Sj5vxj&#x2B;dTX94/0sF8fvK&#x2B;Xf3PN3/n4/Minr/1lS/a3k&#x2B;WD8yHP0V9&#x2B;GD8mLO1L5F98a/1s2dQ6NpP8tOWbKhuGiRVi/Q70p2V7msC7AF/LkuefdpRdS/EWo5sHWqpMaw3YPRsVopiA45l3ZOIBJDw3525jay1o2V1u1BScNefsvae2U0qBqb7W2ubI4TnyO4aQc04xQH/bDGsupSAtUtECwNgeY1yfuF2NX20ZALDpBFit6jY6p5egvwz7jc&#x2B;Qec7L&#x2B;d5eHGx90vRe/KwveY&#x2B;8umH1kg&#x2B;WT3iWf8b74Z1n8TMW4WvloS/L0zrM9YrrZJuE85TZ/olBrTxE1lin99lknncDbfoHLJuIRn36MdZkets4hMARtWaWJCmyOsniQANfY4wg9COid/ME6WYR1WKZRKfWymAAUI&#x2B;oSCAWoO04YWpFqp/ZO4GsQRwXSkIx4dRFHREcAv//2mQybYr1XKwN/5v9rL0HB7j/s&#x2B;Vbw9&#x2B;HJv&#x2B;tz/SSM3Jd4n9brqv/ofJST9PnT&#x2B;bDkfQ7O3ydt9lXzqR&#x2B;qJcPGXL25C6ZZy&#x2B;N5rqTrmVeIubWoWdT41Y2rrwB3bHWjtyh55T6SW7awq1WYC&#x2B;onapF/5acA4v&#x2B;&#x2B;tw7ClCtFejfkm268IPOaWChL7aAvaOFiksHoesWmaeUYllGdhHIVtKAgozGdvJrItCvTURuOTmbC73YvsUC2oP&#x2B;m2PdNQm8nt/zkkv&#x2B;dTmT9uGSL5ZXt5K&#x2B;DNS75AnZw8dfHlz&#x2B;gGyzjr/Du2vTrB60INTfkk6XOGP73yQFcaP5sajsa/0bFkzvgdKDjZttbP/kGlkbuXLSe2guYdZaZmszOX6XqAfMHPRl8yBZLaiYc0QxY0s9isvI6aKliJtWBW62NsJSZ&#x2B;gcLKUUFH5u8AB0bo7uGbcH3317fwbf5m48wOvYD36YvM7Cvs5MLrnkkn9DrnfOd5dvFErx6bKppD2xDlq79yjA9yE5mAPjaJtBwD1kJa5VZsum5RrZNi1tphuLRnrUHp63L1NnNoJh9SQUE7Rg837SmUBa0Zom03kJcF5RSxZwF0G8maRchWwiEHAg9BnvPWoBd7quVdhijBtZgNZhAOvfm0LvxmY/d3H8yXvxeitfcslfl5&#x2B;nkr2yFfOSjxfcwD&#x2B;KjPrqj&#x2B;Q/CLutHBjLvyDh4XNyN53oGe7QXgDxGVk7CiiWwyNttgp7db2BTQSkbuOJ&#x2B;/75kCp27Sqj2acY6N0OUc3rRYFxvwLFpAq1qsXaQdGthg2SRsADyVGMq7YJSXGyea48MJ/pr7bC/er42Da0n7Hx7x3bOSP4/&#x2B;ZwXVdLdWKz7SVfJz8P/11yySVfIx/19ngX3&#x2B;kr32CfO5bp/PUIYOev9St8U17NCvCPq0wUqWa1QvybfzZD8bIUnTPSZRyyg27OqtuyhNqxmTuq1hJjlHydBgCLN0O35Jyr0Xmoz/A3k/zgWGQQwt51/QGoB7XWGCPn1oxK9mtt47dwfP6xuVg7tP72N27cV3h9XHLJF8hL3OqvMId/Wz7nNqg7v19O3v&#x2B;J&#x2B;dgFfAXsaM7oPlt3f89u7pSXlr&#x2B;k/HzSEj1wc77jNj4g9B/g5rV9PS6z8TwxdCfnT59Ydm/C3fYDQ3YzpBpu2by&#x2B;HLQai/Y80DJcmNPrAga6ni2sbzvB1vxhAwm6rrqBjk9k9gBsyqZpf/3/gRw8HnVZZWxzxAN5CRh0ySU/Tq4n61&#x2B;XV7gBvmAOr2cvf3GppgLRK8u3mGQn30nXWspJxH&#x2B;gUUDnJFnliPZTcluGBZ8R4d&#x2B;veitLe//etG36oE7ZYE3lnPNaL0LBYKBcHCIUHYPmGVPRlnEObFZWDgE7t6bxBl2o9FrrKKXE4FtrqBiAmfxahv/2tv&#x2B;7EbfHjKAPRBLPKQnvGeWSS36SXPf2K8l1LS55r5y33L2EfO2UHtMBPiF5yUfK/kw&#x2B;Q2347ICEu/1vRehu6BiPzvPRcedMO/rnAfUI9Ju7QwPTz4lKl4mD&#x2B;HuzTnM3N6b7xJYQApJ&#x2B;EvTPRcU0qKDzbKSUfnX9Ht/0G9Qg8&#x2B;O5e/HkiK8vXznVb7Qsl1xyySVruV5iHyOfv4zf1zj9jeR8ZtKnH5wz9cXvmvMP5rmJWZ&#x2B;4ebIpIHAwkGG675J/NnfZjZuxtifF1ibTnpM1ve8F8palG8H6FmyQbjZZRIvJ&#x2B;5lzhs&#x2B;kmLIJDCNeayndPK0f79fJm4kOgZPXeC&#x2B;u96Hh3infzEByT6638CWX/AB5Pz/hO76&#x2B;vki&#x2B;eGWeG&#x2B;7EUe/h1j4x3KfIJ3/EX7bnS75AQGKhZ6AD0&#x2B;1B/4BFz6Wr/tta2ypblh&#x2B;sh0Aob2C9MHMOaDUz5DbYmwpDzrk1U/9rOUlVQjbiOrDde78oBHYmmc8eFeeAMvSeJ&#x2B;1CvZdc8vVyfR0v2ZOde&#x2B;O6YT5UPvoB/I60&#x2B;PYa0ShfKV8JeM7bvD&#x2B;cFPR0DYG8c&#x2B;A62731D5zMBdSxZewhKcX1pbEZdZaN&#x2B;0kSka/jBDhi915dZCJa1RVen44EIqfEaAd26LV4XF2NsqAAlVIWOSC2sH4H9L8y/8&#x2B;/AEr&#x2B;hXO85MXkuuW&#x2B;pbznXfHMsedDZr/pS&#x2B;ybTvt9sggC/J5KwjeWnWfqGcD9mRHte/k3X1As&#x2B;L4720Uh3p0Q4c3eTqoT/F0NV6eZIGaUB163J2mnFK0obNSMLv3xXH1sqSRYZ4iNY26mwtqvrIlO38PYOSOfTf65fAV/Xa5LcEkvPwJUfdaN/fmL85qQ7meYOc5WIXjfyW7fey&#x2B;/gJ96iR&#x2B;CoT/jZvtGcqY02Bnp7OiCWU&#x2B;4Ds602T7wwcxCm4dsYvR1g64g1/4ofcVlEofsNNYW&#x2B;ZzzJvmnkz4ImLKnD9jtH/Vd/NfSgH7fmV9yySWfJ4&#x2B;&#x2B;GZ57k/wlRf1TXnpHK/CDXrNqpHvqwr08Bff6IP7j8jQjaC13o37Py&#x2B;asDtSbM0lFmwYKW4eAZfXwGd8MZujS&#x2B;DRTZKCz8XeKgY7SFxWeFYA9Vg/DI04m/l/LO18iX/x2eP8r73qdXXLJvyvfILv8zgvqy2d&#x2B;/1X5nd&#x2B;l73K/fJ8Tv753lxzLR/kEPlyYxf9AWL73jNhH/lgVARY/RptdD0jcaW38y6DerRIBqx5KKaAMSR2AjXNQ6TYezOyMvJRp/9EhLnLLJZdc8oy80nvvQ&#x2B;Qr5/nYi/cbqF5Pyvk1n5P9/dzVeE25QALl&#x2B;y7FGuvbLWlLk7mLjdcPLz0A6&#x2B;3dn2vWvsX9SL5v1ABxAtjiAOzNVhzD/977bQVg88935vM5Ly/4IXzBKf1s&#x2B;b4L/n1nfskT8nmRuP/AjfRVJ3gHCv/4df4sOcB5aybDZ8inhrgoirpuj78gH0IK2iwfdlJq3U4ctC4&#x2B;cJAz9HBuEgTcbZ8jepcM/r1gg7tDFFMJeN1AFIB3foqeCPD9i&#x2B;Hk/8CX9ZJLnpHva7m55PXlevH&#x2B;Zfnb6//Q62W3FNT7zuI1w&#x2B;K/rzwdcfupsgcvn5gtuzqG9Qf39oGqsCc2g&#x2B;fsBFD/w2Y/jC2uyzCA4&#x2B;xGv7qt1rnQ/bg75VPNPl&#x2B;&#x2B;7DPzlWjp&#x2B;nZecsklHyA/601yqawPySb8vTBxe8eN9C/cgWdKCH&#x2B;sfEjYwENuhPPugi4faLc4eauOGHdtVso6M&#x2B;j6Id2qQ3zqMjFgYPYAdLvvHn9mmOfkuYxAZ3r7qD7/lnzfmV/ysfL1H&#x2B;x/4SP3wfLzntbXS9B88Ep8btDXh8Jf9iReIQTfWr7pG/sD0wF9xhymacIPagsdR39TzuDyTS/BQ5UHugPxp&#x2B;X9ty3l5P8DFHa9SLhio&#x2B;UAAAAASUVORK5CYII=" />
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>